PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, CK; Yang, CY; Jeng, YM; Chen, CL; Wu, HH; Chang, YC; Ma, C; Kuo, WH; Chang, KJ; Shew, JY; Lee, WH				Huang, C-K; Yang, C-Y; Jeng, Y-M; Chen, C-L; Wu, H-H; Chang, Y-C; Ma, C.; Kuo, W-H; Chang, K-J; Shew, J-Y; Lee, W-H			Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-kappa B-mediated antiapoptotic pathway	ONCOGENE			English	Article						antiapoptosis; autocrine; IL-17RB; NF-kappa B; tumorigenesis	CYTOKINE RECEPTOR; TUMOR-DEVELOPMENT; PROSTATE-CANCER; IL-17; EXPRESSION; IDENTIFICATION; GROWTH; TRASTUZUMAB; METASTASIS; APOPTOSIS	Gain of function of membrane receptor was a good strategy exploited by cancer cells to benefit own growth and survival. Overexpression of HER2 has been found to serve as a target for developing trastuzumab to treat 20-25% of breast cancer. However, little or none of the other membrane receptor was found to be useful as a potential target for breast cancer treatment since then. Here, we showed that amplified signaling of interleukin-17 receptor B (IL-17RB) and its ligand IL-17B promoted tumorigenicity in breast cancer cells and impeded acinus formation in immortalized normal mammary epithelial cells. External signal transmitted through IL-17RB activated nuclear factor-kappa B to upregulate antiapoptotic factor Bcl-2 and induced etoposide resistance. Elevated expression of IL-17RB had a stronger correlation with poor prognosis than HER2 in breast cancer patients. Interestingly, breast cancer patients with high expression of IL-17RB and HER2 had the shortest survival rate. Depletion of IL-17RB in trastuzumab-resistant breast cancer cells significantly reduced their tumorigenic activity, suggesting that IL-17RB and HER2 have an independent role in breast carcinogenesis. Furthermore, treatment with antibodies specifically against IL-17RB or IL-17B effectively attenuated tumorigenicity of breast cancer cells. These results suggest that the amplified IL-17RB/IL-17B signaling pathways may serve as a therapeutic target for developing treatment to manage IL-17RB-associated breast cancer.	[Huang, C-K; Shew, J-Y; Lee, W-H] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10764, Taiwan; [Huang, C-K; Yang, C-Y; Chen, C-L; Wu, H-H; Chang, Y-C; Ma, C.; Shew, J-Y; Lee, W-H] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Jeng, Y-M] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Kuo, W-H; Chang, K-J] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chang, K-J] Cheng Chin Gen Hosp, Taichung, Taiwan; [Lee, W-H] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu	Chang, Yi-cheng/O-1334-2018; Alex, Che/AAF-3280-2019	Chang, Yi-cheng/0000-0002-8077-5011; Alex, Che/0000-0002-4741-2307; Chang, King jen/0000-0001-9811-3422; JENG, YUNG-MING/0000-0002-3878-4491; KUO, WEN-HUNG/0000-0002-9881-4605	Academia Sinica (Taiwan); NIH [CA94170]; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	Academia Sinica (Taiwan)(Academia Sinica - Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Hung-Wen Lai for kindly providing a Herceptin (Trastuzumab)-resistant strain of SKBR3, and Dr Wendy W Hwang-Verslues and Dr Pei-Chi Wei for reading this manuscript. This work was supported by Academia Sinica (Taiwan) and by NIH (CA94170; to WHL).	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Furuta S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001374; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Singer CF, 2003, CLIN CANCER RES, V9, P4877; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Tian EM, 2000, ONCOGENE, V19, P2098, DOI 10.1038/sj.onc.1203577; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	35	71	75	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 5	2014	33	23					2968	2977		10.1038/onc.2013.268	http://dx.doi.org/10.1038/onc.2013.268			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EL	23851503				2022-12-25	WOS:000337232200003
J	Franchini, AM; Hunt, D; Melendez, JA; Drake, JR				Franchini, Anthony M.; Hunt, Danielle; Melendez, J. Andres; Drake, James R.			Fc gamma R-driven Release of IL-6 by Macrophages Requires NOX2-dependent Production of Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FACTOR-ALPHA SECRETION; NADPH OXIDASE; ACTIVATION; INTERLEUKIN-6; SUPEROXIDE; IGG; P67(PHOX); RECEPTORS; VACCINE	Activation of the Fc gamma R via antigen containing immune complexes can lead to the generation of reactive oxygen species, which are potent signal transducing molecules. However, whether ROS contribute to Fc gamma R signaling has not been studied extensively. We set out to elucidate the role of NADPH oxidase generated ROS in macrophage activation following Fc gamma R engagement using antigen-containing immune complexes. We hypothesized that NOX2 generated ROS is necessary for propagation of downstream Fc gamma R signaling and initiation of the innate immune response. Following exposure of murine bone marrow-derived macrophages (BMDMs) to inactivated Francisella tularensis (iFt)-containing immune complexes, we observed a significant increase in the innate inflammatory cytokine IL-6 at 24 h compared with macrophages treated with Ft LVS-containing immune complexes. Ligation of the Fc gamma R by opsonized Ft also results in significant ROS production. Macrophages lacking the gp91(phox) subunit of NOX2 fail to produce ROS upon Fc gamma R ligation, resulting in decreased Akt phosphorylation and a reduction in the levels of IL-6 compared with wild type macrophages. Similar results were seen following infection of BMDMs with catalase deficient Ft that fail to scavenge hydrogen peroxide. In conclusion, our findings demonstrate that ROS participate in elicitation of an effective innate immune in response to antigen-containing immune complexes through Fc gamma R.	[Franchini, Anthony M.; Hunt, Danielle; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Melendez, J. Andres] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12203 USA	Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute	Drake, JR (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave, Albany, NY 12208 USA.	DrakeJ@mail.amc.edu		Franchini, Anthony/0000-0003-3576-3211; Melendez, Juan/0000-0001-8021-3097	NIAID NIH HHS [P01 AI056320] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON CL, 1986, J BIOL CHEM, V261, P2856; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dube PH, 2004, INFECT IMMUN, V72, P3561, DOI 10.1128/IAI.72.6.3561-3570.2004; Enesa K, 2008, J BIOL CHEM, V283, P18582, DOI 10.1074/jbc.M801312200; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; GOMEZGUERRERO C, 1994, J IMMUNOL, V153, P5247; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044; Huntress EH, 1934, J AM CHEM SOC, V56, P241, DOI 10.1021/ja01316a077; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KIENER PA, 1993, J BIOL CHEM, V268, P24442; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kurtz SL, 2013, INFECT IMMUN, V81, P585, DOI 10.1128/IAI.01249-12; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lim S, 2007, FREE RADICAL BIO MED, V42, P1178, DOI 10.1016/j.freeradbiomed.2007.01.013; Loegering DJ, 2004, INFLAMMATION, V28, P23, DOI 10.1023/B:IFLA.0000014708.87440.45; LUNDQVIST H, 1995, J BIOLUM CHEMILUM, V10, P353, DOI 10.1002/bio.1170100608; Maeda K, 2010, BLOOD, V115, P4699, DOI 10.1182/blood-2009-07-230631; MCCORD JM, 1971, P NATL ACAD SCI USA, V68, P1024, DOI 10.1073/pnas.68.5.1024; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Okada M., 2011, CLIN DEV IMMUNOL, V2011; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; RYAN TC, 1990, J IMMUNOL METHODS, V130, P223, DOI 10.1016/0022-1759(90)90052-W; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; van der Goes A, 1998, J NEUROIMMUNOL, V92, P67, DOI 10.1016/S0165-5728(98)00175-1; VANDENDOBBELSTEEN MEA, 1993, KIDNEY INT, V43, P544, DOI 10.1038/ki.1993.81; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x	47	22	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25098	25108		10.1074/jbc.M113.474106	http://dx.doi.org/10.1074/jbc.M113.474106			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857584	hybrid, Green Published			2022-12-25	WOS:000330619000010
J	Su, SF; Minges, JT; Grossman, G; Blackwelder, AJ; Mohler, JL; Wilson, EM				Su, Shifeng; Minges, John T.; Grossman, Gail; Blackwelder, Amanda J.; Mohler, James L.; Wilson, Elizabeth M.			Proto-oncogene Activity of Melanoma Antigen-A11 (MAGE-A11) Regulates Retinoblastoma-related p107 and E2F1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; RECEPTOR COREGULATOR MAGE-11; ANDROGEN-RECEPTOR; CELL-CYCLE; TRANSCRIPTION FACTOR; PROSTATE-CANCER; ADENOVIRUS E1A; VIRAL ONCOPROTEINS; MOLECULAR-CLONING; TUMOR-SUPPRESSOR	Melanoma antigen-A11 (MAGE-A11) is a low-abundance, primate-specific steroid receptor coregulator in normal tissues of the human reproductive tract that is expressed at higher levels in prostate cancer. Increased expression of MAGE-A11 enhances androgen receptor transcriptional activity and promotes prostate cancer cell growth. Further investigation into the mechanisms of MAGE-A11 function in prostate cancer demonstrated interactions with the retinoblastoma-related protein p107 and Rb tumor suppressor but no interaction with p130 of the Rb family. MAGE-A11 interaction with p107 was associated with transcriptional repression in cells with low MAGE-A11 and transcriptional activation in cells with higher MAGE-A11. Selective interaction of MAGE-A11 with retinoblastoma family members suggested the regulation of E2F transcription factors. MAGE-A11 stabilized p107 by inhibition of ubiquitination and linked p107 to hypophosphorylated E2F1 in association with the stabilization and activation of E2F1. The androgen receptor and MAGE-A11 modulated endogenous expression of the E2F1-regulated cyclin-dependent kinase inhibitor p27(Kip1). The ability of MAGE-A11 to increase E2F1 transcriptional activity was similar to the activity of adenovirus early oncoprotein E1A and depended on MAGE-A11 interactions with p107 and p300. The immunoreactivity of p107 and MAGE-A11 was greater in advanced prostate cancer than in benign prostate, and knockdown with small inhibitory RNA showed that p107 is a transcriptional activator in prostate cancer cells. These results suggest that MAGE-A11 is a proto-oncogene whose increased expression in prostate cancer reverses retinoblastoma-related protein p107 from a transcriptional repressor to a transcriptional activator of the androgen receptor and E2F1.	[Su, Shifeng; Minges, John T.; Grossman, Gail; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Dept Pediat, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Su, Shifeng; Minges, John T.; Grossman, Gail; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Mohler, James L.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Mohler, James L.] SUNY Buffalo, Dept Urol, Buffalo, NY 14263 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			National Institutes of Health [HD16910]; United States Public Health Service NICHD, National Institutes of Health Eunice Kennedy Shriver Grant [HD067721]; NICHD, National Institutes of Health Eunice Kennedy Shriver Grant as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54-HD35041]; National Cancer Institute Grant [P01-CA77739]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067721] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041, R37HD016910, R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service NICHD, National Institutes of Health Eunice Kennedy Shriver Grant; NICHD, National Institutes of Health Eunice Kennedy Shriver Grant as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or part, by National Institutes of Health Grant HD16910, by United States Public Health Service NICHD, National Institutes of Health Eunice Kennedy Shriver Grant HD067721, and by Cooperative Agreement NICHD, National Institutes of Health Eunice Kennedy Shriver Grant U54-HD35041 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. This work was also supported by National Cancer Institute Grant P01-CA77739.	Alevizopoulos K, 2000, ONCOGENE, V19, P2067, DOI 10.1038/sj.onc.1203534; Altintas DM, 2012, MOL ENDOCRINOL, V26, P1531, DOI 10.1210/me.2012-1016; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; BAGCHI S, 1989, P NATL ACAD SCI USA, V86, P4352, DOI 10.1073/pnas.86.12.4352; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; BANDARA LR, 1994, EMBO J, V13, P3104, DOI 10.1002/j.1460-2075.1994.tb06609.x; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; Bellacchio E, 2013, J CELL PHYSIOL, V228, P285, DOI 10.1002/jcp.24137; Ben-Israel H, 2002, FRONT BIOSCI-LANDMRK, V7, pD1369, DOI 10.2741/ben; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Calbo J, 2002, J BIOL CHEM, V277, P50263, DOI 10.1074/jbc.M209181200; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cherian MT, 2012, J BIOL CHEM, V287, P23368, DOI 10.1074/jbc.M112.344671; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; CLAUDIO PP, 1994, CANCER RES, V54, P5556; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; DYSON N, 1993, J VIROL, V67, P7641, DOI 10.1128/JVI.67.12.7641-7647.1993; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; Fang Z, 2012, J BIOL CHEM, V287, P2090, DOI 10.1074/jbc.M111.323303; FATTAEY AR, 1993, MOL CELL BIOL, V13, P7267, DOI 10.1128/MCB.13.12.7267; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Fera D, 2012, BIOCHEMISTRY-US, V51, P9524, DOI 10.1021/bi3011863; FERGUSON B, 1985, MOL CELL BIOL, V5, P2653, DOI 10.1128/MCB.5.10.2653; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; Genovese C, 2006, ONCOGENE, V25, P5201, DOI 10.1038/sj.onc.1209652; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Gregory CW, 2001, CANCER RES, V61, P2892; Hallstrom TC, 2009, CELL CYCLE, V8, P532, DOI 10.4161/cc.8.4.7609; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; Hodul PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052526; Hofman K, 2001, BIOCHEM BIOPH RES CO, V283, P97, DOI 10.1006/bbrc.2001.4738; Hsia EYC, 2010, MOL CANCER RES, V8, P183, DOI 10.1158/1541-7786.MCR-09-0095; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Hume AJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-1; IKEDA MA, 1993, MOL CELL BIOL, V13, P7029, DOI 10.1128/MCB.13.11.7029; James SR, 2013, EPIGENETICS-US, V8, P849, DOI 10.4161/epi.25500; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kondo T, 2001, J BIOL CHEM, V276, P17559, DOI 10.1074/jbc.M009911200; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; LI Y, 1994, CANCER RES, V54, P6078; Li YR, 2012, MOL CELL BIOL, V32, P2454, DOI 10.1128/MCB.06663-11; Lin WC, 2001, GENE DEV, V15, P1833; Liu Q, 2011, J BIOL CHEM, V286, P29951, DOI 10.1074/jbc.M111.244715; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Lu JM, 1998, J BIOL CHEM, V273, P31528, DOI 10.1074/jbc.273.47.31528; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Mallik I, 2008, BBA-MOL CELL RES, V1783, P1737, DOI 10.1016/j.bbamcr.2008.05.006; Minges JT, 2013, J BIOL CHEM, V288, P1939, DOI 10.1074/jbc.M112.428409; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Puri PL, 1998, CANCER RES, V58, P1325; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; SCHWARZ JK, 1993, EMBO J, V12, P1013, DOI 10.1002/j.1460-2075.1993.tb05742.x; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Su SF, 2012, J BIOL CHEM, V287, P34809, DOI 10.1074/jbc.M112.372797; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Takahashi Y, 2000, GENE DEV, V14, P804; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsihlias J, 1998, CANCER RES, V58, P542; Tsihlias J, 2000, ONCOGENE, V19, P670, DOI 10.1038/sj.onc.1203369; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; Wirt SE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-9; Xiao ZX, 1996, P NATL ACAD SCI USA, V93, P4633, DOI 10.1073/pnas.93.10.4633; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yang RM, 1998, J UROLOGY, V159, P941, DOI 10.1016/S0022-5347(01)63776-5; Yang XH, 1997, BIOCHEM BIOPH RES CO, V232, P336, DOI 10.1006/bbrc.1997.6284; Yeh SY, 1998, BIOCHEM BIOPH RES CO, V248, P361, DOI 10.1006/bbrc.1998.8974; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	118	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24809	24824		10.1074/jbc.M113.468579	http://dx.doi.org/10.1074/jbc.M113.468579			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853093	hybrid, Green Published			2022-12-25	WOS:000330612300046
J	Chen, KC; Xie, HL; Cai, YJ				Chen, Kevin C.; Xie, Honglin; Cai, Yujie			Modes of Action of ADP-Ribosylated Elongation Factor 2 in Inhibiting the Polypeptide Elongation Cycle: A Modeling Study	PLOS ONE			English	Article							TRANSFER-RNA TRANSLOCATION; AMINOACYL-TRANSFERASE II; DIPHTHERIA-TOXIN; PROTEIN-SYNTHESIS; SACCHAROMYCES-CEREVISIAE; GUANINE-NUCLEOTIDES; KINETIC MECHANISM; GTPASE ACTIVITY; 80S RIBOSOME; BINDING	Despite the fact that ADP-ribosylation of eukaryotic elongation factor 2 (EF2) leads to inhibition of protein synthesis, the mechanism by which ADP-ribosylated EF2 (ADPR center dot EF2) causes this inhibition remains controversial. Here, we applied modeling approaches to investigate the consequences of various modes of ADPR center dot EF2 inhibitory actions on the two coupled processes, the polypeptide chain elongation and ADP-ribosylation of EF2. Modeling of experimental data indicates that ADPR center dot EF2 fully blocks the late-phase translocation of tRNAs; but the impairment in the translocation upstream process, mainly the GTP-dependent factor binding with the pretranslocation ribosome and/or the guanine nucleotide exchange in EF2, is responsible for the overall inhibition kinetics. The reduced ADPR center dot EF2-ribosome association spares the ribosome to bind and shield native EF2 against toxin attack, thereby deferring the inhibition of protein synthesis inhibition and inactivation of EF2. Minimum association with the ribosome also keeps ADPR center dot EF2 in an accessible state for toxins to catalyze the reverse reaction when nicotinamide becomes available. Our work underscores the importance of unveiling the interactions between ADPR center dot EF2 and the ribosome, and argues against that toxins inhibit protein synthesis through converting native EF2 to a competitive inhibitor to actively disable the ribosome.	[Chen, Kevin C.; Xie, Honglin; Cai, Yujie] Shantou Univ, Multidisciplinary Res Ctr, Shantou, Guangdong, Peoples R China	Shantou University	Chen, KC (corresponding author), Shantou Univ, Multidisciplinary Res Ctr, Shantou, Guangdong, Peoples R China.	ckchen@stu.edu.cn	Chen, Kevin/GYU-8963-2022		NSFC [31171092]; NSFGD [10151503]	NSFC(National Natural Science Foundation of China (NSFC)); NSFGD	Supported by NSFC (31171092) and NSFGD (10151503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERMEK E, 1972, FEBS LETT, V23, P95, DOI 10.1016/0014-5793(72)80293-X; BERMEK E, 1976, J BIOL CHEM, V251, P6544; BURNS G, 1986, FEBS LETT, V208, P217, DOI 10.1016/0014-5793(86)81021-3; COLLIER RJ, 1967, J MOL BIOL, V25, P83, DOI 10.1016/0022-2836(67)90280-X; DAVYDOVA EK, 1990, FEBS LETT, V261, P350, DOI 10.1016/0014-5793(90)80589-B; EVERSE J, 1970, J BIOL CHEM, V245, P899; GILL DM, 1969, COLD SPRING HARB SYM, V34, P595, DOI 10.1101/SQB.1969.034.01.068; GILL DM, 1969, J EXP MED, V129, P1, DOI 10.1084/jem.129.1.1; GILL DM, 1973, J BIOL CHEM, V248, P654; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GOOR RS, 1967, J EXP MED, V126, P899, DOI 10.1084/jem.126.5.899; HUDSON TH, 1987, J BIOL CHEM, V262, P16484; HWANG YW, 1985, J BIOL CHEM, V260, P1498; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2004, J BIOL CHEM, V279, P45919, DOI 10.1074/jbc.M406218200; LI BY, 1994, J BIOL CHEM, V269, P2652; MARZOUKI A, 1991, BIOCHIMIE, V73, P1151, DOI 10.1016/0300-9084(91)90159-X; MOEHRING TJ, 1968, J BACTERIOL, V96, P61, DOI 10.1128/JB.96.1.61-69.1968; MONTANARO L, 1976, BIOCHEM J, V156, P15, DOI 10.1042/bj1560015; MONTANARO L, 1971, BIOCHIM BIOPHYS ACTA, V238, P493, DOI 10.1016/0005-2787(71)90628-9; NURTEN R, 1980, EUR J BIOCHEM, V103, P551, DOI 10.1111/j.1432-1033.1980.tb05979.x; NYGARD O, 1985, BIOCHIM BIOPHYS ACTA, V824, P152, DOI 10.1016/0167-4781(85)90092-2; NYGARD O, 1990, J BIOL CHEM, V265, P6030; NYGARD O, 1984, EUR J BIOCHEM, V145, P345, DOI 10.1111/j.1432-1033.1984.tb08560.x; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; RAEBURN S, 1968, P NATL ACAD SCI USA, V61, P1428, DOI 10.1073/pnas.61.4.1428; RAIMO G, 1995, J BIOL CHEM, V270, P21082, DOI 10.1074/jbc.270.36.21082; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2001, MOL BIOL+, V35, P559, DOI 10.1023/A:1010523026531; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; SITIKOV AS, 1984, FEBS LETT, V176, P406, DOI 10.1016/0014-5793(84)81207-7; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; SPERTI S, 1971, CHEM-BIOL INTERACT, V3, P141, DOI 10.1016/0009-2797(71)90094-9; Tang S, 2001, MOL CELL BIOCHEM, V223, P117, DOI 10.1023/A:1017914413081; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Walker SE, 2008, P NATL ACAD SCI USA, V61, P1428; Wintermeyer W, 2001, COLD SPRING HARB SYM, V66, P449, DOI 10.1101/sqb.2001.66.449; YOULE RJ, 1979, J BIOL CHEM, V254, P1089; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1	44	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e66446	10.1371/journal.pone.0066446	http://dx.doi.org/10.1371/journal.pone.0066446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861744	Green Published, Green Submitted, gold			2022-12-25	WOS:000321692000005
J	Li, ZK; Musich, PR; Cartwright, BM; Wang, H; Zou, Y				Li, Zhengke; Musich, Phillip R.; Cartwright, Brian M.; Wang, Hui; Zou, Yue			UV-Induced Nuclear Import of XPA Is Mediated by Importin-alpha 4 in An ATR-Dependent Manner	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-A; COMPLEMENTATION GROUP-A; XERODERMA-PIGMENTOSUM; DNA-REPAIR; PROTEIN; BINDING; DAMAGE; RECOGNITION; EXPRESSION	Xeroderma pigmentosum Group A (XPA) is a crucial factor in mammalian nucleotide excision repair (NER) and nuclear import of XPA from the cytoplasm for NER is regulated in cellular DNA damage responses in S-phase. In this study, experiments were carried out to determine the transport mechanisms that are responsible for the UV (ultraviolet)-induced nuclear import of XPA. We found that, in addition to the nuclear localization signal (NLS) of XPA, importin-alpha 4 or/and importin-alpha 7 are required for the XPA nuclear import. Further investigation indicated that, importin-alpha 4 and importin-alpha 7 directly interacted with XPA in cells. Interestingly, the binding of importin-alpha 4 to XPA was dependent on UV-irradiation, while the binding of importin-alpha 7 was not, suggesting a role for importin-alpha 7 in nuclear translocation of XPA in the absence of DNA damage, perhaps with specificity to certain non-S-phases of the cell-cycle. Consistent with the previous report of a dependence of UV-induced XPA nuclear import on ataxia telangiectasia and Rad3-related protein (ATR) in S-phase, knockdown of ATR reduced the amount of XPA interacting with importin-alpha 4. In contrast, the GTPase XPA binding protein 1 (XAB1), previously proposed to be required for XPA nuclear import, showed no effect on the nuclear import of XPA in our siRNA knockdown analysis. In conclusion, our results suggest that upon DNA damage transport adaptor importin-alpha 4 imports XPA into the nucleus in an ATR-dependent manner, while XAB1 has no role in this process. In addition, these findings reveal a potential new therapeutic target for the sensitization of cancer cells to chemotherapy.	[Li, Zhengke; Musich, Phillip R.; Cartwright, Brian M.; Wang, Hui; Zou, Yue] E Tennessee State Univ, Dept Biomed Sci, JH Quillen Coll Med, Johnson City, TN 37614 USA	East Tennessee State University	Zou, Y (corresponding author), E Tennessee State Univ, Dept Biomed Sci, JH Quillen Coll Med, Johnson City, TN 37614 USA.	zouy@etsu.edu	Li, Zhengke/J-8527-2016; Zou, Yue/ABA-8429-2020	Li, Zhengke/0000-0001-5560-343X; Musich, Phillip/0000-0001-8816-4242	National Institutes of Health [R01CA86927]; NATIONAL CANCER INSTITUTE [R01CA086927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01CA86927. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels CL, 2007, BIOCHEM BIOPH RES CO, V356, P219, DOI 10.1016/j.bbrc.2007.02.125; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; CORTES P, 1994, P NATL ACAD SCI USA, V91, P7633, DOI 10.1073/pnas.91.16.7633; CUOMO CA, 1994, P NATL ACAD SCI USA, V91, P6156, DOI 10.1073/pnas.91.13.6156; De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Gilljam KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049199; Huang ZM, 2012, P NATL ACAD SCI USA, V109, P553, DOI 10.1073/pnas.1118366109; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; Kumar GR, 2011, MOL CELL BIOL, V31, P3113, DOI 10.1128/MCB.05402-11; Kumar GR, 2010, MOL CELL BIOL, V30, P4996, DOI 10.1128/MCB.00600-10; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Lee TH, 2012, ONCOGENE; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Li Zhengke, 2011, Int J Biochem Mol Biol, V2, P138; Li ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028326; Liu Y, 2005, BIOCHEMISTRY-US, V44, P7361, DOI 10.1021/bi047598y; Liu YB, 2012, CARCINOGENESIS, V33, P1187, DOI 10.1093/carcin/bgs142; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; MIURA N, 1991, J BIOL CHEM, V266, P19786; MIYAMOTO I, 1992, J BIOL CHEM, V267, P12182; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; Orelli B, 2010, J BIOL CHEM, V285, P3705, DOI 10.1074/jbc.M109.067538; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; Patrick SM, 2002, J BIOL CHEM, V277, P16096, DOI 10.1074/jbc.M200816200; Rademakers S, 2003, MOL CELL BIOL, V23, P5755, DOI 10.1128/MCB.23.16.5755-5767.2003; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Serrano MA, 2012, ONCOGENE, V29, P2165; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Solimando L, 2009, J CELL SCI, V122, P83, DOI 10.1242/jcs.031062; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Vasquez KM, 2002, P NATL ACAD SCI USA, V99, P5848, DOI 10.1073/pnas.082193799; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q	52	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68297	10.1371/journal.pone.0068297	http://dx.doi.org/10.1371/journal.pone.0068297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861882	Green Published, gold, Green Submitted			2022-12-25	WOS:000321692000020
J	Li, QJ; Liu, ZF; Dang, EL; Jin, L; He, Z; Yang, LT; Shi, XW; Wang, G				Li, Qiuju; Liu, Zhenfeng; Dang, Erle; Jin, Liang; He, Zheng; Yang, Luting; Shi, Xiaowei; Wang, Gang			Follicular Helper T Cells (Tfh) and IL-21 Involvement in the Pathogenesis of Bullous Pemphigoid	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; DISEASE; AUTOIMMUNITY; BLOCKADE; AUTOANTIBODIES; EXPRESSION; MATURATION; EXPANSION; MODELS	The pathogenesis of bullous pemphigoid (BP) is characterized by the T cell-dependent production of autoantibodies. Recent studies have indicated that follicular T helper cells (Tfh), the key modulator of B cell activation and autoantibody production, are critical in the development of several autoimmune diseases. Tfh cells perform their functions via IL-21, their hallmark cytokine. In the present study, the frequencies of Tfh cells were investigated in the peripheral blood samples of BP patients to evaluate whether Tfh cells involve in this clinical entity. Significantly higher Tfh cell counts were observed in the peripheral blood of BP patients than those in healthy controls (median: 11.25% vs. 4.95%, respectively; P < 0.001). Additionally, the serum IL-21 levels in BP patients were higher than those of the healthy controls (median: 103.98 pg/mL vs 46.77 pg/mL, respectively; P < 0.001). The frequencies of Tfh cells and IL-21 levels were both positively correlated with anti-BP180-NC16A autoantibody titers (R=0.712, P < 0.01 and R=0.578, P=0.030, respectively). After effective therapy, the frequencies of Tfh cells as well as the serum IL-21 levels in BP patients decreased along with clinical improvement. Most importantly, Tfh depleted CD4(+) T cells and anti-IL-21 neutralization antibody could inhibit the T cell-induced B cell activation and secretion of BP autoantibody in vitro. Those results suggest that Tfh cells play an important role in autoantibody production and are involved in the pathogenesis of BP.	[Li, Qiuju; Liu, Zhenfeng; Dang, Erle; Jin, Liang; He, Zheng; Yang, Luting; Shi, Xiaowei; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China	Air Force Military Medical University	Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China.	xjwgang@fmmu.edu.cn	Liu, Zhenfeng/GWV-5162-2022; Wang, Gang/H-6710-2019	Wang, Gang/0000-0002-5842-8080; Dang, Erle/0000-0003-4761-6673	National Natural Science Foundation of China [30972805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30972805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gowthaman U, 2010, INT REV IMMUNOL, V29, P403, DOI 10.3109/08830185.2010.496503; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Hu YL, 2009, J IMMUNOL, V182, P1421, DOI 10.4049/jimmunol.182.3.1421; Kasperkiewicz M, 2007, CLIN REV ALLERG IMMU, V33, P67, DOI 10.1007/s12016-007-0030-y; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Leighty L, 2007, ARCH DERMATOL RES, V299, P417, DOI 10.1007/s00403-007-0790-5; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu Z, 2001, J DERMATOL, V28, P647, DOI 10.1111/j.1346-8138.2001.tb00055.x; Liu Z, 2008, J INVEST DERMATOL, V128, pE22; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Mihai S, 2007, J CELL MOL MED, V11, P462, DOI 10.1111/j.1582-4934.2007.00033.x; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Okamoto T, 2003, J RHEUMATOL, V30, P1157; Olasz Edit B., 2008, V10, P141, DOI 10.1159/000131452; Saito R, 2005, J NEUROIMMUNOL, V170, P172, DOI 10.1016/j.jneuroim.2005.09.001; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Schmidt E, 2000, Adv Dermatol, V16, P113; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Sitaru C, 2005, EXP DERMATOL, V14, P861, DOI 10.1111/j.1600-0625.2005.00367.x; Sitaru C, 2009, J INVEST DERMATOL, V129, P822, DOI 10.1038/jid.2009.12; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Tsuji-Abe Y, 2005, J DERMATOL SCI, V37, P145, DOI 10.1016/j.jdermsci.2004.10.007; Yancey KB, 2000, JAMA-J AM MED ASSOC, V284, P350, DOI 10.1001/jama.284.3.350; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2009, CURR OPIN IMMUNOL, V21, P619, DOI 10.1016/j.coi.2009.09.013; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zillikens D, 1997, J INVEST DERMATOL, V109, P679, DOI 10.1111/1523-1747.ep12338088	41	34	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68145	10.1371/journal.pone.0068145	http://dx.doi.org/10.1371/journal.pone.0068145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861861	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300044
J	Park, YH; Jang, JW; Yang, Y; Kim, JE; Kim, SY				Park, Young Ho; Jang, Jae-Won; Yang, Youngsoon; Kim, Jung Eun; Kim, SangYun			Reflections of Two Parallel Pathways between the Hippocampus and Neocortex in Transient Global Amnesia: A Cross-Sectional Study Using DWI and SPECT	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; PARAHIPPOCAMPAL CORTICES; RECIPROCAL CONNECTIONS; ENTORHINAL CORTEX; HYPOPERFUSION; ANATOMY; ACETAZOLAMIDE; SUBREGIONS; ACTIVATION; RETRIEVAL	Objectives: Two parallel pathways have been proposed between the hippocampus and neocortex. Recently, the anterior and posterior hippocampus showed distinct connectivity with different cortical areas in an fMRI study. We investigated whether the two parallel pathways could be confirmed in patients with transient global amnesia (TGA) which is a natural lesion model of a perturbation of the hippocampus. In addition, we evaluated the relationship between the location of the hippocampal lesion and various clinical variables. Methods: A consecutive series of 37 patients were identified from the TGA registry database of Seoul National University Bundang Hospital. Based on the location of the diffusion-weighted imaging (DWI) lesion along the anterior-posterior axis of the hippocampus, they were divided into the following three groups: head (n = 15), body (n = 15) or tail (n = 7). To evaluate which cortical regions showed hypoperfusion according to the location of the DWI lesion, their SPECT images were compared between two groups using statistical parametric mapping. We performed hierarchical cluster analysis to group demographic and clinical variables, including the location of the DWI lesion, into clusters. Results: Statistical parametric mapping analyses revealed that more anterior DWI lesions were associated with hypoperfusion of the anterior temporal and frontal areas, whereas more posterior lesions were associated with hypoperfusion of the posterior temporal, parietal, occipital and cerebellar areas. The difference was most prominent between the group of hippocampal lesions on the head and tail. Hierarchical cluster analysis demonstrated that vomiting was related to female gender and hippocampal head lesions, whereas vascular risk factors were related to male gender and hippocampal body lesions. Conclusions: We confirmed the parallel pathways between the hippocampus and neocortex with DWI and SPECT images of patients with TGA. Patients with hippocampal head lesions and body lesions were clustered within different groups of clinical variables.	[Park, Young Ho; Jang, Jae-Won; Kim, Jung Eun; Kim, SangYun] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Young Ho; Jang, Jae-Won; Kim, Jung Eun; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Songnam, South Korea; [Yang, Youngsoon] Seoul Vet Hosp, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul Veterans Hospital	Kim, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.	neuroksy@snu.ac.kr						Agosti C, 2010, EUR NEUROL, V63, P291, DOI 10.1159/000292502; Bartsch T, 2006, BRAIN, V129, P2874, DOI 10.1093/brain/awl248; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Duvernoy H. M, 2005, HUMAN HIPPOCAMPUS FU; ESCOFIER B, 1994, COMPUT STAT DATA AN, V18, P121, DOI 10.1016/0167-9473(94)90135-X; EVANS J, 1993, J NEUROL NEUROSUR PS, V56, P1227, DOI 10.1136/jnnp.56.11.1227; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; GOLDENBERG G, 1991, NEUROLOGY, V41, P1748, DOI 10.1212/WNL.41.11.1748; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Jovin TG, 2000, J NEUROIMAGING, V10, P238, DOI 10.1111/jon2000104238; Jung HH, 1996, J NEUROL NEUROSUR PS, V61, P654, DOI 10.1136/jnnp.61.6.654-a; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; LALOUX P, 1992, ARCH NEUROL-CHICAGO, V49, P543, DOI 10.1001/archneur.1992.00530290131022; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Libby LA, 2012, J NEUROSCI, V32, P6550, DOI 10.1523/JNEUROSCI.3711-11.2012; LIN KN, 1993, STROKE, V24, P1093, DOI 10.1161/01.STR.24.7.1093; LIPSITZ SR, 1994, BIOMETRICS, V50, P847, DOI 10.2307/2532798; MATSUDA H, 1993, CLIN NUCL MED, V18, P46, DOI 10.1097/00003072-199301000-00011; Meulman J., 2004, HDB QUANTITATIVE MET; Naber PA, 2001, HIPPOCAMPUS, V11, P99, DOI 10.1002/hipo.1028; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Ryoo I, 2012, NEURORADIOLOGY, V54, P329, DOI 10.1007/s00234-011-0889-4; Sakashita Y, 1997, J NEUROL NEUROSUR PS, V63, P605, DOI 10.1136/jnnp.63.5.605; Schacter DL, 1999, HIPPOCAMPUS, V9, P575, DOI 10.1002/(SICI)1098-1063(1999)9:5<575::AID-HIPO11>3.0.CO;2-K; Scharrer E, 1940, ARCH NEURO PSYCHIATR, V44, P483, DOI 10.1001/archneurpsyc.1940.02280090002001; Schmidtke K, 1998, J NUCL MED, V39, P155; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; STILLHARD G, 1990, J NEUROL NEUROSUR PS, V53, P339, DOI 10.1136/jnnp.53.4.339; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Takeuchi R, 1998, J NUCL MED, V39, P1360; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Warren JD, 2000, J CLIN NEUROSCI, V7, P57, DOI 10.1054/jocn.1998.0129; Winbeck K, 2005, J NEUROL NEUROSUR PS, V76, P438, DOI 10.1136/jnnp.2004.042432; Yang Y, 2009, J CLIN NEUROL, V5, P74, DOI 10.3988/jcn.2009.5.2.74	38	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67447	10.1371/journal.pone.0067447	http://dx.doi.org/10.1371/journal.pone.0067447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861765	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300014
J	Cai, J; Xie, SL; Feng, J; Wang, FP; Xu, QF				Cai, Jin; Xie, Shulian; Feng, Jia; Wang, Feipeng; Xu, Qiufeng			Protective Effect of Polygonum orientale L. Extracts against Clavibater michiganense subsp sepedonicum, the Causal Agent of Bacterial Ring Rot of Potato	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; ANTIMICROBIAL ACTIVITY; ANTIFUNGAL ACTIVITY; CHEMICAL-COMPOSITION; IN-VITRO; OPTIMIZATION; DISEASE; CINNAMOMUM; HERBICIDES; FUNGUS	The Polygonum orientale L. extracts were investigated for antibacterial activity against Clavibater michiganense subsp. sepedonicum (Spieckermann & Kotthoff) Davis et al., the causal agent of a serious disease called bacterial ring rot of potato. The results showed that the leaf extracts of P. orientale had significantly (p<0.05) greater antibacterial activity against C. michiganense subsp. sepedonicum than root, stem, flower extracts in vitro. According to the results of single factor experiments and L(27)3((13)) orthogonal experiments, optimum extraction conditions were A(1)B(3)C(1), extraction time 6 h, temperature 80 degrees C, solid to liquid ratio 1:10 (g:mL). The highest (p<0.05) antibacterial activity was observed when pH was 5, excluding the effect of control. The extracts were stable under ultraviolet (UV). In vivo analysis revealed that 50 mg/mL of P. orientale leaf extracts was effective in controlling decay. Under field conditions, 50 mg/ mL of P. orientale leaf extracts also improved growth parameters (whole plant length, shoot length, root length, plant fresh weight, shoot fresh weight, root fresh weight, dry weight, and number of leaves), in the 2010 and 2011 two growing seasons. Further solvent partition assays showed that the most active compounds were in the petroleum ether fractionation. Transmission electron microscopy (TEM) showed drastic ultrastructural changes caused by petroleum ether fractionation, including bacterial deformation, electron-dense particles, formation of vacuoles and lack of cytoplasmic materials. These results indicated that P. orientale extracts have strong antibacterial activity against C. michiganense subsp. sepedonicum and a promising effect in control of bacterial ring rot of potato disease.	[Cai, Jin; Xie, Shulian; Feng, Jia; Wang, Feipeng; Xu, Qiufeng] Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China	Shanxi University	Xie, SL (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China.	xiesl@sxu.edu.cn						Abdel-Monaim MF, 2011, CROP PROT, V30, P185, DOI 10.1016/j.cropro.2010.09.016; Akhtar Y., 2008, Phytochemistry Reviews, V7, P77, DOI 10.1007/s11101-006-9048-7; Antony J., 2006, Sensor Review, V26, P227, DOI 10.1108/02602280610675519; Askarne L, 2012, CROP PROT, V40, P53, DOI 10.1016/j.cropro.2012.04.023; Aziz AN, 2013, J ETHNOPHARMACOL, V145, P798, DOI 10.1016/j.jep.2012.12.024; Bernardo-Gil MG, 2009, J SUPERCRIT FLUID, V49, P32, DOI 10.1016/j.supflu.2008.12.004; Brady N. C., 1984, NATURE PROPERTIES SO, P528; Cardoso RA, 2010, GENET MOL RES, V9, P231, DOI 10.4238/vol9-1gmr688; Carson Christine F, 2003, Commun Dis Intell Q Rep, V27 Suppl, pS143; Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u; Cheikhyoussef A, 2009, FOOD CONTROL, V20, P553, DOI 10.1016/j.foodcont.2008.08.003; Chen YJ, 2012, J SCI FOOD AGR, V92, P1937, DOI 10.1002/jsfa.5565; Choi GJ, 2010, PLANT PATHOLOGY J, V26, P360, DOI 10.5423/PPJ.2010.26.4.360; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; De Corato U, 2010, CROP PROT, V29, P142, DOI 10.1016/j.cropro.2009.10.012; Demoz BT, 2006, BIOL CONTROL, V37, P68, DOI 10.1016/j.biocontrol.2005.11.010; Diez C, 2008, J CHROMATOGR A, V1180, P10, DOI 10.1016/j.chroma.2007.12.036; Elbadri Gamal Abdalla, 2008, Journal of Asia-Pacific Entomology, V11, P99, DOI 10.1016/j.aspen.2008.04.004; Fousek J, 2003, FOLIA MICROBIOL, V48, P682, DOI 10.1007/BF02993479; Fu WJ, 2005, FOREST BY PRODUCT SP, P40; Harish S, 2008, BIOCONTROL, V53, P555, DOI 10.1007/s10526-007-9098-9; Holley RA, 2005, FOOD MICROBIOL, V22, P273, DOI 10.1016/j.fm.2004.08.006; Ibrahim HR, 1996, J AGR FOOD CHEM, V44, P3799, DOI 10.1021/jf960133x; Ippolito A, 2000, CROP PROT, V19, P715, DOI 10.1016/S0261-2194(00)00095-8; Ismail S, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/269724, 10.1155/2013/696835]; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Jia XY, 2010, CHROMATOGRAPHIA, V71, P839, DOI 10.1365/s10337-010-1547-4; Joshi S, 2008, BIORESOURCE TECHNOL, V99, P4603, DOI 10.1016/j.biortech.2007.07.030; Kagale S, 2004, PHYSIOL MOL PLANT P, V65, P91, DOI 10.1016/j.pmpp.2004.11.008; Khan MSA, 2011, PHYTOMEDICINE, V19, P48, DOI 10.1016/j.phymed.2011.07.005; Kilickap E, 2010, INT J ADV MANUF TECH, V49, P911, DOI 10.1007/s00170-009-2469-x; Knight SC, 1997, ANNU REV PHYTOPATHOL, V35, P349, DOI 10.1146/annurev.phyto.35.1.349; Li HJ, 2012, CURR MICROBIOL, V65, P156, DOI 10.1007/s00284-012-0135-2; Li Z, 2010, FOOD SCI BIOTECHNOL, V19, P1047, DOI 10.1007/s10068-010-0147-2; Liu RM, 2002, FOOD FERM IND, V29, P61; Liu YJ, 2004, MYCOPATHOLOGIA, V157, P185, DOI 10.1023/B:MYCO.0000020598.91469.d1; Mares D, 2005, MYCOPATHOLOGIA, V160, P85, DOI 10.1007/s11046-004-6635-2; Marino M, 2001, INT J FOOD MICROBIOL, V67, P187, DOI 10.1016/S0168-1605(01)00447-0; Mercan N, 2006, ANN MICROBIOL, V56, P373, DOI 10.1007/BF03175035; Michielin EMZ, 2009, BIORESOURCE TECHNOL, V100, P6615, DOI 10.1016/j.biortech.2009.07.061; Nishida M, 2006, J CHROMATOGR B, V842, P106, DOI 10.1016/j.jchromb.2006.07.039; Qasem JR, 1995, ANN APPL BIOL, V127, P215, DOI 10.1111/j.1744-7348.1995.tb06666.x; Qiu YE, 2004, XINJIANG AGR SCI, P88; SECOR GA, 1987, AM POTATO J, V64, P699; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Smania A. Jr., 1999, International Journal of Medicinal Mushrooms, V1, P325; Soylu EM, 2006, MYCOPATHOLOGIA, V161, P119, DOI 10.1007/s11046-005-0206-z; Sun L, 2003, J CHROMATOGR A, V1014, P165, DOI 10.1016/S0021-9673(03)00574-0; Tanaka A, 2013, J WOOD SCI, V59, P155, DOI 10.1007/s10086-012-1310-6; Tao R, 2013, MOLECULES, V18, P2166, DOI 10.3390/molecules18022166; Tegegne G, 2008, CROP PROT, V27, P1052, DOI 10.1016/j.cropro.2007.12.007; Teixeira PC, 2007, INT J FOOD MICROBIOL, V118, P15, DOI 10.1016/j.ijfoodmicro.2007.05.008; van der Wolf JM, 2005, J PHYTOPATHOL, V153, P358, DOI 10.1111/j.1439-0434.2005.00985.x; Viswanathan MBG, 2012, FITOTERAPIA, V83, P1153, DOI 10.1016/j.fitote.2012.07.007; Wang B., 2012, NAT PROD RES DEV, V24, P23, DOI [10.16333/j.1001-6880.2012.s1.005, DOI 10.16333/J.1001-6880.2012.S1.005]; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Wang L, 2010, BIORESOURCE TECHNOL, V101, P5808, DOI 10.1016/j.biortech.2010.02.099; Wang L, 2010, DESALINATION, V254, P68, DOI 10.1016/j.desal.2009.12.012; Wang RuiXia, 2010, Acta Phytopathologica Sinica, V40, P66; Wei Y, 2009, J FOOD COMPOS ANAL, V22, P154, DOI 10.1016/j.jfca.2008.08.006; Wilson CL, 1997, PLANT DIS, V81, P204, DOI 10.1094/PDIS.1997.81.2.204; Wu GQ, 2008, CURR MICROBIOL, V57, P552, DOI 10.1007/s00284-008-9241-6; Xie BX, 2004, NONWOOD FOREST RES, V22, P5; Xiong JH, 2007, FOOD MACH, V23, P78; Yang DM, 2010, J CHIN I FOOD SCI TE, V10, P47; Yazaki Kazufumi, 2008, Phytochemistry Reviews, V7, P513, DOI 10.1007/s11101-007-9079-8; Zhang ZY, 2008, CROP PROT, V27, P920, DOI 10.1016/j.cropro.2007.11.012; [赵海伊 Zhao Haiyi], 2013, [食品科学, Food Science], V34, P236; Zheng XD, 2009, GANSU AGR SCI TECHN, V1, P11; Zhou W, 2010, CHROMATOGRAPHIA, V72, P719, DOI 10.1365/s10337-010-1747-y; 苏峰平, 2012, [中成药, Chinese Traditional Patent Medicine], V34, P938; 陈云, 2010, [山西农业科学, Journal of Shanxi Agricultural Sciences], V38, P140	72	8	9	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68480	10.1371/journal.pone.0068480	http://dx.doi.org/10.1371/journal.pone.0068480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861908	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700088
J	Camus, SMJ; Rochais, C; Blois-Heulin, C; Li, Q; Hausberger, M; Bezard, E				Camus, Sandrine M. J.; Rochais, Celine; Blois-Heulin, Catherine; Li, Qin; Hausberger, Martine; Bezard, Erwan			Birth Origin Differentially Affects Depressive-Like Behaviours: Are Captive-Born Cynomolgus Monkeys More Vulnerable to Depression than Their Wild-Born Counterparts?	PLOS ONE			English	Article							MACAQUES MACACA-MULATTA; RHESUS MACAQUES; STEREOTYPIC BEHAVIOR; NONHUMAN-PRIMATES; SOCIAL-BEHAVIOR; COPING HYPOTHESIS; CUMULATIVE STRESS; EARLY EXPERIENCE; GENUS MACACA; TEMPERAMENT	Background: Adverse early-life experience might lead to the expression of abnormal behaviours in animals and the predisposition to psychiatric disorder (e.g. major depressive disorder) in Humans. Common breeding processes employ weaning and housing conditions different from what happens in the wild. Methods: The present study, therefore, investigated whether birth origin impacts the possible existence of spontaneous atypical/abnormal behaviours displayed by 40 captive-born and 40 wild-born socially-housed cynomolgus macaques in farming conditions using an unbiased ethological scan-sampling analysis followed by multifactorial correspondence and hierarchical clustering analyses. Results: We identified 10 distinct profiles (groups A to J) that significantly differed on several behaviours, body postures, body orientations, distances between individuals and locations in the cage. Data suggest that 4 captive-born and 1 wild-born animals (groups G and J) present depressive-like symptoms, unnatural early life events thereby increasing the risk of developing pathological symptoms. General differences were also highlighted between the captive- and wild-born populations, implying the expression of differential coping mechanisms in response to the same captive environment. Conclusions: Birth origin thus impacts the development of atypical ethologically-defined behavioural profiles, reminiscent of certain depressive-like symptoms. The use of unbiased behavioural observations might allow the identification of animal models of human mental/behavioural disorders and their most appropriate control groups.	[Camus, Sandrine M. J.; Bezard, Erwan] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Camus, Sandrine M. J.; Bezard, Erwan] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Rochais, Celine; Blois-Heulin, Catherine] Univ Rennes 1, UMR CNRS Ethol Anim & Humaine 6552, Stn Biol Paimpont, F-35014 Rennes, France; [Li, Qin] Motac France, Floirac, France; [Hausberger, Martine] Univ Rennes 1, UMR CNRS Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Universite de Rennes; Universite de Rennes	Bezard, E (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France.	erwan.bezard@u-bordeaux2.fr	Bezard, Erwan/ABD-5153-2021	Bezard, Erwan/0000-0002-0410-4638	Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department; Motac Neuroscience Ltd., UK	Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department; Motac Neuroscience Ltd., UK	This work was supported by Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department (EB) and an unrestricted grant from Motac Neuroscience Ltd., UK (EB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Bertrand M, 1969, BEHAV REPERTOIRE STU, P274; BOWLBY J, 1960, PSYCHOANAL STUD CHIL, V15, P9, DOI 10.1080/00797308.1960.11822566; Camus SMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062141; Castellan NJ, 1988, NONPARAMETRIC STAT B; CHAMPOUX M, 1994, LAB ANIM SCI, V44, P351; CHENEY DL, 1990, COGNITION, V37, P167, DOI 10.1016/0010-0277(90)90022-C; Claessens SEF, 2011, PSYCHOPHARMACOLOGY, V214, P141, DOI 10.1007/s00213-010-2118-y; CLARKE AS, 1988, INT J PRIMATOL, V9, P347, DOI 10.1007/BF02737382; COOPER JJ, 1993, ANIM BEHAV, V45, P616, DOI 10.1006/anbe.1993.1072; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; Daskalakis NP, 2012, PHYSIOL BEHAV, V106, P707, DOI 10.1016/j.physbeh.2012.01.015; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Waal F.B.M., 1990, PEACEMAKING PRIMATES; de Waal FBM, 2000, SCI AM, V282, P76, DOI 10.1038/scientificamerican0500-76; De Waal Frans, 2009, QUESTION ANIMAL CULT, P19; DEWAAL FBM, 1993, CHILD DEV, V64, P897, DOI 10.2307/1131225; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; FORDHAM DP, 1991, ANIM PROD, V52, P287, DOI 10.1017/S0003356100012794; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Fureix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039280; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; Hausberger M, 2012, NATURWISSENSCHAFTEN, V99, P291, DOI 10.1007/s00114-012-0902-8; Henry DB, 2005, J FAM PSYCHOL, V19, P121, DOI 10.1037/0893-3200.19.1.121; Henry S, 2012, PHYSIOL BEHAV, V106, P428, DOI 10.1016/j.physbeh.2012.02.025; Jensen KH, 1996, PHYSIOL BEHAV, V59, P741, DOI 10.1016/0031-9384(95)02159-0; Jiang J, 2013, J MED PRIMATOL, V42, P20, DOI 10.1111/jmp.12026; Latham NR, 2008, APPL ANIM BEHAV SCI, V110, P84, DOI 10.1016/j.applanim.2007.03.026; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; Maestripieri D, 2000, BEHAV PROCESS, V49, P167, DOI 10.1016/S0376-6357(00)00083-8; MAESTRIPIERI D, 1991, DEV PSYCHOBIOL, V24, P571, DOI 10.1002/dev.420240805; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P325, DOI [10.1079/9780851990040.0325, 10.1079/9780851990040.0000]; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Montaudouin S, 2004, BEHAV PROCESS, V67, P235, DOI 10.1016/j.beproc.2004.02.008; NAKAMICHI M, 1990, PRIMATES, V31, P213, DOI 10.1007/BF02380943; Nederhof E, 2012, PHYSIOL BEHAV, V106, P691, DOI 10.1016/j.physbeh.2011.12.008; Norscia I, 2011, PRIMATES, V52, P101, DOI 10.1007/s10329-010-0228-0; Novak MA, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P153, DOI 10.1079/9780851990040.0153; Palagi E, 2007, J ANTHROPOL SCI, V85, P63; Provencal N, 2012, J NEUROSCI, V32, P15626, DOI 10.1523/JNEUROSCI.1470-12.2012; Rommeck I, 2011, AM J PRIMATOL, V73, P692, DOI 10.1002/ajp.20953; Rommeck I, 2009, J AM ASSOC LAB ANIM, V48, P395; Rouff JH, 2005, AM J PRIMATOL, V67, P177, DOI 10.1002/ajp.20176; RUSHEN J, 1993, ANIM BEHAV, V45, P613, DOI 10.1006/anbe.1993.1071; Schino G, 1996, ANXIETY, V2, P186; SEAY B, 1962, J CHILD PSYCHOL PSYC, V3, P123, DOI 10.1111/j.1469-7610.1962.tb02047.x; Shivel CA, 2012, EXP NEUROL, V233, P87, DOI 10.1016/j.expneurol.2011.09.026; SOUTHWICK CH, 1967, BEHAVIOUR, V28, P182, DOI 10.1163/156853967X00235; STEVENSON-HINDE J, 1980, Primates, V21, P498, DOI 10.1007/BF02373838; Suomi SJ, 1997, BRIT MED BULL, V53, P170; Suomi SJ, 1991, NEUROBIOLOGY LEARNIN, P195; Suomi SJ, 2008, INTEGR PSYCHOL BEHAV, V42, P354, DOI 10.1007/s12124-008-9072-9; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; Vandeleest JJ, 2011, APPL ANIM BEHAV SCI, V132, P81, DOI 10.1016/j.applanim.2011.02.010; Veenema HC, 1997, NEUROBIOL AGING, V18, P509, DOI 10.1016/S0197-4580(97)00107-3; Zhang P, 2007, AM J PRIMATOL, V69, P1119, DOI 10.1002/ajp.20419	61	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67711	10.1371/journal.pone.0067711	http://dx.doi.org/10.1371/journal.pone.0067711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861787	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700025
J	O'Connor, TD; Kiezun, A; Bamshad, M; Rich, SS; Smith, JD; Turner, E; Leal, SM; Akey, JM				O'Connor, Timothy D.; Kiezun, Adam; Bamshad, Michael; Rich, Stephen S.; Smith, Joshua D.; Turner, Emily; Leal, Suzanne M.; Akey, Joshua M.		NHLBIGO Exome Sequencing Project; Stat Anal Working Grp	Fine-Scale Patterns of Population Stratification Confound Rare Variant Association Tests	PLOS ONE			English	Article							COALESCENT SIMULATION; MISSING HERITABILITY; PREVALENCE; STRATEGIES	Advances in next-generation sequencing technology have enabled systematic exploration of the contribution of rare variation to Mendelian and complex diseases. Although it is well known that population stratification can generate spurious associations with common alleles, its impact on rare variant association methods remains poorly understood. Here, we performed exhaustive coalescent simulations with demographic parameters calibrated from exome sequence data to evaluate the performance of nine rare variant association methods in the presence of fine-scale population structure. We find that all methods have an inflated spurious association rate for parameter values that are consistent with levels of differentiation typical of European populations. For example, at a nominal significance level of 5%, some test statistics have a spurious association rate as high as 40%. Finally, we empirically assess the impact of population stratification in a large data set of 4,298 European American exomes. Our results have important implications for the design, analysis, and interpretation of rare variant genome-wide association studies.	[O'Connor, Timothy D.; Bamshad, Michael; Smith, Joshua D.; Turner, Emily; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kiezun, Adam] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Kiezun, Adam] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; [Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rich, Stephen S.] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of Virginia; Baylor College of Medicine	O'Connor, TD (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	timothydoconnor@gmail.com; akeyj@u.washington.edu	Altshuler, David M/A-4476-2009; de Bakker, Paul IW/B-8730-2009; Barbalić, Maja/E-2161-2017	Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Barbalić, Maja/0000-0001-8914-1691; Caan, Bette/0000-0002-5803-310X; Seshadri, Sudha/0000-0001-6135-2622; Ballantyne, Christie/0000-0002-6432-1730; Quinlan, Aaron/0000-0003-1756-0859; Bustamante, Carlos D./0000-0002-4187-7920; O'Connor, Timothy/0000-0002-0276-1896; Akey, Joshua/0000-0002-4411-1330; Rich, Stephen/0000-0003-3872-7793; Turner, Emily/0000-0001-9040-9229; Shendure, Jay/0000-0002-1516-1865	NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102925, RC2HL102923, RC2HL103010, RC2HL102926, RC2HL102924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008122] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for GO ESP was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO) and RC2 HL-102924 (WHISP). The exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Fleming DM, 2004, EUR J PUBLIC HEALTH, V14, P10, DOI 10.1093/eurpub/14.1.10; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Peloso GM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-64; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Roeder K, 2009, GENOMICS, V93, P1, DOI 10.1016/j.ygeno.2008.04.004; Rosenberg NA, 2006, GENETICS, V173, P1665, DOI 10.1534/genetics.105.055335; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tintle N, 2011, GENET EPIDEMIOL, V35, pS56, DOI 10.1002/gepi.20650; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758; Zondervan KT, 2002, HUM REPROD, V17, P1415, DOI 10.1093/humrep/17.6.1415	39	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e65834	10.1371/journal.pone.0065834	http://dx.doi.org/10.1371/journal.pone.0065834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861739	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700003
J	Zhuang, ZG; Wang, K; Cheng, XL; Qu, XY; Jiang, BQ; Li, ZD; Luo, JM; Shao, ZM; Duan, T				Zhuang, Zhigang; Wang, Kai; Cheng, Xiaolin; Qu, Xueying; Jiang, Beiqi; Li, Zhengdong; Luo, Jianming; Shao, Zhiming; Duan, Tao			LKB1 Inhibits Breast Cancer Partially through Repressing the Hedgehog Signaling Pathway	PLOS ONE			English	Article							EXPRESSION; CELLS; SUPPRESSOR; CARCINOMA; PROTEIN	Constitutive activation of the Hedgehog (Hh) signaling pathway has been implicated in the development of many human malignancies. Hh targets, such as Patched (PTCH), smoothened (SMO), Sonic hedgehog (SHH) and glioma-associated oncogene homologue 1 (GLI1), are markers of Hh signaling activation and expressed in most Hh-associated tumors. The protein kinase LKB1 has been shown to slow proliferation and induce cell-cycle arrest in many cell lines. In this study, we observed that activated LKB1 decreased the expression of factors related to Hh reporter activity in MDA-MB-231 breast cancer cells, including of SMO, SHH and GLI1. In contrast, LKB1 siRNA increased the expression of these target genes. The same results were shown to inhibit the Hh factors Sufu and Hip. Furthermore, we also observed negative correlation between LKB1 and glioma-associated oncogene homologue 1 (GLI1) in three breast cancer cell lines. Meanwhile, LKB1 siRNA rescued the inhibition of cell growth by 3-Keto-N'-(aminoethyl-N'-aminocaproyldihydrocinnamoyl) cyclopamine (KAAD-cyclopamine), an antagonist of the Hh element SMO, which suggests that LKB1 acts as the downstream of SMO. In vivo, LKB1 siRNA increased tumor growth in the mammary fat pad, and the expression levels of Hh displayed similar results in vitro. Overexpression of the LKB1 protein in human breast cancers is associated with the expression of Hh. We found that breast carcinomas with detectable Hh had weak or undetectable expression of LKB1, whereas tumors that expressed high levels of LKB1 had undetectable Hh signaling. In this study, we find that LKB1 are negatively correlated with the expression of Hh related transcription factors. These findings suggest that LKB1 may inhibit tumorigenesis by regulating Hh signaling in certain cancers.	[Zhuang, Zhigang; Wang, Kai; Cheng, Xiaolin; Qu, Xueying; Jiang, Beiqi; Li, Zhengdong; Duan, Tao] Tongji Univ, Dept Breast Surg, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China; [Luo, Jianming; Shao, Zhiming] Fudan Univ, Breast Canc Inst, Canc Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Duan, T (corresponding author), Tongji Univ, Dept Breast Surg, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China.	tduan@yahoo.com			Shanghai Science and Technology Committee [09zr1424800, 124119a4700]; Shanghai Health Bureau scientific research subject [20124164]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Health Bureau scientific research subject	This study was supported by Shanghai Science and Technology Committee (grants 09zr1424800 and 124119a4700). Shanghai Health Bureau scientific research subject (20124164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Esteller M, 2000, ONCOGENE, V19, P164, DOI 10.1038/sj.onc.1203227; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kubo M, 2007, NIHON RINSHO, V28, P142; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Mori Y, 2006, ONCOLOGY-BASEL, V70, P378, DOI 10.1159/000098111; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; Shaw A, 2009, ONCOGENE, V28, P4480, DOI 10.1038/onc.2009.294; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Terry MB, 2002, CANCER EPIDEM BIOMAR, V11, P1100; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118	22	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67431	10.1371/journal.pone.0067431	http://dx.doi.org/10.1371/journal.pone.0067431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861764	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700014
J	Kucharik, CJ; VanLoocke, A; Lenters, JD; Motew, MM				Kucharik, Christopher J.; VanLoocke, Andy; Lenters, John D.; Motew, Melissa M.			Miscanthus Establishment and Overwintering in the Midwest USA: A Regional Modeling Study of Crop Residue Management on Critical Minimum Soil Temperatures	PLOS ONE			English	Article							INTEGRATED BIOSPHERE SIMULATOR; WATER-USE EFFICIENCY; X-GIGANTEUS; ENERGY-BALANCE; CARBON BALANCE; CLIMATE-CHANGE; CORN-BELT; HEAT; PERFORMANCE; GENOTYPES	Miscanthus is an intriguing cellulosic bioenergy feedstock because its aboveground productivity is high for low amounts of agrochemical inputs, but soil temperatures below -3.5 degrees C could threaten successful cultivation in temperate regions. We used a combination of observed soil temperatures and the Agro-IBIS model to investigate how strategic residue management could reduce the risk of rhizome threatening soil temperatures. This objective was addressed using a historical (1978-2007) reconstruction of extreme minimum 10 cm soil temperatures experienced across the Midwest US and model sensitivity studies that quantified the impact of crop residue on soil temperatures. At observation sites and for simulations that had bare soil, two critical soil temperature thresholds (50% rhizome winterkill at-3.5 degrees C and -6.0 degrees C for different Miscanthus genotypes) were reached at rhizome planting depth (10 cm) over large geographic areas. The coldest average annual extreme 10 cm soil temperatures were between -8 degrees C to -11 degrees C across North Dakota, South Dakota, and Minnesota. Large portions of the region experienced 10 cm soil temperatures below -3.5 degrees C in 75% or greater for all years, and portions of North and South Dakota, Minnesota, and Wisconsin experienced soil temperatures below -6.0 degrees C in 50-60% of all years. For simulated management options that established varied thicknesses (1-5 cm) of miscanthus straw following harvest, extreme minimum soil temperatures increased by 2.5 degrees C to 6 degrees C compared to bare soil, with the greatest warming associated with thicker residue layers. While the likelihood of 10 cm soil temperatures reaching -3.5 degrees C was greatly reduced with 2-5 cm of surface residue, portions of the Dakotas, Nebraska, Minnesota, and Wisconsin still experienced temperatures colder than -3.5 degrees C in 50-80% of all years. Nonetheless, strategic residue management could help increase the likelihood of overwintering of miscanthus rhizomes in the first few years after establishment, although low productivity and biomass availability during these early stages could hamper such efforts.	[Kucharik, Christopher J.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Kucharik, Christopher J.; Motew, Melissa M.] Univ Wisconsin, Nelson Inst Ctr Sustainabil & Global Environm, Madison, WI USA; [Kucharik, Christopher J.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI USA; [VanLoocke, Andy] Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; [Lenters, John D.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Nebraska System; University of Nebraska Lincoln	Kucharik, CJ (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	kucharik@wisc.edu		Motew, Melissa/0000-0003-1686-4754; Lenters, John/0000-0002-6895-7592; Kucharik, Christopher/0000-0002-0400-758X; VanLoocke, Andy/0000-0002-7516-8479	U.S. Department of Energy's Office of Science through the Midwestern Regional Center for the National Institute for Climatic Change Research at Michigan Technological University [DE-FC02-06ER64158]; U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]; U.S. Department of Energy Biomass Program Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830]	U.S. Department of Energy's Office of Science through the Midwestern Regional Center for the National Institute for Climatic Change Research at Michigan Technological University(United States Department of Energy (DOE)); U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy Biomass Program Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This research was partially supported by the U.S. Department of Energy's Office of Science through the Midwestern Regional Center for the National Institute for Climatic Change Research at Michigan Technological University, under Award Number DE-FC02-06ER64158. This work was also funded in part by the U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science DE-FC02-07ER64494) and U.S. Department of Energy Biomass Program Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASE JK, 1979, SOIL SCI SOC AM J, V43, P1229, DOI 10.2136/sssaj1979.03615995004300060036x; Amougou N, 2012, GCB BIOENERGY, V4, P698, DOI 10.1111/j.1757-1707.2012.01192.x; BRISTOW KL, 1986, AGR FOREST METEOROL, V36, P193, DOI 10.1016/0168-1923(86)90035-3; Campbell GS., 1998, INTRO ENV BIOPHYSICS, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Cherkauer KA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003575; Cherkauer KA, 1999, J GEOPHYS RES-ATMOS, V104, P19599, DOI 10.1029/1999JD900337; CHUNG SO, 1987, WATER RESOUR RES, V23, P2175, DOI 10.1029/WR023i012p02175; Clemmensen AW, 2004, COMPOST SCI UTIL, V12, P219; Clifton-Brown JC, 2000, NEW PHYTOL, V148, P287, DOI 10.1046/j.1469-8137.2000.00764.x; Clifton-Brown JC, 2000, ANN BOT-LONDON, V86, P191, DOI 10.1006/anbo.2000.1183; Clifton-Brown JC, 2001, AGRON J, V93, P1013, DOI 10.2134/agronj2001.9351013x; COLLATZ GJ, 1992, AUST J PLANT PHYSIOL, V19, P519, DOI 10.1071/PP9920519; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Delire C, 1999, J GEOPHYS RES-ATMOS, V104, P16895, DOI 10.1029/1999JD900212; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; Donner SD, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001808; Dyer JL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027258; El Maayar M, 2001, J GEOPHYS RES-ATMOS, V106, P14339, DOI 10.1029/2001JD900155; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Farrell AD, 2006, ANN APPL BIOL, V149, P337, DOI 10.1111/j.1744-7348.2006.00099.x; Flerchinger GN, 2012, T ASABE, V55, P1395; FLERCHINGER GN, 1991, T ASAE, V34, P2381, DOI 10.13031/2013.31883; Flerchinger GN, 2003, GEODERMA, V116, P217, DOI 10.1016/S0016-7061(03)00102-2; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Gauder M, 2012, ANN APPL BIOL, V160, P126, DOI 10.1111/j.1744-7348.2011.00526.x; GREEF JM, 1993, ANGEW BOT, V67, P87; Heaton E, 2004, BIOMASS BIOENERG, V27, P21, DOI 10.1016/j.biombioe.2003.10.005; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Heaton EA, 2008, CURR OPIN BIOTECH, V19, P202, DOI 10.1016/j.copbio.2008.05.001; Heaton EA, 2010, ADV BOT RES, V56, P75, DOI 10.1016/S0065-2296(10)56003-8; Hillel D., 2003, INTRO ENV SOIL PHYS; Horton R, 1996, THEOR APPL CLIMATOL, V54, P27, DOI 10.1007/BF00863556; Hu Q, 2003, J APPL METEOROL, V42, P1139, DOI 10.1175/1520-0450(2003)042&lt;1139:ADSTDA&gt;2.0.CO;2; Isard SA, 2007, ANN ASSOC AM GEOGR, V97, P467, DOI 10.1111/j.1467-8306.2007.00558.x; JORGENSEN U, 2001, MISCANTHUS ENERGY FI, P68; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Khanna M, 2008, BIOMASS BIOENERG, V32, P482, DOI 10.1016/j.biombioe.2007.11.003; Kucharik CJ, 2007, AGR FOREST METEOROL, V146, P134, DOI 10.1016/j.agrformet.2007.05.011; Kucharik CJ, 2006, AGRON J, V98, P1544, DOI 10.2134/agronj2006.0156; Kucharik CJ, 2006, ECOL MODEL, V196, P1, DOI 10.1016/j.ecolmodel.2005.11.031; Kucharik CJ, 2010, PHYS GEOGR, V31, P1, DOI 10.2747/0272-3646.31.1.1; Kucharik CJ, 2003, EARTH INTERACT, V7; Kucharik CJ, 2003, J ENVIRON QUAL, V32, P247, DOI 10.2134/jeq2003.0247; Kucharik CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P795, DOI 10.1029/1999GB001138; Kunkel KE, 1999, J GEOPHYS RES-ATMOS, V104, P19551, DOI 10.1029/1999JD900050; Kunkel KE, 2007, J ATMOS OCEAN TECH, V24, P64, DOI 10.1175/JTECH2017.1; Lenters JD, 2000, J GEOPHYS RES-ATMOS, V105, P22393, DOI 10.1029/2000JD900277; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Li KY, 2005, J CLIMATE, V18, P3173, DOI 10.1175/JCLI3452.1; MathWorks, 2010, MATLAB 7 11; Miao Z, 2011, IND CROP PROD, V33, P504, DOI 10.1016/j.indcrop.2010.12.016; Miller DA, 1998, EARTH INTERACT, V2, P2, DOI DOI 10.1175/1087-3562(1998)002<0001:ACUSMS>2.3.C0;2; Molling CC, 2005, J AM WATER RESOUR AS, V41, P1289, DOI 10.1111/j.1752-1688.2005.tb03801.x; NUMATA M, 1974, FLORA VEGETATION JAP, P125; Portmann RW, 2009, P NATL ACAD SCI USA, V106, P7324, DOI 10.1073/pnas.0808533106; Price L, 2004, BIOMASS BIOENERG, V26, P3, DOI 10.1016/S0961-9534(03)00062-X; Pyter R, 2009, METHODS MOL BIOL, V581, P41, DOI 10.1007/978-1-60761-214-8_3; Pyter RJ, 2010, BIOMASS BIOENERG, V34, P1466, DOI 10.1016/j.biombioe.2010.04.014; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Sauer TJ, 1998, AGR FOREST METEOROL, V89, P155, DOI 10.1016/S0168-1923(97)00090-7; Sauer TJ, 1996, AGRON J, V88, P733, DOI 10.2134/agronj1996.00021962008800050009x; Sharratt BS, 2002, SOIL TILL RES, V64, P243, DOI 10.1016/S0167-1987(01)00260-4; Sharratt BS, 1998, SOIL TILL RES, V49, P243, DOI 10.1016/S0167-1987(98)00181-0; SHARRATT BS, 1992, AGR FOREST METEOROL, V57, P243, DOI 10.1016/0168-1923(92)90121-J; SHEN Y, 1990, SOIL SCI SOC AM J, V54, P653, DOI 10.2136/sssaj1990.03615995005400030005x; Simunek J, 2008, HYDRUS SOFTWARE SERI, V3, P330; Simunek J, 2008, VADOSE ZONE J, V7, P782, DOI 10.2136/vzj2007.0074; Sinha T, 2008, J HYDROMETEOROL, V9, P936, DOI 10.1175/2008JHM934.1; Sinha T, 2010, J HYDROMETEOROL, V11, P229, DOI 10.1175/2009JHM1141.1; Sinha T, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012188; Smith CM, 2013, J ENVIRON QUAL, V42, P219, DOI 10.2134/jeq2012.0210; Soylu ME, 2011, HYDROL EARTH SYST SC, V15, P787, DOI 10.5194/hess-15-787-2011; Steiner JL, 1996, THEOR APPL CLIMATOL, V54, P1, DOI 10.1007/BF00863553; SUI HJ, 1992, AGR FOREST METEOROL, V61, P281, DOI 10.1016/0168-1923(92)90054-8; TANNER CB, 1990, SOIL SCI SOC AM J, V54, P945, DOI 10.2136/sssaj1990.03615995005400040001x; Twine TE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000599; Van Wijk W., 1963, PHYS PLANT ENV, P102; VanLoocke A, 2012, AGR FOREST METEOROL, V164, P82, DOI 10.1016/j.agrformet.2012.05.016; Vanloocke A, 2010, GCB BIOENERGY, V2, P180, DOI 10.1111/j.1757-1707.2010.01053.x; Wagenaar BM, 1997, BIOMASS BIOENERG, V12, P185, DOI 10.1016/S0961-9534(97)00009-3; Wilhelm WW, 2004, AGRON J, V96, P1, DOI 10.2134/agronj2004.0001; Zeri M, 2011, AGR ECOSYST ENVIRON, V144, P319, DOI 10.1016/j.agee.2011.09.006; Zheng Daolan, 1993, Climate Research, V2, P183, DOI 10.3354/cr002183; Zub HW, 2010, AGRON SUSTAIN DEV, V30, P201, DOI 10.1051/agro/2009034	85	28	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68847	10.1371/journal.pone.0068847	http://dx.doi.org/10.1371/journal.pone.0068847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844244	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000029
J	Li, YY; Cao, MH; Goetz, B; Chen, CQ; Feng, YJ; Chen, CJ; Kasparek, MS; Sibaev, A; Storr, M; Kreis, ME				Li, Yong-yu; Cao, Ming-hua; Goetz, Brigitte; Chen, Chun-qiu; Feng, Ya-jing; Chen, Chang-Jie; Kasparek, Michael S.; Sibaev, Andrej; Storr, Martin; Kreis, Martin E.			The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NEURONAL PATHWAYS; MYENTERIC PLEXUS; CB1 RECEPTORS; GUINEA-PIG; MICE; MOUSE; COLON; EXPRESSION; SYSTEM	Introduction: Intestinal inflammatory responses play a critical role in the pathogenesis of postoperative ileus (POI). As cannabinoid receptor-1 (CB1) is involved in inhibiting gastrointestinal (GI) motility and anti-inflammation, we aimed to explore its contribution to POI. Methods: Experimental POI was induced in adult female CB1-deficient (CB1-/-) mice and wild-type littermates (C57BL/6N) by standardized small bowel manipulation. Twenty-four hours after surgery, GI transit was assessed by charcoal transport. FITC avidin, F4/80, and myeloperoxidase immunohistochemistry techniques were used to evaluate the inflammatory response in the muscularis of ileum and colon. Expressions of p38MAPK and its phosphorylated form (pp38) in the intestine were determined. Plasma levels of proinflammatory cytokines and chemokines were measured by ELISA as well. Results: POI was characterized by decreased GI transit (p<0.01) and accompanied by a marked intestinal and systematic inflammatory response in wild-type and CB1-/- mice. Increased numbers of inflammatory cells, including macrophages, neutrophils, and mast cells were observed in the muscularis of ileum and colon (p<0.01, or p<0.05). Plasma levels of interleukin-6 (IL-6), cytokine-induced neutrophil chemoattractant-1 (CINC-1/KC), and monocyte chemoattractant protein-1 (MCP-1) were elevated (p<0.01, or p<0.05). Expression of p38 and pp38 increased in the intestine (p<0.01, or p<0.05). CB1-/- mice showed an increased inflammatory response during POI, especially the systemic inflammatory markers, such as IL-6, KC, CINC1, and pp38 expression were increased as compared to those in WT mice (p<0.05). Conclusions: Intestinal motility was inhibited during POI. In this condition, inhibition of motility did not seem to be altered by the absence of CB1 receptors, however, an increased inflammatory response was observed in CB1-/- mice. Hence, CB1 receptor activation rather than inhibition may reduce the inflammatory response in POI, which has a remote potential to relate into reduced inhibition of intestinal motility during POI.	[Li, Yong-yu; Cao, Ming-hua; Chen, Chun-qiu; Feng, Ya-jing; Chen, Chang-Jie] Tongji Univ, Sch Med, Inst Digest Dis, Dept Pathophysiol, Shanghai 200092, Peoples R China; [Goetz, Brigitte; Kasparek, Michael S.] Univ Munich, Dept Surg, Hosp Grosshadern, Munich, Germany; [Sibaev, Andrej; Storr, Martin] Univ Munich, Dept Internal Med 2, Hosp Grosshadern, Munich, Germany; [Kreis, Martin E.] Charite, Dept Gen Visceral & Vasc Surg, D-13353 Berlin, Germany	Tongji University; University of Munich; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Li, YY (corresponding author), Tongji Univ, Sch Med, Inst Digest Dis, Dept Pathophysiol, Shanghai 200092, Peoples R China.	liyongyu@tongji.edu.cn		Kreis, Martin E./0000-0002-9312-4840	National Natural Science Foundation of China [81270477, 81170345]; Deutsche Forschungs-gemeinschaft [DFG KA 2329/5-1]; Deutsche Akademische Austauschdienst (DAAD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungs-gemeinschaft(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by the National Natural Science Foundation of China (grants 81270477 to Dr. Yong-yu Li, and 81170345 to Dr. Chun-qiu Chen), and the Deutsche Forschungs-gemeinschaft (DFG KA 2329/5-1 to Dr. Michael S. Kasparek), and a travel grant by the Deutsche Akademische Austauschdienst (DAAD) to Dr. Yong-yu Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami M, 2002, BRIT J PHARMACOL, V135, P1598, DOI 10.1038/sj.bjp.0704625; Barquist E, 1996, AM J PHYSIOL-REG I, V270, pR888, DOI 10.1152/ajpregu.1996.270.4.R888; Bauer AJ, 2004, NEUROGASTROENT MOTIL, V16, P54, DOI 10.1111/j.1743-3150.2004.00558.x; Cao MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052921; Casu MA, 2003, EUR J PHARMACOL, V459, P97, DOI 10.1016/S0014-2999(02)02830-3; Coutts AA, 1998, CAN J PHYSIOL PHARM, V76, P340, DOI 10.1139/cjpp-76-3-340; Coutts AA, 2002, J COMP NEUROL, V448, P410, DOI 10.1002/cne.10270; De Jonge WJ, 2004, GASTROENTEROLOGY, V127, P535, DOI 10.1053/j.gastro.2004.04.017; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; DeWinter BY, 1997, BRIT J PHARMACOL, V120, P464, DOI 10.1038/sj.bjp.0700913; Di Marzo V, 2006, GUT, V55, P1373, DOI 10.1136/gut.2005.090472; Gao ZR, 2010, LANGENBECK ARCH SURG, V395, P407, DOI 10.1007/s00423-010-0594-5; Hornby PJ, 2004, BRIT J PHARMACOL, V141, P1335, DOI 10.1038/sj.bjp.0705783; Kalff JC, 1999, GASTROENTEROLOGY, V117, P378, DOI 10.1053/gast.1999.0029900378; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kathmann M, 2001, BRIT J PHARMACOL, V132, P1169, DOI 10.1038/sj.bjp.0703987; Kirkup AJ, 2001, AM J PHYSIOL-GASTR L, V280, pG787, DOI 10.1152/ajpgi.2001.280.5.G787; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Kreis ME, 2003, ZBL CHIR, V128, P320, DOI 10.1055/s-2003-38797; Landi M, 2002, EUR J PHARMACOL, V450, P77, DOI 10.1016/S0014-2999(02)02053-8; Li YY, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01419.x; LIVINGSTON EH, 1990, DIGEST DIS SCI, V35, P121, DOI 10.1007/BF01537233; Manara L, 2002, DIGEST LIVER DIS, V34, P262, DOI 10.1016/S1590-8658(02)80146-3; Mancinelli R, 2001, LIFE SCI, V69, P101, DOI 10.1016/S0024-3205(01)01110-9; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Marzo VD, 2008, NAT REV DRUG DISCOV, V7, P438; Mascolo N, 2002, FASEB J, V16, P1973, DOI 10.1096/fj.02-0338fje; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mueller MH, 2008, ANN SURG, V247, P791, DOI 10.1097/SLA.0b013e31816a9d97; Mueller MH, 2011, J GASTROINTEST SURG, V15, P891, DOI 10.1007/s11605-011-1481-2; Ohama Takashi, 2007, Journal of Smooth Muscle Research, V43, P43, DOI 10.1540/jsmr.43.43; Pinto L, 2002, GASTROENTEROLOGY, V123, P227, DOI 10.1053/gast.2002.34242; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Scaldaferri F, 2009, EUR J IMMUNOL, V39, P290, DOI 10.1002/eji.200838316; Snoek SA, 2012, NEUROGASTROENT MOTIL, V24, P172, DOI 10.1111/j.1365-2982.2011.01820.x; Spiller RC, 2003, CURR OPIN GASTROEN, V19, P103, DOI 10.1097/00001574-200303000-00001; Storr M, 2004, AM J PHYSIOL-GASTR L, V286, pG110, DOI 10.1152/ajpgi.00148.2003; Storr M, 2008, GASTROENTEROLOGY, V134, pA430; The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022; Tsuchida Y, 2011, GUT, V60, P638, DOI 10.1136/gut.2010.227546; Wright K, 2005, GASTROENTEROLOGY, V129, P437, DOI 10.1053/j.gastro.2005.05.026	42	7	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67427	10.1371/journal.pone.0067427	http://dx.doi.org/10.1371/journal.pone.0067427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844009	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000071
J	Loughry, WJ; Perez-Heydrich, C; McDonough, CM; Oli, MK				Loughry, William J.; Perez-Heydrich, Carolina; McDonough, Colleen M.; Oli, Madan K.			Population Dynamics and Range Expansion in Nine-Banded Armadillos	PLOS ONE			English	Article							DASYPUS-NOVEMCINCTUS; SENSITIVITY-ANALYSIS; RECORDS; DISPERSAL; ELASTICITIES; SUCCESS; SPREAD; SPEED	Understanding why certain species can successfully colonize new areas while others do not is a central question in ecology. The nine-banded armadillo (Dasypus novemcinctus) is a conspicuous example of a successful invader, having colonized much of the southern United States in the last 200 years. We used 15 years (1992-2006) of capture-mark-recapture data from a population of armadillos in northern Florida in order to estimate, and examine relationships among, various demographic parameters that may have contributed to this ongoing range expansion. Modeling across a range of values for gamma, the probability of juveniles surviving in the population until first capture, we found that population growth rates varied from 0.80 for gamma = 0.1, to 1.03 for gamma = 1.0. Growth rates approached 1.0 only when gamma >= 0.80, a situation that might not occur commonly because of the high rate of disappearance of juveniles. Net reproductive rate increased linearly with gamma, but life expectancy (estimated at 3 years) was independent of gamma. We also found that growth rates were lower during a 3-year period of hardwood removal that removed preferred habitat than in the years preceding or following. Life-table response experiment (LTRE) analysis indicated the decrease in growth rate during logging was primarily due to changes in survival rates of adults. Likewise, elasticity analyses of both deterministic and stochastic population growth rates revealed that survival parameters were more influential on population growth than were those related to reproduction. Collectively, our results are consistent with recent theories regarding biological invasions which posit that populations no longer at the leading edge of range expansion do not exhibit strong positive growth rates, and that high reproductive output is less critical in predicting the likelihood of successful invasion than are life-history strategies that emphasize allocation of resources to future, as opposed to current, reproduction.	[Loughry, William J.; McDonough, Colleen M.] Valdosta State Univ, Dept Biol, Valdosta, GA 31698 USA; [Perez-Heydrich, Carolina] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	University System of Georgia; Valdosta State University; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida	Loughry, WJ (corresponding author), Valdosta State Univ, Dept Biol, Valdosta, GA 31698 USA.	jloughry@valdosta.edu			Earthwatch; American Philosophical Society; faculty research awards from Valdosta State University; University of Florida Open Access Publishing Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	Earthwatch; American Philosophical Society; faculty research awards from Valdosta State University; University of Florida Open Access Publishing Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Field work was supported by Earthwatch, the American Philosophical Society, and faculty research awards from Valdosta State University. Publication supported by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba Agustin Manuel, 2010, Edentata, V11, P135; Altwegg R, 2013, DIVERS DISTRIB, V19, P60, DOI 10.1111/j.1472-4642.2012.00943.x; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Audubon John James, 1854, QUADRUPEDS N AM, V3; Caswell H, 2005, AUST NZ J STAT, V47, P75, DOI 10.1111/j.1467-842X.2005.00373.x; CASWELL H, 1989, ECOL MODEL, V46, P221, DOI 10.1016/0304-3800(89)90019-7; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Dobson FS, 2001, AM NAT, V158, P236, DOI 10.1086/321322; Eichler S. Erich, 2011, Edentata, V12, P7; Ellner SP, 2012, THEOR POPUL BIOL, V82, P283, DOI 10.1016/j.tpb.2012.03.005; Elton C., 1958; Freeman PW, 1998, SOUTHWEST NAT, V43, P491; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Haridas CV, 2005, AM NAT, V166, P481, DOI 10.1086/444444; Hofmann Joyce E., 2009, Transactions of the Illinois State Academy of Science, V102, P95; Hostetler JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034379; HUMPHREY SR, 1974, BIOSCIENCE, V24, P457, DOI 10.2307/1296853; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Loughry WJ, 2013, J MAMMAL, V94, P408, DOI 10.1644/12-MAMM-A-198.1; Loughry W.J., 2013, 9 BANDED ARMADILLO N; Loughry WJ, 1996, AM MIDL NAT, V135, P53, DOI 10.2307/2426871; Loughry WJ, 1998, CAN J ZOOL, V76, P1815, DOI 10.1139/cjz-76-10-1815; Loughry WJ, 2001, ACTA THERIOL, V46, P393, DOI 10.1007/BF03192446; McDonough CM, 1997, AM MIDL NAT, V138, P299, DOI 10.2307/2426823; McDonough CM, 2005, WILDLIFE SOC B, V33, P1198, DOI 10.2193/0091-7648(2005)33[1198:IOLMPO]2.0.CO;2; McDonough CM, 2007, SOUTHEAST NAT, V6, P381, DOI 10.1656/1528-7092(2007)6[381:PDONAI]2.0.CO;2; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Peppler Richard D., 2008, P151; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Platt SG, 1995, BRIMLEYANA, P89; Prodohl PA, 1996, P ROY SOC B-BIOL SCI, V263, P1643, DOI 10.1098/rspb.1996.0240; Rolland V, 2011, WILDLIFE RES, V38, P396, DOI 10.1071/WR10239; Royama T., 1992, ANAL POPULATION ECOL; Shigesada N, 1997, BIOL INVASIONS THEOR; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol D, 2012, SCIENCE, V337, P580, DOI 10.1126/science.1221523; STEVENSON H M, 1974, Florida Field Naturalist, V2, P8; Stuart James N., 2007, Prairie Naturalist, V39, P163; Taulman JF, 1996, J BIOGEOGR, V23, P635, DOI 10.1111/j.1365-2699.1996.tb00024.x; Tuljapurkar S, 2003, AM NAT, V162, P489, DOI 10.1086/378648; Van Deelen TR, 2002, SOUTHWEST NAT, V47, P489; Whitaker Jr JO, 2010, MAMMALS INDIANA FIEL; Zenni RD, 2013, OIKOS, V122, P801, DOI 10.1111/j.1600-0706.2012.00254.x	44	9	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68311	10.1371/journal.pone.0068311	http://dx.doi.org/10.1371/journal.pone.0068311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844183	Green Published, gold			2022-12-25	WOS:000321733000138
J	Tonk, L; Sampayo, EM; Weeks, S; Magno-Canto, M; Hoegh-Guldberg, O				Tonk, Linda; Sampayo, Eugenia M.; Weeks, Scarla; Magno-Canto, Marites; Hoegh-Guldberg, Ove			Host-Specific Interactions with Environmental Factors Shape the Distribution of Symbiodinium across the Great Barrier Reef	PLOS ONE			English	Article							CORAL GENUS MADRACIS; ALGAL ENDOSYMBIONTS; SYMBIONT DIVERSITY; BLEACHING SUSCEPTIBILITY; SCLERACTINIAN CORALS; SERIATOPORA-HYSTRIX; CLIMATE-CHANGE; CLADE-D; ZOOXANTHELLAE; PATTERNS	Background: The endosymbiotic dinoflagellates (genus Symbiodinium) within coral reef invertebrates are critical to the survival of the holobiont. The genetic variability of Symbiodinium may contribute to the tolerance of the symbiotic association to elevated sea surface temperatures (SST). To assess the importance of factors such as the local environment, host identity and biogeography in driving Symbiodinium distributions on reef-wide scales, data from studies on reef invertebrate-Symbiodinium associations from the Great Barrier Reef (GBR) were compiled. Methodology/Principal Findings: The resulting database consisted of 3717 entries from 26 studies. It was used to explore ecological patterns such as host-specificity and environmental drivers structuring community complexity using a multi-scalar approach. The data was analyzed in several ways: (i) frequently sampled host species were analyzed independently to investigate the influence of the environment on symbiont distributions, thereby excluding the influence of host specificity, (ii) host species distributions across sites were added as an environmental variable to determine the contribution of host identity on symbiont distribution, and (iii) data were pooled based on clade (broad genetic groups dividing the genus Symbiodinium) to investigate factors driving Symbiodinium distributions using lower taxonomic resolution. The results indicated that host species identity plays a dominant role in determining the distribution of Symbiodinium and environmental variables shape distributions on a host species-specific level. SST derived variables (especially SSTstdev) most often contributed to the selection of the best model. Clade level comparisons decreased the power of the predictive model indicating that it fails to incorporate the main drivers behind Symbiodinium distributions. Conclusions/Significance: Including the influence of different host species on Symbiodinium distributional patterns improves our understanding of the drivers behind the complexity of Symbiodinium-invertebrate symbioses. This will increase our ability to generate realistic models estimating the risk reefs are exposed to and their resilience in response to a changing climate.	[Tonk, Linda; Sampayo, Eugenia M.; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Tonk, Linda; Sampayo, Eugenia M.; Hoegh-Guldberg, Ove] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Weeks, Scarla; Magno-Canto, Marites] Univ Queensland, Biophys Oceanog Grp, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia; [Tonk, Linda; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland	Tonk, L (corresponding author), Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia.	l.tonk@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Weeks, Scarla J/E-8632-2013	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Weeks, Scarla J/0000-0002-0579-7069	Great Barrier Reef Foundation; Queensland Smart State Fellowship Award; ARC Centre of Excellence for Coral Reef Studies	Great Barrier Reef Foundation; Queensland Smart State Fellowship Award; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	LT, SW and OHG were supported by funding from the Great Barrier Reef Foundation, the Queensland Smart State Fellowship Award (to OHG) and the ARC Centre of Excellence for Coral Reef Studies. EMS was supported by the ARC Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2011, CONT SHELF RES, V31, P1384, DOI 10.1016/j.csr.2011.05.018; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bongaerts P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-303; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Chen CA, 2005, CORAL REEFS, V24, P11, DOI 10.1007/s00338-004-0389-7; Chen CA, 2003, ZOOL STUD, V42, P540; Cooper TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025536; Diekmann OE, 2003, CORAL REEFS, V22, P29, DOI 10.1007/s00338-002-0273-2; Diekmann OE, 2002, MAR ECOL PROG SER, V227, P221, DOI 10.3354/meps227221; Dove SG, 2008, PLANT CELL ENVIRON, V31, P1523, DOI 10.1111/j.1365-3040.2008.01852.x; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Finney JC, 2010, MICROB ECOL, V60, P250, DOI 10.1007/s00248-010-9681-y; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; Frade PR, 2008, LIMNOL OCEANOGR, V53, P2711, DOI 10.4319/lo.2008.53.6.2711; Goulet TL, 2008, MAR BIOL, V154, P795, DOI 10.1007/s00227-008-0972-5; Goulet TL, 2008, MAR ECOL PROG SER, V355, P45, DOI 10.3354/meps07214; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Hill M, 2011, MOL PHYLOGENET EVOL, V59, P81, DOI 10.1016/j.ympev.2011.01.006; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Howells EJ, 2009, CORAL REEFS, V28, P215, DOI 10.1007/s00338-008-0450-z; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; LaJeunesse TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029013; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Lee Z, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003802; Lien YT, 2007, CORAL REEFS, V26, P35, DOI 10.1007/s00338-006-0185-7; Lien YT, 2012, ZOOL SCI, V29, P173, DOI 10.2108/zsj.29.173; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; McGinley MP, 2012, MAR ECOL PROG SER, V462, P1, DOI 10.3354/meps09914; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Pochon X, 2007, CORAL REEFS, V26, P867, DOI 10.1007/s00338-007-0279-x; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Rodriguez-Lanetty M, 2003, MAR BIOL, V143, P1193, DOI 10.1007/s00227-003-1165-x; Rodriguez-Lanetty M, 2003, MAR BIOL, V143, P501, DOI 10.1007/s00227-003-1105-9; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Teneva L, 2012, CORAL REEFS, V31, P1, DOI 10.1007/s00338-011-0812-9; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Tonk L, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-7; Ulstrup KE, 2008, MAR ECOL PROG SER, V361, P139, DOI 10.3354/meps07360; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; Van Oppen MJH, 2005, MOL ECOL, V14, P2403, DOI 10.1111/j.1365-294X.2005.02545.x; van Oppen MJH, 2004, MAR BIOL, V144, P1, DOI 10.1007/s00227-003-1187-4; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; van Woesik R, 2012, P ROY SOC B-BIOL SCI, V279, P2448, DOI 10.1098/rspb.2011.2621; Venn AA, 2008, BIOL BULL-US, V215, P243, DOI 10.2307/25470708; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Weeks SJ, 2010, CORAL REEFS, V29, P975, DOI 10.1007/s00338-010-0644-z; Weeks S, 2012, REMOTE SENS-BASEL, V4, P3781, DOI 10.3390/rs4123781; Wicks LC, 2010, MAR ECOL PROG SER, V400, P101, DOI 10.3354/meps08398	78	51	52	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68533	10.1371/journal.pone.0068533	http://dx.doi.org/10.1371/journal.pone.0068533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844217	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000014
J	Njanpop-Lafourcade, BM; Hugonnet, S; Djogbe, H; Kodjo, A; N'douba, AK; Taha, MK; Stoeckel, P; Gessner, BD				Njanpop-Lafourcade, Berthe-Marie; Hugonnet, Stephane; Djogbe, Honore; Kodjo, Agbenoko; N'douba, Adele Kacou; Taha, Muhamed-Kheir; Stoeckel, Philippe; Gessner, Bradford D.			Mobile Microbiological Laboratory Support for Evaluation of a Meningitis Epidemic in Northern Benin	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; BURKINA-FASO; MOLECULAR CHARACTERISTICS; MENINGOCOCCAL MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL MENINGITIS; SEROGROUP W135; DISEASE; BELT; SEROTYPE-1	Background: Fixed laboratory capacity in Africa may be inadequate; mobile microbiological laboratories may address this issue but their utility has seldom been evaluated. Methods: During 2012, the Benin Ministry of Health requested mobile microbiological laboratory (LaboMobil (R)) support following the failure of polysaccharide meningococcal A+C vaccine to prevent an epidemic in five Northern districts. Within four days, the intervention was initiated. A fixed site in Northern Togo, Pasteur Institutes in Cote d'Ivoire and France, and a research laboratory in Burkina Faso provided additional laboratory support. Results: Local laboratories initially reported most cases to have Gram-positive diplococci suggestive of pneumococcal meningitis. The LaboMobil (R) evaluated 200 cerebrospinal fluid (CSF) samples and 59 stored isolates collected from 149 individuals. Of the 74 individuals with etiologic confirmation, 60 (81%) had NmW135 and 11 (15%) NmX identified; no pneumococci were identified. Testing in France on 30 NmW135 and 3 NmX confirmed the etiology in all cases. All five districts had crossed the epidemic threshold (10 cases per 100,000 per week), all had NmW135 identified and four had NmX identified. NmX were identified as X: ST-181: ccST-181: 5-1: 10-1: F1-31 and NmW135 as W: ST-11: ccST-11: 5: 2: F1-1. Conclusions: In an area with limited local laboratory capacity, a mobile microbiology laboratory intervention occurred in four days through the cooperation of four African and one European country. Results were different from those reported by local laboratories. Despite the introduction of serogroup A meningococcal and 13-valent pneumococcal conjugate vaccines, endemic and epidemic meningitis will continue in the region, emphasizing the usefulness of the LaboMobil (R) in the short and medium term.	[Njanpop-Lafourcade, Berthe-Marie; Stoeckel, Philippe] AMP, Paris, France; [Hugonnet, Stephane] World Hlth Org, Geneva, Switzerland; [Djogbe, Honore] Minist Hlth, Cotonou, Benin; [Kodjo, Agbenoko] Reg Hosp Lab, Dapaong, Togo; [N'douba, Adele Kacou] Inst Pasteur, Abidjan, Cote Ivoire; [Taha, Muhamed-Kheir] World Hlth Org, Inst Pasteur, Natl Meningococcal Reference Ctr, Collaborating Ctr, Paris, France; [Gessner, Bradford D.] AMP, Bur Liaison, Ferney Voltaire, France	Agence de Medecine Preventive; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization	Gessner, BD (corresponding author), AMP, Bur Liaison, Ferney Voltaire, France.	bgessner@aamp.org		Kodjo, Angeli/0000-0002-7247-9765	World Health Organization, Geneva, Switzerland	World Health Organization, Geneva, Switzerland(World Health Organization)	The current evaluation was supported partially by funding from the World Health Organization, Geneva, Switzerland. Human resources were contributed by the Benin and Togo Ministries of Health and the Pasteur Institutes of Cote d'Ivoire and France. Employees from each of these funding sources contributed to the current investigation and to the drafting of the manuscript.	AJELLO GW, 1984, J CLIN MICROBIOL, V20, P55, DOI 10.1128/JCM.20.1.55-58.1984; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; Djibo S, 2003, TROP MED INT HEALTH, V8, P1118, DOI 10.1046/j.1360-2276.2003.01126.x; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Fox AJ, 2007, FEMS MICROBIOL REV, V31, P84, DOI 10.1111/j.1574-6976.2006.00048.x; Gagneux SP, 2002, J INFECT DIS, V185, P618, DOI 10.1086/339010; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Kristiansen PA, 2012, CLIN INFECT DIS; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mueller JE, 2006, EXPERT REV VACCINES, V5, P319, DOI 10.1586/14760584.5.3.319; Ndihokubwayo J.B.K., 2010, AFRICAN HLTH MONITOR, P47; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Tikhomirov Eugene, 1997, World Health Statistics Quarterly, V50, P170; Traore Y, 2008, 1 FACTS, V1; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; Traore Y, 2006, CLIN INFECT DIS, V43, P817, DOI 10.1086/507339; US Centers for Disease Control and Prevention, 2010, CDCSA201002; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	25	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68401	10.1371/journal.pone.0068401	http://dx.doi.org/10.1371/journal.pone.0068401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844195	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000159
J	Rapanoel, HA; Mazandu, GK; Mulder, NJ				Rapanoel, Holifidy A.; Mazandu, Gaston K.; Mulder, Nicola J.			Predicting and Analyzing Interactions between Mycobacterium tuberculosis and Its Human Host	PLOS ONE			English	Article							GENE ONTOLOGY; IN-VITRO; PROTEIN; IDENTIFICATION; BINDING; TOOL	The outcome of infection by Mycobacterium tuberculosis (Mtb) depends greatly on how the host responds to the bacteria and how the bacteria manipulates the host, which is facilitated by protein-protein interactions. Thus, to understand this process, there is a need for elucidating protein interactions between human and Mtb, which may enable us to characterize specific molecular mechanisms allowing the bacteria to persist and survive under different environmental conditions. In this work, we used the interologs method based on experimentally verified intra-species and inter-species interactions to predict human-Mtb functional interactions. These interactions were further filtered using known human-Mtb interactions and genes that are differentially expressed during infection, producing 190 interactions. Further analysis of the subcellular location of proteins involved in these human-Mtb interactions confirms feasibility of these interactions. We also conducted functional analysis of human and Mtb proteins involved in these interactions, checking whether these proteins play a role in infection and/or disease, and enriching Mtb proteins in a previously predicted list of drug targets. We found that the biological processes of the human interacting proteins suggested their involvement in apoptosis and production of nitric oxide, whereas those of the Mtb interacting proteins were relevant to the intracellular environment of Mtb in the host. Mapping these proteins onto KEGG pathways highlighted proteins belonging to the tuberculosis pathway and also suggested that Mtb proteins might use the host to acquire nutrients, which is in agreement with the intracellular lifestyle of Mtb. This indicates that these interactions can shed light on the interplay between Mtb and its human host and thus, contribute to the process of designing novel drugs with new biological mechanisms of action.	[Rapanoel, Holifidy A.; Mazandu, Gaston K.; Mulder, Nicola J.] Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Cape Town	Mulder, NJ (corresponding author), Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Nicola.Mulder@uct.ac.za	Mazandu, Gaston/AAH-6401-2019	Mazandu, Gaston/0000-0002-6441-8006; Mulder, Nicola J/0000-0003-4905-0941	National Research Foundation (NRF); Claude Leon Foundation	National Research Foundation (NRF); Claude Leon Foundation	This work has been supported by the National Research Foundation (NRF) and the Claude Leon Foundation Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Chen L, 2011, AFR J MICROBIOL RES, V5, P394; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Forst CV, 2006, DRUG DISCOV TODAY, V11, P220, DOI 10.1016/S1359-6446(05)03735-9; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kumar R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S16; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Luo MK, 2005, NAT CHEM BIOL, V1, P149, DOI 10.1038/nchembio717; Mazandu GK, 2012, INT J MOL SCI, V13, P7283, DOI 10.3390/ijms13067283; Mazandu Gaston K., 2011, Advances in Bioinformatics, V2011, P801478, DOI 10.1155/2011/801478; Mazandu GK, 2012, INFECT GENET EVOL, V12, P922, DOI 10.1016/j.meegid.2011.10.027; Mazandu GK, 2011, INFECT GENET EVOL, V11, P725, DOI 10.1016/j.meegid.2011.04.012; Mazandu GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018607; Mazandu GK, 2012, TUBERCULOSIS RISK FA; Mustafa AS, 2009, EXPERT REV VACCINES, V8, P1309, DOI [10.1586/erv.09.93, 10.1586/ERV.09.93]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Pruess Manuela, 2005, In Silico Biology, V5, P179; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Song CH, 2003, J CLIN IMMUNOL, V23, P194, DOI 10.1023/A:1023309928879; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Takahashi K, 2004, BIOCHEM BIOPH RES CO, V325, P203, DOI 10.1016/j.bbrc.2004.10.021; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	39	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67472	10.1371/journal.pone.0067472	http://dx.doi.org/10.1371/journal.pone.0067472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844013	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000047
J	Jiang, K; Yang, ZH; Cheng, L; Wang, SB; Ning, K; Zhou, L; Lin, J; Zhong, H; Wang, LS; Li, Y; Huang, JJ; Zhang, H; Ye, QN				Jiang, Kai; Yang, Zhihong; Cheng, Long; Wang, Shibin; Ning, Kang; Zhou, Lei; Lin, Jing; Zhong, Hui; Wang, Lisheng; Li, Yang; Huang, Junjian; Zhang, Hao; Ye, Qinong			Mediator of ERBB2-driven Cell Motility (MEMO) Promotes Extranuclear Estrogen Receptor Signaling Involving the Growth Factor Receptors IGF1R and ERBB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; REGULATED GENE-EXPRESSION; ACTIVATED PROTEIN-KINASE; FACTOR-I RECEPTOR; ER-ALPHA; INTERACTING PROTEIN; NUCLEAR ACTIONS; MEMBRANE; PHOSPHORYLATION; PATHWAYS	In addition to nuclear estrogen receptor (ER) acting as a transcription factor, extranuclear ER also plays an important role in cancer cell growth regulation through activation of kinase cascades. However, the molecular mechanisms by which extranuclear ER exerts its function are still poorly understood. Here, we report that mediator of ERBB2-driven cell motility (MEMO) regulates extranuclear functions of ER. MEMO physically and functionally interacted with ER. Through its interaction with the growth factor receptors IGF1R and ERBB2, MEMO mediated extranuclear functions of ER, including activation of mitogen-activated protein kinase (MAPK) and protein kinase B/AKT, two important growth regulatory protein kinases, and integration of function with nuclear ER. Activation of MAPK and AKT was responsible for MEMO modulation of ER phosphorylation and estrogen-responsive gene expression. Moreover, MEMO increased anchorage-dependent and -independent growth of ER-positive breast cancer cells in vitro and was required for estrogen-induced breast tumor growth in nude mice. Together, our studies identified MEMO as a new component of extranuclear ER signalosome and suggest an essential role for MEMO in the regulation of ER-positive breast cancer cell growth.	[Jiang, Kai; Yang, Zhihong; Cheng, Long; Ning, Kang; Zhong, Hui; Huang, Junjian; Zhang, Hao; Ye, Qinong] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing 100850, Peoples R China; [Wang, Shibin; Li, Yang] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Gen Surg, Beijing 100037, Peoples R China; [Ning, Kang] Liaoning Ctr Dis Control & Prevent, Liaoning 110005, Peoples R China; [Zhou, Lei] Shijitan Hosp, Dept Tumor, Beijing 100038, Peoples R China; [Lin, Jing] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Clin Lab, Beijing 100037, Peoples R China; [Wang, Lisheng] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing 1000850, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Academy of Military Medical Sciences - China	Zhang, H (corresponding author), Beijing Inst Biotechnol, Dept Med Mol Biol, 27 Tai Ping Lu Rd, Beijing 100850, Peoples R China.	zhanghal197@hotmail.com; yeqn66@yahoo.com		Jiang, Kai/0000-0002-8507-1945; Cheng, Long/0000-0002-4752-1298	Major State Basic Research Development Program Grants [2011CB504202, 2012CB945100]; National Natural Science Foundation Grants [81072173, 81272913, 30625035]; National Key Technologies R&D Program for New Drugs Grant [2009ZX09301-002]	Major State Basic Research Development Program Grants(National Basic Research Program of China); National Natural Science Foundation Grants(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs Grant	This work was supported by Major State Basic Research Development Program Grants 2011CB504202 and 2012CB945100, National Natural Science Foundation Grants 81072173, 81272913, and 30625035, and National Key Technologies R&D Program for New Drugs Grant 2009ZX09301-002.	Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Boonyaratanakornkit V, 2011, STEROIDS, V76, P877, DOI 10.1016/j.steroids.2011.02.017; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Burns KA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187773; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Cheng L, 2012, J CLIN INVEST, V122, P2857, DOI 10.1172/JCI62676; Creighton CJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r28; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; JOEL PB, 1995, MOL ENDOCRINOL, V9, P1041, DOI 10.1210/me.9.8.1041; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Levin ER, 2008, BREAST CANCER RES TR, V108, P351, DOI 10.1007/s10549-007-9618-4; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; MANDAL S, 2007, BMC CANCER, V7, P1471; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Murphy LC, 2011, ENDOCR-RELAT CANCER, V18, pR1, DOI 10.1677/ERC-10-0070; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Pietras RJ, 2007, CLIN CANCER RES, V13, P4672, DOI 10.1158/1078-0432.CCR-07-1373; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Qiu C, 2008, J BIOL CHEM, V283, P2734, DOI 10.1074/jbc.M703523200; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Song RXD, 2007, ENDOCRINOLOGY, V148, P4091, DOI 10.1210/en.2007-0240; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Song RXD, 2010, J STEROID BIOCHEM, V118, P219, DOI 10.1016/j.jsbmb.2009.09.018; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Sun Y, 2006, NUCLEIC ACIDS RES, V34, P6314, DOI 10.1093/nar/gkl914; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; Vogel C, 2010, JPN J CLIN ONCOL, V40, P999, DOI 10.1093/jjco/hyq084; Wang XH, 2008, BBA-MOL CELL RES, V1783, P1220, DOI 10.1016/j.bbamcr.2008.01.026; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200	50	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24590	24599		10.1074/jbc.M113.467837	http://dx.doi.org/10.1074/jbc.M113.467837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861392	Green Published, hybrid			2022-12-25	WOS:000330612300027
J	Andrello, M; Mouillot, D; Beuvier, J; Albouy, C; Thuiller, W; Manel, S				Andrello, Marco; Mouillot, David; Beuvier, Jonathan; Albouy, Camille; Thuiller, Wilfried; Manel, Stephanie			Low Connectivity between Mediterranean Marine Protected Areas: A Biophysical Modeling Approach for the Dusky Grouper Epinephelus marginatus	PLOS ONE			English	Article							REEF FISH METAPOPULATIONS; OCEAN CIRCULATION MODEL; PELAGIC LARVAL DURATION; CLIMATE-CHANGE SCENARIO; POPULATION CONNECTIVITY; RESERVE NETWORKS; FISHERIES MANAGEMENT; EMPIRICAL-EVALUATION; PISCES SERRANIDAE; BARRIER-REEF	Marine protected areas (MPAs) are major tools to protect biodiversity and sustain fisheries. For species with a sedentary adult phase and a dispersive larval phase, the effectiveness of MPA networks for population persistence depends on connectivity through larval dispersal. However, connectivity patterns between MPAs remain largely unknown at large spatial scales. Here, we used a biophysical model to evaluate connectivity between MPAs in the Mediterranean Sea, a region of extremely rich biodiversity that is currently protected by a system of approximately a hundred MPAs. The model was parameterized according to the dispersal capacity of the dusky grouper Epinephelus marginatus, an archetypal conservation-dependent species, with high economic importance and emblematic in the Mediterranean. Using various connectivity metrics and graph theory, we showed that Mediterranean MPAs are far from constituting a true, well-connected network. On average, each MPA was directly connected to four others and MPAs were clustered into several groups. Two MPAs (one in the Balearic Islands and one in Sardinia) emerged as crucial nodes for ensuring multi-generational connectivity. The high heterogeneity of MPA distribution, with low density in the South-Eastern Mediterranean, coupled with a mean dispersal distance of 120 km, leaves about 20% of the continental shelf without any larval supply. This low connectivity, here demonstrated for a major Mediterranean species, poses new challenges for the creation of a future Mediterranean network of well-connected MPAs providing recruitment to the whole continental shelf. This issue is even more critical given that the expected reduction of pelagic larval duration following sea temperature rise will likely decrease connectivity even more.	[Andrello, Marco; Manel, Stephanie] Univ Aix Marseille, Inst Rech Dev, Lab Populat Environm & Dev, UMR 151, Marseille, France; [Andrello, Marco; Thuiller, Wilfried] Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5119, Grenoble, France; [Mouillot, David] Univ Montpellier 2, UMR Ecol Syst Marins Cotiers 5119, Montpellier, France; [Mouillot, David] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Beuvier, Jonathan] Mercator Ocean, Ramonville Saint Agne, France; [Beuvier, Jonathan] Meteo France, Ctr Natl Rech Meteorol, Grp Etud Atmosphere Meteorol, UMR 3589,CNRS, Toulouse, France; [Albouy, Camille] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Manel, Stephanie] UMR Bot & Bioinformat Architecture Plantes 5120, Montpellier, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Universite de Montpellier; James Cook University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Meteo France; University of Quebec	Andrello, M (corresponding author), Univ Aix Marseille, Inst Rech Dev, Lab Populat Environm & Dev, UMR 151, Marseille, France.	marco.andrello@gmail.com	Thuiller, Wilfried/G-3283-2010; albouy, camille/ABD-2206-2021; Andrello, Marco/G-4197-2016; albouy, camille/H-9317-2012	Thuiller, Wilfried/0000-0002-5388-5274; albouy, camille/0000-0003-1629-2389; Andrello, Marco/0000-0001-7590-2736; albouy, camille/0000-0003-1629-2389	Fondation pour la Recherche sur la biodiversite; Fondation Total; Institut Universitaire de France; Marie Curie International Outgoing Fellowship (FISHECO) [IOF-GA-2009-236316]; Groupe de Mission Mercator Coriolis (GMMC) in the context of the SiMED project; Grand Equipement National de Calcul Intensif (GENCI) [010227]	Fondation pour la Recherche sur la biodiversite; Fondation Total; Institut Universitaire de France; Marie Curie International Outgoing Fellowship (FISHECO)(European Commission); Groupe de Mission Mercator Coriolis (GMMC) in the context of the SiMED project; Grand Equipement National de Calcul Intensif (GENCI)	This work was funded by 'Fondation pour la Recherche sur la biodiversite' (www.fondationbiodiversite.fr) and 'Fondation Total' (fondation.total.com) through the 'Fishconnect' project. SM and DM were funded by the Institut Universitaire de France (iuf.amue.fr). DM was supported by a Marie Curie International Outgoing Fellowship (FISHECO) with agreement number IOF-GA-2009-236316. The numerical work for NEMOMED12 was supported by the Groupe de Mission Mercator Coriolis (GMMC) in the context of the SiMED project. This work was granted access to the HPC resources of IDRIS (Institut du Developpement et des Ressources en Informatique Scientifique) of the Centre National de la Recherche Scientifique (CNRS) (project number 010227) made by Grand Equipement National de Calcul Intensif (GENCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; Albert CH, 2010, ECOGRAPHY, V33, P1028, DOI 10.1111/j.1600-0587.2010.06421.x; Albouy C, 2012, GLOBAL CHANGE BIOL, V18, P2995, DOI 10.1111/j.1365-2486.2012.02772.x; Allendorf FW, 2007, CONSERVATION GENETIC, Vxix; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; ARAKAWA A, 1981, MON WEATHER REV, V109, P18, DOI 10.1175/1520-0493(1981)109<0018:APEAEC>2.0.CO;2; Armsworth PR, 2002, ECOLOGY, V83, P1092, DOI 10.1890/0012-9658(2002)083[1092:RLPRAL]2.0.CO;2; Barnier B, 2006, OCEAN DYNAM, V56, P543, DOI 10.1007/s10236-006-0082-1; Basterretxea G, 2012, FISH OCEANOGR, V21, P291, DOI 10.1111/j.1365-2419.2012.00625.x; Bell JJ, 2008, BIOL CONSERV, V141, P2807, DOI 10.1016/j.biocon.2008.08.017; Berglund M, 2012, ECOL MODEL, V240, P105, DOI 10.1016/j.ecolmodel.2012.04.011; Berne S, 2004, GOLFE LION CARTE MOR; Beuvier J, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007679; Beuvier J, 2012, MERCATOR OCEAN QUART, V46, P60; Beuvier J, 2011, THESIS ECOLE POLYTEC; BLANKE B, 1993, J PHYS OCEANOGR, V23, P1363, DOI 10.1175/1520-0485(1993)023<1363:VOTTAO>2.0.CO;2; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Bodilis P, 2003, CYBIUM, V27, P123; Boglione C, 2009, AQUACULTURE, V291, P48, DOI 10.1016/j.aquaculture.2009.02.041; Bonhommeau S, 2009, J FISH BIOL, V74, P1891, DOI 10.1111/j.1095-8649.2009.02298.x; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Botsford LW, 2001, ECOL LETT, V4, P144; Buston PM, 2011, P ROYAL SOC B; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coll M., 2010, PLOS ONE, V5; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; CSARDI G., 2006, INTERJOURNAL COMPLEX, V1695; Cunha ME, 2009, SCI MAR, V73, P201, DOI 10.3989/scimar.2009.73s1201; de Almeida Rodrigues Filho J, 2009, ENVIRON BIOL FISH, V85, P301; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052108; DIFRANCO A, 2012, PLOS ONE, V7; Francour P, 2001, AQUAT CONSERV, V11, P155, DOI 10.1002/aqc.442; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Gerber LR, 2005, CAN J FISH AQUAT SCI, V62, P863, DOI 10.1139/F05-046; Gerber LR, 2003, ECOL APPL, V13, pS47; Glamuzina B, 1998, SCI MAR, V62, P373; Gruss A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019960; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Halpern BS, 2003, ECOL APPL, V13, pS117; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Heemstra P.C., 1993, GROUPERS WORLD FAMIL, V16; Hereu B, 2006, MAR ECOL PROG SER, V325, P187, DOI 10.3354/meps325187; Herrmann MJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032442; Ingleby B, 2007, J MARINE SYST, V65, P158, DOI 10.1016/j.jmarsys.2005.11.019; Jacobi MN, 2012, ECOGRAPHY, V35, P1004, DOI 10.1111/j.1600-0587.2012.07281.x; Jacobi MN, 2011, ECOL APPL, V21, P1861, DOI 10.1890/10-0915.1; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kaplan DM, 2006, ECOL APPL, V16, P2248, DOI 10.1890/1051-0761(2006)016[2248:DPRAEM]2.0.CO;2; Kaplan DM, 2009, ECOL APPL, V19, P433, DOI 10.1890/07-1705.1; Kininmonth S, 2011, ECOL MODEL, V222, P1272, DOI 10.1016/j.ecolmodel.2011.01.012; Kininmonth SJ, 2010, THEOR ECOL-NETH, V3, P75, DOI 10.1007/s12080-009-0055-3; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Largier JL, 2003, ECOL APPL, V13, pS71; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Lembo Giuseppe, 2002, Marine Life, V9, P37; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Macpherson E, 2006, MAR ECOL PROG SER, V327, P257, DOI 10.3354/meps327257; Madec G., 2017, NEMO OCEAN ENGINE; Maggio T, 2006, ITAL J ZOOL, V73, P275, DOI 10.1080/11250000600804599; Millot C, 2005, MEDITERRANEAN SEA; Monin AS, 1982, TURBULENCE OCEAN; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Pairaud IL, 2011, J MARINE SYST, V88, P20, DOI 10.1016/j.jmarsys.2011.02.010; Pastor J, 2009, CR BIOL, V332, P732, DOI 10.1016/j.crvi.2009.03.010; Pebesma E., 2005, R NEWS, V5, P9; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; PINARDI N, 1993, DEEP-SEA RES PT II, V40, P1299, DOI 10.1016/0967-0645(93)90071-T; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renones O, 2007, J FISH BIOL, V71, P346, DOI 10.1111/j.1095-8649.2007.01482.x; Renones O, 2010, SCI MAR, V74, P523, DOI 10.3989/scimar.2010.74n3523; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rixen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022702; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Saenz-Agudelo P, 2011, P ROY SOC B-BIOL SCI, V278, P2954, DOI 10.1098/rspb.2010.2780; Sala E, 2012, PLOS ONE, V7; Schunter C, 2011, J EXP MAR BIOL ECOL, V401, P126, DOI 10.1016/j.jembe.2011.01.021; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Somot S, 2008, GLOBAL PLANET CHANGE, V63, P112, DOI 10.1016/j.gloplacha.2007.10.003; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spedicato M. T., 2000, Cahiers Options Mediterraneennes, V47, P227; Srinivasan UT, 2012, MAR POLICY, V36, P544, DOI 10.1016/j.marpol.2011.10.001; Swearer SE, 2002, B MAR SCI, V70, P251; Testor P, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002861; Tonani M, 2008, OCEAN SCI, V4, P1, DOI 10.5194/os-4-1-2008; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; Whitehead Peter J. P, 1986, FISHES N E ATLANTIC; Zabala M, 1997, SCI MAR, V61, P65	107	97	98	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68564	10.1371/journal.pone.0068564	http://dx.doi.org/10.1371/journal.pone.0068564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861917	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000321692000030
J	Dong, XL; Zhai, YF; Hu, MY; Zhong, GH; Huang, WJ; Zheng, ZH; Han, PF				Dong, Xiaolin; Zhai, Yifan; Hu, Meiying; Zhong, Guohua; Huang, Wanjun; Zheng, Zhihua; Han, Pengfei			Proteomic and Properties Analysis of Botanical Insecticide Rhodojaponin III-Induced Response of the Diamondback Moth, Plutella xyllostella (L.)	PLOS ONE			English	Article							ODORANT-BINDING PROTEIN; APOLIPOPHORIN-III; CHEMOSENSORY PROTEIN; PHEROMONE-BINDING; EXPRESSION; ANTHERAEA; GENE	Background: Rhodojaponin III, as a botanical insecticide, affects a wide variety of biological processes in insects, including reduction of feeding, suspension of development, and oviposition deterring of adults in a dose-dependent manner. However, the mode of these actions remains obscure. Principal Findings: In this study, a comparative proteomic approach was adopted to examine the effect of rhodojaponin III on the Plutella xyllostella (L.). Following treating 48 hours, newly emergence moths were collected and protein samples were prepared. The proteins were separated by 2-DE, and total 31 proteins were significantly affected by rhodojaponin III compared to the control identified by MALDI-TOF/TOF-MS/MS. These differentially expressed proteins act in the nervous transduction, odorant degradation and metabolic change pathways. Further, gene expression patterns in treated and untreated moths were confirmed by qRT-PCR and western blot analysis. RNAi of the chemosensory protein (PxCSP) gene resulted in oviposition significantly increased on cabbage plants treated with rhodojaponin III. Conclusions: These rhodojaponin III-induced proteins and gene properties analysis would be essential for a better understanding of the potential molecular mechanism of the response to rhodojaponin III from moths of P. xylostella.	[Dong, Xiaolin; Hu, Meiying; Zhong, Guohua; Huang, Wanjun; Zheng, Zhihua; Han, Pengfei] South China Agr Univ, Coll Resources & Environm, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China; [Zhai, Yifan] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China Agricultural University; Sun Yat Sen University	Hu, MY (corresponding author), South China Agr Univ, Coll Resources & Environm, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn			National Natural Science Foundation, PR China [31071713]	National Natural Science Foundation, PR China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation, PR China (No. 31071713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, CROP PROT, V38, P7, DOI 10.1016/j.cropro.2012.03.006; [Anonymous], 1988, HDB PLANTS PEST CONT; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Campanacci V, 2003, P NATL ACAD SCI USA, V100, P5069, DOI 10.1073/pnas.0836654100; Castelo Branco M., 1997, Anais da Sociedade Entomologica do Brasil, V26, P75, DOI 10.1590/S0301-80591997000100010; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Cui SY, 2006, PEPTIDES, V27, P1226, DOI 10.1016/j.peptides.2005.11.011; Dettloff M, 1998, IMMUNE STIMULATION L, P243; Dong XL, 2013, J INSECT PHYSIOL, V59, P26, DOI 10.1016/j.jinsphys.2012.11.004; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Ge LQ, 2011, J PROTEOME RES, V10, P4597, DOI 10.1021/pr200414g; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hovemann BT, 1997, GENE, V189, P213, DOI 10.1016/S0378-1119(96)00851-7; HU MY, 1993, J ECON ENTOMOL, V86, P706, DOI 10.1093/jee/86.3.706; Huang ZW, 2004, PESTIC BIOCHEM PHYS, V80, P85, DOI 10.1016/j.pestbp.2004.07.001; Irving P, 2004, CR BIOL, V327, P557, DOI 10.1016/j.crvi.2004.03.007; KLOCKE JA, 1991, PHYTOCHEMISTRY, V30, P1797, DOI 10.1016/0031-9422(91)85015-R; Konishi H, 2001, PROTEOMICS, V1, P1162, DOI 10.1002/1615-9861(200109)1:9<1162::AID-PROT1162>3.3.CO;2-J; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YX, 2010, J PROTEOME RES, V9, P5053, DOI 10.1021/pr100356t; Mitsumasu K, 2008, ZOOL SCI, V25, P693, DOI 10.2108/zsj.25.693; Niere M, 1999, BBA-PROTEIN STRUCT M, V1433, P16, DOI 10.1016/S0167-4838(99)00148-X; NISHIDA R, 1989, J CHEM ECOL, V15, P2565, DOI 10.1007/BF01014732; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; Picone D, 2001, EUR J BIOCHEM, V268, P4794, DOI 10.1046/j.1432-1327.2001.02408.x; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; PRESTWICH GD, 1989, EXPERIENTIA, V45, P263, DOI 10.1007/BF01951812; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; Rogers ME, 1999, J EXP BIOL, V202, P1625; ROTHSCHILD M, 1988, PHYTOCHEMISTRY, V27, P101, DOI 10.1016/0031-9422(88)80598-3; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; Ryerse J, 1997, BBA-BIOMEMBRANES, V1327, P193, DOI 10.1016/S0005-2736(97)00058-8; Santos VC, 2011, NEOTROP ENTOMOL, V40, P264, DOI 10.1590/S1519-566X2011000200017; Schneider A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052007; Shelby KS, 2009, J INVERTEBR PATHOL, V101, P86, DOI 10.1016/j.jip.2009.05.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHINFOON C, 1993, J APPL ENTOMOL, V116, P479, DOI 10.1111/j.1439-0418.1993.tb01224.x; SOULAGES JL, 1995, P NATL ACAD SCI USA, V92, P5650, DOI 10.1073/pnas.92.12.5650; Steinbrecht RA, 1996, CHEM SENSES, V21, P719, DOI 10.1093/chemse/21.6.719; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; SUN DH, 1995, J NEUROBIOL, V26, P119, DOI 10.1002/neu.480260110; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tsuchihara K, 2005, CHEM SENSES, V30, P559, DOI 10.1093/chemse/bji049; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2005, MOL BASIS PHEROMONE; VOLLER A, 1980, P SOC EXP BIOL MED, V163, P402; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zhang YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047611; Zhong GuoHua, 2000, Journal of South China Agricultural University, V21, P40	56	9	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67723	10.1371/journal.pone.0067723	http://dx.doi.org/10.1371/journal.pone.0067723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861792	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300024
J	Galarraga, O; Wirtz, VJ; Santa-Ana-Tellez, Y; Korenromp, EL				Galarraga, Omar; Wirtz, Veronika J.; Santa-Ana-Tellez, Yared; Korenromp, Eline L.			Financing HIV Programming: How Much Should Low- And Middle-Income Countries and their Donors Pay?	PLOS ONE			English	Article							GLOBAL FUND; HEALTH; HIV/AIDS; PREVENTION; INNOVATION; PATENTS; POLICY; COSTS; AID	Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in terms of actual versus expected national domestic funding, considering resource needs and donor financing. With UNAIDS and World Bank data, we examine domestic and donor HIV program funding in relation to need in 84 low-and middle-income countries. We estimate expected domestic contributions per person living with HIV (PLWH) as a function of per capita income, relative size of the health sector, and per capita foreign debt service. Countries are categorized according to levels of actual versus expected domestic contributions, and resource gap. Compared to national resource needs (UNAIDS Investment Framework), we identify imbalances among countries in actual versus expected domestic and donor contributions: 17 countries, with relatively high HIV prevalence and GNI per capita, have domestic funding below expected (median per PLWH $143 and $376, respectively), yet total available funding including from donors would exceed the need ($368 and $305, respectively) if domestic contribution equaled expected. Conversely, 27 countries have actual domestic funding above the expected (medians $294 and $149) but total (domestic+donor) funding does not meet estimated need ($685 and $1,173). Across the 84 countries, in 2009, estimated resource need totaled $10.3 billion, actual domestic contributions $5.1 billion and actual donor contributions $3.7 billion. If domestic contributions would increase to the expected level in countries where the actual was below expected, total domestic contributions would increase to $7.4 billion, turning a funding gap of $1.5 billion into a surplus of $0.8 billion. Even with imperfect funding and resource-need data, the proposed country classification could help improve coherence and efficiency in domestic and international allocations.	[Galarraga, Omar] Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Providence, RI 02912 USA; [Galarraga, Omar; Wirtz, Veronika J.; Santa-Ana-Tellez, Yared] Mexican Sch Publ Hlth, Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico; [Wirtz, Veronika J.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Santa-Ana-Tellez, Yared] UIPS, WHO Collaborating Ctr Pharmaceut Policy & Regulat, Utrecht, Netherlands; [Korenromp, Eline L.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Brown University; Instituto Nacional de Salud Publica; Boston University; Utrecht University; Erasmus University Rotterdam; Erasmus MC	Galarraga, O (corresponding author), Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Providence, RI 02912 USA.	omar_galarraga@brown.edu	Wirtz, Veornika/AAG-9712-2019; Galarraga, Omar/N-1622-2019	Galarraga, Omar/0000-0002-9985-9266; Wirtz, Veronika J./0000-0002-0863-8768; Santa-Ana-Tellez, Yared/0000-0003-3086-446X	Bill and Melinda Gates Foundation through the INSP/Consortium for Research on HIV/AIDS and Tuberculosis (CISIDAT); United States National Institutes of Health (NIH)/Fogarty International Center [K01-TW008016-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW008016] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation through the INSP/Consortium for Research on HIV/AIDS and Tuberculosis (CISIDAT); United States National Institutes of Health (NIH)/Fogarty International Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The research was partially funded by the Bill and Melinda Gates Foundation through the INSP/Consortium for Research on HIV/AIDS and Tuberculosis (CISIDAT). Additional funding for Omar Galarraga was provided by United States National Institutes of Health (NIH)/Fogarty International Center (K01-TW008016-04). The opinions expressed in the paper do not reflect the views of any of the funding or the other organizations that supported or facilitated the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-221; Andersen R, 2008, MODERN METHODS ROBUS, pxv; Bokhari FAS, 2007, HEALTH ECON, V16, P257, DOI 10.1002/hec.1157; Brugha R, 2005, TROP MED INT HEALTH, V10, P623, DOI 10.1111/j.1365-3156.2005.01437.x; Burton B, 2004, BRIT MED J, V328, P486, DOI 10.1136/bmj.328.7438.486; Cohen RL, 2012, J ACQUIR IMMUNE DEFI; Collier, 2007, BOTTOM BILLION WHY P, pXIII; Easterly W., 2006, WHITE MANS BURDEN WH; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Garg CC, 2012, HEALTH AFFAIR, V31, P417, DOI 10.1377/hlthaff.2008.0815; Global Fund, 2010, VAL MON IMPR VAL MON; Global Fund, 2012, APPR GRANT AM DISB; Global Fund, 2011, POL EL CRIT COUNT FI; Hesterl V, 2009, 26 RES DEV I; Kaiser Family Foundation, 2012, FIN RESP AIDS LOW AN; Kaplan WA, 2012, HLTH POLICY; Kapp C, 2002, LANCET, V360, P1225, DOI 10.1016/S0140-6736(02)11294-3; Kerouedan D, 2010, Bull Soc Pathol Exot, V103, P119, DOI 10.1007/s13149-010-0051-2; Koenker R, 2005, QUANTILE REGRESSION, pxv; Lane C, 2007, HEALTH AFFAIR, V26, P935, DOI 10.1377/hlthaff.26.4.935; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; Lordan G, 2011, SOC SCI MED, V73, P351, DOI 10.1016/j.socscimed.2011.05.045; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Munderi Paula, 2012, AIDS, V26 Suppl 2, pS97, DOI 10.1097/QAD.0b013e32835bdde6; Nations U, 2001, UN GEN ASS 26 SPEC S; Sachs J., 2005, END POVERTY EC POSSI, pxviii; Savedoff WD, 2007, HEALTH AFFAIR, V26, P962, DOI 10.1377/hlthaff.26.4.962; Saxenian H, 2011, HEALTH AFFAIR, V30, P1122, DOI 10.1377/hlthaff.2011.0332; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shadlen KC, 2012, EUR J DEV RES, V24, P300, DOI 10.1057/ejdr.2012.9; Shadlen KC, 2009, COMP POLIT, V42, P41, DOI 10.5129/001041509X12911362972791; The Global Fund, 2011, 25 BOARD M ACCR GHAN; Thirumurthy H, 2012, HEALTH AFFAIR, V31, P1470, DOI 10.1377/hlthaff.2012.0217; UNAIDS, 2012, UNGASS COUNTR PROGR; UNAIDS, 2010, JOINT ACT RES UNAIDS; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2012, COUNTR REP DAT 2009; UNAIDS, 2010, 2010 UNAIDS REP GLOB; United Nations Economic and Social Commission for Asia and the Pacific, 2008, UNESPCAP UNAIDS EXP; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wirtz VJ, 2012, HLTH POLICY PLAN; World bank, 2011, DAT CAT; World Bank, 2010, COUNTR CLASS DAT; Zeitz PS, 2003, WHAT IS US FAIR SHAR	45	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67565	10.1371/journal.pone.0067565	http://dx.doi.org/10.1371/journal.pone.0067565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DW	23861772	Green Published, gold			2022-12-25	WOS:000321425300017
J	Matlaf, LA; Harkins, LE; Bezrookove, V; Cobbs, CS; Soroceanu, L				Matlaf, Lisa A.; Harkins, Lualhati E.; Bezrookove, Vladimir; Cobbs, Charles S.; Soroceanu, Liliana			Cytomegalovirus pp71 Protein Is Expressed in Human Glioblastoma and Promotes Pro-Angiogenic Signaling by Activation of Stem Cell Factor	PLOS ONE			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; IE1 PROTEIN; GROWTH; LOCALIZATION; PROGRESSION; INFECTION; FAMILY; CYCLE; DAXX; P65	Glioblastoma multiforme (GBM) is a highly malignant primary central nervous system neoplasm characterized by tumor cell invasion, robust angiogenesis, and a mean survival of 15 months. Human cytomegalovirus (HCMV) infection is present in > 90% of GBMs, although the role the virus plays in GBM pathogenesis is unclear. We report here that HCMV pp71, a viral protein previously shown to promote cell cycle progression, is present in a majority of human GBMs and is preferentially expressed in the CD133+, cancer stem-like cell population. Overexpression of pp71 in adult neural precursor cells resulted in potent induction of stem cell factor (SCF), an important pro-angiogenic factor in GBM. Using double immunofluorescence, we demonstrate in situ co-localization of pp71 and SCF in clinical GBM specimens. pp71 overexpression in both normal and transformed glial cells increased SCF secretion and this effect was specific, since siRNA mediated knockdown of pp71 or treatment with the antiviral drug cidofovir resulted in decreased expression and secretion of SCF by HCMV-infected cells. pp71-induced upregulation of SCF resulted in downstream activation of its putative endothelial cell receptor, c-kit, and angiogenesis as measured by increased capillary tube formation in vitro. We demonstrate that pp71 induces a pro-inflammatory response via activation of NFKB signaling which drives SCF expression. Furthermore, we show that pp71 levels and NFKB activation are selectively augmented in the mesenchymal subtype of human GBMs, characterized by worst patient outcome, suggesting that HCMV pp71-induced paracrine signaling may contribute to the aggressive phenotype of this human malignancy.	[Matlaf, Lisa A.; Bezrookove, Vladimir; Cobbs, Charles S.; Soroceanu, Liliana] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Harkins, Lualhati E.] Birmingham Vet Adm Hosp, Birmingham, AL USA; [Cobbs, Charles S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco	Soroceanu, L (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA.	sorocel@cpmcri.org			American Brain Tumor Association; National Institutes of Health [R01NS070289-02, 1R21NS067395-01]; American Cancer Society [RSG-09-197-01]; Accelerated Brain Cancer Cure Foundation; Flaming Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067395, R01NS070289] Funding Source: NIH RePORTER	American Brain Tumor Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Accelerated Brain Cancer Cure Foundation; Flaming Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	L.M. is the recipient of a fellowship from American Brain Tumor Association in honor of Joel A. Gingras Jr. These studies were supported by the National Institutes of Health, Grants R01NS070289-02 to C.S.C.; 1R21NS067395-01 to L.S., by American Cancer Society grant RSG-09-197-01 to C.S.C and by additional funds from the Accelerated Brain Cancer Cure Foundation and the Flaming Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Joshua C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000768; Barami K, 2010, J CLIN NEUROSCI, V17, P819, DOI 10.1016/j.jocn.2009.10.040; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Bhattacharjee B, 2012, J VIROL, V86, P6815, DOI 10.1128/JVI.00015-12; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Castillo JP, 2000, J VIROL, V74, P8028, DOI 10.1128/JVI.74.17.8028-8037.2000; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cinatl J, 2004, FEMS MICROBIOL REV, V28, P59, DOI 10.1016/j.femsre.2003.07.005; Cobbs CS, 2002, CANCER RES, V62, P3347; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Hasegawa T, 2008, INVEST OPHTH VIS SCI, V49, P2178, DOI 10.1167/iovs.07-0632; Hwang JW, 2007, VIROLOGY, V367, P334, DOI 10.1016/j.virol.2007.05.037; Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251; Kalejta RF, 2004, J CELL BIOCHEM, V93, P37, DOI 10.1002/jcb.20177; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kalejta RF, 2002, FRONT BIOSCI-LANDMRK, V7, pD295, DOI 10.2741/kalejta; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Levesque-Sergerie JP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-93; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Melnick M, 2012, EXP MOL PATHOL, V92, P118, DOI 10.1016/j.yexmp.2011.10.011; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Park DM, 2009, MOL CELLS, V28, P7, DOI 10.1007/s10059-009-0111-2; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Prados Michael D., 2000, Seminars in Oncology, V27, P1; Price RL, 2012, CANC RES; Purow B, 2004, HEMATOL ONCOL CLIN N, V18, P1161, DOI 10.1016/j.hoc.2004.05.003; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Saffert RT, 2007, J VIROL, V81, P9109, DOI 10.1128/JVI.00827-07; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Sicurella C, 2001, BLOOD CELL MOL DIS, V27, P470, DOI 10.1006/bcmd.2001.0407; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soroceanu L, 2009, CNS CANC MODELS MARK; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Suhasini M, 1999, ONCOGENE, V18, P7360, DOI 10.1038/sj.onc.1203158; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Trgovcich J, 2006, J VIROL, V80, P951, DOI 10.1128/JVI.80.2.951-963.2006; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang XB, 2005, J VIROL, V79, P95, DOI 10.1128/JVI.79.1.95-105.2005; YUROCHKO AD, 1995, J VIROL, V69, P5391, DOI 10.1128/JVI.69.9.5391-5400.1995; Zafiropoulos A, 2003, CANCER LETT, V198, P77, DOI 10.1016/S0304-3835(03)00269-6	49	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68176	10.1371/journal.pone.0068176	http://dx.doi.org/10.1371/journal.pone.0068176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861869	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300049
J	Mikami, S; Nakashima, A; Nakagawa, K; Maruhashi, T; Iwamoto, Y; Kajikawa, M; Matsumoto, T; Kihara, Y; Chayama, K; Noma, K; Ochi, M; Nishimura, M; Tsuji, K; Kato, Y; Goto, C; Higashi, Y				Mikami, Shinsuke; Nakashima, Ayumu; Nakagawa, Keigo; Maruhashi, Tatsuya; Iwamoto, Yumiko; Kajikawa, Masato; Matsumoto, Takeshi; Kihara, Yasuki; Chayama, Kazuaki; Noma, Kensuke; Ochi, Mitsuo; Nishimura, Masahiro; Tsuji, Koichiro; Kato, Yukio; Goto, Chikara; Higashi, Yukihito			Autologous Bone-Marrow Mesenchymal Stem Cell Implantation and Endothelial Function in a Rabbit Ischemic Limb Model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; STROMAL CELLS; GROWTH; DISEASE; PROLIFERATION; ANGIOGENESIS; ACTIVATION; MECHANISMS; EXPRESSION; HINDLIMB	Background: The purpose of this study was to determine whether autologous mesenchymal stem cells (MSCs) implantation improves endothelial dysfunction in a rabbit ischemic limb model. Methods: We evaluated the effect of MSC implantation on limb blood flow (LBF) responses to acetylcholine (ACh), an endothelium-dependent vasodilator, and sodium nitroprusside (SNP), an endothelium-independent vasodilator, in rabbits with limb ischemia in which cultured MSCs were implanted (n = 20) or saline was injected as a control group (n = 20). LBF was measured using an electromagnetic flowmeter. A total of 10(6) MSCs were implanted into each ischemic limb. Results: Histological sections of ischemic muscle showed that capillary index (capillary/muscle fiber) was greater in the MSC implantation group than in the control group. Laser Doppler blood perfusion index was significantly increased in the MSC implantation group compared with that in the control group. LBF response to ACh was greater in the MSC group than in the control group. After administration of N-G-nitro-L-arginine, a nitric oxide synthase inhibitor, LBF response to ACh was similar in the MSC implantation group and control group. Vasodilatory effects of SNP in the two groups were similar. Conclusions: These findings suggest that MSC implantation induces angiogenesis and augments endothelium-dependent vasodilation in a rabbit ischemic model through an increase in nitric oxide production.	[Mikami, Shinsuke; Maruhashi, Tatsuya; Iwamoto, Yumiko; Kajikawa, Masato; Matsumoto, Takeshi; Kihara, Yasuki] Hiroshima Univ, Dept Cardiovasc Med, Grad Sch Biomed Sci, Hiroshima, Japan; [Nakashima, Ayumu; Noma, Kensuke; Higashi, Yukihito] Hiroshima Univ Hosp, Div Regenerat & Med, Hiroshima, Japan; [Nakagawa, Keigo; Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Grad Sch Biomed Sci, Hiroshima, Japan; [Noma, Kensuke; Higashi, Yukihito] Hiroshima Univ, Dept Cardiovasc Regenerat & Med, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Ochi, Mitsuo] Hiroshima Univ, Dept Orthoped Surg, Grad Sch Biomed Sci, Hiroshima, Japan; [Nishimura, Masahiro] Nagasaki Univ, Dept Prosthet Dent, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Tsuji, Koichiro] Two Cells Co Ltd, Hiroshima, Japan; [Kato, Yukio] Hiroshima Univ, Dept Dent & Med Biochem, Grad Sch Biomed Sci, Hiroshima, Japan; [Goto, Chikara] Hirohsima Int Univ, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Nagasaki University; Hiroshima University	Higashi, Y (corresponding author), Hiroshima Univ Hosp, Div Regenerat & Med, Hiroshima, Japan.	yhigashi@hiroshima-u.ac.jp	Chayama, Kazuaki/B-2493-2016; Nakashima, Ayumu/N-9158-2017; Higashi, Yukihito/G-5343-2019; Nishimura, Masahiro/ABD-7504-2020; Nakashima, Ayumu/CAF-0274-2022	Nakashima, Ayumu/0000-0002-7838-1494; Nishimura, Masahiro/0000-0001-5552-0693; Nakashima, Ayumu/0000-0002-7838-1494; Chayama, Kazuaki/0000-0002-5530-5341	Grants-in-Aid for Scientific Research [25670369] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; BAUTERS C, 1995, CIRCULATION, V91, P2802, DOI 10.1161/01.CIR.91.11.2802; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GILLUM RF, 1990, AM HEART J, V120, P1414, DOI 10.1016/0002-8703(90)90257-X; Higashi Y, 2004, CIRCULATION, V109, P1215, DOI 10.1161/01.CIR.0000121427.53291.78; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Igarashi A, 2007, TISSUE ENG, V13, P2405, DOI 10.1089/ten.2006.0340; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Iwase T, 2005, CARDIOVASC RES, V66, P543, DOI 10.1016/j.cardiores.2005.02.006; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LUSCHER TF, 1990, AM J HYPERTENS, V3, P317, DOI 10.1093/ajh/3.4.317; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Miller VM, 1998, AM J PHYSIOL, V255, pH446; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rajagopalan S, 2001, CIRCULATION, V104, P753, DOI 10.1161/hc3201.095192; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Santa Maria L, 2004, EXP CELL RES, V300, P418, DOI 10.1016/j.yexcr.2004.07.017; SESSA WC, 1994, CIRC RES, V74, P349, DOI 10.1161/01.RES.74.2.349; Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; VALLANCE P, 1989, LANCET, V2, P997; VANHOUTTE PM, 1989, HYPERTENSION, V13, P658, DOI 10.1161/01.HYP.13.6.658; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	39	16	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67739	10.1371/journal.pone.0067739	http://dx.doi.org/10.1371/journal.pone.0067739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861797	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700030
J	Di Cello, F; Cope, L; Li, HL; Jeschke, J; Wang, W; Baylin, SB; Zahnow, CA				Di Cello, Francescopaolo; Cope, Leslie; Li, Huili; Jeschke, Jana; Wang, Wei; Baylin, Stephen B.; Zahnow, Cynthia A.			Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer	PLOS ONE			English	Article							INVASIVE DUCTAL CARCINOMA; EPITHELIAL-CELLS; DNA-METHYLATION; JUNCTIONS; FEATURES; OCCLUDIN; SUBTYPE; BENIGN; TUMORS; GRADE	Downregulation of the tight junction protein claudin 1 is a frequent event in breast cancer and is associated with recurrence, metastasis, and reduced survival, suggesting a tumor suppressor role for this protein. Tumor suppressor genes are often epigenetically silenced in cancer. Downregulation of claudin 1 via DNA promoter methylation may thus be an important determinant in breast cancer development and progression. To investigate if silencing of claudin 1 has an epigenetic etiology in breast cancer we compared gene expression and methylation data from 217 breast cancer samples and 40 matched normal samples available through the Cancer Genome Atlas (TCGA). Moreover, we analyzed claudin 1 expression and methylation in 26 breast cancer cell lines. We found that methylation of the claudin 1 promoter CpG island is relatively frequent in estrogen receptor positive (ER+) breast cancer and is associated with low claudin 1 expression. In contrast, the claudin 1 promoter was not methylated in most of the ER-breast cancers samples and some of these tumors overexpress claudin 1. In addition, we observed that the demethylating agents, azacitidine and decitabine can upregulate claudin 1 expression in breast cancer cell lines that have a methylated claudin 1 promoter. Taken together, our results indicate that DNA promoter methylation is causally associated with downregulation of claudin 1 in a subgroup of breast cancer that includes mostly ER+ tumors, and suggest that epigenetic therapy to restore claudin 1 expression might represent a viable therapeutic strategy in this subtype of breast cancer.	[Di Cello, Francescopaolo; Cope, Leslie; Li, Huili; Jeschke, Jana; Wang, Wei; Baylin, Stephen B.; Zahnow, Cynthia A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Zahnow, CA (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins, Sch Med, Baltimore, MD 21218 USA.	zahnoci@jhmi.edu		Jeschke, Jana/0000-0002-6047-2558; Wang, Wei/0000-0003-1339-4080	Flight Attendant Medical Research Institute [062544_YCSA, 072156_CIA]; Safeway Foundation; Irving Hansen Foundation; Johns Hopkins Center in Urban Environmental Health Pilot Project Program; National Institutes of Health [P30 ES003819, P30 CA006973]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; Safeway Foundation; Irving Hansen Foundation; Johns Hopkins Center in Urban Environmental Health Pilot Project Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Flight Attendant Medical Research Institute (062544_YCSA, 072156_CIA), the Safeway Foundation, the Irving Hansen Foundation, the Johns Hopkins Center in Urban Environmental Health Pilot Project Program, and The National Institutes of Health (P30 ES003819, P30 CA006973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard AA, 2009, VIRCHOWS ARCH, V454, P647, DOI 10.1007/s00428-009-0770-6; Boireau S, 2007, CARCINOGENESIS, V28, P246, DOI 10.1093/carcin/bgl120; Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433; Cataldo VD, 2009, EXPERT REV ANTICANC, V9, P875, DOI 10.1586/ERA.09.61; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Gerhard R, 2012, BREAST, V21, P354, DOI 10.1016/j.breast.2012.03.001; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gupta IR, 2010, CLIN GENET, V77, P314, DOI 10.1111/j.1399-0004.2010.01397.x; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hoevel T, 2004, INT J CANCER, V108, P374, DOI 10.1002/ijc.11571; Ignatoski KMW, 1999, BREAST CANCER RES TR, V54, P173, DOI 10.1023/A:1006135331912; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Kramer F, 2000, HUM GENET, V107, P249, DOI 10.1007/s004390000375; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Lewis CM, 2005, CLIN CANCER RES, V11, P166; Lu SL, 2013, MODERN PATHOL, V26, P485, DOI 10.1038/modpathol.2012.187; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morohashi S, 2007, INT J MOL MED, V20, P139; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Ogoshi K, 2011, GENOMICS, V98, P280, DOI 10.1016/j.ygeno.2011.07.003; Osanai M, 2007, CANCER SCI, V98, P1557, DOI 10.1111/j.1349-7006.2007.00569.x; Ricardo S, 2012, HISTOL HISTOPATHOL, V27, P1283, DOI 10.14670/HH-27.1283; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Santos FPS, 2010, EXPERT REV ANTICANC, V10, P9, DOI [10.1586/ERA.09.164, 10.1586/era.09.164]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Stresemann C, 2008, MOL CANCER THER, V7, P2998, DOI 10.1158/1535-7163.MCT-08-0411; Szasz AM, 2011, CLIN EXP METASTAS, V28, P55, DOI 10.1007/s10585-010-9357-5; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; Yan PS, 2006, CLIN CANCER RES, V12, P6626, DOI 10.1158/1078-0432.CCR-06-0467; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	39	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68630	10.1371/journal.pone.0068630	http://dx.doi.org/10.1371/journal.pone.0068630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844228	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000019
J	Porter, K; Lin, YZ; Liton, PB				Porter, Kristine; Lin, Yizhi; Liton, Paloma B.			Cathepsin B Is Up-Regulated and Mediates Extracellular Matrix Degradation in Trabecular Meshwork Cells Following Phagocytic Challenge	PLOS ONE			English	Article							LYSOSOMAL CYSTEINE PROTEASES; DISTINCT SIGNALING PATHWAYS; THYROID EPITHELIAL-CELLS; ELECTRON-MICROSCOPY; ENDOTHELIAL-CELLS; MEDFLY HEMOCYTES; ANTERIOR CHAMBER; PROCATHEPSIN-B; ORGAN-CULTURE; IN-VITRO	Cells in the trabecular meshwork (TM), a tissue responsible for draining aqueous humor out of the eye, are known to be highly phagocytic. Phagocytic activity in TM cells is thought to play an important role in outflow pathway physiology. However, the molecular mechanisms triggered by phagocytosis in TM cells are unknown. Here we investigated the effects of chronic phagocytic stress on lysosomal function using different phagocytic ligands (E. coli, carboxylated beads, collagen I-coated beads, and pigment). Lysotracker red co-localization and electron micrographs showed the maturation of E. coli-and collagen I-coated beads-containing phagosomes into phagolysosomes. Maturation of phagosomes into phagolysosomes was not observed with carboxylated beads or pigment particles. In addition, phagocytosis of E. coli and collagen I-coated beads led to increased lysosomal mass, and the specific up-regulation and activity of cathepsin B (CTSB). Higher levels of membrane-bound and secreted CTSB were also detected. Moreover, in vivo zymography showed the intralysosomal degradation of ECM components associated with active CTSB, as well as an overall increased gelatinolytic activity in phagocytically challenged TM cells. This increased gelatinolytic activity with phagocytosis was partially blocked with an intracellular CTSB inhibitor. Altogether, these results suggest a potential role of phagocytosis in outflow pathway tissue homeostasis through the up-regulation and/or proteolytic activation of extracellular matrix remodeling genes.	[Porter, Kristine; Lin, Yizhi; Liton, Paloma B.] Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA	Duke University	Liton, PB (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.	paloma.liton@dm.duke.edu	Liton, Paloma/K-4229-2019	Liton, Paloma/0000-0002-1440-3762	National Institutes of Health [R01EY020491, R21EY019137]; ARRA [R21EY019137-S, P30EY005722]; American Health Assistance Foundation [G2012022]; NATIONAL EYE INSTITUTE [R01EY020491, R21EY019137, P30EY005722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01EY020491, R21EY019137, ARRA R21EY019137-S, P30EY005722, American Health Assistance Foundation (G2012022) and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LC, 2007, EXP CELL RES, V313, P1045, DOI 10.1016/j.yexcr.2006.12.019; Aisa MC, 2003, BBA-GEN SUBJECTS, V1621, P149, DOI 10.1016/S0304-4165(03)00054-0; BILL A, 1971, EXP EYE RES, V12, P275, DOI 10.1016/0014-4835(71)90149-7; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; Booth JW, 2001, SEMIN IMMUNOL, V13, P357, DOI 10.1006/smim.2001.0332; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Broemme D, EXTRACELLULAR MATRIX, P23; BULLER C, 1990, INVEST OPHTH VIS SCI, V31, P2156; Cavallo-Medved D, 2009, EXP CELL RES, V315, P1234, DOI 10.1016/j.yexcr.2009.01.021; Giusti I, 2008, NEOPLASIA, V10, P481, DOI 10.1593/neo.08178; GRIERSON I, 1973, BRIT J OPHTHALMOL, V57, P400, DOI 10.1136/bjo.57.6.400; GRIERSON I, 1978, BRIT J OPHTHALMOL, V62, P694, DOI 10.1136/bjo.62.10.694; Hoffmann E, 2010, EUR J CELL BIOL, V89, P693, DOI 10.1016/j.ejcb.2010.04.006; IWAMOTO T, 1971, AM J OPHTHALMOL, V72, P420, DOI 10.1016/0002-9394(71)91315-8; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; JOHNSON DH, 1989, CURR EYE RES, V8, P1121, DOI 10.3109/02713688909000037; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; KOBAYASHI H, 1993, BIOCHIM BIOPHYS ACTA, V1178, P55, DOI 10.1016/0167-4889(93)90109-3; KOBAYASHI H, 1991, J BIOL CHEM, V266, P5147; Koblinski JE, 2002, J BIOL CHEM, V277, P32220, DOI 10.1074/jbc.M204708200; Lamprou I, 2005, BBA-MOL CELL RES, V1744, P1, DOI 10.1016/j.bbamcr.2004.09.031; Lamprou I, 2007, IMMUNOLOGY, V121, P314, DOI 10.1111/j.1365-2567.2007.02576.x; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Li JH, 2009, AM J PATHOL, V175, P1124, DOI 10.2353/ajpath.2009.090113; Linke M, 2002, J CELL SCI, V115, P4877, DOI 10.1242/jcs.00184; Linke M, 2002, BIOL CHEM, V383, P773, DOI 10.1515/BC.2002.081; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Liton PB, 2005, INVEST OPHTH VIS SCI, V46, P183, DOI 10.1167/iovs.04-0330; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; MACH L, 1994, J BIOL CHEM, V269, P13030; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; MCCORMICK D, 1993, NEUROPATH APPL NEURO, V19, P146, DOI 10.1111/j.1365-2990.1993.tb00420.x; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Oh YK, 1996, J CELL BIOL, V132, P585, DOI 10.1083/jcb.132.4.585; Podgorski I, 2005, NEOPLASIA, V7, P207, DOI 10.1593/neo.04349; Porter KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034792; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Roberts R, 2005, DRUG NEWS PERSPECT, V18, P605, DOI 10.1358/dnp.2005.18.10.949485; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; Rohen J W, 1968, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V175, P143, DOI 10.1007/BF02385060; ROHEN JW, 1975, A GRAEF ARCH KLIN EX, V193, P95, DOI 10.1007/BF00419354; Rong YG, 2011, P NATL ACAD SCI USA, V108, P7826, DOI 10.1073/pnas.1013800108; Sameni M, 2000, NEOPLASIA, V2, P496, DOI 10.1038/sj.neo.7900116; SAMUELSON DA, 1984, AM J VET RES, V45, P2359; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; SCHLAGENHAUFF B, 1992, CANCER, V70, P1133, DOI 10.1002/1097-0142(19920901)70:5<1133::AID-CNCR2820700518>3.0.CO;2-O; SHABO AL, 1972, AM J OPHTHALMOL, V73, P25, DOI 10.1016/0002-9394(72)90300-5; SHIRATO S, 1989, INVEST OPHTH VIS SCI, V30, P2499; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; TRIPATHI RC, 1982, EXP EYE RES, V35, P611, DOI 10.1016/S0014-4835(82)80074-2; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; VANBUSKIRK EM, 1978, AM J OPHTHALMOL, V85, P160; Vreemann A, 2009, BIOL CHEM, V390, P481, DOI 10.1515/BC.2009.055; YAMASHITA T, 1965, AM J OPHTHALMOL, V60, P427, DOI 10.1016/0002-9394(65)90706-3; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; ZHOU LL, 1995, INVEST OPHTH VIS SCI, V36, P787	66	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68668	10.1371/journal.pone.0068668	http://dx.doi.org/10.1371/journal.pone.0068668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844232	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000022
J	Delgado, FF; Cermak, N; Hecht, VC; Son, S; Li, YZ; Knudsen, SM; Olcum, S; Higgins, JM; Chen, JZ; Grover, WH; Manalis, SR				Delgado, Francisco Feijo; Cermak, Nathan; Hecht, Vivian C.; Son, Sungmin; Li, Yingzhong; Knudsen, Scott M.; Olcum, Selim; Higgins, John M.; Chen, Jianzhu; Grover, William H.; Manalis, Scott R.			Intracellular Water Exchange for Measuring the Dry Mass, Water Mass and Changes in Chemical Composition of Living Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HUMAN ERYTHROCYTES; RIBONUCLEIC-ACID; BUOYANT DENSITY; SINGLE CELLS; GROWTH-RATE; PROTEIN; MICROSCOPY; VOLUME; CYCLE	We present a method for direct non-optical quantification of dry mass, dry density and water mass of single living cells in suspension. Dry mass and dry density are obtained simultaneously by measuring a cell's buoyant mass sequentially in an H2O-based fluid and a D2O-based fluid. Rapid exchange of intracellular H2O for D2O renders the cell's water content neutrally buoyant in both measurements, and thus the paired measurements yield the mass and density of the cell's dry material alone. Utilizing this same property of rapid water exchange, we also demonstrate the quantification of intracellular water mass. In a population of E. coli, we paired these measurements to estimate the percent dry weight by mass and volume. We then focused on cellular dry density - the average density of all cellular biomolecules, weighted by their relative abundances. Given that densities vary across biomolecule types (RNA, DNA, protein), we investigated whether we could detect changes in biomolecular composition in bacteria, fungi, and mammalian cells. In E. coli, and S. cerevisiae, dry density increases from stationary to exponential phase, consistent with previously known increases in the RNA/protein ratio from up-regulated ribosome production. For mammalian cells, changes in growth conditions cause substantial shifts in dry density, suggesting concurrent changes in the protein, nucleic acid and lipid content of the cell.	[Delgado, Francisco Feijo; Hecht, Vivian C.; Knudsen, Scott M.; Olcum, Selim; Grover, William H.; Manalis, Scott R.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Cermak, Nathan; Manalis, Scott R.] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Son, Sungmin; Manalis, Scott R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Li, Yingzhong; Chen, Jianzhu; Grover, William H.; Manalis, Scott R.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Higgins, John M.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Higgins, John M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Higgins, John M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Manalis, SR (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	scottm@media.mit.edu	Olcum, Selim/I-8523-2012	Olcum, Selim/0000-0002-6417-1007; Feijo Delgado, Francisco/0000-0001-9528-3389; Grover, William/0000-0001-6854-8951; Cermak, Nathan/0000-0002-8389-8236	Physical Sciences Oncology Center at the Massachusetts Institute of Technology from the United States National Cancer Institute [U54CA143874]; United States National Institutes of Health [P50GM68762, R01CA170592]; Institute for Collaborative Biotechnologies from the United States Army Research Office [W911NF-09-D-0001]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/47736/2008]; Directorate For Geosciences [1129359] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA014051, U54CA143874, R01CA170592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK098087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	Physical Sciences Oncology Center at the Massachusetts Institute of Technology from the United States National Cancer Institute; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Collaborative Biotechnologies from the United States Army Research Office; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Physical Sciences Oncology Center at the Massachusetts Institute of Technology (U54CA143874) from the United States National Cancer Institute. Center for Cell Decision Process Grant (P50GM68762) and contract R01CA170592, both from the United States National Institutes of Health. Institute for Collaborative Biotechnologies through contract number W911NF-09-D-0001 from the United States Army Research Office. F. F. D. acknowledges support from Fundacao para a Ciencia e a Tecnologia, Portugal, through a graduate fellowship (SFRH/BD/47736/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; ANDERSON N. G., 1966, NAT CANCER INST MONOGR, V21, P253; BARER R, 1953, NATURE, V171, P720, DOI 10.1038/171720a0; BEAMAN TC, 1982, J BACTERIOL, V150, P870, DOI 10.1128/JB.150.2.870-877.1982; BOEHLKE KW, 1975, J BACTERIOL, V121, P429, DOI 10.1128/JB.121.2.429-433.1975; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BRATBAK G, 1984, APPL ENVIRON MICROB, V48, P755, DOI 10.1128/AEM.48.4.755-757.1984; Bremer H, 2008, ECOSAL ESCHERICHIA C, P1553, DOI [10.1128/ecosal.5.2.3., DOI 10.1128/EC0SAL.5.2.3]; Bryan AK, 2010, P NATL ACAD SCI USA, V107, P999, DOI 10.1073/pnas.0901851107; Carrera M, 2008, J APPL MICROBIOL, V105, P68, DOI 10.1111/j.1365-2672.2008.03758.x; DENNIS PP, 1974, J BACTERIOL, V119, P270, DOI 10.1128/JB.119.1.270-281.1974; ENGELHARD HH, 1991, CYTOMETRY, V12, P68, DOI 10.1002/cyto.990120110; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; GAMBLE CN, 1960, J BIOPHYS BIOCHEM CY, V8, P53, DOI 10.1083/jcb.8.1.53; GREGERSEN MI, 1967, SCIENCE, V157, P825, DOI 10.1126/science.157.3790.825; Grover WH, 2011, P NATL ACAD SCI USA, V108, P10992, DOI 10.1073/pnas.1104651108; Halasz A, 1991, CHEM COMPOSITION BIO, P319; Harz A, 2009, CYTOM PART A, V75A, P104, DOI 10.1002/cyto.a.20682; Jang Y, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009673; KUBITSCHEK HE, 1983, J BACTERIOL, V155, P1027, DOI 10.1128/JB.155.3.1027-1032.1983; Lee J, 2011, SPACE, P82; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; MITCHISON JM, 1958, EXP CELL RES, V15, P214, DOI 10.1016/0014-4827(58)90077-6; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; PANIJPAN B, 1977, J CHEM EDUC, V54, P172, DOI 10.1021/ed054p172; POLAKIS ES, 1966, BIOCHEM J, V98, P883, DOI 10.1042/bj0980883; Potma EO, 2001, P NATL ACAD SCI USA, V98, P1577, DOI 10.1073/pnas.031575698; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Sherman F, 1998, ENCY MOL BIOL MOL ME, P302; Short KW, 2005, BIOPHYS J, V88, P4274, DOI 10.1529/biophysj.103.038604; THOMSON JF, 1974, ARCH BIOCHEM BIOPHYS, V160, P130, DOI 10.1016/S0003-9861(74)80017-2; TISA LS, 1982, APPL ENVIRON MICROB, V43, P1307, DOI 10.1128/AEM.43.6.1307-1310.1982; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Watson JD, 1972, MOL BIOL GENE; WEED RI, 1963, J CLIN INVEST, V42, P581, DOI 10.1172/JCI104747; Weng YC, 2011, LAB CHIP, V11, P4174, DOI 10.1039/c1lc20736a; Yamada EA, 2005, J AGR FOOD CHEM, V53, P3931, DOI 10.1021/jf0400821	40	89	92	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67590	10.1371/journal.pone.0067590	http://dx.doi.org/10.1371/journal.pone.0067590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844039	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000062
J	Makedonov, I; Black, SE; MacIntosh, BJ				Makedonov, Ilia; Black, Sandra E.; MacIntosh, Bradley J.			BOLD fMRI in the White Matter as a Marker of Aging and Small Vessel Disease	PLOS ONE			English	Article							DIFFUSION TENSOR MRI; ALZHEIMERS-DISEASE; FUNCTIONAL MRI; ISCHEMIC LEUKOARAIOSIS; PHYSIOLOGICAL NOISE; BRAIN IMAGES; HYPERINTENSITIES; LESIONS; DYSFUNCTION; ROBUST	Purpose: Determine whether white matter signal fluctuation on T2* weighted BOLD contrast images are associated with aging and cerebral small vessel disease (SVD). Methodology: Resting state BOLD data were collected with a 250 ms repetition time (TR) to achieve unaliased, ungated cardiac sampled BOLD (cs-BOLD) images on 11 young adult controls, 10 healthy older adult controls and 7 adults with extensive white matter hyperintensities (WMH) from SVD. Tissue classes (WM and GM) were segmented on T1 images. WMH were identified on FLAIR images in the SVD group. Raw physiological noise (sigma(physio)) and cardiac pulsatility (i.e. fluctuations at the cardiac frequency) were calculated voxel wise and group differences were tested by ANOVA. It was also possible to calculate sigma(physio) in 2s TR cardiac aliased whole-brain BOLD (wb-BOLD) data (N = 84) obtained from the International Consortium for Brain Mapping. Results: CS-BOLD metrics showed an aging and SVD effects (p<0.0005). Covariates such as thermal noise, WM volume and partial volume did not influence the significant aging effect seen on the cardiac pulsatility metric (p<0.017) but did influence the sigma(physio) (p = 0.184). As a verification of the cs-BOLD findings, the wb-BOLD also showed a linear aging effect of sigma(physio) in WM. In the SVD adults, cardiac pulsatility and sigma(physio) were lower in WMH regions compared to normal appearing white matter (NAWM) regions (p<0.0013 and p<0.002, respectively). Cardiac pulsatility was better able to distinguish WMH regions from NAWM than sigma(physio) as measured by effect size (Cohen's d 2.2 and 0.88, respectively). Conclusion: NAWM was found to have graded increases in cardiac pulsations due to age and SVD, independently. Within SVD participants, WMH lesions had reduced physiological noise compared to NAWM. Cardiac pulsatility in resting BOLD data may provide a complementary dynamic measure of WM integrity to add to static FLAIR anatomical images.	[Makedonov, Ilia; Black, Sandra E.; MacIntosh, Bradley J.] Sunnybrook Hlth Sci Ctr, Heart & Stroke Fdn Ctr Stroke Recovery, Toronto, ON M4N 3M5, Canada; [Makedonov, Ilia; Black, Sandra E.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Black, Sandra E.] Sunnybrook Hlth Sci Ctr, Dept Med Neurol, Toronto, ON M4N 3M5, Canada; [Black, Sandra E.] Univ Toronto, Toronto, ON, Canada; [Makedonov, Ilia; Black, Sandra E.; MacIntosh, Bradley J.] Sunnybrook Res Inst, Brain Sci Res Program, Toronto, ON, Canada; [MacIntosh, Bradley J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Makedonov, I (corresponding author), Sunnybrook Hlth Sci Ctr, Heart & Stroke Fdn Ctr Stroke Recovery, Toronto, ON M4N 3M5, Canada.	i.makedonov@utoronto.ca		Black, Sandra/0000-0001-7093-8289; MacIntosh, Bradley/0000-0001-7300-2355	Canadian Institutes of Health Research Institute of Aging Catalyst Grant [211653]; Canadian Institutes of Health Research [MT12139]; Natural Science & Engineering Research Council Discovery Grant; Heart and Stroke Foundation Centre for Stroke Recovery	Canadian Institutes of Health Research Institute of Aging Catalyst Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science & Engineering Research Council Discovery Grant; Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada)	Canadian Institutes of Health Research Institute of Aging Catalyst Grant 211653, Canadian Institutes of Health Research MT12139, Natural Science & Engineering Research Council Discovery Grant, Heart and Stroke Foundation Centre for Stroke Recovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AWAD IA, 1986, STROKE, V17, P1090, DOI 10.1161/01.STR.17.6.1090; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Biswal B, 1996, MAGNET RESON MED, V35, P107, DOI 10.1002/mrm.1910350114; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brickman AM, 2009, PSYCHIAT RES-NEUROIM, V172, P117, DOI 10.1016/j.pscychresns.2008.11.006; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brown WR, 2007, J NEUROL SCI, V257, P62, DOI 10.1016/j.jns.2007.01.015; Carmichael O, 2012, NEUROBIOL AGING, V33, P83, DOI 10.1016/j.neurobiolaging.2010.01.021; Chung CP, 2010, MED HYPOTHESES, V75, P85, DOI 10.1016/j.mehy.2010.01.042; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; de Groot JC, 2000, ANN NEUROL, V47, P145; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DUYN JH, 1994, NMR BIOMED, V7, P83, DOI 10.1002/nbm.1940070113; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Gao FQ, 2012, ALZH ASS INT C; Gao JH, 2012, NEUROIMAGE, V62, P1035, DOI 10.1016/j.neuroimage.2011.09.088; Gibson E, 2010, J MAGN RESON IMAGING, V31, P1311, DOI 10.1002/jmri.22004; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Henry-Feugeas MC, 2008, MED HYPOTHESES, V70, P866, DOI 10.1016/j.mehy.2007.07.027; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Hickie I, 1997, BIOL PSYCHIAT, V42, P367, DOI 10.1016/S0006-3223(96)00363-0; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Joutel A., 2002, Journal de la Societe de Biologie, V196, P109; Kidwell CS, 2001, J NEUROIMAGING, V11, P229, DOI 10.1111/j.1552-6569.2001.tb00039.x; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Makedonov I, 2013, EUR J NEUROL, V20, P243, DOI 10.1111/j.1468-1331.2012.03785.x; Marstrand JR, 2002, STROKE, V33, P972, DOI 10.1161/01.STR.0000012808.81667.4B; MOODY DM, 1995, RADIOLOGY, V194, P469, DOI 10.1148/radiology.194.2.7824728; Mungas D, 2001, NEUROLOGY, V57, P2229, DOI 10.1212/WNL.57.12.2229; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Resnick SM, 2003, J NEUROSCI, V23, P3295; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Sakakibara R, 1999, J NEUROL NEUROSUR PS, V67, P658, DOI 10.1136/jnnp.67.5.658; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P670, DOI 10.1111/j.1365-2990.2007.00890.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Speck O, 1998, MAGNET RESON MED, V40, P243, DOI 10.1002/mrm.1910400210; Wang HH, 2008, J MAGN RESON IMAGING, V27, P866, DOI 10.1002/jmri.21007; Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837; Whitman GT, 2001, NEUROLOGY, V57, P990, DOI 10.1212/WNL.57.6.990; Wowk B, 1997, MAGNET RESON MED, V38, P1029, DOI 10.1002/mrm.1910380625; Yacoub E, 2005, NEUROIMAGE, V24, P738, DOI 10.1016/j.neuroimage.2004.09.002; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	50	48	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67652	10.1371/journal.pone.0067652	http://dx.doi.org/10.1371/journal.pone.0067652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844047	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000067
J	Rinsky, JL; Nadimpalli, M; Wing, S; Hall, D; Baron, D; Price, LB; Larsen, J; Stegger, M; Stewart, J; Heaney, CD				Rinsky, Jessica L.; Nadimpalli, Maya; Wing, Steve; Hall, Devon; Baron, Dothula; Price, Lance B.; Larsen, Jesper; Stegger, Marc; Stewart, Jill; Heaney, Christopher D.			Livestock-Associated Methicillin and Multidrug Resistant Staphylococcus aureus Is Present among Industrial, Not Antibiotic-Free Livestock Operation Workers in North Carolina	PLOS ONE			English	Article							UNITED-STATES; MRSA; ST398; COLONIZATION; TRANSMISSION; INFECTIONS; PREVALENCE; ANIMALS	Objectives: Administration of antibiotics to food animals may select for drug-resistant pathogens of clinical significance, such as methicillin-resistant Staphylococcus aureus (MRSA). In the United States, studies have examined prevalence of MRSA carriage among individuals exposed to livestock, but prevalence of multidrug-resistant S. aureus (MDRSA) carriage and the association with livestock raised with versus without antibiotic selective pressure remains unclear. We aimed to examine prevalence, antibiotic susceptibility, and molecular characteristics of S. aureus among industrial livestock operation (ILO) and antibiotic-free livestock operation (AFLO) workers and household members in North Carolina. Methods: Participants in this cross-sectional study were interviewed and provided a nasal swab for S. aureus analysis. Resulting S. aureus isolates were assessed for antibiotic susceptibility, multi-locus sequence type, and absence of the scn gene (a marker of livestock association). Results: Among 99 ILO and 105 AFLO participants, S. aureus nasal carriage prevalence was 41% and 40%, respectively. Among ILO and AFLO S. aureus carriers, MRSA was detected in 7% (3/41) and 7% (3/42), respectively. Thirty seven percent of 41 ILO versus 19% of 42 AFLO S. aureus-positive participants carried MDRSA. S. aureus clonal complex (CC) 398 was observed only among workers and predominated among ILO (13/34) compared with AFLO (1/35) S. aureus-positive workers. Only ILO workers carried scn-negative MRSA CC398 (2/34) and scn-negative MDRSA CC398 (6/34), and all of these isolates were tetracycline resistant. Conclusions: Despite similar S. aureus and MRSA prevalence among ILO and AFLO-exposed individuals, livestock-associated MRSA and MDRSA (tetracycline-resistant, CC398, scn-negative) were only present among ILO-exposed individuals. These findings support growing concern about antibiotics use and confinement in livestock production, raising questions about the potential for occupational exposure to an opportunistic and drug-resistant pathogen, which in other settings including hospitals and the community is of broad public health importance.	[Rinsky, Jessica L.; Wing, Steve] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Nadimpalli, Maya; Stewart, Jill] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Hall, Devon; Baron, Dothula] REACH, Warsaw, NC USA; [Price, Lance B.] George Washington Univ, Dept Environm & Occupat Hlth, Washington, DC USA; [Larsen, Jesper; Stegger, Marc] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Heaney, Christopher D.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Heaney, Christopher D.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; George Washington University; Statens Serum Institut; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Heaney, CD (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	cheaney@jhsph.edu	Stewart, Jill/T-6862-2018; Larsen, Jesper/AAJ-3161-2021	Stewart, Jill/0000-0002-3474-5233; Larsen, Jesper/0000-0003-0582-0457; Stegger, Marc/0000-0003-0321-1180; Nadimpalli, Maya/0000-0002-6526-116X	North Carolina Translational and Clinical Sciences Institute; North Carolina Occupational Safety and Health Education and Research Center; W.K. Kellogg Health Scholars Program - Community Track; Gillings Innovation Laboratory award from the UNC Gillings School of Global Public Health; National Institute of Environmental Health Sciences (NIEHS) [T32ES007018]; Royster Society fellowship; EPA Science to Achieve Results fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007018] Funding Source: NIH RePORTER	North Carolina Translational and Clinical Sciences Institute; North Carolina Occupational Safety and Health Education and Research Center; W.K. Kellogg Health Scholars Program - Community Track; Gillings Innovation Laboratory award from the UNC Gillings School of Global Public Health; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Royster Society fellowship; EPA Science to Achieve Results fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this study was provided by the North Carolina Translational and Clinical Sciences Institute, North Carolina Occupational Safety and Health Education and Research Center, the W.K. Kellogg Health Scholars Program - Community Track, and a Gillings Innovation Laboratory award from the UNC Gillings School of Global Public Health. CDH was supported by the W.K. Kellogg Health Scholars Program - Community Track, JLR by the National Institute of Environmental Health Sciences (NIEHS; award no. T32ES007018), and MN by a Royster Society fellowship and an EPA Science to Achieve Results fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Baptiste KE, 2005, EMERG INFECT DIS, V11, P1942, DOI 10.3201/eid1112.050241; Bramble M, 2011, VECTOR-BORNE ZOONOT, V11, P617, DOI 10.1089/vbz.2010.0025; Casey JA, 2013, EPIDEMIOL INFECT, V141, P1166, DOI 10.1017/S0950268812001872; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clinical and Laboratory Standards Institute, 2012, M7A9 CLIN LAB STAND, V11th; Clinical and Laboratory Standards Institute, 2010, M100S200 CLIN LAB ST; Cromwell G.L., 2001, SWINE NUTR, V2, P401; Cuny C, 2012, APPL ENVIRON MICROB, V78, P1296, DOI 10.1128/AEM.07260-11; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feinman S.E., 1978, DRAFT ENV IMPACT STA; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Larsen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031245; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lowder BV, 2010, VIRULENCE, V1, P283, DOI 10.4161/viru.1.4.11838; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Osadebe LU, 2013, ZOONOSES PUBLIC HLTH, V60, P234, DOI 10.1111/j.1863-2378.2012.01527.x; Poulsen AB, 2003, J ANTIMICROB CHEMOTH, V51, P419, DOI 10.1093/jac/dkg084; Rafee Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-45; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Silbergeld EK, 2008, MED CLIN N AM, V92, P1391, DOI 10.1016/j.mcna.2008.07.003; Smith TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063704; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith Tara C, 2009, PLoS One, V4, pe4258, DOI 10.1371/journal.pone.0004258; Statens Serum Institut Danish Medicines Agency National Veterinary Insitute National Food Institute, 2010, DANMAP 2010 US ANT A; Steward CD, 2005, J CLIN MICROBIOL, V43, P1716, DOI 10.1128/JCM.43.4.1716-1721.2005; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; United States Food and Drug Administration, 2011, SUMM REP ANT SOLD DI; USDA, 2010, US DEP AGR 2010 NAT; USDA, 2007, US DEP AGR CENS AGR; USDOC, 2010, US DEP COMM 2010 CUR; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P343, DOI 10.1111/j.1469-0691.2010.03227.x; Werner G, 2012, VET MICROBIOL, V160, P162, DOI [10.1016/j.vetmic.2012.05.019, 10.1016/j.vetmic.2012.05.005]; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wing S, 2002, ENVIRON HEALTH PERSP, V110, P437, DOI 10.1289/ehp.02110437; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P225, DOI 10.2307/3454438; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	61	105	106	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67641	10.1371/journal.pone.0067641	http://dx.doi.org/10.1371/journal.pone.0067641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844044	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000065
J	Yao, DW; Xu, JR; Zhou, ZL; Li, ST; Yang, DJ				Yao, Da-Wei; Xu, Jia-Rong; Zhou, Zhen-Lei; Li, Shang-Tong; Yang, De-Ji			Microsatellite Instability in Chicken Lymphoma Induced by Gallid Herpesvirus 2	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; EPSTEIN-BARR-VIRUS; MISMATCH REPAIR GENES; GASTRIC CARCINOMAS; CANCER; DNA; INFECTION; CRITERIA; SERUM; P53	Microsatellite instability (MSI) has been found in a range of human tumors, and little is known of the links between MSI and herpesvirus. In order to investigate the relationship between MSI and Gallid herpesvirus 2 (GaHV-2)-induced lymphoma, fifteen Marek's disease (MD) lymphomas were analyzed through using 46 microsatellite markers, which were amplified by PCR from DNA specimens of lymphoma and normal muscular tissues from the same chicken. PCR products were evaluated by denaturing polyacrylamide gel electrophoresis for MSI analysis. MSI was proved in all lymphomas, at least in one locus. Thirty of the 46 microsatellite markers had microsatellite alterations. These results suggested that GaHV-2-induced lymphoma in chickens is related to MSI, and this is the first report to demonstrate that MSI is associated with the GaHV-2 induced lymphoma in chicken.	[Yao, Da-Wei; Xu, Jia-Rong; Zhou, Zhen-Lei; Li, Shang-Tong; Yang, De-Ji] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, DJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	yangdeji63@sohu.com			National Natural Science Foundation of China [3087847]; 948 Ministry of Agriculture Project [2011-z20]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 948 Ministry of Agriculture Project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by a grant from the National Natural Science Foundation of China (3087847), the 948 Ministry of Agriculture Project (2011-z20) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajithdoss DK, 2009, VIRUS RES, V142, P57, DOI 10.1016/j.virusres.2009.01.008; Arzimanoglou II, 1998, CANCER-AM CANCER SOC, V82, P1808, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO;2-J; Boland CR, 1998, CANCER RES, V58, P5248; Chang MS, 2000, PATHOL INT, V50, P486, DOI 10.1046/j.1440-1827.2000.01072.x; Chang MS, 2003, J PATHOL, V199, P447, DOI 10.1002/path.1302; Cheng HH, 2008, STADLER GEN, P115, DOI 10.1007/978-0-387-76723-9_9; Damania B, 2004, NAT REV MICROBIOL, V2, P656, DOI 10.1038/nrmicro958; Deng XF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-348; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Hag K, 2010, VET IMMUNOL IMMUNOP, V138, P292, DOI 10.1016/j.vetimm.2010.10.007; Hoffmann JS, 1998, INT J ONCOL, V12, P377; Honma M, 2000, MOL CARCINOGEN, V28, P203, DOI 10.1002/1098-2744(200008)28:4<203::AID-MC3>3.0.CO;2-1; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Kaiser HE, 2008, SELECTED ASPECTS CAN, P169; Keohavong P, 2005, MICROSATELLITE INSTA, P293; Leung SY, 1999, BRIT J CANCER, V79, P582, DOI 10.1038/sj.bjc.6690092; Lu ZJ, 2010, VIRUS RES, V153, P250, DOI 10.1016/j.virusres.2010.08.010; Lupiani B, 2004, P NATL ACAD SCI USA, V101, P11815, DOI 10.1073/pnas.0404508101; Miturski R, 2002, EXP BIOL MED, V227, P579, DOI 10.1177/153537020222700805; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; Sanchez-Cespedes M, 1998, ANN ONCOL, V9, P113, DOI 10.1023/A:1008230331221; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; [尚月丽 SHANG Yue-li], 2009, [南京农业大学学报, Journal of Nanjing Agricultural University], V32, P115; Utting M, 2002, CLIN CANCER RES, V8, P35; Wu MS, 2000, GASTROENTEROLOGY, V118, P1031, DOI 10.1016/S0016-5085(00)70355-6; YEE CJ, 1994, CANCER RES, V54, P1641; Yoon BS, 2008, YONSEI MED J, V49, P272, DOI 10.3349/ymj.2008.49.2.272	28	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68058	10.1371/journal.pone.0068058	http://dx.doi.org/10.1371/journal.pone.0068058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844155	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000135
J	Alfonso-Perez, T; Dominguez-Sanchez, MS; Garcia-Dominguez, M; Reyes, JC				Alfonso-Perez, T.; Dominguez-Sanchez, M. S.; Garcia-Dominguez, M.; Reyes, J. C.			Cytoplasmic interaction of the tumour suppressor protein hSNF5 with dynamin-2 controls endocytosis	ONCOGENE			English	Article						rhabdoid tumours; nucleocytoplasmic shuttling; chromatin remodelling; endocytosis	CLATHRIN-MEDIATED ENDOCYTOSIS; CRYSTAL-STRUCTURE; TRANSCRIPTION FACTOR; SH3 DOMAIN; CELLS; CANCER; GTPASE; INI1/HSNF5; COMPLEX; TUMORIGENESIS	Human SNF5 (hSNF5; INI1, SMARCB1 or BAF47) is a component of the human SWI/SNF chromatin remodelling complex and a tumour suppressor mutated in rhabdoid tumours. It also associates with the integrase of the human immunodeficiency virus (HIV)-1. We show by fluorescence loss in photobleaching that hSNF5 is constantly shuttling between the nucleus and the cytoplasm, raising the question of what the role of hSNF5 is in the cytoplasm. Here, we demonstrate that hSNF5 directly interacts with the GTPase dynamin-2 (DNM2) in the cytoplasm. DNM2 is a large GTPase involved in endocytosis and vesicle dynamics, which has been related to HIV-1 internalization. We show that hSNF5 colocalizes with DNM2 in endocytic vesicles. Depletion of hSNF5, but not of other components of the SWI/SNF complex, destabilizes DNM2 and impairs DNM2-dependent endocytosis. Furthermore, we show that hSNF5 inhibits assembly-stimulated DNM2 GTPase activity but not basal GTPase activity in vitro. Altogether, these results indicate that hSNF5 affects both the stability and the activity of DNM2, uncovering an unexpected role of hSNF5 in modulating endocytosis, and open new perspectives in understanding the role of hSNF5 in tumour genesis.	[Alfonso-Perez, T.; Dominguez-Sanchez, M. S.; Reyes, J. C.] CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Mol Biol, Seville 41092, Spain; [Garcia-Dominguez, M.] CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Stem Cells Dept, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Reyes, JC (corresponding author), CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Mol Biol, Av Amer Vespucio, Seville 41092, Spain.	mario.garcia@cabimer.es; jose.reyes@cabimer.es	Reyes, Jose C/K-3699-2014; Alfonso-Perez, Tatiana/Q-9269-2016; Garcia-Dominguez, Mario/K-3674-2014	Reyes, Jose C/0000-0002-8042-5142; Garcia-Dominguez, Mario/0000-0003-2211-8731	Spanish Ministerio de Economia y Competitividad [BFU2011-23442, CSD2006-00049]; Junta de Andalucia and Fundacion Ramon Areces [P06-CVI-4844]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia and Fundacion Ramon Areces(Junta de Andalucia)	We thank C Muchardt, M Yaniv, SL Schmid and MA McNiven for providing plasmids, and P Dominguez for microscopy technical support. This work was supported by Grants BFU2011-23442 and CSD2006-00049 from the Spanish Ministerio de Economia y Competitividad, P06-CVI-4844 from Junta de Andalucia and Fundacion Ramon Areces.	Bukrinsky M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-49; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Ceballos-Chavez M, 2012, P NATL ACAD SCI USA, V109, P8085, DOI 10.1073/pnas.1121522109; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; Das S, 2009, J BIOL CHEM, V284, P19903, DOI 10.1074/jbc.M808141200; Deitcher D, 2001, TRENDS NEUROSCI, V24, P625, DOI 10.1016/S0166-2236(00)01927-5; Dundr M, 2003, CURR PROTOC CELL BIO; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Giebel B, 2006, CURR BIOL, V16, pR91, DOI 10.1016/j.cub.2006.01.022; Giudicelli F, 2003, DEV BIOL, V253, P150, DOI 10.1006/dbio.2002.0864; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Joshi S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-78; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Koster M, 2005, CURR OPIN BIOTECH, V16, P28, DOI 10.1016/j.copbio.2004.11.002; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; McKenna ES, 2012, CELL CYCLE, V11, P1956, DOI 10.4161/cc.20280; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; PEARSE BMF, 1982, P NATL ACAD SCI-BIOL, V79, P451, DOI 10.1073/pnas.79.2.451; Roberts CWM, 2009, CANCER BIOL THER, V8, P412, DOI 10.4161/cbt.8.5.8019; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stojanova A, 2009, BIOCHEM CELL BIOL, V87, P163, DOI 10.1139/O08-113; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; Treich I, 1997, MOL CELL BIOL, V17, P1768, DOI 10.1128/MCB.17.4.1768; TUMA PL, 1995, J BIOL CHEM, V270, P26707, DOI 10.1074/jbc.270.44.26707; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Vachtenheim J, 2010, BIOCHEM BIOPH RES CO, V392, P454, DOI 10.1016/j.bbrc.2010.01.048; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068	51	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 5	2014	33	23					3064	3074		10.1038/onc.2013.276	http://dx.doi.org/10.1038/onc.2013.276			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EL	23851497				2022-12-25	WOS:000337232200013
J	Fullston, T; Teague, EMCO; Palmer, NO; DeBlasio, MJ; Mitchell, M; Corbett, M; Print, CG; Owens, JA; Lane, M				Fullston, Tod; Teague, E. Maria C. Ohlsson; Palmer, Nicole O.; DeBlasio, Miles J.; Mitchell, Megan; Corbett, Mark; Print, Cristin G.; Owens, Julie A.; Lane, Michelle			Paternal obesity initiates metabolic disturbances in two generations of mice with incomplete penetrance to the F-2 generation and alters the transcriptional profile of testis and sperm microRNA content	FASEB JOURNAL			English	Article						nongenetic transmission; epigenetic alteration; methylation; DNA damage; ROS	BODY-MASS INDEX; HIGH-FAT DIET; SEMEN QUALITY; REPRODUCTIVE HORMONES; HUMAN SPERMATOZOA; MIRNA EXPRESSION; GENE-EXPRESSION; RNA; IMPACT; TIME	Obesity is highly prevalent, and its incidence is increasing. The previous study showing a major effect of paternal obesity on metabolic health of offspring is confounded by comorbidity with diabetes. Therefore, we investigated the effect of diet-induced paternal obesity, in the absence of diabetes, on the metabolic health of two resultant generations and the molecular profiles of the testes and sperm. Founder (F-0) male C57BL6 mice were fed either a high-fat diet (HFD) or a control diet (CD); n = 10/diet for a period of 10 wk. Testis expression of mRNA/microRNAs was analyzed by microarray and qPCR and sperm microRNA abundance by qPCR. Two subsequent generations were generated by mating F-0 and then F-1 mice to CD mice, and their metabolic health was investigated. All mice, other than F-0 males, were maintained on a CD. HFD feeding induced paternal obesity with a 21% increase in adiposity, but not overt diabetes, and initiated intergenerational transmission of obesity and insulin resistance in two generations of offspring. This distinct phenotypic constellation is either partially or fully transmitted to both female and male F-1 offspring and further transmitted through both parental lineages to the F-2 generation, with a heightened effect on female F-1 offspring (+67% in adiposity) and their F-2 sons (+24% in adiposity). Founder male obesity altered the testes expression of 414 mRNAs by microarray and 11 microRNAs by qPCR, concomitant with alterations in sperm microRNA content and a 25% reduction in global methylation of germ cell DNA. Diet-induced paternal obesity modulates sperm microRNA content and germ cell methylation status, which are potential signals that program offspring health and initiate the transmission of obesity and impaired metabolic health to future generations. This study implicates paternal obesity in the transgenerational amplification of obesity and type 2 diabetes in humans.Fullston, T., Ohlsson Teague, E. M. C., Palmer, N. O., DeBlasio, M. J., Mitchell, M., Corbett, M., Print, C. G., Owens, J. A., Lane, M. Paternal obesity initiates metabolic disturbances in two generations of mice with incomplete penetrance to the F-2 generation and alters the transcriptional profile of testis and sperm microRNA content.	[Fullston, Tod; Teague, E. Maria C. Ohlsson; Palmer, Nicole O.; DeBlasio, Miles J.; Mitchell, Megan; Owens, Julie A.; Lane, Michelle] Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA 5005, Australia; [Corbett, Mark] Univ Adelaide, Discipline Paediat, Sch Paediat & Reprod Hlth, Robinson Inst, Adelaide, SA 5005, Australia; [Print, Cristin G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, New Zealand Bioinformat Inst, Auckland 1, New Zealand; [Lane, Michelle] Repromed, Adelaide, SA, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide; University of Auckland; University of Auckland	Fullston, T (corresponding author), Univ Adelaide, Level 3 Med Sch South, Adelaide, SA 5005, Australia.	tod.fullston@adelaide.edu.au	Mitchell, Megan/CAG-5875-2022; De Blasio, Miles/D-5460-2011; Corbett, Mark/A-8063-2010; Mitchell, Megan/CAG-5838-2022; De Blasio, Miles J/GQB-1536-2022; Owens, Julie A/C-9744-2009; De Blasio, Miles/AAB-7234-2019	Mitchell, Megan/0000-0002-4284-2201; Corbett, Mark/0000-0001-9298-3072; Mitchell, Megan/0000-0002-4284-2201; De Blasio, Miles J/0000-0002-4797-5193; Owens, Julie A/0000-0002-7498-1353; De Blasio, Miles/0000-0002-4797-5193; Print, Cristin/0000-0001-8345-7812	National Health and Medical Research Council (NHMRC); M. S. McLeod Research Fund Fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); M. S. McLeod Research Fund Fellowship	The authors acknowledge the intellectual input of Hassan W. Bakos at the conception of the study and the technical contributions of Samantha Schulz and Verity Bell (School of Pediatrics and Reproductive Health, University of Adelaide). The authors also thank Daniel Hurley and Vicky Fan (University of Auckland) for bioinformatic support. This work was supported by a National Health and Medical Research Council (NHMRC) program grant awarded to M.L. ML. is the recipient of an NHMRC Senior Research Fellowship. T.F. is the recipient of an NHMRC Early Career Research Fellowship. M.C. is a recipient of an M. S. McLeod Research Fund Fellowship. The authors declare no conflicts of interest. T.F., E.M.C.O.T., N.O.P., M.M., J.A.O., and M.L. designed the experiments. T.F., E.M.C.O.T., N.O.P., M.J.D. and M.L. executed the experiments. All authors contributed to data analysis and interpretation. T.F., J.A.O., and M.L. prepared the manuscript. All authors reviewed and approved the final manuscript.	Abd El Naby WS, 2013, ZYGOTE, V21, P31, DOI 10.1017/S0967199411000566; Abu-Halima M, 2013, FERTIL STERIL, V99, P1249, DOI 10.1016/j.fertnstert.2012.11.054; Adiga SK, 2010, FERTIL STERIL, V93, P2486, DOI 10.1016/j.fertnstert.2009.06.015; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; Bedzhov I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002609; Begg S., 2007, BURDEN DIS INJURY AU; Bhat GK, 2006, J ANDROL, V27, P302, DOI 10.2164/jandrol.05133; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Das S, 2013, ONCOGENE, V32, P2927, DOI 10.1038/onc.2012.311; De Blasio MJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE75, DOI 10.1152/ajpendo.00689.2006; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; El Hajj N, 2011, SEX DEV, V5, P60, DOI 10.1159/000323806; Fall CHD, 2011, ANN HUM BIOL, V38, P410, DOI 10.3109/03014460.2011.592513; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; Freeman E, 2012, INT J OBESITY, V36, P12, DOI 10.1038/ijo.2011.198; Fullston T, 2012, HUM REPROD, V27, P1391, DOI 10.1093/humrep/des030; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gong ZW, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/320482; Grandjean V, 2009, GYNECOL OBSTET FERTI, V37, P558, DOI 10.1016/j.gyobfe.2009.04.005; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hulf T, 2013, ONCOGENE, V32, P2891, DOI 10.1038/onc.2012.300; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Lane M, 2002, HUM REPROD, V17, P2686, DOI 10.1093/humrep/17.10.2686; Leibel NI, 2006, J CLIN ENDOCR METAB, V91, P1275, DOI 10.1210/jc.2005-1707; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Lin CC, 2008, INT J OCCUP ENV HEAL, V14, P112, DOI 10.1179/oeh.2008.14.2.112; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047; Madison-Villar MJ, 2011, J MOL EVOL, V73, P316, DOI 10.1007/s00239-011-9478-8; Magnusdottir EV, 2005, HUM REPROD, V20, P208, DOI 10.1093/humrep/deh569; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Marczylo EL, 2012, EPIGENETICS-US, V7, P432, DOI 10.4161/epi.19794; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; NASRESFAHANI MH, 1990, DEVELOPMENT, V109, P501; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Ning HX, 2009, DIFFERENTIATION, V78, P253, DOI 10.1016/j.diff.2009.07.009; Ogus S, 2003, ENDOCRINOLOGY, V144, P2865, DOI 10.1210/en.2002-0178; Ostermeier GC, 2005, J ANDROL, V26, P70; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V302, pE768, DOI 10.1152/ajpendo.00401.2011; Palmer NO, 2011, REPROD FERT DEVELOP, V23, P929, DOI 10.1071/RD10326; Piovan C, 2012, MOL ONCOL, V6, P458, DOI 10.1016/j.molonc.2012.03.003; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rassoulzadegan M, 2010, ORGANOGENESIS, V6, P33, DOI 10.4161/org.6.1.11094; Santulli G, 2012, DIABETES, V61, P692, DOI 10.2337/db11-1027; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tanic M, 2012, BREAST CANCER RES TR, V134, P41, DOI 10.1007/s10549-011-1905-4; Tripurani SK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-25; Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; van der Heijden GW, 2006, DEV BIOL, V298, P458, DOI 10.1016/j.ydbio.2006.06.051; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Yamauchi Y, 2011, ASIAN J ANDROL, V13, P31, DOI 10.1038/aja.2010.75; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Youngson NA, 2011, ASIAN J ANDROL, V13, P195, DOI 10.1038/aja.2010.163	85	365	380	2	76	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4226	4243		10.1096/fj.12-224048	http://dx.doi.org/10.1096/fj.12-224048			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23845863				2022-12-25	WOS:000329747100033
J	Koenigs, A; Hammerschmidt, C; Jutras, BL; Pogoryelov, D; Barthel, D; Skerka, C; Kugelstadt, D; Wallich, R; Stevenson, B; Zipfel, PF; Kraiczy, P				Koenigs, Arno; Hammerschmidt, Claudia; Jutras, Brandon L.; Pogoryelov, Denys; Barthel, Diana; Skerka, Christine; Kugelstadt, Dominik; Wallich, Reinhard; Stevenson, Brian; Zipfel, Peter F.; Kraiczy, Peter			BBA70 of Borrelia burgdorferi Is a Novel Plasminogen-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACQUIRING SURFACE PROTEIN-1; LYME-DISEASE SPIROCHETE; FACTOR H-BINDING; BACTERIAL-CELL SURFACE; TICK INFECTION CYCLE; IMMUNE EVASION; FUNCTIONAL-CHARACTERIZATION; LEPTOSPIRA-INTERROGANS; COMPLEMENT INHIBITOR; EXTRACELLULAR-MATRIX	The Lyme disease spirochete Borrelia burgdorferi lacks endogenous, surface-exposed proteases. In order to efficiently disseminate throughout the host and penetrate tissue barriers, borreliae rely on recruitment of host proteases, such as plasmin(ogen). Here we report the identification of a novel plasminogen-binding protein, BBA70. Binding of plasminogen is dose-dependent and is affected by ionic strength. The BBA70-plasminogen interaction is mediated by lysine residues, primarily located in a putative C-terminal alpha-helix of BBA70. These lysine residues appear to interact with the lysine-binding sites in plasminogen kringle domain 4 because a deletion mutant of plasminogen lacking that domain was unable to bind to BBA70. Bound to BBA70, plasminogen activated by urokinase-type plasminogen activator was able to degrade both a synthetic chromogenic substrate and the natural substrate fibrinogen. Furthermore, BBA70-bound plasmin was able to degrade the central complement proteins C3b and C5 and inhibited the bacteriolytic effects of complement. Consistent with these functional activities, BBA70 is located on the borrelial outer surface. Additionally, serological evidence demonstrated that BBA70 is produced during mammalian infection. Taken together, recruitment and activation of plasminogen could play a beneficial role in dissemination of B. burgdorferi in the human host and may possibly aid the spirochete in escaping the defense mechanisms of innate immunity.	[Koenigs, Arno; Hammerschmidt, Claudia; Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, D-60596 Frankfurt, Germany; [Jutras, Brandon L.; Stevenson, Brian] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA; [Pogoryelov, Denys] Goethe Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Barthel, Diana; Skerka, Christine; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Kugelstadt, Dominik] Sekisui Virotech GmbH, D-65428 Russelsheim, Germany; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany; [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kentucky; Goethe University Frankfurt; Hans Knoll Institute (HKI); Ruprecht Karls University Heidelberg; Friedrich Schiller University of Jena	Kraiczy, P (corresponding author), Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	kraiczy@em.uni-frankfurt.de		Jutras, Brandon/0000-0002-7989-1031	Deutsche Forschungsgemeinschaft [Kr3383/1-2]; Collaborative Research Center 807 of the German Research Foundation; Collaborative Research Center 902 of the German Research Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Center 807 of the German Research Foundation; Collaborative Research Center 902 of the German Research Foundation	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Kr3383/1-2 (to P. K.).; Supported by Collaborative Research Center 807 and Collaborative Research Center 902 of the German Research Foundation.	ANGLESCANO E, 1994, CHEM PHYS LIPIDS, V67-8, P353, DOI 10.1016/0009-3084(94)90157-0; [Anonymous], THROMB HAEMOST, V77, P1; BANYAI L, 1984, J BIOL CHEM, V259, P6466; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Brissette CA, 2010, CLIN VACCINE IMMUNOL, V17, P274, DOI 10.1128/CVI.00437-09; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Bykowski T, 2008, INT J MED MICROBIOL, V298, P249, DOI 10.1016/j.ijmm.2007.10.002; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Candela M, 2010, MICROBIOL-SGM, V156, P1609, DOI 10.1099/mic.0.038307-0; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Castellino FJ, 1997, CIBA F SYMP, V212, P46; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1999, INFECT IMMUN, V67, P3929, DOI 10.1128/IAI.67.8.3929-3936.1999; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; Crother TR, 2004, INFECT IMMUN, V72, P5063, DOI 10.1128/IAI.72.9.5063-5072.2004; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Domingos RF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-50; Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gebbia JA, 2001, INFECT IMMUN, V69, P456, DOI 10.1128/IAI.69.1.456-462.2001; GOGUEN JD, 1995, INFECT AGENT DIS, V4, P47; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; Hammerschmidt C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/349657; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Herzberger P, 2009, INT J MED MICROBIOL, V299, P141, DOI 10.1016/j.ijmm.2008.06.005; Hodzic E, 2003, INFECT IMMUN, V71, P5042, DOI 10.1128/IAI.71.9.5042-5055.2003; Hodzic E, 2002, INFECT IMMUN, V70, P3382, DOI 10.1128/IAI.70.7.3382-3388.2002; Hu LT, 1997, INFECT IMMUN, V65, P4989, DOI 10.1128/IAI.65.12.4989-4995.1997; Hughes JL, 2008, INFECT IMMUN, V76, P2498, DOI 10.1128/IAI.01583-07; Joshi KK, 2012, BBA-PROTEINS PROTEOM, V1824, P326, DOI 10.1016/j.bbapap.2011.10.010; Jutras Brandon L, 2010, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01e02s19; KLEMPNER MS, 1995, J INFECT DIS, V171, P1258, DOI 10.1093/infdis/171.5.1258; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kost C, 1996, EUR J BIOCHEM, V236, P682, DOI 10.1111/j.1432-1033.1996.0682d.x; Kraiczy P, 2004, INT J MED MICROBIOL, V293, P152, DOI 10.1016/S1433-1128(04)80029-9; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; Kraiczy P, 2006, WIEN KLIN WOCHENSCHR, V118, P669, DOI 10.1007/s00508-006-0691-1; KRAMER MD, 1990, IMMUNOBIOLOGY, V181, P357, DOI 10.1016/S0171-2985(11)80504-8; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; KUUSELA P, 1990, EUR J BIOCHEM, V193, P759, DOI 10.1111/j.1432-1033.1990.tb19397.x; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; LIJNEN HR, 1995, BAILLIERE CLIN HAEM, V8, P277, DOI 10.1016/S0950-3536(05)80268-9; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P143, DOI 10.1111/j.1432-1033.1994.tb20005.x; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Mendes RS, 2011, INFECT IMMUN, V79, P4657, DOI 10.1128/IAI.05583-11; Montgomery RR, 1996, J EXP MED, V183, P261, DOI 10.1084/jem.183.1.261; Nogueira SV, 2012, INFECT IMMUN, V80, P82, DOI 10.1128/IAI.05671-11; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PILLEMER L, 1953, J EXP MED, V97, P573, DOI 10.1084/jem.97.4.573; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; PREISSNER KT, 1990, BIOCHEM BIOPH RES CO, V168, P966, DOI 10.1016/0006-291X(90)91123-A; RADOLF JD, 1988, INFECT IMMUN, V56, P490, DOI 10.1128/IAI.56.2.490-498.1988; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; RINGNER M, 1994, FEMS IMMUNOL MED MIC, V9, P29, DOI 10.1016/0928-8244(94)00012-3; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; SALONEN EM, 1985, J BIOL CHEM, V260, P2302; SALONEN EM, 1984, FEBS LETT, V172, P29, DOI 10.1016/0014-5793(84)80866-2; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11; ULLBERG M, 1990, INFECT IMMUN, V58, P21, DOI 10.1128/IAI.58.1.21-25.1990; ULLBERG M, 1989, APMIS, V97, P996, DOI 10.1111/j.1699-0463.1989.tb00508.x; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2011, MICROB PATHOGENESIS, V51, P360, DOI 10.1016/j.micpath.2011.06.008; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weisel J W, 1996, Ukr Biokhim Zh (1978), V68, P41; WEISEL JW, 1994, J MOL BIOL, V235, P1117, DOI 10.1006/jmbi.1994.1061; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110	87	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25229	25243		10.1074/jbc.M112.413872	http://dx.doi.org/10.1074/jbc.M112.413872			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861404	hybrid, Green Published			2022-12-25	WOS:000330619000022
J	Piksa, K; Nowak, J; Zmihorski, M; Bogdanowicz, W				Piksa, Krzysztof; Nowak, Jakub; Zmihorski, Michal; Bogdanowicz, Wieslaw			Nonlinear Distribution Pattern of Hibernating Bats in Caves along an Elevational Gradient in Mountain (Carpathians, Southern Poland)	PLOS ONE			English	Article							SPECIES RICHNESS; ALTITUDINAL DISTRIBUTION; GLOBAL ANALYSIS; DIVERSITY; TEMPERATURE; EXTENSION; RANGE; AREA	Background: Thermal gradients along changes in elevation in mountainous environments are reflected by different biotas. Although there have been studies of elevation variation in bat assemblages in summer, winter changes in the same gradients remain unknown. Methodology/Principal Findings: The objective of this study was to document changes in the species composition of bats hibernating in caves along a temperate elevational gradient. We studied 70 caves between from 300 m to 1,930 m altitude along a slope of the Carpathian Mountains in southern Poland. We recorded changes in bats, including species richness, abundance, altitudinal distribution and dominance during consecutive winters between 2003 and 2009. Similarity of dominance of faunal structure was assessed by using the Bray-Curtis similarity index. We used the generalised additive model and rarefaction to study the variation in species richness, and generalized additive mixed models to examine the effect of abiotic factors on the qualitative and quantitative structure of bat assemblages. During 351 surveys we recorded 13,856 hibernating bats from 15 species. Species richness peaked around mid-elevation (1,100-1,400 m a.s.l.) with richness declining at both higher and lower elevations. Based on the results of a cluster analysis, we could distinguish among four altitudinal zones that differed in species richness and dominance structure. Conclusions/Significance: This is the first study documenting changes in species richness and variation of structure of bats hibernating in caves along an elevational gradient. The most surprising and key finding is the fact that changes in the structure of assemblages of hibernating bats along the altitudinal gradient occurred in jumps, forming zones similar to those observed in the vegetation zones. Moreover, species richness and dominance structure of assemblages of hibernating bats in the mountains depended not only on location above sea level, but also on local geomorphologic conditions which strongly affected the microclimate of the caves.	[Piksa, Krzysztof] Cracow Pedag Univ, Inst Biol, Krakow, Poland; [Nowak, Jakub] Cracow Caving Club, Krakow, Poland; [Zmihorski, Michal; Bogdanowicz, Wieslaw] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland	Pedagogical University of Cracow; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences	Piksa, K (corresponding author), Cracow Pedag Univ, Inst Biol, Krakow, Poland.	krzychu@up.krakow.pl		Bogdanowicz, Wieslaw/0000-0003-1196-2494; Piksa, Krzysztof/0000-0001-5057-895X; Zmihorski, Michal/0000-0001-5137-1635; , Michal/0000-0002-2951-3462	Pedagogical University of Cracow	Pedagogical University of Cracow	Funding was provided by the Pedagogical University of Cracow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARATAUD M, 2004, RHINOLOPHE, V17, P11; Barry R. G., 1981, MOUNTAIN WEATHER CLI; Bhatt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046237; BOGDANOWICZ W, 1983, ACTA THERIOL, V28, P357, DOI 10.4098/AT.arch.83-31; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Chawla A, 2008, J MT SCI-ENGL, V5, P157, DOI 10.1007/s11629-008-0079-y; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 1994, CHANGE MARINE COMMUN; Colwell RK, 2009, ESTIMATES STAT ESTIM; Fleming TH, 2003, BAT ECOLOGY, P156; Forero-Medina G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028535; GAISLER J, 1970, Bijdragen tot de Dierkunde, V40, P33; Georgiakakis P, 2010, HYSTRIX, V21, P43; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GRAHAM GL, 1983, J MAMMAL, V64, P559, DOI 10.2307/1380511; Grytnes J., 2007, ENCY BIODIVERSITY, P1, DOI [DOI 10.1038/NCLIMATE1347, DOI 10.1016/B978-012226865-6/00503-1]; Harmata W., 1969, Acta Theriologica, V14, P49; HEANEY LR, 1989, J TROP ECOL, V5, P259, DOI 10.1017/S0266467400003643; Horacek Ivan, 2000, P11; Hutterer R., 2005, NATURSCHUTZ BIOL VIE, V28, P1; JUSTE J, 1995, J TROP ECOL, V11, P141; Kanuch P, 2006, BIOLOGIA, V61, P605, DOI 10.2478/s11756-006-0097-6; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kunz T.H., 1982, P1; Lavrenchenko Leonid A., 2004, Bonner Zoologische Beitraege, V52, P127; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lourenco S, 2008, PARASITOL RES, V104, P127, DOI 10.1007/s00436-008-1170-6; Lyman C.P., 1982, HIBERNATION TORPOR M; MacArthur R.H., 1972, pvii; Margielewski W, 2003, GEOMORPHOLOGY, V54, P325, DOI 10.1016/S0169-555X(02)00375-6; Maryanto I, 2011, HYSTRIX, V22, P167, DOI 10.4404/Hystrix-22.1-4480; Mateo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032586; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; Nagel A., 1991, Myotis, V29, P109; Niermann N, 2007, ACTA CHIROPTEROL, V9, P361; OWEN JG, 1990, J MAMMAL, V71, P1, DOI 10.2307/1381311; Patterson BD, 1996, J ZOOL, V240, P637, DOI 10.1111/j.1469-7998.1996.tb05313.x; Perry RW, 2012, ENVIRON REV, V21, P28, DOI DOI 10.1139/ER-2012-0042; Pierson E. D., 2001, SEASONAL PATTERNS BA; Piksa K, 2008, ACTA CHIROPTEROL, V10, P69, DOI 10.3161/150811008X331108; Piksa K, 2011, ACTA CHIROPTEROL, V13, P113, DOI 10.3161/150811011X578660; Price LW, 1981, MOUNTAINS MAN; Pulina M, 1974, KLIMA TATIER, P702; R Core Team, 2012, R LANG ENV STAT COMP; Rachmatulina I.K., 1989, P409; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rehak Zdenek, 2006, Lynx (Prague), V37, P201; Sachanowicz Konrad, 2006, Vespertilio, V9-10, P151; Sachanowicz K, 2006, ACTA CHIROPTEROL, V8, P543, DOI 10.3161/1733-5329(2006)8[543:FREOPK]2.0.CO;2; Sachanowicz Konrad, 2012, Acta Zoologica Cracoviensia, V55, P97, DOI 10.3409/azc.55_1.97; Sanchez-Cordero V, 2001, GLOBAL ECOL BIOGEOGR, V10, P63, DOI 10.1046/j.1466-822x.2001.00235.x; Schwilk DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031173; Siarzewski W, 1994, JASKINIE TATRZANSKIE, V5, P11; Siivonen Y, 2008, MAMMALIA, V72, P50, DOI 10.1515/MAMM.2008.003; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Storz JF, 1996, SOUTHWEST NAT, V41, P322; Szewczak JM, 1998, GREAT BASIN NAT, V58, P66; Tuttle MD, 1977, NAT CAV MAN S P ALB, P108; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wang JJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P743, DOI 10.1111/j.1466-8238.2011.00718.x; Warszynska J, 1995, POLISH CARPATHIANS N; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Wigley T, 1976, SCI SPELEOLOGY, V3, P329; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodward F.I., 1987, CLIMATE PLANT DISTRI	71	17	17	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68066	10.1371/journal.pone.0068066	http://dx.doi.org/10.1371/journal.pone.0068066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861850	gold, Green Submitted, Green Published			2022-12-25	WOS:000321425300039
J	Fletcher, L; Evans, TM; Watts, LT; Jimenez, DF; Digicaylioglu, M				Fletcher, Lauren; Evans, Teresa M.; Watts, Lora Talley; Jimenez, David F.; Digicaylioglu, Murat			Rapamycin Treatment Improves Neuron Viability in an In Vitro Model of Stroke	PLOS ONE			English	Article							MAMMALIAN TARGET; ISCHEMIC-STROKE; AMYLOID-BETA; MTOR; PROTEIN; INVOLVEMENT; MECHANISMS; COMPLEX; GROWTH; DEATH	Ischemic stroke is the leading cause of serious, long-term adult disability and is associated with sensorimotor and cognitive impairments due to neuronal degeneration. Currently, recombinant tissue plasminogen activator (rTPA) is the only FDA-approved medical therapy for treatment of patients with acute ischemic stroke. However, rTPA can only be given within 3 hours of symptom onset, and only 2% of patients are eligible. Therefore, there is an urgent need for novel neuroprotective treatment options for ischemic stroke. An emerging treatment for a diverse range of neurological disorders associated with neurodegeneration is rapamycin, a key modulator of the mammalian target of rapamycin (mTOR) pathway. The mTOR pathway is the primary regulator of the cellular response to nutrient availability, changes in energy status and stress as seen following ischemia and reperfusion. However, rapamycin's effects on mTORC1 and mTORC2 are poorly understood in neurons. In the current study we show that rapamycin can prevent the activation of both mTORC1 and mTORC2 in cortical neurons and improve cell survival following oxygen glucose deprivation (OGD), an in vitro model of ischemic stroke. This work further supports the investigation of rapamycin as a novel neuroprotectant for ischemic stroke.	[Fletcher, Lauren; Evans, Teresa M.; Jimenez, David F.; Digicaylioglu, Murat] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Digicaylioglu, M (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA.	muratd@uthscsa.edu	Watts, Lora Talley/A-2724-2012	Watts, Lora Talley/0000-0002-2337-1504; Evans, Teresa/0000-0002-3860-2205	University of Texas Health Science Center San Antonio; National Cancer Institute [P30 CA54174]; National Institute of Aging [P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316] Funding Source: NIH RePORTER	University of Texas Health Science Center San Antonio; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Images were generated in the Core Optical Imaging Facility, which is supported by the University of Texas Health Science Center San Antonio, a National Cancer Institute grant no. P30 CA54174 (Cancer Therapy and Research Center) and a National Institute of Aging grant no. P01AG19316. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; Adams HP, 2001, EUR NEUROL, V45, P61; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Chauhan A, 2011, BEHAV BRAIN RES, V225, P603, DOI 10.1016/j.bbr.2011.08.035; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P374, DOI 10.4161/oxim.3.6.14787; Cimarosti H, 2008, NEUROSCIENTIST, V14, P626, DOI 10.1177/1073858408322677; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Fahling M, 2009, ACTA PHYSIOL, V195, P205, DOI 10.1111/j.1748-1716.2008.01894.x; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hermann DM, 2007, CIRCULATION, V116, P363, DOI 10.1161/CIRCULATIONAHA.107.712380; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kroczynska B, 2009, CYTOKINE, V48, P138, DOI 10.1016/j.cyto.2009.07.009; Li WM, 2007, CIRC RES, V100, P79, DOI 10.1161/01.RES.0000253094.03023.3f; Liebeskind DS, 2010, CURR OPIN NEUROL, V23, P36, DOI 10.1097/WCO.0b013e328334da32; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Matheny RW, 2009, EXP BIOL MED, V234, P1264, DOI 10.3181/0904-MR-138; Menzies FM, 2010, AUTOPHAGY, V6, P286, DOI 10.4161/auto.6.2.11078; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Neary JT, 2005, IUBMB LIFE, V57, P711, DOI 10.1080/15216540500319143; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sharp ZD, 2010, J GERONTOL A-BIOL, V65, P580, DOI 10.1093/gerona/glp212; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Towfighi A, 2011, STROKE, V42, P2351, DOI 10.1161/STROKEAHA.111.621904; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xu YY, 2011, BRAIN RES, V1375, P49, DOI 10.1016/j.brainres.2010.12.029; Yuan Y, 2010, BRAIN RES, V1367; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13	42	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68281	10.1371/journal.pone.0068281	http://dx.doi.org/10.1371/journal.pone.0068281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861877	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700077
J	Gonzalo-Gobernado, R; Calatrava-Ferreras, L; Reimers, D; Herranz, AS; Rodriguez-Serrano, M; Miranda, C; Jimenez-Escrig, A; Diaz-Gil, JJ; Bazan, E				Gonzalo-Gobernado, Rafael; Calatrava-Ferreras, Lucia; Reimers, Diana; Sanchez Herranz, Antonio; Rodriguez-Serrano, Macarena; Miranda, Cristina; Jimenez-Escrig, Adriano; Jose Diaz-Gil, Juan; Bazan, Eulalia			Neuroprotective Activity of Peripherally Administered Liver Growth Factor in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NEURAL STEM-CELLS; SPONTANEOUSLY HYPERTENSIVE-RATS; NEUROTROPHIC FACTOR PRODUCTION; GLYCATION END-PRODUCTS; BCL-X-L; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; FACTOR-ALPHA; TNF-ALPHA	Liver growth factor (LGF) is a hepatic mitogen purified some years ago that promotes proliferation of different cell types and the regeneration of damaged tissues, including brain tissue. Considering the possibility that LGF could be used as a therapeutic agent in Parkinson's disease, we analyzed its potential neuroregenerative and/or neuroprotective activity when peripherally administered to unilaterally 6-hydroxydopamine (6-OHDA)-lesioned rats. For these studies, rats subjected to nigrostriatal lesions were treated intraperitoneally twice a week with LGF (5 microg/rat) for 3 weeks. Animals were sacrificed 4 weeks after the last LGF treatment. The results show that LGF stimulates sprouting of tyrosine hydroxylase-positive terminals and increases tyrosine hydroxylase and dopamine transporter expression, as well as dopamine levels in the denervated striatum of 6-OHDA-lesioned rats. In this structure, LGF activates microglia and raises tumor necrosis factor-alpha protein levels, which have been reported to have a role in neuroregeneration and neuroprotection. Besides, LGF stimulates the phosphorylation of MAPK/ERK1/2 and CREB, and regulates the expression of proteins which are critical for cell survival such as Bcl2 and Akt. Because LGF partially protects dopamine neurons from 6-OHDA neurotoxicity in the substantia nigra, and reduces motor deficits in these animals, we propose LGF as a novel factor that may be useful in the treatment of Parkinson's disease.	[Gonzalo-Gobernado, Rafael; Calatrava-Ferreras, Lucia; Reimers, Diana; Sanchez Herranz, Antonio; Rodriguez-Serrano, Macarena; Miranda, Cristina; Bazan, Eulalia] Inst Ramon & Cajal Invest Sanitaria, Serv Neurobiol, Madrid, Spain; [Jimenez-Escrig, Adriano] Hosp Univ Ramon & Cajal, Serv Neurol, Madrid, Spain; [Jose Diaz-Gil, Juan] Inst Invest Sanitaria Puerta Hierro Majadahonda, Madrid, Spain	Hospital Universitario Ramon y Cajal	Bazan, E (corresponding author), Inst Ramon & Cajal Invest Sanitaria, Serv Neurobiol, Madrid, Spain.	eulalia.bazan@hrc.es	rodriguez, macarena/E-8790-2018; Gonzalo-Gobernado, Rafael/F-2675-2016; Calatrava Ferreras, Lucía/E-6320-2016; Reimers, Diana/K-6584-2017	rodriguez, macarena/0000-0003-3499-5926; Gonzalo-Gobernado, Rafael/0000-0002-6357-105X; Calatrava Ferreras, Lucía/0000-0003-1389-769X; Reimers, Diana/0000-0002-2837-099X; Jimenez-Escrig, Adriano/0000-0002-4927-1886	Spanish Fondo de Investigaciones Sanitarias [FISS PI060315]; Agencia Lain Entralgo [NDG7/09]; Agencia Lain Entralgo; FiBio Hospital Ramon y Cajal fellowship; Contrato de Personal de Apoyo a la Investigacion (FISS)	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia Lain Entralgo; Agencia Lain Entralgo; FiBio Hospital Ramon y Cajal fellowship; Contrato de Personal de Apoyo a la Investigacion (FISS)	This work was supported by the Spanish Fondo de Investigaciones Sanitarias (FISS PI060315) and Agencia Lain Entralgo (NDG7/09). LC and RG-G were the recipients of Agencia Lain Entralgo and FiBio Hospital Ramon y Cajal fellowships, respectively, and MRS was the recipient of a Contrato de Personal de Apoyo a la Investigacion (FISS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso-Oramas D, 2009, NEUROBIOL DIS, V36, P494, DOI 10.1016/j.nbd.2009.09.002; Aron L, 2011, TRENDS NEUROSCI, V34, P88, DOI 10.1016/j.tins.2010.11.001; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Barneda-Zahonero B, 2009, MOL BIOL CELL, V20, P5051, DOI 10.1091/mbc.E09-05-0424; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Batchelor PE, 2003, J CLIN NEUROSCI, V10, P523, DOI 10.1016/S0967-5868(03)00004-3; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; CARLSSON A, 1973, J PHARM PHARMACOL, V25, P437, DOI 10.1111/j.2042-7158.1973.tb09129.x; Chakrabarty K, 2007, EUR J NEUROSCI, V25, P1971, DOI 10.1111/j.1460-9568.2007.05457.x; Chertoff M, 2011, EXP NEUROL, V227, P237, DOI 10.1016/j.expneurol.2010.11.010; Chung YC, 2010, J IMMUNOL, V185, P1230, DOI 10.4049/jimmunol.1000208; Cohen AD, 2011, BRAIN RES, V1370, P80, DOI 10.1016/j.brainres.2010.11.006; Conde MV, 2011, AM J PHYSIOL-HEART C, V301, pH1153, DOI 10.1152/ajpheart.00886.2010; Condezo-Hoyos L, 2012, J HYPERTENS, V30, P1185, DOI 10.1097/HJH.0b013e328353824b; Condezo-Hoyos L, 2009, FREE RADICAL BIO MED, V46, P656, DOI 10.1016/j.freeradbiomed.2008.12.002; Creson TK, 2009, J MOL NEUROSCI, V37, P123, DOI 10.1007/s12031-008-9122-2; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Diaz Gil JJ, 1994, GROWTH REGULAT, V4, P113; Diaz-Gil JJ, 1999, J HEPATOL, V30, P1065, DOI 10.1016/S0168-8278(99)80261-X; Diaz-Gil JJ, 2003, J HEPATOL, V38, P598, DOI 10.1016/S0168-8278(03)00030-8; Diaz-Gil JJ, 2009, HISTOL HISTOPATHOL, V24, P473, DOI 10.14670/HH-24.473; DIAZGIL JJ, 1986, BIOCHEM J, V235, P49, DOI 10.1042/bj2350049; DIAZGIL JJ, 1987, BIOCHEM J, V243, P443, DOI 10.1042/bj2430443; DIAZGIL JJ, 1988, HEPATOLOGY, V8, P484, DOI 10.1002/hep.1840080308; Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Fujino H, 2009, ACTA NEUROPATHOL, V117, P75, DOI 10.1007/s00401-008-0440-9; Gonzalez-Aparicio R, 2010, EXP NEUROL, V226, P136, DOI 10.1016/j.expneurol.2010.08.016; Gonzalo-Gobernado R, 2011, 14 C NAC SOC ESP NEU; Gonzalo-Gobernado R, 2009, J HISTOCHEM CYTOCHEM, V57, P491, DOI 10.1369/jhc.2009.952275; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; He F, 2008, COLLOID SURFACE B, V61, P290, DOI 10.1016/j.colsurfb.2007.09.009; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; Hung SY, 2010, NEUROPHARMACOLOGY, V58, P321, DOI 10.1016/j.neuropharm.2009.11.003; Kirik D, 2001, EUR J NEUROSCI, V13, P1589, DOI 10.1046/j.0953-816x.2001.01534.x; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kraft AD, 2009, NEUROTOXICOLOGY, V30, P785, DOI 10.1016/j.neuro.2009.07.001; Lee HT, 2010, J NEUROCHEM, V113, P79, DOI 10.1111/j.1471-4159.2010.06584.x; Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje; Lewis-Tuffin LJ, 2004, MOL CELL NEUROSCI, V25, P536, DOI 10.1016/j.mcn.2003.10.010; Liang JF, 2010, BRAIN RES, V1322, P8, DOI 10.1016/j.brainres.2010.01.083; Lim J, 2000, MOL CELL BIOCHEM, V212, P51, DOI 10.1023/A:1007148719497; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Liste I, 2004, J NEUROSCI, V24, P10786, DOI 10.1523/JNEUROSCI.3208-04.2004; Liu LM, 2009, NUCL MED BIOL, V36, P941, DOI 10.1016/j.nucmedbio.2009.06.005; Lu J, 2010, BRAIN PATHOL, V20, P952, DOI 10.1111/j.1750-3639.2010.00397.x; Matsuzaki H, 1999, J NEUROCHEM, V73, P2037; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MENA MA, 1995, CLIN NEUROPHARMACOL, V18, P410, DOI 10.1097/00002826-199510000-00004; Milligan SA, 1998, ARCH BIOCHEM BIOPHYS, V352, P255, DOI 10.1006/abbi.1998.0603; Mitchell HM, 2011, J NEUROCHEM, V117, P187, DOI 10.1111/j.1471-4159.2010.07103.x; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Offen D, 2001, NEUROSCI LETT, V316, P129, DOI 10.1016/S0304-3940(01)02344-8; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perez-Crespo M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-21; Polazzi E, 2002, REV NEUROSCIENCE, V13, P221; Predescu D, 2004, AM J PHYSIOL-LUNG C, V287, pL895, DOI 10.1152/ajplung.00075.2004; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Reimers D, 2006, J HISTOCHEM CYTOCHEM, V54, P457, DOI 10.1369/jhc.5A6805.2005; Reimers D, 2012, CURR STEM CELL RES T, V7, P15, DOI 10.2174/157488812798483421; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Sagare AP, 2011, J NEUROSCI RES, V89, P967, DOI 10.1002/jnr.22670; Sanders EJ, 2008, GEN COMP ENDOCR, V156, P613, DOI 10.1016/j.ygcen.2008.02.005; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Shah P, 2006, BRAIN RES, V1107, P13, DOI 10.1016/j.brainres.2006.05.097; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; SINGH J, 1986, J CHROMATOGR, V380, P321, DOI 10.1016/S0378-4347(00)83660-9; Smith BA, 2011, BRAIN RES, V1386, P70, DOI 10.1016/j.brainres.2011.02.003; Somoza B, 2006, CARDIOVASC RES, V69, P764, DOI 10.1016/j.cardiores.2005.08.021; Stanic D, 2004, BRAIN RES, V1023, P83, DOI 10.1016/j.brainres.2004.07.012; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; Wang W, 2003, J NEUROCHEM, V84, P189, DOI 10.1046/j.1471-4159.2003.01544.x; Wang Z, 2002, ACTA PHARMACOL SIN, V23, P974; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; Wree A, 2011, NEUROBIOL DIS, V41, P291, DOI 10.1016/j.nbd.2010.09.017; Yan M, 2011, NEUROCHEM INT, V58, P549, DOI 10.1016/j.neuint.2011.01.013; Yang XX, 2010, J MOL NEUROSCI, V42, P145, DOI 10.1007/s12031-010-9336-y; Yasuhara T, 2004, EUR J NEUROSCI, V19, P1494, DOI 10.1111/j.1460-9568.2004.03254.x; Yu XR, 2006, ACTA BIOCH BIOPH SIN, V38, P241, DOI 10.1111/j.1745-7270.2006.00152.x; Yuan HB, 2010, J NEUROSCI RES, V88, P1348, DOI 10.1002/jnr.22304; Zhang L, 2010, BRAIN RES, V1357, P157, DOI 10.1016/j.brainres.2010.08.007; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zheng WH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-51; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002; Zhu ZH, 2006, BRAIN RES, V1114, P1, DOI 10.1016/j.brainres.2006.07.070; Ziv I, 1997, APOPTOSIS, V2, P149, DOI 10.1023/A:1026408313758	96	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67771	10.1371/journal.pone.0067771	http://dx.doi.org/10.1371/journal.pone.0067771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861803	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700034
J	Hu, GZ; Witzig, TE; Gupta, M				Hu, Guangzhen; Witzig, Thomas E.; Gupta, Mamta			A Novel Missense (M206K) STAT3 Mutation in Diffuse Large B Cell Lymphoma Deregulates STAT3 Signaling	PLOS ONE			English	Article							COILED-COIL DOMAIN; ACTIVATION; EXPRESSION; INHIBITOR; LEUKEMIA; PROLIFERATION; TG101348; SEQUENCE; RECEPTOR	Persistent STAT3 activation has been found in activated B-cell like diffuse large B cell tumors (DLBCL). To investigate whether genetic mutations play a role in aberrant STAT3 signaling in DLBCL, we bi-directionally sequenced all 24 exons of the STAT3 gene in DLBCL tumors (n = 40). We identified 2 novel point mutations in 2 separate (2/40; 5%) patients at exon 7 and 24. Point mutation 2552G>A was a silent mutation in the stop codon. Another heterozygous mutation 857T > A encoded a methionine substitution by lysine at codon 206 (M206K) in the coiled-coil domain of STAT3. We performed site directed mutagenesis to mutate wild type (WT) STAT3 alpha and STAT3 beta at codon 206 and constructed stable cell lines by lentiviral transfection of STAT3 alpha(WT), STAT3 alpha(M206K), STAT3 beta(WT) and STAT3 beta(M206K) plasmids. The mutation was found to increase STAT3 phosphorylation in STAT3 alpha mutant cell lines with no effect on the STAT3 beta mutant cell line. Transcriptional activation was also increased in the STAT3 alpha mutant cells compared with STAT3 alpha(WT) cells as detected by a luciferase reporter assay. Moreover, STAT3 alpha(M206K) mutant cells were resistant to JAK2 pathway inhibition compared to STAT3 alpha(WT) cells. These results indicate that missense mutations in STAT3 increase signaling through the JAK/STAT pathway. JAK2 inhibitors may be useful in the patient with this STAT3 mutation as well as those with pathway activation by other mechanisms.	[Hu, Guangzhen; Witzig, Thomas E.; Gupta, Mamta] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Gupta, M (corresponding author), Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA.	gupta.mamta@mayo.edu	Hu, Guangzhen/B-2240-2015		Iowa/Mayo Lymphoma Specialized Program of Research Excellence [P50 CA097274, R01CA127433]; NATIONAL CANCER INSTITUTE [R01CA127433, P50CA097274] Funding Source: NIH RePORTER	Iowa/Mayo Lymphoma Specialized Program of Research Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported through Iowa/Mayo Lymphoma Specialized Program of Research Excellence (P50 CA097274) to MG; R01CA127433 to TEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa T, 2011, INT J ONCOL, V38, P1245, DOI 10.3892/ijo.2011.957; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Dumoutier L, 2009, J BIOL CHEM, V284, P26377, DOI 10.1074/jbc.M109.007955; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Gupta M, 2012, BLOOD, V120, P4400, DOI 10.1182/blood-2012-05-428466; Gupta M, 2012, BLOOD, V119, P2844, DOI 10.1182/blood-2011-10-388538; Gupta M, 2009, BLOOD, V113, P5206, DOI 10.1182/blood-2008-09-179762; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kumanovics A, 2010, J CLIN IMMUNOL, V30, P886, DOI 10.1007/s10875-010-9452-z; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lasho TL, 2008, LEUKEMIA, V22, P1790, DOI 10.1038/leu.2008.56; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Sato N, 2005, BIOCHEM BIOPH RES CO, V336, P617, DOI 10.1016/j.bbrc.2005.08.145; Scuto A, 2011, CANCER RES, V71, P3182, DOI 10.1158/0008-5472.CAN-10-2380; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Witzig TE, 2013, LEUKEMIA LYMPHOMA, V54, P397, DOI 10.3109/10428194.2012.708931; Wu ZL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-31; Zhang T, 2000, MOL CELL BIOL, V20, P7132, DOI 10.1128/MCB.20.19.7132-7139.2000	25	18	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67851	10.1371/journal.pone.0067851	http://dx.doi.org/10.1371/journal.pone.0067851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861822	Green Submitted, gold, Green Published			2022-12-25	WOS:000323350700050
J	Liang, Y; He, HS; Fraser, JS; Wu, ZW				Liang, Yu; He, Hong S.; Fraser, Jacob S.; Wu, ZhiWei			Thematic and Spatial Resolutions Affect Model-Based Predictions of Tree Species Distribution	PLOS ONE			English	Article							ECOLOGICAL PROCESSES; LANDSCAPE PATTERN; CHANGING SCALE; FOREST; HETEROGENEITY; SIMULATION; BIODIVERSITY; ECOSYSTEM; POPULATIONS; DYNAMICS	Subjective decisions of thematic and spatial resolutions in characterizing environmental heterogeneity may affect the characterizations of spatial pattern and the simulation of occurrence and rate of ecological processes, and in turn, model-based tree species distribution. Thus, this study quantified the importance of thematic and spatial resolutions, and their interaction in predictions of tree species distribution (quantified by species abundance). We investigated how model-predicted species abundances changed and whether tree species with different ecological traits (e. g., seed dispersal distance, competitive capacity) had different responses to varying thematic and spatial resolutions. We used the LANDIS forest landscape model to predict tree species distribution at the landscape scale and designed a series of scenarios with different thematic (different numbers of land types) and spatial resolutions combinations, and then statistically examined the differences of species abundance among these scenarios. Results showed that both thematic and spatial resolutions affected model-based predictions of species distribution, but thematic resolution had a greater effect. Species ecological traits affected the predictions. For species with moderate dispersal distance and relatively abundant seed sources, predicted abundance increased as thematic resolution increased. However, for species with long seeding distance or high shade tolerance, thematic resolution had an inverse effect on predicted abundance. When seed sources and dispersal distance were not limiting, the predicted species abundance increased with spatial resolution and vice versa. Results from this study may provide insights into the choice of thematic and spatial resolutions for model-based predictions of tree species distribution.	[Liang, Yu; He, Hong S.; Wu, ZhiWei] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China; [He, Hong S.; Fraser, Jacob S.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Missouri System; University of Missouri Columbia	He, HS (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China.	heh@missouri.edu	Wu, Zhiwei/AHC-9115-2022; Yu, Liang/AFO-1361-2022	Fraser, Jacob/0000-0002-4960-3713; He, Hong S./0000-0002-3983-2512	973 project [2011CB403206, 2012BAD22B04]; National Natural Science Foundation of China [41071120]	973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this research was provided by "the 973 project'' 2011CB403206, 2012BAD22B04, and the National Natural Science Foundation of China 41071120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; [Anonymous], 2004, FOOD WEBS LANDSCAPE; Bailey D, 2007, LANDSCAPE ECOL, V22, P461, DOI 10.1007/s10980-006-9035-9; Brotons L, 2004, LANDSCAPE ECOL, V19, P663, DOI 10.1007/s10980-005-0165-2; Buyantuyev A, 2007, LANDSCAPE ECOL, V22, P7, DOI 10.1007/s10980-006-9010-5; Castilla G, 2009, LANDSCAPE ECOL, V24, P15, DOI 10.1007/s10980-008-9310-z; Coreau A, 2009, ECOL LETT, V12, P1277, DOI 10.1111/j.1461-0248.2009.01392.x; COSTANZA R, 1994, LANDSCAPE ECOL, V9, P47, DOI 10.1007/BF00135078; Duelli P, 1997, AGR ECOSYST ENVIRON, V62, P81, DOI 10.1016/S0167-8809(96)01143-7; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; DUTILLEUL P, 1993, OIKOS, V66, P152, DOI 10.2307/3545210; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Hao Z.Q., 2001, J APPL ECOL, V12, P653, DOI DOI 10.1073/PNAS.221363798); He HS, 2008, FOREST ECOL MANAG, V254, P371, DOI 10.1016/j.foreco.2007.09.069; He HS, 1999, ECOL MODEL, V114, P213, DOI 10.1016/S0304-3800(98)00147-1; He HS, 2002, INT J GEOGR INF SCI, V16, P93, DOI 10.1080/13658810110075978; He HS, 1999, ECOSYSTEMS, V2, P308, DOI 10.1007/s100219900082; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; KADMON R, 1990, AM NAT, V135, P382, DOI 10.1086/285052; Kolasa J., 1991, ECOLOGICAL HETEROGEN, V86, P1, DOI DOI 10.1007/978-1-4612-3062-5_1; Kumar S, 2006, ECOLOGY, V87, P3186, DOI 10.1890/0012-9658(2006)87[3186:SHINAN]2.0.CO;2; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LI H, 1995, OIKOS, V73, P280, DOI 10.2307/3545921; LI HB, 1994, ECOLOGY, V75, P2446, DOI 10.2307/1940898; Liang Y., 2011, CHINESE GEOGR SCI, V21, P1; Liang Y, 2012, LANDSCAPE ECOL, V27, P1031, DOI 10.1007/s10980-012-9759-7; Liang Y, 2011, ANN FOREST SCI, V68, P899, DOI 10.1007/s13595-011-0096-9; Lovett G. M., 2005, ECOSYSTEM FUNCTION H; Mladenoff D.J., 1999, SPATIAL MODELING FOR; Moorcroft PR, 2006, TRENDS ECOL EVOL, V21, P400, DOI 10.1016/j.tree.2006.04.009; Morin X, 2007, ECOLOGY, V88, P2280, DOI 10.1890/06-1591.1; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Post WM, 1996, CLIMATIC CHANGE, V34, P253, DOI 10.1007/BF00224636; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; ROUGHGARDEN J, 1986, THEOR POPUL BIOL, V29, P235, DOI 10.1016/0040-5809(86)90010-9; Scheiter S, 2009, GLOBAL CHANGE BIOL, V15, P2224, DOI 10.1111/j.1365-2486.2008.01838.x; Shao GF, 1996, CAN J FOREST RES, V26, P206, DOI 10.1139/x26-024; Shao GF, 2003, GLOBAL PLANET CHANGE, V37, P307, DOI 10.1016/S0921-8181(02)00204-7; Stone R, 2006, SCIENCE, V313, P1379, DOI 10.1126/science.313.5792.1379; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Syphard AD, 2004, ECOL MODEL, V180, P21, DOI 10.1016/j.ecolmodel.2004.01.017; Tischendorf L, 2001, LANDSCAPE ECOL, V16, P235, DOI 10.1023/A:1011112719782; Turner MG, 2001, LANDSAPE ECOLOGY THE; WERNER EE, 1983, ECOLOGY, V64, P1525, DOI 10.2307/1937507; Wiens JA, 2002, APPLYING LANDSCAPE ECOLOGY IN BIOLOGICAL CONSERVATION, P3; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Wu JG, 2002, LANDSCAPE ECOL, V17, P761, DOI 10.1023/A:1022995922992; [赵淑清 Zhao Shuqing], 2004, [生物多样性, Chinese Biodiversity], V12, P164	51	19	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67889	10.1371/journal.pone.0067889	http://dx.doi.org/10.1371/journal.pone.0067889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861828	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700056
J	Hicks, SL; Wilson, I; Muhammed, L; Worsfold, J; Downes, SM; Kennard, C				Hicks, Stephen L.; Wilson, Iain; Muhammed, Louwai; Worsfold, John; Downes, Susan M.; Kennard, Christopher			A Depth-Based Head-Mounted Visual Display to Aid Navigation in Partially Sighted Individuals	PLOS ONE			English	Article							SENSORY SUBSTITUTION; VISION; ENHANCEMENT; BLIND	Independent navigation for blind individuals can be extremely difficult due to the inability to recognise and avoid obstacles. Assistive techniques such as white canes, guide dogs, and sensory substitution provide a degree of situational awareness by relying on touch or hearing but as yet there are no techniques that attempt to make use of any residual vision that the individual is likely to retain. Residual vision can restricted to the awareness of the orientation of a light source, and hence any information presented on a wearable display would have to limited and unambiguous. For improved situational awareness, i.e. for the detection of obstacles, displaying the size and position of nearby objects, rather than including finer surface details may be sufficient. To test whether a depth-based display could be used to navigate a small obstacle course, we built a real-time head-mounted display with a depth camera and software to detect the distance to nearby objects. Distance was represented as brightness on a low-resolution display positioned close to the eyes without the benefit focussing optics. A set of sighted participants were monitored as they learned to use this display to navigate the course. All were able to do so, and time and velocity rapidly improved with practise with no increase in the number of collisions. In a second experiment a cohort of severely sight-impaired individuals of varying aetiologies performed a search task using a similar low-resolution head-mounted display. The majority of participants were able to use the display to respond to objects in their central and peripheral fields at a similar rate to sighted controls. We conclude that the skill to use a depth-based display for obstacle avoidance can be rapidly acquired and the simplified nature of the display may appropriate for the development of an aid for sight-impaired individuals.	[Hicks, Stephen L.; Wilson, Iain; Muhammed, Louwai; Kennard, Christopher] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Worsfold, John] Royal Natl Inst Blind People, London, England; [Downes, Susan M.] Oxford Univ Hosp NHS Trust, Oxford, England; [Downes, Susan M.] Univ Oxford, Nuffield Lab Ophthalmol, Oxford OX2 6AW, England; [Downes, Susan M.; Kennard, Christopher] NIHR Biomed Res Ctr, Oxford, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Hicks, SL (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	stephen.hicks@ndcn.ox.ac.uk		Muhammed, Louwai/0000-0002-2262-4063	National Institute for Health Research (NIHR); NIHR Biomedical Research Centre, Oxford; National Institute for Health Research [II-LB-1111-20005] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the National Institute for Health Research (NIHR) under the i4i programme. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. CK and SD are supported by the NIHR Biomedical Research Centre, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Atabany WI, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-27; Alexander MS, 2011, J NEUROPHYSIOL, V106, P860, DOI 10.1152/jn.01040.2010; Apfelbaum HL, 2008, OPHTHAL PHYSL OPT, V28, P204, DOI 10.1111/j.1475-1313.2008.00537.x; Bach-Y-Rita P, 2004, ANN NY ACAD SCI, V1013, P83, DOI 10.1196/annals.1305.006; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bourbakis N, 2008, IEEE ENG MED BIOL, V27, P49, DOI 10.1109/MEMB.2007.901780; Cupples ME, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e542; Everingham MR, 2003, INT J HUM-COMPUT INT, V15, P231, DOI 10.1207/S15327590IJHC1502_3; Federation of Ophthalmic and Dispensing Opticians, 2012, FUND RIGHT SIGHT; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; Hart PM, 2005, BRIT J OPHTHALMOL, V89, P1127, DOI 10.1136/bjo.2004.059683; Hart PM, 1999, BRIT J OPHTHALMOL, V83, P1115, DOI 10.1136/bjo.83.10.1115; Johnson LA, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P869; Luo G, 2009, INVEST OPHTH VIS SCI, V50, P4509, DOI 10.1167/iovs.08-2916; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; MASSOF RW, 1992, OPTOMETRY VISION SCI, V69, P32, DOI 10.1097/00006324-199201000-00005; OSHEA RP, 1994, VISION RES, V34, P1595, DOI 10.1016/0042-6989(94)90116-3; PELI E, 1991, INVEST OPHTH VIS SCI, V32, P2337; Proulx MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001840; Ruch T.C., 1960, MED PHYSL BIOPHYSICS MED PHYSL BIOPHYSICS, V18th; Sampaio E, 2001, BRAIN RES, V908, P204, DOI 10.1016/S0006-8993(01)02667-1; Striem-Amit E, 2012, NEURON, V76, P640, DOI 10.1016/j.neuron.2012.08.026; Striem-Amit E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033136; Tu ZW, 2005, INT J COMPUT VISION, V63, P113, DOI 10.1007/s11263-005-6642-x; World Health Organization, 2010, NEW EST VIS IMP BLIN	25	60	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67695	10.1371/journal.pone.0067695	http://dx.doi.org/10.1371/journal.pone.0067695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844067	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000094
J	Zhang, ZF; Shively, JE				Zhang, Zhifang; Shively, John E.			Acceleration of Bone Repair in NOD/SCID Mice by Human Monoosteophils, Novel LL-37-Activated Monocytes	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; OSTEOBLAST-LINEAGE CELLS; OSTEOCLAST DIFFERENTIATION; ALPHA-3-BETA-1 INTEGRIN; REGULATORY MECHANISMS; PRECURSOR CELLS; MATRIX; ATHEROSCLEROSIS; VASCULOGENESIS; OSTEOACTIVIN	Background: An incomplete understanding of bone forming cells during wound healing and ectopic calcification has led to a search for circulating cells that may fulfill this function. Previously, we showed that monoosteophils, a novel lineage of calcifying/bone-forming cells generated by treatment of monocytes with the natural peptide LL-37, are candidates. In this study, we have analyzed their gene expression profile and bone repair function. Methods and Findings: Human monoosteophils can be distinguished from monocytes, macrophages and osteoclasts by their unique up-regulation of integrin alpha 3 and down-regulation of CD14 and CD16. Monoosteophils express high mRNA and protein levels of SPP1 (osteopontin), GPNMB (osteoactivin), CHI3L1 (cartilage glycoprotein-39), CHIT1 (Chitinase 1), MMP-7, CCL22 and MAPK13 (p38MAPK delta). Monocytes from wild type, but not MAPK13 KO mice are also capable of monoosteophil differentiation, suggesting that MAPK13 regulates this process. When human monoosteophils were implanted in a freshly drilled hole in mid-diaphyseal femurs of NOD/SCID mice, significant bone repair required only 14 days compared to at least 24 days in control treated injuries. Conclusion: Human derived monoosteophils, characterized as CD45(+) alpha 3(+) alpha 3 beta(+) CD34(-) CD14(-)BAP (bone alkaline phosphatase)(-) cells, can function in an animal model of bone injury.	[Zhang, Zhifang; Shively, John E.] City Hope Natl Med Ctr, Dept Immunol, Beckman Res Inst, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Dept Immunol, Beckman Res Inst, Duarte, CA USA.	jshively@coh.org			City of Hope; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	City of Hope funded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x; Benjamin M, 2004, INT REV CYTOL, V233, P1, DOI 10.1016/S0074-7696(04)33001-9; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Choi YH, 2010, INT J BIOCHEM CELL B, V42, P662, DOI 10.1016/j.biocel.2009.12.011; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Eghbali-Fatourechi GZ, 2007, BONE, V40, P1370, DOI 10.1016/j.bone.2006.12.064; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Fadini GP, 2012, CIRCULATION, V125, P2772, DOI 10.1161/CIRCULATIONAHA.112.090860; Fadini GP, 2011, CIRC RES, V108, P1112, DOI 10.1161/CIRCRESAHA.110.234088; Gossl M, 2010, EUR HEART J, V31, P2909, DOI 10.1093/eurheartj/ehq373; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Johansen JS, 1999, RHEUMATOLOGY, V38, P618, DOI 10.1093/rheumatology/38.7.618; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Khan AN, 2010, ANN THORAC MED, V5, P67, DOI 10.4103/1817-1737.62469; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Laguna JC, 2012, PHARMACOGENOMICS, V13, P477, DOI [10.2217/PGS.12.9, 10.2217/pgs.12.9]; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Lundstrom A, 1998, BIOCHEM BIOPH RES CO, V250, P735, DOI 10.1006/bbrc.1998.9389; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y; NAKAI M, 1992, CANCER RES, V52, P5395; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Pignolo RJ, 2011, J BONE MINER RES, V26, P1685, DOI 10.1002/jbmr.370; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Seta Noriyuki, 2007, Keio Journal of Medicine, V56, P41, DOI 10.2302/kjm.56.41; Shalhoub V, 2010, J CELL BIOCHEM, V111, P911, DOI 10.1002/jcb.22779; Standal T, 2004, EXP ONCOL, V26, P179; Suda RK, 2009, STEM CELLS, V27, P2209, DOI 10.1002/stem.150; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zhang ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013985; Zuo C, 2012, OSTEOPOROSIS INT, V23, P1653, DOI 10.1007/s00198-012-1909-x	45	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67649	10.1371/journal.pone.0067649	http://dx.doi.org/10.1371/journal.pone.0067649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844045	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000087
J	Cote, SC; Plante, A; Tardif, MR; Tremblay, MJ				Cote, Sandra C.; Plante, Audrey; Tardif, Melanie R.; Tremblay, Michel J.			Dectin-1/TLR2 and NOD2 Agonists Render Dendritic Cells Susceptible to Infection by X4-Using HIV-1 and Promote cis-Infection of CD4(+) T Cells	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; DC-SIGN; PRODUCTIVE INFECTION; DISTINCT SUBSETS; VAGINAL FLORA; VIRUS; TRANSMISSION; LYMPHOCYTES; ACTIVATION; MECHANISMS	HIV-1 pathogenesis is intimately linked with microbial infections and innate immunity during all stages of the disease. While the impact of microbial-derived products in transmission of R5-using virus to CD4(+) T cells by dendritic cells (DCs) has been addressed before, very limited data are available on the effect of such compounds on DC-mediated dissemination of X4-tropic variant. Here, we provide evidence that treatment of DCs with dectin-1/TLR2 and NOD2 ligands increases cis-infection of autologous CD4(+) T cells by X4-using virus. This phenomenon is most likely associated with an enhanced permissiveness of DCs to productive infection with X4 virus, which is linked to increased surface expression of CXCR4 and the acquisition of a maturation profile by DCs. The ensuing DC maturation enhances susceptibility of CD4(+) T cells to productive infection with HIV-1. This study highlights the crucial role of DCs at different stages of HIV-1 infection and particularly in spreading of viral strains displaying a X4 phenotype.	[Cote, Sandra C.; Plante, Audrey; Tardif, Melanie R.; Tremblay, Michel J.] Ctr Hosp Univ Quebec Pavillon CHUL, Quebec City, PQ, Canada; [Tremblay, Michel J.] Univ Laval, Dept Microbiol Infectiol & Immunol, Fac Med, Quebec City, PQ, Canada	Laval University; Laval University	Tremblay, MJ (corresponding author), Ctr Hosp Univ Quebec Pavillon CHUL, Quebec City, PQ, Canada.	michel.j.tremblay@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR) [MOP-79542]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was made possible through an operating grant to M.J.T. from the Canadian Institutes of Health Research (CIHR) (MOP-79542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Amati L, 2006, CURR PHARM DESIGN, V12, P4247, DOI 10.2174/138161206778743583; Arhel N, 2009, J CLIN INVEST, V119, P2965, DOI 10.1172/JCI38994; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Ayinde D, 2012, NAT REV MICROBIOL, V10, P675, DOI 10.1038/nrmicro2862; Berg LM, 2012, ANN NY ACAD SCI; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Bounou S, 2002, J VIROL, V76, P1004, DOI 10.1128/JVI.76.3.1004-1014.2002; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; Cavrois M, 2006, J VIROL, V80, P1992, DOI 10.1128/JVI.80.4.1992-1999.2006; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Dornadula G, 1999, VIROLOGY, V253, P10, DOI 10.1006/viro.1998.9465; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Fiser AL, 2010, JAIDS-J ACQ IMM DEF, V53, P162, DOI 10.1097/QAI.0b013e3181c72033; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Gilbert C, 2007, J IMMUNOL, V178, P2862, DOI 10.4049/jimmunol.178.5.2862; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Humrich JY, 2006, IMMUNOLOGY, V117, P238, DOI 10.1111/j.1365-2567.2005.02292.x; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kiertscher SM, 1996, J LEUKOCYTE BIOL, V59, P208, DOI 10.1002/jlb.59.2.208; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lin YL, 2005, JAIDS-J ACQ IMM DEF, V39, P530; Loisel-Meyer S, 2012, P NATL ACAD SCI USA, V109, P2549, DOI 10.1073/pnas.1121427109; MARGOLICK JB, 1987, J IMMUNOL, V138, P1719; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; Oswald-Richter K, 2004, EUR J IMMUNOL, V34, P1705, DOI 10.1002/eji.200424892; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Ren WZ, 2010, J VIROL, V84, P340, DOI 10.1128/JVI.01865-09; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Su B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-P182; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van der Vlist M, 2011, CURR OPIN HIV AIDS, V6, P348, DOI 10.1097/COH.0b013e328349a2d1; van Montfort T, 2008, J VIROL, V82, P7886, DOI 10.1128/JVI.00245-08; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279	59	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67735	10.1371/journal.pone.0067735	http://dx.doi.org/10.1371/journal.pone.0067735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844079	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000088
J	Niu, LL; Zhang, YL; Qian, M; Meng, L; Xiao, Y; Wang, YY; Liu, X; Zheng, RQ; Zheng, HR				Niu, Lili; Zhang, Yanling; Qian, Ming; Meng, Long; Xiao, Yang; Wang, Yuanyuan; Liu, Xin; Zheng, Rongqin; Zheng, Hairong			Impact of Multiple Cardiovascular Risk Factors on Carotid Intima-Media Thickness and Elasticity	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; ARTERIAL STIFFNESS; METABOLIC SYNDROME; SMOKING-CESSATION; WAVE REFLECTION; YOUNG-ADULTS; DISEASE; EVENTS	Background: Carotid intima-media thickness (IMT) and elasticity have been shown to be independent predictors of cardiovascular disease (CVD). Cardiovascular risk factors (CVRFs) includes hypertension, dyslipidemia, diabetes, overweight and smoking. The objective was to investigate whether the clustering of three or more components of CVRFs has a greater impact on carotid IMT and elasticity than individual components of CVRFs. Methods: One hundred and seventy-three participants without clinical CVD were classified as the multiple CVRFs patients with three or more CVRFs (n = 55) and control group with two or less CVRFs (n = 118). Carotid IMT and elastic modulus were measured by B-mode ultrasound and vessel texture matching method (VTMM), respectively. Results: The multiple CVRFs conferred a disproportionate increase in carotid IMT (43%, p<0.0001) and elastic modulus (60%, p<0.0001), compared with control group. Multiple regression models, which included age, gender, as well as each individual component of CVRFs as continuous variables, showed that multiple CVRFs was an independent determinant of both IMT (p = 0.042) and elasticity (p = 0.008). In the analysis of variance adjusted with age, subjects with single, double, and multiple CVRFs, increased by 8.1%, 42.2%, and 66% for IMT, 54.6%, 94.3%, and 125.2% for elastic modulus, respectively, compared to subjects without CVRFs. Conclusions: The clustering of multiple CVRFs has a greater impact on carotid IMT and elasticity than individual components of CVRFs. This suggests that the components of CVRFs interact to synergistically impact carotid IMT and elasticity.	[Niu, Lili; Qian, Ming; Meng, Long; Xiao, Yang; Liu, Xin; Zheng, Hairong] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Zhang, Yanling; Zheng, Rongqin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Yuanyuan] Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Sun Yat Sen University; Fudan University	Zheng, RQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China.	zhengrongqin@hotmail.com; hr.zheng@siat.ac.cn	XIAO, YANG/GPW-5529-2022; Lv, Yuanjie/AER-0767-2022		National Research Program (973) from Ministry of Science and Technology, China [2011CB707903, 2013CB733800]; National Science Foundation Grants (NSFC) [81027006, 61020106008, 11002152, 11272329, 61031003, 61002001]	National Research Program (973) from Ministry of Science and Technology, China; National Science Foundation Grants (NSFC)	The work was supported by National Research Program (973 Grant Nos. 2011CB707903 and 2013CB733800) from Ministry of Science and Technology, China, and National Science Foundation Grants (NSFC Grant Nos. 81027006, 61020106008, 11002152, 11272329, 61031003 and 61002001). The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2001, J HYPERTENS, V19, P381, DOI 10.1097/00004872-200103000-00005; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Clarke R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001177; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Fagard RH, 2001, J AM COLL CARDIOL, V38, P227, DOI 10.1016/S0735-1097(01)01362-6; Frimodt-Moller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041757; Ginsburg GS, 2007, J AM COLL CARDIOL, V50, P930, DOI 10.1016/j.jacc.2007.05.025; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jatoi NA, 2007, HYPERTENSION, V49, P981, DOI 10.1161/HYPERTENSIONAHA.107.087338; KANNEL WB, 1988, AM J CARDIOL, V62, P1109, DOI 10.1016/0002-9149(88)90558-9; Kelly TN, 2008, CIRCULATION, V118, P1558, DOI 10.1161/CIRCULATIONAHA.107.723593; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Li ZH, 1999, HYPERTENSION, V33, P116, DOI 10.1161/01.HYP.33.1.116; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Luc G, 1996, J LIPID RES, V37, P508; Magnussen CG, 2009, J AM COLL CARDIOL, V53, P860, DOI 10.1016/j.jacc.2008.09.061; Malloy MJ, 2012, CURR OPIN LIPIDOL, V23, P591, DOI 10.1097/MOL.0b013e328359f162; Manco M, 2010, ATHEROSCLEROSIS, V209, P463, DOI 10.1016/j.atherosclerosis.2009.10.014; Manisty C, 2010, J AM COLL CARDIOL, V56, P24, DOI 10.1016/j.jacc.2010.03.030; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Niu LL, 2012, ULTRASOUND MED BIOL, V38, P524, DOI 10.1016/j.ultrasmedbio.2011.12.010; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; OROURKE MF, 1968, CIRC RES, V23, P567, DOI 10.1161/01.RES.23.4.567; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Rigotti NA, 2010, CIRCULATION, V121, P221, DOI 10.1161/CIRCULATIONAHA.109.869008; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Scuteri A, 2004, J AM COLL CARDIOL, V43, P1388, DOI 10.1016/j.jacc.2003.10.061; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stein JH, 2011, NEW ENGL J MED, V365, P1640, DOI 10.1056/NEJMc1109714; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Weingartner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013467; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yarnell JWG, 2001, ARTERIOSCL THROM VAS, V21, P1340, DOI 10.1161/hq0801.093505	38	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67809	10.1371/journal.pone.0067809	http://dx.doi.org/10.1371/journal.pone.0067809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844099	gold, Green Submitted, Green Published			2022-12-25	WOS:000321341000102
J	Reynolds, CM; Li, ML; Gray, C; Vickers, MH				Reynolds, Clare M.; Li, Minglan; Gray, Clint; Vickers, Mark H.			Pre-Weaning Growth Hormone Treatment Ameliorates Bone Marrow Macrophage Inflammation in Adult Male Rat Offspring following Maternal Undernutrition	PLOS ONE			English	Article							ADIPOSE-TISSUE MACROPHAGES; INDUCED INSULIN-RESISTANCE; TUMOR-NECROSIS-FACTOR; NLRP3 INFLAMMASOME; OBESITY; DIFFERENTIATION; EXPRESSION; DISEASE; MICE; ACCUMULATION	Maternal undernutrition (UN) is associated with the development of obesity and metabolic complications in adult offspring. While the role of inflammation in obesity and related comorbidities has been well established, there is little evidence regarding the effects of maternal UN-induced programming on immune function in male adult offspring. This study examines the effects growth hormone (GH), which is known to induce anti-inflammatory effects, on maternal UN-induced bone marrow macrophage (BMM) function in adult male offspring. Sprague-Dawley rats were assigned to chow (C) or UN (50% ad libitum; UN) diet throughout gestation. Male C and UN pups received saline (CS/UNS) or GH (2.5 mu g/g/d; CGH/UNGH) from day 3-21. Bone marrow hematopoietic cells were differentiated to a macrophage phenotype in the presence of M-CSF (50 ng/ ml). Differentiated bone marrow macrophages (BMM) were stimulated with LPS (100 ng/ ml) for 6 h. UNS-derived BMM had significantly increased secretion and expression of IL-1 beta and IL-6 following LPS stimulation. This was accompanied by increased expression of IL-1R1, IL-6R and TLR4. Pre-weaning GH treatment reversed this pro-inflammatory phenotype. Furthermore UNGH displayed increased expression of markers of alternative (M2) macrophage activation, mannose receptor and PPAR gamma. This study demonstrates that fetal UN exposure primes hematopoietic immune cells to a more potent pro-inflammatory phenotype with heightened cytokine secretion and receptor expression. Furthermore these cells are pre-disposed to pro-inflammatory M1 macrophage phenotype which has wide-reaching and important effects in terms of obesity and metabolic disease.	[Vickers, Mark H.] Univ Auckland, Natl Res Ctr Growth & Dev, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Natl Res Ctr Growth & Dev, Gravida, Auckland 1, New Zealand	University of Auckland; University of Auckland	Vickers, MH (corresponding author), Univ Auckland, Natl Res Ctr Growth & Dev, Liggins Inst, Auckland 1, New Zealand.	m.vickers@auckland.ac.nz		Reynolds, Clare/0000-0001-5782-6303; Li, Minglan/0000-0002-3095-7490; Vickers, Mark/0000-0003-4876-9356	Gravida, National Centre for Growth and Development and the Health Research Council of New Zealand	Gravida, National Centre for Growth and Development and the Health Research Council of New Zealand	This work was funded by Gravida, National Centre for Growth and Development and the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Badr G, 2011, CELL PHYSIOL BIOCHEM, V27, P381, DOI 10.1159/000327964; Cuesta S, 2011, REJUV RES, V14, P501, DOI 10.1089/rej.2011.1166; Dasu MR, 2009, ENDOCRINOLOGY, V150, P3457, DOI 10.1210/en.2008-1757; Franco C, 2007, J CLIN ENDOCR METAB, V92, P2644, DOI 10.1210/jc.2007-0068; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gray C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053505; GUARCELLO V, 1991, CELL IMMUNOL, V136, P291, DOI 10.1016/0008-8749(91)90353-D; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Koch JM, 2010, J ANIM SCI, V88, P1619, DOI 10.2527/jas.2009-2392; Liu L, 2010, PSYCHIAT RES, V176, P1, DOI 10.1016/j.psychres.2008.10.024; Lu CX, 2010, ENDOCRINOLOGY, V151, P2189, DOI 10.1210/en.2009-1194; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Miyazawa K, 1998, J BIOCHEM, V124, P1130, DOI 10.1093/oxfordjournals.jbchem.a022231; Nagamatsu T, 2010, REPROD SCI, V17, P209, DOI 10.1177/1933719109349962; Naito M, 2008, PATHOL INT, V58, P143, DOI 10.1111/j.1440-1827.2007.02203.x; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Palmer AC, 2011, ADV NUTR, V2, P377, DOI 10.3945/an.111.000570; Remacle C, 2011, AM J CLIN NUTR, V94, p1846S, DOI 10.3945/ajcn.110.001651; Reynolds CM, 2012, MOL NUTR FOOD RES, V56, P1212, DOI 10.1002/mnfr.201200058; Reynolds CM, 2009, J NUTR, V139, P2351, DOI 10.3945/jn.109.113035; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; Takano A, 2001, DIABETES, V50, P1891, DOI 10.2337/diabetes.50.8.1891; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vickers MH, 2011, WORLD J DIABETES, V2, P137, DOI 10.4239/wjd.v2.i9.137; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2002, J ENDOCRINOL, V175, P615, DOI 10.1677/joe.0.1750615; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	34	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68262	10.1371/journal.pone.0068262	http://dx.doi.org/10.1371/journal.pone.0068262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844177	Green Submitted, gold, Green Published			2022-12-25	WOS:000321341000148
J	Zhu, YW; Dai, JX; Zhang, TC; Li, X; Fang, PF; Wang, HJ; Jiang, YL; Yu, XJ; Xia, T; Niu, LW; Guo, YJ; Teng, MK				Zhu, Yuwei; Dai, Jianxin; Zhang, Tiancheng; Li, Xu; Fang, Pengfei; Wang, Huajing; Jiang, Yongliang; Yu, Xiaojie; Xia, Tian; Niu, Liwen; Guo, Yajun; Teng, Maikun			Structural Insights into the Neutralization Mechanism of Monoclonal Antibody 6C2 against Ricin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; IN-VITRO; A-CHAIN; TOXICITY; SUBUNIT; DEPURINATION; PROTECTION; VACCINE; MICE; INHIBITION	Ricin belongs to the type II ribosome-inactivating proteins that depurinate the universally conserved alpha-sarcin loop of rRNA. The RNA N-glycosidase activity of ricin also largely depends on the ribosomal proteins that play an important role during the process of rRNA depurination. Therefore, the study of the interaction between ricin and the ribosomal elements will be better to understand the catalysis mechanism of ricin. The antibody 6C2 is a mouse monoclonal antibody exhibiting unusually potent neutralizing ability against ricin, but the neutralization mechanism remains unknown. Here, we report the 2.8 angstrom crystal structure of 6C2 Fab in complex with the A-chain of ricin (RTA), which reveals an extensive antigen-antibody interface that contains both hydrogen bonds and van der Waals contacts. The complementarity-determining region loops H1, H2, H3, and L3 form a pocket to accommodate the epitope on the RTA (residues Asp(96)-Thr(116)). ELISA results show that Gln(98), Glu(99), Glu(102), and Thr(105) (RTA) are the key residues that play an important role in recognizing 6C2. With the perturbation of the 6C2 Fab-RTA interface, 6C2 loses its neutralization ability, measured based on the inhibition of protein synthesis in a cell-free system. Finally, we propose that the neutralization mechanism of 6C2 against ricin is that the binding of 6C2 hinders the interaction between RTAand the ribosome and the surface plasmon resonance and pulldown results confirm our hypothesis. In short, our data explain the neutralization mechanism of mAb 6C2 against ricin and provide a structural basis for the development of improved antibody drugs with better specificity and higher affinity.	[Zhu, Yuwei; Li, Xu; Fang, Pengfei; Jiang, Yongliang; Niu, Liwen; Teng, Maikun] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhu, Yuwei; Li, Xu; Fang, Pengfei; Jiang, Yongliang; Niu, Liwen; Teng, Maikun] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhu, Yuwei; Li, Xu; Fang, Pengfei; Jiang, Yongliang; Niu, Liwen; Teng, Maikun] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230026, Anhui, Peoples R China; [Dai, Jianxin; Zhang, Tiancheng; Wang, Huajing; Yu, Xiaojie; Xia, Tian; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Dai, Jianxin; Zhang, Tiancheng; Wang, Huajing; Yu, Xiaojie; Xia, Tian; Guo, Yajun] State Key Lab Antibody Med & Targeting Therapy, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Naval Medical University	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn; mkteng@ustc.edu.cn	yu, xiaojie/GSI-9676-2022; Fang, Pengfei/O-3696-2015	Fang, Pengfei/0000-0002-3448-5494; Li, Xu/0000-0001-5221-0817	Chinese Ministry of Science and Technology [2012CB917200, 2009CB825500]; Chinese National Natural Science Foundation [31270014, 31130018, 31170726, 30900224, 10979039]; Ministry of Science and Technology 973 Project [2010CB833600, 2010CB735605]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology 973 Project(National Basic Research Program of China)	This work was supported by Chinese Ministry of Science and Technology Grants 2012CB917200 and 2009CB825500; Chinese National Natural Science Foundation Grants 31270014, 31130018, 31170726, 30900224, and 10979039; and Ministry of Science and Technology 973 Project Grants 2010CB833600 and 2010CB735605.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; CHANH TC, 1993, IMMUNOL INVEST, V22, P63, DOI 10.3109/08820139309066194; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Dai JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.196584; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ehrlich P., 1891, UEBER RICIN DEUT MED, V17, P976; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo Y, 1988, Nucleic Acids Symp Ser, P139; ENDO Y, 1988, J BIOL CHEM, V263, P8735; GODAL A, 1983, INT J CANCER, V32, P515, DOI 10.1002/ijc.2910320420; GRIFFITHS GD, 1995, HUM EXP TOXICOL, V14, P155, DOI 10.1177/096032719501400201; HARLEY SM, 1982, P NATL ACAD SCI-BIOL, V79, P5935, DOI 10.1073/pnas.79.19.5935; Hartley MR, 2004, MINI-REV MED CHEM, V4, P487, DOI 10.2174/1389557043403828; HEWETSON JF, 1993, VACCINE, V11, P743, DOI 10.1016/0264-410X(93)90259-Z; Ho MC, 2009, P NATL ACAD SCI USA, V106, P20276, DOI 10.1073/pnas.0911606106; HOUSTON LL, 1982, J TOXICOL-CLIN TOXIC, V19, P385, DOI 10.3109/15563658208992492; KIM YS, 1992, BIOCHEMISTRY-US, V31, P3294, DOI 10.1021/bi00127a035; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMLEY PV, 1994, HYBRIDOMA, V13, P417, DOI 10.1089/hyb.1994.13.417; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; MONTANARO L, 1975, BIOCHEM J, V146, P127, DOI 10.1042/bj1460127; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; MORRIS KN, 1992, P NATL ACAD SCI USA, V89, P4869, DOI 10.1073/pnas.89.11.4869; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Smallshaw JE, 2005, VACCINE, V23, P4775, DOI 10.1016/j.vaccine.2005.04.037; Smallshaw JE, 2007, VACCINE, V25, P7459, DOI 10.1016/j.vaccine.2007.08.018; Smallshaw JE, 2012, CURR TOP MICROBIOL, V357, P259, DOI 10.1007/82_2011_156; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; TAYLOR S, 1994, PLANT J, V5, P827, DOI 10.1046/j.1365-313X.1994.5060827.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WILSON IA, 1991, CIBA F SYMP, V159, P13; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075	39	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25165	25172		10.1074/jbc.M113.480830	http://dx.doi.org/10.1074/jbc.M113.480830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23853097	Green Published, hybrid			2022-12-25	WOS:000330619000016
J	Hernandez-Rocamora, VM; Garcia-Montanes, C; Reija, B; Monterroso, B; Margolin, W; Alfonso, C; Zorrilla, S; Rivas, G				Hernandez-Rocamora, Victor M.; Garcia-Montanes, Concepcion; Reija, Belen; Monterroso, Begona; Margolin, William; Alfonso, Carlos; Zorrilla, Silvia; Rivas, German			MinC Protein Shortens FtsZ Protofilaments by Preferentially Interacting with GDP-bound Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL DIVISION; TO-POLE OSCILLATION; ASSAY; ULTRACENTRIFUGATION; POLYMERIZATION; CYTOKINESIS; DYNAMICS; SUGGESTS; REVEALS; MONOMER	The interaction of MinC with FtsZ and its effects on FtsZ polymerization were studied under close to physiological conditions by a combination of biophysical methods. The Min system is a widely conserved mechanism in bacteria that ensures the correct placement of the division machinery at midcell. MinC is the component of this system that effectively interacts with FtsZ and inhibits the formation of the Z-ring. Here we report that MinC produces a concentration-dependent reduction in the size of GTP-induced FtsZ protofilaments (FtsZ-GTP) as demonstrated by analytical ultracentrifugation, dynamic light scattering, fluorescence correlation spectroscopy, and electron microscopy. Our experiments show that, despite being shorter, FtsZ protofilaments maintain their narrow distribution in size in the presence of MinC. The protein had the same effect regardless of its addition prior to or after FtsZ polymerization. Fluorescence anisotropy measurements indicated that MinC bound to FtsZ-GDP with a moderate affinity (apparent K-D similar to 10 mu M at 100 mM KCl and pH 7.5) very close to the MinC concentration corresponding to the midpoint of the inhibition of FtsZ assembly. Only marginal binding of MinC to FtsZ-GTP protofilaments was observed by analytical ultracentrifugation and fluorescence correlation spectroscopy. Remarkably, MinC effects on FtsZ-GTP protofilaments and binding affinity to FtsZ-GDP were strongly dependent on ionic strength, being severely reduced at 500 mM KCl compared with 100 mM KCl. Our results support a mechanism in which MinC interacts with FtsZ-GDP, resulting in smaller protofilaments of defined size and having the same effect on both preassembled and growing FtsZ protofilaments.	[Hernandez-Rocamora, Victor M.; Garcia-Montanes, Concepcion; Monterroso, Begona; Alfonso, Carlos; Zorrilla, Silvia; Rivas, German] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Reija, Belen; Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Margolin, William] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Texas System; University of Texas Health Science Center Houston	Zorrilla, S (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	silvia@cib.csic.es; grivas@cib.csic.es	Monterroso, Begoña/J-9748-2014; Rivas, German/AFL-7528-2022; Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014; Zorrilla, Silvia/J-9771-2014	Monterroso, Begoña/0000-0003-2538-084X; Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Zorrilla, Silvia/0000-0002-6309-9058; Hernandez-Rocamora, Victor M./0000-0003-2517-5707	Human Frontier Science Program Grant [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Spanish Government [BIO2008-04478-C03, CSICPIE-201020I001, BFU2010-14910, BIO2011-28941-C03]	Human Frontier Science Program Grant(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported in part by Human Frontier Science Program Grant RGP0050/2010 (to G. R. and W. M.), European Commission Contract HEALTH-F3-2009-223431 (to G. R.), and Spanish Government Grants BIO2008-04478-C03 (to G. R.), CSICPIE-201020I001 (to C. A.), BFU2010-14910 (to S. Z.), and BIO2011-28941-C03 (to G. R. and S. Z.).	Blasios V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060690; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Harry E., 2006, INT REV CYTOL, V253, P27; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P6108, DOI 10.1021/bi300891q; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Okuno T, 2009, BIOL PHARM BULL, V32, P1473, DOI 10.1248/bpb.32.1473; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Rivas German, 2013, Biophys Rev, V5, P63, DOI 10.1007/s12551-013-0115-1; Rosales T, 2008, ANAL BIOCHEM, V381, P270, DOI 10.1016/j.ab.2008.05.056; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shiomi D, 2007, J BACTERIOL, V189, P236, DOI 10.1128/JB.00666-06; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Yu XC, 1998, J BIOL CHEM, V273, P10216, DOI 10.1074/jbc.273.17.10216	42	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24625	24635		10.1074/jbc.M113.483222	http://dx.doi.org/10.1074/jbc.M113.483222			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853099	hybrid, Green Published			2022-12-25	WOS:000330612300030
J	Mikula, M; Bomsztyk, K; Goryca, K; Chojnowski, K; Ostrowski, J				Mikula, Michal; Bomsztyk, Karol; Goryca, Krzysztof; Chojnowski, Krzysztof; Ostrowski, Jerzy			Heterogeneous Nuclear Ribonucleoprotein (HnRNP) K Genome-wide Binding Survey Reveals Its Role in Regulating 3 '-End RNA Processing and Transcription Termination at the Early Growth Response 1 (EGR1) Gene through XRN2 Exonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; POLYMERASE-II TRANSCRIPTION; ANDROGEN RECEPTOR; PROMOTER; COMPLEX; ELEMENT; INTERACTOME; ELONGATION; EXPRESSION; RECRUITS	The heterogeneous nuclear ribonucleoprotein K (hnRNPK) is a nucleic acid-binding protein that acts as a docking platform integrating signal transduction pathways to nucleic acid-related processes. Given that hnRNPK could be involved in other steps that compose gene expression the definition of its genome-wide occupancy is important to better understand its role in transcription and co-transcriptional processes. Here, we used chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) to analyze the genome-wide hnRNPK-DNA interaction in colon cancer cell line HCT116. 9.1/3.6 and 7.0/3.4 million tags were sequenced/mapped, then 1809 and 642 hnRNPK binding sites were detected in quiescent and 30-min serum-stimulated cells, respectively. The inspection of sequencing tracks revealed inducible hnRNPK recruitment along a number of immediate early gene loci, including EGR1 and ZFP36, with the highest densities present at the transcription termination sites. Strikingly, hnRNPK knockdown with siRNA resulted in increased pre-RNA levels transcribed downstream of the EGR1 polyadenylation (A) site suggesting altered 3'-end pre-RNA degradation. Further ChIP survey of hnRNPK knockdown uncovered decreased recruitment of the 5'-3' exonuclease XRN2 along EGR1 and downstream of the poly(A) signal without altering RNA polymerase II density at these sites. Immunoprecipitation of hnRNPK and XRN2 from intact and RNase A-treated nuclear extracts followed by shotgun mass spectrometry revealed the presence of hnRNPK and XRN2 in the same complexes along with other spliceosome-related proteins. Our data suggest that hnRNPK may play a role in recruitment of XRN2 to gene loci thus regulating coupling 3'-end pre-mRNA processing to transcription termination.	[Mikula, Michal; Goryca, Krzysztof; Ostrowski, Jerzy] Maria Sklodowska Curie Mem Canc Ctr, Dept Genet, PL-02781 Warsaw, Poland; [Mikula, Michal; Goryca, Krzysztof; Ostrowski, Jerzy] Inst Oncol, PL-02781 Warsaw, Poland; [Mikula, Michal; Bomsztyk, Karol] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Chojnowski, Krzysztof] Warsaw Univ Technol, Inst Radioelect, PL-00661 Warsaw, Poland; [Ostrowski, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, PL-01813 Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Washington; University of Washington Seattle; Warsaw University of Technology; Centre of Postgraduate Medical Education - Poland	Mikula, M (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Dept Genet, PL-02781 Warsaw, Poland.	mikula.michal@gmail.com	Mikula, Michal/G-8276-2011	Mikula, Michal/0000-0003-3447-7328; Ostrowski, Jerzy/0000-0003-1363-3766	National Institutes of Health Grants [R01 DK083310, R37 DK45978]; Ministry of Science and Higher Education Grant [IP2010 026770]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083310, R37DK045978] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Higher Education Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK083310 and R37 DK45978 (to K. B.) and Ministry of Science and Higher Education Grant IP2010 026770.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54; Da Silva N, 2002, BLOOD, V100, P3536, DOI 10.1182/blood.V100.10.3536; Davidson L, 2012, EMBO J, V31, P2566, DOI 10.1038/emboj.2012.101; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Gilmour DS, 2008, J BIOL CHEM, V283, P661, DOI 10.1074/jbc.R700032200; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kubo T, 2006, NUCLEIC ACIDS RES, V34, P6264, DOI 10.1093/nar/gkl794; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Mikula M, 2011, J BIOL CHEM, V286, P9763, DOI 10.1074/jbc.M110.213330; Mikula M, 2010, DNA RES, V17, P245, DOI 10.1093/dnares/dsq016; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Shi LH, 2008, J BIOL CHEM, V283, P36474, DOI 10.1074/jbc.M805980200; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Stains JP, 2005, BIOCHEM J, V385, P613, DOI 10.1042/BJ20040680; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yang Q, 2011, WIRES RNA, V2, P732, DOI 10.1002/wrna.88; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24788	24798		10.1074/jbc.M113.496679	http://dx.doi.org/10.1074/jbc.M113.496679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23857582	hybrid, Green Published			2022-12-25	WOS:000330612300044
J	Morawski, PA; Mehra, P; Chen, CX; Bhatti, T; Wells, AD				Morawski, Peter A.; Mehra, Parul; Chen, Chunxia; Bhatti, Tricia; Wells, Andrew D.			Foxp3 Protein Stability Is Regulated by Cyclin-dependent Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXP3; CD4(+) T-CELLS; PROMOTER OCCUPANCY; CLONAL EXPANSION; GENE-EXPRESSION; SCID MICE; TGF-BETA; IN-VIVO; CDK2; INHIBITION	Foxp3 is a transcription factor required for the development of regulatory T cells (Treg). Mice and humans with a loss of Foxp3 function suffer from uncontrolled autoimmunity and inflammatory disease. Expression of Foxp3 is necessary for the anti-inflammatory capacity of Treg, but whether Foxp3 activity is further subject to regulation by extracellular signals is unclear. The primary structure of Foxp3 contains four cyclin-dependent kinase (CDK) motifs (Ser/Thr-Pro) within the N-terminal repressor domain, and we show that CDK2 can partner with cyclin E to phosphorylate Foxp3 at these sites. Consistent with our previous demonstration that CDK2 negatively regulates Treg function, we find that mutation of the serine or threonine at each CDK motif to alanine (S/T -> A) results in enhanced Foxp3 protein stability in CD4(+) T cells. T cells expressing the S/T -> A mutant of Foxp3 showed enhanced induction (e. g. CD25) and repression (e. g. IL2) of canonical Foxp3-responsive genes, exhibited an increased capacity to suppress conventional T cell proliferation in vitro, and were highly effective at ameliorating colitis in an in vivo model of inflammatory bowel disease. These results indicate that CDK2 negatively regulates the stability and activity of Foxp3 and implicate CDK-coupled receptor signal transduction in the control of regulatory T cell function and stability.	Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wells, AD (corresponding author), 916F Abramson Res Ctr, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	adwells@mail.med.upenn.edu	Morawski, Peter/F-2866-2019	Morawski, Peter/0000-0001-9159-4032	National Institutes of Health [R01-AI054643-06]; Goldie Simon Preceptorship Award; Lupus Foundation of America Philadelphia Tri-State Chapter; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldie Simon Preceptorship Award; Lupus Foundation of America Philadelphia Tri-State Chapter; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI054643-06 (to A. D. W.). This work was also supported by the 2011 Goldie Simon Preceptorship Award sponsored by the Lupus Foundation of America Philadelphia Tri-State Chapter and the Pennsylvania Department of Health (to P. A. M.).	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Aranda R, 1997, J IMMUNOL, V158, P3464; Bashir T, 2005, NAT CELL BIOL, V7, P779, DOI 10.1038/ncb0805-779; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Berthet C, 2007, MOL CELL BIOL, V27, P5079, DOI 10.1128/MCB.00029-07; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chunder N, 2012, J IMMUNOL, V189, P5659, DOI 10.4049/jimmunol.1202313; Conner EM, 1997, J PHARMACOL EXP THER, V282, P1615; COPPOCK DL, 1995, EXP CELL RES, V221, P92, DOI 10.1006/excr.1995.1356; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gallorini M, 2012, BIODRUGS, V26, P377, DOI 10.2165/11634060-000000000-00000; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Kamesaki H, 1998, J IMMUNOL, V160, P770; Kasprowicz DJ, 2003, J IMMUNOL, V171, P1216, DOI 10.4049/jimmunol.171.3.1216; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KIM YH, 1992, J IMMUNOL, V149, P17; KIM YH, 1994, J IMMUNOL, V152, P4328; Konig S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040896; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kwon HS, 2012, J IMMUNOL, V188, P2712, DOI 10.4049/jimmunol.1100903; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li LQ, 2009, CELL CYCLE, V8, P1794, DOI 10.4161/cc.8.11.8738; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	46	70	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24494	24502		10.1074/jbc.M113.467704	http://dx.doi.org/10.1074/jbc.M113.467704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853094	Green Published, hybrid			2022-12-25	WOS:000330612300018
J	Lau, WM; Doucet, M; Stadel, R; Huang, D; Weber, KL; Kominsky, SL				Lau, Wen Min; Doucet, Michele; Stadel, Ryan; Huang, David; Weber, Kristy L.; Kominsky, Scott L.			Enpp1: A Potential Facilitator of Breast Cancer Bone Metastasis	PLOS ONE			English	Article							INFANTILE ARTERIAL CALCIFICATION; INORGANIC PYROPHOSPHATE; PLASMA; HYPOPHOSPHATASIA; MINERALIZATION; HYDROXYAPATITE; PATHOGENESIS; OSTEOPONTIN; DISORDERS; MEMBRANE	Bone is the most common site of breast cancer metastasis and once established, it is frequently incurable. Critical to our ability to prevent and treat bone metastasis is the identification of the key factors mediating its establishment and understanding their biological function. To address this issue we previously carried out an in vivo selection process to isolate murine mammary tumor sublines possessing an enhanced ability to colonize the bone. A comparison of gene expression between parental cells and sublines by genome-wide cDNA microarray analysis revealed several potential mediators of bone metastasis, including the pyrophosphate-generating ectoenzyme Enpp1. By qRT-PCR and Western analysis we found that expression of Enpp1 was elevated in human breast cancer cell lines known to produce bone metastasis in animal models compared to non-metastatic and normal mammary epithelial cell lines. Further, in clinical specimens, levels of Enpp1 were significantly elevated in human primary breast tumors relative to normal mammary epithelium, with highest levels observed in breast-bone metastasis as determined by qRT-PCR and immunohistochemical analysis. To examine the potential role of Enpp1 in the development of bone metastasis, Enpp1 expression was stably increased in the breast cancer cell line MDA-MB-231 and the ability to colonize the bone following intracardiac and direct intratibial injection of athymic nude mice was determined. By both routes of administration, increased expression of Enpp1 enhanced the ability of MDA-MB-231 cells to form tumors in the bone relative to cells expressing vector alone, as determined by digital radiography and histological analysis. Taken together, these data suggest a potential role for Enpp1 in the development of breast cancer bone metastasis.	[Lau, Wen Min; Doucet, Michele; Stadel, Ryan; Huang, David; Weber, Kristy L.; Kominsky, Scott L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA	Johns Hopkins University	Kominsky, SL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA.	kominsc@jhmi.edu						Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Belleannee C, 2010, AM J PHYSIOL-CELL PH, V298, pC817, DOI 10.1152/ajpcell.00460.2009; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; HUANG R, 1994, J CLIN INVEST, V94, P560, DOI 10.1172/JCI117370; Lau WM, 2010, INT J CANCER, V126, P876, DOI 10.1002/ijc.24780; Marchio C, 2008, J PATHOL, V215, P398, DOI 10.1002/path.2368; MEYER JL, 1973, CALC TISS RES, V13, P295, DOI 10.1007/BF02015419; Rodriguez C, 2000, GENE CHROMOSOME CANC, V27, P76, DOI 10.1002/(SICI)1098-2264(200001)27:1<76::AID-GCC10>3.0.CO;2-E; RUSSELL RGG, 1971, J CLIN INVEST, V50, P961, DOI 10.1172/JCI106589; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Saito T, 2011, BONE, V49, P913, DOI 10.1016/j.bone.2011.06.029	17	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e66752	10.1371/journal.pone.0066752	http://dx.doi.org/10.1371/journal.pone.0066752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861746	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300006
J	Chesworth, R; Brown, RM; Kim, JH; Lawrence, AJ				Chesworth, Rose; Brown, Robyn M.; Kim, Jee Hyun; Lawrence, Andrew J.			The Metabotropic Glutamate 5 Receptor Modulates Extinction and Reinstatement of Methamphetamine-Seeking in Mice	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS CORE; COCAINE-SEEKING; MGLUR5 RECEPTORS; FOOD-SEEKING; SYNAPTIC POTENTIATION; NMDA RECEPTORS; DRUG-ADDICTION; PROTEIN-KINASE	Methamphetamine (METH) is a highly addictive psychostimulant with no therapeutics registered to assist addicts in discontinuing use. Glutamatergic dysfunction has been implicated in the development and maintenance of addiction. We sought to assess the involvement of the metabotropic glutamate 5 receptor (mGlu5) in behaviours relevant to METH addiction because this receptor has been implicated in the actions of other drugs of abuse, including alcohol, cocaine and opiates. mGlu5 knockout (KO) mice were tested in intravenous self-administration, conditioned place preference and locomotor sensitization. Self-administration of sucrose was used to assess the response of KO mice to a natural reward. Acquisition and maintenance of self-administration, as well as the motivation to self-administer METH was intact in mGlu5 KO mice. Importantly, mGlu5 KO mice required more extinction sessions to extinguish the operant response for METH, and exhibited an enhanced propensity to reinstate operant responding following exposure to drug-associated cues. This phenotype was not present when KO mice were tested in an equivalent paradigm assessing operant responding for sucrose. Development of conditioned place preference and locomotor sensitization were intact in KO mice; however, conditioned hyperactivity to the context previously paired with drug was elevated in KO mice. These data demonstrate a role for mGlu5 in the extinction and reinstatement of METH-seeking, and suggests a role for mGlu5 in regulating contextual salience.	[Chesworth, Rose; Brown, Robyn M.; Kim, Jee Hyun; Lawrence, Andrew J.] Florey Inst Neurosci & Mental Hlth, Behav Neurosci Div, Parkville, Vic, Australia; [Chesworth, Rose; Brown, Robyn M.; Kim, Jee Hyun; Lawrence, Andrew J.] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Brown, Robyn M.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Medical University of South Carolina	Lawrence, AJ (corresponding author), Florey Inst Neurosci & Mental Hlth, Behav Neurosci Div, Parkville, Vic, Australia.	andrewjl@unimelb.edu.au	Brown, Robyn M/AAO-3694-2021; Kim, Jee Hyun/F-8777-2012	Brown, Robyn M/0000-0003-4167-3634; Kim, Jee Hyun/0000-0002-1299-4300; Chesworth, Rose/0000-0002-3758-9598	National Health and Medical Research Council (NHMRC) of Australia [APP1022201]; NHMRC; Australian Research Council Fellowship; Rotary Health Australia; Alan and Elizabeth Finkel Foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council); Rotary Health Australia; Alan and Elizabeth Finkel Foundation	The present study was supported by a project grant (APP1022201) from the National Health and Medical Research Council (NHMRC) of Australia awarded to AL and JK, NHMRC fellowships and scholarships awarded to AL, RB, and RC, Australian Research Council Fellowship awarded to JK. RC also acknowledges support from Rotary Health Australia, as well as The Alan and Elizabeth Finkel Foundation. The authors acknowledge the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amen SL, 2011, NEUROPSYCHOPHARMACOL, V36, P871, DOI 10.1038/npp.2010.226; Aoki T, 2004, EUR J NEUROSCI, V20, P1633, DOI 10.1111/j.1460-9568.2004.03609.x; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Backstrom P, 2007, PSYCHOPHARMACOLOGY, V192, P571, DOI 10.1007/s00213-007-0753-8; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Ben-Shahar O, 2009, SYNAPSE, V63, P598, DOI 10.1002/syn.20640; Besheer J, 2008, ALCOHOL CLIN EXP RES, V32, P209, DOI 10.1111/j.1530-0277.2007.00570.x; Bespalov AY, 2005, NEUROPHARMACOLOGY, V49, P167, DOI 10.1016/j.neuropharm.2005.06.007; Beveridge TJR, 2011, NEUROSCI LETT, V496, P15, DOI 10.1016/j.neulet.2011.03.077; Bird M K, 2009, Curr Mol Pharmacol, V2, P83; Bird MK, 2008, INT J NEUROPSYCHOPH, V11, P765, DOI 10.1017/S1461145708008572; Bird MK, 2010, INT J NEUROPSYCHOPH, V13, P133, DOI 10.1017/S1461145709990162; Bird MK, 2009, TRENDS PHARMACOL SCI, V30, P617, DOI 10.1016/j.tips.2009.09.008; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown Amanda L., 2011, International Journal of Neuropsychopharmacology, V14, P1099, DOI 10.1017/S1461145710001367; Brown R, 2012, INT STUD ASS SAN DIE, P1; Brown RM, 2012, DRUG ALCOHOL DEPEN, V123, P264, DOI 10.1016/j.drugalcdep.2011.11.002; Brown RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015889; Brown RM, 2009, NEUROPSYCHOPHARMACOL, V34, P844, DOI 10.1038/npp.2008.72; Busse CS, 2004, NEUROPSYCHOPHARMACOL, V29, P1971, DOI 10.1038/sj.npp.1300540; Cahir E, 2011, NEUROPSYCHOPHARMACOL, V36, P1505, DOI 10.1038/npp.2011.35; Cantin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011592; Carroll FI, 2008, ANN NY ACAD SCI, V1141, P221, DOI 10.1196/annals.1441.015; Chaudhri N, 2008, BIOL PSYCHIAT, V64, P203, DOI 10.1016/j.biopsych.2008.03.007; Chen CC, 2012, NEUROSCI LETT, V524, P65, DOI 10.1016/j.neulet.2012.07.014; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Christensen CJ, 2008, PHARMACOL BIOCHEM BE, V91, P209, DOI 10.1016/j.pbb.2008.07.009; Christoffersen GRJ, 2008, BEHAV BRAIN RES, V191, P235, DOI 10.1016/j.bbr.2008.03.032; Cleva RM, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00093; Cleva RM, 2011, BEHAV NEUROSCI, V125, P10, DOI 10.1037/a0022339; Conklin CA, 2002, ADDICTION, V97, P155, DOI 10.1046/j.1360-0443.2002.00014.x; Cowen MS, 2007, PSYCHOPHARMACOLOGY, V190, P21, DOI 10.1007/s00213-006-0583-0; Cowen MS, 2005, J PHARMACOL EXP THER, V315, P590, DOI 10.1124/jpet.105.090449; D'Souza MS, 2011, NEUROPHARMACOLOGY, V61, P1399, DOI 10.1016/j.neuropharm.2011.08.028; Duncan JR, 2011, PHARM BIOCH BEHAV, V100, P811; Edwards S, 2011, ADDICT BIOL, V16, P450, DOI 10.1111/j.1369-1600.2010.00296.x; Eiler WJA, 2011, LIFE SCI, V89, P862, DOI 10.1016/j.lfs.2011.09.014; Eisch AJ, 1996, SYNAPSE, V22, P217, DOI 10.1002/(SICI)1098-2396(199603)22:3<217::AID-SYN3>3.0.CO;2-F; Ernst T, 2008, J NEUROIMMUNE PHARM, V3, P165, DOI 10.1007/s11481-008-9108-4; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Fontanez-Nuin DE, 2011, CEREB CORTEX, V21, P727, DOI 10.1093/cercor/bhq147; Galuska CM, 2011, BEHAV PHARMACOL, V22, P312, DOI 10.1097/FBP.0b013e3283473be4; Gass JT, 2009, PSYCHOPHARMACOLOGY, V204, P587, DOI 10.1007/s00213-009-1490-y; Gass JT, 2009, BIOL PSYCHIAT, V65, P717, DOI 10.1016/j.biopsych.2008.11.001; Gass JT, 2009, NEUROPSYCHOPHARMACOL, V34, P820, DOI 10.1038/npp.2008.140; Ghasemzadeh MB, 1999, J NEUROCHEM, V72, P157, DOI 10.1046/j.1471-4159.1999.0720157.x; Herrold AA, 2013, EUR NEUROPSYCHOPHARM, V23, P691, DOI 10.1016/j.euroneuro.2012.05.014; Herzig V, 2005, ADDICT BIOL, V10, P243, DOI 10.1080/13556210500223272; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Iacovelli L, 2013, NEUROPHARMACOLOGY, V66, P24, DOI 10.1016/j.neuropharm.2012.05.005; Jia ZP, 1998, LEARN MEMORY, V5, P331; Jones JL, 2008, SYNAPSE, V62, P219, DOI 10.1002/syn.20486; KAIYA H, 1983, FOLIA PSYCHIAT NEU J, V37, P107; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kenny P, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-3; Knackstedt LA, 2010, J NEUROSCI, V30, P7984, DOI 10.1523/JNEUROSCI.1244-10.2010; Knackstedt LA, 2010, BIOL PSYCHIAT, V67, P81, DOI 10.1016/j.biopsych.2009.07.018; Knackstedt LA, 2009, CURR OPIN PHARMACOL, V9, P59, DOI 10.1016/j.coph.2008.12.003; Kumaresan V, 2009, BEHAV BRAIN RES, V202, P238, DOI 10.1016/j.bbr.2009.03.039; LaLumiere RT, 2012, EUR J NEUROSCI, V35, P614, DOI 10.1111/j.1460-9568.2012.07991.x; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Lominac KD, 2006, DRUG ALCOHOL DEPEN, V85, P142, DOI 10.1016/j.drugalcdep.2006.04.003; Lu YM, 1997, J NEUROSCI, V17, P5196; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Martin-Fardon R, 2009, J PHARMACOL EXP THER, V329, P1084, DOI 10.1124/jpet.109.151357; McGeehan AJ, 2003, SYNAPSE, V47, P240, DOI 10.1002/syn.10166; McPherson CS, 2010, CEREB CORTEX, V20, P941, DOI 10.1093/cercor/bhp159; Mickiewicz AL, 2009, NEUROPSYCHOPHARMACOL, V34, P874, DOI 10.1038/npp.2008.111; Millan EZ, 2010, J NEUROSCI, V30, P4626, DOI 10.1523/JNEUROSCI.4933-09.2010; Moussawi K, 2011, P NATL ACAD SCI USA, V108, P385, DOI 10.1073/pnas.1011265108; Moussawi K, 2010, EUR J PHARMACOL, V639, P115, DOI 10.1016/j.ejphar.2010.01.030; Novak M, 2010, J NEUROSCI, V30, P11973, DOI 10.1523/JNEUROSCI.2550-10.2010; Olive MF, 2010, EUR J PHARMACOL, V639, P47, DOI 10.1016/j.ejphar.2010.01.029; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Osborne MPH, 2008, ANN NY ACAD SCI, V1139, P206, DOI 10.1196/annals.1432.034; Parmentier-Batteur S, 2012, NEUROPHARMACOLOGY, V62, P1453, DOI 10.1016/j.neuropharm.2010.11.013; Pennay A, 2008, PREVENTION RES Q SEP, P1; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Pierce RC, 1996, J NEUROSCI, V16, P1550; REBERG D, 1972, Learning and Motivation, V3, P246, DOI 10.1016/0023-9690(72)90021-5; Rokosik SL, 2013, NEUROREPORT, V24, P152, DOI 10.1097/WNR.0b013e32835e11a2; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Sailasuta N, 2010, SUBST ABUS-RES TREAT, V4, P9, DOI 10.4137/SART.S4625; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Sinclair CM, 2012, PHARMACOL BIOCHEM BE, V101, P329, DOI 10.1016/j.pbb.2012.01.014; Soria G, 2008, PSYCHOPHARMACOLOGY, V199, P593, DOI 10.1007/s00213-008-1184-x; Stankeviciute NM, 2014, ADDICT BIOL, V19, P972, DOI 10.1111/adb.12064; Stoker AK, 2012, PSYCHOPHARMACOLOGY, V221, P317, DOI 10.1007/s00213-011-2578-8; Suto N, 2010, PSYCHOPHARMACOLOGY, V211, P267, DOI 10.1007/s00213-010-1890-z; Tessari M, 2004, EUR J PHARMACOL, V499, P121, DOI 10.1016/j.ejphar.2004.07.056; Torregrossa MM, 2010, J NEUROSCI, V30, P10526, DOI 10.1523/JNEUROSCI.2523-10.2010; Uys JD, 2010, PROG MOL BIOL TRANSL, V98, P367; Veeneman MMJ, 2011, PSYCHOPHARMACOLOGY, V214, P863, DOI 10.1007/s00213-010-2095-1; Wang XS, 2013, ADDICT BIOL, V18, P40, DOI 10.1111/j.1369-1600.2011.00432.x; Watterson LR, 2013, PSYCHOPHARMACOLOGY, V225, P151, DOI 10.1007/s00213-012-2804-z; Widholm J. J., 2011, J ADDICT RES THER S, VS1, P4; Xi Zheng-Xiong, 2008, Curr Drug Abuse Rev, V1, P303; Yan YJ, 2006, BEHAV BRAIN RES, V168, P137, DOI 10.1016/j.bbr.2005.11.030; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004; Yucel M, 2007, MOL PSYCHIATR, V12, P691, DOI 10.1038/sj.mp.4001955	105	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68371	10.1371/journal.pone.0068371	http://dx.doi.org/10.1371/journal.pone.0068371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861896	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700082
J	Cruz, L; Meyers, C				Cruz, Linda; Meyers, Craig			Differential Dependence on Host Cell Glycosaminoglycans for Infection of Epithelial Cells by High-Risk HPV Types	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; MINOR CAPSID PROTEIN; HEPARAN-SULFATE; EXTRACELLULAR-MATRIX; HUMAN KERATINOCYTES; SURFACE-BINDING; CERVICAL-CANCER; L2; RECEPTOR; DNA	Human papillomavirus (HPV) infection is the leading cause of cervical cancer world-wide. Here, we show that native HPV particles produced in a differentiated epithelium have developed different strategies to infect the host. Using biochemical inhibition assays and glycosaminoglycan (GAG)-negative cells, we show that of the four most common cancer-causing HPV types, HPV18, HPV31, and HPV45 are largely dependent on GAGs to initiate infection. In contrast, HPV16 can bind and enter through a GAG-independent mechanism. Infections of primary human keratinocytes, natural host cells for HPV infections, support our conclusions. Further, this renders the different virus types differentially susceptible to carrageenan, a microbicide targeting virus entry. Our data demonstrates that ordered maturation of papillomavirus particles in a differentiating epithelium may alter the virus entry mechanism. This study should facilitate a better understanding of the attachment and infection by the main oncogenic HPV types, and development of inhibitors of HPV infection.	[Cruz, Linda; Meyers, Craig] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Meyers, C (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA.	cmm10@psu.edu			PHS grant from the National Institute of Allergy and Infectious Disease [R01AI57988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057988] Funding Source: NIH RePORTER	PHS grant from the National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a PHS grant from the National Institute of Allergy and Infectious Disease (R01AI57988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, AIDS PATIENT CARE ST, V25, P265; Bauer PH, 1999, J VIROL, V73, P5826, DOI 10.1128/JVI.73.7.5826-5832.1999; Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Cerqueira C., 2013, CELL MICROBIOL; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016405; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; Culp TD, 2006, VIROLOGY, V347, P147, DOI 10.1016/j.virol.2005.11.025; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; Dasgupta J, 2011, J BIOL CHEM, V286, P2617, DOI 10.1074/jbc.M110.160184; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Evander M, 1997, J VIROL, V71, P2449, DOI 10.1128/JVI.71.3.2449-2456.1997; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Fligge C, 2001, J VIROL, V75, P7727, DOI 10.1128/JVI.75.16.7727-7731.2001; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Kines RC, 2009, P NATL ACAD SCI USA, V106, P20458, DOI 10.1073/pnas.0908502106; Lembo D, 2008, ANTIMICROB AGENTS CH, V52, P1374, DOI 10.1128/AAC.01467-07; Luciani S, 2009, IMMUNOTHERAPY-UK, V1, P795, DOI 10.2217/IMT.09.48; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Neu U, 2010, CELL HOST MICROBE, V8, P309, DOI 10.1016/j.chom.2010.09.004; Patterson NA, 2005, J VIROL, V79, P6838, DOI 10.1128/JVI.79.11.6838-6847.2005; Pereira R, 2009, ARCH VIROL, V154, P187, DOI 10.1007/s00705-009-0310-3; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Sapp M, 2009, VIROLOGY, V384, P400, DOI 10.1016/j.virol.2008.12.022; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Smith JL, 2007, J VIROL, V81, P9922, DOI 10.1128/JVI.00988-07; Surviladze Z, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002519; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Woodham AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043519; Yang RC, 2003, J BIOL CHEM, V278, P12546, DOI 10.1074/jbc.M208691200; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003; Zhao KN, 1998, VIROLOGY, V243, P482, DOI 10.1006/viro.1998.9091; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	47	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68379	10.1371/journal.pone.0068379	http://dx.doi.org/10.1371/journal.pone.0068379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861898	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700083
J	Dasgupta, K; Da Costa, D; Pillay, S; De Civita, M; Gougeon, R; Leong, A; Bacon, S; Stotland, S; Chetty, VT; Garfield, N; Majdan, A; Meltzer, S				Dasgupta, Kaberi; Da Costa, Deborah; Pillay, Sabrina; De Civita, Mirella; Gougeon, Rejeanne; Leong, Aaron; Bacon, Simon; Stotland, Stephen; Chetty, V. Tony; Garfield, Natasha; Majdan, Agnieszka; Meltzer, Sara			Strategies to Optimize Participation in Diabetes Prevention Programs following Gestational Diabetes: A Focus Group Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; RISK PERCEPTION; SELF-EFFICACY; MELLITUS; WOMEN; INTERVENTION; POPULATION; PREVALENCE; HISTORIES	Objective: We performed a qualitative study among women within 5 years of Gestational Diabetes (GDM) diagnosis. Our aim was to identify the key elements that would enhance participation in a type 2 diabetes (DM2) prevention program. Research Design and Methods: Potential participants received up to three invitation letters from their GDM physician. Four focus groups were held. Discussants were invited to comment on potential facilitators/barriers to participation and were probed on attitudes towards meal replacement and Internet/social media tools. Recurring themes were identified through qualitative content analysis of discussion transcripts. Results: Among the 1,201 contacted and 79 eligible/interested, 29 women attended a focus group discussion. More than half of discussants were overweight/obese, and less than half were physically active. For DM2 prevention, a strong need for social support to achieve changes in dietary and physical activity habits was expressed. In this regard, face-to-face interactions with peers and professionals were preferred, with adjunctive roles for Internet/social media. Further, direct participation of partners/spouses in a DM2 prevention program was viewed as important to enhance support for behavioural change at home. Discussants highlighted work and child-related responsibilities as potential barriers to participation, and emphasized the importance of childcare support to allow attendance. Meal replacements were viewed with little interest, with concerns that their use would provide a poor example of eating behaviour to children. Conclusions: Among women within 5 years of a GDM diagnosis who participated in a focus group discussion, participation in a DM2 prevention program would be enhanced by face-to-face interactions with professionals and peers, provision of childcare support, and inclusion of spouses/partners.	[Dasgupta, Kaberi; Da Costa, Deborah; Pillay, Sabrina; De Civita, Mirella; Gougeon, Rejeanne; Leong, Aaron; Garfield, Natasha; Majdan, Agnieszka; Meltzer, Sara] McGill Univ, Dept Med, Montreal, PQ, Canada; [Bacon, Simon] Concordia Univ, Dept Exercise Sci, Montreal, PQ, Canada; [Stotland, Stephen] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Chetty, V. Tony] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McGill University; Concordia University - Canada; McGill University; McMaster University	Dasgupta, K (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	kaberi.dasgupta@mcgill.ca	Bacon, Simon/B-2637-2012	Bacon, Simon/0000-0001-7075-0358	Canadian Institutes of Health Research (Institute of Circulatory and Respiratory Health and Institute of Gender and Health) [CAI 117789]	Canadian Institutes of Health Research (Institute of Circulatory and Respiratory Health and Institute of Gender and Health)	Funding was provided by the Canadian Institutes of Health Research (CAI 117789; Institute of Circulatory and Respiratory Health and Institute of Gender and Health). Sehar Manji, assistant to KD at the McGill University Health Centre Research Institute, provided important support in the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardini G, 2010, DIABETES CARE, V33, P411, DOI 10.2337/dc09-1342; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Booth ML, 2000, PREV MED, V31, P15, DOI 10.1006/pmed.2000.0661; Clark HD, 2003, DIABETES CARE, V26, P265, DOI 10.2337/diacare.26.2.265; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Dasgupta K, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-125; Dietz PM, 2008, OBSTET GYNECOL, V112, P868, DOI 10.1097/AOG.0b013e318184db63; Egeland GM, 2010, DIABETIC MED, V27, P257, DOI 10.1111/j.1464-5491.2010.02944.x; Ferrara A, 2011, DIABETES CARE; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gorin AA, 2008, INT J OBESITY, V32, P1678, DOI 10.1038/ijo.2008.150; Jones EJ, 2012, JOGNN-J OBST GYN NEO, V41, P246, DOI 10.1111/j.1552-6909.2012.01339.x; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; Kim C, 2008, DIABETES EDUCATOR, V34, P719, DOI 10.1177/0145721708321005; Kim C, 2007, DIABETES CARE, V30, P2281, DOI 10.2337/dc07-0618; Krueger R. A., 1988, FOCUS GROUPS PRACTIC; Malcolm JC, 2006, DIABETIC MED, V23, P565, DOI 10.1111/j.1464-5491.2006.01840.x; Meltzer SJ, 2010, BJOG-INT J OBSTET GY, V117, P407, DOI 10.1111/j.1471-0528.2009.02475.x; Morrison MK, 2009, AUST NZ J OBSTET GYN, V49, P494, DOI 10.1111/j.1479-828X.2009.01056.x; Moses RG, 1996, DIABETES CARE, V19, P1348, DOI 10.2337/diacare.19.12.1348; Nicklas JM, 2011, BMC PREGNANCY CHILDB, P11; Ostbye T, 2009, AM J PREV MED, V37, P173, DOI 10.1016/j.amepre.2009.05.016; Pirkola J, 2010, J CLIN ENDOCR METAB, V95, P772, DOI 10.1210/jc.2009-1075; Pridjian G, 2010, OBSTET GYN CLIN N AM, V37, P255, DOI 10.1016/j.ogc.2010.02.017; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Sternfeld B, 1999, PREV MED, V28, P313, DOI 10.1006/pmed.1998.0470; WHITE E, 1991, AM J PREV MED, V7, P319, DOI 10.1016/S0749-3797(18)30905-X; Yun Shumei, 2007, Prev Chronic Dis, V4, pA07; Zehle K, 2008, DIABETES EDUCATOR, V34, P807, DOI 10.1177/0145721708323641	30	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67878	10.1371/journal.pone.0067878	http://dx.doi.org/10.1371/journal.pone.0067878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861824	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000323350700052
J	Raoof, M; Cisneros, BT; Corr, SJ; Palalon, F; Curley, SA; Koshkina, NV				Raoof, Mustafa; Cisneros, Brandon T.; Corr, Stuart J.; Palalon, Flavio; Curley, Steven A.; Koshkina, Nadezhda V.			Tumor Selective Hyperthermia Induced by Short-Wave Capacitively-Coupled RF Electric-Fields	PLOS ONE			English	Article								There is a renewed interest in developing high-intensity short wave capacitively-coupled radiofrequency (RF) electric-fields for nanoparticle-mediated tumor-targeted hyperthermia. However, the direct thermal effects of such high-intensity electric-fields (13.56 MHZ, 600 W) on normal and tumor tissues are not completely understood. In this study, we investigate the heating behavior and dielectric properties of normal mouse tissues and orthotopically-implanted human hepatocellular and pancreatic carcinoma xenografts. We note tumor-selective hyperthermia (relative to normal mouse tissues) in implanted xenografts that can be explained on the basis of differential dielectric properties. Furthermore, we demonstrate that repeated RF exposure of tumor-bearing mice can result in significant anti-tumor effects compared to control groups without detectable harm to normal mouse tissues.	[Raoof, Mustafa; Cisneros, Brandon T.; Corr, Stuart J.; Palalon, Flavio; Curley, Steven A.; Koshkina, Nadezhda V.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Raoof, Mustafa] Univ Arizona, Hlth Sci Ctr, Dept Surg, Tucson, AZ USA; [Cisneros, Brandon T.; Corr, Stuart J.] Rice Univ, Dept Chem, Houston, TX USA; [Curley, Steven A.] Rice Univ, Dept Mech Engn & Mat Sci, Houston, TX 77251 USA	University of Texas System; UTMD Anderson Cancer Center; University of Arizona; University of Arizona Health Sciences; Rice University; Rice University	Koshkina, NV (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	nvkoshki@mdanderson.org	Raoof, Mustafa/D-1664-2012	CORR, STUART/0000-0002-9865-5309	National Institutes of Health (NIH) [U54CA143837]; NIH M. D. Anderson Cancer Center [CA016672]; Kanzius Research Foundation (SAC, Erie, Pennsylvania); NATIONAL CANCER INSTITUTE [U54CA143837, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH M. D. Anderson Cancer Center; Kanzius Research Foundation (SAC, Erie, Pennsylvania); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded from the National Institutes of Health (NIH) (U54CA143837), NIH M. D. Anderson Cancer Center Support grant CA016672, and an unrestricted research grant from the Kanzius Research Foundation (SAC, Erie, Pennsylvania). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora D, 2002, IEEE T BIO-MED ENG, V49, P629, DOI 10.1109/TBME.2002.1010846; CHEUNG AY, 1982, BRIT J CANCER, V45, P16; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; Corr SJ, 2012, ACS SYM SER, V1113, P81; Corr SJ, 2012, J PHYS CHEM C, V116, P24380, DOI 10.1021/jp309053z; Cruz-Monserrate Z, 2012, GUT, V61, P1315, DOI 10.1136/gutjnl-2011-300544; DEFORD JA, 1991, MED BIOL ENG COMPUT, V29, P197, DOI 10.1007/BF02447108; DICKSON JA, 1979, LANCET, V1, P202, DOI 10.1016/S0140-6736(79)90594-4; FAJARDO LF, 1984, CANCER RES, V44, P4826; GERWECK LE, 1985, CANCER RES, V45, P3408; Gladman AS, 2004, INT J HYPERTHER, V20, P539, DOI 10.1080/02656730410001668366; Glazer ES, 2010, CLIN CANCER RES, V16, P5712, DOI 10.1158/1078-0432.CCR-10-2055; Glazer ES, 2010, CANCER-AM CANCER SOC, V116, P3285, DOI 10.1002/cncr.25135; Haemmerich D, 2003, PHYSIOL MEAS, V24, P251, DOI 10.1088/0967-3334/24/2/302; KAWASHIMA E, 1963, Sanfujinka Chiryo, V6, P628; LEE CKK, 1989, RADIOL CLIN N AM, V27, P543; Nielsen OS, 2001, EUR J CANCER, V37, P1587, DOI 10.1016/S0959-8049(01)00193-9; Raoof M, 2013, BIOMATERIALS, V34, P1862, DOI 10.1016/j.biomaterials.2012.11.033; Raoof M, 2012, NANOMED-NANOTECHNOL, V8, P1096, DOI 10.1016/j.nano.2012.02.001; Raoof M, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/676957; Raoof M, 2012, INT J HYPERTHER, V28, P202, DOI 10.3109/02656736.2012.666318; REFINETTI R, 1988, Journal de Physiologie (Paris), V83, P300; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; SMITH SR, 1986, IEEE T BIO-MED ENG, V33, P522, DOI 10.1109/TBME.1986.325740; SONG CW, 1986, INT J RADIAT ONCOL, V12, P365, DOI 10.1016/0360-3016(86)90352-4; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Yarmolenko PS, 2011, INT J HYPERTHER, V27, P320, DOI 10.3109/02656736.2010.534527	27	48	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68506	10.1371/journal.pone.0068506	http://dx.doi.org/10.1371/journal.pone.0068506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861912	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700089
J	Chan, PL; Zheng, J; Liu, YP; Lam, KT; Xiang, Z; Mao, HW; Liu, Y; Qin, G; Lau, YL; Tu, WW				Chan, Ping-Lung; Zheng, Jian; Liu, Yinping; Lam, Kwok-Tai; Xiang, Zheng; Mao, Huawei; Liu, Yuan; Qin, Gang; Lau, Yu-Lung; Tu, Wenwei			TLR5 Signaling Enhances the Proliferation of Human Allogeneic CD40-Activated B Cell Induced CD4(hi)CD25(+) Regulatory T Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; SUPPRESSIVE CAPACITY; FLAGELLIN; STIMULATION; EXPRESSION; ABSENCE; FOXP3; CYCLE; TCR	Although diverse functions of different toll-like receptors (TLR) on human natural regulatory T cells have been demonstrated recently, the role of TLR-related signals on human induced regulatory T cells remain elusive. Previously our group developed an ex vivo high-efficient system in generating human alloantigen-specific CD4(hi)CD25(+) regulatory T cells from naive CD4(+)CD25(-) T cells using allogeneic CD40-activated B cells as stimulators. In this study, we investigated the role of TLR5-related signals on the generation and function of these novel CD4(hi)CD25(+) regulatory T cells. It was found that induced CD4(hi)CD25(+) regulatory T cells expressed an up-regulated level of TLR5 compared to their precursors. The blockade of TLR5 using anti-TLR5 antibodies during the co-culture decreased CD4(hi)CD25(+) regulatory T cells proliferation by induction of S phase arrest. The S phase arrest was associated with reduced ERK1/2 phosphorylation. However, TLR5 blockade did not decrease the CTLA-4, GITR and FOXP3 expressions, and the suppressive function of CD4(hi)CD25(+) regulatory T cells. In conclusion, we discovered a novel function of TLR5-related signaling in enhancing the proliferation of CD4(hi)CD25(+) regulatory T cells by promoting S phase progress but not involved in the suppressive function of human CD40-activated B cell-induced CD4(hi)CD25(+) regulatory T cells, suggesting a novel role of TLR5-related signals in the generation of induced regulatory T cells.	[Chan, Ping-Lung; Zheng, Jian; Liu, Yinping; Lam, Kwok-Tai; Xiang, Zheng; Mao, Huawei; Liu, Yuan; Qin, Gang; Lau, Yu-Lung; Tu, Wenwei] Univ Hong Kong, Dept Paediat & Adolescent Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tu, WW (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	wwtu@hku.hk	; Lau, Yu Lung/C-4322-2009	Chan, Ping Lung/0000-0002-5639-2117; Lau, Yu Lung/0000-0002-4780-0289; Liu, Yuan/0000-0003-4880-5185	NSFC/RGC Joint Research Scheme [N_HKU 747/11]; General Research Fund, Research Grants Council of Hong Kong [HKU 781211M]; Area of Excellence program [AoE/M-12/06]; University Grants Committee of Hong Kong Special Administrative Region	NSFC/RGC Joint Research Scheme(National Natural Science Foundation of China (NSFC)); General Research Fund, Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Area of Excellence program; University Grants Committee of Hong Kong Special Administrative Region	This work was supported in part by NSFC/RGC Joint Research Scheme (N_HKU 747/11), General Research Fund, Research Grants Council of Hong Kong (HKU 781211M); Area of Excellence program (AoE/M-12/06), University Grants Committee of Hong Kong Special Administrative Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alpdogan O, 2012, SEMIN ONCOL, V39, P629, DOI 10.1053/j.seminoncol.2012.10.001; [Anonymous], 2000, CHAMP CHIP TRANSCR F; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chen SC, 2004, J BIOL CHEM, V279, P13755, DOI 10.1074/jbc.M310064200; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Fallarino F, 2009, J IMMUNOL, V183, P6303, DOI 10.4049/jimmunol.0901577; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gogishvili T, 2013, EUR J IMMUNOL, V43, P188, DOI 10.1002/eji.201242824; He HQ, 2011, IMMUNOBIOLOGY, V216, P678, DOI 10.1016/j.imbio.2010.11.002; Huang F, 2010, ACTA BIOCH BIOPH SIN, V42, P325, DOI 10.1093/abbs/gmq025; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Kuhn A, 2008, ARCH DERMATOL RES, V5, P5; Le Bras S, 2006, J CLIN INVEST, V116, P1473, DOI 10.1172/JCI28880; Lourenco EV, 2011, AUTOIMMUNITY, V44, P33, DOI 10.3109/08916931003782155; Lupino E, 2012, J IMMUNOL, V188, P2545, DOI 10.4049/jimmunol.1102938; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Marsland BJ, 2007, J IMMUNOL, V178, P3466, DOI 10.4049/jimmunol.178.6.3466; Milkova L, 2009, EXP DERMATOL, V21, P21; Neish AS, 2007, AM J PHYSIOL-GASTR L, V292, pG462, DOI 10.1152/ajpgi.00274.2006; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Oberg HH, 2010, J IMMUNOL, V184, P4733, DOI 10.4049/jimmunol.0804279; Redmond WL, 2009, CRIT REV IMMUNOL, V29, P187, DOI 10.1615/CritRevImmunol.v29.i3.10; Salamone GV, 2010, LAB INVEST, V90, P1049, DOI 10.1038/labinvest.2010.77; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Schmidt A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002179; Schmidt-Weber CB, 1999, J IMMUNOL, V162, P238; Simone Rita, 2009, Open Microbiol J, V3, P1, DOI 10.2174/1874285800903010001; Soligo M, 2011, EUR J IMMUNOL, V41, P503, DOI 10.1002/eji.201040712; Song EJ, 2011, INT J MOL MED, V28, P115, DOI 10.3892/ijmm.2011.656; Steiner TS, 2010, CELL IMMUNOL, V264, P135, DOI 10.1016/j.cellimm.2010.05.012; Sun J, 2007, AM J PHYSIOL-GASTR L, V292, pG767, DOI 10.1152/ajpgi.00447.2006; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Szymczak-Workman AL, 2009, J IMMUNOL, V182, P5188, DOI 10.4049/jimmunol.0803123; Tu WW, 2008, BLOOD, V112, P2554, DOI 10.1182/blood-2008-04-152041; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; von Boehmer H, 2008, NAT IMMUNOL, V9, P121, DOI 10.1038/ni0208-121; Wakamatsu E, 2013, P NATL ACAD SCI USA, V110, P1023, DOI 10.1073/pnas.1220688110; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Zheng J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004943; Zheng JA, 2011, EUR J IMMUNOL, V41, P128, DOI 10.1002/eji.201040724; Zheng J, 2010, CELL MOL IMMUNOL, V7, P44, DOI 10.1038/cmi.2009.103	50	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67969	10.1371/journal.pone.0067969	http://dx.doi.org/10.1371/journal.pone.0067969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844139	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000121
J	Enciso-Rodriguez, FE; Gonzalez, C; Rodriguez, EA; Lopez, CE; Landsman, D; Barrero, LS; Marino-Ramirez, L				Enciso-Rodriguez, Felix E.; Gonzalez, Carolina; Rodriguez, Edwin A.; Lopez, Camilo E.; Landsman, David; Stella Barrero, Luz; Marino-Ramirez, Leonardo			Identification of Immunity Related Genes to Study the Physalis peruviana - Fusarium oxysporum Pathosystem	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; DISEASE RESISTANCE GENES; LEUCINE-RICH REPEATS; NBS-LRR PROTEINS; ANTIINFLAMMATORY ACTIVITY; ATP-BINDING; IN-VITRO; SEQUENCES; KINASE; PERCEPTION	The Cape gooseberry (Physalis peruviana L) is an Andean exotic fruit with high nutritional value and appealing medicinal properties. However, its cultivation faces important phytosanitary problems mainly due to pathogens like Fusarium oxysporum, Cercospora physalidis and Alternaria spp. Here we used the Cape gooseberry foliar transcriptome to search for proteins that encode conserved domains related to plant immunity including: NBS (Nucleotide Binding Site), CC (Coiled-Coil), TIR (Toll/Interleukin-1 Receptor). We identified 74 immunity related gene candidates in P. peruviana which have the typical resistance gene (R-gene) architecture, 17 Receptor like kinase (RLKs) candidates related to PAMP-Triggered Immunity (PTI), eight (TIR-NBS-LRR, or TNL) and nine (CC-NBS-LRR, or CNL) candidates related to Effector-Triggered Immunity (ETI) genes among others. These candidate genes were categorized by molecular function (98%), biological process (85%) and cellular component (79%) using gene ontology. Some of the most interesting predicted roles were those associated with binding and transferase activity. We designed 94 primers pairs from the 74 immunity-related genes (IRGs) to amplify the corresponding genomic regions on six genotypes that included resistant and susceptible materials. From these, we selected 17 single band amplicons and sequenced them in 14 F. oxysporum resistant and susceptible genotypes. Sequence polymorphisms were analyzed through preliminary candidate gene association, which allowed the detection of one SNP at the PpIRG-63 marker revealing a nonsynonymous mutation in the predicted LRR domain suggesting functional roles for resistance.	[Enciso-Rodriguez, Felix E.; Stella Barrero, Luz; Marino-Ramirez, Leonardo] Colombian Corp Agr Res CORPOICA, CBB, Plant Mol Genet Lab, Bogota, Colombia; [Gonzalez, Carolina; Rodriguez, Edwin A.] Colombian Corp Agr Res CORPOICA, CBB, Mol Microbiol Lab, Bogota, Colombia; [Lopez, Camilo E.] Univ Nacl Colombia, Lab Fitopatol Mol, Dept Biol, Bogota, Colombia; [Landsman, David; Marino-Ramirez, Leonardo] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Stella Barrero, Luz; Marino-Ramirez, Leonardo] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Universidad Nacional de Colombia; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Marino-Ramirez, L (corresponding author), Colombian Corp Agr Res CORPOICA, CBB, Plant Mol Genet Lab, Bogota, Colombia.	marino@ncbi.nlm.nih.gov	Landsman, David/C-5923-2009; Mariño-Ramírez, Leonardo/N-5395-2019; Landsman, David/GZK-5496-2022; Mariño-Ramírez, Leonardo/I-5759-2013	Landsman, David/0000-0002-9819-6675; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Enciso-Rodriguez, Felix/0000-0002-3490-6586	Colombian Ministry of Agriculture [054/08072-2008L4787-3281, 054/08190-2008L7922-3322]; Intramural Research Program of the National Institutes of Health; National Library of Medicine; National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE [ZIALM082713, ZIALM000071] Funding Source: NIH RePORTER	Colombian Ministry of Agriculture; Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Support for this research was provided by a grant from the Colombian Ministry of Agriculture Contract Nos. 054/08072-2008L4787-3281 to Luz Stella Barrero and 054/08190-2008L7922-3322 to Victor Manuel Nunez Zarantes. This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine, and National Center for Biotechnology Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakker E, 2011, THEOR APPL GENET, V123, P493, DOI 10.1007/s00122-011-1602-z; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bedoya-Reina OC, 2010, GENE, V458, P27, DOI 10.1016/j.gene.2010.03.005; Bernal A, 2013, BIOPROSPECCION DESAR; Bonilla M, 2009, AGENDA PROSPECTIVA I; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; CIAT, 1987, SIST EST EV GERM FRI; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Couch BC, 2006, MOL PLANT MICROBE IN, V19, P288, DOI 10.1094/MPMI-19-0288; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Eddy Sean R, 2009, Genome Inform, V23, P205; El-Bramawy MASA, 2009, TUNISIAN J PLANT PRO, V4, P29; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Estupinan R, 2007, EFECTO AGENTE CAUSAL, P89; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fenyk S, 2012, J BIOL CHEM, V287, P4023, DOI 10.1074/jbc.M111.314450; Franco LA, 2007, BIOMEDICA, V27, P110, DOI 10.7705/biomedica.v27i1.237; Garzon-Martinez GA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-151; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Gu Lianfeng, 2007, Journal of Genetics and Genomics, V34, P247, DOI 10.1016/S1673-8527(07)60026-5; Jauhar PP, 2006, CROP SCI, V46, P1841, DOI 10.2135/cropsci2005.07-0223; Jiang HY, 2007, PLANT SCI, V173, P253, DOI 10.1016/j.plantsci.2007.05.010; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Jones DA, 1997, ADV BOT RES, V24, P89; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li YQ, 2007, MOL PLANT MICROBE IN, V20, P1449, DOI 10.1094/MPMI-20-11-1449; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martínez Fabio Ernesto, 2008, Agron. colomb., V26, P389; Martinez W, 2010, IMMUNOPHARM IMMUNOT, V32, P63, DOI 10.1080/08923970903143957; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; MENZEL M. Y., 1951, Proceedings of the American Philosophical Society, V95, P132; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mueller LA, 2005, PLANT PHYSIOL, V138, P1310, DOI 10.1104/pp.105.060707; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; NAMIKI F, 1994, APPL ENVIRON MICROB, V60, P2684, DOI 10.1128/AEM.60.8.2684-2691.1994; Offord V, 2010, DEV COMP IMMUNOL, V34, P1035, DOI 10.1016/j.dci.2010.05.004; Pinto MD, 2009, J MED FOOD, V12, P278, DOI 10.1089/jmf.2008.0113; Plocik A, 2004, MOL PHYLOGENET EVOL, V31, P153, DOI 10.1016/S1055-7903(03)00274-4; Popenoe H, 1990, LOST CROPS INCAS LIT, P241; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; Pritchard JK, 2000, GENETICS, V155, P945; Radwan O, 2008, MOL GENET GENOMICS, V280, P111, DOI 10.1007/s00438-008-0346-1; Rafiqi M, 2009, SEMIN CELL DEV BIOL, V20, P1017, DOI 10.1016/j.semcdb.2009.04.010; Ramadan MF, 2011, FOOD RES INT, V44, P1830, DOI 10.1016/j.foodres.2010.12.042; Rodrigues E, 2009, CIENCIA TECNOL ALIME, V29, P642, DOI 10.1590/S0101-20612009000300029; Rozen S, 2000, Methods Mol Biol, V132, P365; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider D, 2010, IEEE SPECTRUM, V47, P48, DOI 10.1109/MSPEC.2010.5372501; Shen KA, 1998, MOL PLANT MICROBE IN, V11, P815, DOI 10.1094/MPMI.1998.11.8.815; Simbaqueba J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026719; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Soriano JM, 2005, THEOR APPL GENET, V110, P980, DOI 10.1007/s00122-005-1920-0; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang Y, 2008, GENETICS, V180, P391, DOI 10.1534/genetics.108.087981; Wu SJ, 2009, FOOD CHEM TOXICOL, V47, P1132, DOI 10.1016/j.fct.2009.01.044; Wu SJ, 2005, BIOL PHARM BULL, V28, P963, DOI 10.1248/bpb.28.963; Yaish MWF, 2004, GENOME, V47, P650, DOI 10.1139/G04-027; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	79	36	44	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68500	10.1371/journal.pone.0068500	http://dx.doi.org/10.1371/journal.pone.0068500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844210	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000011
J	Markhus, MW; Skotheim, S; Graff, IE; Froyland, L; Braarud, HC; Stormark, KM; Malde, MK				Markhus, Maria Wik; Skotheim, Siv; Graff, Ingvild Eide; Froyland, Livar; Braarud, Hanne Cecilie; Stormark, Kjell Morten; Malde, Marian Kjellevold			Low Omega-3 Index in Pregnancy Is a Possible Biological Risk Factor for Postpartum Depression	PLOS ONE			English	Article							ESSENTIAL FATTY-ACIDS; EDINBURGH POSTNATAL DEPRESSION; FISH CONSUMPTION; MATERNAL DEPRESSION; DOUBLE-BLIND; PERINATAL DEPRESSION; SYMPTOMS; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; PREVALENCE	Background: Depression is a common disorder affecting 10-15% women in the postpartum period. Postpartum depression can disrupt early mother-infant interaction, and constitutes a risk factor for early child development. Recently, attention has been drawn to the hypothesis that a low intake of seafood in pregnancy can be a risk factor for postpartum depression. Seafood is a unique dietary source of the marine omega-3 fatty acids and is a natural part of a healthy balanced diet that is especially important during pregnancy. Methods: In a community based prospective cohort in a municipality in Western Norway, we investigated both nutritional and psychological risk factors for postpartum depression. The source population was all women who were pregnant within the period November 2009 - June 2011. The fatty acid status in red blood cells was assessed in the 28th gestation week and participants were screened for postpartum depression using the Edinburgh Postnatal Depression Scale (EPDS) three months after delivery. The aim of the present study was to investigate if a low omega-3 index in pregnancy is a possible risk factor for postpartum depression. Results: In a simple regression model, the omega-3 index was associated with the EPDS score in a nonlinear inverse manner with an R square of 19. Thus, the low omega-3 index explained 19% of the variance in the EPDS score. The DPA content, DHA content, omega-3 index, omega-3/omega-6 ratio, total HUFA score, and the omega-3 HUFA score were all inversely correlated with the EPDS score. The EPDS scores of participants in the lowest omega-3 index quartile were significantly different to the three other omega-3 index quartiles. Conclusion: In this study population, a low omega-3 index in late pregnancy was associated with higher depression score three months postpartum.	[Markhus, Maria Wik; Graff, Ingvild Eide; Froyland, Livar; Malde, Marian Kjellevold] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Skotheim, Siv; Braarud, Hanne Cecilie; Stormark, Kjell Morten] Uni Res, Reg Ctr Child & Youth Mental Hlth & Child Welf, Uni Hlth, Bergen, Norway; [Markhus, Maria Wik; Froyland, Livar] Univ Bergen, Fac Med & Dent, Dept Biomed, Bergen, Norway; [Stormark, Kjell Morten] Univ Bergen, Dept Clin Psychol, Fac Psychol, Bergen, Norway	University of Bergen; University of Bergen	Markhus, MW (corresponding author), Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway.	maria.wik.markhus@nifes.no	Kjellevold, Marian/Q-6334-2019; Markhus, Maria Wik/AAL-9055-2021; Kjellevold, Marian/C-2973-2012	Kjellevold, Marian/0000-0001-7070-5784; Markhus, Maria Wik/0000-0002-0196-5387; Kjellevold, Marian/0000-0001-7070-5784				AL MDM, 1995, BRIT J NUTR, V74, P55, DOI 10.1079/BJN19950106; Araujo P, 2008, J CHROMATOGR A, V1212, P106, DOI 10.1016/j.chroma.2008.10.006; Assies J, 2004, PROSTAG LEUKOTR ESS, V70, P349, DOI 10.1016/j.plefa.2003.12.009; Assies J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010635; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Becker W, 2007, FISKKONSUMTION RISK; Berle JO, 2003, J AFFECT DISORDERS, V76, P151, DOI 10.1016/S0165-0327(02)00082-4; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Blum JS, 1999, J PERS, V67, P93, DOI 10.1111/1467-6494.00049; CODDINGTON RD, 1972, J PSYCHOSOM RES, V16, P205, DOI 10.1016/0022-3999(72)90045-1; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; COX JL, 1993, BRIT J PSYCHIAT, V163, P27, DOI 10.1192/bjp.163.1.27; da Rocha CMM, 2012, MATERN CHILD NUTR, V8, P36, DOI 10.1111/j.1740-8709.2010.00256.x; Dahl Lisbeth, 2006, Tidsskr Nor Laegeforen, V126, P309; Dahl L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-127; de Groot RHM, 2012, PROSTAG LEUKOTR ESS, V86, P113, DOI 10.1016/j.plefa.2012.01.002; De Vriese SR, 2003, LIFE SCI, V73, P3181, DOI 10.1016/j.lfs.2003.02.001; Eberhard-Gran M, 2003, SOC PSYCH PSYCH EPID, V38, P551, DOI 10.1007/s00127-003-0679-3; *EFSA, 2005, EFSA J, V236, P1, DOI DOI 10.2903/J.EFSA.2005.236; EFSA, 2009, EFSA J, V1176, P11; FAO, 1997, REV STAT WORLD AQ; FAO/WHO, 2011, REP JOINT EXP CONS R; Fodevaredirektoratet, 2003, HELH FISK FISK; Freeman MP, 2008, J AFFECT DISORDERS, V110, P142, DOI 10.1016/j.jad.2007.12.228; Freeman MP, 2006, ACTA PSYCHIAT SCAND, V113, P31, DOI 10.1111/j.1600-0447.2005.00660.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Golding J, 2009, EPIDEMIOLOGY, V20, P598, DOI 10.1097/EDE.0b013e31819d6a57; Harris William S, 2010, Curr Cardiol Rep, V12, P503, DOI 10.1007/s11886-010-0141-6; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Helsedirektoratet, 2011, UTV NORSK KOSTH; HIBBELN JR, 1995, AM J CLIN NUTR, V62, P1; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hibbeln JR, 2002, J AFFECT DISORDERS, V69, P15, DOI 10.1016/S0165-0327(01)00374-3; HORNSTRA G, 1995, EUR J OBSTET GYN R B, V61, P57, DOI 10.1016/0028-2243(95)02153-J; Jacka FN, 2013, BRIT J NUTR, V109, P2059, DOI 10.1017/S0007114512004102; Judge MP, 2011, FASEB J, V25; Kang JX, 1996, CIRCULATION, V94, P1774, DOI 10.1161/01.CIR.94.7.1774; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Koletzko B, 2008, NESTLE NUTR WORKS SE, V62, P35, DOI 10.1159/000146246; Koletzko B, 2007, BRIT J NUTR, V98, P873, DOI 10.1017/S0007114507764747; LANDS WEM, 1995, AM J CLIN NUTR, V61, p721S, DOI 10.1093/ajcn/61.3.721S; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Makrides M, 2003, ASIA PAC J CLIN NU S, V12, pS37; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Malde M, 2012, INT J NURSING MIDWIF, V4, P4; Markhus M, 2013, FOOD NUTR R IN PRESS; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Mathiesen KS, 1999, SOC PSYCH PSYCH EPID, V34, P61, DOI 10.1007/s001270050113; McNamara RK, 2009, PROSTAG LEUKOTR ESS, V81, P223, DOI 10.1016/j.plefa.2009.05.017; Miles EA, 2011, AM J CLIN NUTR, V94, p1986S, DOI 10.3945/ajcn.110.001636; Miller LJ, 2011, PSYCHIAT CLIN N AM, V34, P53, DOI 10.1016/j.psc.2010.11.010; Milte CM, 2009, NUTR REV, V67, P573, DOI 10.1111/j.1753-4887.2009.00229.x; Montgomery C, 2003, BRIT J NUTR, V90, P135, DOI 10.1079/BJN2003888; Moser DK, 2000, NURS RES, V49, P109, DOI 10.1097/00006199-200003000-00008; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nesheim MC., 2007, SEAFOOD CHOICES BALA, DOI 10.17226/11762; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Oken E, 2005, ENVIRON HEALTH PERSP, V113, P1376, DOI 10.1289/ehp.8041; Otto SJ, 2003, PROSTAG LEUKOTR ESS, V69, P237, DOI 10.1016/S0952-3278(03)00090-5; Peet M, 1998, BIOL PSYCHIAT, V43, P315, DOI 10.1016/S0006-3223(97)00206-0; Popa T A, 2012, J Med Life, V5, P414; Pottala JV, 2012, PROSTAG LEUKOTR ESS, V86, P161, DOI 10.1016/j.plefa.2012.03.002; Raeder MB, 2007, J AFFECT DISORDERS, V101, P245, DOI 10.1016/j.jad.2006.11.006; Redshaw M., 2007, RECORDED DELIVERY NA; Rees AM, 2008, AUST NZ J PSYCHIAT, V42, P199, DOI 10.1080/00048670701827267; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Russell FD, 2012, MAR DRUGS, V10, P2535, DOI 10.3390/md10112535; SACN, 2004, ADV FISH CONS BEN RI; Savitz DA, 1999, PAEDIATR PERINAT EP, V13, P114; Schotte CKW, 2006, DEPRESS ANXIETY, V23, P312, DOI 10.1002/da.20177; Shapiro GD, 2012, CAN J PSYCHIAT, V57, P704, DOI 10.1177/070674371205701108; Shelton RC, 2010, CNS DRUGS, V24, P131, DOI 10.2165/11530280-000000000-00000; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos Artemis P., 2009, V99, P1, DOI 10.1159/000192755; Skotheim S, 2013, INFANT BEHAV DEV, V36, P419, DOI 10.1016/j.infbeh.2013.03.009; Sontrop J, 2008, PAEDIATR PERINAT EP, V22, P389, DOI 10.1111/j.1365-3016.2008.00941.x; Stark KD, 2008, LIPIDS, V43, P45, DOI 10.1007/s11745-007-3128-3; Strom M, 2012, HYPERTENSION, V59, P36, DOI 10.1161/HYPERTENSIONAHA.111.179382; Strom M, 2009, AM J CLIN NUTR, V90, P149, DOI 10.3945/ajcn.2009.27552; Su KP, 2008, J CLIN PSYCHIAT, V69, P644, DOI 10.4088/JCP.v69n0418; Sublette ME, 2011, J CLIN PSYCHIAT, V72, P1577, DOI 10.4088/JCP.10m06634; TREVARTHEN C., 1979, SPEECH BEGINNINGS HU, P321; *VKM, 2007, COMPR ASS FISH OTH S; WHIFFEN VE, 1992, CLIN PSYCHOL REV, V12, P485, DOI 10.1016/0272-7358(92)90068-J; WHO, 2012, MAT MENT HLTH CHILD; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	91	62	66	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67617	10.1371/journal.pone.0067617	http://dx.doi.org/10.1371/journal.pone.0067617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844041	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000086
J	Mochida, T; Kimura, T; Hiroya, S; Kitagawa, N; Gomi, H; Kondo, T				Mochida, Takemi; Kimura, Toshitaka; Hiroya, Sadao; Kitagawa, Norimichi; Gomi, Hiroaki; Kondo, Tadahisa			Speech Misperception: Speaking and Seeing Interfere Differently with Hearing	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; MIRROR NEURONS; MOTOR CORTEX; PERCEPTION; INTEGRATION; EXCITABILITY; CONSONANTS; RESPONSES; LANGUAGE; OPINION	Speech perception is thought to be linked to speech motor production. This linkage is considered to mediate multimodal aspects of speech perception, such as audio-visual and audio-tactile integration. However, direct coupling between articulatory movement and auditory perception has been little studied. The present study reveals a clear dissociation between the effects of a listener's own speech action and the effects of viewing another's speech movements on the perception of auditory phonemes. We assessed the intelligibility of the syllables [pa], [ta], and [ka] when listeners silently and simultaneously articulated syllables that were congruent/incongruent with the syllables they heard. The intelligibility was compared with a condition where the listeners simultaneously watched another's mouth producing congruent/incongruent syllables, but did not articulate. The intelligibility of [ta] and [ka] were degraded by articulating [ka] and [ta] respectively, which are associated with the same primary articulator (tongue) as the heard syllables. But they were not affected by articulating [pa], which is associated with a different primary articulator (lips) from the heard syllables. In contrast, the intelligibility of [ta] and [ka] was degraded by watching the production of [pa]. These results indicate that the articulatory-induced distortion of speech perception occurs in an articulator-specific manner while visually induced distortion does not. The articulator-specific nature of the auditory-motor interaction in speech perception suggests that speech motor processing directly contributes to our ability to hear speech.	[Mochida, Takemi; Kimura, Toshitaka; Hiroya, Sadao; Kitagawa, Norimichi; Gomi, Hiroaki; Kondo, Tadahisa] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Mochida, T (corresponding author), NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	mochida.takemi@lab.ntt.co.jp	Gomi, Hiroaki/AEL-2645-2022	Gomi, Hiroaki/0000-0003-3541-2251	Nippon Telegraph; Telephone Corporation	Nippon Telegraph; Telephone Corporation	This work was supported by Nippon Telegraph and Telephone Corporation (http://www.ntt.co.jp/index_e.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS PL, 1983, J ACOUST SOC AM, V74, P34, DOI 10.1121/1.389685; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; Devlin JT, 2007, BRAIN, V130, P610, DOI 10.1093/brain/awl331; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; FOWLER CA, 1991, J EXP PSYCHOL HUMAN, V17, P816, DOI 10.1037/0096-1523.17.3.816; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Gault RH, 1924, J ABNORMAL PSYCHOL S, V19, DOI DOI 10.1037/H0065752; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Hickok G, 2008, BRAIN LANG, V107, P179, DOI 10.1016/j.bandl.2008.09.006; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; Kaiser J, 2005, CEREB CORTEX, V15, P646, DOI 10.1093/cercor/bhh166; Kauramaki J, 2010, J NEUROSCI, V30, P1314, DOI 10.1523/JNEUROSCI.1950-09.2010; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Lotto AJ, 2009, TRENDS COGN SCI, V13, P110, DOI 10.1016/j.tics.2008.11.008; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Mottonen R, 2002, COGNITIVE BRAIN RES, V13, P417, DOI 10.1016/S0926-6410(02)00053-8; Mottonen R, 2009, J NEUROSCI, V29, P9819, DOI 10.1523/JNEUROSCI.6018-08.2009; Munhall KG, 2009, CURR BIOL, V19, P735, DOI 10.1016/j.cub.2009.03.019; Okada K, 2009, NEUROSCI LETT, V452, P219, DOI 10.1016/j.neulet.2009.01.060; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Sams M, 2005, COGNITIVE BRAIN RES, V23, P429, DOI 10.1016/j.cogbrainres.2004.11.006; Sato M, 2010, SPEECH COMMUN, V52, P533, DOI 10.1016/j.specom.2009.12.004; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; SEKIYAMA K, 1991, J ACOUST SOC AM, V90, P1797, DOI 10.1121/1.401660; Stevens K.N., 2000, ACOUSTIC PHONETICS, V30; Watkins K, 2004, J COGNITIVE NEUROSCI, V16, P978, DOI 10.1162/0898929041502616; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; WELLER M, 1993, J NEUROL, V240, P199, DOI 10.1007/BF00818705; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wilson SM, 2006, NEUROIMAGE, V33, P316, DOI 10.1016/j.neuroimage.2006.05.032; Zheng ZZ, 2010, J COGNITIVE NEUROSCI, V22, P1770, DOI 10.1162/jocn.2009.21324	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68619	10.1371/journal.pone.0068619	http://dx.doi.org/10.1371/journal.pone.0068619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844227	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000018
J	Zorick, T; Mandelkern, MA				Zorick, Todd; Mandelkern, Mark A.			Multifractal Detrended Fluctuation Analysis of Human EEG: Preliminary Investigation and Comparison with the Wavelet Transform Modulus Maxima Technique	PLOS ONE			English	Article							NEURONAL AVALANCHES; HUMAN BRAIN; FUNCTIONAL-STATE; SLEEP-APNEA; SIGNALS; OSCILLATIONS; DYNAMICS; CORTEX; SERIES	Recently, many lines of investigation in neuroscience and statistical physics have converged to raise the hypothesis that the underlying pattern of neuronal activation which results in electroencephalography (EEG) signals is nonlinear, with self-affine dynamics, while scalp-recorded EEG signals themselves are nonstationary. Therefore, traditional methods of EEG analysis may miss many properties inherent in such signals. Similarly, fractal analysis of EEG signals has shown scaling behaviors that may not be consistent with pure monofractal processes. In this study, we hypothesized that scalp-recorded human EEG signals may be better modeled as an underlying multifractal process. We utilized the Physionet online database, a publicly available database of human EEG signals as a standardized reference database for this study. Herein, we report the use of multifractal detrended fluctuation analysis on human EEG signals derived from waking and different sleep stages, and show evidence that supports the use of multifractal methods. Next, we compare multifractal detrended fluctuation analysis to a previously published multifractal technique, wavelet transform modulus maxima, using EEG signals from waking and sleep, and demonstrate that multifractal detrended fluctuation analysis has lower indices of variability. Finally, we report a preliminary investigation into the use of multifractal detrended fluctuation analysis as a pattern classification technique on human EEG signals from waking and different sleep stages, and demonstrate its potential utility for automatic classification of different states of consciousness. Therefore, multifractal detrended fluctuation analysis may be a useful pattern classification technique to distinguish among different states of brain function.	[Zorick, Todd] Greater Los Angeles Vet Adm Healthcare Syst, Dept Psychiat, Los Angeles, CA USA; [Mandelkern, Mark A.] Greater Los Angeles Vet Adm Healthcare Syst, Dept Imaging, Los Angeles, CA USA; [Zorick, Todd] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Mandelkern, Mark A.] Univ Calif Irvine, Dept Phys, Irvine, CA 92717 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Irvine	Zorick, T (corresponding author), Greater Los Angeles Vet Adm Healthcare Syst, Dept Psychiat, Los Angeles, CA USA.	tzorick@mednet.ucla.edu						Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Arneodo A, 1998, J MATH PHYS, V39, P4142, DOI 10.1063/1.532489; Arneodo A., 2008, SCHOLARPEDIA, V3, P4103, DOI DOI 10.4249/SCHOLARPEDIA.4103; Coeurjolly J.-F., 2001, J STAT SOFTW, V5, P1, DOI 10.18637/jss.v005.i07; Dick O. E., 2012, Human Physiology, V38, P249, DOI 10.1134/S036211971202003X; Dick OE, 2012, NEUROCOMPUTING, V82, P207, DOI 10.1016/j.neucom.2011.11.013; Feder J, 1988, FRACTALS; Fisher A.J., 1997, MULTIFRACTALITY DEUT; Galaska R, 2007, J ELECTROCARDIOL S1, V40, pS41; Gao JB, 2011, COGN NEURODYNAMICS, V5, P171, DOI 10.1007/s11571-011-9151-3; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Grech D, 2012, ACTA PHYS POL A, V121, pB34; Ichimaru Y, 1999, PSYCHIAT CLIN NEUROS, V53, P175, DOI 10.1046/j.1440-1819.1999.00527.x; Kantelhardt J.W., 2009, ENCY COMPLEXITY SYST, P3754; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kantelhardt JW, 2003, PHYSICA A, V330, P240, DOI 10.1016/j.physa.2003.08.019; Kaplan AY, 2005, SIGNAL PROCESS, V85, P2190, DOI 10.1016/j.sigpro.2005.07.010; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Lee JM, 2002, COMPUT BIOL MED, V32, P37, DOI 10.1016/S0010-4825(01)00031-2; Lee JS, 2007, CLIN NEUROPHYSIOL, V118, P2489, DOI 10.1016/j.clinph.2007.08.001; Lee JS, 2007, INT J CLIN EXP HYP, V55, P14, DOI 10.1080/00207140600995810; Makowiec D, 2009, PHYSICA A, V388, P3486, DOI 10.1016/j.physa.2009.05.005; MANDELBROT B, 1974, CR ACAD SCI A MATH, V278, P355; Mandelbrot B.B., 1997, WORKING PAPER; MANDELBROT BB, 1989, PURE APPL GEOPHYS, V131, P5, DOI 10.1007/BF00874478; MUZY JF, 1993, PHYS REV E, V47, P875, DOI 10.1103/PhysRevE.47.875; Nunez P, 2010, BRAIN MIND STRUCTURE; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Oswiecimka P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016103; Pan CP, 2004, PHYS LETT A, V329, P130, DOI 10.1016/j.physleta.2004.06.070; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Qianli M, 2005, SLEEP STAGE CHARACTE, P4526; Rowan AaT E, 2003, PRIMER EEG MINIATLAS; Schroeder M, 2009, FRACTALS CHAOS POWER; Schulz H, 2008, J CLIN SLEEP MED, V4, P99; Schwilden H, 2006, BEST PRACT RES-CLIN, V20, P31, DOI 10.1016/j.bpa.2005.09.001; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Solovey G, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00044; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; STANLEY HE, 1988, NATURE, V335, P405, DOI 10.1038/335405a0; Team RC, 2012, R LANG ENV STAT COMP; Varotsos PA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031106; Weisstein EW, 2013, SAMPLE VARIANCE DIST	50	62	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68360	10.1371/journal.pone.0068360	http://dx.doi.org/10.1371/journal.pone.0068360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844189	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000141
J	Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Rief, P; Hackl, G; Pilger, E; Brodmann, M				Gary, Thomas; Pichler, Martin; Belaj, Klara; Hafner, Franz; Gerger, Armin; Froehlich, Harald; Eller, Philipp; Rief, Peter; Hackl, Gerald; Pilger, Ernst; Brodmann, Marianne			Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients	PLOS ONE			English	Article							INFLAMMATION; NEUTROPHIL	Background: Platelet-to-Lymphocyte Ratio (PLR) is an easily applicable blood test. An elevated PLR has been associated with poor prognosis in patients with different oncologic disorder. As platelets play a key role in atherosclerosis and atherothrombosis, we investigated PLR and its association with critical limb ischemia (CLI) and other vascular endpoints in peripheral arterial occlusive disease (PAOD) patients. Methods and Findings: We evaluated 2121 PAOD patients treated at our institution from 2005 to 2010. PLR was calculated and the cohort was categorized into tertiles according to the PLR. An optimal cut-off value for the continuous PLR was calculated by applying a receiver operating curve analysis to discriminate between CLI and non-CLI. In our cohort occurrence of CLI significantly increased with an increase in PLR. As an optimal cut-off value, a PLR of 150 was identified. Two groups were categorized, one containing 1228 patients (PLR <= 150) and a second group with 893 patients (PLR>150). CLI was more frequent in PLR>150 patients (410(45.9%)) compared to PLR <= 150 patients (270(22.0%)) (p<0.001), as was prior myocardial infarction (51(5.7%) vs. 42(3.5%), p=0.02). Regarding inflammatory parameters, C-reactive protein (median 7.0 mg/l (3.0-24.25) vs. median 5.0 mg/l (2.0-10.0)) and fibrinogen (median 457 mg/dl (359.0-583.0) vs. 372 mg/dl (317.25-455.75)) also significantly differed in the two patient groups (both p<0.001). Finally, a PLR>150 was associated with an OR of 1.9 (95% CI 1.7-2.1) for CLI even after adjustment for other well-established vascular risk factors. Conclusions: An increased PLR is significantly associated with patients at high risk for CLI and other cardiovascular endpoints. The PLR is a broadly available and cheap marker, which could be used to highlight patients at high risk for vascular endpoints.	[Gary, Thomas; Belaj, Klara; Hafner, Franz; Froehlich, Harald; Eller, Philipp; Rief, Peter; Hackl, Gerald; Pilger, Ernst; Brodmann, Marianne] Med Univ Graz, Dept Internal Med, Div Vasc Med, Graz, Austria; [Pichler, Martin; Gerger, Armin] Med Univ Graz, Dept Internal Med, Div Oncol, Graz, Austria	Medical University of Graz; Medical University of Graz	Gary, T (corresponding author), Med Univ Graz, Dept Internal Med, Div Vasc Med, Graz, Austria.	thomas.gary@medunigraz.at		Pichler, Martin/0000-0002-8701-9462; Froehlich, Harald/0000-0003-4415-9809				Aerden D, 2011, ANN VASC SURG, V25, P770, DOI 10.1016/j.avsg.2010.12.025; Bertele V, 1999, EUR J VASC ENDOVASC, V18, P401, DOI 10.1053/ejvs.1999.0934; Bertomeu V, 2008, EUR J VASC ENDOVASC, V36, P189, DOI 10.1016/j.ejvs.2008.02.004; Gary T, 2012, ATHEROSCLEROSIS, V225, P517, DOI 10.1016/j.atherosclerosis.2012.10.025; Gary T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056745; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; HIRSCH AT, 2006, CIRCULATION, V113, pE463, DOI [DOI 10.1161/CIRCULATI0NAHA.106.174526, 10.1161/CIRCULATIONAHA.106.174526]; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Iso Y, 2010, ATHEROSCLEROSIS, V209, P167, DOI 10.1016/j.atherosclerosis.2009.08.028; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.656705; Lindemann S, 2007, J THROMB HAEMOST, V5, P203, DOI 10.1111/j.1538-7836.2007.02517.x; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Novo S., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P219, DOI 10.2174/1568006043335989; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Suades R, 2012, THROMB HAEMOSTASIS, V108, P1208, DOI 10.1160/TH12-07-0486; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Tasoglu I, 2013, CLIN APPL THROMB HEM	18	169	175	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67688	10.1371/journal.pone.0067688	http://dx.doi.org/10.1371/journal.pone.0067688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844064	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000078
J	Huang, HC; Chang, TM; Chang, YJ; Wen, HY				Huang, Huey-Chun; Chang, Tsong-Min; Chang, Yu-Jia; Wen, Hsin-Yun			UVB Irradiation Regulates ERK1/2-and p53-Dependent Thrombomodulin Expression in Human Keratinocytes	PLOS ONE			English	Article							FACTOR-KAPPA-B; INDUCED SKIN CARCINOGENESIS; KRUPPEL-LIKE FACTOR-2; TUMOR-NECROSIS-FACTOR; ULTRAVIOLET-RADIATION; DOWN-REGULATION; TRANSCRIPTIONAL REPRESSION; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; P53	Thrombomodulin (TM) is highly expressed in endothelial cells and acts as a natural anticoagulation factor to maintain circulation homeostasis. TM is an interesting molecule with many physiological functions, including anti-inflammation, anti-thrombosis, and carcinogenesis inhibition. TM can also be detected on the spinous layer of epidermal keratinocytes. However, the role of epidermal TM is still under investigation. In this study, we investigated keratinocyte TM expression and regulation in response to sub-cytotoxic ultraviolet B (UVB) irradiation. Oxidative stress was assessed with DCF and the results revealed that UVB irradiation significantly and dose-dependently augmented reactive oxygen species (ROS) production in HaCaT cells. In addition, low-dose UVB irradiation decreased TM mRNA and protein levels. Blocking ROS production and ERK activation prevented UVB-induced TM down-regulation. The nuclear p53 accumulation and TM promoter binding was observed within 3 h after UVB exposure. Small interfering RNA-mediated p53 knockdown disrupted the UVB-mediated TM protein down-regulation. Our study demonstrates that UVB irradiation results in ROS accumulation and ERK activation, which causes the nuclear p53 accumulation and TM promoter binding to inhibit TM expression. This study provides novel evidence demonstrating that p53 serves as a key regulator of keratinocyte TM expression.	[Huang, Huey-Chun; Wen, Hsin-Yun] China Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Care, Taichung, Taiwan; [Chang, Tsong-Min] Hung Kuang Univ, Dept Appl Cosmetol, Taichung, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Dept Surg, Taipei, Taiwan	China Medical University Taiwan; Hungkuang University; Taipei Medical University	Huang, HC (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Care, Taichung, Taiwan.	lchuang@mail.cmu.edu.tw	Huang, Huey-Chun/O-3852-2015	Huang, Huey-Chun/0000-0002-3300-5946; Chang, Yu-Jia/0000-0003-3978-3244	China Medical University [CMU95-320, CMU96-229]; National Science Council [NSC 95-2320-B-039-020, NSC101-2320-B-039-037]	China Medical University(China Medical University); National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported in part by grants from China Medical University CMU95-320, CMU96-229, and grants of National Science Council (NSC 95-2320-B-039-020 and NSC101-2320-B-039-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Ahmed KM, 2009, FREE RADICAL BIO MED, V46, P1543, DOI 10.1016/j.freeradbiomed.2009.03.012; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; Berneburg M, 2000, PHOTODERMATOL PHOTO, V16, P239, DOI 10.1034/j.1600-0781.2000.160601.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brash DE, 2006, BRIT J DERMATOL, V154, P8, DOI 10.1111/j.1365-2133.2006.07230.x; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Cao C, 2008, J CELL PHYSIOL, V215, P506, DOI 10.1002/jcp.21336; Chang H, 2003, FREE RADICAL RES, V37, P655, DOI 10.1080/1071576031000094907; Chang H, 2002, BIOL CHEM, V383, P703, DOI 10.1515/BC.2002.072; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Furuta J, 2005, MELANOMA RES, V15, P15, DOI 10.1097/00008390-200502000-00004; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; ISHII H, 1992, BLOOD, V80, P2556; Iwata M, 2008, BIOCHEM BIOPH RES CO, V377, P642, DOI 10.1016/j.bbrc.2008.10.049; Jackson DE, 1996, PATHOLOGY, V28, P225, DOI 10.1080/00313029600169024; Kang ES, 2011, FREE RADICAL BIO MED, V50, P680, DOI 10.1016/j.freeradbiomed.2010.12.021; Kao YC, 2010, MOL CELL BIOL, V30, P4767, DOI 10.1128/MCB.01021-09; Koutsi A, 2008, INT J BIOCHEM CELL B, V40, P1669, DOI 10.1016/j.biocel.2007.06.024; Kumar A, 2011, ARTERIOSCL THROM VAS, V31, P133, DOI 10.1161/ATVBAHA.110.215061; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Li YP, 2009, J DERMATOL SCI, V54, P143, DOI 10.1016/j.jdermsci.2009.01.009; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; MlZutani H, 1996, BRIT J DERMATOL, V135, P187; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Peterson JJ, 1999, AM J PATHOL, V155, P1569, DOI 10.1016/S0002-9440(10)65473-9; Peus D, 1999, J INVEST DERMATOL, V112, P751, DOI 10.1046/j.1523-1747.1999.00584.x; Raife TJ, 1998, J INVEST MED, V46, P127; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Rong YY, 2010, FEBS LETT, V584, P852, DOI 10.1016/j.febslet.2010.01.048; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Sohn RH, 2005, BLOOD, V105, P3910, DOI 10.1182/blood-2004-03-0928; Song DM, 2009, BLOOD, V114, P2521, DOI 10.1182/blood-2009-02-205914; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Thomas-Ahner JM, 2007, CANCER RES, V67, P3468, DOI 10.1158/0008-5472.CAN-06-3798; Tomita N, 1998, J HYPERTENS, V16, P993, DOI 10.1097/00004872-199816070-00013; Varani J, 2002, J INVEST DERMATOL, V119, P122, DOI 10.1046/j.1523-1747.2002.01810.x; von Bulow S, 2005, BURNS, V31, P459, DOI 10.1016/j.burns.2004.11.021; Wang L, 2005, ONCOGENE, V24, P3020, DOI 10.1038/sj.onc.1208547; Zbytek B, J STEROID B IN PRESS	51	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67632	10.1371/journal.pone.0067632	http://dx.doi.org/10.1371/journal.pone.0067632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844043	Green Submitted, gold, Green Published			2022-12-25	WOS:000321341000064
J	MacKenzie, MG; Hamilton, DL; Pepin, M; Patton, A; Baar, K				MacKenzie, Matthew G.; Hamilton, David Lee; Pepin, Mark; Patton, Amy; Baar, Keith			Inhibition of Myostatin Signaling through Notch Activation following Acute Resistance Exercise	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; MESSENGER-RNA; KINASE PHOSPHORYLATION; INTRACELLULAR DOMAIN; PROTEIN-METABOLISM; PROMYOGENIC FACTOR; GENE-EXPRESSION; MICE; MASS; REGENERATION	Myostatin is a TGF beta family member and negative regulator of muscle size. Due to the complexity of the molecular pathway between myostatin mRNA/protein and changes in transcription, it has been difficult to understand whether myostatin plays a role in resistance exercise-induced skeletal muscle hypertrophy. To circumvent this problem, we determined the expression of a unique myostatin target gene, Mighty, following resistance exercise. Mighty mRNA increased by 6 h (82.9 +/- 24.21%) and remained high out to 48 h (56.5 +/- 19.67%) after resistance exercise. Further examination of the soleus, plantaris and tibialis anterior muscles showed that the change in Mighty mRNA at 6 h correlated with the increase in muscle size associated with this protocol (R-2 = 0.9996). The increase in Mighty mRNA occurred both independent of Smad2 phosphorylation and in spite of an increase in myostatin mRNA (341.8 +/- 147.14% at 3 h). The myostatin inhibitor SKI remained unchanged. However, activated Notch, another potential inhibitor of TGF beta signaling, increased immediately following resistance exercise (83 +/- 11.2%) and stayed elevated out to 6 h (78 +/- 16.6%). Electroportion of the Notch intracellular domain into the tibialis anterior resulted in an increase in Mighty mRNA (63 +/- 13.4%) that was equivalent to the canonical Notch target HES-1 (94.4 +/- 7.32%). These data suggest that acute resistance exercise decreases myostatin signaling through the activation of the TGF beta inhibitor Notch resulting in a decrease in myostatin transcriptional activity that correlates well with muscle hypertrophy.	[MacKenzie, Matthew G.; Hamilton, David Lee; Baar, Keith] Univ Dundee, Div Mol Physiol, Dundee, Scotland; [Hamilton, David Lee] Univ Stirling, Hlth & Exercise Sci Res Grp, Stirling FK9 4LA, Scotland; [Pepin, Mark; Baar, Keith] Univ Calif Davis, Davis, CA 95616 USA; [Patton, Amy; Baar, Keith] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Baar, Keith] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of Dundee; University of Stirling; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Baar, K (corresponding author), Univ Dundee, Div Mol Physiol, Dundee, Scotland.	FMBlab@googlemail.com	Pepin, Mark/AAI-1950-2019	Pepin, Mark/0000-0003-0114-560X; Hamilton, David/0000-0002-5620-4788; Baar, Keith/0000-0001-9337-6186	BBSRC; Wellcome Trust [077426/Z/05/Z]; Hellman Family Foundation	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Hellman Family Foundation	DLH was funded by a BBSRC PhD studentship. The work was supported by a Wellcome Trust project grant to KB (077426/Z/05/Z) and the Hellman Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiho M, 2010, LIFE SCI, V86, P59, DOI 10.1016/j.lfs.2009.11.011; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Blokzijl A, 2002, CURR BIOL, V12, P35, DOI 10.1016/S0960-9822(01)00623-6; Braga M, 2012, MOL CELL ENDOCRINOL, V350, P39, DOI 10.1016/j.mce.2011.11.019; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chu JL, 2002, J BIOL CHEM, V277, P7587, DOI 10.1074/jbc.M111044200; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Dalbo VJ, 2011, J GERONTOL A-BIOL, V66, P855, DOI 10.1093/gerona/glr091; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Dong YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058554; Garma T, 2007, J APPL PHYSIOL, V102, P135, DOI 10.1152/japplphysiol.00776.2006; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Hulmi JJ, 2007, MED SCI SPORT EXER, V39, P289, DOI 10.1249/01.mss.0000241650.15006.6e; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Kim JS, 2007, J APPL PHYSIOL, V103, P1488, DOI 10.1152/japplphysiol.01194.2006; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Marshall A, 2008, EXP CELL RES, V314, P1013, DOI 10.1016/j.yexcr.2008.01.004; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Ross DA, 2001, MOL CELL BIOL, V21, P7537, DOI 10.1128/MCB.21.22.7537-7544.2001; Sakuma K, 2004, ACTA NEUROPATHOL, V108, P241, DOI 10.1007/s00401-004-0884-5; Salerno MS, 2009, EXP CELL RES, V315, P2012, DOI 10.1016/j.yexcr.2009.04.014; Serra C, 2013, J GERONTOL A-BIOL, V68, P17, DOI 10.1093/gerona/gls083; Sun DF, 2006, KIDNEY INT, V70, P453, DOI 10.1038/sj.ki.5001532; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Sutrave P, 2000, GENE, V241, P107, DOI 10.1016/S0378-1119(99)00461-8; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; WONG TS, 1990, J APPL PHYSIOL, V69, P1718, DOI 10.1152/jappl.1990.69.5.1718; WONG TS, 1990, J APPL PHYSIOL, V69, P1709, DOI 10.1152/jappl.1990.69.5.1709; Yamaguchi A, 2006, PFLUG ARCH EUR J PHY, V453, P203, DOI 10.1007/s00424-006-0127-9	37	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68743	10.1371/journal.pone.0068743	http://dx.doi.org/10.1371/journal.pone.0068743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844238	Green Published, gold			2022-12-25	WOS:000321341000179
J	VanDalen, KK; Hall, JS; Clark, L; McLean, RG; Smeraski, C				VanDalen, Kaci K.; Hall, Jeffrey S.; Clark, Larry; McLean, Robert G.; Smeraski, Cynthia			West Nile Virus Infection in American Robins: New Insights on Dose Response	PLOS ONE			English	Article							LOUIS-ENCEPHALITIS-VIRUS; NORTHEASTERN UNITED-STATES; HOST FEEDING PATTERNS; VECTOR COMPETENCE; DIPTERA-CULICIDAE; MOSQUITOS DIPTERA; AVIAN HOSTS; TRANSMISSION; BIRDS; AMPLIFICATION	West Nile virus (WNV) is a vector-borne pathogen that was first detected in the United States in 1999. The natural transmission cycle of WNV involves mosquito vectors and avian hosts, which vary in their competency to transmit the virus. American robins are an abundant backyard species in the United States and appear to have an important role in the amplification and dissemination of WNV. In this study we examine the response of American robins to infection with various WNV doses within the range of those administered by some natural mosquito vectors. Thirty American robins were assigned a WNV dosage treatment and needle inoculated with 10(0.95) PFU, 10(1.26) PFU, 10(2.15) PFU, or 10(3.15) PFU. Serum samples were tested for the presence of infectious WNV and/or antibodies, while oral swabs were tested for the presence of WNV RNA. Five of the 30 (17%) robins had neutralizing antibodies to WNV prior to the experiment and none developed viremia or shed WNV RNA. The proportion of WNV-seronegative birds that became viremic after WNV inoculation increased in a dose dependent manner. At the lowest dose, only 40% (2/5) of the inoculated birds developed productive infections while at the highest dose, 100% (7/7) of the birds became viremic. Oral shedding of WNV RNA followed a similar trend where robins inoculated with the lower two doses were less likely to shed viral RNA (25%) than robins inoculated with one of the higher doses (92%). Viremia titers and morbidity did not increase in a dose dependent manner; only two birds succumbed to infection and, interestingly, both were inoculated with the lowest dose of WNV. It is clear that the disease ecology of WNV is a complex interplay of hosts, vectors, and viral dose delivered.	[VanDalen, Kaci K.; Hall, Jeffrey S.; Clark, Larry; McLean, Robert G.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Smeraski, Cynthia] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); Colorado State University	VanDalen, KK (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA.	Kaci.vandalen@aphis.usda.gov		Hall, Jeffrey/0000-0001-5599-2826	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The manuscript was reviewed for general policy statements committing the USDA to action, but otherwise the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, VERT EC BIRD SPEC; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Beaty BC., 1995, VIRAL RICKETTSIAL CH, P189; Blitvich BJ, 2003, J CLIN MICROBIOL, V41, P1041, DOI 10.1128/JCM.41.3.1041-1047.2003; Clark L, 2006, J WILDLIFE DIS, V42, P14, DOI 10.7589/0090-3558-42.1.14; Fang Y, 2006, AM J TROP MED HYG, V75, P480, DOI 10.4269/ajtmh.2006.75.480; Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536; Hamer GL, 2008, VECTOR-BORNE ZOONOT, V8, P57, DOI 10.1089/vbz.2007.0123; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2010, VECTOR-BORNE ZOONOT, V10, P377, DOI 10.1089/vbz.2009.0029; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2002, EMERG INFECT DIS, V8, P741, DOI 10.3201/eid0807.020157; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; McLean RG, 2001, ANN NY ACAD SCI, V951, P54; MCLEAN RG, 1985, J MED ENTOMOL, V22, P232, DOI 10.1093/jmedent/22.2.232; MCLEAN RG, 1993, AM J TROP MED HYG, V49, P46, DOI 10.4269/ajtmh.1993.49.46; McLean RG, 2006, ORNITHOL MONOGR, P44; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Nemeth N, 2006, J WILDLIFE DIS, V42, P1, DOI 10.7589/0090-3558-42.1.1; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Sallabanks R, 1999, BIRDS N AM, P28; Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; Styer LM, 2006, AM J TROP MED HYG, V75, P337, DOI 10.4269/ajtmh.2006.75.337; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Vanlandingham DL, 2004, AM J TROP MED HYG, V71, P120, DOI 10.4269/ajtmh.2004.71.120; Wheeler SS, 2012, AM J TROP MED HYG, V87, P559, DOI 10.4269/ajtmh.2012.11-0654	37	25	26	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68537	10.1371/journal.pone.0068537	http://dx.doi.org/10.1371/journal.pone.0068537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844218	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000170
J	Yanez, CO; Morales, AR; Yue, XL; Urakami, T; Komatsu, M; Jarvinen, TAH; Belfield, KD				Yanez, Ciceron O.; Morales, Alma R.; Yue, Xiling; Urakami, Takeo; Komatsu, Masanobu; Jarvinen, Tero A. H.; Belfield, Kevin D.			Deep Vascular Imaging in Wounds by Two-Photon Fluorescence Microscopy	PLOS ONE			English	Article							CYCLIC RGD PEPTIDES; TISSUE; ALPHA(V)BETA(3); RECOGNITION	Deep imaging within tissue (over 300 mu m) at micrometer resolution has become possible with the advent of two-photon fluorescence microscopy (2PFM). The advantages of 2PFM have been used to interrogate endogenous and exogenous fluorophores in the skin. Herein, we employed the integrin (cell-adhesion proteins expressed by invading angiogenic blood vessels) targeting characteristics of a two-photon absorbing fluorescent probe to image new vasculature and fibroblasts up to approximate to 1600 mu m within wound (neodermis)/granulation tissue in lesions made on the skin of mice. Reconstruction revealed three dimensional (3D) architecture of the vascular plexus forming at the regenerating wound tissue and the presence of a fibroblast bed surrounding the capillaries. Biologically crucial events, such as angiogenesis for wound healing, may be illustrated and analyzed in 3D on the whole organ level, providing novel tools for biomedical applications.	[Yanez, Ciceron O.; Morales, Alma R.; Yue, Xiling; Belfield, Kevin D.] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA; [Belfield, Kevin D.] Univ Cent Florida, Coll Opt & Photon, Orlando, FL 32816 USA; [Urakami, Takeo; Komatsu, Masanobu] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL USA; [Jarvinen, Tero A. H.] Univ Tampere, Dept Orthopaed Surg, Tampere City Hosp, FIN-33101 Tampere, Finland; [Jarvinen, Tero A. H.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; Sanford Burnham Prebys Medical Discovery Institute; Tampere University; Tampere University	Belfield, KD (corresponding author), Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA.	belfield@ucf.edu	Komatsu, Masanobu/AAV-3013-2020; Belfield, Kevin D/D-4765-2009	Belfield, Kevin D/0000-0002-7339-2813; Jarvinen, Tero/0000-0002-4027-1759; Komatsu, Masanobu/0000-0001-7548-137X	National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering) [R15 EB008858-01]; National Institutes of Health (National Cancer Institute) [R01 CA125255]; James and Esther King Biomedical Research Program [10KD-11]; National Science Foundation [CHE-0832622]; NATIONAL CANCER INSTITUTE [R01CA125255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R15EB008858] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James and Esther King Biomedical Research Program; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors wish to acknowledge the National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering R15 EB008858-01 to K. D. B., National Cancer Institute R01 CA125255 to M. K.), the James and Esther King Biomedical Research Program (10KD-11) and the National Science Foundation (CHE-0832622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; CAVANI A, 1993, J INVEST DERMATOL, V101, P600, DOI 10.1111/1523-1747.ep12366057; Chen WL, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247157; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; HIRANO Y, 1991, J BIOMED MATER RES, V25, P1523, DOI 10.1002/jbm.820251209; Jarvinen TAH, 2010, P NATL ACAD SCI USA, V107, P21671, DOI 10.1073/pnas.1016233107; Kobat D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646209; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Morales AR, 2010, ORG BIOMOL CHEM, V8, P2600, DOI 10.1039/b925934a; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Pawlicki M, 2009, ANGEW CHEM INT EDIT, V48, P3244, DOI 10.1002/anie.200805257; PETICOLA.WL, 1967, ANNU REV PHYS CHEM, V18, P233, DOI 10.1146/annurev.pc.18.100167.001313; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; So PTC, 1998, OPT EXPRESS, V3, P339, DOI 10.1364/OE.3.000339; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6	18	24	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67559	10.1371/journal.pone.0067559	http://dx.doi.org/10.1371/journal.pone.0067559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844028	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000056
J	Zha, J; Li, BZ; Shen, MH; Hu, ML; Song, H; Yuan, YJ				Zha, Jian; Li, Bing-Zhi; Shen, Ming-Hua; Hu, Meng-Long; Song, Hao; Yuan, Ying-Jin			Optimization of CDT-1 and XYL1 Expression for Balanced Co-Production of Ethanol and Xylitol from Cellobiose and Xylose by Engineered Saccharomyces cerevisiae	PLOS ONE			English	Article							GLUCOSE REPRESSION; LIGNOCELLULOSIC MATERIALS; FERMENTATION; REDUCTASE; YEAST; TRANSFORMATION; BIOREFINERIES; DEHYDROGENASE; CHALLENGES; TRANSPORT	Production of ethanol and xylitol from lignocellulosic hydrolysates is an alternative to the traditional production of ethanol in utilizing biomass. However, the conversion efficiency of xylose to xylitol is restricted by glucose repression, causing a low xylitol titer. To this end, we cloned genes CDT-1 (encoding a cellodextrin transporter) and gh1-1 (encoding an intracellular beta-glucosidase) from Neurospora crassa and XYL1 (encoding a xylose reductase that converts xylose into xylitol) from Scheffersomyces stipitis into Saccharomyces cerevisiae, enabling simultaneous production of ethanol and xylitol from a mixture of cellobiose and xylose (main components of lignocellulosic hydrolysates). We further optimized the expression levels of CDT-1 and XYL1 by manipulating their promoters and copy-numbers, and constructed an engineered S. cerevisiae strain (carrying one copy of PGK1p-CDT1 and two copies of TDH3p-XYL1), which showed an 85.7% increase in xylitol production from the mixture of cellobiose and xylose than that from the mixture of glucose and xylose. Thus, we achieved a balanced co-fermentation of cellobiose (0.165 g/L/h) and xylose (0.162 g/L/h) at similar rates to co-produce ethanol (0.36 g/g) and xylitol (1.00 g/g).	[Zha, Jian; Li, Bing-Zhi; Shen, Ming-Hua; Hu, Meng-Long; Song, Hao; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Dept Pharmaceut Engn,Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Song, Hao] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Tianjin University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yuan, YJ (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Dept Pharmaceut Engn,Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	Li, Bing-Zhi/I-6107-2013; Song, Hao/G-6207-2010	Li, Bing-Zhi/0000-0003-4121-3048; Song, Hao/0000-0001-5553-2539; Zha, Jian/0000-0001-8630-5208	National High Technology Research and Development Program ("863'' Program) [2012AA02A701]; National Natural Science Foundation of China [21020102040]; National Basic Research Program of China ("973'' Program) [2013CB733601]; International Joint Research Project of Tianjin [11ZCGHHZ00500]	National High Technology Research and Development Program ("863'' Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China ("973'' Program)(National Basic Research Program of China); International Joint Research Project of Tianjin	This work was funded by the National High Technology Research and Development Program ("863'' Program: 2012AA02A701), the National Natural Science Foundation of China (Major International Joint Research Project: 21020102040), the National Basic Research Program of China ("973'' Program: 2013CB733601), and International Joint Research Project of Tianjin (11ZCGHHZ00500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SM, 2004, ENZYME MICROB TECH, V35, P545, DOI 10.1016/j.enzmictec.2004.08.006; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cheng HR, 2011, MICROB CELL FACT, V10, DOI [10.1186/1475-2859-10-5, 10.1186/1475-2859-10-43]; Cheng KK, 2010, APPL MICROBIOL BIOT, V87, P411, DOI 10.1007/s00253-010-2612-5; Chu BCH, 2007, BIOTECHNOL ADV, V25, P425, DOI 10.1016/j.biotechadv.2007.04.001; Demirbas MF, 2009, APPL ENERG, V86, pS151, DOI 10.1016/j.apenergy.2009.04.043; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Eliasson A, 2000, APPL ENVIRON MICROB, V66, P3381, DOI 10.1128/AEM.66.8.3381-3386.2000; Fernando S, 2006, ENERG FUEL, V20, P1727, DOI 10.1021/ef060097w; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Granstrom TB, 2007, APPL MICROBIOL BIOT, V74, P277, DOI 10.1007/s00253-006-0761-3; Ha SJ, 2013, METAB ENG, V15, P134, DOI 10.1016/j.ymben.2012.11.005; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; HALLBORN J, 1991, BIO-TECHNOL, V9, P1090, DOI 10.1038/nbt1191-1090; Hu CM, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-25; Huang CF, 2011, BIORESOURCE TECHNOL, V102, P3322, DOI 10.1016/j.biortech.2010.10.111; Jeppsson M, 2003, FEMS YEAST RES, V3, P167, DOI 10.1016/S1567-1356(02)00186-1; Jin YS, 2003, APPL BIOCHEM BIOTECH, V105, P277; Jojima T, 2010, APPL MICROBIOL BIOT, V85, P471, DOI 10.1007/s00253-009-2292-1; Kim YS, 1999, J BIOTECHNOL, V67, P159, DOI 10.1016/S0168-1656(98)00172-2; Ko BS, 2006, APPL ENVIRON MICROB, V72, P4207, DOI 10.1128/AEM.02699-05; Kumar S, 2009, J IND MICROBIOL BIOT, V36, P1483, DOI 10.1007/s10295-009-0636-6; Lee WJ, 2000, PROCESS BIOCHEM, V35, P1199, DOI 10.1016/S0032-9592(00)00165-5; Lee WJ, 2002, APPL MICROBIOL BIOT, V60, P186, DOI 10.1007/s00253-002-1085-6; Li SJ, 2010, MOL BIOSYST, V6, P2129, DOI 10.1039/c0mb00063a; Liu EK, 2010, BIOCHEM ENG J, V48, P204, DOI 10.1016/j.bej.2009.10.011; Lu CF, 2007, APPL ENVIRON MICROB, V73, P6072, DOI 10.1128/AEM.00955-07; Matsushika A, 2008, J BIOSCI BIOENG, V106, P306, DOI 10.1263/jbb.106.306; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Nair NU, 2010, METAB ENG, V12, P462, DOI 10.1016/j.ymben.2010.04.005; Oh EJ, 2013, METAB ENG, V15, P226, DOI 10.1016/j.ymben.2012.09.003; Prakash G, 2011, BIORESOURCE TECHNOL, V102, P3304, DOI 10.1016/j.biortech.2010.10.074; Qin L, 2012, BIORESOURCE TECHNOL, V112, P319, DOI 10.1016/j.biortech.2012.02.134; Roca E, 1996, BIOTECHNOL BIOENG, V51, P317, DOI [10.1002/(SICI)1097-0290(19960805)51:3<317::AID-BIT7>3.0.CO;2-G, 10.1002/(SICI)1097-0290(19960805)51:3&lt;317::AID-BIT7&gt;3.0.CO;2-G]; Runquist D, 2009, APPL MICROBIOL BIOT, V82, P123, DOI 10.1007/s00253-008-1773-y; Runquist D, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-5; Shao Z. Y., 2009, NUCLEIC ACIDS RES, V37, P10; SIKORSKI RS, 1989, GENETICS, V122, P19; SKOOG K, 1990, APPL ENVIRON MICROB, V56, P3389, DOI 10.1128/AEM.56.11.3389-3394.1990; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Subtil T, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-14; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; THESTRUP HN, 1995, APPL ENVIRON MICROB, V61, P2043, DOI 10.1128/AEM.61.5.2043-2045.1995; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; Wang XJ, 2012, EUR J NUTR, V51, P39, DOI 10.1007/s00394-012-0326-4; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; Xia JM, 2011, BIOTECHNOL BIOENG, V108, P12, DOI 10.1002/bit.22910; Zhong C, 2009, APPL MICROBIOL BIOT, V84, P667, DOI 10.1007/s00253-009-2001-0	51	27	34	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68317	10.1371/journal.pone.0068317	http://dx.doi.org/10.1371/journal.pone.0068317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844185	Green Published, gold			2022-12-25	WOS:000321341000153
J	Lee, MT; Leung, YK; Chung, I; Tarapore, P; Ho, SM				Lee, Ming-Tsung; Leung, Yuet-Kin; Chung, Irving; Tarapore, Pheruza; Ho, Shuk-Mei			Estrogen Receptor beta (ER beta 1) Transactivation Is Differentially Modulated by the Transcriptional Coregulator Tip60 in a cis-Acting Element-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; HISTONE ACETYLTRANSFERASE ACTIVITY; CREB-BINDING PROTEIN; ER-ALPHA; PROSTATE-CANCER; GENE-EXPRESSION; ANDROGEN RECEPTOR; NUCLEAR RECEPTORS; PARTIAL AGONIST; HINGE REGION	Estrogen receptor (ER) beta 1 and ER alpha have overlapping and distinct functions despite their common use of estradiol as the physiological ligand. These attributes are explained in part by their differential utilization of coregulators and ligands. Although Tip60 has been shown to interact with both receptors, its regulatory role in ER beta 1 transactivation has not been defined. In this study, we found that Tip60 enhances transactivation of ER beta 1 at the AP-1 site but suppresses its transcriptional activity at the estrogen-response element (ERE) site in an estradiol-independent manner. However, different estrogenic compounds can modify the Tip60 action. The corepressor activity of Tip60 at the ERE site is abolished by diarylpropionitrile, genistein, equol, and bisphenol A, whereas its coactivation at the AP-1 site is augmented by fulvestrant (ICI 182,780). GRIP1 is an important tethering mediator for ERs at the AP-1 site. We found that coexpression of GRIP1 synergizes the action of Tip60. Although Tip60 is a known acetyltransferase, it is unable to acetylate ER beta 1, and its coregulatory functions are independent of its acetylation activity. In addition, we showed the co-occupancy of ER beta 1 and Tip60 at ERE and AP-1 sites of ER beta 1 target genes. Tip60 differentially regulates the endogenous expression of the target genes by modulating the binding of ER beta 1 to the cis-regulatory regions. Thus, we have identified Tip60 as the first dual-function coregulator of ER beta 1.	[Lee, Ming-Tsung; Leung, Yuet-Kin; Chung, Irving; Tarapore, Pheruza; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Div Environm Genet & Mol Toxicol, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Leung, Yuet-Kin; Tarapore, Pheruza; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH 45267 USA; [Leung, Yuet-Kin; Tarapore, Pheruza; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Inst Canc, Cincinnati, OH 45267 USA; [Ho, Shuk-Mei] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Ho, SM (corresponding author), Univ Cincinnati, Dept Environm Hlth, Rm 130,Kettering Lab Complex,3223 Eden Ave, Cincinnati, OH 45267 USA.	shuk-mei.ho@uc.edu	Tarapore, Pheruza/A-8876-2013; Leung, Ricky/H-5958-2019	Tarapore, Pheruza/0000-0003-0911-3661; Leung, Ricky/0000-0003-2063-277X	National Institutes of Health from NIEHS [R01CA015776, R01DK061084, R01ES015584, U01ES019480, U01ES020988, P30ES006096]; Veterans Affairs [I01BX000675]; Congressionally Directed Medical Research Program Department of Defense [PC094619, BC094017]; NATIONAL CANCER INSTITUTE [R01CA015776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019480, U01ES020988, P30ES006096, R01ES015584] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; Veterans Affairs(US Department of Veterans Affairs); Congressionally Directed Medical Research Program Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA015776, R01DK061084, R01ES015584, U01ES019480, U01ES020988, and P30ES006096 from NIEHS (to S. M. H.). This work was also supported by Veterans Affairs Grant I01BX000675 (to S. M. H.) and Congressionally Directed Medical Research Program Department of Defense Grants PC094619 (to P. T.) and BC094017 (to M. T. L.).	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bjornstrom Linda, 2004, Nucl Recept, V2, P3, DOI 10.1186/1478-1336-2-3; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Burns KA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187773; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Chang EC, 2008, MOL ENDOCRINOL, V22, P1032, DOI 10.1210/me.2007-0356; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Fu MF, 2004, BIOCHEM PHARMACOL, V68, P1199, DOI 10.1016/j.bcp.2004.05.037; Fujimoto N, 2004, J STEROID BIOCHEM, V88, P53, DOI 10.1016/j.jsbmb.2003.10.006; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gaughan L, 2001, J BIOL CHEM, V276, P46841, DOI 10.1074/jbc.M103710200; Harris DM, 2005, EXP BIOL MED, V230, P558, DOI 10.1177/153537020523000807; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Ho SM, 2011, ENDOCRIN METAB CLIN, V40, P591, DOI 10.1016/j.ecl.2011.05.002; Holmes KA, 2008, CANCER RES, V68, P7380, DOI 10.1158/0008-5472.CAN-08-0133; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Jeong KW, 2012, MOL ENDOCRINOL, V26, P955, DOI 10.1210/me.2012-1066; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jeyakunnar M, 2011, J BIOL CHEM, V286, P12971, DOI 10.1074/jbc.M110.205112; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Leung YK, 2010, ENDOCR-RELAT CANCER, V17, P675, DOI 10.1677/ERC-09-0294; Liu Y, 2008, P NATL ACAD SCI USA, V105, P2604, DOI 10.1073/pnas.0712085105; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Ma YX, 2010, MOL ENDOCRINOL, V24, P76, DOI 10.1210/me.2009-0218; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; Nikov GN, 2000, ENVIRON HEALTH PERSP, V108, P867, DOI 10.2307/3434995; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Paige LA, 1999, P NATL ACAD SCI USA, V96, P3999, DOI 10.1073/pnas.96.7.3999; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Routledge EJ, 2000, J BIOL CHEM, V275, P35986, DOI 10.1074/jbc.M006777200; Sanchez M, 2013, ONCOGENE, V32, P117, DOI 10.1038/onc.2012.19; Sanchez M, 2007, J BIOL CHEM, V282, P4830, DOI 10.1074/jbc.M607908200; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Shiota M, 2010, PROSTATE, V70, P540, DOI 10.1002/pros.21088; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wang CG, 2011, J STEROID BIOCHEM, V123, P91, DOI 10.1016/j.jsbmb.2010.12.003; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang Y, 2006, P NATL ACAD SCI USA, V103, P9908, DOI 10.1073/pnas.0510596103; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Wong CW, 2001, BIOCHEMISTRY-US, V40, P6756, DOI 10.1021/bi010379h; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Zhao CY, 2010, CANCER RES, V70, P5174, DOI 10.1158/0008-5472.CAN-09-4407; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397; Zwart W, 2010, J CELL SCI, V123, P1253, DOI 10.1242/jcs.061135	71	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25038	25052		10.1074/jbc.M113.476952	http://dx.doi.org/10.1074/jbc.M113.476952			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857583	hybrid, Green Published			2022-12-25	WOS:000330619000005
J	Lan, T; Wang, XR; Zeng, QY				Lan, Ting; Wang, Xiao-Ru; Zeng, Qing-Yin			Structural and Functional Evolution of Positively Selected Sites in Pine Glutathione S-Transferase Enzyme Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE FAMILY; DIVERSIFICATION; DIVERGENCE; SYNTHASE; RESIDUES; REVEALS	Phylogenetic analyses have identified positive selection as an important driver of protein evolution, both structural and functional. However, the lack of appropriate combined functional and structural assays has generally hindered attempts to elucidate patterns of positively selected sites and their effects on enzyme activity and substrate specificity. In this study we investigated the evolutionary divergence of the glutathione S-transferase (GST) family in Pinus tabuliformis, a pine that is widely distributed from northern to central China, including cold temperate and drought-stressed regions. GSTs play important roles in plant stress tolerance and detoxification. We cloned 44 GST genes from P. tabuliformis and found that 26 of the 44 belong to the largest (Tau) class of GSTs and are differentially expressed across tissues and developmental stages. Substitution models identified five positively selected sites in the Tau GSTs. To examine the functional significance of these positively selected sites, we applied protein structural modeling and site-directed mutagenesis. We found that four of the five positively selected sites significantly affect the enzyme activity and specificity; thus their variation broadens the GST family substrate spectrum. In addition, positive selection has mainly acted on secondary substrate binding sites or sites close to (but not directly at) the primary substrate binding site; thus their variation enables the acquisition of new catalytic functions without compromising the protein primary biochemical properties. Our study sheds light on selective aspects of the functional and structural divergence of the GST family in pine and other organisms.	[Lan, Ting; Zeng, Qing-Yin] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Wang, Xiao-Ru] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden	Chinese Academy of Sciences; Institute of Botany, CAS; Umea University	Zeng, QY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	qingyin.zeng@ibcas.ac.cn	Wang, Xiao-Ru/H-6811-2012; Wang, Xiao-Ru/AAC-4444-2020	Wang, Xiao-Ru/0000-0002-6150-7046; Wang, Xiao-Ru/0000-0002-6150-7046; Lan, Ting/0000-0001-8491-3365; Zeng, Qing-Yin/0000-0002-5730-3016	National Basic Research Program of China [2009CB119104]; Natural Science Foundation of China [30830010, 91231103]; Vetenskapsradet, Sweden	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Vetenskapsradet, Sweden(Swedish Research Council)	This work was supported by National Basic Research Program of China Grant 2009CB119104, Natural Science Foundation of China Grants 30830010 and 91231103), and Vetenskapsradet, Sweden.	Agrawal GK, 2002, PLANT SCI, V163, P1153, DOI 10.1016/S0168-9452(02)00331-X; Axarli I, 2009, J MOL BIOL, V385, P984, DOI 10.1016/j.jmb.2008.10.084; Barkman TJ, 2007, MOL BIOL EVOL, V24, P1320, DOI 10.1093/molbev/msm053; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Falara V, 2011, PLANT PHYSIOL, V157, P770, DOI 10.1104/pp.111.179648; Frova C, 2003, PHYSIOL PLANTARUM, V119, P469, DOI 10.1046/j.1399-3054.2003.00183.x; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HUBER R, 1987, BIOCHEM SOC T, V15, P1009, DOI 10.1042/bst0151009; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; Mao JF, 2011, AM NAT, V177, P424, DOI 10.1086/658905; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martinez-Castilla LP, 2003, P NATL ACAD SCI USA, V100, P13407, DOI 10.1073/pnas.1835864100; Mondragon-Palomino M, 2005, MOL BIOL EVOL, V22, P2444, DOI 10.1093/molbev/msi241; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Mueller LA, 2000, PLANT PHYSIOL, V123, P1561, DOI 10.1104/pp.123.4.1561; Padhi SK, 2010, CHEM BIOL, V17, P863, DOI 10.1016/j.chembiol.2010.06.013; RICCI G, 1994, ANAL BIOCHEM, V218, P463, DOI 10.1006/abio.1994.1209; Sabbagh A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-62; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; Thom R, 2002, BIOCHEMISTRY-US, V41, P7008, DOI 10.1021/bi015964x; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; Williams SG, 2009, MOL BIOL EVOL, V26, P1055, DOI 10.1093/molbev/msp020; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Yang X, 2009, PLANT PHYSIOL BIOCH, V47, P1061, DOI 10.1016/j.plaphy.2009.07.003; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Zeng QY, 2005, FEBS LETT, V579, P2657, DOI 10.1016/j.febslet.2005.03.086; Zeng QY, 2005, BIOCHIMIE, V87, P445, DOI 10.1016/j.biochi.2005.01.002; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	51	41	43	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24441	24451		10.1074/jbc.M113.456863	http://dx.doi.org/10.1074/jbc.M113.456863			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846689	Green Published, hybrid			2022-12-25	WOS:000330612300014
J	Grossmann, T; Vaish, A; Franz, J; Schroeder, R; Stoneking, M; Friederici, AD				Grossmann, Tobias; Vaish, Amrisha; Franz, Janett; Schroeder, Roland; Stoneking, Mark; Friederici, Angela D.			Emotional Voice Processing: Investigating the Role of Genetic Variation in the Serotonin Transporter across Development	PLOS ONE			English	Article							EARLY LANGUAGE-ACQUISITION; BRAIN RESPONSES; SOCIAL COGNITION; INFANTS; PROSODY; SPEECH; POLYMORPHISM; RECOGNITION; POTENTIALS; EXPRESSION	The ability to effectively respond to emotional information carried in the human voice plays a pivotal role for social interactions. We examined how genetic factors, especially the serotonin transporter genetic variation (5-HTTLPR), affect the neurodynamics of emotional voice processing in infants and adults by measuring event-related brain potentials (ERPs). The results revealed that infants distinguish between emotions during an early perceptual processing stage, whereas adults recognize and evaluate the meaning of emotions during later semantic processing stages. While infants do discriminate between emotions, only in adults was genetic variation associated with neurophysiological differences in how positive and negative emotions are processed in the brain. This suggests that genetic association with neurocognitive functions emerges during development, emphasizing the role that variation in serotonin plays in the maturation of brain systems involved in emotion recognition.	[Grossmann, Tobias] Max Planck Inst Human Cognit & Brain Sci, Early Social Dev Grp, Leipzig, Germany; [Vaish, Amrisha] Max Planck Inst Evolutionare Anthropol, Dept Dev & Comparit Psychol, D-04103 Leipzig, Germany; [Franz, Janett] Max Delbruck Ctr Mol Med, Berlin, Germany; [Schroeder, Roland; Stoneking, Mark] Max Planck Inst Evolutionare Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Friederici, Angela D.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany	Max Planck Society; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Max Planck Society	Grossmann, T (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Early Social Dev Grp, Leipzig, Germany.	grossman@cbs.mpg.de	Grossmann, Tobias/H-6364-2019	Grossmann, Tobias/0000-0002-1116-6423				Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; Csibra G., 2008, HDB DEV COGNITIVE NE, V2nd ed., P247; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DeHaan M., 2007, INFANT EEG EVENT REL; Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; Fernald A., 1992, ADAPTED MIND EVOLUTI, P391, DOI DOI 10.1007/BF00852474; Fox E., 2012, RAINY BRAIN SUNNY BR; Fox E, 2009, P ROYAL SOC B; Friederici AD, 2005, TRENDS COGN SCI, V9, P481, DOI 10.1016/j.tics.2005.08.008; Friedrich M, 2005, J COGNITIVE NEUROSCI, V17, P1785, DOI 10.1162/089892905774589172; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gottlieb G, 2007, DEVELOPMENTAL SCI, V10, P1, DOI 10.1111/j.1467-7687.2007.00556.x; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Grossmann T, 2005, NEUROREPORT, V16, P1825, DOI 10.1097/01.wnr.0000185964.34336.b1; Grossmann T, 2011, DEV COGN NEUROS-NETH, V1, P57, DOI 10.1016/j.dcn.2010.07.001; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; Heberlein AS, 2009, EMOT REV, V1, P162, DOI 10.1177/1754073908100441; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kushnerenko E, 2002, NEUROREPORT, V13, P1843, DOI 10.1097/00001756-200210280-00002; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Parisel E, 2010, INT J PSYCHOPHYSIOL, V77, P239, DOI 10.1016/j.ijpsycho.2010.06.032; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Quam C, 2012, CHILD DEV, V83, P236, DOI 10.1111/j.1467-8624.2011.01700.x; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Scherer K.R., 1988, P171; Scherer Klaus R., 1989, HDB PSYCHOPHYSIOLOGY; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schutter DJLG, 2004, INT J PSYCHOPHYSIOL, V53, P29, DOI 10.1016/j.ijpsycho.2004.01.003; Slater A, 2007, INTRO INFANT DEV; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Wambacq IJA, 2004, NEUROREPORT, V15, P555, DOI 10.1097/00001756-200403010-00034	55	13	13	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68377	10.1371/journal.pone.0068377	http://dx.doi.org/10.1371/journal.pone.0068377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861897	gold, Green Published, Green Accepted			2022-12-25	WOS:000321692000026
J	Cao, YJ; Xian, M; Zou, HB; Zhang, HB				Cao, Yujin; Xian, Mo; Zou, Huibin; Zhang, Haibo			Metabolic Engineering of Escherichia coli for the Production of Xylonate	PLOS ONE			English	Article							D-XYLOSE METABOLISM; SACCHAROMYCES-CEREVISIAE; PSEUDOMONAS-FRAGI; ACID PRODUCTION; DEHYDROGENASE; GENES	Xylonate is a valuable chemical for versatile applications. Although the chemical synthesis route and microbial conversion pathway were established decades ago, no commercial production of xylonate has been obtained so far. In this study, the industrially important microorganism Escherichia coli was engineered to produce xylonate from xylose. Through the coexpression of a xylose dehydrogenase (xdh) and a xylonolactonase (xylC) from Caulobacter crescentus, the recombinant strain could convert 1 g/L xylose to 0.84 g/L xylonate and 0.10 g/L xylonolactone after being induced for 12 h. Furthermore, the competitive pathway for xylose catabolism in E. coli was blocked by disrupting two genes (xylA and xylB) encoding xylose isomerase and xylulose kinase. Under fed-batch conditions, the finally engineered strain produced up to 27.3 g/L xylonate and 1.7 g/L xylonolactone from 30 g/L xylose, about 88% of the theoretical yield. These results suggest that the engineered E. coli strain has a promising perspective for large-scale production of xylonate.	[Cao, Yujin; Xian, Mo; Zou, Huibin; Zhang, Haibo] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biobased Mat, Qingdao, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Xian, M (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biobased Mat, Qingdao, Peoples R China.	xianmo@qibebt.ac.cn	Zhang, Haibo/ABB-0042-2022; Zou, Huibin/AAD-6159-2020	Zhang, Haibo/0000-0003-3728-9840; Zou, Huibin/0000-0002-0805-3022	National Defense Innovation Foundation of Chinese Academy of Sciences [CXJJ-11-M56]; National Natural Science Foundation of China [21202179]; Sci-Tech Development Project of Qingdao [12-4-1-45-nsh]; 'Twelfth Five-Year Plan' in National Science and Technology for the Rural Development [2012BAD32B06-2]; National High-Tech R&D Program of China [SS2013AA050703-2]	National Defense Innovation Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-Tech Development Project of Qingdao; 'Twelfth Five-Year Plan' in National Science and Technology for the Rural Development; National High-Tech R&D Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Defense Innovation Foundation of Chinese Academy of Sciences (No. CXJJ-11-M56), National Natural Science Foundation of China (No. 21202179), Sci-Tech Development Project of Qingdao (No. 12-4-1-45-nsh), 'Twelfth Five-Year Plan' in National Science and Technology for the Rural Development (No. 2012BAD32B06-2) and National High-Tech R&D Program of China (No. SS2013AA050703-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghall S, 2007, FEMS MICROBIOL LETT, V277, P249, DOI 10.1111/j.1574-6968.2007.00969.x; BUCHERT J, 1986, BIOTECHNOL LETT, V8, P541, DOI 10.1007/BF01028079; BUCHERT J, 1988, APPL MICROBIOL BIOT, V29, P375, DOI 10.1007/BF00265822; BUCHERT J, 1988, APPL MICROBIOL BIOT, V27, P333; Cao YJ, 2011, APPL MICROBIOL BIOT, V91, P1545, DOI 10.1007/s00253-011-3304-5; Chemler JA, 2010, METAB ENG, V12, P96, DOI 10.1016/j.ymben.2009.07.003; Chun BW, 2006, APPL BIOCHEM BIOTECH, V131, P645, DOI 10.1385/ABAB:131:1:645; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVID JD, 1970, BIOCHIM BIOPHYS ACTA, V201, P497, DOI 10.1016/0304-4165(70)90171-6; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Governo AT, 2004, ELECTROCHIM ACTA, V49, P1535, DOI 10.1016/j.electacta.2003.11.013; ISHIZAKI H, 1973, J AGR CHEM SOC JPN, V47, P755, DOI 10.1271/nogeikagaku1924.47.755; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Johnsen U, 2009, J BIOL CHEM, V284, P27290, DOI 10.1074/jbc.M109.003814; LIEN OG, 1959, ANAL CHEM, V31, P1363, DOI 10.1021/ac60152a035; Niu W, 2003, J AM CHEM SOC, V125, P12998, DOI 10.1021/ja036391+; Nygard Y, 2011, METAB ENG, V13, P383, DOI 10.1016/j.ymben.2011.04.001; Ramachandran S, 2006, FOOD TECHNOL BIOTECH, V44, P185; ROSENFELD SA, 1984, MOL GEN GENET, V194, P410, DOI 10.1007/BF00425552; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; Toivari M, 2012, METAB ENG, V14, P427, DOI 10.1016/j.ymben.2012.03.002; Toivari MH, 2012, APPL MICROBIOL BIOT, V96, P1, DOI 10.1007/s00253-012-4288-5; Toivari MH, 2010, APPL MICROBIOL BIOT, V88, P751, DOI 10.1007/s00253-010-2787-9; Vickers CE, 2012, BIOTECHNOL LETT, V34, P585, DOI 10.1007/s10529-011-0821-3; Werpy T., 2004, TOP VALUE ADDED CHEM, VI; Yang F, 2012, APPL MICROBIOL BIOT, V93, P487, DOI 10.1007/s00253-011-3712-6	27	30	35	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67305	10.1371/journal.pone.0067305	http://dx.doi.org/10.1371/journal.pone.0067305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861757	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300010
J	Endeman, D; Klaassen, LJ; Kamermans, M				Endeman, Duco; Klaassen, Lauw J.; Kamermans, Maarten			Action Spectra of Zebrafish Cone Photoreceptors	PLOS ONE			English	Article							VISUAL PIGMENTS; BRACHYDANIO-RERIO; GAP-JUNCTIONS; SENSITIVITY; SYSTEM; ULTRAVIOLET; RETINA; CELLS; FISH	Zebrafish is becoming an increasingly popular model in the field of visual neuroscience. Although the absorption spectra of its cone photopigments have been described, the cone action spectra were still unknown. In this study we report the action spectra of the four types of zebrafish cone photoreceptors, determined by measuring voltage responses upon light stimulation using whole cell patch clamp recordings. A generic template of photopigment absorption spectra was fit to the resulting action spectra in order to establish the maximum absorption wavelength, the A2-based photopigment contribution and the size of the beta-wave of each cone-type. Although in general there is close correspondence between zebrafish cone action- and absorbance spectra, our data suggest that in the case of MWS- and LWS-cones there is appreciable contribution of A2-based photopigments and that the beta-wave for these cones is smaller than expected based on the absorption spectra.	[Endeman, Duco; Klaassen, Lauw J.; Kamermans, Maarten] Netherlands Inst Neurosci, Dept Retinal Signal Proc, Amsterdam, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam	Kamermans, M (corresponding author), Netherlands Inst Neurosci, Dept Retinal Signal Proc, Amsterdam, Netherlands.	m.kamermans@nin.knaw.nl			Netherlands Organization for Scientific Research (NWO) [ALW-805.47.067]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant (ALW-805.47.067) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BEATTY DD, 1984, VISION RES, V24, P1563, DOI 10.1016/0042-6989(84)90314-6; Bilotta J, 2005, INT J DEV NEUROSCI, V23, P15, DOI 10.1016/j.ijdevneu.2004.09.004; Bilotta J, 2001, INT J DEV NEUROSCI, V19, P621, DOI 10.1016/S0736-5748(01)00050-8; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Cameron DA, 2002, VISUAL NEUROSCI, V19, P365, DOI 10.1017/S0952523802192121; Chinen A, 2003, GENETICS, V163, P663; Dixon LJ, 2004, DOC OPHTHALMOL, V109, P17, DOI 10.1007/s10633-004-1124-y; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Goldsmith P, 2003, SEMIN CELL DEV BIOL, V14, P11, DOI 10.1016/S1084-9521(02)00167-2; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; HAROSI FI, 1994, VISION RES, V34, P1359, DOI 10.1016/0042-6989(94)90134-1; Haug MF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-8; KANEKO A, 1985, JPN J PHYSIOL, V35, P355, DOI 10.2170/jjphysiol.35.355; LOEW ER, 1976, VISION RES, V16, P891, DOI 10.1016/0042-6989(76)90217-0; LYTHGOE JN, 1989, J EXP BIOL, V146, P1; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; NG B, 1995, J NEUROSCI METH, V56, P37, DOI 10.1016/0165-0270(94)00087-W; Palacios AG, 1996, VISUAL NEUROSCI, V13, P411, DOI 10.1017/S0952523800008099; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; ROBINSON J, 1993, P NATL ACAD SCI USA, V90, P6009, DOI 10.1073/pnas.90.13.6009; Saszik S, 1999, VISION RES, V39, P1051, DOI 10.1016/S0042-6989(98)00237-5; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; TSUKAMOTO Y, 1992, VISION RES, V32, P1809, DOI 10.1016/0042-6989(92)90042-H; VANDIJK BW, 1984, VISION RES, V24, P211, DOI 10.1016/0042-6989(84)90123-8; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; WOOD P, 1992, J FISH BIOL, V41, P601, DOI 10.1111/j.1095-8649.1992.tb02686.x	30	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68540	10.1371/journal.pone.0068540	http://dx.doi.org/10.1371/journal.pone.0068540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861916	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300068
J	Loquai, C; Scheurich, V; Syring, N; Schmidtmann, I; Rietz, S; Werner, A; Grabbe, S; Beutel, ME				Loquai, Carmen; Scheurich, Vera; Syring, Nils; Schmidtmann, Irene; Rietz, Stephan; Werner, Andreas; Grabbe, Stephan; Beutel, Manfred E.			Screening for Distress in Routine Oncological Care-A Survey in 520 Melanoma Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; STEM-CELL TRANSPLANTATION; CANCER-PATIENTS; PSYCHOSOCIAL DISTRESS; PSYCHOLOGIC DISTRESS; EMOTIONAL DISTRESS; THERMOMETER; DEPRESSION; PREDICTORS; STRATEGIES	Introduction: Despite the increasing incidence of melanoma little is known about patients' emotional distress associated with this disease. Supplemented by the problem list (PL), the distress thermometer (DT) is a recommended screening instrument to measure psychosocial distress in cancer patients. Our objective was to explore the acceptance and the feasibility of the DT and PL as a concise screening tool in an ambulatory setting for routine care and to elucidate determinants of distress in melanoma patients with regard to sociodemographic and clinical variables. Methods: Consecutive melanoma outpatients were asked to complete the DT with the PL prior to their scheduled consultation. Demographic and clinical data were obtained from the patients' charts. Clinical data included melanoma stage, time since diagnosis, previous treatment, current treatment, and other cancer disease. Results: Out of 734 patients recruited into the study, 520 patients (71%) completed both the DT and the PL. Forty-seven percent met the >= 5 cut-off score for distress. Younger and employed patients reported higher distress than older and retired patients. A cut-off score of >= 5 was closely associated with self-reported emotional sources of distress, with practical problems, especially at work, family problems (dealing with the partner), and physical problems like pain, appearance, getting around, and nausea. Apart from higher distress under current systemic treatment, no associations were found between distress and clinical data. Conclusion: The DT together with the PL seems to be an economically reasonable screening tool to measure psychosocial distress in melanoma patients. In particular, younger melanoma patients who are currently employed are prone to experience distress at some point after diagnosis, but there appears to be almost no association between clinical data and the extent of distress. To characterize the impact of distress on disease outcome and quality of life in melanoma patients, further research is needed.	[Loquai, Carmen; Syring, Nils; Rietz, Stephan; Grabbe, Stephan] Johannes Gutenberg Univ Mainz, Dept Dermatol, D-55122 Mainz, Rhineland Palat, Germany; [Scheurich, Vera; Beutel, Manfred E.] Johannes Gutenberg Univ Mainz, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Rhineland Palat, Germany; [Schmidtmann, Irene] Johannes Gutenberg Univ Mainz, Inst Med Biostat Epidemiol & Informat, D-55122 Mainz, Rhineland Palat, Germany; [Werner, Andreas] Tumor Ctr Rhineland Pfalz, Mainz, Rhineland Palat, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Loquai, C (corresponding author), Johannes Gutenberg Univ Mainz, Dept Dermatol, D-55122 Mainz, Rhineland Palat, Germany.	carmen.loquai@unimedizin-mainz.de	Loquai, Carmen/AAW-9241-2020; Grabe, Stephan/AAJ-4578-2021	Grabe, Stephan/0000-0002-6863-8719				Agresti A., 2007, INTRO CATEGORICAL DA, P372, DOI DOI 10.1002/0470114754; Atkinson TM, 2012, ANN SURG ONCOL; AWMF online, 2013, S3 GUID MAL MEL; Beutel ME, 2009, HAUTARZT, V60, P727, DOI 10.1007/s00105-009-1814-1; Blum A, 2003, PSYCHOTHER PSYCH MED, V53, P258; Brown JE, 2000, BRIT J CANCER, V83, P1448, DOI 10.1054/bjoc.2000.1471; Bultz BD, 2005, J CLIN ONCOL, V23, P6440, DOI 10.1200/JCO.2005.02.3259; German Cancer Society, 2010, ERH HAUTKR; Graves KD, 2007, LUNG CANCER, V55, P215, DOI 10.1016/j.lungcan.2006.10.001; Holland J, 1999, ONCOLOGY-NY, V13, P113; Jacobsen PB, 2005, CANCER-AM CANCER SOC, V103, P1494, DOI 10.1002/cncr.20940; Kasparian NA, 2011, PSYCHOONCOLOGY; Kasparian NA, 2009, ARCH DERMATOL, V145, P1415, DOI 10.1001/archdermatol.2009.308; Kendall J, 2011, PSYCHO-ONCOLOGY, V20, P594, DOI 10.1002/pon.1907; Kennard BD, 2004, J CLIN PSYCHOL MED S, V11, P31, DOI 10.1023/B:JOCS.0000016267.21912.74; Kneier AW, 2003, SURG CLIN N AM, V83, P417, DOI 10.1016/S0039-6109(02)00088-9; Lehto US, 2007, J PSYCHOSOM RES, V63, P9, DOI 10.1016/j.jpsychores.2007.01.001; Loquai C, 2008, EUR J DERMATOL, V18, P29; McDonald M V, 1999, Oncol Nurs Forum, V26, P593; Mehnert A, 2006, Z PSYCHIATR PSYCH PS, V54, P213, DOI 10.1024/1661-4747.54.3.213; Mergenthaler U, 2011, ANN ONCOL, V22, P931, DOI 10.1093/annonc/mdq455; Mertz BG, 2012, EUR J ONCOL NURS, V16, P439, DOI 10.1016/j.ejon.2011.10.001; Mosher CE, 2010, BONE MARROW TRANSPL, V45, P570, DOI 10.1038/bmt.2009.166; National Comprehensive Cancer Network, 2012, NCCN DISTR MAN CLIN; Newton-Bishop JA, 2004, J INVEST DERM SYMP P, V9, P152, DOI 10.1046/j.1087-0024.2003.09118.x; Ollerton I, 1995, J Psychiatr Ment Health Nurs, V2, P91, DOI 10.1111/j.1365-2850.1995.tb00148.x; Pelletier G, 2002, J NEURO-ONCOL, V57, P41, DOI 10.1023/A:1015728825642; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; Prieto JM, 2005, J CLIN ONCOL, V23, P6063, DOI 10.1200/JCO.2005.05.751; Prieto JM, 2002, J CLIN ONCOL, V20, P1907, DOI 10.1200/JCO.2002.07.101; Roberts N, 2012, J CLIN PSYCHOL MED S; Roth AJ, 1998, CANCER, V82, P1904, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X; Simard EP, 2012, CA CANC J CLIN; Skarstein J, 2000, J PSYCHOSOM RES, V49, P27, DOI 10.1016/S0022-3999(00)00080-5; Sollner W, 2001, BRIT J CANCER, V84, P179, DOI 10.1054/bjoc.2000.1545; Stark D, 2002, J CLIN ONCOL, V20, P3137, DOI 10.1200/JCO.2002.08.549; Trask PC, 2001, J CLIN ONCOL, V19, P2844, DOI 10.1200/JCO.2001.19.11.2844; Tuinman MA, 2008, CANCER-AM CANCER SOC, V113, P870, DOI 10.1002/cncr.23622; Ziefle S, 2011, J IMMUNOTHER, V34, P403, DOI 10.1097/CJI.0b013e31821b7a4b	39	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e66800	10.1371/journal.pone.0066800	http://dx.doi.org/10.1371/journal.pone.0066800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DW	23861748	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300007
J	Xu, LJ; Jiang, T; Zhang, FJ; Han, JF; Liu, J; Zhao, H; Li, XF; Liu, RJ; Deng, YQ; Wu, XY; Zhu, SY; Qin, ED; Qin, CF				Xu, Li-Juan; Jiang, Tao; Zhang, Fu-Jun; Han, Jian-Feng; Liu, Juan; Zhao, Hui; Li, Xiao-Feng; Liu, Rui-Ju; Deng, Yong-Qiang; Wu, Xiao-Yan; Zhu, Shun-Ya; Qin, E-De; Qin, Cheng-Feng			Global Transcriptomic Analysis of Human Neuroblastoma Cells in Response to Enterovirus Type 71 Infection	PLOS ONE			English	Article							GENE-EXPRESSION; CYNOMOLGUS MONKEYS; IN-VITRO; NEUROLOGICAL MANIFESTATIONS; PROTEIN-SYNTHESIS; MOUTH-DISEASE; CHILDREN; OUTBREAK; HAND; FOOT	Human enterovirus type 71 (EV71) is the major pathogen of hand-foot-and-mouth disease (HFMD) and has been associated with severe neurological disease and even death in infants and young children. The pathogenesis of EV71 infection in the human central nervous system remains unclear. In this study, human whole genome microarray was employed to perform transcriptome profiling in SH-SY5Y human neuroblastoma cells infected with EV71. The results indicated that EV71 infection lead to altered expression of 161 human mRNAs, including 74 up-regulated genes and 87 down-regulated genes. Bioinformatics analysis indicated the possible roles of the differentially regulated mRNAs in selected pathways, including cell cycle/proliferation, apoptosis, and cytokine/chemokine responses. Finally, the microarray results were validated using real-time RT-PCR with high identity. Overall, our results provided fundamental information regarding the host response to EV71 infection in human neuroblastoma cells, and this finding will help explain the pathogenesis of EV71 infection and virus-host interaction.	[Xu, Li-Juan; Jiang, Tao; Han, Jian-Feng; Liu, Juan; Zhao, Hui; Li, Xiao-Feng; Deng, Yong-Qiang; Wu, Xiao-Yan; Zhu, Shun-Ya; Qin, E-De; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Xu, Li-Juan] PLA 404 Hosp, Weihai, Peoples R China; [Zhang, Fu-Jun] Rizhao Hosp Tradit Chinese Med, Rizhao, Peoples R China; [Liu, Rui-Ju] Liaocheng Peoples Hosp, Liaocheng, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	qincf@bmi.ac.cn	Qin, Cheng-Feng/I-6839-2019; Tao, Jiang/AAE-6623-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926	Beijing Natural Science Foundation [7122129, 7112108]; National Natural Science Foundation of China [31270195]; Beijing Nova Program of Science and Technology [2010B041]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program of Science and Technology	This work was supported by the Beijing Natural Science Foundation (7122129, 7112108) and the National Natural Science Foundation of China (No.31270195). CFQ was supported by Beijing Nova Program of Science and Technology (No.2010B041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOL VI, 1989, J VIROL, V63, P4034, DOI 10.1128/JVI.63.9.4034-4038.1989; Brandon NJ, 2007, BIOCHEM SOC T, V35, P1283, DOI 10.1042/BST0351283; Camargo LM, 2008, NOVART FDN SYMP, V289, P216; Camargo LM, 2008, NOVART FDN SYMP, V289, P238; Camargo Luiz M, 2008, Novartis Found Symp, V289, P208; Cao RY, 2011, J CLIN VIROL, V51, P242, DOI 10.1016/j.jcv.2011.05.002; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Chan SL, 2000, J BIOL CHEM, V275, P17925, DOI 10.1074/jbc.C000146200; Chan SL, 1999, J BIOL CHEM, V274, P32461, DOI 10.1074/jbc.274.45.32461; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chen CY, 2001, AM J NEURORADIOL, V22, P200; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Cordey S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002826; Dai YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-77; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; HAGIWARA A, 1984, ARCH VIROL, V79, P273, DOI 10.1007/BF01310816; Han JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-106; HASHIMOTO I, 1978, ARCH VIROL, V56, P257, DOI 10.1007/BF01317855; HAYWARD JC, 1989, PEDIATR INFECT DIS J, V8, P611, DOI 10.1097/00006454-198909000-00009; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502; Jeong SM, 2010, J BIOL CHEM, V285, P2340, DOI 10.1074/jbc.M109.026997; Khalid SS, 2011, HEPATOL INT, V5, P782, DOI 10.1007/s12072-011-9252-4; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; LAMONICA N, 1989, J VIROL, V63, P2357, DOI 10.1128/JVI.63.5.2357-2360.1989; Leong WF, 2006, CELL MICROBIOL, V8, P565, DOI 10.1111/j.1462-5822.2005.00644.x; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Nagata N, 2002, J MED VIROL, V67, P207, DOI 10.1002/jmv.2209; Ng D K, 2001, Hong Kong Med J, V7, P193; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Porteous DJ, 2006, BIOL PSYCHIAT, V60, P123, DOI 10.1016/j.biopsych.2006.04.008; ROSS RA, 1983, J NATL CANCER I, V71, P741; Schoenebeck B, 2005, MOL CELL NEUROSCI, V30, P249, DOI 10.1016/j.mcn.2005.07.017; Shen WC, 2000, NEURORADIOLOGY, V42, P124, DOI 10.1007/s002340050030; Shih SR, 2008, J NEUROVIROL, V14, P53, DOI 10.1080/13550280701798980; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Sukarieh R, 2010, J GEN VIROL, V91, P1224, DOI 10.1099/vir.0.018069-0; Tung WH, 2010, CELL SIGNAL, V22, P234, DOI 10.1016/j.cellsig.2009.09.018; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Q, 2008, MOL CELL NEUROSCI, V37, P187, DOI 10.1016/j.mcn.2007.10.006; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048069, 10.1371/journal.pone.0051667, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0032405, 10.1371/journal.pone.0036274]; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Yao PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051996; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	59	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e65948	10.1371/journal.pone.0065948	http://dx.doi.org/10.1371/journal.pone.0065948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861741	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300005
J	Barrett, CW; Singh, K; Motley, AK; Lintel, MK; Matafonova, E; Bradley, AM; Ning, W; Poindexter, SV; Parang, B; Reddy, VK; Chaturvedi, R; Fingleton, BM; Washington, MK; Wilson, KT; Davies, SS; Hill, KE; Burk, RF; Williams, CS				Barrett, Caitlyn W.; Singh, Kshipra; Motley, Amy K.; Lintel, Mary K.; Matafonova, Elena; Bradley, Amber M.; Ning, Wei; Poindexter, Shenika V.; Parang, Bobak; Reddy, Vishruth K.; Chaturvedi, Rupesh; Fingleton, Barbara M.; Washington, Mary K.; Wilson, Keith T.; Davies, Sean S.; Hill, Kristina E.; Burk, Raymond F.; Williams, Christopher S.			Dietary Selenium Deficiency Exacerbates DSS-Induced Epithelial Injury and AOM/DSS-Induced Tumorigenesis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; OXIDATIVE DNA-DAMAGE; ULCERATIVE-COLITIS; CROHNS-DISEASE; GLUTATHIONE-PEROXIDASE; INTESTINAL CANCER; MOUSE MODEL; GI-GPX; EXPRESSION; SELENOPROTEINS	Selenium (Se) is an essential micronutrient that exerts its functions via selenoproteins. Little is known about the role of Se in inflammatory bowel disease (IBD). Epidemiological studies have inversely correlated nutritional Se status with IBD severity and colon cancer risk. Moreover, molecular studies have revealed that Se deficiency activates WNT signaling, a pathway essential to intestinal stem cell programs and pivotal to injury recovery processes in IBD that is also activated in inflammatory neoplastic transformation. In order to better understand the role of Se in epithelial injury and tumorigenesis resulting from inflammatory stimuli, we examined colonic phenotypes in Se-deficient or -sufficient mice in response to dextran sodium sulfate (DSS)-induced colitis, and azoxymethane (AOM) followed by cyclical administration of DSS, respectively. In response to DSS alone, Se-deficient mice demonstrated increased morbidity, weight loss, stool scores, and colonic injury with a concomitant increase in DNA damage and increases in inflammation-related cytokines. As there was an increase in DNA damage as well as expression of several EGF and TGF-beta pathway genes in response to inflammatory injury, we sought to determine if tumorigenesis was altered in the setting of inflammatory carcinogenesis. Se-deficient mice subjected to AOM/DSS treatment to model colitis-associated cancer (CAC) had increased tumor number, though not size, as well as increased incidence of high grade dysplasia. This increase in tumor initiation was likely due to a general increase in colonic DNA damage, as increased 8-OHdG staining was seen in Se-deficient tumors and adjacent, non-tumor mucosa. Taken together, our results indicate that Se deficiency worsens experimental colitis and promotes tumor development and progression in inflammatory carcinogenesis.	[Barrett, Caitlyn W.; Singh, Kshipra; Motley, Amy K.; Lintel, Mary K.; Bradley, Amber M.; Ning, Wei; Poindexter, Shenika V.; Parang, Bobak; Reddy, Vishruth K.; Chaturvedi, Rupesh; Wilson, Keith T.; Hill, Kristina E.; Burk, Raymond F.; Williams, Christopher S.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol, Nashville, TN 37212 USA; [Matafonova, Elena; Davies, Sean S.] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Barrett, Caitlyn W.; Poindexter, Shenika V.; Parang, Bobak; Fingleton, Barbara M.; Wilson, Keith T.; Williams, Christopher S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Davies, Sean S.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Washington, Mary K.; Wilson, Keith T.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Wilson, Keith T.; Williams, Christopher S.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Singh, Kshipra; Chaturvedi, Rupesh; Wilson, Keith T.; Williams, Christopher S.] Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Williams, CS (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol, Nashville, TN 37212 USA.	christopher.williams@vanderbilt.edu	Williams, Christopher/W-3524-2019	Williams, Christopher/0000-0002-1541-579X; Reddy, Vishruth/0000-0002-9150-7784; Fingleton, Barbara/0000-0003-1132-0782; Wilson, Keith/0000-0003-4421-1830; Davies, Sean/0000-0001-9879-8062	National Institutes of Health [DK080221, R01DK82813, P50CA095103, R01AT004821, R01AT004821-S1, R01DK053620, P01CA028842, P01CA116087, 1F31CA167920]; Vanderbilt Digestive Disease Research Center [P30 DK058404]; Office of Medical Research, Department of Veterans Affair [1I01BX001426, 1I01BX001453, ACS-RSG 116552]; NCI [T32CA009592-26]; NCI Cancer Center Support Grant [P30CA068485]; NATIONAL CANCER INSTITUTE [P01CA116087, T32CA009592, R01CA190612, P01CA028842, P50CA095103, F31CA167920, P30CA068485] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK096718, K08DK080221, R01DK053620, R01DK082813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459, T32GM007347] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center; Office of Medical Research, Department of Veterans Affair; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health grants DK080221 (CSW), R01DK82813 (RFB), P50CA095103 (MKW), R01AT004821 (KTW), R01AT004821-S1 (KTW), R01DK053620 (KTW), P01CA028842 (KTW), P01CA116087 (KTW), 1F31CA167920 (CWB), and P30 DK058404 (Vanderbilt Digestive Disease Research Center), Merit Review Grants from the Office of Medical Research, Department of Veterans Affairs 1I01BX001426 (CSW) and 1I01BX001453 (KTW), and ACS-RSG 116552 (CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by an NCI T-32 Supplement T32CA009592-26. This publication was also supported in part by the NCI Cancer Center Support Grant P30CA068485 utilizing the Translational Pathology shared resource, which provided tissue processing and staining services. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the NIH.	Al-Taie OH, 2004, NUTR CANCER, V48, P6, DOI 10.1207/s15327914nc4801_2; Andoh A, 2005, NUTRITION, V21, P574, DOI 10.1016/j.nut.2004.08.025; Barrett CW, 2013, CANCER RES, V73, P1245, DOI 10.1158/0008-5472.CAN-12-3150; Barrett CW, 2011, CANCER RES, V71, P1302, DOI 10.1158/0008-5472.CAN-10-3317; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Beckett GJ, 2005, J ENDOCRINOL, V184, P455, DOI 10.1677/joe.1.05971; Bera S, 2013, MUTAGENESIS, V28, P127, DOI 10.1093/mutage/ges064; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; Carrier J, 2002, J NUTR, V132, P3146, DOI 10.1093/jn/131.10.3146; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Cho Min Haeng, 2010, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V25, P269; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; CLARK LC, 1991, ARCH ENVIRON HEALTH, V46, P37, DOI 10.1080/00039896.1991.9937427; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; Damiani CR, 2007, J GASTROEN HEPATOL, V22, P1846, DOI 10.1111/j.1440-1746.2007.04890.x; Denson LA, 2013, INFLAMM BOWEL DIS, DOI [10.1097/MIB.0-b013e31828134b3, DOI 10.1097/MIB.0-B013E31828134B3]; Dincer Y, 2007, DIGEST DIS SCI, V52, P1636, DOI 10.1007/s10620-006-9386-8; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Ferguson LR, 2012, MUTAT RES-FUND MOL M, V733, P100, DOI 10.1016/j.mrfmmm.2011.12.011; Florian S, 2001, FREE RADICAL RES, V35, P655, DOI 10.1080/10715760100301181; Frierson HF, 2002, AM J PATHOL, V161, P1315, DOI 10.1016/S0002-9440(10)64408-2; Gentschew L, 2012, NUTRIENTS, V4, P1247, DOI 10.3390/nu4091247; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Han PD, 1999, GASTROENTEROL CLIN N, V28, P423, DOI 10.1016/S0889-8553(05)70063-7; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hoffenberg EJ, 1997, AM J CLIN NUTR, V65, P1482, DOI 10.1093/ajcn/65.5.1482; Hong MY, 2005, EXP BIOL MED, V230, P464; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Jaworska K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059051; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kipp AP, 2012, BBA-GEN SUBJECTS, V1820, P1588, DOI 10.1016/j.bbagen.2012.05.016; KIRSNER JB, 1979, JAMA-J AM MED ASSOC, V242, P1177; KIRSNER JB, 1991, DM-DIS MON, V37, P605, DOI 10.1016/S0011-5029(05)80013-6; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Koller FL, 2012, LAB INVEST, V92, P1749, DOI 10.1038/labinvest.2012.141; Krehl S, 2012, CARCINOGENESIS, V33, P620, DOI 10.1093/carcin/bgr288; Kuroki F, 2003, DIGEST DIS, V21, P266, DOI 10.1159/000073346; Langenskiod M, 2008, J SURG ONCOL, V97, P409, DOI 10.1002/jso.20961; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mannick EE, 2004, CLIN IMMUNOL, V112, P247, DOI 10.1016/j.clim.2004.03.014; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; MODJTAHEDI H, 1994, INT J ONCOL, V4, P277; Mork H, 2000, NUTR CANCER, V37, P108, DOI 10.1207/S15327914NC3701_14; Murawaki Y, 2008, CANCER LETT, V259, P218, DOI 10.1016/j.canlet.2007.10.019; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; Ojuawo A, 2002, Cent Afr J Med, V48, P116; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; RANNEM T, 1992, AM J CLIN NUTR, V56, P933, DOI 10.1093/ajcn/56.5.933; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Reimund JM, 2000, CLIN NUTR, V19, P43, DOI 10.1054/clnu.1999.0073; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RINGSTAD J, 1993, SCAND J GASTROENTERO, V28, P605, DOI 10.3109/00365529309096096; Saltzman BS, 2008, CANCER RES, V68, P1236, DOI 10.1158/0008-5472.CAN-07-2144; Schrauzer G N, 1977, Adv Exp Med Biol, V91, P323; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; Skrzypczak M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013091, DOI 10.1371/J0URNAL.P0NE.0013091]; Steinbrenner H, 2013, ANTIOXID REDOX SIGN, V19, P181, DOI 10.1089/ars.2013.5246; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Stucchi AF, 2000, AM J PHYSIOL-GASTR L, V279, pG1298, DOI 10.1152/ajpgi.2000.279.6.G1298; Sturniolo GC, 1998, SCAND J GASTROENTERO, V33, P644, DOI 10.1080/00365529850171936; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trivedi PP, 2013, CHEM-BIOL INTERACT, V201, P19, DOI 10.1016/j.cbi.2012.12.004; Vatn Morten H, 2009, Curr Gastroenterol Rep, V11, P481; Washington MK, 2013, GASTROENTEROLOGY; Yin F, 2012, ANTIOXID REDOX SIGN, V17, P1714, DOI 10.1089/ars.2012.4639; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053	78	66	68	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67845	10.1371/journal.pone.0067845	http://dx.doi.org/10.1371/journal.pone.0067845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861820	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700048
J	Drahos, J; Wu, MX; Anderson, WF; Trivers, KF; King, J; Rosenberg, PS; Eheman, C; Cook, MB				Drahos, Jennifer; Wu, Manxia; Anderson, William F.; Trivers, Katrina F.; King, Jessica; Rosenberg, Philip S.; Eheman, Christie; Cook, Michael B.			Regional Variations in Esophageal Cancer Rates by Census Region in the United States, 1999-2008	PLOS ONE			English	Article							HISTOLOGY DIFFERENCES; OVERLAPPING REGIONS; NATIONAL PROGRAM; COMPARING TRENDS; GASTRIC CARDIA; SEER PROGRAM; EPIDEMIOLOGY; SURVEILLANCE; COMPLETENESS; CARCINOMAS	Background: Assessment of cancer incidence trends within the U.S. have mostly relied upon Surveillance, Epidemiology, and End Results (SEER) data, with implicit inference that such is representative of the general population. However, many cancer policy decisions are based at a more granular level. To help inform such, analyses of regional cancer incidence data are needed. Leveraging the unique resource of National Program of Cancer Registries (NPCR)-SEER, we assessed whether regional rates and trends of esophageal cancer significantly deviated from national estimates. Methods: From NPCR-SEER, we extracted cancer case counts and populations for whites aged 45-84 years by calendar year, histology, sex, and census region for the period 1999-2008. We calculated age-standardized incidence rates (ASRs), annual percent changes (APCs), and male-to-female incidence rate ratios (IRRs). Results: This analysis included 65,823 esophageal adenocarcinomas and 27,094 esophageal squamous cell carcinomas diagnosed during 778 million person-years. We observed significant geographic variability in incidence rates and trends, especially for esophageal adenocarcinomas in males: ASRs were highest in the Northeast (17.7 per 100,000) and Midwest (18.1). Both were significantly higher than the national estimate (16.0). In addition, the Northeast APC was 62% higher than the national estimate (3.19% vs. 1.97%). Lastly, IRRs remained fairly constant across calendar time, despite changes in incidence rates. Conclusion: Significant regional variations in esophageal cancer incidence trends exist in the U.S. Stable IRRs may indicate the predominant factors affecting incidence rates are similar in men and women.	[Drahos, Jennifer; Anderson, William F.; Rosenberg, Philip S.; Cook, Michael B.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Drahos, Jennifer] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Wu, Manxia; Trivers, Katrina F.; King, Jessica; Eheman, Christie] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Drahos, J (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	jennifer.drahos@nih.gov	Cook, Michael B/A-5641-2009	Cook, Michael B/0000-0002-0533-7302; Rosenberg, Philip/0000-0001-6349-9126; Drahos, Jennifer/0000-0002-8454-9863	Intramural Program of the National Cancer Institute at the National Institutes of Health and Department of Health and Human Services [CA00350]; NATIONAL CANCER INSTITUTE [ZIACP010183] Funding Source: NIH RePORTER	Intramural Program of the National Cancer Institute at the National Institutes of Health and Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Program of the National Cancer Institute at the National Institutes of Health and Department of Health and Human Services (CA00350). There are no financial disclosures from any of the authors. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG; [Anonymous], SAS 9 2; [Anonymous], 2000, CENSUS DATA SURVEILL; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Brown Linda Morris, 2002, Surg Oncol Clin N Am, V11, P235, DOI 10.1016/S1055-3207(02)00002-9; Centers for Disease Control and Prevention, NAT PROGR CANC REG U; Centers for Disease Control and Prevention. National Program of Cancer Registries (NPCR), TECHN NOT USCS PUBL; Centers for Disease Control and Prevention. National Program of Cancer Registries (NPCR), TECHN NOT STAT METH; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Edgren G, 2013, GUT; Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117; Kubo A, 2004, AM J GASTROENTEROL, V99, P582, DOI 10.1111/j.1572-0241.2004.04131.x; Kubo A, 2002, CANCER, V95, P2096, DOI 10.1002/cncr.10940; Li Y, 2008, BIOMETRICS, V64, P1280, DOI 10.1111/j.1541-0420.2008.01002.x; Li Y, 2008, BIOMETRICAL J, V50, P608, DOI 10.1002/bimj.200710430; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Surveillance Research Program National Cancer Institute, SEER STAT SOFTW VERS; Thoburn KK, 2007, CANCER-AM CANCER SOC, V109, P1607, DOI 10.1002/cncr.22566; Tiwari RC, 2006, STAT METHODS MED RES, V15, P547, DOI 10.1177/0962280206070621; Tiwari Ram C, 2010, J Data Sci, V8, P471; Trivers KF, 2008, INT J CANCER, V123, P1422, DOI 10.1002/ijc.23691; Walters Kimberly A, 2011, J Data Sci, V8, P631; Wingo PA, 2003, CANCER CAUSE CONTROL, V14, P175, DOI 10.1023/A:1023002322935; Wu XC, 2006, CANCER-AM CANCER SOC, V106, P683, DOI 10.1002/cncr.21542; Wu XC, 2007, CANCER CAUSE CONTROL, V18, P585, DOI 10.1007/s10552-007-9000-1; Younes M, 2002, SCAND J GASTROENTERO, V37, P1359, DOI 10.1080/003655202762671215; ZIPPIN C, 1995, CANCER, V76, P2343, DOI 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#	28	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67913	10.1371/journal.pone.0067913	http://dx.doi.org/10.1371/journal.pone.0067913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861830	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700058
J	Freed, LA; Cann, RL				Freed, Leonard A.; Cann, Rebecca L.			Females Lead Population Collapse of the Endangered Hawaii Creeper	PLOS ONE			English	Article							MISLEADING TREND ANALYSIS; PARENTAL CARE; SEX-RATIOS; BIRDS; EXTINCTION; DECLINE; COMPENSATION; CONSEQUENCES; REPRODUCTION; INVESTMENT	Population collapses result from drastic environmental changes, but the sexes may differ in vulnerability. Collapse of the endangered Hawaii creeper (Oreomystis mana) at Hakalau Forest National Wildlife Refuge resulted from food limitation associated with increased numbers of an introduced bird (Japanese white-eye, Zosterops japonicus), which competes with the creeper for food. Both creeper sexes had stunted bill growth and the greatest change in molt of native species in the community. With a surge in numbers of white-eyes, a recent cohort of adult females had very low survival after breeding, while adult males from the same cohort, and older females and males, continued to have high survival. Lower female survival resulted in a significantly more male-biased adult sex ratio. Recent low female survival was based on a great cost of reproduction, indicated by molt-breeding overlap that was previously avoided, and lower fat during the lengthy fledgling period. The difference in female survival between cohorts was associated with stunted bills from being reared in and then breeding in an increasingly poor food environment. Trend analysis of survey data indicate that the bird is declining throughout the refuge, with males being 72-80% of adults left six years after the white-eye increased. Competition over time was consistent with that previously documented over space on the Island of Hawaii. Adaptive management to recover the bird in this protected area needs to focus on improving both adult female survival and the adult sex ratio.	[Freed, Leonard A.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Cann, Rebecca L.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Freed, LA (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	lfreed@hawaii.edu			World Environment and Resources Program of the John D. and Catherine T. MacArthur Foundation [8900287]; Multiple Stressors of Wildlife Program of the Environmental Protection Agency [R82-9093]	World Environment and Resources Program of the John D. and Catherine T. MacArthur Foundation; Multiple Stressors of Wildlife Program of the Environmental Protection Agency	Funding was received from the World Environment and Resources Program of the John D. and Catherine T. MacArthur Foundation ($817,752)(8900287), and from the Multiple Stressors of Wildlife Program of the Environmental Protection Agency ($510,091)(R82-9093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1969, LIVING BIRD; Arnold KE, 2007, J AVIAN BIOL, V38, P356, DOI 10.1111/j.2007.0908-8857.03818.x; Arnqvist Goran, 2005, pUnpaginated; ATKINSON S, 1994, J REPROD FERTIL, V100, P225; Avise JC, 2008, P NATL ACAD SCI USA, V105, P11453, DOI 10.1073/pnas.0802504105; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Breitwisch R., 1989, Current Ornithology, V6, P1; Camp RJ, 2010, CONDOR, V112, P196, DOI 10.1525/cond.2010.080113; Camp RJ, 2009, HCSU011 U HAW HIL HA; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHARNOV E L, 1982; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; DeGroot M.H., 2002, PROBABILITY STAT; Diamond J.M., 1984, P824; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; DRENT RH, 1980, ARDEA, V68, P225; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; Freed LA, 2005, CONDOR, V107, P753, DOI 10.1650/7820.1; Freed Lenoard A., 2012, NeoBiota, V13, P43; Freed LA, 2008, J PARASITOL, V94, P1009, DOI 10.1645/GE-1378.1; Freed LA, 2013, CONDOR, V115, P442, DOI 10.1525/cond.2013.110165; Freed LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029834; Freed LA, 2010, CONDOR, V112, P213, DOI 10.1525/cond.2010.090092; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Freed LA, 2009, EVOL ECOL RES, V11, P731; Freed LA, 2008, EVOL ECOL RES, V10, P931; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; GAMBINO P, 1987, J TROP ECOL, V3, P169, DOI 10.1017/S0266467400001942; Green RE, 2008, P ROY SOC B-BIOL SCI, V275, P2381, DOI 10.1098/rspb.2008.0473; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Hart PJ, 2003, AUK, V120, P82, DOI 10.1642/0004-8038(2003)120[0082:SADOMF]2.0.CO;2; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jones KS, 2009, AM NAT, V174, P122, DOI 10.1086/599299; Kalmbach Ellen, 2007, P133; LAURIE WA, 1990, J ANIM ECOL, V59, P529, DOI 10.2307/4879; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Lens L, 1998, BIODIVERS CONSERV, V7, P869, DOI 10.1023/A:1008815606931; Lepson JK, 2002, BIRDS N AM; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Lindsey GD, 2009, CONSERVATION BIOL HA; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Medeiros MC, 2009, AUK, V126, P319, DOI 10.1525/auk.2009.08013; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MOUNTAINSPRING S, 1985, ECOL MONOGR, V55, P219, DOI 10.2307/1942558; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; MURPHY ME, 1988, CAN J ZOOL, V66, P1403, DOI 10.1139/z88-206; Nur N., 1990, NATO ASI Series Series G Ecological Sciences, V24, P281; Payne R.B., 1972, P103; Peck RW, 2008, BIOL INVASIONS, V10, P1441, DOI 10.1007/s10530-008-9218-1; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pratt Thane K., 2009, P552; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; RICHNER H, 1995, P NATL ACAD SCI USA, V92, P1192, DOI 10.1073/pnas.92.4.1192; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; Robinson RA, 2004, J ANIM ECOL, V73, P670, DOI 10.1111/j.0021-8790.2004.00841.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Russell EM, 2004, BEHAV ECOL, V15, P831, DOI 10.1093/beheco/arh088; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Scott J.M., 1986, STUD AVIAN BIOL, V9, P1; Scott SN, 2003, EVOLUTION, V57, P2147; Sherman PW, 2002, ECOLOGY, V83, P2816, DOI 10.1890/0012-9658(2002)083[2816:DOAPCT]2.0.CO;2; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Steifetten O, 2006, BIOL CONSERV, V132, P88, DOI 10.1016/j.biocon.2006.03.016; Stutchbury B.J.M., 2001, BEHAV ECOLOGY TROPIC; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V255, P147, DOI 10.1098/rspb.1994.0021; Szabo P, 2006, OIKOS, V112, P612, DOI 10.1111/j.0030-1299.2006.14128.x; Tilman David, 2007, P84; VanderWerf EA, 1998, CONDOR, V100, P541, DOI 10.2307/1369721; West SA, 2009, MONOGR POPUL BIOL, V44, P162; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Woodruff DS, 2001, P NATL ACAD SCI USA, V98, P5471, DOI 10.1073/pnas.101093798; Woodworth BL, 2001, STUD AVIAN BIOL-SER, P164	81	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67914	10.1371/journal.pone.0067914	http://dx.doi.org/10.1371/journal.pone.0067914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861831	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700059
J	Lamb, R; Ablett, MP; Spence, K; Landberg, G; Sims, AH; Clarke, RB				Lamb, Rebecca; Ablett, Matthew P.; Spence, Katherine; Landberg, Goeran; Sims, Andrew H.; Clarke, Robert B.			Wnt Pathway Activity in Breast Cancer Sub-Types and Stem-Like Cells	PLOS ONE			English	Article							MEDIATES RADIATION-RESISTANCE; SIGNALING PATHWAY; BETA-CATENIN; HISTOLOGIC GRADE; GROWTH-FACTOR; EXPRESSION; GENE; PROTEIN; POPULATION; MARKER	Introduction: Wnt signalling has been implicated in stem cell regulation however its role in breast cancer stem cell regulation remains unclear. Methods: We used a panel of normal and breast cancer cell lines to assess Wnt pathway gene and protein expression, and for the investigation of Wnt signalling within stem cell-enriched populations, mRNA and protein expression was analysed after the selection of anoikis-resistant cells. Finally, cell lines and patient-derived samples were used to investigate Wnt pathway effects on stem cell activity in vitro. Results: Wnt pathway signalling increased in cancer compared to normal breast and in both cell lines and patient samples, expression of Wnt pathway genes correlated with estrogen receptor (ER) expression. Furthermore, specific Wnt pathway genes were predictive for recurrence within subtypes of breast cancer. Canonical Wnt pathway genes were increased in breast cancer stem cell-enriched populations in comparison to normal breast stem cell-enriched populations. Furthermore in cell lines, the ligand Wnt3a increased whilst the inhibitor DKK1 reduced mammosphere formation with the greatest inhibitory effects observed in ER+ve breast cancer cell lines. In patient-derived metastatic breast cancer samples, only ER-ve mammospheres were responsive to the ligand Wnt3a. However, the inhibitor DKK1 efficiently inhibited both ER+ve and ER-ve breast cancer but not normal mammosphere formation, suggesting that the Wnt pathway is aberrantly activated in breast cancer mammospheres. Conclusions: Collectively, these data highlight differential Wnt signalling in breast cancer subtypes and activity in patient-derived metastatic cancer stem-like cells indicating a potential for Wnt-targeted treatment in breast cancers.	[Lamb, Rebecca; Landberg, Goeran] Univ Manchester, Breakthrough Breast Canc Res Unit, Manchester, Lancs, England; [Ablett, Matthew P.; Spence, Katherine; Clarke, Robert B.] Univ Manchester, Breast Biol Grp, Manchester, Lancs, England; [Sims, Andrew H.] Edinburgh Canc Res Ctr, Appl Bioinformat Canc, Edinburgh, Midlothian, Scotland	University of Manchester; University of Manchester; University of Edinburgh	Lamb, R (corresponding author), Univ Manchester, Breakthrough Breast Canc Res Unit, Manchester, Lancs, England.	rlamb@picr.man.ac.uk; Robert.clarke@manchester.ac.uk	Clarke, Robert/AAA-3442-2021; spence, kath/C-1599-2019; Sims, Andrew/E-4819-2012	Clarke, Robert/0000-0001-5407-3123; spence, kath/0000-0002-8137-165X; Sims, Andrew/0000-0001-9082-3665	Breast Cancer Campaign; Breast Cancer Now [EDN-DIXON] Funding Source: researchfish	Breast Cancer Campaign; Breast Cancer Now	The study was supported by Breast Cancer Campaign (R.B. Clarke) (http://www.breastcancercampaign.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Brisken C, 2000, GENE DEV, V14, P650; Calza S, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1517; Chen MS, 2007, J CELL SCI, V120, P468, DOI 10.1242/jcs.03348; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Collu GM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1671; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jonsson M, 2002, CANCER RES, V62, P409; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; KALER P, 2009, CANC MICROENVIRON; Khalil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033421; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Klopocki E, 2004, INT J ONCOL, V25, P641; Leandersson K, 2006, NUCLEIC ACIDS RES, V34, P3988, DOI 10.1093/nar/gkl571; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; MacDonald BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023537; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Singh JK, 2013, CLIN CANCER RES, V19, P643, DOI 10.1158/1078-0432.CCR-12-1063; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Su HY, 2010, INT J CANCER, V127, P555, DOI 10.1002/ijc.25083; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Veeck J, 2008, CARCINOGENESIS, V29, P991, DOI 10.1093/carcin/bgn076; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xie D, 2001, CANCER RES, V61, P8917; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhou XL, 2010, ACTA PHARMACOL SIN, V31, P202, DOI 10.1038/aps.2009.200	51	100	104	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67811	10.1371/journal.pone.0067811	http://dx.doi.org/10.1371/journal.pone.0067811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861811	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700039
J	Parra, M; Liu, X; Derrick, SC; Yang, A; Tian, JH; Kolibab, K; Kumar, S; Morris, SL				Parra, Marcela; Liu, Xia; Derrick, Steven C.; Yang, Amy; Tian, Jinhua; Kolibab, Kristopher; Kumar, Sanjai; Morris, Sheldon L.			Molecular Analysis of Non-Specific Protection against Murine Malaria Induced by BCG Vaccination	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; PLASMODIUM-FALCIPARUM; ANTIMICROBIAL PEPTIDE; MICE; CATHELICIDIN; INFECTION; EOSINOPHIL; TUBERCULOSIS; METAANALYSIS; MORTALITY	Although the effectiveness of BCG vaccination in preventing adult pulmonary tuberculosis (TB) has been highly variable, epidemiologic studies have suggested that BCG provides other general health benefits to vaccinees including reducing the impact of asthma, leprosy, and possibly malaria. To further evaluate whether BCG immunization protects against malarial parasitemia and to define molecular correlates of this non-specific immunity, mice were vaccinated with BCG and then challenged 2 months later with asexual blood stage Plasmodium yoelii 17XNL (PyNL) parasites. Following challenge with PyNL, significant decreases in parasitemia were observed in BCG vaccinated mice relative to naive controls. To identify immune molecules that may be associated with the BCG-induced protection, gene expression was evaluated by RT-PCR in i) naive controls, ii) BCG-vaccinated mice, iii) PyNL infected mice and iv) BCG vaccinated/PyNL infected mice at 0, 1, 5, and 9 days after the P. yoelii infection. The expression results showed that i) BCG immunization induces the expression of at least 18 genes including the anti-microbial molecules lactoferrin, eosinophil peroxidase, eosinophil major basic protein and the cathelicidin-related antimicrobial peptide (CRAMP); ii) an active PyNL infection suppresses the expression of important immune response molecules; and iii) the extent of PyNL-induced suppression of specific genes is reduced in BCG-vaccinated/PyNL infected mice. To validate the gene expression data, we demonstrated that pre-treatment of malaria parasites with lactoferrin or the cathelicidin LL-37 peptide decreases the level of PyNL parasitemias in mice. Overall, our study suggests that BCG vaccination induces the expression of non-specific immune molecules including antimicrobial peptides which may provide an overall benefit to vaccinees by limiting infections of unrelated pathogens such as Plasmodium parasites.	[Parra, Marcela; Liu, Xia; Derrick, Steven C.; Yang, Amy; Tian, Jinhua; Kolibab, Kristopher; Kumar, Sanjai; Morris, Sheldon L.] USFDA, Ctr Biol Evaluat & Review, Bethesda, MD USA	US Food & Drug Administration (FDA)	Morris, SL (corresponding author), USFDA, Ctr Biol Evaluat & Review, Bethesda, MD USA.	sheldon.morris@fda.hhs.gov			FDA	FDA(United States Department of Health & Human Services)	FDA internal funding supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2011, HUM VACCINES, V7, P120, DOI 10.4161/hv.7.1.13848; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; Chromek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046476; Cirioni O, 2008, SHOCK, V30, P443, DOI 10.1097/SHK.0b013e31816d2269; CLARK IA, 1976, NATURE, V259, P309, DOI 10.1038/259309a0; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; D'Avila H, 2007, INFECT IMMUN, V75, P1507, DOI 10.1128/IAI.01326-06; Dean SN, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-114; El-Zein M, 2010, INT J EPIDEMIOL, V39, P469, DOI 10.1093/ije/dyp307; FRITSCH G, 1987, EXP PARASITOL, V63, P1, DOI 10.1016/0014-4894(87)90072-5; Goter-Robinson C, 2006, VACCINE, V24, P3522, DOI 10.1016/j.vaccine.2006.02.005; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Kin NW, 2011, EUR J IMMUNOL, V41, P3006, DOI 10.1002/eji.201141606; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Leversen NA, 2012, SCAND J IMMUNOL, V75, P489, DOI 10.1111/j.1365-3083.2012.02683.x; LEVINE MI, 1946, AM REV TUBERC PULM, V53, P517; Lim J, 2009, CLIN VACCINE IMMUNOL, V16, P122, DOI 10.1128/CVI.00359-08; Malik A, 2012, CRIT REV MICROBIOL, V38, P168, DOI 10.3109/1040841X.2011.645519; Mendez-Samperio P, 2008, CLIN VACCINE IMMUNOL, V15, P1450, DOI 10.1128/CVI.00178-08; Mendez-Samperio P, 2010, PEPTIDES, V31, P1791, DOI 10.1016/j.peptides.2010.06.016; MenezesdeLimaJunior O, 1997, J LEUKOCYTE BIOL, V62, P778, DOI 10.1002/jlb.62.6.778; Merle CSC, 2010, EXPERT REV VACCINES, V9, P209, DOI 10.1586/ERV.09.161; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Mollenkopf HJ, 2006, MICROBES INFECT, V8, P136, DOI 10.1016/j.micinf.2005.06.015; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nizet V, 2003, SCAND J INFECT DIS, V35, P670, DOI 10.1080/00365540310015629; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; ORTIZORTIZ L, 1975, J IMMUNOL, V114, P1424; POST CLA, 1992, REV SAUDE PUBL, V26, P369, DOI 10.1590/S0034-89101992000600001; Rivas-Santiago B, 2012, INT J ANTIMICROB AGE; Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392; Shakibaei M, 1996, J EXP MED, V184, P1699, DOI 10.1084/jem.184.5.1699; SMRKOVSKI LL, 1978, J IMMUNOL, V121, P1257; Sonawane A, 2011, CELL MICROBIOL, V13, P1601, DOI 10.1111/j.1462-5822.2011.01644.x; TABBARA KF, 1975, AM J OPHTHALMOL, V79, P641, DOI 10.1016/0002-9394(75)90804-1; TRNKA L, 1994, TUBERCLE LUNG DIS, V75, P348, DOI 10.1016/0962-8479(94)90080-9; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; VELEMA JP, 1991, INT J EPIDEMIOL, V20, P474, DOI 10.1093/ije/20.2.474; WATERS LS, 1987, INFECT IMMUN, V55, P877, DOI 10.1128/IAI.55.4.877-881.1987; Were T, 2009, MICROBES INFECT, V11, P811, DOI 10.1016/j.micinf.2009.04.021; Williams SK, 2010, EXPERT OPIN PHARMACO, V11, P947, DOI 10.1517/14656561003657145; Wuerth K, 2011, EUR J IMMUNOL, V41, P2817, DOI 10.1002/eji.201142055; Zheng W, 2009, FOLIA PARASIT, V56, P242, DOI 10.14411/fp.2009.028	44	38	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e66115	10.1371/journal.pone.0066115	http://dx.doi.org/10.1371/journal.pone.0066115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861742	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700005
J	Yim, SA; Lim, YS; Kim, JW; Hwang, SB				Yim, Seung-Ae; Lim, Yun-Sook; Kim, Jong-Wook; Hwang, Soon B.			Nonstructural 5A Protein of Hepatitis C Virus Interacts with Pyruvate Carboxylase and Modulates Viral Propagation	PLOS ONE			English	Article							MEDIATED APOPTOSIS; INFECTIOUS VIRUS; LIPID DROPLET; CELL-DEATH; MITOCHONDRIA; REPLICATION; PROMOTER; BINDING; CORE; NS5A	Hepatitis C virus (HCV) is highly dependent on cellular factors for its own propagation. By employing tandem affinity purification method, we identified pyruvate carboxylase (PC) as a cellular partner for NS5A protein. NS5A interacted with PC through the N-terminal region of NS5A and the biotin carboxylase domain of PC. PC expression was decreased in cells expressing NS5A and HCV-infected cells. Promoter activity of PC was also decreased by NS5A protein. However, FAS expression was increased in cells expressing NS5A and cell culture grown HCV (HCVcc)-infected cells. Silencing of PC promoted fatty acid synthase (FAS) expression level. These data suggest HCV may modulate PC via NS5A protein for its own propagation.	[Yim, Seung-Ae; Lim, Yun-Sook; Kim, Jong-Wook; Hwang, Soon B.] Hallym Univ, Ilsong Inst Life Sci, Natl Res Lab Hepatitis Virus C, Anyang, South Korea	Hallym University	Hwang, SB (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Natl Res Lab Hepatitis Virus C, Anyang, South Korea.	sbhwang@hallym.ac.kr			Ministry of Education, Science and Technology, Korea [2008-2004100, 2012026351]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea [1020290]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea	This work was supported by Basic Science Research Program (2012026351) and Biotechnology Development (2008-2004100) from the Ministry of Education, Science and Technology, Korea, and by the National R&D Program (1020290) for Cancer Control, Ministry for Health and Welfare, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Boonsaen T, 2007, BIOCHEM J, V405, P359, DOI 10.1042/BJ20070276; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; Clippinger AJ, 2008, J VIROL, V82, P6798, DOI 10.1128/JVI.00154-08; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Garcia-Arcos I, 2010, LIPIDS, V45, P1101, DOI 10.1007/s11745-010-3492-2; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lim YS, 2011, J BIOL CHEM, V286, P11290, DOI 10.1074/jbc.M110.194472; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lonardo A, 2006, J VIRAL HEPATITIS, V13, P73, DOI 10.1111/j.1365-2893.2005.00669.x; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Marin-Valencia I, 2010, MOL GENET METAB, V101, P9, DOI 10.1016/j.ymgme.2010.05.004; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moon HS, 2006, MOL CELLS, V21, P7; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; ROBINSON BH, 1984, AM J HUM GENET, V36, P283; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Takahara Y, 2008, WORLD J GASTROENTERO, V14, P2010, DOI 10.3748/wjg.14.2010; Wang JD, 2006, FEBS LETT, V580, P4392, DOI 10.1016/j.febslet.2006.07.002	31	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68170	10.1371/journal.pone.0068170	http://dx.doi.org/10.1371/journal.pone.0068170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861867	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700074
J	Abolafya, M; Onmus, O; Sekercioglu, CH; Bilgin, R				Abolafya, Moris; Onmus, Ortac; Sekercioglu, Cagan H.; Bilgin, Rasit			Using Citizen Science Data to Model the Distributions of Common Songbirds of Turkey Under Different Global Climatic Change Scenarios	PLOS ONE			English	Article							RANGE SHIFTS; BIRDS; COMMUNITY; RESPONSES; PATTERNS; IMPACTS	In this study, we evaluated the potential impact of climate change on the distributions of Turkey's songbirds in the 21st century by modelling future distributions of 20 resident and nine migratory species under two global climate change scenarios. We combined verified data from an ornithological citizen science initiative (www.kusbank.org) with maximum entropy modeling and eight bioclimatic variables to estimate species distributions and projections for future time periods. Model predictions for resident and migratory species showed high variability, with some species projected to lose and others projected to gain suitable habitat. Our study helps improve the understanding of the current and potential future distributions of Turkey's songbirds and their responses to climate change, highlights effective strategies to maximize avian conservation efforts in the study region, and provides a model for using citizen science data for biodiversity research in a large developing country with few professional field biologists. Our results demonstrate that climate change will not affect every species equally in Turkey. Expected range reductions in some breeding species will increase the risk of local extinction, whereas others are likely to expand their ranges.	[Abolafya, Moris; Bilgin, Rasit] Bogazici Univ, Inst Environm Sci, Istanbul, Turkey; [Onmus, Ortac] Ege Univ, Dept Biol, Nat Hist Museum, Res & Applicat Ctr, Izmir, Turkey; [Sekercioglu, Cagan H.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Sekercioglu, Cagan H.] KuzeyDoga Dernegi, Kars, Turkey	Bogazici University; Ege University; Ministry of Culture & Tourism - Turkey; Ministry of Energy & Natural Resources - Turkey; Utah System of Higher Education; University of Utah	Bilgin, R (corresponding author), Bogazici Univ, Inst Environm Sci, Istanbul, Turkey.	rasit.bilgin@boun.edu.tr	Onmuş, Ortaç/I-4717-2015; Bilgin, Rasit/A-3129-2016; Sekercioglu, Cagan H/A-2331-2013	Sekercioglu, Cagan H/0000-0001-9639-294X; Sekercioglu, Cagan H./0000-0003-3193-0377	Research Fund of Bogazici University in Istanbul [11Y00D6]	Research Fund of Bogazici University in Istanbul(Bogazici University)	This study was supported by a grant (No: 11Y00D6) from the Research Fund of Bogazici University in Istanbul to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, KUSB BIRD DAT; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Barbet-Massin M, 2009, BIOL LETTERS, V5, P248, DOI 10.1098/rsbl.2008.0715; Bilgin R, 2012, ACTA CHIROPTEROL, V14, P425, DOI 10.3161/150811012X661747; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bozdogan M., 2006, TURKIYENIN ONEMLI DO; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Jonzen N, 2007, CLIM RES, V35, P177, DOI 10.3354/cr00724; Kesisoglu A, 2010, DISTRIBUTION PATTERN; Kirwan G.M., 2008, BIRDS TURKEY; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Menzel A, 2002, CLIMATIC CHANGE, V54, P379, DOI 10.1023/A:1016125215496; Monahan WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042097; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Peh KSH, 2007, CONDOR, V109, P437, DOI 10.1650/0010-5422(2007)109[437:PEOCCO]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Ramirez J, 2009, WORKING CLIMATE DATA; Rissler LJ, 2006, AM NAT, V167, P655, DOI 10.1086/503332; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roselaar C.S., 1995, SONGBIRDS TURKEY ATL; Schaefer HC, 2008, GLOBAL ECOL BIOGEOGR, V17, P38, DOI 10.1111/j.1466-8238.2007.00341.x; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V151, P69, DOI 10.1016/j.biocon.2011.10.024; Sekercioglu CH, 2011, BIOL CONSERV, V144, P2752, DOI 10.1016/j.biocon.2011.06.025; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tryjanowski P, 2002, IBIS, V144, P62, DOI 10.1046/j.0019-1019.2001.00022.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wood C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001220; Wormworth J, 2011, WINGED SENTINELS: BIRDS AND CLIMATE CHANGE, P1, DOI 10.1017/CBO9781139150026	47	20	21	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68037	10.1371/journal.pone.0068037	http://dx.doi.org/10.1371/journal.pone.0068037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844151	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000126
J	Choi, K; Park, J; Lee, J; Han, EC; Choi, C				Choi, Kyungsun; Park, Junseong; Lee, Jungsul; Han, Eun Chun; Choi, Chulhee			Mutant Ubiquitin Attenuates Interleukin-1 beta- and Tumor Necrosis Factor-alpha-Induced Pro-Inflammatory Signaling in Human Astrocytic Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MITOCHONDRIAL DYNAMICS; POLYUBIQUITIN CHAINS; PROTEASOME; EXPRESSION; ACCUMULATION; DEGENERATION; INHIBITION; ACTIVATION; DISORDERS	A frameshift mutation of ubiquitin called ubiquitin(+1) (UBB+1) was found in the aging and Alzheimer's disease brains and thought to be associated with neuronal dysfuction and degeneration. Even though ubiquitylation has been known to regulate vital cellular functions mainly through proteasome-dependent degradation of polyubiquitinated substrates, proteolysis-independent roles of ubiquitylation have emerged as key mechanisms in various signaling cascades. In this study, we have investigated the effect of UBB+1 on proinflammatory signaling such as interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) in human astrocytes. Treatment with TNF-alpha and IL-1 beta induced expression of CCL2 and CXCL8 by human astrocytic cells; while ectopic expression of UBB+1 significantly abrogated the proinflammatory cytokine-induced expression of chemokines. Ectopic expression of UBB+1 suppressed TNF-alpha- and IL-1 beta-induced activation of NF-kappa B and JNK signaling pathway. Furthermore, we have demonstrated that polyubiquitylation of TRAFs and subsequent phosphorylation of TAK1 were significantly inhibited by stable expression of UBB+1. Collectively, these results suggest that UBB+1 may affect proinflammatory signaling in the central nervous system via inhibitory mechanisms of ubiquitin-dependent signaling in human astrocytes.	[Choi, Kyungsun; Park, Junseong; Lee, Jungsul; Choi, Chulhee] Korea Adv Inst Sci & Technol, Cell Signaling & BioImaging Lab, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Park, Junseong; Choi, Chulhee] Korea Adv Inst Sci & Technol, KI BioCentury, Taejon 305701, South Korea; [Han, Eun Chun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Choi, K (corresponding author), Korea Adv Inst Sci & Technol, Cell Signaling & BioImaging Lab, Dept Bio & Brain Engn, Taejon 305701, South Korea.	ccbioks@kaist.ac.kr; cchoi@kaist.ac.kr	Lee, Jungsul/A-7851-2013; Park, Junseong/C-1973-2012; Choi, Chulhee/C-1642-2011	Lee, Jungsul/0000-0002-8600-5851; Choi, Chulhee/0000-0001-5542-9136	National Research Foundation of Korea (NRF) grant [2012R1A2A4A01007108]; Korea government(MEST)	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant (No. 2012R1A2A4A01007108) funded by the Korea government(MEST) (to C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Chadwick L, 2012, NEUROPATH APPL NEURO, V38, P118, DOI 10.1111/j.1365-2990.2011.01236.x; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Choi C, 2002, MOL CELL BIOL, V22, P724, DOI 10.1128/MCB.22.3.724-736.2002; Choi KS, 2007, FEBS LETT, V581, P4691, DOI 10.1016/j.febslet.2007.08.065; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Pril R, 2006, NEUROBIOL AGING, V27, P515, DOI 10.1016/j.neurobiolaging.2005.04.016; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; De Vrij FMS, 2001, FASEB J, V15, P2680, DOI 10.1096/fj.01-0438com; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Escobar-Henriques M, 2012, BIOCHIM BIOPHYS ACTA, V1833, P162; Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com; Fratta P, 2004, NEUROLOGY, V63, P1114, DOI 10.1212/01.WNL.0000138574.56908.5D; Hol EM, 2005, TRENDS MOL MED, V11, P488, DOI 10.1016/j.molmed.2005.09.001; Jones RW, 2001, LANCET, V358, P436, DOI 10.1016/S0140-6736(01)05667-7; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee J, 2010, BIOCHEM BIOPH RES CO, V391, P33, DOI 10.1016/j.bbrc.2009.10.155; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Majumder S, 1996, J NEUROSCI RES, V45, P758, DOI 10.1002/(SICI)1097-4547(19960915)45:6<758::AID-JNR12>3.0.CO;2-S; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Olive M, 2008, NEUROPATH APPL NEURO, V34, P76, DOI 10.1111/j.1365-2990.2007.00864.x; Owens T, 2005, BRAIN RES REV, V48, P178, DOI 10.1016/j.brainresrev.2004.12.007; Ransohoff RM, J CLIN INVEST, V122, P1164; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P101, DOI 10.1016/j.bbadis.2011.10.016; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tan Z, 2007, CELL DEATH DIFFER, V14, P1721, DOI 10.1038/sj.cdd.4402180; Tank EMH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000382; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; van Tijn P, 2012, NEUROCHEM INT, V61, P739, DOI 10.1016/j.neuint.2012.07.007; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Weninger SC, 2001, NAT MED, V7, P527, DOI 10.1038/87839; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamasaki T, 2012, J SIGNAL TRANSDUCT	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67891	10.1371/journal.pone.0067891	http://dx.doi.org/10.1371/journal.pone.0067891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844119	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000111
J	Edwards, MA; Derocher, AE; Nagy, JA				Edwards, Mark A.; Derocher, Andrew E.; Nagy, John A.			Home Range Size Variation in Female Arctic Grizzly Bears Relative to Reproductive Status and Resource Availability	PLOS ONE			English	Article							LONG-DISTANCE MOVEMENTS; BROWN BEARS; POPULATION-DYNAMICS; HABITAT SELECTION; CENTRAL AUSTRALIA; CENTRAL ALBERTA; URSUS-ARCTOS; BLACK BEARS; MULE DEER; STRATEGIES	The area traversed in pursuit of resources defines the size of an animal's home range. For females, the home range is presumed to be a function of forage availability. However, the presence of offspring may also influence home range size due to reduced mobility, increased nutritional need, and behavioral adaptations of mothers to increase offspring survival. Here, we examine the relationship between resource use and variation in home range size for female barren-ground grizzly bears (Ursus arctos) of the Mackenzie Delta region in Arctic Canada. We develop methods to test hypotheses of home range size that address selection of cover where cover heterogeneity is low, using generalized linear mixed-effects models and an information-theoretic approach. We found that the reproductive status of female grizzlies affected home range size but individually-based spatial availability of highly selected cover in spring and early summer was a stronger correlate. If these preferred covers in spring and early summer, a period of low resource availability for grizzly bears following den-emergence, were patchy and highly dispersed, females travelled farther regardless of the presence or absence of offspring. Increased movement to preferred covers, however, may result in greater risk to the individual or family.	[Edwards, Mark A.] Govt Alberta, Royal Alberta Museum, Edmonton, AB, Canada; [Edwards, Mark A.; Derocher, Andrew E.; Nagy, John A.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Edwards, MA (corresponding author), Govt Alberta, Royal Alberta Museum, Edmonton, AB, Canada.	mark.edwards@gov.ab.ca	Derocher, Andrew/J-4469-2012	Derocher, Andrew/0000-0002-1104-7774	University of Alberta; Inuvialuit Land Claim Wildlife Studies Implementation Fund; Alberta Cooperative Conservation Research Unit; Western Biophysical Program of the Government of Northwest Territories; Polar Continental Shelf Project; Endangered Species Recovery Fund - World Wildlife Fund; Lorraine Allison Scholarship Trust Fund; Circumpolar/Boreal Alberta Research Grant; Indian and Northern Affairs Canada Northern Scientific Training Program; Natural Sciences and Engineering Research Council of Canada; ConocoPhillips (North) Canada Limited; Government of Northwest Territories; Department of Environment and Natural Resources (Inuvik Region)	University of Alberta(University of Alberta); Inuvialuit Land Claim Wildlife Studies Implementation Fund; Alberta Cooperative Conservation Research Unit; Western Biophysical Program of the Government of Northwest Territories; Polar Continental Shelf Project(Natural Resources Canada); Endangered Species Recovery Fund - World Wildlife Fund; Lorraine Allison Scholarship Trust Fund; Circumpolar/Boreal Alberta Research Grant; Indian and Northern Affairs Canada Northern Scientific Training Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ConocoPhillips (North) Canada Limited; Government of Northwest Territories; Department of Environment and Natural Resources (Inuvik Region)	Funding for this study was provided by the University of Alberta, Government of Northwest Territories, Department of Environment and Natural Resources (Inuvik Region), the Inuvialuit Land Claim Wildlife Studies Implementation Fund, ConocoPhillips (North) Canada Limited, Alberta Cooperative Conservation Research Unit, Western Biophysical Program of the Government of Northwest Territories, Polar Continental Shelf Project, Endangered Species Recovery Fund - World Wildlife Fund, Lorraine Allison Scholarship Trust Fund (http://www.arctic.ucalgary.ca/scholarships/the-lorraine-allison-memorial-scholarship), Circumpolar/Boreal Alberta Research Grant (http://www.ualberta.ca/ccinst/GRANTS/grants.html#cbar), Indian and Northern Affairs Canada Northern Scientific Training Program, and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by ConocoPhillips (North) Canada Limited. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agrell J, 1998, OIKOS, V83, P507, DOI 10.2307/3546678; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; [Anonymous], 1987, BEARS BIOL MANAG; BALLARD WB, 1982, CAN FIELD NAT, V96, P1; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; BEYER HL, 2005, HAWTHS ANAL TOOLS AR; BLANCHARD BM, 1991, BIOL CONSERV, V58, P41, DOI 10.1016/0006-3207(91)90044-A; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Chatterjee S., 2015, REGRESSION ANAL EXAM; CLARK BK, 1988, AM MIDL NAT, V120, P276, DOI 10.2307/2425999; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; Duda R. O., 1973, PATTERN CLASSIFICATI; Edwards MA, 2011, OECOLOGIA, V165, P877, DOI 10.1007/s00442-010-1869-9; Edwards MA, 2009, ANIM BEHAV, V77, P23, DOI 10.1016/j.anbehav.2008.09.025; Ferguson SH, 2000, ECOGRAPHY, V23, P193, DOI 10.1034/j.1600-0587.2000.230205.x; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Fryxell J.M., 1997, INDIVIDUAL BEHAV COM; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Haythornthwaite AS, 2006, J ZOOL, V270, P543, DOI 10.1111/j.1469-7998.2006.00186.x; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; HOSMER DW, 1989, APPL LOGISTIC REGRES; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Huberty C.J., 1994, APPL DISCRIMINANT AN; Illius A.W., 2006, LARGE HERBIVORE ECOL, P71; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; KOZAKIEWICZ M, 1993, LANDSCAPE ECOL, V8, P19, DOI 10.1007/BF00129864; Labisky RF, 1998, J WILDLIFE MANAGE, V62, P1329, DOI 10.2307/3801998; Lambert JDH, 1972, MACKENZIE DELTA AREA, P51; Letnic Mike, 2002, Australian Mammalogy, V23, P125; Liberg O, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P221; LINDZEY FG, 1977, J WILDLIFE MANAGE, V41, P413, DOI 10.2307/3800510; Logan K.A., 2001, DESERT PUMA EVOLUTIO; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACHUTCHON A.G., 1996, GRIZZY BEAR HABITAT; Mackay JR, 1963, DEP MINES TECHNICAL, V8; Manly B.F.J., 2002, RESOURCE SELECTION A; Matson TK, 2007, J ZOOL, V271, P318, DOI 10.1111/j.1469-7998.2006.00216.x; McCune B., 2011, PC ORD MULTIVARIATE; McGarigal K., 1994, FRAGSTATS SPATIAL PA, V2, P128; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; McLoughlin PD, 2000, ECOSCIENCE, V7, P123, DOI 10.1080/11956860.2000.11682580; McLoughlin PD, 2003, ECOSCIENCE, V10, P11, DOI 10.1080/11956860.2003.11682744; McLoughlin Philip D., 1999, Ursus, V11, P79; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; MILNE BT, 1992, AM NAT, V139, P32, DOI 10.1086/285312; Ministry of Natural Resources, 2000, CAN DIG EL DAT; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nagy J.A., 1983, STUDY GRIZZLY BEARS; Nicholson MC, 1997, J MAMMAL, V78, P483, DOI 10.2307/1382900; Nielsen SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053721; Oftedal O.T., 1985, P215; Phillips MK, 1987, URSUS, V68, P1645; Porsild AE, 1980, VASCULAR PLANTS CONT; Powell R.A., 1997, ECOLOGY BEHAV N AM B; Rabe-Hesketh S, 2004, HDB STAT ANAL USING; REDPATH SM, 1995, J ANIM ECOL, V64, P652, DOI 10.2307/5807; REYNOLDS DG, 1980, INT C BEAR RES MANAG, V4, P181; Royall R., 1997, STAT EVIDENCE LIKELI; Said S, 2005, J ZOOL, V267, P301, DOI 10.1017/S0952836905007454; Sandell M., 1989, P164; SAUER PEGGY R., 1966, N Y FISH GAME J, V13, P125; Savage RE, 1931, FISHERY INVESTIGATIO, V2, P1; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Skrondal A., 2004, GEN LATENT VARIABLE; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Unlimited Ducks, 2002, LOW MACK RIV DELT NW; Viereck LA, 1992, PNWGTR286 USDA; WIELGUS RB, 1995, J WILDLIFE MANAGE, V59, P552, DOI 10.2307/3802462; WISHART D, 1969, BIOMETRICS, V25, P165, DOI 10.2307/2528688; WOODBURY MR, 1996, CHEM IMMOBILIZATION; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; YOUNG BF, 1982, J WILDLIFE MANAGE, V46, P845, DOI 10.2307/3808217; Zar JH, 1999, BIOSTATISTICAL ANAL	84	16	16	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68130	10.1371/journal.pone.0068130	http://dx.doi.org/10.1371/journal.pone.0068130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844162	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000130
J	Kang, DW; Park, JG; Ilhan, ZE; Wallstrom, G; LaBaer, J; Adams, JB; Krajmalnik-Brown, R				Kang, Dae-Wook; Park, Jin Gyoon; Ilhan, Zehra Esra; Wallstrom, Garrick; LaBaer, Joshua; Adams, James B.; Krajmalnik-Brown, Rosa			Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children	PLOS ONE			English	Article							GUT MICROBIOTA; DIVERSITY; MERCURY; GLUTATHIONE; BACTERIA; RATS	High proportions of autistic children suffer from gastrointestinal (GI) disorders, implying a link between autism and abnormalities in gut microbial functions. Increasing evidence from recent high-throughput sequencing analyses indicates that disturbances in composition and diversity of gut microbiome are associated with various disease conditions. However, microbiome-level studies on autism are limited and mostly focused on pathogenic bacteria. Therefore, here we aimed to define systemic changes in gut microbiome associated with autism and autism-related GI problems. We recruited 20 neurotypical and 20 autistic children accompanied by a survey of both autistic severity and GI symptoms. By pyrosequencing the V2/V3 regions in bacterial 16S rDNA from fecal DNA samples, we compared gut microbiomes of GI symptom-free neurotypical children with those of autistic children mostly presenting GI symptoms. Unexpectedly, the presence of autistic symptoms, rather than the severity of GI symptoms, was associated with less diverse gut microbiomes. Further, rigorous statistical tests with multiple testing corrections showed significantly lower abundances of the genera Prevotella, Coprococcus, and unclassified Veillonellaceae in autistic samples. These are intriguingly versatile carbohydrate-degrading and/or fermenting bacteria, suggesting a potential influence of unusual diet patterns observed in autistic children. However, multivariate analyses showed that autism-related changes in both overall diversity and individual genus abundances were correlated with the presence of autistic symptoms but not with their diet patterns. Taken together, autism and accompanying GI symptoms were characterized by distinct and less diverse gut microbial compositions with lower levels of Prevotella, Coprococcus, and unclassified Veillonellaceae.	[Kang, Dae-Wook; Ilhan, Zehra Esra; Krajmalnik-Brown, Rosa] Arizona State Univ, Swette Ctr Environm Biotechnol, Biodesign Inst, Tempe, AZ 85069 USA; [Park, Jin Gyoon; Wallstrom, Garrick; LaBaer, Joshua] Arizona State Univ, Virginia G Piper Ctr Personalized Diagnost, Biodesign Inst, Tempe, AZ USA; [Wallstrom, Garrick] Arizona State Univ, Dept Biomed Informat, Scottsdale, AZ USA; [Adams, James B.] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ USA; [Krajmalnik-Brown, Rosa] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Krajmalnik-Brown, R (corresponding author), Arizona State Univ, Swette Ctr Environm Biotechnol, Biodesign Inst, Tempe, AZ 85069 USA.	Dr.Rosy@asu.edu	Krajmalnik-Brown, Rosa/AAA-4803-2021; Romanova, Raisa/O-5724-2018; Kang, Dae-Wook/AAP-3589-2020	Kang, Dae-Wook/0000-0002-2585-1974; Ilhan, Zehra Esra/0000-0002-3387-9424; Krajmalnik-Brown, Rosa/0000-0001-6064-3524	Autism Research Institute (San Diego, CA)	Autism Research Institute (San Diego, CA)	This research was funded by Autism Research Institute (San Diego, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. B., 2008, Toxicological and Environmental Chemistry, V90, P739, DOI 10.1080/02772240701699294; Adams JB, 2007, J TOXICOL ENV HEAL A, V70, P1046, DOI 10.1080/15287390601172080; Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; Daly K, 2012, BRIT J NUTR, V107, P989, DOI 10.1017/S0007114511003825; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Finegold SM, 2011, MED HYPOTHESES, V77, P270, DOI 10.1016/j.mehy.2011.04.032; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gronow S, 2010, STAND GENOMIC SCI, V2, P57, DOI 10.4056/sigs.521107; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hashizume K, 2003, J NUTR, V133, P3187, DOI 10.1093/jn/133.10.3187; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Horvath K, 1999, J PEDIATR-US, V135, P559, DOI 10.1016/S0022-3476(99)70052-1; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Li GZ, 2011, ENVIRON SCI TECHNOL, V45, P8359, DOI 10.1021/es2016523; Lonsdale D, 2002, NEUROENDOCRINOL LETT, V23, P303; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Minami T, 2007, ENVIRON TOXICOL PHAR, V24, P316, DOI 10.1016/j.etap.2007.08.004; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Potter DM, 2005, STAT MED, V24, P693, DOI 10.1002/sim.1931; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Salazar N, 2008, APPL ENVIRON MICROB, V74, P4737, DOI 10.1128/AEM.00325-08; Sandler RH, 2000, J CHILD NEUROL, V15, P429, DOI 10.1177/088307380001500701; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider CK, 2006, J AUTISM DEV DISORD, V36, P1053, DOI 10.1007/s10803-006-0141-y; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Sharp WG, 2013, J AUTISM DEV DISORD, DOI [10.1007/s10803-10013-11771-10805, DOI 10.1007/S10803-10013-11771-10805]; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Sun Y, 2011, METHODS MOL BIOL, V733, P129, DOI 10.1007/978-1-61779-089-8_9; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhu YG, 2007, NEUROCHEM INT, V50, P671, DOI 10.1016/j.neuint.2006.12.013; Ziv-El M, 2011, APPL MICROBIOL BIOT, V92, P1063, DOI 10.1007/s00253-011-3388-y	70	547	593	1	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68322	10.1371/journal.pone.0068322	http://dx.doi.org/10.1371/journal.pone.0068322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844187	Green Submitted, gold, Green Published			2022-12-25	WOS:000321733000140
J	Rabahi, T; Fargier, P; Sarraj, AR; Clouzeau, C; Massarelli, R				Rabahi, Tahar; Fargier, Patrick; Sarraj, Ahmad Rifai; Clouzeau, Cyril; Massarelli, Raphael			Effect of Action Verbs on the Performance of a Complex Movement	PLOS ONE			English	Article							MOTOR SYSTEM; LANGUAGE; REPRESENTATIONS; PERCEPTION; CORTEX; BRAIN; ACTIVATION; SIMULATION; ATTENTION; GESTURES	The interaction between language and motor action has been approached by studying the effect of action verbs, kinaesthetic imagery and mental subtraction upon the performance of a complex movement, the squat vertical jump (SVJ). The time of flight gave the value of the height of the SVJ and was measured with an Optojump (R) and a Myotest (R) apparatuses. The results obtained by the effects of the cognitive stimuli showed a statistically significant improvement of the SVJ performance after either loudly or silently pronouncing, hearing or reading the verb saute (jump in French language). Action verbs specific for other motor actions (pince = pinch, leche = lick) or non-specific (bouge = move) showed no or little effect. A meaningless verb for the French subjects (tiao = jump in Chinese) showed no effect as did reve (dream), tombe (fall) and stop. The verb gagne (win) improved significantly the SVJ height, as did its antonym perds (lose) suggesting a possible influence of affects in the subjects' performance. The effect of the specific action verb jump upon the heights of SVJ was similar to that obtained after kinaesthetic imagery and after mental subtraction of two digits numbers from three digits ones; possibly, in the latter, because of the intervention of language in calculus. It appears that the effects of the specific action verb jump did seem effective but not totally exclusive for the enhancement of the SVJ performance. The results imply an interaction among language and motor brain areas in the performance of a complex movement resulting in a clear specificity of the corresponding action verb. The effect upon performance may probably be influenced by the subjects' intention, increased attention and emotion produced by cognitive stimuli among which action verbs.	[Rabahi, Tahar; Fargier, Patrick; Massarelli, Raphael] Univ Lyon 1, CRIS, EA 647, F-69622 Villeurbanne, France; [Sarraj, Ahmad Rifai] Univ Libanaise Rafic Hariri, Dept Physiotherapie, Fac Sante Publ 1, Hadath Beyrouth, Lebanon; [Clouzeau, Cyril] Inst Super Osteopathie ISOSTEO, Unite Rech, Limonest Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rabahi, T (corresponding author), Univ Lyon 1, CRIS, EA 647, F-69622 Villeurbanne, France.	taharrabahi@gmail.com	Sarraj, Ahmad Rifai/H-2548-2018	Sarraj, Ahmad Rifai/0000-0003-4719-890X				Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bedny M, 2011, ANN NY ACAD SCI, V1224, P81, DOI 10.1111/j.1749-6632.2011.06013.x; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Cappa SF, 2012, CORTEX, V48, P785, DOI 10.1016/j.cortex.2012.04.010; Casartelli N, 2010, J STRENGTH COND RES, V24, P3186, DOI 10.1519/JSC.0b013e3181d8595c; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Dalla Volta R, 2009, EXP BRAIN RES, V196, P403, DOI 10.1007/s00221-009-1864-8; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Fernandino L, 2010, BRAIN LANG, V112, P44, DOI 10.1016/j.bandl.2009.02.003; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Frak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009728; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Garagnani M, 2008, EUR J NEUROSCI, V27, P492, DOI 10.1111/j.1460-9568.2008.06015.x; Gentilucci M, 1998, EUR J NEUROSCI, V10, P752, DOI 10.1046/j.1460-9568.1998.00060.x; Gentilucci M, 2008, J PHYSIOL-PARIS, V102, P21, DOI 10.1016/j.jphysparis.2008.03.002; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gentilucci M, 2012, BEHAV BRAIN RES, V233, P130, DOI 10.1016/j.bbr.2012.04.036; Guillot A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00247; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00149; Havas DA, 2007, PSYCHON B REV, V14, P436, DOI 10.3758/BF03194085; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Hoyek N, 2009, LEARN INDIVID DIFFER, V19, P555, DOI 10.1016/j.lindif.2009.07.003; HUBLEY CL, 1983, EUR J APPL PHYSIOL O, V50, P247, DOI 10.1007/BF00422163; INGVAR DH, 1977, ANN NEUROL, V2, P230, DOI 10.1002/ana.410020309; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Kazui H, 2000, PSYCHIAT CLIN NEUROS, V54, P479, DOI 10.1046/j.1440-1819.2000.00739.x; Kemmerer D, 2008, BRAIN LANG, V107, P16, DOI 10.1016/j.bandl.2007.09.003; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lin JFL, 2012, CEREB CORTEX, V22, P1851, DOI 10.1093/cercor/bhr263; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Moseley R, 2012, CEREB CORTEX, V22, P1634, DOI 10.1093/cercor/bhr238; Nazir TA, 2008, Q J EXP PSYCHOL, V61, P933, DOI 10.1080/17470210701625667; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Peran P, 2010, BRAIN RES, V1328, P89, DOI 10.1016/j.brainres.2010.02.082; Perry HM, 1939, ARCH PSYCHOL, V4, P5; Pinheiro J, 2001, MIXED EFFECTS MODELS; Postle N, 2008, NEUROIMAGE, V43, P634, DOI 10.1016/j.neuroimage.2008.08.006; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Rizzolatti G, 2010, SO QUEL CHE FAI CERV; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sackett RS, 1935, J GEN PSYCHOL, V13, P113, DOI 10.1080/00221309.1935.9917869; Schuster C, 2011, BMC MED, V17, P9; Shtyrov Y, 2012, NEUROPSYCHOLOGIA, V50, P2605, DOI 10.1016/j.neuropsychologia.2012.07.012; Talairach J., 1988, COPLANAR STEREOTAXIC; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tranel D, 2003, COGN NEUROPSYCHOL, V20, P409, DOI 10.1080/02643290244000248; Tschentscher N, 2012, NEUROIMAGE, V59, P3139, DOI 10.1016/j.neuroimage.2011.11.037; van Dam WO, 2010, NEUROIMAGE, V53, P1318, DOI 10.1016/j.neuroimage.2010.06.071; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; Vogt S, 1996, COGNITIVE BRAIN RES, V3, P79, DOI 10.1016/0926-6410(95)00032-1; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Willems RM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00116; Wulf G, 2002, PSYCHON B REV, V9, P185, DOI 10.3758/BF03196276; Zatsiorsky V., 1983, BIOMECHANICS 8 B, V56, P1152; Zwaan RA, 2004, COGNITIVE SCI, V28, P611, DOI 10.1016/j.cogsci.2004.03.004	69	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68687	10.1371/journal.pone.0068687	http://dx.doi.org/10.1371/journal.pone.0068687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844233	Green Submitted, gold, Green Published			2022-12-25	WOS:000321733000023
J	Rantamaki, T; Kemppainen, S; Autio, H; Staven, S; Koivisto, H; Kojima, M; Antila, H; Miettinen, PO; Karkkainen, E; Karpova, N; Vesa, L; Lindemann, L; Hoener, MC; Tanila, H; Castren, E				Rantamaki, Tomi; Kemppainen, Susanna; Autio, Henri; Staven, Saara; Koivisto, Hennariikka; Kojima, Masami; Antila, Hanna; Miettinen, Pasi O.; Karkkainen, Elisa; Karpova, Nina; Vesa, Liisa; Lindemann, Lothar; Hoener, Marius C.; Tanila, Heikki; Castren, Eero			The Impact of Bdnf Gene Deficiency to the Memory Impairment and Brain Pathology of APPswe/PS1dE9 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC-FACTOR; AMYLOID DEPOSITION; MESSENGER-RNA; CHOLINERGIC NEURONS; DECREASED-LEVELS; PARIETAL CORTEX; CELL-SURVIVAL; WILD-TYPE; EXPRESSION	Brain-derived neurotrophic factor (BDNF) importantly regulates learning and memory and supports the survival of injured neurons. Reduced BDNF levels have been detected in the brains of Alzheimer's disease (AD) patients but the exact role of BDNF in the pathophysiology of the disorder remains obscure. We have recently shown that reduced signaling of BDNF receptor TrkB aggravates memory impairment in APPswe/PS1dE9 (APdE9) mice, a model of AD. The present study examined the influence of Bdnf gene deficiency (heterozygous knockout) on spatial learning, spontaneous exploratory activity and motor coordination/balance in middle-aged male and female APdE9 mice. We also studied brain BDNF protein levels in APdE9 mice in different ages showing progressive amyloid pathology. Both APdE9 and Bdnf mutations impaired spatial learning in males and showed a similar trend in females. Importantly, the effect was additive, so that double mutant mice performed the worst. However, APdE9 and Bdnf mutations influenced spontaneous locomotion in contrasting ways, such that locomotor hyperactivity observed in APdE9 mice was normalized by Bdnf deficiency. Obesity associated with Bdnf deficiency did not account for the reduced hyperactivity in double mutant mice. Bdnf deficiency did not alter amyloid plaque formation in APdE9 mice. Before plaque formation (3 months), BDNF protein levels where either reduced (female) or unaltered (male) in the APdE9 mouse cortex. Unexpectedly, this was followed by an age-dependent increase in mature BDNF protein. Bdnf mRNA and phospho-TrkB levels remained unaltered in the cortical tissue samples of middle-aged APdE9 mice. Immunohistological studies revealed increased BDNF immunoreactivity around amyloid plaques indicating that the plaques may sequester BDNF protein and prevent it from activating TrkB. If similar BDNF accumulation happens in human AD brains, it would suggest that functional BDNF levels in the AD brains are even lower than reported, which could partially contribute to learning and memory problems of AD patients.	[Rantamaki, Tomi; Autio, Henri; Antila, Hanna; Karpova, Nina; Vesa, Liisa; Tanila, Heikki; Castren, Eero] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Kemppainen, Susanna; Staven, Saara; Koivisto, Hennariikka; Miettinen, Pasi O.; Karkkainen, Elisa; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Kojima, Masami] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Osaka, Japan; [Lindemann, Lothar; Hoener, Marius C.] F Hoffmann La Roche & Co Ltd, Discovery Neurosci, CH-4002 Basel, Switzerland; [Tanila, Heikki] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	University of Helsinki; University of Eastern Finland; National Institute of Advanced Industrial Science & Technology (AIST); Roche Holding; Kuopio University Hospital; University of Eastern Finland	Castren, E (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	eero.castren@helsinki.fi	Karpova, Nina/L-6724-2013; Hoener, Marius C/I-6464-2012	Karpova, Nina/0000-0002-3197-4559; Hoener, Marius C/0000-0001-6510-6250; Castren, Eero/0000-0002-1402-2791; Rantamaki, Tomi/0000-0002-0052-1434; Antila, Hanna/0000-0001-8317-4564; Kemppainen, Susanna/0000-0001-5372-1918	EU [FP6-037831, HEALTH-F2-2007-201159]; Academy of Finland Center of Excellence program; Sigrid Juselius Foundation	EU(European Commission); Academy of Finland Center of Excellence program(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by EU 6th Framework program grant FP6-037831, EU 7th Framework program grant HEALTH-F2-2007-201159, Academy of Finland Center of Excellence program and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Burbach GJ, 2004, J NEUROSCI, V24, P2421, DOI 10.1523/JNEUROSCI.5599-03.2004; Castello NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039566; Chen KS, 1997, J NEUROSCI, V17, P7288; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Di Lieto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032869; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fahnestock M, 2002, J NEURAL TRANSM-SUPP, P241; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; HEFTI F, 1986, J NEUROSCI, V6, P2155; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kadir A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.015; Karpova NN, 2010, CELL MOL NEUROBIOL, V30, P1117, DOI 10.1007/s10571-010-9544-6; Karpova NN, 2009, EUR NEUROPSYCHOPHARM, V19, P97, DOI 10.1016/j.euroneuro.2008.09.002; Kemppainen S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.006; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; Li LY, 2008, J MOL NEUROSCI, V34, P157, DOI 10.1007/s12031-007-9022-x; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Murer MG, 1999, NEUROSCIENCE, V88, P1015, DOI 10.1016/S0306-4522(98)00219-X; MURRAY KD, 1994, NEUROSCIENCE, V60, P37, DOI 10.1016/0306-4522(94)90202-X; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Peng S, 2009, J NEUROSCI, V29, P9321, DOI 10.1523/JNEUROSCI.4736-08.2009; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rantamaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020567; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Szapacs ME, 2004, NEUROBIOL DIS, V16, P572, DOI 10.1016/j.nbd.2004.04.010; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Uutela M, 2012, GENES BRAIN BEHAV, V11, P513, DOI 10.1111/j.1601-183X.2012.00784.x	50	42	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68722	10.1371/journal.pone.0068722	http://dx.doi.org/10.1371/journal.pone.0068722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844236	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000024
J	Seabra, SG; Bras, PG; Zina, V; da Silva, EB; Rebelo, MT; Figueiredo, E; Mendel, Z; Paulo, OS; Franco, JC				Seabra, Sofia G.; Bras, Patricia G.; Zina, Vera; da Silva, Elsa Borges; Rebelo, Maria Teresa; Figueiredo, Elisabete; Mendel, Zvi; Paulo, Octavio S.; Franco, Jose Carlos			Molecular Evidence of Polyandry in the Citrus Mealybug, Planococcus citri (Hemiptera: Pseudococcidae)	PLOS ONE			English	Article							SCALE INSECTS; REPRODUCTIVE-BIOLOGY; GENOTYPING ERRORS; PRACTICAL GUIDE; CONSEQUENCES; EVOLUTION; CONFLICT; MICROSATELLITES; HETEROZYGOSITY; POPULATIONS	The occurrence of polyandry in Planococcus citri, presumed by earlier observations of mating behavior, was confirmed using microsatellite genotyping of pools of over 400 eggs resulting from controlled crosses of one female with two males. The genetic contribution of both mated males was confirmed in 13 out of 43 crosses. In three crosses it was possible to determine that only the first male fertilized the eggs, which may be due to sperm competition or unviable sperm supply. The microsatellite analysis also allowed the confirmation of aspects of the chromosomal inheritance detected previously in cytogenetic studies in Planococcus citri, namely that only one of the alleles is transmitted by the male, indicating that the males are functionally haploid, supporting the observation of Paternal Genome Elimination (PGE) in these insects.	[Seabra, Sofia G.; Bras, Patricia G.; Paulo, Octavio S.] Univ Lisbon, Fac Ciencias, Computat Biol & Populat Genom Grp, Ctr Biol Ambiental,Dept Biol Anim, Lisbon, Portugal; [Zina, Vera; da Silva, Elsa Borges; Franco, Jose Carlos] Univ Tecn Lisboa, Ctr Estudos Florestais, Inst Super Agron, P-1100 Lisbon, Portugal; [Rebelo, Maria Teresa] Univ Lisbon, Fac Ciencias, Ctr Estudos Ambiente & Mar, Dept Biol Anim, Lisbon, Portugal; [Figueiredo, Elisabete] Univ Tecn Lisboa, Ctr Engn Biossistemas, Inst Super Agron, P-1100 Lisbon, Portugal; [Mendel, Zvi] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Seabra, SG (corresponding author), Univ Lisbon, Fac Ciencias, Computat Biol & Populat Genom Grp, Ctr Biol Ambiental,Dept Biol Anim, Lisbon, Portugal.	sgseabra@fc.ul.pt	Paulo, Octávio/D-9921-2011; Figueiredo, Elisabete/AAY-8128-2020; Rebelo, MT/A-3772-2013; Seabra, Sofia G/B-3808-2013; Silva, Elsa Borges/A-3522-2012; Franco, José Carlos/B-8534-2009	Paulo, Octávio/0000-0001-5408-5212; Figueiredo, Elisabete/0000-0002-0795-4216; Rebelo, MT/0000-0002-2724-2195; Seabra, Sofia G/0000-0003-1413-2349; Silva, Elsa Borges/0000-0002-7000-3536; Franco, José Carlos/0000-0002-0898-3510; Zina, Vera/0000-0002-5202-881X	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/AGR-AAM/099560/2008]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was funded by Fundacao para a Ciencia e a Tecnologia, Portugal (http://www.fct.pt/;project PTDC/AGR-AAM/099560/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist G, 2006, ETHOLOGY, V112, P748, DOI 10.1111/j.1439-0310.2006.01211.x; Belkhir K., GENETIX 4 05 LOGICIE; Ben-Dov Y., 1994, SYSTEMATIC CATALOGUE; Birkhead TR, 1998, SPERM COMPETITION SE; Boake CRB, 1996, ANNU REV ENTOMOL, V41, P211, DOI 10.1146/annurev.en.41.010196.001235; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Bretman A, 2005, MOL ECOL, V14, P2169, DOI 10.1111/j.1365-294X.2005.02556.x; BROWN SW, 1961, GENETICS, V46, P983; Chambers GK, 2000, COMP BIOCHEM PHYS B, V126, P455, DOI 10.1016/S0305-0491(00)00233-9; da Silva EB, 2013, J INSECT BEHAV, V26, P304, DOI 10.1007/s10905-012-9344-6; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Franco JC, 2004, PHYTOPARASITICA, V32, P507, DOI 10.1007/BF02980445; FRANCO JC, 2004, ANAIS I SUPERIOR AGR, V49, P353; Franco JC, 2009, BIORATIONAL CONTROL OF ARTHROPOD PESTS: APPLICATION AND RESISTANCE MANAGEMENT, P233, DOI 10.1007/978-90-481-2316-2_10; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hedrick PW, 1997, ANNU REV ECOL SYST, V28, P55, DOI 10.1146/annurev.ecolsys.28.1.55; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hosken DJ, 2003, EVOL BIOL, V33, P173; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Lanier G.N., 1990, BEHAV MODIFYING CHEM, P25; Martins Renata F, 2012, J Genet, V91, pe75; Millar JG., 2005, ACS SYM SER, P11, DOI 10.1021/bk-2005-0906.ch002; NESTEL D, 1995, ENVIRON ENTOMOL, V24, P506, DOI 10.1093/ee/24.3.506; Normark BB, 2003, ANNU REV ENTOMOL, V48, P397, DOI 10.1146/annurev.ento.48.091801.112703; NUR U, 1990, DEVELOPMENT, P29; NUR U, 1977, GENETICS, V86, P149; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Price TAR, 2008, SCIENCE, V322, P1241, DOI 10.1126/science.1163766; R Development Core Team R, 2012, R LANG ENV STAT COMP; Ross L, 2010, BIOL REV, V85, P807, DOI 10.1111/j.1469-185X.2010.00127.x; Ross L, 2010, EVOL ECOL RES, V12, P89; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Silva E. B. da, 2009, IOBC/WPRS Bulletin, V41, P3; Simmons LW, 2007, MOL ECOL, V16, P4613, DOI 10.1111/j.1365-294X.2007.03528.x; Slate J, 2009, MOL ECOL, V18, P1815, DOI 10.1111/j.1365-294X.2009.04115.x; Suckling DM, 2000, CROP PROT, V19, P677, DOI 10.1016/S0261-2194(00)00090-9; Thornhill R, 2001, EVOLUTION INSECT MAT; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tripet F, 2003, AM J TROP MED HYG, V68, P1; Walton VM, 2006, J ECON ENTOMOL, V99, P1280, DOI 10.1603/0022-0493-99.4.1280; Waterworth RA, 2012, J ECON ENTOMOL, V105, P949, DOI 10.1603/EC12002; Waterworth RA, 2011, ANN ENTOMOL SOC AM, V104, P249, DOI 10.1603/AN10139; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	49	5	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68241	10.1371/journal.pone.0068241	http://dx.doi.org/10.1371/journal.pone.0068241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844173	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000134
J	Bi, YH; Zhong, HS; Xu, K; Zhang, Z; Qi, X; Xia, YH; Ren, L				Bi, Yonghua; Zhong, Hongshan; Xu, Ke; Zhang, Zhen; Qi, Xun; Xia, Yonghui; Ren, Ling			Development of a Novel Rabbit Model of Abdominal Aortic Aneurysm via a Combination of Periaortic Calcium Chloride and Elastase Incubation	PLOS ONE			English	Article							INDUCED SACCULAR ANEURYSMS; STENT-GRAFT MATERIAL; PERIARTERIAL APPLICATION; SIMULTANEOUS INHIBITION; CAROTID-ARTERY; RAT MODEL; KAPPA-B; INFLAMMATION; BIOCOMPATIBILITY; ENLARGEMENT	Background: The purpose of this study was to introduce a novel, simple and effective technique for creating a reliable rabbit model of abdominal aortic aneurysm (AAA) via a combination of periaortic calcium chloride (CaCl2) and elastase incubation. Methods: Forty-eight New Zealand white rabbits were divided into four groups. The AAA model was developed via a 20-minute periaortic incubation of CaCl2 (0.5 mol/L) and elastase (1 Unit/mu L) in a 1.5-cm aortic segment (Group CE). A single incubation of CaCl2 (Group C) or elastase (Group E) and a sham operation group (Sham Group) were used for the controls. Diameter was measured by serial digital subtraction angiography imaging on days 5, 15 and 30. Animals were sacrificed on day 5 and day 30 for histopathological and immunohistochemical studies. Results: All animals in Group CE developed aneurysm, with an average dilation ratio of 65.3% +/- 8.9% on day 5, 86.5% +/- 28.7% on day 15 and 203.6% +/- 39.1% on day 30. No aneurysm was found in Group C, and only one aneurysm was seen on day 5 in Group E. Group CE exhibited less intima-media thickness, endothelial recovery, elastin and smooth muscle cell (SMC) content, but stronger expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and RAM11 compared to the controls. Conclusions: The novel rabbit model of AAA created by using a combination of periaortic CaCl2 and elastase incubation is simple and effective to perform and is valuable for elucidating AAA mechanisms and therapeutic interventions in experimental studies.	[Bi, Yonghua; Zhong, Hongshan; Xu, Ke; Qi, Xun; Xia, Yonghui; Ren, Ling] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China; [Bi, Yonghua] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Zhong, Hongshan; Xu, Ke; Zhang, Zhen; Qi, Xun; Xia, Yonghui; Ren, Ling] Key Lab Diagnost Imaging & Intervent Radiol Liaon, Shenyang, Peoples R China; [Zhang, Zhen] China Med Univ, Affiliated Hosp 1, Dept Ultrasound, Shenyang, Peoples R China	China Medical University; Zhengzhou University; China Medical University	Xu, K (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China.	kexu@vip.sina.com			National Natural Science Foundations of China [81000654, 81171443, 81000620]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundations of China (Grant No. 81000654, 81171443 and 81000620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; ANIDJAR S, 1992, J VASC SURG, V16, P139, DOI 10.1016/0741-5214(92)90101-D; Basalyga DM, 2004, CIRCULATION, V110, P3480, DOI 10.1161/01.CIR.0000148367.08413.E9; Chiou AC, 2001, J SURG RES, V99, P371, DOI 10.1006/jsre.2001.6207; Cloft HJ, 2000, RADIOLOGY, V214, P557, DOI 10.1148/radiology.214.2.r00fe21557; ERNST CB, 1993, NEW ENGL J MED, V328, P1167; Freestone T, 1997, ARTERIOSCL THROM VAS, V17, P10, DOI 10.1161/01.ATV.17.1.10; Fujiwara NH, 2005, J VASC INTERV RADIOL, V16, P1229, DOI 10.1097/01.RVI.0000171690.21149.8F; GERTZ SD, 1988, J CLIN INVEST, V81, P649, DOI 10.1172/JCI113368; HANKE H, 1990, CIRC RES, V67, P651, DOI 10.1161/01.RES.67.3.651; HELPERN VJ, 1994, J VASC SURG, V20, P51, DOI 10.1016/0741-5214(94)90175-9; Hoshina K, 2003, J VASC SURG, V37, P1067, DOI 10.1016/S0741-5214(03)70052-4; Huang GY, 2009, J HYPERTENS, V27, P1829, DOI 10.1097/HJH.0b013e32832db36b; Isenburg JC, 2007, CIRCULATION, V115, P1729, DOI 10.1161/CIRCULATIONAHA.106.672873; Jiao L, 2010, ACTA CARDIOL, V65, P499, DOI 10.1080/AC.65.5.2056235; Kallmes DF, 2002, AM J NEURORADIOL, V23, P295; Kobayashi H, 2004, EUR J VASC ENDOVASC, V28, P71, DOI 10.1016/j.ejvs.2004.03.015; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Mastoraki ST, 2012, ANN VASC SURG, V26, P250, DOI 10.1016/j.avsg.2011.09.003; Matsushita M, 1999, EUR SURG RES, V31, P305, DOI 10.1159/000008707; Miskolczi L, 1998, NEUROSURGERY, V43, P595, DOI 10.1097/00006123-199809000-00110; Miyake T, 2006, GENE THER, V13, P695, DOI 10.1038/sj.gt.3302704; Miyake T, 2007, CIRC RES, V101, P1175, DOI 10.1161/CIRCRESAHA.107.148668; Origuchi N, 1998, INT ANGIOL, V17, P113; Palmieri D, 2011, J SURG RES, V171, pE237, DOI 10.1016/j.jss.2011.07.041; Sasaki K, 2004, NEUROL MED-CHIR, V44, P467, DOI 10.2176/nmc.44.467; SCHULZ H, 1989, SCAND J CLIN LAB INV, V49, P381, DOI 10.3109/00365518909089111; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Short JG, 2001, AM J NEURORADIOL, V22, P1833; Sinha I, 2004, SURGERY, V136, P176, DOI 10.1016/j.surg.2004.04.010; Sinha I, 2006, ANN NY ACAD SCI, V1085, P367, DOI 10.1196/annals.1383.027; Tanaka A, 2009, J VASC SURG, V50, P1423, DOI 10.1016/j.jvs.2009.08.062; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; White JV, 1996, ANN NY ACAD SCI, V800, P97, DOI 10.1111/j.1749-6632.1996.tb33302.x; Yamaguchi T, 2001, J SURG RES, V95, P161, DOI 10.1006/jsre.2000.6025; Yasuda H, 2005, NEUROPATHOLOGY, V25, P66, DOI 10.1111/j.1440-1789.2004.00590.x; Zhang Q, 2011, J SURG RES, V167, pE385, DOI 10.1016/j.jss.2011.01.017; Zhong HS, 2009, J VASC SURG, V50, P1433, DOI 10.1016/j.jvs.2009.07.071; Zhong HS, 2009, J ENDOVASC THER, V16, P154, DOI 10.1583/08-2617.1	39	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68476	10.1371/journal.pone.0068476	http://dx.doi.org/10.1371/journal.pone.0068476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844207	gold, Green Submitted, Green Published			2022-12-25	WOS:000321341000163
J	Ferguson, BD; Liu, R; Rolle, CE; Tan, YHC; Krasnoperov, V; Kanteti, R; Tretiakova, MS; Cervantes, GM; Hasina, R; Hseu, RD; Iafrate, AJ; Karrison, T; Ferguson, MK; Husain, AN; Faoro, L; Vokes, EE; Gill, PS; Salgia, R				Ferguson, Benjamin D.; Liu, Ren; Rolle, Cleo E.; Tan, Yi-Hung Carol; Krasnoperov, Valery; Kanteti, Rajani; Tretiakova, Maria S.; Cervantes, Gustavo M.; Hasina, Rifat; Hseu, Robyn D.; Iafrate, A. John; Karrison, Theodore; Ferguson, Mark K.; Husain, Aliya N.; Faoro, Leonardo; Vokes, Everett E.; Gill, Parkash S.; Salgia, Ravi			The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TOPOISOMERASE-I ACTIVITY; BIOLOGICAL SIGNIFICANCE; TUMOR ADVANCEMENT; EXPRESSION; SURVIVAL; EPHRINB2; INHIBITORS; COMPLEX; HEAD	Despite progress in locoregional and systemic therapies, patient survival from lung cancer remains a challenge. Receptor tyrosine kinases are frequently implicated in lung cancer pathogenesis, and some tyrosine kinase inhibition strategies have been effective clinically. The EphB4 receptor tyrosine kinase has recently emerged as a potential target in several other cancers. We sought to systematically study the role of EphB4 in lung cancer. Here, we demonstrate that EphB4 is overexpressed 3-fold in lung tumors compared to paired normal tissues and frequently exhibits gene copy number increases in lung cancer. We also show that overexpression of EphB4 promotes cellular proliferation, colony formation, and motility, while EphB4 inhibition reduces cellular viability in vitro, halts the growth of established tumors in mouse xenograft models when used as a single-target strategy, and causes near-complete regression of established tumors when used in combination with paclitaxel. Taken together, these data suggest an important role for EphB4 as a potential novel therapeutic target in lung cancer. Clinical trials investigating the efficacy of anti-EphB4 therapies as well as combination therapy involving EphB4 inhibition may be warranted.	[Ferguson, Benjamin D.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Ferguson, Benjamin D.; Rolle, Cleo E.; Tan, Yi-Hung Carol; Kanteti, Rajani; Cervantes, Gustavo M.; Hasina, Rifat; Hseu, Robyn D.; Faoro, Leonardo; Vokes, Everett E.; Salgia, Ravi] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Tretiakova, Maria S.; Husain, Aliya N.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Ferguson, Mark K.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Karrison, Theodore] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ferguson, Mark K.; Salgia, Ravi] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Liu, Ren; Gill, Parkash S.] Univ So Calif, Dept Med, Div Med Oncol, Los Angeles, CA USA; [Krasnoperov, Valery; Gill, Parkash S.] Vasgene Therapeut Inc, Los Angeles, CA USA; [Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Southern California; Harvard University; Massachusetts General Hospital	Salgia, R (corresponding author), Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rsalgia@medicine.bsd.uchicago.edu	Tretiakova, Maria/U-3320-2019; Vokes, Everett/Q-2146-2019; Ferguson, Benjamin/O-3214-2013	Ferguson, Benjamin/0000-0001-8358-3368; Tan, Yi-Hung Carol/0000-0001-7541-007X	NIH/NICHD [T32HD009007]; ASCO Translational Award; NIH/NCI [R01 CA 129501 05]; Janice Lamb McArdle Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA129501] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ASCO Translational Award; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Janice Lamb McArdle Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported in part by NIH/NICHD T32HD009007, "Graduate Training in Growth and Development" (BDF), ASCO Translational Award (EEV), NIH/NCI R01 CA 129501 05 (RS), and Janice Lamb McArdle Cancer Research Foundation (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2008, BRIT J CANCER, V98, P845, DOI 10.1038/sj.bjc.6604216; Alam SM, 2007, ANN ONCOL, V18, P485, DOI 10.1093/annonc/mdl414; Alam SM, 2009, GYNECOL ONCOL, V114, P84, DOI 10.1016/j.ygyno.2009.03.017; Bardelle C, 2008, BIOORG MED CHEM LETT, V18, P5717, DOI 10.1016/j.bmcl.2008.09.087; Bardelle C, 2008, BIOORG MED CHEM LETT, V18, P2776, DOI 10.1016/j.bmcl.2008.04.015; Bardelle C, 2010, BIOORG MED CHEM LETT, V20, P6242, DOI 10.1016/j.bmcl.2010.08.100; Barlaam B, 2011, BIOORG MED CHEM LETT, V21, P2207, DOI 10.1016/j.bmcl.2011.03.009; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Cabezon-Gutierrez L, 2012, LUNG, V190, P381, DOI 10.1007/s00408-012-9391-y; Cheng EH, 2012, NAT MED, V18, P494, DOI 10.1038/nm.2725; Cheng H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-5; Chhatriwala H, 2006, CANCER BIOL THER, V5, P1600, DOI 10.4161/cbt.5.12.3546; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; Cohen EEW, 2010, J CLIN ONCOL, V28, P3336, DOI 10.1200/JCO.2009.27.0397; DASSONVILLE O, 1993, J CLIN ONCOL, V11, P1873, DOI 10.1200/JCO.1993.11.10.1873; Davalos V, 2006, CANCER RES, V66, P8943, DOI 10.1158/0008-5472.CAN-05-4640; DEFFIE AM, 1989, CANCER RES, V49, P58; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Flanagan JG, 1997, CELL, V90, P403; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hasina R, 2013, CANCER RES, V73, P184, DOI 10.1158/0008-5472.CAN-12-0915; Herath NI, 2012, EUR J CANCER, V48, P753, DOI 10.1016/j.ejca.2011.07.003; Hermes A, 2008, J CLIN ONCOL, V26, P4261, DOI 10.1200/JCO.2007.15.7545; HEUSER L, 1979, CANCER, V43, P1888, DOI 10.1002/1097-0142(197905)43:5<1888::AID-CNCR2820430545>3.0.CO;2-M; Ichimura E, 1996, JPN J CANCER RES, V87, P1063, DOI 10.1111/j.1349-7006.1996.tb03111.x; Ishikawa M, 2012, LUNG CANCER, V76, P431, DOI 10.1016/j.lungcan.2011.12.004; Ji XD, 2011, CANCER RES, V71, P1156, DOI 10.1158/0008-5472.CAN-10-0717; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kumar SR, 2007, BRIT J CANCER, V96, P1083, DOI 10.1038/sj.bjc.6603642; Kumar SR, 2006, AM J PATHOL, V169, P279, DOI 10.2353/ajpath.2006.050889; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Lee YC, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-119; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Masood R, 2006, INT J CANCER, V119, P1236, DOI 10.1002/ijc.21926; Maulik G, 2004, J ENVIRON PATHOL TOX, V23, P237, DOI 10.1615/JEnvPathToxOncol.v23.i4.10; Minamiya Y, 2010, LUNG CANCER, V68, P466, DOI 10.1016/j.lungcan.2009.07.015; Oberholzer M, 1996, HISTOCHEM CELL BIOL, V105, P333, DOI 10.1007/BF01463655; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Reynolds CP, 2005, METH MOLEC MED, V111, P335; Rosell R, 2006, CLIN CANCER RES, V12, P7222, DOI 10.1158/1078-0432.CCR-06-0627; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sakai A, 2012, J THORAC ONCOL, V7, P1337, DOI 10.1097/JTO.0b013e31825cca4c; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Spannuth WA, 2010, MOL CANCER THER, V9, P2377, DOI 10.1158/1535-7163.MCT-10-0200; Spano JP, 2004, ANN ONCOL, V15, P613, DOI 10.1093/annonc/mdh136; Stephenson S A, 2001, BMC Mol Biol, V2, P15, DOI 10.1186/1471-2199-2-15; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Xia G, 2006, ONCOGENE, V25, P769, DOI 10.1038/sj.onc.1209108; Xia GB, 2005, CLIN CANCER RES, V11, P4305, DOI 10.1158/1078-0432.CCR-04-2109; Xia GB, 2005, CANCER RES, V65, P4623, DOI 10.1158/0008-5472.CAN-04-2667; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Yavrouian EJ, 2008, ARCH OTOLARYNGOL, V134, P985, DOI 10.1001/archotol.134.9.985; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054674; Zheng MF, 2012, MOL MED REP, V6, P405, DOI 10.3892/mmr.2012.936	62	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67668	10.1371/journal.pone.0067668	http://dx.doi.org/10.1371/journal.pone.0067668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844053	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000071
J	Li, ZJ; Li, Q; Geng, LL; Chen, XH; Bi, KS				Li, Zuojing; Li, Qing; Geng, Lulu; Chen, Xiaohui; Bi, Kaishun			Use of the Local False Discovery Rate for Identification of Metabolic Biomarkers in Rat Urine Following Genkwa Flos-Induced Hepatotoxicity	PLOS ONE			English	Article							MASS-SPECTROMETRY; METABONOMICS; GENOMICS	Metabolomics is concerned with characterizing the large number of metabolites present in a biological system using nuclear magnetic resonance (NMR) and HPLC/MS (high-performance liquid chromatography with mass spectrometry). Multivariate analysis is one of the most important tools for metabolic biomarker identification in metabolomic studies. However, analyzing the large-scale data sets acquired during metabolic fingerprinting is a major challenge. As a posterior probability that the features of interest are not affected, the local false discovery rate (LFDR) is a good interpretable measure. However, it is rarely used to when interrogating metabolic data to identify biomarkers. In this study, we employed the LFDR method to analyze HPLC/MS data acquired from a metabolomic study of metabolic changes in rat urine during hepatotoxicity induced by Genkwa flos (GF) treatment. The LFDR approach was successfully used to identify important rat urine metabolites altered by GF-stimulated hepatotoxicity. Compared with principle component analysis (PCA), LFDR is an interpretable measure and discovers more important metabolites in an HPLC/MS-based metabolomic study.	[Li, Zuojing] Shenyang Pharmaceut Univ, Sch Med Devices, Shenyang, Peoples R China; [Li, Zuojing; Li, Qing; Geng, Lulu; Chen, Xiaohui; Bi, Kaishun] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Bi, KS (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China.	kaishunbi.syphu@gmail.com.com	Li, Qing/AAD-3286-2022	Li, Qing/0000-0003-3087-4692				Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bottcher C, 2007, ANAL CHEM, V79, P1507, DOI 10.1021/ac061037q; Box G. E. P., 1954, ANN MATH STAT, V25, P33, DOI [DOI 10.1214/A0MS/1177728786, 10.1214/aoms/1177728786]; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Efron B., 2010, LARGE SCALE INFERENC, V1; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Fukushima A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-1; Geng LL, 2013, PHYTOTHER RES, V27, P521, DOI 10.1002/ptr.4748; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Lenz EM, 2004, ANALYST, V129, P535, DOI 10.1039/b400159c; Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; Moco S, 2007, TRAC-TREND ANAL CHEM, V26, P855, DOI 10.1016/j.trac.2007.08.003; Plumb RS, 2003, RAPID COMMUN MASS SP, V17, P2632, DOI 10.1002/rcm.1250; Plumb RS, 2002, RAPID COMMUN MASS SP, V16, P1991, DOI 10.1002/rcm.813; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rousseau R, 2008, CHEMOMETR INTELL LAB, V91, P54, DOI 10.1016/j.chemolab.2007.06.008; Sweetlove LJ, 2005, NEW PHYTOL, V168, P9, DOI 10.1111/j.1469-8137.2005.01513.x; Wall M. E., 2003, PRACTICAL APPROACH M, P91, DOI [10.1007/0-306-47815-3_5, DOI 10.1007/0-306-47815-3_5]; Wilson ID, 2005, J CHROMATOGR B, V817, P67, DOI 10.1016/j.jchromb.2004.07.045; Yang ZY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-87	24	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67451	10.1371/journal.pone.0067451	http://dx.doi.org/10.1371/journal.pone.0067451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844011	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000045
J	Nesler, KR; Sand, RI; Symmes, BA; Pradhan, SJ; Boin, NG; Laun, AE; Barbee, SA				Nesler, Katherine R.; Sand, Robert I.; Symmes, Breanna A.; Pradhan, Sarala J.; Boin, Nathan G.; Laun, Anna E.; Barbee, Scott A.			The miRNA Pathway Controls Rapid Changes in Activity-Dependent Synaptic Structure at the Drosophila melanogaster Neuromuscular Junction	PLOS ONE			English	Article							RECEPTOR TYROSINE PHOSPHATASES; CONTROLS DENDRITIC PLASTICITY; ACTIVITY-REGULATED MICRORNA; ACTIN NUCLEATION FACTOR; GENOME-WIDE ANALYSIS; MOTOR AXON GUIDANCE; TRANSCRIPTION FACTOR; II RECEPTOR; GROWTH; EXPRESSION	It is widely accepted that long-term changes in synapse structure and function are mediated by rapid activity-dependent gene transcription and new protein synthesis. A growing amount of evidence suggests that the microRNA (miRNA) pathway plays an important role in coordinating these processes. Despite recent advances in this field, there remains a critical need to identify specific activity-regulated miRNAs as well as their key messenger RNA (mRNA) targets. To address these questions, we used the larval Drosophila melanogaster neuromuscular junction (NMJ) as a model synapse in which to identify novel miRNA-mediated mechanisms that control activity-dependent synaptic growth. First, we developed a screen to identify miRNAs differentially regulated in the larval CNS following spaced synaptic stimulation. Surprisingly, we identified five miRNAs (miRs-1, -8, -289, -314, and -958) that were significantly downregulated by activity. Neuronal misexpression of three miRNAs (miRs-8, -289, and -958) suppressed activity-dependent synaptic growth suggesting that these miRNAs control the translation of biologically relevant target mRNAs. Functional annotation cluster analysis revealed that putative targets of miRs-8 and -289 are significantly enriched in clusters involved in the control of neuronal processes including axon development, pathfinding, and growth. In support of this, miR-8 regulated the expression of a wingless 3'UTR (wg 3' untranslated region) reporter in vitro. Wg is an important presynaptic regulatory protein required for activity-dependent axon terminal growth at the fly NMJ. In conclusion, our results are consistent with a model where key activity-regulated miRNAs are required to coordinate the expression of genes involved in activity-dependent synaptogenesis.	[Nesler, Katherine R.; Sand, Robert I.; Symmes, Breanna A.; Pradhan, Sarala J.; Boin, Nathan G.; Laun, Anna E.; Barbee, Scott A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Nesler, Katherine R.; Sand, Robert I.; Symmes, Breanna A.; Pradhan, Sarala J.; Boin, Nathan G.; Laun, Anna E.; Barbee, Scott A.] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80208 USA; [Barbee, Scott A.] Univ Denver, Mol & Cellular Biophys Program, Denver, CO 80208 USA; [Barbee, Scott A.] Univ Colorado, Colorado Intellectual & Dev Disabil Res Ctr IDDRC, Aurora, CO USA	University of Denver; University of Denver; University of Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Barbee, SA (corresponding author), Univ Denver, Dept Biol Sci, Denver, CO 80208 USA.	scott.barbee@du.edu			National Institutes of Health [R01DA26048]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by a project grant from the National Institutes of Health (R01DA26048) to SAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Baudet ML, 2013, SEMIN CELL DEV BIOL, V24, P146, DOI 10.1016/j.semcdb.2012.11.004; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Bejarano F, 2012, DEVELOPMENT, V139, P2821, DOI 10.1242/dev.079939; Bredy TW, 2011, NEUROBIOL LEARN MEM, V96, P89, DOI 10.1016/j.nlm.2011.04.004; Ceman S, 2011, PHARMACOL THERAPEUT, V130, P26, DOI 10.1016/j.pharmthera.2011.01.004; Crowner D, 2002, DEVELOPMENT, V129, P1317; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Freeman A, 2011, MOL CELL NEUROSCI, V46, P535, DOI 10.1016/j.mcn.2010.12.010; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Gates MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-37; GINIGER E, 1994, DEVELOPMENT, V120, P1385; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Karr J, 2009, J CELL BIOL, V185, P685, DOI 10.1083/jcb.200902062; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Lin TY, 2009, DEVELOPMENT, V136, P3099, DOI 10.1242/dev.033324; Lippi G, 2011, J CELL BIOL, V194, P889, DOI 10.1083/jcb.201103006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Menon KP, 2004, NEURON, V44, P663, DOI 10.1016/j.neuron.2004.10.028; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pawson C, 2008, J NEUROSCI, V28, P11111, DOI 10.1523/JNEUROSCI.0833-08.2008; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pradhan SJ, 2012, J CELL SCI, V125, P6105, DOI 10.1242/jcs.113043; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Ryazansky SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-371; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Siegel G, 2011, CURR OPIN GENET DEV, V21, P491, DOI 10.1016/j.gde.2011.04.008; Silver SJ, 2007, P NATL ACAD SCI USA, V104, P18151, DOI 10.1073/pnas.0706673104; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Sun KL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002515; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Tsurudome K, 2010, NEURON, V68, P879, DOI 10.1016/j.neuron.2010.11.016; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vo NK, 2010, CURR OPIN NEUROBIOL, V20, P457, DOI 10.1016/j.conb.2010.04.002; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yao J, 2006, J NEUROSCI, V26, P8137, DOI 10.1523/JNEUROSCI.1183-06.2006; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X	71	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68385	10.1371/journal.pone.0068385	http://dx.doi.org/10.1371/journal.pone.0068385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844193	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000157
J	Spaniol, V; Wyder, S; Aebi, C				Spaniol, Violeta; Wyder, Stefan; Aebi, Christoph			RNA-Seq-Based Analysis of the Physiologic Cold Shock-Induced Changes in Moraxella catarrhalis Gene Expression	PLOS ONE			English	Article							BRO BETA-LACTAMASE; ESCHERICHIA-COLI; BRANHAMELLA-CATARRHALIS; NEISSERIA-MENINGITIDIS; NASOPHARYNGEAL COLONIZATION; SERUM RESISTANCE; IV PILI; TEMPERATURE; PROTEIN; VIRULENCE	Background: Moraxella catarrhalis, a major nasopharyngeal pathogen of the human respiratory tract, is exposed to rapid downshifts of environmental temperature when humans breathe cold air. The prevalence of pharyngeal colonization and respiratory tract infections caused by M. catarrhalis is greatest in winter. We investigated how M. catarrhalis uses the physiologic exposure to cold air to regulate pivotal survival systems that may contribute to M. catarrhalis virulence. Results: In this study we used the RNA-seq techniques to quantitatively catalogue the transcriptome of M. catarrhalis exposed to a 26 degrees C cold shock or to continuous growth at 37 degrees C. Validation of RNA-seq data using quantitative RT-PCR analysis demonstrated the RNA-seq results to be highly reliable. We observed that a 26 degrees C cold shock induces the expression of genes that in other bacteria have been related to virulence a strong induction was observed for genes involved in high affinity phosphate transport and iron acquisition, indicating that M. catarrhalis makes a better use of both phosphate and iron resources after exposure to cold shock. We detected the induction of genes involved in nitrogen metabolism, as well as several outer membrane proteins, including ompA, m35-like porin and multidrug efflux pump (acrAB) indicating that M. catarrhalis remodels its membrane components in response to downshift of temperature. Furthermore, we demonstrate that a 26 degrees C cold shock enhances the induction of genes encoding the type IV pili that are essential for natural transformation, and increases the genetic competence of M. catarrhalis, which may facilitate the rapid spread and acquisition of novel virulence-associated genes. Conclusion: Cold shock at a physiologically relevant temperature of 26 degrees C induces in M. catarrhalis a complex of adaptive mechanisms that could convey novel pathogenic functions and may contribute to enhanced colonization and virulence.	[Spaniol, Violeta; Aebi, Christoph] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Wyder, Stefan] Univ Bern, Dept Clin Res, Bern, Switzerland; [Aebi, Christoph] Univ Bern, Inselspital, Dept Pediat, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern	Spaniol, V (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	violeta.spaniol@ifik.unibe.ch	Kummer, Juerg/B-3322-2011	Wyder, Stefan/0000-0002-3412-0292; Aebi, Christoph/0000-0003-3554-7949	Swiss National Science Foundation (SNF) [3100A0-102246, 3100A0-116053]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (SNF) grants 3100A0-102246 and 3100A0-116053 (to CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Boddey JA, 2006, INFECT IMMUN, V74, P5374, DOI 10.1128/IAI.00569-06; Bootsma HJ, 2000, MOL MICROBIOL, V36, P93, DOI 10.1046/j.1365-2958.2000.01828.x; Bootsma HJ, 1996, ANTIMICROB AGENTS CH, V40, P966, DOI 10.1128/AAC.40.4.966; BUTLER CA, 1991, J BACTERIOL, V173, P5793, DOI 10.1128/jb.173.18.5793-5799.1991; CATLIN BW, 1990, CLIN MICROBIOL REV, V3, P293, DOI 10.1128/CMR.3.4.293-320.1990; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; de Vries SPW, 2009, MICROBIOL MOL BIOL R, V73, P389, DOI 10.1128/MMBR.00007-09; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Farewell A, 1998, J BACTERIOL, V180, P4704, DOI 10.1128/JB.180.17.4704-4710.1998; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Griffiths NJ, 2007, CELL MICROBIOL, V9, P2968, DOI 10.1111/j.1462-5822.2007.01038.x; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Gupta N, 2011, INDIAN J PATHOL MICR, V54, P769, DOI 10.4103/0377-4929.91496; Han YP, 2005, MICROBES INFECT, V7, P335, DOI 10.1016/j.micinf.2004.11.005; Heiniger N, 2005, INFECT IMMUN, V73, P8247, DOI 10.1128/IAI.73.12.8247-8255.2005; Hendley JO, 2005, APMIS, V113, P213, DOI 10.1111/j.1600-0463.2005.apm1130310.x; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hsu SF, 2012, J MICROBIOL IMMUNOL, V45, P134, DOI 10.1016/j.jmii.2011.09.004; Jetter M, 2010, J ANTIMICROB CHEMOTH, V65, P2089, DOI 10.1093/jac/dkq312; Jones PG, 1996, P NATL ACAD SCI USA, V93, P76, DOI 10.1073/pnas.93.1.76; Khan MA, 2010, J ANTIMICROB CHEMOTH, V65, P91, DOI 10.1093/jac/dkp401; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Kristo A, 2006, PEDIATR INFECT DIS J, V25, P108, DOI 10.1097/01.inf.0000201048.65828.b5; Lamarche MG, 2008, J BACTERIOL, V190, P5256, DOI 10.1128/JB.01536-07; Lamarche MG, 2005, INFECT IMMUN, V73, P4138, DOI 10.1128/IAI.73.7.4138-4145.2005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llobet E, 2009, ANTIMICROB AGENTS CH, V53, P298, DOI 10.1128/AAC.00657-08; Lopez-Garcia P, 2000, BIOESSAYS, V22, P738; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; Luke NR, 2004, INFECT IMMUN, V72, P6262, DOI 10.1128/IAI.72.11.6262-6270.2004; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; MBAKI N, 1987, TOHOKU J EXP MED, V153, P111, DOI 10.1620/tjem.153.111; Meier PS, 2006, FEMS MICROBIOL LETT, V262, P72, DOI 10.1111/j.1574-6968.2006.00365.x; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Morrissey I, 2008, J ANTIMICROB CHEMOTH, V62, pII97, DOI 10.1093/jac/dkn356; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Palmu AAI, 2004, CLIN INFECT DIS, V38, P234, DOI 10.1086/380642; Perez-Gutierrez C, 2010, INFECT IMMUN, V78, P2768, DOI 10.1128/IAI.01417-09; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; PRUGNOLA A, 1995, MICROBIOL-UK, V141, P2529, DOI 10.1099/13500872-141-10-2529; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reines M, 2012, J BACTERIOL, V194, P3173, DOI 10.1128/JB.00308-12; Revai K, 2006, PEDIATRICS, V117, P1823, DOI 10.1542/peds.2005-1983; Rouadi P, 1999, J APPL PHYSIOL, V87, P400, DOI 10.1152/jappl.1999.87.1.400; Rozen S, 2000, Methods Mol Biol, V132, P365; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; SARUBBI FA, 1990, AM J MED, V88, pS9, DOI 10.1016/0002-9343(90)90254-B; SCHRYVERS AB, 1989, INFECT IMMUN, V57, P2425, DOI 10.1128/IAI.57.8.2425-2429.1989; Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10; Spaniol V, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-182; Spaniol V, 2009, J INFECT DIS, V200, P1593, DOI 10.1086/644640; Stevanin TM, 2005, INFECT IMMUN, V73, P3322, DOI 10.1128/IAI.73.6.3322-3329.2005; STRALEY SC, 1995, TRENDS MICROBIOL, V3, P310, DOI 10.1016/S0966-842X(00)88960-X; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; VANHARE GF, 1987, PEDIATR INFECT DIS J, V6, P92, DOI 10.1097/00006454-198701000-00047; Verhaegh SJC, 2011, MICROBIOL-SGM, V157, P169, DOI 10.1099/mic.0.042929-0; Wang W, 2007, INFECT IMMUN, V75, P4959, DOI 10.1128/IAI.00073-07; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991; White-Ziegler CA, 2007, J BACTERIOL, V189, P5429, DOI 10.1128/JB.01929-06; Xu H, 2008, LETT APPL MICROBIOL, V47, P290, DOI 10.1111/j.1472-765X.2008.02429.x	74	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68298	10.1371/journal.pone.0068298	http://dx.doi.org/10.1371/journal.pone.0068298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844181	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000321341000150
J	Taft, RA; Low, BE; Byers, SL; Murray, SA; Kutny, P; Wiles, MV				Taft, Robert A.; Low, Benjamin E.; Byers, Shannon L.; Murray, Stephen A.; Kutny, Peter; Wiles, Michael V.			The Perfect Host: A Mouse Host Embryo Facilitating More Efficient Germ Line Transmission of Genetically Modified Embryonic Stem Cells	PLOS ONE			English	Article							TRANSGENIC MICE; GENE; VASA; EXPRESSION; KARYOTYPE; HOMOLOG; CULTURE; PROTEIN	There is a continual need to improve efficiency in creating precise genetic modifications in mice using embryonic stem cells (ESCs). We describe a novel approach resulting in 100% germline transmission from competent injected ESCs. We developed an F1 mouse host embryo (Perfect Host, PH) that selectively ablates its own germ cells via tissue-specific induction of diphtheria toxin. This approach allows competent microinjected ESCs to fully dominate the germline, eliminating competition for this critical niche in the developing and adult animal. This is in contrast to conventional methods, where competition from host germ cells results in offspring derived from host cells and ESCs, necessitating extensive breeding of chimeras and genotyping to identify germline. The germline transmission process is also complicated by variability in the actual number of ESCs that colonize the germline niche and the proportion that are germline competent. To validate the PH approach we used ESC lines derived from 129 F1, BALB/cByJ, and BTBR backgrounds as well as an iPS line. Resulting chimeric males produced 194 offspring, all paternally derived from the introduced stem cells, with no offspring being derived from the host genome. We further tested this approach using eleven genetically modified C57BL/6N ESC lines (International Knockout Mouse Consortium). ESC germline transmission was observed in 9/11 (82%) lines using PH blastocysts, compared to 6/11 (55%) when conventional host blastocysts were used. Furthermore, less than 35% (83/240) of mice born in the first litters from conventional chimeras were confirmed to be of ESC-origin. By comparison, 100% (137/137) of the first litter offspring of PH chimeras were confirmed as ESC-derived. Together, these data demonstrate that the PH approach increases the probability of germline transmission and speeds the generation of ESC derived animals from chimeras. Collectively, this approach reduces the time and costs inherent in the production of genetically modified animals.	[Taft, Robert A.; Low, Benjamin E.; Byers, Shannon L.; Murray, Stephen A.; Kutny, Peter; Wiles, Michael V.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Wiles, MV (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Michael.Wiles@jax.org		Taft, Robert/0000-0002-3634-3342; wiles, michael/0000-0002-3620-8386	National Center for Research Resources/Office of the Director, NIH [R21 RR031289, OD011190]; Jackson Laboratory; Seed Grant from the Maine Technology Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR031289] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011185, R24OD011190] Funding Source: NIH RePORTER	National Center for Research Resources/Office of the Director, NIH; Jackson Laboratory; Seed Grant from the Maine Technology Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by Grant Number R21 RR031289 (M.V.W.) and OD011190 (R.T. and S.M.) from the National Center for Research Resources/Office of the Director, NIH, and by The Jackson Laboratory. This work was also supported by a Seed Grant from the Maine Technology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bendel-Stenzel M, 1998, SEMIN CELL DEV BIOL, V9, P393, DOI 10.1006/scdb.1998.0204; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BREITMAN ML, 1990, MOL CELL BIOL, V10, P474, DOI 10.1128/MCB.10.2.474; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Guo JL, 2005, IN VITRO CELL DEV-AN, V41, P278; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; MCLAREN A, 1992, ANDROLOGIA, V24, P243; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2002, MANIPULATING MOUSE E; Ogawa T, 2000, INT J ANDROL, V23, P57, DOI 10.1046/j.1365-2605.2000.00017.x; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; Petkov PM, 2004, GENOMICS, V83, P902, DOI 10.1016/j.ygeno.2003.11.007; Suzuki H, 1997, EXP ANIM TOKYO, V46, P17, DOI 10.1538/expanim.46.17; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Wiles MV, 2010, METHODS MOL BIOL, V602, P23, DOI 10.1007/978-1-60761-058-8_2; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Wu S, 2006, DEVELOPMENT, V133, P581, DOI 10.1242/dev.02236; Zohni K, 2012, HUM REPROD, V27, P44, DOI 10.1093/humrep/der357	26	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67826	10.1371/journal.pone.0067826	http://dx.doi.org/10.1371/journal.pone.0067826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844102	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000104
J	Yu, F; Gao, W; Yokochi, T; Suenaga, Y; Ando, K; Ohira, M; Nakamura, Y; Nakagawara, A				Yu, F.; Gao, W.; Yokochi, T.; Suenaga, Y.; Ando, K.; Ohira, M.; Nakamura, Y.; Nakagawara, A.			RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma	ONCOGENE			English	Article						RUNX3; MYCN; neuroblastoma; tumor suppressor	N-MYC; TUMOR-SUPPRESSOR; EXPRESSION; CANCER; GROWTH; GENE; IDENTIFICATION; PROGRESSION; INHIBITION; PROGNOSIS	RUNX3, a runt-related transcription factor, has a crucial role in dorsal root ganglion neurogenesis. Recent studies have suggested that RUNX3 acts as a tumor suppressor in stomach, colon and breast cancer. However, the biological role of RUNX3 in neuroblastoma remains elusive. Here we report that high levels of RUNX3 expression contribute to the favorable outcome in patients with neuroblastoma, whereas low levels of RUNX3 expression result in poor outcome. Array-based analysis suggested that the allelic loss at chromosome 1p36 is one of the reasons why expression of RUNX3 is downregulated in advanced neuroblastomas. Interestingly, the several patients survived from neuroblastoma with both high mRNA expressions of MYCN and RUNX3, suggesting that RUNX3 high expression might overcome the aggressive behavior of MYCN. Exogenous expression of RUNX3 strongly inhibits cell proliferation and migration in neuroblastoma cell lines. Furthermore, RUNX3 reduces the stability of MYCN protein in MYCN-amplified neuroblastoma cell lines, and this RUNX3-mediated MYCN degradation may depend on the physical interaction between RUNX3 and MYCN. Thus, our findings provide a tumor-suppressing mechanism by which RUNX3 inhibits the MYCN activity in neuroblastoma.	[Yu, F.; Gao, W.; Yokochi, T.; Suenaga, Y.; Ando, K.; Nakamura, Y.; Nakagawara, A.] Chiba Canc Ctr, Res Inst, Div Biochem & Innovat Canc Therapeut, Chiba 2608717, Japan; [Yu, F.; Nakagawara, A.] Chiba Univ, Grad Sch Med, Dept Mol Biol & Oncol, Chiba, Japan; [Yu, F.] Hebei Med Univ, Forth Hosp, Dept Thorac Surg, Shijiazhuang, Hebei, Peoples R China; [Gao, W.] Hebei Med Univ, Forth Hosp, Dept Surg 1, Shijiazhuang, Hebei, Peoples R China; [Ohira, M.] Chiba Canc Ctr, Res Inst, Div Canc Genom, Chiba 2608717, Japan	Chiba Cancer Center; Chiba University; Hebei Medical University; Hebei Medical University; Chiba Cancer Center	Nakagawara, A (corresponding author), Chiba Canc Ctr, Res Inst, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	akiranak@chiba-cc.jp		Suenaga, Yusuke/0000-0001-6902-5386	Ministry of Health, Labour and Welfare for Third Term Comprehensive Control Research for Cancer; JSPS [24249061]; Takeda Science Foundation	Ministry of Health, Labour and Welfare for Third Term Comprehensive Control Research for Cancer; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare for Third Term Comprehensive Control Research for Cancer, JSPS KAKENHI (Grant number 24249061) and a Grant from Takeda Science Foundation.	Akter J, 2011, CLIN CANCER RES, V17, P6681, DOI 10.1158/1078-0432.CCR-11-0313; Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Chen L, 2008, CANCER RES, V70, P1377; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Chuang LSH, 2010, ONCOGENE, V29, P2605, DOI 10.1038/onc.2010.88; Cotterill SJ, 2000, EUR J CANCER, V36, P901, DOI 10.1016/S0959-8049(00)00058-7; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Guo WH, 2002, ONCOGENE, V21, P8351, DOI 10.1038/sj.onc.1206037; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Huang B, 2012, ONCOGENE, V31, P527, DOI 10.1038/onc.2011.252; Inoue KI, 2007, J BIOL CHEM, V282, P24175, DOI 10.1074/jbc.M703746200; Inoue K, 2011, GENE, V487, P151, DOI 10.1016/j.gene.2011.05.016; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lee CWL, 2011, GYNECOL ONCOL, V122, P410, DOI 10.1016/j.ygyno.2011.04.044; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lin FC, 2012, ONCOGENE, V31, P4302, DOI 10.1038/onc.2011.596; Maris JM, 2000, J CLIN ONCOL, V18, P1888, DOI 10.1200/JCO.2000.18.9.1888; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Nakagawara A, 2004, PROG BRAIN RES, V146, P233, DOI 10.1016/S0079-6123(03)46015-9; NAKAGAWARA A, 1992, CANCER RES, V52, P1364; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Nakagawara A, 1998, Hum Cell, V11, P115; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Ohira M, 2003, ONCOGENE, V22, P5525, DOI 10.1038/sj.onc.1206853; Ohira M, 2000, ONCOGENE, V19, P4302, DOI 10.1038/sj.onc.1203786; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Riley RD, 2004, CLIN CANCER RES, V10, P4, DOI 10.1158/1078-0432.CCR-1051-2; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Suenaga Y, 2009, BIOCHEM BIOPH RES CO, V390, P21, DOI 10.1016/j.bbrc.2009.09.044; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Tomioka N, 2008, ONCOGENE, V27, P441, DOI 10.1038/sj.onc.1210661; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Yamada C, 2010, J BIOL CHEM, V285, P16693, DOI 10.1074/jbc.M109.055525; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05	42	9	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2601	2609		10.1038/onc.2013.221	http://dx.doi.org/10.1038/onc.2013.221			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23851507				2022-12-25	WOS:000336502700006
J	Heymann, JB; Bartho, JD; Rybakova, D; Venugopal, HP; Winkler, DC; Sen, A; Hurst, MRH; Mitra, AK				Heymann, J. Bernard; Bartho, Joseph D.; Rybakova, Daria; Venugopal, Hari P.; Winkler, Dennis C.; Sen, Anindito; Hurst, Mark R. H.; Mitra, Alok K.			Three-dimensional Structure of the Toxin-delivery Particle Antifeeding Prophage of Serratia entomophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMMON EVOLUTIONARY ORIGIN; PSEUDOMONAS-AERUGINOSA; TAIL LENGTH; GRASS GRUB; SECRETION APPARATUS; AMBER DISEASE; BACTERIOPHAGE-T4; PROTEIN; SHEATH; PHAGE	The Serratia entomophila antifeeding prophage (Afp) is a bullet-shaped toxin-delivery apparatus similar to the R-pyocins of Pseudomonas aeruginosa. Morphologically it resembles the sheathed tail of bacteriophages such as T4, including a baseplate at one end. It also shares features with the type VI secretion systems. Cryo-electron micrographs of tilted Afp specimens (up to 60 degrees) were analyzed to determine the correct cyclic symmetry to overcome the limitation imposed by exclusively side views in nominally untilted specimens. An asymmetric reconstruction shows clear 6-fold cyclic symmetry contrary to a previous conclusion of 4-fold symmetry based on analysis of only the preferred side views (Sen, A., Rybakova, D., Hurst, M. R., and Mitra, A. K. (2010) J. Bacteriol. 192, 4522-4525). Electron tomography of negatively stained Afp revealed right-handed helical striations in many of the particles, establishing the correct hand. Higher quality micrographs of untilted specimens were processed to produce a reconstruction at 2.0-nm resolution with imposed 6-fold symmetry. The helical parameters of the sheath were determined to be 8.14 nm for the subunit rise along and 40.5 degrees for the rotation angle around the helix. The sheath is similar to that of the T4 phage tail but with a different arrangement of the subdomain of the polymerizing sheath protein( s). The central tube is similar to the diameter and axial width of the Hcp1 hexamer of P. aeruginosa type VI secretion system. The tube extends through the baseplate into a needle resembling the "puncture device" of the T4 tail. The tube contains density that may be the toxin and/or a length-determining protein.	[Heymann, J. Bernard; Winkler, Dennis C.] NIAMS, NIH, Bethesda, MD 20892 USA; [Bartho, Joseph D.; Venugopal, Hari P.; Sen, Anindito; Mitra, Alok K.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Rybakova, Daria; Hurst, Mark R. H.] Agresearch, Innovat Farm Syst, Christchurch 8140, New Zealand	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Auckland; AgResearch - New Zealand	Mitra, AK (corresponding author), Univ Auckland, Sch Biol Sci, Thomas Bldg,3A Symonds St, Auckland 1142, New Zealand.	a.mitra@auckland.ac.nz	Heymann, Bernard/H-8265-2019; Mitra, Alok/P-7800-2016	Heymann, Bernard/0000-0002-8872-5326; Winkler, Dennis/0000-0003-1445-6554; Hurst, Mark/0000-0001-5826-5253; Rybakova, Daria/0000-0002-1756-6014; Mitra, Alok/0000-0003-0891-5697; Bartho, Joseph Dale/0000-0003-3853-2347	Faculty Research Development Fund from the University of Auckland; Foundation of Research, Science and Technology, New Zealand [C10X0804]; Intramural Research Program of NIAMS, National Institutes of Health	Faculty Research Development Fund from the University of Auckland; Foundation of Research, Science and Technology, New Zealand(New Zealand Foundation for Research, Science and Technology); Intramural Research Program of NIAMS, National Institutes of Health	This work was supported by a Faculty Research Development Fund from the University of Auckland (to A. K. M.), by Foundation of Research, Science and Technology, New Zealand Grant C10X0804 (to M. R. H. H.), and by the Intramural Research Program of NIAMS, National Institutes of Health (to J. B. H. and D. C. W.).	ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128; Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Glare TR, 1996, FEMS MICROBIOL LETT, V139, P117, DOI 10.1016/0378-1097(96)00128-0; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Heymann JB, 2013, J STRUCT BIOL, V184, P43, DOI 10.1016/j.jsb.2013.05.006; Heymann JB, 2005, J BIOL CHEM, V280, P7156, DOI 10.1074/jbc.M411712200; Hurst MRH, 2007, FEMS MICROBIOL LETT, V270, P42, DOI 10.1111/j.1574-6968.2007.00645.x; Hurst MRN, 2011, PLASMID, V65, P32, DOI 10.1016/j.plasmid.2010.10.001; Hurst MRH, 2004, J BACTERIOL, V186, P5116, DOI 10.1128/jb.186.15.5116-5128.2004; Hurst MRH, 2000, J BACTERIOL, V182, P5127, DOI 10.1128/JB.182.18.5127-5138.2000; ISHII SHIN-ICHI, 1965, J MOL BIOL, V13, P428; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; MOODY MF, 1967, J MOL BIOL, V25, P167, DOI 10.1016/0022-2836(67)90136-2; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Nguyen AH, 1999, BIOSCI BIOTECH BIOCH, V63, P1360, DOI 10.1271/bbb.63.1360; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rybakova D, 2013, MOL MICROBIOL, V89, P702, DOI 10.1111/mmi.12305; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sen A, 2010, J BACTERIOL, V192, P4522, DOI 10.1128/JB.00224-10; TAKEDA Y, 1975, J BIOCHEM-TOKYO, V77, P679, DOI 10.1093/oxfordjournals.jbchem.a130770; TAKEDA Y, 1983, J BIOCHEM-TOKYO, V94, P1013, DOI 10.1093/oxfordjournals.jbchem.a134398; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Vianelli A, 2000, J BACTERIOL, V182, P680, DOI 10.1128/JB.182.3.680-688.2000; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006	37	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25276	25284		10.1074/jbc.M113.456145	http://dx.doi.org/10.1074/jbc.M113.456145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857636	hybrid, Green Published			2022-12-25	WOS:000330619000026
J	Huang, MLH; Austin, CJD; Sari, MA; Rahmanto, YS; Ponka, P; Vyoral, D; Richardson, DR				Huang, Michael Li-Hsuan; Austin, Christopher J. D.; Sari, Marie-Agnes; Rahmanto, Yohan Suryo; Ponka, Prem; Vyoral, Daniel; Richardson, Des R.			Hepcidin Bound to alpha(2)-Macroglobulin Reduces Ferroportin-1 Expression and Enhances Its Activity at Reducing Serum Iron Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; GROWTH-FACTOR-BETA; LOW-DENSITY-LIPOPROTEIN; TRANSFORMING GROWTH-FACTOR-BETA-1; BINDING-PROTEIN; ALPHA-MACROGLOBULINS; PLASMA-CLEARANCE; LDL RECEPTOR; FACTOR-BB; ALPHA-2-MACROGLOBULIN	Hepcidin regulates iron metabolism by down-regulating ferroportin-1 (Fpn1). We demonstrated that hepcidin is complexed to the blood transport protein, alpha(2)-macroglobulin (alpha M-2) (Peslova, G., Petrak, J., Kuzelova, K., Hrdy, I., Halada, P., Kuchel, P. W., Soe-Lin, S., Ponka, P., Sutak, R., Becker, E., Huang, M. L., Suryo Rahmanto, Y., Richardson, D. R., and Vyoral, D. (2009) Blood 113, 6225-6236). However, nothing is known about the mechanism of hepcidin binding to alpha M-2 or the effects of the alpha M-2.hepcidin complex in vivo. We show that decreased Fpn1 expression can be mediated by hepcidin bound to native alpha M-2 and also, for the first time, hepcidin bound to methylamine-activated alpha M-2 (alpha M-2-MA). Passage of high molecular weight alpha M-2.hepcidin or alpha M-2-MA.hepcidin complexes (approximate to 725 kDa) through a Sephadex G-25 size exclusion column retained their ability to decrease Fpn1 expression. Further studies using ultrafiltration indicated that hepcidin binding to alpha M-2 and alpha M-2-MA was labile, resulting in some release from the protein, and this may explain its urinary excretion. To determine whether alpha(2)MMA.hepcidin is delivered to cells via the alpha M-2 receptor (Lrp1), we assessed alpha(2)Muptake and Fpn1 expression in Lrp1-/- and Lrp1(+)/(+) cells. Interestingly, alpha M-2.hepcidin or alpha M-2-MA.hepcidin demonstrated similar activities at decreasing Fpn1 expression in Lrp1-/- and Lrp1(+)/(+) cells, indicating that Lrp1 is not essential for Fpn1 regulation. In vivo, hepcidin bound to alpha M-2 or alpha M-2-MA did not affect plasma clearance of alpha M-2/alpha M-2-MA. However, serum iron levels were reduced to a significantly greater extent in mice treated with alpha M-2.hepcidin or alpha M-2-MA.hepcidin relative to unbound hepcidin. This effect could be mediated by the ability of alpha M-2 or alpha M-2-MA to retard kidney filtration of bound hepcidin, increasing its half-life. A model is proposed that suggests that unlike proteases, which are irreversibly bound to activated alpha M-2, hepcidin remains labile and available to down-regulate Fpn1.	[Huang, Michael Li-Hsuan; Austin, Christopher J. D.; Rahmanto, Yohan Suryo; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia; [Sari, Marie-Agnes] Univ Paris 05, Lab Chim & Biochim Pharmacol & Toxicol, CNRS, UMR8601, F-75006 Paris, France; [Ponka, Prem] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Vyoral, Daniel] Inst Hematol & Blood Transfus, CR-12820 Prague 2, Czech Republic; [Vyoral, Daniel] Charles Univ Prague, Inst Pathol Physiol, Fac Med 1, Prague 12853 2, Czech Republic	University of Sydney; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Lady Davis Institute; McGill University; Institute of Hematology Prague; Charles University Prague	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Huang, Michael L.-H./AAK-2237-2020; Girelli, Domenico/B-1183-2008; Ponka, Prem/A-4123-2011; Suryo Rahmanto, Yohan/K-8043-2018	Huang, Michael L.-H./0000-0003-0693-7833; Girelli, Domenico/0000-0001-9684-1899; Suryo Rahmanto, Yohan/0000-0003-1453-7872; Richardson, Des/0000-0003-0960-6415; Ponka, Prem/0000-0001-5835-1477; Richardson, Des/0000-0002-5506-3274	Canadian Institutes of Health Research; Project for Conceptual Development of Research Organizations of the Czech Ministry of Health [00023736]; Czech Ministry of Education [PRVOUK P24/LF1/3]; European Fund for Regional Development [ERDF OPPK CZ.2.16/3.1.00/24, ERDF OPPK CZ.2.16/3.1.00/28007 001]; National Health and Medical Research Council of Australia [571123, 632698]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Project for Conceptual Development of Research Organizations of the Czech Ministry of Health; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); European Fund for Regional Development(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by operating grants from the Canadian Institutes of Health Research.; Supported by the Project for Conceptual Development of Research Organizations (00023736) of the Czech Ministry of Health; Grant PRVOUK P24/LF1/3 from the Czech Ministry of Education; and Grants ERDF OPPK CZ.2.16/3.1.00/24001 and ERDF OPPK CZ.2.16/3.1.00/28007 from the European Fund for Regional Development.; Supported by Senior Principal Research Fellowship 571123 and Project Grant 632698 from the National Health and Medical Research Council of Australia. To whom correspondence should be addressed: Dept. of Pathology, Blackburn Bldg., D06, University of Sydney, NSW 2006, Australia. Tel.: 61-2-9036-6548; Fax: 61-2-9351-3429; E-mail: d.richardson@med.usyd.edu.au.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Bhattacharjee G, 2000, J BIOL CHEM, V275, P26806; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Colledge N. R., 2010, DAVIDSONS PRINCIPLES, P459; CROOKSTON KP, 1993, BIOCHEM J, V293, P443, DOI 10.1042/bj2930443; CROOKSTON KP, 1994, BIOCHEM BIOPH RES CO, V200, P1578, DOI 10.1006/bbrc.1994.1631; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; DENNIS PA, 1989, J BIOL CHEM, V264, P7210; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Goncalves AS, 2006, BIOCHEM J, V396, P265, DOI 10.1042/BJ20051682; GONIAS SL, 1983, ANN NY ACAD SCI, V421, P457, DOI 10.1111/j.1749-6632.1983.tb18139.x; GONIAS SL, 1994, ANN NY ACAD SCI, V737, P273, DOI 10.1111/j.1749-6632.1994.tb44318.x; Gonias SL, 2000, J BIOL CHEM, V275, P5826, DOI 10.1074/jbc.275.8.5826; HALL SW, 1992, BIOCHEM J, V281, P569, DOI 10.1042/bj2810569; Hocquellet A, 2012, PEPTIDES, V36, P303, DOI 10.1016/j.peptides.2012.06.001; Huang MLH, 2011, ANTIOXID REDOX SIGN, V15, P3003, DOI 10.1089/ars.2011.3921; HUANG SS, 1988, J BIOL CHEM, V263, P1535; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; Itkonen O, 2012, CLIN CHEM, V58, P1158, DOI 10.1373/clinchem.2012.186916; Itkonen O, 2012, CLIN CHIM ACTA, V413, P696, DOI 10.1016/j.cca.2011.12.015; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kluver E, 2002, J PEPT RES, V59, P241, DOI 10.1034/j.1399-3011.2002.00980.x; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Koliaraki V, 2008, BIOCHIMIE, V90, P726, DOI 10.1016/j.biochi.2008.01.012; Kong WN, 2008, J CELL BIOCHEM, V104, P629, DOI 10.1002/jcb.21654; KRATZSCH J, 1995, J CLIN ENDOCR METAB, V80, P585, DOI 10.1210/jc.80.2.585; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LAMARRE J, 1990, LAB INVEST, V62, P545; LAMARRE J, 1991, J CLIN INVEST, V87, P39, DOI 10.1172/JCI114998; Leake DS, 1997, ATHEROSCLEROSIS, V129, P149, DOI 10.1016/S0021-9150(96)06035-2; Mathew S, 2003, BIOCHEM J, V374, P123, DOI 10.1042/BJ20021655; MATSUDA T, 1989, J IMMUNOL, V142, P148; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Nemeth E, 2006, BLOOD, V107, P328, DOI 10.1182/blood-2005-05-2049; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nguyen NB, 2006, AM J PHYSIOL-LUNG C, V291, pL417, DOI 10.1152/ajplung.00484.2005; NIEMULLER CA, 1995, ENDOCRINOLOGY, V136, P5343, DOI 10.1210/en.136.12.5343; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; OVERBERGH L, 1995, J LIPID RES, V36, P1774; PANYUTICH A, 1991, AM J RESP CELL MOL, V5, P101, DOI 10.1165/ajrcmb/5.2.101; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peslova G, 2009, BLOOD, V113, P6225, DOI 10.1182/blood-2009-01-201590; PHILIP A, 1991, J BIOL CHEM, V266, P22290; Pizzo S. V., 2000, HEMOSTASIS THROMBOSI, P367; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; RICHARDSON D, 1992, J BIOL CHEM, V267, P13972; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; Sari M.-A., 2011, AM J HEMATOL, V86, pE14; SKOGH T, 1982, GUT, V23, P1077, DOI 10.1136/gut.23.12.1077; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Westwood M, 2001, J BIOL CHEM, V276, P41668, DOI 10.1074/jbc.M102793200; WOLLENBERG GK, 1991, AM J PATHOL, V138, P265; Yeh KY, 2009, AM J PHYSIOL-GASTR L, V296, pG55, DOI 10.1152/ajpgi.90298.2008	65	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25450	25465		10.1074/jbc.M113.471573	http://dx.doi.org/10.1074/jbc.M113.471573			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846698	hybrid, Green Published			2022-12-25	WOS:000330619000041
J	Ordureau, A; Enesa, K; Nanda, S; Le Francois, B; Peggie, M; Prescott, A; Albert, PR; Cohen, P				Ordureau, Alban; Enesa, Karine; Nanda, Sambit; Le Francois, Brice; Peggie, Mark; Prescott, Alan; Albert, Paul R.; Cohen, Philip			DEAF1 Is a Pellino1-interacting Protein Required for Interferon Production by Sendai Virus and Double-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR DEPRESSIVE DISORDER; UBIQUITIN LIGASE PELLINO; FACTOR-I DEAF-1; KAPPA-B; ACTIVATION; IDENTIFICATION; EXPRESSION; INDUCTION; KINASE; IRAK1	Double-stranded (ds) RNA of viral origin, a ligand for Melanoma Differentiation-associated gene 5 (MDA5) and Toll-Like Receptor 3 (TLR3), induces the TANK-Binding Kinase 1 (TBK1)-dependent phosphorylation and activation of Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquitin ligase Pellino1, which are required for interferon beta (IFN beta) gene transcription. Here, we report that Pellino1 interacts with the transcription factor Deformed Epidermal Autoregulatory Factor 1 (DEAF1). The interaction is independent of the E3 ligase activity of Pellino1, but weakened by the phosphorylation of Pellino1. We show that DEAF1 binds to the IFN beta promoter and to IRF3 and IRF7, that it is required for the transcription of the IFN beta gene and IFN beta secretion in MEFs infected with Sendai virus or transfected with poly(I:C). DEAF1 is also needed for TLR3-dependent IFN beta production. Taken together, our results identify DEAF1 as a novel component of the signal transduction network by which dsRNA of viral origin stimulates IFN beta production.	[Ordureau, Alban; Enesa, Karine; Nanda, Sambit; Peggie, Mark; Cohen, Philip] Univ Dundee, Sir James Black Ctr, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Prescott, Alan] Univ Dundee, Sir James Black Ctr, Coll Life Sci, Dundee DD1 5EH, Scotland; [Le Francois, Brice; Albert, Paul R.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa Hosp Res Inst Neurosci, Ottawa, ON K1H 8M5, Canada	University of Dundee; University of Dundee; University of Ottawa; Ottawa Hospital Research Institute	Cohen, P (corresponding author), Univ Dundee, Sir James Black Ctr, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk	Albert, Paul/E-4804-2010; Ordureau, Alban/C-7558-2012; Prescott, Alan/Y-5956-2018	Albert, Paul/0000-0002-1809-3554; Ordureau, Alban/0000-0002-4924-8520; Prescott, Alan/0000-0002-0747-7317	UK Medical Research Council; Medical Research Council [MC_EX_G0800765, MR/K000985/1, MC_EX_UU_G0800765, MC_UU_12016/11, MC_U127084348] Funding Source: researchfish; MRC [MR/K000985/1, MC_EX_UU_G0800765, MC_U127084348, MC_UU_12016/11, MC_EX_G0800765] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council.	Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Cubeddu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039218; Czesak M, 2012, J BIOL CHEM, V287, P6615, DOI 10.1074/jbc.M111.293027; Enesa K, 2012, J BIOL CHEM, V287, P34825, DOI 10.1074/jbc.M112.367557; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Goswami DB, 2010, J NEUROCHEM, V112, P397, DOI 10.1111/j.1471-4159.2009.06462.x; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Haghayeghi A, 2010, MECH DEVELOP, V127, P301, DOI 10.1016/j.mod.2010.01.004; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kuttenkeuler D, 2010, J INNATE IMMUN, V2, P181, DOI 10.1159/000248649; Lee YS, 2010, BIOCHEM BIOPH RES CO, V393, P836, DOI 10.1016/j.bbrc.2010.02.094; Lemonde S, 2003, J NEUROSCI, V23, P8788; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; Lo Surdo P, 2003, MOL ENDOCRINOL, V17, P1283, DOI 10.1210/me.2002-0409; Manne U, 2001, CLIN CANCER RES, V7, P3495; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reed DE, 2008, P NATL ACAD SCI USA, V105, P8351, DOI 10.1073/pnas.0802921105; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	41	18	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24569	24580		10.1074/jbc.M113.479550	http://dx.doi.org/10.1074/jbc.M113.479550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846693	Green Published, hybrid			2022-12-25	WOS:000330612300025
J	Takeshita, Y; Hashimoto, Y; Nawa, M; Uchino, H; Matsuoka, M				Takeshita, Yuji; Hashimoto, Yuichi; Nawa, Mikiro; Uchino, Hiroyuki; Matsuoka, Masaaki			SH3-binding Protein 5 Mediates the Neuroprotective Effect of the Secreted Bioactive Peptide Humanin by Inhibiting c-Jun NH2-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; N-TERMINAL KINASE; ALZHEIMERS-DISEASE; IN-VIVO; PRECURSOR PROTEIN; MEMORY IMPAIRMENT; ISCHEMIA/REPERFUSION INJURY; RELEVANT INSULTS; BINDING-PROTEIN; MAP-KINASE	Humanin is a secreted bioactive peptide that suppresses cell toxicity caused by a variety of insults. The neuroprotective effect of Humanin against Alzheimer disease (AD)-related death is mediated by the binding of Humanin to its heterotrimeric Humanin receptor composed of ciliary neurotrophic receptor alpha, WSX-1, and gp130, as well as the activation of intracellular signaling pathways including a JAK2 and STAT3 signaling axis. Despite the elucidation of the signaling pathways by which Humanin mediates its neuroprotection, the transcriptional targets of Humanin that behaves as effectors of Humanin remains undefined. In the present study, Humanin increased the mRNA and protein expression of SH3 domain-binding protein 5 (SH3BP5), which has been known to be a JNK interactor, in neuronal cells. Similar to Humanin treatment, overexpression of SH3BP5 inhibited AD-related neuronal death, while siRNA-mediated knockdown of endogenous SH3BP5 expression attenuated the neuroprotective effect of Humanin. These results indicate that SH3BP5 is a downstream effector of Humanin. Furthermore, biochemical analysis has revealed that SH3BP5 binds to JNK and directly inhibits JNK through its two putative mitogen-activated protein kinase interaction motifs (KIMs).	[Takeshita, Yuji; Hashimoto, Yuichi; Nawa, Mikiro; Matsuoka, Masaaki] Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1608402, Japan; [Takeshita, Yuji; Uchino, Hiroyuki] Tokyo Med Univ, Dept Anesthesiol, Shinjuku Ku, Tokyo 1600023, Japan	Tokyo Medical University; Tokyo Medical University	Matsuoka, M (corresponding author), Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	sakimatu@tokyo-med.ac.jp	Hashimoto, Yuichi/N-1508-2015	Hashimoto, Yuichi/0000-0001-5863-3618	Promotion of Science and Technology project for private universities; Ministry of Education, Culture, Sports, Science, and Technology (MEXT);  [23390059];  [25460343]; Grants-in-Aid for Scientific Research [24790264] Funding Source: KAKEN	Promotion of Science and Technology project for private universities; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Grant-in-aid for Scientific Research (B) (Grant 23390059) (to M. M.), the Promotion of Science and Technology project for private universities, with a matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to M. M.), and the Grant-in-Aid for Scientific Research (C) (Grant 25460343) (to Y. H.).	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Chambers JW, 2013, J BIOL CHEM, V288, P4000, DOI 10.1074/jbc.M112.406777; Chambers JW, 2013, J BIOL CHEM, V288, P1079, DOI 10.1074/jbc.M112.421354; Chambers JW, 2011, ACS CHEM BIOL, V6, P808, DOI 10.1021/cb200062a; Chiba T, 2005, J NEUROSCI, V25, P10252, DOI 10.1523/JNEUROSCI.3348-05.2005; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Colon E, 2006, J CELL PHYSIOL, V208, P373, DOI 10.1002/jcp.20672; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2003, J PHARMACOL EXP THER, V306, P889, DOI 10.1124/jpet.103.051383; Hashimoto Y, 2003, J NEUROCHEM, V84, P864, DOI 10.1046/j.1471-4159.2003.01585.x; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2009, BIOCHEM BIOPH RES CO, V389, P95, DOI 10.1016/j.bbrc.2009.08.095; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Kawasumi M, 2002, NEUROSIGNALS, V11, P236, DOI 10.1159/000067424; Krejcova G, 2004, J PEPT SCI, V10, P636, DOI 10.1002/psc.569; Kunesova G, 2008, PEPTIDES, V29, P1982, DOI 10.1016/j.peptides.2008.06.019; Lue YH, 2010, ENDOCRINOLOGY, V151, P350, DOI 10.1210/en.2009-0577; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Matsuoka M, 2011, J ALZHEIMERS DIS, V24, P27, DOI 10.3233/JAD-2011-102076; Matsuoka Masaaki, 2009, Recent Pat CNS Drug Discov, V4, P37; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Matsushita M, 1998, BIOCHEM BIOPH RES CO, V245, P337, DOI 10.1006/bbrc.1998.8420; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Muzumdar RH, 2010, ARTERIOSCL THROM VAS, V30, P1940, DOI 10.1161/ATVBAHA.110.205997; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Niikura T, 2002, J NEUROSCI RES, V70, P380, DOI 10.1002/jnr.10354; Niikura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016259; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; Oh YK, 2011, ATHEROSCLEROSIS, V219, P65, DOI 10.1016/j.atherosclerosis.2011.06.038; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tachi N, 2012, BIOCHEM J, V442, P413, DOI 10.1042/BJ20100993; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Wang D, 2005, APOPTOSIS, V10, P963, DOI 10.1007/s10495-005-1191-x; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Win S, 2011, J BIOL CHEM, V286, P35071, DOI 10.1074/jbc.M111.276089; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamada M, 2005, BEHAV BRAIN RES, V164, P139, DOI 10.1016/j.bbr.2005.03.026; Yamadori T, 1999, P NATL ACAD SCI USA, V96, P6341, DOI 10.1073/pnas.96.11.6341; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Zhang WJ, 2012, PHARMACOL BIOCHEM BE, V100, P361, DOI 10.1016/j.pbb.2011.09.012	53	15	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24691	24704		10.1074/jbc.M113.469692	http://dx.doi.org/10.1074/jbc.M113.469692			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861391	Green Published, hybrid			2022-12-25	WOS:000330612300036
J	Decker, C; Olu, K; Arnaud-Haond, S; Duperron, S				Decker, Carole; Olu, Karine; Arnaud-Haond, Sophie; Duperron, Sebastien			Physical Proximity May Promote Lateral Acquisition of Bacterial Symbionts in Vesicomyid Clams	PLOS ONE			English	Article							REDUCTIVE GENOME EVOLUTION; CHEMOAUTOTROPHIC BACTERIA; OLIGONUCLEOTIDE PROBES; GIANT POCKMARK; SEEP; BIVALVIA; RECOMBINATION; PLIOCARDIINAE; ENDOSYMBIONT; RESPIRATION	Vesicomyid clams harbor intracellular sulfur-oxidizing bacteria that are predominantly maternally inherited and co-speciate with their hosts. Genome recombination and the occurrence of non-parental strains were recently demonstrated in symbionts. However, mechanisms favoring such events remain to be identified. In this study, we investigated symbionts in two phylogenetically distant vesicomyid species, Christineconcha regab and Laubiericoncha chuni, which sometimes co-occur at a cold-seep site in the Gulf of Guinea. We showed that each of the two species harbored a single dominant bacterial symbiont strain. However, for both vesicomyid species, the symbiont from the other species was occasionally detected in the gills using fluorescence in situ hybridization and gene sequences analyses based on six symbiont marker genes. Symbiont strains co-occurred within a single host only at sites where both host species were found; whereas one single symbiont strain was detected in C. regab specimens from a site where no L. chuni individuals had been observed. These results suggest that physical proximity favored the acquisition of non-parental symbiont strains in Vesicomyidae. Over evolutionary time, this could potentially lead to genetic exchanges among symbiont species and eventually symbiont displacement. Symbiont densities estimated using 3D fluorescence in situ hybridization varied among host species and sites, suggesting flexibility in the association despite the fact that a similar type of metabolism is expected in all symbionts.	[Decker, Carole; Olu, Karine; Arnaud-Haond, Sophie] IFREMER, Ctr Brest, Lab Environm Profond, REM EEP, Plouzane, France; [Duperron, Sebastien] UPMC CNRS IRD MNHN, UMR Systemat Adaptat Evolut Adaptat Milieux Extre, Paris, France; [Duperron, Sebastien] Univ Paris 06, Paris, France	Ifremer; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Decker, C (corresponding author), IFREMER, Ctr Brest, Lab Environm Profond, REM EEP, Plouzane, France.	carole.decker@ifremer.fr	Duperron, Sebastien/C-4712-2011; Arnaud-Haond, Sophie/B-2479-2008	Arnaud-Haond, Sophie/0000-0001-5814-8452; Olu, Karine/0000-0002-4906-4131; duperron, sebastien/0000-0002-6422-6821	ANR [ANR06BDV005, GDR2907]; German Research Foundation Research Center Ocean Margins/Center for Marine Environmental Sciences at the University Bremen for the Meteor cruises	ANR(French National Research Agency (ANR)); German Research Foundation Research Center Ocean Margins/Center for Marine Environmental Sciences at the University Bremen for the Meteor cruises	This work was done with the support of the ANR Deep Oases (ANR06BDV005) and GDR Ecchis (GDR2907) projects for scientific collaborations and of the German Research Foundation Research Center Ocean Margins/Center for Marine Environmental Sciences at the University Bremen for the Meteor cruises. No other current external funding sources have been obtained for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; [Anonymous], 2010, R LANG ENV STAT COMP; ARP AJ, 1984, PHYSIOL ZOOL, V57, P648, DOI 10.1086/physzool.57.6.30155991; Audzijonyte A, 2012, SYST BIODIVERS, V10, P403, DOI 10.1080/14772000.2012.744112; BEGUN DJ, 1991, GENETICS, V129, P1147; Cambon-Bonavita MA, 2009, DEEP-SEA RES PT II, V56, P2248, DOI 10.1016/j.dsr2.2009.04.007; CARY SC, 1993, P NATL ACAD SCI USA, V90, P5695, DOI 10.1073/pnas.90.12.5695; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Decker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033359; Decker C, 2012, CR BIOL, V335, P261, DOI 10.1016/j.crvi.2012.03.002; DISTEL DL, 1988, J BACTERIOL, V170, P2506, DOI 10.1128/jb.170.6.2506-2510.1988; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2009, GENEIOUS WEBSITE GEN; Duperron S, 2005, APPL ENVIRON MICROB, V71, P1694, DOI 10.1128/AEM.71.4.1694-1700.2005; Duperron S, 2011, GEOBIOLOGY, V9, P481, DOI 10.1111/j.1472-4669.2011.00300.x; Endow K, 1988, HEREDITY, V42, P50; Fiala-Medioni A, 1987, SYMBIOSIS, V4, P63; FIALAMEDIONI A, 1984, CR ACAD SCI III-VIE, V298, P487; FIALAMEDIONI A, 1988, OCEANOL ACTA, V11, P185; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujiwara Yoshihiro, 2000, Venus the Japanese Journal of Malacology, V59, P307; Goffredi SK, 2002, MAR ECOL PROG SER, V225, P227, DOI 10.3354/meps225227; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halary S, 2008, 3D FISH QUANTIFICATI, P1; HENTSCHEL U, 1993, MAR ECOL PROG SER, V94, P35, DOI 10.3354/meps094035; Hurtado LA, 2003, APPL ENVIRON MICROB, V69, P2058, DOI 10.1128/AEM.69.4.2058-2064.2003; Krylova EM, 2011, ZOOSYSTEMA, V33, P83, DOI 10.5252/z2011n1a4; Krylova EM, 2010, J MOLLUS STUD, V76, P107, DOI 10.1093/mollus/eyp052; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Kuwahara H, 2008, EXTREMOPHILES, V12, P365, DOI 10.1007/s00792-008-0141-2; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Kuwahara H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-285; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Marcon Y, MARINE ECOLOGY; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Newton ILG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-585; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Ondreas H, 2005, GEO-MAR LETT, V25, P281, DOI 10.1007/s00367-005-0213-6; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Roeselers G, 2012, APPL MICROBIOL BIOT, V94, P1, DOI 10.1007/s00253-011-3819-9; Roy KOL, 2007, MAR ECOL-EVOL PERSP, V28, P115, DOI 10.1111/j.1439-0485.2006.00145.x; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Stewart FJ, 2008, MOL BIOL EVOL, V25, P673, DOI 10.1093/molbev/msn010; Stewart FJ, 2009, ENVIRON MICROBIOL, V11, P2136, DOI 10.1111/j.1462-2920.2009.01933.x; Stewart FJ, 2009, MOL BIOL EVOL, V26, P1391, DOI 10.1093/molbev/msp049; Thiele J, 1931, VALDIVIA; Von Cosel R, 2008, ZOOSTYSTEMA; von Cosel R, 2009, DEEP-SEA RES PT II, V56, P2350, DOI 10.1016/j.dsr2.2009.04.016; Wenzhofer F., 2012, BIOGEOSCIENCES DISCU, V9, P8337, DOI DOI 10.5194/BG-9-5031-2012; Wilmot DB, 1992, OXYGEN NITROGEN DEPE	58	21	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e64830	10.1371/journal.pone.0064830	http://dx.doi.org/10.1371/journal.pone.0064830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861734	Green Published, gold			2022-12-25	WOS:000321692000002
J	Nagao, Y				Nagao, Yoshiro			Decreasing Fertility Rate Correlates with the Chronological Increase and Geographical Variation in Incidence of Kawasaki Disease in Japan	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENGUE TRANSMISSION; CORONARY ANEURYSMS; RISK-FACTORS; INFECTIONS; CHILDREN; HOSPITALIZATIONS; EPIDEMIOLOGY; SEASONALITY; VARIABILITY	Background: Kawasaki disease (KD) is a common cause of acquired paediatric heart disease in developed countries. KD was first identified in the 1960s in Japan, and has been steadily increasing since it was first reported. The aetiology of KD has not been defined, but is assumed to be infection-related. The present study sought to identify the factor(s) that mediate the geographical variation and chronological increase of KD in Japan. Methods and Findings: Based upon data reported between 1979 and 2010 from all 47 prefectures in Japan, the incidence and mean patient age at the onset of KD were estimated. Using spatial and time-series analyses, incidence and mean age were regressed against climatic/socioeconomic variables. Both incidence and mean age of KD were inversely correlated with the total fertility rate (TFR; i.e., the number of children that would be born to one woman). The extrapolation of a time-series regressive model suggested that KD emerged in the 1960s because of a dramatic decrease in TFR in the 1940s through the 1950s. Conclusions: Mean patient age is an inverse surrogate for the hazard of contracting the aetiologic agent. Therefore, the observed negative correlation between mean patient age and TFR suggests that a higher TFR is associated with KD transmission. This relationship may be because a higher TFR facilitates sibling-to-sibling transmission. Additionally, the observed inverse correlation between incidence and TFR implies a paradoxical "negative'' correlation between the incidence and the hazard of contracting the aetiologic agent. It was hypothesized that a decreasing TFR resulted in a reduced hazard of contracting the agent for KD, thereby increasing KD incidence.	Onoda Hosp, Minamisoma City, Fukushima, Japan		Nagao, Y (corresponding author), Onoda Hosp, Minamisoma City, Fukushima, Japan.	in_the_pacific214@yahoo.co.jp		Nagao, Yoshiro/0000-0003-3411-0729				ANDERSON R M, 1991; ANSELIN L, 1992, REG SCI URBAN ECON, V22, P509, DOI 10.1016/0166-0462(92)90042-Y; BELL DM, 1981, NEW ENGL J MED, V304, P1568, DOI 10.1056/NEJM198106253042603; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bronstein DE, 2000, PEDIATR INFECT DIS J, V19, P1087, DOI 10.1097/00006454-200011000-00012; Burgner D, 2005, INT J INFECT DIS, V9, P185, DOI 10.1016/j.ijid.2005.03.002; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2005, EPIDEMIOLOGY, V16, P220, DOI 10.1097/01.ede.0000152901.06689.d4; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang RKR, 2002, PEDIATR INFECT DIS J, V21, P1150, DOI 10.1097/00006454-200212000-00013; Checkley W, 2009, EPIDEMIOLOGY, V20, P194, DOI 10.1097/EDE.0b013e3181961a9b; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; Daniels LB, 2012, CURR OPIN CARDIOL, V27, P572, DOI 10.1097/HCO.0b013e3283588f06; ESRI Japan, 2012, CIT TOWNS VILL JAP; FUJITA Y, 1989, PEDIATRICS, V84, P666; FURUSHO K, 1984, LANCET, V2, P1055; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Harnden A, 2009, PEDIATR INFECT DIS J, V28, P21, DOI 10.1097/INF.0b013e3181812ca4; Holman RC, 2010, PEDIATR INFECT DIS J, V29, P483, DOI 10.1097/INF.0b013e3181cf8705; Iemura M, 2000, HEART, V83, P307, DOI 10.1136/heart.83.3.307; Inaba H, 2008, MATH MODEL NAT PHENO, V3, P194, DOI 10.1051/mmnp:2008050; Kao AS, 2008, PEDIATR INFECT DIS J, V27, P981, DOI 10.1097/INF.0b013e31817acf4f; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; Kawasaki T, 1967, Arerugi, V16, P178; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Khor CC, 2011, J MED GENET, V48, P467, DOI 10.1136/jmg.2010.086611; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Lanphear BP, 1998, PEDIATR INFECT DIS J, V17, P792, DOI 10.1097/00006454-199809000-00008; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; MAY RM, 1985, MATH BIOSCI, V77, P141, DOI 10.1016/0025-5564(85)90093-8; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; Ministry of Health Labor and Welfare, 1986, SURV PHYS DENT PHARM; Ministry of Health Labour and Welfare, 1975, SPEC REP DYN DEM SUR; Ministry of Internal Affairs and Communications, 1975, EST POP; Ministry of Internal Affairs and Communications, 1975, STAT IND SOC LIF; MUSO E, 1993, CLIN NEPHROL, V40, P7; Nagao Y, 2008, EPIDEMIOL INFECT, V136, P843, DOI 10.1017/S0950268807008990; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Nakamura Y, 2008, J EPIDEMIOL, V18, P273, DOI 10.2188/jea.JE2008030; Nakamura Y, 2008, PEDIATR INT, V50, P287, DOI 10.1111/j.1442-200X.2008.02572.x; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; OKANO M, 1990, J MED VIROL, V32, P53, DOI 10.1002/jmv.1890320109; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pisati M, 2001, STATA TECHNICAL B, V55, P33; Pitzer VE, 2012, P ROY SOC B-BIOL SCI, V279, P2736, DOI 10.1098/rspb.2011.2464; Pitzer VE, 2011, J R SOC INTERFACE, V8, P1584, DOI 10.1098/rsif.2011.0062; Pitzer VE, 2009, J THEOR BIOL, V260, P175, DOI 10.1016/j.jtbi.2009.06.008; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Rowley AH, 2011, J INFECT DIS, V203, P1021, DOI 10.1093/infdis/jiq136; Shingadia D, 2002, LANCET INFECT DIS, V2, P310, DOI 10.1016/S1473-3099(02)00265-7; Suenaga T, 2009, J PEDIATR-US, V155, P266, DOI 10.1016/j.jpeds.2009.03.013; TAUBERT KA, 1991, J PEDIATR-US, V119, P279, DOI 10.1016/S0022-3476(05)80742-5; The World Bank, 2012, FERT RAT TOT BIRTHS; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Tsuchida S, 1996, ACTA PAEDIATR, V85, P995, DOI 10.1111/j.1651-2227.1996.tb14201.x; TULJAPURKAR S, 1991, THEOR POPUL BIOL, V40, P322, DOI 10.1016/0040-5809(91)90059-O; Turkay S, 2006, J NATL MED ASSOC, V98, P1350; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; University Corporation for Atmospheric Research, 2012, GLOB SUMM DAY MONTH; YANAGAWA H, 1995, ARCH PEDIAT ADOL MED, V149, P779, DOI 10.1001/archpedi.1995.02170200069011; Yanagawa H, 2004, EPIDEMIOLOGY KAWASAK, P17; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	67	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67934	10.1371/journal.pone.0067934	http://dx.doi.org/10.1371/journal.pone.0067934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861836	gold, Green Published, Green Submitted			2022-12-25	WOS:000321692000013
J	Sallustio, F; Serino, G; Costantino, V; Curci, C; Cox, SN; De Palma, G; Schena, FP				Sallustio, Fabio; Serino, Grazia; Costantino, Vincenzo; Curci, Claudia; Cox, Sharon N.; De Palma, Giuseppe; Schena, Francesco P.			miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; STEM/PROGENITOR CELLS; KIDNEY REPAIR; MICRORNAS; ACTIVATION; TARGETS; BIOLOGY; INJURY; MOUSE	Adult renal progenitor cells (ARPCs) were recently identified in the cortex of the renal parenchyma and it was demonstrated that they were positive for PAX2, CD133, CD24 and exhibited multipotent differentiation ability. Recent studies on stem cells indicated that microRNAs (miRNAs), a class of noncoding small RNAs that participate in the regulation of gene expression, may play a key role in stem cell self-renewal and differentiation. Distinct sets of miRNAs are specifically expressed in pluripotent stem cells but not in adult tissues, suggesting a role for miRNAs in stem cell self-renewal. We compared miRNA expression profiles of ARPCs with that of mesenchymal stem cells (MSCs) and renal proximal tubular cells (RPTECs) finding distinct sets of miRNAs that were specifically expressed in ARPCs. In particular, miR-1915 and miR-1225-5p regulated the expression of important markers of renal progenitors, such as CD133 and PAX2, and important genes involved in the repair mechanisms of ARPCs, such as TLR2. We demonstrated that the expression of both the renal stem cell markers CD133 and PAX2 depends on lower miR-1915 levels and that the increase of miR-1915 levels improved capacity of ARPCs to differentiate into adipocyte-like and epithelial-like cells. Finally, we found that the low levels of miR-1225-5p were responsible for high TLR2 expression in ARPCs. Therefore, together, miR-1915 and miR-1225-5p seem to regulate important traits of renal progenitors: the stemness and the repair capacity.	[Sallustio, Fabio; Serino, Grazia; Costantino, Vincenzo; Cox, Sharon N.; Schena, Francesco P.] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy; [Sallustio, Fabio; Curci, Claudia; De Palma, Giuseppe; Schena, Francesco P.] CARSO Consortium, Bari, Italy; [Sallustio, Fabio] Univ Salento, Dept Sci Biol & Environm Sci & Technol, Lecce, Italy; [Schena, Francesco P.] European Res Ctr Kidney Dis, Schena Fdn, Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Salento	Schena, FP (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy.	paolo.schena@uniba.it	Sallustio, Fabio/D-2326-2011; Serino, Grazia/K-2255-2018; Schena, Francesco P/K-6982-2016; Curci, Claudia/A-6918-2013; Cox, Sharon Natasha/H-1306-2015; Sallustio, Fabio/AFP-7212-2022; De Palma, Giuseppe/J-4860-2018	Sallustio, Fabio/0000-0002-5132-6532; Serino, Grazia/0000-0002-2971-0802; Schena, Francesco P/0000-0001-7927-5207; Curci, Claudia/0000-0003-2055-7837; Cox, Sharon Natasha/0000-0002-8488-440X; Sallustio, Fabio/0000-0002-5132-6532; De Palma, Giuseppe/0000-0002-6108-096X	Ministero dell'Istruzione, dell'Universita e della Ricerca (MiUR) [PRIN 2008M9WSJX, PON-REC ONEV 134/2011, FIRB RBAP11B2SX]; Regione Puglia [44/09 BISIMANE, 2006 PS 144/06]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MiUR)(Ministry of Education, Universities and Research (MIUR)); Regione Puglia(Regione Puglia)	This study was supported by a grant from Ministero dell'Istruzione, dell'Universita e della Ricerca (MiUR) (PRIN 2008M9WSJX; PON-REC ONEV 134/2011; FIRB RBAP11B2SX) and "Regione Puglia'' (Progetto strategico 44/09 BISIMANE; Progetto strategico 2006 PS 144/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angelotti ML, 2012, STEM CELLS, V30, P1714, DOI 10.1002/stem.1130; Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Bussolati B, 2009, CURR STEM CELL RES T, V4, P2, DOI 10.2174/157488809787169129; Camussi G, 2010, CURR OPIN NEPHROL HY, V19, P7, DOI 10.1097/MNH.0b013e328332fb6f; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dressler GR, 1999, INT J DEV BIOL, V43, P463; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Ferrell CM, 2005, STEM CELLS, V23, P644, DOI 10.1634/stemcells.2004-0198; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Imgrund M, 1999, KIDNEY INT, V56, P1423, DOI 10.1046/j.1523-1755.1999.00663.x; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; Maeshima A, 2002, J AM SOC NEPHROL, V13, P2850, DOI 10.1097/01.ASN.0000035086.93977.E9; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Procino G, 2011, CELL PHYSIOL BIOCHEM, V28, P683, DOI 10.1159/000335762; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sallustio F, 2013, KIDNEY INT, V83, P392, DOI 10.1038/ki.2012.413; Sallustio F, 2010, FASEB J, V24, P514, DOI 10.1096/fj.09-136481; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Simone S, 2012, AM J PHYSIOL-RENAL, V303, pF23, DOI 10.1152/ajprenal.00328.2011; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023	33	40	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68296	10.1371/journal.pone.0068296	http://dx.doi.org/10.1371/journal.pone.0068296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861881	Green Published, gold, Green Submitted			2022-12-25	WOS:000321692000019
J	Su, B; Peng, XH; Jiang, DM; Wu, J; Qiao, B; Li, WC; Qi, XT				Su, Bao; Peng, Xiaohua; Jiang, Dianming; Wu, Jun; Qiao, Bo; Li, Weichao; Qi, Xiaotong			In Vitro and In Vivo Evaluations of Nano-Hydroxyapatite/Polyamide 66/Glass Fibre (n-HA/PA66/GF) as a Novel Bioactive Bone Screw	PLOS ONE			English	Article							COMPOSITE SCAFFOLDS; MAGNESIUM ALLOYS; BIOCOMPATIBILITY; STRENGTH; IMPLANTS	In this study, we prepared nano-hydroxyapatite/polyamide 66/glass fibre (n-HA/PA66/GF) bioactive bone screws. The microstructure, morphology and coating of the screws were characterised, and the adhesion, proliferation and viability of MC3T3-E1 cells on n-HA/PA66/GF scaffolds were determined using scanning electron microscope, CCK-8 assays and cellular immunofluorescence analysis. The results confirmed that n-HA/PA66/GF scaffolds were biocompatible and had no negative effect on MC3T3-E1 cells in vitro. To investigate the in vivo biocompatibility, internal fixation properties and osteogenesis of the bioactive screws, both n-HA/PA66/GF screws and metallic screws were used to repair intercondylar femur fractures in dogs. General photography, CT examination, micro-CT examination, histological staining and biomechanical assays were performed at 4, 8, 12 and 24 weeks after operation. The n-HA/PA66/GF screws exhibited good biocompatibility, high mechanical strength and extensive osteogenesis in the host bone. Moreover, 24 weeks after implantation, the maximum push-out load of the bioactive screws was greater than that of the metallic screws. As shown by their good cytocompatibility, excellent biomechanical strength and fast formation and ingrowth of new bone, n-HA/PA66/GF screws are thus suitable for orthopaedic clinical applications.	[Su, Bao; Jiang, Dianming; Wu, Jun; Qiao, Bo; Li, Weichao; Qi, Xiaotong] Chongqing Med Univ, Dept Orthopaed, Affiliated Hosp 1, Chongqing, Peoples R China; [Peng, Xiaohua] Shanghai Jiao Tong Univ, Dept Resp Med, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China	Chongqing Medical University; Shanghai Jiao Tong University	Jiang, DM (corresponding author), Chongqing Med Univ, Dept Orthopaed, Affiliated Hosp 1, Chongqing, Peoples R China.	jdm571026@vip.163.com			Chongqing Committee of Science and Technology [CSTC2009AB5080]	Chongqing Committee of Science and Technology	This research was supported by the Tackling Project of the Chongqing Committee of Science and Technology (No. CSTC2009AB5080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2011, J MATER SCI-MATER M, V22, P1825, DOI 10.1007/s10856-011-4361-0; Benli S, 2008, J BIOMECH, V41, P3229, DOI 10.1016/j.jbiomech.2008.08.003; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006; Drynda A, 2013, J BIOMED MATER RES A, V101, P33, DOI 10.1002/jbm.a.34300; Duan YH, 2012, ARCH MED SCI, V8, P199, DOI 10.5114/aoms.2012.28545; Ferguson SJ, 1996, MED ENG PHYS, V18, P241, DOI 10.1016/1350-4533(95)00041-0; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Hirst LS, 2004, PHYS REV LETT, V93, P931; HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P123, DOI 10.1007/BF00443385; Huang D, 2011, J BIOMAT SCI-POLYM E, V22, P931, DOI 10.1163/092050610X496576; Jansen J, 2011, BIOMATERIALS, V32, P4994, DOI 10.1016/j.biomaterials.2011.03.062; Jie W, 2004, EUR POLYM J, V40, P509, DOI 10.1016/j.eurpolymj.2003.10.028; Kim HM, 2002, KEY ENG MATER, V218-2, P621, DOI 10.4028/www.scientific.net/KEM.218-220.621; Klein CPAT DA, 2004, J BIOMED MATER RES, V14, P769; KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306; Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009; Lee WT, 2012, J BIOMED MATER RES B, V100B, P1044, DOI 10.1002/jbm.b.32669; Li JD, 2009, J MATER SCI-MATER M, V20, P1031, DOI 10.1007/s10856-008-3664-2; Li Y., 1994, J MATER SCI-MATER M, V5, P252, DOI DOI 10.1007/BF00122393); Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Peng QM, 2012, J MECH BEHAV BIOMED, V10, P128, DOI 10.1016/j.jmbbm.2012.02.024; Polimeni G, 2008, CLIN IMPLANT DENT R, V10, P99, DOI 10.1111/j.1708-8208.2007.00067.x; Qu YL, 2010, INT J NANOMED, V5, P429; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Uhthoff H K, 1973, J Bone Joint Surg Br, V55, P633; Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014; Wang H, 2009, J POLYM SCI POL CHEM, V47, P658, DOI 10.1002/pola.23171; Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707; Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001	33	20	22	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68342	10.1371/journal.pone.0068342	http://dx.doi.org/10.1371/journal.pone.0068342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861888	Green Submitted, Green Published, gold			2022-12-25	WOS:000321692000022
J	Gauthier, N; Wu, JW; Wang, SP; Allard, P; Mamer, OA; Sweetman, L; Moser, AB; Kratz, L; Alvarez, F; Robitaille, Y; Lepine, F; Mitchell, GA				Gauthier, Nicolas; Wu, Jiang Wei; Wang, Shu Pei; Allard, Pierre; Mamer, Orval A.; Sweetman, Lawrence; Moser, Ann B.; Kratz, Lisa; Alvarez, Fernando; Robitaille, Yves; Lepine, Francois; Mitchell, Grant A.			A Liver-Specific Defect of Acyl-CoA Degradation Produces Hyperammonemia, Hypoglycemia and a Distinct Hepatic Acyl-CoA Pattern	PLOS ONE			English	Article							COENZYME-A PROFILES; RAT-LIVER; LYASE HL; 3-HYDROXY-3-METHYLGLUTARYL-COA LYASE; PYRUVATE-CARBOXYLASE; DEFICIENT MICE; METABOLISM; QUANTIFICATION; SPECTROMETRY; INHIBITION	Most conditions detected by expanded newborn screening result from deficiency of one of the enzymes that degrade acyl-coenzyme A (CoA) esters in mitochondria. The role of acyl-CoAs in the pathophysiology of these disorders is poorly understood, in part because CoA esters are intracellular and samples are not generally available from human patients. We created a mouse model of one such condition, deficiency of 3-hydroxy-3-methylglutaryl-CoA lyase (HL), in liver (HLLKO mice). HL catalyses a reaction of ketone body synthesis and of leucine degradation. Chronic HL deficiency and acute crises each produced distinct abnormal liver acyl-CoA patterns, which would not be predictable from levels of urine organic acids and plasma acylcarnitines. In HLLKO hepatocytes, ketogenesis was undetectable. Carboxylation of [2-C-14] pyruvate diminished following incubation of HLLKO hepatocytes with the leucine metabolite 2-ketoisocaproate (KIC). HLLKO mice also had suppression of the normal hyperglycemic response to a systemic pyruvate load, a measure of gluconeogenesis. Hyperammonemia and hypoglycemia, cardinal features of many inborn errors of acyl-CoA metabolism, occurred spontaneously in some HLLKO mice and were inducible by administering KIC. KIC loading also increased levels of several leucine-related acyl-CoAs and reduced acetyl-CoA levels. Ultrastructurally, hepatocyte mitochondria of KIC-treated HLLKO mice show marked swelling. KIC-induced hyperammonemia improved following administration of carglumate (N-carbamyl-L-glutamic acid), which substitutes for the product of an acetyl-CoA-dependent reaction essential for urea cycle function, demonstrating an acyl-CoA-related mechanism for this complication.	[Gauthier, Nicolas; Wu, Jiang Wei; Wang, Shu Pei; Allard, Pierre; Alvarez, Fernando; Mitchell, Grant A.] Univ Montreal, CHU St Justine, Ctr Rech, Montreal, PQ, Canada; [Gauthier, Nicolas; Wu, Jiang Wei; Wang, Shu Pei; Allard, Pierre; Alvarez, Fernando; Mitchell, Grant A.] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ, Canada; [Robitaille, Yves] Univ Montreal, CHU St Justine, Dept Pathol, Montreal, PQ, Canada; [Gauthier, Nicolas; Mitchell, Grant A.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Mamer, Orval A.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Sweetman, Lawrence] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Moser, Ann B.; Kratz, Lisa] Johns Hopkins Sch Med, Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD USA; [Lepine, Francois] INRS Inst Armand Frappier, Laval, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; McGill University; Baylor Scott & White Health; Baylor University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; University of Quebec; Institut national de la recherche scientifique (INRS)	Mitchell, GA (corresponding author), Univ Montreal, CHU St Justine, Ctr Rech, Montreal, PQ, Canada.	grant.mitchell@recherche-ste-justine.qc.ca		alvarez, fernando/0000-0002-0534-5142	CIHR grant [178978]; Fondation Go bursary	CIHR grant(Canadian Institutes of Health Research (CIHR)); Fondation Go bursary	Funding was provided by CIHR grant 178978 to GM (cihr-irsc.gc.ca) and Fondation Go bursary to NG (lafondationgo.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMARINA LI, 1994, J BIOL CHEM, V269, P31929; Barritt G. J., 1985, PYRUVATE CARBOXYLASE, P179; Chandler RJ, 2009, FASEB J, V23, P1252, DOI 10.1096/fj.08-121848; CORKEY BE, 1982, J BIOL CHEM, V257, P9668; CORKEY BE, 1990, PROG CLIN BIOL RES, V321, P217; CORKEY BE, 1988, J CLIN INVEST, V82, P782, DOI 10.1172/JCI113679; COUDE FX, 1979, J CLIN INVEST, V64, P1544, DOI 10.1172/JCI109614; DiMauro S, 2006, MITOCHONDRIAL MED; Fung C-H, 1971, THESIS CASE W RESERV; Gao L, 2007, J CHROMATOGR B, V853, P303, DOI 10.1016/j.jchromb.2007.03.029; Harris SR, 2011, J BIOL CHEM, V286, P5895, DOI 10.1074/jbc.M110.196808; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; KELLEHER JK, 1985, ANAL BIOCHEM, V151, P55, DOI 10.1016/0003-2697(85)90052-1; Levrat V, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-2; Lieu YK, 1997, AM J PHYSIOL-ENDOC M, V272, pE359, DOI 10.1152/ajpendo.1997.272.3.E359; Mack M, 2006, FEBS J, V273, P2012, DOI 10.1111/j.1742-4658.2006.05218.x; MARTINREQUERO A, 1983, J BIOL CHEM, V258, P3673; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Minkler PE, 2006, ANAL BIOCHEM, V352, P24, DOI 10.1016/j.ab.2006.02.015; MITCHELL GA, 1993, J BIOL CHEM, V268, P4376; Mitchell GA, 2001, METABOLIC MOL BASIS, P2327; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Palladino AA, 2012, MOL GENET METAB, V107, P679, DOI 10.1016/j.ymgme.2012.10.007; Puisac B, 2005, BIOPHYS CHEM, V115, P241, DOI 10.1016/j.bpc.2004.12.031; Roe C, 1989, METABOLIC BASIS INHE, P889; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sweetman L., 2001, METABOLIC MOL BASES, P2125; THOMPSON GN, 1990, EUR J PEDIATR, V149, P346, DOI 10.1007/BF02171564; Wang SP, 1998, HUM MOL GENET, V7, P2057, DOI 10.1093/hmg/7.13.2057; WIMHURST JM, 1970, BIOCHEM J, V120, P79, DOI 10.1042/bj1200079; Zeczycki Tonya N, 2010, Open Enzym Inhib J, V3, P8; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	33	64	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e60581	10.1371/journal.pone.0060581	http://dx.doi.org/10.1371/journal.pone.0060581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861731	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000321425300001
J	Li, YH; Guo, XH; Xue, Q; Zhu, M; Gao, L; Wang, Y				Li, Yanhua; Guo, Xinhong; Xue, Qiao; Zhu, Mei; Gao, Lei; Wang, Yu			Single Cell Gene Profiling Revealed Heterogeneity of Paracrine Effects of Bone Marrow Cells in Mouse Infarcted Hearts	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEMATOPOIETIC STEM-CELLS; ISCHEMIC-MYOCARDIUM; MONONUCLEAR-CELLS; CLINICAL-TRIAL; DOUBLE-BLIND; TRANSPLANTATION; REGENERATION; MECHANISMS; CYTOKINES	It is now recognized that transplantation of bone marrow cells (BMCs) into infarcted hearts has the capacity to improve the cardiac function through paracrine effects. However, detailed expression levels of paracrine factors in BMCs in infarcted hearts are poorly described. By use of laser capture microdissection combined with real-time PCR, we depicted the expression profiles of paracrine factors in infarcted hearts versus normal hearts. Consistent with the in vivo observation, a similar expression pattern was evidenced in cultured BMCs. Furthermore, BMCs displayed heterogeneity of paracrine effects in infarcted hearts as analyzed at the single cell level using single cell PCR. Interestingly, the CD45(+) subpopulation showed higher expression levels of angiogenic factors compared to other subpopulations. Finally, most angiogenic factors were induced under the microenvironment of infarction. Our study demonstrated the heterogeneity of paracrine effects in BMCs at single cell level in infarcted hearts, highlighting preferential expression of angiogenic factors in the CD45+ subpopulation. These findings broaden our understanding of paracrine effects of BMCs in vivo, and offer new insights into BMCs therapy in myocardial infarction (MI).	[Li, Yanhua; Guo, Xinhong; Xue, Qiao; Zhu, Mei; Gao, Lei; Wang, Yu] Chinese Peoples Liberat Army PLA, Gen Hosp, Inst Geriatr Cardiol, Beijing, Peoples R China		Wang, Y (corresponding author), Chinese Peoples Liberat Army PLA, Gen Hosp, Inst Geriatr Cardiol, Beijing, Peoples R China.	Wangyu301hospital@yahoo.cn			National High-Tech R&D Program of China (863 Program) [2006AA02Z469]	National High-Tech R&D Program of China (863 Program)	This work was supported by the National High-Tech R&D Program of China (863 Program, 2006AA02Z469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Fuchs S, 2003, J AM COLL CARDIOL, V41, P1721, DOI 10.1016/S0735-1097(03)00328-0; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hamano K, 2001, JPN CIRC J, V65, P845, DOI 10.1253/jcj.65.845; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kinnaird T, 2004, CIRC RES, V95, P354, DOI 10.1161/01.RES.0000137878.26174.66; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ripa RS, 2006, CIRCULATION, V113, P1983, DOI 10.1161/CIRCULATIONAHA.105.610469; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68270	10.1371/journal.pone.0068270	http://dx.doi.org/10.1371/journal.pone.0068270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861876	gold, Green Published, Green Submitted			2022-12-25	WOS:000321425300053
J	Stegeman, S; Jolly, LA; Premarathne, S; Gecz, J; Richards, LJ; Mackay-Sim, A; Wood, SA				Stegeman, Shane; Jolly, Lachlan A.; Premarathne, Susitha; Gecz, Jozef; Richards, Linda J.; Mackay-Sim, Alan; Wood, Stephen A.			Loss of Usp9x Disrupts Cortical Architecture, Hippocampal Development and TGF beta-Mediated Axonogenesis	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; FAM DEUBIQUITYLATING ENZYME; CELL-CELL JUNCTIONS; NEURAL STEM-CELLS; DEUBIQUITINATING ENZYME; TRANSFORMING GROWTH-FACTOR-BETA-1; PROTEIN TRAFFICKING; EXPRESSION ANALYSIS; NERVOUS-SYSTEM; LIQUID FACETS	The deubiquitylating enzyme Usp9x is highly expressed in the developing mouse brain, and increased Usp9x expression enhances the self-renewal of neural progenitors in vitro. USP9X is a candidate gene for human neurodevelopmental disorders, including lissencephaly, epilepsy and X-linked intellectual disability. To determine if Usp9x is critical to mammalian brain development we conditionally deleted the gene from neural progenitors, and their subsequent progeny. Mating Usp9x(loxP/loxP) mice with mice expressing Cre recombinase from the Nestin promoter deleted Usp9x throughout the entire brain, and resulted in early postnatal lethality. Although the overall brain architecture was intact, loss of Usp9x disrupted the cellular organization of the ventricular and sub-ventricular zones, and cortical plate. Usp9x absence also led to dramatic reductions in axonal length, in vivo and in vitro, which could in part be explained by a failure in Tgf-beta signaling. Deletion of Usp9x from the dorsal telencephalon only, by mating with Emx1-cre mice, was compatible with survival to adulthood but resulted in reduction or loss of the corpus callosum, a dramatic decrease in hippocampal size, and disorganization of the hippocampal CA3 region. This latter phenotypic aspect resembled that observed in Doublecortin knock-out mice, which is an Usp9x interacting protein. This study establishes that Usp9x is critical for several aspects of CNS development, and suggests that its regulation of Tgf-beta signaling extends to neurons.	[Stegeman, Shane; Premarathne, Susitha; Mackay-Sim, Alan; Wood, Stephen A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Jolly, Lachlan A.; Gecz, Jozef] South Australian Pathol Womens & Childrens Hosp, Neurogenet Res Program, Adelaide, SA, Australia; [Jolly, Lachlan A.; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Richards, Linda J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Richards, Linda J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	Griffith University; University of Adelaide; University of Queensland; University of Queensland	Wood, SA (corresponding author), Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia.	s.wood@griffith.edu.au	Wood, Stephen A/E-8357-2011; Jolly, Lachlan/B-5892-2015; Mackay-Sim, Alan/C-3431-2008; Gecz, Jozef/X-3469-2019; Richards AO, Linda/P-6372-2014	Wood, Stephen A/0000-0002-2576-7457; Jolly, Lachlan/0000-0003-4538-2658; Mackay-Sim, Alan/0000-0003-4446-5371; Gecz, Jozef/0000-0002-7884-6861; Richards AO, Linda/0000-0002-7590-7390; Premarathne, Susitha/0000-0003-0018-5554	National Health and Medical Research Council of Australia [APP1009248, APP628952, APP250340]; Women's and Children's Hospital Foundation; Australian Government Department of Health and Ageing	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Women's and Children's Hospital Foundation; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This work was supported by a grant from the National Health and Medical Research Council of Australia APP1009248 to SAW, APP628952 and APP250340 to JG, a grant from the Women's and Children's Hospital Foundation to LAJ, and a grant to AMS from the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KM, 2005, ESSAYS BIOCHEM, V41, P49, DOI 10.1042/EB0410049; Brault V, 2001, DEVELOPMENT, V128, P1253; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Caronia G, 2010, J NEUROSCI, V30, P6291, DOI 10.1523/JNEUROSCI.0550-10.2010; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dupont S, 2012, FEBS LETT, V586, P1913, DOI 10.1016/j.febslet.2012.03.037; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Dwyer ND, 2010, CELL, V142, P21, DOI 10.1016/j.cell.2010.06.024; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2005, MOL CELL NEUROSCI, V28, P153, DOI 10.1016/j.mcn.2004.09.005; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; ISHIHARA A, 1994, BRAIN RES, V639, P21, DOI 10.1016/0006-8993(94)91759-0; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jolly LA, 2009, MOL BIOL CELL, V10, P1091; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lim KL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S13; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Pasinetti GM, 2001, J NEUROSCI RES, V65, P471, DOI 10.1002/jnr.1176; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Piper M, 2010, J NEUROSCI, V30, P9127, DOI 10.1523/JNEUROSCI.6167-09.2010; Pramparo T, 2010, J NEUROSCI, V30, P3002, DOI 10.1523/JNEUROSCI.4851-09.2010; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rogers N, 2010, NEUROPATH APPL NEURO, V36, P113, DOI [10.1111/j.1365-2990.2009.01063.x, 10.1111/j.1365-2990.2010.01063.x]; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sometani A, 2001, J NEUROSCI RES, V66, P369, DOI 10.1002/jnr.1229; Staropoli JF, 2005, J MOL NEUROSCI, V27, P175, DOI 10.1385/JMN:27:2:175; Stinchfield MJ, 2012, DEVELOPMENT, V139, P2721, DOI 10.1242/dev.077206; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuoc TC, 2010, CELL CYCLE, V9, P3174, DOI 10.4161/cc.9.16.12551; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Xu J, 2005, J NEUROSCI RES, V80, P47, DOI 10.1002/jnr.20429; Xu ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009725; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	69	54	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68287	10.1371/journal.pone.0068287	http://dx.doi.org/10.1371/journal.pone.0068287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861879	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300055
J	Wang, L; Deng, F; Ren, WJ; Yang, WY				Wang, Li; Deng, Fei; Ren, Wan-Jun; Yang, Wen-Yu			Effects of Shading on Starch Pasting Characteristics of Indica Hybrid Rice (Oryza sativa L.)	PLOS ONE			English	Article							PHOTOSYNTHETIC CAPACITY; AMYLOSE CONTENT; VISCOSITY; CULTIVARS; RESPONSES; RVA	Rice is an important staple crop throughout the world, but environmental stress like low-light conditions can negatively impact crop yield and quality. Using pot experiments and field experiments, we studied the effects of shading on starch pasting viscosity and starch content with six rice varieties for three years, using the Rapid Visco Analyser to measure starch pasting viscosity. Shading at different growth stages and in different rice varieties all affected the starch pasting characteristics of rice. The effects of shading on starch pasting viscosity at middle and later growth stages were greater than those at earlier stages. Shading enhanced breakdown but reduced hold viscosity and setback at tillering-elongation stage. Most pasting parameters changed significantly with shading after elongation stage. Furthermore, the responses of different varieties to shading differed markedly. The change scope of starch pasting viscosity in Dexiang 4103 was rather small after heading, while that in IIyou 498 and Gangyou 906 was small before heading. We observed clear tendencies in peak viscosity, breakdown, and pasting temperature of the five rice varieties with shading in 2010 and 2011. Correlation analysis indicated that the rice amylose content was negatively correlated with breakdown, but was positively correlated with setback. Based on our results, IIyou 498, Gangyou 906, and Dexiang 4103 had higher shade endurance, making these varieties most suitable for high-quality rice cultivation in low-light regions.	[Wang, Li; Deng, Fei; Ren, Wan-Jun; Yang, Wen-Yu] Sichuan Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Ren, WJ (corresponding author), Sichuan Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China.	rwjun@126.com	Deng, Fei/GQP-1228-2022; Zhou, Yu/HHN-3071-2022	yang, wenyu/0000-0001-5885-3450; Deng, Fei/0000-0003-3996-9698	Ministry of Science and Technology of the People's Republic of China [2006BAD02A05, 2011BAD16B05-04, 2012BAD04B13-2]; Science and Technology Department of Sichuan Province [2011YZGG-24]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Science and Technology Department of Sichuan Province	This study was partially supported by the Ministry of Science and Technology of the People's Republic of China, http://www.most.gov.cn/ (2006BAD02A05, 2011BAD16B05-04 and 2012BAD04B13-2) and the Science and Technology Department of Sichuan Province, http://www.scst.gov.cn/info/(2011YZGG-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 2000, DET PAST PROP RIC RA; Bao Jin-Song, 2006, Acta Genetica Sinica, V33, P1007, DOI 10.1016/S0379-4172(06)60136-4; Bao JS, 2004, J AGR FOOD CHEM, V52, P6010, DOI 10.1021/jf049234i; Cai KunZheng, 1999, Chinese Journal of Applied Ecology, V10, P193; Chaturvedi G. S., 1989, Philippine Journal of Crop Science, V14, P61; [邓飞 DENG Fei], 2009, [四川农业大学学报, Journal of Sichuan Agricultural University], V27, P265; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Gregoriou K, 2007, PHOTOSYNTHETICA, V45, P172, DOI 10.1007/s11099-007-0029-x; Hawksworth D, 1985, RICE DIS; Huang WX, 1998, AGR NATURAL RESOURCE, P157; Huylenbroeck J. M. van, 2001, International Turfgrass Society Research Journal, V9, P353; JARVIS CE, 1993, J SCI FOOD AGR, V63, P53, DOI 10.1002/jsfa.2740630109; Jiang D, 2009, J AGRON CROP SCI, V195, P89, DOI 10.1111/j.1439-037X.2008.00353.x; Jiao DM, 2001, PHOTOSYNTHETICA, V39, P167, DOI 10.1023/A:1013758504857; Jin L, 2010, J CEREAL SCI, V51, P159, DOI 10.1016/j.jcs.2009.11.007; Li Tian, 2006, Rice Science, V13, P51; Liu Qi-hua, 2009, Yingyong Shengtai Xuebao, V20, P2135; McGrance SJ, 1998, STARCH-STARKE, V50, P158, DOI 10.1002/(SICI)1521-379X(199804)50:4<158::AID-STAR158>3.0.CO;2-7; Singh N, 2006, FOOD HYDROCOLLOID, V20, P532, DOI 10.1016/j.foodhyd.2005.05.003; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Thangaraj M., 1990, Madras Agricultural Journal, V77, P220; VENKATESWARLU B, 1977, PLANT SOIL, V46, P713, DOI 10.1007/BF00015937; Viji MM, 1997, J AGRON CROP SCI, V178, P193, DOI 10.1111/j.1439-037X.1997.tb00490.x; Wan XiangYuan, 2004, Acta Agronomica Sinica, V30, P1185; Wang H, 2007, SCI HORTIC-AMSTERDAM, V112, P66, DOI 10.1016/j.scienta.2006.12.007; Wang XQ, 2010, AGR SCI CHINA, V9, P1101, DOI 10.1016/S1671-2927(09)60196-6; Yan CJ, 2011, THEOR APPL GENET, V122, P63, DOI 10.1007/s00122-010-1423-5; Yao YL, 2000, SOIL SCI PLANT NUTR, V46, P631, DOI 10.1080/00380768.2000.10409128; Zaidul ISM, 2007, FOOD CHEM, V102, P1105, DOI 10.1016/j.foodchem.2006.06.056; Zhu DF, 2000, BRIDGING RICE YIELD, P69	30	38	39	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68220	10.1371/journal.pone.0068220	http://dx.doi.org/10.1371/journal.pone.0068220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861872	gold, Green Published, Green Submitted			2022-12-25	WOS:000321425300051
J	Dunne, KA; Allam, A; McIntosh, A; Houston, SA; Cerovic, V; Goodyear, CS; Roe, AJ; Beatson, SA; Milling, SW; Walker, D; Wall, DM				Dunne, Karl A.; Allam, Amr; McIntosh, Anne; Houston, Stephanie A.; Cerovic, Vuk; Goodyear, Carl S.; Roe, Andrew J.; Beatson, Scott A.; Milling, Simon W.; Walker, Daniel; Wall, Daniel M.			Increased S-Nitrosylation and Proteasomal Degradation of Caspase-3 during Infection Contribute to the Persistence of Adherent Invasive Escherichia coli (AIEC) in Immune Cells	PLOS ONE			English	Article							DENDRITIC CELL; CROHNS-DISEASE; ILEAL MUCOSA; UBIQUITIN LIGASE; STRAIN LF82; E.-COLI; SALMONELLA; APOPTOSIS; TYPHIMURIUM; INFLAMMATION	Adherent invasive Escherichia coli (AIEC) have been implicated as a causative agent of Crohn's disease (CD) due to their isolation from the intestines of CD sufferers and their ability to persist in macrophages inducing granulomas. The rapid intracellular multiplication of AIEC sets it apart from other enteric pathogens such as Salmonella Typhimurium which after limited replication induce programmed cell death (PCD). Understanding the response of infected cells to the increased AIEC bacterial load and associated metabolic stress may offer insights into AIEC pathogenesis and its association with CD. Here we show that AIEC persistence within macrophages and dendritic cells is facilitated by increased proteasomal degradation of caspase-3. In addition S-nitrosylation of pro- and active forms of caspase-3, which can inhibit the enzymes activity, is increased in AIEC infected macrophages. This S-nitrosylated caspase-3 was seen to accumulate upon inhibition of the proteasome indicating an additional role for S-nitrosylation in inducing caspase-3 degradation in a manner independent of ubiquitination. In addition to the autophagic genetic defects that are linked to CD, this delay in apoptosis mediated in AIEC infected cells through increased degradation of caspase-3, may be an essential factor in its prolonged persistence in CD patients.	[Dunne, Karl A.; Allam, Amr; McIntosh, Anne; Houston, Stephanie A.; Cerovic, Vuk; Goodyear, Carl S.; Roe, Andrew J.; Milling, Simon W.; Walker, Daniel; Wall, Daniel M.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Beatson, Scott A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Beatson, Scott A.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia	University of Glasgow; University of Queensland; University of Queensland	Wall, DM (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	donal.wall@glasgow.ac.uk	Beatson, Scott/B-6985-2013	Beatson, Scott/0000-0002-1806-3283; roe, andrew/0000-0003-3698-6134; Walker, Daniel/0000-0002-4206-2942; Allam, Amr/0000-0002-8743-3639; Goodyear, Carl/0000-0001-5926-5941	Tenovus-Scotland Pump-priming award; BBSRC - Biotechnology and Biological Sciences Research Council [BB/K008005/1]; BBSRC [BB/K008005/1] Funding Source: UKRI; MRC [MR/K021095/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K008005/1] Funding Source: researchfish; Medical Research Council [MR/K021095/1] Funding Source: researchfish	Tenovus-Scotland Pump-priming award; BBSRC - Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Tenovus-Scotland Pump-priming award (http://www.tenovus-scotland.org.uk/) and by the BBSRC - Biotechnology and Biological Sciences Research Council Grant number BB/K008005/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANO F, 1995, FEBS LETT, V368, P425, DOI 10.1016/0014-5793(95)00700-J; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Ashare A, 2007, J IMMUNOL, V179, P505, DOI 10.4049/jimmunol.179.1.505; Baumgart DC, 2005, GUT, V54, P228, DOI 10.1136/gut.2004.040360; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Bueno SM, 2012, IMMUNOLOGY, V137, P28, DOI 10.1111/j.1365-2567.2012.03614.x; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chen M, 2007, BLOOD, V109, P4360, DOI 10.1182/blood-2006-11-056424; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cooper KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022260; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Forsberg M, 2003, J LEUKOCYTE BIOL, V74, P620, DOI 10.1189/jlb.1202586; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Grant AJ, 2008, IMMUNOLOGY, V125, P28, DOI 10.1111/j.1365-2567.2008.02814.x; Gusarov I, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003181; Hicks SW, 2010, CURR OPIN MICROBIOL, V13, P41, DOI 10.1016/j.mib.2009.11.008; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hwang J, 2011, BBA-REV CANCER, V1816, P147, DOI 10.1016/j.bbcan.2011.05.005; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Jiang ZL, 2009, WOUND REPAIR REGEN, V17, P224, DOI 10.1111/j.1524-475X.2009.00459.x; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; Lai YC, 2011, CIRC RES, V109, P1375, DOI 10.1161/CIRCRESAHA.111.256479; Lee CM, 2008, J BIOL CHEM, V283, P889, DOI 10.1074/jbc.M708821200; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; LIU LM, 1995, ADV EXP MED BIOL, V371, P271; Maejima Y, 2005, J MOL CELL CARDIOL, V38, P163, DOI 10.1016/j.yjmcc.2004.10.012; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Martinez-Medina M, 2009, J CLIN MICROBIOL, V47, P3968, DOI 10.1128/JCM.01484-09; Miquel S, 2010, PLOS ONE, P5; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Raso T, 2011, CURR MICROBIOL, V63, P131, DOI 10.1007/s00284-011-9947-8; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Savidge TC, 2011, NAT MED, V17, P1136, DOI 10.1038/nm.2405; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Song M, 2013, MOL MICROBIOL, V87, P609, DOI 10.1111/mmi.12119; Soundararajan V, 2011, INNATE IMMUN-LONDON, V17, P548, DOI 10.1177/1753425910377099; Srikanth CV, 2010, SCIENCE, V330, P390, DOI 10.1126/science.1194598; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wall DM, 2007, CELL MICROBIOL, V9, P2299, DOI 10.1111/j.1462-5822.2007.00960.x; Wine E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-180; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Zeigler MM, 2003, J BIOL CHEM, V278, P12894, DOI 10.1074/jbc.M213125200; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x	62	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68386	10.1371/journal.pone.0068386	http://dx.doi.org/10.1371/journal.pone.0068386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861899	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000323350700084
J	Babbs, CF; Shi, RY				Babbs, Charles F.; Shi, Riyi			Subtle Paranodal Injury Slows Impulse Conduction in a Mathematical Model of Myelinated Axons	PLOS ONE			English	Article							MAMMALIAN SPINAL-CORD; POTASSIUM CHANNELS; NERVE-FIBERS; ACTION-POTENTIALS; IONIC CURRENTS; COMPRESSION; AFTERPOTENTIALS; DEMYELINATION; SIMULATIONS; COMPUTATION	This study explores in detail the functional consequences of subtle retraction and detachment of myelin around the nodes of Ranvier following mild-to-moderate crush or stretch mediated injury. An equivalent electrical circuit model for a series of equally spaced nodes of Ranvier was created incorporating extracellular and axonal resistances, paranodal resistances, nodal capacitances, time varying sodium and potassium currents, and realistic resting and threshold membrane potentials in a myelinated axon segment of 21 successive nodes. Differential equations describing membrane potentials at each nodal region were solved numerically. Subtle injury was simulated by increasing the width of exposed nodal membrane in nodes 8 through 20 of the model. Such injury diminishes action potential amplitude and slows conduction velocity from 19.1 m/sec in the normal region to 7.8 m/sec in the crushed region. Detachment of paranodal myelin, exposing juxtaparanodal potassium channels, decreases conduction velocity further to 6.6 m/sec, an effect that is partially reversible with potassium ion channel blockade. Conduction velocity decreases as node width increases or as paranodal resistance falls. The calculated changes in conduction velocity with subtle paranodal injury agree with experimental observations. Nodes of Ranvier are highly effective but somewhat fragile devices for increasing nerve conduction velocity and decreasing reaction time in vertebrate animals. Their fundamental design limitation is that even small mechanical retractions of myelin from very narrow nodes or slight loosening of paranodal myelin, which are difficult to notice at the light microscopic level of observation, can cause large changes in myelinated nerve conduction velocity.	[Babbs, Charles F.] Purdue Univ, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA; Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Babbs, CF (corresponding author), Purdue Univ, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA.	babbs@purdue.edu						Babbs CF, 1999, CIRCULATION, V100, P2146, DOI 10.1161/01.CIR.100.21.2146; BASSER PJ, 1993, MED BIOL ENG COMPUT, V31, pS87, DOI 10.1007/BF02446655; BLIGHT AR, 1985, NEUROSCIENCE, V15, P13, DOI 10.1016/0306-4522(85)90119-8; Boron W.F., 2005, MED PHYSL; Brophy JJ, 1966, BASIC ELECT SCI; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; Crawford DK, 2009, NEUROSCIENCE, V164, P1407, DOI 10.1016/j.neuroscience.2009.09.069; Di Fiori MSH, 1981, ATLAS HUMAN HISTOLOG; ffrench-Constant C, 2004, SCIENCE, V304, P688, DOI 10.1126/science.1097851; FITZHUGH R, 1962, BIOPHYS J, V2, P11, DOI 10.1016/S0006-3495(62)86837-4; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Geddes L. A., 1975, PRINCIPLES APPL BIOM; Giuliodori MJ, 2004, ADV PHYSIOL EDUC, V28, P80, DOI 10.1152/advan.00045.2003; GOLDMAN L, 1968, BIOPHYS J, V8, P596, DOI 10.1016/S0006-3495(68)86510-5; Hartline DK, 2007, CURR BIOL, V17, pR29, DOI 10.1016/j.cub.2006.11.042; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; MCNEAL DR, 1976, IEEE T BIO-MED ENG, V23, P329, DOI 10.1109/TBME.1976.324593; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Nygren A, 1999, J THEOR BIOL, V199, P329, DOI 10.1006/jtbi.1999.0962; Ong HH, 2010, NEUROIMAGE, V51, P1360, DOI 10.1016/j.neuroimage.2010.03.063; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi RY, 2011, NEUROSCI BULL, V27, P36, DOI 10.1007/s12264-011-1048-y; Shi YZ, 2011, J NEUROCHEM, V117, P554, DOI 10.1111/j.1471-4159.2011.07226.x; SHRAGER P, 1987, J PHYSIOL-LONDON, V392, P587, DOI 10.1113/jphysiol.1987.sp016798; STEPHANOVA DI, 1995, BIOL CYBERN, V73, P275, DOI 10.1007/BF00201429; Stephanova DI, 1997, BIOL CYBERN, V76, P311, DOI 10.1007/s004220050342; Sun W, 2012, J NEUROTRAUM, V29, P1; Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009; WAXMAN SG, 1985, SCIENCE, V228, P1502, DOI 10.1126/science.2409596; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Zhu F, 2006, J APPL PHYSIOL, V100, P717, DOI 10.1152/japplphysiol.00669.2005	38	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67767	10.1371/journal.pone.0067767	http://dx.doi.org/10.1371/journal.pone.0067767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844090	gold, Green Submitted, Green Published			2022-12-25	WOS:000321733000102
J	Chen, YC; Chu, LY; Yang, SF; Chen, HL; Yet, SF; Wu, KK				Chen, Yen-Chung; Chu, Ling-Yun; Yang, Shu-Fan; Chen, Hua-Ling; Yet, Shaw-Fang; Wu, Kenneth K.			Prostacyclin and PPAR alpha Agonists Control Vascular Smooth Muscle Cell Apoptosis and Phenotypic Switch through Distinct 14-3-3 Isoforms	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; SERUM RESPONSE FACTOR; GROWTH-FACTOR; ENDOTHELIAL-CELLS; DELTA ACTIVATION; PROTEINS; SURVIVAL; STRESS; FAMILY; CYCLOOXYGENASE-2	We hypothesized that prostacyclin (PGI(2)) protects vascular smooth muscle cell (VSMC) against apoptosis and phenotypic switch through peroxisome proliferator-activated receptor-alpha (PPAR alpha) activation and 14-3-3 upregulation. Here we showed that transfection of rat aortic VSMC, A-10, with PGI(2)-producing vectors, Ad-COPI, resulted in attenuated H2O2-induced apoptosis accompanied by a selective increase in 14-3-3 beta and 14-3-3 theta expression. Carbaprostacyclin (cPGI(2)) and Wy14,643 exerted a similar effect. The effects of PGI(2) were abrogated by MK886, a PPAR alpha antagonist, but not GSK3787, a PPAR delta antagonist. PPAR alpha transfection upregulated 14-3-3 beta and theta expression and attenuated H2O2-induced apoptosis. H2O2-induced 14-3-3 beta but not 14-3-3 theta degradation was blocked by a caspase 3 inhibitor. Furthermore, 14-3-3 beta but not 14-3-3 theta overexpression reduced, while 14-3-3 beta siRNA aggravated apoptosis. VSMC contractile proteins and serum response factor (SRF) were reduced in H2O2-treated A-10 cells which were concurrently prevented by caspase 3 inhibitor. By contrast, PGI(2) prevented H2O2-induced SM22 alpha and Calponin-1 degradation without influencing SRF. cPGI(2) and Wy14,643 also effectively blocked VSMC phenotypic switch induced by growth factors (GFs). GFs suppressed 14-3-3 beta, theta, epsilon and eta isoforms and cPGI(2) prevented the decline of beta, theta and eta, but not epsilon. 14-3-3 theta siRNA abrogated the protective effect of cPGI(2) on SM22 alpha and Calponin-1 while 14-3-3 theta or 14-3-3 beta overexpression partially restored SM22 alpha. These results indicated that PGI(2) protects VSMCs via PPAR alpha by upregulating 14-3-3 beta and 14-3-3 theta. 14-3-3 beta upregulation confers resistance to apoptosis whereas 14-3-3 theta and beta upregulation protects SM22 alpha and Calponin-1 from degradation.	[Chen, Yen-Chung; Chu, Ling-Yun; Yang, Shu-Fan; Chen, Hua-Ling; Yet, Shaw-Fang; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Coll Life Sci, Inst Biotechnol, Hsinchu, Taiwan; [Wu, Kenneth K.] China Med Univ, Metabol Med Res Ctr, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Wu, KK (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli, Taiwan.	kkgo@nhri.org.tw	Yang, Shufan/AAF-7942-2021; Yet, Shaw-Fang/B-1067-2010; Yang, Shufan/AAI-6707-2021; Chu, Liang-Yin/B-3915-2009; Yet, Shaw-Fang/O-8583-2019	Yang, Shufan/0000-0003-0531-2903; 	National Health Research Institutes of Taiwan	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by intramural grants from National Health Research Institutes of Taiwan (http://english.nhri.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SR, 1999, J BIOL CHEM, V274, P5038, DOI 10.1074/jbc.274.8.5038; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; CORJAY MH, 1989, J BIOL CHEM, V264, P10501; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Feil S, 2004, CIRC RES, V94, P863, DOI 10.1161/01.RES.0000126417.38728.F6; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Hao CM, 1999, AM J PHYSIOL-RENAL, V277, pF352, DOI 10.1152/ajprenal.1999.277.3.F352; Hao CM, 2002, J BIOL CHEM, V277, P21341, DOI 10.1074/jbc.M200695200; Huang JC, 2007, HUM REPROD, V22, P807, DOI 10.1093/humrep/del429; Huang JC, 2004, HUM REPROD, V19, P2900, DOI 10.1093/humrep/deh524; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kuzelova K, 2009, J CELL BIOCHEM, V106, P673, DOI 10.1002/jcb.22061; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; McCormick SM, 2000, ANN BIOMED ENG, V28, P824, DOI 10.1114/1.1289472; MONCADA S, 1978, PHARMACOL REV, V30, P293; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Shyue SK, 2001, CIRCULATION, V103, P2090; Tsai MC, 2009, CIRC RES, V105, P471, DOI 10.1161/CIRCRESAHA.109.193656; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; VANPUTTEN V, 1994, CIRC RES, V75, P1126, DOI 10.1161/01.RES.75.6.1126; Wang L, 2010, CIRC RES, V106, P514, DOI 10.1161/CIRCRESAHA.109.202762; Wu JS, 2009, J CELL PHYSIOL, V220, P58, DOI 10.1002/jcp.21730; Wu KK, 1998, P ASSOC AM PHYSICIAN, V110, P163; Yu HX, 2011, ARTERIOSCL THROM VAS, V31, P2402, DOI 10.1161/ATVBAHA.111.235622; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	34	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e69702	10.1371/journal.pone.0069702	http://dx.doi.org/10.1371/journal.pone.0069702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844263	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000036
J	Hayama, S; Nakiri, S; Nakanishi, S; Ishii, N; Uno, T; Kato, T; Konno, F; Kawamoto, Y; Tsuchida, S; Ochiai, K; Omi, T				Hayama, Shin-ichi; Nakiri, Sachie; Nakanishi, Setsuko; Ishii, Naomi; Uno, Taiki; Kato, Takuya; Konno, Fumiharu; Kawamoto, Yoshi; Tsuchida, Shuichi; Ochiai, Kazuhiko; Omi, Toshinori			Concentration of Radiocesium in the Wild Japanese Monkey (Macaca fuscata) over the First 15 Months after the Fukushima Daiichi Nuclear Disaster	PLOS ONE			English	Article							CHERNOBYL; RADIATION; ABUNDANCE; ACCIDENT; MACAQUES; BOAR	Following the massive earthquake that struck eastern Japan on March 11, 2011, a nuclear reactor core meltdown occurred at the Fukushima Daiichi Nuclear Power Plant, operated by Tokyo Electric Power Company, and was followed by the release of large amounts of radioactive materials. The objective of this study was to measure the concentration of radiocesium Cs-134 and Cs-137 in the muscle of Japanese monkeys (Macaca fuscata) inhabiting the forest area of Fukushima City and to determine the change in concentration over time as well as the relationship with the level of soil contamination. Cesium concentrations in the muscle of monkeys captured at locations with 100,000-300,000 Bq/m(2) were 6,000-25,000 Bq/kg in April 2011 and decreased over 3 months to around 1,000 Bq/kg. However, the concentration increased again to 2,000-3,000 Bq/kg in some animals during and after December 2011 before returning to 1,000 Bq/kg in April 2012, after which it remained relatively constant. This pattern of change in muscle radiocesium concentration was similar to that of the change in radiocesium concentration in atmospheric fallout. Moreover, the monkeys feed on winter buds and the cambium layer of tree bark potentially containing higher concentrations of radiocesium than that in the diet during the rest of the year. The muscle radiocesium concentration in the monkeys related significantly with the level of soil contamination at the capture locations.	[Hayama, Shin-ichi; Nakiri, Sachie; Ishii, Naomi; Uno, Taiki; Kato, Takuya; Tsuchida, Shuichi; Ochiai, Kazuhiko; Omi, Toshinori] Nippon Vet & Life Sci Univ, Tokyo, Japan; [Nakanishi, Setsuko] Conservat & Anim Welf Trust, Tokyo, Japan; [Konno, Fumiharu] Shin Fukushima Agr Cooperat, Fukushima, Japan; [Kawamoto, Yoshi] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan	Nippon Veterinary & Life Science University; Kyoto University	Hayama, S (corresponding author), Nippon Vet & Life Sci Univ, Tokyo, Japan.	hayama@nvlu.ac.jp		Omi, Toshinori/0000-0001-9303-2746; HAYAMA, Shin-ichi/0000-0002-4882-7969; OCHIAI, Kazuhiko/0000-0002-5736-0598	Cooperative Research Grant of Primate Research Institute, Kyoto University; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan	Cooperative Research Grant of Primate Research Institute, Kyoto University; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This study was supported by the Cooperative Research Grant of Primate Research Institute, Kyoto University and the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], RES 3 AIRB MON SURV; Beresford NA, 2004, J RADIOL PROT, V24, pA89, DOI 10.1088/0952-4746/24/4A/006; Beresford Nicholas A., 2011, Integrated Environmental Assessment and Management, V7, P371, DOI 10.1002/ieam.238; EIKELMANN I M H, 1990, Rangifer, P35; Enari H, 2013, PRIMATES IN PRESS; Fukushima Prefecture, 2012, MANAGEMENT PLAN JAPA, P34; Hayama S, 2011, J VET MED SCI, V73, P809, DOI 10.1292/jvms.10-0420; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; Hohmann U, 2005, EUR J WILDLIFE RES, V51, P263, DOI 10.1007/s10344-005-0108-x; Imaki H, 2000, BIOSPH CONSERV, V3, P1; Iwamoto M., 1987, PRIMATE RES, V3, P18, DOI 10.2354/psj.3.18; Japanese Ministry of Education, RES MON ENV RAD LEV; Japanese Ministry of Environment, 2012, JAP RED LIST; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; KOYAMA N, 1992, PRIMATES, V33, P33, DOI 10.1007/BF02382761; Moller AP, 2013, ECOL INDIC, V24, P75, DOI 10.1016/j.ecolind.2012.06.001; Moller AP, 2012, ENVIRON POLLUT, V164, P36, DOI 10.1016/j.envpol.2012.01.008; Primate Research Institute, KYOT U GUID FIEL RES; ROSOFF B, 1963, RADIAT RES, V19, P643, DOI 10.2307/3571485; Strebl F, 2007, J ENVIRON RADIOACTIV, V98, P137, DOI 10.1016/j.jenvrad.2006.02.009; Suzuki A., 1965, Primates, V6, P31, DOI 10.1007/BF01794458; Tagami K, 2011, SCI TOTAL ENVIRON, V409, P4885, DOI 10.1016/j.scitotenv.2011.07.067; Tsuji Y, 2006, AM J PRIMATOL, V68, P1068, DOI 10.1002/ajp.20307; WADA K, 1980, Primates, V21, P468, DOI 10.1007/BF02373835; WATANUKI Y, 1994, PRIMATES, V35, P15, DOI 10.1007/BF02381482; WATANUKI Y, 1993, PRIMATES, V34, P419, DOI 10.1007/BF02382651; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P255, DOI 10.1111/j.1749-6632.2009.04830.x; Yoshida S, 2011, RADIAT PROT DOSIM, V146, P326, DOI 10.1093/rpd/ncr181	28	26	27	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68530	10.1371/journal.pone.0068530	http://dx.doi.org/10.1371/journal.pone.0068530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844216	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000013
J	Lee, YH; Zimmerman, JN; Custodio, W; Xiao, YZ; Basiri, T; Hatibovic-Kofman, S; Siqueira, WL				Lee, Young Ho; Zimmerman, Jason N.; Custodio, William; Xiao, Yizhi; Basiri, Tayebeh; Hatibovic-Kofman, Sahza; Siqueira, Walter L.			Proteomic Evaluation of Acquired Enamel Pellicle during In Vivo Formation	PLOS ONE			English	Article							PROLINE-RICH PROTEINS; MASS-SPECTROMETRY; BINDING DOMAINS; IDENTIFICATION; STATHERIN; HISTATINS; VITRO; HYDROXYAPATITE; COMPONENTS; COMPLEXES	Acquired enamel pellicle (AEP) is a protein film that forms on the enamel surface of teeth by selective adsorption of proteins and peptides present in the mouth. This protein film forms the interface between enamel and the damage oral biofilm, which modulates the attachment of bacteria found in oral biofilm. The overall goal of this study was to gain insight into the biological formation of the human in vivo AEP. This study hypothesized that AEP is created by the formation of successive protein layers, which consist of initial binding to enamel and subsequent protein-protein interactions. This hypothesis was examined by observing quantitative and qualitative changes in pellicle composition during the first two hours of AEP formation in the oral cavity. Quantitative mass spectrometry approaches were used to generate an AEP protein profile for each time-point studied. Relative proteomic quantification was carried out for the 50 proteins observed in all four time-points. Notably, the abundance of important salivary proteins, such as histatin 1, decrease with increasing of the AEP formation, while other essential proteins such as statherin showed constant relative abundance in all time-points. In summary, this is the first study that investigates the dynamic process to the AEP formation by using proteomic approaches. Our data demonstrated that there are significant qualitative and quantitative proteome changes during the AEP formation, which in turn will likely impact the development of oral biofilms.	[Siqueira, Walter L.] Univ Western Ontario, Dept Biochem, London, ON, Canada; Univ Western Ontario, Sch Dent, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Siqueira, WL (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	walter.siqueira@uwo.ca	Siqueira, Walter/ABE-4069-2021; Custodio, William/B-8257-2014; Siqueira, Walter/ABE-8924-2020	Custodio, William/0000-0003-1416-1414; Siqueira, Walter/0000-0003-1921-3658	Natural Sciences and Engineering Research Council of Canada (NSERC grant) [371813]; Canadian Institutes of Health Research, (CIHR grant) [106657, 97577]; Canada Foundation for Innovation-Leaders Opportunity Fund (CFI-LOF grant) [25116]; CIHR New Investigator Award [113166]; Ontario Dental Association (ODA); CIHR Schulich Dentistry undergraduate dental student scholarship; CIHR undergraduate scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC grant); Canadian Institutes of Health Research, (CIHR grant)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation-Leaders Opportunity Fund (CFI-LOF grant); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Ontario Dental Association (ODA); CIHR Schulich Dentistry undergraduate dental student scholarship; CIHR undergraduate scholarship	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC grant #371813), the Canadian Institutes of Health Research, (CIHR grant #106657 and grant #97577), and the Canada Foundation for Innovation-Leaders Opportunity Fund (CFI-LOF grant #25116). WLS is recipient of a CIHR New Investigator Award (grant #113166). JNZ is recipient of an Ontario Dental Association (ODA) and CIHR Schulich Dentistry undergraduate dental student scholarship. YHL is recipient of a CIHR undergraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; BENNICK A, 1983, ARCH ORAL BIOL, V28, P19, DOI 10.1016/0003-9969(83)90022-5; Carlen A, 1998, CARIES RES, V32, P447, DOI 10.1159/000016486; Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; EDGERTON M, 1992, J PROSTHET DENT, V68, P683, DOI 10.1016/0022-3913(92)90387-P; EGGEN KH, 1982, SCAND J DENT RES, V90, P182; EGGEN KH, 1983, SCAND J DENT RES, V91, P439; Helmerhorst EJ, 2006, ARCH ORAL BIOL, V51, P1061, DOI 10.1016/j.archoralbio.2006.06.005; Helmerhorst EJ, 2010, J PROTEOME RES, V9, P5413, DOI 10.1021/pr100653r; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; Iontcheva I, 2000, J DENT RES, V79, P732; KOUSVELARI EE, 1980, J DENT RES, V59, P1430, DOI 10.1177/00220345800590081201; Li J, 2004, J DENT RES, V83, P60, DOI 10.1177/154405910408300112; Li J, 2003, ORAL MICROBIOL IMMUN, V18, P183, DOI 10.1034/j.1399-302X.2003.00065.x; MAYHALL C W, 1975, Alabama Journal of Medical Sciences, V12, P252; McDonald EE, 2011, J DENT RES, V90, P268, DOI 10.1177/0022034510388653; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; RYKKE M, 1990, SCAND J DENT RES, V98, P129; Schupbach P, 2001, EUR J ORAL SCI, V109, P60, DOI 10.1034/j.1600-0722.2001.00925.x; Siqueira WL, 2007, ANN NY ACAD SCI, V1098, P504, DOI 10.1196/annals.1384.023; Siqueira WL, 2007, J PROTEOME RES, V6, P2152, DOI 10.1021/pr060580k; Siqueira WL, 2012, PROTEOMICS, V12, P3426, DOI 10.1002/pmic.201100665; Siqueira WL, 2009, ARCH ORAL BIOL, V54, P437, DOI 10.1016/j.archoralbio.2009.01.011; Vitorino R, 2004, BIOCHEM BIOPH RES CO, V320, P342, DOI 10.1016/j.bbrc.2004.05.169; Vitorino R, 2008, J SEP SCI, V31, P523, DOI 10.1002/jssc.200700486; Vitorino R, 2007, BIOMED CHROMATOGR, V21, P1107, DOI 10.1002/bmc.830; Yao Y, 2001, ARCH ORAL BIOL, V46, P293, DOI 10.1016/S0003-9969(00)00134-5; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200	29	56	58	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67919	10.1371/journal.pone.0067919	http://dx.doi.org/10.1371/journal.pone.0067919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844127	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000114
J	Muniz, CP; Troncoso, LL; Moreira, MA; Soares, EA; Pissinatti, A; Bonvicino, CR; Seuanez, HN; Sharma, B; Jia, HW; Shankar, A; Switzer, WM; Santos, AF; Soares, MA				Muniz, Claudia P.; Troncoso, Lian L.; Moreira, Miguel A.; Soares, Esmeralda A.; Pissinatti, Alcides; Bonvicino, Cibele R.; Seuanez, Hector N.; Sharma, Bechan; Jia, Hongwei; Shankar, Anupama; Switzer, William M.; Santos, Andre F.; Soares, Marcelo A.			Identification and Characterization of Highly Divergent Simian Foamy Viruses in a Wide Range of New World Primates from Brazil	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; GENETIC DIVERSITY; INFECTION; HUMANS; PREVALENCE; EVOLUTION; MONKEYS; AIDS	Foamy viruses naturally infect a wide range of mammals, including Old World (OWP) and New World primates (NWP), which are collectively called simian foamy viruses (SFV). While NWP species in Central and South America are highly diverse, only SFV from captive marmoset, spider monkey, and squirrel monkey have been genetically characterized and the molecular epidemiology of SFV infection in NWPs remains unknown. We tested a large collection of genomic DNA (n = 332) comprising 14 genera of NWP species for the presence of SFV polymerase (pol) sequences using generic PCR primers. Further molecular characterization of positive samples was carried out by LTR-gag and larger pol sequence analysis. We identified novel SFVs infecting nine NWP genera. Prevalence rates varied between 14-30% in different species for which at least 10 specimens were tested. High SFV genetic diversity among NWP up to 50% in LTR-gag and 40% in pol was revealed by intragenus and intrafamilial comparisons. Two different SFV strains infecting two captive yellow-breasted capuchins did not group in species-specific lineages but rather clustered with SFVs from marmoset and spider monkeys, indicating independent cross-species transmission events. We describe the first SFV epidemiology study of NWP, and the first evidence of SFV infection in wild NWPs. We also document a wide distribution of distinct SFVs in 14 NWP genera, including two novel co-speciating SFVs in capuchins and howler monkeys, suggestive of an ancient evolutionary history in NWPs for at least 28 million years. A high SFV genetic diversity was seen among NWP, yet these viruses seem able to jump between NWP species and even genera. Our results raise concerns for the risk of zoonotic transmission of NWP SFV to humans as these primates are regularly hunted for food or kept as pets in forest regions of South America.	[Muniz, Claudia P.; Troncoso, Lian L.; Seuanez, Hector N.; Santos, Andre F.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Moreira, Miguel A.; Soares, Esmeralda A.; Bonvicino, Cibele R.; Seuanez, Hector N.; Soares, Marcelo A.] Inst Nacl Canc, Programa Genet, Rio De Janeiro, Brazil; [Pissinatti, Alcides] Ctr Primatol Rio de Janeiro, Rio De Janeiro, Brazil; [Bonvicino, Cibele R.] Inst Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil; [Sharma, Bechan] Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India; [Jia, Hongwei; Shankar, Anupama; Switzer, William M.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca); Fundacao Oswaldo Cruz; University of Allahabad; Centers for Disease Control & Prevention - USA	Soares, MA (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	masoares@biologia.ufrj.br	Santos, Andre FA/I-5734-2016; Bonvicino, Cibele/O-3390-2014; Soares, Marcelo A/G-5662-2010; Ferreira, Miguel/HHZ-6251-2022; Moreira, Miguel/AAN-7405-2020; Sharma, Bechan/G-6836-2015	Sharma, Bechan/0000-0002-7835-9406	Instituto Nacional de Cancer; Brazilian Research Council (CNPq) [563766/2008-5]; Rio de Janeiro State Science Foundation [E-26/102.858/2008]	Instituto Nacional de Cancer; Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation	This work was supported by intramural grants of the Instituto Nacional de Cancer, by the Brazilian Research Council (CNPq) grant # 563766/2008-5 (MAS), and by the Rio de Janeiro State Science Foundation grant # E-26/102.858/2008 (MAS). CRM was recipient of a Masters Student scholarship by CNPq while conducting this study. Use of trade names is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services, the Public Health Service, or the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUZZI A, 1993, BIOCHIM BIOPHYS ACTA, V1155, P1, DOI 10.1016/0304-419X(93)90019-9; Ayouba A, 2013, INFECT GENE IN PRESS, V18; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Betsem E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002306; Blewett EL, 2000, VIROLOGY, V278, P183, DOI 10.1006/viro.2000.0649; Boneva RS, 2007, AIDS RES HUM RETROV, V23, P1330, DOI 10.1089/aid.2007.0104; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; Casado F, 2010, J HERED, V101, P261, DOI 10.1093/jhered/esp119; Etienne L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-4; Gessain A, 2008, FUTURE VIROL, V3, P71, DOI 10.2217/17460794.3.1.71; Groves CP, 2005, MAMMAL SPECIES WORLD, P111; Han GZ, 2012, J VIROL, V86, P7696, DOI 10.1128/JVI.00650-12; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; HERCHENRODER O, 1994, VIROLOGY, V201, P187, DOI 10.1006/viro.1994.1285; Huang F, 2012, AIDS RES HUM RETROV, V28, P591, DOI [10.1089/AID.2011.0305, 10.1089/aid.2011.0305]; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jones-Engel L, 2008, EMERG INFECT DIS, V14, P1200, DOI 10.3201/eid1408.071430; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; Khan AS, 2009, EXPERT REV ANTI-INFE, V7, P569, DOI [10.1586/eri.09.39, 10.1586/ERI.09.39]; KUPIEC JJ, 1991, GENE, V101, P185, DOI 10.1016/0378-1119(91)90410-D; Leendertz FH, 2008, J VIROL, V82, P7741, DOI 10.1128/JVI.00549-08; Leendertz SAJ, 2010, J VIROL, V84, P7427, DOI 10.1128/JVI.00697-10; Ling BH, 2004, J VIROL, V78, P8902, DOI 10.1128/JVI.78.16.8902-8908.2004; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; Menezes AN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-248; Moreira MAM, 2010, CYTOGENET GENOME RES, V128, P88, DOI 10.1159/000291485; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Mouinga-Ondeme A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-105; Murray SM, 2006, J MED PRIMATOL, V35, P225, DOI 10.1111/j.1600-0684.2006.00171.x; Nascimento FF, 2008, AM J PRIMATOL, V70, P423, DOI 10.1002/ajp.20507; Pacheco B, 2010, J VIROL, V84, P4095, DOI 10.1128/JVI.02631-09; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Sandstrom PA, 2000, LANCET, V355, P551, DOI 10.1016/S0140-6736(99)05292-7; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schweizer M, 1997, J VIROL, V71, P4821, DOI 10.1128/JVI.71.6.4821-4824.1997; Soares EA, 2010, INFECT GENET EVOL, V10, P246, DOI 10.1016/j.meegid.2009.11.012; Switzer W, 2009, 16 C RETR OPP INF MO; Switzer WM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-100; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Switzer WM, 2004, J VIROL, V78, P2780, DOI 10.1128/JVI.78.6.2780-2789.2004; Switzer WM, 2011, MOL DETECTION VIRAL, P131; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thuemer L, 2007, VIROLOGY, V369, P191, DOI 10.1016/j.virol.2007.07.018; Wolfe ND, 2004, EMERG INFECT DIS, V10, P2094, DOI 10.3201/eid1012.040062; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	47	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67568	10.1371/journal.pone.0067568	http://dx.doi.org/10.1371/journal.pone.0067568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844033	Green Published, gold			2022-12-25	WOS:000321733000081
J	Regis, LN; Acioli, RV; Silveira, JC; Melo-Santos, MAV; Souza, WV; Ribeiro, CNMN; da Silva, JCS; Monteiro, AMV; Oliveira, CMF; Barbosa, RMR; Braga, C; Rodrigues, MAB; Silva, MGNM; Ribeiro, PJ; Bonat, WH; Medeiros, LCD; Carvalho, MS; Furtado, AF				Regis, Leda N.; Acioli, Ridelane Veiga; Silveira, Jose Constantino, Jr.; Varjal Melo-Santos, Maria Alice; Souza, Wayner Vieira; Nogueira Ribeiro, Candida M.; Serafim da Silva, Juliana C.; Vieira Monteiro, Antonio Miguel; Oliveira, Claudia M. F.; Barbosa, Rosangela M. R.; Braga, Cynthia; Benedetti Rodrigues, Marco Aurelio; Silva, Marilu Gomes N. M.; Ribeiro, Paulo Justiniano, Jr.; Bonat, Wagner Hugo; de Castro Medeiros, Liliam Cesar; Carvalho, Marilia Sa; Furtado, Andre Freire			Sustained Reduction of the Dengue Vector Population Resulting from an Integrated Control Strategy Applied in Two Brazilian Cities	PLOS ONE			English	Article							MASS TRAPPING SCHEME; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; BACILLUS-SPHAERICUS; EMILIA-ROMAGNA; URBAN AREA; ALBOPICTUS; CULICIDAE; DIPTERA; SURVEILLANCE	Aedes aegypti has developed evolution-driven adaptations for surviving in the domestic human habitat. Several trap models have been designed considering these strategies and tested for monitoring this efficient vector of Dengue. Here, we report a real-scale evaluation of a system for monitoring and controlling mosquito populations based on egg sampling coupled with geographic information systems technology. The SMCP-Aedes, a system based on open technology and open data standards, was set up from March/2008 to October/2011 as a pilot trial in two sites of Pernambuco Brazil: Ipojuca (10,000 residents) and Santa Cruz (83,000), in a joint effort of health authorities and staff, and a network of scientists providing scientific support. A widespread infestation by Aedes was found in both sites in 2008-2009, with 96.8%-100% trap positivity. Egg densities were markedly higher in SCC than in Ipojuca. A 90% decrease in egg density was recorded in SCC after two years of sustained control pressure imposed by suppression of >7,500,000 eggs and >3,200 adults, plus larval control by adding fishes to cisterns. In Ipojuca, 1.1 million mosquito eggs were suppressed and a 77% reduction in egg density was achieved. This study aimed at assessing the applicability of a system using GIS and spatial statistic analysis tools for quantitative assessment of mosquito populations. It also provided useful information on the requirements for reducing well-established mosquito populations. Results from two cities led us to conclude that the success in markedly reducing an Aedes population required the appropriate choice of control measures for sustained mass elimination guided by a user-friendly mosquito surveillance system. The system was able to support interventional decisions and to assess the program's success. Additionally, it created a stimulating environment for health staff and residents, which had a positive impact on their commitment to the dengue control program.	[Regis, Leda N.; Silveira, Jose Constantino, Jr.; Varjal Melo-Santos, Maria Alice; Oliveira, Claudia M. F.; Barbosa, Rosangela M. R.] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Entomol, Recife, PE, Brazil; [Acioli, Ridelane Veiga] Secretaria Estadual Saude, Recife, PE, Brazil; [Souza, Wayner Vieira] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Saude Colet, Recife, PE, Brazil; [Nogueira Ribeiro, Candida M.] Secretaria Municipal Saude, Santa Cruz Do Capibaribe, PE, Brazil; [Serafim da Silva, Juliana C.] Secretaria Municipal Saude, Ipojuca, PE, Brazil; [Vieira Monteiro, Antonio Miguel] INPE, Div Proc Imagens, Sao Jose Dos Campos, SP, Brazil; [Braga, Cynthia] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Parasitol, Recife, PE, Brazil; [Benedetti Rodrigues, Marco Aurelio; Silva, Marilu Gomes N. M.] Univ Fed Pernambuco, Dept Eletron & Sistemas, Recife, PE, Brazil; [Ribeiro, Paulo Justiniano, Jr.; Bonat, Wagner Hugo] Univ Fed Parana, Dept Estat, BR-80060000 Curitiba, PR, Brazil; [de Castro Medeiros, Liliam Cesar] Ctr Ciencia Sistema Terr, INPE, Sao Jose Dos Campos, SP, Brazil; [Carvalho, Marilia Sa] Fundacao Oswaldo Cruz Fiocruz, Rio De Janeiro, RJ, Brazil; [Furtado, Andre Freire] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Virol, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Instituto Nacional de Pesquisas Espaciais (INPE); Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Universidade Federal do Parana; Instituto Nacional de Pesquisas Espaciais (INPE); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Regis, LN (corresponding author), Fundacao Oswaldo Cruz Fiocruz Pe, Dept Entomol, Recife, PE, Brazil.	leda@cpqam.fiocruz.br	Medeiros, Líliam/J-8593-2014; Souza, Wayner V/H-3798-2013; Braga, Cynthia/A-8204-2013; CARVALHO, MARILIA/AAD-8283-2020; Barbosa, Rosângela/AAC-3339-2020; Ribeiro, Paulo/GYA-1014-2022; Monteiro, Antonio Miguel Vieira/C-1757-2012	Braga, Cynthia/0000-0002-7862-6455; CARVALHO, MARILIA/0000-0002-9566-0284; Barbosa, Rosângela/0000-0002-1171-598X; Monteiro, Antonio Miguel Vieira/0000-0003-1477-1749; Ribeiro Junior, Paulo Justiniano/0000-0001-5302-9446; Benedetti Rodrigues, Marco Aurelio/0000-0002-5143-3696; Souza, Wayner/0000-0002-0939-9332; Medeiros, Liliam/0000-0002-8142-6673; Silva, Juliana/0000-0002-0201-8883	CNPq [PQ-301277/2005-2, APQ-479214/2010-7]; FACEPE [APQ-0692-2.13/08]; PDTSP-FIOCRUZ [RDVE-03]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); PDTSP-FIOCRUZ	This work received financial support from grants from CNPq, http://www.cnpq.br (PQ-301277/2005-2 and APQ-479214/2010-7); FACEPE, http://www.facepe.br (APQ-0692-2.13/08); and PDTSP-FIOCRUZ, http://www.fiocruz.br (RDVE-03). The State Health Department of Pernambuco offered ground transport for people and materials related to the project from Recife to Santa Cruz do Capibaribe and Ipojuca, during 2008-2011. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albieri A, 2010, B INSECTOL, V63, P209; Bailey T, 1995, INTERACTIVE SPATIAL; Barbazan P, 1997, J AM MOSQUITO CONTR, V13, P263; Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Beech C, 2009, ASIA PAC J MOL BIOL, V17, P75; Bellini R, 1996, J AM MOSQUITO CONTR, V12, P632; Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154; Bonat WH, 2009, REV BRAS BIOM, V27, P519; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; Chansang C, 2007, AM J TROP MED HYG, V77, P897, DOI 10.4269/ajtmh.2007.77.897; De Barro P, 2011, J VERBRAUCH LEBENSM, V6, P1, DOI 10.1007/s00003-011-0692-5; Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x; Lagrotta MT, 2008, CAD SAUDE PUBLICA, V24, P70, DOI 10.1590/S0102-311X2008000100007; Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505; HOUGARD JM, 1993, B WORLD HEALTH ORGAN, V71, P367; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Kaplan L, 2010, BIOL INVASIONS, V12, P3277, DOI 10.1007/s10530-010-9721-z; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Kay BH, 2010, AM J TROP MED HYG, V82, P822, DOI 10.4269/ajtmh.2010.09-0503; Khatchikian C, 2011, MED VET ENTOMOL, V25, P268, DOI 10.1111/j.1365-2915.2010.00935.x; Kittayapong P, 2008, AM J TROP MED HYG, V78, P70, DOI 10.4269/ajtmh.2008.78.70; Kumar A, 1996, J AM MOSQUITO CONTR, V12, P409; Lenhart AE, 2005, ACTA TROP, V96, P56, DOI 10.1016/j.actatropica.2005.06.020; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; MONTGOMERY BL, 2005, ARBOVIRUS RES AUST, V9, P268; Morato VCG, 2005, REV SAUDE PUBL, V39, P553, DOI 10.1590/S0034-89102005000400006; Obenauer PJ, 2009, J MED ENTOMOL, V46, P1507, DOI 10.1603/033.046.0639; Polson K. A., 2002, Dengue Bulletin, V26, P178; Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x; Regis L, 2000, T ROY SOC TROP MED H, V94, P488, DOI 10.1016/S0035-9203(00)90061-0; Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008; Regis L, 2009, AN ACAD BRAS CIENC, V81, P655, DOI 10.1590/S0001-37652009000400004; Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076; Ritchie SA, 2009, MED VET ENTOMOL, V23, P295, DOI 10.1111/j.1365-2915.2009.00833.x; Santos S. R. A., 2003, Dengue Bulletin, V27, P156; SCHOFIELD CJ, 1991, ANN SOC BELG MED TR, V71, P201; Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001; Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77; Silva MGNM, 2011, 33 ANN INT C IEEE EN; Silva-Filha MH, 2001, J AM MOSQUITO CONTR, V17, P45; Stein M, 2005, REV SAUDE PUBL, V39, P559, DOI 10.1590/S0034-89102005000400007; Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003; WHO, 2011, TECHNICAL PUBLICATIO, V60; Williams CR, 2005, ARBOVIRUS RES AUSTR, V9, P397; Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2	53	38	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67682	10.1371/journal.pone.0067682	http://dx.doi.org/10.1371/journal.pone.0067682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844059	Green Published, gold			2022-12-25	WOS:000321733000092
J	Wang, MY; Verdier, J; Benedito, VA; Tang, YH; Murray, JD; Ge, YB; Becker, JD; Carvalho, H; Rogers, C; Udvardi, M; He, J				Wang, Mingyi; Verdier, Jerome; Benedito, Vagner A.; Tang, Yuhong; Murray, Jeremy D.; Ge, Yinbing; Becker, Joerg D.; Carvalho, Helena; Rogers, Christian; Udvardi, Michael; He, Ji			LegumeGRN: A Gene Regulatory Network Prediction Server for Functional and Comparative Studies	PLOS ONE			English	Article							EXPRESSION ATLAS; INFERENCE; DATABASE; ASSOCIATION; INFORMATION; PATHWAY; WEB	Building accurate gene regulatory networks (GRNs) from high-throughput gene expression data is a long-standing challenge. However, with the emergence of new algorithms combined with the increase of transcriptomic data availability, it is now reachable. To help biologists to investigate gene regulatory relationships, we developed a web-based computational service to build, analyze and visualize GRNs that govern various biological processes. The web server is preloaded with all available Affymetrix GeneChip-based transcriptomic and annotation data from the three model legume species, i.e., Medicago truncatula, Lotus japonicus and Glycine max. Users can also upload their own transcriptomic and transcription factor datasets from any other species/organisms to analyze their in-house experiments. Users are able to select which experiments, genes and algorithms they will consider to perform their GRN analysis. To achieve this flexibility and improve prediction performance, we have implemented multiple mainstream GRN prediction algorithms including co-expression, Graphical Gaussian Models (GGMs), Context Likelihood of Relatedness (CLR), and parallelized versions of TIGRESS and GENIE3. Besides these existing algorithms, we also proposed a parallel Bayesian network learning algorithm, which can infer causal relationships (i.e., directionality of interaction) and scale up to several thousands of genes. Moreover, this web server also provides tools to allow integrative and comparative analysis between predicted GRNs obtained from different algorithms or experiments, as well as comparisons between legume species. The web site is available at http://legumegrn.noble.org.	[Wang, Mingyi; Verdier, Jerome; Tang, Yuhong; Ge, Yinbing; Udvardi, Michael; He, Ji] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; [Benedito, Vagner A.] W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; [Murray, Jeremy D.; Rogers, Christian] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Becker, Joerg D.] Inst Gulbenkian Ciencias, Plant Genom Lab, Oeiras, Portugal; [Carvalho, Helena] Univ Porto, Inst Mol & Cell Biol, P-4100 Oporto, Portugal; [He, Ji] NCI, Canc Genom Res Lab, Div Canc Epidemiol & Genet, SAIC Frederick Inc, Bethesda, MD 20892 USA	Noble Research Institute; West Virginia University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Instituto Gulbenkian de Ciencia; Universidade do Porto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Wang, MY (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, POB 2180, Ardmore, OK 73402 USA.	mwang@noble.org	Murray, Jeremy D./F-8409-2011; Udvardi, Michael/GPX-4653-2022; Becker, Jorg/A-5930-2011; Carvalho, Helena G/E-9357-2012	Murray, Jeremy D./0000-0003-3000-9199; Udvardi, Michael/0000-0001-9850-0828; Becker, Jorg/0000-0002-6845-6122; Carvalho, Helena G/0000-0003-0651-7601; Tang, Yuhong/0000-0003-2967-778X; Verdier, Jerome/0000-0003-3039-2159	Oklahoma Center for The Advancement of Science and Technology (OCAST) [PSB11-031]; BBSRC [BB/I025441/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025441/1] Funding Source: researchfish	Oklahoma Center for The Advancement of Science and Technology (OCAST); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Oklahoma Center for The Advancement of Science and Technology (OCAST Grant No. PSB11-031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Brown G., 2005, Information Fusion, V6, P5, DOI 10.1016/j.inffus.2004.04.004; Chen T, 1999, Pac Symp Biocomput, P29; Colombo DM, 2012, MODIFICATION PC ALGO; de Borda JC, 1781, MEMOIRE ELECT SCRUTI; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Goffard N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-87; Goffard N, 2006, BIOINFORMATICS, V22, P2958, DOI 10.1093/bioinformatics/btl517; Haibe-Kains B, 2012, NUCLEIC ACIDS RES, V40, pD866, DOI 10.1093/nar/gkr1050; Haury A.-C., 2012, TIGRESS TRUSTFUL INF; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Kuffner R, 2012, BIOINFORMATICS, V28, P1376, DOI 10.1093/bioinformatics/bts143; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Monke G, 2012, NUCLEIC ACIDS RES, V40, P8240, DOI 10.1093/nar/gks594; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; OPITZ D, 1999, J ARTIFICIAL INTELLI, V11, P12; Parcy F, 1997, PLANT CELL, V9, P1265, DOI 10.1105/tpc.9.8.1265; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Shoemaker RC, 1996, GENETICS, V144, P329; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Teng S, 2008, PLANT J, V55, P372, DOI 10.1111/j.1365-313X.2008.03515.x; Verdier J, 2013, PLANT J, V74, P351, DOI 10.1111/tpj.12119; Wang MY, 2010, MOL BIOSYST, V6, P988, DOI 10.1039/b917571g; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Watanabe Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S12; Xiao YF, 2009, CURR GENOMICS, V10, P511, DOI 10.2174/138920209789208237	42	6	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67434	10.1371/journal.pone.0067434	http://dx.doi.org/10.1371/journal.pone.0067434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844010	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000072
J	Chaban, B; Albert, A; Links, MG; Gardy, J; Tang, P; Hill, JE				Chaban, Bonnie; Albert, Arianne; Links, Matthew G.; Gardy, Jennifer; Tang, Patrick; Hill, Janet E.			Characterization of the Upper Respiratory Tract Microbiomes of Patients with Pandemic H1N1 Influenza	PLOS ONE			English	Article							CPN60; DIVERSITY; SEQUENCE; TOOL; REPRESENTATION; COMMUNITIES; IMPROVEMENT; LIBRARIES; TARGET	The upper respiratory tract microbiome has an important role in respiratory health. Influenza A is a common viral infection that challenges that health, and a well-recognized sequela is bacterial pneumonia. Given this connection, we sought to characterize the upper respiratory tract microbiota of individuals suffering from the pandemic H1N1 influenza A outbreak of 2009 and determine if microbiome profiles could be correlated with patient characteristics. We determined the microbial profiles of 65 samples from H1N1 patients by cpn60 universal target amplification and sequencing. Profiles were examined at the phylum and nearest neighbor "species" levels using the characteristics of patient gender, age, originating health authority, sample type and designation (STAT/non-STAT). At the phylum level, Actinobacteria-, Firmicutes- and Proteobacteria-dominated microbiomes were observed, with none of the patient characteristics showing significant profile composition differences. At the nearest neighbor "species" level, the upper respiratory tract microbiomes were composed of 13-20 "species" and showed a trend towards increasing diversity with patient age. Interestingly, at an individual level, most patients had one to three organisms dominant in their microbiota. A limited number of discrete microbiome profiles were observed, shared among influenza patients regardless of patient status variables. To assess the validity of analyses derived from sequence read abundance, several bacterial species were quantified by quantitative PCR and compared to the abundance of cpn60 sequence read counts obtained in the study. A strong positive correlation between read abundance and absolute bacterial quantification was observed. This study represents the first examination of the upper respiratory tract microbiome using a target other than the 16S rRNA gene and to our knowledge, the first thorough examination of this microbiome during a viral infection.	[Chaban, Bonnie; Links, Matthew G.; Hill, Janet E.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Albert, Arianne] Womens Hlth Res Inst, Vancouver, BC, Canada; [Links, Matthew G.] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Gardy, Jennifer; Tang, Patrick] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Tang, Patrick] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of Saskatchewan; Agriculture & Agri Food Canada; University of British Columbia	Hill, JE (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada.	janet.hill@usask.ca	Links, Matthew G./P-4949-2019; Hill, Janet E./B-5001-2011; Albert, Arianne/AAG-7518-2019	Links, Matthew G./0000-0003-1917-6789; Hill, Janet E./0000-0002-2187-6277; Albert, Arianne/0000-0002-3050-0888; Gardy, Jennifer/0000-0001-7255-7631; Quigley, Bonnie/0000-0003-3787-0993; Tang, Patrick/0000-0003-1583-5484	Genome BC; BC Centre for Disease Control; British Columbia Provincial Health Services Authority Laboratories; Canadian Institutes of Health Research	Genome BC; BC Centre for Disease Control; British Columbia Provincial Health Services Authority Laboratories; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding for this project was provided by Genome BC, BC Centre for Disease Control, the British Columbia Provincial Health Services Authority Laboratories and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chaban B, 2012, MICROB ECOL, V63, P348, DOI 10.1007/s00248-011-9931-7; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Director-General Who, 2011, 64 WORLD HLTH ASS WO, P49; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hill JE, 2010, APPL ENVIRON MICROB, V76, P4550, DOI 10.1128/AEM.01510-09; Hill JE, 2006, ENVIRON MICROBIOL, V8, P741, DOI 10.1111/j.1462-2920.2005.00944.x; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; JEYNES BJ, 1975, ANAT REC, V182, P289, DOI 10.1002/ar.1091820303; Kindt R, 2012, VEGAN COMM EC PACK R; Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112, DOI 10.1128/AEM.62.9.3112-3120.1996; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Links MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049755; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marcet-Houben M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-646; Martinez D, 2004, NAT BIOTECHNOL, V22, P899, DOI 10.1038/nbt0704-899b; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; R Development Core Team, 2012, R LANG ENV STAT COMP; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	37	48	52	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69559	10.1371/journal.pone.0069559	http://dx.doi.org/10.1371/journal.pone.0069559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844261	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000193
J	Herskovits, AZ; Locascio, JJ; Peskind, ER; Li, G; Hyman, BT				Herskovits, Adrianna Z.; Locascio, Joseph J.; Peskind, Elaine R.; Li, Ge; Hyman, Bradley T.			A Luminex Assay Detects Amyloid beta Oligomers in Alzheimer's Disease Cerebrospinal Fluid	PLOS ONE			English	Article							A-BETA; NATIONAL INSTITUTE; PRECURSOR PROTEIN; NEUROPATHOLOGIC ASSESSMENT; ASSOCIATION GUIDELINES; ANALYTICAL PLATFORMS; CLINICAL-DIAGNOSIS; TOTAL TAU; PEPTIDE; BRAIN	Amyloid beta (a beta) protein assembles into larger protein aggregates during the pathogenesis of Alzheimer's disease (AD) and there is increasing evidence that soluble a beta oligomers are a critical pathologic species. Diagnostic evaluations rely on the measurement of increased tau and decreased a beta 42 in the cerebrospinal fluid (CSF) from AD patients and evidence for oligomeric a beta in patient CSF is conflicting. In this study, we have adapted a monoclonal single antibody sandwich ELISA assay to a Luminex platform and found that this assay can detect oligomerized a beta 42 and sAPP alpha fragments. We evaluated oligomeric a beta reactivity in 20 patients with AD relative to 19 age matched controls and compared these values with a commercially available Alzbio3 kit that detects tau, phosphorylated tau and a beta 42 on the same diagnostic platform. We found that CSF samples of patients with AD had elevated a beta oligomers compared to control subjects (p < 0.05) and the ratio of a beta oligomers to a beta 42 was also significantly elevated (p < 0.0001). Further research to develop high sensitivity analytical platforms and rigorous methods of developing stable assay standards will be needed before the analysis of oligomeric a beta becomes a routine diagnostic assay for the evaluation of late onset AD patients.	[Herskovits, Adrianna Z.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Locascio, Joseph J.] Massachusetts Gen Hosp, Alzheimers Dis Res Ctr, Memory Disorders Unit, Boston, MA 02114 USA; [Locascio, Joseph J.] Massachusetts Gen Hosp, Alzheimers Dis Res Ctr, Movement Disorders Unit, Boston, MA 02114 USA; [Peskind, Elaine R.; Li, Ge] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Peskind, Elaine R.] Vet Affairs Puget Sound Hlth Care Syst, Mental Illness Res & Educ Clin Ctr, Seattle, WA USA; [Herskovits, Adrianna Z.; Hyman, Bradley T.] Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Harvard University; Massachusetts General Hospital	Herskovits, AZ (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	azherskovits@partners.org			NIH [P50AG05134, 2T32HL007627-26]; NIH/NIA [P50 AG005136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136, P50AG005134, R01AG015339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIH P50AG05134 (B.T.H.) and 2T32HL007627-26 (A.Z.H.) and NIH/NIA P50 AG005136 (E.P. and G.L.). BTH is a consultant for Takeda Pharmaceutical Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bombois S, 2013, CURR ALZHEIMER RES, V10, P357, DOI 10.2174/1567205011310040002; Brinkmalm G, 2013, BRAIN RES; Bruggink KA, 2013, ANAL BIOCHEM, V433, P112, DOI 10.1016/j.ab.2012.09.014; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Fagan AM, 2011, ARCH NEUROL-CHICAGO, V68, P1137, DOI 10.1001/archneurol.2011.105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Hock C, 1998, EUR NEUROL, V39, P111, DOI 10.1159/000007917; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Irwin DJ, 2012, ARCH NEUROL-CHICAGO, V69, P1018, DOI 10.1001/archneurol.2012.26; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kasai T, 2012, BIOCHEM BIOPH RES CO, V422, P375, DOI 10.1016/j.bbrc.2012.04.146; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Le Bastard N, 2013, J ALZHEIMERS DIS, V33, P117, DOI 10.3233/JAD-2012-121246; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Mattsson N, 2012, NEUROLOGY, V78, P468, DOI 10.1212/WNL.0b013e3182477eed; Mattsson N, 2011, ALZHEIMERS DEMENT, V7, P386, DOI 10.1016/j.jalz.2011.05.2243; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Santos AN, 2007, J ALZHEIMERS DIS, V11, P117; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; PALMERT MR, 1990, NEUROLOGY, V40, P1028, DOI 10.1212/WNL.40.7.1028; Puttfarcken PS, 1996, EXP NEUROL, V138, P73, DOI 10.1006/exnr.1996.0048; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Santos AN, 2012, J ALZHEIMERS DIS, V29, P171, DOI 10.3233/JAD-2012-111361; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shaw LM, 2011, ACTA NEUROPATHOL, V121, P597, DOI 10.1007/s00401-011-0808-0; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Vanderstichele H, 2005, STANDARDIZED MULTIPA, P183; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wechsler D, 1983, MANUAL WECHSLER MEMO; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zetterberg Henrik, 2008, Handb Clin Neurol, V89, P261, DOI 10.1016/S0072-9752(07)01224-9; [No title captured]	48	43	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67898	10.1371/journal.pone.0067898	http://dx.doi.org/10.1371/journal.pone.0067898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844122	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000115
J	Martini, M; Canella, R; Fesce, R; Rossi, ML				Martini, Marta; Canella, Rita; Fesce, Riccardo; Rossi, Maria Lisa			The Amplitude and Inactivation Properties of the Delayed Potassium Currents Are Regulated by Protein Kinase Activity in Hair Cells of the Frog Semicircular Canals	PLOS ONE			English	Article							IONIC CURRENTS; BKCA CHANNEL; CA2+ CURRENT; PHOSPHORYLATION; MODULATION; CALCIUM; ACTIVATION; MECHANISMS; ATP	In hair cells dissected from the frog crista ampullaris, the combination of a calcium-dependent (IKCa) and a purely voltage-dependent component (IKV) gives rise to the delayed potassium current complex (IKD). These currents have been recently reported to display slow depolarization-induced inactivation and biphasic inactivation removal by hyperpolarization. The amplitude and inactivation kinetics of both IKCa and IKV are drastically modulated by a previously unrecognized mechanism of protein phosphorylation (sensitive to kinase inhibitors H89 and KT5823), which does not interfere with the transient potassium current (IA) or the calcium current (ICa). IKD amplitude was stable in cells patched with pipettes containing 8 mM ATP or under perforated-patch; under these conditions, a 10 min treatment with 10 mu M H89 or 1-10 mu M KT5823 reduced IKD amplitude by a mean of 67% at +40 mV. Similarly affected was the isolated IKV component (ICa blocked with Cd2+). Thus, a large potassium conductance can be activated by depolarization, but it is made available to the cell to a variable extent that depends on membrane potential and protein kinase activity. The total gKD ranged 4.6-44.0 nS in control cells, according to the level of steady-state inactivation, and was reduced to 1.4-2.7 nS after protein kinase inhibition. When sinusoidal membrane potential changes in the -70/-10 mV range were applied, to mimic receptor response to hair bundle deflection, IKD proved the main current dynamically activated and the only one regulated by PK: H89 decreased the total outward charge during each cycle by 60%. Phosphorylation appears to control both the amount of IKCa and IKV conductance activated by depolarization and the fraction thereof which can be rescued by removal of inactivation. The balance between the depolarizing transduction current and the repolarizing potassium current, and eventually the transmitter release at the cytoneural junction, are therefore modulated by a phosphorylation-mediated process.	[Martini, Marta; Canella, Rita; Rossi, Maria Lisa] Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy; [Fesce, Riccardo] Insubria Univ, Ctr Neurosci, Varese, Italy; [Fesce, Riccardo] Insubria Univ, DISTA, Varese, Italy	University of Ferrara; University of Insubria; University of Insubria	Rossi, ML (corresponding author), Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy.	rsm@unife.it		fesce, riccardo/0000-0001-9473-896X; Rossi, Maria Lisa/0000-0002-9057-7422	Ferrara University	Ferrara University	Local funds to MLR from the Ferrara University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanza A, 2007, J NEUROPHYSIOL, V97, P1188, DOI 10.1152/jn.00849.2006; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; BELLUZZI O, 1991, PROG BIOPHYS MOL BIO, V55, P1, DOI 10.1016/0079-6107(91)90009-H; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; Jagger DJ, 1999, PFLUG ARCH EUR J PHY, V437, P409, DOI 10.1007/s004240050795; Jagger DJ, 1999, NEUROSCI LETT, V263, P145, DOI 10.1016/S0304-3940(99)00128-7; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lv P, 2010, J NEUROPHYSIOL, V103, P2494, DOI 10.1152/jn.00017.2010; Martini M, 2000, BIOPHYS J, V78, P1240, DOI 10.1016/S0006-3495(00)76681-1; Martini M, 2007, EUR BIOPHYS J BIOPHY, V36, P779, DOI 10.1007/s00249-007-0172-0; Martini M, 2009, AM J PHYSIOL-REG I, V296, pR1585, DOI 10.1152/ajpregu.90981.2008; Martini M, 2009, PFLUG ARCH EUR J PHY, V457, P1327, DOI 10.1007/s00424-008-0598-y; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Park KS, 2008, PHYSIOLOGY, V23, P49, DOI 10.1152/physiol.00031.2007; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Roeper J, 1997, J NEUROSCI, V17, P3379; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67784	10.1371/journal.pone.0067784	http://dx.doi.org/10.1371/journal.pone.0067784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844092	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000096
J	Nogeire, TM; Davis, FW; Duggan, JM; Crooks, KR; Boydston, EE				Nogeire, Theresa M.; Davis, Frank W.; Duggan, Jennifer M.; Crooks, Kevin R.; Boydston, Erin E.			Carnivore Use of Avocado Orchards across an Agricultural-Wildland Gradient	PLOS ONE			English	Article							OCCUPANCY; BIODIVERSITY; DYNAMICS; MAMMALS	Wide-ranging species cannot persist in reserves alone. Consequently, there is growing interest in the conservation value of agricultural lands that separate or buffer natural areas. The value of agricultural lands for wildlife habitat and connectivity varies as a function of the crop type and landscape context, and quantifying these differences will improve our ability to manage these lands more effectively for animals. In southern California, many species are present in avocado orchards, including mammalian carnivores. We examined occupancy of avocado orchards by mammalian carnivores across agricultural-wildland gradients in southern California with motion-activated cameras. More carnivore species were detected with cameras in orchards than in wildland sites, and for bobcats and gray foxes, orchards were associated with higher occupancy rates. Our results demonstrate that agricultural lands have potential to contribute to conservation by providing habitat or facilitating landscape connectivity.	[Nogeire, Theresa M.; Duggan, Jennifer M.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Davis, Frank W.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Crooks, Kevin R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Boydston, Erin E.] US Geol Survey, Western Ecol Res Ctr, Thousand Oaks, CA USA	University of Washington; University of Washington Seattle; University of California System; University of California Santa Barbara; Colorado State University; United States Department of the Interior; United States Geological Survey	Nogeire, TM (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	tnogeire@gmail.com	Davis, Frank W./B-7010-2009	Davis, Frank W./0000-0002-4643-5718	The Bren School at UCSB, Orange County Great Park Corporation, and the U.S.G.S	The Bren School at UCSB, Orange County Great Park Corporation, and the U.S.G.S	Partial funding for this study was provided by The Bren School at UCSB, Orange County Great Park Corporation, and the U.S.G.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Beier P, 2008, ARIZONA MISSING LINK; Beier P, 2006, CONNECTIVITY CONSERV, P555, DOI DOI 10.1046/J.1523-1739.2003.01458.X; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Borchert M, 2008, CALIF FISH GAME, V94, P61; Brosi BJ, 2006, ENDANGERED SPECIES A, V2, P256; Conservation International, 2010, BIOD HOTSP; Cosentino BJ, 2011, LANDSCAPE ECOLOGY, V26, P1; Cox RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014508; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Donovan T.M., 2007, EXERCISES OCCUPANCY; Duggan JM, 2011, LANDSCAPE ECOL, V26, P1477, DOI 10.1007/s10980-011-9652-9; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Keeley J.E., 2000, N AM TERRESTRIAL VEG, P203; Landis JD, 2003, WE WILL GROW BASELIN; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; Lopez-Bao JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014569; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Padial JM, 2002, MAMM BIOL, V67, P137, DOI 10.1078/1616-5047-00021; Ray J. C., 2005, LARGE CARNIVORES CON; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shapira I, 2007, ANIMAL CONSERVATION, V11, P1; Singleton P.H., 2002, LANDSCAPE PERMEABILI; Thibault KM, 2010, J MAMMAL, V91, P787, DOI 10.1644/09-MAMM-S-142.1	32	14	14	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68025	10.1371/journal.pone.0068025	http://dx.doi.org/10.1371/journal.pone.0068025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844147	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000129
J	Hone, AJ; Ruiz, M; Scadden, M; Christensen, S; Gajewiak, J; Azam, L; McIntosh, JM				Hone, Arik J.; Ruiz, Miguel; Scadden, Mick'l; Christensen, Sean; Gajewiak, Joanna; Azam, Layla; McIntosh, J. Michael			Positional Scanning Mutagenesis of alpha-Conotoxin PeIA Identifies Critical Residues That Confer Potency and Selectivity for alpha 6/alpha 3 beta 2 beta 3 and alpha 3 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT MESSENGER-RNAS; CHOLINERGIC-RECEPTORS; NIGROSTRIATAL DAMAGE; DOPAMINE RELEASE; RAT RETINA; BINDING; SUBTYPES; BRAIN; MII; EXPRESSION	The nicotinic acetylcholine receptor (nAChR) subtype alpha 6 beta 2* (the asterisk denotes the possible presence of additional subunits) has been identified as an important molecular target for the pharmacotherapy of Parkinson disease and nicotine dependence. The alpha 6 subunit is closely related to the alpha 3 subunit, and this presents a problem in designing ligands that discriminate between alpha 6 beta 2* and alpha 3 beta 2* nAChRs. We used positional scanning mutagenesis of alpha-conotoxin PeIA, which targets both alpha 6 beta 2* and alpha 3 beta 2*, in combination with mutagenesis of the alpha 6 and alpha 3 subunits, to gain molecular insights into the interaction of PeIA with heterologously expressed alpha 6/alpha 3 beta 2 beta 3 and alpha 3 beta 2 receptors. Mutagenesis of PeIA revealed that Asn(11) was located in an important position that interacts with the alpha 6 and alpha 3 subunits. Substitution of Asn(11) with a positively charged amino acid essentially abolished the activity of PeIA for alpha 3 beta 2 but not for alpha 6/alpha 3 beta 2 beta 3 receptors. These results were used to synthesize a PeIA analog that was > 15,000- fold more potent on alpha 6/alpha 3 beta 2 beta 3 than alpha 3 beta 2 receptors. Analogs with an N11R substitution were then used to show a critical interaction between the 11th position of PeIA and Glu(152) of the alpha 6 subunit and Lys(152) of the alpha 3 subunit. The results of these studies provide molecular insights into designing ligands that selectively target alpha 6 beta 2* nAChRs.	[McIntosh, J. Michael] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84132 USA; [Hone, Arik J.; Ruiz, Miguel; Scadden, Mick'l; Christensen, Sean; Gajewiak, Joanna; Azam, Layla; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84132 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84132 USA; [McIntosh, J. Michael] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	McIntosh, JM (corresponding author), Dept Psychiat, 50 North 1900 East, Salt Lake City, UT 84132 USA.	mcintosh.mike@gmail.com			National Institutes of Health [GM103801, GM48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103801, P01GM048677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM103801 and GM48677.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2010, TOXINS, V2, P1471, DOI 10.3390/toxins2061471; Azam L, 2005, J PHARMACOL EXP THER, V312, P231, DOI 10.1124/jpet.104.071456; Azam L, 2008, J BIOL CHEM, V283, P11625, DOI 10.1074/jbc.M710288200; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Baddick CG, 2011, BIOCHEM PHARMACOL, V82, P828, DOI 10.1016/j.bcp.2011.04.019; Beissner M, 2012, MOL PHARMACOL, V82, P711, DOI 10.1124/mol.112.078683; Bohr IJ, 2005, EXP NEUROL, V191, P292, DOI 10.1016/j.expneurol.2004.10.004; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Cordero-Erausquin M, 2004, PAIN, V109, P308, DOI 10.1016/j.pain.2004.01.034; Cox BC, 2008, J NEUROCHEM, V105, P1924, DOI 10.1111/j.1471-4159.2008.05282.x; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Endo T, 2005, J NEUROPHYSIOL, V94, P3893, DOI 10.1152/jn.00211.2005; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Gotti C, 2005, MOL PHARMACOL, V67, P2007, DOI 10.1124/mol.105.011940; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hone AJ, 2012, MOL PHARMACOL, V82, P972, DOI 10.1124/mol.112.080853; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; Hone AJ, 2009, J NEUROCHEM, V111, P80, DOI 10.1111/j.1471-4159.2009.06299.x; Huang LPZ, 2011, NEUROPHARMACOLOGY, V60, P861, DOI 10.1016/j.neuropharm.2010.12.032; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Kim HW, 2012, FASEB J, V26, P4102, DOI 10.1096/fj.12-204487; Kulak JM, 2002, MOL PHARMACOL, V61, P230, DOI 10.1124/mol.61.1.230; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Liu LW, 2012, MOL PHARMACOL, V81, P541, DOI 10.1124/mol.111.076661; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SL, 2013, J BIOL CHEM, V288, P894, DOI 10.1074/jbc.M112.427898; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Meyer EL, 2008, J NEUROCHEM, V105, P1761, DOI 10.1111/j.1471-4159.2008.05266.x; Moretti M, 2004, MOL PHARMACOL, V66, P85, DOI 10.1124/mol.66.1.85; Perez XA, 2010, MOL PHARMACOL, V78, P971, DOI 10.1124/mol.110.067561; Pucci L, 2011, FASEB J, V25, P3775, DOI 10.1096/fj.10-179853; Quik M, 2001, J NEUROSCI, V21, P5494, DOI 10.1523/JNEUROSCI.21-15-05494.2001; Quik M, 2000, J COMP NEUROL, V425, P58, DOI 10.1002/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Wooters TE, 2011, BRIT J PHARMACOL, V163, P346, DOI 10.1111/j.1476-5381.2011.01220.x	47	40	45	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25428	25439		10.1074/jbc.M113.482059	http://dx.doi.org/10.1074/jbc.M113.482059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846688	Green Published, hybrid			2022-12-25	WOS:000330619000039
J	Bosch, B; Berger, AC; Khandelwal, S; Heipertz, EL; Scharf, B; Santambrogio, L; Roche, PA				Bosch, Berta; Berger, Adam C.; Khandelwal, Sanjay; Heipertz, Erica L.; Scharf, Brian; Santambrogio, Laura; Roche, Paul A.			Disruption of Multivesicular Body Vesicles Does Not Affect Major Histocompatibility Complex (MHC) Class II-Peptide Complex Formation and Antigen Presentation by Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL HOMEOSTASIS; COMPARTMENTS; TRANSPORT; DISEASE; TRAFFICKING; MOLECULES; CLATHRIN; PATHWAY; BODIES; GENE	The antigen processing compartments in antigen-presenting cells (APCs) have well known characteristics of multivesicular bodies (MVBs). However, the importance of MVB integrity to APC function remains unknown. In this study, we have altered the ultrastructure of the MVB by perturbing cholesterol content genetically through the use of a deletion of the lipid transporter Niemann-Pick type C1 (NPC1). Immunofluorescence and electron microscopic analyses reveal that the antigen processing compartments in NPC1(-/-) dendritic cells (DCs) have an abnormal ultrastructure in that the organelles are enlarged and the intraluminal vesicles are almost completely absent and those remaining are completely disorganized. MHC-II is restricted to the limiting membrane of these enlarged MVBs where it colocalizes with the peptide editor H2-DM. Curiously, proteolytic removal of the chaperone protein Invariant chain from MHC-II, degradation of internalized foreign antigens, and antigenic-peptide binding to nascent MHC-II are normal in NPC1(-/-) DCs. Antigen-pulsed NPC1(-/-) DCs are able to effectively activate antigen-specific CD4 T cells in vitro, and immunization of NPC1(-/-) mice reveals surprisingly normal CD4 T cell activation in vivo. Our data thus reveal that the localization of MHC-II on the intraluminal vesicles of multivesicular antigen processing compartments is not required for efficient antigen presentation by DCs.	[Bosch, Berta; Berger, Adam C.; Khandelwal, Sanjay; Heipertz, Erica L.; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Scharf, Brian; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol Microbiol & Immunol, Bronx, NY 10461 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine	Roche, PA (corresponding author), NIH, Bldg 10,Rm 4B36, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC009404, ZIABC011033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health (to P. A. R.).	Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; DEMEL RA, 1965, J BIOL CHEM, V240, P2749; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Muntasell A, 2007, EMBO J, V26, P4263, DOI 10.1038/sj.emboj.7601842; Murk JL, 2002, SEMIN CELL DEV BIOL, V13, P303, DOI 10.1016/S1084952102000605; Poloso NJ, 2004, J IMMUNOL, V173, P4539, DOI 10.4049/jimmunol.173.7.4539; Potolicchio H, 2005, J IMMUNOL, V175, P4935, DOI 10.4049/jimmunol.175.8.4935; RODRIGUEZ GM, 1992, J IMMUNOL, V149, P2894; Stang E, 1998, J IMMUNOL, V160, P4696; STPIERRE Y, 1990, J IMMUNOL, V145, P812; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VANIER MT, 1991, DEV NEUROSCI-BASEL, V13, P307, DOI 10.1159/000112178; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Zhang JR, 2008, J CLIN INVEST, V118, P2281, DOI [10.1172/JCI32561, 10.1172/JC132561]; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	25	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24286	24292		10.1074/jbc.M113.461996	http://dx.doi.org/10.1074/jbc.M113.461996			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846690	Green Published, hybrid			2022-12-25	WOS:000330612300001
J	Mateyak, MK; Kinzy, TG				Mateyak, Maria K.; Kinzy, Terri Goss			ADP-ribosylation of Translation Elongation Factor 2 by Diphtheria Toxin in Yeast Inhibits Translation and Cell Separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FACTOR-II; PROTEIN-SYNTHESIS; RIBOSOMAL TRANSLOCASE; DIPHTHAMIDE; BIOSYNTHESIS; NUCLEOTIDE; RESISTANT; MUTANTS; TARGET	Eukaryotic translation elongation factor 2 (eEF2) facilitates the movement of the peptidyl tRNA-mRNA complex from the A site of the ribosome to the P site during protein synthesis. ADP-ribosylation (ADP(R)) of eEF2 by bacterial toxins on a unique diphthamide residue inhibits its translocation activity, but the mechanism is unclear. We have employed a hormone-inducible diphtheria toxin (DT) expression system in Saccharomyces cerevisiae which allows for the rapid induction of ADP(R)-eEF2 to examine the effects of DT in vivo. ADP(R) of eEF2 resulted in a decrease in total protein synthesis consistent with a defect in translation elongation. Association of eEF2 with polyribosomes, however, was unchanged upon expression of DT. Upon prolonged exposure to DT, cells with an abnormal morphology and increased DNA content accumulated. This observation was specific to DT expression and was not observed when translation elongation was inhibited by other methods. Examination of these cells by electron microscopy indicated a defect in cell separation following mitosis. These results suggest that expression of proteins late in the cell cycle is particularly sensitive to inhibition by ADP(R)-eEF2.	[Mateyak, Maria K.; Kinzy, Terri Goss] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes La, Piscataway, NJ 08854 USA.	kinzytg@rutgers.edu		Kinzy, Terri/0000-0003-1394-9226; Mateyak, Maria/0000-0003-0859-1901	National Institutes of Health [R21 AI076245]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health R21 AI076245.	Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Baladron V, 2002, EUKARYOT CELL, V1, P774, DOI 10.1128/EC.1.5.774-786.2002; BERMEK E, 1972, FEBS LETT, V23, P95, DOI 10.1016/0014-5793(72)80293-X; BERMEK E, 1976, J BIOL CHEM, V251, P6544; BURKE DJ, 1991, MOL CELL BIOL, V11, P3691, DOI 10.1128/MCB.11.7.3691; BURNS G, 1986, FEBS LETT, V208, P217, DOI 10.1016/0014-5793(86)81021-3; Chen J, 2012, CURR OPIN STRUC BIOL, V22, P804, DOI 10.1016/j.sbi.2012.09.004; CHEN JYC, 1985, MOL CELL BIOL, V5, P3357, DOI 10.1128/MCB.5.12.3357; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; DAVYDOVA EK, 1990, FEBS LETT, V261, P350, DOI 10.1016/0014-5793(90)80589-B; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; DUNLOP PC, 1983, J BIOL CHEM, V258, P4754; Esposito A. M., 2010, J VIS EXP, V15, P1948; Esposito AM, 2010, J BIOL CHEM, V285, P37995, DOI 10.1074/jbc.M110.160887; Falnes PO, 2000, J BIOL CHEM, V275, P4363, DOI 10.1074/jbc.275.6.4363; FENDRICK JL, 1989, P NATL ACAD SCI USA, V86, P554, DOI 10.1073/pnas.86.2.554; FOLEY BT, 1995, J BIOL CHEM, V270, P23218, DOI 10.1074/jbc.270.39.23218; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Jorgensen R, 2004, J BIOL CHEM, V279, P45919, DOI 10.1074/jbc.M406218200; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; KIMATA Y, 1994, J BIOL CHEM, V269, P13497; LEE H, 1984, P NATL ACAD SCI-BIOL, V81, P2703, DOI 10.1073/pnas.81.9.2703; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Liu SH, 2012, P NATL ACAD SCI USA, V109, P13817, DOI 10.1073/pnas.1206933109; MARZOUKI A, 1989, FEBS LETT, V255, P72, DOI 10.1016/0014-5793(89)81063-4; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; McIsaac RS, 2011, MOL BIOL CELL, V22, P4447, DOI 10.1091/mbc.E11-05-0466; Meitinger F, 2012, CELL CYCLE, V11, P219, DOI 10.4161/cc.11.2.18857; MOEHRING TJ, 1984, MOL CELL BIOL, V4, P642, DOI 10.1128/MCB.4.4.642; MONTANARO L, 1976, BIOCHEM J, V156, P15, DOI 10.1042/bj1560015; MONTANARO L, 1971, BIOCHIM BIOPHYS ACTA, V238, P493, DOI 10.1016/0005-2787(71)90628-9; MURAKAMI S, 1982, MOL CELL BIOL, V2, P588, DOI 10.1128/MCB.2.5.588; NYGARD O, 1990, J BIOL CHEM, V265, P6030; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; PHAN LD, 1993, J BIOL CHEM, V268, P8665; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Uthman S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003334; Valente L, 2003, CELL MOL LIFE SCI, V60, P2115, DOI 10.1007/s00018-003-2334-2; VANNESS BG, 1980, J BIOL CHEM, V255, P717; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	51	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24647	24655		10.1074/jbc.M113.488783	http://dx.doi.org/10.1074/jbc.M113.488783			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853096	Green Published, hybrid			2022-12-25	WOS:000330612300032
J	Ananthakrishnan, R; Kumar, K; Ganesh, M; Kumar, AMV; Krishnan, N; Swaminathan, S; Edginton, M; Arunagiri, K; Gupta, D				Ananthakrishnan, Ramya; Kumar, Kaliyaperumal; Ganesh, Marimuthu; Kumar, Ajay M. V.; Krishnan, Nalini; Swaminathan, Sowmya; Edginton, Mary; Arunagiri, K.; Gupta, Devesh			The Profile and Treatment Outcomes of the Older (Aged 60 Years and Above) Tuberculosis Patients in Tamilnadu, South India	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PREVALENCE	Background: With changing demographic patterns in the context of a high tuberculosis (TB) burden country, like India, there is very little information on the clinical and demographic factors associated with poor treatment outcome in the sub-group of older TB patients. The study aimed to assess the proportion of older TB patients (60 years of age and more), to compare the type of TB and treatment outcomes between older TB patients and other TB patients (less than 60 years of age) and to describe the demographic and clinical characteristics of older TB patients and assess any associations with TB treatment outcomes. Methods: A retrospective cohort study involving a review of records from April to June 2011 in the 12 selected districts of Tamilnadu, India. Demographic, clinical and WHO defined disease classifications and treatment outcomes of all TB patients aged 60 years and above were extracted from TB registers maintained routinely by Revised National TB Control Program (RNTCP). Results: Older TB patients accounted for 14% of all TB patients, of whom 47% were new sputum positive. They had 38% higher risk of unfavourable treatment outcomes as compared to all other TB patients (Relative risk (RR)-1.4, 95% CI 1.2-1.6). Among older TB patients, the risk for unfavourable treatment outcomes was higher for those aged 70 years and more (RR 1.5, 95% CI 1.2-1.9), males (RR 1.5, 95% CI 1.0-2.1), re-treatment patients (RR 2.5, 95% CI 1.9-3.2) and those who received community-based Direct Observed Treatment (RR 1.4, 95% CI 1.1-1.9). Conclusion: Treatment outcomes were poor in older TB patients warranting special attention to this group - including routine assessment and recording of co-morbidities, a dedicated recording, reporting and monitoring of outcomes for this age-group and collaboration with National programme of non-communicable diseases for comprehensive management of co-morbidities.	[Ananthakrishnan, Ramya; Kumar, Kaliyaperumal; Ganesh, Marimuthu; Krishnan, Nalini] REACH, Madras, Tamil Nadu, India; [Kumar, Ajay M. V.] Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India; [Swaminathan, Sowmya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Edginton, Mary] Int Union TB & Lung Dis Union, Paris, France; [Arunagiri, K.] State TB Off, Madras, Tamil Nadu, India; [Gupta, Devesh] Govt India, Cent TB Div, Minist Hlth & Family Welf, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Ananthakrishnan, R (corresponding author), REACH, Madras, Tamil Nadu, India.	ramyardr@gmail.com		Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Operational Research by Centre for Operational Research, International Union Against Tuberculosis and Lung Disease; Union South-East Asia Office, New Delhi, India; Operational Research Unit, Medecins sans Frontieres, Brussels Operational Center, Luxembourg; Department for International Development, UK	Operational Research by Centre for Operational Research, International Union Against Tuberculosis and Lung Disease; Union South-East Asia Office, New Delhi, India; Operational Research Unit, Medecins sans Frontieres, Brussels Operational Center, Luxembourg; Department for International Development, UK	This research was supported through an Operational Research by Centre for Operational Research, International Union Against Tuberculosis and Lung Disease; The Union South-East Asia Office, New Delhi, India; the Operational Research Unit, Medecins sans Frontieres, Brussels Operational Center, Luxembourg. Funding for this course came from an anonymous donor and the Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora V K, 2003, Indian J Chest Dis Allied Sci, V45, P231; Balakrishnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046502; Bhushan B, 2012, INT J TUBERC LUNG D, V16, P1210, DOI 10.5588/ijtld.11.0778; Central TB Division, 2011, RNTCP PERF REP IND 2; Central Tuberculosis Division, 2012, TUB IND 2012 ANN REP; Chan-Yeung M, 2002, INT J TUBERC LUNG D, V6, P771; Gaur S. N., 2004, Indian Journal of Tuberculosis, V51, P83; Geeta Pardeshi, 2007, Indian Journal of Community Medicine, V32, P292; Gholamali G., 2007, Journal of Medical Sciences (Pakistan), V7, P888; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Leung CC, 2002, J AM GERIATR SOC, V50, P1219, DOI 10.1046/j.1532-5415.2002.50308.x; Monthly Bulletin on Family Welfare Directorate of Family welfare Tamil Nadu, 2006, MONTHL B FAM WELF DI; MORRIS CDW, 1990, THORAX, V45, P912, DOI 10.1136/thx.45.12.912; Mukherjee A, 2008, J INDIAN ACAD GERIAT, V4, P60; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; Registrar General and Census Commissioner, 2012, ANN HLTH SURV 2010 1; Sood R, 2000, J INDIAN ACAD CLIN M, V5, P156; Subramani R, 2008, INT J TUBERC LUNG D, V12, P916; Toure NO, 2010, REV MAL RESPIR, V27, P1062, DOI 10.1016/j.rmr.2010.04.017; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	23	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67288	10.1371/journal.pone.0067288	http://dx.doi.org/10.1371/journal.pone.0067288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861755	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000321692000007
J	Sanyal, T; Kumar, V; Nag, TC; Jain, S; Sreenivas, V; Wadhwa, S				Sanyal, Tania; Kumar, Vivek; Nag, Tapas Chandra; Jain, Suman; Sreenivas, Vishnu; Wadhwa, Shashi			Prenatal Loud Music and Noise: Differential Impact on Physiological Arousal, Hippocampal Synaptogenesis and Spatial Behavior in One Day-Old Chicks	PLOS ONE			English	Article							BRAIN NOREPINEPHRINE CONCENTRATIONS; PROTEIN-PROTEIN INTERACTIONS; COMPLEX RHYTHM STIMULUS; LONG-TERM POTENTIATION; PIGEON COLUMBA-LIVIA; MEMORY CONSOLIDATION; POSTSYNAPTIC DENSITY; ALZHEIMERS-DISEASE; RESTRAINT STRESS; MEMBRANE-PROTEIN	Prenatal auditory stimulation in chicks with species-specific sound and music at 65 dB facilitates spatial orientation and learning and is associated with significant morphological and biochemical changes in the hippocampus and brainstem auditory nuclei. Increased noradrenaline level due to physiological arousal is suggested as a possible mediator for the observed beneficial effects following patterned and rhythmic sound exposure. However, studies regarding the effects of prenatal high decibel sound (110 dB; music and noise) exposure on the plasma noradrenaline level, synaptic protein expression in the hippocampus and spatial behavior of neonatal chicks remained unexplored. Here, we report that high decibel music stimulation moderately increases plasma noradrenaline level and positively modulates spatial orientation, learning and memory of one day-old chicks. In contrast, noise at the same sound pressure level results in excessive increase of plasma noradrenaline level and impairs the spatial behavior. Further, to assess the changes at the molecular level, we have quantified the expression of functional synapse markers: synaptophysin and PSD-95 in the hippocampus. Compared to the controls, both proteins show significantly increased expressions in the music stimulated group but decrease in expressions in the noise group. We propose that the differential increase of plasma noradrenaline level and altered expression of synaptic proteins in the hippocampus are responsible for the observed behavioral consequences following prenatal 110 dB music and noise stimulation.	[Sanyal, Tania; Kumar, Vivek; Nag, Tapas Chandra; Wadhwa, Shashi] All India Inst Med Sci, Dept Anat, New Delhi 110029, India; [Jain, Suman] All India Inst Med Sci, Dept Physiol, New Delhi, India; [Sreenivas, Vishnu] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Wadhwa, S (corresponding author), All India Inst Med Sci, Dept Anat, New Delhi 110029, India.	shashiwadhwa@hotmail.com	NAG, TAPAS CHANDRA/R-6285-2019; KUMAR, VIVEK/AAE-7170-2021	NAG, TAPAS CHANDRA/0000-0002-6962-0844; KUMAR, VIVEK/0000-0002-5897-4495	Department of Biotechnology, Goverment of India [BT/PR10651/Med/30/102/2008]; Department of Biotechnology, Goverment of India [BT/PR10651/Med/30/102/2008]	Department of Biotechnology, Goverment of India; Department of Biotechnology, Goverment of India	This work was supported by the Department of Biotechnology, Goverment of India, grant number: BT/PR10651/Med/30/102/2008. (URL 1: http://dbtneuro.ncbs.res.in/node/12; URL 2: http://dbtindia.nic.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2011, EXP GERONTOL, V46, P53, DOI 10.1016/j.exger.2010.10.001; ALDRIDGE D, 1994, BIOMED PHARMACOTHER, V48, P275, DOI 10.1016/0753-3322(94)90172-4; Azmi S, 2000, TUMOR BIOL, V21, P3, DOI 10.1159/000030105; Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; BERGMANN M, 1993, DEV BRAIN RES, V74, P235, DOI 10.1016/0165-3806(93)90009-Y; Bisagno V, 2004, PHARMACOL BIOCHEM BE, V78, P541, DOI 10.1016/j.pbb.2004.04.023; Bowman RE, 2001, BRAIN RES, V904, P279, DOI 10.1016/S0006-8993(01)02474-X; Braun K, 1999, BEHAV BRAIN RES, V98, P211, DOI 10.1016/S0166-4328(98)00086-2; BURESOVA O, 1964, PHYSIOL BOHEMOSLOV, V13, P220; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Calakos N, 1996, PHYSIOL REV, V76, P1; Calhoun ME, 1998, NEUROBIOL AGING, V19, P599, DOI 10.1016/S0197-4580(98)00098-0; CASINI G, 1986, J COMP NEUROL, V245, P454, DOI 10.1002/cne.902450403; Chaudhury S, 2008, BRAIN RES, V1191, P96, DOI 10.1016/j.brainres.2007.11.021; Chaudhury S, 2010, DEV NEUROSCI-BASEL, V32, P114, DOI 10.1159/000279758; Chaudhury S, 2009, SYNAPSE, V63, P152, DOI 10.1002/syn.20585; Chaudhury S, 2006, J CHEM NEUROANAT, V32, P117, DOI 10.1016/j.jchemneu.2006.07.002; CHEN KS, 1995, NEUROSCIENCE, V68, P19, DOI 10.1016/0306-4522(95)00099-5; Chikahisa S, 2006, BEHAV BRAIN RES, V169, P312, DOI 10.1016/j.bbr.2006.01.021; COHEN GM, 1978, ACTA OTO-LARYNGOL, V86, P342, DOI 10.3109/00016487809124756; COLL CG, 1984, CHILD DEV, V55, P1005, DOI 10.2307/1130152; COLLIAS N, 1953, BEHAVIOUR, V5, P175, DOI 10.1163/156853953X00104; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; De Wied D, 1991, Methods Achiev Exp Pathol, V15, P167; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Dehnhard N, 2011, J COMP PHYSIOL B, V181, P83, DOI 10.1007/s00360-010-0508-4; Del Giudice M, 2011, DEV PSYCHOBIOL, V53, P214, DOI 10.1002/dev.20506; Dhabhar FS, 1997, NEUROENDOCRINOLOGY, V65, P360, DOI 10.1159/000127196; Di Marco S, 2009, J NEUROSCI, V29, P13691, DOI 10.1523/JNEUROSCI.3854-09.2009; DMITRIEVA LP, 1994, BEHAV NEURAL BIOL, V61, P19, DOI 10.1016/S0163-1047(05)80040-8; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Feltenstein MW, 2003, PHYSIOL BEHAV, V78, P489, DOI 10.1016/S0031-9384(03)00030-1; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Field SE, 2007, NEUROBIOL LEARN MEM, V88, P321, DOI 10.1016/j.nlm.2007.04.001; Frick KM, 2003, NEUROBIOL AGING, V24, P615, DOI 10.1016/S0197-4580(02)00138-0; Gibbs ME, 2001, EUR J NEUROSCI, V14, P1369, DOI 10.1046/j.0953-816x.2001.01742.x; Gibbs ME, 2000, NEUROSCIENCE, V95, P913; GILBERT DB, 1989, PHARMACOL BIOCHEM BE, V34, P439, DOI 10.1016/0091-3057(89)90340-7; GOLD PE, 1978, BEHAV BIOL, V24, P168, DOI 10.1016/S0091-6773(78)93045-6; GOLD PE, 1978, BEHAV BIOL, V23, P509, DOI 10.1016/S0091-6773(78)91614-0; GOTTLIEB G, 1978, J COMP PHYSIOL PSYCH, V92, P375, DOI 10.1037/h0077473; GRABS D, 1994, EUR J NEUROSCI, V6, P1765, DOI 10.1111/j.1460-9568.1994.tb00569.x; Griefahn B, 1986, NOISE POLLUTION EFFE, P265; HORNE JA, 1994, SLEEP, V17, P146, DOI 10.1093/sleep/17.2.146; HOSKINS C, 1988, J MUSIC THER, V25, P73, DOI 10.1093/jmt/25.2.73; Hunt CA, 1996, J NEUROSCI, V16, P1380; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Jain Suman, 2004, Indian Journal of Physiology and Pharmacology, V48, P174; Johnson JK, 1998, NEUROL RES, V20, P666; Jones TA, 2006, J NEUROPHYSIOL, V96, P128, DOI 10.1152/jn.00599.2005; Kagan J, 1999, BIOL PSYCHIAT, V46, P1536, DOI 10.1016/S0006-3223(99)00137-7; Kauser H, 2011, DEV NEUROSCI-BASEL, V33, P48, DOI 10.1159/000322449; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim H, 2006, BRAIN DEV-JPN, V28, P109, DOI 10.1016/j.braindev.2005.05.008; Kohl Z, 2002, GENES BRAIN BEHAV, V1, P46, DOI 10.1046/j.1601-1848.2001.00009.x; KUGLER J, 1990, INT J NEUROSCI, V51, P233, DOI 10.3109/00207459008999705; Lazic M, 2007, DEV PSYCHOBIOL, V49, P548, DOI 10.1002/dev.20230; Leventhall H G, 2004, Noise Health, V6, P59; Lewis TL, 2009, OPTOMETRY VISION SCI, V86, P640, DOI 10.1097/OPX.0b013e3181a7296b; LICKLITER R, 1992, Q J EXP PSYCHOL-B, V44B, P199; Liu XY, 1996, DEMENTIA, V7, P128, DOI 10.1159/000106867; LORD TR, 1993, PERCEPT MOTOR SKILL, V76, P451, DOI 10.2466/pms.1993.76.2.451; Manire CA, 2007, COMP BIOCHEM PHYS A, V148, P926, DOI 10.1016/j.cbpa.2007.09.017; MCGAUGH JL, 1983, ANNU REV PSYCHOL, V34, P297, DOI 10.1146/annurev.ps.34.020183.001501; Men DS, 1999, NEUROBIOL LEARN MEM, V71, P289, DOI 10.1006/nlme.1998.3880; Metzger M, 1998, J COMP NEUROL, V395, P380; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MOCKEL M, 1994, EUR J APPL PHYSIOL, V68, P451, DOI 10.1007/BF00599512; MORTON LL, 1990, J MUSIC THER, V27, P195, DOI 10.1093/jmt/27.4.195; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; PORTER D, 1984, J EXP PSYCHOL ANIM B, V10, P138; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; QUERLEU D, 1984, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V13, P125; Quirarte GL, 1998, BRAIN RES, V808, P134, DOI 10.1016/S0006-8993(98)00795-1; Rabinowitz PM, 2000, AM FAM PHYSICIAN, V61, P2749; Rao S, 1999, NIMBUS RECORDS ROTTE; Rauscher FH, 1997, NEUROL RES, V19, P2; Reznick JS, 1989, PERSPECTIVES BEHAV I, P17; RIBATTI D, 1993, ANN ANAT, V175, P85; Rickard NS, 2009, J COMP PSYCHOL, V123, P217, DOI 10.1037/a0015117; Rogers L. J., 1995, DEV BRAIN BEHAV CHIC; Rogers LJ, 2008, BRAIN RES BULL, V76, P235, DOI 10.1016/j.brainresbull.2008.02.001; ROGERS LJ, 1990, BEHAV BRAIN RES, V38, P211, DOI 10.1016/0166-4328(90)90176-F; ROGERS LJ, 1982, NATURE, V297, P223, DOI 10.1038/297223a0; ROGERS LJ, 1991, NEUROSCI LETT, V121, P63, DOI 10.1016/0304-3940(91)90650-I; Ross JC, 2012, P 2 COMPMUSIC WORKSH, P133; SAITO S, 1994, J NEUROSCI RES, V39, P57, DOI 10.1002/jnr.490390108; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; SCHRECKENBERG G M, 1987, Bulletin New Jersey Academy of Science, V32, P77; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Sleigh MJ, 1996, J COMP PSYCHOL, V110, P233, DOI 10.1037/0735-7036.110.3.233; Smith TD, 2000, J NEUROSCI, V20, P6587, DOI 10.1523/JNEUROSCI.20-17-06587.2000; Stillman MJ, 1998, PHYSIOL BEHAV, V64, P605, DOI 10.1016/S0031-9384(98)00091-2; Strasser R, 1997, BEHAV NEUROSCI, V111, P1245, DOI 10.1037/0735-7044.111.6.1245; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Toukhsati SR, 2005, BEHAV BRAIN RES, V159, P105, DOI 10.1016/j.bbr.2004.10.007; Toukhsati SR, 2004, J COMP PSYCHOL, V118, P65, DOI 10.1037/0735-7036.118.1.65; Toukhsati SR, 2001, J COMP PSYCHOL, V115, P132, DOI 10.1037/0735-7036.115.2.132; TSAI HM, 1981, J COMP NEUROL, V198, P275, DOI 10.1002/cne.901980207; Vickers CA, 2006, BRAIN RES, V1090, P89, DOI 10.1016/j.brainres.2006.03.075; Volman SF, 1997, BRAIN BEHAV EVOLUT, V49, P110, DOI 10.1159/000112985; Wadhwa S, 1999, INT J DEV NEUROSCI, V17, P239, DOI 10.1016/S0736-5748(99)00005-2; Watanabe S, 1999, BEHAV PROCESS, V47, P53, DOI 10.1016/S0376-6357(99)00049-2; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WILD JM, 1993, J COMP NEUROL, V337, P32; Xu HY, 2004, J NEUROCHEM, V91, P1380, DOI 10.1111/j.1471-4159.2004.02827.x; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Zuckerman M, 1991, PSYCHOBIOLOGY PERSON, P408; [No title captured], DOI DOI 10.12697/SSS.2009.37.3-4.03	117	30	33	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67347	10.1371/journal.pone.0067347	http://dx.doi.org/10.1371/journal.pone.0067347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861759	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300012
J	Bondzio, A; Lodemann, U; Weise, C; Einspanier, R				Bondzio, Angelika; Lodemann, Ulrike; Weise, Christoph; Einspanier, Ralf			Cry1Ab Treatment Has No Effects on Viability of Cultured Porcine Intestinal Cells, but Triggers Hsp70 Expression	PLOS ONE			English	Article							THURINGIENSIS TOXIN CRY1AB; GENETICALLY-MODIFIED MAIZE; HEAT-SHOCK RESPONSE; BACILLUS-THURINGIENSIS; EPITHELIAL-CELLS; IN-VITRO; MOLECULAR CHAPERONES; IMMUNE-RESPONSE; HNRNP K; HEAT-SHOCK-PROTEIN-70	In vitro testing can contribute to reduce the risk that the use of genetically modified (GM) crops and their proteins show unintended toxic effects. Here we introduce a porcine intestinal cell culture (IPEC-J2) as appropriate in vitro model and tested the possible toxic potential of Cry1Ab protein, commonly expressed in GM-maize. For comprehensive risk assessment we used WST-1 conversion and ATP content as metabolic markers for proliferation, lactate dehydrogenase release as indicator for cells with compromised membrane and transepithelial electrical resistance as parameter indicating membrane barrier function. The results were compared to the effects of valinomycin, a potassium ionophore, known to induce cytotoxic effects in most mammalian cell types. Whereas no toxicity was observed after Cry1Ab treatment, valinomycin induced a decrease in IPEC-J2 viability. This was confirmed by dynamic monitoring of cellular responses. Additionally, two dimensional differential in-gel electrophoresis was performed. Only three proteins were differentially expressed. The functions of these proteins were associated with responses to stress. The up-regulation of heat shock protein Hsp70 was verified by Western blotting as well as by enzyme-linked immunosorbent assay and may be related to a protective function. These findings suggest that the combination of in vitro testing and proteomic analysis may serve as a promising tool for mechanism based safety assessment.	[Bondzio, Angelika; Einspanier, Ralf] Free Univ Berlin, Inst Vet Biochem, Berlin, Germany; [Lodemann, Ulrike] Free Univ Berlin, Inst Vet Physiol, Berlin, Germany; [Weise, Christoph] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Free University of Berlin; Free University of Berlin; Free University of Berlin	Bondzio, A (corresponding author), Free Univ Berlin, Inst Vet Biochem, Berlin, Germany.	bondzio@zedat.fu-berlin.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 852/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) through grant SFB 852/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi R, 2013, PHARMACOLOGY, V91, P104, DOI 10.1159/000345930; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Bendiek J., 2006, Journal fuer Verbraucherschutz und Lebensmittelsicherheit/Journal of Consumer Protection and Food Safety, V1, P241, DOI 10.1007/s00003-006-0041-2; Bolkent S, 2002, TOXICOL IN VITRO, V16, P159, DOI 10.1016/S0887-2333(01)00108-4; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Bondzio A, 2008, FOOD CHEM TOXICOL, V46, P1976, DOI 10.1016/j.fct.2008.01.038; Cencic A, 2010, INT J FOOD MICROBIOL, V141, pS4, DOI 10.1016/j.ijfoodmicro.2010.03.026; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chowdhury EH, 2003, VET HUM TOXICOL, V45, P72; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; de Vendomois JS, 2009, INT J BIOL SCI, V5, P706; Devriendt B, 2010, DEV COMP IMMUNOL, V34, P1175, DOI 10.1016/j.dci.2010.06.009; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; EFSA, 2008, FOOD CHEM TOXICOL, V46, P2, DOI DOI 10.1016/J.FCT.2008.02.008; EFSA (European Food Safety Agency), 2010, EFSA J, V8, P1699; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heinemann JA, 2011, ENVIRON INT, V37, P1285, DOI 10.1016/j.envint.2011.05.006; Hirata I, 2009, DIGESTION, V79, P243, DOI 10.1159/000215352; Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P143; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Hug K, 2008, MEDICINA-LITHUANIA, V44, P87, DOI 10.3390/medicina44020012; Inai Y, 1997, CELL STRUCT FUNCT, V22, P555, DOI 10.1247/csf.22.555; JEHLE JA, 2007, PRODUCTION BT TOXIN; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kilic A, 2008, FOOD CHEM TOXICOL, V46, P1164, DOI 10.1016/j.fct.2007.11.016; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Laubitz D, 2006, EXP PHYSIOL, V91, P867, DOI 10.1113/expphysiol.2006.033365; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; Liang P, 1997, J CELL SCI, V110, P1431; Luber-Narod J, 2001, TOXICOL IN VITRO, V15, P571, DOI 10.1016/S0887-2333(01)00067-4; Ludwig D, 1999, DIGEST DIS SCI, V44, P1440, DOI 10.1023/A:1026616221950; Lutz B, 2005, J AGR FOOD CHEM, V53, P1453, DOI 10.1021/jf049222x; Marques-Santos LF, 2006, CELL BIOL INT, V30, P197, DOI 10.1016/j.cellbi.2005.10.021; Mesnage R, 2013, J APPL TOXICOL, V33, P695, DOI 10.1002/jat.2712; Mukhopadhyay I, 2003, J BIOCHEM MOL TOXIC, V17, P249, DOI 10.1002/jbt.10086; Musch MW, 1996, AM J PHYSIOL-CELL PH, V270, pC429, DOI 10.1152/ajpcell.1996.270.2.C429; Nguyen Thu Hang, 2004, IOBC-WPRS Bulletin, V27, P125; Niles Andrew L, 2009, Curr Chem Genomics, V3, P33, DOI 10.2174/1875397300903010033; Nunez-Valdez ME, 2001, BBA-PROTEIN STRUCT M, V1546, P122, DOI 10.1016/S0167-4838(01)00132-7; Omary M B, 1998, Subcell Biochem, V31, P105; Paul V, 2010, TRANSGENIC RES, V19, P683, DOI 10.1007/s11248-009-9339-z; Phipps RH, 2003, J DAIRY SCI, V86, P4070, DOI 10.3168/jds.S0022-0302(03)74019-3; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Ryoo IJ, 2006, BIOL PHARM BULL, V29, P817, DOI 10.1248/bpb.29.817; Sagstad A, 2007, J FISH DIS, V30, P201, DOI 10.1111/j.1365-2761.2007.00808.x; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Shi HJ, 2011, J PROTEOMICS, V75, P339, DOI 10.1016/j.jprot.2011.07.025; Shimada N, 2003, J VET MED SCI, V65, P187, DOI 10.1292/jvms.65.187; Starsichova A, 2009, BIOL PROCED ONLINE, V11, P316, DOI 10.1007/s12575-009-9017-9; Stumpff F, 2007, J MEMBRANE BIOL, V219, P37, DOI 10.1007/s00232-007-9059-3; Su CY, 1998, J MOL CELL CARDIOL, V30, P587, DOI 10.1006/jmcc.1997.0622; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007; Vistejnova L, 2009, NEUROENDOCRINOL LETT, V30, P121; von Kries C, 2012, BIOTECHNOL J, V7, P569, DOI 10.1002/biot.201100321; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Zhong X, 2012, CELL STRESS CHAPERON, V17, P495, DOI 10.1007/s12192-012-0326-6	65	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67079	10.1371/journal.pone.0067079	http://dx.doi.org/10.1371/journal.pone.0067079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861753	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700009
J	Kenny, JG; Moran, J; Kolar, SL; Ulanov, A; Li, Z; Shaw, LN; Josefsson, E; Horsburgh, MJ				Kenny, John G.; Moran, Josephine; Kolar, Stacey L.; Ulanov, Alexander; Li, Zhong; Shaw, Lindsey N.; Josefsson, Elisabet; Horsburgh, Malcolm J.			Mannitol Utilisation is Required for Protection of Staphylococcus aureus from Human Skin Antimicrobial Fatty Acids	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ANTIBACTERIAL ACTIVITY; STRESS RESISTANCE; OXIDATIVE STRESS; IN-VIVO; VIRULENCE; EXPRESSION; LIPIDS; STARVATION; ABSCESSES	Mannitol (Mtl) fermentation, with the subsequent production of acid, is a species signature of Staphylococcus aureus, and discriminates it from most other members of the genus. Inactivation of the gene mtlD, encoding Mtl-1-P dehydrogenase was found to markedly reduce survival in the presence of the antimicrobial fatty acid, linoleic acid. We demonstrate that the sugar alcohol has a potentiating action for this membrane-acting antimicrobial. Analysis of cellular metabolites revealed that, during exponential growth, the mtlD mutant accumulated high levels of Mtl and Mtl-P. The latter metabolite was not detected in its isogenic parent strain or a deletion mutant of the entire mtlABFD operon. In addition, the mtlD mutant strain exhibited a decreased MIC for H2O2, however virulence was unaffected in a model of septic arthritis.	[Kenny, John G.; Moran, Josephine; Horsburgh, Malcolm J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Kolar, Stacey L.; Shaw, Lindsey N.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL USA; [Ulanov, Alexander; Li, Zhong] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA; [Josefsson, Elisabet] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	University of Liverpool; State University System of Florida; University of South Florida; University of Illinois System; University of Illinois Urbana-Champaign; University of Gothenburg	Horsburgh, MJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	M.J.Horsburgh@liverpool.ac.uk	Horsburgh, Malcolm J/H-9657-2013; Kenny, John/HCI-1952-2022; Shaw, Lindsey/AAI-1741-2020	Kenny, John/0000-0003-2994-6169; Shaw, Lindsey/0000-0002-0629-8990; Moran, Josephine/0000-0002-8278-9548	BBSRC grant [BB/D003563/1]; National Institute of Allergies and Infectious Diseases [AI090350]; BBSRC [BB/D003563/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D003563/1, 975395] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090350, R01AI080626] Funding Source: NIH RePORTER	BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Allergies and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by BBSRC grant BB/D003563/1 (MJH) and in part AI090350 (LNS) from the National Institute of Allergies and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI MNA, 1970, LIPIDS, V5, P838, DOI 10.1007/BF02531977; Bergsson G, 2001, APMIS, V109, P670, DOI 10.1034/j.1600-0463.2001.d01-131.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; CAMPBELL IM, 1983, J CLIN MICROBIOL, V18, P408, DOI 10.1128/JCM.18.2.408-415.1983; Chaturvedi V, 1997, J BACTERIOL, V179, P157, DOI 10.1128/jb.179.1.157-162.1997; Chiang YJ, 2005, J AM SOC HORTIC SCI, V130, P605, DOI 10.21273/JASHS.130.4.605; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Dawe AL, 2009, MICROBIOL-SGM, V155, P3913, DOI 10.1099/mic.0.029033-0; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; DYE ES, 1981, INFECT IMMUN, V32, P98, DOI 10.1128/IAI.32.1.98-104.1981; EDWARDS KG, 1981, J BACTERIOL, V146, P1020, DOI 10.1128/JB.146.3.1020-1029.1981; ENGLER HD, 1992, J MED MICROBIOL, V37, P238, DOI 10.1099/00222615-37-4-238; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; GALBRAITH H, 1973, J APPL BACTERIOL, V36, P659, DOI 10.1111/j.1365-2672.1973.tb04151.x; GALBRAITH H, 1973, J APPL BACTERIOL, V36, P647, DOI 10.1111/j.1365-2672.1973.tb04150.x; GALBRAITH H, 1973, J APPL BACTERIOL, V36, P635, DOI 10.1111/j.1365-2672.1973.tb04149.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233, DOI 10.1099/00221287-115-1-233; Grkovic S, 2003, MICROBIOL-SGM, V149, P785, DOI 10.1099/mic.0.25951-0; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Horsburgh MJ, 2004, INFECT IMMUN, V72, P3073, DOI 10.1128/IAI.72.5.3073-3076.2004; Horsburgh MJ, 2001, MICROBIOL-SGM, V147, P2933, DOI 10.1099/00221287-147-11-2933; Josefsson E, 2008, MICROB PATHOGENESIS, V44, P103, DOI 10.1016/j.micpath.2007.08.010; Kelsey JA, 2006, LIPIDS, V41, P951, DOI 10.1007/s11745-006-5048-z; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; Kohler T, 2009, J BACTERIOL, V191, P4482, DOI 10.1128/JB.00221-09; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Massey RC, 2006, NAT REV MICROBIOL, V4, P953, DOI 10.1038/nrmicro1551; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; NIEMAN C, 1954, BACTERIOL REV, V18, P147, DOI 10.1128/MMBR.18.2.147-163.1954; Pappas A, 2002, J INVEST DERMATOL, V118, P164, DOI 10.1046/j.0022-202x.2001.01612.x; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; SAIER MH, 1976, J BIOL CHEM, V251, P3834; Solomon PS, 2007, TRENDS MICROBIOL, V15, P257, DOI 10.1016/j.tim.2007.04.002; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Watanabe S, 2003, J BACTERIOL, V185, P4816, DOI 10.1128/JB.185.16.4816-4824.2003; Watson SP, 1998, J BACTERIOL, V180, P1750, DOI 10.1128/JB.180.7.1750-1758.1998; Wisselink HW, 2005, APPL ENVIRON MICROB, V71, P1507, DOI 10.1128/AEM.71.3.1507-1514.2005; Won SR, 2007, FEBS LETT, V581, P4999, DOI 10.1016/j.febslet.2007.09.045; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028	46	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67698	10.1371/journal.pone.0067698	http://dx.doi.org/10.1371/journal.pone.0067698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861785	Green Submitted, gold, Green Published			2022-12-25	WOS:000323350700024
J	Bastos, RG; Suarez, CE; Laughery, JM; Johnson, WC; Ueti, MW; Knowles, DP				Bastos, Reginaldo G.; Suarez, Carlos E.; Laughery, Jacob M.; Johnson, Wendell C.; Ueti, Massaro W.; Knowles, Donald P.			Differential Expression of Three Members of the Multidomain Adhesion CCp Family in Babesia bigemina, Babesia bovis and Theileria equi	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; IN-VITRO; SEXUAL DEVELOPMENT; GENOME-SEQUENCE; PROTEIN; GENES; TRANSMISSION; PARASITES; MALARIA; MIDGUT	Members of the CCp protein family have been previously described to be expressed on gametocytes of apicomplexan Plasmodium parasites. Knocking out Plasmodium CCp genes blocks the development of the parasite in the mosquito vector, making the CCp proteins potential targets for the development of a transmission-blocking vaccine. Apicomplexans Babesia bovis and Babesia bigemina are the causative agents of bovine babesiosis, and apicomplexan Theileria equi causes equine piroplasmosis. Bovine babesiosis and equine piroplasmosis are the most economically important parasite diseases that affect worldwide cattle and equine industries, respectively. The recent sequencing of the B. bovis and T. equi genomes has provided the opportunity to identify novel genes involved in parasite biology. Here we characterize three members of the CCp family, named CCp1, CCp2 and CCp3, in B. bigemina, B. bovis and T. equi. Using B. bigemina as an in vitro model, expression of all three CCp genes and proteins was demonstrated in temperature-induced sexual stages. Transcripts for all three CCp genes were found in vivo in blood stages of T. equi, and transcripts for CCp3 were detected in vivo in blood stages of B. bovis. However, no protein expression was detected in T. equi blood stages or B. bovis blood stages or B. bovis tick stages. Collectively, the data demonstrated a differential pattern of expression of three orthologous genes of the multidomain adhesion CCp family by B. bigemina, B. bovis and T. equi. The novel CCp members represent potential targets for innovative approaches to control bovine babesiosis and equine piroplasmosis.	[Bastos, Reginaldo G.; Laughery, Jacob M.; Knowles, Donald P.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Suarez, Carlos E.; Johnson, Wendell C.; Ueti, Massaro W.; Knowles, Donald P.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA	Washington State University; United States Department of Agriculture (USDA)	Bastos, RG (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	rgbastos@vetmed.wsu.edu			USDA-ARS (United States Department of Agriculture - Agricultural Research Service) CRIS project	USDA-ARS (United States Department of Agriculture - Agricultural Research Service) CRIS project	This work was supported by USDA-ARS (United States Department of Agriculture - Agricultural Research Service) CRIS project number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos RG, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-57; Becker CAM, 2010, MOL BIOCHEM PARASIT, V174, P36, DOI 10.1016/j.molbiopara.2010.06.011; Becker CAM, 2013, EXP PARASITOL, V133, P51, DOI 10.1016/j.exppara.2012.10.007; Bishop R, 2004, PARASITOLOGY, V129, pS271, DOI 10.1017/S0031182003004748; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Bousema JT, 2007, PARASITE IMMUNOL, V29, P309, DOI 10.1111/j.1365-3024.2007.00948.x; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Delrieu I, 2002, MOL BIOCHEM PARASIT, V121, P11, DOI 10.1016/S0166-6851(02)00016-6; Dessens JT, 2004, TRENDS PARASITOL, V20, P102, DOI 10.1016/j.pt.2004.01.002; Dixon MWA, 2008, TRENDS PARASITOL, V24, P168, DOI 10.1016/j.pt.2008.01.004; ERP EE, 1978, AM J TROP MED HYG, V27, P1061, DOI 10.4269/ajtmh.1978.27.1061; Ferreri LM, 2012, INT J PARASITOL, V42, P131, DOI 10.1016/j.ijpara.2011.10.004; Friedhoff K T, 1990, Rev Sci Tech, V9, P1187; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Goff WL, 1998, ANN NY ACAD SCI, V849, P161, DOI 10.1111/j.1749-6632.1998.tb11046.x; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hunfeld KP, 2008, INT J PARASITOL, V38, P1219, DOI 10.1016/j.ijpara.2008.03.001; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Lavazec C, 2009, MOL BIOCHEM PARASIT, V163, P1, DOI 10.1016/j.molbiopara.2008.09.002; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; MEHLHORN H, 1984, ADV PARASIT, V23, P37, DOI 10.1016/S0065-308X(08)60285-7; Mosqueda J, 2004, INT J PARASITOL, V34, P1229, DOI 10.1016/j.ijpara.2004.07.003; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Pradel G, 2006, EXP PARASITOL, V112, P263, DOI 10.1016/j.exppara.2005.11.010; Pradel G, 2004, J EXP MED, V199, P1533, DOI 10.1084/jem.20031274; Raine JD, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030030; Ribeiro MFB, 1998, VET PARASITOL, V76, P19, DOI 10.1016/S0304-4017(97)00205-7; Schwint ON, 2009, ANTIMICROB AGENTS CH, V53, P4327, DOI 10.1128/AAC.00404-09; Simon N, 2009, J BIOL CHEM, V284, P14537, DOI 10.1074/jbc.M808472200; Sinden RE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-70; Stiller D, 2002, J MED ENTOMOL, V39, P667, DOI 10.1603/0022-2585-39.4.667; Suarez CE, 2011, PARASITOLOGY, V138, P809, DOI 10.1017/S0031182011000321; Suarez CE, 2003, MOL BIOCHEM PARASIT, V127, P101, DOI 10.1016/S0166-6851(02)00311-0; Templeton TJ, 2010, MOL BIOL EVOL, V27, P235, DOI 10.1093/molbev/msp226; Ueti MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044713; Ueti MW, 2003, J CLIN MICROBIOL, V41, P5803, DOI 10.1128/JCM.41.12.5803-5809.2003; VEGA CA, 1985, AM J VET RES, V46, P416; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007	39	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67765	10.1371/journal.pone.0067765	http://dx.doi.org/10.1371/journal.pone.0067765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844089	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000101
J	Ebrahimi, B; Eirin, A; Li, ZL; Zhu, XY; Zhang, X; Lerman, A; Textor, SC; Lerman, LO				Ebrahimi, Behzad; Eirin, Alfonso; Li, Zilun; Zhu, Xiang-Yang; Zhang, Xin; Lerman, Amir; Textor, Stephen C.; Lerman, Lilach O.			Mesenchymal Stem Cells Improve Medullary Inflammation and Fibrosis after Revascularization of Swine Atherosclerotic Renal Artery Stenosis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; EXPERIMENTAL RENOVASCULAR DISEASE; OXIDATIVE STRESS; INJURY; KIDNEY; MICROVESICLES; MECHANISMS; ISCHEMIA; PROTECT; REPAIR	Atherosclerotic renal artery stenosis (ARAS) raises blood pressure and can reduce kidney function. Revascularization of the stenotic renal artery alone does not restore renal medullary structure and function. This study tested the hypothesis that addition of mesenchymal stem cells (MSC) to percutaneous transluminal renal angioplasty (PTRA) can restore stenotic-kidney medullary tubular transport function and attenuate its remodeling. Twenty-seven swine were divided into three ARAS (high-cholesterol diet and renal artery stenosis) and a normal control group. Six weeks after ARAS induction, two groups were treated with PTRA alone or PTRA supplemented with adipose-tissue-derived MSC (10 x 10(6) cells intra-renal). Multi-detector computed tomography and blood-oxygenation-level-dependent (BOLD) MRI studies were performed 4 weeks later to assess kidney hemodynamics and function, and tissue collected a few days later for histology and micro-CT imaging. PTRA effectively decreased blood pressure, yet medullary vascular density remained low. Addition of MSC improved medullary vascularization in ARAS+PTRA+MSC and increased angiogenic signaling, including protein expression of vascular endothelial growth-factor, its receptor (FLK-1), and hypoxia-inducible factor-1 alpha. ARAS+PTRA+MSC also showed attenuated inflammation, although oxidative-stress remained elevated. BOLD-MRI indicated that MSC normalized oxygen-dependent tubular response to furosemide (-4.3 +/- 0.9, -0.1 +/- 0.4, -1.6 +/- 0.9 and -3.6 +/- 1.0 s(-1) in Normal, ARAS, ARAS+PTRA and ARAS+PTRA+MSC, respectively, p<0.05), which correlated with a decrease in medullary tubular injury score (R-2 = 0.33, p = 0.02). Therefore, adjunctive MSC delivery in addition to PTRA reduces inflammation, fibrogenesis and vascular remodeling, and restores oxygen-dependent tubular function in the stenotic-kidney medulla, although additional interventions might be required to reduce oxidative-stress. This study supports development of cell-based strategies for renal protection in ARAS.	[Ebrahimi, Behzad; Eirin, Alfonso; Li, Zilun; Zhu, Xiang-Yang; Zhang, Xin; Textor, Stephen C.; Lerman, Lilach O.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Li, Zilun] Sun Yat Sen Univ, Div Vasc Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Lerman, Amir] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Mayo Clinic; Sun Yat Sen University; Mayo Clinic	Lerman, LO (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.	lerman.lilach@mayo.edu	Lerman, Lilach/M-4962-2017; Eirin, Alfonso/N-9873-2013	Ebrahimi, Behzad/0000-0001-6907-7696; Eirin, Alfonso/0000-0002-3864-9644; Zhang, Xin/0000-0003-4128-9261	National Institutes of Health [DK73608, DK77013, HL77131, HL085307, UL1RR000135, C06-RR018898]; Mayo Clinic Center for Regenerative Medicine Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018898] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085307, R01HL077131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073608, R21DK077013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Regenerative Medicine Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly supported by National Institutes of Health Grant numbers DK73608, DK77013, HL77131, HL085307, UL1RR000135, and C06-RR018898, and in part by the Mayo Clinic Center for Regenerative Medicine Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Chade AR, 2010, STEM CELLS, V28, P1039, DOI 10.1002/stem.426; Chade AR, 2009, CIRCULATION, V119, P547, DOI 10.1161/CIRCULATIONAHA.108.788653; Cooper CJ, 2006, AM HEART J, V152, P59, DOI 10.1016/j.ahj.2005.09.011; Daghini E, 2010, J HYPERTENS, V28, pE210, DOI 10.1097/01.hjh.0000378850.53880.bd; Daghini E, 2007, RADIOLOGY, V243, P405, DOI 10.1148/radiol.2432060655; de Mast Q, 2009, J HYPERTENS, V27, P1333, DOI 10.1097/HJH.0b013e328329bbf4; Ebrahimi B, 2012, AM J PHYSIOL-RENAL, V302, pF1478, DOI 10.1152/ajprenal.00563.2011; Ebrahimi B, 2012, INVEST RADIOL, V47, P175, DOI 10.1097/RLI.0b013e318234e75b; Eirin A, 2012, HYPERTENSION, V60, P1242, DOI 10.1161/HYPERTENSIONAHA.112.199919; Eirin A, 2012, STEM CELLS, V30, P1030, DOI 10.1002/stem.1047; Eirin A, 2011, AM J PHYSIOL-RENAL, V300, pF1394, DOI 10.1152/ajprenal.00697.2010; Favreau F, 2010, KIDNEY INT, V78, P1110, DOI 10.1038/ki.2010.142; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Herrera MB, 2004, INT J MOL MED, V14, P1035; Krier JD, 2001, AM J PHYSIOL-RENAL, V281, pF630, DOI 10.1152/ajprenal.2001.281.4.F630; Lerman LO, 2009, PROG CARDIOVASC DIS, V52, P196, DOI 10.1016/j.pcad.2009.09.002; Lerman LO, 1999, J AM SOC NEPHROL, V10, P1455; Makino A, 2002, HYPERTENSION, V39, P667, DOI 10.1161/hy0202.103469; Marigo I, 2011, SEMIN IMMUNOPATHOL, V33, P593, DOI 10.1007/s00281-011-0267-7; Mori T, 2004, HYPERTENSION, V43, P341, DOI 10.1161/01.HYP.0000113295.31481.36; Mori T, 2003, HYPERTENSION, V42, P588, DOI 10.1161/01.HYP.0000091821.39824.09; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Semedo P, 2007, TRANSPL P, V39, P421, DOI 10.1016/j.transproceed.2007.01.036; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Timmers L, 2008, STEM CELL RES, V1, P129, DOI 10.1016/j.scr.2008.02.002; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Urbieta-Caceres VH, 2010, AM J PHYSIOL-RENAL, V299, pF135, DOI 10.1152/ajprenal.00159.2010; Ward WK, 2003, BIOSENS BIOELECTRON, V19, P155, DOI 10.1016/S0956-5663(03)00180-5; Warner L, 2011, INVEST RADIOL, V46, P41, DOI 10.1097/RLI.0b013e3181f0213f; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; Zhu XY, 2013, STEM CELLS, V31, P117, DOI 10.1002/stem.1263	33	79	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67474	10.1371/journal.pone.0067474	http://dx.doi.org/10.1371/journal.pone.0067474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844014	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000074
J	Dias, ACF; Dini-Andreote, F; Hannula, SE; Andreote, FD; Silva, MDPE; Salles, JF; de Boer, W; van Veen, J; van Elsas, JD				Franco Dias, Armando Cavalcante; Dini-Andreote, Francisco; Hannula, Silja Emilia; Andreote, Fernando Dini; Pereira e Silva, Michele de Cassia; Salles, Joana Falcao; de Boer, Wietse; van Veen, Johannes; van Elsas, Jan Dirk			Different Selective Effects on Rhizosphere Bacteria Exerted by Genetically Modified versus Conventional Potato Lines	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; BURKHOLDERIA-CEPACIA COMPLEX; MICROBIAL-POPULATIONS; COMMUNITY STRUCTURE; SOIL TYPE; SP-NOV.; PLANT; DIVERSITY; GROWTH; CARBON	Background: In this study, we assessed the actively metabolizing bacteria in the rhizosphere of potato using two potato cultivars, i.e. the genetically-modified (GM) cultivar Modena (having tubers with altered starch content) and the near-isogenic non-GM cultivar Karnico. To achieve our aims, we pulse-labelled plants at EC90 stage with C-13-CO2 and analysed their rhizosphere microbial communities 24 h, 5 and 12 days following the pulse. In the analyses, phospholipid fatty acid/stable isotope probing (PLFA-SIP) as well as RNA-SIP followed by reverse transcription and PCR-DGGE and clone library analysis, were used to determine the bacterial groups that actively respond to the root-released C-13 labelled carbonaceous compounds. Methodology/Principal findings: The PLFA-SIP data revealed major roles of bacteria in the uptake of root-released C-13 carbon, which grossly increased with time. Gram-negative bacteria, including members of the genera Pseudomonas and Burkholderia, were strong accumulators of the C-13-labeled compounds at the two cultivars, whereas Gram-positive bacteria were lesser responders. PCR-DGGE analysis of cDNA produced from the two cultivar types showed that these had selected different bacterial, alpha-and betaproteobacterial communities at all time points. Moreover, an effect of time was observed, indicating dynamism in the structure of the active bacterial communities. PCR-DGGE as well as clone library analyses revealed that the main bacterial responders at cultivar Karnico were taxonomically affiliated with the genus Pseudomonas, next to Gluconacetobacter and Paracoccus. Cultivar Modena mainly attracted Burkholderia, next to Moraxella-like (Moraxellaceae family) and Sphingomonas types. Conclusions/Significance: Based on the use of Pseudomonas and Burkholderia as proxies for differentially-selected bacterial genera, we conclude that the selective forces exerted by potato cultivar Modena on the active bacterial populations differed from those exerted by cultivar Karnico.	[Franco Dias, Armando Cavalcante; Dini-Andreote, Francisco; Pereira e Silva, Michele de Cassia; Salles, Joana Falcao; van Elsas, Jan Dirk] Univ Groningen RUG, Dept Microbial Ecol, Ctr Ecol & Evolutionary Studies CEES, Groningen, Netherlands; [Hannula, Silja Emilia; de Boer, Wietse; van Veen, Johannes] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Franco Dias, Armando Cavalcante; Andreote, Fernando Dini] Univ Sao Paulo, Dept Soil Sci, ESALQ USP, Piracicaba, Brazil	University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Universidade de Sao Paulo	Dini-Andreote, F (corresponding author), Univ Groningen RUG, Dept Microbial Ecol, Ctr Ecol & Evolutionary Studies CEES, Groningen, Netherlands.	f.dini.andreote@rug.nl	Dias, Armando Cavalcante Franco/F-5878-2012; Salles, Joana Falcao/AAG-7070-2020; Falcao Salles, Joana/A-7313-2008; de Boer, Wietse/C-2737-2011; Andreote, Fernando Dini/B-8499-2012; Dini-Andreote, Francisco/M-6176-2017; Hannula, Silja Emilia/C-7462-2012; van Veen, Johannes A/C-3697-2011; de Cassia Pereira e Silva, Michele/D-3918-2016; Dias, Armando Cavalcante Franco/O-1477-2019; KNAW, NIOO-KNAW/A-4320-2012	Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Salles, Joana Falcao/0000-0003-4317-7263; Falcao Salles, Joana/0000-0003-4317-7263; de Boer, Wietse/0000-0002-5380-2993; Andreote, Fernando Dini/0000-0002-9883-9968; Dini-Andreote, Francisco/0000-0002-6654-0769; Hannula, Silja Emilia/0000-0003-1398-2018; de Cassia Pereira e Silva, Michele/0000-0002-6426-8474; Dias, Armando Cavalcante Franco/0000-0002-2651-6270; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research (NWO)-ERGO program; FAPESP [2008/54013-8]	Netherlands Organisation for Scientific Research (NWO)-ERGO program(Netherlands Organization for Scientific Research (NWO)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Netherlands Organisation for Scientific Research (NWO)-ERGO program and FAPESP (Proc. 2008/54013-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; Baldani JI, 1997, SOIL BIOL BIOCHEM, V29, P911, DOI 10.1016/S0038-0717(96)00218-0; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bernard L, 2007, ENVIRON MICROBIOL, V9, P752, DOI 10.1111/j.1462-2920.2006.01197.x; Boersma FGH, 2009, APPL ENVIRON MICROB, V75, P1979, DOI 10.1128/AEM.02489-08; BOSCHKER H. T. S., 2004, MOL MICROBIAL ECOLOG, P1673; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Costa R, 2007, ENVIRON MICROBIOL, V9, P2260, DOI 10.1111/j.1462-2920.2007.01340.x; Dalmastri C, 1999, MICROBIAL ECOL, V38, P273, DOI 10.1007/s002489900177; de Almeida CV, 2009, WORLD J MICROB BIOT, V25, P1757, DOI 10.1007/s11274-009-0073-8; De Bruijn FJ, 2013, MOL MICROBIAL ECOLOG, P746; de Vetten N, 2003, NAT BIOTECHNOL, V21, P439, DOI 10.1038/nbt801; Dias ACF, 2012, SOIL BIOL BIOCHEM, V50, P85, DOI 10.1016/j.soilbio.2012.03.006; DiCello F, 1997, APPL ENVIRON MICROB, V63, P4485, DOI 10.1128/AEM.63.11.4485-4493.1997; Dini-Andreote F, 2013, PLANT SOIL, V373, P1, DOI 10.1007/s11104-013-1687-z; Dohrmann AB, 2005, APPL ENVIRON MICROB, V71, P7750, DOI 10.1128/AEM.71.12.7750-7758.2005; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Duineveld BM, 1998, APPL ENVIRON MICROB, V64, P4950; Elliott GN, 2007, NEW PHYTOL, V173, P168, DOI 10.1111/j.1469-8137.2006.01894.x; FROSTEGARD A, 1993, APPL ENVIRON MICROB, V59, P3605; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Ghosh W, 2006, SYST APPL MICROBIOL, V29, P396, DOI 10.1016/j.syapm.2005.10.004; GLEIXNER G, 1998, 214 NAT M AM CHEM SO, V707, P34; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Gschwendtner S, 2011, FEMS MICROBIOL ECOL, V76, P564, DOI 10.1111/j.1574-6941.2011.01073.x; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haichar FE, 2012, FEMS MICROBIOL ECOL, V81, P291, DOI 10.1111/j.1574-6941.2012.01345.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hannula SE, 2012, NEW PHYTOL, V194, P784, DOI 10.1111/j.1469-8137.2012.04089.x; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hardoim PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030438; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kropf S, 2004, J STAT PLAN INFER, V125, P31, DOI 10.1016/j.jspi.2003.07.021; Kumar R, 2012, B ENVIRON CONTAM TOX, V88, P781, DOI 10.1007/s00128-012-0578-y; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lu Y, 2006, ENVIRON MICROBIOL, V9, P474; Luvizotto DM, 2010, WORLD J MICROB BIOT, V26, P1829, DOI 10.1007/s11274-010-0364-0; Lynch JM, 1994, APPL SOIL ECOL, V1, P193, DOI 10.1016/0929-1393(94)90010-8; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Mauclaire L, 2003, J MICROBIOL METH, V55, P635, DOI 10.1016/S0167-7012(03)00205-7; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; Ogita N, 2006, BIOSCI BIOTECH BIOCH, V70, P2325, DOI 10.1271/bbb.60299; Prosser JI, 2006, CURR OPIN BIOTECH, V17, P98, DOI 10.1016/j.copbio.2006.01.001; RADEMAKER JLW, 1999, MOL MICROBIAL ECOLOG, P1; Ramette A, 2005, APPL ENVIRON MICROB, V71, P1193, DOI 10.1128/AEM.71.3.1193-1201.2005; Rangel-Castro JI, 2005, ENVIRON MICROBIOL, V7, P828, DOI 10.1111/j.1462-2920.2005.00756.x; Rasche F, 2006, FEMS MICROBIOL ECOL, V56, P219, DOI 10.1111/j.1574-6941.2005.00027.x; Rasche F, 2009, NEW PHYTOL, V181, P802, DOI 10.1111/j.1469-8137.2008.02744.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salles JF, 2002, APPL ENVIRON MICROB, V68, P1595, DOI 10.1128/AEM.68.4.1595-1603.2002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Semenov AV, 2012, SOIL BIOL BIOCHEM, V49, P88, DOI 10.1016/j.soilbio.2012.02.016; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Smyth EM, 2011, J APPL MICROBIOL, V111, P683, DOI 10.1111/j.1365-2672.2011.05079.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104	66	26	27	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67948	10.1371/journal.pone.0067948	http://dx.doi.org/10.1371/journal.pone.0067948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844136	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000119
J	Wang, ZY; Zhang, PX; Kou, YH; Yin, XF; Han, N; Jiang, BG				Wang, Zhiyong; Zhang, Peixun; Kou, Yuhui; Yin, Xiaofeng; Han, Na; Jiang, Baoguo			Hedysari Extract Improves Regeneration after Peripheral Nerve Injury by Enhancing the Amplification Effect	PLOS ONE			English	Article							GROWTH-FACTOR DELIVERY; SPINAL-CORD; AXON GROWTH; SCHWANN; CONDUITS; CELLS; RATS	Radix Hedysari is an herbal preparation frequently used in traditional Chinese medicine. It can promote regeneration after peripheral nerve injury, but its effect on the amplification ratio (the ratio of distal to proximal fibers) during peripheral nerve regeneration has not yet been examined. In this study, we explored the effect of Hedysari extract on the amplification ratio in the peripheral nerve. Male Sprague-Dawley rats were separated into three groups at random: normal group (without surgery), model group (given sleeve nerve bridging surgery, but without adjuvant treatment) and treatment group (given sleeve nerve bridging surgery and then given Hedysari extract as adjuvant treatment). Twelve weeks after surgery, general observations, electrophysiological examination, histological analysis, morphometric measurements, and amplification ratio calculations were made. The results showed that nerve conduction velocity, the fiber and axon diameter, the g-ratio, the number of regenerating nerve fibers and the amplification ratio were better in the treatment group than in the model group, suggesting that Hedysari extract can effectively promote the growth of lateral buds in the proximal nerve stump and substantially improve the amplification effect during peripheral nerve regeneration.	[Wang, Zhiyong; Zhang, Peixun; Kou, Yuhui; Yin, Xiaofeng; Han, Na; Jiang, Baoguo] Peking Univ, Dept Trauma & Orthoped, Peoples Hosp, Beijing 100871, Peoples R China	Peking University	Zhang, PX (corresponding author), Peking Univ, Dept Trauma & Orthoped, Peoples Hosp, Beijing 100871, Peoples R China.	zhangpeixun@126.com; jiangbaoguo@vip.sina.com		Jiang, Baoguo/0000-0001-8436-5266; Kou, Yuhui/0000-0003-1523-825X; Han, Na/0000-0002-2472-8245; Yin, Xiaofeng/0000-0001-9932-642X	National Natural Science Fund [31171150, 31271284, 81171146, 30971526, 30801169]; Beijing City Science and Technology New Star Classification [A-2008-10]; Educational Ministry New Century Excellent Talents Support Project [BMU 20110270]; National Eleven Five State Science and Technology Support Program [2007BAI04B06]; National Natural Science Youth Science Fund [31100860]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Beijing City Science and Technology New Star Classification; Educational Ministry New Century Excellent Talents Support Project; National Eleven Five State Science and Technology Support Program; National Natural Science Youth Science Fund	This study was supported by National Natural Science Fund (31171150, 31271284, 81171146, 30971526, 30801169), Beijing City Science and Technology New Star Classification (A-2008-10), Educational Ministry New Century Excellent Talents Support Project (BMU 20110270), National Eleven Five State Science and Technology Support Program (2007BAI04B06) and National Natural Science Youth Science Fund (31100860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Berger A, 1999, UNFALLCHIRURG, V102, P59, DOI 10.1007/s001130050373; Blesch A, 1999, J NEUROSCI, V19, P3556; Cui XM, 1998, TCM PHARM CLIN, V14, P19; Ide C, 1996, NEUROSCI RES, V25, P101; IDE C, 1983, ARCH HISTOL JAPON, V46, P243, DOI 10.1679/aohc.46.243; Jiang BG, 2007, EUR NEUROL, V58, P12, DOI 10.1159/000102161; [姜保国 Jiang Baoguo], 2002, [中华显微外科杂志, Chinese Journal of Microsurgery], V25, P38; Jiang BG, 2006, ARTIF CELL BLOOD SUB, V34, P55, DOI 10.1080/10731190500430149; Jin Z.S., 2004, CHIN J TCM WM CRIT C, V11, P141; Madduri S, 2012, J CONTROL RELEASE, V161, P274, DOI 10.1016/j.jconrel.2011.11.036; RUTISHAUSER U, 1985, J NEUROSCI RES, V13, P123, DOI 10.1002/jnr.490130109; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Song QH, 2000, J ETHNOPHARMACOL, V73, P111, DOI 10.1016/S0378-8741(00)00273-7; Su KX, 2005, J YOUJIANG MINZU COL, V4, P445; Sun HY, 2012, NEUROL RES, V34, P491, DOI 10.1179/1743132812Y.0000000037; Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; [魏光如 Wei Guangru], 2004, [中华手外科杂志, Chinese Journal of Hand Surgery], V20, P177; Wei SY, 2009, AM J CHINESE MED, V37, P57, DOI 10.1142/S0192415X09006618; Wei SY, 2009, J ETHNOPHARMACOL, V123, P51, DOI 10.1016/j.jep.2009.02.030; [杨德梅 Yang Demei], 2006, [中华手外科杂志, Chinese Journal of Hand Surgery], V22, P308; Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066; Zhang J. P., 1998, CHIN J INT MED, V18, P76; Zhang PX, 2011, ARTIF CELL BLOOD SUB, V39, P39, DOI 10.3109/10731199.2010.494583; Zhang PX, 2005, J RECONSTR MICROSURG, V21, P565, DOI 10.1055/s-2005-922437; Zhang ZH, 2005, J JILIN MED, V26, P132; Zheng HJ, 1991, J LANZHOU U, V37, P82	29	21	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67921	10.1371/journal.pone.0067921	http://dx.doi.org/10.1371/journal.pone.0067921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844128	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000115
J	Majid, S; Dar, AA; Saini, S; Deng, GR; Chang, I; Greene, K; Tanaka, Y; Dahiya, R; Yamamura, S				Majid, Shahana; Dar, Altaf A.; Saini, Sharanjot; Deng, Guoren; Chang, Inik; Greene, Kirsten; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro			MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; METASTASIS; MODEL	MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression by targeted repression of transcription and translation. In this study we show that miRNA-23b (miR-23b) acts as a tumor suppressor in bladder cancer. Quantitative real-time PCR analysis showed that miR-23b is significantly down-regulated in bladder cancer cell lines and tumor tissues compared to non-malignant cells and normal tissue samples. We also demonstrate that miR-23b expression has a potential to be diagnostic and prognostic biomarker in bladder cancer. High miR-23b expression is positively correlated with higher overall survival of bladder cancer patients as revealed by Kaplan-Meier analysis. ROC analysis showed that miR-23b expression can distinguish between normal and bladder cancer tissues. Further we elucidated the biological significance of miR-23b in bladder cancer. Over-expression of miR-23b in bladder cancer cells inhibited cell proliferation and impaired colony formation. Fluorescence activated cell sorting (FACS) analysis revealed that re-expression of miR-23b in bladder cancer cells induced G0/G1 cell cycle arrest and apoptosis while inhibiting cell migration and invasion. Luciferase reporter assays demonstrated that Zeb1, a crucial regulator of epithelial-to-mesenchymal transition (EMT), is a direct target of miR-23b in bladder cancer. These results show that loss of miR-23b confers a proliferative advantage and promotes bladder cancer cell migration and invasion. Furthermore, re-expression of miR-23b may be a beneficial therapeutic strategy for the treatment of human bladder cancer.	[Majid, Shahana; Saini, Sharanjot; Deng, Guoren; Chang, Inik; Greene, Kirsten; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro] VA Med Ctr, Dept Urol, San Francisco, CA USA; [Majid, Shahana; Saini, Sharanjot; Deng, Guoren; Chang, Inik; Greene, Kirsten; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro] UCSF, San Francisco, CA USA; [Dar, Altaf A.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA	University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute	Majid, S (corresponding author), VA Med Ctr, Dept Urol, San Francisco, CA USA.	SMajid@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health [RO1CA138642, RO1CA130860, RO1CA160079, I01BX001123]; VA Merit Review; VA Program Project; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079, R01CA130860] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review(US Department of Veterans Affairs); VA Program Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Center for Research Resources of the National Institutes of Health through grant numbers RO1CA138642, RO1CA130860, RO1CA160079, I01BX001123, VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Black PC, 2007, CANCER METAST REV, V26, P623, DOI 10.1007/s10555-007-9084-9; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Majid S, 2012, CANCER RES, V72, P6435, DOI 10.1158/0008-5472.CAN-12-2181; Majid S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046743; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Metts MC, 2000, J NATL MED ASSOC, V92, P285; Saini S, 2011, CANCER PREV RES, V4, P1698, DOI 10.1158/1940-6207.CAPR-11-0267; Saunders MA, 2009, RNA BIOL, V6, P324, DOI 10.4161/rna.6.3.8871; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shen ZC, 2008, PHARM RES-DORDR, V25, P1500, DOI 10.1007/s11095-008-9566-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Uchida Y, 2011, UROL ONCOL; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050203	23	105	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67686	10.1371/journal.pone.0067686	http://dx.doi.org/10.1371/journal.pone.0067686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844063	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000077
J	Williams, TR; Moyne, AL; Harris, LJ; Marco, ML				Williams, Thomas R.; Moyne, Anne-Laure; Harris, Linda J.; Marco, Maria L.			Season, Irrigation, Leaf Age, and Escherichia coli Inoculation Influence the Bacterial Diversity in the Lettuce Phyllosphere	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PSEUDOMONAS-SYRINGAE; PERSISTENCE; O157/H7; SOIL; VARIABILITY; POPULATIONS; SURVIVAL; O157-H7; LEAVES	The developmental and temporal succession patterns and disturbance responses of phyllosphere bacterial communities are largely unknown. These factors might influence the capacity of human pathogens to persist in association with those communities on agriculturally-relevant plants. In this study, the phyllosphere microbiota was identified for Romaine lettuce plants grown in the Salinas Valley, CA, USA from four plantings performed over 2 years and including two irrigation methods and inoculations with an attenuated strain of Escherichia coli O157:H7. High-throughput DNA pyrosequencing of the V5 to V9 variable regions of bacterial 16S rRNA genes recovered in lettuce leaf washes revealed that the bacterial diversity in the phyllosphere was distinct for each field trial but was also strongly correlated with the season of planting. Firmicutes were generally most abundant in early season (June) plantings and Proteobacteria comprised the majority of bacteria recovered later in the year (August and October). Comparisons within individual field trials showed that bacterial diversity differed between sprinkler (overhead) and drip (surface) irrigated lettuce and increased over time as the plants grew. The microbiota were also distinct between control and E. coli O157:H7-inoculated plants and between E. coli O157: H7-inoculated plants with and without surviving pathogen cells. The bacterial inhabitants of the phyllosphere therefore appear to be affected by seasonal, irrigation, and biological factors in ways that are relevant for assessments of fresh produce food safety.	[Williams, Thomas R.; Moyne, Anne-Laure; Harris, Linda J.; Marco, Maria L.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Moyne, Anne-Laure; Harris, Linda J.] Univ Calif Davis, Western Ctr Food Safety, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Marco, ML (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.	mmarco@ucdavis.edu	Marco, Maria/H-2322-2014; Harris, Linda J/B-5030-2011	Harris, Linda J/0000-0002-1911-752X	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2010-65201-20572]; Center for Produce Safety; California Lettuce and Leafy Greens Research Board; U.S. Food and Drug Administration [U01-002-527]	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture; Center for Produce Safety; California Lettuce and Leafy Greens Research Board; U.S. Food and Drug Administration	This project was partially supported by the Agriculture and Food Research Initiative Grant 2010-65201-20572 from the USDA National Institute of Food and Agriculture (http://www.csrees.usda.gov/). This project was also supported by The Center for Produce Safety (https://cps.ucdavis.edu/), the California Lettuce and Leafy Greens Research Board (http://www.calgreens.org/about-us.html), and the U.S. Food and Drug Administration, Project No. U01-002-527 (www.fda.gov). The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Barker-Reid F, 2009, J FOOD PROTECT, V72, P458, DOI 10.4315/0362-028X-72.3.458; Bell CW, 2009, MICROB ECOL, V58, P827, DOI 10.1007/s00248-009-9529-5; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Centers for Disease Control and Prevention, 2010, INV UPD MULT OUTBR H; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Choi S, 2011, J APPL MICROBIOL, V111, P1465, DOI 10.1111/j.1365-2672.2011.05175.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Cuiv PO, 2011, MICROB ECOL, V61, P353, DOI 10.1007/s00248-010-9771-x; De Costa DM, 2006, J AGRON CROP SCI, V192, P209, DOI 10.1111/j.1439-037X.2006.00207.x; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Doyle MP, 2008, J APPL MICROBIOL, V105, P317, DOI 10.1111/j.1365-2672.2008.03746.x; ERCOLANI G L, 1979, Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschaftliche Abteilung Mikrobiologie der Landwirtschaft der Technologie und des Umweltschutzes, V134, P402; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Finkel OM, 2011, APPL ENVIRON MICROB, V77, P7647, DOI 10.1128/AEM.05565-11; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Heaton JC, 2008, J APPL MICROBIOL, V104, P613, DOI 10.1111/j.1365-2672.2007.03587.x; HIRANO SS, 1989, APPL ENVIRON MICROB, V55, P623, DOI 10.1128/AEM.55.3.623-630.1989; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Ibekwe AM, 2009, LETT APPL MICROBIOL, V49, P784, DOI 10.1111/j.1472-765X.2009.02745.x; Islam M, 2004, J FOOD PROTECT, V67, P1365, DOI 10.4315/0362-028X-67.7.1365; Jackson CR, 2011, MICROB ECOL, V61, P113, DOI 10.1007/s00248-010-9742-2; Kadivar H, 2003, MICROBIAL ECOL, V45, P353, DOI 10.1007/s00248-002-1065-5; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Larsen P, 2012, J BIOTECHNOL, V160, P17, DOI 10.1016/j.jbiotec.2012.03.009; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lopez-Velasco G, 2012, INT J FOOD MICROBIOL, V153, P351, DOI 10.1016/j.ijfoodmicro.2011.11.026; Lopez-Velasco G, 2010, FOOD MICROBIOL, V27, P476, DOI 10.1016/j.fm.2009.12.010; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Morris CE, 2002, PHYLLOSPHERE MICROBIOLOGY, P365; Moyne AL, 2011, FOOD MICROBIOL, V28, P1417, DOI 10.1016/j.fm.2011.02.001; PEDERSEN JC, 1992, APPL ENVIRON MICROB, V58, P1064, DOI 10.1128/AEM.58.3.1064-1066.1992; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Rastogi G, 2010, J MICROBIOL METH, V83, P127, DOI 10.1016/j.mimet.2010.08.006; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Redford AJ, 2009, MICROB ECOL, V58, P189, DOI 10.1007/s00248-009-9495-y; Reisberg EE, 2012, ANTON LEEUW INT J G, V101, P551, DOI 10.1007/s10482-011-9669-8; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sakai M, 2004, J MICROBIOL METH, V59, P81, DOI 10.1016/j.mimet.2004.06.005; Smith Birgitte, 2011, Open Microbiol J, V5, P14, DOI 10.2174/1874285801105010014; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Telias A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-81; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; WILSON M, 1994, APPL ENVIRON MICROB, V60, P4468, DOI 10.1128/AEM.60.12.4468-4477.1994; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898; Zhang BG, 2008, FEMS MICROBIOL LETT, V284, P102, DOI 10.1111/j.1574-6968.2008.01178.x; Zwielehner J, 2008, MOL NUTR FOOD RES, V52, P614, DOI 10.1002/mnfr.200700158	68	94	98	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68642	10.1371/journal.pone.0068642	http://dx.doi.org/10.1371/journal.pone.0068642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844230	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000176
J	Feng, J; Zhao, T; Zhang, Y; Ma, Y; Jiang, YR				Feng, Jing; Zhao, Tong; Zhang, Yan; Ma, Yan; Jiang, Yanrong			Differences in Aqueous Concentrations of Cytokines in Macular Edema Secondary to Branch and Central Retinal Vein Occlusion	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; PROLIFERATIVE DIABETIC-RETINOPATHY; INTRAVITREAL TRIAMCINOLONE; BEVACIZUMAB AVASTIN; INTERLEUKIN-6; EXPRESSION; NEOVASCULARIZATION; RANIBIZUMAB; POPULATION; STATES	Purpose: This study investigates the differential aqueous concentrations of interleukin 6, 8, 1 beta (IL-6, IL-8, IL-1 beta, respectively), serum amyloid A (SAA), transforming growth factor (TGF)-beta, basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) in eyes with macular edema as a result of a branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) Principal Findings: Significantly higher concentrations of IL-6, IL-8, IL-1 beta, TGF-beta, bFGF, SAA, and VEGF were found in the aqueous humor of CRVO and BRVO patients than in the aqueous humor of control patients. A significant correlation was observed between the concentration of bFGF and the inner central macular thickness (CMT) of BRVO patients (r = 0.688; P = 0.02). A significant correlation was observed between the concentration of SAA and both the full and outer CMT of the ischemic group (r = 0.545 and 0.683, respectively; P = 0.04 and 0.01, respectively). In the non-ischemic group, the level of IL-6 was significantly associated with inner CMT (r = 0.560; P = 0.03). The full and outer CMT was significantly reduced in CRVO patients when compared with BRVO patients (P = 0.02 and 0.02, respectively) after injection of intravitreal bevacizumab (IVB) at 4 weeks. Significance: Serum amyloid A as a major protein involved in the acute and chronic stages of inflammation, and IL-6 and bFGF were significantly associated with the extent of macular edema in patients with RVO. Besides VEGF, other inflammatory cytokines and angiogenesic factors may be associated with RVO. This finding may have implications for the medical treatment of RVO.	[Jiang, Yanrong] Peking Univ, Dept Ophthalmol, Peoples Hosp, Beijing 100871, Peoples R China; Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China	Peking University	Jiang, YR (corresponding author), Peking Univ, Dept Ophthalmol, Peoples Hosp, Beijing 100871, Peoples R China.	drjyr@vip.sina.com		Feng, Jing/0000-0002-7658-9865	People's Hospital of Peking University [RDC2012-21]; Ph.D. Programs Foundation of Ministry of Education of China [20110001110042]; EFSD/CDS/Lilly grant	People's Hospital of Peking University; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); EFSD/CDS/Lilly grant	This study was supported by the study and development fund of the People's Hospital of Peking University (No. RDC2012-21), Ph.D. Programs Foundation of Ministry of Education of China (No. 20110001110042, http://www.cutech.edu.cn/cn/rootfiles/2011/12/05/1322550574368276-1322550574468608. xls), and an EFSD/CDS/Lilly grant (http://www.europeandiabetesfoundation.org/Lilly/EFSD-CDS-Lilly-Recipients.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, ARCH OPHTHALMOL, V115, P486; Boyd SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P1644; Campochiaro PA, 2008, MOL THER, V16, P791, DOI 10.1038/mt.2008.10; Channa R, 2011, CLIN OPHTHALMOL, V5, P705, DOI 10.2147/OPTH.S7632; Clarkson J G, 1994, Trans Am Ophthalmol Soc, V92, P203; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; Ding XY, 2011, RETINA-J RET VIT DIS, V31, P838, DOI 10.1097/IAE.0b013e3181f4420d; Frank RN, 1996, AM J OPHTHALMOL, V122, P393, DOI 10.1016/S0002-9394(14)72066-5; Funk M, 2009, INVEST OPHTH VIS SCI, V50, P1025, DOI 10.1167/iovs.08-2510; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P458; HOLZINGER C, 1993, IMMUNOL LETT, V35, P109, DOI 10.1016/0165-2478(93)90078-G; Hung KH, 2010, J OCUL PHARMACOL TH, V26, P85, DOI 10.1089/jop.2009.0090; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Kaneda S, 2011, INVEST OPHTH VIS SCI, V52, P2982, DOI 10.1167/iovs.10-6299; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Lee WJ, 2012, BRIT J OPHTHALMOL, V96, P1426, DOI 10.1136/bjophthalmol-2012-301913; Ma Y, 2011, AM J OPHTHALMOL, V152, P678, DOI 10.1016/j.ajo.2011.03.007; Noma H, 2008, EYE, V22, P42, DOI 10.1038/sj.eye.6702498; Nuti E, 2011, RETINA-J RET VIT DIS, V31, P1863, DOI 10.1097/IAE.0b013e318219de8b; Park CH, 2003, AM J OPHTHALMOL, V136, P419, DOI 10.1016/S0002-9394(03)00228-9; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; SIVALINGAM A, 1990, ARCH OPHTHALMOL-CHIC, V108, P869, DOI 10.1001/archopht.1990.01070080113046; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Spaide RF, 2009, AM J OPHTHALMOL, V147, P298, DOI 10.1016/j.ajo.2008.08.016; Stahl A, 2010, EUR J OPHTHALMOL, V20, P180, DOI 10.1177/112067211002000125; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Turello M, 2010, J THROMB THROMBOLYS, V29, P459, DOI 10.1007/s11239-009-0384-5; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Upragarin N, 2005, VET IMMUNOL IMMUNOP, V106, P39, DOI 10.1016/j.vetimm.2005.01.004; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Zittermann SI, 2006, AM J PATHOL, V168, P835, DOI 10.2353/ajpath.2006.050479; 1995, OPHTHALMOLOGY, V102, P1425	34	35	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68149	10.1371/journal.pone.0068149	http://dx.doi.org/10.1371/journal.pone.0068149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861862	gold, Green Submitted, Green Published			2022-12-25	WOS:000321425300045
J	Rex, K; Jeffries, S; Brown, ML; Carlson, T; Coxon, A; Fajardo, F; Frank, B; Gustin, D; Kamb, A; Kassner, PD; Li, S; Li, YH; Morgenstern, K; Plant, M; Quon, K; Ruefli-Brasse, A; Schmidt, J; Swearingen, E; Walker, N; Wang, ZL; Watson, JEV; Wickramasinghe, D; Wong, M; Xu, GF; Wesche, H				Rex, Karen; Jeffries, Shawn; Brown, Matthew L.; Carlson, Timothy; Coxon, Angela; Fajardo, Flordeliza; Frank, Brendon; Gustin, Darin; Kamb, Alexander; Kassner, Paul D.; Li, Shyun; Li, Yihong; Morgenstern, Kurt; Plant, Matthew; Quon, Kim; Ruefli-Brasse, Astrid; Schmidt, Joanna; Swearingen, Elissa; Walker, Nigel; Wang, Zhulun; Watson, J. E. Vivienne; Wickramasinghe, Dineli; Wong, Mariwil; Xu, Guifen; Wesche, Holger			Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability	PLOS ONE			English	Article							INHIBITS ANGIOGENESIS; CANCER-CELLS; SPHINGOSINE-1-PHOSPHATE; GROWTH; XENOGRAFTS; RECEPTORS; DISCOVERY; APOPTOSIS; TARGETS	Sphingosine kinases (SPHKs) are enzymes that phosphorylate the lipid sphingosine, leading to the formation of sphingosine-1-phosphate (S1P). In addition to the well established role of extracellular S1P as a mitogen and potent chemoattractant, SPHK activity has been postulated to be an important intracellular regulator of apoptosis. According to the proposed rheostat theory, SPHK activity shifts the intracellular balance from the pro-apoptotic sphingolipids ceramide and sphingosine to the mitogenic S1P, thereby determining the susceptibility of a cell to apoptotic stress. Despite numerous publications with supporting evidence, a clear experimental confirmation of the impact of this mechanism on tumor cell viability in vitro and in vivo has been hampered by the lack of suitable tool reagents. Utilizing a structure based design approach, we developed potent and specific SPHK1/2 inhibitors. These compounds completely inhibited intracellular S1P production in human cells and attenuated vascular permeability in mice, but did not lead to reduced tumor cell growth in vitro or in vivo. In addition, siRNA experiments targeting either SPHK1 or SPHK2 in a large panel of cell lines failed to demonstrate any statistically significant effects on cell viability. These results show that the SPHK rheostat does not play a major role in tumor cell viability, and that SPHKs might not be attractive targets for pharmacological intervention in the area of oncology.	[Rex, Karen; Jeffries, Shawn; Coxon, Angela; Fajardo, Flordeliza; Frank, Brendon; Li, Shyun; Ruefli-Brasse, Astrid; Schmidt, Joanna; Watson, J. E. Vivienne; Wickramasinghe, Dineli; Wong, Mariwil; Wesche, Holger] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA; [Brown, Matthew L.; Gustin, Darin; Li, Yihong] Amgen Inc, Med Chem, San Francisco, CA USA; [Carlson, Timothy; Xu, Guifen] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA USA; [Kamb, Alexander] Amgen Inc, Discovery Sci, San Francisco, CA USA; [Kassner, Paul D.; Swearingen, Elissa] Amgen Inc, Genome Anal Unit, San Francisco, CA USA; [Morgenstern, Kurt; Plant, Matthew; Walker, Nigel; Wang, Zhulun] Amgen Inc, Mol Struct & Characterizat, Cambridge, MA USA; [Quon, Kim] Amgen Inc, Therapeut Innovat Unit, Seattle, WA USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Wesche, H (corresponding author), Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA.	hwesche@amgen.com	Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022	Wang, Zhong Lin/0000-0002-5530-0380; Kassner, Paul/0000-0002-1471-1191	Amgen Inc.	Amgen Inc.(Amgen)	All authors have an affiliation to the commercial funder of this research (Amgen Inc.). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Babij C, 2011, CANCER RES, V71, P5818, DOI 10.1158/0008-5472.CAN-11-0778; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; English D, 1999, J HEMATOTH STEM CELL, V8, P627, DOI 10.1089/152581699319795; French KJ, 2003, CANCER RES, V63, P5962; Hedges L.V., 1985, STAT METHODS META AN; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; LaMontagne K, 2006, CANCER RES, V66, P221, DOI 10.1158/0008-5472.CAN-05-2001; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Nemoto S, 2009, J BIOL CHEM, V284, P10422, DOI 10.1074/jbc.M900735200; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Orr Gandy KA, 2012, BIOCH BIOPHYS ACTA; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Polverino A, 2006, CANCER RES, V66, P8715, DOI 10.1158/0008-5472.CAN-05-4665; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025	23	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68328	10.1371/journal.pone.0068328	http://dx.doi.org/10.1371/journal.pone.0068328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861887	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300058
J	Desmond, NA; Nyirenda, D; Dube, Q; Mallewa, M; Molyneux, E; Lalloo, DG; Heyderman, RS				Desmond, Nicola A.; Nyirenda, Deborah; Dube, Queen; Mallewa, MacPherson; Molyneux, Elizabeth; Lalloo, David G.; Heyderman, Robert S.			Recognising and Treatment Seeking for Acute Bacterial Meningitis in Adults and Children in Resource-Poor Settings: A Qualitative Study	PLOS ONE			English	Article							DECISION-MAKING; HEALTH-CARE; LAY EPIDEMIOLOGY; BEHAVIOR; FEVER; BLANTYRE; DISTRICT; ILLNESS; MALARIA; DISEASE	Objective: High mortality burden from Acute Bacterial Meningitis (ABM) in resource-poor settings has been frequently blamed on delays in treatment seeking. We explored treatment-seeking pathways from household to primary health care and referral for ABM in Malawi. Design: A cross-sectional qualitative study using narrative in-depth interviews, semi-structured interviews and focus group discussions. Participants: Adults and children with proven and probable acute bacterial meningitis and/or their carers; adults from urban and peri-urban communities; and primary health care workers (HCW). Setting: Queen Elizabeth Central Hospital (QECH), urban and peri-urban private and government primary health centres and communities in Blantyre District, Malawi. Results: Whilst communities associated meningitis with a stiff neck, in practice responses focused on ability to recognise severe illness. Misdiagnosis of meningitis as malaria was common. Subsequent action by families depended on the extent to which normal social life was disrupted by the illness and depended on the age and social position of the sufferer. Seizures and convulsions were considered severe symptoms but were often thought to be malaria. Presumptive malaria treatment at home often delayed formal treatment seeking. Further delays in treatment seeking were caused by economic barriers and perceptions of inefficient or inadequate primary health services. Conclusions: Given the difficulties in diagnosis of meningitis where malaria is common, any intervention for ABM at primary level must focus on recognising severe illness, and encouraging action at the household, community and primary health levels. Overcoming barriers to recognition and social constraints at community level require broad community-based strategies and may provide a route to addressing poor clinical outcomes.	[Desmond, Nicola A.; Nyirenda, Deborah; Mallewa, MacPherson; Heyderman, Robert S.] Malawi Liverpool Wellcome Trust Res Programme, Blantyre, Malawi; [Desmond, Nicola A.; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Dube, Queen; Molyneux, Elizabeth] Univ Malawi, Queen Elizabeth Cent Hosp, Blantyre, Malawi; [Dube, Queen; Molyneux, Elizabeth] Univ Malawi, Coll Med, Blantyre, Malawi	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Malawi	Desmond, NA (corresponding author), Malawi Liverpool Wellcome Trust Res Programme, Blantyre, Malawi.	ndesmond@liverpool.ac.uk	Desmond, Nicola/ABA-6504-2020; Desmond, Nicola/GYQ-8574-2022	Desmond, Nicola/0000-0002-2874-8569; Heyderman, Robert/0000-0003-4573-449X; Nyirenda, Deborah/0000-0002-5867-4687; Lalloo, David/0000-0001-7680-2200	Meningitis Research Foundation, UK; MLW Clinical Research Programme Core grant from the Wellcome Trust, UK	Meningitis Research Foundation, UK(Meningitis Research Foundation (MRF)); MLW Clinical Research Programme Core grant from the Wellcome Trust, UK	The research was funded by the Meningitis Research Foundation, UK (http://www.meningitis.org) and the MLW Clinical Research Programme Core grant from the Wellcome Trust, UK (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All researchers are independent from the funders. The corresponding author, Nicola Desmond, had full access to all the data in the study and had final responsibility for the decision to publish.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Brennan CA, 2003, BRIT J GEN PRACT, V53, P626; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; College of Medicine UoM, 2008, ETAT MAL PROJ REP EV; Crump JA, 2003, EMERG INFECT DIS, V9, P539, DOI 10.3201/eid0905.020428; Farr AC, 2005, J HLTH COMMUNICATION, V10; Filmer D, 2005, HEALTH POLICY PLANN, V20, P337, DOI 10.1093/heapol/czi043; Foley EE, 2008, MED ANTHROPOL Q, V22, P257, DOI 10.1111/j.1548-1387.2008.00025.x; FRANKEL S, 1991, BRIT J GEN PRACT, V41, P428; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Granier S, 1998, BRIT MED J, V316, P276, DOI 10.1136/bmj.316.7127.276; Gray A, 2008, WHAT ARE PREREQUISIT; Green E C, 1996, Med Anthropol, V17, P83; Haddad S, 1998, SOC SCI MED, V47, P381, DOI 10.1016/S0277-9536(98)00075-6; Hatchett LA, 2004, AIDS CARE, V16, P827, DOI 10.1080/09540120412331290112; Holtz TH, 2003, T ROY SOC TROP MED H, V97, P491, DOI 10.1016/S0035-9203(03)80003-2; Hunt K, 2001, INT J EPIDEMIOL, V30, P442, DOI 10.1093/ije/30.3.442; Kuipers M, 1994, SNAKES INFECT CHEST; Maglio A-ST., 2005, QUALITATIVE RES, V5, P475, DOI [10.1177/1468794105056924, DOI 10.1177/1468794105056924]; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Pelton S. I., 2010, Journal of Adolescent Health, V46, pS9, DOI 10.1016/j.jadohealth.2009.11.220; Pokhrel S, 2004, HEALTH POLICY PLANN, V19, P218, DOI 10.1093/heapol/czh027; Pool R, 2001, WOMEN INFERTILITY SU; Sauerborn R, 1996, Health Transit Rev, V6, P131; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Seale C., 1999, QUALITY QUALITATIVE; Sen A., 1990, PERSISTENT INEQUALIT; Shin SH, 2012, EXPERT OPIN PHARMACO, V13, P2189, DOI 10.1517/14656566.2012.724399; Sigauque B, 2008, ACTA TROP, V105, P21, DOI 10.1016/j.actatropica.2007.01.006; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Tanner M, 1998, SOC SCI MED, V46, P523, DOI 10.1016/S0277-9536(97)00195-0; Tolhurst R, 2008, SOC SCI MED, V66, P1106, DOI 10.1016/j.socscimed.2007.11.032; UNDP, 2011, MAL COUNTR PROF HUM; Vaahtera M, 2000, PAEDIATR PERINAT EP, V14, P363, DOI 10.1046/j.1365-3016.2000.00308.x	37	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68163	10.1371/journal.pone.0068163	http://dx.doi.org/10.1371/journal.pone.0068163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861864	Green Published, Green Accepted, gold			2022-12-25	WOS:000323350700073
J	Misra, SK; Biswas, J; Kondaiah, P; Bhattacharya, S				Misra, Santosh K.; Biswas, Joydeep; Kondaiah, Paturu; Bhattacharya, Santanu			Gene Transfection in High Serum Levels: Case Studies with New Cholesterol Based Cationic Gemini Lipids	PLOS ONE			English	Article							IN-VITRO; DNA; DELIVERY; CELLS; EFFICIENCY; LIPOPLEXES; LIPOSOMES; MEMBRANE; THERAPY; VECTORS	Background: Six new cationic gemini lipids based on cholesterol possessing different positional combinations of hydroxyethyl (-CH2CH2OH) and oligo-oxyethylene -(CH2CH2O)(n)- moieties were synthesized. For comparison the corresponding monomeric lipid was also prepared. Each new cationic lipid was found to form stable, clear suspensions in aqueous media. Methodology/Principal Findings: To understand the nature of the individual lipid aggregates, we have studied the aggregation properties using transmission electron microscopy (TEM), dynamic light scattering (DLS), zeta potential measurements and X-ray diffraction (XRD). We studied the lipid/DNA complex (lipoplex) formation and the release of the DNA from such lipoplexes using ethidium bromide. These gemini lipids in presence of a helper lipid, 1, 2-dioleoyl phophatidyl ethanol amine (DOPE) showed significant enhancements in the gene transfection compared to several commercially available transfection agents. Cholesterol based gemini having -CH2-CH2-OH groups at the head and one oxyethylene spacer was found to be the most effective lipid, which showed transfection activity even in presence of high serum levels (50%) greater than Effectene, one of the potent commercially available transfecting agents. Most of these geminis protected plasmid DNA remarkably against DNase I in serum, although the degree of stability was found to vary with their structural features. Conclusions/Significance: -OH groups present on the cationic headgroups in combination with oxyethylene linkers on cholesterol based geminis, gave an optimized combination of new genera of gemini lipids possessing high transfection efficiency even in presence of very high percentage of serum. This property makes them preferential transfection reagents for possible in vivo studies.	[Misra, Santosh K.; Biswas, Joydeep; Bhattacharya, Santanu] Indian Inst Sci, Dept Organ Chem, Bangalore 560012, Karnataka, India; [Kondaiah, Paturu] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Bhattacharya, Santanu] JNCASR, Chem Biol Unit, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Bhattacharya, S (corresponding author), Indian Inst Sci, Dept Organ Chem, Bangalore 560012, Karnataka, India.	sb@orgchem.iisc.ernet.in	Mishra, Santosh/S-7516-2017; Biswas, Joydeep/N-1534-2013; Bhattacharya, Santanu/N-6531-2019; BHATTACHARYA, SANTANU/E-9739-2010; Bhattacharya, Santanu/GRS-4780-2022	Mishra, Santosh/0000-0001-8616-2606; Biswas, Joydeep/0000-0002-8055-3187; Bhattacharya, Santanu/0000-0001-9040-8971; BHATTACHARYA, SANTANU/0000-0001-9040-8971; Misra, Santosh K./0000-0002-3313-4895	Department of Science and Technology; CSIR, New Delhi	Department of Science and Technology(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology. J.B. thanks the CSIR, New Delhi, for the award of a research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 1998, NATURE, V392, P25; Bajaj A, 2008, J MED CHEM, V51, P2533, DOI 10.1021/jm7010436; Bajaj A, 2008, BIOMACROMOLECULES, V9, P991, DOI 10.1021/bm700930y; Bajaj A, 2008, BBA-BIOMEMBRANES, V1778, P1222, DOI 10.1016/j.bbamem.2007.12.010; Bajaj A, 2007, BIOCONJUGATE CHEM, V18, P1537, DOI 10.1021/bc070010q; Banerjee R, 1999, J MED CHEM, V42, P4292, DOI 10.1021/jm9806446; Banerjee R, 2001, J MED CHEM, V44, P4176, DOI 10.1021/jm000466s; Benatti CR, 2007, CHEM PHYS LIPIDS, V145, P27, DOI 10.1016/j.chemphyslip.2006.10.002; Betker JL, 2013, THER DELIV, V4, P453, DOI [10.4155/tde.13.16, 10.4155/TDE.13.16]; Beyer U, 2001, PHARM RES-DORDR, V18, P29, DOI 10.1023/A:1011018525121; Bhattacharya S, 2004, BIOCONJUGATE CHEM, V15, P508, DOI 10.1021/bc0340215; Bhattacharya S, 1998, BIOCHEMISTRY-US, V37, P7764, DOI 10.1021/bi971772j; Bhattacharya S, 2003, J PHYS CHEM B, V107, P3719, DOI 10.1021/jp0272771; Bhattacharya S, 2009, CHEM COMMUN, P4632, DOI 10.1039/b900666b; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Braun CS, 2005, J PHARM SCI-US, V94, P423, DOI 10.1002/jps.20251; Candiani G, 2008, J GENE MED, V10, P637, DOI 10.1002/jgm.1186; Candiani G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013430; Cardoso AMS, 2011, BBA-BIOMEMBRANES, V1808, P341, DOI 10.1016/j.bbamem.2010.09.026; Chae HY, 2005, EXP MOL MED, V37, P513, DOI 10.1038/emm.2005.64; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; Curiel TJ, 1997, GENE THER, V4, P1284, DOI 10.1038/sj.gt.3300538; Dileep PV, 2001, FEBS LETT, V509, P327, DOI 10.1016/S0014-5793(01)03193-3; Ding W, 2008, INT J PHARMACEUT, V354, P196, DOI 10.1016/j.ijpharm.2007.10.051; Duchler M, 2001, J GENE MED, V3, P115; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FELGNER PL, 1989, NATURE, V337, P387, DOI 10.1038/337387a0; GAO X, 1991, BIOCHEM BIOPH RES CO, V179, P280, DOI 10.1016/0006-291X(91)91366-K; Ghosh YK, 2002, BIOCONJUGATE CHEM, V13, P378, DOI 10.1021/bc010048h; Ghosh YK, 2000, FEBS LETT, V473, P341, DOI 10.1016/S0014-5793(00)01558-1; Guo B, 2001, BIOTECHNIQUES, V31, P314, DOI 10.2144/01312st02; Hasegawa S, 2002, BIOORG MED CHEM LETT, V12, P1299, DOI 10.1016/S0960-894X(02)00119-1; Hattori Y, 2005, CANCER GENE THER, V12, P796, DOI 10.1038/sj.cgt.7700844; Hattori Y, 2007, J CONTROL RELEASE, V120, P122, DOI 10.1016/j.jconrel.2007.04.012; Hirsch-Lerner D, 2005, BBA-BIOMEMBRANES, V1714, P71, DOI 10.1016/j.bbamem.2005.04.008; Kerner M, 2001, BBA-MOL CELL BIOL L, V1532, P128, DOI 10.1016/S1388-1981(01)00118-4; Kim D, 2011, MACROMOL RES, V19, P573, DOI 10.1007/s13233-011-0606-5; KNOWLES MR, 1995, NEW ENGL J MED, V333, P823, DOI 10.1056/NEJM199509283331302; Marty R, 2009, NUCLEIC ACIDS RES, V37, P849, DOI 10.1093/nar/gkn1003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakanishi M, 2003, CURR MED CHEM, V10, P1289, DOI 10.2174/0929867033457395; Percot A, 2004, INT J PHARMACEUT, V278, P143, DOI 10.1016/j.ijpharm.2004.03.003; Perouzel E, 2003, BIOCONJUGATE CHEM, V14, P884, DOI 10.1021/bc034068q; Rajesh M, 2007, J AM CHEM SOC, V129, P11408, DOI 10.1021/ja0704683; Resina S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006058; Reynier P, 2004, J DRUG TARGET, V12, P25, DOI 10.1080/10611860410001683040; Riquelme BD, 2006, J BIOCHEM BIOPH METH, V68, P31, DOI 10.1016/j.jbbm.2005.12.009; Rittner K, 2002, MOL THER, V5, P104, DOI 10.1006/mthe.2002.0523; Rodriguez-Pulido A, 2008, J PHYS CHEM B, V112, P2187, DOI 10.1021/jp7095828; Simberg D, 2001, J BIOL CHEM, V276, P47453, DOI 10.1074/jbc.M105588200; Sochanik A, 2000, CANCER GENE THER, V7, P513, DOI 10.1038/sj.cgt.7700167; Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630; Wang J, 2002, J CONTROL RELEASE, V83, P157, DOI 10.1016/S0168-3659(02)00180-3; YANG YP, 1994, NAT GENET, V7, P362, DOI 10.1038/ng0794-362; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Yla-Herttuala S, 2000, LANCET, V355, P213, DOI 10.1016/S0140-6736(99)04180-X; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493	57	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68305	10.1371/journal.pone.0068305	http://dx.doi.org/10.1371/journal.pone.0068305			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861884	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000323350700078
J	Welch, DB; Seitz, AR				Welch, Dan B.; Seitz, Aaron R.			Processing Irrelevant Location Information: Practice and Transfer Effects in a Simon Task	PLOS ONE			English	Article							STIMULUS-RESPONSE COMPATIBILITY; S-R COMPATIBILITY; ACTIVATION; INTERFERENCE; ACCOUNT; DISPLAY; CODES; TIME; CUE	How humans produce cognitively driven fine motor movements is a question of fundamental importance in how we interact with the world around us. For example, we are exposed to a constant stream of information and we must select the information that is most relevant by which to guide our actions. In the present study, we employed a well-known behavioral assay called the Simon task to better understand how humans are able to learn to filter out irrelevant information. We trained subjects for four days with a visual stimulus presented, alternately, in central and lateral locations. Subjects responded with one hand moving a joystick in either the left or right direction. They were instructed to ignore the irrelevant location information and respond based on color (e.g. red to the right and green to the left). On the fifth day, an additional testing session was conducted where the task changed and the subjects had to respond by shape (e.g. triangle to the right and rectangle to the left). They were instructed to ignore the color and location, and respond based solely on the task relevant shape. We found that the magnitude of the Simon effect decreases with training, however it returns in the first few trials after a break. Furthermore, task-defined associations between response direction and color did not significantly affect the Simon effect based on shape, and no significant associative learning from the specific stimulus-response features was found for the centrally located stimuli. We discuss how these results are consistent with a model involving route suppression/gating of the irrelevant location information. Much of the learning seems to be driven by subjects learning to suppress irrelevant location information, however, this seems to be an active inhibition process that requires a few trials of experience to engage.	[Welch, Dan B.] So Illinois Univ, Sch Dent Med, Dept Growth Dev & Struct, Alton, IL USA; [Welch, Dan B.; Seitz, Aaron R.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	Southern Illinois University System; Southern Illinois University; University of California System; University of California Riverside	Welch, DB (corresponding author), So Illinois Univ, Sch Dent Med, Dept Growth Dev & Struct, Alton, IL USA.	dwelch@siue.edu						Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; GUIARD Y, 1994, PSYCHOL RES-PSYCH FO, V56, P210, DOI 10.1007/BF00419709; HASBROUCQ T, 1991, J EXP PSYCHOL HUMAN, V17, P246, DOI 10.1037/0096-1523.17.1.246; HEDGE A, 1975, ACTA PSYCHOL, V39, P427, DOI 10.1016/0001-6918(75)90041-4; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P270, DOI 10.1007/BF00419687; Iani C, 2009, MEM COGNITION, V37, P358, DOI 10.3758/MC.37.3.358; Nicoletti Umilta C, 1989, J EXPT PSYCHOL HUMAN, V15, P164; Notebaert W, 2001, PSYCHOL RES-PSYCH FO, V65, P170, DOI 10.1007/s004260000054; OLEARY MJ, 1994, PSYCHOL RES-PSYCH FO, V56, P196, DOI 10.1007/BF00419707; PASHLER H, 1991, J EXP PSYCHOL LEARN, V17, P20, DOI 10.1037/0278-7393.17.1.20; PROCTOR RW, 1993, J EXP PSYCHOL LEARN, V19, P922, DOI 10.1037/0278-7393.19.4.922; Proctor RW, 1999, MEM COGNITION, V27, P63, DOI 10.3758/BF03201214; PROCTOR RW, 1995, ACTA PSYCHOL, V90, P275, DOI 10.1016/0001-6918(95)00030-X; Proctor RW, 2012, J EXPT PSYCHOL; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; SIMON JR, 1972, J EXP PSYCHOL, V92, P405, DOI 10.1037/h0032269; SIMON JR, 1973, J EXP PSYCHOL, V101, P175, DOI 10.1037/h0035766; SIMON JR, 1970, J EXP PSYCHOL, V85, P311, DOI 10.1037/h0029522; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; SIMON JR, 1990, ACTA PSYCHOL, V73, P159, DOI 10.1016/0001-6918(90)90077-S; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Soetens E, 2010, ATTEN PERCEPT PSYCHO, V72, P895, DOI 10.3758/APP.72.4.895; STOFFER TH, 1991, PSYCHOL RES-PSYCH FO, V53, P127, DOI 10.1007/BF01371820; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Tagliabue M, 2002, MEM COGNITION, V30, P18, DOI 10.3758/BF03195261; Tagliabue M, 2000, J EXP PSYCHOL HUMAN, V26, P648, DOI 10.1037//0096-1523.26.2.648; UMILTA C, 1987, PSYCHOL RES-PSYCH FO, V49, P81, DOI 10.1007/BF00308672; Umilta C, 1990, STIMULUS RESPONSE CO, P508; Umilta C, 1985, ATTENTION PERFORMANC; Valle-Inclan F, 2002, ATTENTION PERFORM, V19, P474	31	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e64993	10.1371/journal.pone.0064993	http://dx.doi.org/10.1371/journal.pone.0064993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861735	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700002
J	Aloisi, A; Barca, A; Romano, A; Guerrieri, S; Storelli, C; Rinaldi, R; Verri, T				Aloisi, Alessandra; Barca, Amilcare; Romano, Alessandro; Guerrieri, Sara; Storelli, Carlo; Rinaldi, Rosaria; Verri, Tiziano			Anti-Aggregating Effect of the Naturally Occurring Dipeptide Carnosine on A beta 1-42 Fibril Formation	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; LIGAND EFFICIENCY; MOUSE MODEL; AMINO-ACID; HOMOCARNOSINE; NEUROTOXICITY; A-BETA(1-42); INHIBITORS	Carnosine is an endogenous dipeptide abundant in the central nervous system, where by acting as intracellular pH buffering molecule, Zn/Cu ion chelator, antioxidant and anti-crosslinking agent, it exerts a well-recognized multi-protective homeostatic function for neuronal and non-neuronal cells. Carnosine seems to counteract proteotoxicity and protein accumulation in neurodegenerative conditions, such as Alzheimer's Disease (AD). However, its direct impact on the dynamics of AD-related fibril formation remains uninvestigated. We considered the effects of carnosine on the formation of fibrils/aggregates of the amyloidogenic peptide fragment A beta 1-42, a major hallmark of AD injury. Atomic force microscopy and thioflavin T assays showed inhibition of A beta 1-42 fibrillogenesis in vitro and differences in the aggregation state of A beta 1-42 small pre-fibrillar structures (monomers and small oligomers) in the presence of carnosine. in silico molecular docking supported the experimental data, calculating possible conformational carnosine/A beta 1-42 interactions. Overall, our results suggest an effective role of carnosine against A beta 1-42 aggregation.	[Aloisi, Alessandra; Guerrieri, Sara; Rinaldi, Rosaria] Ist Nanosci Lecce, NNL, CNR, Lecce, Italy; [Barca, Amilcare; Romano, Alessandro; Guerrieri, Sara; Storelli, Carlo; Verri, Tiziano] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy; [Rinaldi, Rosaria] Univ Salento, Math & Phys E De Giorgi Dept, Lecce, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Salento; University of Salento	Rinaldi, R (corresponding author), Ist Nanosci Lecce, NNL, CNR, Lecce, Italy.	ross.rinaldi@unisalento.it; tiziano.verri@unisalento.it	aloisi, alessandra/O-1432-2015; Verri, Tiziano/K-1442-2013; RINALDI, ROSARIA/N-3560-2015; Romano, Alessandro/AAN-8124-2020; Barca, Amilcare/I-1281-2019	aloisi, alessandra/0000-0002-9654-2108; Verri, Tiziano/0000-0003-4983-2767; RINALDI, ROSARIA/0000-0003-2798-9341; Barca, Amilcare/0000-0002-3117-2724; Romano, Alessandro/0000-0003-2766-8847	University of Salento; fondi ex-60%; Progetto Strategico PS105; Fondazione Umberto Veronesi	University of Salento; fondi ex-60%; Progetto Strategico PS105; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This work was partially supported by grants from the University of Salento (http://www.unisalento.it), fondi ex-60% (2009-2012; to TV and CS), Progetto Strategico PS105 (2009-2012; to RR) and Fondazione Umberto Veronesi (http://www.fondazioneveronesi.it/) (2011; to RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Amijee H, 2009, BIOCHEM SOC T, V37, P692, DOI 10.1042/BST0370692; Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Arisi I, 2011, J ALZHEIMERS DIS, V24, P721, DOI 10.3233/JAD-2011-101881; Attanasio F, 2009, BIOCHEMISTRY-US, V48, P6522, DOI 10.1021/bi900343n; Bakardjiev A, 1998, GLIA, V24, P346, DOI 10.1002/(SICI)1098-1136(199811)24:3<346::AID-GLIA9>3.0.CO;2-#; Bakardjiev A, 2000, BIOCHEMISTRY-MOSCOW+, V65, P779; Balion CM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-38; Bellia F, 2012, AMINO ACIDS, V43, P153, DOI 10.1007/s00726-011-1178-6; Bettens K, 2010, HUM MOL GENET, V19, pR4, DOI 10.1093/hmg/ddq142; Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711; Boldyrev AA, 2010, REJUV RES, V13, P156, DOI 10.1089/rej.2009.0923; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P419, DOI 10.1080/10408440802003991; Chini MG, 2009, J PEPT SCI, V15, P229, DOI 10.1002/psc.1095; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Cornelli U, 2010, NEURODEGENER DIS, V7, P193, DOI 10.1159/000295663; Corona C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017971; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; De Marchis S, 2000, J COMP NEUROL, V426, P378, DOI 10.1002/1096-9861(20001023)426:3<378::AID-CNE3>3.0.CO;2-1; DeMarchis S, 1997, NEUROSCI LETT, V237, P37, DOI 10.1016/S0304-3940(97)00800-8; Fernandez-Busquets X, 2010, CURR ALZHEIMER RES, V7, P428, DOI 10.2174/156720510791383787; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Fu QL, 2008, CELL MOL NEUROBIOL, V28, P307, DOI 10.1007/s10571-007-9235-0; Fung SY, 2003, BIOPHYS J, V85, P537, DOI 10.1016/S0006-3495(03)74498-1; Gallant S, 2000, BIOCHEMISTRY-MOSCOW+, V65, P866; Garcia-Sosa AT, 2008, J CHEM INF MODEL, V48, P2074, DOI 10.1021/ci800242z; Garcia-Sosa AT, 2010, J COMPUT CHEM, V31, P174, DOI 10.1002/jcc.21306; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Guiotto A, 2005, J MED CHEM, V48, P6156, DOI 10.1021/jm050507q; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Herculano B, 2013, J ALZHEIMERS DIS, V33, P983, DOI 10.3233/JAD-2012-121324; Hetenyi C, 2007, BIOINFORMATICS, V23, P2678, DOI 10.1093/bioinformatics/btm431; Hickman SE, 2010, CNS NEUROL DISORD-DR, V9, P168, DOI 10.2174/187152710791011982; Hipkiss AR, 2007, J ALZHEIMERS DIS, V11, P229; Hipkiss AR, 2011, MOL ASPECTS MED, V32, P267, DOI 10.1016/j.mam.2011.10.004; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Hipkiss AR, 2009, EXPERT REV NEUROTHER, V9, P583, DOI [10.1586/ern.09.32, 10.1586/ERN.09.32]; Hipkiss AR, 2009, EXP GERONTOL, V44, P237, DOI 10.1016/j.exger.2008.11.001; Hipkiss AR, 1998, ANN NY ACAD SCI, V854, P37, DOI 10.1111/j.1749-6632.1998.tb09890.x; Hobart LJ, 2004, LIFE SCI, V75, P1379, DOI 10.1016/j.lfs.2004.05.002; Hoffmann AM, 1996, NEUROSCI LETT, V215, P29, DOI 10.1016/S0304-3940(96)12937-2; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Karpuj M, 2004, AMINO ACIDS, V26, P373, DOI 10.1007/s00726-004-0082-8; Katzman R., 1978, ALZHEIMERS DIS SENIL; Kawahara M, 2011, METALLOMICS, V3, P726, DOI 10.1039/c1mt00015b; Kawahara Masahiro, 2007, Recent Pat CNS Drug Discov, V2, P145, DOI 10.2174/157488907780832698; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Koyama H, 2011, J CLIN TOXICOL S, VS3; Kulebyakin K, 2012, AMINO ACIDS, V43, P91, DOI 10.1007/s00726-011-1135-4; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Liu DX, 2006, BIOCHEMISTRY-US, V45, P10963, DOI 10.1021/bi060955f; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Mayeux R, 2011, NEUROBIOL AGING, V32, pS10, DOI 10.1016/j.neurobiolaging.2011.09.004; Mitew S, 2010, ACTA NEUROPATHOL, V119, P567, DOI 10.1007/s00401-010-0657-2; Munch G, 1997, BBA-MOL BASIS DIS, V1360, P17, DOI 10.1016/S0925-4439(96)00062-2; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohkawara T, 2006, WORLD J GASTROENTERO, V12, P6178, DOI 10.3748/wjg.v12.i38.6178; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Park KM, 2010, CELL SIGNAL, V22, P519, DOI 10.1016/j.cellsig.2009.11.006; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Preston JE, 1998, NEUROSCI LETT, V242, P105, DOI 10.1016/S0304-3940(98)00058-5; Reddy V Prakash, 2005, Sci Aging Knowledge Environ, V2005, ppe12, DOI 10.1126/sageke.2005.18.pe12; Rezai-Zadeh K, 2011, CURR ALZHEIMER RES, V8, P156, DOI 10.2174/156720511795256017; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027649; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Yan H, 2008, MOL VIS, V14, P2282; YOSHIKAWA T, 1991, BIOCHIM BIOPHYS ACTA, V1115, P15, DOI 10.1016/0304-4165(91)90005-2	82	49	49	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68159	10.1371/journal.pone.0068159	http://dx.doi.org/10.1371/journal.pone.0068159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844165	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000132
J	Cheng, AS; Morsch, M; Murata, Y; Ghazanfari, N; Reddel, SW; Phillips, WD				Cheng, Anson; Morsch, Marco; Murata, Yui; Ghazanfari, Nazanin; Reddel, Stephen W.; Phillips, William D.			Sequence of Age-Associated Changes to the Mouse Neuromuscular Junction and the Protective Effects of Voluntary Exercise	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; MUSCLE-FIBERS; OLD RATS; MICE; DENSITY	Loss of connections between motor neurons and skeletal muscle fibers contribute to motor impairment in old age, but the sequence of age-associated changes that precede loss of the neuromuscular synapse remains uncertain. Here we determine changes in the size of neuromuscular synapses within the tibialis anterior muscle across the life span of C57BL/6J mice. Immunofluorescence, confocal microscopy and morphometry were used to measure the area occupied by nerve terminal synaptophysin staining and postsynaptic acetylcholine receptors at motor endplates of 2, 14, 19, 22, 25 and 28month old mice. The key findings were: 1) At middle age (14-months) endplate acetylcholine receptors occupied 238 +/- 11 mu m(2) and nerve terminal synaptophysin 168 +/- 14 mu m(2) (mean +/- SEM). 2) Between 14-months and 19-months (onset of old age) the area occupied by postsynaptic acetylcholine receptors declined 30%. At many endplates the large acetylcholine receptor plaque became fragmented into multiple smaller acetylcholine receptor clusters. 3) Between 19- and 25-months, the fraction of endplate acetylcholine receptors covered by synaptophysin fell 21%. By 28-months, half of the endplates imaged retained <= 50 mu m(2) area of synaptophysin staining. 4) Within aged muscles, the degree to which an endplate remained covered by synaptophysin did not depend upon the total area of acetylcholine receptors, nor upon the number of discrete receptor clusters. 5) Voluntary wheel-running exercise, beginning late in middle-age, prevented much of the age-associated loss of nerve terminal synaptophysin. In summary, a decline in the area of endplate acetylcholine receptor clusters at the onset of old age was followed by loss of nerve terminal synaptophysin from the endplate. Voluntary running exercise, begun late in middle age, substantially inhibited the loss of nerve terminal from aging motor endplates.	[Cheng, Anson; Morsch, Marco; Murata, Yui; Ghazanfari, Nazanin; Phillips, William D.] Univ Sydney, Physiol & Bosch Inst, Sydney, NSW 2006, Australia; [Reddel, Stephen W.] Concord Hosp, Dept Mol Med, Concord, NSW, Australia	University of Sydney; Concord Repatriation General Hospital	Phillips, WD (corresponding author), Univ Sydney, Physiol & Bosch Inst, Sydney, NSW 2006, Australia.	billp@physiol.usyd.edu.au		Reddel, Stephen/0000-0002-0169-3350; Morsch, Marco/0000-0001-9484-8050; Phillips, William/0000-0002-5405-8422	National Health and Medical Research Council (Australia) [570930]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	The work presented was supported by a project grant from the National Health and Medical Research Council (Australia; http://www.nhmrc.gov.au/; grant number 570930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIZONO N, 1984, ACTA PATHOL JAPON, V34, P1243; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; CAMPBELL MJ, 1973, J NEUROL NEUROSUR PS, V36, P174, DOI 10.1136/jnnp.36.2.174; Chai RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028090; Chipman PH, 2010, EUR J NEUROSCI, V31, P238, DOI 10.1111/j.1460-9568.2009.07049.x; COURTNEY J, 1981, J PHYSIOL-LONDON, V320, P435, DOI 10.1113/jphysiol.1981.sp013960; Deschenes MR, 2006, NEUROSCIENCE, V137, P1277, DOI 10.1016/j.neuroscience.2005.10.042; Deschenes MR, 2003, J NEUROBIOL, V57, P246, DOI 10.1002/neu.10271; Fahim MA, 1997, J APPL PHYSIOL, V83, P59, DOI 10.1152/jappl.1997.83.1.59; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; Flurkey K, 2007, FACULTY RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Harrison DE, 2008, BASELINE LIFE SPAN D; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Kadhiresan VA, 1996, J PHYSIOL-LONDON, V493, P543, DOI 10.1113/jphysiol.1996.sp021402; LAND BR, 1980, P NATL ACAD SCI-BIOL, V77, P3736, DOI 10.1073/pnas.77.6.3736; Li Y, 2011, J NEUROSCI, V31, P14910, DOI 10.1523/JNEUROSCI.3590-11.2011; Ling SM, 2009, ARCH PHYS MED REHAB, V90, P1237, DOI 10.1016/j.apmr.2008.09.565; Messi ML, 2003, J NEUROSCI, V23, P1351, DOI 10.1523/JNEUROSCI.23-04-01351.2003; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB117, DOI 10.1093/gerona/55.3.B117; Morsch M, 2013, J PHYSIOL-LONDON, V591, P2747, DOI 10.1113/jphysiol.2013.251827; Morsch M, 2012, EXP NEUROL, V237, P286, DOI 10.1016/j.expneurol.2012.06.034; Prakash YS, 1998, MUSCLE NERVE, V21, P887, DOI 10.1002/(SICI)1097-4598(199807)21:7<887::AID-MUS6>3.0.CO;2-2; ROSENHEIMER JL, 1990, INT J DEV NEUROSCI, V8, P643, DOI 10.1016/0736-5748(90)90059-B; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; STALBERG E, 1975, J NEUROL NEUROSUR PS, V38, P874, DOI 10.1136/jnnp.38.9.874; Urbanchek MG, 2001, J GERONTOL A-BIOL, V56, pB191, DOI 10.1093/gerona/56.5.B191; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107	29	49	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67970	10.1371/journal.pone.0067970	http://dx.doi.org/10.1371/journal.pone.0067970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844140	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000122
J	Halfter, W; Monnier, C; Muller, D; Oertle, P; Uechi, G; Balasubramani, M; Safi, F; Lim, R; Loparic, M; Henrich, PB				Halfter, Willi; Monnier, Christophe; Mueller, David; Oertle, Philipp; Uechi, Guy; Balasubramani, Manimalha; Safi, Farhad; Lim, Roderick; Loparic, Marko; Henrich, Paul Bernhard			The Bi-Functional Organization of Human Basement Membranes	PLOS ONE			English	Article							INNER LIMITING MEMBRANE; COLLAGEN-IV; AXONAL GROWTH; MESSENGER-RNA; 7-S COLLAGEN; BASAL LAMINA; GENE LAMC2; CHAIN GENE; EXPRESSION; LOCALIZATION	The current basement membrane (BM) model proposes a single-layered extracellular matrix (ECM) sheet that is predominantly composed of laminins, collagen IVs and proteoglycans. The present data show that BM proteins and their domains are asymmetrically organized providing human BMs with side-specific properties: A) isolated human BMs roll up in a side-specific pattern, with the epithelial side facing outward and the stromal side inward. The rolling is independent of the curvature of the tissue from which the BMs were isolated. B) The epithelial side of BMs is twice as stiff as the stromal side, and C) epithelial cells adhere to the epithelial side of BMs only. Side-selective cell adhesion was also confirmed for BMs from mice and from chick embryos. We propose that the bi-functional organization of BMs is an inherent property of BMs and helps build the basic tissue architecture of metazoans with alternating epithelial and connective tissue layers.	[Halfter, Willi] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Monnier, Christophe; Mueller, David; Oertle, Philipp; Lim, Roderick; Loparic, Marko] Univ Basel, Bioctr, CH-4056 Basel, Switzerland; [Uechi, Guy; Balasubramani, Manimalha] Univ Pittsburgh, Prote Core Facil, Pittsburgh, PA USA; [Safi, Farhad] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Henrich, Paul Bernhard] Univ Basel, Dept Ophthalmol, Basel, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Basel; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Basel	Halfter, W (corresponding author), Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA.	whalfter@pitt.edu		Muller, David/0000-0003-1914-3768; Lim, Roderick/0000-0001-5015-6087; Monnier, Christophe/0000-0002-0071-7269	University of Pittsburgh; Biocenter of the University of Basel; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	University of Pittsburgh(University of Pittsburgh); Biocenter of the University of Basel; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The publication was funded by the University of Pittsburgh and the Biocenter of the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Balasubramani M, 2010, MATRIX BIOL, V29, P471, DOI 10.1016/j.matbio.2010.04.002; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Candiello J, 2007, FEBS J, V274, P2897, DOI 10.1111/j.1742-4658.2007.05823.x; Candiello J, 2010, MATRIX BIOL, V29, P402, DOI 10.1016/j.matbio.2010.03.004; Cann GM, 1996, DEV BIOL, V180, P82, DOI 10.1006/dbio.1996.0286; Chen J, 2011, INVEST OPHTH VIS SCI, V52, P8957, DOI 10.1167/iovs.11-8078; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Danysh BP, 2009, EXP EYE RES, V88, P151, DOI 10.1016/j.exer.2008.08.002; Danysh BP, 2008, ANAT REC, V291, P1619, DOI 10.1002/ar.20753; Davis GE, 1978, SCIENCE, V236, P106; DONG LJ, 1991, DIFFERENTIATION, V48, P157, DOI 10.1111/j.1432-0436.1991.tb00254.x; Dong SC, 2002, J COMP NEUROL, V447, P261, DOI 10.1002/cne.10245; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Halfter W, 2005, INVEST OPHTH VIS SCI, V46, P2202, DOI 10.1167/iovs.04-1419; HALFTER W, 1992, EUR J NEUROSCI, V4, P840, DOI 10.1111/j.1460-9568.1992.tb00194.x; HALFTER W, 1987, J NEUROSCI, V7, P3712; HALFTER W, 1983, DEV BIOL, V95, P56, DOI 10.1016/0012-1606(83)90006-4; Hasenson S, 2005, EXP EYE RES, V81, P415, DOI 10.1016/j.exer.2005.02.015; Henrich PB, 2012, INVEST OPHTH VIS SCI, V29, P2561; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Hudson BG, 1995, EXTRACELLULAR MATRIX; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; Lee J, 2007, INVEST OPHTH VIS SCI, V48, P2483, DOI 10.1167/iovs.06-1211; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P1402; NAYAK BR, 1991, J BIOL CHEM, V266, P13978; Neumann KH, 2004, NEPHROL DIAL TRANSPL, V19, P805, DOI 10.1093/ndt/gfh067; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; SARTHY V, 1993, INVEST OPHTH VIS SCI, V34, P145; Schlie K, 2010, J VIROL, V84, P3178, DOI 10.1128/JVI.02240-09; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; SUNDARRAJ N, 1982, IMMUNOLOGY, V47, P133; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; Uechi G, 2013, PROTEOMIC ANAL UNPUB; Vazquez F, 1996, MATURITAS, V25, P209, DOI 10.1016/S0378-5122(96)01066-3; Willem M, 2002, DEVELOPMENT, V129, P2711; Yin Y, 2003, GENESIS, V36, P114, DOI 10.1002/gene.10206; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	61	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67660	10.1371/journal.pone.0067660	http://dx.doi.org/10.1371/journal.pone.0067660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844050	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000321733000089
J	Jeru, I; Hentgen, V; Cochet, E; Duquesnoy, P; Le Borgne, G; Grimprel, E; Stojanovic, KS; Karabina, S; Grateau, G; Amselem, S				Jeru, Isabelle; Hentgen, Veronique; Cochet, Emmanuelle; Duquesnoy, Philippe; Le Borgne, Gaelle; Grimprel, Emmanuel; Stojanovic, Katia Stankovic; Karabina, Sonia; Grateau, Gilles; Amselem, Serge			The Risk of Familial Mediterranean Fever in MEFV Heterozygotes: A Statistical Approach	PLOS ONE			English	Article							DIAGNOSTIC-VALUE; CLINICAL SPECTRUM; ARMENIAN PATIENTS; CARRIER RATES; GENE ANALYSIS; LARGE COHORT; MUTATIONS; POPULATION; FREQUENCY; INFLAMMATION	Background: Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disorder due to MEFV mutations and one of the most frequent Mediterranean genetic diseases. The observation of many heterozygous patients in whom a second mutated allele was excluded led to the proposal that heterozygosity could be causal. However, heterozygosity might be coincidental in many patients due to the very high rate of mutations in Mediterranean populations. Objective: To better delineate the pathogenicity of heterozygosity in order to improve genetic counselling and disease management. Methods: Complementary statistical approaches were used: estimation of FMF prevalence at population levels, genotype comparison in siblings from 63 familial forms, and genotype study in 557 patients from four Mediterranean populations. Results: At the population level, we did not observe any contribution of heterozygosity to disease prevalence. In affected siblings of patients carrying two MEFV mutations, 92% carry two mutated alleles, whereas 4% are heterozygous with typical FMF diagnosis. We demonstrated statistically that patients are more likely to be heterozygous than healthy individuals, as shown by the higher ratio heterozygous carriers/non carriers in patients (p < 10(-7) - p < 0.003). The risk for heterozygotes to develop FMF was estimated between 2.1x10(-3) and 5.8x10(-3) and the relative risk, as compared to non carriers, between 6.3 and 8.1. Conclusions: This is the first statistical demonstration that heterozygosity is not responsible for classical Mendelian FMF per se, but constitutes a susceptibility factor for clinically-similar multifactorial forms of the disease. We also provide a first estimate of the risk for heterozygotes to develop FMF.	[Jeru, Isabelle; Duquesnoy, Philippe; Le Borgne, Gaelle; Karabina, Sonia; Amselem, Serge] INSERM, UMR S933, Paris, France; [Jeru, Isabelle; Le Borgne, Gaelle; Grimprel, Emmanuel; Karabina, Sonia; Grateau, Gilles; Amselem, Serge] Univ Paris 06, UMR S933, Paris, France; [Jeru, Isabelle; Cochet, Emmanuelle; Amselem, Serge] Hop Trousseau, AP HP, Serv Genet & Embryol Med, F-75571 Paris, France; [Jeru, Isabelle; Cochet, Emmanuelle; Duquesnoy, Philippe; Karabina, Sonia; Grateau, Gilles; Amselem, Serge] UPMC, AP HP, INSERM, Dept Hosp Univ Inflammat Immunopathol Biotherapy, Paris, France; [Jeru, Isabelle; Cochet, Emmanuelle; Duquesnoy, Philippe; Karabina, Sonia; Grateau, Gilles; Amselem, Serge] CNRS, Paris, France; [Hentgen, Veronique] Ctr Hosp Versailles, CeReMAI, Le Chesnay, France; [Grimprel, Emmanuel] Hop Trousseau, AP HP, Serv Pediat Gen, F-75571 Paris, France; [Stojanovic, Katia Stankovic; Grateau, Gilles] Hop Tenon, Ctr Reference Amyloses Origine Inflammatoire & Fi, F-75970 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Jeru, I (corresponding author), INSERM, UMR S933, Paris, France.	isabelle.jeru@trs.aphp.fr	HENTGEN, Véronique/AAR-1348-2021		Institut national de la sante et de la recherche medicale (INSERM); Universite Pierre et Marie Curie Paris; Agence Nationale pour la Recherche (ANR) [06-MRAR-010-02]	Institut national de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie Paris; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by grants from the Institut national de la sante et de la recherche medicale (INSERM); the Universite Pierre et Marie Curie Paris 6; and the Agence Nationale pour la Recherche (ANR) [06-MRAR-010-02]. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Idir D, 2011, RHEUMATOLOGY, V50, P2306, DOI 10.1093/rheumatology/ker328; Aksentijevich I, 1997, CELL, V90, P797; Al-Alami JR, 2003, SAUDI MED J, V24, P1055; Aldea A, 2004, AM J MED GENET A, V124A, P67, DOI 10.1002/ajmg.a.20296; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 2000, QJM-INT J MED, V93, P217, DOI 10.1093/qjmed/93.4.217; Booty MG, 2009, ARTHRITIS RHEUM-US, V60, P1851, DOI 10.1002/art.24569; Caglar MK, 2008, ACTA REUMATOL PORT, V33, P415; Cazeneuve C, 1999, AM J HUM GENET, V65, P88, DOI 10.1086/302459; Cazeneuve C, 2003, ARTHRITIS RHEUM-US, V48, P2324, DOI 10.1002/art.11102; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Dode C, 2000, AM J MED GENET, V92, P241, DOI 10.1002/(SICI)1096-8628(20000605)92:4<241::AID-AJMG3>3.3.CO;2-7; Federici S, 2012, ANN RHEUM DIS, V71, P1961, DOI 10.1136/annrheumdis-2011-200977; Giaglis S, 2007, CLIN GENET, V71, P458, DOI 10.1111/j.1399-0004.2007.00789.x; Hentgen V, 2013, ARTHRITIS RHEUM; Kalyoncu M, 2006, CLIN EXP RHEUMATOL, V24, pS120; KHACHADURIAN A K, 1974, Birth Defects Original Article Series, V10, P62; Kone-Paut I, 2009, RHEUMATOLOGY, V48, P840, DOI 10.1093/rheumatology/kep121; Lachmann HJ, 2006, RHEUMATOLOGY, V45, P746, DOI 10.1093/rheumatology/kei279; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; Moradian MM, 2010, J HUM GENET, V55, P389, DOI 10.1038/jhg.2010.52; Ozen S, 1999, Curr Opin Rheumatol, V11, P393, DOI 10.1097/00002281-199909000-00011; Ozen S, 2003, J RHEUMATOL, V30, P2014; ROGERS DB, 1989, AM J MED GENET, V34, P168, DOI 10.1002/ajmg.1320340206; Samuels J, 1998, MEDICINE, V77, P268, DOI 10.1097/00005792-199807000-00005; Sarkisian T, 2008, Georgian Med News, P105; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; Stoffels M, 2013, ANN RHEUM DIS; Stoffman N, 2000, EUR J HUM GENET, V8, P307, DOI 10.1038/sj.ejhg.5200446; Tchernitchko D, 2005, ARTHRITIS RHEUM-US, V52, P3603, DOI 10.1002/art.21408; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Touitou I, 2013, J MED GENET; van Gijn ME, 2008, EUR J HUM GENET, V16, P1404, DOI 10.1038/ejhg.2008.135; Yilmaz E, 2001, EUR J HUM GENET, V9, P553, DOI 10.1038/sj.ejhg.5200674; ZEMER D, 1986, NEW ENGL J MED, V314, P1001, DOI 10.1056/NEJM198604173141601	39	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68431	10.1371/journal.pone.0068431	http://dx.doi.org/10.1371/journal.pone.0068431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844200	Green Submitted, gold, Green Published			2022-12-25	WOS:000321733000005
J	Korner-Nievergelt, F; Brinkmann, R; Niermann, I; Behr, O				Korner-Nievergelt, Fraenzi; Brinkmann, Robert; Niermann, Ivo; Behr, Oliver			Estimating Bat and Bird Mortality Occurring at Wind Energy Turbines from Covariates and Carcass Searches Using Mixture Models	PLOS ONE			English	Article							MIGRATORY BATS; FATALITY; RADAR; ABUNDANCE; PATTERNS; IMPACTS; FARMS	Environmental impacts of wind energy facilities increasingly cause concern, a central issue being bats and birds killed by rotor blades. Two approaches have been employed to assess collision rates: carcass searches and surveys of animals prone to collisions. Carcass searches can provide an estimate for the actual number of animals being killed but they offer little information on the relation between collision rates and, for example, weather parameters due to the time of death not being precisely known. In contrast, a density index of animals exposed to collision is sufficient to analyse the parameters influencing the collision rate. However, quantification of the collision rate from animal density indices (e.g. acoustic bat activity or bird migration traffic rates) remains difficult. We combine carcass search data with animal density indices in a mixture model to investigate collision rates. In a simulation study we show that the collision rates estimated by our model were at least as precise as conventional estimates based solely on carcass search data. Furthermore, if certain conditions are met, the model can be used to predict the collision rate from density indices alone, without data from carcass searches. This can reduce the time and effort required to estimate collision rates. We applied the model to bat carcass search data obtained at 30 wind turbines in 15 wind facilities in Germany. We used acoustic bat activity and wind speed as predictors for the collision rate. The model estimates correlated well with conventional estimators. Our model can be used to predict the average collision rate. It enables an analysis of the effect of parameters such as rotor diameter or turbine type on the collision rate. The model can also be used in turbine-specific curtailment algorithms that predict the collision rate and reduce this rate with a minimal loss of energy production.	[Korner-Nievergelt, Fraenzi] Oikostat GmbH, Ettiswil, Switzerland; [Korner-Nievergelt, Fraenzi] Swiss Ornithol Inst, Sempach, Switzerland; [Brinkmann, Robert; Niermann, Ivo] Leibniz Univ Hannover, Inst Umweltplanung, D-30167 Hannover, Germany; [Brinkmann, Robert] Freiburg Inst Appl Anim Ecol, Freiburg, Germany; [Behr, Oliver] Univ Erlangen Nurnberg, Inst Tierphysiol, D-91054 Erlangen, Germany	Swiss Ornithological Institute; Leibniz University Hannover; University of Erlangen Nuremberg	Behr, O (corresponding author), Univ Erlangen Nurnberg, Inst Tierphysiol, D-91054 Erlangen, Germany.	obehr@biologie.uni-erlangen.de		Korner-Nievergelt, Franzi/0000-0001-9081-3563	German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety [FKZ 0327638]; Germany Ministry for environmental protection	German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety; Germany Ministry for environmental protection	The research was funded by the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (FKZ 0327638 A, B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Franzi Korner-Nievergelt is employed by oikostat GmbH. This company carried out a part of the research in the project as a contractor but did not fund the project. The research has solely been funded by the Germany Ministry for environmental protection. There are, hence, no conflicts regarding employment, consultancy, patents, products in development or marketed products etc, neither does this alter our adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, AUTOMATISCHE RUFANAL; Arnett E.B., 2009, PATTERNS BAT FATALIT; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; Baerwald EF, 2011, J WILDLIFE MANAGE, V75, P1103, DOI 10.1002/jwmg.147; Baerwald EF, 2009, J MAMMAL, V90, P1341, DOI 10.1644/09-MAMM-S-104R.1; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Behr O, 2011, ENTWICKLUNG METHODEN, P354; Behr O., 2011, METHODEN UNTERSUCHUN, P287; Bernardino J, 2013, NEW ZEAL J ZOOL, V40, P63, DOI 10.1080/03014223.2012.758155; Bispo R, 2012, ENV ECOLOGICAL STAT; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brinkmann R., 2011, ENTWICKLUNG METHODEN; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bruderer B, 1997, NATURWISSENSCHAFTEN, V84, P1, DOI 10.1007/s001140050338; Bruderer B, 1997, NATURWISSENSCHAFTEN, V84, P45, DOI 10.1007/s001140050348; BWE BW, 2012, INST WIND DEUTSCHL; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; De Lucas M., 2007, BIRDS WIND FARMS RIS; Dulac Perrine, 2010, Symbioses, V25, P32; Eichhorn M, 2012, ECOL SOC, V17, DOI 10.5751/ES-04594-170201; Guinard E, 2012, BIOL CONSER IN PRESS; Higgins K. F., 2007, BIRDS AND WIND FARMS, V275, P153; Hull CL, 2010, AUSTRALAS J ENV MAN, V17, P77, DOI 10.1080/14486563.2010.9725253; Huso M, 2012, DATA SERIES US GEOLO, V729; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Johnson GD, 2004, WILDLIFE SOC B, V32, P1278, DOI 10.2193/0091-7648(2004)032[1278:BACACM]2.0.CO;2; Kerns J., 2005, RELATIONSHIPS BATS W, P24; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Korner-Nievergelt F, 2011, WILDLIFE BIOL, V17, P350, DOI 10.2981/10-121; Kunz TH, 2007, J WILDLIFE MANAGE, V71, P2449, DOI 10.2193/2007-270; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Liechti F, 1995, J FIELD ORNITHOL, V66, P457; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Lunn D., 2009, BUGS PROJECT EVOLUTI, P1; Madders M, 2006, IBIS, V148, P43, DOI 10.1111/j.1474-919X.2006.00506.x; Niermann I., 2011, SYSTEMATISCHE SCHLAG, P40; Osborn RG, 2000, AM MIDL NAT, V143, P41, DOI 10.1674/0003-0031(2000)143[0041:BMAWWT]2.0.CO;2; R Development Core Team, 2012, R LANG ENV STAT COMP; Rawlings JO, 1998, APPL REGRESSION ANAL, DOI 10.1007/b98890; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Santos SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025383; Schaub M, 2012, BIOL CONSERV, V155, P111, DOI 10.1016/j.biocon.2012.06.021; Solymos P, 2012, ENVIRONMETRICS ONLIN; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Weller TJ, 2012, J WILDLIFE MANAGE, V76, P619, DOI 10.1002/jwmg.260	50	40	41	3	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67997	10.1371/journal.pone.0067997	http://dx.doi.org/10.1371/journal.pone.0067997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844144	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000123
J	Merkel, B; Lydersen, C; Yoccoz, NG; Kovacs, KM				Merkel, Benjamin; Lydersen, Christian; Yoccoz, Nigel G.; Kovacs, Kit M.			The World's Northernmost Harbour Seal Population-How Many Are There?	PLOS ONE			English	Article							PRINS KARLS FORLAND; HAUL-OUT BEHAVIOR; PHOCA-VITULINA; MAXIMUM-LIKELIHOOD; TUGIDAK ISLAND; GLACIER BAY; COMMON SEAL; ABUNDANCE; AGE; SVALBARD	This study presents the first abundance estimate for the world's northernmost harbour seal (Phoca vitulina) population, which resides in Svalbard, Norway, based on three digital stereoscopic photographic surveys conducted in 2009 and 2010. The counts from these high resolution 3D images were combined with a novel method for estimating correction factors for animals that were in the water at the time of the surveys, in which extensive behavioural data from radio-tagged harbour seals were used together with age distribution data to estimate the proportion of seals of various age and sex classes hauled out at the times of the surveys. To detect possible seasonal shifts in age distribution between surveys, lengths of hauled out seals were measured from the stereoscopic images. No body-length differences were detected between the surveys; but, this may be due to a high degree of sexual dimorphism exhibited in this population. Applying the modelled correction factors, a total of 1888 (95% CI: 1660-3023), 1742 (1381-3549) and 1812 (1656-4418) harbour seals were estimated for the surveys flown on 01 August 2009, 01 August 2010 and 19 August 2010, respectively. The similarity between the three survey estimates (despite significant differences in the number of animals actually counted on the photos from each survey effort) suggests that the variation in numbers of hauled out seals is reasonably accurately adjusted for by the haul-out probability model. The low population size, the limited spatial distribution of the population and its reduced genetic diversity make this population vulnerable to chance events, such as disease epidemics.	[Merkel, Benjamin; Lydersen, Christian; Kovacs, Kit M.] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Merkel, Benjamin; Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	Norwegian Polar Institute; UiT The Arctic University of Tromso	Kovacs, KM (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	Kit.Kovacs@npolar.no	Yoccoz, Nigel/C-8561-2014	Yoccoz, Nigel/0000-0003-2192-1039	Norwegian Research Council [184644]; Norwegian Polar Institute	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Polar Institute	This study was funded by the Norwegian Research Council (Sea and Coastal Programme, grant no 184644) and the Norwegian Polar Institute. The funding agents had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLEN SG, 1985, MAR MAMMAL SCI, V1, P84, DOI 10.1111/j.1748-7692.1985.tb00532.x; Andersen LW, 2011, BIOL J LINN SOC, V102, P420, DOI 10.1111/j.1095-8312.2010.01577.x; Andersen SM, 2004, CAN J ZOOL, V82, P1230, DOI 10.1139/Z04-093; Arndt W, 1900, FUNA ARCTICA ZUSAMME; Bigg M.A., 1981, HDB MARINE MAMMALS, V2, P1; Bigg MA, 1969, B FISH RES BD CAN, V172; Bjorge Arne, 2007, Aquatic Mammals, V33, P269, DOI 10.1578/AM.33.3.2007.269; Boulva J, 1979, B FISH RES BD CAN, V200; Boveng PL, 2003, MAR MAMMAL SCI, V19, P111, DOI 10.1111/j.1748-7692.2003.tb01096.x; Bowen WD, 1999, CAN J ZOOL, V77, P978, DOI 10.1139/cjz-77-6-978; Bowen WD, 2003, J ZOOL, V261, P155, DOI 10.1017/S0952836903004047; Burns JJ, 1984, NOAA TECHNICAL REPOR, V12, P17; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Carlens H, 2006, MAR MAMMAL SCI, V22, P379, DOI 10.1111/j.1748-7692.2006.00034.x; Cox DR, 2007, ANN APPL STAT, V1, P1, DOI 10.1214/07-AOAS113; Cronin M, 2007, J ZOOL, V273, P131, DOI 10.1111/j.1469-7998.2007.00316.x; Cunningham L, 2010, J MAR BIOL ASSOC UK, V90, P1659, DOI 10.1017/S002531540999155X; Daniel RG, 2003, MAR MAMMAL SCI, V19, P128, DOI 10.1111/j.1748-7692.2003.tb01097.x; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; Gales NJ, 2009, MAR MAMMAL SCI, V25, P725, DOI 10.1111/j.1748-7692.2008.00279.x; Gilbert JR, 2005, MAR MAMMAL SCI, V21, P519, DOI 10.1111/j.1748-7692.2005.tb01246.x; Gjertz I, 2001, POLAR BIOL, V24, P209, DOI 10.1007/s003000000197; GJERTZ I, 1992, MAR MAMMAL SCI, V8, P103, DOI 10.1111/j.1748-7692.1992.tb00369.x; Hamel S, 2012, METHODS ECOL EVOL, V3, P731, DOI 10.1111/j.2041-210X.2012.00195.x; Harkonen T, 2002, CAN J ZOOL, V80, P1498, DOI 10.1139/Z02-141; Harkonen T, 1999, J APPL ECOL, V36, P825, DOI 10.1046/j.1365-2664.1999.00434.x; HARKONEN T, 1990, OPHELIA, V32, P211; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvey JT, 2011, MAR MAMMAL SCI, V27, P719, DOI 10.1111/j.1748-7692.2010.00446.x; Hastings KK, 2012, J MAMMAL, V93, P1368, DOI 10.1644/11-MAMM-A-291.1; Hauksson Erlingur, 1992, Hafrannsoknir, V43, P23; Hoef JMV, 2010, COMPUTATION STAT, V25, P39, DOI 10.1007/s00180-009-0160-1; Hop H, 2002, POLAR RES, V21, P167, DOI 10.1111/j.1751-8369.2002.tb00073.x; Jorgensen C, 2001, J EXP BIOL, V204, P3993; King JE., 1983, SEALS WORLD BRIT MUS; Kovacs Kit M., 2008, Science Progress, V91, P117, DOI 10.3184/003685008X324010; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Labansen AL, 2007, ICES J MAR SCI, V64, P1246, DOI 10.1093/icesjms/fsm090; London JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038180; Lydersen C, 2005, POLAR BIOL, V28, P156, DOI 10.1007/s00300-004-0656-7; Lydersen Christian, 2010, NAMMCO Scientific Publications, V8, P47; Lydersen Christian, 2002, P1; MARKUSSEN NH, 1989, J ZOOL, V219, P433, DOI 10.1111/j.1469-7998.1989.tb02591.x; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; MUELBERT MMC, 1993, CAN J ZOOL, V71, P1405, DOI 10.1139/z93-194; OLESIUK PF, 1990, CAN J FISH AQUAT SCI, V47, P992, DOI 10.1139/f90-114; PITCHER KW, 1981, CAN FIELD NAT, V95, P292; PRESTRUD P, 1990, MAR MAMMAL SCI, V6, P215, DOI 10.1111/j.1748-7692.1990.tb00245.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reder S, 2003, POLAR BIOL, V27, P6, DOI 10.1007/s00300-003-0557-1; Ries EH, 1998, J APPL ECOL, V35, P332, DOI 10.1046/j.1365-2664.1998.00305.x; Roen R, 1995, DEV MAR BIO, V4, P61; Small RJ, 2003, MAR MAMMAL SCI, V19, P344, DOI 10.1111/j.1748-7692.2003.tb01113.x; Teilmann J, 2010, ICES J MAR SCI, V67, P952, DOI 10.1093/icesjms/fsq001; THOMPSON P, 1987, J ZOOL, V212, P597, DOI 10.1111/j.1469-7998.1987.tb05958.x; THOMPSON P, 1988, MAMMAL REV, V18, P105, DOI 10.1111/j.1365-2907.1988.tb00080.x; Thompson PM, 1997, J APPL ECOL, V34, P43, DOI 10.2307/2404846; VanParijs SM, 1997, ANIM BEHAV, V54, P35, DOI 10.1006/anbe.1996.0426; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	62	14	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67576	10.1371/journal.pone.0067576	http://dx.doi.org/10.1371/journal.pone.0067576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844035	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000083
J	Stenner, F; Liewen, H; Gottig, S; Henschler, R; Markuly, N; Kleber, S; Faust, M; Mischo, A; Bauer, S; Zweifel, M; Knuth, A; Renner, C; Wadle, A				Stenner, Frank; Liewen, Heike; Goettig, Stephan; Henschler, Reinhard; Markuly, Norbert; Kleber, Sascha; Faust, Michael; Mischo, Axel; Bauer, Stefan; Zweifel, Martin; Knuth, Alexander; Renner, Christoph; Wadle, Andreas			RP1 Is a Phosphorylation Target of CK2 and Is Involved in Cell Adhesion	PLOS ONE			English	Article							PROTEIN-KINASE CK2; EB1 FAMILY PROTEINS; CANCER-CELLS; GENE FAMILY; ASSOCIATION; BINDING; PROLIFERATION; EXPRESSION; ADDICTION; SURVIVAL	RP1 (synonym: MAPRE2, EB2) is a member of the microtubule binding EB1 protein family, which interacts with APC, a key regulatory molecule in the Wnt signalling pathway. While the other EB1 proteins are well characterized the cellular function and regulation of RP1 remain speculative to date. However, recently RP1 has been implicated in pancreatic cancerogenesis. CK2 is a pleiotropic kinase involved in adhesion, proliferation and anti-apoptosis. Overexpression of protein kinase CK2 is a hallmark of many cancers and supports the malignant phenotype of tumor cells. In this study we investigate the interaction of protein kinase CK2 with RP1 and demonstrate that CK2 phosphorylates RP1 at Ser(236) in vitro. Stable RP1 expression in cell lines leads to a significant cleavage and down-regulation of N-cadherin and impaired adhesion. Cells expressing a Phosphomimicking point mutant RP1-ASP(236) show a marked decrease of adhesion to endothelial cells under shear stress. Inversely, we found that the cells under shear stress downregulate endogenous RP1, most likely to improve cellular adhesion. Accordingly, when RP1 expression is suppressed by shRNA, cells lacking RP1 display significantly increased cell adherence to surfaces. In summary, RP1 phosphorylation at Ser(236) by CK2 seems to play a significant role in cell adhesion and might initiate new insights in the CK2 and EB1 family protein association.	[Stenner, Frank; Liewen, Heike; Markuly, Norbert; Kleber, Sascha; Mischo, Axel; Knuth, Alexander; Renner, Christoph; Wadle, Andreas] Univ Zurich Hosp, Div Oncol, CH-8091 Zurich, Switzerland; [Goettig, Stephan; Henschler, Reinhard] Goethe Univ Frankfurt, DRK Inst Transfus Med & Immune Hematol, D-60054 Frankfurt, Germany; [Faust, Michael] Univ Saarland, Inst Med Biochem & Mol Biol, Homburg, Germany; [Bauer, Stefan] Med Oncol Off, Lebach, Germany; [Zweifel, Martin] Univ Bern, Inselspital, Inst Med Oncol, CH-3010 Bern, Switzerland	University of Zurich; University Zurich Hospital; Goethe University Frankfurt; Saarland University; University of Bern; University Hospital of Bern	Stenner, F (corresponding author), Univ Zurich Hosp, Div Oncol, CH-8091 Zurich, Switzerland.	stennerf@uhbs.ch	knuth, alexander/H-2608-2014	knuth, alexander/0000-0002-9318-2784; Stenner, Frank/0000-0003-4541-8817; Liewen, Heike/0000-0002-6161-4749				Abiatari I, 2009, INT J ONCOL, V35, P1111, DOI 10.3892/ijo_00000426; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Bu W, 2001, ONCOGENE, V20, P3185, DOI 10.1038/sj.onc.1204429; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; Donella-Deana A, 2001, BIOCHEM J, V357, P563, DOI 10.1042/0264-6021:3570563; Duncan JS, 2010, BBA-PROTEINS PROTEOM, V1804, P505, DOI 10.1016/j.bbapap.2009.11.001; Faust M, 1999, FEBS LETT, V462, P51, DOI 10.1016/S0014-5793(99)01492-1; Grey F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000967; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; HERRMANN CPE, 1991, ONCOGENE, V6, P877; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; KNOWLES GC, 1992, J HISTOCHEM CYTOCHEM, V40, P1605, DOI 10.1177/40.10.1527379; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Renner C, 1997, J IMMUNOL, V159, P1276; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Seger D, 2001, J BIOL CHEM, V276, P16998, DOI 10.1074/jbc.M003766200; SHINOURA N, 1995, BRIT J CANCER, V72, P627, DOI 10.1038/bjc.1995.384; Su LK, 2001, GENOMICS, V71, P142, DOI 10.1006/geno.2000.6428; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67595	10.1371/journal.pone.0067595	http://dx.doi.org/10.1371/journal.pone.0067595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844040	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000085
J	Ahmad, Y; Sharma, NK; Garg, I; Ahmad, MF; Sharma, M; Bhargava, K				Ahmad, Yasmin; Sharma, Narendra K.; Garg, Iti; Ahmad, Mohammad Faiz; Sharma, Manish; Bhargava, Kalpana			An Insight into the Changes in Human Plasma Proteome on Adaptation to Hypobaric Hypoxia	PLOS ONE			English	Article							AMYLOID-P-COMPONENT; RETINOL-BINDING-PROTEIN; APOLIPOPROTEIN-A-I; INDUCIBLE FACTOR-I; PULMONARY ARTERIAL-HYPERTENSION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GC-GLOBULIN; INSULIN-RESISTANCE; ANOXIA TOLERANCE; OVARIAN-CANCER	Adaptation to hypobaric hypoxia is required by animals and human in several physiological and pathological situations. Hypobaric hypoxia is a pathophysiological condition triggering redox status disturbances of cell organization leading, via oxidative stress, to proteins, lipids, and DNA damage. Identifying the molecular variables playing key roles in this process would be of paramount importance to shed light on the mechanisms known to counteract the negative effects of oxygen lack. To obtain a molecular signature, changes in the plasma proteome were studied by using proteomic approach. To enrich the low-abundance proteins in human plasma, two highly abundant proteins, albumin and IgG, were first removed. By comparing the plasma proteins of high altitude natives with those of a normal control group, several proteins with a significant alteration were found. The up-regulated proteins were identified as vitamin D-binding protein, hemopexin, alpha-1-antitrypsin, haptoglobin beta-chain, apolipoprotein A1, transthyretin and hemoglobin beta chain. The down-regulated proteins were transferrin, complement C3, serum amyloid, complement component 4A and plasma retinol binding protein. Among these proteins, the alterations of transthyretin and transferrin were further confirmed by ELISA and Western blotting analysis. Since all the up-and down-regulated proteins identified above are well-known inflammation inhibitors and play a positive anti-inflammatory role, these results show that there is some adaptive mechanism that sustains the inflammation balance in high altitude natives exposed to hypobaric hypoxia.	[Ahmad, Yasmin; Sharma, Narendra K.; Sharma, Manish; Bhargava, Kalpana] Minist Def, Peptide & Prote Div, DIPAS, DRDO, Delhi, India; [Garg, Iti] Minist Def, Dept Genom, DIPAS, DRDO, Delhi, India; [Ahmad, Mohammad Faiz] Jamia Millia Islamia, Dept Chem, New Delhi 110025, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Jamia Millia Islamia	Ahmad, Y (corresponding author), Minist Def, Peptide & Prote Div, DIPAS, DRDO, Delhi, India.	yasminchem@gmail.com	Garg, Iti/GYU-6396-2022; Sharma, Narendra/D-2451-2017	Sharma, Narendra/0000-0002-8681-3840	Defence Research Development Organization (DRDO), Ministry of Defence, Government of India [TC/321/Task - 145 (YA)/DIPAS/2008]	Defence Research Development Organization (DRDO), Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO))	Financial support for this study is provided by a grant from TC/321/Task - 145 (YA)/DIPAS/2008, Defence Research Development Organization (DRDO), Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Salam VB, 2006, PROTEOMICS, V6, P2286, DOI 10.1002/pmic.200500510; Ahmad Y., 2009, J PROTEOM BIOINFORM, V2, P495, DOI DOI 10.4172/JPB.1000111; Ahmad Y, 2011, FUNCT INTEGR GENOMIC, V11, P407, DOI 10.1007/s10142-011-0234-3; Amador A, 2007, AM J TRANSPLANT, V7, P2180, DOI 10.1111/j.1600-6143.2007.01914.x; Anantharamaiah GM, 2007, J LIPID RES, V48, P1915, DOI 10.1194/jlr.R700010-JLR200; Anderson GJ, 2005, SEMIN LIVER DIS, V25, P420, DOI 10.1055/s-2005-923314; ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421; Bates SR, 2005, AM J PHYSIOL-LUNG C, V289, pL980, DOI 10.1152/ajplung.00234.2005; Bauer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028578; Bellovino D, 1996, EXP CELL RES, V222, P77, DOI 10.1006/excr.1996.0010; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Bradbury MWB, 1997, J NEUROCHEM, V69, P443; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cavill I, 2002, BEST PRACT RES CL HA, V15, P399, DOI 10.1053/beha.2002.0004; Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672; Chang MHY, 2004, BIOCHEM J, V382, P481, DOI 10.1042/BJ20031752; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Congote LF, 2008, PEPTIDES, V29, P39, DOI 10.1016/j.peptides.2007.10.011; Cook HT, 2006, NAT CLIN PRACT RHEUM, V2, P330, DOI 10.1038/ncprheum0191; Cowan KN, 2000, NAT MED, V6, P698, DOI 10.1038/76282; Dahl B, 2001, INTENS CARE MED, V27, P394, DOI 10.1007/s001340000837; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; FRISANCHO AR, 1975, SCIENCE, V187, P313, DOI 10.1126/science.1089311; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Han CZ, 2005, ENDOCRINE, V26, P19, DOI 10.1385/ENDO:26:1:019; Handelman GJ, 2008, HEART FAIL REV, V13, P393, DOI 10.1007/s10741-008-9086-x; HANLEY JM, 1985, ARCH BIOCHEM BIOPHYS, V239, P404, DOI 10.1016/0003-9861(85)90706-4; HAUGEN TH, 1981, J BIOL CHEM, V256, P1055; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Hulmes J.D., 2004, CLIN PROTEOM, V1, P17; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; JESSEN TH, 1991, P NATL ACAD SCI USA, V88, P6519, DOI 10.1073/pnas.88.15.6519; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lasztity N, 2002, CLIN CHEM LAB MED, V40, P1320, DOI 10.1515/CCLM.2002.227; LEDOUXCORBUSIER M, 1975, J CUTAN PATHOL, V2, P25, DOI 10.1111/j.1600-0560.1975.tb00827.x; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Lomas DA, 2002, J CLIN INVEST, V110, P1585, DOI 10.1172/JCI200216782; MAIRBAURL H, 1994, INT J SPORTS MED, V15, P51, DOI 10.1055/s-2007-1021020; Mangan MSJ, 2008, TISSUE ANTIGENS, V72, P1, DOI 10.1111/j.1399-0039.2008.01059.x; Massip-Salcedo M, 2007, LIVER INT, V27, P6, DOI 10.1111/j.1478-3231.2006.01390.x; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Napoli C, 2004, J CARDIOVASC PHARM T, V9, P1, DOI 10.1177/107424840400900i101; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; OH SK, 1987, CANCER RES, V47, P5120; Palha JA, 2002, CLIN CHEM LAB MED, V40, P1292, DOI 10.1515/CCLM.2002.223; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; PEPYS MB, 1987, BIOCHEM BIOPH RES CO, V148, P308, DOI 10.1016/0006-291X(87)91111-9; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Schellenberg D, 1998, AM J RESP CRIT CARE, V157, P957, DOI 10.1164/ajrccm.157.3.9706106; Schlossmacher P, 2002, CLIN CHEM LAB MED, V40, P1339, DOI 10.1515/CCLM.2002.231; SCHUMACKER PT, 1993, AM J PHYSIOL, V265, pL395, DOI 10.1152/ajplung.1993.265.4.L395; Schweigert FJ, 2005, CANCER RES, V65, P1114; Son WK, 2003, PROTEOMICS, V3, P2393, DOI 10.1002/pmic.200300605; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Storey KB, 1996, COMP BIOCHEM PHYS B, V113, P23, DOI 10.1016/0305-0491(95)02043-8; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Subramanian RM, 2007, HEPATOLOGY, V45, P455, DOI 10.1002/hep.21462; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673; Tseng CF, 2004, PROTEOMICS, V4, P2221, DOI 10.1002/pmic.200300787; Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X; Turko IV, 2003, J BIOL CHEM, V278, P35844, DOI 10.1074/jbc.M303139200; van Pel M, 2006, P NATL ACAD SCI USA, V103, P1469, DOI 10.1073/pnas.0510192103; Van Vlierberghe H, 2004, CLIN CHIM ACTA, V345, P35, DOI 10.1016/j.cccn.2004.03.016; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x; WOOD SP, 1988, J MOL BIOL, V202, P169, DOI 10.1016/0022-2836(88)90529-3; Xie Y, 2000, J DERMATOL SCI, V24, P25, DOI 10.1016/S0923-1811(00)00078-5; YAMAMOTO N, 1991, IMMUNOLOGY, V74, P420; Yamamoto N, 1997, CANCER RES, V57, P2187; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zhang JQ, 2009, RESP MED, V103, P1801, DOI 10.1016/j.rmed.2009.07.017; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b	96	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67548	10.1371/journal.pone.0067548	http://dx.doi.org/10.1371/journal.pone.0067548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844025	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000054
J	Chng, ZZ; Peh, GSL; Herath, WB; Cheng, TYD; Ang, HP; Toh, KP; Robson, P; Mehta, JS; Colman, A				Chng, Zhenzhi; Peh, Gary S. L.; Herath, Wishva B.; Cheng, Terence Y. D.; Ang, Heng-Pei; Toh, Kah-Peng; Robson, Paul; Mehta, Jodhbir S.; Colman, Alan			High Throughput Gene Expression Analysis Identifies Reliable Expression Markers of Human Corneal Endothelial Cells	PLOS ONE			English	Article							COL8A2 GENE; MISSENSE MUTATIONS; EYE DEVELOPMENT; VIII COLLAGEN; MESSENGER-RNA; NEURAL CREST; DYSTROPHY; SLC4A11; PITX2; PUMP	Considerable interest has been generated for the development of suitable corneal endothelial graft alternatives through cell-tissue engineering, which can potentially alleviate the shortage of corneal transplant material. The advent of less invasive suture-less key-hole surgery options such as Descemet's Stripping Endothelial Keratoplasty (DSEK) and Descemet's Membrane Endothelial Keratoplasty (DMEK), which involve transplantation of solely the endothelial layer instead of full thickness cornea, provide further impetus for the development of alternative endothelial grafts for clinical applications. A major challenge for this endeavor is the lack of specific markers for this cell type. To identify genes that reliably mark corneal endothelial cells (CECs) in vivo and in vitro, we performed RNA-sequencing on freshly isolated human CECs (from both young and old donors), CEC cultures, and corneal stroma. Gene expression of these corneal cell types was also compared to that of other human tissue types. Based on high throughput comparative gene expression analysis, we identified a panel of markers that are: i) highly expressed in CECs from both young donors and old donors; ii) expressed in CECs in vivo and in vitro; and iii) not expressed in corneal stroma keratocytes and the activated corneal stroma fibroblasts. These were SLC4A11, COL8A2 and CYYR1. The use of this panel of genes in combination reliably ascertains the identity of the CEC cell type.	[Chng, Zhenzhi; Cheng, Terence Y. D.; Colman, Alan] A STAR Inst Med Biol, Singapore, Singapore; [Peh, Gary S. L.; Ang, Heng-Pei; Toh, Kah-Peng; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Herath, Wishva B.; Robson, Paul] Genome Inst Singapore, Singapore, Singapore; [Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; Singapore National Eye Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Singapore National Eye Center; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.	jodmehta@gmail.com; alan.colman@imb.a-star.edu.sg	Peh, Gary/A-8327-2010; Robson, Paul/A-3464-2009; Mehta, Jodhbir/O-6192-2015	Peh, Gary/0000-0002-5387-4209; Robson, Paul/0000-0002-0191-3958; 	Agency for Science, Technology and Research TCRP Grant [TCR0101673]	Agency for Science, Technology and Research TCRP Grant	This study is supported by Agency for Science, Technology and Research TCRP Grant (TCR0101673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PA, 1995, INVEST OPHTH VIS SCI, V36, P1115; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Bonanno JA, 2012, EXP EYE RES, V95, P2, DOI 10.1016/j.exer.2011.06.004; BONTING SL, 1961, ARCH BIOCHEM BIOPHYS, V95, P416, DOI 10.1016/0003-9861(61)90170-9; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Corti C, 2011, SCHIZOPHR RES, V128, P7, DOI 10.1016/j.schres.2011.01.021; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Edelhauser HF, 2000, CORNEA, V19, P263, DOI 10.1097/00003226-200005000-00002; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P4504, DOI 10.1167/iovs.05-0497; Gottsch JD, 2003, ARCH OPHTHALMOL-CHIC, V121, P252; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Jiao XD, 2007, J MED GENET, V44, P64, DOI 10.1136/jmg.2006.044644; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 2002, INVEST OPHTH VIS SCI, V43, P2152; KAPOOR R, 1986, BIOCHEMISTRY-US, V25, P3930, DOI 10.1021/bi00361a029; KAUFMAN HE, 1977, INVEST OPHTH VIS SCI, V16, P265; Kobayashi A, 2004, JPN J OPHTHALMOL, V48, P195, DOI 10.1007/s10384-003-0063-6; Liskova P, 2007, BRIT J OPHTHALMOL, V91, P1717, DOI 10.1136/bjo.2007.115154; Lwigale PY, 2005, DEV BIOL, V288, P284, DOI 10.1016/j.ydbio.2005.09.046; Madan P, 2007, J BIOL CHEM, V282, P12127, DOI 10.1074/jbc.M700696200; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; Peh G. S., 2012, INT J BIOMATER, V2012; Peh Gary S L, 2013, BMC Res Notes, V6, P176, DOI 10.1186/1756-0500-6-176; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Rose L, 2009, CAN J OPHTHALMOL, V44, P401, DOI 10.3129/i09-090; Sakai R, 2002, INVEST OPHTH VIS SCI, V43, P1749; Sanchez C, 2012, AM J PHYSIOL-HEART C, V302, pH1146, DOI 10.1152/ajpheart.00668.2011; SAVION N, 1986, EXP EYE RES, V43, P355, DOI 10.1016/S0014-4835(86)80072-0; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Sugrue SP, 1997, EXP EYE RES, V64, P11, DOI 10.1006/exer.1996.0175; Sune G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013930; Tan DTH, 2009, ANN ACAD MED SINGAP, V38, P332; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Violette MI, 2006, DEV BIOL, V289, P406, DOI 10.1016/j.ydbio.2005.11.004; Vitale L, 2002, GENE, V290, P141, DOI 10.1016/S0378-1119(02)00550-4; Vitale L, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-66; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yellore VS, 2005, INVEST OPHTH VIS SCI, V46, P1599, DOI 10.1167/iovs.04-1321; Zacharias AL, 2010, DEV DYNAM, V239, P3215, DOI 10.1002/dvdy.22459	49	46	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67546	10.1371/journal.pone.0067546	http://dx.doi.org/10.1371/journal.pone.0067546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844023	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000053
J	Foster, DB; Liu, T; Rucker, J; O'Meally, RN; Devine, LR; Cole, RN; O'Rourke, B				Foster, D. Brian; Liu, Ting; Rucker, Jasma; O'Meally, Robert N.; Devine, Lauren R.; Cole, Robert N.; O'Rourke, Brian			The Cardiac Acetyl-Lysine Proteome	PLOS ONE			English	Article							REGULATORY LIGHT-CHAIN; SWISS-MODEL; MITOCHONDRIAL ENERGETICS; PEPTIDE IDENTIFICATIONS; STATISTICAL-MODEL; OXIDATIVE STRESS; PROTEINS; TANDEM; SIRT3; PHOSPHORYLATION	In the heart, lysine acetylation has been implicated in processes ranging from transcriptional control of pathological remodeling, to cardioprotection arising from caloric restriction. Given the emerging importance of this post-translational modification, we used a proteomic approach to investigate the broader role of lysine acetylation in the heart using a guinea pig model. Briefly, hearts were fractionated into myofilament-, mitochondrial- and cytosol-enriched fractions prior to proteolysis and affinity-enrichment of acetylated peptides. LC-MS/MS analysis identified 1075 acetylated peptides, harboring 994 acetylation sites that map to 240 proteins with a global protein false discovery rate <0.8%. Mitochondrial targets account for 59% of identified proteins and 64% of sites. The majority of the acetyl-proteins are enzymes involved in fatty acid metabolism, oxidative phosphorylation or the TCA cycle. Within the cytosolic fraction, the enzymes of glycolysis, fatty acid synthesis and lipid binding are prominent. Nuclear targets included histones and the transcriptional regulators E1A(p300) and CREB binding protein. Comparison of our dataset with three previous global acetylomic studies uniquely revealed 53 lysine-acetylated proteins. Specifically, newly-identified acetyl-proteins include Ca2+-handling proteins, RyR2 and SERCA2, and the myofilament proteins, myosin heavy chain, myosin light chains and subunits of the Troponin complex, among others. These observations were confirmed by anti-acetyl-lysine immunoblotting. In summary, cardiac lysine acetylation may play a role in cardiac substrate selection, bioenergetic performance, and maintenance of redox balance. New sites suggest a host of potential mechanisms by which excitation-contraction coupling may also be modulated.	[Foster, D. Brian; Liu, Ting; Rucker, Jasma; O'Rourke, Brian] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [O'Meally, Robert N.; Devine, Lauren R.; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Foster, DB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	dbrianfoster@jhmi.edu	Foster, D. Brian/C-6350-2009; Foster, D. Brian/S-9108-2019	Foster, D. Brian/0000-0002-9290-9590; Foster, D. Brian/0000-0002-9290-9590; O'Rourke, Brian/0000-0002-5548-4853; Liu, Ting/0000-0002-8304-5751	National Heart Lung and Blood Institute Proteomic Initiative [HHSN268201000032C]; NIH/NHLBI [R01HL101235, R21HL108052]; American Heart Association [12SDG12060056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101235, R01HL105216, R21HL108052] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute Proteomic Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart Lung and Blood Institute Proteomic Initiative contract HHSN268201000032C (BO, RNC) and by NIH/NHLBI grants R01HL101235 (BO) and R21HL108052 (DBF, BO). DBF is also supported by American Heart Association National Scientist Development Grant 12SDG12060056. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Diffee GM, 1996, BIOPHYS J, V71, P341, DOI 10.1016/S0006-3495(96)79231-7; Feng C, 2009, EXP CELL RES, V315, P3044, DOI 10.1016/j.yexcr.2009.05.005; Foster DB, 2008, BIOCHEM BIOPH RES CO, V366, P649, DOI 10.1016/j.bbrc.2007.11.154; Fraenkel-Conrat H, 1957, METHOD ENZYMOL, P247; Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047; Giblin FJ, 2013, MOL VIS, V19, P267; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Hanson BJ, 2001, ELECTROPHORESIS, V22, P950, DOI 10.1002/1522-2683()22:5<950::AID-ELPS950>3.0.CO;2-D; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kembro JM, 2013, BIOPHYS J, V104, P332, DOI 10.1016/j.bpj.2012.11.3808; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kou CYC, 2010, BIOCHEM BIOPH RES CO, V400, P278, DOI 10.1016/j.bbrc.2010.08.064; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Kuang SQ, 1996, J MOL CELL CARDIOL, V28, P1879, DOI 10.1006/jmcc.1996.0180; Li L, 2010, MOL CELL BIOCHEM, V345, P309, DOI 10.1007/s11010-010-0586-3; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; REINACH FC, 1986, NATURE, V322, P80, DOI 10.1038/322080a0; Riordan J F, 1972, Methods Enzymol, V25, P494, DOI 10.1016/S0076-6879(72)25045-5; Rottbauer W, 1996, CIRCULATION, V94, P943; Sack MN, 2012, J MOL CELL CARDIOL, V52, P520, DOI 10.1016/j.yjmcc.2011.11.004; Samant SA, 2011, J BIOL CHEM, V286, P5567, DOI 10.1074/jbc.M110.163865; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw PG, 2011, ANAL CHEM, V83, P3623, DOI 10.1021/ac1026176; Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Snijders APL, 2008, J PROTEOME RES, V7, P4326, DOI 10.1021/pr800260a; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Suckow MA, 2012, AM COLL LAB, P1; Tabb DL, 2006, NAT PROTOC, V1, P2213, DOI 10.1038/nprot.2006.330; Tae H, 2009, EUR BIOPHYS J BIOPHY, V39, P51, DOI 10.1007/s00249-009-0455-8; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Trivedi CM, 2008, J BIOL CHEM, V283, P26484, DOI 10.1074/jbc.M803686200; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wei AC, 2011, BIOPHYS J, V100, P2894, DOI 10.1016/j.bpj.2011.05.027; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou LF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000657	69	69	70	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67513	10.1371/journal.pone.0067513	http://dx.doi.org/10.1371/journal.pone.0067513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844019	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000049
J	Carabajal, AP; Sterli, J; Muller, J; Hilger, A				Paulina Carabajal, Ariana; Sterli, Juliana; Mueller, Johannes; Hilger, Andre			Neuroanatomy of the Marine Jurassic Turtle Plesiochelys etalloni (Testudinata, Plesiochelyidae)	PLOS ONE			English	Article							ANATOMY; EAR; ENDOCAST; REPTILES; HEARING; BRAIN	Turtles are one of the least explored clades regarding endocranial anatomy with few available descriptions of the brain and inner ear of extant representatives. In addition, the paleoneurology of extinct turtles is poorly known and based on only a few natural cranial endocasts. The main goal of this study is to provide for the first time a detailed description of the neuroanatomy of an extinct turtle, the Late Jurassic Plesiochelys etalloni, including internal carotid circulation, cranial endocast and inner ear, based on the first digital 3D reconstruction using micro CT scans. The general shape of the cranial endocast of P. etalloni is tubular, with poorly marked cephalic and pontine flexures. Anteriorly, the olfactory bulbs are clearly differentiated suggesting larger bulbs than in any other described extinct or extant turtle, and indicating a higher capacity of olfaction in this taxon. The morphology of the inner ear of P. etalloni is comparable to that of extant turtles and resembles those of slow-moving terrestrial vertebrates, with markedly low, short and robust semicircular canals, and a reduced lagena. In P. etalloni the arterial pattern is similar to that found in extant cryptodires, where all the internal carotid branches are protected by bone. As the knowledge of paleoneurology in turtles is scarce and the application of modern techniques such as 3D reconstructions based on CT scans is almost unexplored in this clade, we hope this paper will trigger similar investigations of this type in other turtle taxa.	[Paulina Carabajal, Ariana] Consejo Nacl Invest Cient & Tecn, Museo Carmen Funes, Neuquen, Argentina; [Sterli, Juliana] Consejo Nacl Invest Cient & Tecn, Museo Egidio Feruglio, Trelew, Chubut, Argentina; [Mueller, Johannes] Humboldt Univ, Museum Naturkunde, Leibniz Inst Evolut & Biodiversitatsforsch, D-10099 Berlin, Germany; [Hilger, Andre] Helmholtz Zentrum Mat & Energie, Berlin, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Carabajal, AP (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Carmen Funes, Neuquen, Argentina.	a.paulinacarabajal@conicet.gov.ar	Sterli, Juliana/I-3526-2019; Müller, Johannes/A-6293-2017	Müller, Johannes/0000-0001-5801-856X; Sterli, Juliana/0000-0003-2942-5558; Hilger, Andre/0000-0002-6454-7967; Paulina Carabajal, Ariana/0000-0002-7820-4770	Ale-Arg fellowship	Ale-Arg fellowship	This study was partially financed by an Ale-Arg fellowship to JS. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT PHILIP W., 1967, TULANE STUD ZOOL, V14, P81; [Anonymous], 1979, B AM MUS NAT HIST, V164, P67; Bardet Nathalie, 1995, Palaeovertebrata (Montpellier), V24, P177; Billon-Bruyat JP, 2005, PALAEOGEOGR PALAEOCL, V216, P359, DOI 10.1016/j.palaeo.2004.11.011; Boistel R, 2010, BIOL LETTERS, V6, P740, DOI 10.1098/rsbl.2010.0322; Brinkman D.B., 1991, Journal of Vertebrate Paleontology, V11, P302; Brinkman Donald B., 2013, P147; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Buchholtz EA, 1999, BRAIN RES BULL, V48, P351, DOI 10.1016/S0361-9230(98)00174-9; Buffetaut Eric, 1994, Geobios Memoire Special (Villeurbanne), V16, P259; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; Carabajal Ariana Paulina, 2012, [古脊椎动物学报, Vertebrata Palasiatica], V50, P85; Christensen-Dalsgaard J, 2012, P ROY SOC B-BIOL SCI, V279, P2816, DOI 10.1098/rspb.2012.0290; David R, 2010, CR PALEVOL, V9, P397, DOI 10.1016/j.crpv.2010.07.012; de Broin France, 1994, Geobios Memoire Special (Villeurbanne), V16, P167; Edinger T., 1934, PSYCH NEUROL BLADEN, V3-4, P396; Edinger T, 1929, FOSSILEN GEHIME ERGE, V28, P249; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; GAFFNEY E S, 1975, Bulletin of the American Museum of Natural History, V155, P387; Gaffney E.S., 1976, Bulletin Am Mus nat Hist, V157, P487; Gaffney E.S., 1982, American Museum Novitates, P1; Gaffney E.S., 1975, American Museum Novitates, VNo. 2574, P1; Gaffney E.S., 1977, American Museum Novitates, VNo. 2639, P1; GAFFNEY E S, 1968, Fieldiana Geology, V16, P193; Gaffney Eugene S., 1995, American Museum Novitates, V3130, P1; Holliday CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030471; Hopson J.A., 1979, P39; Jamniczky HA, 2004, ANIM BIOL, V54, P417, DOI 10.1163/1570756042729537; Jamniczky HA, 2007, J MORPHOL, V268, P571, DOI 10.1002/jmor.10539; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2004, J PALEONTOL, V78, P989, DOI 10.1666/0022-3360(2004)078<0989:DAPFTC>2.0.CO;2; LENHARDT M L, 1985, Journal of Auditory Research, V25, P66; Manley GA, 2010, J EXP BIOL, V213, P1876, DOI 10.1242/jeb.040196; McDowell S. B., 1961, Bulletin of the Museum of Comparative Zoology, V125, P23; Miyashita Tetsuto, 2013, P71; PARSONS TS, 1959, EVOLUTION, V13, P175, DOI 10.2307/2405871; Rogers SW, 1998, NEURON, V21, P673, DOI 10.1016/S0896-6273(00)80585-1; Sanders RK, 2005, ACTA PALAEONTOL POL, V50, P601; Sedlmayr JC, 2002, THESIS OHIO U OHIO; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sterli J, 2007, PALAEONTOGR ABT A, V281, P1; Sterli J, 2010, CAN J EARTH SCI, V47, P1337, DOI 10.1139/E10-061; Sterli J, 2010, J VERTEBR PALEONTOL, V30, P351, DOI 10.1080/02724631003617597; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Weber EG, 1978, B AM MUS NAT HIST; Wersall J., 1974, P123; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Wyneken J, 2001, NMFSSEFSC470 NOAA, DOI DOI 10.1007/SPRINGERREFERENCE_; ZANGERL R, 1960, FIELDIANA GEOLOGY ME, V3, P281, DOI DOI 10.5962/BHL.TITLE.5245	53	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69264	10.1371/journal.pone.0069264	http://dx.doi.org/10.1371/journal.pone.0069264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844257	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000189
J	Wang, SW; DelProposto, Z; Wang, HY; Ding, XW; Ji, CH; Wang, B; Xu, MS				Wang, Shiwei; DelProposto, Zachary; Wang, Haoyu; Ding, Xuewei; Ji, Conghua; Wang, Bei; Xu, Maosheng			Differentiation of Breast Cancer from Fibroadenoma with Dual-Echo Dynamic Contrast-Enhanced MRI	PLOS ONE			English	Article							PERFUSION; PERMEABILITY; RESOLUTION; LESIONS; QUANTIFICATION; ACQUISITION; TUMORS	Dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) of the breast is a routinely used imaging method which is highly sensitive for detecting breast malignancy. Specificity, though, remains suboptimal. Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI), an alternative dynamic contrast imaging technique, evaluates perfusion-related parameters unique from DCE MRI. Previous work has shown that the combination of DSC MRI with DCE MRI can improve diagnostic specificity, though an additional administration of intravenous contrast is required. Dual-echo MRI can measure both T1W DCE MRI and T-2*W DSC MRI parameters with a single contrast bolus, but has not been previously implemented in breast imaging. We have developed a dual-echo gradient-echo sequence to perform such simultaneous measurements in the breast, and use it to calculate the semi-quantitative T1W and T-2*W related parameters such as peak enhancement ratio, time of maximal enhancement, regional blood flow, and regional blood volume in 20 malignant lesions and 10 benign fibroadenomas in 38 patients. Imaging parameters were compared to surgical or biopsy obtained tissue samples. Receiver operating characteristic (ROC) curves and area under the ROC curves were calculated for each parameter and combination of parameters. The time of maximal enhancement derived from DCE MRI had a 90% sensitivity and 69% specificity for predicting malignancy. When combined with DSC MRI derived regional blood flow and volume parameters, sensitivity remained unchanged at 90% but specificity increased to 80%. In conclusion, we show that dual-echo MRI with a single administration of contrast agent can simultaneously measure both T1W and T-2*W related perfusion and kinetic parameters in the breast and the combination of DCE MRI and DSC MRI parameters improves the diagnostic performance of breast MRI to differentiate breast cancer from benign fibroadenomas.	[Wang, Shiwei; Ding, Xuewei; Xu, Maosheng] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [DelProposto, Zachary] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Wang, Haoyu] Peking Univ, Beijing Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Ji, Conghua] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Clin Evaluat & Anal Ctr, Hangzhou, Zhejiang, Peoples R China; [Wang, Bei] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Breast Dis, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Henry Ford Health System; Henry Ford Hospital; Peking University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Wang, HY (corresponding author), Peking Univ, Beijing Key Lab Med Phys & Engn, Beijing 100871, Peoples R China.	benfox.w@gmail.com; xumaosh@yahoo.com.cn			Zhejiang Provincial Bureau of Health, Hangzhou, China [2011KYA121]	Zhejiang Provincial Bureau of Health, Hangzhou, China	This research was supported by the Zhejiang Provincial Bureau of Health, Hangzhou, China (2011KYA121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Benner T, 1997, MAGN RESON IMAGING, V15, P307, DOI 10.1016/S0730-725X(96)00392-X; Bluemke DA, 2004, JAMA-J AM MED ASSOC, V292, P2735, DOI 10.1001/jama.292.22.2735; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; de Bazelaire C, 2006, EUR RADIOL, V16, P2083, DOI 10.1007/s00330-006-0198-1; Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9; Gilles R, 1996, J COMPUT ASSIST TOMO, V20, P9, DOI 10.1097/00004728-199601000-00003; Henderson E, 1998, MAGN RESON IMAGING, V16, P1057, DOI 10.1016/S0730-725X(98)00130-1; Huang W, 2004, RADIOLOGY, V232, P585, DOI 10.1148/radiol.2322030547; Kim EJ, 2004, MAGN RESON IMAGING, V22, P307, DOI 10.1016/j.mri.2004.01.012; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Kvistad KA, 2000, RADIOLOGY, V216, P545, DOI 10.1148/radiology.216.2.r00au36545; Li J, 2009, MED PHYS, V36, P3786, DOI 10.1118/1.3152113; Liney GP, 1999, JMRI-J MAGN RESON IM, V10, P945, DOI 10.1002/(SICI)1522-2586(199912)10:6<945::AID-JMRI6>3.3.CO;2-9; Ludemann L, 2009, ANN BIOMED ENG, V37, P749, DOI 10.1007/s10439-009-9645-x; Makkat S, 2007, J MAGN RESON IMAGING, V25, P1159, DOI 10.1002/jmri.20937; Moy L, 2009, AM J ROENTGENOL, V193, P986, DOI 10.2214/AJR.08.1229; Mussurakis S, 1998, RADIOLOGY, V206, P465, DOI 10.1148/radiology.206.2.9457201; Peters NHGM, 2008, RADIOLOGY, V246, P116, DOI 10.1148/radiol.2461061298; SHAMES DM, 1993, MAGNET RESON MED, V29, P616, DOI 10.1002/mrm.1910290506; Taillieu F, 2006, RADIOLOGY, V241, P737, DOI 10.1148/radiol.2413051168; Vassiou K, 2009, EUR J RADIOL, V70, P69, DOI 10.1016/j.ejrad.2008.01.012; Wang HY, 2010, MED PHYS, V37, P4971, DOI 10.1118/1.3483094; Yang XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/732848; Yu YM, 2010, RADIOLOGY, V257, P47, DOI 10.1148/radiol.10092169	25	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67731	10.1371/journal.pone.0067731	http://dx.doi.org/10.1371/journal.pone.0067731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844077	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000086
J	Yu, Y; Shen, H; Zeng, LL; Ma, QM; Hu, DW				Yu, Yang; Shen, Hui; Zeng, Ling-Li; Ma, Qiongmin; Hu, Dewen			Convergent and Divergent Functional Connectivity Patterns in Schizophrenia and Depression	PLOS ONE			English	Article							DEFAULT-MODE; DISCRIMINATIVE ANALYSIS; NETWORK CONNECTIVITY; MAJOR DEPRESSION; BIPOLAR DISORDER; WORKING-MEMORY; LOW-FREQUENCY; BRAIN; NEUROANATOMY; 1ST-EPISODE	Major depression and schizophrenia are two of the most serious psychiatric disorders and share similar behavioral symptoms. Whether these similar behavioral symptoms underlie any convergent psychiatric pathological mechanisms is not yet clear. To address this issue, this study sought to investigate the whole-brain resting-state functional magnetic resonance imaging (MRI) of major depression and schizophrenia by using multivariate pattern analysis. Thirty-two schizophrenic patients, 19 major depressive disorder patients and 38 healthy controls underwent resting-state functional MRI scanning. A support vector machine in conjunction with intrinsic discriminant analysis was used to solve the multi-classification problem, resulting in a correct classification rate of 80.9% via leave-one-out cross-validation. The depression and schizophrenia groups both showed altered functional connections associated with the medial prefrontal cortex, anterior cingulate cortex, thalamus, hippocampus, and cerebellum. However, the prefrontal cortex, amygdala, and temporal poles were found to be affected differently by major depression and schizophrenia. Our preliminary study suggests that altered connections within or across the default mode network and the cerebellum may account for the common behavioral symptoms between major depression and schizophrenia. In addition, connections associated with the prefrontal cortex and the affective network showed promise as biomarkers for discriminating between the two disorders.	[Yu, Yang; Shen, Hui; Zeng, Ling-Li; Ma, Qiongmin; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Hu, DW (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Hu, Dewen/D-1978-2015; Hu, Dewen/AAN-8511-2020	Zeng, Ling-Li/0000-0002-0515-256X	National Basic Research Program of China [2011CB707802]; National Science Foundation of China [61003202]; National High-Tech Program of China [2012AA011601]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (Grant No 2011CB707802), the National Science Foundation of China (Grant No 61003202), and the National High-Tech Program of China (Grant No 2012AA011601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, pS159; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P943; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Barch DM, 2003, BIOL PSYCHIAT, V53, P376, DOI 10.1016/S0006-3223(02)01674-8; Bearden CE, 2001, BIPOLAR DISORD, V3, P106, DOI 10.1034/j.1399-5618.2001.030302.x; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Boksman K, 2005, SCHIZOPHR RES, V75, P247, DOI 10.1016/j.schres.2004.09.025; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buchanan RW, 1998, AM J PSYCHIAT, V155, P1049, DOI 10.1176/ajp.155.8.1049; Buchsbaum MS, 1998, SCHIZOPHRENIA BULL, V24, P343, DOI 10.1093/oxfordjournals.schbul.a033331; Ding SL, 2009, J COMP NEUROL, V514, P595, DOI 10.1002/cne.22053; ELKIS H, 1995, ARCH GEN PSYCHIAT, V52, P735; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fox MD, 2008, P HDB, P575; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2011, J AFFECT DISORDERS, V135, P326, DOI 10.1016/j.jad.2011.06.048; Hafner H, 2005, EUR ARCH PSY CLIN N, V255, P167, DOI 10.1007/s00406-005-0584-8; Hamazaki K, 2012, J PSYCHIATR RES, V46, P1024, DOI 10.1016/j.jpsychires.2012.04.012; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Hinkley LBN, 2011, BIOL PSYCHIAT, V70, P1134, DOI 10.1016/j.biopsych.2011.06.029; Honey GD, 2005, BRAIN, V128, P2597, DOI 10.1093/brain/awh632; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Ilonen T, 1999, PSYCHIAT RES, V87, P183, DOI 10.1016/S0165-1781(99)00061-X; Jafri MJ, 2007, BIOMEDICAL IMAGING N, P468; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kohler C, 1998, BIOL PSYCHIAT, V43, P165, DOI 10.1016/S0006-3223(97)00033-4; Koshino H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022909; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Landro NI, 2001, NEUROPSY NEUROPSY BE, V14, P233; LIDDLE PF, 1987, BRIT J PSYCHIAT, V151, P145, DOI 10.1192/bjp.151.2.145; LIDDLE PF, 1987, PSYCHOL MED, V17, P49, DOI 10.1017/S0033291700012976; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040968; Maier W, 2002, SCHIZOPHR RES, V57, P259, DOI 10.1016/S0920-9964(01)00288-2; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Meda SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007911; Menon V, 2001, NEUROIMAGE, V13, P433, DOI 10.1006/nimg.2000.0699; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Morch N, 1997, LECT NOTES COMPUT SC, V1230, P259; Mulholland C, 2000, ADV PSYCHIAT TREAT, V6, P169, DOI [10.1192/apt.6.3.169, DOI 10.1192/APT.6.3.169]; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Pagani M, 2009, PSYCHIAT RES-NEUROIM, V173, P8, DOI 10.1016/j.pscychresns.2008.07.016; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Picard H, 2008, SCHIZOPHRENIA BULL, V34, P155, DOI 10.1093/schbul/sbm049; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robins L.N., 1991, PSYCHIAT DISORDERS A; Salvador R, 2010, HUM BRAIN MAPP, V31, P2003, DOI 10.1002/hbm.20993; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Talamini LM, 2005, ARCH GEN PSYCHIAT, V62, P485, DOI 10.1001/archpsyc.62.5.485; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Os J, 1999, SOC PSYCH PSYCH EPID, V34, P459, DOI 10.1007/s001270050220; Vapnik V., 1995, NATURES STAT LEARNIN; Wang Y, 2010, PATTERN RECOGN, V43, P3580, DOI 10.1016/j.patcog.2010.05.021; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	74	31	31	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68250	10.1371/journal.pone.0068250	http://dx.doi.org/10.1371/journal.pone.0068250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844175	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000147
J	Arts, DL; Visscher, S; Opstelten, W; Korevaar, JC; Abu-Hanna, A; van Weert, HCPM				Arts, Derk L.; Visscher, Stefan; Opstelten, Wim; Korevaar, Joke C.; Abu-Hanna, Ameen; van Weert, Henk C. P. M.			Frequency and Risk Factors for Under- and Over-Treatment in Stroke Prevention for Patients with Non-Valvular Atrial Fibrillation in General Practice	PLOS ONE			English	Article							EURO HEART SURVEY; ANTITHROMBOTIC TREATMENT; MANAGEMENT; ANTICOAGULATION; GUIDELINES	Objective: To determine adequacy of antithrombotic treatment in patients with non-valvular atrial fibrillation. To determine risk factors for under- and over-treatment. Design: Retrospective, cross-sectional study of electronic health records from 36 general practitioners in 2008. Setting: General practice in the Netherlands. Subjects: Primary care physicians (n = 36) and patients (n = 981) aged 65 years and over. Main Outcome Measures: Rates of adequate, under and over-treatment, risk factors for under and over-treatment. Results: Of the 981 included patients with a mean of age 78, 18% received no antithrombotic treatment (under-treatment), 13% received antiplatelet drugs and 69% received oral anticoagulation (OAC). Further, 43% of the included patients were treated adequately, 26% were under-treated, and 31% were over-treated. Patients with a previous ischaemic stroke were at high risk for under-treatment (OR 2.4, CI 1.6-3.5), whereas those with contraindications for OAC were at high risk for over-treatment (OR 37.0, CI 18.1-79.9). Age over 75 (OR 0.2, CI: 0.1-0.3]), diabetes (OR 0.1, CI: 0.1-0.3), heart failure (OR 0.2, CI: 0.10.3), hypertension (OR 0.1, CI: 0.1-0.2) and previous ischaemic stroke (OR 0.04, CI: 0.02-0.11) protected against over-treatment. Conclusions: In general practice, CHADS2-criteria are being used, but the antithrombotic treatment of patients with atrial fibrillation frequently deviates from guidelines on this topic. Patients with previous stroke are at high risk of not being prescribed OAC. Contraindications for OAC, however, seem to be frequently overlooked.	[Arts, Derk L.; van Weert, Henk C. P. M.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Arts, Derk L.; Abu-Hanna, Ameen] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [Visscher, Stefan; Korevaar, Joke C.] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Opstelten, Wim] Dutch Coll Gen Practitioners, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Institute for Health Services Research	Arts, DL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.l.arts@amc.nl		Arts, Derk/0000-0001-5702-5856; Abu-Hanna, Ameen/0000-0003-4324-7954				Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; (CCMO) CCoRIHS, 2013, WMO DOES YOUR STUD H; de Lusignan S, 2005, J PUBLIC HEALTH-UK, V27, P85, DOI 10.1093/pubmed/fdh201; DeWilde S, 2006, HEART, V92, P1064, DOI 10.1136/hrt.2005.069492; Dinh T, 2007, INT J CLIN PRACT, V61, P24, DOI 10.1111/j.1742-1241.2006.01241.x; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gorin L, 2011, CHEST, V140, P911, DOI 10.1378/chest.10-2436; Harrell Jr F. E., 2012, RMS REGRESSION MODEL; Hart RG, 2007, ANN INTERNAL MED; Heiberger RM, 2011, HH STAT AN DAT DISPL; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Nieuwlaat R, 2006, EUR HEART J, V27, P3018, DOI 10.1093/eurheartj/ehl015; Ogilvie IM, 2011, THROMB HAEMOSTASIS, V106, P34, DOI 10.1160/TH10-10-0674; Ogilvie IM, 2011, AM J CARDIOL, V108, P151, DOI 10.1016/j.amjcard.2011.02.353; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Team R. D. C, 2011, R LANG ENV STAT COMP; Verheij R.A., 2009, LANDELIJK INFORMATIE; Wess ML, 2008, J GEN INTERN MED, V23, P411, DOI 10.1007/s11606-007-0477-9; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	22	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67806	10.1371/journal.pone.0067806	http://dx.doi.org/10.1371/journal.pone.0067806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861809	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300031
J	Lysenko, A; Urban, M; Bennett, L; Tsoka, S; Janowska-Sejda, E; Rawlings, CJ; Hammond-Kosack, KE; Saqi, M				Lysenko, Artem; Urban, Martin; Bennett, Laura; Tsoka, Sophia; Janowska-Sejda, Elzbieta; Rawlings, Chris J.; Hammond-Kosack, Kim E.; Saqi, Mansoor			Network-Based Data Integration for Selecting Candidate Virulence Associated Proteins in the Cereal Infecting Fungus Fusarium graminearum	PLOS ONE			English	Article							PHI-BASE; REVEALS; ANNOTATION; FGDB	The identification of virulence genes in plant pathogenic fungi is important for understanding the infection process, host range and for developing control strategies. The analysis of already verified virulence genes in phytopathogenic fungi in the context of integrated functional networks can give clues about the underlying mechanisms and pathways directly or indirectly linked to fungal pathogenicity and can suggest new candidates for further experimental investigation, using a 'guilt by association' approach. Here we study 133 genes in the globally important Ascomycete fungus Fusarium graminearum that have been experimentally tested for their involvement in virulence. An integrated network that combines information from gene co-expression, predicted protein-protein interactions and sequence similarity was employed and, using 100 genes known to be required for virulence, we found a total of 215 new proteins potentially associated with virulence of which 29 are annotated as hypothetical proteins. The majority of these potential virulence genes are located in chromosomal regions known to have a low recombination frequency. We have also explored the taxonomic diversity of these candidates and found 25 sequences, which are likely to be fungal specific. We discuss the biological relevance of a few of the potentially novel virulence associated genes in detail. The analysis of already verified virulence genes in phytopathogenic fungi in the context of integrated functional networks can give clues about the underlying mechanisms and pathways directly or indirectly linked to fungal pathogenicity and can suggest new candidates for further experimental investigation, using a 'guilt by association' approach.	[Lysenko, Artem; Janowska-Sejda, Elzbieta; Rawlings, Chris J.; Saqi, Mansoor] Rothamsted Res, Dept Computat & Syst Biol, Harpenden, Herts, England; [Bennett, Laura; Tsoka, Sophia] Kings Coll London, Dept Informat, Sch Nat & Math Sci, London, England; [Urban, Martin; Janowska-Sejda, Elzbieta; Hammond-Kosack, Kim E.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of London; King's College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Hammond-Kosack, KE (corresponding author), Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England.	kim.hammond-kosack@rothamsted.ac.uk	; Urban, Martin/G-6004-2010	Tsoka, Sophia/0000-0001-8403-1282; Rawlings, Christopher/0000-0003-3702-1633; Urban, Martin/0000-0003-2440-4352; Saqi, Mansoor/0000-0003-1222-475X; Lysenko, Artem/0000-0002-1441-0604; Hammond-Kosack, kim/0000-0002-9699-485X	BBSRC through the Institute Strategic Programme 20:20 Wheat(R) [BB/J/00426X/1]; BBSRC [BB/I000488/1, BB/G015716/1]; Leverhulme Trust [RPG-2012-686]; BBSRC National Capability [BB/J/004383/1]; BBSRC [BBS/E/C/00005192, BB/G014159/2, BB/G014159/1, BBS/E/C/00005203, BB/G013969/1, BBS/E/C/00004941, BB/F006012/1, BB/F006039/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G014159/2, BB/G015716/1, BB/G013969/1, BBS/E/C/00004941, BB/F006012/1, BBS/E/C/00005192, BB/G014159/1, BB/I000488/1, BB/F006039/1, BBS/E/C/00005203] Funding Source: researchfish	BBSRC through the Institute Strategic Programme 20:20 Wheat(R)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); BBSRC National Capability(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MS, MU and KHK are supported by the BBSRC (http://www.bbsrc.ac.uk) through the Institute Strategic Programme 20:20 Wheat (R) (grant BB/J/00426X/1). In addition the PHI-base project receives support from the BBSRC grant BB/I000488/1 and AL was supported by BBSRC grant BB/G015716/1. ST acknowledges support from the Leverhulme Trust (http://www.leverhulme.ac.uk, grant RPG-2012-686). The PHI-base project also receives support as a BBSRC National Capability (BB/J/004383/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniw J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-447; Baldwin TK, 2006, MOL PLANT MICROBE IN, V19, P1451, DOI 10.1094/MPMI-19-1451; Beacham A, 2011, THESIS EXETER U EXET; Bennett Laura, 2012, Computational Methods in Systems Biology. Proceedings of the 10th International Conference, CMSB 2012, P69, DOI 10.1007/978-3-642-33636-2_6; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brown NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/626345; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Dyer RB, 2005, J AGR FOOD CHEM, V53, P9281, DOI 10.1021/jf051441a; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD456, DOI 10.1093/nar/gkj026; Hagberg A, 2008, EXPLORING NETWORK ST, P11, DOI DOI 10.25080/ISSN.2575-9752; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Liu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013021; Lysenko A, 2009, BRIEF BIOINFORM, V10, P676, DOI 10.1093/bib/bbp047; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; McCormick SP, 2010, APPL ENVIRON MICROB, V76, P136, DOI 10.1128/AEM.02017-09; McCormick SP, 2004, APPL ENVIRON MICROB, V70, P2044, DOI 10.1128/AEM.70.4.2044-2051.2004; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Nunes CC, 2012, MOL PLANT PATHOL, V13, P519, DOI 10.1111/j.1364-3703.2011.00766.x; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Saitoh H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002711; Schneider D, 2010, IEEE SPECTRUM, V47, P48, DOI 10.1109/MSPEC.2010.5372501; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; SIEGEL S., 1956, NONPARAMETRIC STAT B; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Urban M, 2013, FUSARIUM: GENOMICS, MOLECULAR AND CELLULAR BIOLOGY, P43; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Wise Roger P., 2007, V406, P347; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Wong P, 2011, NUCLEIC ACIDS RES, V39, pD637, DOI 10.1093/nar/gkq1016; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yuen GY, 2007, INT J FOOD MICROBIOL, V119, P126, DOI 10.1016/j.ijfoodmicro.2007.07.033; Zhao XM, 2009, J PROTEOME RES, V8, P4714, DOI 10.1021/pr900415b	47	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67926	10.1371/journal.pone.0067926	http://dx.doi.org/10.1371/journal.pone.0067926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861834	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700062
J	Ksenofontov, AL; Paalme, V; Arutyunyan, AM; Semenyuk, PI; Fedorova, NV; Rumvolt, R; Baratova, LA; Jarvekulg, L; Dobrov, EN				Ksenofontov, Alexander L.; Paalme, Viiu; Arutyunyan, Alexander M.; Semenyuk, Pavel I.; Fedorova, Natalia V.; Rumvolt, Reet; Baratova, Ludmila A.; Jaervekuelg, Lilian; Dobrov, Eugeny N.			Partially Disordered Structure in Intravirus Coat Protein of Potyvirus Potato Virus A	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; CIRCULAR-DICHROISM	Potyviruses represent the most biologically successful group of plant viruses, but to our knowledge, this work is the first detailed study of physicochemical characteristics of potyvirus virions. We measured the UV absorption, far and near UV circular dichroism spectra, intrinsic fluorescence spectra, and differential scanning calorimetry (DSC) melting curves of intact particles of a potato virus A (PVA). PVA virions proved to have a peculiar combination of physicochemical properties. The intravirus coat protein (CP) subunits were shown to contain an unusually high fraction of disordered structures, whereas PVA virions had an almost normal thermal stability. Upon heating from 20 degrees C to 55 degrees C, the fraction of disordered structures in the intravirus CP further increased, while PVA virions remained intact at up to 55 degrees C, after which their disruption (and DSC melting) started. We suggest that the structure of PVA virions below 55 degrees C is stabilized by interactions between the remaining structured segments of intravirus CP. It is not improbable that the biological efficiency of PVA relies on the disordered structure of intravirus CP.	[Ksenofontov, Alexander L.; Arutyunyan, Alexander M.; Semenyuk, Pavel I.; Fedorova, Natalia V.; Baratova, Ludmila A.; Dobrov, Eugeny N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Paalme, Viiu; Rumvolt, Reet; Jaervekuelg, Lilian] Tallinn Univ Technol, Inst Gene Technol, EE-19086 Tallinn, Estonia; [Paalme, Viiu; Rumvolt, Reet; Jaervekuelg, Lilian] Competence Ctr Canc Res, Tallinn, Estonia	Lomonosov Moscow State University; Tallinn University of Technology; Competence Centre for Cancer Research	Jarvekulg, L (corresponding author), Tallinn Univ Technol, Inst Gene Technol, EE-19086 Tallinn, Estonia.	lilian.jarvekulg@ttu.ee; dobrov@belozersky.msu.ru	Arutyunyan, Alexander/G-8654-2012; Ksenofontov, Alexander/AAH-1774-2021; Semenyuk, Pavel I/E-2974-2012; Ksenofontov, Alexander L/D-6747-2012	Ksenofontov, Alexander/0000-0003-1585-7907; Semenyuk, Pavel I/0000-0001-7759-6445; Ksenofontov, Alexander L/0000-0003-1585-7907	Competence Center for Cancer Research [1.7]; Russian Foundation for Basic Research Program [12-04-01472-a, 13-04-00290-a];  [AR11121]	Competence Center for Cancer Research; Russian Foundation for Basic Research Program; 	This work has been supported by Grant no. 1.7 from the Competence Center for Cancer Research and Project AR11121 (Estonia) and by the Russian Foundation for Basic Research Program (project no's. 12-04-01472-a and 13-04-00290-a http://www.rfbr.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baratova LA, 2001, J VIROL, V75, P9696, DOI 10.1128/JVI.75.20.9696-9702.2001; Clare DK, 2010, J STRUCT BIOL, V171, P303, DOI 10.1016/j.jsb.2010.06.011; DOBROV EN, 1977, BIOCHIM BIOPHYS ACTA, V475, P623, DOI 10.1016/0005-2787(77)90323-9; Dobrov EN, 2014, J BIOMOL STRUCT DYN, V32, P701, DOI 10.1080/07391102.2013.788983; Gabrenaite-Verkhovskaya R, 2008, J GEN VIROL, V89, P829, DOI 10.1099/vir.0.83406-0; Gibbs A, 2010, ANNU REV PHYTOPATHOL, V48, P205, DOI 10.1146/annurev-phyto-073009-114404; GOODMAN RM, 1975, VIROLOGY, V68, P287, DOI 10.1016/0042-6822(75)90272-X; Habchi J, 2012, MOL BIOSYST, V8, P69, DOI 10.1039/c1mb05204g; HOMER RB, 1975, BIOCHIM BIOPHYS ACTA, V378, P296, DOI 10.1016/0005-2787(75)90117-3; JOHNSON KH, 1992, J BIOMOL STRUCT DYN, V9, P733, DOI 10.1080/07391102.1992.10507952; Kendall A, 2008, J VIROL, V82, P9546, DOI 10.1128/JVI.00895-08; Kendall A, 2013, VIROLOGY, V436, P173, DOI 10.1016/j.virol.2012.11.008; Ksenofontov AL, 2006, MOL BIOL+, V40, P172; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Longhi S, 2012, ADV EXP MED BIOL, V725, P126, DOI 10.1007/978-1-4614-0659-4_8; Makarov VV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060942, DOI 10.1371/J0URNAL.P0NE.0060942]; NAMBA K, 1989, J MOL BIOL, V208, P307, DOI 10.1016/0022-2836(89)90391-4; Nemykh MA, 2008, VIROLOGY, V373, P61, DOI 10.1016/j.virol.2007.11.024; Orlov VN, 1998, FEBS LETT, V433, P307, DOI 10.1016/S0014-5793(98)00924-7; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Shukla S, 2013, MOL PHARMACEUT, V10, P33, DOI 10.1021/mp300240m; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; TIKCHONENKO TI, 1966, J MOL BIOL, V18, P58, DOI 10.1016/S0022-2836(66)80076-1; Tollin P, 1988, PLANT VIRUSES, V4, P51; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Torrance L, 2006, J MOL BIOL, V357, P1, DOI 10.1016/j.jmb.2005.12.021; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Wei TY, 2010, J VIROL, V84, P799, DOI 10.1128/JVI.01824-09; Woody RW, 2009, J AM CHEM SOC, V131, P8234, DOI 10.1021/ja901218m	29	17	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67830	10.1371/journal.pone.0067830	http://dx.doi.org/10.1371/journal.pone.0067830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844104	Green Submitted, gold, Green Published			2022-12-25	WOS:000321733000105
J	Manriquez, PH; Jara, ME; Mardones, ML; Navarro, JM; Torres, R; Lardies, MA; Vargas, CA; Duarte, C; Widdicombe, S; Salisbury, J; Lagos, NA				Manriquez, Patricio H.; Elisa Jara, Maria; Loreto Mardones, Maria; Navarro, Jorge M.; Torres, Rodrigo; Lardies, Marcos A.; Vargas, Cristian A.; Duarte, Cristian; Widdicombe, Stephen; Salisbury, Joseph; Lagos, Nelson A.			Ocean Acidification Disrupts Prey Responses to Predator Cues but Not Net Prey Shell Growth in Concholepas concholepas (loco)	PLOS ONE			English	Article							CALCIFICATION RATE; CARBONIC-ACID; BEHAVIOR; CO2; FISH; TEMPERATURE; SEAWATER; DISSOCIATION; POPULATIONS; GASTROPODA	Background: Most research on Ocean Acidification (OA) has largely focused on the process of calcification and the physiological trade-offs employed by calcifying organisms to support the building of calcium carbonate structures. However, there is growing evidence that OA can also impact upon other key biological processes such as survival, growth and behaviour. On wave-swept rocky shores the ability of gastropods to self-right after dislodgement, and rapidly return to normal orientation, reduces the risk of predation. Methodology/Principal Findings: The impacts of OA on this self-righting behaviour and other important parameters such as growth, survival, shell dissolution and shell deposition in Concholepas concholepas (loco) were investigated under contrasting pCO(2) levels. Although no impacts of OA on either growth or net shell calcification were found, the results did show that OA can significantly affect self-righting behaviour during the early ontogeny of this species with significantly faster righting times recorded for individuals of C. concholepas reared under increased average pCO(2) concentrations (+/- SE) (716 +/- 12 and 1036 +/- 14 mu atm CO2) compared to those reared at concentrations equivalent to those presently found in the surface ocean (388 +/- 8 mu atm CO2). When loco were also exposed to the predatory crab Acanthocyclus hassleri, righting times were again increased by exposure to elevated CO2, although self-righting times were generally twice as fast as those observed in the absence of the crab. Conclusions and Significance: These results suggest that self-righting in the early ontogeny of C. concholepas will be positively affected by pCO(2) levels expected by the end of the 21st century and beginning of the next one. However, as the rate of self-righting is an adaptive trait evolved to reduce lethal predatory attacks, our result also suggest that OA may disrupt prey responses to predators in nature.	[Manriquez, Patricio H.; Elisa Jara, Maria; Loreto Mardones, Maria; Navarro, Jorge M.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, LECOT, Fac Ciencias, Valdivia, Chile; [Manriquez, Patricio H.; Elisa Jara, Maria; Loreto Mardones, Maria; Navarro, Jorge M.] Univ Austral Chile, Lab Costero Recursos Acuat Calfuco, Fac Ciencias, Valdivia, Chile; [Torres, Rodrigo] CIEP, Coyhaique, Chile; [Lardies, Marcos A.] Univ Adolfo Ibanez, Fac Artes Liberales, Santiago, Chile; [Vargas, Cristian A.] Univ Concepcion, Lab Funcionamiento Ecosistemas Acuat LAFE, Unidad Sistemas Acuat, Ctr Ciencias Ambientales EULA, Concepcion, Chile; [Duarte, Cristian] Univ Andres Bello, Fac Ecol & Recursos Nat, Dept Ecol & Biodiversidad, Santiago, Chile; [Widdicombe, Stephen] Plymouth Marine Lab, Plymouth, Devon, England; [Salisbury, Joseph] Univ New Hampshire, Ocean Proc Anal Lab, Durham, NH 03824 USA; [Lagos, Nelson A.] Univ Santo Tomas, Fac Ciencias, Santiago, Chile	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Adolfo Ibanez; Universidad de Concepcion; Universidad Andres Bello; Plymouth Marine Laboratory; University System Of New Hampshire; University of New Hampshire; Universidad Santo Tomas	Manriquez, PH (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, LECOT, Fac Ciencias, Valdivia, Chile.	patriciohmanriquez@gmail.com	Lardies, Marco A/R-6203-2017; Duarte, Cristian/I-4013-2016; Navarro, Jorge/B-7928-2008	Lardies, Marco A/0000-0003-3525-1830; Navarro, Jorge/0000-0001-9920-190X; Manriquez, Patricio/0000-0001-6586-764X; Duarte, Cristian/0000-0002-7033-3551; Vargas, Cristian A./0000-0002-1486-3611; Mardones, Maria Loreto/0000-0001-5216-4240	Programa de Investigacion Asociativa, PIA-CONICYT-CHILE [ACT-132]; Project Fondecyt Grant [1090624]; project Fondecyt [1080023]; NERC UK Ocean Acidification Programme; NERC [pml010004] Funding Source: UKRI; Natural Environment Research Council [pml010004] Funding Source: researchfish	Programa de Investigacion Asociativa, PIA-CONICYT-CHILE; Project Fondecyt Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); project Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NERC UK Ocean Acidification Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was mainly funded by the Programa de Investigacion Asociativa, PIA-CONICYT-CHILE (Grant Anillos ACT-132, to P.H.M., N.A.L., C.A.V., M.A.L., R.T. & J.M.N.) and the Project Fondecyt Grant 1090624 (to N.L., C.V., M.A.L., R.T. and P.H.M.). Additional financial support came from project Fondecyt 1080023 to P.H.M., N.A.L and Dr. Juan Carlos Castilla. SW acknowledges financial support from the NERC UK Ocean Acidification Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz G, 2012, J EXP MAR BIOL ECOL, V412, P20, DOI 10.1016/j.jembe.2011.10.014; Amaral V, 2012, MAR ECOL PROG SER, V445, P117, DOI 10.3354/meps09487; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; Bryan PJ, 1997, J CHEM ECOL, V23, P645, DOI 10.1023/B:JOEC.0000006401.97339.b9; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Caparroy P, 1998, MAR ECOL PROG SER, V168, P109, DOI 10.3354/meps168109; Castaneda LE, 2004, EVOL ECOL RES, V6, P579; Castilla J.C., 1979, Biodiversity: a challenge for development research and policy, V12, P115; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; Dalesman S, 2011, J EXP BIOL, V214, P2528, DOI 10.1242/jeb.058024; de la Haye KL, 2012, J EXP MAR BIOL ECOL, V412, P134, DOI 10.1016/j.jembe.2011.11.013; Devine BM, 2012, CORAL REEFS, V31, P229, DOI 10.1007/s00338-011-0837-0; Dickson A. G., 1994, ORNLCDIAC74 DOE; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; DUBOIS R, 1980, VELIGER, V23, P83; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Franc A, 1968, TRAITE ZOOLOGIE ANAT, VV, P178; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Haraldsson C, 1997, DEEP-SEA RES PT I, V44, P2031, DOI 10.1016/S0967-0637(97)00088-5; Huaquin LG, 2000, J MED APPL MALACOLOG, V10, P145; Jacobsen HP, 2004, OIKOS, V104, P43, DOI 10.1111/j.0030-1299.2004.12369.x; Karnik V, 2012, J EXP BIOL, V215, P536, DOI 10.1242/jeb.061432; Kleitman N, 1941, BIOL BULL-US, V80, P292, DOI 10.2307/1537716; Leclercq N, 2000, GLOB CHANGE BIOL, V6, P329, DOI 10.1046/j.1365-2486.2000.00315.x; Leiva GE, 2002, REV FISH BIOL FISHER, V11, P283; Lewis E., 1998, PROGRAM DEV CO2 SYST, P21; Manriquez PH, 2008, AQUACULTURE, V279, P99, DOI 10.1016/j.aquaculture.2008.03.031; Manriquez PH, 2013, MAR ECOL PROG SER, V472, P169, DOI 10.3354/meps10055; Manriquez PH, 2009, P NATL ACAD SCI USA, V106, P16298, DOI 10.1073/pnas.0908655106; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; MINITAB Inc, 2003, NATURE CLIM CHANGE, V14; Morley SA, 2012, MAR ECOL PROG SER, V450, P81, DOI 10.3354/meps09577; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; NAVARRETE SA, 1988, J EXP MAR BIOL ECOL, V118, P115, DOI 10.1016/0022-0981(88)90235-3; NAVARRO JM, 1994, COMP BIOCHEM PHYS A, V108, P39, DOI 10.1016/0300-9629(94)90051-5; Navarro JM, 2013, CHEMOSPHERE, V90, P1242, DOI 10.1016/j.chemosphere.2012.09.063; Navarro JM, 2010, MAR BIOL, V157, P1967, DOI 10.1007/s00227-010-1465-x; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Orr MV, 2007, J EXP BIOL, V210, P4150, DOI 10.1242/jeb.010173; PALMER AR, 1981, NATURE, V292, P150, DOI 10.1038/292150a0; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Ramajo L, 2012, J MAR BIOL IN PRESS; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2011, NATURE CLIM CHANGE, V1, P308; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; Seuront L, 2011, PHYSICA A, V390, P250, DOI 10.1016/j.physa.2010.09.025; Storch D, 2009, J EXP BIOL, V212, P1371, DOI 10.1242/jeb.030205; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vermeij G.J., 1993, NATURAL HIST SHELLS; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	67	55	55	0	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68643	10.1371/journal.pone.0068643	http://dx.doi.org/10.1371/journal.pone.0068643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844231	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000321733000021
J	Smits, JGC; van Beek, JKL				Smits, Johannes G. C.; van Beek, Jan K. L.			ECO: A Generic Eutrophication Model Including Comprehensive Sediment-Water Interaction	PLOS ONE			English	Article							ORGANIC-MATTER MINERALIZATION; EARLY DIAGENETIC PROCESSES; NORTH-SEA; ECOSYSTEM MODEL; DISTURBED SEDIMENTS; NUTRIENT DYNAMICS; KINETIC-MODELS; LAKE VELUWE; PHOSPHORUS; COASTAL	The content and calibration of the comprehensive generic 3D eutrophication model ECO for water and sediment quality is presented. Based on a computational grid for water and sediment, ECO is used as a tool for water quality management to simulate concentrations and mass fluxes of nutrients (N, P, Si), phytoplankton species, detrital organic matter, electron acceptors and related substances. ECO combines integral simulation of water and sediment quality with sediment diagenesis and closed mass balances. Its advanced process formulations for substances in the water column and the bed sediment were developed to allow for a much more dynamic calculation of the sediment-water exchange fluxes of nutrients as resulting from steep concentration gradients across the sediment-water interface than is possible with other eutrophication models. ECO is to more accurately calculate the accumulation of organic matter and nutrients in the sediment, and to allow for more accurate prediction of phytoplankton biomass and water quality in response to mitigative measures such as nutrient load reduction. ECO was calibrated for shallow Lake Veluwe (The Netherlands). Due to restoration measures this lake underwent a transition from hypertrophic conditions to moderately eutrophic conditions, leading to the extensive colonization by submerged macrophytes. ECO reproduces observed water quality well for the transition period of ten years. The values of its process coefficients are in line with ranges derived from literature. ECO's calculation results underline the importance of redox processes and phosphate speciation for the nutrient return fluxes. Among other things, the results suggest that authigenic formation of a stable apatite-like mineral in the sediment can contribute significantly to oligotrophication of a lake after a phosphorus load reduction.	[Smits, Johannes G. C.; van Beek, Jan K. L.] Deltares, Marine & Coastal Syst, Delft, Netherlands	Deltares	Smits, JGC (corresponding author), Deltares, Marine & Coastal Syst, Delft, Netherlands.	johannes.smits@deltares.nl		van Beek, Jan/0000-0002-4019-7202	Strategic Research program of Deltares	Strategic Research program of Deltares	This study was funded by the Strategic Research program of Deltares (wwww.deltares.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Strategic Research program of Deltares, the employer of all authors. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aguilera DR, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000899; Anschutz P, 2007, ESTUAR COAST SHELF S, V72, P447, DOI 10.1016/j.ecss.2006.11.012; Arndt S, 2011, J MARINE SYST, V84, P49, DOI 10.1016/j.jmarsys.2010.08.005; BANKS RB, 1977, J ENV ENG DIV-ASCE, V103, P489; Berner R.A., 1980, EARLY DIAGENESIS THE; Blauw AN, 2009, HYDROBIOLOGIA, V618, P175, DOI 10.1007/s10750-008-9575-x; BOERS P, 1991, WATER RES, V25, P591, DOI 10.1016/0043-1354(91)90131-9; Boers PCM, 1998, WATER SCI TECHNOL, V37, P31, DOI 10.2166/wst.1998.0169; Boudreau B. P., 1997, MODELLING TRANSPORT, V171, DOI 10.1016/s0264-8172(98)80005-6; Boudreau BP, 1996, COMPUT GEOSCI, V22, P479, DOI 10.1016/0098-3004(95)00115-8; Brigolin D, 2011, J MARINE SYST, V87, P239, DOI 10.1016/j.jmarsys.2011.04.006; Brinkman AG, 1986, THESIS TU TWENTE ENS; BURDIGE DJ, 1991, J MAR RES, V49, P727, DOI 10.1357/002224091784995710; Burger DF, 2008, ECOL MODEL, V211, P411, DOI 10.1016/j.ecolmodel.2007.09.028; Canavan RW, 2006, GEOCHIM COSMOCHIM AC, V70, P2836, DOI 10.1016/j.gca.2006.03.012; Dale AW, 2008, J MAR RES, V66, P127, DOI 10.1357/002224008784815775; Dauwe B, 2001, MAR ECOL PROG SER, V215, P13, DOI 10.3354/meps215013; DEJONGE VN, 1993, HYDROBIOLOGIA, V253, P151, DOI 10.1007/BF00050735; Deltares, 2013, D WAT QUAL WAT QUAL; DiToro D, 2001, SEDIMENT FLUX MODELI; Dittrich M, 2009, ECOL MODEL, V220, P2751, DOI 10.1016/j.ecolmodel.2009.07.015; Guss S, 1998, ESTUAR COAST SHELF S, V46, P143, DOI 10.1006/ecss.1997.0265; Hochard S, 2010, ECOL MODEL, V221, P1687, DOI 10.1016/j.ecolmodel.2010.04.002; Hosper H., 1986, HYDROBIOL B, P183, DOI DOI 10.1007/BF02291162; JAGTMAN E, 1992, HYDROBIOLOGIA, V233, P187, DOI 10.1007/BF00016107; Janse JH, 2010, ECOL MODEL, V221, P654, DOI 10.1016/j.ecolmodel.2009.07.023; Janse J.H, 2005, MODEL STUDIES EUTROP; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Lancelot C, 2005, MAR ECOL PROG SER, V289, P63, DOI 10.3354/meps289063; Lewis GN, 2007, ECOL MODEL, V209, P121, DOI 10.1016/j.ecolmodel.2007.06.015; Los FJ, 2007, J MARINE SYST, V64, P201, DOI 10.1016/j.jmarsys.2006.03.009; Los FJ, 2009, THESIS WAGENINGEN U; Luff R, 2000, DEEP-SEA RES PT II, V47, P3039, DOI 10.1016/S0967-0645(00)00058-8; Luff R, 2004, CONT SHELF RES, V24, P1099, DOI 10.1016/j.csr.2004.03.010; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; Neumann T, 2008, J MARINE SYST, V74, P592, DOI 10.1016/j.jmarsys.2008.05.003; Patsch J, 2008, CONT SHELF RES, V28, P767, DOI 10.1016/j.csr.2007.12.013; Raick C, 2005, J MARINE SYST, V55, P177, DOI 10.1016/j.jmarsys.2004.09.005; Reed DC, 2011, LIMNOL OCEANOGR, V56, P1075, DOI 10.4319/lo.2011.56.3.1075; RUARDIJ P, 1995, NETH J SEA RES, V33, P453, DOI 10.1016/0077-7579(95)90057-8; SANTSCHI P, 1990, MAR CHEM, V30, P269, DOI 10.1016/0304-4203(90)90076-O; SCHINK DR, 1977, MAR GEOL, V23, P133, DOI 10.1016/0025-3227(77)90086-X; Slomp CP, 2007, BIOGEOSCIENCES, V4, P155, DOI 10.5194/bg-4-155-2007; Slomp CP, 1996, J MAR RES, V54, P1179, DOI 10.1357/0022240963213745; Slomp CP, 1998, LIMNOL OCEANOGR, V43, P832, DOI 10.4319/lo.1998.43.5.0832; SMITS JGC, 1993, HYDROBIOLOGIA, V253, P281, DOI 10.1007/BF00050749; Soetaert K, 1996, GEOCHIM COSMOCHIM AC, V60, P1019, DOI 10.1016/0016-7037(96)00013-0; Soetaert K, 1996, J MAR RES, V54, P1207, DOI 10.1357/0022240963213808; Soetaert K, 2000, EARTH-SCI REV, V51, P173, DOI 10.1016/S0012-8252(00)00004-0; Soetaert K, 2009, HYDROBIOLOGIA, V629, P239, DOI 10.1007/s10750-009-9777-x; Stumm W, 1996, AQUATIC CHEM; Trolle D, 2008, ECOL MODEL, V219, P138, DOI 10.1016/j.ecolmodel.2008.08.005; Van Der Molen DT, 1998, WATER RES, V32, P3281, DOI 10.1016/S0043-1354(98)00117-1; Van Eck GTM, 1986, SEDIMENTS WATER INTE, P289; Van Koningsveld M, 2010, BEIJ CHIN P WODCON 1; VANDERBORGHT JP, 1977, LIMNOL OCEANOGR, V22, P787, DOI 10.4319/lo.1977.22.5.0787; VANDERBORGHT JP, 1977, LIMNOL OCEANOGR, V22, P794, DOI 10.4319/lo.1977.22.5.0794; VANDERMOLEN DT, 1994, HYDROBIOLOGIA, V275, P479, DOI 10.1007/BF00026736; Wang YF, 1996, GEOCHIM COSMOCHIM AC, V60, P2993, DOI 10.1016/0016-7037(96)00140-8; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; WESTRICH JT, 1984, LIMNOL OCEANOGR, V29, P236, DOI 10.4319/lo.1984.29.2.0236; Wijsman JWM, 2002, ESTUAR COAST SHELF S, V54, P403, DOI 10.1006/ecss.2000.0655	64	23	23	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68104	10.1371/journal.pone.0068104	http://dx.doi.org/10.1371/journal.pone.0068104			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844160	Green Published, gold			2022-12-25	WOS:000321733000129
J	Dantas, TJ; Daly, OM; Conroy, PC; Tomas, M; Wang, YF; Lalor, P; Dockery, P; Ferrando-May, E; Morrison, CG				Dantas, Tiago J.; Daly, Owen M.; Conroy, Pauline C.; Tomas, Martin; Wang, Yifan; Lalor, Pierce; Dockery, Peter; Ferrando-May, Elisa; Morrison, Ciaran G.			Calcium-Binding Capacity of Centrin2 Is Required for Linear POC5 Assembly but Not for Nucleotide Excision Repair	PLOS ONE			English	Article							GROUP-C PROTEIN; MOLECULAR-CLONING; DNA-REPAIR; CELL-CYCLE; CENTROSOME; COMPLEX; DUPLICATION; GENE; PHOSPHORYLATION; BIOGENESIS	Centrosomes, the principal microtubule-organising centres in animal cells, contain centrins, small, conserved calcium-binding proteins unique to eukaryotes. Centrin2 binds to xeroderma pigmentosum group C protein (XPC), stabilising it, and its presence slightly increases nucleotide excision repair (NER) activity in vitro. In previous work, we deleted all three centrin isoforms present in chicken DT40 cells and observed delayed repair of UV-induced DNA lesions, but no centrosome abnormalities. Here, we explore how centrin2 controls NER. In the centrin null cells, we expressed centrin2 mutants that cannot bind calcium or that lack sites for phosphorylation by regulatory kinases. Expression of any of these mutants restored the UV sensitivity of centrin null cells to normal as effectively as expression of wild-type centrin. However, calcium-binding-deficient and T118A mutants showed greatly compromised localisation to centrosomes. XPC recruitment to laser-induced UV-like lesions was only slightly slower in centrin-deficient cells than in controls, and levels of XPC and its partner HRAD23B were unaffected by centrin deficiency. Interestingly, we found that overexpression of the centrin interactor POC5 leads to the assembly of linear, centrin-dependent structures that recruit other centrosomal proteins such as PCM-1 and NEDD1. Together, these observations suggest that assembly of centrins into complex structures requires calcium binding capacity, but that such assembly is not required for centrin activity in NER.	[Dantas, Tiago J.; Daly, Owen M.; Conroy, Pauline C.; Wang, Yifan; Morrison, Ciaran G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Lalor, Pierce; Dockery, Peter] Natl Univ Ireland Galway, Sch Med, Galway, Ireland; [Tomas, Martin; Ferrando-May, Elisa] Univ Konstanz, Bioimaging Ctr, Constance, Germany; [Tomas, Martin] Univ Konstanz, Dept Phys, Ctr Appl Photon, Constance, Germany	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Konstanz; University of Konstanz	Morrison, CG (corresponding author), Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland.	Ciaran.Morrison@nuigalway.ie	Morrison, Ciaran/AAH-2034-2019; Morrison, Ciaran/B-6568-2008	Morrison, Ciaran/0000-0003-2401-7029; Morrison, Ciaran/0000-0003-2401-7029; Dockery, Peter/0000-0001-5103-6589; Dantas, Tiago J./0000-0002-0120-4895	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/40940/2007]; National Biophotonics and Imaging Platform Ireland; Science Foundation Ireland [08/IN.1/B1029, 10/IN. 1/B2972]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); National Biophotonics and Imaging Platform Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	TJD received a predoctoral fellowship from the Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BD/40940/2007; www.fct.pt). The authors are indebted to a Programme for Research in Third Level Institutions (PRTLI) 4 grant to fund the National Biophotonics and Imaging Platform Ireland (www.nbipireland.ie) for the TEM. This work was supported by Science Foundation Ireland Principal Investigator awards 08/IN.1/B1029 and 10/IN. 1/B2972 (www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acu ID, 2010, CANCER RES, V70, P3320, DOI 10.1158/0008-5472.CAN-09-3800; Alieva IB, 2004, CELL BIOL INT, V28, P139, DOI 10.1016/j.cellbi.2003.11.013; Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Araki M, 2000, MUTAT RES-DNA REPAIR, V459, P147, DOI 10.1016/S0921-8777(99)00067-1; Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Camenisch U, 2009, EMBO J, V28, P2387, DOI 10.1038/emboj.2009.187; Charbonnier JB, 2007, J MOL BIOL, V373, P1032, DOI 10.1016/j.jmb.2007.08.046; Conroy PC, 2012, CELL CYCLE, V11, P3769, DOI 10.4161/cc.21986; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dantas TJ, 2012, CELL MOL LIFE SCI, V69, P2979, DOI 10.1007/s00018-012-0961-1; Dantas TJ, 2011, J CELL BIOL, V193, P307, DOI 10.1083/jcb.201012093; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Delaval B, 2011, CELL CYCLE, V10, P3964, DOI 10.4161/cc.10.22.18150; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; ERRABOLU R, 1994, J CELL SCI, V107, P9; Geimer S, 2005, EUKARYOT CELL, V4, P1253, DOI 10.1128/EC.4.7.1253-1263.2005; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hart PE, 1999, GENOMICS, V60, P111, DOI 10.1006/geno.1999.5880; HUANG B, 1988, J CELL BIOL, V107, P133, DOI 10.1083/jcb.107.1.133; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Klein UR, 2009, J CELL SCI, V122, P3312, DOI 10.1242/jcs.050245; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Krasikova YS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P346, DOI 10.1134/S0006297912040050; LEE VD, 1993, P NATL ACAD SCI USA, V90, P11039, DOI 10.1073/pnas.90.23.11039; Li S, 2006, J CELL BIOL, V173, P867, DOI 10.1083/jcb.200603153; Lukasiewicz KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021291; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; Majumder S, 2010, MOL BIOL CELL, P2; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Nishi R, 2005, MOL CELL BIOL, V25, P5664, DOI 10.1128/MCB.25.13.5664-5674.2005; Paoletti A, 1996, J CELL SCI, V109, P3089; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Popescu A, 2003, J BIOL CHEM, V278, P40252, DOI 10.1074/jbc.M302546200; Renaud E, 2011, DNA REPAIR, V10, P835, DOI 10.1016/j.dnarep.2011.05.003; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Salisbury JL, 2004, CURR BIOL, V14, pR27, DOI 10.1016/j.cub.2003.12.019; SALISBURY JL, 1984, J CELL BIOL, V99, P962, DOI 10.1083/jcb.99.3.962; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2010, MUTAT RES-FUND MOL M, V685, P29, DOI 10.1016/j.mrfmmm.2009.08.004; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thompson JR, 2006, J BIOL CHEM, V281, P18746, DOI 10.1074/jbc.M513667200; Trautlein D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp932; Trojan P, 2008, BBA-MOL CELL RES, V1783, P1248, DOI 10.1016/j.bbamcr.2008.01.006; UZAWA M, 1995, DEV BIOL, V171, P51, DOI 10.1006/dbio.1995.1259; Veeraraghavan S, 2002, J BIOL CHEM, V277, P28564, DOI 10.1074/jbc.M112232200; Vonderfecht T, 2011, MOL BIOL CELL, V22, P2221, DOI 10.1091/mbc.E11-02-0151; Wang QE, 2007, NUCLEIC ACIDS RES, V35, P5338, DOI 10.1093/nar/gkm550; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Wolfrum U, 1998, EXP CELL RES, V242, P10, DOI 10.1006/excr.1998.4038; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031	69	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68487	10.1371/journal.pone.0068487	http://dx.doi.org/10.1371/journal.pone.0068487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844208	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000164
J	Esnault, S; Kelly, EA; Schwantes, EA; Liu, LY; DeLain, LP; Hauer, JA; Bochkov, YA; Denlinger, LC; Malter, JS; Mathur, SK; Jarjour, NN				Esnault, Stephane; Kelly, Elizabeth A.; Schwantes, Elizabeth A.; Liu, Lin Ying; DeLain, Larissa P.; Hauer, Jami A.; Bochkov, Yury A.; Denlinger, Loren C.; Malter, James S.; Mathur, Sameer K.; Jarjour, Nizar N.			Identification of Genes Expressed by Human Airway Eosinophils after an In Vivo Allergen Challenge	PLOS ONE			English	Article							PERIPHERAL-BLOOD EOSINOPHILS; INFLAMMATORY RESPONSES; RECEPTOR; PROTEIN; MEPOLIZUMAB; ACTIVATION; GENERATION; ASTHMA; SPUTUM; CELLS	Background: The mechanism for the contribution of eosinophils (EOS) to asthma pathophysiology is not fully understood. Genome-wide expression analysis of airway EOS by microarrays has been limited by the ability to generate high quality RNA from sufficient numbers of airway EOS. Objective: To identify, by genome-wide expression analyses, a compendium of expressed genes characteristic of airway EOS following an in vivo allergen challenge. Methods: Atopic, mild asthmatic subjects were recruited for these studies. Induced sputum was obtained before and 48h after a whole lung allergen challenge (WLAC). Individuals also received a segmental bronchoprovocation with allergen (SBP-Ag) 1 month before and after administering a single dose of mepolizumab (anti-IL-5 monoclonal antibody) to reduce airway EOS. Bronchoalveolar lavage (BAL) was performed before and 48 h after SBP-Ag. Gene expression of sputum and BAL cells was analyzed by microarrays. The results were validated by qPCR in BAL cells and purified BAL EOS. Results: A total of 299 transcripts were up-regulated by more than 2-fold in total BAL cells following SBP-Ag. Mepolizumab treatment resulted in a reduction of airway EOS by 54.5% and decreased expression of 99 of the 299 transcripts. 3 of 6 post-WLAC sputum samples showed increased expression of EOS-specific genes, along with the expression of 361 other genes. Finally, the intersection of the 3 groups of transcripts (increased in BAL post SBP-Ag (299), decreased after mepolizumab (99), and increased in sputum after WLAC (365)) was composed of 57 genes characterizing airway EOS gene expression. Conclusion: We identified 57 genes that were highly expressed by BAL EOS compared to unseparated BAL cells after in vivo allergen challenge. 41 of these genes had not been previously described in EOS and are thus potential new candidates to elucidate EOS contribution to airway biology.	[Esnault, Stephane; Kelly, Elizabeth A.; Schwantes, Elizabeth A.; Liu, Lin Ying; DeLain, Larissa P.; Hauer, Jami A.; Denlinger, Loren C.; Mathur, Sameer K.; Jarjour, Nizar N.] Univ Wisconsin, Dept Med, Allergy Pulm & Crit Care Med Div, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Bochkov, Yury A.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Malter, James S.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Southwestern Medical Center Dallas	Esnault, S (corresponding author), Univ Wisconsin, Dept Med, Allergy Pulm & Crit Care Med Div, Sch Med & Publ Hlth, Madison, WI 53706 USA.	sesnault@medicine.wisc.edu	Esnault, Stephane/AAO-4712-2020; Esnault, Stephane/AAJ-4511-2020	Esnault, Stephane/0000-0001-7238-8671; Kelly, Elizabeth/0000-0001-7335-6698; Bochkov, Yury/0000-0003-2618-4496	University of Wisconsin General Clinical Research Center [NIH M01RR03186]; University of Wisconsin Institute for Clinical and Translational Research [NCRR/NIH 1UL1RR025011];  [NIH HL088594]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER	University of Wisconsin General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Wisconsin Institute for Clinical and Translational Research; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a Program Project Grant (NIH HL088594), the University of Wisconsin General Clinical Research Center grant (NIH M01RR03186), and the University of Wisconsin Institute for Clinical and Translational Research (NCRR/NIH 1UL1RR025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Bates ME, 2010, J IMMUNOL, V184, P7125, DOI 10.4049/jimmunol.0900634; Bates ME, 2004, AM J RESP CELL MOL, V30, P736, DOI 10.1165/rcmb.2003-0234OC; Boulay ME, 2002, CLIN EXP ALLERGY, V32, P1441, DOI 10.1046/j.1365-2745.2002.01508.x; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Broekema M, 2010, RESP MED, V104, P1254, DOI 10.1016/j.rmed.2010.03.030; Broekema M, 2010, AM J RESP CRIT CARE; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P803, DOI 10.1016/j.jaci.2009.11.048; CALHOUN WJ, 1993, AM REV RESPIR DIS, V147, P1465, DOI 10.1164/ajrccm/147.6_Pt_1.1465; Castro M, 2011, AM J RESP CRIT CARE; Chen C, 2003, BIOCHEM J, V374, P97, DOI 10.1042/BJ20030242; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; del Rio ML, 2010, J LEUKOCYTE BIOL, V87, P223, DOI 10.1189/jlb.0809590; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Esnault S, 2012, CLIN EXP ALLERGY, V42, P1756, DOI 10.1111/j.1365-2222.2012.04060.x; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Giannini L, 2008, J CELL MOL MED, V12, P2381, DOI 10.1111/j.1582-4934.2008.00258.x; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Homer RJ, 2011, ARCH PATHOL LAB MED, V135, P780, DOI 10.1043/2010-0296-RA.1; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Inoue M, 1998, BIOCHEM BIOPH RES CO, V252, P307, DOI 10.1006/bbrc.1998.9645; Jarjour NN, 1997, AM J RESP CRIT CARE, V155, P1515, DOI 10.1164/ajrccm.155.5.9154851; Johansson MW, 2013, CLIN EXP ALLERGY, V43, P292, DOI 10.1111/j.1365-2222.2012.04065.x; Johansson MW, 2008, J IMMUNOL, V180, P7622, DOI 10.4049/jimmunol.180.11.7622; Karmaus PWF, 2011, J LEUKOCYTE BIOL, V90, P983, DOI 10.1189/jlb.0511219; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kelly EAB, 2012, CYTOKINE, V58, P199, DOI 10.1016/j.cyto.2012.01.009; Kishimoto S, 2006, INT ARCH ALLERGY IMM, V140, P3, DOI 10.1159/000092704; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Lilly CM, 2005, AM J RESP CRIT CARE, V171, P579, DOI 10.1164/rccm.200404-532OC; Liu LY, 2007, J IMMUNOL, V179, P4840, DOI 10.4049/jimmunol.179.7.4840; Liu LY, 2006, ALLERGY, V61, P589, DOI 10.1111/j.1398-9995.2006.01060.x; Liu LY, 2000, J ALLERGY CLIN IMMUN, V106, P1063; Liu LY, 2002, J IMMUNOL, V169, P6452, DOI 10.4049/jimmunol.169.11.6452; Lopuhaa CE, 2002, CLIN EXP ALLERGY, V32, P1720, DOI 10.1046/j.1365-2222.2002.01542.x; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nakajima T, 2001, BLOOD, V98, P1127, DOI 10.1182/blood.V98.4.1127; Oka S, 2004, J LEUKOCYTE BIOL, V76, P1002, DOI 10.1189/jlb.0404252; Osanai A, 2011, INFECT IMMUN, V79, P858, DOI 10.1128/IAI.00466-10; Park SY, 2013, J IMMUNOL; PIN I, 1992, AM REV RESPIR DIS, V145, P1265, DOI 10.1164/ajrccm/145.6.1265; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Sashchenko LP, 2007, BLOOD, V110, P1997, DOI 10.1182/blood-2006-12-064444; Spencer LA, 2009, J LEUKOCYTE BIOL, V85, P117, DOI 10.1189/jlb.0108058; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; Temple R, 2001, AM J RESP CELL MOL, V25, P425, DOI 10.1165/ajrcmb.25.4.4456; Tydell CC, 2002, J BIOL CHEM, V277, P19658, DOI 10.1074/jbc.M200659200; Zoerner AA, 2011, CLIN PHARMACOL THER, V90, P388, DOI 10.1038/clpt.2011.94	54	44	47	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67560	10.1371/journal.pone.0067560	http://dx.doi.org/10.1371/journal.pone.0067560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844029	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000057
J	Gmiterek, A; Wojtowicz, H; Mackiewicz, P; Radwan-Oczko, M; Kantorowicz, M; Chomyszyn-Gajewska, M; Fraszczak, M; Bielecki, M; Olczak, M; Olczak, T				Gmiterek, Anna; Wojtowicz, Halina; Mackiewicz, Pawel; Radwan-Oczko, Malgorzata; Kantorowicz, Malgorzata; Chomyszyn-Gajewska, Maria; Fraszczak, Magdalena; Bielecki, Marcin; Olczak, Mariusz; Olczak, Teresa			The Unique hmuY Gene Sequence as a Specific Marker of Porphyromonas gingivalis	PLOS ONE			English	Article							REAL-TIME PCR; CORONARY-HEART-DISEASE; PERIODONTAL PATHOGENS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; QUANTITATIVE DETECTION; BACTEROIDES-FORSYTHUS; PREVOTELLA-INTERMEDIA; BACTERIAL DIVERSITY; PLAQUE; PRIMERS	Porphyromonas gingivalis, a major etiological agent of chronic periodontitis, acquires heme from host hemoproteins using the HmuY hemophore. The aim of this study was to develop a specific P. gingivalis marker based on a hmuY gene sequence. Subgingival samples were collected from 66 patients with chronic periodontitis and 40 healthy subjects and the entire hmuY gene was analyzed in positive samples. Phylogenetic analyses demonstrated that both the amino acid sequence of the HmuY protein and the nucleotide sequence of the hmuY gene are unique among P. gingivalis strains/isolates and show low identity to sequences found in other species (below 50 and 56%, respectively). In agreement with these findings, a set of hmuY gene-based primers and standard/real-time PCR with SYBR Green chemistry allowed us to specifically detect P. gingivalis in patients with chronic periodontitis (77.3%) and healthy subjects (20%), the latter possessing lower number of P. gingivalis cells and total bacterial cells. Isolates from healthy subjects possess the hmuY gene-based nucleotide sequence pattern occurring in W83/W50/A7436 (n = 4), 381/ATCC 33277 (n = 3) or TDC60 (n = 1) strains, whereas those from patients typically have TDC60 (n = 21), W83/W50/A7436 (n = 17) and 381/ATCC 33277 (n = 13) strains. We observed a significant correlation between periodontal index of risk of infectiousness (PIRI) and the presence/absence of P. gingivalis (regardless of the hmuY gene-based sequence pattern of the isolate identified [r = 0.43; P = 0.0002] and considering particular isolate pattern [r = 0.38; P = 0.0012]). In conclusion, we demonstrated that the hmuY gene sequence or its fragments may be used as one of the molecular markers of P. gingivalis.	[Gmiterek, Anna; Wojtowicz, Halina; Bielecki, Marcin; Olczak, Mariusz; Olczak, Teresa] Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50138 Wroclaw, Poland; [Mackiewicz, Pawel] Univ Wroclaw, Fac Biotechnol, Dept Genom, PL-50138 Wroclaw, Poland; [Radwan-Oczko, Malgorzata] Wroclaw Med Univ, Unit Oral Pathol, Dept Periodontol, Wroclaw, Poland; [Kantorowicz, Malgorzata; Chomyszyn-Gajewska, Maria] Jagiellonian Univ, Coll Med, Dept Periodontol & Oral Med, Krakow, Poland; [Fraszczak, Magdalena] Univ Environm & Life Sci, Inst Genet, Wroclaw, Poland	University of Wroclaw; University of Wroclaw; Wroclaw Medical University; Jagiellonian University; Collegium Medicum Jagiellonian University; Wroclaw University of Environmental & Life Sciences	Olczak, T (corresponding author), Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50138 Wroclaw, Poland.	Teresa.Olczak@biotech.uni.wroc.pl	Frąszczak, Magdalena/A-2614-2017	Fraszczak, Magdalena/0000-0002-8012-4980	Ministry of Science and Higher Education/National Science Center (Poland) [N N303 518438]; Wroclaw Research Center EIT+ under the project "Biotechnologies and advanced medical technologies - BioMed'' [POIG 01.01.02-02-003/08/00]; European Regional Development Fund (Operational Program Innovative Economy) [1.1.2]	Ministry of Science and Higher Education/National Science Center (Poland); Wroclaw Research Center EIT+ under the project "Biotechnologies and advanced medical technologies - BioMed''; European Regional Development Fund (Operational Program Innovative Economy)	This study was supported by grant no. N N303 518438 from the Ministry of Science and Higher Education/National Science Center (Poland) and by Wroclaw Research Center EIT+ under the project "Biotechnologies and advanced medical technologies - BioMed'' (POIG 01.01.02-02-003/08/00) financed from the European Regional Development Fund (Operational Program Innovative Economy, 1.1.2) ( to TO). The funders had no role in study design, data collection and analysis, and preparation of the manuscript. The decision to publish was made by the authors, following IP review.	Abiko Y, 2010, J PERIODONTAL RES, V45, P389, DOI 10.1111/j.1600-0765.2009.01250.x; Amano A, 2000, J DENT RES, V79, P1664, DOI 10.1177/00220345000790090501; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Botta GA, 2000, J ANTIMICROB CHEMOTH, V43, P1523; Boutaga K, 2006, J CLIN PERIODONTOL, V33, P427, DOI 10.1111/j.1600-051X.2006.00925.x; Boutaga K, 2003, J CLIN MICROBIOL, V41, P4950, DOI 10.1128/JCM.41.11.4950-4954.2003; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Craig RG, 2003, J PERIODONTOL, V74, P1007, DOI 10.1902/jop.2003.74.7.1007; Criscuolo A, 2011, MOL PHYLOGENET EVOL, V61, P944, DOI 10.1016/j.ympev.2011.08.029; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Doungudomdacha S, 2000, J MED MICROBIOL, V49, P861, DOI 10.1099/0022-1317-49-10-861; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; Gaetti-Jardim E, 2009, J MED MICROBIOL, V58, P1568, DOI 10.1099/jmm.0.013383-0; Geerts SO, 2004, J PERIODONTOL, V75, P1274, DOI 10.1902/jop.2004.75.9.1274; Graves DT, 2000, CURR OPIN INFECT DIS, V13, P227, DOI 10.1097/00001432-200006000-00005; GRENIER D, 1987, J CLIN MICROBIOL, V25, P738, DOI 10.1128/JCM.25.4.738-740.1987; Griffen AL, 1998, J CLIN MICROBIOL, V36, P3239, DOI 10.1128/JCM.36.11.3239-3242.1998; Griffen AL, 1999, J CLIN MICROBIOL, V37, P4028, DOI 10.1128/JCM.37.12.4028-4033.1999; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guyodo H, 2012, FEMS IMMUNOL MED MIC, V64, P175, DOI 10.1111/j.1574-695X.2011.00877.x; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Hyvarinen K, 2009, INNATE IMMUN-LONDON, V15, P195, DOI 10.1177/1753425908101920; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; 윤정호, 2008, Journal of Periodontal & Implant Science, V38, P143; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Kim HS, 2010, J CLIN MICROBIOL, V48, P545, DOI 10.1128/JCM.01631-09; Kirakodu SS, 2008, OPEN DENT J, V2, P49, DOI 10.2174/1874210600802010049; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P755; KRIEG NR, 2001, BERGEYS MANUAL SYSTE, V1, P33; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Kuboniwa M, 2004, ORAL MICROBIOL IMMUN, V19, P168, DOI 10.1111/j.0902-0055.2004.00135.x; Kuboniwa M, 2010, PERIODONTOL 2000, V52, P38, DOI 10.1111/j.1600-0757.2009.00311.x; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lange D E, 1978, Dtsch Zahnarztl Z, V33, P8; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lyons SR, 2000, J CLIN MICROBIOL, V38, P2362; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Marcelino SL, 2010, ANAEROBE, V16, P629, DOI 10.1016/j.anaerobe.2010.08.007; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marsh PD, 2004, CARIES RES, V38, P204, DOI 10.1159/000077756; Martin FE, 2002, J CLIN MICROBIOL, V40, P1698, DOI 10.1128/JCM.40.5.1698-1704.2002; Meurman JH, 2004, CRIT REV ORAL BIOL M, V15, P403, DOI 10.1177/154411130401500606; Moon JH, 2012, FEMS IMMUNOL MED MIC, V64, P425, DOI 10.1111/j.1574-695X.2011.00889.x; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NEIDERS ME, 1989, J PERIODONTAL RES, V24, P192, DOI 10.1111/j.1600-0765.1989.tb02005.x; Nonnenmacher C, 2004, J MICROBIOL METH, V59, P117, DOI 10.1016/j.mimet.2004.06.006; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; Olczak T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-134; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Park SN, 2011, J MICROBIOL, V49, P315, DOI 10.1007/s12275-011-1028-y; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rocas IN, 2012, J CLIN MICROBIOL, V50, P1721, DOI 10.1128/JCM.00531-12; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Sabbah W, 2010, INT DENT J, V60, P370, DOI 10.1922/IDJ_2480Sabbah05; Sakamoto M, 2001, MICROBIOL IMMUNOL, V45, P39, DOI 10.1111/j.1348-0421.2001.tb01272.x; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Smalley JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017182; Suzuki J, 2010, EXPERT OPIN THER TAR, V14, P1023, DOI 10.1517/14728222.2010.511616; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tran SD, 1999, J CLIN MICROBIOL, V37, P3504, DOI 10.1128/JCM.37.11.3504-3508.1999; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; Vitkov L, 2005, ORAL MICROBIOL IMMUN, V20, P317, DOI 10.1111/j.1399-302X.2005.00233.x; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	79	14	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67719	10.1371/journal.pone.0067719	http://dx.doi.org/10.1371/journal.pone.0067719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844074	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000083
J	Zanacchi, FC; Lavagnino, Z; Faretta, M; Furia, L; Diaspro, A				Zanacchi, Francesca Cella; Lavagnino, Zeno; Faretta, Mario; Furia, Laura; Diaspro, Alberto			Light-Sheet Confined Super-Resolution Using Two-Photon Photoactivation	PLOS ONE			English	Article							DIFFRACTION-LIMIT; LOCALIZATION; MICROSCOPY; RECONSTRUCTION; ACTIVATION; SCATTERING; NANOSCOPY; PROTEINS; EMBRYOS; DEEP	Light-sheet microscopy is a useful tool for performing biological investigations of thick samples and it has recently been demonstrated that it can also act as a suitable architecture for super-resolution imaging of thick biological samples by means of individual molecule localization. However, imaging in depth is still limited since it suffers from a reduction in image quality caused by scattering effects. This paper sets out to investigate the advantages of non-linear photoactivation implemented in a selective plane illumination configuration when imaging scattering samples. In particular, two-photon excitation is proven to improve imaging capabilities in terms of imaging depth and is expected to reduce light-sample interactions and sample photo-damage. Here, two-photon photoactivation is coupled to individual molecule localization methods based on light-sheet illumination (IML-SPIM), allowing super-resolution imaging of nuclear pH2AX in NB4 cells.	[Zanacchi, Francesca Cella; Lavagnino, Zeno; Diaspro, Alberto] Ist Italiano Tecnol, Dept Nanophys, Genoa, Italy; [Lavagnino, Zeno; Diaspro, Alberto] Univ Genoa, Genoa, Italy; [Faretta, Mario; Furia, Laura] European Inst Oncol, Dept Expt Oncol, Milan, Italy	Istituto Italiano di Tecnologia - IIT; University of Genoa; IRCCS European Institute of Oncology (IEO)	Zanacchi, FC (corresponding author), Ist Italiano Tecnol, Dept Nanophys, Genoa, Italy.	francesca.cella@iit.it	Faretta, Mario/H-8946-2012; Diaspro, Alberto/E-7833-2010; Lavagnino, Zeno/AAB-3806-2019; Zanacchi, Francesca Cella/ABI-1651-2020; Cella Zanacchi, Francesca/H-4310-2011	Faretta, Mario/0000-0003-1678-5781; Diaspro, Alberto/0000-0002-4916-5928; Lavagnino, Zeno/0000-0002-7247-8084; Cella Zanacchi, Francesca/0000-0002-2427-3009				Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Collini M, 2006, Q REV BIOPHYS, V15, P1; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Difato F, 2011, P SPIE; Fahrbach FO, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1646; Folling J, 2007, ANGEW CHEM INT EDIT, V46, P6266, DOI 10.1002/anie.200702167; Folling J, 2008, CHEMPHYSCHEM, V9, P321, DOI 10.1002/cphc.200700655; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Gunewardene MS, 2011, BIOPHYS J, V101, P1522, DOI 10.1016/j.bpj.2011.07.049; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2011, NAT METHODS, V8, P304, DOI 10.1038/nmeth0411-304; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; LANOTTE M, 1991, BLOOD, V77, P1080; Lavagnino Z, 2013, OPT EXPRESS, V21, P5998, DOI 10.1364/OE.21.005998; Mazza D, 2007, APPL OPTICS, V46, P7401, DOI 10.1364/AO.46.007401; Mertz J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3324890; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/NMETH.1447, 10.1038/nmeth.1447]; Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586; Mukamel EA, 2012, BIOPHYS J, V102, P2391, DOI 10.1016/j.bpj.2012.03.070; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Palero J, 2010, OPT EXPRESS, V18, P8491, DOI 10.1364/OE.18.008491; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Post JN, 2005, FEBS LETT, V579, P325, DOI 10.1016/j.febslet.2004.11.092; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider M, 2005, BIOPHYS J, V89, P1346, DOI 10.1529/biophysj.104.054502; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; Silvestri L, 2012, OPT EXPRESS, V20, P20582, DOI 10.1364/OE.20.020582; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Starr R, 2012, OPT LETT, V37, P413, DOI 10.1364/OL.37.000413; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/nmeth.2062, 10.1038/NMETH.2062]; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Vaziri A, 2008, P NATL ACAD SCI USA, V105, P20221, DOI 10.1073/pnas.0810636105; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; York AG, 2011, NAT METHODS, V8, P327, DOI 10.1038/NMETH.1571; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/NMETH.1744, 10.1038/nmeth.1744]; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	45	45	47	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67667	10.1371/journal.pone.0067667	http://dx.doi.org/10.1371/journal.pone.0067667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844052	Green Published, gold			2022-12-25	WOS:000321341000070
J	Liu, BY; Shats, I; Angus, SP; Gatza, ML; Nevins, JR				Liu, Beiyu; Shats, Igor; Angus, Steven P.; Gatza, Michael L.; Nevins, Joseph R.			Interaction of E2F7 Transcription Factor with E2F1 and C-terminal-binding Protein (CtBP) Provides a Mechanism for E2F7-dependent Transcription Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER; CELL-CYCLE; DNA; ACTIVATION; NETWORK; IDENTIFICATION; ORGANIZATION; RECRUITMENT; DISTINCT; COMPLEX	Previous work has identified distinct functions for E2F proteins during a cellular proliferative response including a role for E2F1-3 in the activation of transcription at G1/S and a role for E2F4-8 in repressing the same group of E2F1-3 target genes as cells progress through S phase. We now find that E2F7 and E2F8, which are induced by E2F1-3 at G1/S, can form a heterodimer with E2F1 through interactions involving the DNA-binding domains of the two proteins. In vitro DNA interaction assays demonstrate the formation of an E2F1-E2F7 complex, as well as an E2F7-E2F7 complex on adjacent E2F-binding sites. We also show that E2F7 recruits the co-repressor C-terminal-binding protein (CtBP) and that CtBP2 is essential for E2F7 to repress E2F1 transcription. Taken together, these findings suggest a mechanism for the repression of transcription by E2F7.	[Liu, Beiyu; Shats, Igor; Angus, Steven P.; Gatza, Michael L.; Nevins, Joseph R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Duke Inst Genome Sci & Policy, 2121 CIEMAS Bldg,Box 3382 DUMC, Durham, NC 27710 USA.	j.nevins@duke.edu	Shats, Igor/AAD-8775-2019	Shats, Igor/0000-0001-6449-5979; Angus, Steven/0000-0002-7655-657X; Gatza, Michael/0000-0001-6796-7791	National Institutes of Health Grants [CA104663, CA106520]; NATIONAL CANCER INSTITUTE [R01CA106520, R01CA104663] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104663 and CA106520 (to J. R. N.).	Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Carvajal L. A., GENES DEV, V26, P1533; Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; DeGregori J, 2006, CURR MOL MED, V6, P739; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Nevins JR, 1997, METHOD ENZYMOL, V283, P205; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Pandit SK, 2012, NAT CELL BIOL, V14, P1181, DOI 10.1038/ncb2585; RAYCHAUDHURI P, 1990, J VIROL, V64, P2702, DOI 10.1128/JVI.64.6.2702-2710.1990; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Weijts BGMW, 2012, EMBO J, V31, P3871, DOI 10.1038/emboj.2012.231; Westendorp B, 2012, NUCLEIC ACIDS RES, V40, P3511, DOI 10.1093/nar/gkr1203; Wong JV, 2011, CELL CYCLE, V10; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Zalmas LP, 2008, EMBO REP, V9, P252, DOI 10.1038/sj.embor.7401158; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666	41	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24581	24589		10.1074/jbc.M113.467506	http://dx.doi.org/10.1074/jbc.M113.467506			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853115	Green Published, hybrid			2022-12-25	WOS:000330612300026
J	Axiak-Bechtel, SM; Kumar, SR; Hansen, SA; Bryan, JN				Axiak-Bechtel, Sandra M.; Kumar, Senthil R.; Hansen, Sarah A.; Bryan, Jeffrey N.			Y-chromosome DNA Is Present in the Blood of Female Dogs Suggesting the Presence of Fetal Microchimerism	PLOS ONE			English	Article							CELL MICROCHIMERISM; MATERNAL PLASMA; CANCER; IMMUNOLOGY; CHIMERISM; MODELS; KIDNEY; WOMEN; LIVER; SERUM	Fetal microchimerism has been suggested to play contradictory roles in women's health, with factors including age of the recipient, time elapsed since microchimerism occurred, and microchimeric cell type modulating disease. Both beneficial and harmful effects have been identified in wound healing and tissue regeneration, immune mediated disease, and cancer. This area of research is relatively new, and hindered by the time course from occurrence of fetal microchimerism to the multifactorial development of disease. Dogs represent an excellent model for study of fetal microchimerism, as they share our environment, have a naturally condensed lifespan, and spontaneously develop immune-mediated diseases and cancers similar to their human counterparts. However, fetal microchimerism has not been described in dogs. These experiments sought preliminary evidence that dogs develop fetal microchimerism following pregnancy. We hypothesized that Y chromosomal DNA would be detected in the peripheral blood mononuclear cells of female dogs collected within two months of parturition. We further hypothesized that Y chromosomal DNA would be detected in banked whole blood DNA samples from parous female Golden Retrievers with at least one male puppy in a prior litter. Amplification of DNA extracted from five female Golden Retrievers that had whelped within the two months prior to collection revealed strong positive bands for the Y chromosome. Of banked, parous samples, 36% yielded positive bands for the Y chromosome. This is the first report of persistent Y chromosomal DNA in post-partum female dogs and these results suggest that fetal microchimerism occurs in the canine species. Evaluation of the contributions of fetal microchimeric cells to disease processes in dogs as a model for human disease is warranted.	[Axiak-Bechtel, Sandra M.; Kumar, Senthil R.; Hansen, Sarah A.; Bryan, Jeffrey N.] Univ Missouri, Comparat Oncol & Epigenet Lab, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Kumar, Senthil R.] Harry S Truman Vet Hosp, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital	Bryan, JN (corresponding author), Univ Missouri, Comparat Oncol & Epigenet Lab, Dept Vet Med & Surg, Columbia, MO 65211 USA.	bryanjn@missouri.edu		Bryan, Jeffrey/0000-0002-6820-9850; Axiak-Bechtel, Sandra/0000-0002-7773-5959	University of Missouri College of Veterinary Medicine Committee on Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R25OD010951] Funding Source: NIH RePORTER	University of Missouri College of Veterinary Medicine Committee on Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would also like to acknowledge the University of Missouri College of Veterinary Medicine Committee on Research for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyon C, 2011, EUR J OBSTET GYN R B, V158, P148, DOI 10.1016/j.ejogrb.2011.05.008; CAIN GR, 1989, AM J VET RES, V50, P1282; Cirello V, 2010, INT J CANCER, V126, P2874, DOI 10.1002/ijc.24993; Dubernard G, 2009, INT J CANCER, V124, P1054, DOI 10.1002/ijc.24036; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; FOURNEL C, 1992, LUPUS, V1, P133, DOI 10.1177/096120339200100303; Fugazzola L, 2012, J CLIN ENDOCR METAB, V97, P1452, DOI 10.1210/jc.2011-3160; Fugazzola L, 2011, NAT REV ENDOCRINOL, V7, P89, DOI 10.1038/nrendo.2010.216; Gadi VK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001706; Gadi VK, 2007, CANCER RES, V67, P9035, DOI 10.1158/0008-5472.CAN-06-4209; Graham PA, 2001, VET CLIN N AM-SMALL, V31, P915, DOI 10.1016/S0195-5616(01)50005-4; Graves SS, 2008, BIOL BLOOD MARROW TR, V14, P1201, DOI 10.1016/j.bbmt.2008.08.005; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Houfflin-Debarge V, 2000, FETAL DIAGN THER, V15, P102, DOI 10.1159/000020985; Jayaraman S, 2010, J IMMUNOL, V184, P3008, DOI 10.4049/jimmunol.0903615; Kallenbach LR, 2011, CANCER RES, V71, P8, DOI 10.1158/0008-5472.CAN-10-0618; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P82, DOI 10.1111/j.1399-0039.2006.00614.x; Lee ESM, 2010, MOL HUM REPROD, V16, P869, DOI 10.1093/molehr/gaq067; Lee TH, 2001, TRANSFUSION, V41, P276, DOI 10.1046/j.1537-2995.2001.41020276.x; LIEGEOIS A, 1977, TRANSPLANT P, V9, P273; Lo YMD, 2000, CLIN CHEM, V46, P1903; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Nassar D, 2012, FASEB J, V26, P149, DOI 10.1096/fj.11-180695; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; O'Donoghue K, 2008, REPROD BIOMED ONLINE, V16, P382, DOI 10.1016/S1472-6483(10)60600-1; Olivier M, 1998, ANIM GENET, V29, P146, DOI 10.1046/j.1365-2052.1998.00299.x; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Smid M, 1999, CLIN CHEM, V45, P1570; Stikvoort A, 2013, BIOL BLOOD MARROW TR, V19, P838, DOI 10.1016/j.bbmt.2013.02.015; Turin L, 2007, VET RES COMMUN, V31, P205, DOI 10.1007/s11259-007-0095-3; Turin Lauretta, 2007, Biotechnology Journal, V2, P486, DOI 10.1002/biot.200600218; Villamil JA, 2009, J CANCER EPIDEMIOL, V2009, DOI [10.1155/2009/591753, 10.1155/2009/747803]; Wang Y, 2004, BIOCHEM BIOPH RES CO, V325, P961, DOI 10.1016/j.bbrc.2004.10.105; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037	35	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68114	10.1371/journal.pone.0068114	http://dx.doi.org/10.1371/journal.pone.0068114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861856	gold, Green Submitted, Green Published			2022-12-25	WOS:000321692000015
J	Wang, YJ; Zhang, CJ; Hao, QN; Sha, AH; Zhou, R; Zhou, XA; Yuan, LP				Wang, Yejian; Zhang, Chanjuan; Hao, Qinnan; Sha, Aihua; Zhou, Rong; Zhou, Xinan; Yuan, Longping			Elucidation of miRNAs-Mediated Responses to Low Nitrogen Stress by Deep Sequencing of Two Soybean Genotypes	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; COMPUTATIONAL IDENTIFICATION; ARABIDOPSIS-THALIANA; PLANT MICRORNAS; USE EFFICIENCY; TARGET GENES; SHORT RNAS; TIME; PREDICTION	Nitrogen (N) is a major limiting factor in crop production, and plant adaptive responses to low N are involved in many post-transcriptional regulation. Recent studies indicate that miRNAs play important roles in adaptive responses. However, miRNAs in soybean adaptive responses to N limitation have been not reported. We constructed sixteen libraries to identify low N-responsive miRNAs on a genome-wide scale using samples from 2 different genotypes (low N sensitive and low N tolerant) subjected to various periods of low nitrogen stress. Using high-throughput sequencing technology (Illumina-Solexa), we identified 362 known miRNAs variants belonging to 158 families and 90 new miRNAs belonging to 55 families. Among these known miRNAs variants, almost 50% were not different from annotated miRNAs in miRBase. Analyses of their expression patterns showed 150 known miRNAs variants as well as 2 novel miRNAs with differential expressions. These differentially expressed miRNAs between the two soybean genotypes were compared and classified into three groups based on their expression patterns. Predicted targets of these miRNAs were involved in various metabolic and regulatory pathways such as protein degradation, carbohydrate metabolism, hormone signaling pathway, and cellular transport. These findings suggest that miRNAs play important roles in soybean response to low N and contribute to the understanding of the genetic basis of differences in adaptive responses to N limitation between the two soybean genotypes. Our study provides basis for expounding the complex gene regulatory network of these miRNAs.	[Wang, Yejian; Yuan, Longping] Cent S Univ, Long Ping Branch, Grad Sch, Changsha, Hunan, Peoples R China; [Wang, Yejian; Zhang, Chanjuan; Hao, Qinnan; Sha, Aihua; Zhou, Rong; Zhou, Xinan] Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China; [Yuan, Longping] Natl Hybrid Rice R&D Ctr, Changsha, Hunan, Peoples R China; [Hao, Qinnan] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Wang, Yejian] Hunan Acad Agr Sci, Inst Crops Res, Changsha, Hunan, Peoples R China	Central South University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Hunan Academy of Agricultural Sciences	Zhou, XA (corresponding author), Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China.	zhouocri@sina.com; lpyuan@hhrrc.ac.cn			special funds from the major issue of National Transgenic Project [2011ZX08004-005]; modern agricultural technology system [CARS-040PS08]; National Natural Science Foundation of China [31201153]; Crop Germplasm Resource Protection Project [NB07-2130315-06, NB08-2130315- (25-31)-06]	special funds from the major issue of National Transgenic Project; modern agricultural technology system; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Crop Germplasm Resource Protection Project	This work was funded by special funds from the major issue of National Transgenic Project (2011ZX08004-005), the modern agricultural technology system (CARS-040PS08), the National Natural Science Foundation of China (No. 31201153) and the Crop Germplasm Resource Protection Project (NB07-2130315-06, NB08-2130315- (25-31)-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bi YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-281; BONGUEBARTELSMAN M, 1995, PLANT PHYSIOL BIOCH, V33, P539; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Dezulian T., 2005, GENOME BIOL, V6, pP13, DOI DOI 10.1186/GB-2005-6-11-P13; Diaz U, 2006, PLANT CELL PHYSIOL, V47, P74, DOI 10.1093/pcp/pci225; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding L, 2005, ANN BOT-LONDON, V96, P925, DOI 10.1093/aob/mci244; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Harper J.E., 1987, SOYBEANS IMPROVEMENT, P497; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; KHAMIS S, 1990, PLANT PHYSIOL, V94, P1436, DOI 10.1104/pp.94.3.1436; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Mette MF, 2002, PLANT PHYSIOL, V130, P6, DOI 10.1104/pp.007047; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Ono K, 1996, PLANT CELL PHYSIOL, V37, P1083, DOI 10.1093/oxfordjournals.pcp.a029057; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peng MS, 2007, PLANT MOL BIOL, V65, P775, DOI 10.1007/s11103-007-9241-0; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Song C, 2010, PLANT BIOLOGY, V12, P927, DOI 10.1111/j.1438-8677.2009.00300.x; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Todd CD, 2004, PLANTA, V219, P1003, DOI 10.1007/s00425-004-1305-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wang YW, 2009, BIOCHEM BIOPH RES CO, V378, P799, DOI 10.1016/j.bbrc.2008.11.140; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Zeng HQ, 2010, J PLANT PHYSIOL, V167, P1289, DOI 10.1016/j.jplph.2010.04.017; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	78	36	41	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67423	10.1371/journal.pone.0067423	http://dx.doi.org/10.1371/journal.pone.0067423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861762	Green Submitted, Green Published, gold			2022-12-25	WOS:000321692000008
J	Ichinose, G; Saito, M; Suzuki, S				Ichinose, Genki; Saito, Masaya; Suzuki, Shinsuke			Collective Chasing Behavior between Cooperators and Defectors in the Spatial Prisoner's Dilemma	PLOS ONE			English	Article							INDIRECT RECIPROCITY; CONTINGENT MOVEMENT; EVOLUTION; ASSORTMENT; MIGRATION; MECHANISM; ALTRUISM; DRIVEN; CHAOS; GAMES	Cooperation is one of the essential factors for all biological organisms in major evolutionary transitions. Recent studies have investigated the effect of migration for the evolution of cooperation. However, little is known about whether and how an individuals' cooperativeness coevolves with mobility. One possibility is that mobility enhances cooperation by enabling cooperators to escape from defectors and form clusters; the other possibility is that mobility inhibits cooperation by helping the defectors to catch and exploit the groups of cooperators. In this study we investigate the coevolutionary dynamics by using the prisoner's dilemma game model on a lattice structure. The computer simulations demonstrate that natural selection maintains cooperation in the form of evolutionary chasing between the cooperators and defectors. First, cooperative groups grow and collectively move in the same direction. Then, mutant defectors emerge and invade the cooperative groups, after which the defectors exploit the cooperators. Then other cooperative groups emerge due to mutation and the cycle is repeated. Here, it is worth noting that, as a result of natural selection, the mobility evolves towards directional migration, but not to random or completely fixed migration. Furthermore, with directional migration, the rate of global population extinction is lower when compared with other cases without the evolution of mobility (i.e., when mobility is preset to random or fixed). These findings illustrate the coevolutionary dynamics of cooperation and mobility through the directional chasing between cooperators and defectors.	[Ichinose, Genki; Saito, Masaya] Anan Natl Coll Technol, Anan, Tokushima, Japan; [Suzuki, Shinsuke] Hokkaido Univ, Grad Sch Letters, Sapporo, Hokkaido, Japan; [Suzuki, Shinsuke] Riken Brain Sci Inst, Lab Integrated Theoret Neurosci, Wako, Saitama, Japan; [Suzuki, Shinsuke] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	Hokkaido University; RIKEN; California Institute of Technology	Ichinose, G (corresponding author), Anan Natl Coll Technol, Anan, Tokushima, Japan.	igenki@gmail.com	Ichinose, Genki/G-6442-2015		JSPS KAKENHI [232648]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant-in-Aid for JSPS Fellows Number 232648. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2004, J THEOR BIOL, V231, P249, DOI 10.1016/j.jtbi.2004.06.020; Cong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035776; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; ENQUIST M, 1993, ANIM BEHAV, V45, P747, DOI 10.1006/anbe.1993.1089; Eriksson A, 2005, J THEOR BIOL, V232, P399, DOI 10.1016/j.jtbi.2004.08.020; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P2259, DOI 10.1098/rspb.2005.3248; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Helbing D, 2008, ADV COMPLEX SYST, V11, P641, DOI 10.1142/S0219525908001866; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Ichinose G, 2007, P 2007 IEEE S ART LI, P236; Ichinose G, 2008, ECOL MODEL, V210, P221, DOI 10.1016/j.ecolmodel.2007.07.025; Janssen MA, 2006, J THEOR BIOL, V243, P134, DOI 10.1016/j.jtbi.2006.06.012; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Killingback T, 2006, P ROY SOC B-BIOL SCI, V273, P1477, DOI 10.1098/rspb.2006.3476; Le Galliard JF, 2005, AM NAT, V165, P206, DOI 10.1086/427090; Majeski S. J., 1999, Complexity, V5, P16, DOI 10.1002/(SICI)1099-0526(199909/10)5:1<16::AID-CPLX3>3.0.CO;2-M; Masuda N, 2003, PHYS LETT A, V313, P55, DOI 10.1016/S0375-9601(03)00693-5; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; NOWAK M, 1993, P NATL ACAD SCI USA, V90, P5091, DOI 10.1073/pnas.90.11.5091; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ono S, 2003, J THEOR BIOL, V220, P55, DOI 10.1006/jtbi.2003.3144; Pepper JW, 2007, ARTIF LIFE, V13, P1, DOI 10.1162/artl.2007.13.1.1; Pepper JW, 2002, AM NAT, V160, P205, DOI 10.1086/341018; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Sober E., 1998, OTHERS EVOLUTION PSY; Suzuki S, 2008, J THEOR BIOL, V252, P686, DOI 10.1016/j.jtbi.2008.02.007; Suzuki S, 2008, THEOR POPUL BIOL, V73, P426, DOI 10.1016/j.tpb.2007.12.005; Suzuki S, 2011, J THEOR BIOL, V287, P42, DOI 10.1016/j.jtbi.2011.07.019; Szolnoki A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036110; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101	51	5	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67702	10.1371/journal.pone.0067702	http://dx.doi.org/10.1371/journal.pone.0067702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861786	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300022
J	Ferro, M; Bruzzese, D; Perdona, S; Marino, A; Mazzarella, C; Perruolo, G; D'Esposito, V; Cosimato, V; Buonerba, C; Di Lorenzo, G; Musi, G; De Cobelli, O; Chun, FK; Terracciano, D				Ferro, Matteo; Bruzzese, Dario; Perdona, Sisto; Marino, Ada; Mazzarella, Claudia; Perruolo, Giuseppe; D'Esposito, Vittoria; Cosimato, Vincenzo; Buonerba, Carlo; Di Lorenzo, Giuseppe; Musi, Gennaro; De Cobelli, Ottavio; Chun, Felix K.; Terracciano, Daniela			Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml	PLOS ONE			English	Article							ISOFORM P2PSA; MULTICENTER; PREDICTION; SERUM; DERIVATIVES; VALIDATION; OUTCOMES	Many efforts to reduce prostate specific antigen (PSA) overdiagnosis and overtreatment have been made. To this aim, Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) have been proposed as new more specific biomarkers. We evaluated the ability of phi and PCA3 to identify prostate cancer (PCa) at initial prostate biopsy in men with total PSA range of 2-10 ng/ml. The performance of phi and PCA3 were evaluated in 300 patients undergoing first prostate biopsy. ROC curve analyses tested the accuracy (AUC) of phi and PCA3 in predicting PCa. Decision curve analyses (DCA) were used to compare the clinical benefit of the two biomarkers. We found that the AUC value of phi (0.77) was comparable to those of %p2PSA (0.76) and PCA3 (0.73) with no significant differences in pairwise comparison (%p2PSA vs phi p = 0.673, %p2PSA vs. PCA3 p = 0.417 and phi vs. PCA3 p = 0.247). These three biomarkers significantly outperformed fPSA (AUC = 0.60), %fPSA (AUC = 0.62) and p2PSA (AUC = 0.63). At DCA, phi and PCA3 exhibited a very close net benefit profile until the threshold probability of 25%, then phi index showed higher net benefit than PCA3. Multivariable analysis showed that the addition of phi and PCA3 to the base multivariable model (age, PSA, %fPSA, DRE, prostate volume) increased predictive accuracy, whereas no model improved single biomarker performance. Finally we showed that subjects with active surveillance (AS) compatible cancer had significantly lower phi and PCA3 values (p < 0.001 and p = 0.01, respectively). In conclusion, both phi and PCA3 comparably increase the accuracy in predicting the presence of PCa in total PSA range 2-10 ng/ml at initial biopsy, outperforming currently used %fPSA.	[Perdona, Sisto] Fdn G Pascale, Urol Unit, Naples, Italy; [Bruzzese, Dario] Univ Naples Federico II, Dept Prevent Med Sci, Naples, Italy; [Ferro, Matteo] Univ Naples Federico II, Urol Unit, Naples, Italy; [Marino, Ada; Mazzarella, Claudia; Perruolo, Giuseppe; D'Esposito, Vittoria; Cosimato, Vincenzo; Terracciano, Daniela] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Buonerba, Carlo; Di Lorenzo, Giuseppe] Univ Naples Federico II, Oncol Unit, Naples, Italy; [Ferro, Matteo; Musi, Gennaro; De Cobelli, Ottavio] European Inst Oncol, Div Urol, Milan, Italy; [Chun, Felix K.] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany	IRCCS Fondazione Pascale; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; IRCCS European Institute of Oncology (IEO); University of Hamburg; University Medical Center Hamburg-Eppendorf	Terracciano, D (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	daniela.terracciano@unina.it	Terracciano, Daniela/AAB-9521-2022; DE COBELLI, OTTAVIO/O-2315-2017; Buonerba, Carlo/J-6095-2018; giuseppe, perruolo/AAW-3869-2021; D'Esposito, Vittoria/K-7633-2016; Chun, Felix/M-4652-2015; Bruzzese, Dario/H-4621-2012; perdonà, sisto/AAB-9017-2019; Ferro, Matteo/K-3705-2018; MUSI, Gennaro/AAP-8884-2020	Terracciano, Daniela/0000-0003-4296-429X; DE COBELLI, OTTAVIO/0000-0002-0699-8620; Buonerba, Carlo/0000-0002-1806-442X; D'Esposito, Vittoria/0000-0002-3675-8062; Chun, Felix/0000-0001-8486-9536; Bruzzese, Dario/0000-0001-9911-4646; MUSI, Gennaro/0000-0003-0833-9183; Ferro, Matteo/0000-0002-9250-7858; GIUSEPPE, DI LORENZO/0000-0001-7414-1568; Perruolo, Giuseppe/0000-0003-0479-8729				Auprich M, 2011, EUR UROL, V60, P1045, DOI 10.1016/j.eururo.2011.08.003; Auprich M, 2010, EUR UROL, V58, P727, DOI 10.1016/j.eururo.2010.06.038; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Durand X, 2012, BJU INT, V110, P43, DOI 10.1111/j.1464-410X.2011.10682.x; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Ferro M, 2012, CLIN CHIM ACTA, V413, P1274, DOI 10.1016/j.cca.2012.04.017; Groskopf J, 2006, CLIN CHEM, V52, P1089, DOI 10.1373/clinchem.2005.063289; Guazzoni G, 2012, EUR UROL, V61, P455, DOI 10.1016/j.eururo.2011.10.038; Guazzoni G, 2011, EUR UROL, V60, P214, DOI 10.1016/j.eururo.2011.03.052; Guo WG, 2009, BIOMETRIKA, V96, P1012, DOI 10.1093/biomet/asp048; Hansen J, 2013, EUR UROL, V63, P201, DOI 10.1016/j.eururo.2012.07.030; Isharwal S, 2011, UROLOGY, V77, pe761; Lazzeri M, 2013, EUR UROL, V63, P986, DOI 10.1016/j.eururo.2013.01.011; Loeb S, 2006, J UROLOGY, V175, P902, DOI 10.1016/S0022-5347(05)00327-7; Perdona S, 2013, PROSTATE, V73, P227, DOI 10.1002/pros.22561; Scattoni V, 2013, J UROLOGY, V190, P496, DOI 10.1016/j.juro.2013.02.3184; Semjonow A, 2010, CLIN BIOCHEM, V43, P926, DOI 10.1016/j.clinbiochem.2010.04.062; Stephan C, 2013, CLIN CHEM, V59, P280, DOI 10.1373/clinchem.2012.195560; Stephan C, 2013, CLIN CHEM, V59, P306, DOI 10.1373/clinchem.2012.195784; Steyerberg EW, 2008, MED DECIS MAKING, V28, P146, DOI 10.1177/0272989X07312725; Tosoian JJ, 2012, J UROLOGY, V188, P1131, DOI 10.1016/j.juro.2012.06.009; Tosoian JJ, 2010, J UROLOGY, V183, P534, DOI 10.1016/j.juro.2009.10.003; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; van den Bergh RCN, 2010, BJU INT, V105, P956, DOI 10.1111/j.1464-410X.2009.08887.x; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361	25	79	86	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67687	10.1371/journal.pone.0067687	http://dx.doi.org/10.1371/journal.pone.0067687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861782	gold, Green Submitted, Green Published			2022-12-25	WOS:000323350700021
J	Ng, XW; Huang, YY; Chen, HH; Burnett, JC; Boey, FYC; Venkatraman, SS				Ng, Xu Wen; Huang, Yingying; Chen, Horng H.; Burnett, John C., Jr.; Boey, Freddy Y. C.; Venkatraman, Subbu S.			Cenderitide-Eluting Film for Potential Cardiac Patch Applications	PLOS ONE			English	Article							CHIMERIC NATRIURETIC PEPTIDE; MYOCARDIAL-INFARCTION; HEART-FAILURE; SUPPORT DEVICE; CD-NP; FIBROBLASTS; SYSTEM; CARDIOTROPHIN-1; DEGRADATION; NESIRITIDE	Cenderitide, also known as CD-NP, is a designer peptide developed by combining native mammalian c-type natriuretic peptide (CNP) and the C-terminus isolated from the dendroapis natriuretic peptide (DNP) of the venom from the green mamba. In early studies, intravenous and subcutaneous infusion of cenderitide was reported to reduce left ventricular (LV) mass and ameliorate cardiac remodelling. In this work, biodegradable polymeric films encapsulating CD-NP were developed and were investigated for their in vitro release and degradation characteristics. Subsequently, the bioactivity of released peptide and its effects on human cardiac fibroblast (HCF) were explored. We achieved sustained release from three films with low, intermediate and high release profiles for 30 days. Moreover, the bioactivity of released peptide was verified from the elevated production of cyclic guanosine monophospate (cGMP). The CD-NP released from films was able to inhibit the proliferation of hypertrophic HCF as well as suppress DNA synthesis in HCF. Furthermore, the sustained delivery from films showed comparable or superior suppressive actions on hypertrophic HCF compared to daily infusion of CD-NP. The results suggest that these films could be used to inhibit fibrosis and reduce cardiac remodelling via local delivery as cardiac patches.	[Ng, Xu Wen; Huang, Yingying; Boey, Freddy Y. C.; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Chen, Horng H.; Burnett, John C., Jr.] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Mayo Clinic	Venkatraman, SS (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	assubbu@ntu.edu.sg	Venkatraman, Subramanian/A-2228-2011; Boey, Freddy Yin Chiang/G-2618-2017	Venkatraman, Subramanian/0000-0002-8693-1070; 	National Research Foundation - Competitive Research Programme [NRF-CRP 2-2007-01]	National Research Foundation - Competitive Research Programme	This work was supported by the following grant: The National Research Foundation - Competitive Research Programme, http://www.nrf.gov.sg/(NRF-CRP 2-2007-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi Z, 2004, PHARMACOL THERAPEUT, V102, P223, DOI 10.1016/j.pharmthera.2004.04.004; ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8; Aronson D, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2004.05.027; Aronson D, 2012, PHARMACOL THERAPEUT, V135, P1, DOI 10.1016/j.pharmthera.2012.03.002; Asakura M, 2004, CIRC J, V68, P95, DOI 10.1253/circj.68.95; Barletta G, 1998, HYPERTENSION, V31, P802, DOI 10.1161/01.HYP.31.3.802; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bristow MR, 2002, CIRCULATION, V106, P1430, DOI 10.1161/01.CIR.0000034024.61382.42; Burnett JC, 2009, PCT Patent Application No PCT, Patent No. 046095; Chen HH, 2009, HEART, V95, P1315, DOI 10.1136/hrt.2008.153916; Chen HH, 2002, CIRCULATION, V105, P999, DOI 10.1161/hc0802.104282; Chen HH, 2002, J AM COLL CARDIOL, V40, P1186, DOI 10.1016/S0735-1097(02)02127-7; Chen HH, 2006, EUR HEART J SUPPL, V8, pE18, DOI 10.1093/eurheartj/sul026; Dickey DM, 2011, J MOL CELL CARDIOL, V51, P67, DOI 10.1016/j.yjmcc.2011.03.013; Freed DH, 2003, CARDIOVASC RES, V60, P365, DOI 10.1016/S0008-6363(03)00534-0; FURUYA M, 1992, BIOCHEM BIOPH RES CO, V183, P964, DOI 10.1016/S0006-291X(05)80284-0; Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Kitakaze M, 2007, LANCET, V370, P2102; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Liao SY, 2010, J CARD FAIL, V16, P590, DOI 10.1016/j.cardfail.2010.02.007; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; Liu KL, 2011, MOL PHARMACEUT, V8, P2173, DOI 10.1021/mp200513b; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Mann DL, 2007, ANN THORAC SURG, V84, P1226, DOI 10.1016/j.athoracsur.2007.03.095; Mann DL, 2012, J THORAC CARDIOV SUR, V143, P1036, DOI 10.1016/j.jtcvs.2011.06.014; Mattos C, 2001, CURR OPIN STRUC BIOL, V11, P761, DOI 10.1016/S0959-440X(01)00278-0; Mazzaferri EL, 2012, AM HEART J, V163, P812, DOI 10.1016/j.ahj.2012.02.013; Michaels AD, 2003, CIRCULATION, V107, P2697, DOI 10.1161/01.CIR.0000070547.88378.EA; Mitrovic V, 2006, EUR HEART J, V27, P2823, DOI 10.1093/eurheartj/ehl337; Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007; Nikolic SD, 2009, J CARD FAIL, V15, P790, DOI 10.1016/j.cardfail.2009.05.014; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Rose RA, 2010, CURR OPIN INVEST DR, V11, P349; Schmitt M, 2004, ARTERIOSCL THROM VAS, V24, P911, DOI 10.1161/01.ATV.zhq0504.7914; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Socki T, 2005, J AM COLL CARDIOL, V45, P608, DOI 10.1016/j.jacc.2004.10.067; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Tonnessen T, 2005, EUR J HEART FAIL, V7, P704, DOI 10.1016/j.ejheart.2005.07.005; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; van de Weert M, 2000, PHARM RES-DORDR, V17, P1159, DOI 10.1023/A:1026498209874; WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68346	10.1371/journal.pone.0068346	http://dx.doi.org/10.1371/journal.pone.0068346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861890	Green Published, gold			2022-12-25	WOS:000323350700081
J	Ball, G; Boardman, JP; Arichi, T; Merchant, N; Rueckert, D; Edwards, AD; Counsell, SJ				Ball, Gareth; Boardman, James P.; Arichi, Tomoki; Merchant, Nazakat; Rueckert, Daniel; Edwards, A. David; Counsell, Serena J.			Testing the Sensitivity of Tract-Based Spatial Statistics to Simulated Treatment Effects in Preterm Neonates	PLOS ONE			English	Article							TERM-EQUIVALENT AGE; WHITE-MATTER; PREMATURE-INFANTS; POWER CALCULATION; BRAIN; BIRTH; ERYTHROPOIETIN; OUTCOMES; DISEASE; FMRI	Early neuroimaging may provide a surrogate marker for brain development and outcome after preterm birth. Tract-Based Spatial Statistics (TBSS) is an advanced Diffusion Tensor Image (DTI) analysis technique that is sensitive to the effects of prematurity and may provide a quantitative marker for neuroprotection following perinatal brain injury or preterm birth. Here, we test the sensitivity of TBSS to detect diffuse microstructural differences in the developing white matter of preterm infants at term-equivalent age by modelling a 'treatment' effect as a global increase in fractional anisotropy (FA). As proof of concept we compare these simulations to a real effect of increasing age at scan. 3-Tesla, 15-direction diffusion tensor imaging (DTI) was acquired from 90 preterm infants at term-equivalent age. Datasets were randomly assigned to 'treated' or 'untreated' groups of increasing size and voxel-wise increases in FA were used to simulate global treatment effects of increasing magnitude in all 'treated' maps. 'Treated' and 'untreated' FA maps were compared using TBSS. Predictions from simulated data were then compared to exemplar TBSS group comparisons based on increasing postmenstrual age at scan. TBSS proved sensitive to global differences in FA within a clinically relevant range, even in relatively small group sizes, and simulated data were shown to predict well a true biological effect of increasing age on white matter development. These data confirm that TBSS is a sensitive tool for detecting global group-wise differences in FA in this population.	[Ball, Gareth; Arichi, Tomoki; Merchant, Nazakat; Edwards, A. David; Counsell, Serena J.] Kings Coll London, Ctr Dev Brain, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Boardman, James P.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, Biomed Image Anal Grp, London, England	University of London; King's College London; University of Edinburgh; Imperial College London	Ball, G (corresponding author), Kings Coll London, Ctr Dev Brain, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England.	gareth.ball@kcl.ac.uk	Edwards, Anthony/HCI-9626-2022; counsell, serena j/I-9012-2014; Boardman, James/K-5472-2015; Arichi, Tomoki/AFR-9798-2022	Arichi, Tomoki/0000-0002-3550-1644; Ball, Gareth/0000-0003-3509-1435; Counsell, Serena/0000-0002-8033-5673; Rueckert, Daniel/0000-0002-5683-5889; Merchant, Nazakat/0000-0001-7520-3169; Boardman, James/0000-0003-3904-8960; Edwards, Anthony David/0000-0003-4801-7066	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and at Imperial College London; MRC; EPSRC; Garfield Weston Foundation; MRC [G1002033, MR/K006355/1] Funding Source: UKRI; Medical Research Council [G1002033, MR/K006355/1] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and at Imperial College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Garfield Weston Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and at Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Funding for the research was supplied by MRC, EPSRC and the Garfield Weston Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Bierer R, 2006, PEDIATRICS, V118, pE635, DOI 10.1542/peds.2005-3186; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Boardman JP, 2006, NEUROIMAGE, V32, P70, DOI 10.1016/j.neuroimage.2006.03.029; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Counsell SJ, 2008, BRAIN, V131, P3201, DOI 10.1093/brain/awn268; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; Delobel-Ayoub M, 2009, PEDIATRICS, V123, P1485, DOI 10.1542/peds.2008-1216; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Huppi PS, 1998, PEDIATR RES, V44, P584; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Joyce KE, 2012, NEUROINFORMATICS, V10, P351, DOI 10.1007/s12021-012-9152-3; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; Limperopoulos C, 2010, NAT REV NEUROL, V6, P301, DOI 10.1038/nrneurol.2010.66; Maitre NL, 2012, JAMA-J AM MED ASSOC, V307, P304, DOI 10.1001/jama.2011.2026; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; McAnulty G, 2009, ACTA PAEDIATR, V98, P1920, DOI 10.1111/j.1651-2227.2009.01492.x; Milgrom J, 2010, PEDIATR RES, V67, P330, DOI 10.1203/PDR.0b013e3181cb8e2f; Mumford JA, 2008, NEUROIMAGE, V39, P261, DOI 10.1016/j.neuroimage.2007.07.061; Murphy K, 2004, NEUROIMAGE, V22, P879, DOI 10.1016/j.neuroimage.2004.02.005; Neubauer AP, 2010, ANN NEUROL, V67, P657, DOI 10.1002/ana.21977; Olivier P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007128; Porter EJ, 2010, PEDIATR RES, V68, P205, DOI 10.1203/00006450-201011001-00399; Rathbone R, 2011, NEUROLOGY, V77, P1510, DOI 10.1212/WNL.0b013e318233b215; Rose SE, 2008, MAGN RESON MED, V60, P761, DOI 10.1002/mrm.21689; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; Skiold B, 2010, ACTA PAEDIATR, V99, P842, DOI 10.1111/j.1651-2227.2009.01634.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tusor N, 2012, PEDIATR RES, DOI [10.1038/pr.2012.40;10.1038/pr.2012.40, DOI 10.1038/PR.2012.40;10.1038/PR.2012.40]; Van Hecke W, 2009, NEUROIMAGE, V46, P692, DOI 10.1016/j.neuroimage.2009.02.032; van Kooij BJM, 2012, AM J NEURORADIOL, V33, P188, DOI 10.3174/ajnr.A2723; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Welin AK, 2007, PEDIATR RES, V61, P153, DOI 10.1203/01.pdr.0000252546.20451.1a	39	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67706	10.1371/journal.pone.0067706	http://dx.doi.org/10.1371/journal.pone.0067706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844070	gold, Green Published			2022-12-25	WOS:000321733000096
J	Drecktrah, D; Hall, LS; Hoon-Hanks, LL; Samuels, DS				Drecktrah, Dan; Hall, Laura S.; Hoon-Hanks, Laura L.; Samuels, D. Scott			An Inverted Repeat in the ospC Operator Is Required for Induction in Borrelia burgdorferi	PLOS ONE			English	Article							OUTER-SURFACE PROTEIN; LYME-DISEASE SPIROCHETE; RESPONSE REGULATOR RRP2; GENE-EXPRESSION; ESCHERICHIA-COLI; MAMMALIAN INFECTION; CIRCULAR PLASMID; VIRULENCE FACTOR; DNA GYRASE; RPOS	Borrelia burgdorferi, the spirochete that causes Lyme disease, differentially regulates synthesis of the outer membrane lipoprotein OspC to infect its host. OspC is required to establish infection but then repressed in the mammal to avoid clearance by the adaptive immune response. Inverted repeats (IR) upstream of the promoter have been implicated as an operator to regulate ospC expression. We molecularly dissected the distal inverted repeat (dIR) of the ospC operator by site-directed mutagenesis at its endogenous location on the circular plasmid cp26. We found that disrupting the dIR but maintaining the proximal IR prevented induction of OspC synthesis by DNA supercoiling, temperature, and pH. Moreover, the base-pairing potential of the two halves of the dIR was more important than the nucleotide sequence in controlling OspC levels. These results describe a cis-acting element essential for the expression of the virulence factor OspC.	[Drecktrah, Dan; Hall, Laura S.; Hoon-Hanks, Laura L.; Samuels, D. Scott] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Samuels, D. Scott] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana	Samuels, DS (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	scott.samuels@umontana.edu	Samuels, D Scott/B-7549-2012	Samuels, D Scott/0000-0001-8352-7593	Public Health Service [AI051486, P20 GM103546]; National Institutes of Health; Watkins Scholarship from The University of Montana; Undergraduate Research Internship through the National Science Foundation EPSCoR program [EPS-0701906]; Davidson Honors College; Honors Fellowship through the Montana Integrative Learning Experience for Students (MILES) program from the Howard Hughes Medical Institute-Undergraduate Science Education Program [52005905]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103546] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Watkins Scholarship from The University of Montana; Undergraduate Research Internship through the National Science Foundation EPSCoR program; Davidson Honors College; Honors Fellowship through the Montana Integrative Learning Experience for Students (MILES) program from the Howard Hughes Medical Institute-Undergraduate Science Education Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grants AI051486 to D.S.S. and P20 GM103546 to the Center for Biomolecular Structure and Dynamics from the National Institutes of Health. L.L.H.-H. was supported by a Watkins Scholarship from The University of Montana, an Undergraduate Research Internship through the National Science Foundation EPSCoR program under Grant EPS-0701906, an Undergraduate Research Award from the Davidson Honors College, and an Honors Fellowship through the Montana Integrative Learning Experience for Students (MILES) program under Grant 52005905 from the Howard Hughes Medical Institute-Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Archambault L, 2013, BIOCHEM BIOPH RES CO, V433, P73, DOI 10.1016/j.bbrc.2013.02.063; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Battisti JM, 2008, INFECT IMMUN, V76, P5228, DOI 10.1128/IAI.00410-08; Beaurepaire C, 2007, MOL MICROBIOL, V63, P443, DOI 10.1111/j.1365-2958.2006.05533.x; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Damman CJ, 2000, J BACTERIOL, V182, P6791, DOI 10.1128/JB.182.23.6791-6797.2000; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; DRLICA K, 1978, J MOL BIOL, V120, P145, DOI 10.1016/0022-2836(78)90061-X; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Earnhart CG, 2005, INFECT IMMUN, V73, P7869, DOI 10.1128/IAI.73.12.7869-7877.2005; Earnhart CG, 2011, CLIN VACCINE IMMUNOL, V18, P901, DOI 10.1128/CVI.05004-11; Earnhart CG, 2010, MOL MICROBIOL, V76, P393, DOI 10.1111/j.1365-2958.2010.07103.x; Eggers CH, 2004, J BACTERIOL, V186, P7390, DOI 10.1128/JB.186.21.7390-7402.2004; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; FUCHS R, 1992, MOL MICROBIOL, V6, P503, DOI 10.1111/j.1365-2958.1992.tb01495.x; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Gilbert MA, 2007, MOL MICROBIOL, V63, P1259, DOI 10.1111/j.1365-2958.2007.05593.x; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hatfield GW, 2002, ANNU REV GENET, V36, P175, DOI 10.1146/annurev.genet.36.032902.111815; Hoon-Hanks LL, 2012, FEMS IMMUNOL MED MIC, V66, P157, DOI 10.1111/j.1574-695X.2012.00996.x; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Hyde JA, 2010, INFECT IMMUN, V78, P265, DOI 10.1128/IAI.01018-09; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Knight SW, 2000, J BACTERIOL, V182, P2048, DOI 10.1128/JB.182.7.2048-2051.2000; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; MARCONI RT, 1993, J BACTERIOL, V175, P926, DOI 10.1128/JB.175.4.926-932.1993; MARGOLIS N, 1994, GENE, V143, P105, DOI 10.1016/0378-1119(94)90613-0; MARGOLIS N, 1994, J BACTERIOL, V176, P6427, DOI 10.1128/JB.176.21.6427-6432.1994; MAXWELL A, 1993, MOL MICROBIOL, V9, P681, DOI 10.1111/j.1365-2958.1993.tb01728.x; McDowell JV, 2002, INFECT IMMUN, V70, P4196, DOI 10.1128/IAI.70.8.4196-4203.2002; Montgomery RR, 1996, J EXP MED, V183, P261, DOI 10.1084/jem.183.1.261; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Ouyang Z, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/J0URNAL.PPAT.1001272; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pal U, 2000, J CLIN INVEST, V106, P561, DOI 10.1172/JCI9427; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Piesman J., 2010, BORRELIA MOL BIOL HO, P251; Radolf JD, 2008, MOL MICROBIOL, V69, P1, DOI 10.1111/j.1365-2958.2008.06226.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; SADZIENE A, 1993, INFECT IMMUN, V61, P2192, DOI 10.1128/IAI.61.5.2192-2195.1993; Saier MH, 2008, CRIT REV BIOCHEM MOL, V43, P89, DOI [10.1080/10409230801921262, 10.1080/10409230801921262 ]; Samuels D S, 1995, Methods Mol Biol, V47, P253; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; SAMUELS DS, 1994, J BACTERIOL, V176, P6045, DOI 10.1128/jb.176.19.6045-6049.1994; SAMUELS DS, 1993, ANTIMICROB AGENTS CH, V37, P46, DOI 10.1128/AAC.37.1.46; Schwan TG, 2003, BIOCHEM SOC T, V31, P108, DOI 10.1042/BST0310108; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Seshu J, 2004, INFECT IMMUN, V72, P1580, DOI 10.1128/IAI.72.3.1580-1586.2004; Singh SK, 2004, LANCET INFECT DIS, V4, P575; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Tilly K, 1997, MOL MICROBIOL, V25, P361, DOI 10.1046/j.1365-2958.1997.4711838.x; Tilly K, 2013, MOL MICROBI IN PRESS; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Troxell B, 2013, INFECT IMMU IN PRESS; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	87	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68799	10.1371/journal.pone.0068799	http://dx.doi.org/10.1371/journal.pone.0068799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844242	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000027
J	Pan, XF; Zhang, K; Yang, XA; Liang, JY; Sun, HX; Li, XJ; Zou, Y; Xu, QQ; An, G; Li, G; Xu, QH				Pan, Xingfei; Zhang, Ka; Yang, Xiaoan; Liang, Jiayi; Sun, Haixia; Li, Xuejun; Zou, Yong; Xu, Qingqiang; An, Geng; Li, Gang; Xu, Qihuan			Relapse Rate and Associated-Factor of Recurrence after Stopping NUCs Therapy with Different Prolonged Consolidation Therapy in HBeAg Positive CHB Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; E-ANTIGEN SEROCONVERSION; PACIFIC CONSENSUS STATEMENT; VIRUS DNA; NATURAL-HISTORY; DURABILITY; MANAGEMENT; INFECTION; GENOTYPES; LEVEL	Background: Many chronic hepatitis B (CHB) patients recur after off-therapy and have to accept prolonged consolidation therapy with NUCs. We investigated the rate of HBV relapse after stopping NUCs therapy with different time period of prolonged consolidation therapy in HBeAg positive CHB patients, and analyzed the associated-factor of recurrence. Methods: We recruited 162 HBeAg-positive CHB patients who met the standard of stopping NUCs therapy recommended by the 2005 APASL. Patients in group A, without the prolonged consolidation therapy, were as controls. Patients in group B were divided into 3 subgroups (group B1, 7 (range 3-11) months of the prolonged consolidation therapy; group B2, 17 (range 13-20) months of the prolonged consolidation therapy; group B3, 28 (range 25-34) months of the prolonged consolidation therapy). Virologic relapse was defined as an increase in serum HBV DNA to > 10(3) copies/ml after off-therapy. Results: One hundred and thirty-six patients (group A, 40 patients; group B1, 54 patients; group B2, 23 patients; group B3, 19 patients) were eligible for this study. The cumulative rates of relapse in group B at 6 months and 48 months were 29.2%, 41.7% after off-therapy, respectively. The cumulative rates of relapse in group B were statistically lower than that in group A at the same time periods. The cumulative rate of relapse in group B3 or group B2 was statistically lower than that in group B1, respectively. On multivariate analysis by Cox's proportional hazard model, age at off-therapy, baseline ALT and the different time period of the prolonged consolidation therapy were associated with the relapse of HBV after off-therapy. Conclusions: Consolidation therapy with NUCs after HBeAg seroconversion should be further prolonged. Age at off-therapy, ALT at baseline and the time period of the prolonged consolidation therapy could provide information to direct anti-viral therapy.	[Pan, Xingfei; Zhang, Ka; Yang, Xiaoan; Sun, Haixia; Li, Xuejun; Li, Gang; Xu, Qihuan] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Jiayi] Sun Yat Sen Univ, Ultrasound Div, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Zou, Yong] Sun Yat Sen Univ, Dept Blood Transfus, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Qingqiang] Zhengzhou Childrens Hosp, Dept Dermatol, Zhengzhou, Peoples R China; [An, Geng] Guangzhou Med Univ, Dept Reprod Med Ctr, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Xu, QH (corresponding author), Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	xqh0303@yahoo.com.cn			Guangdong Natural Science Foundation [S2011010004680]; Program for New Century Excellent Talents in University [NCET-04-0797]; Medical Research Fund of Guangdong Pharmaceutical Association [2011G23, 2012GRS01]; National Natural Science Fund of China [81000180]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Medical Research Fund of Guangdong Pharmaceutical Association; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Project Supported by Guangdong Natural Science Foundation (Grant No. S2011010004680), Program for New Century Excellent Talents in University (NCET-04-0797), Medical Research Fund of Guangdong Pharmaceutical Association (Grant No. 2011G23, 2012GRS01), and National Natural Science Fund of China (Grant No. 81000180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chien RN, 2003, HEPATOLOGY, V38, P1267, DOI 10.1053/jhep.2003.50458; Chu CM, 2007, GASTROENTEROLOGY, V133, P1458, DOI 10.1053/j.gastro.2007.08.039; Dandri Maura, 2005, Hepatology, V42, P1453, DOI 10.1002/hep.20976; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Glebe D, 2007, WORLD J GASTROENTERO, V13, P8, DOI 10.3748/wjg.v13.i1.8; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2004, J MED VIROL, V72, P363, DOI 10.1002/jmv.10534; Ke WM, 2011, J VIRAL HEPATITIS, V18, P637, DOI 10.1111/j.1365-2893.2011.01444.x; Lee CM, 2002, J HEPATOL, V37, P669, DOI 10.1016/S0168-8278(02)00267-2; Liaw YF, 2005, LIVER INT, V25, P472, DOI 10.1111/j.1478-3231.2005.01134.x; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Orito E, 2001, HEPATOLOGY, V34, P590, DOI 10.1053/jhep.2001.27221; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Reijnders JGP, 2010, GASTROENTEROLOGY, V139, P491, DOI 10.1053/j.gastro.2010.03.059; Song MJ, 2012, WORLD J GASTROENTERO, V18, P6277, DOI 10.3748/wjg.v18.i43.6277; van Nunen AB, 2003, GUT, V52, P420, DOI 10.1136/gut.52.3.420; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Xu XW, 2005, CLIN MICROBIOL INFEC, V11, P52, DOI 10.1111/j.1469-0691.2004.01029.x; Yan J, 2011, HEPAT MON, V11, P358	25	21	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68568	10.1371/journal.pone.0068568	http://dx.doi.org/10.1371/journal.pone.0068568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844222	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000015
J	Assouline, S; Or, D				Assouline, Shmuel; Or, Dani			Plant Water Use Efficiency over Geological Time - Evolution of Leaf Stomata Configurations Affecting Plant Gas Exchange	PLOS ONE			English	Article							ATMOSPHERIC CO2; CONDUCTANCE; DIFFUSION; PHOTOSYNTHESIS; OPTIMIZATION; ASSIMILATION; ENRICHMENT; DENSITY; CARBON; MODEL	Plant gas exchange is a key process shaping global hydrological and carbon cycles and is often characterized by plant water use efficiency (WUE - the ratio of CO2 gain to water vapor loss). Plant fossil record suggests that plant adaptation to changing atmospheric CO2 involved correlated evolution of stomata density (d) and size (s), and related maximal aperture, a(max). We interpreted the fossil record of s and d correlated evolution during the Phanerozoic to quantify impacts on gas conductance affecting plant transpiration, E, and CO2 uptake, A, independently, and consequently, on plant WUE. A shift in stomata configuration from large s-low d to small s-high d in response to decreasing atmospheric CO2 resulted in large changes in plant gas exchange characteristics. The relationships between gas conductance, g(ws), A and E and maximal relative transpiring leaf area, (a(max).d), exhibited hysteretic-like behavior. The new WUE trend derived from independent estimates of A and E differs from established WUE-CO2 trends for atmospheric CO2 concentrations exceeding 1,200 ppm. In contrast with a nearly-linear decrease in WUE with decreasing CO2 obtained by standard methods, the newly estimated WUE trend exhibits remarkably stable values for an extended geologic period during which atmospheric CO2 dropped from 3,500 to 1,200 ppm. Pending additional tests, the findings may affect projected impacts of increased atmospheric CO2 on components of the global hydrological cycle.	[Assouline, Shmuel] ARO Volcani Ctr, Inst Soil Water & Environm Sci, Dept Environm Phys & Irrigat, Bet Dagan, Israel; [Or, Dani] Swiss Fed Inst Technol, Inst Terr Ecosyst ITES, Dept Environm Sci D UWIS, Zurich, Switzerland	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Swiss Federal Institutes of Technology Domain; ETH Zurich	Assouline, S (corresponding author), ARO Volcani Ctr, Inst Soil Water & Environm Sci, Dept Environm Phys & Irrigat, Bet Dagan, Israel.	vwshmuel@agri.gov.il	Or, Dani/D-8768-2012	Or, Dani/0000-0002-3236-2933	Israeli Ministry of Agriculture Fund	Israeli Ministry of Agriculture Fund	Supported by Chief Scientist of the Israeli Ministry of Agriculture Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Assouline S, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009121; Ball J.T., 1987, PROGR PHOTOSYNTHESIS, P221, DOI [10.1007/978-94-017-0519-6_48, DOI 10.1007/978-94-017-0519-6_48]; BANGE GGJ, 1953, ACTA BOT NEERL, V2, P255; Beerling DJ, 1997, BOT J LINN SOC, V124, P137, DOI 10.1006/bojl.1997.0098; Beerling DJ, 2001, NATURE, V410, P352, DOI 10.1038/35066546; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Brown HT, 1900, PHILOS T R SOC LON B, V193, P223, DOI 10.1098/rstb.1900.0014; Cooke J.R., 1967, ACTA BIOTHEOR, V17, P95, DOI [DOI 10.1007/BF01625092, 10.1007/BF01625092]; Cooke JR, 1969, ASAE ANN M; Cowan I. R., 1977, Advances in Botanical Research, V4, P117, DOI 10.1016/S0065-2296(08)60370-5; Cowan I R, 1977, Symp Soc Exp Biol, V31, P471; de Boer HJ, 2011, P NATL ACAD SCI USA, V108, P4041, DOI 10.1073/pnas.1100555108; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Franks PJ, 2009, GEOBIOLOGY, V7, P227, DOI 10.1111/j.1472-4669.2009.00193.x; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Franks PJ, 2001, PLANT PHYSIOL, V125, P935, DOI 10.1104/pp.125.2.935; Haworth M, 2011, J EXP BOT, V62, P2419, DOI 10.1093/jxb/err086; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Katul G, 2010, ANN BOT-LONDON, V105, P431, DOI 10.1093/aob/mcp292; Katul GG, 2000, PLANT CELL ENVIRON, V23, P1313, DOI 10.1046/j.1365-3040.2000.00641.x; KELLER KENNETH H., 1967, MATH BIOSCI, V1, P421, DOI 10.1016/0025-5564(67)90012-0; Korner C, 2003, PHILOS T ROY SOC A, V361, P2023, DOI 10.1098/rsta.2003.1241; Lammertsma EI, 2011, P NATL ACAD SCI USA, V108, P4035, DOI 10.1073/pnas.1100371108; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; MEIDNER H, 1975, J EXP BOT, V26, P666, DOI 10.1093/jxb/26.5.666; Mora CI, 1996, SCIENCE, V271, P1105, DOI 10.1126/science.271.5252.1105; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; PARKHURST DF, 1994, NEW PHYTOL, V126, P449, DOI 10.1111/j.1469-8137.1994.tb04244.x; PARLANGE JY, 1970, PLANT PHYSIOL, V46, P337, DOI 10.1104/pp.46.2.337; Piel C, 2002, J EXP BOT, V53, P2423, DOI 10.1093/jxb/erf095; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; Roelfsema MRG, 2013, NEW PHYTOL, V197, P11, DOI 10.1111/nph.12050; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; . SCARTH G. W., 1927, PROTOPLASMA, V2, P498, DOI 10.1007/BF01604752; SCHLUNDER EU, 1988, CHEM ENG SCI, V43, P2685, DOI 10.1016/0009-2509(88)80012-5; Scotese C.R., 1994, PANGEA PALEOCLIMATE, V288, P57, DOI DOI 10.1130/SPE288-P57; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shahraeeni E, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011857; Sperry JS, 2003, INT J PLANT SCI, V164, pS115, DOI 10.1086/368398; Suzuki M., 1968, J CHEM ENG JAPAN, V1, DOI [10.1252/jcej.1.26, DOI 10.1252/JCEJ.1.26]; Tanner C.B., 1983, LIMITATIONS EFFICIEN; TING IP, 1963, AM J BOT, V50, P866, DOI 10.2307/2439773; VANDEWATER PK, 1994, SCIENCE, V264, P239, DOI 10.1126/science.264.5156.239; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; WAGGONER PE, 1965, SCIENCE, V150, P1413, DOI 10.1126/science.150.3702.1413; White F. M., 2006, VISCOUS FLUID FLOW	53	24	24	1	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67757	10.1371/journal.pone.0067757	http://dx.doi.org/10.1371/journal.pone.0067757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844085	Green Published, gold			2022-12-25	WOS:000321341000092
J	Heegaard, PMH; Miller, I; Sorensen, NS; Soerensen, KE; Skovgaard, K				Heegaard, Peter M. H.; Miller, Ingrid; Sorensen, Nanna Skall; Soerensen, Karen Elisabeth; Skovgaard, Kerstin			Pig alpha 1-Acid Glycoprotein: Characterization and First Description in Any Species as a Negative Acute Phase Protein	PLOS ONE			English	Article							ACID-SOLUBLE GLYCOPROTEIN; C-REACTIVE PROTEIN; ALPHA(1)-ACID GLYCOPROTEIN; ACTINOBACILLUS-PLEUROPNEUMONIAE; ALPHA1-ACID GLYCOPROTEIN; SERUM-HAPTOGLOBIN; INFECTION; HEALTH; GENES; MODEL	The serum protein alpha 1-acid glycoprotein (AGP), also known as orosomucoid, is generally described as an archetypical positive acute phase protein. Here, porcine AGP was identified, purified and characterized from pooled pig serum. It was found to circulate as a single chain glycoprotein having an apparent molecular weight of 43 kDa by SDS-PAGE under reducing conditions, of which approximately 17 kDa were accounted for by N-bound oligosaccharides. Those data correspond well with the properties of the protein predicted from the single porcine AGP gene (ORM1, Q29014 (UniProt)), containing 5 putative glycosylation sites. A monoclonal antibody (MAb) was produced and shown to quantitatively and specifically react with all microheterogenous forms of pig AGP as analyzed by 2-D electrophoresis. This MAb was used to develop an immunoassay (ELISA) for quantification of AGP in pig serum samples. The adult serum concentrations of pig AGP were in the range of 1-3 mg/ml in a number of conventional pig breeds while it was lower in Gottingen and Ossabaw minipigs (in the 0.3 to 0.6 mg/ml range) and higher in young (2-5 days old) conventional pigs (mean: 6.6 mg/ml). Surprisingly, pig AGP was found to behave as a negative acute phase protein during a range of experimental infections and aseptic inflammation with significant decreases in serum concentration and in hepatic ORM1 expression during the acute phase response. To our knowledge this is the first description in any species of AGP being a negative acute phase protein.	[Heegaard, Peter M. H.; Sorensen, Nanna Skall; Skovgaard, Kerstin] Tech Univ Denmark, Natl Vet Inst, Innate Immunol Grp, Frederiksberg, Denmark; [Miller, Ingrid] Univ Vet Med Vienna, Dept Biomed Sci, Inst Med Biochem, Vienna, Austria; [Soerensen, Karen Elisabeth] Univ Copenhagen, Dept Vet Dis Biol, Sect Pathol, Frederiksberg, Denmark	Technical University of Denmark; University of Veterinary Medicine Vienna; University of Copenhagen	Heegaard, PMH (corresponding author), Tech Univ Denmark, Natl Vet Inst, Innate Immunol Grp, Frederiksberg, Denmark.	pmhh@vet.dtu.dk	; Heegaard, Peter/E-9794-2015	Miller, Ingrid/0000-0002-7192-0109; Heegaard, Peter/0000-0003-4506-4932; skovgaard, kerstin/0000-0001-5663-4879	EU [QLK5-2001-02219]	EU(European Commission)	The study was partly supported by EU shared cost project QLK5-2001-02219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Asai T, 1999, VET IMMUNOL IMMUNOP, V70, P143, DOI 10.1016/S0165-2427(99)00069-0; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Carpintero R, 2005, INFECT IMMUN, V73, P3184, DOI 10.1128/IAI.73.5.3184-3187.2005; Ceciliani F, 2007, CURR PROTEIN PEPT SC, V8, P91, DOI 10.2174/138920307779941497; CHARLWOOD PA, 1976, BIOCHIM BIOPHYS ACTA, V453, P81, DOI 10.1016/0005-2795(76)90252-X; CHIU KM, 1977, IMMUNOLOGY, V32, P997; COOPER R, 1986, J BIOL CHEM, V261, P1849; COSTELLO MJ, 1984, CLIN EXP IMMUNOL, V55, P465; COUPERWHITE S, 1994, ANIM GENET, V25, P285, DOI 10.1111/j.1365-2052.1994.tb00208.x; DENTE L, 1987, EMBO J, V6, P2289, DOI 10.1002/j.1460-2075.1987.tb02503.x; Eckersall PD, 1996, VET IMMUNOL IMMUNOP, V51, P377, DOI 10.1016/0165-2427(95)05527-4; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; GODING JW, 1980, J IMMUNOL METHODS, V39, P285, DOI 10.1016/0022-1759(80)90230-6; Greiner LL, 2001, J ANIM SCI, V79, P1272; Heegaard PMH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-50; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; HEEGAARD PMH, 1986, MARKER PROTEINS INFL, V3, P275; Henryon M, 2006, ANIM SCI, V82, P597, DOI 10.1079/ASC200671; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; ITOH H, 1993, CAN J VET RES, V57, P74; Jungersen G, 1999, INT J PARASITOL, V29, P1307, DOI 10.1016/S0020-7519(99)00078-8; Kahlisch D, 2009, VET RES, V40, DOI 10.1051/vetres/2009043; Klitgaard K, 2012, PLOS ONE, DOI [10.1371/journal.pone.0035549, DOI 10.1371/J0URNAL.P0NE.0035549]; KOJ A, 1984, BIOCHEM J, V224, P505, DOI 10.1042/bj2240505; KREMER JMH, 1988, PHARMACOL REV, V40, P1; LAMPREAVE F, 1982, COMP BIOCHEM PHYS B, V72, P215, DOI 10.1016/0305-0491(82)90037-2; LAMPREAVE F, 1984, INT J BIOCHEM, V16, P47, DOI 10.1016/0020-711X(84)90049-1; LAMPREAVE F, 1994, ELECTROPHORESIS, V15, P672, DOI 10.1002/elps.1150150195; Lecchi C, 2013, VET J, V196, P47, DOI 10.1016/j.tvjl.2012.07.022; Ligresti G, 2012, PLOS ONE, DOI [10.1371/journal.pone.0041387, DOI 10.1371/J0URNAL.P0NE.0041387]; Mackiewicz A, 1993, ACUTE PHASE PROTEINS, P107; MANIL L, 1986, J IMMUNOL METHODS, V90, P25, DOI 10.1016/0022-1759(86)90379-0; Miller I, 2004, PROTEOMICS, V4, P257, DOI 10.1002/pmic.200300546; Miller I, 2006, ELECTROPHORESIS, V27, P1626, DOI 10.1002/elps.200500744; Miller Ingrid, 2012, Methods Mol Biol, V854, P373, DOI 10.1007/978-1-61779-573-2_26; Miller I, 2009, RES VET SCI, V86, P362, DOI 10.1016/j.rvsc.2008.05.018; MORTENSEN RF, 1983, J IMMUNOL, V130, P885; Nakano M, 2004, GLYCOBIOLOGY, V14, P431, DOI 10.1093/glycob/cwh034; Ongay S, 2010, ANAL BIOANAL CHEM, V398, P845, DOI 10.1007/s00216-010-3948-5; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Petersen HH, 2002, PREV VET MED, V54, P325, DOI 10.1016/S0167-5877(02)00054-5; Riber U, 2011, VET MICROBIOL, V149, P406, DOI 10.1016/j.vetmic.2010.11.028; Rodgaard T, 2013, VET IMMUNOL IMMUNOP, V151, P325, DOI 10.1016/j.vetimm.2012.11.002; SCHMID K, 1977, BIOCHIM BIOPHYS ACTA, V492, P291, DOI 10.1016/0005-2795(77)90080-0; Skovgaard K, 2013, INNATE IMMUN-LONDON, V19, P531, DOI 10.1177/1753425912473668; Skovgaard K, 2010, INNATE IMMUN-LONDON, V16, P343, DOI 10.1177/1753425909342730; Skovgaard K, 2009, VET RES, V40, DOI 10.1051/vetres/2009006; Soerensen KE, 2012, APMIS, V120, P909, DOI 10.1111/j.1600-0463.2012.02917.x; Son DS, 1996, VET QUART, V18, P10, DOI 10.1080/01652176.1996.9694603; Sorensen NS, 2006, VET IMMUNOL IMMUNOP, V113, P157, DOI 10.1016/j.vetimm.2006.04.008; STONE RT, 1987, DEV GENET, V8, P295, DOI 10.1002/dvg.1020080411; Tecles F, 2007, CAN J VET RES, V71, P161; Theilgaard-Monch K, 2005, J LEUKOCYTE BIOL, V78, P462, DOI 10.1189/jlb.0105042; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANDIJK W, 1995, GLYCOCONJUGATE J, V12, P227, DOI 10.1007/BF00731324; Yang YQ, 2012, VET MICROBIOL, V158, P237, DOI 10.1016/j.vetmic.2012.01.021	59	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68110	10.1371/journal.pone.0068110	http://dx.doi.org/10.1371/journal.pone.0068110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844161	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000138
J	Jiang, JY; Wu, XF; Tang, HL; Luo, GX				Jiang, Jieyun; Wu, Xianfang; Tang, Hengli; Luo, Guangxiang			Apolipoprotein E Mediates Attachment of Clinical Hepatitis C Virus to Hepatocytes by Binding to Cell Surface Heparan Sulfate Proteoglycan Receptors	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; TARGET-CELLS; INFECTION; GLYCOSAMINOGLYCANS; PARTICLES; CULTURE; GLYCOPROTEIN; INTERACTS; INHIBIT; DOMAIN	Our previous studies demonstrated that the cell culture-grown hepatitis C virus of genotype 2a (HCVcc) uses apolipoprotein E (apoE) to mediate its attachment to the surface of human hepatoma Huh-7.5 cells. ApoE mediates HCV attachment by binding to the cell surface heparan sulfate (HS) which is covalently attached to the core proteins of proteoglycans (HSPGs). In the present study, we further determined the physiological importance of apoE and HSPGs in the HCV attachment using a clinical HCV of genotype 1b (HCV1b) obtained from hepatitis C patients and human embryonic stem cell-differentiated hepatocyte-like cells (DHHs). DHHs were found to resemble primary human hepatocytes. Similar to HCVcc, HCV1b was found to attach to the surface of DHHs by the apoE-mediated binding to the cell surface HSPGs. The apoE-specific monoclonal antibody, purified HSPGs, and heparin were all able to efficiently block HCV1b attachment to DHHs. Similarly, the removal of heparan sulfate from cell surface by treatment with heparinase suppressed HCV1b attachment to DHHs. More significantly, HCV1b attachment was potently inhibited by a synthetic peptide derived from the apoE receptor-binding region as well as by an HSPG-binding peptide. Likewise, the HSPG-binding peptide prevented apoE from binding to heparin in a dose-dependent manner, as determined by an in vitro heparin pull-down assay. Collectively, these findings demonstrate that HSPGs serve as major HCV attachment receptors on the surface of human hepatocytes to which the apoE protein ligand on the HCV envelope binds.	[Jiang, Jieyun; Luo, Guangxiang] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Wu, Xianfang; Tang, Hengli] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Luo, Guangxiang] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Luo, Guangxiang] Peking Univ, Coll Basic Med Sci, Dept Microbiol, Beijing 100871, Peoples R China	University of Kentucky; State University System of Florida; Florida State University; University of Alabama System; University of Alabama Birmingham; Peking University	Luo, GX (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA.	gluo@uab.edu	Wu, Xianfang/O-5004-2019; Wu, Xianfang/HII-9315-2022; Tang, Hengli/F-2085-2014	Wu, Xianfang/0000-0002-2995-935X; 	National Institutes of Health [AI097318, AI091953]; NSFC [81130082]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091953, R01AI097318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI097318 and AI091953. It is also partially supported by NSFC (81130082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Basu A, 2004, J VIROL, V78, P4478, DOI 10.1128/JVI.78.9.4478-4486.2004; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hu YP, 2011, NAT CHEM, V3, P557, DOI 10.1038/nchem.1073; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lee TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009945; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Liu Jia, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P1025, DOI 10.3969/j.issn.1672-7347.2011.11.001; Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665; Luo GXG, 2004, MIL DRUG TH, P67; Mahley RW, 1999, J LIPID RES, V40, P1; Melnikova I, 2011, NAT REV DRUG DISCOV, V10, P93, DOI 10.1038/nrd3361; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2007, J MED VIROL, V79, P714, DOI 10.1002/jmv.20842; Okamoto K, 2012, J GEN VIROL, V93, P761, DOI 10.1099/vir.0.037853-0; Salvador B, 2013, J VIROL, V87, P3295, DOI 10.1128/JVI.01621-12; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; WHO, 1998, LANCET, V351, P1415; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617	42	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67982	10.1371/journal.pone.0067982	http://dx.doi.org/10.1371/journal.pone.0067982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844141	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000125
J	Gebremedhin, D; Terashvili, M; Wickramasekera, N; Zhang, DX; Rau, N; Miura, H; Harder, DR				Gebremedhin, Debebe; Terashvili, Maia; Wickramasekera, Nadi; Zhang, David X.; Rau, Nicole; Miura, Hiroto; Harder, David R.			Redox Signaling via Oxidative Inactivation of PTEN Modulates Pressure-Dependent Myogenic Tone in Rat Middle Cerebral Arteries	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; REACTIVE OXYGEN; SUPEROXIDE; SHEAR; PATHOPHYSIOLOGY; INHIBITOR; ISCHEMIA; ZSTK474; CELLS	The present study examined the level of generation of reactive oxygen species (ROS) and roles of inactivation of the phosphatase PTEN and the PI3K/Akt signaling pathway in response to an increase in intramural pressure-induced myogenic cerebral arterial constriction. Step increases in intraluminal pressure of cannulated cerebral arteries induced myogenic constriction and concomitant formation of superoxide (O2(center dot)(-)) and its dismutation product hydrogen peroxide (H2O2) as determined by fluorescent HPLC analysis, microscopic analysis of intensity of dihydroethidium fluorescence and attenuation of pressure-induced myogenic constriction by pretreatment with the ROS scavenger 4,hydroxyl-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol) or Mito-tempol or MitoQ in the presence or absence of PEG-catalase. An increase in intraluminal pressure induced oxidation of PTEN and activation of Akt. Pharmacological inhibition of endogenous PTEN activity potentiated pressure-dependent myogenic constriction and caused a reduction in NPo of a 238 pS arterial kappa(Ca) channel current and an increase in [Ca2+](i) level in freshly isolated cerebral arterial muscle cells (CAMCs), responses that were attenuated by Inhibition of the PI3K/Akt pathway. These findings demonstrate an increase in intraluminal pressure induced increase in ROS production triggered redox-sensitive signaling mechanism emanating from the cross-talk between oxidative inactivation of PTEN and activation of the PI3K/Akt signaling pathway that involves in the regulation of pressure-dependent myogenic cerebral arterial constriction.	[Gebremedhin, Debebe; Terashvili, Maia; Wickramasekera, Nadi; Rau, Nicole; Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Zhang, David X.; Miura, Hiroto] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Gebremedhin, Debebe; Terashvili, Maia; Wickramasekera, Nadi; Zhang, David X.; Rau, Nicole; Miura, Hiroto; Harder, David R.] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; [Harder, David R.] Clement Zablocki VA Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Gebremedhin, D (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mariyei@mcw.edu	Terashvili, Maia/AAX-6817-2021		National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) [RO1 HL033833, PO1 HL059996, RO1 HL105997, R01 HL092105]; VA Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092105, R01HL033833, P01HL059996, R01HL105997] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) Grants RO1 HL033833, PO1 HL059996, RO1 HL105997, R01 HL092105 and also by the VA Research Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai K, 2011, CANCER SCI, V102, P1176, DOI 10.1111/j.1349-7006.2011.01916.x; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Carnevale D, 2012, CARDIOVASC RES, V93, P200, DOI 10.1093/cvr/cvr288; Clarke DD, 1989, BASIC NEUROCHEMISTRY, P565; Doppenberg EMR, 1998, SURG NEUROL, V49, P650, DOI 10.1016/S0090-3019(97)00355-8; Duong HQ, 2012, ONCOL REP, V27, P182, DOI 10.3892/or.2011.1503; FOLKOW B, 1964, CIRC RES, V15, P279; Gebremedhin D, 2003, J NEUROSCI, V23, P1678; Gebremedhin D, 2008, AM J PHYSIOL-HEART C, V294, pH107, DOI 10.1152/ajpheart.01416.2006; Gebremedhin D, 2010, J CEREBR BLOOD F MET, V30, P1777, DOI 10.1038/jcbfm.2010.70; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARDER DR, 1984, CIRC RES, V55, P197, DOI 10.1161/01.RES.55.2.197; Huang A, 1998, CIRC RES, V83, P960; Kong DX, 2010, ACTA PHARMACOL SIN, V31, P1189, DOI 10.1038/aps.2010.150; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lehoux S, 2006, CARDIOVASC RES, V71, P269, DOI 10.1016/j.cardiores.2006.05.008; Liu B, 2009, BBA-BIOMEMBRANES, V1788, P2174, DOI 10.1016/j.bbamem.2009.07.016; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Phillips SA, 2006, J APPL PHYSIOL, V100, P1117, DOI 10.1152/japplphysiol.00994.2005; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Ungvari Z, 2003, ARTERIOSCL THROM VAS, V23, P418, DOI 10.1161/01.ATV.0000061735.85377.40; Wan XP, 2011, J BIOL CHEM, V286, P2843, DOI 10.1074/jbc.M110.125526; Zagorac D, 2005, STROKE, V36, P2589, DOI 10.1161/01.STR.0000189997.84161.95; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062	33	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68498	10.1371/journal.pone.0068498	http://dx.doi.org/10.1371/journal.pone.0068498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861911	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300065
J	Hristov, KL; Afeli, SAY; Parajuli, SP; Cheng, QP; Rovner, ES; Petkov, GV				Hristov, Kiril L.; Afeli, Serge A. Y.; Parajuli, Shankar P.; Cheng, Qiuping; Rovner, Eric S.; Petkov, Georgi V.			Neurogenic Detrusor Overactivity Is Associated with Decreased Expression and Function of the Large Conductance Voltage- and Ca2+-Activated K+ Channels	PLOS ONE			English	Article							LOWER URINARY-TRACT; BLADDER SMOOTH-MUSCLE; DIFFERENTIAL REGULATION; GENE-TRANSFER; TOLERABILITY; INCONTINENCE; ACTIVATION; CALCIUM; SAFETY; RATS	Patients suffering from a variety of neurological diseases such as spinal cord injury, Parkinson's disease, and multiple sclerosis often develop neurogenic detrusor overactivity (NDO), which currently lacks a universally effective therapy. Here, we tested the hypothesis that NDO is associated with changes in detrusor smooth muscle (DSM) large conductance Ca2+-activated K+ (BK) channel expression and function. DSM tissue samples from 33 patients were obtained during open bladder surgeries. NDO patients were clinically characterized preoperatively with pressure-flow urodynamics demonstrating detrusor overactivity, in the setting of a clinically relevant neurological condition. Control patients did not have overactive bladder and did not have a clinically relevant neurological disease. We conducted quantitative polymerase chain reactions (qPCR), perforated patch-clamp electrophysiology on freshly-isolated DSM cells, and functional studies on DSM contractility. qPCR experiments revealed that DSM samples from NDO patients showed decreased BK channel mRNA expression in comparison to controls. Patch-clamp experiments demonstrated reduced whole cell and transient BK currents (TBKCs) in freshly-isolated DSM cells from NDO patients. Functional studies on DSM contractility showed that spontaneous phasic contractions had a decreased sensitivity to iberiotoxin, a selective BK channel inhibitor, in DSM strips isolated from NDO patients. These results reveal the novel finding that NDO is associated with decreased DSM BK channel expression and function leading to increased DSM excitability and contractility. BK channel openers or BK channel gene transfer could be an alternative strategy to control NDO. Future clinical trials are needed to evaluate the value of BK channel opening drugs or gene therapies for NDO treatment and to identify any possible adverse effects.	[Hristov, Kiril L.; Afeli, Serge A. Y.; Parajuli, Shankar P.; Cheng, Qiuping; Petkov, Georgi V.] Univ S Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA; [Rovner, Eric S.; Petkov, Georgi V.] Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Petkov, GV (corresponding author), Univ S Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA.	petkov@cop.sc.edu			National Institutes of Health [DK084284]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health DK084284 grant to GVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Afeli SAY, 2012, AM J PHYSIOL-RENAL, V303, pF559, DOI 10.1152/ajprenal.00615.2011; Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Armstrong RB, 2007, INT UROL NEPHROL, V39, P1069, DOI 10.1007/s11255-006-9157-7; Aydin M, 2012, BJU INT, V110, pE402, DOI 10.1111/j.1464-410X.2012.11137.x; Brading AF, 1997, UROLOGY, V50, P57, DOI 10.1016/S0090-4295(97)00591-8; Brown SM, 2008, AM J PHYSIOL-RENAL, V295, pF1149, DOI 10.1152/ajprenal.00440.2007; Brubaker L, 2008, J UROLOGY, V180, P217, DOI 10.1016/j.juro.2008.03.028; CARDENAS DD, 1995, PARAPLEGIA, V33, P326, DOI 10.1038/sc.1995.73; Chang SH, 2010, AM J PHYSIOL-RENAL, V298, pF1416, DOI 10.1152/ajprenal.00595.2009; Christ GJ, 2001, AM J PHYSIOL-REG I, V281, pR1699, DOI 10.1152/ajpregu.2001.281.5.R1699; Conte A, 2012, EUR J NEUROL, V19, P725, DOI 10.1111/j.1468-1331.2011.03618.x; Gras J, 2012, DRUG TODAY, V48, P25, DOI 10.1358/dot.2012.48.1.1738056; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hayase M, 2009, J UROLOGY, V181, P2355, DOI 10.1016/j.juro.2009.01.013; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; Herrera GM, 2002, J PHYSIOL-LONDON, V541, P483, DOI 10.1113/jphysiol.2002.017707; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Hristov KL, 2012, AM J PHYSIOL-CELL PH, V302, pC1632, DOI 10.1152/ajpcell.00417.2011; Hristov KL, 2011, AM J PHYSIOL-CELL PH, V301, pC903, DOI 10.1152/ajpcell.00495.2010; Kuo HC, 2010, EUR UROL, V58, P919, DOI 10.1016/j.eururo.2010.09.007; Kuo YC, 2013, INT J UROL, V20, P40, DOI 10.1111/j.1442-2042.2012.03035.x; Layne JJ, 2010, AM J PHYSIOL-REG I, V298, pR378, DOI 10.1152/ajpregu.00458.2009; Li LK, 2008, BJU INT, V101, P1588, DOI 10.1111/j.1464-410X.2008.07522.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melman A, 2008, GENE THER, V15, P364, DOI 10.1038/sj.gt.3303093; Melman A, 2007, ISR MED ASSOC J, V9, P143; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Nardi A, 2008, CURR MED CHEM, V15, P1126, DOI 10.2174/092986708784221412; Nitti VW, 2007, J UROLOGY, V178, P2488, DOI 10.1016/j.juro.2007.08.033; Oefelein MG, 2011, DRUG SAFETY, V34, P733, DOI 10.2165/11592790-000000000-00000; Oger S, 2011, BJU INT, V108, P604, DOI 10.1111/j.1464-410X.2010.09935.x; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Petkov GV, 2005, AM J PHYSIOL-CELL PH, V288, pC1255, DOI 10.1152/ajpcell.00381.2004; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Soder RP, 2011, EUR J PHARMACOL, V670, P252, DOI 10.1016/j.ejphar.2011.08.013; Sprossmann F, 2009, FEBS J, V276, P1680, DOI 10.1111/j.1742-4658.2009.06900.x; Staskin DR, 2009, J UROLOGY, V181, P1764, DOI 10.1016/j.juro.2008.11.125; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Thorneloe KS, 2005, AM J PHYSIOL-RENAL, V289, pF604, DOI 10.1152/ajprenal.00060.2005; Tyagi P, 2010, IDRUGS, V13, P713; Wagg Adrian, 2006, Am J Geriatr Pharmacother, V4, P14, DOI 10.1016/j.amjopharm.2006.03.004; Xin WK, 2012, AM J PHYSIOL-CELL PH, V302, pC1361, DOI 10.1152/ajpcell.00432.2011; Zinner N, 2006, INT J CLIN PRACT, V60, P119, DOI 10.1111/j.1368-5031.2005.00770.x	45	42	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68052	10.1371/journal.pone.0068052	http://dx.doi.org/10.1371/journal.pone.0068052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861849	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300038
J	Shao, L; Fan, XH; Cheng, NT; Wu, LH; Cheng, YY				Shao, Li; Fan, Xiaohui; Cheng, Ningtao; Wu, Leihong; Cheng, Yiyu			Determination of Minimum Training Sample Size for Microarray-Based Cancer Outcome Prediction-An Empirical Assessment	PLOS ONE			English	Article							EXPRESSION PATTERNS; CLASSIFICATION; CHEMOTHERAPY; SURVIVAL	The promise of microarray technology in providing prediction classifiers for cancer outcome estimation has been confirmed by a number of demonstrable successes. However, the reliability of prediction results relies heavily on the accuracy of statistical parameters involved in classifiers. It cannot be reliably estimated with only a small number of training samples. Therefore, it is of vital importance to determine the minimum number of training samples and to ensure the clinical value of microarrays in cancer outcome prediction. We evaluated the impact of training sample size on model performance extensively based on 3 large-scale cancer microarray datasets provided by the second phase of MicroArray Quality Control project (MAQC-II). An SSNR-based (scale of signal-to-noise ratio) protocol was proposed in this study for minimum training sample size determination. External validation results based on another 3 cancer datasets confirmed that the SSNR-based approach could not only determine the minimum number of training samples efficiently, but also provide a valuable strategy for estimating the underlying performance of classifiers in advance. Once translated into clinical routine applications, the SSNR-based protocol would provide great convenience in microarray-based cancer outcome prediction in improving classifier reliability.	[Shao, Li; Fan, Xiaohui; Wu, Leihong] Zhejiang Univ, Sch Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Ningtao] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Cheng, Ningtao] Emory Univ, Atlanta, GA 30322 USA; [Cheng, Yiyu] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; University System of Georgia; Georgia Institute of Technology; Emory University; Zhejiang University	Fan, XH (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn; chengyy@zju.edu.cn	Wu, Leihong/AAM-9483-2020; FAN, Xiaohui/F-6458-2010	Wu, Leihong/0000-0002-4093-3708; FAN, Xiaohui/0000-0002-6336-3007	National Science Foundation of China [30830121, 81173465]; Zhejiang Provincial Natural Science Foundation of China [R2080693]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Science Foundation of China (30830121, 81173465) and the Zhejiang Provincial Natural Science Foundation of China (R2080693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; de Valpine P, 2009, BIOSTATISTICS, V10, P424, DOI 10.1093/biostatistics/kxp001; DeRisi J, 1996, NAT GENET, V14, P457; Dobbin KK, 2008, CLIN CANCER RES, V14, P108, DOI 10.1158/1078-0432.CCR-07-0443; Dobbin KK, 2007, BIOSTATISTICS, V8, P101, DOI 10.1093/biostatistics/kxj036; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8; Fu WJJ, 2005, BIOINFORMATICS, V21, P63, DOI 10.1093/bioinformatics/bth461; Gadbury GL, 2004, STAT METHODS MED RES, V13, P325, DOI 10.1191/0962280204sm369ra; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hwang DH, 2002, BIOINFORMATICS, V18, P1184, DOI 10.1093/bioinformatics/18.9.1184; Kim KY, 2009, J BIOSCI BIOENG, V108, P252, DOI 10.1016/j.jbiosc.2009.03.017; Kundu S, 1998, STAT PROBABIL LETT, V37, P19, DOI 10.1016/S0167-7152(98)00094-7; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mukherjee S, 2003, J COMPUT BIOL, V10, P119, DOI 10.1089/106652703321825928; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; The MicroArray Quality Control Consortium, 2010, PHARMACOGENOMICS J, pS5; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Niel TG, 2005, REMOTE SENS ENVIRON, V98, P468, DOI 10.1016/j.rse.2005.08.011; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	24	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68579	10.1371/journal.pone.0068579	http://dx.doi.org/10.1371/journal.pone.0068579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861920	Green Submitted, gold, Green Published			2022-12-25	WOS:000321425300071
J	Vassall, KA; Bessonov, K; De Avila, M; Polverini, E; Harauz, G				Vassall, Kenrick A.; Bessonov, Kyrylo; De Avila, Miguel; Polverini, Eugenia; Harauz, George			The Effects of Threonine Phosphorylation on the Stability and Dynamics of the Central Molecular Switch Region of 18.5-kDa Myelin Basic Protein	PLOS ONE			English	Article							AZE AZETIDINE-2-CARBOXYLIC ACID; LINEAR EXTRAPOLATION METHOD; RANDOM COIL TRANSITIONS; SECONDARY STRUCTURE; MULTIPLE-SCLEROSIS; ALPHA-HELIX; CHEMICAL-SHIFT; IMMUNODOMINANT EPITOPE; KDA ISOFORM; BINDING	The classic isoforms of myelin basic protein (MBP) are essential for the formation and maintenance of myelin in the central nervous system of higher vertebrates. The protein is involved in all facets of the development, compaction, and stabilization of the multilamellar myelin sheath, and also interacts with cytoskeletal and signaling proteins. The predominant 18.5-kDa isoform of MBP is an intrinsically-disordered protein that is a candidate auto-antigen in the human demyelinating disease multiple sclerosis. A highly-conserved central segment within classic MBP consists of a proline-rich region (murine 18.5-kDa sequence -T92-P93-R94-T95-P96-P97-P98-S99-) containing a putative SH3-ligand, adjacent to a region that forms an amphipathic alpha-helix (P82-I90) upon interaction with membranes, or under membrane-mimetic conditions. The T92 and T95 residues within the proline-rich region can be post-translationally modified through phosphorylation by mitogen-activated protein (MAP) kinases. Here, we have investigated the structure of the a-helical and proline-rich regions in dilute aqueous buffer, and have evaluated the effects of phosphorylation at T92 and T95 on the stability and dynamics of the alpha-helical region, by utilizing four 36-residue peptides (S72-S107) with differing phosphorylation status. Nuclear magnetic resonance spectroscopy reveals that both the alpha-helical as well as the proline-rich regions are disordered in aqueous buffer, whereas they are both structured in a lipid environment (cf., Ahmed et al., Biochemistry 51, 7475-9487, 2012). Thermodynamic analysis of trifluoroethanol-titration curves monitored by circular dichroism spectroscopy reveals that phosphorylation, especially at residue T92, impedes formation of the amphipathic alpha-helix. This conclusion is supported by molecular dynamics simulations, which further illustrate that phosphorylation reduces the folding reversibility of the alpha-helix upon temperature perturbation and affect the global structure of the peptides through altered electrostatic interactions. The results support the hypothesis that the central conserved segment of MBP constitutes a molecular switch in which the conformation and/or intermolecular interactions are mediated by phosphorylation/dephosphorylation at T92 and T95.	[Vassall, Kenrick A.; Bessonov, Kyrylo; De Avila, Miguel; Harauz, George] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Polverini, Eugenia] Univ Parma, Dept Phys, I-43100 Parma, Italy	University of Guelph; University of Parma	Harauz, G (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	gharauz@uoguelph.ca		Polverini, Eugenia/0000-0003-1665-2129; Harauz, George/0000-0002-6114-9947	Natural Sciences and Engineering Research Council of Canada [RG121541]; Multiple Sclerosis Society of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Multiple Sclerosis Society of Canada	This work was supported by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant RG121541 to GH; http://www.nserc-crsng.gc.ca/). GH is a Tier 1 Canada Research Chair. KAV and MDA were recipients of a Postdoctoral Fellowship and of a Doctoral Studentship, respectively, from the Multiple Sclerosis Society of Canada (http://mssociety.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MAM, 2007, BIOCHEMISTRY-US, V46, P9700, DOI 10.1021/bi700632x; Ahmed MAM, 2012, BIOCHEMISTRY-US, V51, P7475, DOI 10.1021/bi300998x; Ahmed MAM, 2010, BIOPHYS J, V99, P1247, DOI 10.1016/j.bpj.2010.06.022; Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; Bamm VV, 2011, BIOPHYS J, V101, P1248, DOI 10.1016/j.bpj.2011.07.035; Bates IR, 2004, J BIOL CHEM, V279, P5757, DOI 10.1074/jbc.M311504200; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bertolucci CM, 2008, BIOCHEMISTRY-US, V47, P548, DOI 10.1021/bi702103n; Bessonov K, 2013, J MOL GRAPH MODEL, V39, P118, DOI 10.1016/j.jmgm.2012.11.006; Bessonov K, 2010, PHYTOCHEMISTRY, V71, P502, DOI 10.1016/j.phytochem.2009.12.010; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boggs J. M., 2008, MYELIN BASIC PROTEIN; Boggs JM, 2006, BIOCHEMISTRY-US, V45, P391, DOI 10.1021/bi0519194; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Chellgren BW, 2004, BIOCHEMISTRY-US, V43, P5864, DOI 10.1021/bi049922v; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cubellis MV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S8; DeBruin LS, 2007, NEUROCHEM RES, V32, P213, DOI 10.1007/s11064-006-9137-4; DeBruin LS, 2005, J NEUROSCI RES, V80, P211, DOI 10.1002/jnr.20452; DEIBLER GE, 1990, PROTEINS, V7, P32, DOI 10.1002/prot.340070104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doig AJ, 2008, PROG MOL BIOL TRANSL, V83, P1, DOI 10.1016/S0079-6603(08)00601-6; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; Errington Neil, 2006, V340, P3; Fares C, 2006, FEBS J, V273, P601, DOI 10.1111/J.1742-4658.2005.05093.X; Fatemeh MD, 2012, BIOINFORMATICS, V28, pi75, DOI DOI 10.1093/BI0INF0RMATICS/BTS209; Fields RD, 2005, NEUROSCIENTIST, V11, P528, DOI 10.1177/1073858405282304; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; Harauz G, 2009, CURR PROTEIN PEPT SC, V10, P196, DOI 10.2174/138920309788452218; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hill CMD, 2005, BIOCHEMISTRY-US, V44, P16672, DOI 10.1021/bi050646+; Hill CMD, 2005, BIOCHEM BIOPH RES CO, V329, P362, DOI 10.1016/j.bbrc.2005.01.151; Hirschberg D, 2003, J PROTEIN CHEM, V22, P177, DOI 10.1023/A:1023479131488; HOLTZER ME, 1992, BIOPOLYMERS, V32, P1589, DOI 10.1002/bip.360321116; HOLTZER ME, 1992, BIOPOLYMERS, V32, P1675, DOI 10.1002/bip.360321209; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ioannidou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030775; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanelis V, 2000, J BIOMOL NMR, V16, P253, DOI 10.1023/A:1008355012528; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim JK, 2003, MOL CELL PROTEOMICS, V2, P453, DOI 10.1074/mcp.M200050-MCP200; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Koehler J, 2012, MATERIALS, V5, P1774, DOI 10.3390/ma5101774; Lam SL, 2003, BIOPOLYMERS, V69, P270, DOI 10.1002/bip.10354; Li F, 2013, J PHYS CHEM B, V117, P3560, DOI 10.1021/jp4007334; Libich DS, 2008, BIOPHYS J, V94, P4847, DOI 10.1529/biophysj.107.125823; Libich DS, 2010, BIOCHEM CELL BIOL, V88, P143, DOI [10.1139/o09-123, 10.1139/O09-123]; Libich DS, 2004, J BIOMOL NMR, V29, P545, DOI 10.1023/B:JNMR.0000034348.99658.d7; Mansiaux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018401; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Medveczky P, 2006, FEBS LETT, V580, P545, DOI 10.1016/j.febslet.2005.12.067; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; Miron VE, 2011, BBA-MOL BASIS DIS, V1812, P184, DOI 10.1016/j.bbadis.2010.09.010; Murray TJ, 2009, J NEUROL SCI, V277, pS3, DOI 10.1016/S0022-510X(09)70003-6; Musse AA, 2006, P NATL ACAD SCI USA, V103, P4422, DOI 10.1073/pnas.0509158103; Narayanan R, 2008, J AM CHEM SOC, V130, P11477, DOI 10.1021/ja803221c; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PERSAUD R, 1988, BIOCHIM BIOPHYS ACTA, V966, P357, DOI 10.1016/0304-4165(88)90085-2; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Polverini E, 2008, BIOCHEMISTRY-US, V47, P267, DOI 10.1021/bi701336n; Polverini E, 2011, BBA-BIOMEMBRANES, V1808, P674, DOI 10.1016/j.bbamem.2010.11.030; RAMWANI JJ, 1989, BIOCHEMISTRY-US, V28, P6538, DOI 10.1021/bi00442a002; RANDALL CS, 1985, BIOCHEMISTRY-US, V24, P1998, DOI 10.1021/bi00329a030; Ronga L, 2008, J PEPT SCI, V14, P1096, DOI 10.1002/psc.1046; Rubenstein E, 2008, J NEUROPATH EXP NEUR, V67, P1035, DOI 10.1097/NEN.0b013e31818add4a; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; SANCHO J, 1992, J MOL BIOL, V224, P749, DOI 10.1016/0022-2836(92)90559-3; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHULZ P, 1988, BIOCHEMISTRY-US, V27, P7793, DOI 10.1021/bi00420a031; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Simons M, 2012, BBA-MOL CELL BIOL L, V1821, P1146, DOI 10.1016/j.bbalip.2012.01.011; Smith GST, 2012, J NEUROSCI RES, V90, P28, DOI 10.1002/jnr.22733; Smith GS, 2012, NEUROPSYCHOPHARMACOL, V37, P1, DOI 10.1038/npp.2011.233; Sobottka B, 2011, GLIA, V59, P1841, DOI 10.1002/glia.21228; SolerGonzalez AS, 1997, EUR J BIOCHEM, V249, P724, DOI 10.1111/j.1432-1033.1997.t01-1-00724.x; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Stariha RL, 1997, J NEUROCHEM, V68, P945; Stys PK, 2011, TRENDS NEUROSCI, V34, P393, DOI 10.1016/j.tins.2011.06.004; Stys PK, 2010, CAN J NEUROL SCI, V37, pS16, DOI 10.1017/S0317167100022393; Tait AR, 2008, FEBS LETT, V582, P2685, DOI 10.1016/j.febslet.2008.06.050; Tait S, 2010, P NATL ACAD SCI USA, V107, P17627, DOI 10.1073/pnas.1008242107; Tizzano B, 2005, PROTEINS, V59, P72, DOI 10.1002/prot.20395; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Tsutsui S, 2009, ANN NEUROL, V66, P711, DOI 10.1002/ana.21845; ULMER JB, 1984, DEV NEUROSCI-BASEL, V6, P345, DOI 10.1159/000112361; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VARTANIAN T, 1986, SCIENCE, V234, P1395, DOI 10.1126/science.2431483; VUISTER GW, 1993, J BIOMOL NMR, V3, P67; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang CC, 2012, J PROTEOME RES, V11, P4791, DOI 10.1021/pr201196e; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; [No title captured]	109	29	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68175	10.1371/journal.pone.0068175	http://dx.doi.org/10.1371/journal.pone.0068175			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861868	Green Published, gold			2022-12-25	WOS:000321425300048
J	Wen, XT; Rangarajan, G; Ding, MZ				Wen, Xiaotong; Rangarajan, Govindan; Ding, Mingzhou			Is Granger Causality a Viable Technique for Analyzing fMRI Data?	PLOS ONE			English	Article							BOLD HEMODYNAMIC-RESPONSES; EVENT-RELATED FMRI; FUNCTIONAL MRI; NEURONAL MECHANISMS; ALPHA OSCILLATIONS; TIME-SERIES; HUMAN BRAIN; CONNECTIVITY; ATTENTION; NETWORK	Multivariate neural data provide the basis for assessing interactions in brain networks. Among myriad connectivity measures, Granger causality (GC) has proven to be statistically intuitive, easy to implement, and generate meaningful results. Although its application to functional MRI (fMRI) data is increasing, several factors have been identified that appear to hinder its neural interpretability: (a) latency differences in hemodynamic response function (HRF) across different brain regions, (b) low-sampling rates, and (c) noise. Recognizing that in basic and clinical neuroscience, it is often the change of a dependent variable (e.g., GC) between experimental conditions and between normal and pathology that is of interest, we address the question of whether there exist systematic relationships between GC at the fMRI level and that at the neural level. Simulated neural signals were convolved with a canonical HRF, down-sampled, and noise-added to generate simulated fMRI data. As the coupling parameters in the model were varied, fMRI GC and neural GC were calculated, and their relationship examined. Three main results were found: (1) GC following HRF convolution is a monotonically increasing function of neural GC; (2) this monotonicity can be reliably detected as a positive correlation when realistic fMRI temporal resolution and noise level were used; and (3) although the detectability of monotonicity declined due to the presence of HRF latency differences, substantial recovery of detectability occurred after correcting for latency differences. These results suggest that Granger causality is a viable technique for analyzing fMRI data when the questions are appropriately formulated.	[Wen, Xiaotong; Ding, Mingzhou] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32610 USA; [Rangarajan, Govindan] Indian Inst Sci, Dept Math, Bangalore 560012, Karnataka, India; [Rangarajan, Govindan] Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India	State University System of Florida; University of Florida; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Ding, MZ (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32610 USA.	mding@bme.ufl.edu			NIH [MH079388, MH097320]; DST Center for Mathematical Biology; UGC Centre for Advanced Studies; DST IRHPA Center for Neuroscience; J.C. Bose Fellowship; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097320, R01MH079388] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DST Center for Mathematical Biology; UGC Centre for Advanced Studies; DST IRHPA Center for Neuroscience; J.C. Bose Fellowship; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants MH079388 and MH097320. GR was also supported by the DST Center for Mathematical Biology, UGC Centre for Advanced Studies, DST IRHPA Center for Neuroscience and J.C. Bose Fellowship. XW was also supported by the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Bandettini PA, 1997, NMR BIOMED, V10, P197, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<197::AID-NBM466>3.0.CO;2-S; Biswal BB, 2010, CEREB CORTEX, V20, P2188, DOI 10.1093/cercor/bhp284; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Casanova R, 2008, NEUROIMAGE, V40, P1606, DOI 10.1016/j.neuroimage.2008.01.011; Chang C, 2008, NEUROIMAGE, V43, P90, DOI 10.1016/j.neuroimage.2008.06.030; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Cohen ER, 2004, NEUROIMAGE, V23, P613, DOI 10.1016/j.neuroimage.2004.06.021; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Curtis CE, 2005, NEUROIMAGE, V26, P177, DOI 10.1016/j.neuroimage.2005.01.040; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; David O, 2011, NEUROIMAGE, V58, P306, DOI 10.1016/j.neuroimage.2009.09.073; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Evdokimidis I, 2001, COGNITIVE BRAIN RES, V12, P89, DOI 10.1016/S0926-6410(01)00037-4; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 2011, NEUROIMAGE, V58, P303, DOI 10.1016/j.neuroimage.2009.09.031; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gelfand I, 1959, AM MATH SOC TRANSL S, V2, P99; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hu SQ, 2012, NEUROCOMPUTING, V76, P44, DOI 10.1016/j.neucom.2010.10.017; Hu SQ, 2011, IEEE T NEURAL NETWOR, V22, P829, DOI 10.1109/TNN.2011.2123917; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Katwal SB, 2013, NEUROIMAGE, V66, P436, DOI 10.1016/j.neuroimage.2012.10.052; Kay KN, 2008, HUM BRAIN MAPP, V29, P142, DOI 10.1002/hbm.20379; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Luchtmann M, 2010, EXP BRAIN RES, V204, P1, DOI 10.1007/s00221-010-2277-4; Magon S, 2009, NEUROIMAGE, V45, P702, DOI 10.1016/j.neuroimage.2008.12.059; Marrelec G, 2003, HUM BRAIN MAPP, V19, P1, DOI 10.1002/hbm.10100; McDowell JE, 2005, NEUROREPORT, V16, P663, DOI 10.1097/00001756-200505120-00002; Menon RS, 1998, P NATL ACAD SCI USA, V95, P10902, DOI 10.1073/pnas.95.18.10902; Miao XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025546; NAKAMURA K, 1994, J NEUROPHYSIOL, V71, P1206, DOI 10.1152/jn.1994.71.3.1206; Nalatore H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031123; Nalatore H, 2009, J NEUROSCI METH, V179, P131, DOI 10.1016/j.jneumeth.2009.01.013; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Roebroeck A, 2011, NEUROIMAGE, V58, P296, DOI 10.1016/j.neuroimage.2009.09.036; Rogers BP, 2010, MAGN RESON IMAGING, V28, P1058, DOI 10.1016/j.mri.2010.03.002; ROLLS E T, 1992, P143; Rolls ET, 2000, ANNU REV PSYCHOL, V51, P599, DOI 10.1146/annurev.psych.51.1.599; Rolls ET, 2000, HIPPOCAMPUS, V10, P380, DOI 10.1002/1098-1063(2000)10:4<380::AID-HIPO4>3.0.CO;2-0; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sestieri C, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.001.2007; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Shokri-Kojori E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00411; Smith SM, 2012, NEUROIMAGE, V59, P1228, DOI 10.1016/j.neuroimage.2011.08.015; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Steffener J, 2010, NEUROIMAGE, V49, P2113, DOI 10.1016/j.neuroimage.2009.11.014; Wager TD, 2005, NEUROIMAGE, V26, P99, DOI 10.1016/j.neuroimage.2005.01.011; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wen XT, 2013, J NEUROSCI, V33, P6444, DOI 10.1523/JNEUROSCI.4939-12.2013; Wen XT, 2012, NEUROIMAGE, V60, P1587, DOI 10.1016/j.neuroimage.2012.01.079; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; Witt ST, 2009, BRAIN IMAGING BEHAV, V3, P220, DOI 10.1007/s11682-009-9064-5; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006; Zhou ZY, 2009, BRAIN RES, V1289, P22, DOI 10.1016/j.brainres.2009.06.096	76	56	58	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67428	10.1371/journal.pone.0067428	http://dx.doi.org/10.1371/journal.pone.0067428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861763	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000323350700013
J	Bode, C; Yang, XP; Kiu, H; Klinman, DM				Bode, Christian; Yang, Xiang-Ping; Kiu, Hiu; Klinman, Dennis M.			Suppressive Oligodeoxynucleotides Promote the Development of Th17 Cells	PLOS ONE			English	Article							T-HELPER-CELLS; CANDIDA-ALBICANS INFECTIONS; CYTOKINE GM-CSF; TGF-BETA; HOST-DEFENSE; T(H)17 CELLS; MICE; DIFFERENTIATION; INFLAMMATION; GENERATION	Synthetic oligonucleotides containing repetitive TTAGGG motifs mimic the immunosuppressive activity of telomeric DNA. These suppressive oligonucleotides (Sup ODN) are effective in the treatment/prevention of various inflammatory and autoimmune diseases in mice. The therapeutic activity of Sup ODN was originally attributed to the inhibition of Th1 cell activation. Current results indicate that Sup ODN also promote the maturation of naive CD4(+) T cells into Th17 effectors. The generation of Th17 cells is linked to the prolonged activation of signal transducer and activator of transcription (STAT) 3 mediated by suppressor of cytokine signaling 3 (SOCS3) inhibition. In vivo studies show that treatment with Sup ODN promotes Th17 responsiveness under physiological conditions, increasing host resistance to Candida albicans infection. These findings support the development of Sup ODN to suppress pathological inflammatory conditions and improve host resistance to fungal pathogens.	[Bode, Christian; Kiu, Hiu; Klinman, Dennis M.] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA; [Yang, Xiang-Ping] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Klinman, DM (corresponding author), NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA.	klinmand@mail.nih.gov	Bode, Christian/AAL-1486-2021	Bode, Christian/0000-0002-0830-870X; Yang, Xiang-Ping/0000-0001-9003-1772	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010853] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cheng X, 2008, J MOL CELL CARDIOL, V45, P168, DOI 10.1016/j.yjmcc.2008.04.003; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dejima T, 2011, INFECT IMMUN, V79, P4503, DOI 10.1128/IAI.05799-11; Dong L, 2005, ARTHRITIS RHEUM-US, V52, P651, DOI 10.1002/art.20810; Dong L, 2004, ARTHRITIS RHEUM-US, V50, P1686, DOI 10.1002/art.20263; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fujimoto C, 2009, CLIN EXP IMMUNOL, V156, P528, DOI 10.1111/j.1365-2249.2009.03918.x; Ghoreschi K, 2011, TRENDS IMMUNOL, V32, P395, DOI 10.1016/j.it.2011.06.007; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ikeuchi H, 2011, CANCER PREV RES, V4, P752, DOI 10.1158/1940-6207.CAPR-10-0290; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Kang HK, 2007, J IMMUNOL, V178, P7849, DOI 10.4049/jimmunol.178.12.7849; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Odds FC, 2000, MICROBIOL-SGM, V146, P1881, DOI 10.1099/00221287-146-8-1881; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato T, 2008, J IMMUNOL, V180, P7648, DOI 10.4049/jimmunol.180.11.7648; Shirota H, 2005, J IMMUNOL, V174, P4579, DOI 10.4049/jimmunol.174.8.4579; Shirota H, 2004, J IMMUNOL, V173, P5002, DOI 10.4049/jimmunol.173.8.5002; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385	47	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67991	10.1371/journal.pone.0067991	http://dx.doi.org/10.1371/journal.pone.0067991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844143	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000127
J	Campagne, P; Kruger, M; Pasquet, R; Le Ru, B; Van den Berg, J				Campagne, Pascal; Kruger, Marlene; Pasquet, Remy; Le Ru, Bruno; Van den Berg, Johnnie			Dominant Inheritance of Field-Evolved Resistance to Bt Corn in Busseola fusca	PLOS ONE			English	Article							PINK-BOLLWORM LEPIDOPTERA; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; COTTON BOLLWORM; GENETIC-BASIS; STEM BORER; MAIZE; CROPS; SUPPRESSION; NOCTUIDAE	Transgenic crops expressing Bacillus thuringiensis (Bt) toxins have been adopted worldwide, notably in developing countries. In spite of their success in controlling target pests while allowing a substantial reduction of insecticide use, the sustainable control of these pest populations is threatened by the evolution of resistance. The implementation of the "high dose/refuge" strategy for managing insect resistance in transgenic crops aims at delaying the evolution of resistance to Bt crops in pest populations by promoting survival of susceptible insects. However, a crucial condition for the "high dose/refuge" strategy to be efficient is that the inheritance of resistance should be functionally recessive. Busseola fusca developed high levels of resistance to the Bt toxin Cry 1Ab expressed in Bt corn in South Africa. To test whether the inheritance of B. fusca resistance to the Bt toxin could be considered recessive we performed controlled crosses with this pest and evaluated its survival on Bt and non-Bt corn. Results show that resistance of B. fusca to Bt corn is dominant, which refutes the hypothesis of recessive inheritance. Survival on Bt corn was not lower than on non-Bt corn for both resistant larvae and the F-1 progeny from resistant x susceptible parents. Hence, resistance management strategies of B. fusca to Bt corn must address non-recessive resistance.	[Campagne, Pascal; Pasquet, Remy; Le Ru, Bruno] CNRS, Lab Evolut Genome & Speciat, Unit Rech IRD 072, UPR9034, Gif Sur Yvette, France; [Campagne, Pascal; Pasquet, Remy; Le Ru, Bruno] Univ Paris 11, Orsay, France; [Kruger, Marlene; Van den Berg, Johnnie] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Campagne, Pascal; Pasquet, Remy; Le Ru, Bruno] Int Ctr Insect Physiol & Ecol, Noctuid Stem Borers Biodivers Africa Project, Div Environm Hlth, Nairobi, Kenya; [Campagne, Pascal] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; North West University - South Africa; International Centre of Insect Physiology & Ecology (ICIPE); Rutgers State University New Brunswick	Campagne, P (corresponding author), CNRS, Lab Evolut Genome & Speciat, Unit Rech IRD 072, UPR9034, Gif Sur Yvette, France.	campagne@aesop.rutgers.edu	PASQUET, Remy/J-6746-2016; Van den Berg, Johnnie/M-7256-2013; Le Ru, bruno/K-3480-2016; LE RU, BRUNO/C-5862-2011	Van den Berg, Johnnie/0000-0002-6831-3180; Le Ru, bruno/0000-0002-4208-3727; 	Biosafety South Africa [08-001]	Biosafety South Africa	This study was funded by Biosafety South Africa (Grant 08-001) and the authors accordingly give due credit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony VM, 2012, CURR OPIN BIOTECH, V23, P278, DOI 10.1016/j.copbio.2011.11.020; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bourguet D, 1998, J EVOLUTION BIOL, V11, P103, DOI 10.1046/j.1420-9101.1998.11010103.x; Bourguet D, 1996, GENETICS, V143, P407; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2001, J ECON ENTOMOL, V94, P1571, DOI 10.1603/0022-0493-94.6.1571; Charlesworth B, 1998, CURR BIOL, V8, pR502, DOI 10.1016/S0960-9822(98)70318-5; Davison AC, 1997, BOOTSTRAP METHODS TH; EPA-SAP US [US Environmental Protection Agency - Scientific Advisory Panel], 1998, FIN REP SUBP BAC THU; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Huang Fangneng, 2006, Insect Science, V13, P73, DOI 10.1111/j.1744-7917.2006.00070.x; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Janmaat AF, 2005, P ROY SOC B-BIOL SCI, V272, P1031, DOI 10.1098/rspb.2004.3040; Kruger M, 2012, AFR ENTOMOL, V20, P35, DOI 10.4001/003.020.0105; Kruger M, 2011, ENVIRON ENTOMOL, V40, P477, DOI 10.1603/EN09220; Kruger M, 2012, J APPL ENTOMOL, V136, P38, DOI 10.1111/j.1439-0418.2011.01616.x; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Nair R, 2010, J INVERTEBR PATHOL, V104, P31, DOI 10.1016/j.jip.2010.01.004; OHH BK, 1970, GENETICS, V66, P517; Onstad D. W., 2007, INSECT RESISTANCE MA; Pilcher CD, 2002, J ECON ENTOMOL, V95, P878, DOI 10.1603/0022-0493-95.5.878; R Development Core Team, 2012, R LANG ENV STAT COMP; Siegfried Blair D., 2007, American Entomologist, V53, P208; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Subramanya G, 2011, ENTOMOL RES, V41, P18, DOI 10.1111/j.1748-5967.2010.00313.x; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2010, SOUTHWEST ENTOMOL, V35, P417, DOI 10.3958/059.035.0326; Tabashnik BE, 2010, SCIENCE, V330, P189, DOI 10.1126/science.1196864; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu XY, 2009, J INVERTEBR PATHOL, V102, P44, DOI 10.1016/j.jip.2009.06.006; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109	46	49	53	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69675	10.1371/journal.pone.0069675	http://dx.doi.org/10.1371/journal.pone.0069675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844262	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000194
J	Huttmann, S; Buchhaupt, M; Schrader, J				Huettmann, Sonja; Buchhaupt, Markus; Schrader, Jens			Identification of a Caldariomyces fumago Mutant Secreting an Inactive Form of Chloroperoxidase Lacking the Heme Group and N-Glycans	PLOS ONE			English	Article							GLYCOSYLATION; PEROXIDASE; ENZYME; EXPRESSION; PROTEINS; AMYLASE; ROLES	By mutant colony screening of Caldariomyces fumago a mutant was isolated which was slightly greenish on fructose minimal medium and grew slower in comparison to the wild type. The supernatant samples lacked the Soret band typical for the heme group of the CPO and nearly no CPO activity was detected. SDS-PAGE analysis of mutant culture supernatant samples showed production of a 38-40 kDa protein while wild type samples contain the 42 kDa CPO protein. Protein identification using nanoLC-ESI-MS/MS was performed and based on three peptides the protein in the mutant culture was identified as CPO. No differences in the CPO gene sequences of wild type and mutant were found indicating a post-translational defect in protein maturation. Deglycosylation experiments using CPO from wild type and mutant were carried out. After removing N-linked oligosaccharides from wild type CPO a protein band at 38-40 kDa was detected. Our results reveal that the mutant protein lacks the heme group as well as the N-glycans.	[Huettmann, Sonja; Buchhaupt, Markus; Schrader, Jens] DECHEMA Res Inst, Frankfurt, Germany		Schrader, J (corresponding author), DECHEMA Res Inst, Frankfurt, Germany.	schrader@dechema.de		Buchhaupt, Markus/0000-0003-2720-5973	German Federal Ministry of Economics and Technology (BMWi) by the German Federation of Industrial Research Associations "Otto von Guericke" e.V. (AiF) [16152 N]	German Federal Ministry of Economics and Technology (BMWi) by the German Federation of Industrial Research Associations "Otto von Guericke" e.V. (AiF)	This project has been funded by the German Federal Ministry of Economics and Technology (BMWi) by the German Federation of Industrial Research Associations "Otto von Guericke" e.V. (AiF) (project number 16152 N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXLEY MJ, 1986, J BIOL CHEM, V261, P5058; Bao LG, 2001, ARCH BIOCHEM BIOPHYS, V386, P17, DOI 10.1006/abbi.2000.2187; Bennett JW, 1991, APPL MOL GENETICS FU; Buchhaupt M, 2012, APPL ENVIRON MICROB, V78, P5923, DOI 10.1128/AEM.00570-12; CARMICHAEL RD, 1989, APPL ENVIRON MICROB, V55, P17, DOI 10.1128/AEM.55.1.17-20.1989; Conesa A, 2001, J BIOL CHEM, V276, P17635, DOI 10.1074/jbc.M010571200; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Desnick RJ, 1998, BIOCHEM J, V332, P798; GRIFFIN BW, 1991, PEROXIDASES CHEM BIO, V2, P85; HAGER LP, 1966, J BIOL CHEM, V241, P1769; Haines WR, 1994, THESIS U ILLINOIS UR; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; KENIGSBERG P, 1987, ARCH BIOCHEM BIOPHYS, V254, P409, DOI 10.1016/0003-9861(87)90118-4; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253; Mechref Y, 2002, CHEM REV, V102, P321, DOI 10.1021/cr0103017; MORRIS DR, 1966, J BIOL CHEM, V241, P1763; NAUSEEF WM, 1992, BLOOD, V80, P2622; PICKARD MA, 1991, J IND MICROBIOL, V7, P235, DOI 10.1007/BF01577650; PICKARD MA, 1982, CAN J MICROBIOL, V28, P1382, DOI 10.1139/m82-205; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; SAE ASW, 1979, PHYTOCHEMISTRY, V18, P1785, DOI 10.1016/0031-9422(79)83052-6; Sambrook J, 2001, MOL CLONING LAB MANU; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Tams JW, 1999, BBA-PROTEIN STRUCT M, V1432, P214, DOI 10.1016/S0167-4838(99)00103-X; TERASHIMA M, 1994, EUR J BIOCHEM, V226, P249, DOI 10.1111/j.1432-1033.1994.tb20048.x; Yanez E, 1998, BIOCHEM J, V329, P65, DOI 10.1042/bj3290065; Yazbik V, 2010, PROCESS BIOCHEM, V45, P279, DOI 10.1016/j.procbio.2009.09.006; ZONG Q, 1995, BIOCHEMISTRY-US, V34, P12420, DOI 10.1021/bi00038a040	33	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67857	10.1371/journal.pone.0067857	http://dx.doi.org/10.1371/journal.pone.0067857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844113	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000111
J	Leandro, MJ; Sychrova, H; Prista, C; Loureiro-Dias, MC				Leandro, Maria Jose; Sychrova, Hana; Prista, Catarina; Loureiro-Dias, Maria C.			ZrFsy1, a High-Affinity Fructose/H+ Symporter from Fructophilic Yeast Zygosaccharomyces rouxii	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; GENE; TRANSPORT; GLUCOSE; IDENTIFICATION; TRANSFORMATION; EXPRESSION; SYSTEMS; STRAIN	Zygosaccharomyces rouxii is a fructophilic yeast than can grow at very high sugar concentrations. We have identified an ORF encoding a putative fructose/H+ symporter in the Z. rouxii CBS 732 genome database. Heterologous expression of this ORF in a S. cerevisiae strain lacking its own hexose transporters (hxt-null) and subsequent kinetic characterization of its sugar transport activity showed it is a high-affinity low-capacity fructose/H+ symporter, with K-m 0.45 +/- 0.07 mM and V-max 0.57 +/- 0.02 mmol h(-1) (gdw)(-1). We named it ZrFsy1. This protein also weakly transports xylitol and sorbose, but not glucose or other hexoses. The expression of ZrFSY1 in Z. rouxii is higher when the cells are cultivated at extremely low fructose concentrations (<0.2%) and on non-fermentable carbon sources such as mannitol and xylitol, where the cells have a prolonged lag phase, longer duplication times and change their microscopic morphology. A clear phenotype was determined for the first time for the deletion of a fructose/H+ symporter in the genome where it occurs naturally. The effect of the deletion of ZrFSY1 in Z. rouxii cells is only evident when the cells are cultivated at very low fructose concentrations, when the ZrFsy1 fructose symporter is the main active fructose transporter system.	[Leandro, Maria Jose; Prista, Catarina; Loureiro-Dias, Maria C.] Univ Tecn Lisboa, Inst Super Agron, CBAA, P-1100 Lisbon, Portugal; [Leandro, Maria Jose; Sychrova, Hana] Inst Physiol AS CR, Dept Membrane Transport, Vvi, Prague, Czech Republic	Universidade de Lisboa; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Leandro, MJ (corresponding author), Univ Tecn Lisboa, Inst Super Agron, CBAA, P-1100 Lisbon, Portugal.	mjleandro@isa.utl.pt	Prista, Catarina/N-7079-2013; Loureiro-Dias, Maria C/N-7331-2013; Prista, C./H-9049-2019; Leandro, Maria/K-5461-2015; Sychrova, Hana/B-1350-2012	Prista, Catarina/0000-0001-9307-1905; Loureiro-Dias, Maria C/0000-0002-6340-2416; Prista, C./0000-0001-9307-1905; Leandro, Maria/0000-0002-2254-4610; Sychrova, Hana/0000-0001-5967-5019	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/41812/2007, SFRH/BPD/85143/2012]; Research Project "Improvement of fructose fermentation by industrial Saccharomyces cerevisiae strains'' [PTDC/AGR-ALI/112802/2009]; Czech MSMT LC531 [GACR P503/10/0307, AV0Z 50110509, RVO6798582]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Research Project "Improvement of fructose fermentation by industrial Saccharomyces cerevisiae strains''; Czech MSMT LC531	This work was supported by Fundacao para a Ciencia e Tecnologia, Portugal (Post-Doctoral fellowships SFRH/BPD/41812/2007 to M.J.L. and SFRH/BPD/85143/2012 to C.P., FCT Ciencia 2007 and Research Project "Improvement of fructose fermentation by industrial Saccharomyces cerevisiae strains'' (PTDC/AGR-ALI/112802/2009)) and Czech MSMT LC531, GACR P503/10/0307, AV0Z 50110509 and RVO6798582 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos J, 2012, BIOCHIM BIOPHYS ACTA, V1828, P201; ARNOLD WN, 1974, J BACTERIOL, V120, P886, DOI 10.1128/JB.120.2.886-894.1974; de Sousa HR, 2004, YEAST, V21, P519, DOI 10.1002/yea.1118; Diezemann A, 2003, CURR GENET, V43, P281, DOI 10.1007/s00294-003-0392-5; Doehlemann G, 2005, FUNGAL GENET BIOL, V42, P601, DOI 10.1016/j.fgb.2005.03.001; EMMERICH W, 1983, J GEN MICROBIOL, V129, P3311; Fell JW, 2000, YEASTS TAXONOMIC STU, Vxviii; Galeote V, 2010, MICROBIOL-SGM, V156, P3754, DOI 10.1099/mic.0.041673-0; Goncalves P, 2000, J BACTERIOL, V182, P5628, DOI 10.1128/JB.182.19.5628-5630.2000; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kinclova-Zimmermannova O, 2005, J BIOL CHEM, V280, P30638, DOI 10.1074/jbc.M506341200; Leandro MJ, 2011, MICROBIOL-SGM, V157, P601, DOI 10.1099/mic.0.044446-0; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOUREIRODIAS MC, 1984, BIOCHEM J, V222, P293, DOI 10.1042/bj2220293; Maresova L, 2007, BIOTECHNIQUES, V43, P667, DOI 10.2144/000112620; Martorell P, 2007, INT J FOOD MICROBIOL, V114, P234, DOI 10.1016/j.ijfoodmicro.2006.09.014; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Ok T, 1997, J GEN APPL MICROBIOL, V43, P39, DOI 10.2323/jgam.43.39; Palma M, 2007, J MOL MICROB BIOTECH, V12, P241, DOI 10.1159/000099645; Palma M, 2009, FEMS YEAST RES, V9, P526, DOI 10.1111/j.1567-1364.2009.00511.x; Pina C, 2004, MICROBIOL-SGM, V150, P2429, DOI 10.1099/mic.0.26979-0; Pribylova L, 2003, J MICROBIOL METH, V55, P481, DOI 10.1016/S0167-7012(03)00197-0; Pribylova L, 2007, FEMS YEAST RES, V7, P1285, DOI 10.1111/j.1567-1364.2007.00308.x; Pribylova L, 2007, CHROMOSOME RES, V15, P439, DOI 10.1007/s10577-007-1136-z; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SousaDias S, 1996, MICROBIOL-UK, V142, P1733, DOI 10.1099/13500872-142-7-1733; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Zaragoza O, 2003, J MICROBIOL METH, V52, P141, DOI 10.1016/S0167-7012(02)00154-9	33	20	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68165	10.1371/journal.pone.0068165	http://dx.doi.org/10.1371/journal.pone.0068165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844167	gold, Green Published			2022-12-25	WOS:000321341000141
J	Lohse, B; Helgstrand, C; Kristensen, JBL; Leurs, U; Cloos, PAC; Kristensen, JL; Clausen, RP				Lohse, Brian; Helgstrand, Charlotte; Kristensen, Jan B. L.; Leurs, Ulrike; Cloos, Paul A. C.; Kristensen, Jesper L.; Clausen, Rasmus P.			Posttranslational Modifications of the Histone 3 Tail and Their Impact on the Activity of Histone Lysine Demethylases In Vitro	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; CHROMATIN; H3; GENOME; GENES; CODE; PHOSPHORYLATION; HETEROCHROMATIN; SENESCENCE; DYNAMICS	Posttranslational modifications (PTMs) of the histone H3 tail such as methylation, acetylation and phosphorylation play important roles in epigenetic signaling. Here we study the effect of some of these PTMs on the demethylation rates of methylated lysine 9 in vitro using peptide substrates mimicking histone H3. Various combinations with other PTMs were employed to study possible cross-talk effects by comparing enzyme kinetic characteristics. We compared the kinetics of histone tail substrates for truncated histone lysine demethylases KDM4A and KDM4C containing only the catalytic core (cc) and some combinations were characterized on full length (FL) KDM4A and KDM4C. We found that the substrates combining trimethylated K4 and K9 resulted in a significant increase in the catalytic activity for FL-KDM4A. For the truncated versions of KDM4A and KDM4C a two-fold increase in the catalytic activity toward bis-trimethylated substrates could be observed. Furthermore, a significant difference in the catalytic activity between dimethylated and trimethylated substrates was found for full length demethylases in line with what has been reported previously for truncated demethylases. Histone peptide substrates phosphorylated at T11 could not be demethylated by neither truncated nor full length KDM4A and KDM4C, suggesting that phosphorylation of threonine 11 prevents demethylation of the H3K9me3 mark on the same peptide. Acetylation of K14 was also found to influence demethylation rates significantly. Thus, for truncated KDM4A, acetylation on K14 of the substrate leads to an increase in enzymatic catalytic efficiency (k(cat)/K-m), while for truncated KDM4C it induces a decrease, primarily caused by changes in K-m. This study demonstrates that demethylation activities towards trimethylated H3K9 are significantly influenced by other PTMs on the same peptide, and emphasizes the importance of studying these interactions at the peptide level to get a more detailed understanding of the dynamics of epigenetic marks.	[Lohse, Brian; Helgstrand, Charlotte; Kristensen, Jan B. L.; Leurs, Ulrike; Kristensen, Jesper L.; Clausen, Rasmus P.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Cloos, Paul A. C.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Lohse, B (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark.	bril@sund.ku.dk; rac@sund.ku.dk	Kristensen, Jesper/AAP-4439-2021; Clausen, Rasmus P/A-6812-2008; Kristensen, Jesper/E-3581-2010	Kristensen, Jesper/0000-0002-5613-1267; Clausen, Rasmus P/0000-0001-9466-9431; Kristensen, Jesper/0000-0002-5613-1267; Leurs, Ulrike/0000-0002-8828-3505; Cloos, Paul/0000-0001-5863-0054; Lohse, Brian/0000-0003-0479-8980	University of Copenhagen Program of Excellence; Danish National Research Foundation; Danish Medical Research Council; Danish Cancer Society; Lundbeckfonden	University of Copenhagen Program of Excellence; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Lundbeckfonden(Lundbeckfonden)	The University of Copenhagen Program of Excellence, the Danish National Research Foundation, the Danish Medical Research Council, and the Danish Cancer Society are gratefully acknowledged for supporting the research. Lundbeckfonden is acknowledged for support to J.B.L. Kristensen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Govin J, 2010, GENE DEV, V24, P1772, DOI 10.1101/gad.1954910; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krishnan S, 2013, STRUCTURE, V21, P98, DOI 10.1016/j.str.2012.10.018; Krishnan S, 2012, ANAL BIOCHEM, V420, P48, DOI 10.1016/j.ab.2011.08.034; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lohse B, 2011, ANGEW CHEM INT EDIT, V50, P9100, DOI 10.1002/anie.201101849; Lohse B, 2011, BIOORGAN MED CHEM, V19, P3625, DOI 10.1016/j.bmc.2011.01.046; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Wang Y, 2012, J BIOL CHEM, V287, P4386, DOI 10.1074/jbc.M111.329417; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yang YW, 2003, ENDOCRINOLOGY, V144, P5658, DOI 10.1210/en.2003-0798	31	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67653	10.1371/journal.pone.0067653	http://dx.doi.org/10.1371/journal.pone.0067653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844048	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000068
J	Amako, Y; Igloi, Z; Mankouri, J; Kazlauskas, A; Saksela, K; Dallas, M; Peers, C; Harris, M				Amako, Yutaka; Igloi, Zsofia; Mankouri, Jamel; Kazlauskas, Arunas; Saksela, Kalle; Dallas, Mark; Peers, Chris; Harris, Mark			Hepatitis C Virus NS5A Inhibits Mixed Lineage Kinase 3 to Block Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5A; BETA-CATENIN; SRC-HOMOLOGY-3 DOMAIN; POTASSIUM CURRENTS; CORE PROTEIN; PHOSPHORYLATION; STRESS; IDENTIFICATION; REPLICATION; ACTIVATION	Hepatitis C virus (HCV) infection results in the activation of numerous stress responses including oxidative stress, with the potential to induce an apoptotic state. Previously we have shown that HCV attenuates the stress-induced, p38MAPK-mediated up-regulation of the K+ channel Kv2.1, to maintain the survival of infected cells in the face of cellular stress. We demonstrated that this effect was mediated by HCV non-structural 5A (NS5A) protein, which impaired p38MAPK activity through a polyproline motif-dependent interaction, resulting in reduction of phosphorylation activation of Kv2.1. In this study, we investigated the host cell proteins targeted by NS5A to mediate Kv2.1 inhibition. We screened a phage-display library expressing the entire complement of human SH3 domains for novel NS5A-host cell interactions. This analysis identified mixed lineage kinase 3 (MLK3) as a putative NS5A interacting partner. MLK3 is a serine/threonine protein kinase that is a member of the MAPK kinase kinase (MAP3K) family and activates p38MAPK. An NS5A-MLK3 interaction was confirmed by co-immunoprecipitation and Western blot analysis. We further demonstrate a novel role of MLK3 in the modulation of Kv2.1 activity, whereby MLK3 overexpression leads to the up-regulation of channel activity. Accordingly, coexpression of NS5A suppressed this stimulation. Additionally we demonstrate that overexpression of MLK3 induced apoptosis, which was also counteracted by NS5A. We conclude that NS5A targets MLK3 with multiple downstream consequences for both apoptosis and K+ homeostasis.	[Amako, Yutaka; Igloi, Zsofia; Mankouri, Jamel; Harris, Mark] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Dallas, Mark; Peers, Chris] Univ Leeds, Div Cardiovasc & Diabet Res, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Kazlauskas, Arunas; Saksela, Kalle] Univ Helsinki, Cent Hosp, Haartman Inst, Dept Virol, FI-00014 Helsinki, Finland; [Kazlauskas, Arunas; Saksela, Kalle] HUSLAB, FI-00014 Helsinki, Finland	University of Leeds; University of Leeds; University of Helsinki; Helsinki University Central Hospital	Harris, M (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	m.harris@leeds.ac.uk	Dallas, Mark/Q-6117-2019; Dallas, Mark L/A-6654-2013	Dallas, Mark/0000-0002-5190-0522; Harris, Mark/0000-0002-9821-1003; Peers, Chris/0000-0002-8354-346X; Saksela, Kalle/0000-0003-0827-122X; Mankouri, Jamel/0000-0002-4325-3687	Wellcome Trust [090805]; Marie Curie Career Integration Grant from the European Commission [304072 HCVFAO FP7-PEOPLE-2011-CIG]	Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Career Integration Grant from the European Commission	This study was supported by a grant (to M. H. and C. P.) from the Wellcome Trust (Grant Number 090805).; Recipient of a Marie Curie Career Integration Grant (304072 HCVFAO FP7-PEOPLE-2011-CIG) from the European Commission.	Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; GALLO KA, 1994, J BIOL CHEM, V269, P15092; He Y, 2006, HEPATITIS C VIRUSES; Higgs MR, 2013, ONCOGENE, V32, P4683, DOI 10.1038/onc.2012.484; Hong HY, 2007, BIOCHEM BIOPH RES CO, V362, P307, DOI 10.1016/j.bbrc.2007.07.165; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Humphrey RK, 2013, J BIOL CHEM, V288, P2428, DOI 10.1074/jbc.M112.425884; Ikematsu N, 2011, P NATL ACAD SCI USA, V108, P18132, DOI 10.1073/pnas.1106201108; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kim KY, 2004, J BIOL CHEM, V279, P29478, DOI 10.1074/jbc.M313947200; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Milward A, 2010, J GEN VIROL, V91, P373, DOI 10.1099/vir.0.015305-0; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Norris CA, 2012, J NEUROSCI, V32, P8865, DOI 10.1523/JNEUROSCI.0937-12.2012; Pal S, 2003, J NEUROSCI, V23, P4798; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Sharma M, 2012, MOL PHARMACOL, V82, P1001, DOI 10.1124/mol.112.079863; Street A, 2005, J VIROL, V79, P5006, DOI 10.1128/JVI.79.8.5006-5016.2005; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; Tang RX, 2012, WORLD J GASTROENTERO, V18, P1485, DOI 10.3748/wjg.v18.i13.1485; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2007, J VIROL, V81, P8853, DOI 10.1128/JVI.00753-07; Thylur RP, 2011, J BIOL CHEM, V286, P37470, DOI 10.1074/jbc.M111.298943; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268	46	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24753	24763		10.1074/jbc.M113.491985	http://dx.doi.org/10.1074/jbc.M113.491985			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23857585	Green Published, hybrid			2022-12-25	WOS:000330612300041
J	Kimura, M; Okumura, N; Kose, S; Takao, T; Imamoto, N				Kimura, Makoto; Okumura, Nobuaki; Kose, Shingo; Takao, Toshifumi; Imamoto, Naoko			Identification of Cargo Proteins Specific for Importin-beta with Importin-alpha Applying a Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based in Vitro Transport System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; PORE-TARGETING COMPLEX; CAP-BINDING COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; QUANTITATIVE PROTEOMICS; MAMMALIAN-CELLS; SEQUENCE; EXPORT; EXPRESSION; RECEPTORS	The human importin (Imp)-beta family consists of 21 nucleocytoplasmic transport carrier proteins, which transport thousands of proteins (cargoes) across the nuclear envelope through nuclear pores in specific directions. To understand the nucleocytoplasmic transport in a physiological context, the specificity of cargoes for their cognate carriers should be determined; however, only a limited number of nuclear proteins have been linked to specific carriers. To address this biological question, we recently developed a novel method to identify carrier-specific cargoes. This method includes the following three steps: (i) the cells are labeled by stable isotope labeling by amino acids in cell culture (SILAC); (ii) the labeled cells are permeabilized, and proteins in the unlabeled cell extracts are transported into the nuclei of the permeabilized cells by a particular carrier; and (iii) the proteins in the nuclei are quantitatively identified by LCMS/MS. The effectiveness of this method was demonstrated by the identification of transportin (Trn)-specific cargoes. Here, we applied this method to identify cargo proteins specific for Imp-beta, which is a predominant carrier that exclusively utilizes Imp-alpha as an adapter for cargo binding. We identified candidate cargoes, which included previously reported and potentially novel Imp-beta cargoes. In in vitro binding assays, most of the candidate cargoes bound to Imp-alpha in one of three binding modes: directly, via Imp-alpha, or via other cargoes. Thus, our method is effective for identifying a variety of Imp-beta cargoes. The identified Imp-beta and Trn cargoes were compared, ensuring the carrier specificity of the method and illustrating the complexity of these transport pathways.	[Kimura, Makoto; Kose, Shingo; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan; [Okumura, Nobuaki] Osaka Univ, Inst Prot Res, Lab Homeostat Integrat, Suita, Osaka 5650871, Japan; [Takao, Toshifumi] Osaka Univ, Inst Prot Res, Lab Prot Profiling & Funct Prote, Suita, Osaka 5650871, Japan	RIKEN; Osaka University; Osaka University	Kimura, M (corresponding author), RIKEN, Cellular Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	makimura@riken.jp; nimamoto@riken.jp	Imamoto, Naoko/A-7458-2015	Imamoto, Naoko/0000-0002-2886-3022; Kimura, Makoto/0000-0003-0868-5334	RIKEN Special Project Funding for Basic Science in Cellular System Project Research; Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Grants-in-Aid for Scientific Research [23570164] Funding Source: KAKEN	RIKEN Special Project Funding for Basic Science in Cellular System Project Research; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the RIKEN Special Project Funding for Basic Science in Cellular System Project Research and the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program)," which was initiated by the Council for Science and Technology Policy (CSTP) (to N. I.).	Antoine M, 2005, BIOCHEM BIOPH RES CO, V335, P146, DOI 10.1016/j.bbrc.2005.07.069; BISCHOFF FR, 1995, METHOD ENZYMOL, V257, P135; Blazek E, 2006, PROTEOMICS, V6, P2070, DOI 10.1002/pmic.200500449; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Chou CW, 2010, FEBS LETT, V584, P4151, DOI 10.1016/j.febslet.2010.08.044; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Fukumoto M, 2011, CELL STRUCT FUNCT, V36, P57, DOI 10.1247/csf.10026; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Hieda M, 2001, J BIOL CHEM, V276, P16824, DOI 10.1074/jbc.M008299200; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Huang JG, 2010, GENE, V451, P38, DOI 10.1016/j.gene.2009.11.009; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jackson EB, 2005, NUCLEIC ACIDS RES, V33, P3303, DOI 10.1093/nar/gki641; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kim BJ, 2006, J BIOL CHEM, V281, P12041, DOI 10.1074/jbc.M512630200; Kimura M, 2013, MOL CELL PROTEOMICS, V12, P145, DOI 10.1074/mcp.M112.019414; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 2002, CELL PHYSIOL BIOCHEM, V12, P335; Koike M, 1999, ONCOGENE, V18, P7495, DOI 10.1038/sj.onc.1203247; Koike M, 1999, EXP CELL RES, V250, P401, DOI 10.1006/excr.1999.4507; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Ly-Huynh JD, 2011, BIOL REPROD, V85, P1191, DOI 10.1095/biolreprod.111.091686; Major AT, 2011, BBA-MOL CELL RES, V1813, P1668, DOI 10.1016/j.bbamcr.2011.03.008; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsubae M, 2000, FEBS LETT, V468, P171, DOI 10.1016/S0014-5793(00)01218-7; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miyamoto Y, 2013, BBA-MOL CELL RES, V1833, P731, DOI 10.1016/j.bbamcr.2012.11.005; Moroianu J, 1996, P NATL ACAD SCI USA, V93, P6572, DOI 10.1073/pnas.93.13.6572; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038990; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Qu DB, 2007, J NEUROCHEM, V103, P408, DOI 10.1111/j.1471-4159.2007.04747.x; Sato M, 2011, J COMP NEUROL, V519, P1770, DOI 10.1002/cne.22600; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Song N, 2012, ANGIOGENESIS, V15, P697, DOI 10.1007/s10456-012-9284-y; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thakar K, 2013, MOL CELL PROTEOMICS, V12, P664, DOI 10.1074/mcp.M112.024877; Wang CI, 2012, MOL CELL PROTEOMICS, V11, P1105, DOI 10.1074/mcp.M111.016592; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574	60	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24540	24549		10.1074/jbc.M113.489286	http://dx.doi.org/10.1074/jbc.M113.489286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846694	hybrid, Green Published			2022-12-25	WOS:000330612300022
J	von Tscharner, V; Enders, H; Maurer, C				von Tscharner, Vinzenz; Enders, Hendrik; Maurer, Christian			Subspace Identification and Classification of Healthy Human Gait	PLOS ONE			English	Article							MOVEMENT PATTERNS; VARIABILITY	Purpose: The classification between different gait patterns is a frequent task in gait assessment. The base vectors were usually found using principal component analysis (PCA) is replaced by an iterative application of the support vector machine (SVM). The aim was to use classifyability instead of variability to build a subspace (SVM space) that contains the information about classifiable aspects of a movement. The first discriminant of the SVM space will be compared to a discriminant found by an independent component analysis (ICA) in the SVM space. Methods: Eleven runners ran using shoes with different midsoles. Kinematic data, representing the movements during stance phase when wearing the two shoes, was used as input to a PCA and SVM. The data space was decomposed by an iterative application of the SVM into orthogonal discriminants that were able to classify the two movements. The orthogonal discriminants spanned a subspace, the SVM space. It represents the part of the movement that allowed classifying the two conditions. The data in the SVM space was reconstructed for a visual assessment of the movement difference. An ICA was applied to the data in the SVM space to obtain a single discriminant. Cohen's d effect size was used to rank the PCA vectors that could be used to classify the data, the first SVM discriminant or the ICA discriminant. Results: The SVM base contains all the information that discriminates the movement of the two shod conditions. It was shown that the SVM base contains some redundancy and a single ICA discriminant was found by applying an ICA in the SVM space. Conclusions: A combination of PCA, SVM and ICA is best suited to extract all parts of the gait pattern that discriminates between the two movements and to find a discriminant for the classification of dichotomous kinematic data.	[von Tscharner, Vinzenz; Enders, Hendrik; Maurer, Christian] Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB, Canada	University of Calgary	von Tscharner, V (corresponding author), Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB, Canada.	tvvon@ucalgary.ca	Maurer, Christian/AAS-9688-2020	Maurer, Christian/0000-0002-8426-813X	National Sciences and Engineering Resource Council; da Vinci Foundation; Biomechanigg Research Inc.	National Sciences and Engineering Resource Council; da Vinci Foundation; Biomechanigg Research Inc.	The project was supported by National Sciences and Engineering Resource Council, the da Vinci Foundation and the Biomechanigg Research Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaqtash M, 2011, IEEE ENG MED BIO, P453, DOI 10.1109/IEMBS.2011.6090063; Barton JG, 1997, GAIT POSTURE, V5, P28, DOI 10.1016/S0966-6362(96)01070-3; BATES BT, 1983, J BIOMECH, V16, P181, DOI 10.1016/0021-9290(83)90125-2; Begg R, 2005, J BIOMECH, V38, P401, DOI 10.1016/j.jbiomech.2004.05.002; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eskofier BM, 2011, COMPUT METHOD BIOMEC, P37; Gu SC, 2010, NEUROCOMPUTING, V73, P1669, DOI 10.1016/j.neucom.2009.09.021; Guidetti L, 1996, J ELECTROMYOGR KINES, V6, P37, DOI 10.1016/1050-6411(95)00015-1; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Janssen D, 2011, HUM MOVEMENT SCI, V30, P966, DOI 10.1016/j.humov.2010.08.010; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lozano-Ortiz CA, 2010, IEEE ENG MED BIO, P1413, DOI 10.1109/IEMBS.2010.5626715; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; Nigg BM, 2012, J BIOMECH, V45, P1692, DOI 10.1016/j.jbiomech.2012.03.027; RAMSEY J. O., 2005, FUNCTIONAL DATA ANAL; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; von Tscharner V, 2010, J ELECTROMYOGR KINES, V20, P676, DOI 10.1016/j.jelekin.2009.11.005; von Tscharner Vinzenz, 2009, J Electromyogr Kinesiol, V19, pe334, DOI 10.1016/j.jelekin.2008.07.001	26	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e65063	10.1371/journal.pone.0065063	http://dx.doi.org/10.1371/journal.pone.0065063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861736	gold, Green Published, Green Submitted			2022-12-25	WOS:000321692000003
J	Hukic, DS; Frisen, L; Backlund, L; Lavebratt, C; Landen, M; Traskman-Bendz, L; Edman, G; Schalling, M; Osby, U				Hukic, Dzana Sudic; Frisen, Louise; Backlund, Lena; Lavebratt, Catharina; Landen, Mikael; Traskman-Bendz, Lil; Edman, Gunnar; Schalling, Martin; Osby, Urban			Cognitive Manic Symptoms in Bipolar Disorder Associated with Polymorphisms in the DAOA and COMT Genes	PLOS ONE			English	Article							FACIAL EMOTION RECOGNITION; MAJOR DEPRESSIVE DISORDER; AMINO-ACID OXIDASE; WORKING-MEMORY; PREFRONTAL COGNITION; MOOD EPISODES; G72/G30 LOCUS; I DISORDER; SCHIZOPHRENIA; GENOTYPE	Introduction: Bipolar disorder is characterized by severe mood symptoms including major depressive and manic episodes. During manic episodes, many patients show cognitive dysfunction. Dopamine and glutamate are important for cognitive processing, thus the COMT and DAOA genes that modulate the expression of these neurotransmitters are of interest for studies of cognitive function. Methodology: Focusing on the most severe episode of mania, a factor was found with the combined symptoms of talkativeness, distractibility, and thought disorder, considered a cognitive manic symptoms (CMS) factor. 488 patients were genotyped, out of which 373 (76%) had talkativeness, 269 (55%) distractibility, and 372 (76%) thought disorder. 215 (44%) patients were positive for all three symptoms, thus showing CMS (Table 1). As population controls, 1,044 anonymous blood donors (ABD) were used. Case-case and case-control design models were used to investigate genetic associations between cognitive manic symptoms in bipolar 1 disorder and SNPs in the COMT and DAOA genes. Results: The finding of this study was that cognitive manic symptoms in patients with bipolar 1 disorder was associated with genetic variants in the DAOA and COMT genes. Nominal association for DAOA SNPs and COMT SNPs to cognitive symptoms factor in bipolar 1 disorder was found in both allelic (Table 2) and haplotypic (Table 3) analyses. Genotypic association analyses also supported our findings. However, only one association, when CMS patients were compared to ABD controls, survived correction for multiple testing by max (T) permutation. Data also suggested interaction between SNPs rs2391191 in DAOA and rs5993883 in COMT in the case-control model. Conclusion: Identifying genes associated with cognitive functioning has clinical implications for assessment of prognosis and progression. Our finding are consistent with other studies showing genetic associations between the COMT and DAOA genes and impaired cognition both in psychiatric disorders and in the general population.	[Hukic, Dzana Sudic; Backlund, Lena; Lavebratt, Catharina; Schalling, Martin; Osby, Urban] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden; [Hukic, Dzana Sudic; Lavebratt, Catharina; Schalling, Martin; Osby, Urban] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Hukic, Dzana Sudic; Edman, Gunnar; Osby, Urban] Tiohundra AB, Dept Psychiat, Norrtalje, Sweden; [Frisen, Louise; Backlund, Lena; Landen, Mikael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Landen, Mikael] Gothenburg Univ, Sahlgrenska Acad, Dept Neurosci & Psychol, S-41124 Gothenburg, Sweden; [Traskman-Bendz, Lil] Univ Lund Hosp, Dept Clin Sci, S-22185 Lund, Sweden; [Edman, Gunnar; Osby, Urban] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Family Med CeFam, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Gothenburg; Lund University; Skane University Hospital; Karolinska Institutet	Hukic, DS (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden.	dzana.hukic@ki.se	Schalling, Martin/F-1518-2015; Landen, Mikael/AAD-7917-2020	Schalling, Martin/0000-0001-5011-2922; Lavebratt, Catharina/0000-0003-4987-2718; Backlund, Lena/0000-0001-9399-5024	Karolinska Institutet; Swedish Research Council; Soderstrom-Konigska Foundation; Psychiatry Southwest, Stockholm; Stockholm County Council	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderstrom-Konigska Foundation; Psychiatry Southwest, Stockholm; Stockholm County Council(Stockholm County Council)	This project was supported by grants from Karolinska Institutet, the Swedish Research Council, the Soderstrom-Konigska Foundation, and Psychiatry Southwest, Stockholm. Financial support was also provided through the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2012, INT J PSYCHIAT CLIN; Andreou D, 2012, EUR ARCH PSY CLIN N, V262, P549, DOI 10.1007/s00406-012-0313-z; Backlund L, 2011, BIPOLAR DISORD, V13, P500, DOI 10.1111/j.1399-5618.2011.00952.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellgrove MA, 2005, EXP BRAIN RES, V163, P352, DOI 10.1007/s00221-004-2180-y; Burdick KE, 2010, ACTA PSYCHIAT SCAND, V122, P499, DOI 10.1111/j.1600-0447.2010.01590.x; Burnet PWJ, 2008, MOL PSYCHIATR, V13, P658, DOI 10.1038/mp.2008.47; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Chen YS, 2004, MOL PSYCHIATR, V9, P87, DOI 10.1038/sj.mp.4001453; Craddock N, 2001, BIPOLAR DISORD, V3, P284, DOI 10.1034/j.1399-5618.2001.30604.x; Craddock N, 2006, EUR J HUM GENET, V14, P660, DOI 10.1038/sj.ejhg.5201549; Dalvie S, 2010, AFR J PSYCHIATRY, V13, P297; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Rocca CCD, 2009, REV BRAS PSIQUIATR, V31, P171, DOI 10.1590/S1516-44462009000200015; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ekman CJ, 2010, ACTA PSYCHIAT SCAND, V122, P507, DOI 10.1111/j.1600-0447.2010.01586.x; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Gomez L, 2009, AM J MED GENET B, V150B, P1007, DOI 10.1002/ajmg.b.30904; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; Jiao HY, 2007, J NEUROCHEM, V103, P840, DOI 10.1111/j.1471-4159.2007.04840.x; Kirov G, 1998, MOL PSYCHIATR, V3, P342, DOI 10.1038/sj.mp.4000385; Korostishevsky M, 2004, BIOL PSYCHIAT, V56, P169, DOI 10.1016/j.biopsych.2004.04.006; KREMEN WS, 1994, SCHIZOPHRENIA BULL, V20, P103, DOI 10.1093/schbul/20.1.103; Lelli-Chiesa G, 2011, PSYCHOL MED, V41, P779, DOI 10.1017/S0033291710001431; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Maj M, 1998, AM J PSYCHIAT, V155, P30, DOI 10.1176/ajp.155.1.30; Malhotra AK, 1996, NEUROPSYCHOPHARMACOL, V14, P301, DOI 10.1016/0893-133X(95)00137-3; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; McCullumsmith RE, 2002, NEUROPSYCHOPHARMACOL, V26, P368, DOI 10.1016/S0893-133X(01)00370-0; Meador-Woodruff JH, 2001, BRAIN RES BULL, V55, P631, DOI 10.1016/S0361-9230(01)00523-8; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Muller DJ, 2011, BIPOLAR DISORD, V13, P198, DOI 10.1111/j.1399-5618.2011.00905.x; Nicodemus KK, 2007, HUM GENET, V120, P889, DOI 10.1007/s00439-006-0257-3; Niculescu AB, 2010, AM J MED GENET B, V153B, P847, DOI 10.1002/ajmg.b.31076; Nixon DC, 2011, BIOL PSYCHIAT, V69, P1006, DOI 10.1016/j.biopsych.2010.10.031; Palomino A, 2007, SCHIZOPHR RES, V95, P174, DOI 10.1016/j.schres.2007.06.012; Papolos DF, 1998, MOL PSYCHIATR, V3, P346, DOI 10.1038/sj.mp.4000410; Perlis RH, 2006, AM J PSYCHIAT, V163, P217, DOI 10.1176/appi.ajp.163.2.217; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schiffer HH, 2002, MOL NEUROBIOL, V25, P191, DOI 10.1385/MN:25:2:191; Schulze TG, 2005, AM J PSYCHIAT, V162, P2101, DOI 10.1176/appi.ajp.162.11.2101; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; Shifman S, 2004, AM J MED GENET B, V128B, P61, DOI 10.1002/ajmg.b.30032; Smoller Jordan W, 2007, Curr Psychiatry Rep, V9, P504, DOI 10.1007/s11920-007-0069-8; Soeiro-de-Souza MG, 2012, J AFFECT DISORDERS, V136, P370, DOI 10.1016/j.jad.2011.11.021; Sole B, 2011, ACTA PSYCHIAT SCAND; Soronen P, 2008, BIOL PSYCHIAT, V64, P438, DOI 10.1016/j.biopsych.2008.03.028; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; Williams NM, 2006, ARCH GEN PSYCHIAT, V63, P366, DOI 10.1001/archpsyc.63.4.366; Zou FG, 2005, SCHIZOPHR RES, V73, P257, DOI 10.1016/j.schres.2004.01.015	54	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67450	10.1371/journal.pone.0067450	http://dx.doi.org/10.1371/journal.pone.0067450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861766	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300015
J	Mugyenyi, CK; Elliott, SR; McCallum, FJ; Anders, RF; Marsh, K; Beeson, JG				Mugyenyi, Cleopatra K.; Elliott, Salenna R.; McCallum, Fiona J.; Anders, Robin F.; Marsh, Kevin; Beeson, James G.			Antibodies to Polymorphic Invasion-Inhibitory and Non-Inhibitory Epitopes of Plasmodium falciparum Apical Membrane Antigen 1 in Human Malaria	PLOS ONE			English	Article							VACCINE-CANDIDATE; CLINICAL MALARIA; ERYTHROCYTE INVASION; MEROZOITE ANTIGENS; IMMUNE-RESPONSES; AMA1; PROTECTION; TRANSMISSION; ASSOCIATION; CHILDREN	Background: Antibodies to P. falciparum apical membrane protein 1 (AMA1) may contribute to protective immunity against clinical malaria by inhibiting blood stage growth of P. falciparum, and AMA1 is a leading malaria vaccine candidate. Currently, there is limited knowledge of the acquisition of strain-specific and cross-reactive antibodies to AMA1 in humans, or the acquisition of invasion-inhibitory antibodies to AMA1. Methodology/Findings: We examined the acquisition of human antibodies to specific polymorphic invasion-inhibitory and non-inhibitory AMA1 epitopes, defined by the monoclonal antibodies 1F9 and 2C5, respectively. Naturally acquired antibodies were measured in cohorts of Kenyan children and adults. Antibodies to the invasion-inhibitory 1F9 epitope and non-inhibitory 2C5 epitope were measured indirectly by competition ELISA. Antibodies to the 1F9 and 2C5 epitopes were acquired by children and correlated with exposure, and higher antibody levels and prevalence were observed with increasing age and with active P. falciparum infection. Of note, the prevalence of antibodies to the inhibitory 1F9 epitope was lower than antibodies to AMA1 or the 2C5 epitope. Antibodies to AMA1 ectodomain, the 1F9 or 2C5 epitopes, or a combination of responses, showed some association with protection from P. falciparum malaria in a prospective longitudinal study. Furthermore, antibodies to the invasion-inhibitory 1F9 epitope were positively correlated with parasite growth-inhibitory activity of serum antibodies. Conclusions/Significance: Individuals acquire antibodies to functional, polymorphic epitopes of AMA1 that may contribute to protective immunity, and these findings have implications for AMA1 vaccine development. Measuring antibodies to the 1F9 epitope by competition ELISA may be a valuable approach to assessing human antibodies with invasion-inhibitory activity in studies of acquired immunity and vaccine trials of AMA1.	[Mugyenyi, Cleopatra K.; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med, Coast, Kilifi, Kenya; [Elliott, Salenna R.; Beeson, James G.] Burnet Inst, Melbourne, Vic, Australia; [McCallum, Fiona J.; Beeson, James G.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Anders, Robin F.] La Trobe Univ, Bundoora, Vic 3086, Australia; [Beeson, James G.] Monash Univ, Clayton, Vic 3800, Australia	Kenya Medical Research Institute; Burnet Institute; Walter & Eliza Hall Institute; La Trobe University; Monash University	Beeson, JG (corresponding author), Burnet Inst, Melbourne, Vic, Australia.	beeson@burnet.edu.au		Anders, Robin/0000-0002-0693-4547	Wellcome Trust, UK; National Health and Medical Research Council of Australia; Australian Research Council; Victorian State Government Operational Infrastructure; PATH Malaria Vaccine Initiative; US Agency for International Development	Wellcome Trust, UK(Wellcome Trust); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian State Government Operational Infrastructure; PATH Malaria Vaccine Initiative; US Agency for International Development(United States Agency for International Development (USAID))	Funding was provided by the Wellcome Trust, UK (project grant; http://www.wellcome.ac.uk/); National Health and Medical Research Council of Australia (project grant; Infrastructure for Research Institutes Support Scheme grant; http://www.nhmrc.gov.au/); Australian Research Council (Future Fellowship to JB; http://www.arc.gov.au/); Victorian State Government Operational Infrastructure Support grant (http://www.vic.gov.au/); PATH Malaria Vaccine Initiative (http://www.malariavaccine.org/); and US Agency for International Development (http://www.usaid.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Chelimo K, 2005, PEDIATR INFECT DIS J, V24, P680, DOI 10.1097/01.inf.0000172151.28851.fd; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Coley AM, 2001, PROTEIN ENG, V14, P691, DOI 10.1093/protein/14.9.691; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Drew DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051023; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Johnson AH, 2004, INFECT IMMUN, V72, P2762, DOI 10.1128/IAI.72.5.2762-2771.2004; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Mackintosh CL, 2008, INT J PARASITOL, V38, P1445, DOI 10.1016/j.ijpara.2008.03.009; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MBOGO CNM, 1995, AM J TROP MED HYG, V52, P201, DOI 10.4269/ajtmh.1995.52.201; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Ouattara A, 2013, J INFECT DIS, V207, P511, DOI 10.1093/infdis/jis709; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2003, GENETICS, V165, P555; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wilson S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-67	55	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68304	10.1371/journal.pone.0068304	http://dx.doi.org/10.1371/journal.pone.0068304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861883	Green Published, gold			2022-12-25	WOS:000321425300057
J	Carmean, CM; Bobe, AM; Yu, JC; Volden, PA; Brady, MJ				Carmean, Christopher M.; Bobe, Alexandria M.; Yu, Justin C.; Volden, Paul A.; Brady, Matthew J.			Refeeding-Induced Brown Adipose Tissue Glycogen Hyper-Accumulation in Mice Is Mediated by Insulin and Catecholamines	PLOS ONE			English	Article							COLD-EXPOSURE; NOREPINEPHRINE TURNOVER; ENERGY-EXPENDITURE; METABOLIC SYNDROME; FAT THERMOGENESIS; SKELETAL-MUSCLE; GLUCOSE; RATS; RESISTANCE; OBESITY	Brown adipose tissue (BAT) generates heat during adaptive thermogenesis through a combination of oxidative metabolism and uncoupling protein 1-mediated electron transport chain uncoupling, using both free-fatty acids and glucose as substrate. Previous rat-based work in 1942 showed that prolonged partial fasting followed by refeeding led to a dramatic, transient increase in glycogen stores in multiple fat depots. In the present study, the protocol was replicated in male CD1 mice, resulting in a 2000-fold increase in interscapular BAT (IBAT) glycogen levels within 4-12 hours (hr) of refeeding, with IBAT glycogen stores reaching levels comparable to fed liver glycogen. Lesser effects occurred in white adipose tissues (WAT). Over the next 36 hr, glycogen levels dissipated and histological analysis revealed an over-accumulation of lipid droplets, suggesting a potential metabolic connection between glycogenolysis and lipid synthesis. 24 hr of total starvation followed by refeeding induced a robust and consistent glycogen over-accumulation similar in magnitude and time course to the prolonged partial fast. Experimentation demonstrated that hyperglycemia was not sufficient to drive glycogen accumulation in IBAT, but that elevated circulating insulin was sufficient. Additionally, pharmacological inhibition of catecholamine production reduced refeeding-induced IBAT glycogen storage, providing evidence of a contribution from the central nervous system. These findings highlight IBAT as a tissue that integrates both canonically-anabolic and catabolic stimulation for the promotion of glycogen storage during recovery from caloric deficit. The preservation of this robust response through many generations of animals not subjected to food deprivation suggests that the over-accumulation phenomenon plays a critical role in IBAT physiology.	[Carmean, Christopher M.; Bobe, Alexandria M.; Volden, Paul A.; Brady, Matthew J.] Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA; [Yu, Justin C.; Brady, Matthew J.] Univ Chicago, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Brady, MJ (corresponding author), Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA.	mbrady1@uchicago.edu			National Institutes of Health [RO1-DK064772, P60-DK020595]; Kovler Diabetes Center Leadership Board Studentship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064772, P60DK020595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kovler Diabetes Center Leadership Board Studentship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health RO1-DK064772, P60-DK020595, and the Kovler Diabetes Center Leadership Board Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNUM CP, 1958, AM J PHYSIOL, V195, P301, DOI 10.1152/ajplegacy.1958.195.2.301; BARRETT EJ, 1994, METABOLISM, V43, P285, DOI 10.1016/0026-0495(94)90094-9; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493; Burcelin R, 2000, DIABETES, V49, P1635, DOI 10.2337/diabetes.49.10.1635; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2012, NATURE, V488, P286, DOI 10.1038/488286a; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Cettour-Rose P, 2005, DIABETES, V54, P751, DOI 10.2337/diabetes.54.3.751; Cinti S, 2011, ANN MED, V43, P104, DOI 10.3109/07853890.2010.535557; DESAUTELS M, 1988, AM J PHYSIOL, V255, pE120, DOI 10.1152/ajpendo.1988.255.2.E120; DULLOO AG, 1990, AM J CLIN NUTR, V52, P415, DOI 10.1093/ajcn/52.3.415; Farkas V, 1999, ARCH BIOCHEM BIOPHYS, V365, P54, DOI 10.1006/abbi.1999.1157; FAWCETT DW, 1948, ENDOCRINOLOGY, V42, P454, DOI 10.1210/endo-42-6-454; FAWCETT DW, 1949, ENDOCRINOLOGY, V45, P609, DOI 10.1210/endo-45-6-609; FELIPE A, 1990, BIOCHEM INT, V21, P537; FOSTER DO, 1980, CAN J PHYSIOL PHARM, V58, P915, DOI 10.1139/y80-140; FOSTER DO, 1982, CAN J PHYSIOL PHARM, V60, P747, DOI 10.1139/y82-104; GLICK Z, 1989, PHYSIOL BEHAV, V45, P243, DOI 10.1016/0031-9384(89)90125-X; GLICK Z, 1985, AM J PHYSIOL, V249, pE519, DOI 10.1152/ajpendo.1985.249.5.E519; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; HOLNESS MJ, 1991, BIOCHEM J, V277, P429, DOI 10.1042/bj2770429; IGUCHI A, 1989, METABOLISM, V38, P1216, DOI 10.1016/0026-0495(89)90162-5; Jakus PB, 2008, J LIPID RES, V49, P332, DOI 10.1194/jlr.M700316-JLR200; Jurczak MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE952, DOI 10.1152/ajpendo.00559.2006; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Karhunen LJ, 2008, REGUL PEPTIDES, V149, P70, DOI 10.1016/j.regpep.2007.10.008; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kochan Z, 1997, METABOLISM, V46, P10, DOI 10.1016/S0026-0495(97)90160-8; LEVIN BE, 1995, AM J PHYSIOL-REG I, V268, pR389, DOI 10.1152/ajpregu.1995.268.2.R389; MCCORMACK JG, 1983, PROG LIPID RES, V21, P195, DOI 10.1016/0163-7827(82)90009-1; Mounien L, 2010, FASEB J, V24, P1747, DOI 10.1096/fj.09-144923; MURALIDHARA DV, 1994, AM J PHYSIOL, V266, pR1907; Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Robin JP, 2008, J NUTR, V138, P861, DOI 10.1093/jn/138.5.861; RODIN J, 1990, INT J OBESITY, V14, P303; Saha PK, 2004, J BIOL CHEM, V279, P35150, DOI 10.1074/jbc.M405499200; SHACKNEY SE, 1966, J BIOL CHEM, V241, P4004; SHIBATA H, 1989, AM J PHYSIOL, V257, pR96, DOI 10.1152/ajpregu.1989.257.1.R96; SHIKAMA H, 1978, AM J PHYSIOL, V235, pE354, DOI 10.1152/ajpendo.1978.235.4.E354; SIDMAN RL, 1954, ANAT RECORD, V118, P487, DOI 10.1002/ar.1091180303; SIDMAN RL, 1956, ANAT REC, V124, P723, DOI 10.1002/ar.1091240408; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Stephens M, 2011, CLIN ENDOCRINOL, V74, P661, DOI 10.1111/j.1365-2265.2011.04018.x; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; Swoap SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004038; Teruel T, 1996, BIOCHEM J, V319, P627, DOI 10.1042/bj3190627; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; TUERKISCHER E, 1946, J PHYSIOL-LONDON, V104, P361, DOI 10.1113/jphysiol.1946.sp004128; Tuerkischer E, 1942, J PHYSIOL-LONDON, V100, P385, DOI 10.1113/jphysiol.1942.sp003950; Ugleholdt R, 2011, DAN MED BULL, V58; Vaughan CH, 2012, AM J PHYSIOL-REG I, V302, pR1049, DOI 10.1152/ajpregu.00640.2011; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; WERTHEIMER E, 1945, J PHYSIOL-LONDON, V103, P359, DOI 10.1113/jphysiol.1945.sp004084; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037103	59	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67807	10.1371/journal.pone.0067807	http://dx.doi.org/10.1371/journal.pone.0067807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861810	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700038
J	Leotoing, L; Wauquier, F; Guicheux, J; Miot-Noirault, E; Wittrant, Y; Coxam, V				Leotoing, Laurent; Wauquier, Fabien; Guicheux, Jerome; Miot-Noirault, Elisabeth; Wittrant, Yohann; Coxam, Veronique			The Polyphenol Fisetin Protects Bone by Repressing NF-kappa B and MKP-1-Dependent Signaling Pathways in Osteoclasts	PLOS ONE			English	Article							RECEPTOR ACTIVATOR; CELL-PROLIFERATION; IN-VIVO; DIFFERENTIATION; INFLAMMATION; RANKL; EXPRESSION; FLAVONOIDS; INHIBITOR; DISEASE	Osteoporosis is a bone pathology leading to increase fractures risk and challenging quality of life. Since current treatments could exhibit deleterious side effects, the use of food compounds derived from plants represents a promising innovative alternative due to their potential therapeutic and preventive activities against human diseases. In this study, we investigated the ability of the polyphenol fisetin to counter osteoporosis and analyzed the cellular and molecular mechanisms involved. In vivo, fisetin consumption significantly prevented bone loss in estrogen deficiency and inflammation mice osteoporosis models. Indeed, bone mineral density, micro-architecture parameters and bone markers were positively modulated by fisetin. Consistent with in vivo results, we showed that fisetin represses RANKL-induced osteoclast differentiation and activity as demonstrated by an inhibition of multinucleated cells formation, TRAP activity and differentiation genes expression. The signaling pathways NF-kappa B, p38 MAPK, JNK and the key transcription factors c-Fos and NFATc1 expressions induced by RANKL, were negatively regulated by fisetin. We further showed that fisetin inhibits the constitutive proteasomal degradation of MKP-1, the phosphatase that deactivates p38 and JNK. Consistently, using shRNA stable cell lines, we demonstrated that impairment of MKP-1 decreases fisetin potency. Taken together, these results strongly support that fisetin should be further considered as a bone protective agent.	[Leotoing, Laurent; Wauquier, Fabien; Miot-Noirault, Elisabeth; Wittrant, Yohann; Coxam, Veronique] Clermont Univ, Univ Auvergne, Clermont Ferrand, France; [Leotoing, Laurent; Wauquier, Fabien; Wittrant, Yohann; Coxam, Veronique] INRA, UMR 1019, Unite Nutr Humaine, CRNH Auvergne, Clermont Ferrand, France; [Guicheux, Jerome] Univ Nantes, UFR Odontol, Nantes, France; [Guicheux, Jerome] NSERM, UMRS 791, LIOAD, Nantes, France; [Miot-Noirault, Elisabeth] INSERM, UMR 990, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Coxam, V (corresponding author), Clermont Univ, Univ Auvergne, Clermont Ferrand, France.	veronique.coxam@clermont.inra.fr	Miot-Noirault, Elisabeth/Y-2272-2019; guicheux, Jerome/F-7767-2013	guicheux, Jerome/0000-0003-2754-3024	FEDER (Fonds Europeens de Developpement Regional); Conseil Regional Auvergne through the network of Nutravita, a cluster of excellence in nutrition in Auvergne	FEDER (Fonds Europeens de Developpement Regional)(European Commission); Conseil Regional Auvergne through the network of Nutravita, a cluster of excellence in nutrition in Auvergne(Region Auvergne-Rhone-Alpes)	This work was supported by grants to L.L. from FEDER (Fonds Europeens de Developpement Regional) and Conseil Regional Auvergne through the network of Nutravita, a cluster of excellence in nutrition in Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arai Y, 2000, J NUTR, V130, P2243; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; BISKOBING DM, 1995, J BONE MINER RES, V10, P1025; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Breinholt V, 1998, CHEM RES TOXICOL, V11, P622, DOI 10.1021/tx970170y; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Brown K, 2009, MUTAGENESIS, V24, P391, DOI 10.1093/mutage/gep022; Carlson J, 2009, AM J PATHOL, V175, P1564, DOI 10.2353/ajpath.2009.090035; Chien CS, 2010, MOL CELL BIOCHEM, V333, P169, DOI 10.1007/s11010-009-0217-z; Choi SW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/810563; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Geraets L, 2009, BIOCHEM BIOPH RES CO, V382, P598, DOI 10.1016/j.bbrc.2009.03.071; Goh FY, 2012, EUR J PHARMACOL, V679, P109, DOI 10.1016/j.ejphar.2012.01.002; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Khan N, 2008, CANCER RES, V68, P8555, DOI 10.1158/0008-5472.CAN-08-0240; Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027; Lawan A, 2012, CELL MOL LIFE SCI; Lee JD, 2009, INT IMMUNOPHARMACOL, V9, P268, DOI 10.1016/j.intimp.2008.11.005; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Leotoing L, 2011, J BIOL CHEM, V286, P32277, DOI 10.1074/jbc.M111.236448; Liu SH, 2010, J AGR FOOD CHEM; Mahalingam CD, 2011, J ENDOCRINOL, V211, P145, DOI 10.1530/JOE-11-0144; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Rizzoli Rene, 2011, Expert Rev Clin Pharmacol, V4, P593; Sakai E, 2013, J PHARMACOL SCI, V121, P288, DOI 10.1254/jphs.12243FP; Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wancket LM, 2012, LIFE SCI, V90, P237, DOI 10.1016/j.lfs.2011.11.017; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; Zand RSR, 2000, BREAST CANCER RES TR, V62, P35, DOI 10.1023/A:1006422302173	47	48	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68388	10.1371/journal.pone.0068388	http://dx.doi.org/10.1371/journal.pone.0068388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861901	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700085
J	Rocha, FL; Roque, ALR; de Lima, JS; Cheida, CC; Lemos, FG; de Azevedo, FC; Arrais, RC; Bilac, D; Herrera, HM; Mourao, G; Jansen, AM				Rocha, Fabiana Lopes; Rodrigues Roque, Andre Luiz; de Lima, Juliane Saab; Cheida, Carolina Carvalho; Lemos, Frederico Gemesio; de Azevedo, Fernanda Cavalcanti; Arrais, Ricardo Corassa; Bilac, Daniele; Herrera, Heitor Miraglia; Mourao, Guilherme; Jansen, Ana Maria			Trypanosoma cruzi Infection in Neotropical Wild Carnivores (Mammalia: Carnivora): At the Top of the T-cruzi Transmission Chain	PLOS ONE			English	Article							COATI NASUA-NASUA; TRIATOMINE BUGS; CHAGAS-DISEASE; EVANSI KINETOPLASTIDA; ORAL-TRANSMISSION; PANTANAL REGION; AMAZON BASIN; MANED WOLF; RESERVOIR; RANGELI	Little is known on the role played by Neotropical wild carnivores in the Trypanosoma cruzi transmission cycles. We investigated T. cruzi infection in wild carnivores from three sites in Brazil through parasitological and serological tests. The seven carnivore species examined were infected by T. cruzi, but high parasitemias detectable by hemoculture were found only in two Procyonidae species. Genotyping by Mini-exon gene, PCR-RFLP (1f8/Akw21I) and kDNA genomic targets revealed that the raccoon (Procyon cancrivorus) harbored TcI and the coatis (Nasua nasua) harbored TcI, TcII, TcIII-IV and Trypanosoma rangeli, in single and mixed infections, besides four T. cruzi isolates that displayed odd band patterns in the Mini-exon assay. These findings corroborate the coati can be a bioaccumulator of T. cruzi Discrete Typing Units (DTU) and may act as a transmission hub, a connection point joining sylvatic transmission cycles within terrestrial and arboreal mammals and vectors. Also, the odd band patterns observed in coatis' isolates reinforce that T. cruzi diversity might be much higher than currently acknowledged. Additionally, we assembled our data with T. cruzi infection on Neotropical carnivores' literature records to provide a comprehensive analysis of the infection patterns among distinct carnivore species, especially considering their ecological traits and phylogeny. Altogether, fifteen Neotropical carnivore species were found naturally infected by T. cruzi. Species diet was associated with T. cruzi infection rates, supporting the hypothesis that predator-prey links are important mechanisms for T. cruzi maintenance and dispersion in the wild. Distinct T. cruzi infection patterns across carnivore species and study sites were notable. Musteloidea species consistently exhibit high parasitemias in different studies which indicate their high infectivity potential. Mesocarnivores that feed on both invertebrates and mammals, including the coati, a host that can be bioaccumulator of T. cruzi DTU's, seem to take place at the top of the T. cruzi transmission chain.	[Rocha, Fabiana Lopes; Rodrigues Roque, Andre Luiz; Bilac, Daniele; Jansen, Ana Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil; [Rocha, Fabiana Lopes] TRIADE, Inst Brasileiro Med Conservacao, Recife, PE, Brazil; [Rocha, Fabiana Lopes; Lemos, Frederico Gemesio; de Azevedo, Fernanda Cavalcanti; Arrais, Ricardo Corassa] PCMC, Araguari, MG, Brazil; [de Lima, Juliane Saab] Univ Fed Mato Grosso do Sul, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil; [Cheida, Carolina Carvalho] Inst Pesquisas Cananeia IPeC, Programa Pesquisa Vida Selvagem, Projeto Carnivoros, Sao Paulo, Brazil; [Lemos, Frederico Gemesio] UFG, Dept Ciencias Biol, Catalao, Go, Brazil; [Arrais, Ricardo Corassa] Univ Sao Paulo, Dept Med Prevent & Saude Anim, Sao Paulo, Brazil; [Herrera, Heitor Miraglia] Univ Catolica Dom Bosco, Campo Grande, MS, Brazil; [Mourao, Guilherme] Embrapa Pantanal, Lab Vida Selvagem, Empresa Brasileira Pesquisa Agr, Corumba, MS, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade Catolica Dom Bosco (UCDB); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Jansen, AM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil.	jansen@ioc.fiocruz.br	Roque, André Luiz Rodrigues/W-7528-2019; Azevedo, Fernanda/AAB-4277-2019; Rocha, Fabiana/J-5471-2015; Mourão, Guilherme M/C-3319-2013; Azevedo, Fernanda Cavalcanti/J-1734-2014; Herrera, Heitor Miraglia/K-3759-2012; Lemos, Frederico Gemesio/G-1991-2014	Azevedo, Fernanda/0000-0002-2424-6860; Mourão, Guilherme M/0000-0002-8300-4191; Azevedo, Fernanda Cavalcanti/0000-0002-2424-6860; Herrera, Heitor Miraglia/0000-0003-2404-8765; Lemos, Frederico Gemesio/0000-0002-3027-5713; Rocha, Fabiana Lopes/0000-0003-0819-6290; Roque, Andre/0000-0002-8740-052X; Jansen, Ana Maria/0000-0001-5804-6210	ChagasEpiNet [223034]; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) [9777.256.476.13022008]; National Research Center for the Conservation of Natural Predators - CENAP/ICMBio; Wildlife Conservation Society [OWOH 2008_001]; Consorcio Capim Branco de Energia; CNPq Edital Universal [014/2008]; PDJ-CNPq [150608/2013-6]; Smithsonian Institution; Neotropical Grassland Conservancy; Idea Wild. U.S. Fish and Wildlife Service; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	ChagasEpiNet; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); National Research Center for the Conservation of Natural Predators - CENAP/ICMBio; Wildlife Conservation Society; Consorcio Capim Branco de Energia; CNPq Edital Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PDJ-CNPq; Smithsonian Institution(Smithsonian Institution); Neotropical Grassland Conservancy; Idea Wild. U.S. Fish and Wildlife Service; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by ChagasEpiNet 223034. Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) - 9777.256.476.13022008. National Research Center for the Conservation of Natural Predators - CENAP/ICMBio. Wildlife Conservation Society - OWOH 2008_001. Consorcio Capim Branco de Energia. CNPq Edital Universal 014/2008. PDJ-CNPq 150608/2013-6. Smithsonian Institution. Neotropical Grassland Conservancy. Idea Wild. U.S. Fish and Wildlife Service. A doctoral grant was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to FLR and CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; Albuquerque R D, 1968, Rev Bras Biol, V28, P457; ALBUQUERQUE R D R, 1970, Revista do Instituto de Medicina Tropical de Sao Paulo, V12, P375; Alho Cleber J.R., 2012, Animals, V2, P591, DOI 10.3390/ani2040591; Aliaga C, 2011, INFECT GENET EVOL, V11, P1155, DOI 10.1016/j.meegid.2010.11.013; Alves FM, 2011, VECTOR-BORNE ZOONOT, V11, P835, DOI 10.1089/vbz.2010.0096; [Anonymous], 2002, WHO TECHN REP SER; Araujo CAC, 2011, EXP PARASITOL, V127, P308, DOI 10.1016/j.exppara.2010.07.013; BARRETTO M P, 1972, Revista Brasileira de Biologia, V32, P413; Barretto M. P, 1971, Revta Inst Med trop S Paulo, V13, P346; BARRETTO M P, 1970, Revista Brasileira de Biologia, V30, P431; Barretto M.P., 1979, Revista do Instituto Adolfo Lutz, V39, P25; Bianchi RC, 2009, THESIS FEDERAL U MAT; Brown EL, 2010, VECTOR-BORNE ZOONOT, V10, P757, DOI 10.1089/vbz.2009.0009; CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227; Cardinal MV, 2008, INT J PARASITOL, V38, P1533, DOI 10.1016/j.ijpara.2008.04.010; Ceballos LA, 2006, ACTA TROP, V98, P286, DOI 10.1016/j.actatropica.2006.06.003; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Courtenay O, 2006, J ZOOL, V268, P45, DOI 10.1111/j.1469-7998.2005.00021.x; Ramirez JD, 2012, INFECT GENET EVOL, V12, P1743, DOI 10.1016/j.meegid.2012.06.018; DAVIS DS, 1980, J WILDLIFE DIS, V16, P403, DOI 10.7589/0090-3558-16.3.403; Deane L. M., 1964, Revista Brasileira de Malariologia, V16, P27; DEANE LEONIDAS M., 1961, REV INST MED TROP SAO PAULO, V3, P15; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Dray S, 2007, J STAT SOFTW, V22, P120; Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5; FERRIOLLI F JR, 1968, Revista do Instituto de Medicina Tropical de Sao Paulo, V10, P354; Gaunt M, 2000, MEM I OSWALDO CRUZ, V95, P557, DOI 10.1590/S0074-02762000000400019; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Herrera HM, 2008, T ROY SOC TROP MED H, V102, P1133, DOI 10.1016/j.trstmh.2008.04.041; Herrera HM, 2011, T ROY SOC TROP MED H, V105, P380, DOI 10.1016/j.trstmh.2011.04.008; Hirsch BT, 2011, MAMMALIA, V75, P301, DOI 10.1515/MAMM.2011.030; Hirsch BT, 2011, MOL ECOL, V20, P409, DOI 10.1111/j.1365-294X.2010.04940.x; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; IBAMA, 2005, PLAN MAN PARQ NAC SE, P1; Jacomo ATDA, 2004, J ZOOL, V262, P99; Jansen AM, 2010, ELSEV INSIGHT, P249, DOI 10.1016/B978-0-12-384876-5.00011-3; Jean Desbiez Arnaud Leonard, 2010, Small Carnivore Conservation, V42, P14; Desbiez ALJ, 2010, BIOTROPICA, V42, P372, DOI 10.1111/j.1744-7429.2009.00601.x; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; LAINSON R, 1979, T ROY SOC TROP MED H, V73, P193, DOI 10.1016/0035-9203(79)90211-6; Lemos F.G., 2011, MIDDLE SIZED CARNIVO, P143; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Lisboa CV, 2009, VET PARASITOL, V165, P19, DOI 10.1016/j.vetpar.2009.07.002; Machado EMM, 2001, AM J TROP MED HYG, V65, P958, DOI 10.4269/ajtmh.2001.65.958; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Martinelli M. M., 2010, NATUREZA LINE, V8, P150; Martins R, 2008, REV BRAS ZOOL, V25, P427, DOI 10.1590/S0101-81752008000300007; Mazza S, 1940, MISION ESTUD PATOL R, V45, P119; Mendes PC, 2008, HYGEIA REV BRAS GEO, V3, P176; MILES MA, 1981, T ROY SOC TROP MED H, V75, P667, DOI 10.1016/0035-9203(81)90145-0; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Mortara Renato A., 2008, V47, P101; NEGHME A, 1962, AN C INT DOENCA CHAG, V3, P1069; Noireau F, 2009, VET RES, V40, DOI 10.1051/vetres/2009009; Nowak R. M., 2005, WALKERS CARNIVORES W; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Perez E, 2013, INFECT GENET EVOL, V13, P116, DOI 10.1016/j.meegid.2012.09.014; PIETROKOVSKY SM, 1991, J PARASITOL, V77, P643, DOI 10.2307/3283177; Queirolo D, 2007, ACTA THERIOL, V52, P391, DOI 10.1007/BF03194237; Rademaker V, 2009, ACTA TROP, V111, P102, DOI 10.1016/j.actatropica.2009.02.006; Rocha FL, 2013, PARASITOLOGY, V140, P160, DOI 10.1017/S0031182012001539; Roellig DM, 2010, PARASITOLOGY, V137, P959, DOI 10.1017/S0031182009991995; Roellig DM, 2009, INT J PARASITOL, V39, P1603, DOI 10.1016/j.ijpara.2009.06.007; Roellig DM, 2009, J PARASITOL, V95, P360, DOI 10.1645/GE-1740.1; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Rozas M, 2007, AM J TROP MED HYG, V77, P647, DOI 10.4269/ajtmh.2007.77.647; Rozas M, 2007, J INFECT DIS, V195, P1381, DOI 10.1086/513440; Sano EE, 2010, ENVIRON MONIT ASSESS, V166, P113, DOI 10.1007/s10661-009-0988-4; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Thioulouse J, 1995, ENVIRON ECOL STAT, V2, P1, DOI 10.1007/BF00452928; Thomas ME, 2007, MEM I OSWALDO CRUZ, V102, P559, DOI 10.1590/S0074-02762007005000068; Tibayrenc M, 2010, ADV EXP MED BIOL, V673, P200; Toso A, 2011, REV MED CHILE, V139, P258, DOI /S0034-98872011000200017; TRAVI BL, 1994, AM J TROP MED HYG, V50, P557, DOI 10.4269/ajtmh.1994.50.557; Vallejo GA, 1999, ACTA TROP, V72, P203, DOI 10.1016/S0001-706X(98)00085-0; Vynne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028939; Whiting D'Andurain Carlos, 1946, REV CHILENA HIG Y MED PREVENT, V8, P69; WISNIVESKYCOLLI C, 1992, T ROY SOC TROP MED H, V86, P38, DOI 10.1016/0035-9203(92)90433-D; Yoshida N, 2011, TRENDS PARASITOL, V27, P459, DOI 10.1016/j.pt.2011.06.006; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	86	57	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67463	10.1371/journal.pone.0067463	http://dx.doi.org/10.1371/journal.pone.0067463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861767	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700015
J	Tremmel, DM; Resad, S; Little, CJ; Wesley, CS				Tremmel, Daniel M.; Resad, Sedat; Little, Christopher J.; Wesley, Cedric S.			Notch and PKC Are Involved in Formation of the Lateral Region of the Dorso-Ventral Axis in Drosophila Embryos	PLOS ONE			English	Article							PROTEIN-KINASE-C; TOLL-LIKE RECEPTORS; CELL-FATE; LIGAND ENDOCYTOSIS; DOWN-REGULATION; NUCLEAR ACCESS; CROSS-TALK; GERM-LINE; DELTA; CACTUS	The Notch gene encodes an evolutionarily conserved cell surface receptor that generates regulatory signals based on interactions between neighboring cells. In Drosophila embryos it is normally expressed at a low level due to strong negative regulation. When this negative regulation is abrogated neurogenesis in the ventral region is suppressed, the development of lateral epidermis is severely disrupted, and the dorsal aminoserosa is expanded. Of these phenotypes only the antineurogenic phenotype could be linked to excess canonical Notch signaling. The other phenotypes were linked to high levels of Notch protein expression at the surface of cells in the lateral regions indicating that a non-canonical Notch signaling activity normally functions in these regions. Results of our studies reported here provide evidence. They show that Notch activities are inextricably linked to that of Pkc98E, the homolog of mammalian PKC delta. Notch and Pkc98E up-regulate the levels of the phosphorylated form of I kappa BCactus, a negative regulator of Toll signaling, and Mothers against dpp (MAD), an effector of Dpp signaling. Our data suggest that in the lateral regions of the Drosophila embryos Notch activity, in conjunction with Pkc98E activity, is used to form the slopes of the opposing gradients of Toll and Dpp signaling that specify cell fates along the dorso-ventral axis.	[Wesley, Cedric S.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wesley, CS (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	cswesley@wisc.edu		Tremmel, Daniel/0000-0002-1725-5582	NIH [1 R21 HD062928]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by NIH 1 R21 HD062928 (to CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsadik A, 2011, HUM IMMUNOL, V72, P1188, DOI 10.1016/j.humimm.2011.08.015; Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ASHBURNER M, 2004, DROSOPHHILA LAB HDB, P1409; Baker R, 1996, DEVELOPMENT, V122, P617; Bardin AJ, 2006, DEV CELL, V10, P245, DOI 10.1016/j.devcel.2005.12.017; Bardot B, 2005, EXP CELL RES, V304, P202, DOI 10.1016/j.yexcr.2004.10.030; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Brennan K, 1997, GENETICS, V147, P177; Bynagari-Settipalli Yamini S., 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P292; CABRERA CV, 1990, DEVELOPMENT, V110, P733; CAMPOSORTEGA JA, 1997, EMBRYONIC DEV DROSOP, P405; Chanut-Delalande H, 2006, PLOS BIOL; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Cowden J, 2002, DEVELOPMENT, V129, P1785; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Dansereau DA, 2002, DEVELOPMENT, V129, P5553, DOI 10.1242/dev.00153; Dasu MR, 2012, CLIN SCI, V122, P203, DOI 10.1042/CS20110357; de Barry J, 2010, EXP GERONTOL, V45, P64, DOI 10.1016/j.exger.2009.10.015; DECELIS JF, 1994, MECH DEVELOP, V46, P109, DOI 10.1016/0925-4773(94)90080-9; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fernandez NQ, 2001, DEVELOPMENT, V128, P2963; Fischer DF, 2005, FASEB J, V19, P1451, DOI 10.1096/fj.04-3395.com; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Gho M, 1996, DEVELOPMENT, V122, P1673; GOVIND S, 1993, DEVELOPMENT, V117, P135; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Harlow E., 1999, USING ANTIBODIES LAB; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Heitzler P, 2010, CURR TOP DEV BIOL, V92, P457, DOI 10.1016/S0070-2153(10)92014-0; Hertzog P, 2008, IMMUNITY, V29, P663, DOI 10.1016/j.immuni.2008.10.006; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Lall S, 2001, ANNU REV GENET, V35, P407, DOI 10.1146/annurev.genet.35.102401.090832; Langdon T, 2006, DEV DYNAM, V235, P998, DOI 10.1002/dvdy.20735; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; LeComte M, 2006, DEV DYNAM, V235, P411, DOI 10.1002/dvdy.20650; Lee MR, 2008, EXPERT OPIN THER TAR, V12, P535, DOI 10.1517/14728222.12.5.535 ; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; LYMAN D, 1993, P NATL ACAD SCI USA, V90, P10395, DOI 10.1073/pnas.90.21.10395; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Mok LP, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-6; Morel V, 2000, GENE DEV, V14, P377; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Muir A, 2011, J BIOL CHEM, V286, P41905, DOI 10.1074/jbc.R111.299768; Munger JS, 2011, COLD SPRING HARB PER, V3, P1; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Parks AL, 2000, DEVELOPMENT, V127, P1373; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pear WS, 2004, CURR OPIN HEMATOL, V11, P426, DOI 10.1097/01.moh.0000143965.90813.70; Poulson DF, 1937, P NATL ACAD SCI USA, V23, P133, DOI 10.1073/pnas.23.3.133; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; ROSENTHAL A, 1987, EMBO J, V6, P433, DOI 10.1002/j.1460-2075.1987.tb04773.x; Roth S, 2003, PHILOS T ROY SOC B, V358, P1317, DOI 10.1098/rstb.2003.1325; ROTH S, 1991, DEVELOPMENT, V112, P371; Roth S, 2001, CURR BIOL, V11, pR779, DOI 10.1016/S0960-9822(01)00469-9; Sambrook J, 2001, MOL CLONING LAB MANU; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shepherd A, 2010, DEV DYNAM, V239, P1220, DOI 10.1002/dvdy.22262; Shepherd AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008063; Shieh BH, 2002, J BIOCHEM, V132, P523, DOI 10.1093/oxfordjournals.jbchem.a003252; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Spector D. L., 1998, CELLS LAB MANUAL; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Suhir H, 2010, CLIN REV ALLERG IMMU, V38, P11, DOI 10.1007/s12016-009-8135-0; Sullivan W, 2000, DROSOPHILA PROTOCOLS, P697; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Torres IL, 2003, DEV CELL, V5, P547, DOI 10.1016/S1534-5807(03)00272-7; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Vallejo JG, 2011, CLIN SCI, V121, P1, DOI 10.1042/CS20100539; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Wesley CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021876; Wesley CS, 1999, MOL CELL BIOL, V19, P5743; Wesley CS, 2003, MOL CELL BIOL, V23, P5581, DOI 10.1128/MCB.23.16.5581-5593.2003; Wesley CS, 2000, J BIOL CHEM, V275, P9099, DOI 10.1074/jbc.275.13.9099; Wesley CS, 2000, J CELL BIOL, V149, P683, DOI 10.1083/jcb.149.3.683; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Wilkin MB, 2005, MOL MEMBR BIOL, V22, P279, DOI 10.1080/09687860500129778; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	110	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67789	10.1371/journal.pone.0067789	http://dx.doi.org/10.1371/journal.pone.0067789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861806	Green Submitted, gold, Green Published			2022-12-25	WOS:000323350700036
J	Vargas-Ortiz, E; Espitia-Rangel, E; Tiessen, A; Delano-Frier, JP				Vargas-Ortiz, Erandi; Espitia-Rangel, Eduardo; Tiessen, Axel; Paul Delano-Frier, John			Grain Amaranths Are Defoliation Tolerant Crop Species Capable of Utilizing Stem and Root Carbohydrate Reserves to Sustain Vegetative and Reproductive Growth after Leaf Loss	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; CHENOPODIUM-RUBRUM; BIOMASS ALLOCATION; MECHANICAL INJURY; NICOTIANA-TABACUM; DROUGHT TOLERANCE; SUCROSE SYNTHASE; STARCH SYNTHESIS; PLANT TOLERANCE; POTATO-TUBERS	Tolerance to defoliation can be defined as the degree to which productivity is affected by photosynthetic area reduction. This trait was studied in grain amaranth (Amaranthus cruentus and A. hypochondriacus), which are considered to be a highly defoliation-tolerant species. The physiological and biochemical responses to increasing levels of mechanical leaf removal up to total defoliation were quantified. Tolerance appeared to be dependent on various factors: (i) amount of lost tissue; (ii) mechanics of leaf tissue removal; (iii) environment, and (iv) species tested. Thus, grain amaranth was found to be a highly tolerant species under green-house conditions when leaf tissue loss was performed by gradual perforation. However, tolerance was compromised under similar conditions when defoliation was done by gradual cutting of the leaf. Also tolerance in completely defoliated plants tended to decrease under field conditions, where differences between A. cruentus and A. hypochondriacus were observed. All non-structural carbohydrate (NSC) levels were reduced in stems and roots of totally defoliated amaranths one day after treatment. Such depletion probably provided the carbon (C) resources needed to sustain the early recovery process in the absence of photosynthetic capacity. This was corroborated by shading of intact plants, which produced the same rapid and drastic reduction of NSC levels in these tissues. These results emphasize the role of stored NSCs, particularly starch, in buffering the impact of severe defoliation in amaranth. The fall in sucrose synthase and cell wall invertase activity observed in stems and roots soon after defoliation was consistent with their predicted shift from sink to source tissues. It is concluded that mobilization of C stores in stems and roots, is a physiologically important trait underlying tolerance to defoliation in grain amaranth.	[Vargas-Ortiz, Erandi; Tiessen, Axel; Paul Delano-Frier, John] Ctr Invest & Estudios Avanzados, Unidad Irapuato, Unidad Biotecnol & Ingn Genet Plantas, Guanajuato, Mexico; [Espitia-Rangel, Eduardo] Inst Nacl Invest Forestales Agr & Pecuarias, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Delano-Frier, JP (corresponding author), Ctr Invest & Estudios Avanzados, Unidad Irapuato, Unidad Biotecnol & Ingn Genet Plantas, Guanajuato, Mexico.	jdelano@ira.cinvestav.mx	Délano-Frier, John/B-5768-2015; Tiessen, Axel/AAF-2113-2020; Tiessen, Axel/D-5959-2011	Tiessen, Axel/0000-0001-5572-4274; Tiessen, Axel/0000-0001-5572-4274; Vargas-Ortiz, Erandi/0000-0002-9784-8248	European Union through the Amaranth-Future Food project [FP6-032263]; Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico); JDF scholarship; CONACYT scholarship [205326]	European Union through the Amaranth-Future Food project; Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); JDF scholarship; CONACYT scholarship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the European Union through the Amaranth-Future Food project (FP6-032263; to JDF). Financial support by Mexico Tierra de Amaranto A. C. and The Deborah Presser-Velder Foundation is also acknowledged. It was also supported by grants from the Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico) to AT and JDF and CONACYT scholarships to EVO (No. 205326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, TRENDS PLANT SCI, V5, P309, DOI 10.1016/S1360-1385(00)01679-4; Akiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030015; Akubugwo IE, 2007, AFR J BIOTECHNOL, V6, P2833; ANDERSEN RA, 1969, PHYTOCHEMISTRY, V8, P2139, DOI 10.1016/S0031-9422(00)88172-8; Castrillon-Arbelaez PA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-163; Huerta-Ocampo JA, 2011, CURR NUTR FOOD SCI, V7, P1, DOI 10.2174/157340111794941076; [Anonymous], GLOB BIOGEOCHEM CYCL; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner D. M., 2000, Plant Breeding Reviews, V19, P227, DOI 10.1002/9780470650172.ch7; Cabrera-Bosquet L, 2012, J INTEGR PLANT BIOL, V54, P312, DOI 10.1111/j.1744-7909.2012.01116.x; Delaney KJ, 2008, PLANT ECOL, V199, P187, DOI 10.1007/s11258-008-9423-0; Delano-Frier JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-363; Delano-Frier JP, 2004, J CHEM ECOL, V30, P1001, DOI 10.1023/B:JOEC.0000028464.36353.bb; Delano- Frier JP, 2012, ARTIFICIAL PHOTOSYNT, P155; Fang XW, 2008, ECOL RES, V23, P863, DOI 10.1007/s11284-007-0449-x; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Gassmann AJ, 2004, J ECOL, V92, P882, DOI 10.1111/j.0022-0477.2004.00920.x; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; GODT DE, 1995, J PLANT PHYSIOL, V146, P231, DOI 10.1016/S0176-1617(11)82046-8; HELMS TC, 1994, CAN J PLANT SCI, V74, P699, DOI 10.4141/cjps94-126; Herbers K, 1998, CURR OPIN PLANT BIOL, V1, P207, DOI 10.1016/S1369-5266(98)80106-4; Hernandez-Casillas J.M., 2010, CONSERVACION USO REC; Hikosaka K, 2005, ANN BOT-LONDON, V95, P1025, DOI 10.1093/aob/mci111; Hikosaka K, 2005, ANN BOT-LONDON, V95, P521, DOI 10.1093/aob/mci050; HILL RM, 1982, J AGR FOOD CHEM, V30, P465, DOI 10.1021/jf00111a014; Hochwender CG, 2012, OECOLOGIA, V169, P49, DOI 10.1007/s00442-011-2176-9; Ida TY, 2012, ANN BOT-LONDON, V109, P237, DOI 10.1093/aob/mcr273; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Kaplan I, 2008, ECOL LETT, V11, P841, DOI 10.1111/j.1461-0248.2008.01200.x; Kosola KR, 2001, OECOLOGIA, V129, P65, DOI 10.1007/s004420100694; Lee JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012306; Li WH, 2012, WEED BIOL MANAG, V12, P40, DOI 10.1111/j.1445-6664.2012.00432.x; Marshall DL, 2005, ANN BOT-LONDON, V95, P1049, DOI 10.1093/aob/mci116; McCormick AJ, 2008, ANN BOT-LONDON, V101, P89, DOI 10.1093/aob/mcm258; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Monneveux P, 2008, J AGR SCI-CAMBRIDGE, V146, P287, DOI 10.1017/S0021859608007818; Moreira X, 2012, J ECOL, V100, P810, DOI 10.1111/j.1365-2745.2011.01938.x; Moreno DM, 1999, GENET RESOUR CROP EV, V46, P225, DOI 10.1023/A:1008605531633; Myers JA, 2007, J ECOL, V95, P383, DOI 10.1111/j.1365-2745.2006.01207.x; NELSON ND, 1984, CAN J FOREST RES, V14, P924, DOI 10.1139/x84-164; Nielsen TH, 1997, PLANT PHYSIOL, V113, P503, DOI 10.1104/pp.113.2.503; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Orians CM, 2011, OECOLOGIA, V167, P1, DOI 10.1007/s00442-011-1968-2; Papakosta, 2006, P NAT SCI MATICA SRP, V110, P123; PATTERSON DT, 1977, PLANT PHYSIOL, V59, P384, DOI 10.1104/pp.59.3.384; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rivera-Solis G, 2012, PLANT ECOL, V213, P303, DOI 10.1007/s11258-011-9977-0; ROITSCH T, 1995, PLANT PHYSIOL, V108, P285, DOI 10.1104/pp.108.1.285; SAEBO A, 1995, PLANT CELL TISS ORG, V41, P177, DOI 10.1007/BF00051588; SEGURANIETO M, 1992, J AGR FOOD CHEM, V40, P1553, DOI 10.1021/jf00021a016; Shukla S, 2006, PLANT FOOD HUM NUTR, V61, P23, DOI 10.1007/s11130-006-0004-x; Silla F, 2008, TREES-STRUCT FUNCT, V22, P785, DOI 10.1007/s00468-008-0239-2; Silva-Sanchez C, 2008, J AGR FOOD CHEM, V56, P1233, DOI 10.1021/jf072911z; Stevens MT, 2008, FUNCT ECOL, V22, P40, DOI 10.1111/j.1365-2435.2007.01356.x; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Suwa T, 2008, AM J BOT, V95, P434, DOI 10.3732/ajb.95.4.434; Synkova H, 2006, PLANT SCI, V171, P607, DOI 10.1016/j.plantsci.2006.06.002; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Tang JY, 2006, J EXP BOT, V57, P527, DOI 10.1093/jxb/erj032; Taylor JRN, 2002, PSEUDOCEREALS AND LESS COMMON CEREALS, P25; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; Umashankara KB, 2007, THESIS U AGR SCI DHA; WANG F, 1993, PLANT PHYSIOL, V101, P321, DOI 10.1104/pp.101.1.321; WEAVER SE, 1980, CAN J PLANT SCI, V60, P1215, DOI 10.4141/cjps80-175; WELTER SC, 1991, ENVIRON ENTOMOL, V20, P1537, DOI 10.1093/ee/20.6.1537; Wright DP, 1998, PLANT CELL ENVIRON, V21, P209, DOI 10.1046/j.1365-3040.1998.00280.x; Wyka T, 2000, ARCT ANTARCT ALP RES, V32, P438, DOI 10.2307/1552393; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; [No title captured]	74	25	26	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67879	10.1371/journal.pone.0067879	http://dx.doi.org/10.1371/journal.pone.0067879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861825	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700053
J	Viscidi, EW; Triche, EW; Pescosolido, MF; McLean, RL; Joseph, RM; Spence, SJ; Morrow, EM				Viscidi, Emma W.; Triche, Elizabeth W.; Pescosolido, Matthew F.; McLean, Rebecca L.; Joseph, Robert M.; Spence, Sarah J.; Morrow, Eric M.			Clinical Characteristics of Children with Autism Spectrum Disorder and Co-Occurring Epilepsy	PLOS ONE			English	Article							UNITED-STATES; PREVALENCE; RESOURCE; SEIZURES; ABNORMALITIES; EPIDEMIOLOGY; DISABILITIES; INDIVIDUALS; REGRESSION; DIAGNOSIS	Objectives: To estimate the prevalence of epilepsy in children with Autism Spectrum Disorder (ASD) and to determine the demographic and clinical characteristics of children with ASD and epilepsy in a large patient population. Methods: Cross-sectional study using four samples of children with ASD for a total of 5,815 participants with ASD. The prevalence of epilepsy was estimated from a population-based sample. Children with and without epilepsy were compared on demographic and clinical characteristics. Multivariate logistic regression was used to examine the association between demographic and clinical characteristics and epilepsy. Results: The average prevalence of epilepsy in children with ASD 2-17 years was 12.5%; among children aged 13 years and older, 26% had epilepsy. Epilepsy was associated with older age, lower cognitive ability, poorer adaptive and language functioning, a history of developmental regression and more severe ASD symptoms. The association between epilepsy and the majority of these characteristics appears to be driven by the lower IQ of participants with epilepsy. In a multivariate regression model, only age and cognitive ability were independently associated with epilepsy. Children age 10 or older had 2.35 times the odds of being diagnosed with epilepsy (p <.001) and for a one standard deviation increase in IQ, the odds of having epilepsy decreased by 47% (p <.001). Conclusion: This is among the largest studies to date of patients with ASD and co-occurring epilepsy. Based on a representative sample of children with ASD, the average prevalence of epilepsy is approximately 12% and reaches 26% by adolescence. Independent associations were found between epilepsy and older age and lower cognitive ability. Other risk factors, such as poor language and developmental regression, are not associated with epilepsy after controlling for IQ. These findings can help guide prognosis and alert clinicians to patients with ASD who are at increased risk for epilepsy.	[Viscidi, Emma W.; Triche, Elizabeth W.] Brown Univ, Div Biol & Med, Dept Epidemiol, Providence, RI 02912 USA; [Viscidi, Emma W.; Pescosolido, Matthew F.; Morrow, Eric M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Mol Med Lab, Providence, RI 02912 USA; [Viscidi, Emma W.; Pescosolido, Matthew F.; Morrow, Eric M.] Brown Univ, Inst Brain Sci, Mol Med Lab, Providence, RI 02912 USA; [Pescosolido, Matthew F.; McLean, Rebecca L.; Morrow, Eric M.] Brown Univ, Sch Med, Dev Disorders Genet Res Program, Emma Pendleton Bradley Hosp, Providence, RI 02912 USA; [Pescosolido, Matthew F.; McLean, Rebecca L.; Morrow, Eric M.] Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [McLean, Rebecca L.] Brown Univ, Mem Hosp Rhode Isl, Neurodev Ctr, Dept Pediat,Med Sch, Pawtucket, RI 02860 USA; [Joseph, Robert M.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Joseph, Robert M.; Spence, Sarah J.; Morrow, Eric M.] Autism Consortium, Boston, MA USA; [Spence, Sarah J.] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA	Brown University; Brown University; Brown University; Brown University; Brown University; Brown University; Boston University; Harvard University; Boston Children's Hospital; Harvard Medical School	Morrow, EM (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Mol Med Lab, Providence, RI 02912 USA.	eric_morrow@brown.edu	Triche, Elizabeth/I-4986-2014; Morrow, Eric/J-2767-2013	Morrow, Eric/0000-0003-3430-3520; Joseph, Robert/0000-0001-6879-0254; Pescosolido, Matthew/0000-0002-5994-0123	NIMH [1K23MH080954-05]; Career Award in Medical Science from the Burroughs Wellcome Fund; T32 pre-doctoral training grant [5T32MH019927-18]; Brown University Institute for Brain Science pre-doctoral funding; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019927, K23MH080954, U24MH081810] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Career Award in Medical Science from the Burroughs Wellcome Fund; T32 pre-doctoral training grant; Brown University Institute for Brain Science pre-doctoral funding; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	EMM has received support from NIMH, 1K23MH080954-05, and a Career Award in Medical Science from the Burroughs Wellcome Fund. EWV has received support from a T32 pre-doctoral training grant, 5T32MH019927-18, and Brown University Institute for Brain Science pre-doctoral funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiet C, 2008, BIOL PSYCHIAT, V64, P577, DOI 10.1016/j.biopsych.2008.04.030; [Anonymous], 1993, EPILEPSIA, V34, P592; APA, 2000, DIAGNOSTIC STAT MANU; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Berg AT, 2012, EPILEPSY BEHAV, V23, P193, DOI 10.1016/j.yebeh.2012.01.015; Blumberg S.J., 2009, VITAL HLTH STAT, V1; Boltor PF, 2011, BRIT J PSYCHIAT, V198, P289, DOI 10.1192/bjp.bp.109.076877; Canitano R, 2005, J CHILD NEUROL, V20, P27, DOI 10.1177/08830738050200010401; Canitano R, 2007, EUR CHILD ADOLES PSY, V16, P61, DOI 10.1007/s00787-006-0563-2; Cuccaro ML, 2011, J AUTISM DEV DISORD; Danielsson S, 2005, EPILEPSIA, V46, P918, DOI 10.1111/j.1528-1167.2005.57504.x; Deonna T, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00697.x; DEYKIN EY, 1979, AM J PSYCHIAT, V136, P1310; Dunn L. M., 1997, BRIT PICTURE VOCABUL, V3rd; ELLENBERG JH, 1984, ANN NEUROL, V15, P127, DOI 10.1002/ana.410150204; Elliott C, 2007, DIFFERENTIAL ABILITY; FARAONE SV, 1995, J AM ACAD CHILD PSY, V34, P1001, DOI 10.1097/00004583-199508000-00009; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Hara H, 2007, BRAIN DEV-JPN, V29, P486, DOI 10.1016/j.braindev.2006.12.012; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Hishinuma ES, 2000, ASSESSMENT, V7, P17, DOI 10.1177/107319110000700102; Hrdlicka M, 2004, EUR CHILD ADOLES PSY, V13, P209, DOI 10.1007/s00787-004-0353-7; Kielinen M, 2004, AUTISM, V8, P49, DOI 10.1177/1362361304040638; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Lajonchere CM, 2010, NEURON, V68, P187, DOI 10.1016/j.neuron.2010.10.009; Levy SE, 2010, J DEV BEHAV PEDIATR, V31, P267, DOI 10.1097/DBP.0b013e3181d5d03b; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Maski KP, 2011, CURR OPIN PEDIATR, V23, P609, DOI 10.1097/MOP.0b013e32834c9282; Mouridsen SE, 1999, DEV MED CHILD NEUROL, V41, P110, DOI 10.1017/S0012162299000213; Mullen E. M, 1995, MULLEN SCALES EARLY; Neale BM, 2012, NATURE; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; O'Roak B.J., 2012, NATURE; OLSSON I, 1988, ARCH NEUROL-CHICAGO, V45, P666, DOI 10.1001/archneur.1988.00520300086024; Pavone P, 2004, NEUROPEDIATRICS, V35, P207, DOI 10.1055/s-2004-821079; Pickett J, 2011, J CHILD NEUROL, V26, P932, DOI 10.1177/0883073811402203; Rapin I, 1998, ANN NEUROL, V43, P7, DOI 10.1002/ana.410430106; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Roid GH., 2003, STANFORD BINET INTEL, V5th; ROSSI PG, 1995, BRAIN DEV-JPN, V17, P169, DOI 10.1016/0387-7604(95)00019-8; Rutter M, 2003, ADI R AUTISM DIAGNOS, V60; Schieve L. A., 2006, Morbidity and Mortality Weekly Report, V55, P481; Simons, 2010, SFARI BAS SSC RES WE; Sparrow S. S., 2005, VINELAND ADAPTIVE BE, V2nd, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; TUCHMAN RF, 1991, PEDIATRICS, V88, P1219; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Tuchman R, 2010, BRAIN DEV-JPN, V32, P709, DOI 10.1016/j.braindev.2010.04.008; Turk J, 2009, ACTA PAEDIATR, V98, P675, DOI 10.1111/j.1651-2227.2008.01184.x; U.S. Department of Health and Human Services MaCHB, 2009, HLTH WELL BEING CHIL; Van Eeghen AM, 2013, DEV MED CHILD NEUROL, V55, P146, DOI 10.1111/dmcn.12044; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; VOLKMAR FR, 1990, J AM ACAD CHILD PSY, V29, P127, DOI 10.1097/00004583-199001000-00020; Wechsler D., 1967, WPPSI MANUAL WECHSLE; Wechsler D., 1999, WECHSLER ABBREVIATED; WONG V, 1993, J CHILD NEUROL, V8, P316, DOI 10.1177/088307389300800405	61	133	136	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67797	10.1371/journal.pone.0067797	http://dx.doi.org/10.1371/journal.pone.0067797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861807	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700037
J	Kaushik, S; Singh, N; Yamini, S; Singh, A; Sinha, M; Arora, A; Kaur, P; Sharma, S; Singh, TP				Kaushik, Sanket; Singh, Nagendra; Yamini, Shavait; Singh, Avinash; Sinha, Mau; Arora, Ashish; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			The Mode of Inhibitor Binding to Peptidyl-tRNA Hydrolase: Binding Studies and Structure Determination of Unbound and Bound Peptidyl- tRNA Hydrolase from Acinetobacter baumannii	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PHOSPHOLIPASE A(2); RESISTANT; PROTEIN; COMPLEX; INFECTIONS; REFINEMENT; RESOLUTION; PNEUMONIA; ACID	The incidences of infections caused by an aerobic Gram-negative bacterium, Acinetobacter baumannii are very common in hospital environments. It usually causes soft tissue infections including urinary tract infections and pneumonia. It is difficult to treat due to acquired resistance to available antibiotics is well known. In order to design specific inhibitors against one of the important enzymes, peptidyl-tRNA hydrolase from Acinetobacter baumannii, we have determined its three-dimensional structure. Peptidyl-tRNA hydrolase (AbPth) is involved in recycling of peptidyl-tRNAs which are produced in the cell as a result of premature termination of translation process. We have also determined the structures of two complexes of AbPth with cytidine and uridine. AbPth was cloned, expressed and crystallized in unbound and in two bound states with cytidine and uridine. The binding studies carried out using fluorescence spectroscopic and surface plasmon resonance techniques revealed that both cytidine and uridine bound to AbPth at nanomolar concentrations. The structure determinations of the complexes revealed that both ligands were located in the active site cleft of AbPth. The introduction of ligands to AbPth caused a significant widening of the entrance gate to the active site region and in the process of binding, it expelled several water molecules from the active site. As a result of interactions with protein atoms, the ligands caused conformational changes in several residues to attain the induced tight fittings. Such a binding capability of this protein makes it a versatile molecule for hydrolysis of peptidyl-tRNAs having variable peptide sequences. These are the first studies that revealed the mode of inhibitor binding in Peptidyl-tRNA hydrolases which will facilitate the structure based ligand design.	[Kaushik, Sanket; Singh, Nagendra; Yamini, Shavait; Singh, Avinash; Sinha, Mau; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Arora, Ashish] Cent Drug Res Inst, Lucknow 226001, Uttar Pradesh, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com		Singh, Nagendra/0000-0003-0419-0684; SINHA, MAU/0000-0003-3011-9160	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi; Indian Council of Medical Research, New Delhi	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	TPS thanks the Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi for the award of Distinguished Biotechnology Research Professorship. The financial assistance from the Indian Council of Medical Research, New Delhi is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; Brisse S, 2000, J CLIN MICROBIOL, V38, P3636, DOI 10.1128/JCM.38.10.3636-3645.2000; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; Charland M. B., 1995, SIGMAPLOT SCI VERSIO; Chen MZ, 2001, CHEST, V120, P1072, DOI 10.1378/chest.120.4.1072; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endimiani A, 2011, CLIN INFECT DIS, V52, pS373, DOI 10.1093/cid/cir054; Fan Ji-cai, 2006, J Zhejiang Univ Sci B, V7, P452, DOI 10.1631/jzus.2006.B0452; GOODHART GL, 1977, JAMA-J AM MED ASSOC, V238, P1516, DOI 10.1001/jama.238.14.1516; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Hsueh PR, 2002, EMERG INFECT DIS, V8, P827; Hughes RC, 2012, ACTA CRYSTALLOGR F, V68, P1472, DOI 10.1107/S1744309112045770; Ito K, 2012, NUCLEIC ACIDS RES, V40, P10521, DOI 10.1093/nar/gks790; Jabeen T, 2005, ACTA CRYSTALLOGR D, V61, P1579, DOI 10.1107/S0907444905029604; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar Ashok, 2012, Int J Biochem Mol Biol, V3, P58; Kushwaha GS, 2013, PROTEINS, V81, P896, DOI 10.1002/prot.24248; Kushwaha GS, 2012, BBA-PROTEINS PROTEOM, V1824, P679, DOI 10.1016/j.bbapap.2012.02.005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee K, 2011, YONSEI MED J, V52, P879, DOI 10.3349/ymj.2011.52.6.879; Lim TP, 2011, PLOS ONE, V6, P184; Ling J, 2007, P NATL ACAD SCI USA, V104, P72, DOI 10.1073/pnas.0606272104; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MENNINGER JR, 1979, J BACTERIOL, V137, P694, DOI 10.1128/JB.137.1.694-696.1979; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oncul O, 2002, J HOSP INFECT, V51, P47, DOI 10.1053/jhin.2002.1205; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pachon J, 2009, CURR OPIN INVEST DR, V10, P150; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Schmitt E, 1997, EMBO J, V16, P4760, DOI 10.1093/emboj/16.15.4760; SEIFERT H, 1993, ANTIMICROB AGENTS CH, V37, P750, DOI 10.1128/AAC.37.4.750; Selvaraj M, 2007, J MOL BIOL, V372, P186, DOI 10.1016/j.jmb.2007.06.053; Singh G, 2005, PROTEIN SCI, V14, P395, DOI 10.1110/ps.041115505; Singh N, 2008, PROTEINS, V64, P80; Singh N, 2009, J MOL RECOGNIT, V22, P437, DOI 10.1002/jmr.960; Singh NS, 2004, NUCLEIC ACIDS RES, V32, P6028, DOI 10.1093/nar/gkh924; Singh RK, 2005, J DRUG TARGET, V13, P113, DOI 10.1080/10611860400024078; Tickle IJ, 2012, ACTA CRYSTALLOGR D, V68, P454, DOI 10.1107/S0907444911035918; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Zeana C, 2003, INFECT CONT HOSP EP, V24, P275, DOI 10.1086/502209; Zhou H, 2011, ANTIMICROB AGENTS CH, V55, P4506, DOI 10.1128/AAC.01134-10	45	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67547	10.1371/journal.pone.0067547	http://dx.doi.org/10.1371/journal.pone.0067547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844024	gold, Green Submitted, Green Published			2022-12-25	WOS:000321733000078
J	Hassounah, NB; Nagle, R; Saboda, K; Roe, DJ; Dalkin, BL; McDermott, KM				Hassounah, Nadia B.; Nagle, Ray; Saboda, Kathylynn; Roe, Denise J.; Dalkin, Bruce L.; McDermott, Kimberly M.			Primary Cilia Are Lost in Preinvasive and Invasive Prostate Cancer	PLOS ONE			English	Article							BETA-CATENIN EXPRESSION; E-CADHERIN; INTRAEPITHELIAL NEOPLASIA; ALPHA-CATENIN; INHIBITION; CARCINOMA; DISEASE; PROTEIN; LESIONS; CELLS	Prostate cancer is the second most commonly diagnosed cancer in men worldwide. Little is known about the role of primary cilia in preinvasive and invasive prostate cancer. However, reduced cilia expression has been observed in human cancers including pancreatic cancer, renal cell carcinoma, breast cancer, cholangiocarcinoma, and melanoma. The aim of this study was to characterize primary cilia expression in preinvasive and invasive human prostate cancer, and to investigate the correlation between primary cilia and the Wnt signaling pathway. Human prostate tissues representative of stages of prostate cancer formation (normal prostate, prostatic intraepithelial neoplasia (PIN), and invasive prostate cancer (including perineural invasion)) were stained for ciliary proteins. The frequency of primary cilia was determined. A decrease in the percentage of ciliated cells in PIN, invasive cancer and perineural invasion lesions was observed when compared to normal. Cilia lengths were also measured to indirectly test functionality. Cilia were shorter in PIN, cancer, and perineural invasion lesions, suggesting dysfunction. Primary cilia have been shown to suppress the Wnt pathway. Increased Wnt signaling has been implicated in prostate cancer. Therefore, we investigated a correlation between loss of primary cilia and increased Wnt signaling in normal prostate and in preinvasive and invasive prostate cancer. To investigate Wnt signaling in our cohort, serial tissue sections were stained for beta-catenin as a measure of Wnt signaling. Nuclear beta-catenin was analyzed and Wnt signaling was found to be higher in un-ciliated cells in the normal prostate, PIN, a subset of invasive cancers, and perineural invasion. Our results suggest that cilia normally function to suppress the Wnt signaling pathway in epithelial cells and that cilia loss may play a role in increased Wnt signaling in some prostate cancers. These results suggest that cilia are dysfunctional in human prostate cancer, and increase Wnt signaling occurs in a subset of cancers.	[Hassounah, Nadia B.; Saboda, Kathylynn; Roe, Denise J.; McDermott, Kimberly M.] Univ Arizona, Ctr Canc, Tucson, AZ 85721 USA; [Nagle, Ray; McDermott, Kimberly M.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [McDermott, Kimberly M.] Univ Arizona, Inst Bio5, Tucson, AZ USA; [Dalkin, Bruce L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA	University of Arizona; University of Arizona; University of Arizona; University of Washington; University of Washington Seattle	McDermott, KM (corresponding author), Univ Arizona, Ctr Canc, Tucson, AZ 85721 USA.	kmcdermott@azcc.arizona.edu			Science Foundation of Arizona; Cancer Biology Training Grant (NIH) [T32CA009213]; University of Arizona Cancer Center Support Grant (NIH) [P30CA023074]; R00 (NIH-NICHD) [R00HD056965]; Better than Ever Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD056965] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009213, P30CA023074] Funding Source: NIH RePORTER	Science Foundation of Arizona; Cancer Biology Training Grant (NIH); University of Arizona Cancer Center Support Grant (NIH); R00 (NIH-NICHD); Better than Ever Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Science Foundation of Arizona (http://www.sfaz.org), the Cancer Biology Training Grant (NIH; T32CA009213), the University of Arizona Cancer Center Support Grant (NIH; P30CA023074), an R00 (NIH-NICHD; R00HD056965); and the Better than Ever Foundation (http://azcc.arizona.edu/outreach/bte). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa S, 2005, ANTICANCER RES, V25, P4707; Arenas MI, 2000, HISTOCHEM J, V32, P659, DOI 10.1023/A:1004111331752; Assikis VJ, 2004, CLIN CANCER RES, V10, P6770, DOI 10.1158/1078-0432.CCR-04-0275; Bismar TA, 2004, AM J CLIN PATHOL, V121, P557, DOI 10.1309/447049GV52H7D258; BN R, 2013, CANC RES; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; de Medina SGD, 1998, HUM PATHOL, V29, P1005, DOI 10.1016/S0046-8177(98)90208-8; Egeberg Dorte L, 2012, Cilia, V1, P15, DOI 10.1186/2046-2530-1-15; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Goeman L, 2003, PROSTATE CANCER P D, V6, P305, DOI 10.1038/sj.pcan.4500681; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassounah NB, 2012, CLIN CANCER RES, V18, P2429, DOI 10.1158/1078-0432.CCR-11-0755; Horvath LG, 2005, INT J CANCER, V113, P415, DOI 10.1002/ijc.20599; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Kapoor A, 2012, CAN J UROL, V19, P10; Karlou M, 2012, PROSTATE, V72, P1638, DOI 10.1002/pros.22517; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027410; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; Morita N, 1999, BRIT J CANCER, V79, P1879, DOI 10.1038/sj.bjc.6690299; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OHTSUKI Y, 1979, Japanese Journal of Clinical Electron Microscopy, V12, P81; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Sakai I, 2004, UROL ONCOL, V4, P27; Schmidt LJ, 2007, PROSTATE, V67, P1111, DOI 10.1002/pros.20602; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schraml P, 2009, MODERN PATHOL, V22, P31, DOI 10.1038/modpathol.2008.132; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; THEISS M, 1995, PROSTATE, V27, P13, DOI 10.1002/pros.2990270104; van Leenders GJLH, 2001, J PATHOL, V195, P563, DOI 10.1002/path.993; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Whitaker HC, 2008, PROSTATE, V68, P1196, DOI 10.1002/pros.20780; Willemarck N, 2010, CANCER RES, V70, P9453, DOI 10.1158/0008-5472.CAN-10-2324; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856; Zhang JX, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-50	45	86	88	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68521	10.1371/journal.pone.0068521	http://dx.doi.org/10.1371/journal.pone.0068521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844214	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000168
J	Pylro, VS; de Freitas, ALM; Otoni, WC; da Silva, IR; Borges, AC; Costa, MD				Pylro, Victor Satler; Moreira de Freitas, Andre Luiz; Otoni, Wagner Campos; da Silva, Ivo Ribeiro; Borges, Arnaldo Chaer; Costa, Mauricio Dutra			Calcium Oxalate Crystals in Eucalypt Ectomycorrhizae: Morphochemical Characterization	PLOS ONE			English	Article							CYTOSOLIC CALCIUM; ACCUMULATION; HYPAPHORINE; MORPHOLOGY; CRYSTALLIZATION; LEGUMINOSAE; RAPHIDES; LEAVES	Ectomycorrhizal fungi are ubiquitous in forest ecosystems, benefitting plants principally by increasing the uptake of water and nutrients such as calcium from the soil. Previous work has demonstrated accumulation of crystallites in eucalypt ectomycorrhizas, but detailed morphological and chemical characterization of these crystals has not been performed. In this work, cross sections of acetic acid-treated and cleared ectomycorrhizal fragments were visualized by polarized light microscopy to evaluate the location of crystals within cortical root cells. Ectomycorrhizal sections were also observed by scanning electron microscopy (SEM) coupled with energy dispersive x-ray (EDS) microprobe analysis. The predominant forms of crystals were crystal sand (granules) and concretions. Calcium, carbon and oxygen were detected by EDS as constituent elements and similar elemental profiles were observed between both crystal morphologies. All analyzed crystalline structures were characterized as calcium oxalate crystals. This is the first report of the stoichiometry and morphology of crystals occurring in eucalypt ectomycorrhizas in tropical soils. The data corroborates the role of ectomycorrhizae in the uptake and accumulation of calcium in the form of calcium oxalate crystals in hybrid eucalypt plants.	[Pylro, Victor Satler; Moreira de Freitas, Andre Luiz; Borges, Arnaldo Chaer; Costa, Mauricio Dutra] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Otoni, Wagner Campos] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil; [da Silva, Ivo Ribeiro] Univ Fed Vicosa, Dept Solos, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Costa, MD (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mdcosta@ufv.br	Otoni, Wagner C/D-6439-2013; Pylro, Victor Satler/G-6045-2010; Costa, Maurício/AAV-1267-2020	Otoni, Wagner C/0000-0002-9614-9373; Pylro, Victor Satler/0000-0003-2154-9150; Costa, Mauricio/0000-0002-0828-4437	FAPEMIG [APQ-00403-09]; CNPq; CAPES	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by FAPEMIG (www.fapemig.br) grant APQ-00403-09, CNPq (www.cnpq.br), and CAPES (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez V. V. H., 2000, Boletim Informativo da Sociedade Brasileira de Cie~ncia do Solo, V25, P27; Arnott HJ, 2000, INT J PLANT SCI, V161, P133, DOI 10.1086/314230; Arocena JM, 2001, MYCORRHIZA, V10, P209, DOI 10.1007/s005720000082; ASSAILLY A, 1954, CR HEBD ACAD SCI, V238, P1902; Bradbury JH, 1998, J SCI FOOD AGR, V76, P608, DOI [10.1002/(SICI)1097-0010(199804)76:4&lt;608::AID-JSFA996&gt;3.0.CO;2-2, 10.1002/(SICI)1097-0010(199804)76:4<608::AID-JSFA996>3.3.CO;2-U]; BRUBAKER CL, 1989, CAN J BOT, V67, P1664, DOI 10.1139/b89-210; BUSH DS, 1993, PLANT PHYSIOL, V103, P7, DOI 10.1104/pp.103.1.7; CALMES J, 1970, B SOC BOT FR, V117, P189, DOI 10.1080/00378941.1970.10838762; CONNOLLY JH, 1995, CAN J BOT, V73, P927, DOI 10.1139/b95-101; Copley J, 2000, NATURE, V406, P452, DOI 10.1038/35020131; Dauphin A, 2007, PROTOPLASMA, V231, P83, DOI 10.1007/s00709-006-0240-9; Ditengou FA, 2000, PLANTA, V211, P722, DOI 10.1007/s004250000342; ENTRY JA, 1992, SOIL BIOL BIOCHEM, V24, P447, DOI 10.1016/0038-0717(92)90207-E; Faheed F, 2013, TURK J BOT, V37, P139, DOI 10.3906/bot-1112-19; Franceschi V, 2001, TRENDS PLANT SCI, V6, P331, DOI 10.1016/S1360-1385(01)02014-3; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; GOEDERT WJ, 1983, J SOIL SCI, V34, P405, DOI 10.1111/j.1365-2389.1983.tb01045.x; Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+; Harper JF, 2001, TRENDS PLANT SCI, V6, P395, DOI 10.1016/S1360-1385(01)02023-4; He HH, 2012, ANN BOT-LONDON, V109, P887, DOI 10.1093/aob/mcs004; Horner H.T., 1995, CALCIUM OXALATE BIOL, P53; Horner HT, 2009, INT J PLANT SCI, V170, P343, DOI 10.1086/596338; Jauregui-Zuniga D, 2005, PLANT SCI, V168, P1163, DOI 10.1016/j.plantsci.2004.12.013; KAUSCH AP, 1981, SCAN ELECTRON MICROS, P263; Lersten NR, 2011, AM J BOT, V98, P1, DOI 10.3732/ajb.1000247; Macnish AJ, 2003, AUST J BOT, V51, P565, DOI 10.1071/BT03035; MALAJCZUK N, 1982, NEW PHYTOL, V92, P527, DOI 10.1111/j.1469-8137.1982.tb03411.x; Mazen AMA, 2004, NEW PHYTOL, V161, P435, DOI 10.1111/j.1469-8137.2004.00923.x; Meric C, 2009, ACTA BIOL CRACOV BOT, V51, P105; Modenesi P, 2000, LICHENOLOGIST, V32, P505, DOI 10.1006/lich.2000.0276; Monje PV, 2002, PLANT PHYSIOL, V128, P707, DOI 10.1104/pp.010630; Nakata PA, 2003, PLANT SCI, V164, P901, DOI 10.1016/S0168-9452(03)00120-1; Panheleux M, 1999, BRIT POULTRY SCI, V40, P240, DOI 10.1080/00071669987665; Pereira J.C.D., 2000, CARACTERISTICAS MADE; Pittman JK, 2003, CURR OPIN PLANT BIOL, V6, P257, DOI 10.1016/S1369-5266(03)00036-0; Reboutier D, 2002, MOL PLANT MICROBE IN, V15, P932, DOI 10.1094/MPMI.2002.15.9.932; RITCHEY KD, 1982, SOIL SCI, V133, P378, DOI 10.1097/00010694-198206000-00007; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Saltz D, 2000, PLANT ECOL, V148, P127, DOI 10.1023/A:1009895512145; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; SPITZER E, 1982, CAN J BOT, V60, P1381, DOI 10.1139/b82-175; SWANSON FJ, 1988, BIOSCIENCE, V38, P92, DOI 10.2307/1310614; Touryan LA, 2004, NAT MATER, V3, P239, DOI 10.1038/nmat1096; Vale F.R, 1996, PESQ AGROPEC BRAS BE, V31, P609; Volk GM, 2004, ANN BOT-LONDON, V93, P741, DOI 10.1093/aob/mch092; Volk GM, 2002, PLANT BIOLOGY, V4, P34, DOI 10.1055/s-2002-20434; Webb MA, 1999, PLANT CELL, V11, P751, DOI 10.1105/tpc.11.4.751; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Gonzalez JAZ, 2009, REV BRAS CIENC SOLO, V33, P555, DOI 10.1590/S0100-06832009000300007	51	5	5	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67685	10.1371/journal.pone.0067685	http://dx.doi.org/10.1371/journal.pone.0067685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844062	gold, Green Submitted, Green Published			2022-12-25	WOS:000321341000076
J	Sims-Robinson, C; Hur, J; Hayes, JM; Dauch, JR; Keller, PJ; Brooks, SV; Feldman, EL				Sims-Robinson, Catrina; Hur, Junguk; Hayes, John M.; Dauch, Jacqueline R.; Keller, Peter J.; Brooks, Susan V.; Feldman, Eva L.			The Role of Oxidative Stress in Nervous System Aging	PLOS ONE			English	Article							CUZN-SUPEROXIDE-DISMUTASE; MITOCHONDRIAL DYSFUNCTION; MOTOR AXONOPATHY; MUSCLE ATROPHY; SCHWANN-CELLS; GENECHIP DATA; LIFE-SPAN; MICE; NEURONS; DEGENERATION	While oxidative stress is implicated in aging, the impact of oxidative stress on aging in the peripheral nervous system is not well understood. To determine a potential mechanism for age-related deficits in the peripheral nervous system, we examined both functional and morphological changes and utilized microarray technology to compare normal aging in wildtype mice to effects in copper/zinc superoxide dismutase-deficient (Sod1(-/-)) mice, a mouse model of increased oxidative stress. Sod1(-/-) mice exhibit a peripheral neuropathy phenotype with normal sensory nerve function and deficits in motor nerve function. Our data indicate that a decrease in the synthesis of cholesterol, which is vital to myelin formation, correlates with the structural deficits in axons, myelin, and the cell body of motor neurons in the Sod1(+/+) mice at 30 months and the Sod1(-/-) mice at 20 months compared with mice at 2 months. Collectively, we have demonstrated that the functional and morphological changes within the peripheral nervous system in our model of increased oxidative stress are manifested earlier and resemble the deficits observed during normal aging.	[Sims-Robinson, Catrina; Hur, Junguk; Hayes, John M.; Dauch, Jacqueline R.; Keller, Peter J.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Brooks, Susan V.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	efeldman@umich.edu	Hur, Junguk/J-6229-2019	Hur, Junguk/0000-0002-0736-2149; Brooks, Susan/0000-0003-1954-967X; Robinson, Catrina/0000-0003-4776-5839; Feldman, Eva/0000-0002-9162-2694	National Institute of Aging (NIA) [AG-020591]; Aging Training Grant (NIA) [T32-AG000114]; Nathan Shock Center's Functional Assessment Core (NIA) [AG-013283]; Animal Models of Diabetic Complications Consortium (NIH) [U01-DK076160]; Juvenile Diabetes Research Foundation Postdoctoral Fellowship; Program for Neurology Research and Discovery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK076160, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283, P01AG020591, T32AG000114] Funding Source: NIH RePORTER	National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Aging Training Grant (NIA); Nathan Shock Center's Functional Assessment Core (NIA); Animal Models of Diabetic Complications Consortium (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Postdoctoral Fellowship(Juvenile Diabetes Research Foundation); Program for Neurology Research and Discovery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding Information/Grant Support: This work was supported by grants from the National Institute of Aging (NIA, AG-020591), Aging Training Grant (NIA T32-AG000114), Nathan Shock Center's Functional Assessment Core (NIA, AG-013283), Animal Models of Diabetic Complications Consortium (NIH U01-DK076160), the A. Alfred Taubman Medical Research Institute, a Juvenile Diabetes Research Foundation Postdoctoral Fellowship [to JH], and the Program for Neurology Research and Discovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Boulis NM, 2002, J NEUROSURG, V96, P212, DOI 10.3171/spi.2002.96.2.0212; Clement AB, 2009, J NEUROCHEM, V111, P669, DOI 10.1111/j.1471-4159.2009.06360.x; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; Fischer LR, 2012, EXP NEUROL, V233, P163, DOI 10.1016/j.expneurol.2011.09.020; Fischer LR, 2010, ACTA NEUROPATHOL, V119, P249, DOI 10.1007/s00401-009-0631-z; Flood DG, 1999, AM J PATHOL, V155, P663, DOI 10.1016/S0002-9440(10)65162-0; Fu Q, 1998, J NEUROCHEM, V71, P549; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5; Huang TT, 1997, ARCH BIOCHEM BIOPHYS, V344, P424, DOI 10.1006/abbi.1997.0237; Hur J, 2009, BIOINFORMATICS, V25, P838, DOI 10.1093/bioinformatics/btp049; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Larkin LM, 2011, AM J PHYSIOL-REG I, V301, pR1400, DOI 10.1152/ajpregu.00093.2011; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Liu JP, 2010, MOL CELL NEUROSCI, V43, P33, DOI 10.1016/j.mcn.2009.07.013; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Roubenoff R, 2001, CAN J APPL PHYSIOL, V26, P78, DOI 10.1139/h01-006; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sentman ML, 2006, J BIOL CHEM, V281, P6904, DOI 10.1074/jbc.M510764200; Shefner JM, 1999, NEUROLOGY, V53, P1239, DOI 10.1212/WNL.53.6.1239; Sims-Robinson C, 2012, DIABETOLOGIA; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Toews AD, 1997, NEUROCHEM RES, V22, P1271, DOI 10.1023/A:1021941215310; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; Van Remmen H, 2003, EXERC SPORT SCI REV, V31, P149, DOI 10.1097/00003677-200307000-00009; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047	46	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68011	10.1371/journal.pone.0068011	http://dx.doi.org/10.1371/journal.pone.0068011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844146	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000128
J	Watanabe, T; Hiasa, Y; Tokumoto, Y; Hirooka, M; Abe, M; Ikeda, Y; Matsuura, B; Chung, RT; Onji, M				Watanabe, Takao; Hiasa, Yoichi; Tokumoto, Yoshio; Hirooka, Masashi; Abe, Masanori; Ikeda, Yoshio; Matsuura, Bunzo; Chung, Raymond T.; Onji, Morikazu			Protein Kinase R Modulates c-Fos and c-Jun Signaling to Promote Proliferation of Hepatocellular Carcinoma with Hepatitis C Virus Infection	PLOS ONE			English	Article							TUMOR-SUPPRESSOR FUNCTION; INITIATION-FACTOR EIF-2; MALIGNANT-TRANSFORMATION; GENE-EXPRESSION; CELL-LINE; PKR; LIVER; RNA; INTERLEUKIN-8; REPLICATION	Double-stranded RNA-activated protein kinase R (PKR) is known to be upregulated by hepatitis C virus (HCV) and overexpressed in hepatocellular carcinoma (HCC). However, the precise roles of PKR in HCC with HCV infection remain unclear. Two HCV replicating cell lines (JFH-1 and H77s), generated by transfection of Huh7.5.1 cells, were used for experiments reported here. PKR expression was modulated with siRNA and a PKR expression plasmid, and cancer-related genes were assessed by real-time PCR and Western blotting; cell lines were further analyzed using a proliferation assay. Modulation of genes by PKR was also assessed in 34 human HCC specimens. Parallel changes in c-Fos and c-Jun gene expression with PKR were observed. Levels of phosphorylated c-Fos and c-Jun were upregulated by an increase of PKR, and were related to levels of phosphorylated JNK1 and Erk1/2. DNA binding activities of c-Fos and c-Jun also correlated with PKR expression, and cell proliferation was dependent on PKR-modulated c-Fos and c-Jun expression. Coordinate expression of c-Jun and PKR was confirmed in human HCC specimens with HCV infection. PKR upregulated c-Fos and c-Jun activities through activation of Erk1/2 and JNK1, respectively. These modulations resulted in HCC cell proliferation with HCV infection. These findings suggest that PKR-related proliferation pathways could be an attractive therapeutic target.	[Watanabe, Takao; Hiasa, Yoichi; Tokumoto, Yoshio; Hirooka, Masashi; Abe, Masanori; Ikeda, Yoshio; Matsuura, Bunzo; Onji, Morikazu] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Chung, Raymond T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Chung, Raymond T.] Harvard Univ, Sch Med, Boston, MA USA	Ehime University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hiasa, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	hiasa@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021	Hiasa, Yoichi/0000-0003-4117-339X	Japan Society for the Promotion of Science, KAKENHI [24590980]; Program for Enhancing Systematic Education in Graduate School from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japanese Ministry of Health, Labor and Welfare, Japan	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Enhancing Systematic Education in Graduate School from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japanese Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by the following: a Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science, KAKENHI 24590980 (to Y.H.); the Program for Enhancing Systematic Education in Graduate School from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T.W.); and by a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor and Welfare, Japan (to Y.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Chang QS, 2009, J HEPATOL, V50, P323, DOI 10.1016/j.jhep.2008.07.037; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chung RT, 2001, P NATL ACAD SCI USA, V98, P9847, DOI 10.1073/pnas.171319698; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Hiasa Y, 2003, AM J GASTROENTEROL, V98, P2528, DOI 10.1016/S0002-9270(03)01696-4; Hiasa Y, 2008, HEPATOLOGY, V48, P59, DOI 10.1002/hep.22289; Hideshima T, 2003, BLOOD, V101, P703, DOI 10.1182/blood-2002-06-1874; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Masumoto T, 1998, HEPATO-GASTROENTEROL, V45, P1630; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Murayama T, 1997, J VIROL, V71, P5692, DOI 10.1128/JVI.71.7.5692-5695.1997; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Nishina H, 2004, J BIOCHEM, V136, P123, DOI 10.1093/jb/mvh117; Ohta H, 2006, CLIN EXP METASTAS, V23, P381, DOI 10.1007/s10585-006-9047-5; Okuda K, 1998, J GASTROEN HEPATOL, V13, pS294, DOI 10.1111/j.1440-1746.1998.tb01896.x; Pflugheber J, 2002, P NATL ACAD SCI USA, V99, P4650, DOI 10.1073/pnas.062055699; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Rivas-Estilla AM, 2002, J VIROL, V76, P10637, DOI 10.1128/JVI.76.21.10637-10653.2002; RYSECK RP, 1991, ONCOGENE, V6, P533; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; Schultz RM, 2003, PROG DRUG RES, V60, P59; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906; Tokumoto Y, 2007, J MED VIROL, V79, P1120, DOI 10.1002/jmv.20902; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WILLIAMS BRG, 1995, SEMIN VIROL, V6, P191, DOI 10.1006/smvy.1995.0024; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Yuen MF, 2001, CANCER, V91, P106, DOI 10.1002/1097-0142(20010101)91:1<106::AID-CNCR14>3.0.CO;2-2; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200; Zhao LJ, 2005, EXP CELL RES, V305, P23, DOI 10.1016/j.yexcr.2004.12.024	48	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67750	10.1371/journal.pone.0067750	http://dx.doi.org/10.1371/journal.pone.0067750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844083	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000091
J	Yoshihara, M; Akasaka, H; Ohnishi, H; Miki, T; Furukawa, T; Yuda, S; Saitoh, S; Miura, T				Yoshihara, Mayumi; Akasaka, Hiroshi; Ohnishi, Hirofumi; Miki, Takayuki; Furukawa, Tetsuaki; Yuda, Satoshi; Saitoh, Shigeyuki; Miura, Tetsuji			Glucagon-Like Peptide-1 Secretory Function as an Independent Determinant of Blood Pressure: Analysis in the Tanno-Sobetsu Study	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; NITRIC-OXIDE PRODUCTION; GLP-1 RECEPTOR; ANALOG LIRAGLUTIDE; ENDOTHELIAL-CELLS; HEALTHY-SUBJECTS; HUMANS; EXENDIN-4; GLUCOSE; HYPERTENSION	Aims: Roles of glucagon-like peptide-1 (GLP-1) in extra-pancreatic tissues remain unclear. The aim of this study was to examine determinants of GLP-1 secretory function and possible contribution of GLP-1 to blood pressure (BP) regulation. Methods and Results: We recruited 128 subjects who received annual examinations and 75g-oral glucose tolerance tests (OGTT) in the Tanno-Sobetsu cohort. Subjects on regular medications for cardiovascular and/or metabolic diseases were excluded, and data for the remaining 103 subjects were used for the univariate and multivariate analyses. Age, plasma glucose (PG), hemoglobin A1c (HbA1c), plasma insulin, and serum lipids were not selected as independent determinants of fasting GLP-1 level by multiple linear regression analysis. However, age and female sex were selected as independent positive determinants of the area under the curve of GLP-1 level during OGTT (AUC(GLP-1)), an index of GLP-1 secretory function. Multiple linear regression analysis indicated that AUC(GLP-1) was an independent negative predictor of systolic BP (SBP), while AUC(GLP-1) was not correlated with fasting PG or HbA1c level. In subgroup analyses using the median of AUC(GLP-1) to divide the study subjects into high and low GLP-1 response groups, AUC(GLP-1) was significantly correlated with both SBP and diastolic BP (r = 0.40 and 0.28, respectively) in the low GLP-1 response group but not in the high GLP-1 response group. Conclusions: The results of the present study suggest that GLP-1 secretory function is involved in prevention of BP elevation and that the GLP-1 response to oral glucose rather increases with aging perhaps as an adaptive phenomenon.	[Yoshihara, Mayumi; Akasaka, Hiroshi; Ohnishi, Hirofumi; Miki, Takayuki; Furukawa, Tetsuaki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Ohnishi, Hirofumi] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Yuda, Satoshi] Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Sapporo, Hokkaido, Japan; [Saitoh, Shigeyuki] Sapporo Med Univ, Dept Nursing, Sch Hlth Sci, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Miura, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan.	miura@sapmed.ac.jp		Ohnishi, Hirofumi/0000-0002-5873-6438	Japanese Ministry of Health, Labor, and Welfare [H19-cardiovascular-common-021, H20-cardiovascular-common-013]	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by research grants from Scientific Research (H19-cardiovascular-common-021 and H20-cardiovascular-common-013) from the Japanese Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TCM, 2005, OBES RES, V13, P710, DOI 10.1038/oby.2005.80; Akasaka H, 2012, J HYPERTENS, V30, pe303; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bharucha AE, 2008, AM J PHYSIOL-REG I, V295, pR874, DOI 10.1152/ajpregu.00153.2008; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Carroll JF, 2007, OBESITY, V15, P2974, DOI 10.1038/oby.2007.355; Damholt B, 2006, J CLIN PHARMACOL, V46, P635, DOI 10.1177/0091270006288215; de Luis D, 2012, ANN NUTR METAB, V61, P70, DOI 10.1159/000339378; Dong ZH, 2013, AM J PHYSIOL-ENDOC M, V304, pE222, DOI 10.1152/ajpendo.00473.2012; Edwards CMB, 1998, CLIN SCI, V95, P719, DOI 10.1042/cs0950719; Erdogdu O, 2010, MOL CELL ENDOCRINOL, V325, P26, DOI 10.1016/j.mce.2010.04.022; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Goto H, 2011, BIOCHEM BIOPH RES CO, V405, P79, DOI 10.1016/j.bbrc.2010.12.131; Gutzwiller JP, 2006, DIGESTION, V73, P142, DOI 10.1159/000094334; Gutzwiller JP, 2004, J CLIN ENDOCR METAB, V89, P3055, DOI 10.1210/jc.2003-031403; Hattori Y, 2010, DIABETOLOGIA, V53, P2256, DOI 10.1007/s00125-010-1831-8; Hirata Y, 2013, EUR J PHARMACOL, V699, P106, DOI 10.1016/j.ejphar.2012.11.057; Jorgensen TOL, 2000, EUR J ENDOCRINOL, V143, P593, DOI 10.1530/eje.0.1430593; Kawano Y, 2007, HYPERTENS RES, V30, P887, DOI 10.1291/hypres.30.887; Kim M, 2013, NAT MED, V19, P567, DOI 10.1038/nm.3128; Korosi J, 2001, J GERONTOL A-BIOL, V56, pM575, DOI 10.1093/gerona/56.9.M575; Li W, 2010, PEPTIDES, V31, P625, DOI 10.1016/j.peptides.2009.11.008; Lim GE, 2009, ENDOCRINOLOGY, V150, P580, DOI 10.1210/en.2008-0726; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendis B, 2012, BRIT J CLIN PHARMACO, V74, P437, DOI 10.1111/j.1365-2125.2012.04214.x; Mitsumata K, 2012, HYPERTENSION, V60, P1124, DOI 10.1161/HYPERTENSIONAHA.112.201129; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Ohnishi H, 2006, DIABETES CARE, V29, P1128, DOI 10.2337/dc06-0222; Okerson T, 2010, AM J HYPERTENS, V23, P334, DOI 10.1038/ajh.2009.245; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Ravassa S, 2012, CARDIOVASC RES, V94, P316, DOI 10.1093/cvr/cvs123; Rieg T, 2012, AM J PHYSIOL-RENAL, V303, pF963, DOI 10.1152/ajprenal.00259.2012; SCHUSDZIARRA V, 1988, HORM RES, V29, P75, DOI 10.1159/000180972; Tahara N, 2013, CLIN BIOCHEM, V46, P300, DOI 10.1016/j.clinbiochem.2012.11.023; Tesauro M, 2013, DIABETES CARE, V36, P683, DOI 10.2337/dc12-0763; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Yerram P, 2012, CURR OPIN NEPHROL HY, V21, P463, DOI 10.1097/MNH.0b013e328356bccd; Yu M, 2003, J HYPERTENS, V21, P1125, DOI 10.1097/00004872-200306000-00012; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	43	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67578	10.1371/journal.pone.0067578	http://dx.doi.org/10.1371/journal.pone.0067578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844037	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000061
J	Lin, JS; Ma, LS; Lai, EM				Lin, Jer-Sheng; Ma, Lay-Sun; Lai, Erh-Min			Systematic Dissection of the Agrobacterium Type VI Secretion System Reveals Machinery and Secreted Components for Subcomplex Formation	PLOS ONE			English	Article							ICMF FAMILY PROTEIN; PATHOGENICITY ISLAND; TAIL; GENE; VIRULENCE; REQUIRES; ENCODES; COMPLEX; LOCUS; FORMS	The type VI secretion system (T6SS) is widely distributed in pathogenic Proteobacteria. Sequence and structural analysis of T6SS reveals a resemblance to the T4 bacteriophage tail, in which an outer sheath structure contracts an internal tube for injecting nucleic acid into bacterial cells. However, the molecular details of how this phage tail-like T6SS structure is assembled in vivo and executed for exoprotein or effector secretion remain largely unknown. Here, we used a systematic approach to identify T6SS machinery and secreted components and investigate the interaction among the putative sheath and tube components of Agrobacterium tumefaciens. We showed that 14 T6SS components play essential roles in the secretion of the T6SS hallmark exoprotein Hcp. In addition, we discovered a novel T6SS exoprotein, Atu4347, that is dispensable for Hcp secretion. Interestingly, Atu4347 and the putative tube components, Hcp and VgrG, are mainly localized in the cytoplasm but also detected on the bacterial surface. Atu4342 (TssB) and Atu4341 (TssC(41)) interact with and stabilize each other, which suggests that they are functional orthologs of the sheath components TssB (VipA) and TssC (VipB), respectively. Importantly, TssB interacts directly with the three exoproteins (Hcp, VgrG, and Atu4347), in which Hcp also interacts directly with VgrG-1 on co-purification from Escherichia coli. Further co-immunoprecipitation and pulldown assays revealed these subcomplex(es) in A. tumefaciens and thereby support T6SS functioning as a contractile phage tail-like structure.	[Lin, Jer-Sheng; Ma, Lay-Sun; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Acad Sinica, Taipei 115, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University	Lai, EM (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	emlai@gate.sinica.edu.tw	Ma, Lay-Sun/ABH-3013-2020; Lai, Erh-Min/ABG-9558-2020	Ma, Lay-Sun/0000-0003-4349-228X; Lai, Erh-Min/0000-0003-3630-8683	National Science Council [NSC 98-2311-B-001 -002 -MY3]; Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was in part supported by a National Science Council grant (NSC 98-2311-B-001 -002 -MY3) and a grant from Academia Sinica to EML. JSL and LSM were in part supported by Academia Sinica Summit project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; Anderson LB, 1996, P NATL ACAD SCI USA, V93, P8889, DOI 10.1073/pnas.93.17.8889; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Durand E, 2012, J BIOL CHEM IN PRESS; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Holland IB, 2010, METHODS MOL BIOL, V619, P1, DOI 10.1007/978-1-60327-412-8_1; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jia YH, 2002, GENE, V284, P113, DOI 10.1016/S0378-1119(02)00385-2; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kapitein N, 2013, CURR OPIN M IN PRESS; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2006, PROTEOMICS, V6, P4130, DOI 10.1002/pmic.200600254; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; LeRoux M, 2012, P NATL ACAD SCI USA, V109, P19804, DOI 10.1073/pnas.1213963109; Leung KY, 2011, CURR OPIN MICROBIOL, V14, P9, DOI 10.1016/j.mib.2010.09.017; Liu AC, 2008, J APPL MICROBIOL, V105, P1372, DOI 10.1111/j.1365-2672.2008.03874.x; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lossi NS, 2012, MOL MICROBIOL, V86, P437, DOI 10.1111/j.1365-2958.2012.08204.x; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Wu CF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002938; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	63	61	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67647	10.1371/journal.pone.0067647	http://dx.doi.org/10.1371/journal.pone.0067647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861778	Green Submitted, gold, Green Published			2022-12-25	WOS:000321425300021
J	Yamashita, T; Rhoads, DD				Yamashita, Tsunemi; Rhoads, Douglas D.			Species Delimitation and Morphological Divergence in the Scorpion Centruroides vittatus (Say, 1821): Insights from Phylogeography	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; HISTORICAL DEMOGRAPHY; PLEISTOCENE REFUGIA; GENETIC DIVERSITY; PROGRAM PACKAGE; RANGE EXPANSION; DNA; RECOMBINATION; MIGRATION; EVOLUTION	Scorpion systematics and taxonomy have recently shown a need for revision, partially due to insights from molecular techniques. Scorpion taxonomy has been difficult with morphological characters as disagreement exists among researchers with character choice for adequate species delimitation in taxonomic studies. Within the family Buthidae, species identification and delimitation is particularly difficult due to the morphological similarity among species and extensive intraspecific morphological diversity. The genus Centruroides in the western hemisphere is a prime example of the difficulty in untangling the taxonomic complexity within buthid scorpions. In this paper, we present phylogeographic, Ecological Niche Modeling, and morphometric analyses to further understand how population diversification may have produced morphological diversity in Centruroides vittatus (Say, 1821). We show that C. vittatus populations in the Big Bend and Trans-Pecos region of Texas, USA are phylogeographically distinct and may predate the Last Glacial Maximum (LGM). In addition, we suggest the extended isolation of Big Bend region populations may have created the C. vittatus variant once known as C. pantheriensis.	[Yamashita, Tsunemi] Arkansas Tech Univ, Dept Biol Sci, Russellville, AR 72801 USA; [Rhoads, Douglas D.] Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA	Arkansas Tech University; University of Arkansas System; University of Arkansas Fayetteville	Yamashita, T (corresponding author), Arkansas Tech Univ, Dept Biol Sci, Russellville, AR 72801 USA.	tyamashita@atu.edu	Rhoads, Douglas/AAP-6270-2020		ATU Undergraduate Research Office, ATU Sponsored Programs, and National Institutes of Health [P20 RR-16460]; BRIN Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER	ATU Undergraduate Research Office, ATU Sponsored Programs, and National Institutes of Health; BRIN Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the ATU Undergraduate Research Office, ATU Sponsored Programs, and National Institutes of Health grant number P20 RR-16460 from the BRIN Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 2002, EVOLUTION, V56, P1632, DOI 10.1111/j.0014-3820.2002.tb01475.x; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Carbone I, 2004, GENETICS, V166, P1611, DOI 10.1534/genetics.166.4.1611; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Cawthon D, 1996, THESIS U ARKANSAS; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Delcourt Paul A., 1993, P71; Drummond A. J., 2009, GENEIOUS V4 6; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fet V, 2000, CATALOG SCORPIONS WO; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Fu YX, 1996, GENETICS, V143, P557; Gaffin Douglas D., 2011, Euscorpius, V122, P1; Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017; Gantenbein B, 2004, EVOLUTION, V58, P2486, DOI 10.1111/j.0014-3820.2004.tb00878.x; Gantenbein B, 2002, MOL ECOL, V11, P925, DOI 10.1046/j.1365-294X.2002.01494.x; Gantenbein Benjamin, 2001, P235; Gertsch W. J., 1939, Contributions from the Baylor University Museum Waco, V24, P17; Graham MR, 2012, ZOOL MIDDLE EAST, V55, P95, DOI 10.1080/09397140.2012.10648924; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Habel JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029403; Hamilton CA, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026207, 10.1371/journal.pone.0020156]; Hedgecock AA, 1993, THESIS APPALACHIAN S; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hickerson MJ, 2005, EVOLUTION, V59, P344; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hintze J., 2007, NCSS 2007 NCSS LLC K; Hughes GB, 2011, J ARACHNOL, V39, P420, DOI 10.1636/Ha11-07.1; Hutchison DW, 1999, HERPETOL MONOGR, V13, P81, DOI 10.2307/1467061; Hutchison DW, 2003, AM MIDL NAT, V149, P148, DOI 10.1674/0003-0031(2003)149[0148:TTCPMA]2.0.CO;2; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Jezkova T, 2009, J MAMMAL, V90, P306, DOI 10.1644/08-MAMM-A-243.1; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Johnson JA, 2008, J HERED, V99, P165, DOI 10.1093/jhered/esn002; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Luttikhuizen PC, 2003, MOL ECOL, V12, P2215, DOI 10.1046/j.1365-294X.2003.01872.x; Mirshamsi O, 2010, J NAT HIST, V44, P2851, DOI 10.1080/00222933.2010.512400; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Murray EA, 2006, THESIS KANSAS STATE; Myers C, 2001, SCORPION BIOLOGY AND RESEARCH, P317; Nei M., 2000, MOL EVOLUTION PHYLOG; Nielsen R, 2001, GENETICS, V158, P885; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Page R.D.M., 1998, MOL EVOLUTION PHYLOG; Parmakelis A, 2006, MOL ECOL, V15, P2883, DOI 10.1111/j.1365-294X.2006.02982.x; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Phillips CA, 2000, COPEIA, P542; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Polis G.A., 1990, P247; Polis GA, 2001, SCORPION BIOLOGY AND RESEARCH, P302; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POSADA D, 2003, PHYLOGENETIC HDB PRA, P256; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Prendini Lorenzo, 2001, P113; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Rebernig CA, 2010, MOL ECOL, V19, P3421, DOI 10.1111/j.1365-294X.2010.04754.x; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Sambrook J, 2001, MOL CLONING LAB MANU; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; SHELLEY RM, 1995, J ARACHNOL, V23, P100; Simard J.M., 1990, P414; Sissom W. David, 2005, P122; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; Smith CI, 2005, MOL ECOL, V14, P1025, DOI 10.1111/j.1365-294X.2005.02472.x; Sousa P, 2011, AFR INVERTEBR, V52, P135, DOI 10.5733/afin.052.0106; Sousa P, 2010, J ARACHNOL, V38, P206, DOI 10.1636/H08-98.1; STAHNKE H L, 1977, Entomological News, V88, P111; STAHNKE H. L., 1956, ENT NEWS, V67, P15; TAJIMA F, 1989, GENETICS, V123, P585; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Teruel Rolando, 2006, Boletin de la SEA, V39, P219; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trauth S. E., 2004, AMPHIBIANS REPTILES, VFirst; Valdez-Cruz NA, 2004, BIOCHIMIE, V86, P387, DOI 10.1016/j.biochi.2004.05.005; Von Haeseler A, 2003, PHYLOGENETIC HDB PRA, P137; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Williams S. C., 1980, OCCASIONAL PAPERS CA, V135, P1; Wilson JS, 2010, BIOL J LINN SOC, V101, P360, DOI 10.1111/j.1095-8312.2010.01526.x; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x	89	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68282	10.1371/journal.pone.0068282	http://dx.doi.org/10.1371/journal.pone.0068282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861878	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300054
J	Al-abd, NM; Mahdy, MAK; Al-Mekhlafi, AMQ; Snounou, G; Abdul-Majid, NB; Al-Mekhlafi, HM; Fong, MY				Al-abd, Nazeh M.; Mahdy, Mohammed A. K.; Al-Mekhlafi, Abdulsalam M. Q.; Snounou, Georges; Abdul-Majid, Nazia B.; Al-Mekhlafi, Hesham M.; Fong, Mun Y.			The Suitability of P. falciparum Merozoite Surface Proteins 1 and 2 as Genetic Markers for In Vivo Drug Trials in Yemen	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; POPULATION-STRUCTURE; DIVERSITY; MALARIA; FREQUENCY; IDENTIFICATION; TRANSMISSION; GOVERNORATE; INFECTIONS; RESISTANCE	Background: The accuracy of the conclusions from in vivo efficacy anti-malarial drug trials depends on distinguishing between recrudescences and re-infections which is accomplished by genotyping genes coding P. falciparum merozoite surface 1 (MSP1) and MSP2. However, the reliability of the PCR analysis depends on the genetic markers' allelic diversity and variant frequency. In this study the genetic diversity of the genes coding for MSP1 and MSP2 was obtained for P. falciparum parasites circulating in Yemen. Methods: Blood samples were collected from 511 patients with fever and screened for malaria parasites using Giemsa-stained blood films. A total 74 samples were infected with P. falciparum, and the genetic diversity was assessed by nested PCR targeting Pfmsp1 (Block2) and Pfmsp2 (block 3). Results: Overall, 58%, 28% and 54% of the isolates harboured parasites of the Pfmsp1 K1, MAD20 and RO33 allelic families, and 55% and 89% harboured those of the Pfmsp2 FC27 and 3D7 allelic families, respectively. For both genetic makers, the multiplicity of the infection (MOI) was significantly higher in the isolates from the foothills/coastland areas as compared to those from the highland (P < 0.05). Pfmsp2 had higher number of distinct allelic variants than Pfmsp1 (20 vs 11). The expected heterozygosity (HE) for Pfmsp1 and Pfmsp2 were 0.82 and 0.94, respectively. Nonetheless, a bias in the frequency distribution of the Pfmsp1 allelic variants was noted from all areas, and of those of Pfmsp2 in the samples collected from the highland areas. Conclusions: Significant differences in the complexity and allelic diversity of Pfmsp1 and Pfmsp2 genes between areas probably reflect differences in the intensity of malaria transmission. The biased distribution of allelic variants suggests that in Yemen Pfmsp1 should not be used for PCR correction of in vivo clinical trials outcomes, and that caution should be exercised when employing Pfmsp2.	[Al-abd, Nazeh M.; Mahdy, Mohammed A. K.; Al-Mekhlafi, Hesham M.; Fong, Mun Y.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Al-abd, Nazeh M.; Abdul-Majid, Nazia B.] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Mahdy, Mohammed A. K.; Al-Mekhlafi, Abdulsalam M. Q.; Al-Mekhlafi, Hesham M.] Sanaa Univ, Fac Med & Hlth Sci, Dept Parasitol, Sanaa, Yemen; [Snounou, Georges] INSERM, Unite Mixte Rech S 945, Paris, France; [Snounou, Georges] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Mahdy, Mohammed A. K.] Univ Sci & Technol, Resarch Dept, Sanaa, Yemen	Universiti Malaya; Universiti Malaya; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Mahdy, MAK (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	alsharaby9@yahoo.com	MAJID, NAZIA ABDUL/B-9215-2010; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016; Mahdy, Mohammed A.K./C-1187-2010; FONG, MUN YIK/B-5443-2010; Snounou, Georges/F-3352-2011	MAJID, NAZIA ABDUL/0000-0002-6817-8046; Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410; Mahdy, Mohammed A.K./0000-0002-8340-5219; Snounou, Georges/0000-0002-6133-6398; kamal, amera/0000-0002-9154-9415	University of Malaya, Kuala Lumpur, Malaysia (HIR-MOHE) [H-20001-00-E00051]	University of Malaya, Kuala Lumpur, Malaysia (HIR-MOHE)	This study was funded by research grants from the University of Malaya, Kuala Lumpur, Malaysia (HIR-MOHE (H-20001-00-E00051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maktari Mohamed T., 2003, Journal of the Egyptian Society of Parasitology, V33, P361; Al-Mekhlafi AM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-94; Al-Mekhlafi AMQ, 2010, TROP BIOMED, V27, P551; Alkadi HO, 2006, CHEMOTHERAPY, V52, P166, DOI 10.1159/000093592; [Anonymous], 2007, METHODS TECHNIQUES C; Ariey F, 1999, AM J TROP MED HYG, V61, P978, DOI 10.4269/ajtmh.1999.61.978; Babiker HA, 1997, PARASITOL TODAY, V13, P262, DOI 10.1016/S0169-4758(97)01075-2; Babiker HA, 1997, AM J TROP MED HYG, V56, P141, DOI 10.4269/ajtmh.1997.56.141; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Ghanchi NK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-1; Greenhouse B, 2006, AM J TROP MED HYG, V75, P836, DOI 10.4269/ajtmh.2006.75.836; Haddad D, 1999, AM J TROP MED HYG, V60, P30, DOI 10.4269/ajtmh.1999.60.30; Joshi H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-60; Kang JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-131; Ministry of planning and international cooperation Y, 2004, NAT CENS YEM; Mubjer RA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-245; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; NMCP, 2002, MAL REP NMCP; Paul REL, 1998, AM J TROP MED HYG, V58, P195, DOI 10.4269/ajtmh.1998.58.195; Paul REL, 1998, PARASITOL TODAY, V14, P197, DOI 10.1016/S0169-4758(98)01226-5; Sakihama N, 2006, AM J TROP MED HYG, V74, P31, DOI 10.4269/ajtmh.2006.74.31; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Smith T, 1999, T ROY SOC TROP MED H, V93, pS15, DOI 10.1016/S0035-9203(99)90322-X; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Soulama I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-135; Takala S, 2002, MOL BIOCHEM PARASIT, V125, P163, DOI 10.1016/S0166-6851(02)00237-2; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization, 2008, The global burden of disease: 2004 update; Zakeri S, 2005, TROP MED INT HEALTH, V10, P1060, DOI 10.1111/j.1365-3156.2005.01477.x; Zwetyenga J, 1998, AM J TROP MED HYG, V59, P726, DOI 10.4269/ajtmh.1998.59.726	32	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67853	10.1371/journal.pone.0067853	http://dx.doi.org/10.1371/journal.pone.0067853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861823	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700051
J	Hoivik, EA; Witsoe, SL; Bergheim, IR; Xu, YJ; Jakobsson, I; Tengholm, A; Doskeland, SO; Bakke, M				Hoivik, Erling A.; Witsoe, Solveig L.; Bergheim, Inger R.; Xu, Yunjian; Jakobsson, Ida; Tengholm, Anders; Doskeland, Stein Ove; Bakke, Marit			DNA Methylation of Alternative Promoters Directs Tissue Specific Expression of Epac2 Isoforms	PLOS ONE			English	Article							EXCHANGE FACTOR; CYCLIC-AMP; SUBCELLULAR-LOCALIZATION; CAMP; GENOME; IDENTIFICATION; ACTIVATION; SECRETION; DYNAMICS; FEATURES	Epac 1 and Epac 2 (Epac1/2; exchange factors directly activated by cAMP) are multidomain proteins that mediate cellular responses upon activation by the signaling molecule cAMP. Epac1 is ubiquitously expressed, whereas Epac2 exhibits a restricted expression pattern. The gene encoding Epac2 gives rise to at least three protein isoforms (Epac2A, Epac2B and Epac2C) that exhibit confined tissue and cell specific expression profiles. Here, we describe alternative promoter usage for the different isoforms of Epac2, and demonstrate that the activity of these promoters depend on the DNA methylation status. Bisulfite sequencing demonstrated that the level of methylation of the promoters in different tissues correlates with Epac2 isoform expression. The presented data indicate that the tissue-specific expression of the Epac2 isoforms is epigenetically regulated, and identify tissue-specific differentially methylated promoter regions within the Epac2 locus that are essential for its transcriptional control.	[Hoivik, Erling A.; Witsoe, Solveig L.; Bergheim, Inger R.; Doskeland, Stein Ove; Bakke, Marit] Univ Bergen, Dept Biomed, Bergen, Norway; [Hoivik, Erling A.] Univ Bergen, Dept Clin Med, Sect Gynecol & Obstet, Bergen, Norway; [Xu, Yunjian; Jakobsson, Ida; Tengholm, Anders] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	University of Bergen; University of Bergen; Uppsala University	Bakke, M (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	Marit.Bakke@biomed.uib.no		Doskeland, Stein Ove/0000-0002-4009-4756	National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway; Meltzer Foundation; Swedish Diabetes Association; Family Ernfors' Foundation; Novo-Nordisk Foundation; Swedish Research Council	National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway(Research Council of Norway); Meltzer Foundation; Swedish Diabetes Association; Family Ernfors' Foundation; Novo-Nordisk Foundation(Novo Nordisk Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway, the Meltzer Foundation (MB), the Swedish Diabetes Association, Family Ernfors' Foundation, Novo-Nordisk Foundation and the Swedish Research Council (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS BIOL, V9, DOI [10.1371/journal.pbio.1001046, DOI 10.1371/JOURNAL.PBIO.1001046]; Aumo L, 2010, ENDOCRINOLOGY, V151, P2151, DOI 10.1210/en.2009-1139; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P6663, DOI 10.1073/pnas.89.14.6663; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Fukuda M, 2011, CELL METAB, V13, P331, DOI 10.1016/j.cmet.2011.01.016; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gloerich M, 2011, J CELL BIOL, V193, P1009, DOI 10.1083/jcb.201011126; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Hoivik EA, 2011, ENDOCRINOLOGY, V152, P2100, DOI 10.1210/en.2010-1305; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Islam D, 2009, AM J PHYSIOL-ENDOC M, V296, pE174, DOI 10.1152/ajpendo.90419.2008; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Landolin JM, 2010, GENOME RES, V20, P890, DOI 10.1101/gr.100370.109; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Niimura M, 2009, J CELL PHYSIOL, V219, P652, DOI 10.1002/jcp.21709; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Srivastava DP, 2012, J NEUROSCI, V32, P11864, DOI 10.1523/JNEUROSCI.1349-12.2012; Ueno H, 2001, GENOMICS, V78, P91, DOI 10.1006/geno.2001.6641; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yang Y, 2012, NEURON, V73, P774, DOI 10.1016/j.neuron.2012.02.003	44	39	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67925	10.1371/journal.pone.0067925	http://dx.doi.org/10.1371/journal.pone.0067925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861833	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700061
J	Viel, T; Schelhaas, S; Wagner, S; Wachsmuth, L; Schwegmann, K; Kuhlmann, M; Faber, C; Kopka, K; Schafers, M; Jacobs, AH				Viel, Thomas; Schelhaas, Sonja; Wagner, Stefan; Wachsmuth, Lydia; Schwegmann, Katrin; Kuhlmann, Michael; Faber, Cornelius; Kopka, Klaus; Schaefers, Michael; Jacobs, Andreas H.			Early Assessment of the Efficacy of Temozolomide Chemotherapy in Experimental Glioblastoma Using [F-18]FLT-PET Imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PROLIFERATION IN-VIVO; SMALL-ANIMAL PET; MALIGNANT GLIOMAS; FLT-PET; THERAPY; BRAIN; METHYLTRANSFERASE	Addition of temozolomide (TMZ) to radiation therapy is the standard treatment for patients with glioblastoma (GBM). However, there is uncertainty regarding the effectiveness of TMZ. Considering the rapid evolution of the disease, methods to assess TMZ efficacy early during treatment would be of great benefit. Our aim was to monitor early effects of TMZ in a mouse model of GBM using positron emission tomography (PET) with 3'-deoxy-3'-[F-18]fluorothymidine ([F-18]FLT). Methods: Human glioma cells sensitive to TMZ (Gli36dEGFR-1) were treated with sub-lethal doses of TMZ to obtain cells with lower sensitivity to TMZ (Gli36dEGFR-2), as measured by growth and clonogenic assays. Gli36dEGFR-1 and Gli36dEGFR-2 cells were subcutaneously (s.c.) or intracranially (i.c.) xenografted into nude mice. Mice were treated for 7 days with daily injection of 25 or 50 mg/kg TMZ. Treatment efficacy was measured using [F-18]FLT-PET before treatment and after 2 days. Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) were used to determine tumor volumes before treatment and after 7 days. Results: A significant difference was observed between TMZ and DMSO treated tumors in terms of variations of [F-18]FLT T/B ratio as soon as day 2 in the i.c. as well as in the s.c. mouse model. Variations of [F-18]FLT T/B uptake ratio between days 0 and 2 correlated with variations of tumor size between days 0 and 7 (s.c. model: n(tumor) = 17 in n(mice) = 11, P<0.01; i.c. model: n(tumor/mice) = 9, P<0.01). Conclusions: Our results indicate that [F-18]FLT-PET may be useful for an early evaluation of the response of GBM to TMZ chemotherapy in patients with glioma.	[Viel, Thomas; Schelhaas, Sonja; Schwegmann, Katrin; Kuhlmann, Michael; Schaefers, Michael; Jacobs, Andreas H.] Univ Munster, EIMI, D-48149 Munster, Germany; [Wagner, Stefan; Schaefers, Michael] Univ Munster, Dept Nucl Med, Univ Hosp Munster, D-48149 Munster, Germany; [Wachsmuth, Lydia; Faber, Cornelius] Univ Munster, Dept Radiol, Univ Hosp Munster, D-48149 Munster, Germany; [Schaefers, Michael; Jacobs, Andreas H.] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany; [Kopka, Klaus] German Canc Res Ctr, Heidelberg, Germany; [Jacobs, Andreas H.] Johanniter Krankenhaus, Dept Geriatr Med, Evangel Kliniken, Bonn, Germany	University of Munster; University of Munster; University of Munster; University of Munster; Helmholtz Association; German Cancer Research Center (DKFZ)	Jacobs, AH (corresponding author), Univ Munster, EIMI, D-48149 Munster, Germany.	ahjacobs@uni-muenster.de	Kopka, Klaus/AAM-7233-2020; Viel, Thomas/K-4576-2013; Jacobs, Andreas H./AAA-6794-2020; Faber, Cornelius/Q-2689-2016	Kopka, Klaus/0000-0003-4846-1271; Faber, Cornelius/0000-0001-7683-7710; Viel, Thomas/0000-0002-0756-9166; Schelhaas, Sonja/0000-0001-6928-4847	BMBF (Bundesministerium fur Bildung und Forschung) grant MoBiMed	BMBF (Bundesministerium fur Bildung und Forschung) grant MoBiMed	The authors thank the European Molecular Imaging Institute (EIMI Munster). This work was supported in part by BMBF (Bundesministerium fur Bildung und Forschung) grant MoBiMed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, CANCER GENE THER, V9, P228, DOI 10.1038/sj.cgt.7700437; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; Buckner JC, 2007, MAYO CLIN PROC, V82, P1271, DOI 10.4065/82.10.1271; Chen W, 2007, J CLIN ONCOL, V25, P4714, DOI 10.1200/JCO.2006.10.5825; Chen YL, 2010, J BIOL CHEM, V285, P27327, DOI 10.1074/jbc.M110.137042; de Wit MCY, 2004, NEUROLOGY, V63, P535, DOI 10.1212/01.WNL.0000133398.11870.9A; Galldiks N, 2010, MOL IMAGING, V9, P40, DOI 10.2310/7290.2010.00002; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Jacobs AH, 2005, J NUCL MED, V46, P1948; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Katz SI, 2011, INT J ONCOL, V39, P91, DOI 10.3892/ijo.2011.1019; Kumar AJ, 2000, RADIOLOGY, V217, P377, DOI 10.1148/radiology.217.2.r00nv36377; Machulla HJ, 2000, J RADIOANAL NUCL CH, V243, P843, DOI 10.1023/A:1010684101509; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Rueger MA, 2011, MOL IMAGING BIOL, V13, P547, DOI 10.1007/s11307-010-0361-6; Schafers KP, 2005, J NUCL MED, V46, P996; Schwarzenberg J, 2012, J NUCL MED, V53, P29, DOI 10.2967/jnumed.111.092387; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Silber JR, 2012, BBA-REV CANCER, V1826, P71, DOI 10.1016/j.bbcan.2011.12.004; Soloviev D, 2012, EUR J CANCER, V48, P416, DOI 10.1016/j.ejca.2011.11.035; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Ullrich R, 2008, CLIN CANCER RES, V14, P2049, DOI 10.1158/1078-0432.CCR-07-1553; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Viel T, 2012, J NUCL MED, V53, P1135, DOI 10.2967/jnumed.111.101659; Vollmar S., 2004, FORSCHUNG WISSENSCHA, P115; Waerzeggers Y, 2010, BBA-MOL BASIS DIS, V1802, P819, DOI 10.1016/j.bbadis.2010.04.009; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Weller M., 2011, SWISS MED WEEKLY, V24, P141; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wells P, 2002, CANCER RES, V62, P5698; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	32	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67911	10.1371/journal.pone.0067911	http://dx.doi.org/10.1371/journal.pone.0067911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861829	gold, Green Submitted, Green Published			2022-12-25	WOS:000323350700057
J	Xiao, JY; Zhang, GX; Qiu, PX; Liu, XJ; Wu, YY; Du, BY; Li, JF; Zhou, J; Li, JJ; Tan, YH				Xiao, Jianyong; Zhang, Guangxian; Qiu, Pengxiang; Liu, Xijuan; Wu, Yingya; Du, Biaoyan; Li, Jiefen; Zhou, Jing; Li, Jingjing; Tan, Yuhui			Tanshinone IIA Increases the Bystander Effect of Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy via Enhanced Gap Junctional Intercellular Communication	PLOS ONE			English	Article							IN-VITRO; BREAST-TUMORS; CELLS; CANCER; EXPRESSION; DIFFERENTIATION; CYTOTOXICITY; CONNEXIN-26; INDUCTION; CARCINOGENESIS	The bystander effect is an intriguing phenomenon by which adjacent cells become sensitized to drug treatment during gene therapy with herpes simplex virus thymidine kinase/ganciclovir (HSV-tk/GCV). This effect is reported to be mediated by gap junctional intercellular communication (GJIC), and therefore, we postulated that upregulation of genes that facilitate GJIC may enhance the HSV-tk/GCV bystander effect. Previous findings have shown Tanshinone IIA (Tan IIA), a chemical substance derived from a Chinese medicine herb, promotes the upregulation of the connexins Cx26 and Cx43 in B16 cells. Because gap junctions are formed by connexins, we hypothesized that Tan IIA might increase GJIC. Our results show that Tan IIA increased GJIC in B16 melanoma cells, leading to more efficient GCV-induced bystander killing in cells stably expressing HSV-tk. Additionally, in vivo experiments demonstrated that tumors in mice with 10% HSV-tk positive B16 cells and 90% wild-type B16 cells became smaller following treatment with the combination of GCV and Tan IIA as compared to GCV or Tan IIA alone. These data demonstrate that Tan IIA can augment the bystander effect of HSV-tk/GCV system through increased gap junction coupling, which adds strength to the promising strategy that develops connexins inducer to potentiate the effects of suicide gene therapy.	[Xiao, Jianyong; Zhang, Guangxian; Qiu, Pengxiang; Liu, Xijuan; Wu, Yingya; Li, Jiefen; Zhou, Jing; Li, Jingjing; Tan, Yuhui] Guangzhou Univ Chinese Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Du, Biaoyan] Guangzhou Univ Chinese Med, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Tan, YH (corresponding author), Guangzhou Univ Chinese Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China.	yuhuitan@yeah.net	谭, 育慧/AAP-4868-2021; Qiu, Pengxiang/J-7535-2019		National Natural Science Foundation of China [30973811, 81274145]; Guangdong Natural Science Foundation [S2012040007005]; Guangdong Provincial Administration of Chinese Traditional Medicine [20121227]; Ministry of Education, Science Technology Development Center [20124425120012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Administration of Chinese Traditional Medicine; Ministry of Education, Science Technology Development Center	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30973811 and 81274145), Guangdong Natural Science Foundation (No. S2012040007005), Guangdong Provincial Administration of Chinese Traditional Medicine (No. 20121227) and Ministry of Education, Science Technology Development Center (No. 20124425120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; Carystinos GD, 1999, CLIN CANCER RES, V5, P61; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; Elshami AA, 1996, GENE THER, V3, P85; FICK J, 1995, P NATL ACAD SCI USA, V92, P11071, DOI 10.1073/pnas.92.24.11071; Fish JM, 2006, CIRCULATION, V113, P1393, DOI 10.1161/CIRCULATIONAHA.105.601690; Garcia-Rodriguez L, 2011, MOL CANCER THER, V10, P505, DOI 10.1158/1535-7163.MCT-10-0693; GOLDBERG GS, 1995, BIOTECHNIQUES, V18, P490; Haass NK, 2006, J HISTOCHEM CYTOCHEM, V54, P171, DOI 10.1369/jhc.5A6719.2005; Haass NK, 2004, J MOL HISTOL, V35, P309; Holden PR, 1997, CARCINOGENESIS, V18, P15, DOI 10.1093/carcin/18.1.15; HOSSAIN MZ, 1994, CELL GROWTH DIFFER, V5, P1253; Jamieson S, 1998, J PATHOL, V184, P37, DOI 10.1002/(SICI)1096-9896(199801)184:1<37::AID-PATH966>3.0.CO;2-D; Jin ZJ, 2004, ACTA PHARMACOL SIN, V25, P146; KOZARSKY KF, 1993, CURR OPIN GENET DEV, V3, P499, DOI 10.1016/0959-437X(93)90126-A; Laird DW, 1999, CANCER RES, V59, P4104; Lawrence TS, 1998, CANCER RES, V58, P2588; Lin R, 2006, J ETHNOPHARMACOL, V108, P217, DOI 10.1016/j.jep.2006.05.004; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042138; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; MEHTA PP, 1991, J MEMBRANE BIOL, V124, P207, DOI 10.1007/BF01994355; Mesnil M, 2000, CANCER RES, V60, P3989; Mesnil M, 1997, CANCER RES, V57, P2929; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; MILLER AD, 1992, NATURE, V357, P455, DOI 10.1038/357455a0; MOOLTEN FL, 1994, CANCER GENE THER, V1, P279; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Park JY, 1997, GENE THER, V4, P909, DOI 10.1038/sj.gt.3300477; Proulx AA, 1997, CELL GROWTH DIFFER, V8, P533; Putzer BM, 1998, HUM GENE THER, V9, P707, DOI 10.1089/hum.1998.9.5-707; Rezze GG, 2011, HUM PATHOL, V42, P409, DOI 10.1016/j.humpath.2010.09.004; Saito-Katsuragi M, 2007, CANCER, V110, P1162, DOI 10.1002/cncr.22894; Saitoh M, 1997, CARCINOGENESIS, V18, P1319, DOI 10.1093/carcin/18.7.1319; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Wang J, 2007, J NEURO-ONCOL, V82, P11, DOI 10.1007/s11060-006-9242-x; Wygoda MR, 1997, CANCER RES, V57, P1699; Yang J, 2012, MOL VIS, V18, P2053; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3; Zhang Y, 2010, CELL PHYSIOL BIOCHEM, V26, P991, DOI 10.1159/000324012	40	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67662	10.1371/journal.pone.0067662	http://dx.doi.org/10.1371/journal.pone.0067662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861780	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700019
J	Auersperg, AMI; Kacelnik, A; von Bayern, AMP				Auersperg, Alice M. I.; Kacelnik, Alex; von Bayern, Auguste M. P.			Explorative Learning and Functional Inferences on a Five-Step Means-Means-End Problem in Goffin's Cockatoos (Cacatua goffini)	PLOS ONE			English	Article							TOOL; MANUFACTURE	To investigate cognitive operations underlying sequential problem solving, we confronted ten Goffin's cockatoos with a baited box locked by five different inter-locking devices. Subjects were either naive or had watched a conspecific demonstration, and either faced all devices at once or incrementally. One naive subject solved the problem without demonstration and with all locks present within the first five sessions (each consisting of one trial of up to 20 minutes), while five others did so after social demonstrations or incremental experience. Performance was aided by species-specific traits including neophilia, a haptic modality and persistence. Most birds showed a ratchet-like progress, rarely failing to solve a stage once they had done it once. In most transfer tests subjects reacted flexibly and sensitively to alterations of the locks' sequencing and functionality, as expected from the presence of predictive inferences about mechanical interactions between the locks.	[Auersperg, Alice M. I.] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Kacelnik, Alex; von Bayern, Auguste M. P.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Auersperg, Alice M. I.; von Bayern, Auguste M. P.] Max Planck Inst Ornithol, Seewiesen, Germany	University of Vienna; University of Oxford; Max Planck Society	Auersperg, AMI (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	alice.auersperg@univie.ac.at; alex.kacelnik@zoo.ox.ac.uk		Auersperg, Alice/0000-0001-7405-9791; von Bayern, Auguste/0000-0002-0981-9456	Austria Science Fond (FWF) [J 3404-B19]; Austrian Science Fund (FWF) [J 3404] Funding Source: researchfish	Austria Science Fond (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This Project was supported by the Austria Science Fond (FWF) Project no. J 3404-B19 to Alice Auersperg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg AMI, 2012, CURR BIOL, V22, pR903, DOI 10.1016/j.cub.2012.09.002; Auersperg AMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020231; Auersperg AMI, 2010, ANIM BEHAV, V80, P783, DOI 10.1016/j.anbehav.2010.08.007; Auersperg AMI, 2013, J COMP PSYC IN PRESS; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; Chappell J, 2012, BEHAV PROCESS, V89, P179, DOI 10.1016/j.beproc.2011.10.001; Cheke LG, 2011, ANIM COGN, V14, P441, DOI 10.1007/s10071-011-0379-4; Diefenbach K, 1985, KAKADUS ENZYKLOPADIE; EPSTEIN R, 1984, NATURE, V308, P61, DOI 10.1038/308061a0; Epstein R, 1999, 2 ENCY CREATIVITY; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Higgins P. J., 1999, HDB AUSTR NZ ANTARCT, V4, P1049; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Martin-Ordas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052074; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Miyata H, 2011, ANIM COGN, V14, P45, DOI 10.1007/s10071-010-0342-9; Overington SE, 2011, BEHAV PROCESS, V87, P274, DOI 10.1016/j.beproc.2011.06.002; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Povinelli D.J., 2000, FOLK PHYS APES CHIMP; Power T. G., 2000, PLAY EXPLORATION CHI; Santos LR, 2005, ANIM COGN, V8, P236, DOI 10.1007/s10071-004-0246-7; Shettleworth S.J., 2009, COGNITION EVOLUTION; Shumaker R.W., 2011, ANIMAL TOOL BEHAV US; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Tomasello M, 1997, PRIMATE COGNITION; Whiten A, 1996, J COMP PSYCHOL, V110, P3, DOI 10.1037/0735-7036.110.1.3; Wimpenny JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006471	34	34	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68979	10.1371/journal.pone.0068979	http://dx.doi.org/10.1371/journal.pone.0068979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844247	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000031
J	Arevalo, H; Plank, G; Helm, P; Halperin, H; Trayanova, N				Arevalo, Hermenegild; Plank, Gernot; Helm, Patrick; Halperin, Henry; Trayanova, Natalia			Tachycardia in Post-Infarction Hearts: Insights from 3D Image-Based Ventricular Models	PLOS ONE			English	Article							EPICARDIAL BORDER ZONE; INFARCT TISSUE HETEROGENEITY; GAP-JUNCTION DISTRIBUTION; REENTRANT CIRCUITS; MYOCARDIAL INFARCTS; CONDUCTION-VELOCITY; IRREVERSIBLE INJURY; SUSCEPTIBILITY; ARRHYTHMIA; CURRENTS	Ventricular tachycardia, a life-threatening regular and repetitive fast heart rhythm, frequently occurs in the setting of myocardial infarction. Recently, the peri-infarct zones surrounding the necrotic scar (termed gray zones) have been shown to correlate with ventricular tachycardia inducibility. However, it remains unknown how the latter is determined by gray zone distribution and size. The goal of this study is to examine how tachycardia circuits are maintained in the infarcted heart and to explore the relationship between the tachycardia organizing centers and the infarct gray zone size and degree of heterogeneity. To achieve the goals of the study, we employ a sophisticated high-resolution electrophysiological model of the infarcted canine ventricles reconstructed from imaging data, representing both scar and gray zone. The baseline canine ventricular model was also used to generate additional ventricular models with different gray zone sizes, as well as models in which the gray zone was represented as different heterogeneous combinations of viable tissue and necrotic scar. The results of the tachycardia induction simulations with a number of high-resolution canine ventricular models (22 altogether) demonstrated that the gray zone was the critical factor resulting in arrhythmia induction and maintenance. In all models with inducible arrhythmia, the scroll-wave filaments were contained entirely within the gray zone, regardless of its size or the level of heterogeneity of its composition. The gray zone was thus found to be the arrhythmogenic substrate that promoted wavebreak and reentry formation. We found that the scroll-wave filament locations were insensitive to the structural composition of the gray zone and were determined predominantly by the gray zone morphology and size. The findings of this study have important implications for the advancement of improved criteria for stratifying arrhythmia risk in post-infarction patients and for the development of new approaches for determining the ablation targets of infarct-related tachycardia.	[Arevalo, Hermenegild; Trayanova, Natalia] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Plank, Gernot] Med Univ Graz, Inst Biophys, Graz, Austria; [Helm, Patrick] Medtronic Inc, Minneapolis, MN USA; [Halperin, Henry] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Johns Hopkins University; Medical University of Graz; Medtronic; Johns Hopkins University	Trayanova, N (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	ntrayanova@jhu.edu	Plank, Gernot/O-3791-2019; Plank, Gernot/C-9498-2011	Plank, Gernot/0000-0002-7380-6908; Plank, Gernot/0000-0002-7380-6908; Trayanova, Natalia/0000-0002-8661-063X	National Intitutes of Health [R01-HL094610, R01-HL103428, R01-HL105216]; NIH [F31-HL099275]; Austrian Science Fund FWF [F3210-N18]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094610, R01HL103428, F31HL099275, R01HL105216] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3201] Funding Source: researchfish	National Intitutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project was supported by National Intitutes of Health grants R01-HL094610, R01-HL103428, R01-HL105216, NIH fellowship F31-HL099275, and Austrian Science Fund FWF grant F3210-N18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo H, 2007, CHAOS, V17, DOI 10.1063/1.2430637; Arheden H, 2000, RADIOLOGY, V215, P520, DOI 10.1148/radiology.215.2.r00ma38520; Ashikaga H, 2007, CIRC RES, V101, P939, DOI 10.1161/CIRCRESAHA.107.158980; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bishop MJ, 2011, IEEE T BIO-MED ENG, V58, P1066, DOI 10.1109/TBME.2010.2096425; Brignole M, 2009, EUROPACE, V11, P1129, DOI 10.1093/europace/eup174; Cabo C, 2006, CARDIOVASC RES, V72, P241, DOI 10.1016/j.cardiores.2006.07.005; Curtis JP, 2009, JAMA-J AM MED ASSOC, V301, P1661, DOI 10.1001/jama.2009.547; de Bakker JMT, 2006, J CARDIOVASC ELECTR, V17, P567, DOI 10.1111/j.1540-8167.2006.00367.x; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; Decker KF, 2010, AM J PHYSIOL-HEART C, V299, pH1588, DOI 10.1152/ajpheart.00362.2010; Dun W, 2004, AM J PHYSIOL-HEART C, V287, pH1046, DOI 10.1152/ajpheart.00082.2004; Engelman ZJ, 2010, CIRC-ARRHYTHMIA ELEC, V3, P195, DOI 10.1161/CIRCEP.109.890459; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Estner HL, 2011, HEART RHYTHM, V8, P1942, DOI 10.1016/j.hrthm.2011.07.027; Fieno DS, 2000, J AM COLL CARDIOL, V36, P1985, DOI 10.1016/S0735-1097(00)00958-X; Gima K, 2002, CIRC RES, V90, P889, DOI 10.1161/01.RES.0000016960.61087.86; Greener ID, 2012, J AM COLL CARDIOL, V60, P1103, DOI 10.1016/j.jacc.2012.04.042; Gurev V, 2011, BIOMECH MODEL MECHAN, V10, P295, DOI 10.1007/s10237-010-0235-5; HARALICK RM, 1987, IEEE T PATTERN ANAL, V9, P532, DOI 10.1109/TPAMI.1987.4767941; Igarashi T, 2012, CIRCULATION, V125, P216, DOI 10.1161/CIRCULATIONAHA.111.053272; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Larson C, 2003, ANN BIOMED ENG, V31, P768, DOI 10.1114/1.1581289; LIMA JAC, 1995, CIRCULATION, V92, P1117, DOI 10.1161/01.CIR.92.5.1117; LUO CH, 1994, CIRC RES, V74, P1097, DOI 10.1161/01.RES.74.6.1097; McDowell KS, 2011, BIOPHYS J, V101, P1307, DOI 10.1016/j.bpj.2011.08.009; Moreno JD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002588; Ng J, 2012, J AM COLL CARDIOL, V60, P423, DOI 10.1016/j.jacc.2012.03.029; Peters NS, 1997, CIRCULATION, V95, P988; Plank G, 2008, PHILOS T R SOC A, V366, P3381, DOI 10.1098/rsta.2008.0112; Prassl AJ, 2009, IEEE T BIO-MED ENG, V56, P1318, DOI 10.1109/TBME.2009.2014243; Pu JL, 1997, CIRC RES, V81, P110, DOI 10.1161/01.RES.81.1.110; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; Rocha BM, 2011, IEEE T BIO-MED ENG, V58, P1055, DOI 10.1109/TBME.2010.2064167; Rodriguez B, 2004, AM J PHYSIOL-HEART C, V286, pH2078, DOI 10.1152/ajpheart.01175.2003; Roes SD, 2009, CIRC-CARDIOVASC IMAG, V2, P183, DOI 10.1161/CIRCIMAGING.108.826529; Rutherford SL, 2012, CIRC RES, V111, P301, DOI 10.1161/CIRCRESAHA.111.260943; Sasano T, 2006, NAT MED, V12, P1256, DOI 10.1038/nm1503; Schmidt A, 2007, CIRCULATION, V115, P2006, DOI 10.1161/CIRCULATIONAHA.106.653568; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; SMITH JH, 1991, AM J PATHOL, V139, P801; Strijkers GJ, 2009, NMR BIOMED, V22, P182, DOI 10.1002/nbm.1299; URSELL PC, 1985, CIRC RES, V56, P436, DOI 10.1161/01.RES.56.3.436; Vadakkumpadan F, 2010, WIRES SYST BIOL MED, V2, P489, DOI 10.1002/wsbm.76; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Winfree A.T., 1987, TIME BREAKS 3 DIMENS; Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4; Yan AT, 2006, CIRCULATION, V114, P32, DOI 10.1161/CIRCULATIONAHA.106.613414; Yao JA, 2003, CIRC RES, V92, P437, DOI 10.1161/01.RES.0000059301.81035.06; Zipes DP, 2006, EUR HEART J, V27, P2099, DOI 10.1093/eurheartj/ehl199; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	55	62	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68872	10.1371/journal.pone.0068872	http://dx.doi.org/10.1371/journal.pone.0068872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844245	Green Submitted, gold, Green Published			2022-12-25	WOS:000321341000182
J	Cheng, M; Guan, XM; Li, H; Cui, XD; Zhang, XY; Li, X; Jing, X; Wu, HY; Avsar, E				Cheng, Min; Guan, Xiumei; Li, Hong; Cui, Xiaodong; Zhang, Xiaoyun; Li, Xin; Jing, Xu; Wu, Haiyan; Avsar, Emil			Shear Stress Regulates Late EPC Differentiation via Mechanosensitive Molecule-Mediated Cytoskeletal Rearrangement	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; FOCAL ADHESIONS; NEOINTIMAL FORMATION; ACTIVATION; INTEGRINS; REENDOTHELIALIZATION; MECHANOTRANSDUCTION; ATHEROSCLEROSIS; RECRUITMENT; DYNAMICS	Background: Previous studies have demonstrated that endothelial progenitor cells (EPCs), in particular late EPCs, play important roles in endothelial maintenance and repair. Recent evidence has revealed shear stress as a key regulator for EPC differentiation. However, the underlying mechanisms regulating the shear stress-induced EPC differentiation have not been understood completely. The present study was undertaken to further investigate the effects of shear stress on the late EPC differentiation, and to elucidate the signal mechanism involved. Methodology/Principal Finding: In vitro and in vivo assays revealed that cytoskeletal remodeling was involved in the shear stress-upregulated expression of endothelial markers vWF and CD31 in late EPCs, with subsequently increased in vivo reendothelialization after arterial injury. Moreover, shear stress activated several mechanosensitive molecules including integrin beta(1), Ras, ERK1/2, paxillin and FAK, which were all involved in both cytoskeletal rearrangement and cell differentiation in response to shear stress in late EPCs. Conclusions/Significance: Shear stress is a key regulator for late EPC differentiation into endothelial cells, which is important for vascular repair, and the cytoskeletal rearrangement mediated by the activation of the cascade of integrin beta(1), Ras, ERK1/2, paxillin and FAK is crucial in this process.	[Cheng, Min; Guan, Xiumei; Li, Hong; Cui, Xiaodong; Zhang, Xiaoyun; Li, Xin; Jing, Xu; Wu, Haiyan] Weifang Med Univ, Med Res Ctr, Weifang, Shandong, Peoples R China; [Avsar, Emil] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Weifang Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cheng, M (corresponding author), Weifang Med Univ, Med Res Ctr, Weifang, Shandong, Peoples R China.	chengmin1976@wfmc.edu.cn			National Natural Science Foundation of China [30900290, 31270993]; Shandong Provincial Natural Science Foundation [ZR2009CQ027]; Program for New Century Excellent Talents in University [NCET-10-0922]; Shandong Province Higher Educational Science and Technology Program [J09LF06]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shandong Province Higher Educational Science and Technology Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by the National Natural Science Foundation of China [grant numbers 30900290, 31270993], the Shandong Provincial Natural Science Foundation [grant number ZR2009CQ027], the Program for New Century Excellent Talents in University [grant number NCET-10-0922], the Shandong Province Higher Educational Science and Technology Program [grant number J09LF06], and the Project-sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan T, 2010, TISSUE ENG PT A, V16, P3547, DOI [10.1089/ten.tea.2010.0014, 10.1089/ten.TEA.2010.0014]; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Brown MA, 2009, TISSUE ENG PT A, V15, P3575, DOI 10.1089/ten.TEA.2008.0444; Campioni D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056377; Cecchi E, 2011, ATHEROSCLEROSIS, V214, P249, DOI 10.1016/j.atherosclerosis.2010.09.008; Cohen D. M., 2008, MECH CONTROL STEM CE; Cui XD, 2012, BIOCHEM BIOPH RES CO, V425, P419, DOI 10.1016/j.bbrc.2012.07.115; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Koskinas KC, 2012, J AM COLL CARDIOL, V59, P1337, DOI 10.1016/j.jacc.2011.10.903; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Obi S, 2012, AM J PHYSIOL-CELL PH, V303, pC595, DOI 10.1152/ajpcell.00133.2012; Osborn EA, 2006, AM J PHYSIOL-CELL PH, V290, pC444, DOI 10.1152/ajpcell.00218.2005; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Shepherd BR, 2006, FASEB J, V20, P1739, DOI 10.1096/fj.05-5682fje; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Tanaka K, 2008, FASEB J, V22, P428, DOI 10.1096/fj.06-6884com; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; van Zyp JV, 2006, CANCER BIOL THER, V5, P1169; Vittorio O, 2013, INTEGR BIOL-UK, V5, P291, DOI 10.1039/c2ib20152f; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Xia WH, 2012, HYPERTENSION, V59, P1225, DOI 10.1161/HYPERTENSIONAHA.111.179820; Xiaodong C, 2012, J MED BIOMECHANICS, V27, P548; Xu QB, 2006, NAT CLIN PRACT CARD, V3, P94, DOI 10.1038/ncpcardio0396; Ye C, 2008, CLIN BIOMECH, V23, pS118, DOI 10.1016/j.clinbiomech.2007.08.018; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050899; Ziegler ME, 2012, AM J PHYSIOL-CELL PH, V303, pC872, DOI 10.1152/ajpcell.00199.2012	37	34	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67675	10.1371/journal.pone.0067675	http://dx.doi.org/10.1371/journal.pone.0067675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844056	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000072
J	Conza, L; Pagani, SC; Gaia, V				Conza, Lisa; Pagani, Simona Casati; Gaia, Valeria			Presence of Legionella and Free-Living Amoebae in Composts and Bioaerosols from Composting Facilities	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; POTTING SOILS; PNEUMOPHILA; COCULTURE; AEROSOLS; WATER; SURVIVAL; SAMPLES	Several species of Legionella cause Legionnaires' disease (LD). Infection may occur through inhalation of Legionella or amoebal vesicles. The reservoirs of Legionella are water, soil, potting soil and compost. Some species of free-living amoebae (FLA) that are naturally present in water and soil were described as hosts for Legionella. This study aimed to understand whether or not the composting facilities could be sources of community-acquired Legionella infections after development of bioaerosols containing Legionella or FLA. We looked for the presence of Legionella (by co-culture) and FLA (by culture) in composts and bioaerosols collected at four composting facilities located in southern Switzerland. We investigated the association between the presence of Legionella and compost and air parameters and presence of FLA. Legionella spp. (including L. pneumophila) were detected in 69.3% (61/88) of the composts and FLA (mainly Acanthamoeba, Vermamoeba, Naegleria and Stenamoeba) in 92.0% (81/88). L. pneumophila and L. bozemanii were most frequently isolated. FLA as potential host for Legionella spp. were isolated from 40.9% (36/88) of the composts in all facilities. In Legionella-positive samples the temperature of compost was significantly lower (P = 0.012) than in Legionella-negative samples. Of 47 bioaerosol samples, 19.1% (9/47) were positive for FLA and 10.6% (5/47) for L. pneumophila. Composts (62.8%) were positive for Legionella and FLA contemporaneously, but both microorganisms were never detected simultaneously in bioaerosols. Compost can release bioaerosol containing FLA or Legionella and could represent a source of infection of community-acquired Legionella infections for workers and nearby residents.	[Conza, Lisa; Pagani, Simona Casati; Gaia, Valeria] Swiss Natl Reference Ctr Legionella, Cantonal Inst Microbiol, Bellinzona, Switzerland		Conza, L (corresponding author), Swiss Natl Reference Ctr Legionella, Cantonal Inst Microbiol, Bellinzona, Switzerland.	lisaconza@gmail.com			Ticino Pulmonary League; Lung Leagues of the Canton Ticino; Dr. Pierluigi Crivelli Foundation	Ticino Pulmonary League; Lung Leagues of the Canton Ticino; Dr. Pierluigi Crivelli Foundation	The work has been partially supported by the Ticino Pulmonary League. A special thanks to Lung Leagues of the Canton Ticino and to the Dr. Pierluigi Crivelli Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BERENDT RF, 1980, J INFECT DIS, V141, P689, DOI 10.1093/infdis/141.5.689; Blatny JM, 2008, ENVIRON SCI TECHNOL, V42, P7360, DOI 10.1021/es800306m; Carvalho E, 2008, AEROBIOLOGIA, V24, P191, DOI 10.1007/s10453-008-9098-y; Casati S, 2010, CLIN MICROBIOL INFEC, V16, P945, DOI 10.1111/j.1469-0691.2009.03009.x; Casati S, 2009, CLIN MICROBIOL INFEC, V15, P571, DOI 10.1111/j.1469-0691.2009.02742.x; Conza L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-49; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; Declerck P, 2007, WATER RES, V41, P3159, DOI 10.1016/j.watres.2007.04.011; den Boer JW, 2007, CLIN MICROBIOL INFEC, V13, P88, DOI 10.1111/j.1469-0691.2006.01562.x; DENNIS PJ, 1988, J APPL BACTERIOL, V65, P135, DOI 10.1111/j.1365-2672.1988.tb01501.x; DENNIS PJL, 1984, J HYG-CAMBRIDGE, V93, P349, DOI 10.1017/S0022172400064901; Descours G, 2012, J CLIN MICROBIOL, V50, P1725, DOI 10.1128/JCM.06531-11; Dey R, 2009, FEMS MICROBIOL LETT, V290, P10, DOI 10.1111/j.1574-6968.2008.01387.x; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Fracchia L, 2006, J APPL MICROBIOL, V100, P973, DOI 10.1111/j.1365-2672.2006.02846.x; Gaia V, 2011, SYST APPL MICROBIOL, V34, P40, DOI 10.1016/j.syapm.2010.11.007; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Helbig JH, 2002, EUR J CLIN MICROBIOL, V21, P710, DOI 10.1007/s10096-002-0820-3; Helbig JH, 1997, J CLIN MICROBIOL, V35, P2841, DOI 10.1128/JCM.35.11.2841-2845.1997; Hryhorczuk D, 2001, ANN AGR ENV MED, V8, P177; Joseph CA, 2010, EURO SURVEILL; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; Lin H, 2009, J APPL MICROBIOL, V106, P606, DOI 10.1111/j.1365-2672.2008.04031.x; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; Ratcliff RM, 1998, J CLIN MICROBIOL, V36, P1560, DOI 10.1128/JCM.36.6.1560-1567.1998; RODRIGUEZZARAGOZA S, 1994, CRIT REV MICROBIOL, V20, P225, DOI 10.3109/10408419409114556; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; Sanchez-Monedero MA, 2005, J AIR WASTE MANAGE, V55, P612, DOI 10.1080/10473289.2005.10464652; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P342, DOI 10.1128/CMR.15.3.342-354.2002; STEELE TW, 1990, APPL ENVIRON MICROB, V56, P2984, DOI 10.1128/AEM.56.10.2984-2988.1990; Storey MV, 2004, SCAND J INFECT DIS, V36, P656, DOI 10.1080/00365540410020785; Taha MPM, 2005, WASTE MANAGE, V25, P445, DOI 10.1016/j.wasman.2005.02.013; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006	33	37	38	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68244	10.1371/journal.pone.0068244	http://dx.doi.org/10.1371/journal.pone.0068244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844174	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000146
J	Hall, LK; Larsen, RT; Knight, RN; Bunnell, KD; McMillan, BR				Hall, Lucas K.; Larsen, Randy T.; Knight, Robert N.; Bunnell, Kevin D.; McMillan, Brock R.			Water Developments and Canids in Two North American Deserts: A Test of the Indirect Effect of Water Hypothesis	PLOS ONE			English	Article							JOAQUIN KIT FOXES; WESTERN UNITED-STATES; GREAT-BASIN DESERT; SOUTHWESTERN ARIZONA; DISPERSAL DISTANCE; LAKE BONNEVILLE; MULE DEER; WILDLIFE; COYOTES; PREDATION	Anthropogenic modifications to landscapes intended to benefit wildlife may negatively influence wildlife communities. Anthropogenic provisioning of free water (water developments) to enhance abundance and distribution of wildlife is a common management practice in arid regions where water is limiting. Despite the long-term and widespread use of water developments, little is known about how they influence native species. Water developments may negatively influence arid-adapted species (e. g., kit fox, Vulpes macrotis) by enabling water-dependent competitors (e.g., coyote, Canis latrans) to expand distribution in arid landscapes (i.e., indirect effect of water hypothesis). We tested the two predictions of the indirect effect of water hypothesis (i.e., coyotes will visit areas with free water more frequently and kit foxes will spatially and temporally avoid coyotes) and evaluated relative use of free water by canids in the Great Basin and Mojave Deserts from 2010 to 2012. We established scent stations in areas with (wet) and without (dry) free water and monitored visitation by canids to these sites and visitation to water sources using infrared-triggered cameras. There was no difference in the proportions of visits to scent stations in wet or dry areas by coyotes or kit foxes at either study area. We did not detect spatial (no negative correlation between visits to scent stations) or temporal (no difference between times when stations were visited) segregation between coyotes and kit foxes. Visitation to water sources was not different for coyotes between study areas, but kit foxes visited water sources more in Mojave than Great Basin. Our results did not support the indirect effect of water hypothesis in the Great Basin or Mojave Deserts for these two canids.	[Hall, Lucas K.; Larsen, Randy T.; McMillan, Brock R.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Larsen, Randy T.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [Knight, Robert N.] United States Army Dugway Proving Ground, Environm Programs, Dugway, UT USA; [Bunnell, Kevin D.] Utah Div Wildlife Resources, Salt Lake City, UT USA	Brigham Young University; Brigham Young University	Hall, LK (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA.	lucashall4@gmail.com			United States Army Dugway Proving Ground; Utah Division of Wildlife Resources	United States Army Dugway Proving Ground; Utah Division of Wildlife Resources	Funding for this project was provided by the United States Army Dugway Proving Ground and the Utah Division of Wildlife Resources. RN Knight (US Army Dugway Proving Ground) and KD Bunnell (Utah Division of Wildlife Resources) were involved in the preparation of the manuscript. The funders had no role in study design, data collection and analysis, or decision to publish.	Arjo WM, 2007, WEST N AM NATURALIST, V67, P389, DOI 10.3398/1527-0904(2007)67[389:CIKFRI]2.0.CO;2; Atwood TC, 2011, J WILDLIFE MANAGE, V75, P1609, DOI 10.1002/jwmg.225; Atwood TC, 2010, J MAMMAL, V91, P490, DOI 10.1644/09-MAMM-A-078.1; Bleich VC, 2006, WILDLIFE SOC B, V34, P627, DOI 10.2193/0091-7648(2006)34[627:QOWATW]2.0.CO;2; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.1890/0012-9658(2002)083[2049:DDOMIP]2.0.CO;2; Brawata RL, 2011, WILDLIFE RES, V38, P426, DOI 10.1071/WR10169; BROECKER WS, 1965, GEOL SOC AM BULL, V76, P537, DOI 10.1130/0016-7606(1965)76[537:RCOLLA]2.0.CO;2; Broyles B, 1995, WILDLIFE SOC B, V23, P663; Cain JW, 2006, WILDLIFE SOC B, V34, P570, DOI 10.2193/0091-7648(2006)34[570:MOTAWB]2.0.CO;2; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Cooper SM, 2000, WILDLIFE SOC B, V28, P660; CURREY DR, 1990, PALAEOGEOGR PALAEOCL, V76, P189, DOI 10.1016/0031-0182(90)90113-L; Cutler TL, 1998, SOUTHWEST NAT, V43, P155; Cypher BL, 1998, J MAMMAL, V79, P204, DOI 10.2307/1382855; Cypher BL, 2000, WILDLIFE MONOGR, P1; Cypher Brian L., 1992, Proceedings of the Vertebrate Pest Conference, V15, P42; Dennis B, 2000, J WILDLIFE MANAGE, V64, P388, DOI 10.2307/3803237; EGOSCUE H. J., 1956, JOUR MAMMAL, V37, P351, DOI 10.2307/1376734; GOLIGHTLY RT, 1984, J MAMMAL, V65, P51, DOI 10.2307/1381199; GOLIGHTLY RT, 1983, J MAMMAL, V64, P624, DOI 10.2307/1380518; Hall LK, 2013, BEHAV PROCESS, V94, P76, DOI 10.1016/j.beproc.2012.12.007; Hamilton AM, 2002, AM MIDL NAT, V147, P123, DOI 10.1674/0003-0031(2002)147[0123:EODFHA]2.0.CO;2; HERVERT JJ, 1986, J WILDLIFE MANAGE, V50, P670, DOI 10.2307/3800979; Horn KJ, 2012, J ARID ENVIRON, V77, P54, DOI 10.1016/j.jaridenv.2011.10.003; Kendall M. G., 1962, RANK CORRELATION MET; Kozlowski AJ, 2008, AM MIDL NAT, V160, P191, DOI 10.1674/0003-0031(2008)160[191:NOARPB]2.0.CO;2; Krausman PR, 2006, WILDLIFE SOC B, V34, P563, DOI 10.2193/0091-7648(2006)34[563:DWFWSP]2.0.CO;2; Larsen RT, 2012, CALIF FISH GAME, V98, P148; Longshore KM, 2009, J ARID ENVIRON, V73, P280, DOI 10.1016/j.jaridenv.2008.09.021; Martinson TJ, 2003, WILDLIFE SOC B, V31, P510; McGrew JC, 1979, MAMM SPECIES, V123, P1; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; MILLS LS, 1991, CAN J ZOOL, V69, P1516, DOI 10.1139/z91-212; Moehrenschlager A, 2007, J MAMMAL, V88, P1029, DOI 10.1644/06-MAMM-A-159R.1; Morgart JR, 2005, WILDLIFE SOC B, V33, P51, DOI 10.2193/0091-7648(2005)33[51:SPUOAA]2.0.CO;2; Neale JCC, 2001, OIKOS, V94, P236, DOI 10.1034/j.1600-0706.2001.940204.x; Nelson JL, 2007, J WILDLIFE MANAGE, V71, P1467, DOI 10.2193/2006-234; O'Brien CS, 2006, WILDLIFE SOC B, V34, P582, DOI 10.2193/0091-7648(2006)34[582:WUOWCI]2.0.CO;2; O'Farrell T.P., 1999, WILD FURBEARER MANAG, P422; OwenSmith N, 1996, S AFR J WILDL RES, V26, P107; R Development Core Team, 2011, R LANG ENV STAT COMP; RAUTENSTRAUCH KR, 1989, J MAMMAL, V70, P197, DOI 10.2307/1381689; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Simpson NO, 2011, CALIF FISH GAME, V97, P190; VALLENTINE JF, 1980, RANGE DEV IMPROVEMEN; Warrick GD, 1999, SOUTHWEST NAT, V44, P367; Warrick GD, 1998, J WILDLIFE MANAGE, V62, P707, DOI 10.2307/3802347; WHITE PJ, 1994, CAN J ZOOL, V72, P1831, DOI 10.1139/z94-247; White PJ, 1996, J MAMMAL, V77, P370, DOI 10.2307/1382810; WHITE PJ, 1995, SOUTHWEST NAT, V40, P342; Zar JH, 1999, BIOSTATISTICAL ANAL	52	13	13	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67800	10.1371/journal.pone.0067800	http://dx.doi.org/10.1371/journal.pone.0067800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844097	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000100
J	Kim, JJ; Cho, HW; Park, HR; Jung, U; Jo, SK; Yee, ST				Kim, Jong-Jin; Cho, Hyun Wook; Park, Hae-Ran; Jung, Uhee; Jo, Sung-Kee; Yee, Sung-Tae			Preventative Effect of an Herbal Preparation (HemoHIM) on Development of Airway Inflammation in Mice via Modulation of Th1/2 Cells Differentiation	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; TH2 POLARIZATION; MOUSE MODEL; T-CELLS; ASTHMA; HYPERRESPONSIVENESS; SUPPRESSION; INHIBITION; RESPONSES; EXTRACT	HemoHIM, an herbal preparation of three edible herbs (Angelica gigas Nakai, Cnidium officinale Makino, Paeonia japonica Miyabe) is known to increase the Th1 immune response as well as reduce the allergic response in human mast cells. Here, our goal was to determine whether or not HemoHIM could induce Th1 cell differentiation as well as inhibit the development of airway inflammation. To study Th1/Th2 cell differentiation, naive CD4(+) T cells isolated from C57BL/6 mouse spleens were cultured with or without HemoHIM. To examine airway inflammation, C57BL/6 mice were fed HemoHIM for 4 weeks before sensitization and provocation with ovalbumin (OVA). In an in vitro experiment, naive CD4(+) T cells displayed increased Th1 (IFN-gamma(+) cell) as well as decreased Th2 (IL-4(+) cell) differentiation in a HemoHIM concentration-dependent manner. Furthermore, in an airway inflammation mice model, eosinophil numbers in BALF, serum levels of OVA-specific IgE and IgG1, and cytokine (IL-4, IL-5, and IL-13) levels in BALF and the supernatant of splenocytes all decreased upon HemoHIM (100 mg/kg body weight) pretreatment (4 weeks). These results show that HemoHIM attenuated allergic airway inflammation in the mouse model through regulation of the Th1/Th2 balance.	[Kim, Jong-Jin; Cho, Hyun Wook; Yee, Sung-Tae] Sunchon Natl Univ, Dept Biol, Sunchon, South Korea; [Park, Hae-Ran; Jung, Uhee; Jo, Sung-Kee] Korea Atom Energy Res Inst KAERI, Radiat Res Div Biotechnol, Adv Radiat Technol Inst, Jeongeup, South Korea; [Yee, Sung-Tae] Sunchon Natl Univ, Dept Pharm, Sunchon, South Korea	Sunchon National University; Korea Atomic Energy Research Institute (KAERI); Sunchon National University	Yee, ST (corresponding author), Sunchon Natl Univ, Dept Biol, Sunchon, South Korea.	sungtae@sunchon.ac.kr		Kim, Jong-Jin/0000-0002-1810-5383	creative research project; Korea Atomic Energy Research Institute, Korea [KAERI 527910-12]	creative research project; Korea Atomic Energy Research Institute, Korea	This work was supported by a creative research project funded from Korea Atomic Energy Research Institute, Korea (KAERI 527910-12)(http://www.kaeri.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; HAN Rui, 2009, Zhejiang Da Xue Xue Bao Yi Xue Ban, V38, P352; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Iwata M, 2004, IMMUNOL LETT, V94, P135, DOI 10.1016/j.imlet.2004.04.013; Jo SK, 2007, PHYTOTHER RES, V21, P625, DOI 10.1002/ptr.2068; Kato T, 2006, EUR J IMMUNOL, V36, P1199, DOI 10.1002/eji.200535140; Kato T, 2004, EUR J IMMUNOL, V34, P1312, DOI 10.1002/eji.200324667; Kim CK, 2010, RESP MED, V104, P1436, DOI 10.1016/j.rmed.2010.03.023; Kim JJ, 2009, J LIFE SCI, V12, P1808; Kim SH, 2009, J MED FOOD, V12, P1353, DOI 10.1089/jmf.2008.1322; Mahajan SG, 2011, EUR J PHARMACOL, V650, P458, DOI 10.1016/j.ejphar.2010.09.075; Meyts I, 2006, J IMMUNOL, V177, P6460, DOI 10.4049/jimmunol.177.9.6460; Miyaura H, 2002, J IMMUNOL, V168, P1087, DOI 10.4049/jimmunol.168.3.1087; Natarajan S, 2008, J IMMUNOL, V181, P8402, DOI 10.4049/jimmunol.181.12.8402; Nemzek JA, 2009, COMPARATIVE MED, V59, P321; Oh SW, 2011, J ETHNOPHARMACOL, V136, P414, DOI 10.1016/j.jep.2010.07.026; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Palmqvist C, 2007, BRIT J PHARMACOL, V151, P725, DOI 10.1038/sj.bjp.0707263; Park HR, 2008, PHYTOTHER RES, V22, P36, DOI 10.1002/ptr.2255; Park HR, 2012, RADIAT RES, V177, P676, DOI 10.1667/RR2768.1; Park HR, 2010, J MED FOOD, V13, P47, DOI 10.1089/jmf.2009.1049; Park HR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-85; Saito K, 2008, J IMMUNOL, V181, P6889, DOI 10.4049/jimmunol.181.10.6889; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; Tada-Oikawa S, 2008, BIOCHEM PHARMACOL, V75, P552, DOI 10.1016/j.bcp.2007.09.011; Torii M, 2010, EUR J IMMUNOL, V40, P787, DOI 10.1002/eji.200939724; Yang EJ, 2011, J ETHNOPHARMACOL, V136, P422, DOI 10.1016/j.jep.2010.05.066; Yang EJ, 2011, PHYTOTHER RES, V25, P59, DOI 10.1002/ptr.3220; Yu J, 2010, ALLERGY ASTHMA IMMUN, V2, P199, DOI 10.4168/aair.2010.2.3.199	31	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68552	10.1371/journal.pone.0068552	http://dx.doi.org/10.1371/journal.pone.0068552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844220	gold, Green Submitted, Green Published			2022-12-25	WOS:000321341000172
J	Montes, VN; Turner, MS; Subramanian, S; Ding, YL; Hayden-Ledbetter, M; Slater, S; Goodspeed, L; Wang, SR; Omer, M; Den Hartigh, LJ; Averill, MM; O'Brien, KD; Ledbetter, J; Chait, A				Montes, Vince N.; Turner, Michael S.; Subramanian, Savitha; Ding, Yilei; Hayden-Ledbetter, Martha; Slater, Sonya; Goodspeed, Leela; Wang, Shari; Omer, Mohamed; Den Hartigh, Laura J.; Averill, Michelle M.; O'Brien, Kevin D.; Ledbetter, Jeffrey; Chait, Alan			T Cell Activation Inhibitors Reduce CD8+T Cell and Pro-Inflammatory Macrophage Accumulation in Adipose Tissue of Obese Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; SERUM AMYLOID A3; INSULIN-RESISTANCE; LDL RECEPTOR; ATHEROSCLEROSIS; PATHOPHYSIOLOGY; APOLIPOPROTEIN; IMMUNOGLOBULIN; COSTIMULATION; CHOLESTEROL	Adipose tissue inflammation and specifically, pro-inflammatory macrophages are believed to contribute to insulin resistance (IR) in obesity in humans and animal models. Recent studies have invoked T cells in the recruitment of pro-inflammatory macrophages and the development of IR. To test the role of the T cell response in adipose tissue of mice fed an obesogenic diet, we used two agents (CTLA-4 Ig and anti-CD40L antibody) that block co-stimulation, which is essential for full T cell activation. C57BL/6 mice were fed an obesogenic diet for 16 weeks, and concomitantly either treated with CTLA-4 Ig, anti-CD40L antibody or an IgG control (300 mu g/week). The treatments altered the immune cell composition of adipose tissue in obese mice. Treated mice demonstrated a marked reduction in pro-inflammatory adipose tissue macrophages and activated CD8+ T cells. Mice treated with anti-CD40L exhibited reduced weight gain, which was accompanied by a trend toward improved IR. CTLA-4 Ig treatment, however, was not associated with improved IR. These data suggest that the presence of pro-inflammatory T cells and macrophages can be altered with co-stimulatory inhibitors, but may not be a significant contributor to the whole body IR phenotype.	[Montes, Vince N.; Subramanian, Savitha; Ding, Yilei; Goodspeed, Leela; Wang, Shari; Omer, Mohamed; Den Hartigh, Laura J.; Averill, Michelle M.; Chait, Alan] Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Turner, Michael S.] Benaroya Res Inst, Seattle, WA USA; [Hayden-Ledbetter, Martha; Slater, Sonya; Ledbetter, Jeffrey] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA; [O'Brien, Kevin D.] Univ Washington, Div Cardiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chait, A (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA.	achait@u.washington.edu	O'Brien, Kevin/CAH-4638-2022; O'Brien, Kevin Douglas/HDO-1461-2022	O'Brien, Kevin/0000-0002-2293-9196; O'Brien, Kevin Douglas/0000-0002-2293-9196; Subramanian, Savitha/0000-0002-4866-2009	NIH (NHLBI) [R01HL094352]; DPPG (NHLBI) [P01HL092969]; Nutrition, Obesity and Atherosclerosis (NHLBI) [T32 HL007028]; DRC (NIDDK) [P30DK017047]; NORC (NIDDK) [P30DK035816]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094352, P01HL092969, T32HL007028, K01HL118711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816, P30DK017047] Funding Source: NIH RePORTER	NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DPPG (NHLBI); Nutrition, Obesity and Atherosclerosis (NHLBI); DRC (NIDDK); NORC (NIDDK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH (NHLBI) R01HL094352; DPPG (NHLBI) P01HL092969; Nutrition, Obesity and Atherosclerosis (NHLBI) T32 HL007028 (www.nhlbi.nih.gov); DRC (NIDDK) P30DK017047; NORC (NIDDK) P30DK035816 (www.niddk.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867; Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; BEATTY PG, 1983, J IMMUNOL, V131, P2913; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Ding Y, 2012, ARTERIOSCLER THROMB; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gerdes N, 2011, THROMBOSIS HAEMOSTAS, P106; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; HANSSON GK, 1989, AM J PATHOL, V135, P169; Harte RA, 1999, HORM METAB RES, V31, P570, DOI 10.1055/s-2007-978797; Hartvigsen K, 2009, J LIPID RES, V50, pS388, DOI 10.1194/jlr.R800100-JLR200; Hayden MS, 1996, TISSUE ANTIGENS, V48, P242, DOI 10.1111/j.1399-0039.1996.tb02642.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Lewis KE, 2004, CIRCULATION, V110, P540, DOI 10.1161/01.CIR.0000136819.93989.E1; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Brien KD, 2005, ARTERIOSCL THROM VAS, V25, P785, DOI 10.1161/01.ATV.0000158383.65277.2b; Poggi M, 2011, ARTERIOSCL THROM VAS, V31, P2251, DOI 10.1161/ATVBAHA.111.231357; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Riella LV, 2012, AM J TRANSPLANT, V12, P846, DOI 10.1111/j.1600-6143.2011.03929.x; Robles-Carrillo L, 2010, J IMMUNOL, V185, P1577, DOI 10.4049/jimmunol.0903888; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Verbinnen B, 2008, J IMMUNOL, V181, P1034, DOI 10.4049/jimmunol.181.2.1034; Watanabe Y, 2012, DIABETES, V61, P1199, DOI 10.2337/db11-1182; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	35	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67709	10.1371/journal.pone.0067709	http://dx.doi.org/10.1371/journal.pone.0067709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844072	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000081
J	Soria-Valles, C; Gutierrez-Fernandez, A; Guiu, M; Mari, B; Fueyo, A; Gomis, RR; Lopez-Otin, C				Soria-Valles, C.; Gutierrez-Fernandez, A.; Guiu, M.; Mari, B.; Fueyo, A.; Gomis, R. R.; Lopez-Otin, C.			The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21	ONCOGENE			English	Article						extracellular matrix; metalloprotease; metastasis; miRNA; TGF-beta	TUMOR-SUPPRESSOR GENE; MATRIX METALLOPROTEINASE-8; MICRORNA-21 TARGETS; LUNG-CANCER; METASTASIS; EXPRESSION; MODULATION; PROTEASES; CLEAVAGE; ROLES	Matrix metalloproteinases (MMPs) have been traditionally implicated in cancer progression because of their ability to degrade the extracellular matrix. However, some members of the MMP family have recently been identified as proteases with antitumor properties. Thus, it has been described that collagenase-2 (MMP-8) has a protective role in tumor and metastasis progression, but the molecular mechanisms underlying these effects are unknown. We show herein that Mmp8 expression causes a decrease in miR-21 levels that in turn leads to a reduction in tumor growth and lung metastasis formation by MDA-MB-231 (4175) breast cancer cells. By using both in vitro and in vivo models, we demonstrate that the mechanism responsible for these MMP-8 beneficial effects involves cleavage of decorin by MMP-8 and a subsequent reduction of transforming growth factor beta (TGF-beta) signaling that controls miR-21 levels. In addition, miR-21 downregulation induced by MMP-8 increases the levels of tumor suppressors such as programmed cell death 4, which may also contribute to the decrease in tumor formation and metastasis of breast cancer cells overexpressing this metalloproteinase. These findings reveal a new signaling pathway for cancer regulation controlled by MMP-8, and contribute to clarify the molecular mechanisms by which tumor-defying proteases may exert their protective function in cancer and metastasis.	[Soria-Valles, C.; Gutierrez-Fernandez, A.; Lopez-Otin, C.] Univ Oviedo, IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo 33006, Spain; [Guiu, M.; Gomis, R. R.] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Mari, B.] CNRS, Valbonne, France; [Mari, B.] Univ Nice, Inst Pharmacol Mol & Cellulaire, Valbonne, France; [Fueyo, A.] Univ Oviedo, IUOPA, Fac Med, Dept Biol,Area Fisiol, Oviedo, Spain	University of Oviedo; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Oviedo	Lopez-Otin, C (corresponding author), Univ Oviedo, IUOPA, Fac Med, Dept Bioquim & Biol Mol, C Fernando Bongera S-N, Oviedo 33006, Spain.	clo@uniovi.es	Fueyo, Antonio/ABH-3243-2020; Mari, Bernard P/GVS-3100-2022; López-Otín, Carlos/AAB-2106-2020; Gomis, Roger R/E-9788-2016; Mari, Bernard P/F-8960-2013; Gutierrez-Fernandez, Ana/ABG-6678-2020; Gutierrez-Fernandez, Ana/AAS-9954-2021; Mari, Bernard P/D-7445-2015; Mari, Bernard/Q-5832-2019	Fueyo, Antonio/0000-0002-7121-9398; Mari, Bernard P/0000-0002-0422-9182; López-Otín, Carlos/0000-0001-6964-1904; Gomis, Roger R/0000-0001-6473-2858; Mari, Bernard P/0000-0002-0422-9182; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard/0000-0002-0422-9182	Ministerio de Economia y Competitividad-Spain; RTICC-Instituto de Salud Carlos III-Spain; European Union; BBVA foundation [2009 SGR1429, SAF2010-21171]; Obra Social Cajastur-Asturias	Ministerio de Economia y Competitividad-Spain; RTICC-Instituto de Salud Carlos III-Spain; European Union(European Commission); BBVA foundation(BBVA Foundation); Obra Social Cajastur-Asturias	We are very grateful to Dr JMP Freije and FG Osorio for helpful comments and to C Garabaya, MF Suarez y S Alvarez for their excellent technical assistance. We also thank the excellent support of the Nice-Sophia Antipolis Functional Genomics Platform. This work was supported by grants from Ministerio de Economia y Competitividad-Spain, RTICC-Instituto de Salud Carlos III-Spain, and European Union (FP7-Microenvimet). BBVA foundation, 2009 SGR1429 and SAF2010-21171 support to RRG was provided. The Instituto Universitario de Oncologia is supported by Obra Social Cajastur-Asturias. CL-O is an Investigator of the Botin Foundation.	Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Fanjul-Fernandez M, 2013, J BIOL CHEM, V288, P14647, DOI 10.1074/jbc.M112.439893; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Knauper V, 1997, FEBS LETT, V405, P60, DOI 10.1016/S0014-5793(97)00158-0; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Korpi JT, 2008, BRIT J CANCER, V98, P766, DOI 10.1038/sj.bjc.6604239; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Montel V, 2004, CANCER RES, V64, P1687, DOI 10.1158/0008-5472.CAN-03-2047; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Noel A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00140; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	35	53	56	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 5	2014	33	23					3054	3063		10.1038/onc.2013.267	http://dx.doi.org/10.1038/onc.2013.267			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EL	23851508				2022-12-25	WOS:000337232200012
J	Roeder, AM; Roettger, Y; Stundel, A; Dodel, R; Geyer, A				Roeder, Andreas M.; Roettger, Yvonne; Stuendel, Anne; Dodel, Richard; Geyer, Armin			Synthetic Dimeric A beta(28-40) Mimics the Complex Epitope of Human Anti-A beta Autoantibodies against Toxic A beta Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; AQUEOUS ENVIRONMENT; PEPTIDE; ANTIBODIES; CONFORMATION; NEUROTOXICITY; STABILIZATION; A-BETA-42	Covalently linked carboxyl-terminal segments of the beta-amyloid peptide (A beta) were tested for their qualification as minimal conformational epitopes of the naturally occurring human autoantibodies against beta-amyloid (nAbs-A beta). nAbs-A beta specifically recognize the toxic oligomers of A beta and not the monomeric or the fibrillar forms of A beta. The synthetic dimers of A beta (28-40) described herein mimic the toxic A beta oligomers but are not kinetic intermediates with uncertain compositions. CD spectra identified a surprisingly rich conformational behavior of selected miniamyloids. We observed a highly cooperative conformational transition of beta-sheet to alpha-helix upon the addition of the helix enforcing co-solvent hexafluoroisopropanol. The CD curves of dimer 9 resembled, in a completely reversible manner, the CD spectra measured during the irreversible fibrillation of the parent A beta (1-40). Synthetic peptide epitopes with high affinities for nAbs-A beta are needed to identify the physiological roles of nAbs-A beta and are promising epitopes for vaccination experiments.	[Roeder, Andreas M.; Geyer, Armin] Univ Marburg, Fac Chem, D-35032 Marburg, Germany; [Roettger, Yvonne; Stuendel, Anne; Dodel, Richard] Univ Marburg, Dept Neurol, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Dodel, R (corresponding author), Univ Marburg, Dept Neurol, Baldingerstr, D-35043 Marburg, Germany.	dodel@med.uni-marburg.de; geyer@staff.uni-marburg.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the Deutsche Forschungsgemeinschaft for financial support and Dr. L. C. Andrei-Selmer and Dr. M. Burg-Roderfeld for technical support.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Dodel R, 2011, [No title captured], Patent No. [PCT/EP2011/071239, 2011071239]; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Fezoui Y, 2000, NAT STRUCT BIOL, V7, P1095, DOI 10.1038/81937; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hauser CAE, 2011, P NATL ACAD SCI USA, V108, P1361, DOI 10.1073/pnas.1014796108; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kok WM, 2009, CHEM COMMUN, P6228, DOI 10.1039/b912784d; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004; Muller-Schiffmann A, 2011, ACS CHEM NEUROSCI, V2, P242, DOI 10.1021/cn200011h; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Takano K, 2006, FEBS J, V273, P150, DOI 10.1111/j.1742-4658.2005.05051.x; Takano K, 2008, CURR ALZHEIMER RES, V5, P540, DOI 10.2174/156720508786898424; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yamaguchi T, 2010, BIOCHEMISTRY-US, V49, P7100, DOI 10.1021/bi100583x; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	37	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27638	27645		10.1074/jbc.M113.463273	http://dx.doi.org/10.1074/jbc.M113.463273			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23846683	hybrid, Green Published			2022-12-25	WOS:000330597300057
J	Masuho, I; Xie, KQ; Martemyanov, KA				Masuho, Ikuo; Xie, Keqiang; Martemyanov, Kirill A.			Macromolecular Composition Dictates Receptor and G Protein Selectivity of Regulator of G Protein Signaling (RGS) 7 and 9-2 Protein Complexes in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEP DOMAIN; R7BP; BINDING; LOCALIZATION; INHIBITION	Regulator of G protein signaling (RGS) proteins play essential roles in the regulation of signaling via G protein-coupled receptors (GPCRs). With hundreds of GPCRs and dozens of G proteins, it is important to understand how RGS regulates selective GPCR-G protein signaling. In neurons of the striatum, two RGS proteins, RGS7 and RGS9-2, regulate signaling by mu-opioid receptor (MOR) and dopamine D2 receptor (D2R) and are implicated in drug addiction, movement disorders, and nociception. Both proteins form trimeric complexes with the atypical G protein beta subunit G beta 5 and a membrane anchor, R7BP. In this study, we examined GTPase-accelerating protein (GAP) activity as well as G alpha and GPCR selectivity of RGS7 and RGS9-2 complexes in live cells using a bioluminescence resonance energy transfer-based assay that monitors dissociation of G protein subunits. We showed that RGS9-2/G beta 5 regulated both Gi and Go with a bias toward Go, but RGS7/G beta 5 could serve as a GAP only for Go. Interestingly, R7BP enhanced GAP activity of RGS7 and RGS9-2 toward Go and Gi and enabled RGS7 to regulate Gi signaling. Neither RGS7 nor RGS9-2 had any activity toward Gz, Gs, or Gq in the absence or presence of R7BP. We also observed no effect of GPCRs (MOR and D2R) on the G protein bias of R7 RGS proteins. However, the GAP activity of RGS9-2 showed a strong receptor preference for D2R over MOR. Finally, RGS7 displayed an four times greater GAP activity relative to RGS9-2. These findings illustrate the principles involved in establishing G protein and GPCR selectivity of striatal RGS proteins.	[Masuho, Ikuo; Xie, Keqiang; Martemyanov, Kirill A.] Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33410 USA	Scripps Research Institute	Martemyanov, KA (corresponding author), Scripps Res Inst Florida, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	kirill@scripps.edu	Masuho, Ikuo/J-6115-2014; Xie, Keqiang/D-4437-2015		National Institutes of Health [DA021743, DA026405]; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405, R01DA021743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA021743 and DA026405.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Baker SA, 2006, BIOCHEMISTRY-US, V45, P10690, DOI 10.1021/bi060376a; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; Celver J, 2010, J NEUROCHEM, V114, P739, DOI 10.1111/j.1471-4159.2010.06805.x; Charlton JJ, 2008, NEURON, V58, P238, DOI 10.1016/j.neuron.2008.02.006; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Garzon J, 2003, NEUROPSYCHOPHARMACOL, V28, P1983, DOI 10.1038/sj.npp.1300263; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, NEURON, V38, P857, DOI 10.1016/S0896-6273(03)00320-9; Masuho I, 2010, J BIOL CHEM, V285, P4781, DOI 10.1074/jbc.M109.058511; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Porter MY, 2010, MOL BIOL CELL, V21, P232, DOI 10.1091/mbc.E09-07-0642; Psigfogeorgou K, 2011, J NEUROSCI, V31, P5617, DOI 10.1523/JNEUROSCI.4146-10.2011; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rojkova AM, 2003, J BIOL CHEM, V278, P12507, DOI 10.1074/jbc.M207302200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Traynor JR, 2009, TRENDS PHARMACOL SCI, V30, P105, DOI 10.1016/j.tips.2008.11.006; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wang Q, 2009, J BIOL CHEM, V284, P18357, DOI 10.1074/jbc.M109.015453; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xie KQ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00049; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100	41	38	38	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25129	25142		10.1074/jbc.M113.462283	http://dx.doi.org/10.1074/jbc.M113.462283			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857581	hybrid, Green Published			2022-12-25	WOS:000330619000013
J	Drucker, P; Pejic, M; Galla, HJ; Gerke, V				Druecker, Patrick; Pejic, Milena; Galla, Hans-Joachim; Gerke, Volker			Lipid Segregation and Membrane Budding Induced by the Peripheral Membrane Binding Protein Annexin A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED EXOCYTOSIS; PHOSPHOLIPID-BINDING; LIGHT-CHAIN; P11; SUBSTRATE; COMPLEX; KINASE; RAFTS; P36; ASSOCIATION	The formation of dynamic membrane microdomains is an important phenomenon in many signal transduction and membrane trafficking events. It is driven by intrinsic properties of membrane lipids and integral as well as membrane-associated proteins. Here we analyzed the ability of one peripherally associated membrane protein, annexin A2 (AnxA2), to induce the formation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2)-rich domains in giant unilamellar vesicles (GUVs) of complex lipid composition. AnxA2 is a cytosolic protein that can bind PI(4,5)P-2 and other acidic phospholipids in a Ca2+-dependent manner and that has been implicated in cellular membrane dynamics in endocytosis and exocytosis. We show that AnxA2 binding to GUVs induces lipid phase separation and the recruitment of PI(4,5)P-2, cholesterol and glycosphingolipids into larger clusters. This property is observed for the full-length monomeric protein, a mutant derivative comprising the C-terminal protein core domain and for AnxA2 residing in a heterotetrameric complex with its intracellular binding partner S100A10. All AnxA2 derivatives inducing PI(4,5)P-2 clustering are also capable of forming interconnections between PI(4,5)P-2-rich microdomains of adjacent GUVs. Furthermore, they can induce membrane indentations rich in PI(4,5)P-2 and inward budding of these membrane domains into the lumen of GUVs. This inward vesiculation is specific for AnxA2 and not shared with other PI(4,5)P-2-binding proteins such as the pleckstrin homology (PH) domain of phospholipase C delta 1. Together our results indicate that annexins such as AnxA2 can efficiently induce membrane deformations after lipid segregation, a mechanism possibly underlying annexin functions in membrane trafficking.	[Druecker, Patrick; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Pejic, Milena; Gerke, Volker] Univ Munster, ZMBE, Inst Med Biochem, D-48149 Munster, Germany	University of Munster; University of Munster	Gerke, V (corresponding author), Univ Munster, ZMBE, Inst Med Biochem, Von Esmarch Str 56, D-48149 Munster, Germany.	gerke@uni-muenster.de		Drucker, Patrick/0000-0003-3353-5880	German Research Council [DFG SFB 858]	German Research Council(German Research Foundation (DFG))	This work was supported by German Research Council Grant DFG SFB 858, Project B4.	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Draeger A, 2003, DEV BIOL, V262, P324, DOI 10.1016/S0012-1606(03)00398-1; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; Faini M, 2013, TRENDS CELL BIOL, V23, P279, DOI 10.1016/j.tcb.2013.01.005; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GERKE V, 1985, J BIOL CHEM, V260, P1688; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Gruenberg Jean, 1993, Trends in Cell Biology, V3, P224, DOI 10.1016/0962-8924(93)90116-I; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Harrist AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005020; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Horger KS, 2009, J AM CHEM SOC, V131, P1810, DOI 10.1021/ja805625u; JOHNSSON N, 1990, J BIOL CHEM, V265, P14464; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Juhasz J, 2012, BBA-BIOMEMBRANES, V1818, P19, DOI 10.1016/j.bbamem.2011.09.006; Kauscher U, 2013, LANGMUIR, V29, P7377, DOI 10.1021/la3045434; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Kiessling V, 2009, BBA-BIOMEMBRANES, V1788, P64, DOI 10.1016/j.bbamem.2008.09.003; Konig J, 1998, J BIOL CHEM, V273, P19679, DOI 10.1074/jbc.273.31.19679; KUBE E, 1992, J BIOL CHEM, V267, P14175; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Menke M, 2004, CHEMBIOCHEM, V5, P1003, DOI 10.1002/cbic.200400004; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Morales-Penningston NF, 2010, BBA-BIOMEMBRANES, V1798, P1324, DOI 10.1016/j.bbamem.2010.03.011; Morel E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001118; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Nazmi AR, 2012, BIOL CHEM, V393, P1141, DOI 10.1515/hsz-2012-0179; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; OSBORN M, 1988, EXP CELL RES, V175, P81, DOI 10.1016/0014-4827(88)90257-1; POWELL MA, 1987, BIOCHEM J, V247, P321, DOI 10.1042/bj2470321; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; Rosengarth A., 2004, ANNEXINS, V1, P129; Ross M, 2003, BIOCHEMISTRY-US, V42, P3131, DOI 10.1021/bi027069z; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Sandvig K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012914; THIEL C, 1991, J BIOL CHEM, V266, P14732; THIEL C, 1992, J CELL SCI, V103, P733; Tran JT, 2002, ACTA CRYSTALLOGR D, V58, P1854, DOI 10.1107/S0907444902013288; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387; Zobiack N, 2002, J CELL SCI, V115, P91	58	66	66	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24764	24776		10.1074/jbc.M113.474023	http://dx.doi.org/10.1074/jbc.M113.474023			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861394	hybrid, Green Published			2022-12-25	WOS:000330612300042
J	Konvalinka, A; Zhou, J; Dimitromanolakis, A; Drabovich, AP; Fang, F; Gurley, S; Coffman, T; John, R; Zhang, SL; Diamandis, EP; Scholey, JW				Konvalinka, Ana; Zhou, Joyce; Dimitromanolakis, Apostolos; Drabovich, Andrei P.; Fang, Fei; Gurley, Susan; Coffman, Thomas; John, Rohan; Zhang, Shao-Ling; Diamandis, Eleftherios P.; Scholey, James W.			Determination of an Angiotensin II-regulated Proteome in Primary Human Kidney Cells by Stable Isotope Labeling of Amino Acids in Cell Culture (SILAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HYPERTENSIVE-RATS; URINARY HEME OXYGENASE-1; PROXIMAL TUBULAR CELLS; IGA NEPHROPATHY; DIABETIC-NEPHROPATHY; CONVERTING-ENZYME; GENE-EXPRESSION; RENAL-DISEASE; BIOLOGICAL NETWORKS; COMBINATION THERAPY	Angiotensin II (AngII), the major effector of the renin-angiotensin system, mediates kidney disease progression by signaling through the AT-1 receptor (AT-1R), but there are no specific measures of renal AngII activity. Accordingly, we sought to define an AngII-regulated proteome in primary human proximal tubular cells (PTEC) to identify potential AngII activity markers in the kidney. We utilized stable isotope labeling with amino acids (SILAC) in PTECs to compare proteomes of AngII-treated and control cells. Of the 4618 quantified proteins, 83 were differentially regulated. SILAC ratios for 18 candidates were confirmed by a different mass spectrometry technique called selected reaction monitoring. Both SILAC and selected reaction monitoring revealed heme oxygenase-1 (HO-1) as the most significantly up-regulated protein in response to AngII stimulation. AngII-dependent regulation of the HO-1 gene and protein was further verified in PTECs. To extend these in vitro observations, we overlaid a network of significantly enriched gene ontology terms from our AngII-regulated proteins with a dataset of differentially expressed kidney genes from AngII-treated wild type mice and AT-1R knock-out mice. Five gene ontology terms were enriched in both datasets and included HO-1. Furthermore, HO-1 kidney expression and urinary excretion were reduced in AngII-treated mice with PTEC-specific AT-1R deletion compared with AngII-treated wild-type mice, thus confirming AT-1R-mediated regulation of HO-1. Our in vitro approach identified novel molecular markers of AngII activity, and the animal studies demonstrated that these markers are relevant in vivo. These interesting proteins hold promise as specific markers of renal AngII activity in patients and in experimental models.	[Konvalinka, Ana; Zhou, Joyce; Fang, Fei; Scholey, James W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Konvalinka, Ana; Scholey, James W.] Univ Toronto, Div Nephrol, Dept Med, Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Dimitromanolakis, Apostolos; Drabovich, Andrei P.; John, Rohan; Diamandis, Eleftherios P.] Univ Toronto, Dept Pathol & Lab Med, Toronto, ON M5G 2C4, Canada; [Dimitromanolakis, Apostolos; Drabovich, Andrei P.; Diamandis, Eleftherios P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1W7, Canada; [Gurley, Susan; Coffman, Thomas] Duke Univ, Dept Med, Div Nephrol, Durham, NC 27710 USA; [Gurley, Susan; Coffman, Thomas] Durham Vet Affairs Med Ctr, Durham, NC 27710 USA; [Zhang, Shao-Ling] Univ Montreal, Hop Hotel Dieu, Fac Med, Montreal, PQ H2W 1T8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Universite de Montreal	Konvalinka, A (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Nephrol, 8N-859,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	ana.konvalinka@mail.utoronto.ca	Konvalinka, Ana/ABE-9480-2020; Konvalinka, Ana/AAH-9581-2020; Drabovich, Andrei/E-9347-2012	Konvalinka, Ana/0000-0001-6672-355X; Drabovich, Andrei/0000-0003-3049-7145; John, Rohan/0000-0001-7946-3013	Kidney Foundation of Canada; operating grant from the Kidney Foundation of Canada; operating grant from the AMGEN Canada	Kidney Foundation of Canada; operating grant from the Kidney Foundation of Canada; operating grant from the AMGEN Canada	Recipient of a fellowship grant from the Kidney Foundation of Canada. To whom correspondence should be addressed: Division of Nephrology, Toronto General Hospital, University Health Network, 8N-859, 200 Elizabeth St., Toronto, Ontario M5G 2C4, Canada. Tel.: 416-586-4800 (Ext. 2968); Fax: 416-340-4999; E-mail: ana. konvalinka@mail.utoronto.ca.; Supported by operating grants from the Kidney Foundation of Canada and from the AMGEN Canada Investigator Sponsored Initiative Research Program.	Aizawa T, 2000, HYPERTENSION, V35, P800, DOI 10.1161/01.HYP.35.3.800; Aizawa T, 2001, KIDNEY INT, V59, P645, DOI 10.1046/j.1523-1755.2001.059002645.x; Alam J, 2003, AM J PHYSIOL-RENAL, V284, pF743, DOI 10.1152/ajprenal.00376.2002; Aminzadeh MA, 2012, TRANSL RES, V160, P309, DOI 10.1016/j.trsl.2012.03.003; Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; Bhaskaran M, 2003, AM J PHYSIOL-RENAL, V284, pF955, DOI 10.1152/ajprenal.00246.2002; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Chang SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/521076; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; da Silva JL, 2001, KIDNEY INT, V59, P1448, DOI 10.1046/j.1523-1755.2001.0590041448.x; Drabovich AP, 2012, MOL CELL PROTEOMICS, V11, P422, DOI 10.1074/mcp.M111.015214; Drabovich AP, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.004127-1, 10.1074/mcp.M110.004127]; Drabovich AP, 2010, J PROTEOME RES, V9, P1236, DOI 10.1021/pr900729g; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; DZAU VJ, 1993, ARCH INTERN MED, V153, P937, DOI 10.1001/archinte.153.8.937; Finckenberg P, 2003, AM J PATHOL, V163, P355, DOI 10.1016/S0002-9440(10)63659-0; Gurley SB, 2011, CELL METAB, V13, P469, DOI 10.1016/j.cmet.2011.03.001; Harrison-Bernard LM, 2002, AM J PHYSIOL-RENAL, V282, pF19, DOI 10.1152/ajprenal.0335.2000; Haugen EN, 2000, KIDNEY INT, V58, P144, DOI 10.1046/j.1523-1755.2000.00150.x; He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133; Imig JD, 1999, AM J PHYSIOL-RENAL, V277, pF303, DOI 10.1152/ajprenal.1999.277.2.F303; Ingelfinger JR, 1999, AM J PHYSIOL-RENAL, V276, pF218, DOI 10.1152/ajprenal.1999.276.2.F218; INGELFINGER JR, 1990, J CLIN INVEST, V85, P417, DOI 10.1172/JCI114454; JOHNSTON CI, 1992, J HYPERTENS, V10, pS13; KIFOR I, 1991, ENDOCRINOLOGY, V129, P823, DOI 10.1210/endo-129-2-823; Kim JA, 2012, AM J PHYSIOL-ENDOC M, V302, pE201, DOI 10.1152/ajpendo.00497.2011; Knight SF, 2007, MICROCIRCULATION, V14, P349, DOI 10.1080/10739680701283018; Kobori H, 2003, HYPERTENSION, V41, P42, DOI 10.1161/01.HYP.0000050102.90932.CF; Kobori H, 2002, KIDNEY INT, V61, P579, DOI 10.1046/j.1523-1755.2002.00155.x; Kobori H, 2007, BIOCHEM BIOPH RES CO, V358, P156, DOI 10.1016/j.bbrc.2007.04.105; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Laverman GD, 2002, KIDNEY INT, V62, P1020, DOI 10.1046/j.1523-1755.2002.00536.x; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LIFTON RP, 1995, P NATL ACAD SCI USA, V92, P8545, DOI 10.1073/pnas.92.19.8545; Liu F, 2008, J AM SOC NEPHROL, V19, P269, DOI 10.1681/ASN.2007010074; Liu GC, 2012, AM J PHYSIOL-RENAL, V302, pF784, DOI 10.1152/ajprenal.00455.2011; Lodha S, 2002, MOL MED, V8, P830, DOI 10.1007/BF03402088; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Makawita S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008599; Makhanova NA, 2010, PHYSIOL GENOMICS, V42A, P211, DOI 10.1152/physiolgenomics.00063.2010; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; MENDELSOHN FAO, 1982, KIDNEY INT, pS78; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mills KT, 2012, NEPHROL DIAL TRANSPL, V27, P3176, DOI 10.1093/ndt/gfs011; Muller DN, 2002, AM J PATHOL, V161, P1679, DOI 10.1016/S0002-9440(10)64445-8; NAFTILAN AJ, 1991, J CLIN INVEST, V87, P1300, DOI 10.1172/JCI115133; Navar LG, 2004, CURR OPIN NEPHROL HY, V13, P107, DOI 10.1097/00041552-200401000-00015; Nishiyama A, 2011, NEPHROL DIAL TRANSPL, V26, P170, DOI 10.1093/ndt/gfq371; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P750, DOI 10.1111/j.1440-1681.2009.05172.x; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; PURDY RE, 1988, CIRC RES, V63, P748, DOI 10.1161/01.RES.63.4.748; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; REAMS G, 1994, NEPHRON, V67, P450, DOI 10.1159/000188215; Reblin T, 2001, AM J KIDNEY DIS, V38, P619, DOI 10.1053/ajkd.2001.26889; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Russo D, 1999, AM J KIDNEY DIS, V33, P851, DOI 10.1016/S0272-6386(99)70416-6; SCHELLING P, 1991, J HYPERTENS, V9, P3; SEIKALY MG, 1990, J CLIN INVEST, V86, P1352, DOI 10.1172/JCI114846; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; TANG SS, 1995, AM J PHYSIOL-RENAL, V268, pF435, DOI 10.1152/ajprenal.1995.268.3.F435; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; VOS PF, 1994, J AM SOC NEPHROL, V5, P215; Wagner C, 1998, KIDNEY INT, V54, pS78, DOI 10.1046/j.1523-1755.1998.06716.x; Wanner C, 1997, KIDNEY INT, pS102; Weidekamm C, 2002, WIEN KLIN WOCHENSCHR, V114, P725; WILCOX CS, 1991, KIDNEY INT, V40, P1090, DOI 10.1038/ki.1991.319; Wolf G, 1997, AM J KIDNEY DIS, V29, P153, DOI 10.1016/S0272-6386(97)90023-8; Wolf G, 2005, KIDNEY INT, V67, P799, DOI 10.1111/j.1523-1755.2005.00145.x; WOLF G, 1990, AM J PHYSIOL, V259, pF768, DOI 10.1152/ajprenal.1990.259.5.F768; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P1558, DOI 10.1681/ASN.2006060554; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yokoyama T, 2011, AM J NEPHROL, V33, P414, DOI 10.1159/000327020; Zager RA, 1999, KIDNEY INT, V56, P1788, DOI 10.1046/j.1523-1755.1999.00745.x; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zhuo JL, 2007, J RENIN-ANGIO-ALDO S, V8, P23, DOI 10.3317/jraas.2007.003; Zhuo JL, 2002, HYPERTENSION, V39, P116, DOI 10.1161/hy0102.100780; ZIMMERMAN JB, 1987, J CLIN INVEST, V80, P443, DOI 10.1172/JCI113092	91	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24834	24847		10.1074/jbc.M113.485326	http://dx.doi.org/10.1074/jbc.M113.485326			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846697	Green Published, hybrid			2022-12-25	WOS:000330612300048
J	Rajendran, G; Dutta, D; Hong, J; Paul, A; Saha, B; Mahato, B; Ray, S; Home, P; Ganguly, A; Weiss, ML; Paul, S				Rajendran, Ganeshkumar; Dutta, Debasree; Hong, James; Paul, Arindam; Saha, Biswarup; Mahato, Biraj; Ray, Soma; Home, Pratik; Ganguly, Avishek; Weiss, Mark L.; Paul, Soumen			Inhibition of Protein Kinase C Signaling Maintains Rat Embryonic Stem Cell Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SELF-RENEWAL; METHYLATION; DIFFERENTIATION; BLASTOCYSTS; ACTIVATION; GENERATION; MICRORNAS; BINDING; MURINE	Embryonic stem cell (ESC) pluripotency is orchestrated by distinct signaling pathways that are often targeted to maintain ESC self-renewal or their differentiation to other lineages. We showed earlier that inhibition of PKC signaling maintains pluripotency in mouse ESCs. Therefore, in this study, we investigated the importance of protein kinase C signaling in the context of rat ESC (rESC) pluripotency. Here we show that inhibition of PKC signaling is an efficient strategy to establish and maintain pluripotent rESCs and to facilitate reprogramming of rat embryonic fibroblasts to rat induced pluripotent stem cells. The complete developmental potential of rESCs was confirmed with viable chimeras and germ line transmission. Our molecular analyses indicated that inhibition of a PKC zeta-NF-kappa B-microRNA-21/microRNA-29 regulatory axis contributes to the maintenance of rESC self-renewal. In addition, PKC inhibition maintains ESC-specific epigenetic modifications at the chromatin domains of pluripotency genes and, thereby, maintains their expression. Our results indicate a conserved function of PKC signaling in balancing self-renewal versus differentiation of both mouse and rat ESCs and indicate that targeting PKC signaling might be an efficient strategy to establish ESCs from other mammalian species.	[Rajendran, Ganeshkumar; Dutta, Debasree; Paul, Arindam; Saha, Biswarup; Mahato, Biraj; Ray, Soma; Home, Pratik; Ganguly, Avishek; Paul, Soumen] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Hong, James; Weiss, Mark L.] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA	University of Kansas; University of Kansas Medical Center; Kansas State University	Paul, S (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA.	spaul2@kumc.edu	Home, Pratik/D-5061-2014; Saha, Biswarup/T-7341-2019; Weiss, Mark L/C-7364-2014; /AAD-2084-2020; Ganguly, Avishek/R-6138-2019	Saha, Biswarup/0000-0003-2797-7308; 	National institutes of Health [HL094892, HL106311, L104322, HD062546]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062546, R21HD075233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106311, R21HL094892, R21HL104322] Funding Source: NIH RePORTER	National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National institutes of Health grants HL094892, HL106311, L104322, and HD062546 (to S. P.). This work was also supported by a gift from the Ronald. D. Deffenbaugh Foundation.	Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; He Hong, 2009, Open Stem Cell J, V1, P30; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Hong J, 2013, STEM CELLS DEV, V22, P431, DOI 10.1089/scd.2012.0279; Hong J, 2012, STEM CELLS DEV, V21, P1571, DOI 10.1089/scd.2011.0370; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Li J, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-4; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liskovykh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027345; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Yan HX, 2012, CARCINOGENESIS, V33, P2001, DOI 10.1093/carcin/bgs238; Yang CS, 2011, RNA, V17, P1451, DOI 10.1261/rna.2664111; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056	34	26	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24351	24362		10.1074/jbc.M113.455725	http://dx.doi.org/10.1074/jbc.M113.455725			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846691	Green Published, hybrid			2022-12-25	WOS:000330612300007
J	Rundqvist, H; Augsten, M; Stromberg, A; Rullman, E; Mijwel, S; Kharaziha, P; Panaretakis, T; Gustafsson, T; Ostman, A				Rundqvist, Helene; Augsten, Martin; Stromberg, Anna; Rullman, Eric; Mijwel, Sara; Kharaziha, Pedram; Panaretakis, Theocharis; Gustafsson, Thomas; Ostman, Arne			Effect of Acute Exercise on Prostate Cancer Cell Growth	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; IGF-I; BINDING-PROTEINS; SERUM-INSULIN; RISK; DIET; HEALTHY; INTENSITY; MEDIATORS; APOPTOSIS	Physical activity is associated with reduced risk of several cancers, including aggressive prostate cancer. The mechanisms mediating the effects are not yet understood; among the candidates are modifications of endogenous hormone levels. Long-term exercise is known to reduce serum levels of growth stimulating hormones. In contrast, the endocrine effects of acute endurance exercise include increased levels of mitogenic factors such as GH and IGF-1. It can be speculated that the elevation of serum growth factors may be detrimental to prostate cancer progression into malignancy. The incentive of the current study is to evaluate the effect of acute exercise serum on prostate cancer cell growth. We designed an exercise intervention where 10 male individuals performed 60 minutes of bicycle exercise at increasing intensity. Serum samples were obtained before (rest serum) and after completed exercise (exercise serum). The established prostate cancer cell line LNCaP was exposed to exercise or rest serum. Exercise serum from 9 out of 10 individuals had a growth inhibitory effect on LNCaP cells. Incubation with pooled exercise serum resulted in a 31% inhibition of LNCaP growth and pre-incubation before subcutaneous injection into SCID mice caused a delay in tumor formation. Serum analyses indicated two possible candidates for the effect; increased levels of IGFBP-1 and reduced levels of EGF. In conclusion, despite the fear of possible detrimental effects of acute exercise serum on tumor cell growth, we show that even the short-term effects seem to add to the overall beneficial influence of exercise on neoplasia.	[Rundqvist, Helene; Augsten, Martin; Mijwel, Sara; Kharaziha, Pedram; Panaretakis, Theocharis; Ostman, Arne] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Stromberg, Anna; Rullman, Eric; Gustafsson, Thomas] Karolinska Inst, Dept Med Lab Sci & Technol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Rundqvist, H (corresponding author), Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden.	helene.rundqvist@ki.se	Kharaziha, Pedram/O-7584-2014; Gustafsson, Thomas/AAH-1056-2019; Rundqvist, Helene/AAE-7334-2020	Kharaziha, Pedram/0000-0002-3598-5271; Rundqvist, Helene/0000-0002-5617-9076; Rullman, Eric/0000-0003-2854-7262; Gustafsson, Thomas/0000-0002-1559-4206; Panaretakis, Theocharis/0000-0001-5754-6950; Mijwel, Sara/0000-0002-6718-5797	Swedish Research Council; Swedish National Centre for Research in Sports; Swedish Medical Association; KI Foundation; Wallenberg Foundation; Swedish Cancer Society; Swedish Society of Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Centre for Research in Sports; Swedish Medical Association; KI Foundation; Wallenberg Foundation(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Society of Medical Research	The present study was supported by the funding of TG: the Swedish Research Council, the Swedish National Centre for Research in Sports, the Swedish Medical Association, the KI Foundation and the Wallenberg Foundation; AO: the Swedish Cancer Society and the Swedish Research Council including support for the Linne center and cancer research network "Starget." HR is supported by a Post Doc training grant from the Swedish Society of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Barnard RJ, 2007, EUR J CANCER PREV, V16, P415, DOI 10.1097/01.cej.0000243851.66985.e4; Barnard RJ, 2003, PROSTATE, V56, P201, DOI 10.1002/pros.10251; Berg U, 2004, HORM RES, V62, P50, DOI 10.1159/000080759; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Galvao DA, 2008, PROSTATE CANCER P D, V11, P160, DOI 10.1038/sj.pcan.4500991; Giovannucci EL, 2005, ARCH INTERN MED, V165, P1005, DOI 10.1001/archinte.165.9.1005; HACKNEY AC, 1988, MED SCI SPORT EXER, V20, P60, DOI 10.1249/00005768-198802000-00009; HELLENIUS MLB, 1995, J INTERN MED, V238, P121, DOI 10.1111/j.1365-2796.1995.tb00909.x; Hsing AW, 2001, JNCI-J NATL CANCER I, V93, P783, DOI 10.1093/jnci/93.10.783; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Lehrer S, 2002, PROSTATE, V50, P1, DOI 10.1002/pros.10026; Liu YP, 2011, EUR UROL, V60, P1029, DOI 10.1016/j.eururo.2011.07.007; Mantzoros CS, 1997, BRIT J CANCER, V76, P1115, DOI 10.1038/bjc.1997.520; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Ngo TH, 2003, ENDOCRINOLOGY, V144, P2319, DOI 10.1210/en.2003-221028; Ngo TH, 2002, CANCER CAUSE CONTROL, V13, P929, DOI 10.1023/A:1021911517010; Nilsen TIL, 2006, INT J CANCER, V119, P2943, DOI 10.1002/ijc.22184; NORTHOFF H, 1991, INT J SPORTS MED, V12, pS9, DOI 10.1055/s-2007-1024743; Orsini N, 2009, BRIT J CANCER, V101, P1932, DOI 10.1038/sj.bjc.6605404; Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x; Pritzlaff CJ, 1999, J APPL PHYSIOL, V87, P498; Roddam AW, 2008, ANN INTERN MED, V149, P461, DOI 10.7326/0003-4819-149-7-200810070-00006; Rundqvist H, 2009, EUR J ENDOCRINOL, V161, P427, DOI 10.1530/EJE-09-0342; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; SCHUURMANS ALG, 1991, J STEROID BIOCHEM, V40, P193, DOI 10.1016/0960-0760(91)90182-5; Schwarz AJ, 1996, J CLIN ENDOCR METAB, V81, P3492, DOI 10.1210/jc.81.10.3492; Sridhar SS, 2010, AM J CLIN ONCOL-CANC, V33, P609, DOI 10.1097/COC.0b013e3181beac33; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Tymchuk CN, 2001, J UROLOGY, V166, P1185, DOI 10.1016/S0022-5347(05)65943-5; Ullen A, 2010, INT J ONCOL, V37, P15, DOI 10.3892/ijo_00000648; Weinstock C, 1997, MED SCI SPORT EXER, V29, P345, DOI 10.1097/00005768-199703000-00009	35	69	69	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67579	10.1371/journal.pone.0067579	http://dx.doi.org/10.1371/journal.pone.0067579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861774	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300018
J	Eisenegger, C; Pedroni, A; Rieskamp, J; Zehnder, C; Ebstein, R; Fehr, E; Knoch, D				Eisenegger, Christoph; Pedroni, Andreas; Rieskamp, Joerg; Zehnder, Christian; Ebstein, Richard; Fehr, Ernst; Knoch, Daria			DAT1 Polymorphism Determines L-DOPA Effects on Learning about Others' Prosociality	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRANSPORTER GENE; SOCIAL-INTERACTION; NUCLEUS-ACCUMBENS; WORKING-MEMORY; HUMAN STRIATUM; REWARD; HUMANS; BRAIN; TRUST	Despite that a wealth of evidence links striatal dopamine to individuals reward learning performance in non-social environments, the neurochemical underpinnings of such learning during social interaction are unknown. Here, we show that the administration of 300 mg of the dopamine precursor L-DOPA to 200 healthy male subjects influences learning about a partners' prosocial preferences in a novel social interaction task, which is akin to a repeated trust game. We found learning to be modulated by a well-established genetic marker of striatal dopamine levels, the 40-bp variable number tandem repeats polymorphism of the dopamine transporter (DAT1 polymorphism). In particular, we found that L-DOPA improves learning in 10/10R genoype subjects, who are assumed to have lower endogenous striatal dopamine levels and impairs learning in 9/10R genotype subjects, who are assumed to have higher endogenous dopamine levels. These findings provide first evidence for a critical role of dopamine in learning whether an interaction partner has a prosocial or a selfish personality. The applied pharmacogenetic approach may open doors to new ways of studying psychiatric disorders such as psychosis, which is characterized by distorted perceptions of others' prosocial attitudes.	[Eisenegger, Christoph] Univ Cambridge, Dept Psychol, Behav & Clin Neurosci Inst, Cambridge, England; [Pedroni, Andreas; Knoch, Daria] Univ Basel, Div Social & Affect Neurosci, Dept Psychol, Basel, Switzerland; [Rieskamp, Joerg] Univ Basel, Ctr Econ Psychol, Dept Psychol, Basel, Switzerland; [Zehnder, Christian] Univ Lausanne, Fac Business & Econ, Quartier UNIL Dorigny, Lausanne, Switzerland; [Ebstein, Richard] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Fehr, Ernst] Univ Zurich, Lab Social & Neural Syst Res, Dept Econ, Zurich, Switzerland	University of Cambridge; University of Basel; University of Basel; University of Lausanne; National University of Singapore; University of Zurich	Eisenegger, C (corresponding author), Univ Cambridge, Dept Psychol, Behav & Clin Neurosci Inst, Cambridge, England.	christoph.eisenegger@gmail.com; andreas.pedroni@unibas.ch; daria.knoch@unibas.ch	Rieskamp, Joerg/D-4004-2013	Rieskamp, Joerg/0000-0003-2632-8015; Zehnder, Christian/0000-0001-6199-4975; Ebstein, Richard/0000-0002-3626-541X	Swiss National Science Foundation [PP00P1_123381, PA00P1_134135, 100014_130352]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by a grant to DK by the Swiss National Science Foundation (PP00P1_123381). CE was supported by the Swiss National Science Foundation (PA00P1_134135). JR acknowledges the Swiss National Science Foundation (100014_130352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Beeler JA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00170; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Brown M, 2004, ECONOMETRICA, V72, P747, DOI 10.1111/j.1468-0262.2004.00511.x; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Clatworthy PL, 2009, J NEUROSCI, V29, P4690, DOI 10.1523/JNEUROSCI.3266-08.2009; Cools R, 2007, NEUROPSYCHOPHARMACOL, V32, P180, DOI 10.1038/sj.npp.1301153; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; Fareri DS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00148; Fett AKJ, 2012, BRAIN, V135, P976, DOI 10.1093/brain/awr359; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hoffman E, 1998, ECON INQ, V36, P335, DOI 10.1111/j.1465-7295.1998.tb01719.x; Ito H, 2008, NEUROIMAGE, V39, P555, DOI 10.1016/j.neuroimage.2007.09.011; Ito H, 2007, ANN NUCL MED, V21, P355, DOI 10.1007/s12149-007-0033-z; Jones RM, 2011, J NEUROSCI, V31, P13039, DOI 10.1523/JNEUROSCI.2972-11.2011; Kaiser R, 2003, NEUROLOGY, V60, P1750, DOI 10.1212/01.WNL.0000068009.32067.A1; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kishida KT, 2012, BIOL PSYCHIAT, V72, P93, DOI 10.1016/j.biopsych.2012.02.037; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Krueger F, 2008, PHILOS T R SOC B, V363, P3859, DOI 10.1098/rstb.2008.0165; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Mata R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039135; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Ostrom E., 2005, TRUST RECIPROCITY IN; Parush N, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00022; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Phan KL, 2010, P NATL ACAD SCI USA, V107, P13099, DOI 10.1073/pnas.1008137107; Rilling JK, 2008, CURR OPIN NEUROBIOL, V18, P159, DOI 10.1016/j.conb.2008.06.003; Rutledge RB, 2009, J NEUROSCI, V29, P15104, DOI 10.1523/JNEUROSCI.3524-09.2009; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Shohamy D, 2011, CURR OPIN NEUROBIOL, V21, P408, DOI 10.1016/j.conb.2011.05.009; Sutton R.S., 1998, INTRO REINFORCEMENT, DOI [10.1109/TNN.1998.712192, DOI 10.1109/TNN.1998.712192]; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027	46	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67820	10.1371/journal.pone.0067820	http://dx.doi.org/10.1371/journal.pone.0067820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861813	Green Published, gold			2022-12-25	WOS:000323350700041
J	Shahi, SK; Singh, VK; Kumar, A				Shahi, Shailesh K.; Singh, Vinay K.; Kumar, Ashok			Detection of Escherichia coli and Associated beta-Lactamases Genes from Diabetic Foot Ulcers by Multiplex PCR and Molecular Modeling and Docking of SHV-1, TEM-1, and OXA-1 beta-Lactamases with Clindamycin and Piperacillin-Tazobactam	PLOS ONE			English	Article							CLASS-A; RESISTANCE; EPIDEMIOLOGY; INFECTION; FAMILY	Diabetic foot ulcer (DFU) is a common and devastating complication in diabetes. Antimicrobial resistance mediated by extended-spectrum beta-lactamases (ESBLs) production by bacteria is considered to be a major threat for foot amputation. The present study deals with the detection of Escherichia coli and the prevalence of bla(TEM), bla(SHV) and bla(OXA) genes directly from biopsy and swab of foot ulcers of diabetic patients. In total, 116 DFU patients were screened, of which 42 suffering with severe DFUs were selected for this study. Altogether 16 E. coli strains were successfully isolated from biopsy and/or swab samples of 15 (35.71%) patients. ESBL production was noted in 12 (75%) strains. Amplification of beta-lactamase genes by multiplex PCR showed the presence of bla(CTX-M) like genes in 10 strains, bla(TEM) and bla(OXA) in 9 strains each, and bla(SHV) in 8 of the total 16 strains of E. coli. Out of the ten antibiotics tested, E. coli strains were found to be resistant to ampicillin (75%), cefoxitin (56.25%), cefazolin (50%), meropenem (37.5%), cefoperazone (25%), cefepime (31.25%), ceftazidime (56.25%), and cefotaxime (68.75%) but all showed sensitivity (100%) to clindamycin and piperacillin-tazobactam. 3D models of the most prevalent variants of beta-lactamases namely TEM-1, SHV-1, OXA-1, and ESBL namely CTX-M-15 were predicted and docking was performed with clindamycin and piperacillin-tazobactam to reveal the molecular basis of drug sensitivity. Docking showed the best docking score with significant interactions, forming hydrogen bond, Van der Waals and polar level interaction with active site residues. Findings of the present study may provide useful insights for the development of new antibiotic drugs and may also prevent ESBLs-mediated resistance problem in DFU. The novel multiplex PCR assay designed in this study may be routinely used in clinical diagnostics of E. coli and associated bla(TEM), bla(SHV), and bla(OXA) like genes.	[Shahi, Shailesh K.; Singh, Vinay K.; Kumar, Ashok] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Kumar, A (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	kasokbt@rediffmail.com	Shahi, Shailesh/ABD-6388-2020	Shahi, Shailesh/0000-0002-8506-7655	ICMR, New Delhi (India) [80/622/2009-ECD-1]; Indian Agricultural Research Institute, New Delhi [NBAIM/AMAAS/MD (19)/AK/BG]	ICMR, New Delhi (India)(Indian Council of Medical Research (ICMR)); Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR))	Shailesh K. Shahi is thankful to ICMR, New Delhi (India), for the award of Senior Research Fellowship (80/622/2009-ECD-1). This work is partially supported by a research grant sanctioned to Ashok Kumar by the Indian Agricultural Research Institute (No. NBAIM/AMAAS/MD (19)/AK/BG), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Alavi SM, 2008, INT J INFECT DIS, V12, pE209, DOI 10.1016/j.ijid.2008.05.519; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Arabaci F., 2009, Journal of Medical Sciences (Pakistan), V9, P103, DOI 10.3923/jms.2009.103.107; Armstrong DG, 2004, CLIN INFECT DIS, V39, pS92, DOI 10.1086/383269; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baudry PJ, 2009, DIAGN MICR INFEC DIS, V63, P319, DOI 10.1016/j.diagmicrobio.2008.12.001; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bos F, 2008, ANTIMICROB AGENTS CH, V52, P1072, DOI 10.1128/AAC.01035-07; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; BRUNBUISSON C, 1987, LANCET, V2, P302; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Chaudhary U, 2004, Indian J Med Microbiol, V22, P75; CLSI, 2018, PERFORMANCE STANDARD; Coque T M, 2008, Euro Surveill, V13; Coudron PE, 1997, J CLIN MICROBIOL, V35, P2593, DOI 10.1128/JCM.35.10.2593-2597.1997; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Gadepalli R, 2006, DIABETES CARE, V29, P1727, DOI 10.2337/dc06-0116; Gao Yue-Dong, 2011, Zoological Research, V32, P262, DOI 10.3724/SP.J.1141.2011.03262; Gupta V, 2008, J ASSOC PHYSICIAN I, P56; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Majiduddin FK, 2002, INT J MED MICROBIOL, V292, P127, DOI 10.1078/1438-4221-00198; Mansouri M., 2009, Journal of Biological Sciences, V9, P362, DOI 10.3923/jbs.2009.362.366; MATAGNE A, 1990, BIOCHEM J, V265, P131, DOI 10.1042/bj2650131; Mathai D, 2002, DIAGN MICR INFEC DIS, V44, P367, DOI 10.1016/S0732-8893(02)00466-2; Mitsuhashi S, 1981, MECH RESISTANCE BETA; Motta RN, 2003, BRAZ J INFECT DIS, V2, P129; Murugan S, 2011, RES J MICROBIOL, DOI [10.3923/jm.2011: 1-9, DOI 10.3923/JM.2011:1-9]; Ness S, 2000, BIOCHEMISTRY-US, V39, P5312, DOI 10.1021/bi992505b; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pattanaik P, 2009, J BIOL CHEM, V284, P945, DOI 10.1074/jbc.M806833200; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Sahu S, 2011, INDIAN MED GAZ, V12, P461; Sana T., 2011, IAJAA, V1; Schwaber MJ, 2005, ANTIMICROB AGENTS CH, V49, P2137, DOI 10.1128/AAC.49.5.2137-2139.2005; Selvakumar B. N., 2007, Journal of Medical Sciences (Pakistan), V7, P443; Shahi SK, 2013, J MOL MODEL, V19, P973, DOI 10.1007/s00894-012-1635-5; Shakil S, 2010, BIOINFORMATION, V4, P468, DOI 10.6026/97320630004468; Shanmugam P, 2013, J CLIN DIAGN RES, V7, P441, DOI 10.7860/JCDR/2013/5091.2794; Shobhana R, 2000, J Assoc Physicians India, V48, P1147; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tofteland S, 2007, J CLIN MICROBIOL, V45, P199, DOI 10.1128/JCM.01319-06; UrbancicRovan V, 1997, CLIN INFECT DIS, V25, pS184, DOI 10.1086/516184; Wagner F W Jr, 1981, Foot Ankle, V2, P64	52	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68234	10.1371/journal.pone.0068234	http://dx.doi.org/10.1371/journal.pone.0068234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861873	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700075
J	Triboulet, S; Dubee, V; Lecoq, L; Bougault, C; Mainardi, JL; Rice, LB; Etheve-Quelquejeu, M; Gutmann, L; Marie, A; Dubost, L; Hugonnet, JE; Simorre, JP; Arthur, M				Triboulet, Sebastien; Dubee, Vincent; Lecoq, Lauriane; Bougault, Catherine; Mainardi, Jean-Luc; Rice, Louis B.; Etheve-Quelquejeu, Melanie; Gutmann, Laurent; Marie, Arul; Dubost, Lionel; Hugonnet, Jean-Emmanuel; Simorre, Jean-Pierre; Arthur, Michel			Kinetic Features of L,D-Transpeptidase Inactivation Critical for beta-Lactam Antibacterial Activity	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS L,D-TRANSPEPTIDASE; DD-CARBOXYPEPTIDASE-TRANSPEPTIDASE; PENICILLIN-BINDING PROTEINS; CRYSTAL-STRUCTURE; PEPTIDOGLYCAN; MECHANISM; INHIBITION; RESISTANCE; MEROPENEM; ANTIBIOTICS	Active-site serine D,D-transpeptidases belonging to the penicillin-binding protein family (PBPs) have been considered for a long time as essential for peptidoglycan cross-linking in all bacteria. However, bypass of the PBPs by an L,D-transpeptidase (Ldt(fm)) conveys high-level resistance to beta-lactams of the penam class in Enterococcus faecium with a minimal inhibitory concentration (MIC) of ampicillin > 2,000 mu g/ml. Unexpectedly, Ldt(fm) does not confer resistance to beta-lactams of the carbapenem class (imipenem MIC = 0.5 mu g/ml) whereas cephems display residual activity (ceftriaxone MIC = 128 mu g/ml). Mass spectrometry, fluorescence kinetics, and NMR chemical shift perturbation experiments were performed to explore the basis for this specificity and identify beta-lactam features that are critical for efficient L,D-transpeptidase inactivation. We show that imipenem, ceftriaxone, and ampicillin acylate Ldtfm by formation of a thioester bond between the active-site cysteine and the beta-lactam-ring carbonyl. However, slow acylation and slow acylenzyme hydrolysis resulted in partial Ldtfm inactivation by ampicillin and ceftriaxone. For ampicillin, Ldt(fm) acylation was followed by rupture of the C-5 - C-6 bond of the beta-lactam ring and formation of a secondary acylenzyme prone to hydrolysis. The saturable step of the catalytic cycle was the reversible formation of a tetrahedral intermediate (oxyanion) without significant accumulation of a non-covalent complex. In agreement, a derivative of Ldt(fm) blocked in acylation bound ertapenem (a carbapenem), ceftriaxone, and ampicillin with similar low affinities. Thus, oxyanion and acylenzyme stabilization are both critical for rapid L,D-transpeptidase inactivation and antibacterial activity. These results pave the way for optimization of the b-lactam scaffold for L,D-transpeptidase-inactivation.	[Triboulet, Sebastien; Dubee, Vincent; Mainardi, Jean-Luc; Gutmann, Laurent; Hugonnet, Jean-Emmanuel; Arthur, Michel] Univ Paris 06, Ctr Rech Cordeliers, Equipe 12, UMR S 872, Paris, France; [Triboulet, Sebastien; Dubee, Vincent; Mainardi, Jean-Luc; Gutmann, Laurent; Hugonnet, Jean-Emmanuel; Arthur, Michel] INSERM, U872, Paris, France; [Triboulet, Sebastien; Dubee, Vincent; Mainardi, Jean-Luc; Gutmann, Laurent; Hugonnet, Jean-Emmanuel; Arthur, Michel] Univ Paris 05, Sorbonne Paris Cite, UMR S 872, Paris, France; [Lecoq, Lauriane; Bougault, Catherine; Simorre, Jean-Pierre] CEA, DSV, IBS, Grenoble, France; [Lecoq, Lauriane; Bougault, Catherine; Simorre, Jean-Pierre] CNRS, UMR 5075, Grenoble, France; [Lecoq, Lauriane; Bougault, Catherine; Simorre, Jean-Pierre] Univ Grenoble 1, Grenoble 1, France; [Mainardi, Jean-Luc; Gutmann, Laurent] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Paris, France; [Rice, Louis B.] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA; [Etheve-Quelquejeu, Melanie] Univ Paris 05, Lab Chim & Biochim Pharmacol & Toxicol, UMR 8601, Paris, France; [Etheve-Quelquejeu, Melanie] CNRS, UMR 8601, Paris, France; [Marie, Arul; Dubost, Lionel] Museum Natl Hist Nat, USM0502, Plateforme Spectrometrie Masse & Prote Museum, F-75231 Paris, France; [Marie, Arul; Dubost, Lionel] CNRS, UMR8041, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Simorre, JP (corresponding author), CEA, DSV, IBS, Grenoble, France.	jean-pierre.simorre@ibs.fr; michel.arthur@crc.jussieu.fr	Dubée, Vincent/F-8768-2018; HUGONNET, Jean-Emmanuel/ABC-7914-2021; Triboulet, Sebastien/AAI-8676-2020; Arthur, Michel/G-3680-2013; MAINARDI, Jean-Luc/E-2714-2014; HUGONNET, Jean-Emmanuel/H-3581-2014	Dubée, Vincent/0000-0002-9982-4741; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Arthur, Michel/0000-0003-1007-636X; MAINARDI, Jean-Luc/0000-0002-4159-0129; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Lecoq, Lauriane/0000-0002-5995-3733; MARIE, Arul/0000-0003-4104-140X; Bougault, Catherine/0000-0003-3358-5255; simorre, jean-pierre/0000-0002-7943-1342	National Institute of Allergy and Infectious Diseases [RO1 AI046626]; Project CARBATUB [ANR 2011 BSV5 024 01]; European Community [261378]; Poste d'Accueil, Institut National de la Sante et de la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045626] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Project CARBATUB; European Community(European Commission); Poste d'Accueil, Institut National de la Sante et de la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases (Grants RO1 AI046626) Agence National de la Recherche and Project CARBATUB (No ANR 2011 BSV5 024 01). ST was supported by the seventh Framework Program of the European Community, Project ORCHID (261378). VD was supported by a Poste d'Accueil, Institut National de la Sante et de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, TUBERCULOSIS 2011 WH; Biarrotte-Sorin S, 2006, J MOL BIOL, V359, P533, DOI 10.1016/j.jmb.2006.03.014; Dubee V, 2012, ANTIMICROB AGENTS CH, V56, P4189, DOI 10.1128/AAC.00665-12; Erdemli SB, 2012, STRUCTURE, V20, P2103, DOI 10.1016/j.str.2012.09.016; FRERE JM, 1976, NATURE, V260, P451, DOI 10.1038/260451a0; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Kim HS, 2013, ACTA CRYSTALLOGR D, V69, P420, DOI 10.1107/S0907444912048998; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Lavollay M, 2011, J BACTERIOL, V193, P778, DOI 10.1128/JB.00606-10; Lecoq L, 2013, ACS CHEM BI IN PRESS, DOI [10.1021/cb4001603, DOI 10.1021/CB4001603)]; Lecoq L, 2012, STRUCTURE, V20, P850, DOI 10.1016/j.str.2012.03.015; Li WJ, 2013, CELL RES, V23, P728, DOI 10.1038/cr.2013.53; Mainard JL, 2002, J BIOL CHEM, V277, P35801, DOI 10.1074/jbc.M204319200; Mainardi JL, 2011, CLIN MICROBIOL INFEC, V17, P1755, DOI 10.1111/j.1469-0691.2011.03699.x; Mainardi JL, 2008, FEMS MICROBIOL REV, V32, P386, DOI 10.1111/j.1574-6976.2007.00097.x; Mainardi JL, 2007, J BIOL CHEM, V282, P30414, DOI 10.1074/jbc.M704286200; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; MARQUET A, 1979, BIOCHEM J, V177, P909, DOI 10.1042/bj1770909; Peltier J, 2011, J BIOL CHEM, V286, P29053, DOI 10.1074/jbc.M111.259150; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; Triboulet S, 2011, J BIOL CHEM, V286, P22777, DOI 10.1074/jbc.M111.239988; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	26	45	45	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67831	10.1371/journal.pone.0067831	http://dx.doi.org/10.1371/journal.pone.0067831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861815	gold, Green Submitted, Green Published			2022-12-25	WOS:000323350700043
J	Jezberova, J; Jezbera, J; Hahn, MW				Jezberova, Jitka; Jezbera, Jan; Hahn, Martin W.			Insights into Variability of Actinorhodopsin Genes of the LG1 Cluster in Two Different Freshwater Habitats	PLOS ONE			English	Article							ACTINOBACTERIA; DIVERSITY; SEQUENCES; LAKES	Actinorhodopsins (ActRs) are recently discovered proteorhodopsins present in Actinobacteria, enabling them to adapt to a wider spectrum of environmental conditions. Frequently, a large fraction of freshwater bacterioplankton belongs to the acI lineage of Actinobacteria and codes the LG1 type of ActRs. In this paper we studied the genotype variability of the LG1 ActRs. We have constructed two clone libraries originating from two environmentally different habitats located in Central Europe; the large alkaline lake Mondsee (Austria) and the small humic reservoir Jiricka (the Czech Republic). The 75 yielded clones were phylogenetically analyzed together with all ActR sequences currently available in public databases. Altogether 156 sequences were analyzed and 13 clusters of ActRs were distinguished. Newly obtained clones are distributed over all three LG1 subgroups - LG1-A, B and C. Eighty percent of the sequences belonged to the acI lineage (LG1-A ActR gene bearers) further divided into LG1-A1 and LG1-A2 subgroups. Interestingly, the two habitats markedly differed in genotype composition with no identical sequence found in both samples of clones. Moreover, Jiricka reservoir contained three so far not reported clusters, one of them LG1-C related, presenting thus completely new, so far undescribed, genotypes of Actinobacteria in freshwaters.	[Jezberova, Jitka; Jezbera, Jan] ASCR, Ctr Biol, Inst Hydrobiol, Vvi, Ceske Budejovice, Czech Republic; [Hahn, Martin W.] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Innsbruck	Jezbera, J (corresponding author), ASCR, Ctr Biol, Inst Hydrobiol, Vvi, Ceske Budejovice, Czech Republic.	jezbera@hbu.cas.cz	Hahn, Martin W./B-9998-2008; Jezbera, Jan/B-5657-2015; Jezberova, Jitka/G-1024-2014	Hahn, Martin W./0000-0003-0501-2556; Jezberova, Jitka/0000-0001-5000-9319	Czech Grant Agency [EEF/10/E011]	Czech Grant Agency(Grant Agency of the Czech Republic)	This study was financially supported by the Czech Grant Agency project EEF/10/E011 awarded to Jan Jezbera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2006, APPL ENVIRON MICROB, V72, P3489, DOI 10.1128/AEM.72.5.3489-3497.2006; [Anonymous], ADV NEURAL INFORM PR; Atamna-Ismaeel N, 2008, ISME J, V2, P656, DOI 10.1038/ismej.2008.27; Debroas D, 2009, ENVIRON MICROBIOL, V11, P2412, DOI 10.1111/j.1462-2920.2009.01969.x; Garcia SL, 2013, ISME J, V7, P137, DOI 10.1038/ismej.2012.86; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P112, DOI 10.1099/ijs.0.001743-0; Hahn MW, 2005, APPL ENVIRON MICROB, V71, P766, DOI 10.1128/AEM.71.2.766-773.2005; Hahn MW, 2003, APPL ENVIRON MICROB, V69, P1442, DOI 10.1128/AEM.69.3.1442-1451.2003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Jezbera J, 2009, INT J SYST EVOL MICR, V59, P2864, DOI 10.1099/ijs.0.010199-0; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Philosof A, 2009, ENVIRON MICROBIOL, V11, P3189, DOI 10.1111/j.1462-2920.2009.02024.x; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sekar R, 2003, APPL ENVIRON MICROB, V69, P2928, DOI 10.1128/AEm.69.5.2928-2935.2003; Sharma AK, 2008, ENVIRON MICROBIOL, V10, P1039, DOI 10.1111/j.1462-2920.2007.01525.x; Sharma AK, 2009, ISME J, V3, P726, DOI 10.1038/ismej.2009.13; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141; Zwickl D., 2006, GARLI GENETIC ALGORI	26	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68542	10.1371/journal.pone.0068542	http://dx.doi.org/10.1371/journal.pone.0068542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844219	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000171
J	Lee, S; Lim, WA; Thorn, KS				Lee, Sidae; Lim, Wendell A.; Thorn, Kurt S.			Improved Blue, Green, and Red Fluorescent Protein Tagging Vectors for S. cerevisiae	PLOS ONE			English	Article							MONOMERIC RED; GENE-EXPRESSION; BRIGHT; VARIANTS; COLOR; CYAN; DETERMINANTS; SENSITIVITY; CASSETTES; ORANGE	Fluorescent protein fusions are a powerful tool to monitor the localization and trafficking of proteins. Such studies are particularly easy to carry out in the budding yeast Saccharomyces cerevisiae due to the ease with which tags can be introduced into the genome by homologous recombination. However, the available yeast tagging plasmids have not kept pace with the development of new and improved fluorescent proteins. Here, we have constructed yeast optimized versions of 19 different fluorescent proteins and tested them for use as fusion tags in yeast. These include two blue, seven green, and seven red fluorescent proteins, which we have assessed for brightness, photostability and perturbation of tagged proteins. We find that EGFP remains the best performing green fluorescent protein, that TagRFP-T and mRuby2 outperform mCherry as red fluorescent proteins, and that mTagBFP2 can be used as a blue fluorescent protein tag. Together, the new tagging vectors we have constructed provide improved blue and red fluorescent proteins for yeast tagging and three color imaging.	[Lee, Sidae; Lim, Wendell A.] Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94143 USA; [Lee, Sidae; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Lim, Wendell A.] Calif Inst Quantitat Biomed Res, San Francisco, CA USA; [Thorn, Kurt S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Thorn, KS (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	kurt.thorn@ucsf.edu		Thorn, Kurt/0000-0001-9310-288X	NIGMS Systems Biology Center [P50 GM081879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879] Funding Source: NIH RePORTER	NIGMS Systems Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this project was provided by an NIGMS Systems Biology Center grant, number P50 GM081879. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hailey DW, 2002, METHOD ENZYMOL, V351, P34; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Petracek ME, 2002, METHOD ENZYMOL, V350, P445, DOI 10.1016/S0076-6879(02)50978-2; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Vorvis C, 2008, YEAST, V25, P651, DOI 10.1002/yea.1611; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wach A, 1997, AID YEA159 3 0 CO 2; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Young CL, 2012, YEAST, V29, P119, DOI 10.1002/yea.2895; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5; Zhang CD, 2010, EUKARYOT CELL, V9, P224, DOI 10.1128/EC.00327-09	38	96	96	10	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67902	10.1371/journal.pone.0067902	http://dx.doi.org/10.1371/journal.pone.0067902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844123	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000116
J	Tian, XS; Guo, JC; Zhu, M; Li, MW; Wu, GC; Xia, Y				Tian, Xuesong; Guo, Jingchun; Zhu, Min; Li, Minwei; Wu, Gencheng; Xia, Ying			delta-Opioid Receptor Activation Rescues the Functional TrkB Receptor and Protects the Brain from Ischemia-Reperfusion Injury in the Rat	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CREB PHOSPHORYLATION; CORTICAL-NEURONS; K+ HOMEOSTASIS; TRUNCATED TRKB; MESSENGER-RNA; EXPRESSION; HYPOXIA; DEATH; MU	Objectives: delta-opioid receptor (DOR) activation reduced brain ischemic infarction and attenuated neurological deficits, while DOR inhibition aggravated the ischemic damage. The underlying mechanisms are, however, not well understood yet. In this work, we asked if DOR activation protects the brain against ischemic injury through a brain-derived neurotrophic factor (BDNF) -TrkB pathway. Methods: We exposed adult male Sprague-Dawley rats to focal cerebral ischemia, which was induced by middle cerebral artery occlusion (MCAO). DOR agonist TAN-67 (60 nmol), antagonist Naltrindole (100 nmol) or artificial cerebral spinal fluid was injected into the lateral cerebroventricle 30 min before MCAO. Besides the detection of ischemic injury, the expression of BDNF, full-length and truncated TrkB, total CREB, p-CREB, p-ATF and CD11b was detected by Western blot and fluorescence immunostaining. Results: DOR activation with TAN-67 significantly reduced the ischemic volume and largely reversed the decrease in full-length TrkB protein expression in the ischemic cortex and striatum without any appreciable change in cerebral blood flow, while the DOR antagonist Naltrindole aggregated the ischemic injury. However, the level of BDNF remained unchanged in the cortex, striatum and hippocampus at 24 hours after MCAO and did not change in response to DOR activation or inhibition. MCAO decreased both total CREB and pCREB in the striatum, but not in the cortex, while DOR inhibition promoted a further decrease in total and phosphorylated CREB in the striatum and decreased pATF-1 expression in the cortex. In addition, MCAO increased C11b expression in the cortex, striatum and hippocampus, and DOR activation specifically attenuated the ischemic increase in the cortex but not in the striatum and hippocampus. Conclusions: DOR activation rescues TrkB signaling by reversing ischemia/reperfusion induced decrease in the full-length TrkB receptor and reduces brain injury in ischemia/reperfusion	[Tian, Xuesong; Guo, Jingchun; Zhu, Min; Li, Minwei; Wu, Gencheng] Fudan Univ, Shanghai Med Coll, Dept Integrat Med & Neurobiol, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Tian, Xuesong; Xia, Ying] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA; [Guo, Jingchun] Shanghai Res Ctr Acupuncture & Meridians, Lab Mol Neurol, Shanghai, Peoples R China	Fudan University; University of Texas System; University of Texas Health Science Center Houston	Guo, JC (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Integrat Med & Neurobiol, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	jingchunguo@shmu.edu.cn; Ying.Xia@uth.tmc.edu		Tian, Xuesong/0000-0001-6162-2856	National Natural Science Foundation of China [30873318, 81072646]; Science and Technology Commission Program of Shanghai [06DZ19734]; National Basic Research Program of China [12CB518502]; National Institutes of Health [AT-004422, HD-034852]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004422] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Program of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by National Natural Science Foundation of China (30873318 and 81072646), Science and Technology Commission Program of Shanghai (06DZ19734), National Basic Research Program of China (12CB518502) and National Institutes of Health (AT-004422 and HD-034852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilecki W, 2000, EUR J PHARMACOL, V390, P1, DOI 10.1016/S0014-2999(00)00018-2; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Chao DM, 2008, CEREB CORTEX, V18, P2217, DOI 10.1093/cercor/bhm247; Chao DM, 2007, J CELL PHYSIOL, V212, P60, DOI 10.1002/jcp.21000; Chao DM, 2007, J CEREBR BLOOD F MET, V27, P356, DOI 10.1038/sj.jcbfm.9600352; Chao DM, 2010, PROG NEUROBIOL, V90, P439, DOI 10.1016/j.pneurobio.2009.12.007; Choi Bo-Ryoung, 2011, Exp Neurobiol, V20, P92, DOI 10.5607/en.2011.20.2.92; Fan LW, 2006, EUR J NEUROSCI, V24, P341, DOI 10.1111/j.1460-9568.2006.04918.x; Fan XA, 2010, STROKE, V41, pS54, DOI 10.1161/STROKEAHA.110.596106; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Gomes JR, 2012, J NEUROSCI, V32, P4610, DOI 10.1523/JNEUROSCI.0374-12.2012; Govindaswami M, 2008, ACAD EMERG MED, V15, P250, DOI 10.1111/j.1553-2712.2008.00048.x; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; He XZ, 2013, CELL MOL LIFE SCI, V70, P2291, DOI 10.1007/s00018-012-1167-2; Hong SS, 2007, BRAIN RES, V1149, P76, DOI 10.1016/j.brainres.2007.02.062; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iwata M, 2007, NEUROSCI LETT, V414, P242, DOI 10.1016/j.neulet.2006.12.021; Kang XZ, 2009, CELL MOL LIFE SCI, V66, P3505, DOI 10.1007/s00018-009-0136-x; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Lim YJ, 2004, ANESTHESIOLOGY, V100, P562, DOI 10.1097/00000542-200403000-00015; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; Narantuya D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011746; Narumiya S, 1998, BRAIN RES, V797, P278, DOI 10.1016/S0006-8993(98)00385-0; Noorian AR, 2011, J NEUROSURG SCI, V55, P127; Ooboshi H, 2011, CURR PHARM DESIGN, V17, P424, DOI 10.2174/138161211795164149; Pabello NG, 2005, BRAIN RES, V1038, P11, DOI 10.1016/j.brainres.2004.12.047; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Persson AI, 2005, NEUROSCI RES, V52, P1, DOI 10.1016/j.neures.2005.01.003; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Su DS, 2007, NEUROSCI LETT, V423, P113, DOI 10.1016/j.neulet.2007.06.044; Tanaka K, 1999, NEUROREPORT, V10, P2245, DOI 10.1097/00001756-199908020-00004; Tanaka K, 1999, BRAIN RES, V818, P520, DOI 10.1016/S0006-8993(98)01263-3; Tian Xue-song, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P632, DOI 10.3736/jcim20080617; Tian Xue-Song, 2008, Shengli Xuebao, V60, P475; Torregrossa MM, 2004, NEUROPSYCHOPHARMACOL, V29, P649, DOI 10.1038/sj.npp.1300345; Vidaurre OG, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.143; Warnick JE, 2005, BEHAV BRAIN RES, V160, P277, DOI 10.1016/j.bbr.2004.12.009; Wong J., 2011, SCHIZOPHR B, V39, P130; XIA Y, 1991, BRAIN RES, V549, P181, DOI 10.1016/0006-8993(91)90457-7; Xia Y, 2001, J COMP NEUROL, V436, P202; Yang YL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-55; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yu ZY, 2009, NEUROL RES, V31, P122, DOI 10.1179/174313209X389866; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zhang HN, 2006, EUR J NEUROSCI, V23, P984, DOI 10.1111/j.1460-9568.2006.04621.x; Zhang J.H., 1999, SOC NEUR ABSTR, V28, P736; Zhang JH, 2006, STROKE, V37, P1094, DOI 10.1161/01.STR.0000206444.29930.18; Zhang JH, 2002, AM J PHYSIOL-CELL PH, V282, pC1225, DOI 10.1152/ajpcell.00226.2001; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zhang R, 2006, NEUROBIOL DIS, V24, P345, DOI 10.1016/j.nbd.2006.07.012; Zhao P, 2000, ACUPUNCTURE ELECTRO, V25, P101, DOI 10.3727/036012900816356163; Zhao P., 2002, SOC NEUR ABSTR, V28, P736; Zhou F, 2013, EVID-BASED COMPL ALT, V2013; Zhou F., 2013, EVID-BASED COMPL ALT, V2013; Zhou F, 2011, J APPL PHYSIOL, V111, P1877, DOI 10.1152/japplphysiol.00313.2011; Zhu L, 2008, NEUROCHEM RES, V33, P784, DOI 10.1007/s11064-007-9495-6	61	26	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69252	10.1371/journal.pone.0069252	http://dx.doi.org/10.1371/journal.pone.0069252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844255	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000187
J	van Casteren, A; Sellers, WI; Thorpe, SKS; Coward, S; Crompton, RH; Ennos, AR				van Casteren, Adam; Sellers, William I.; Thorpe, Susannah K. S.; Coward, Sam; Crompton, Robin H.; Ennos, A. Roland			Factors Affecting the Compliance and Sway Properties of Tree Branches Used by the Sumatran Orangutan (Pongo abelii)	PLOS ONE			English	Article							WILD ORANGUTANS; LOCOMOTION; PRIMATES; MECHANICS; CHIMPANZEES; ADAPTATION; STRATEGIES; INDONESIA; EVOLUTION; PYGMAEUS	The tropical arboreal environment is a mechanically complex and varied habitat. Arboreal inhabitants must adapt to changes in the compliance and stability of supports when moving around trees. Because the orangutan is the largest habitual arboreal inhabitant, it is unusually susceptible to branch compliance and stability and therefore represents a unique animal model to help investigate how animals cope with the mechanical heterogeneity of the tropical canopy. The aim of this study was to investigate how changes in compliance and time of oscillation of branches are related to easily observable traits of arboreal supports. This should help predict how supports react mechanically to the weight and mass of a moving orangutan, and suggest how orangutans themselves predict branch properties. We measured the compliance and time of oscillation of branches from 11 tree species frequented by orangutans in the rainforest of Sumatra. Branches were pulled at several points along their length using a force balance at the end of a stiff rope, and the local diameter of the branch and the distance to its base and tip were measured. Compliance was negatively associated with both local diameter and length to the tip of the branch, and positively, if weakly, associated with length from the trunk. However, branch diameter not only predicted compliance best, but would also be easiest for an orangutan to observe. In contrast, oscillation times of branches were largely unaffected by local diameter, and only significantly increased at diameters below 2 cm. The results of this study validate previous field research, which related locomotory modes to local branch diameter, while suggesting how arboreal animals themselves sense their mechanical environment.	[van Casteren, Adam; Sellers, William I.; Ennos, A. Roland] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Thorpe, Susannah K. S.; Coward, Sam] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Crompton, Robin H.] Univ Liverpool, Inst Aging & Chron Dis, Dept Musculoskeletal Biol 2, Liverpool L69 3BX, Merseyside, England	University of Manchester; University of Birmingham; University of Liverpool	van Casteren, A (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	adam.vancasteren@gmail.com	van Casteren, Adam/AAS-9702-2020; Sellers, William Irvin/Q-3843-2019	van Casteren, Adam/0000-0002-2993-8874; Sellers, William Irvin/0000-0002-2913-5406; Thorpe, Susannah/0000-0002-6160-4452	Natural Environment Research Council [NE/F003730/1]; Sumatran Orangutan Conservation Project (SOCP); Natural Environment Research Council [NE/F003307/1] Funding Source: researchfish; NERC [NE/F003730/1, NE/F003307/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Sumatran Orangutan Conservation Project (SOCP); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by grants from the Natural Environment Research Council (NE/F003730/1) (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Permission to carry out research at Ketambe Reseach Station in the Gunung Leuser National Park was kindly granted by RISTEK (Jakarta), BPKEL (Banda Aceh), PHKA (Jakarta) and TNGL (Medan and Kutacane). I would like to thank the Sumatran Orangutan Conservation Project (SOCP) for their help and support whilst researching at Ketambe. I would like to thank all the staff at Ketambe Research Centre for their support and guidance during my time there with particular thanks to Mahyudin whose tireless effort and support made the research possible.	ALEXANDER R M, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P315; Beismann H, 2000, J EXP BOT, V51, P617, DOI 10.1093/jexbot/51.344.617; Bergman R, 2010, FPLGTR113; Biewener AA., 2003, ANIMAL LOCOMOTION; Bonser RHC, 1999, J EXP BIOL, V202, P1459; CANT JGH, 1992, AM J PHYS ANTHROPOL, V88, P273, DOI 10.1002/ajpa.1330880302; CANT JGH, 1987, AM J PHYS ANTHROPOL, V74, P143, DOI 10.1002/ajpa.1330740202; Channon AJ, 2011, J EXP BIOL, V214, P687, DOI 10.1242/jeb.046797; CROMPTON RH, 1993, P ROY SOC B-BIOL SCI, V254, P41, DOI 10.1098/rspb.1993.0124; DEMES B, 1995, AM J PHYS ANTHROPOL, V96, P419, DOI 10.1002/ajpa.1330960407; Ennos AR, 1997, TRENDS ECOL EVOL, V12, P108, DOI 10.1016/S0169-5347(96)10066-5; Farrar R. A., 1999, ENG DATA BOOK; Gilman CA, 2012, J EXP BIOL, V215, P220, DOI 10.1242/jeb.061838; Gordon J.E., 1978, STRUCTURES WHY THING; Houle A, 2004, INT J PRIMATOL, V25, P237, DOI 10.1023/B:IJOP.0000014652.83830.e4; HUNT KD, 1992, AM J PHYS ANTHROPOL, V87, P83, DOI 10.1002/ajpa.1330870108; Kerdok AE, 2002, J APPL PHYSIOL, V92, P469, DOI 10.1152/japplphysiol.01164.2000; MARKHAM R, 1990, AM J PHYS ANTHROPOL, V81, P1, DOI 10.1002/ajpa.1330810102; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; MCMAHON TA, 1979, J BIOMECH, V12, P893, DOI 10.1016/0021-9290(79)90057-5; Niklas KJ, 1992, PLANT BIOMECHANICS; Pontzer H, 2004, J HUM EVOL, V46, P317, DOI 10.1016/j.jhevol.2003.12.006; Povinelli DJ, 1995, Q REV BIOL, V70, P393, DOI 10.1086/419170; Schmitt D, 1999, J ZOOL, V248, P149, DOI 10.1017/S0952836999006020; Spatz HC, 2007, AM J BOT, V94, P1603, DOI 10.3732/ajb.94.10.1603; Stewart FA, 2011, J HUM EVOL, V61, P388, DOI 10.1016/j.jhevol.2011.05.005; SUGARDJITO J, 1987, INT J PRIMATOL, V8, P17, DOI 10.1007/BF02737112; Thomas P, 2000, TREES THEIR NATURAL, P230; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Thorpe SKS, 2007, BIOLOGY LETT, V3, P253, DOI 10.1098/rsbl.2007.0049; Thorpe SKS, 2005, AM J PHYS ANTHROPOL, V127, P58, DOI 10.1002/ajpa.20151; Thorpe SKS, 2009, P NATL ACAD SCI USA, V106, P12646, DOI 10.1073/pnas.0811537106; van Casteren A, 2012, P NATL ACAD SCI USA, V109, P6873, DOI 10.1073/pnas.1200902109; Vincent JFV, 1992, BIOMECHANICS MAT PRA	34	22	22	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67877	10.1371/journal.pone.0067877	http://dx.doi.org/10.1371/journal.pone.0067877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844116	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000112
J	Barneaud-Rocca, D; Etchebest, C; Guizouarn, H				Barneaud-Rocca, Damien; Etchebest, Catherine; Guizouarn, Helene			Structural Model of the Anion Exchanger 1 (SLC4A1) and Identification of Transmembrane Segments Forming the Transport Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; HUMAN ERYTHROCYTE BAND-3; CELL-VOLUME REGULATION; MEMBRANE DOMAIN; PROTEIN AE1; CATION LEAK; TOPOLOGY; STOMATOCYTOSIS; RESIDUES; REGION	The anion exchanger 1 (AE1), a member of bicarbonate transporter family SLC4, mediates an electroneutral chloride/bicarbonate exchange in physiological conditions. However, some point mutations in AE1 membrane-spanning domain convert the electroneutral anion exchanger into a Na+ and K+ conductance or induce a cation leak in a still functional anion exchanger. The molecular determinants that govern ion movement through this transporter are still unknown. The present study was intended to identify the ion translocation pathway within AE1. In the absence of a resolutive three-dimensional structure of AE1 membrane-spanning domain, in silico modeling combined with site-directed mutagenesis experiments was done. Astructural model of AE1 membrane-spanning domain is proposed, and this model is based on the structure of a uracil-proton symporter. This model was used to design cysteine-scanning mutagenesis on transmembrane (TM) segments 3 and 5. By measuring AE1 anion exchange activity or cation leak, it is proposed that there is a unique transport site comprising TM3-5 and TM8 that should function as an anion exchanger and a cation leak.	[Barneaud-Rocca, Damien; Guizouarn, Helene] Univ Nice Sophia Antipolis, Inst Biol Valrose, UMR7277, F-06100 Nice, France; [Barneaud-Rocca, Damien; Guizouarn, Helene] CNRS, UMR7277, F-06100 Nice, France; [Barneaud-Rocca, Damien; Guizouarn, Helene] INSERM, U1091, F-06100 Nice, France; [Etchebest, Catherine] INSERM, U665, F-75015 Paris, France; [Etchebest, Catherine] Univ Paris Diderot, Sorbonne Paris Cite, UMR S665, F-75015 Paris, France; [Etchebest, Catherine] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Etchebest, Catherine] Lab Excellence GR Ex, F-75739 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Guizouarn, H (corresponding author), Inst Biol Valrose, Batiment Sci Nat,28 Av Valrose, F-06108 Nice 2, France.	helene.guizouarn@unice.fr	etchebest, catherine/O-2485-2019	etchebest, catherine/0000-0002-5871-2372; Guizouarn, Helene/0000-0002-8757-6672				Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Bamberg E, 1992, The Band 3 Proteins: Anion Transporters, Binding Proteins Senescent Antigens; Barneaud-Rocca D, 2011, J BIOL CHEM, V286, P8909, DOI 10.1074/jbc.M110.166819; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bohm R, 1996, BBA-BIOMEMBRANES, V1280, P238, DOI 10.1016/0005-2736(95)00303-7; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; Chu C, 2010, BIOCHEM J, V426, P379, DOI 10.1042/BJ20091525; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Ellory JC, 2009, PHILOS T R SOC B, V364, P189, DOI 10.1098/rstb.2008.0154; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FIEVET B, 1995, EMBO J, V14, P5158, DOI 10.1002/j.1460-2075.1995.tb00200.x; Fievet B, 1998, P NATL ACAD SCI USA, V95, P10996, DOI 10.1073/pnas.95.18.10996; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; GarciaRomeu F, 1996, CELL MOL BIOL, V42, P985; Groves JD, 1999, BIOCHEM J, V344, P699, DOI 10.1042/0264-6021:3440699; Groves JD, 1999, BIOCHEM J, V344, P687, DOI 10.1042/0264-6021:3440687; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; Guizouarn H, 2011, BRIT J HAEMATOL, V152, P655, DOI 10.1111/j.1365-2141.2010.08454.x; Hirai T, 2011, BIOCHEM CELL BIOL, V89, P148, DOI [10.1139/o10-160, 10.1139/O10-160]; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P1049, DOI 10.3324/haematol.2008.002873; JENNINGS ML, 1976, J MEMBRANE BIOL, V28, P187, DOI 10.1007/BF01869697; JENNINGS ML, 1992, J BIOL CHEM, V267, P13964; Kanki T, 2002, BIOCHEMISTRY-US, V41, P13973, DOI 10.1021/bi026619q; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Kuma H, 2002, BIOCHEMISTRY-US, V41, P3380, DOI 10.1021/bi015879p; LINDENTHAL S, 1991, P NATL ACAD SCI USA, V88, P6540, DOI 10.1073/pnas.88.15.6540; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Parker MD, 2007, J PHYSIOL-LONDON, V581, P33, DOI 10.1113/jphysiol.2007.128389; Passow H, 1980, Ann N Y Acad Sci, V341, P361, DOI 10.1111/j.1749-6632.1980.tb47184.x; Paw BH, 2003, NAT GENET, V34, P59, DOI 10.1038/ng1137; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; PUCEAT M, 1995, J BIOL CHEM, V270, P1315, DOI 10.1074/jbc.270.3.1315; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Stewart AK, 2011, AM J PHYSIOL-CELL PH, V300, pC1034, DOI 10.1152/ajpcell.00447.2010; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Taylor AM, 2001, BIOCHEM J, V359, P661, DOI 10.1042/0264-6021:3590661; WAINWRIGHT SD, 1990, BIOCHEM J, V272, P265, DOI 10.1042/bj2720265; Walsh S, 2008, AM J PHYSIOL-RENAL, V295, pF343, DOI 10.1152/ajprenal.00587.2007; Walsh S, 2009, BIOCHEM BIOPH RES CO, V382, P668, DOI 10.1016/j.bbrc.2009.03.062; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamaguchi T, 2010, J STRUCT BIOL, V169, P406, DOI 10.1016/j.jsb.2009.12.009; Zaki L, 1996, CELL MOL BIOL, V42, P1053; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	49	31	32	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26372	26384		10.1074/jbc.M113.465989	http://dx.doi.org/10.1074/jbc.M113.465989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23846695	hybrid, Green Published			2022-12-25	WOS:000330594500003
J	Parveen, N; Varman, R; Nair, S; Das, G; Ghosh, S; Mukhopadhyay, S				Parveen, Nazia; Varman, Raja; Nair, Shiny; Das, Gobardhan; Ghosh, Sudip; Mukhopadhyay, Sangita			Endocytosis of Mycobacterium tuberculosis Heat Shock Protein 60 Is Required to Induce Interleukin-10 Production in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-2; HEAT-SHOCK PROTEINS; IMMUNE-RESPONSES; DENDRITIC CELLS; TNF-ALPHA; SIGNALING CASCADES; IL-10 PRODUCTION	Understanding the signaling pathways involved in the regulation of anti-inflammatory and pro-inflammatory responses in tuberculosis is extremely important in tailoring a macrophage innate response to promote anti-tuberculosis immunity in the host. Although the role of toll-like receptors (TLRs) in the regulation of anti-inflammatory and pro-inflammatory responses is known, the detailed molecular mechanisms by which the Mycobacterium tuberculosis bacteria modulate these innate responses are not clearly understood. In this study, we demonstrate that M. tuberculosis heat shock protein 60 (Mtbhsp60, Cpn60.1, and Rv3417c) interacts with both TLR2 and TLR4 receptors, but its interaction with TLR2 leads to clathrin-dependent endocytosis resulting in an increased production of interleukin (IL)-10 and activated p38 MAPK. Blockage of TLR2-mediated endocytosis inhibited IL-10 production but induced production of tumor necrosis factor (TNF)-alpha and activated ERK1/2. In contrast, upon interaction with TLR4, Mtbhsp60 remained predominantly localized on the cell surface due to poorer endocytosis of the protein that led to decreased IL-10 production and p38 MAPK activation. The Escherichia coli homologue of hsp60 was found to be retained mainly on the macrophage surface upon interaction with either TLR2 or TLR4 that triggered predominantly a pro-inflammatory-type immune response. Our data suggest that cellular localization of Mtbhsp60 upon interaction with TLRs dictates the type of polarization in the innate immune responses in macrophages. This information is likely to help us in tailoring the host protective immune responses against M. tuberculosis.	[Parveen, Nazia; Varman, Raja; Nair, Shiny; Mukhopadhyay, Sangita] Ctr DNA Fingerprinting & Diagnost, Hyderabad 500001, Andhra Pradesh, India; [Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Ghosh, Sudip] Natl Inst Nutr, Mol Biol Unit, Hyderabad 500007, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Mukhopadhyay, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Bldg 7,Gruhakalpa 5-4-399-B, Hyderabad 500001, Andhra Pradesh, India.	sangita@cdfd.org.in		Parveen, Nazia/0000-0002-2918-9498; Mukhopadhyay, Sangita/0000-0002-5511-3315	Indian Council of Medical Research, Government of India [Imm./18/11/12/2008-ECD-1]; Department of Biotechnology, Government of India [BT/PR12854/BRB/10/730/2009]; Department of Biotechnology; Council of Scientific and Industrial Research, India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants from the Indian Council of Medical Research, Government of India Grant Imm./18/11/12/2008-ECD-1, the Department of Biotechnology, Government of India Grant BT/PR12854/BRB/10/730/2009, and a core grant from the Department of Biotechnology (to Centre for DNA Fingerprinting and Diagnostics).; Supported by a research fellowship from the Council of Scientific and Industrial Research, India.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barton GM, 2004, NAT IMMUNOL, V5, P472, DOI 10.1038/ni0504-472; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Cabo-Bilbao A, 2006, J STRUCT BIOL, V155, P482, DOI 10.1016/j.jsb.2006.06.008; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Cavalli V, 2001, FEBS LETT, V498, P190, DOI 10.1016/S0014-5793(01)02484-X; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Clark AC, 1998, METHOD ENZYMOL, V290, P100; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gaston JSH, 2002, CLIN EXP IMMUNOL, V127, P1, DOI 10.1046/j.1365-2249.2002.01759.x; Gobert AP, 2004, J BIOL CHEM, V279, P245, DOI 10.1074/jbc.M307858200; Goldfeld A, 2007, TUBERCULOSIS, V87, pS26, DOI 10.1016/j.tube.2007.05.003; Guex N., 1996, Experientia (Basel), V52, pA26; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Hayashi T, 2006, J THROMB HAEMOST, V4, P1763, DOI 10.1111/j.1538-7836.2006.02042.x; Henderson B, 2009, CELL STRESS CHAPERON, V14, P329, DOI 10.1007/s12192-008-0087-4; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hu YM, 2008, INFECT IMMUN, V76, P1535, DOI 10.1128/IAI.01078-07; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jones BW, 2001, ANN RHEUM DIS, V60, pIII6; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Khan N, 2008, CELL MICROBIOL, V10, P1711, DOI 10.1111/j.1462-5822.2008.01161.x; Khan N, 2007, INT IMMUNOL, V19, P477, DOI 10.1093/intimm/dxm012; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lee J., 2012, MEDIAT INFLAMM, V2012; Lewthwaite JC, 2001, INFECT IMMUN, V69, P7349, DOI 10.1128/IAI.69.12.7349-7355.2001; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loures FV, 2010, INFECT IMMUN, V78, P1078, DOI 10.1128/IAI.01198-09; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marcatili A, 1997, MICROBIOL-UK, V143, P45, DOI 10.1099/00221287-143-1-45; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Monahan IM, 2001, MICROBIOL-SGM, V147, P459, DOI 10.1099/00221287-147-2-459; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Mukhopadhyay S, 2004, FEBS LETT, V567, P275, DOI 10.1016/j.febslet.2004.04.081; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Mukhopadhyay S, 2007, CURR SIGNAL TRANSD T, V2, P121, DOI 10.2174/157436207780619536; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; O'Garra A, 2004, ADV IMMUNOL, V83, P133; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Qamra R, 2004, J MOL BIOL, V342, P605, DOI 10.1016/j.jmb.2004.07.066; Qian C, 2006, BLOOD, V108, P2307, DOI 10.1182/blood-2006-03-005595; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Rahim SS, 2005, IMMUNOLOGY, V114, P313, DOI 10.1111/j.1365-2567.2005.02107.x; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; RETZLAFF C, 1994, INFECT IMMUN, V62, P5689, DOI 10.1128/IAI.62.12.5689-5693.1994; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Rook GAW, 2007, CURR MOL MED, V7, P327; Ryffel B, 2005, TUBERCULOSIS, V85, P395, DOI 10.1016/j.tube.2005.08.021; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schluger NW, 1998, AM J RESP CRIT CARE, V157, P679, DOI 10.1164/ajrccm.157.3.9708002; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Song CH, 2003, J CLIN IMMUNOL, V23, P194, DOI 10.1023/A:1023309928879; Souza CD, 2006, MICROB PATHOGENESIS, V41, P59, DOI 10.1016/j.micpath.2006.04.002; Tabona P, 1998, J IMMUNOL, V161, P1414; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tse HM, 2002, J IMMUNOL, V168, P825, DOI 10.4049/jimmunol.168.2.825; Tsuei AC, 2012, CELL STRESS CHAPERON, V17, P23, DOI 10.1007/s12192-011-0282-6; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x; Yokota S, 2006, INT IMMUNOL, V18, P573, DOI 10.1093/intimm/dxh399; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	95	36	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24956	24971		10.1074/jbc.M113.461004	http://dx.doi.org/10.1074/jbc.M113.461004			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846686	Green Published, hybrid			2022-12-25	WOS:000330612300059
J	Shen, ZLL; Vince, DG; Li, ZM				Shen, Zhilei Liu; Vince, D. Geoffrey; Li, Zong-Ming			In Vivo Study of Transverse Carpal Ligament Stiffness Using Acoustic Radiation Force Impulse (ARFI) Imaging	PLOS ONE			English	Article							FATTY LIVER-DISEASE; WRIST POSTURE; TUNNEL; STABILITY; FIBROSIS; QUANTIFICATION; ELASTOGRAPHY; MUSCLES; THENAR; ARCH	The transverse carpal ligament (TCL) forms the volar boundary of the carpal tunnel and may provide mechanical constraint to the median nerve, leading to carpal tunnel syndrome. Therefore, the mechanical properties of the TCL are essential to better understand the etiology of carpal tunnel syndrome. The purpose of this study was to investigate the in vivo TCL stiffness using acoustic radiation force impulse (ARFI) imaging. The shear wave velocity (SWV) of the TCL was measured using Virtual Touch IQ (TM) software in 15 healthy, male subjects. The skin and the thenar muscles were also examined as reference tissues. In addition, the effects of measurement location and ultrasound transducer compression on the SWV were studied. The SWV of the TCL was dependent on the tissue location, with greater SWV values within the muscle-attached region than those outside of the muscle-attached region. The SWV of the TCL was significantly smaller without compression (5.21 +/- 1.08 m/s) than with compression (6.62 +/- 1.18 m/s). The SWV measurements of the skin and the thenar muscles were also affected by transducer compression, but to different extents than the SWV of the TCL. Therefore to standardize the ARFI imaging procedure, it is recommended that a layer of ultrasound gel be maintained to minimize the effects of tissue compression. This study demonstrated the feasibility of ARFI imaging for assessing the stiffness characteristics of the TCL in vivo, which has the potential to identify pathomechanical changes of the tissue.	[Shen, Zhilei Liu; Vince, D. Geoffrey; Li, Zong-Ming] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Li, Zong-Ming] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA; [Li, Zong-Ming] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, ZM (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	liz4@ccf.org			National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)/NIH [R21AR062753]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062753] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by Grant Number R21AR062753 from The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG TJ, 1979, J BIOMECH, V12, P567, DOI 10.1016/0021-9290(79)90045-9; Bhatia KSS, 2012, ULTRASOUND MED BIOL, V38, P195, DOI 10.1016/j.ultrasmedbio.2011.10.024; Bota S, 2010, J MED ULTRASON, V12, P213; D'Anastasi M, 2011, CLIN HEMORHEOL MICRO, V49, P105, DOI 10.3233/CH-2011-1461; D'Onofrio M, 2009, J PANCREAS, V10, P543; Friedrich-Rust M, 2012, ULTRASONICS, V52, P69, DOI 10.1016/j.ultras.2011.06.012; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; GARCIAELIAS M, 1989, J HAND SURG-AM, V14, P277, DOI 10.1016/0363-5023(89)90021-X; GARCIAELIAS M, 1989, J ORTHOPAED RES, V7, P738, DOI 10.1002/jor.1100070516; Goss BC, 2010, J HAND SURG-AM, V35A, P197, DOI 10.1016/j.jhsa.2009.09.019; Holmes MWR, 2012, J ORTHOP RES, V30, P757, DOI 10.1002/jor.21583; Holmes MWR, 2011, J ORTHOP RES, V29, P1682, DOI 10.1002/jor.21442; Keir PJ, 1999, CLIN BIOMECH, V14, P635, DOI 10.1016/S0268-0033(99)00012-1; KLINE SC, 1992, J BONE JOINT SURG AM, V74A, P1478, DOI 10.2106/00004623-199274100-00006; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kung J, 2005, J HAND SURG-BRIT EUR, V30B, P475, DOI 10.1016/j.jhsb.2005.04.019; Li ZM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148469; Main EK, 2012, J BIOMECH, V45, P1180, DOI 10.1016/j.jbiomech.2012.01.048; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; MESGARZADEH M, 1989, RADIOLOGY, V171, P749, DOI 10.1148/radiology.171.3.2541464; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Palmeri ML, 2011, J HEPATOL, V55, P666, DOI 10.1016/j.jhep.2010.12.019; Shen ZLL, 2013, J APPL PHYSIOL, V114, P225, DOI 10.1152/japplphysiol.01273.2012; Shen ZLL, 2012, ULTRASOUND MED BIOL, V38, P982, DOI 10.1016/j.ultrasmedbio.2012.02.021; Stock KF, 2010, CLIN HEMORHEOL MICRO, V46, P139, DOI 10.3233/CH-2010-1340; Syversveen T, 2012, EUR RADIOL, V22, P2130, DOI 10.1007/s00330-012-2476-4; Tengrootenhuysen M, 2009, ACTA ORTHOP BELG, V75, P467; Tozaki M, 2011, EUR J RADIOL, V80, pE182, DOI 10.1016/j.ejrad.2011.05.020; Xiu KH, 2010, CLIN BIOMECH, V25, P776, DOI 10.1016/j.clinbiomech.2010.05.011; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662; Zhai L, 2012, ULTRASOUND MED BIOL, V38, P50, DOI 10.1016/j.ultrasmedbio.2011.10.002; Zhao H, 2011, ULTRASOUND MED BIOL, V37, P1884, DOI 10.1016/j.ultrasmedbio.2011.07.012	33	20	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68569	10.1371/journal.pone.0068569	http://dx.doi.org/10.1371/journal.pone.0068569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861919	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300070
J	How, C; Hui, ABY; Alajez, NM; Shi, W; Boutros, PC; Clarke, BA; Yan, R; Pintilie, M; Fyles, A; Hedley, DW; Hill, RP; Milosevic, M; Liu, FF				How, Christine; Hui, Angela B. Y.; Alajez, Nehad M.; Shi, Wei; Boutros, Paul C.; Clarke, Blaise A.; Yan, Rui; Pintilie, Melania; Fyles, Anthony; Hedley, David W.; Hill, Richard P.; Milosevic, Michael; Liu, Fei-Fei			MicroRNA-196b Regulates the Homeobox B7-Vascular Endothelial Growth Factor Axis in Cervical Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; HOX GENES; FACTOR RECEPTOR-1; IDENTIFICATION; PROFILES; MIR-196B; PROGRESSION; PREDICTION; INVASION; PCR	The down-regulation of microRNA-196b (miR-196b) has been reported, but its contribution to cervical cancer progression remains to be investigated. In this study, we first demonstrated that miR-196b down-regulation was significantly associated with worse disease-free survival (DFS) for cervical cancer patients treated with combined chemo-radiation. Secondly, using a tri-modal approach for target identification, we determined that homeobox-B7 (HOXB7) was a bona fide target for miR-196b, and in turn, vascular endothelial growth factor (VEGF) was a downstream transcript regulated by HOXB7. Reconstitution of miR-196b expression by transient transfection resulted in reduced cell growth, clonogenicity, migration and invasion in vitro, as well as reduced tumor angiogenesis and tumor cell proliferation in vivo. Concordantly, siRNA knockdown of HOXB7 or VEGF phenocopied the biological effects of miR-196b over-expression. Our findings have demonstrated that the miR-196b/HOXB7/VEGF pathway plays an important role in cervical cancer progression; hence targeting this pathway could be a promising therapeutic strategy for the future management of this disease.	[How, Christine; Hui, Angela B. Y.; Shi, Wei; Hedley, David W.; Hill, Richard P.; Liu, Fei-Fei] Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [How, Christine; Boutros, Paul C.; Hedley, David W.; Hill, Richard P.; Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Alajez, Nehad M.] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia; [Boutros, Paul C.; Yan, Rui] Ontario Inst Canc Res, Toronto, ON, Canada; [Clarke, Blaise A.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Pintilie, Melania] Princess Margaret Hosp, Div Biostat, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Hedley, David W.] Princess Margaret Hosp, Div Med Oncol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Fyles, Anthony; Milosevic, Michael; Liu, Fei-Fei] Princess Margaret Hosp, Dept Radiat Oncol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Fyles, Anthony; Milosevic, Michael; Liu, Fei-Fei] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; King Saud University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Liu, FF (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca		Hill, Richard Peter/0000-0001-5331-8045; Milosevic, Michael/0000-0002-9620-6876; Liu, Fei-Fei/0000-0003-4344-6486; Boutros, Paul/0000-0003-0553-7520; Clarke, Blaise/0000-0002-2585-8391; Fyles, Anthony/0000-0002-3633-2483; Spence, Tara/0000-0001-7098-4103; Alajez, Nehad/0000-0002-1546-1091; Hedley, David/0000-0003-1323-2655	Ontario Institute for Cancer Research [10NOV-399]; Lawrence, Ila and William Gifford Scholarship Fund; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning; CIHR Strategic Training Fellow in the Excellence in Radiation Research for the 21st Century Program [EIRR21]	Ontario Institute for Cancer Research; Lawrence, Ila and William Gifford Scholarship Fund; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning; CIHR Strategic Training Fellow in the Excellence in Radiation Research for the 21st Century Program(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Ontario Institute for Cancer Research (Grant Number: 10NOV-399). Christine How is a CIHR Strategic Training Fellow in the Excellence in Radiation Research for the 21st Century (EIRR21) Program, and is supported by the Lawrence, Ila and William Gifford Scholarship Fund. Support is also provided from the Campbell Family Institute for Cancer Research and the Ministry of Health and Long-term Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bachtiary B, 2002, CANCER LETT, V179, P197, DOI 10.1016/S0304-3835(01)00872-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Buchler P, 2002, ANN SURG, V236, P738, DOI 10.1097/01.SLA.0000036262.67458.E7; Cancer Facts and Figures, 2012, CANC FACTS FIG 2012; Care A, 1996, MOL CELL BIOL, V16, P4842; Care A, 2001, CANCER RES, V61, P6532; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Choi YW, 2007, INT J GYNECOL CANCER, V17, P687, DOI 10.1111/j.1525-1438.2007.00834.x; Cillo C, 2011, INT J CANCER, V129, P2577, DOI 10.1002/ijc.25941; Dirix LY, 1997, BRIT J CANCER, V76, P238, DOI 10.1038/bjc.1997.368; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hui ABY, 2011, CLIN CANCER RES, V17, P7539, DOI 10.1158/1078-0432.CCR-11-2102; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kelly ZL, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-16; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang YY, 2006, ENDOCR-RELAT CANCER, V13, P905, DOI 10.1677/erc.1.01221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Perez-Plasencia Carlos, 2007, Infect Agent Cancer, V2, P16, DOI 10.1186/1750-9378-2-16; Rice KL, 2007, J CLIN INVEST, V117, P865, DOI 10.1172/JCI31861; Ries LAG EM, 2003, SEER CANC STAT REV, P1975; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5472.CAN-06-4283; Schotte D, 2009, LEUKEMIA, V23, P313, DOI 10.1038/leu.2008.286; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Storti P, 2011, LEUKEMIA, V25, P527, DOI 10.1038/leu.2010.270; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Tsai KW, 2010, GENE CHROMOSOME CANC, V49, P969, DOI 10.1002/gcc.20804; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wey JS, 2005, CANCER-AM CANCER SOC, V104, P427, DOI 10.1002/cncr.21145; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zusterzeel PLM, 2009, J CANCER RES CLIN, V135, P283, DOI 10.1007/s00432-008-0442-y	46	56	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67846	10.1371/journal.pone.0067846	http://dx.doi.org/10.1371/journal.pone.0067846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861821	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700049
J	Huang, W; DiFranza, JR; Kennedy, DN; Zhang, NY; Ziedonis, D; Ursprung, S; King, JA				Huang, Wei; DiFranza, Joseph R.; Kennedy, David N.; Zhang, Nanyin; Ziedonis, Douglas; Ursprung, Sanouri; King, Jean A.			Progressive Levels of Physical Dependence to Tobacco Coincide with Changes in the Anterior Cingulum Bundle Microstructure	PLOS ONE			English	Article							SMOKING CUE REACTIVITY; NICOTINE DEPENDENCE; SPATIAL STATISTICS; FAGERSTROM TEST; WHITE-MATTER; SMOKERS; ACTIVATION; NONSMOKERS; ADDICTION; CHECKLIST	Background: The tobacco withdrawal syndrome indicates the development of neurophysiologic dependence. Clinical evidence indicates that neurophysiologic dependence develops through a set sequence of symptom presentation that can be assessed with a new 3-item survey measure of wanting, craving, and needing tobacco, the Level of Physical Dependence (PD). This study sought to determine if advancing neurophysiologic dependence as measured by the Level of PD correlates with characteristics of white matter structure measured by Fractional Anisotropy (FA). Methods: Diffusion-MRI based FA and diffusion tensor imaging probabilistic tractography were used to evaluate 11 smokers and 10 nonsmokers. FA was also examined in relation to two additional measures of dependence severity, the Hooked on Nicotine Checklist (HONC), and the Fagerstrom Test for Nicotine Dependence (FTND). Results: Among smokers, FA in the left anterior cingulate bundle (ACb) correlated negatively with the Level of PD (r = -0.68, p = 0.02) and HONC scores (r = -0.65, p = 0.03), but the correlation for the FTND did not reach statistical significance (r = -49, p = 0.12). With advancing Levels of PD, the density of streamlines between the ACb and precuneus increased (r = -0.67, p < 0.05) and those between the ACb and white matter projecting to the superior-frontal cortex (r = -0.86, p = 0.0006) decreased significantly. Conclusions: The correlations between neural structure and both the clinical Level of PD survey measure and the HONC suggest that the Level of PD and the HONC may reflect the microstructural integrity of white matter, as influenced by tobacco abuse. Given that the Level of PD is measuring a sequence of symptoms of neurophysiologic dependence that develops over time, the correlation between the Level of PD and neural structure suggests that these features might represent neuroplastic changes that develop over time to support the development of neurophysiologic dependence.	[Huang, Wei; Zhang, Nanyin; King, Jean A.] Univ Massachusetts, Sch Med, Dept Psychiat, Ctr Comparat NeuroImaging, Worcester, MA 01655 USA; [DiFranza, Joseph R.; Ursprung, Sanouri] Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA; [Kennedy, David N.; Ziedonis, Douglas] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	King, JA (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Ctr Comparat NeuroImaging, Worcester, MA 01655 USA.	Jean.King@umassmed.edu	Zhang, Nanyin/N-3457-2014	Zhang, Nanyin/0000-0002-5824-9058	National Institutes of Health grant [1 R03 DA024217]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024217] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health grant 1 R03 DA024217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody A, 2006, NEURLA SUBSTRATES RE; Brody AL, 2004, PSYCHIAT RES-NEUROIM, V130, P269, DOI 10.1016/j.pscychresns.2003.12.006; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Daglish MRC, 2001, AM J PSYCHIAT, V158, P1680, DOI 10.1176/appi.ajp.158.10.1680; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; DiFranza J, 2013, ISRN ADDICT IN PRESS; DiFranza JR, 2007, ARCH PEDIAT ADOL MED, V161, P704, DOI 10.1001/archpedi.161.7.704; DiFranza JR, 2012, BRAIN SCI, V2, P523, DOI 10.3390/brainsci2040523; DiFranza JR, 2012, PSYCHOPHARMACOLOGY, V219, P815, DOI 10.1007/s00213-011-2411-4; DiFranza JR, 2012, PHARMACOL BIOCHEM BE, V100, P494, DOI 10.1016/j.pbb.2011.10.018; DiFranza JR, 2011, CURR PEDIATR REV, V7, P88, DOI 10.2174/157339611795735648; DiFranza JR, 2011, J PEDIATR-US, V159, P999, DOI 10.1016/j.jpeds.2011.05.037; DiFranza JR, 2010, J ADOLESCENCE, V33, P209, DOI 10.1016/j.adolescence.2009.03.009; Engelmann JM, 2012, NEUROIMAGE, V60, P252, DOI 10.1016/j.neuroimage.2011.12.024; Franklin T, 2006, BRAIN SIGNATURE CIGA; Froeliger B, 2010, PSYCHOPHARMACOLOGY, V210, P577, DOI 10.1007/s00213-010-1862-3; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Hartwell KJ, 2011, ADDICT BIOL, V16, P654, DOI 10.1111/j.1369-1600.2011.00340.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hudkins M, 2012, PSYCHOPHARMACOLOGY; Jacobsen LK, 2007, J NEUROSCI, V27, P13491, DOI 10.1523/JNEUROSCI.2402-07.2007; Kilts CD, 2004, AM J PSYCHIAT, V161, P233, DOI 10.1176/appi.ajp.161.2.233; Liao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026460; Lim HK, 2005, J PSYCHIATR RES, V39, P333, DOI 10.1016/j.jpsychires.2004.08.004; Lin FC, 2013, DRUG ALCOHOL DEPEN, V129, P82, DOI 10.1016/j.drugalcdep.2012.09.013; London E, 2004, SOC RES NIC TOB 10 A; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; MacPherson L, 2008, ADDICT BEHAV, V33, P880, DOI 10.1016/j.addbeh.2008.02.007; Moolchan ET, 2002, ADDICT BEHAV, V27, P101, DOI 10.1016/S0306-4603(00)00171-4; Paul RH, 2008, NICOTINE TOB RES, V10, P137, DOI 10.1080/14622200701767829; Rubinstein ML, 2011, J ADOLESCENT HEALTH, V48, P7, DOI 10.1016/j.jadohealth.2010.09.016; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Wellman R, 2008, J AM COLL HEALTH, V56, P549, DOI 10.3200/JACH.56.5.549-554; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; Wheeler KC, 2004, J ADOLESCENT HEALTH, V35, P225, DOI 10.1016/j.jadohealth.2003.10.004; Wilson SJ, 2005, NICOTINE TOB RES, V7, P637, DOI 10.1080/14622200500185520; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang XC, 2011, NEUROIMAGE, V54, P42, DOI 10.1016/j.neuroimage.2010.08.008; Zhang XC, 2011, NEUROIMAGE, V54, P131, DOI 10.1016/j.neuroimage.2010.07.063; Zhang XC, 2010, BIOL PSYCHIAT, V68, P674, DOI 10.1016/j.biopsych.2010.06.018	46	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67837	10.1371/journal.pone.0067837	http://dx.doi.org/10.1371/journal.pone.0067837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861816	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700044
J	Kvicerova, J; Hypsa, V				Kvicerova, Jana; Hypsa, Vaclav			Host-Parasite Incongruences in Rodent Eimeria Suggest Significant Role of Adaptation Rather than Cophylogeny in Maintenance of Host Specificity	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DNA EVOLUTION; NUCLEAR 18S; APICOMPLEXA; COCCIDIA; ISOSPORA; OOCYSTS; COSPECIATION; GENUS; SPP.	The degree of host specificity, its phylogenetic conservativeness and origin are virtually unknown in Eimeria. This situation is largely due to the inadequate sample of eimerian molecular data available for reliable phylogenetic analyses. In this study, we extend the data set by adding 71 new sequences of coccidia infecting 16 small-mammal genera, mostly rodents. According to the respective feasibility of PCR gene amplification, the new samples are represented by one or more of the following genes: nuclear 18S rRNA, plastid ORF 470, and mitochondrial COI. Phylogenetic analyses of these sequences confirm the previous hypothesis that Eimeria, in its current morphology-based delimitation, is not a monophyletic group. Several samples of coccidia corresponding morphologically to other genera are scattered among the Eimeria lineages. More importantly, the distribution of eimerians from different hosts indicates that the clustering of eimerian species is influenced by their host specificity, but does not arise from a cophylogenetic/cospeciation process; while several clusters are specific to a particular host group, inner topologies within these clusters do not reflect host phylogeny. This observation suggests that the host specificity of Eimeria is caused by adaptive rather than cophylogenetic processes.	[Kvicerova, Jana; Hypsa, Vaclav] Univ South Bohemia, Dept Parasitol, Fac Sci, Ceske Budejovice, Czech Republic; [Kvicerova, Jana; Hypsa, Vaclav] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Kvicerova, J (corresponding author), Univ South Bohemia, Dept Parasitol, Fac Sci, Ceske Budejovice, Czech Republic.	janaq@centrum.cz	Kvičerová, Jana/Q-9577-2018; Hypša, Václav/ABA-1503-2021; Hypsa, Vaclav/G-9847-2014	Kvičerová, Jana/0000-0001-8370-3008; Hypša, Václav/0000-0001-5572-782X; 	Grant Agency of the Czech Republic [206/08/1019, 206/09/H026]; International Scientific and Technical Cooperation MOBILITY/KONTAKT [MEB 0810106]; Ministry of Education, Youth and Sports of the Czech Republic [LC06073, MSM 6007665801]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); International Scientific and Technical Cooperation MOBILITY/KONTAKT; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Grant Agency of the Czech Republic (grant numbers 206/08/1019, 206/09/H026); the International Scientific and Technical Cooperation MOBILITY/KONTAKT (number MEB 0810106); and the Ministry of Education, Youth and Sports of the Czech Republic (grant numbers LC06073, MSM 6007665801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barta JR, 1997, J PARASITOL, V83, P262, DOI 10.2307/3284453; Barta JR, 2005, J PARASITOL, V91, P726, DOI 10.1645/GE-3341.1; Brabec J, 2006, INT J PARASITOL, V36, P1535, DOI 10.1016/j.ijpara.2006.08.003; Brant SV, 2000, J PARASITOL, V86, P545, DOI 10.1645/0022-3395(2000)086[0545:POSOTG]2.0.CO;2; Brooks DR, 1993, PARASCRIPT PARASITES; Carreno RA, 1998, J EUKARYOT MICROBIOL, V45, P184, DOI 10.1111/j.1550-7408.1998.tb04523.x; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; DEVOS A J, 1970, Onderstepoort Journal of Veterinary Research, V37, P29; Dolnik OV, 2009, J PARASITOL, V95, P169, DOI 10.1645/GE-1873.1; Duszynski DW, 1997, J PARASITOL, V83, P333, DOI 10.2307/3284470; Duszynski DW, 2000, SPECIAL PUBLICATION, P1; Duszynski DW, 2001, PARASITIC DIS WILD M; Fiala I, 2006, INT J PARASITOL, V36, P1521, DOI 10.1016/j.ijpara.2006.06.016; Franzen C, 2000, PARASITOL RES, V86, P669, DOI 10.1007/PL00008550; GARDNER SL, 1990, J PARASITOL, V76, P805, DOI 10.2307/3282798; Golemansky Vassil G., 2007, Acta Zoologica Bulgarica, V59, P81; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAFNER MS, 1988, NATURE, V332, P258, DOI 10.1038/332258a0; HAFNER MS, 1990, SYST ZOOL, V39, P192, DOI 10.2307/2992181; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HIGGS S, 1991, SYST PARASITOL, V20, P203, DOI 10.1007/BF00009784; Huelsenbeck JP, 2000, EVOLUTION, V54, P352, DOI 10.1111/j.0014-3820.2000.tb00039.x; Huelsenbeck JP, 1997, EVOLUTION, V51, P410, DOI [10.1111/j.1558-5646.1997.tb02428.x, 10.2307/2411113]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurkova L, 2005, PARASITOL RES, V97, P33, DOI 10.1007/s00436-005-1353-3; Jirku M, 2002, PROTIST, V153, P379, DOI 10.1078/14344610260450118; Jirku M, 2009, PROTIST, V160, P123, DOI 10.1016/j.protis.2008.08.003; Jirku M, 2009, J EUKARYOT MICROBIOL, V56, P39, DOI 10.1111/j.1550-7408.2008.00362.x; Jousson O, 2000, J EVOLUTION BIOL, V13, P778, DOI 10.1046/j.1420-9101.2000.00221.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KOUDELA B, 1994, CAN J ZOOL, V72, P239, DOI 10.1139/z94-032; Kvicerova J, 2008, PARASITOLOGY, V135, P443, DOI 10.1017/S0031182007004106; Kvicerova J, 2011, PARASITOLOGY, V138, P1217, DOI 10.1017/S0031182011001107; Levine N. D., 1990, COCCIDIAN PARASITES; LEWIS DC, 1983, SYST PARASITOL, V5, P259, DOI 10.1007/BF00009160; LONG PL, 1984, J PROTOZOOL, V31, P535, DOI 10.1111/j.1550-7408.1984.tb05498.x; Lynch AJ, 2007, J PARASITOL, V93, P1230, DOI 10.1645/GE-1206R.1; Matsubayashi M, 2005, PARASITOL RES, V97, P80, DOI 10.1007/s00436-005-1404-9; Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60; Morrison DA, 2004, INT J PARASITOL, V34, P501, DOI 10.1016/j.ijpara.2003.11.006; Nylander J, 2004, MR MODELTEST V2 PROG; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Page RDM, 1998, MOL PHYLOGENET EVOL, V9, P276, DOI 10.1006/mpev.1997.0458; Page RDM, 1996, SYST BIOL, V45, P151, DOI 10.2307/2413612; PARKER BB, 1986, J PARASITOL, V72, P602, DOI 10.2307/3281518; Paterson Adrian M., 1997, P236; Paterson AM, 2001, INT J PARASITOL, V31, P1012, DOI 10.1016/S0020-7519(01)00199-0; Pellerdy L. P., 1974, COCCIDIA COCCIDIOSIS, V2nd; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; Pieniazek NJ, 1997, EMERG INFECT DIS, V3, P381, DOI 10.3201/eid0303.970319; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Power ML, 2009, EXP PARASITOL, V122, P165, DOI 10.1016/j.exppara.2009.02.008; Relman DA, 1996, J INFECT DIS, V173, P440, DOI 10.1093/infdis/173.2.440; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Samarasinghe B, 2008, EXP PARASITOL, V118, P592, DOI 10.1016/j.exppara.2007.10.015; Schwarz RS, 2009, J PARASITOL, V95, P871, DOI 10.1645/GE-1898.1; Seville RS, 2005, J PARASITOL, V91, P857, DOI 10.1645/GE-466R.1; Stefka J, 2008, INT J PARASITOL, V38, P731, DOI 10.1016/j.ijpara.2007.09.011; UPTON SJ, 1992, J PARASITOL, V78, P406, DOI 10.2307/3283636; Weckstein JD, 2004, SYST BIOL, V53, P154, DOI 10.1080/10635150490265085; Whiteman NK, 2004, INT J PARASITOL, V34, P1113, DOI 10.1016/j.ijpara.2004.06.003; Yabsley MJ, 2006, J PARASITOL, V92, P385, DOI 10.1645/GE-592R.1; Zhao X, 2001, PARASITOL RES, V87, P638, DOI 10.1007/s004360100393; Zhao XM, 2001, J PARASITOL, V87, P1120, DOI 10.1645/0022-3395(2001)087[1120:PPOEAA]2.0.CO;2; Zhao XM, 2001, INT J PARASITOL, V31, P715, DOI 10.1016/S0020-7519(01)00136-9	69	30	30	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e63601	10.1371/journal.pone.0063601	http://dx.doi.org/10.1371/journal.pone.0063601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861732	gold, Green Submitted, Green Published			2022-12-25	WOS:000323350700001
J	Shrivastava, S; Schneider, MF				Shrivastava, Shamit; Schneider, Matthias F.			Opto-Mechanical Coupling in Interfaces under Static and Propagative Conditions and Its Biological Implications	PLOS ONE			English	Article							EXTRINSIC FLUORESCENCE; LIPID MONOLAYERS; MEMBRANE; TRANSITIONS; PROBES	Fluorescent dyes are vital for studying static and dynamic patterns and pattern formation in cell biology. Emission properties of the dyes incorporated in a biological interface are known to be sensitive to their local environment. We report that the fluorescence intensity of dye molecules embedded in lipid interfaces is indeed a thermodynamic observable of the system. Opto-mechanical coupling of lipid-dye system was measured as a function of the thermodynamic state of the interface. The corresponding state diagrams quantify the thermodynamic coupling between intensity I and lateral pressure pi. We further demonstrate that the coupling is conserved upon varying the temperature T. Notably, the observed opto-mechanical coupling is not limited to equilibrium conditions, but also holds for propagating pressure pulses. The non-equilibrium data show, that fluorescence is especially sensitive to dynamic changes in state such as the LE-LC phase transition. We conclude that variations in the thermodynamic state (here pi and T, in general pH, membrane potential V, etc also) of lipid membranes are capable of controlling fluorescence intensity. Therefore, interfacial thermodynamic state diagrams of I should be obtained for a proper interpretation of intensity data.	[Shrivastava, Shamit; Schneider, Matthias F.] Boston Univ, Dept Mech & Biomed Engn, Boston, MA 02215 USA	Boston University	Schneider, MF (corresponding author), Boston Univ, Dept Mech & Biomed Engn, Boston, MA 02215 USA.	mfs@bu.edu	shrivastava, shamit/P-5093-2019	shrivastava, shamit/0000-0003-0916-7336; Shrivastava, Shamit/0000-0002-2244-3246	NIH through BU-XTNC; BU-ENG-ME; German Research Foundation (DFG); SHENC-research unit [FOR 1543]	NIH through BU-XTNC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BU-ENG-ME; German Research Foundation (DFG)(German Research Foundation (DFG)); SHENC-research unit	This study was funded by NIH through BU-XTNC (http://nano-cancer.bu.edu/), BU-ENG-ME and the German Research Foundation (DFG), SHENC-research unit FOR 1543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SSL, 2009, PROG NEUROBIOL, V88, P104, DOI 10.1016/j.pneurobio.2009.03.002; Boldyrev IA, 2007, J LIPID RES, V48, P1518, DOI 10.1194/jlr.M600459-JLR200; BROWN RS, 1994, J CHEM PHYS, V100, P6019, DOI 10.1063/1.467112; Caseli L, 2005, LANGMUIR, V21, P4090, DOI 10.1021/la047292s; CONTI F, 1974, BIOPHYS STRUCT MECH, V1, P27, DOI 10.1007/BF01022558; CONTI F, 1975, ANNU REV BIOPHYS BIO, V4, P287, DOI 10.1146/annurev.bb.04.060175.001443; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Einstein A, 1910, ANN PHYS-BERLIN, V33, P1275; Griesbauer J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061909; Griesbauer J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198103; Griesbauer J, 2009, BIOPHYS J, V97, P2710, DOI 10.1016/j.bpj.2009.07.049; Groves JT, 1998, P NATL ACAD SCI USA, V95, P935, DOI 10.1073/pnas.95.3.935; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Heimburg T, 2012, BIOPHYS J, V103, P918, DOI 10.1016/j.bpj.2012.07.010; Honger T, 1996, BIOCHEMISTRY-US, V35, P9003, DOI 10.1021/bi960866a; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, DOI DOI 10.1529/BI0PHYSJ.105.064816.ACCESSED; Kaganer VM, 1999, REV MOD PHYS, V71, P779, DOI 10.1103/RevModPhys.71.779; Kaufmann KK, 1999, KAROLINSKA DOCUMENTS, P326; Kim GH, 2007, BIOPHYS J, V92, P3122, DOI 10.1529/biophysj.106.103754; Lenaz G, 1978, MOL CELL BIOCHEM, V22, DOI [10.1007/BF00241467, DOI 10.1007/BF00241467]; MCCONNELL HM, 1991, ANNU REV PHYS CHEM, V42, P171, DOI 10.1146/annurev.physchem.42.1.171; MCCONNELL HM, 1984, P NATL ACAD SCI USA, V81, P3249, DOI 10.1073/pnas.81.10.3249; MOY VT, 1988, J PHYS CHEM-US, V92, P5233, DOI 10.1021/j100329a033; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; OPDENKAMP JA, 1974, BIOCHIM BIOPHYS ACTA, V345, P253, DOI 10.1016/0005-2736(74)90263-6; OPDENKAMP JAF, 1975, BIOCHIM BIOPHYS ACTA, V406, P169, DOI 10.1016/0005-2736(75)90001-2; Sanden T, 2010, P NATL ACAD SCI USA, V107, P4129, DOI 10.1073/pnas.0908671107; SANDERMANN H, 1978, BIOCHIM BIOPHYS ACTA, V515, P209, DOI 10.1016/0304-4157(78)90015-1; Seeger HM, 2010, BIOPHYS J, V99, P3675, DOI 10.1016/j.bpj.2010.10.042; Soderlund T, 1999, MOL PHARMACOL, V55, P32; TASAKI I, 1969, P NATL ACAD SCI USA, V64, P1362, DOI 10.1073/pnas.64.4.1362; TASAKI I, 1971, P NATL ACAD SCI USA, V68, P938, DOI 10.1073/pnas.68.5.938; Tasaki I., 1982, PHYSL ELECTROCHEMIST; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; VOGEL V, 1988, J COLLOID INTERF SCI, V126, P408, DOI 10.1016/0021-9797(88)90140-3; Wu YK, 1996, BIOPHYS J, V71, P91, DOI 10.1016/S0006-3495(96)79243-3; Zhang YL, 2006, BIOCHEM BIOPH RES CO, V347, P838, DOI 10.1016/j.bbrc.2006.06.152	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67524	10.1371/journal.pone.0067524	http://dx.doi.org/10.1371/journal.pone.0067524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861769	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700016
J	Acimovic, J; Lovgren-Sandblom, A; Olin, M; Ali, Z; Heverin, M; Schule, R; Schols, L; Fischler, B; Fickert, P; Trauner, M; Bjorkhem, I				Acimovic, Jure; Lovgren-Sandblom, Anita; Olin, Maria; Ali, Zeina; Heverin, Maura; Schuele, Rebecca; Schoels, Ludger; Fischler, Bjorn; Fickert, Peter; Trauner, Michael; Bjorkhem, Ingemar			Sulphatation Does Not Appear to Be a Protective Mechanism to Prevent Oxysterol Accumulation in Humans and Mice	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; RECEPTOR LXR-ALPHA; CHOLESTEROL HOMEOSTASIS; 7-ALPHA-HYDROXYLASE GENE; LIVER-DISEASE; HUMAN BRAIN; 24S-HYDROXYCHOLESTEROL; 27-HYDROXYCHOLESTEROL; IDENTIFICATION; METABOLISM	24S- and 27-hydroxycholesterol (24OHC and 27OHC) are potent regulators of different biochemical systems in vitro and are the major circulating oxysterols. A small fraction of these oxysterols has been reported to be sulphated but there are no detailed studies. We considered the possibility that sulphatation is a protective mechanism preventing accumulation of free oxysterols. Using an accurate assay we found the sulphated fraction of 24OHC and 27OHC in circulation of adults to be less than 15% of total. In two patients with a mutation in CYP7B1 and markedly increased levels of 27OHC the sulphated fraction was 8% and 10% respectively. Infants with severe neonatal cholestasis had however markedly increased sulphate fraction of the above oxysterols. In untreated mice the degree of sulphatation of 24OHC and 27OHC in serum varied between 0 and 16%. Similar degree of sulphatation was found in two mouse models with markedly increased levels of 27OHC and 24OHC respectively. Bile duct ligated mice had higher levels of oxysterols than sham-operated controls but the sulphate fraction was not increased. We conclude that a primary increase in the levels of the oxysterols due to increased synthesis or reduced metabolism in adults and mice does not induce increased sulphatation.	[Acimovic, Jure; Lovgren-Sandblom, Anita; Olin, Maria; Ali, Zeina; Heverin, Maura; Bjorkhem, Ingemar] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Chem,Dept Lab Med, Stockholm, Sweden; [Acimovic, Jure] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Ctr Neurol, Tubingen, Germany; [Fischler, Bjorn] Karolinska Inst, Div Pediat CLINTEC, Karolinska Univ Hosp, Stockholm, Sweden; [Fickert, Peter] Med Univ, Res Unit Expt & Mol Hepatol, Div Gastroenterol & Hepatol, Dept Med, Graz, Austria; [Trauner, Michael] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria	Karolinska Institutet; Karolinska University Hospital; University of Ljubljana; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Karolinska Institutet; Karolinska University Hospital; Medical University of Graz; Medical University of Vienna	Acimovic, J (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Chem,Dept Lab Med, Stockholm, Sweden.	jure.acimovic@mf.uni-lj.si	Schöls, Ludger/ABB-2482-2021	Schöls, Ludger/0000-0001-7774-5025; Trauner, Michael/0000-0002-1275-6425; Fickert, Peter/0000-0003-0906-4636; Bjorkhem, Ingemar/0000-0002-0575-9425; Bjorkhem, Ingemar/0000-0001-6087-9190	FEBS short-term fellowship; Swedish Brain Power; Swedish Science Council	FEBS short-term fellowship; Swedish Brain Power; Swedish Science Council	This work was supported by FEBS short-term fellowship (JA). Support was also obtained from Swedish Brain Power and the Swedish Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bjorkhem I, 2001, J LIPID RES, V42, P366; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Bretillon L, 2000, J LIPID RES, V41, P840; BURSTEIN S, 1958, J BIOL CHEM, V233, P331; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Fakheri RJ, 2012, STEROIDS, V77, P575, DOI 10.1016/j.steroids.2012.02.006; Fickert P, 2002, GASTROENTEROLOGY, V123, P1238, DOI 10.1053/gast.2002.35948; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Javitt NB, 2001, ENDOCRINOLOGY, V142, P2978, DOI 10.1210/en.142.7.2978; KORNEL L, 1965, BIOCHEMISTRY-US, V4, P444, DOI 10.1021/bi00879a011; Li XB, 2007, J LIPID RES, V48, P2587, DOI 10.1194/jlr.M700301-JLR200; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Meir K, 2002, J BIOL CHEM, V277, P34036, DOI 10.1074/jbc.M201122200; Meng LJ, 1997, J LIPID RES, V38, P926; Meng LJ, 1996, J STEROID BIOCHEM, V58, P585, DOI 10.1016/0960-0760(96)00080-5; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Ren SL, 2007, BIOCHEM BIOPH RES CO, V360, P802, DOI 10.1016/j.bbrc.2007.06.143; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; SEGAL L, 1960, J BIOL CHEM, V235, P3108; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Vaya J, 2007, J NEUROCHEM, V102, P1727, DOI 10.1111/j.1471-4159.2007.04689.x	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68031	10.1371/journal.pone.0068031	http://dx.doi.org/10.1371/journal.pone.0068031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844150	gold, Green Submitted, Green Published			2022-12-25	WOS:000321733000125
J	Symmonds, M; Wright, ND; Fagan, E; Dolan, RJ				Symmonds, Mkael; Wright, Nicholas D.; Fagan, Elizabeth; Dolan, Raymond J.			Assaying the Effect of Levodopa on the Evaluation of Risk in Healthy Humans	PLOS ONE			English	Article							DECISION-MAKING; PARKINSONS-DISEASE; REWARD PROBABILITY; RECEPTOR GENE; L-DOPA; SEROTONIN; PREDICTION; UNCERTAINTY; VARIANCE; BEHAVIOR	In humans, dopamine is implicated in reward and risk-based decision-making. However, the specific effects of dopamine augmentation on risk evaluation are unclear. Here we sought to measure the effect of 100 mg oral levodopa, which enhances synaptic release of dopamine, on choice behaviour in healthy humans. We use a paradigm without feedback or learning, which solely isolates effects on risk evaluation. We present two studies (n = 20; n = 20) employing a randomised, placebo-controlled, within-subjects design. We manipulated different dimensions of risk in a controlled economic paradigm. We test effects on risk-reward tradeoffs, assaying both aversion to variance (the spread of possible outcomes) and preference for relative losses and gains (asymmetry of outcomes - skewness), dissociating this from potential non-specific effects on choice randomness using behavioural modelling. There were no systematic effects of levodopa on risk attitudes, either for variance or skewness. However, there was a drift towards more risk-averse behaviour over time, indicating that this paradigm was sensitive to detect changes in risk-preferences. These findings suggest that levodopa administration does not change the evaluation of risk. One possible reason is that dopaminergic influences on decision making may be due to changing the response to reward feedback.	[Symmonds, Mkael; Wright, Nicholas D.; Fagan, Elizabeth; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England; [Symmonds, Mkael] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England	University of London; University College London; University of Oxford	Symmonds, M (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England.	mkael.symmonds@googlemail.com	Wright, Nicholas/HHY-7227-2022; Fagan, Elizabeth/F-7815-2014	Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [098362/Z/12/Z, 091593/Z/10/Z]; Wellcome Trust Research Training Fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Research Training Fellowship(Wellcome Trust)	This work was supported by the Wellcome Trust (RJD Senior Investigator Award 098362/Z/12/Z). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593/Z/10/Z). NDW is in receipt of a Wellcome Trust Research Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; ALDERFER CP, 1970, J BUS, V43, P341, DOI 10.1086/295286; Angwin AJ, 2004, J INT NEUROPSYCH SOC, V10, P15, DOI 10.1017/S1355617704101033; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; Breitenstein C, 2006, NEUROPSYCHOPHARMACOL, V31, P2552, DOI 10.1038/sj.npp.1301167; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Camara E, 2010, CEREB CORTEX, V20, P1985, DOI 10.1093/cercor/bhp263; Comings DE, 1997, MOL PSYCHIATR, V2, P44, DOI 10.1038/sj.mp.4000207; Comings DE, 2001, CLIN GENET, V60, P107, DOI 10.1034/j.1399-0004.2001.600204.x; Comings DE, 1996, PHARMACOGENETICS, V6, P223, DOI 10.1097/00008571-199606000-00004; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; COOMBS CH, 1960, J EXP PSYCHOL, V60, P265, DOI 10.1037/h0041444; Copland DA, 2009, CEREB CORTEX, V19, P2651, DOI 10.1093/cercor/bhp017; CREVOISIER C, 1987, European Neurology, V27, P36, DOI 10.1159/000116173; Czernecki V, 2002, NEUROPSYCHOLOGIA, V40, P2257, DOI 10.1016/S0028-3932(02)00108-2; d'Acremont M, 2008, COGN AFFECT BEHAV NE, V8, P363, DOI 10.3758/CABN.8.4.363; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; de Vries MH, 2010, NEUROPSYCHOLOGIA, V48, P3193, DOI 10.1016/j.neuropsychologia.2010.06.024; Delazer M, 2009, NEUROPSYCHOLOGIA, V47, P1901, DOI 10.1016/j.neuropsychologia.2009.02.034; Dethy S, 1997, CLIN CHEM, V43, P740; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-7; FISHBURN PC, 1984, MANAGE SCI, V30, P396, DOI 10.1287/mnsc.30.4.396; Floel A, 2005, NEUROLOGY, V65, P472, DOI 10.1212/01.wnl.0000172340.56307.5e; Forbes E.E., 2007, MOL PSYCHIATR, V14, P60, DOI DOI 10.1038/SJ.MP.4002086; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gallagher DA, 2007, MOVEMENT DISORD, V22, P1757, DOI 10.1002/mds.21611; Golec J, 1998, J POLIT ECON, V106, P205, DOI 10.1086/250007; Grosset KA, 2006, MOVEMENT DISORD, V21, P2206, DOI 10.1002/mds.21110; Ha RY, 2009, PROG NEURO-PSYCHOPH, V33, P1217, DOI 10.1016/j.pnpbp.2009.07.009; Imamura A, 2006, PARKINSONISM RELAT D, V12, P506, DOI 10.1016/j.parkreldis.2006.02.004; Kacelnik A, 1996, AM ZOOL, V36, P402; Kagel JH, 1995, HDB EXPT EC; Kaminski BJ, 2001, J EXP ANAL BEHAV, V75, P275, DOI 10.1901/jeab.2001.75-275; Kischka U, 1996, NEUROPSYCHOLOGIA, V34, P1107, DOI 10.1016/0028-3932(96)00024-3; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Levin IP, 2007, JUDGM DECIS MAK, V2, P225; Lobo DSS, 2010, BIOL PSYCHOL, V85, P33, DOI 10.1016/j.biopsycho.2010.04.008; Long AB, 2009, SOC COGN AFFECT NEUR, V4, P346, DOI 10.1093/scan/nsp020; Lu C, 2006, ARCH NEUROL-CHICAGO, V63, P298, DOI 10.1001/archneur.63.2.298-a; Marco-Pallares J, 2009, BIOL PSYCHIAT, V66, P154, DOI 10.1016/j.biopsych.2009.01.006; McCabe C, 2010, BIOL PSYCHIAT, V67, P439, DOI 10.1016/j.biopsych.2009.11.001; Mihatsch O, 2002, MACH LEARN, V49, P267, DOI 10.1023/A:1017940631555; Molina JA, 2000, MOVEMENT DISORD, V15, P869, DOI 10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I; Moran RJ, 2011, CURR BIOL, V21, P1320, DOI 10.1016/j.cub.2011.06.053; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; Onur OA, 2011, J COGNITIVE NEUROSCI, V23, P2797, DOI 10.1162/jocn.2011.21603; Pelli DG, 2009, HDB OPTICS VISION VI; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Pleger B, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000164; Pothos EN, 2002, BEHAV BRAIN RES, V130, P203, DOI 10.1016/S0166-4328(01)00419-3; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rogers RD, 2003, NEUROPSYCHOPHARMACOL, V28, P153, DOI 10.1038/sj.npp.1300001; ROTHSCHILD M, 1971, J ECON THEORY, V3, P66, DOI 10.1016/0022-0531(71)90034-2; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sevy S, 2006, PSYCHOPHARMACOLOGY, V188, P228, DOI 10.1007/s00213-006-0450-z; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; St Onge JR, 2009, NEUROPSYCHOPHARMACOL, V34, P681, DOI 10.1038/npp.2008.121; Symmonds M, 2011, NEUROIMAGE, V58, P1139, DOI 10.1016/j.neuroimage.2011.06.087; Symmonds M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011090; Takahashi H, 2010, J NEUROSCI, V30, P16567, DOI 10.1523/JNEUROSCI.3933-10.2010; Tanaka SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001333; Tanaka SC, 2009, J NEUROSCI, V29, P15669, DOI 10.1523/JNEUROSCI.2799-09.2009; Tippmann-Peikert M, 2007, NEUROLOGY, V68, P301, DOI 10.1212/01.wnl.0000252368.25106.b6; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Torta DME, 2009, BRAIN COGNITION, V71, P84, DOI 10.1016/j.bandc.2009.04.003; Wright ND, 2012, J NEUROSCI, V32, P7009, DOI 10.1523/JNEUROSCI.0049-12.2012	85	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68177	10.1371/journal.pone.0068177	http://dx.doi.org/10.1371/journal.pone.0068177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844168	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000133
J	Lu, X; Yang, XY; Li, X; Lu, Y; Ren, ZT; Zhao, LY; Hu, XX; Jiang, JD; You, XF				Lu, Xi; Yang, Xinyi; Li, Xue; Lu, Yun; Ren, Zhitao; Zhao, Longyin; Hu, Xinxin; Jiang, Jiandong; You, Xuefu			In Vitro Activity of Sodium New Houttuyfonate Alone and in Combination with Oxacillin or Netilmicin against Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							HOUTTUYNIA-CORDATA; ANTIBACTERIAL ACTIVITIES; ARTESUNATE; HOMOLOGS; MALARIA; TRIAL; MRSA	Background: Staphylococcus aureus can cause severe infections, including bacteremia and sepsis. The spread of methicillin-resistant Staphylococcus aureus (MRSA) highlights the need for novel treatment options. Sodium new houttuyfonate (SNH) is an analogue of houttuynin, the main antibacterial ingredient of Houttuynia cordata Thunb. The aim of this study was to evaluate in vitro activity of SNH and its potential for synergy with antibiotics against hospital-associated MRSA. Methodology: A total of 103 MRSA clinical isolates recovered in two hospitals in Beijing were evaluated for susceptibility to SNH, oxacillin, cephalothin, meropenem, vancomycin, levofloxacin, minocycline, netilmicin, and trimethoprim/sulfamethoxazole by broth microdilution. Ten isolates were evaluated for potential for synergy between SNH and the antibiotics above by checkerboard assay. Time-kill analysis was performed in three isolates to characterize the kill kinetics of SNH alone and in combination with the antibiotics that engendered synergy in checkerboard assays. Besides, two reference strains were included in all assays. Principal Findings: SNH inhibited all test strains with minimum inhibitory concentrations (MICs) ranging from 16 to 64 mu g/mL in susceptibility tests, and displayed inhibition to bacterial growth in concentration-dependent manner in time-kill analysis. In synergy studies, the combinations of SNH-oxacillin, SNH-cephalothin, SNH-meropenem and SNH-netilmicin showed synergistic effects against 12 MRSA strains with median fractional inhibitory concentration (FIC) indices of 0.38, 0.38, 0.25 and 0.38 in checkerboard assays. In time-kill analysis, SNH at 1/2 MIC in combination with oxacillin at 1/128 to 1/64 MIC or netilmicin at 1/8 to 1/2 MIC decreased the viable colonies by >= 2log(10) CFU/mL. Conclusions/Significance: SNH demonstrated in vitro antibacterial activity against 103 hospital-associated MRSA isolates. Combinations of sub-MIC levels of SNH and oxacillin or netilmicin significantly improved the in vitro antibacterial activity against MRSA compared with either drug alone. The SNH-based combinations showed promise in combating MRSA.	[Lu, Xi; Yang, Xinyi; Li, Xue; Lu, Yun; Ren, Zhitao; Zhao, Longyin; Hu, Xinxin; Jiang, Jiandong; You, Xuefu] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Lu, Xi; Yang, Xinyi; Li, Xue; Lu, Yun; Ren, Zhitao; Zhao, Longyin; Hu, Xinxin; Jiang, Jiandong; You, Xuefu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhao, Longyin] Beijing Stand Herbs Med Sci & Technol Dev Co LTD, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jiang, JD (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	jiang.jdong@163.com; xuefuyou@imb.pumc.edu.cn			National Natural Science Foundation of China [30701062, 30672502, 81273427]; National Mega-project for Innovative Drugs, People's Republic of China [2012ZX09301002-001, 2012ZX09301002-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega-project for Innovative Drugs, People's Republic of China	This work was supported by the National Natural Science Foundation of China (30701062, 30672502, and 81273427) and the National Mega-project for Innovative Drugs (2012ZX09301002-001, 2012ZX09301002-005), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Chinese Pharmacopoeia Commission, 2010, CHIN PHARM 1, P208; Chinese Pharmacopoeia Commission, 1995, PHARM PEOPL REP CHIN, P411; Clinical and Laboratory Standards Institute, 2012, M07A99 CLSI; Faiz MA, 2005, LANCET, V366, P717; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; HAYASHI K, 1995, PLANTA MED, V61, P237, DOI 10.1055/s-2006-958063; Jenkins RE, 2012, J ANTIMICROB CHEMOTH, V67, P1405, DOI 10.1093/jac/dks071; Kim GS, 2008, BIOL PHARM BULL, V31, P2012, DOI 10.1248/bpb.31.2012; Li ZB, 2009, MED CHEM RES, V18, P362, DOI 10.1007/s00044-008-9133-0; Liang L., 2006, SHENZHEN J INTEGRATE, V16, P36; Liu GX, 2011, MOLECULES, V16, P8848, DOI 10.3390/molecules16108848; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Lu HM, 2006, J ETHNOPHARMACOL, V104, P245, DOI 10.1016/j.jep.2005.09.012; Lu HM, 2006, CHEM PHARM BULL, V54, P936, DOI 10.1248/cpb.54.936; Maesaki S, 1994, Kansenshogaku Zasshi, V68, P1523; Moellering RC, 2012, J ANTIMICROB CHEMOTH, V67, P4, DOI 10.1093/jac/dkr437; Nasu Masaru, 1994, Japanese Journal of Antibiotics, V47, P1305; Patricia MJ, 1961, BRIT MED J, V14, P124; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; RABBANI GH, 1987, J INFECT DIS, V155, P979, DOI 10.1093/infdis/155.5.979; Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1; Verma P., 2007, ANTIMICROBIAL SUSCEP, P275, DOI DOI 10.1201/9781420014495.CH12; Wang H, 2008, DIAGN MICR INFEC DIS, V62, P226, DOI 10.1016/j.diagmicrobio.2008.06.003; Ye XL, 2006, J ASIAN NAT PROD RES, V8, P327, DOI 10.1080/10286020500035243; Ye XL, 2007, COLLOID SURFACE A, V301, P412, DOI 10.1016/j.colsurfa.2007.01.012; Ye XL, 2009, COLLOID SURFACE A, V350, P130, DOI 10.1016/j.colsurfa.2009.09.017; Yu X, 2005, TIANJIN PHARM, V17, P39; Zhang Z, 1979, NEW MED, V10, P601	30	25	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68053	10.1371/journal.pone.0068053	http://dx.doi.org/10.1371/journal.pone.0068053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844154	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000134
J	Skogberg, G; Gudmundsdottir, J; van der Post, S; Sandstrom, K; Bruhn, S; Benson, M; Mincheva-Nilsson, L; Baranov, V; Telemo, E; Ekwall, O				Skogberg, Gabriel; Gudmundsdottir, Judith; van der Post, Sjoerd; Sandstrom, Kerstin; Bruhn, Soren; Benson, Mikael; Mincheva-Nilsson, Lucia; Baranov, Vladimir; Telemo, Esbjorn; Ekwall, Olov			Characterization of Human Thymic Exosomes	PLOS ONE			English	Article							PROMISCUOUS GENE-EXPRESSION; MHC CLASS-II; DENDRITIC CELLS; EPITHELIAL-CELLS; ANTIGEN PRESENTATION; T-CELLS; SELF-ANTIGEN; TOLERANCE; PROTEINS; VESICLES	Exosomes are nanosized membrane-bound vesicles that are released by various cell types and are capable of carrying proteins, lipids and RNAs which can be delivered to recipient cells. Exosomes play a role in intercellular communication and have been described to mediate immunologic information. In this article we report the first isolation and characterization of exosomes from human thymic tissue. Using electron microscopy, particle size determination, density gradient measurement, flow cytometry, proteomic analysis and microRNA profiling we describe the morphology, size, density, protein composition and microRNA content of human thymic exosomes. The thymic exosomes share characteristics with previously described exosomes such as antigen presentation molecules, but they also exhibit thymus specific features regarding surface markers, protein content and microRNA profile. Interestingly, thymic exosomes carry proteins that have a tissue restricted expression in the periphery which may suggest a role in T cell selection and the induction of central tolerance. We speculate that thymic exosomes may provide the means for intercellular information exchange necessary for negative selection and regulatory T cell formation of the developing thymocytes within the human thymic medulla.	[Skogberg, Gabriel; Gudmundsdottir, Judith; Telemo, Esbjorn; Ekwall, Olov] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Inst Med, Gothenburg, Sweden; [Gudmundsdottir, Judith; Ekwall, Olov] Univ Gothenburg, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden; [van der Post, Sjoerd] Univ Gothenburg, Prote Core Facil, Gothenburg, Sweden; [Sandstrom, Kerstin] Univ Gothenburg, Dept Pediat Anesthesia & Intens Care, Sahlgrenska Acad, Gothenburg, Sweden; [Bruhn, Soren; Benson, Mikael] Linkoping Univ, Ctr Invidualized Medicat, Linkoping, Sweden; [Benson, Mikael] Linkoping Univ, Dept Pediat, Linkoping, Sweden; [Mincheva-Nilsson, Lucia; Baranov, Vladimir] Umea Univ, Dept Clin Microbiol, Div Clin Immunol, Umea, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Linkoping University; Linkoping University; Umea University	Skogberg, G (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Inst Med, Gothenburg, Sweden.	xskoga@gu.se		Ekwall, Olov/0000-0002-4506-9955; van der Post, Sjoerd/0000-0002-7965-5311	Swedish Research Council [80409601]; Region Vastra Gotaland [ALFGBG-771712]; AFA Forsakring [100258]; IngaBritt and Arne Lundbergs Research Foundation; Gothenburg Medical Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Vastra Gotaland; AFA Forsakring; IngaBritt and Arne Lundbergs Research Foundation; Gothenburg Medical Society	This project was supported by the Swedish Research Council (contract 80409601), Region Vastra Gotaland (ALFGBG-771712), AFA Forsakring (contract 100258), IngaBritt and Arne Lundbergs Research Foundation and The Gothenburg Medical Society (all grants received by OE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393; HUMBLET C, 1994, INT IMMUNOL, V6, P1949, DOI 10.1093/intimm/6.12.1949; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Kasai M, 2009, J IMMUNOL, V183, P7278, DOI 10.4049/jimmunol.0804087; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Milicevic Z, 2010, IMMUNOL CELL BIOL, V88, P50, DOI 10.1038/icb.2009.55; Millet V, 2008, EUR J IMMUNOL, V38, P1257, DOI 10.1002/eji.200737982; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Peche H, 2006, AM J TRANSPLANT, V6, P1541, DOI 10.1111/j.1600-6143.2006.01344.x; Petersen SH, 2011, EUR J IMMUNOL, V41, P2556, DOI 10.1002/eji.201141438; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Segura E, 2007, J IMMUNOL, V179, P1489, DOI 10.4049/jimmunol.179.3.1489; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Yang CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022517	50	53	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67554	10.1371/journal.pone.0067554	http://dx.doi.org/10.1371/journal.pone.0067554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844026	Green Submitted, gold, Green Published			2022-12-25	WOS:000321341000055
J	Tabassum, F; Batty, GD				Tabassum, Faiza; Batty, G. David			Are Current UK National Institute for Health and Clinical Excellence (NICE) Obesity Risk Guidelines Useful? Cross-Sectional Associations with Cardiovascular Disease Risk Factors in a Large, Representative English Population	PLOS ONE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; NUTRITION EXAMINATION SURVEY; CAUSE-SPECIFIC MORTALITY; WAIST CIRCUMFERENCE; ORIGINAL WHITEHALL; ABDOMINAL ADIPOSITY; US ADULTS; FOLLOW-UP; OVERWEIGHT	The National Institute for Health and Clinical Excellence (NICE) has recently released obesity guidelines for health risk. For the first time in the UK, we estimate the utility of these guidelines by relating them to the established cardiovascular disease (CVD) risk factors. Health Survey for England (HSE) 2006, a population-based cross-sectional study in England was used with a sample size of 7225 men and women aged >= 35 years (age range: 35-97 years). The following CVD risk factor outcomes were used: hypertension, diabetes, total and high density lipoprotein cholesterol, glycated haemoglobin, fibrinogen, C-reactive protein and Framingham risk score. Four NICE categories of obesity were created based on body mass index (BMI) and waist circumference (WC): no risk (up to normal BMI and low/high WC); increased risk (normal BMI & very high WC, or obese & low WC); high risk (overweight & very high WC, or obese & high WC); and very high risk (obese I & very high WC or obese II/III with any levels of WC. Men and women in the very high risk category had the highest odds ratios (OR) of having unfavourable CVD risk factors compared to those in the no risk category. For example, the OR of having hypertension for those in the very high risk category of the NICE obesity groupings was 2.57 (95% confidence interval 2.06 to 3.21) in men, and 2.15 (1.75 to 2.64) in women. Moreover, a dose-response association between the adiposity groups and most of the CVD risk factors was observed except total cholesterol in men and low HDL in women. Similar results were apparent when the Framingham risk score was the outcome of interest. In conclusion, the current NICE definitions of obesity show utility for a range of CVD risk factors and CVD risk in both men and women.	[Tabassum, Faiza] UCL, Dept Infect & Populat Hlth, London, England; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London; University of London; University College London	Tabassum, F (corresponding author), UCL, Dept Infect & Populat Hlth, London, England.	f.tabassum@ucl.ac.uk	Batty, GD/Y-4401-2018	Batty, GD/0000-0003-1822-5753				Ardern CI, 2004, OBES RES, V12, P1094, DOI 10.1038/oby.2004.137; Ardern CL, 2003, OBES RES, V11, P135, DOI 10.1038/oby.2003.22; Batty GD, 2006, HEART, V92, P886, DOI 10.1136/hrt.2005.072637; Batty GD, 2005, INT J OBESITY, V29, P1267, DOI 10.1038/sj.ijo.0803020; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Craig R, 2008, METHODOLOGY DOCUMENT; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Czernichow S, 2011, EUR J CARDIOV PREV R, V18, P312, DOI 10.1097/HJR.0b013e32833c1aa3; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Han TS, 1996, BRIT MED J, V312, P1227; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Janssen I, 2005, PEDIATRICS, V115, P1623, DOI 10.1542/peds.2004-2588; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Kivimaki M, 2008, OBESITY, V16, P1926, DOI 10.1038/oby.2008.322; Koster A, 2008, AM J EPIDEMIOL, V167, P1465, DOI 10.1093/aje/kwn079; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Logue J, 2011, HEART, V97, P564, DOI 10.1136/hrt.2010.211201; McCrea R, 2012, INT J OBESITY, V36, P414, DOI 10.1038/ijo.2011.65; Nanchahal K, 2005, INT J OBESITY, V29, P317, DOI 10.1038/sj.ijo.0802877; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; National Institutes of Health, 2000, PRACT GUID ID EV TRE; Office for National Statistics, 2005, NATL STAT SOCIO EC C; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Tabassum F, 2009, HLTH SURVEY ENGLAND, V1, P113; Tiffin Paul A, 2011, Child Adolesc Psychiatry Ment Health, V5, P31, DOI 10.1186/1753-2000-5-31; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743	36	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67764	10.1371/journal.pone.0067764	http://dx.doi.org/10.1371/journal.pone.0067764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844088	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000094
J	Xiao, MS; Chang, L; Li, WL; Du, YS; Pan, Y; Zhang, DF; Wen, Y; Luo, J; Li, XY; Yao, YG				Xiao, Mei-Sheng; Chang, Le; Li, Wen-Liang; Du, Yong-Sheng; Pan, Yue; Zhang, Deng-Feng; Wen, Yu; Luo, Juan; Li, Xiao-Yan; Yao, Yong-Gang			Genetic Polymorphisms of the CASP8 Gene Promoter May Not Be Associated with Colorectal Cancer in Han Chinese from Southwest China	PLOS ONE			English	Article							INSERTION-DELETION POLYMORPHISM; NON-HODGKIN-LYMPHOMA; SIGNALING PATHWAYS; RISK; APOPTOSIS; SUSCEPTIBILITY; POPULATION; CASPASE-8; CIGARETTES; CARCINOMAS	Purpose: Caspase 8 (CASP8) plays a critical role in the apoptotic pathway and aberrant regulation of this pathway causes many diseases including cancers. Genetic variants rs3834129 (CTTACT/-) and rs3769821 (T/C) in the promoter region of the CASP8 gene were documented to be associated with multiple solid cancers and non-Hodgkin's lymphoma (NHL), respectively, despite of some controversies. We aimed to discern potential association of these two variants and rs113686495 (CTGTCATT/2), as well as CASP8 mRNA and protein expression levels with colorectal cancer (CRC) in Han Chinese. Methods: We genotyped CASP8 genetic variants in 305 CRC patients and 342 healthy individuals from Kunming, Southwest China. Expression levels of CASP8 mRNA and protein were quantified in paired cancerous and paracancerous normal tissues by using real-time quantitative PCR and western blot, respectively. We compared the frequencies of alleles, genotypes, and haplotypes between the cases and controls. Correlation of CASP8 mRNA and protein expression levels in paired cancerous and paracancerous normal tissues from patients with different genotypes and clinical expression were also evaluated. Results: There was no association of the CASP8 genetic variants with CRC in our case-control study. The CASP8 gene mRNA expression levels in cancerous and paracancerous normal tissues were similar and there was no significant difference between subjects with different genotypes and clinical features. However, we found that CASP8 protein level was significantly lower in cancerous tissues than in paired paracancerous normal tissues. Conclusions: Our results suggest that the three CASP8 genetic variants may not be associated with CRC risk in Han Chinese from southwest China. Aberrant CASP8 protein expression may play a role in the pathogenesis of CRC.	[Xiao, Mei-Sheng; Zhang, Deng-Feng; Yao, Yong-Gang] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China; [Chang, Le; Du, Yong-Sheng; Pan, Yue; Wen, Yu; Luo, Juan; Li, Xiao-Yan] Kunming Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Kunming, Peoples R China; [Li, Wen-Liang] Kunming Med Univ, Dept Oncol, Affiliated Hosp 1, Kunming, Peoples R China; [Zhang, Deng-Feng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; Kunming Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XY (corresponding author), Kunming Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Kunming, Peoples R China.	lixiaoyan-0808@163.com; ygyaozh@gmail.com	Zhang, Deng-Feng/K-1125-2015; Xiao, Meisheng/AAE-9432-2020; Yao, Yong-Gang/AAH-2303-2021	Xiao, Meisheng/0000-0001-9601-9598; Yao, Yong-Gang/0000-0002-2955-0693; Zhang, Deng-Feng/0000-0002-0777-5859	Top Talents Program of Yunnan Province [2009CI119]; National Natural Science Foundation of China [30925021]; Chinese Academy of Sciences	Top Talents Program of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Top Talents Program of Yunnan Province (2009CI119), National Natural Science Foundation of China (30925021) and Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CHEAH PY, 1990, NUTR CANCER, V14, P5, DOI 10.1080/01635589009514073; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; De Vecchi G, 2009, BREAST CANCER RES TR, V113, P607, DOI 10.1007/s10549-008-9963-y; Edge S, 2010, AJCC CANC STAGING HD; Frank B, 2008, BREAST CANCER RES TR, V111, P139, DOI 10.1007/s10549-007-9752-z; Gangwar R, 2009, ANN SURG ONCOL, V16, P2028, DOI 10.1245/s10434-009-0488-3; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Haiman CA, 2008, NAT GENET, V40, P259, DOI 10.1038/ng0308-259; Heijink DM, 2007, CELL ONCOL, V29, P409; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HOSHIYAMA Y, 1993, TOHOKU J EXP MED, V171, P153, DOI 10.1620/tjem.171.153; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Lan Q, 2007, CARCINOGENESIS, V28, P823, DOI 10.1093/carcin/bgl196; Lan Q, 2009, BLOOD, V114, P264, DOI 10.1182/blood-2009-01-198697; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ni CH, 2009, J TOXICOL ENV HEAL A, V72, P712, DOI 10.1080/15287390902841102; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Pan Yi-feng, 2011, Zhejiang Da Xue Xue Bao Yi Xue Ban, V40, P245; Pittman AM, 2008, BRIT J CANCER, V98, P1434, DOI 10.1038/sj.bjc.6604314; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Savas S, 2010, HUM MUTAT, V31, P901, DOI 10.1002/humu.21285; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Sun T, 2008, NAT GENET, V40, P260, DOI 10.1038/ng0308-260; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; Umar M, 2011, J SURG ONCOL, V103, P716, DOI 10.1002/jso.21881; Wang ML, 2009, CLIN CANCER RES, V15, P2567, DOI 10.1158/1078-0432.CCR-08-2829; Xiao MS, 2011, ANN HEMATOL, V90, P1137, DOI 10.1007/s00277-011-1265-5; Xu B, 2008, ONCOLOGY-BASEL, V74, P229, DOI 10.1159/000151392; Yao YG, 2005, FEBS LETT, V579, P1227, DOI 10.1016/j.febslet.2005.01.017; Yin M, 2010, CARCINOGENESIS, V31, P850, DOI 10.1093/carcin/bgq047	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67577	10.1371/journal.pone.0067577	http://dx.doi.org/10.1371/journal.pone.0067577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844036	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000060
J	Ye, Y; Wang, L; Xie, NG				Ye, Ye; Wang, Lu; Xie, Nenggang			Parrondo's Games Based on Complex Networks and the Paradoxical Effect	PLOS ONE			English	Article							STRATEGIES; SYSTEMS	Parrondo's games were first constructed using a simple tossing scenario, which demonstrates the following paradoxical situation: in sequences of games, a winning expectation may be obtained by playing the games in a random order, although each game (game A or game B) in the sequence may result in losing when played individually. The available Parrondo's games based on the spatial niche (the neighboring environment) are applied in the regular networks. The neighbors of each node are the same in the regular graphs, whereas they are different in the complex networks. Here, Parrondo's model based on complex networks is proposed, and a structure of game B applied in arbitrary topologies is constructed. The results confirm that Parrondo's paradox occurs. Moreover, the size of the region of the parameter space that elicits Parrondo's paradox depends on the heterogeneity of the degree distributions of the networks. The higher heterogeneity yields a larger region of the parameter space where the strong paradox occurs. In addition, we use scale-free networks to show that the network size has no significant influence on the region of the parameter space where the strong or weak Parrondo's paradox occurs. The region of the parameter space where the strong Parrondo's paradox occurs reduces slightly when the average degree of the network increases.				wanglu@ahut.edu.cn; xienenggang@aliyun.com			Ministry of Education, Humanities and Social Sciences research [11YJC630208, 13YJAZH106]; Natural Science Foundation of Anhui Province of China [11040606M119]	Ministry of Education, Humanities and Social Sciences research; Natural Science Foundation of Anhui Province of China(Natural Science Foundation of Anhui Province)	This project was supported by Ministry of Education, Humanities and Social Sciences research projects (11YJC630208 and 13YJAZH106), and the Natural Science Foundation of Anhui Province of China (Grant No. 11040606M119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott D, 2010, FLUCT NOISE LETT, V9, P129, DOI 10.1142/S0219477510000010; Allison A, 2005, ANN INT SOC DYN GAME, V7, P613, DOI 10.1007/0-8176-4429-6_32; Allison A, 2001, CHAOS, V11, P715, DOI 10.1063/1.1397769; Almberg WS, 2005, ARTIF INTELL COMPUT, P123; Almeida J, 2005, PHYSICA D, V200, P124, DOI 10.1016/j.physd.2004.10.003; Arena P, 2003, CHAOS SOLITON FRACT, V17, P545, DOI 10.1016/S0960-0779(02)00397-1; Atkinson D., 2007, REASONING RATIONALIT; Boman M., 2001, INTELLIGENT AGENT TE, P150; Cleuren B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.030101; Di Crescenzo A., 2007, MATH SCI, V32, P17; Gomez-Gardenes J., 2006, PHYS REV E, V73, P1; Harmer GP, 2001, CHAOS, V11, P705, DOI 10.1063/1.1395623; Harmer GP, 1999, NATURE, V402, P864, DOI 10.1038/47220; Kestenbaum D, 1997, NEW SCI, V154, P24; Kocarev L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046215; Masuda N, 2004, EUR PHYS J B, V40, P313, DOI 10.1140/epjb/e2004-00279-5; Mihailovic Z, 2006, PHYSICA A, V365, P244, DOI 10.1016/j.physa.2006.01.032; Mihailovic Z, 2003, FLUCT NOISE LETT, V3, pL389, DOI 10.1142/S0219477503001464; Parrondo JMR, 2000, PHYS REV LETT, V85, P5226, DOI 10.1103/PhysRevLett.85.5226; PINSKY R, 1992, ANN I H POINCARE-PR, V28, P519; Reed FA, 2007, GENETICS, V176, P1923, DOI 10.1534/genetics.106.069997; ROSATO A, 1987, PHYS REV LETT, V58, P1038, DOI 10.1103/PhysRevLett.58.1038; Szabo G, 2004, J PHYS A-MATH GEN, V37, P2599, DOI 10.1088/0305-4470/37/7/006; Tang TW, 2004, FLUCT NOISE LETT, V4, pL585, DOI 10.1142/S021947750400221X; Toral R, 2001, FLUCT NOISE LETT, V1, pL7, DOI 10.1142/S021947750100007X; Toyota N, 2012, ARXIV12045249V1 PHYS; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020	27	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67924	10.1371/journal.pone.0067924	http://dx.doi.org/10.1371/journal.pone.0067924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844131	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000121
J	Guo, Y; Chirieac, LR; Bueno, R; Pass, H; Wu, W; Malinowska, IA; Kwiatkowski, DJ				Guo, Y.; Chirieac, L. R.; Bueno, R.; Pass, H.; Wu, W.; Malinowska, I. A.; Kwiatkowski, D. J.			Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma	ONCOGENE			English	Article						TSC1; TSC2; mesothelioma; rapamycin; mTOR	MALIGNANT PLEURAL MESOTHELIOMA; TUBEROUS SCLEROSIS; GENE NF2; CELLS; SURVIVAL; PATHWAY; MTORC1; ACTIVATION; GROWTH; MODEL	Mesothelioma is diagnosed in similar to 2500 patients in the United States every year, most often arising in the pleural space, but also occurring as primary peritoneal mesothelioma. The vast majority of patients with mesothelioma die of their disease within 3 years. We developed a new mouse model of mesothelioma by bladder or intraperitoneal injection of adenovirus Cre into mice with conditional alleles of each of Tp53 and Tsc1. Such mice began to develop malignant ascites about 6 months after injection, which was due to peritoneal mesothelioma, on the basis of tumor morphology and immunohistochemical staining. Mesothelioma cell lines were established, which showed loss of both Tsc1 and Tp53, with mammalian target of rapamycin complex (mTORC)1 activation. Treatment of mice with malignant ascites due to mesothelioma with rapamycin led to a marked reduction in ascites, extended survival and a 95-99% reduction in the mesothelioma tumor volume, in comparison with vehicle-treated mice. To see whether TSC1/TSC2 loss was a common genetic event in human mesothelioma, we examined nine human mesothelioma cell lines, and found that four of nine showed persistent activation of mTORC1, although none had loss of TSC1 or TSC2. A tissue microarray analysis of 198 human mesothelioma specimens showed that 33% of cases had reduced TSC2 expression and 60% showed activation of mTOR, indicating that mTOR activation is common in human mesothelioma, suggesting that it is a potential therapeutic target.	[Guo, Y.; Wu, W.; Malinowska, I. A.; Kwiatkowski, D. J.] Brigham & Womens Hosp, Dept Med, Div Translat Med, Boston, MA 02115 USA; [Guo, Y.; Wu, W.; Malinowska, I. A.; Kwiatkowski, D. J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chirieac, L. R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bueno, R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA; [Pass, H.] NYU, Dept Cardiothorac Surg, Langone Med Ctr, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; New York University; NYU Langone Medical Center	Kwiatkowski, DJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Translat Med, Boston, MA 02115 USA.	dk@rics.bwh.harvard.edu	Chirieac, Lucian R./AAD-2030-2019; Malinowska, Izabela/A-4816-2013	Pass, Harvey/0000-0003-3222-3471	National Institutes of Health [1P01CA120964, 2P50CA090578]; Chip Thayer Fund; NATIONAL CANCER INSTITUTE [P50CA090578, P01CA120964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chip Thayer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Nathanael Gray (Dana Farber Cancer Institute, Boston, MA, USA) for kindly providing mTOR inhibitor Torin1 used in this study. This work was supported by Grants 1P01CA120964 and 2P50CA090578 from the National Institutes of Health, and the Chip Thayer Fund.	Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Auricchio N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031900; BIANCHI AB, 1995, P NATL ACAD SCI USA, V92, P10854, DOI 10.1073/pnas.92.24.10854; Brevet M, 2011, J THORAC ONCOL, V6, P864, DOI 10.1097/JTO.0b013e318215a07d; Burt BM, 2011, CANCER-AM CANCER SOC, V117, P5234, DOI 10.1002/cncr.26143; Dickson MA, 2013, INT J CANCER, V132, P1711, DOI 10.1002/ijc.27800; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P26, DOI 10.6004/jnccn.2012.0006; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hoda MA, 2011, J THORAC ONCOL, V6, P852, DOI 10.1097/JTO.0b013e31820e1a25; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Liang MC, 2010, ONCOGENE, V29, P1588, DOI 10.1038/onc.2009.452; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Marino S, 2000, GENE DEV, V14, P994; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Menges CW, 2012, MOL CANCER RES, V10, P1178, DOI 10.1158/1541-7786.MCR-12-0082; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Opitz I, 2008, EUR J CARDIO-THORAC, V33, P501, DOI 10.1016/j.ejcts.2007.09.045; Penno M B, 1995, Cancer J Sci Am, V1, P196; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Qin W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024919; REDDEL RR, 1989, J NATL CANCER I, V81, P945, DOI 10.1093/jnci/81.12.945; Seager C., 2010, CURR PROTOC PHARM; SEKIDO Y, 1995, CANCER RES, V55, P1227; Suzuki Y, 2009, MOL MED REP, V2, P181, DOI 10.3892/mmr_00000081; Thiele E, 2010, TUBEROUS SCLEROSIS C, P3; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wagner AJ, 2010, J CLIN ONCOL, V28, P835, DOI 10.1200/JCO.2009.25.2981; Wilson SM, 2008, AM J RESP CELL MOL, V39, P576, DOI 10.1165/rcmb.2007-0460OC	35	18	18	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 12	2014	33	24					3151	3160		10.1038/onc.2013.280	http://dx.doi.org/10.1038/onc.2013.280			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK4QU	23851502	Green Submitted, Green Accepted			2022-12-25	WOS:000338410000008
J	Bordelon, H; Russ, PK; Wright, DW; Haselton, FR				Bordelon, Hali; Russ, Patricia K.; Wright, David W.; Haselton, Frederick R.			A Magnetic Bead-Based Method for Concentrating DNA from Human Urine for Downstream Detection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CHLAMYDIA-TRACHOMATIS; SAMPLE PREPARATION; NUCLEIC-ACIDS; DIAGNOSIS; AMPLIFICATION; PURIFICATION	Due to the presence of PCR inhibitors, PCR cannot be used directly on most clinical samples, including human urine, without pre-treatment. A magnetic bead-based strategy is one potential method to collect biomarkers from urine samples and separate the biomarkers from PCR inhibitors. In this report, a 1 mL urine sample was mixed within the bulb of a transfer pipette containing lyophilized nucleic acid-silica adsorption buffer and silica-coated magnetic beads. After mixing, the sample was transferred from the pipette bulb to a small diameter tube, and captured biomarkers were concentrated using magnetic entrainment of beads through pre-arrayed wash solutions separated by small air gaps. Feasibility was tested using synthetic segments of the 140 bp tuberculosis IS6110 DNA sequence spiked into pooled human urine samples. DNA recovery was evaluated by qPCR. Despite the presence of spiked DNA, no DNA was detectable in unextracted urine samples, presumably due to the presence of PCR inhibitors. However, following extraction with the magnetic bead-based method, we found that similar to 50% of spiked TB DNA was recovered from human urine containing roughly 5x10(3) to 5x10(8) copies of IS6110 DNA. In addition, the DNA was concentrated approximately ten-fold into water. The final concentration of DNA in the eluate was 5x10(6), 14x10(6), and 8x10(6) copies/mu L for 1, 3, and 5 mL urine samples, respectively. Lyophilized and freshly prepared reagents within the transfer pipette produced similar results, suggesting that long-term storage without refrigeration is possible. DNA recovery increased with the length of the spiked DNA segments from 10+/-0.9% for a 75 bp DNA sequence to 42+/-4% for a 100 bp segment and 58+/-9% for a 140 bp segment. The estimated LOD was 77 copies of DNA/mu L of urine. The strategy presented here provides a simple means to achieve high nucleic acid recovery from easily obtained urine samples, which does not contain inhibitors of PCR.	[Bordelon, Hali; Russ, Patricia K.; Haselton, Frederick R.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Wright, David W.] Vanderbilt Univ, Dept Chem, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Haselton, FR (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	rick.haselton@vanderbilt.edu			Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative in diagnostics	Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative in diagnostics	This work was supported in part by the Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative in diagnostics. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceti A, 1999, THORAX, V54, P145, DOI 10.1136/thx.54.2.145; Adams NM, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4788922; Berensmeier S, 2006, APPL MICROBIOL BIOT, V73, P495, DOI 10.1007/s00253-006-0675-0; Betsou F, 2003, J CLIN MICROBIOL, V41, P1274, DOI 10.1128/JCM.41.3.1274-1276.2003; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bordelon H, 2011, ACS APPL MATER INTER, V3, P2161, DOI 10.1021/am2004009; Botezatu I, 2000, CLIN CHEM, V46, P1078; Cannas A, 2008, INT J TUBERC LUNG D, V12, P146; Davis KM, 2012, ANAL CHEM, V84, P6136, DOI 10.1021/ac301030m; Dineva MA, 2007, ANALYST, V132, P1193, DOI 10.1039/b705672a; Enk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038947; Moreira VG, 2009, CLIN BIOCHEM, V42, P729, DOI 10.1016/j.clinbiochem.2008.12.021; Gopinath K, 2009, INT J INFECT DIS, V13, P374, DOI 10.1016/j.ijid.2008.07.022; Green C, 2009, LANCET INFECT DIS, V9, P505, DOI 10.1016/S1473-3099(09)70149-5; Hopkins MJ, 2010, SEX TRANSM INFECT, V86, P207, DOI 10.1136/sti.2009.040634; Huggett J, 2009, BIOCHEM SOC T, V37, P419, DOI 10.1042/BST0370419; Lichtenstein AV, 2001, ANN NY ACAD SCI, V945, P239; Mariella R, 2008, BIOMED MICRODEVICES, V10, P777, DOI 10.1007/s10544-008-9190-7; Truong M, 2013, J UROLOGY, V189, P422, DOI 10.1016/j.juro.2012.04.143; Melkonyan HS, 2008, ANN NY ACAD SCI, V1137, P73, DOI 10.1196/annals.1448.015; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Rebollo MJ, 2006, DIAGN MICR INFEC DIS, V56, P141, DOI 10.1016/j.diagmicrobio.2006.03.018; Ritzi-Lehnert M, 2012, EXPERT REV MOL DIAGN, V12, P189, DOI [10.1586/ERM.11.98, 10.1586/erm.11.98]; Sasso LA, 2012, MICROFLUID NANOFLUID, V13, P603, DOI 10.1007/s10404-012-0980-0; Sechi LA, 1997, MOL CELL PROBE, V11, P281, DOI 10.1006/mcpr.1997.0119; Shields MJ, 2012, J FOOD PROTECT, V75, P1243, DOI 10.4315/0362-028X.JFP-12-048; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Umansky SR, 2006, EXPERT REV MOL DIAGN, V6, P153, DOI 10.1586/14737159.6.2.153; Wu HW, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3454767	31	36	38	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68369	10.1371/journal.pone.0068369	http://dx.doi.org/10.1371/journal.pone.0068369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861895	Green Published, gold, Green Submitted			2022-12-25	WOS:000321692000025
J	Elliott, S; Swift, S; Busse, L; Scully, S; Van, G; Rossi, J; Johnson, C				Elliott, Steve; Swift, Susan; Busse, Leigh; Scully, Sheila; Van, Gwyneth; Rossi, John; Johnson, Carol			Epo Receptors Are Not Detectable in Primary Human Tumor Tissue Samples	PLOS ONE			English	Article							BREAST-CANCER CELLS; BONE-MARROW-CELLS; ERYTHROPOIETIN-RECEPTOR; SURFACE EXPRESSION; SIGNALING PATHWAYS; DEPENDENT PATHWAY; GROWTH; LINE; ACTIVATION; KINASE	Erythropoietin (Epo) is a cytokine that binds and activates an Epo receptor (EpoR) expressed on the surface of erythroid progenitor cells to promote erythropoiesis. While early studies suggested EpoR transcripts were expressed exclusively in the erythroid compartment, low-level EpoR transcripts were detected in nonhematopoietic tissues and tumor cell lines using sensitive RT-PCR methods. However due to the widespread use of nonspecific anti-EpoR antibodies there are conflicting data on EpoR protein expression. In tumor cell lines and normal human tissues examined with a specific and sensitive monoclonal antibody to human EpoR (A82), little/no EpoR protein was detected and it was not functional. In contrast, EpoR protein was reportedly detectable in a breast tumor cell line (MCF-7) and breast cancer tissues with an anti-EpoR polyclonal antibody (M-20), and functional responses to rHuEpo were reported with MCF-7 cells. In another study, a functional response was reported with the lung tumor cell line (NCI-H838) at physiological levels of rHuEpo. However, the specificity of M-20 is in question and the absence of appropriate negative controls raise questions about possible false-positive effects. Here we show that with A82, no EpoR protein was detectable in normal human and matching cancer tissues from breast, lung, colon, ovary and skin with little/no EpoR in MCF-7 and most other breast and lung tumor cell lines. We show further that M-20 provides false positive staining with tissues and it binds to a non-EpoR protein that migrates at the same size as EpoR with MCF-7 lysates. EpoR protein was detectable with NCI-H838 cells, but no rHuEpo-induced phosphorylation of AKT, STAT3, pS6RP or STAT5 was observed suggesting the EpoR was not functional. Taken together these results raise questions about the hypothesis that most tumors express high levels of functional EpoR protein.	[Elliott, Steve; Swift, Susan; Busse, Leigh; Scully, Sheila; Van, Gwyneth; Rossi, John; Johnson, Carol] Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen	Elliott, S (corresponding author), Amgen Inc, Thousand Oaks, CA 91320 USA.	selliott@amgen.com						Ammarguellat F, 2001, BIOCHEM BIOPH RES CO, V284, P1031, DOI 10.1006/bbrc.2001.5085; Binder C, 2008, ASSAY DRUG DEV TECHN, V6, P27, DOI 10.1089/adt.2007.111; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; BOSMAN FT, 1988, ACTA HISTOCHEM, P27; BROUDY VC, 1991, BLOOD, V77, P2583, DOI 10.1182/blood.V77.12.2583.2583; BROUDY VC, 1990, BLOOD, V75, P1622; BROUDY VC, 1988, P NATL ACAD SCI USA, V85, P6513, DOI 10.1073/pnas.85.17.6513; Brown WM, 2007, STEM CELLS, V25, P718, DOI 10.1634/stemcells.2006-0687; DANDREA AD, 1991, SEMIN HEMATOL, V28, P152; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Della Ragione F, 2007, J CLIN ONCOL, V25, P1812, DOI 10.1200/JCO.2006.09.7212; Divoky V, 2001, P NATL ACAD SCI USA, V98, P986, DOI 10.1073/pnas.98.3.986; Doan HQ, 2009, ANTICANCER RES, V29, P2473; Dunlop EA, 2006, NEURODEGENER DIS, V3, P94, DOI 10.1159/000092099; Ebong S, 2004, INVEST OPHTH VIS SCI, V45, P872, DOI 10.1167/iovs.03-0311; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Elliott S, 2012, BIOL-TARGETS THER, V6, P163, DOI 10.2147/BTT.S32281; Elliott S, 2012, NEPHROL DIAL TRANSPL, V27, P2733, DOI 10.1093/ndt/gfr698; Elliott S, 2010, J IMMUNOL METHODS, V352, P126, DOI 10.1016/j.jim.2009.10.006; ETHERTON TD, 1984, J ANIM SCI, V59, P366, DOI 10.2527/jas1984.592366x; FRASER JK, 1988, EXP HEMATOL, V16, P836; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Fu P, 2009, BIOCHEM BIOPH RES CO, V379, P696, DOI 10.1016/j.bbrc.2008.12.146; Gaffen SL, 1999, BLOOD, V94, P74, DOI 10.1182/blood.V94.1.74.413k36_74_86; Gewirtz DA, 2006, CLIN CANCER RES, V12, pt; Hardee ME, 2006, MOL CANCER THER, V5, P356, DOI 10.1158/1535-7163.MCT-05-0196; Hardee ME, 2005, BRIT J CANCER, V93, P1350, DOI 10.1038/sj.bjc.6602846; HILTON DJ, 1995, P NATL ACAD SCI USA, V92, P190, DOI 10.1073/pnas.92.1.190; Hsi ED, 2001, ARCH PATHOL LAB MED, V125, P289; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Inthal A, 2008, CLIN CANCER RES, V14, P7196, DOI 10.1158/1078-0432.CCR-07-5051; Jegalian AG, 2002, BLOOD, V99, P2603, DOI 10.1182/blood.V99.7.2603; Jelkmann W, 2008, CRIT REV ONCOL HEMAT, V67, P39, DOI 10.1016/j.critrevonc.2008.03.006; Jeong JY, 2008, INT J CANCER, V122, P274, DOI 10.1002/ijc.23068; Kang JK, 2011, CELL ONCOL, V34, P11, DOI 10.1007/s13402-010-0001-9; Keenan J, 1996, CYTOTECHNOLOGY, V24, P252; Kessler C, 2012, CYTOKINE, V57, P226, DOI 10.1016/j.cyto.2011.11.010; Kirkeby A, 2007, J NEUROSCI METH, V164, P50, DOI 10.1016/j.jneumeth.2007.03.026; KOMATSU N, 1993, BLOOD, V82, P456; KRANTZ SB, 1991, BLOOD, V77, P419; LaMontagne KR, 2006, MOL CANCER THER, V5, P347, DOI 10.1158/1535-7163.MCT-05-0203; Laugsch M, 2008, INT J CANCER, V122, P1005, DOI 10.1002/ijc.23201; Layon ME, 2007, J MOL BIOL, V366, P737, DOI 10.1016/j.jmb.2006.11.094; Leong ASY, 2004, ADV ANAT PATHOL, V11, P86, DOI 10.1097/00125480-200403000-00002; Lester RD, 2005, J BIOL CHEM, V280, P39273, DOI 10.1074/jbc.M509446200; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; LONGMORE GD, 1991, CELL, V67, P1089, DOI 10.1016/0092-8674(91)90286-8; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; MCARTHUR GA, 1995, EXP HEMATOL, V23, P645; MIGLIACCIO AR, 1991, P NATL ACAD SCI USA, V88, P11086, DOI 10.1073/pnas.88.24.11086; MINAMOTO S, 1995, BLOOD, V86, P2281, DOI 10.1182/blood.V86.6.2281.bloodjournal8662281; MITJAVILA MT, 1989, J CELL PHYSIOL, V138, P617, DOI 10.1002/jcp.1041380324; MIURA Y, 1994, J BIOL CHEM, V269, P29962; NEUMANN D, 1993, J BIOL CHEM, V268, P13639; Okazaki T, 2008, NEOPLASIA, V10, P932, DOI 10.1593/neo.08140; PAPAYANNOPOULOU T, 1988, BLOOD, V72, P1029; SANTUCCI MA, 1994, STEM CELLS, V12, P506, DOI 10.1002/stem.5530120506; Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770; Sasaki Y, 2009, ACTA ONCOL, V48, P1062, DOI 10.1080/02841860902913553; Shannon AM, 2005, BRIT J CANCER, V93, P224, DOI 10.1038/sj.bjc.6602685; Shikama Y, 1996, BLOOD, V88, P455, DOI 10.1182/blood.V88.2.455.bloodjournal882455; Sinclair AM, 2008, BRIT J CANCER, V98, P1059, DOI 10.1038/sj.bjc.6604220; Sinclair AM, 2007, CANCER-AM CANCER SOC, V110, P477, DOI 10.1002/cncr.22832; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Slaaby R, 2008, GROWTH HORM IGF RES, V18, P267, DOI 10.1016/j.ghir.2007.09.003; Swift S, 2010, BLOOD, V115, P4254, DOI 10.1182/blood-2009-10-248674; Swift SE, 2010, MOL CANCER THER, V9, P1070, DOI 10.1158/1535-7163.MCT-09-0439; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; Wenker SD, 2010, J CELL BIOCHEM, V110, P151, DOI 10.1002/jcb.22521; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; WOGNUM AW, 1990, BLOOD, V76, P697; WOGNUM AW, 1992, BLOOD, V79, P642; YAMAMURA Y, 1992, EMBO J, V11, P4909, DOI 10.1002/j.1460-2075.1992.tb05597.x; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x; Yin D, 2007, INT J ONCOL, V31, P1193; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004; Zhang C, 2012, BREAST CANCER RES TR, V136, P739, DOI 10.1007/s10549-012-2316-x; Zou XM, 1999, J BIOL CHEM, V274, P18141, DOI 10.1074/jbc.274.26.18141	78	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68083	10.1371/journal.pone.0068083	http://dx.doi.org/10.1371/journal.pone.0068083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861852	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700069
J	Matsumiya, M; Stylianou, E; Griffiths, K; Lang, Z; Meyer, J; Harris, SA; Rowland, R; Minassian, AM; Pathan, AA; Fletcher, H; McShane, H				Matsumiya, Magali; Stylianou, Elena; Griffiths, Kristin; Lang, Zoe; Meyer, Joel; Harris, Stephanie A.; Rowland, Rosalind; Minassian, Angela M.; Pathan, Ansar A.; Fletcher, Helen; McShane, Helen			Roles for Treg Expansion and HMGB1 Signaling through the TLR1-2-6 Axis in Determining the Magnitude of the Antigen-Specific Immune Response to MVA85A	PLOS ONE			English	Article							VACCINIA VIRUS ANKARA; CALMETTE-GUERIN VACCINATION; LARGE GENE LISTS; TUBERCULOSIS VACCINE; DENDRITIC CELLS; RECOMBINANT VACCINIA; MICROARRAY DATA; HUMANS; BCG; IMMUNOGENICITY	A better understanding of the relationships between vaccine, immunogenicity and protection from disease would greatly facilitate vaccine development. Modified vaccinia virus Ankara expressing antigen 85A (MVA85A) is a novel tuberculosis vaccine candidate designed to enhance responses induced by BCG. Antigen-specific interferon-gamma (IFN-gamma) production is greatly enhanced by MVA85A, however the variability between healthy individuals is extensive. In this study we have sought to characterize the early changes in gene expression in humans following vaccination with MVA85A and relate these to long-term immunogenicity. Two days post-vaccination, MVA85A induces a strong interferon and inflammatory response. Separating volunteers into high and low responders on the basis of T cell responses to 85A peptides measured during the trial, an expansion of circulating CD4+ CD25+ Foxp3+ cells is seen in low but not high responders. Additionally, high levels of Toll-like Receptor (TLR) 1 on day of vaccination are associated with an increased response to antigen 85A. In a classification model, combined expression levels of TLR1, TICAM2 and CD14 on day of vaccination and CTLA4 and IL2R alpha two days post-vaccination can classify high and low responders with over 80% accuracy. Furthermore, administering MVA85A in mice with anti-TLR2 antibodies may abrogate high responses, and neutralising antibodies to TLRs 1, 2 or 6 or HMGB1 decrease CXCL2 production during in vitro stimulation with MVA85A. HMGB1 is released into the supernatant following atimulation with MVA85A and we propose this signal may be the trigger activating the TLR pathway. This study suggests an important role for an endogenous ligand in innate sensing of MVA and demonstrates the importance of pattern recognition receptors and regulatory T cell responses in determining the magnitude of the antigen specific immune response to vaccination with MVA85A in humans.	[Matsumiya, Magali; Stylianou, Elena; Griffiths, Kristin; Lang, Zoe; Meyer, Joel; Harris, Stephanie A.; Rowland, Rosalind; Minassian, Angela M.; Pathan, Ansar A.; Fletcher, Helen; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Matsumiya, M (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	magali.matsumiya@msdtc.ox.ac.uk		Minassian, Angela/0000-0001-7832-9824; /0000-0002-6008-2955; Fletcher, Helen/0000-0002-0435-1006; McShane, Helen/0000-0002-2126-5142	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. MM has a Wellcome Trust PhD studentship and HM is a Wellcome Trust Senior Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Betts G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050447; Brennan MJ, 2012, INT J TUBERC LUNG D, V16, P1566, DOI 10.5588/ijtld.12.0569; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dye C, 2013, LANCET, V381, P972, DOI 10.1016/S0140-6736(13)60137-3; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fletcher HA, 2008, VACCINE, V26, P5269, DOI 10.1016/j.vaccine.2008.07.040; Goodman AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025938; Griffiths KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023463; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Guzman E, 2012, J VIROL, V86, P5452, DOI 10.1128/JVI.00264-12; Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Huang B, 2011, GENE THER, V18, P164, DOI 10.1038/gt.2010.121; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kastenmuller W, 2006, VIROLOGY, V350, P276, DOI 10.1016/j.virol.2006.02.039; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kim JW, 2012, EXPERT OPIN BIOL TH, V12, P463, DOI 10.1517/14712598.2012.668516; Krupa M, 2011, VACCINE, V29, P1504, DOI 10.1016/j.vaccine.2010.12.016; Lousberg EL, 2011, EXPERT REV VACCINES, V10, P1435, DOI [10.1586/erv.11.121, 10.1586/ERV.11.121]; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Meyer J, 2013, VACCINE, V31, P1026, DOI 10.1016/j.vaccine.2012.12.042; Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223; Mohamed MR, 2009, CELL CYCLE, V8, P3125, DOI 10.4161/cc.8.19.9683; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; Nakaya H, 2012, SYSTEMS VACCINOLOGY, P1, DOI [10.1002/wsbm.163.Systems, DOI 10.1002/WSBM.163.SYSTEMS]; Odunsi K, 2012, P NATL ACAD SCI USA, V109, P5797, DOI 10.1073/pnas.1117208109; Pascutti MF, 2011, J VIROL, V85, P5532, DOI 10.1128/JVI.02267-10; Pathan A a, 2012, VACCINE, V31, P1, DOI [10.1016/j.vaccine.2012.06.084, DOI 10.1016/J.VACCINE.2012.06.084.PUBMED:23142303]; Perdiguero B, 2012, DELETION VIRAL ANTIA, V7, DOI [10.1371/journal.pone.0048524, DOI 10.1371/J0URNAL.P0NE.0048524]; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tameris MD, 2013, LANCET, V6736, P1, DOI [10.1016/S0140-6736(13)60177-4, DOI 10.1016/S0140-6736(13)60177-4.PUBMED:23391465]; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	61	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67922	10.1371/journal.pone.0067922	http://dx.doi.org/10.1371/journal.pone.0067922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844129	gold, Green Published, Green Accepted			2022-12-25	WOS:000321733000116
J	Arno, B; D'Annessa, I; Tesauro, C; Zuccaro, L; Ottaviani, A; Knudsen, B; Fiorani, P; Desideri, A				Arno, Barbara; D'Annessa, Ilda; Tesauro, Cinzia; Zuccaro, Laura; Ottaviani, Alessio; Knudsen, Birgitta; Fiorani, Paola; Desideri, Alessandro			Replacement of the Human Topoisomerase Linker Domain with the Plasmodial Counterpart Renders the Enzyme Camptothecin Resistant	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SWISS-MODEL; DNA TOPOISOMERASES; FUNCTIONAL LINKER; SINGLE MUTATION; I INHIBITORS; SENSITIVITY; FLEXIBILITY; RELAXATION; COVALENT	A human/plasmodial hybrid enzyme, generated by swapping the human topoisomerase IB linker domain with the corresponding domain of the Plasmodium falciparum enzyme, has been produced and characterized. The hybrid enzyme displays a relaxation activity comparable to the human enzyme, but it is characterized by a much faster religation rate. The hybrid enzyme is also camptothecin resistant. A 3D structure of the hybrid enzyme has been built and its structural-dynamical properties have been analyzed by molecular dynamics simulation. The analysis indicates that the swapped plasmodial linker samples a conformational space much larger than the corresponding domain in the human enzyme. The large linker conformational variability is then linked to important functional properties such as an increased religation rate and a low drug reactivity, demonstrating that the linker domain has a crucial role in the modulation of the topoisomerase IB activity.	[Arno, Barbara; D'Annessa, Ilda; Tesauro, Cinzia; Zuccaro, Laura; Ottaviani, Alessio; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Arno, Barbara; D'Annessa, Ilda; Tesauro, Cinzia; Zuccaro, Laura; Ottaviani, Alessio; Desideri, Alessandro] Univ Roma Tor Vergata, Interuniv Consortium, Natl Inst Biostruct & Biosyst INBB, I-00173 Rome, Italy; [Knudsen, Birgitta] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Fiorani, Paola] CNR, Inst Translat Pharmacol, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Aarhus University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Desideri, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	desideri@uniroma2.it	Ottaviani, Alessio/K-7240-2018	Ottaviani, Alessio/0000-0002-4796-3184; Tesauro, Cinzia/0000-0003-2986-9618; Knudsen, Birgitta Ruth/0000-0002-3484-3802; desideri, alessandro/0000-0003-1541-4217	AIRC [10121]	AIRC(Fondazione AIRC per la ricerca sul cancro)	This work has been supported by the AIRC project 10121 to A.D. and the Minister Erna Hamiltons Grant for Science and Art to B.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSEN AH, 1985, NUCLEIC ACIDS RES, V13, P1543, DOI 10.1093/nar/13.5.1543; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BJORNSTI MA, 1989, CANCER RES, V49, P6318; Castelli S, 2012, BIOL CHEM, V393, P1327, DOI 10.1515/hsz-2012-0240; Champoux JJ, 2000, METH MOL B, V95, P81; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chillemi G, 2005, NUCLEIC ACIDS RES, V33, P3339, DOI 10.1093/nar/gki642; Chillemi G, 2004, BIOPHYS J, V87, P4087, DOI 10.1529/biophysj.104.044925; Chillemi G, 2001, BIOPHYS J, V81, P490, DOI 10.1016/S0006-3495(01)75716-5; Chillemi G, 2008, NUCLEIC ACIDS RES, V36, P5645, DOI 10.1093/nar/gkn558; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Frohlich RF, 2008, BIOCHEMISTRY-US, V47, P7127, DOI 10.1021/bi800031k; Garcia-Estrada C, 2010, P ROY SOC B-BIOL SCI, V277, P1777, DOI 10.1098/rspb.2009.2176; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Juul S, 2012, ACS NANO; KAUH EA, 1995, P NATL ACAD SCI USA, V92, P6299, DOI 10.1073/pnas.92.14.6299; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Lisby M, 1998, BIOCHEMISTRY-US, V37, P10815, DOI 10.1021/bi980757r; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Losasso C, 2008, NUCLEIC ACIDS RES, V36, P5635, DOI 10.1093/nar/gkn557; Losasso C, 2007, J BIOL CHEM, V282, P9855, DOI 10.1074/jbc.M608200200; Mancini G, 2012, PLOS ONE IN PRESS; Mancini G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010934; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; POWELL MJD, 1964, COMPUT J, V7, P155, DOI 10.1093/comjnl/7.2.155; Redinbo MR, 1999, J MOL BIOL, V292, P685, DOI 10.1006/jmbi.1999.3065; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sari L, 2005, NUCLEIC ACIDS RES, V33, P6621, DOI 10.1093/nar/gki935; Scaldaferro S, 2001, CHEM BIOL, V8, P871, DOI 10.1016/S1074-5521(01)00059-X; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7593, DOI 10.1074/jbc.271.13.7593; Szklarczyk O, 2009, PROTEINS, V77, P420, DOI 10.1002/prot.22450; Tesauro C., 2012, J AMINO ACIDS, V2012; van der Merwe M, 2008, J BIOL CHEM, V283, P3305, DOI 10.1074/jbc.M705781200; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yang Z, 2002, J BIOL CHEM, V277, P30815, DOI 10.1074/jbc.M205302200	53	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68404	10.1371/journal.pone.0068404	http://dx.doi.org/10.1371/journal.pone.0068404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844196	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000160
J	Kancha, RK; Bartosch, N; Duyster, J				Kancha, Rama Krishna; Bartosch, Natalie; Duyster, Justus			Analysis of Conformational Determinants Underlying HSP90-Kinase Interaction	PLOS ONE			English	Article							KINASE DOMAIN MUTATION; LARGE-CELL LYMPHOMA; TYROSINE KINASE; NPM-ALK; HSP90 CHAPERONE; BCR-ABL; B-RAF; PROTEIN; INHIBITORS; ACTIVATION	The role of HSP90 in stabilization of oncogenic tyrosine kinases made it an attractive therapeutic target for treating cancer but the molecular basis underlying the interaction between the HSP90 chaperone and client kinases is not elucidated yet. Using kinase inhibitors we show that the inactive conformation of ERBB2 does not interact with HSP90 chaperone and is thus not amenable to degradation upon HSP90 inhibitor treatment, while active ERBB2 kinase conformation promotes interaction with the HSP90 machinery and thus is degraded upon HSP90 inhibitor treatment. Interestingly, the kinase-chaperone interaction is disrupted in case of BCR-ABL and FLT3-ITD when bound to inhibitors irrespective of whether they block the kinase in an active or inactive conformation and thus our results indicate that the stability of the active kinase conformation varies between different kinases.	[Kancha, Rama Krishna; Duyster, Justus] Univ Med Ctr Freiburg, Dept Med 1, Freiburg, Germany; [Bartosch, Natalie] Tech Univ Munich, Dept Internal Med 3, D-80290 Munich, Germany	University of Freiburg; Technical University of Munich; University of Munich	Duyster, J (corresponding author), Univ Med Ctr Freiburg, Dept Med 1, Freiburg, Germany.	direktion-med1@uniklinik-freiburg.de	Kancha, Rama Krishna/B-5992-2009	Kancha, Rama Krishna/0000-0001-8146-1551	Jose Carreras Leukamie-Stiftung	Jose Carreras Leukamie-Stiftung	JD is supported by a grant from the Jose Carreras Leukamie-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; An WG, 2000, CELL GROWTH DIFFER, V11, P355; Bonvini P, 2002, CANCER RES, V62, P1559; Coutinho S, 2000, BLOOD, V96, P618; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guix M, 2008, J CLIN ONCOL, V26, P897, DOI 10.1200/JCO.2007.13.5939; HUANG SS, 1990, J BIOL CHEM, V265, P3340; Hubinger G, 2003, EXP HEMATOL, V31, P226, DOI 10.1016/S0301-472X(02)01084-6; Hubinger G, 1999, EXP HEMATOL, V27, P1796, DOI 10.1016/S0301-472X(99)00116-2; Kancha RK, 2007, EXP HEMATOL, V35, P1522, DOI 10.1016/j.exphem.2007.07.008; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Kancha RK, 2008, HAEMATOL-HEMATOL J, V93, P1718, DOI 10.3324/haematol.13207; pale M, 2010, NATURE REV, V11, P515; Salas A, 2011, BLOOD, V117, P5941, DOI 10.1182/blood-2010-08-300772; Schaefer G, 2007, CANCER RES, V67, P1228, DOI 10.1158/0008-5472.CAN-06-3493; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Weisberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025351; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yao Q, 2003, CLIN CANCER RES, V9, P4483; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68394	10.1371/journal.pone.0068394	http://dx.doi.org/10.1371/journal.pone.0068394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844194	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000158
J	Kopriva, SE; Chiasson, VL; Mitchell, BM; Chatterjee, P				Kopriva, Shelley E.; Chiasson, Valorie L.; Mitchell, Brett M.; Chatterjee, Piyali			TLR3-Induced Placental miR-210 Down-Regulates the STAT6/Interleukin-4 Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; GENE-EXPRESSION; INFLAMMATORY RESPONSE; MICRORNA EXPRESSION; CELL-LINES; TROPHOBLAST; PREECLAMPSIA; HYPOXIA; ACTIVATION; MECHANISMS	Several clinical studies have reported increased placental miR-210 expression in women with PE compared to normotensive women, but whether miR-210 plays a role in the etiology of PE is unknown. We reported that activation of TLR3 produces the PE-like symptoms of hypertension, endothelial dysfunction, and proteinuria in mice only when pregnant, but whether TLR3 activation in pregnant mice and human cytotrophoblasts (CTBs) increases miR-210 and modulates its targets related to inflammation are unknown. Placental miR-210 levels were increased significantly in pregnant mice treated with the TLR3 agonist poly I:C (P-PIC). Both HIF-1 alpha and NF-kappa Bp50, known to bind the miR-210 promoter and induce its expression, were also increased significantly in placentas of P-PIC mice. Target identification algorithms and gene ontology predicted STAT6 as an inflammation-related target of miR-210 and STAT6 was decreased significantly in placentas of P-PIC mice. IL-4, which is regulated by STAT6 and increases during normotensive pregnancy, failed to increase in serum of P-PIC mice. P-PIC TLR3 KO mice did not develop hypertension and placental HIF-1 alpha, NF-kappa Bp50, miR-210, STAT6, and IL-4 levels were unchanged. To determine the placental etiology, treatment of human CTBs with poly I:C significantly increased HIF-1 alpha, NF-kappa Bp50, and miR-210 levels and decreased STAT6 and IL-4 levels. Overexpression of miR-210 in CTBs decreased STAT6 and IL-4 while inhibition of miR-210 increased STAT6 and IL-4. These findings demonstrate that TLR3 activation induces placental miR-210 via HIF-1 alpha and NF-kappa Bp50 leading to decreased STAT6 and IL-4 levels and this may contribute to the development of PE.	[Kopriva, Shelley E.; Chiasson, Valorie L.; Mitchell, Brett M.; Chatterjee, Piyali] Scott & White Healthcare Texas A&M Hlth Sci Ctr, Dept Internal Med, Div Nephrol & Hypertens, Temple, TX USA		Chatterjee, P (corresponding author), Scott & White Healthcare Texas A&M Hlth Sci Ctr, Dept Internal Med, Div Nephrol & Hypertens, Temple, TX USA.	pchatterjee@sw.org		Chatterjee, Piyali/0000-0002-7655-0485	Scientist Development Grant from American Heart Association [13SDG14630018]; Scott and White Memorial Hospital Research Development Grant	Scientist Development Grant from American Heart Association(American Heart Association); Scott and White Memorial Hospital Research Development Grant	This was was supported by Scientist Development Grant (13SDG14630018) from American Heart Association to PC and Scott and White Memorial Hospital Research Development Grant to BMM and PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096; Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Arechavaleta-Velasco F, 2006, AM J PATHOL, V168, P1951, DOI 10.2353/ajpath.2006.050781; Azizieh F, 2005, AM J REPROD IMMUNOL, V54, P30, DOI 10.1111/j.1600-0897.2005.00278.x; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cartwright JE, 1999, BRIT J PHARMACOL, V128, P181, DOI 10.1038/sj.bjp.0702757; Carty DM, 2008, TRENDS CARDIOVAS MED, V18, P186, DOI 10.1016/j.tcm.2008.07.002; Chapoval S, 2010, J LEUKOCYTE BIOL, V87, P1011, DOI 10.1189/jlb.1209772; Chatterjee P, 2011, PLACENTA, V32, P201, DOI 10.1016/j.placenta.2010.12.026; Chatterjee P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041884; Chatterjee P, 2011, HYPERTENSION, V58, P489, DOI 10.1161/HYPERTENSIONAHA.111.172114; Crosby ME, 2009, CURR PHARM DESIGN, V15, P3861, DOI 10.2174/138161209789649367; Enquobahrie Daniel A, 2011, Am J Obstet Gynecol, V204, DOI 10.1016/j.ajog.2010.09.004; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gong AY, 2010, J INFECT DIS, V201, P160, DOI 10.1086/648589; Gonzalez JM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.021; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gunel T, 2011, GENET MOL RES, V10, P4034, DOI 10.4238/2011.November.8.5; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Jonsson Y, 2006, J REPROD IMMUNOL, V70, P83, DOI 10.1016/j.jri.2005.10.007; Kanasaki K, 2009, KIDNEY INT, V76, P831, DOI 10.1038/ki.2009.284; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee DC, 2011, AM J PATHOL, V179, P590, DOI 10.1016/j.ajpath.2011.04.035; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long C, 2007, HYPERTENSION, V49, P569, DOI 10.1161/01.HYP.0000257914.80918.72; Matthiesen L, 2005, CHEM IMMUNOL ALLERGY, V89, P49, DOI 10.1159/000087912; Mazouni C, 2008, J REPROD IMMUNOL, V78, P80, DOI 10.1016/j.jri.2007.10.002; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Paone A, 2010, NEOPLASIA, V12, P539, DOI 10.1593/neo.92106; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Vaughan JE, 2012, HYPERTENS PREGNANCY, V31, P243, DOI 10.3109/10641955.2011.642436; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	55	46	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67760	10.1371/journal.pone.0067760	http://dx.doi.org/10.1371/journal.pone.0067760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844087	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000093
J	Masello, JF; Wikelski, M; Voigt, CC; Quillfeldt, P				Masello, Juan F.; Wikelski, Martin; Voigt, Christian C.; Quillfeldt, Petra			Distribution Patterns Predict Individual Specialization in the Diet of Dolphin Gulls	PLOS ONE			English	Article							STABLE-ISOTOPES; FORAGING PATTERNS; LARUS-SCORESBII; CARBON ISOTOPES; HERRING-GULLS; GREAT SKUAS; PUNTA-TOMBO; HABITAT USE; SEA OTTERS; SEABIRDS	Many animals show some degree of individual specialization in foraging strategies and diet. This has profound ecological and evolutionary implications. For example, populations containing diverse individual foraging strategies will respond in different ways to changes in the environment, thus affecting the capacity of the populations to adapt to environmental changes and to diversify. However, patterns of individual specialization have been examined in few species. Likewise it is usually unknown whether specialization is maintained over time, because examining the temporal scale at which specialization occurs can prove difficult in the field. In the present study, we analyzed individual specialization in foraging in Dolphin Gulls Leucophaeus scoresbii, a scavenger endemic to the southernmost coasts of South America. We used GPS position logging and stable isotope analyses (SIA) to investigate individual specialization in feeding strategies and their persistence over time. The analysis of GPS data indicated two major foraging strategies in Dolphin Gulls from New I. (Falkland Is./Islas Malvinas). Tagged individuals repeatedly attended either a site with mussel beds or seabird and seal colonies during 5 to 7 days of tracking. Females foraging at mussel beds were heavier than those foraging at seabird colonies. Nitrogen isotope ratios (delta N-15) of Dolphin Gull blood cells clustered in two groups, showing that individuals were consistent in their preferred foraging strategies over a period of at least several weeks. The results of the SIA as well as the foraging patterns recorded revealed a high degree of specialization for particular feeding sites and diets by individual Dolphin Gulls. Individual differences in foraging behavior were not related to sex. Specialization in Dolphin Gulls may be favored by the advantages of learning and memorizing optimal feeding locations and behaviors. Specialized individuals may reduce search and handling time and thus, optimize their energy gain and/or minimize time spent foraging.	[Masello, Juan F.; Wikelski, Martin; Quillfeldt, Petra] Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell, Germany; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Evolutionary Ecol Res Grp, Berlin, Germany	Max Planck Society; Leibniz Institut fur Zoo und Wildtierforschung	Masello, JF (corresponding author), Univ Giessen, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany.	juan.f.masello@bio.uni-giessen.de	Quillfeldt, Petra/A-9549-2009; Masello, Juan/C-7133-2009	Quillfeldt, Petra/0000-0002-4450-8688; Masello, Juan/0000-0002-6826-4016	Deutsche Forschungsgemeinschaft [QU148/1ff]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study received financial support from the Deutsche Forschungsgemeinschaft (QU148/1ff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2002, AQUAT CONSERV, V12, P39, DOI 10.1002/aqc.474; Annett CA, 1999, ECOLOGY, V80, P288, DOI 10.1890/0012-9658(1999)080[0288:LTROIW]2.0.CO;2; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Barlow KE, 2002, MAR BIOL, V140, P205, DOI 10.1007/s00227-001-0691-7; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bugoni L, 2009, MAR ECOL PROG SER, V374, P273, DOI 10.3354/meps07750; Castellanos A., 1935, HORNERO, V6, P22; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; CAWKELL E. M., 1961, IBIS, V103a, P1, DOI 10.1111/j.1474-919X.1961.tb02417.x; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; Dahl TM, 2003, MAR ECOL PROG SER, V256, P257, DOI 10.3354/meps256257; DAVIS JWF, 1975, J ANIM ECOL, V44, P795, DOI 10.2307/3719; Davoren GK, 2003, ECOL MONOGR, V73, P463, DOI 10.1890/02-0208; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DEVILLERS P, 1977, Gerfaut, V67, P254; DOHERTY S, 1994, ETHOLOGY, V97, P177; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Forero MG, 2004, J ANIM ECOL, V73, P789, DOI 10.1111/j.0021-8790.2004.00852.x; Forero MG, 2002, ECOLOGY, V83, P3466, DOI 10.1890/0012-9658(2002)083[3466:CFCEVI]2.0.CO;2; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; Gandini PA, 2008, ORNITOL NEOTROP, V19, P109; Golet GH, 2000, AUK, V117, P82, DOI 10.1642/0004-8038(2000)117[0082:APCACG]2.0.CO;2; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hahn S, 2003, POLAR BIOL, V26, P552, DOI 10.1007/s00300-003-0522-z; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Holland RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008264; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; JEHL JR, 1973, AUK, V90, P114; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; MCCLEERY RH, 1986, J ANIM ECOL, V55, P245, DOI 10.2307/4705; Michalik A, 2010, POLAR BIOL, V33, P1537, DOI 10.1007/s00300-010-0843-7; Michener R.H., 1994, P138; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morrison RIG, 2004, AUK, V121, P333, DOI 10.1642/0004-8038(2004)121[0333:UOBSIS]2.0.CO;2; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Nisbet ICT, 2002, MAR ECOL PROG SER, V242, P267, DOI 10.3354/meps242267; Olive PJW, 2003, J ANIM ECOL, V72, P608, DOI 10.1046/j.1365-2656.2003.00730.x; OWENS NJP, 1987, ADV MAR BIOL, V24, P389; PARMELEE DF, 1975, CONDOR, V77, P218, DOI 10.2307/1365800; PARNELL A, 2008, STABLE ISOTOPE ANAL; PIEROTTI R, 1991, ECOLOGY, V72, P319, DOI 10.2307/1938925; Quillfeldt P, 2006, AREA DESCRIPTION BRE, P78283; Quillfeldt P, 2008, MAR BIOL, V155, P593, DOI 10.1007/s00227-008-1048-2; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quillfeldt P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-15; R Development Core Team, 2009, R FDN STAT COMP; Rey AR, 2000, POLAR BIOL, V23, P338; Reynolds P. W., 1935, Ibis, V1935, P65; Ropert-Coudert Y, 2003, WATERBIRDS, V26, P403, DOI 10.1675/1524-4695(2003)026[0403:IDSITL]2.0.CO;2; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; SIBLY RM, 1983, J ANIM ECOL, V52, P35, DOI 10.2307/4586; SIBLY RM, 1983, J ANIM ECOL, V52, P51, DOI 10.2307/4587; Stephens D.W., 1986, pi; Stillman RA, 2002, J ANIM ECOL, V71, P874, DOI 10.1046/j.1365-2656.2002.00652.x; Strange G, 2010, BLACK BROWED ALBATRO, P1230; Strange I., 2007, NEW ISLAND FALKLAND; Strange IJ, 1992, FIELD GUIDE WILDLIFE; Suarez N, 2005, IBIS, V147, P544, DOI 10.1111/j.1474-919x.2005.00426.x; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Votier SC, 2004, J APPL ECOL, V41, P1117, DOI 10.1111/j.0021-8901.2004.00974.x; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Weaver D. K, 1970, Bird Banding, V41, P28, DOI 10.2307/4511621; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; Woods RW, 1975, BIRDS FALKLAND ISLAN; Yorio P, 2004, WATERBIRDS, V27, P193, DOI 10.1675/1524-4695(2004)027[0193:FPOBOG]2.0.CO;2; Yorio P, 1996, CONDOR, V98, P208, DOI 10.2307/1369138; Yorio P, 1999, BIRD CONSERV INT, V9, P299, DOI 10.1017/S0959270900003506; Yorio Pablo, 2005, Hornero, V20, P53	80	31	31	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67714	10.1371/journal.pone.0067714	http://dx.doi.org/10.1371/journal.pone.0067714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844073	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000082
J	Pinloche, E; McEwan, N; Marden, JP; Bayourthe, C; Auclair, E; Newbold, CJ				Pinloche, Eric; McEwan, Neil; Marden, Jean-Philippe; Bayourthe, Corinne; Auclair, Eric; Newbold, C. Jamie			The Effects of a Probiotic Yeast on the Bacterial Diversity and Population Structure in the Rumen of Cattle	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; SACCHAROMYCES-CEREVISIAE CULTURE; FRAGMENT-LENGTH-POLYMORPHISMS; HIGH-GRAIN DIET; REAL-TIME PCR; RUMINAL FERMENTATION; DAIRY-COWS; IN-VITRO; MICROBIAL FERMENTATION; MEGASPHAERA-ELSDENII	It has been suggested that the ability of live yeast to improve milk yield and weight gain in cattle is because the yeast stimulates bacterial activity within the rumen. However it remains unclear if this is a general stimulation of all species or a specific stimulation of certain species. Here we characterised the change in the bacterial population within the rumen of cattle fed supplemental live yeast. Three cannulated lactating cows received a daily ration (24 kg/d) of corn silage (61% of DM), concentrates (30% of DM), dehydrated alfalfa (9% of DM) and a minerals and vitamins mix (1% of DM). The effect of yeast (BIOSAF SC 47, Lesaffre Feed Additives, France; 0.5 or 5 g/d) was compared to a control (no additive) in a 363 Latin square design. The variation in the rumen bacterial community between treatments was assessed using Serial Analysis of V1 Ribosomal Sequence Tag (SARST-V1) and 454 pyrosequencing based on analysis of the 16S rRNA gene. Compared to the control diet supplementation of probiotic yeast maintained a healthy fermentation in the rumen of lactating cattle (higher VFA concentration [high yeast dose only], higher rumen pH, and lower Eh and lactate). These improvements were accompanied with a shift in the main fibrolytic group (Fibrobacter and Ruminococcus) and lactate utilising bacteria (Megasphaera and Selenomonas). In addition we have shown that the analysis of short V1 region of 16s rRNA gene (50-60 bp) could give as much phylogenetic information as a longer read (454 pyrosequencing of 250 bp). This study also highlights the difficulty of drawing conclusions on composition and diversity of complex microbiota because of the variation caused by the use of different methods (sequencing technology and/or analysis).	[Pinloche, Eric; McEwan, Neil; Newbold, C. Jamie] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Pinloche, Eric; Marden, Jean-Philippe; Auclair, Eric] Lesaffre Feed Addit, Marcq En Baroeul, France; [Bayourthe, Corinne] INRA, TANDEM UMR1289, F-31326 Castanet Tolosan, France; [Bayourthe, Corinne] Univ Toulouse, INPT ENSAT, INP ENVT, TANDEM UMR1289, Castanet Tolosan, France	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Newbold, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	cjn@aber.ac.uk		McEwan, Neil/0000-0003-3839-9072	Lesaffre Feed Additives, Marquette-Lez-Lille, France	Lesaffre Feed Additives, Marquette-Lez-Lille, France	The authors acknowledge the generous financial support of Lesaffre Feed Additives, Marquette-Lez-Lille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; [Anonymous], 1997, RUMEN MICROBIAL ECOS; Boyd R.D., 1991, J ANIM SCI, V69, P56, DOI [10.2527/1991.69suppl_256x., DOI 10.2527/1991.69SUPPL_256X]; Busquet M, 2006, J DAIRY SCI, V89, P761, DOI 10.3168/jds.S0022-0302(06)72137-3; Callaway ES, 1997, J DAIRY SCI, V80, P2035, DOI 10.3168/jds.S0022-0302(97)76148-4; Cardozo PW, 2005, J ANIM SCI, V83, P2572; Chaucheyras F, 1996, CAN J MICROBIOL, V42, P927, DOI 10.1139/m96-119; Coolen MJL, 2005, APPL ENVIRON MICROB, V71, P8729, DOI 10.1128/AEM.71.12.8729-8737.2005; Dijkstra J, 2002, NUTR RES REV, V15, P67, DOI 10.1079/NRR200237; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Dowd S.E., 2008, BMC MICROBIOLOGY, V8; ERASMUS LJ, 1992, J DAIRY SCI, V75, P3056, DOI 10.3168/jds.S0022-0302(92)78069-2; ESDALE WJ, 1972, J DAIRY SCI, V55, P964, DOI 10.3168/jds.S0022-0302(72)85603-0; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Goad DW, 1998, J ANIM SCI, V76, P234; HALL TA, 1999, BIOEDIT USER FRIENDL, V41, P95; HARRISON GA, 1988, J DAIRY SCI, V71, P2967, DOI 10.3168/jds.S0022-0302(88)79894-X; Hongoh Y, 2003, FEMS MICROBIOL LETT, V221, P299, DOI 10.1016/S0378-1097(03)00218-0; JOUANY JP, 1994, ARCH ANIM NUTR, V46, P133, DOI 10.1080/17450399409381766; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Krause KM, 2005, J DAIRY SCI, V88, P3633, DOI 10.3168/jds.S0022-0302(05)73048-4; Lan GQ, 2002, INT J SYST EVOL MICR, V52, P713, DOI [10.1099/ijs.0.01930-0, 10.1099/00207713-52-3-713]; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Marden JP, 2008, J DAIRY SCI, V91, P3528, DOI 10.3168/jds.2007-0889; Marden JP, 2005, J DAIRY SCI, V88, P277, DOI 10.3168/jds.S0022-0302(05)72685-0; MARTIN SA, 1994, J ANIM SCI, V72, P3019, DOI 10.2527/1994.72113019x; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Middelbos IS, 2009, FASEB J, V23; Morgan JP, 1996, ANN STAT, V24, P1185; Mosoni P, 2007, J APPL MICROBIOL, V103, P2676, DOI 10.1111/j.1365-2672.2007.03517.x; Mwenya B, 2005, J DAIRY SCI, V88, P1404, DOI 10.3168/jds.S0022-0302(05)72808-3; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Newbold CJ, 1996, BRIT J NUTR, V76, P249, DOI 10.1079/BJN19960029; Newbold CJ, 1998, CAN J ANIM SCI, V78, P241, DOI 10.4141/A97-086; Nocek JE, 1997, J DAIRY SCI, V80, P1005, DOI 10.3168/jds.S0022-0302(97)76026-0; Owens FN, 1998, J ANIM SCI, V76, P275; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; PIVA G, 1993, J DAIRY SCI, V76, P2717, DOI 10.3168/jds.S0022-0302(93)77608-0; PLATA F, 1994, ANIM FEED SCI TECH, V49, P203, DOI 10.1016/0377-8401(94)90046-9; PLAYNE MJ, 1983, BIOTECHNOL BIOENG, V25, P1251, DOI 10.1002/bit.260250508; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; ROGER V, 1990, APPL ENVIRON MICROB, V56, P3081, DOI 10.1128/AEM.56.10.3081-3087.1990; Rossi F, 2004, ANIM RES, V53, P177, DOI 10.1051/animres:2004009; Russell J. B., 2002, RUMEN MICROBIOLOGY I; RUSSELL JB, 1981, APPL ENVIRON MICROB, V41, P1394, DOI 10.1128/AEM.41.6.1394-1399.1981; SAUVANT D, 2004, ALLT 20 ANN S BIOT F, P221; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Soto-Cruz O, 2001, BRAZ ARCH BIOL TECHN, V44, P179, DOI 10.1590/S1516-89132001000200011; STREETER MN, 1990, J ANIM SCI, V68, P3429; Tajima K, 1999, FEMS MICROBIOL ECOL, V29, P159, DOI 10.1111/j.1574-6941.1999.tb00607.x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tajima K, 2000, ANAEROBE, V6, P273, DOI 10.1006/anae.2000.0353; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALLACE RJ, 1992, FEMS MICROBIOL LETT, V100, P529, DOI 10.1111/j.1574-6968.1992.tb05751.x; Wallace RJ, 1993, BIOTECHNOLOGY FEED I; Weimer PJ, 1998, J ANIM SCI, V76, P3114; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; WILLIAMS PEV, 1991, J ANIM SCI, V69, P3016, DOI 10.2527/1991.6973016x; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Yu ZT, 2006, ENVIRON MICROBIOL, V8, P603, DOI 10.1111/j.1462-2920.2005.00933.x	68	108	122	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67824	10.1371/journal.pone.0067824	http://dx.doi.org/10.1371/journal.pone.0067824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844101	Green Published, gold			2022-12-25	WOS:000321341000103
J	Kang, K; Peng, X; Zhang, XY; Wang, YN; Zhang, LS; Gao, L; Weng, TT; Zhang, HH; Ramchandran, R; Raj, JU; Gou, DM; Liu, L				Kang, Kang; Peng, Xiao; Zhang, Xiaoying; Wang, Yuna; Zhang, Lishu; Gao, Li; Weng, Tingting; Zhang, Honghao; Ramchandran, Ramaswamy; Raj, J. Usha; Gou, Deming; Liu, Lin			MicroRNA-124 Suppresses the Transactivation of Nuclear Factor of Activated T Cells by Targeting Multiple Genes and Inhibits the Proliferation of Pulmonary Artery Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; REGULATES EXPRESSION; MIR-124; NFATC3; DIFFERENTIATION; HYPERTENSION; CALCINEURIN; CALMODULIN; MYOCARDIN; CALCIUM	Abnormal proliferation and phenotypic modulation of pulmonary artery smooth muscle cells (PASMC) contributes to the pathogenesis of numerous cardiovascular disorders, including pulmonary arterial hypertension (PAH). The nuclear factor of activated T cells (NFAT) signaling pathway is linked to PASMC proliferation and PAH. MicroRNAs (miRNAs) are small non-coding RNAs that function in diverse biological processes. To systemically identify the specific miRNAs that regulate the NFAT pathway, a human primary miRNA library was applied for cell-based high throughput screening with the NFAT luciferase reporter system. Eight miRNAs were found to modulate NFAT activity efficiently. Of them, miR-124 robustly inhibited NFAT reporter activity and decreased both the dephosphorylation and the nuclear translocation of NFAT. miR-124 also inhibited NFAT-dependent transcription of IL-2 in Jurkat T cells. miR-124 exerted its effects by targeting multiple genes, including a known component of the NFAT pathway, NFATc1, and two new regulators of NFAT signaling, CAMTA1 (calmodulin-binding transcription activator 1) and PTBP1 (polypyrimidine tract-binding protein 1). Physiologically, miR-124 was down-regulated by hypoxia in human PASMC, consistent with the activation of NFAT during this process. Down-regulation of miR-124 was also observed in 3-week hypoxia-treated mouse lungs. Furthermore, the overexpression of miR-124 not only inhibited human PASMC proliferation but also maintained its differentiated phenotype by repressing the NFAT pathway. Taken together, our data provide the first evidence that miR-124 acts as an inhibitor of the NFAT pathway. Down-regulation of miR-124 in hypoxia-treated PASMC and its antiproliferative and prodifferentiation effects imply a potential value for miR124 in the treatment of PAH.	[Kang, Kang; Peng, Xiao; Zhang, Xiaoying; Wang, Yuna; Gou, Deming] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen 518060, Guangdong, Peoples R China; [Zhang, Lishu; Gao, Li; Weng, Tingting; Zhang, Honghao; Gou, Deming; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA; [Ramchandran, Ramaswamy; Raj, J. Usha; Gou, Deming] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA	Shenzhen University; Oklahoma State University System; Oklahoma State University - Stillwater; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gou, DM (corresponding author), Shenzhen Univ, Coll Life Sci, Nanhai Ave 3688, Shenzhen 518060, Guangdong, Peoples R China.	dmgou@szu.edu.cn; lin.liu@okstate.edu		Zhang, Honghao/0000-0002-2338-6992	National Natural Science Foundation of China [81170047]; National Basic Research Program of China 973 Program [2012CB124701]; Shenzhen Overseas High Level Talents Innovation Program [YFZZ20111009]; Shenzhen Municipal Basic Research Program [JC201006010725A]; American Heart Association [0865162F]; National Institutes of Health from NHLBI [R01 HL083188, R01 HL071628, R01 HL052146, R01 HL075187]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071628, R01HL075187, R01HL052146, R01HL083188] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Shenzhen Overseas High Level Talents Innovation Program; Shenzhen Municipal Basic Research Program; American Heart Association(American Heart Association); National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China Grant 81170047 (to D. G.), National Basic Research Program of China 973 Program Grant 2012CB124701, Shenzhen Overseas High Level Talents Innovation Program Grant YFZZ20111009 (to D. G.), Shenzhen Municipal Basic Research Program Grant JC201006010725A (to D. G.), American Heart Association Grant-in-aid 0865162F (to D. G.), and National Institutes of Health Grants R01 HL083188, R01 HL071628, and R01 HL052146 (to L. L.) and R01 HL075187 (to J. U. R.) from NHLBI.	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Baroukh NN, 2009, FEBS J, V276, P6509, DOI 10.1111/j.1742-4658.2009.07353.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bierer R, 2011, AM J PHYSIOL-LUNG C, V301, pL872, DOI 10.1152/ajplung.00405.2010; Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104; Catuogno S, 2013, ONCOGENE, V32, P341, DOI 10.1038/onc.2012.51; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cho SC, 2005, MOL CELL BIOL, V25, P1283, DOI 10.1128/MCB.25.4.1283-1297.2005; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; Finkler A, 2007, FEBS LETT, V581, P3893, DOI 10.1016/j.febslet.2007.07.051; Franco M, 2006, MOL CELL BIOL, V26, P1932, DOI 10.1128/MCB.26.5.1932-1947.2006; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; Gou DM, 2012, AM J PHYSIOL-LUNG C, V303, pL682, DOI 10.1152/ajplung.00344.2011; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Laine SK, 2012, J CELL BIOCHEM, V113, P2687, DOI 10.1002/jcb.24144; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Q, 2010, AM J PHYSIOL-HEART C, V298, pH1340, DOI 10.1152/ajpheart.00592.2009; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Lindenblatt C, 2009, CELL CYCLE, V8, P2019, DOI 10.4161/cc.8.13.8816; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Martin SE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm141; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nde PN, 2006, INFECT IMMUN, V74, P1643, DOI 10.1128/IAI.74.3.1643-1648.2006; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Qiao LP, 2006, ENDOCRINOLOGY, V147, P3060, DOI 10.1210/en.2005-1507; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Rubin Lewis J, 2006, Proc Am Thorac Soc, V3, P111, DOI 10.1513/pats.200510-112JH; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smith P, 2011, J NEUROCHEM, V116, P240, DOI 10.1111/j.1471-4159.2010.07097.x; Thompson J, 2006, EMBO J, V25, P2757, DOI 10.1038/sj.emboj.7601161; Venkatesh N, 2004, P NATL ACAD SCI USA, V101, P8969, DOI 10.1073/pnas.0402803101; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-123; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Weitzel RP, 2009, BLOOD, V113, P6648, DOI 10.1182/blood-2008-09-181156; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	60	89	101	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25414	25427		10.1074/jbc.M113.460287	http://dx.doi.org/10.1074/jbc.M113.460287			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23853098	hybrid, Green Published			2022-12-25	WOS:000330619000038
J	Shakespear, MR; Hohenhaus, DM; Kelly, GM; Kamal, NA; Gupta, P; Labzin, LI; Schroder, K; Garceau, V; Barbero, S; Iyer, A; Hume, DA; Reid, RC; Irvine, KM; Fairlie, DP; Sweet, MJ				Shakespear, Melanie R.; Hohenhaus, Daniel M.; Kelly, Greg M.; Kamal, Nabilah A.; Gupta, Praveer; Labzin, Larisa I.; Schroder, Kate; Garceau, Valerie; Barbero, Sheila; Iyer, Abishek; Hume, David A.; Reid, Robert C.; Irvine, Katharine M.; Fairlie, David P.; Sweet, Matthew J.			Histone Deacetylase 7 Promotes Toll-like Receptor 4-dependent Proinflammatory Gene Expression in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INNATE IMMUNE-RESPONSES; IN-VIVO; SYSTEMIC INFLAMMATION; TRANSCRIPTION FACTOR; CELL-FUNCTION; INHIBITORS; ACTIVATION; LIPOPOLYSACCHARIDE; PROTEIN	Broad-spectrum inhibitors of histone deacetylases (HDACs) constrain Toll-like receptor (TLR)-inducible production of key proinflammatory mediators. Here we investigated HDAC-dependent inflammatory responses in mouse macrophages. Of the classical Hdacs, Hdac7 was expressed at elevated levels in inflammatory macrophages (thioglycollate-elicited peritoneal macrophages) as compared with bone marrow-derived macrophages and the RAW264 cell line. Overexpression of a specific, alternatively spliced isoform of Hdac7 lacking the N-terminal 22 amino acids (Hdac7-u), but not the Refseq Hdac7 (Hdac7-s), promoted LPS-inducible expression of Hdac-dependent genes (Edn1, Il-12p40, and Il-6) in RAW264 cells. A novel class IIa-selective HDAC inhibitor reduced recombinant human HDAC7 enzyme activity as well as TLR-induced production of inflammatory mediators in thioglycollate-elicited peritoneal macrophages. Both LPS and Hdac7-u up-regulated the activity of the Edn1 promoter in an HDAC-dependent fashion in RAW264 cells. Ahypoxia-inducible factor (HIF) 1 binding site in this promoter was required for HDAC-dependent TLR-inducible promoter activity and for Hdac7-and HIF-1 alpha-mediated transactivation. Coimmunoprecipitation assays showed that both Hdac7-u and Hdac7-s interacted with HIF-1 alpha, whereas only Hdac7-s interacted with the transcriptional repressor CtBP1. Thus, Hdac7-u positively regulates HIF-1 alpha-dependent TLR signaling in macrophages, whereas an interaction with CtBP1 likely prevents Hdac7-s from exerting this effect. Hdac7 may represent a potential inflammatory disease target.	[Shakespear, Melanie R.; Hohenhaus, Daniel M.; Kelly, Greg M.; Kamal, Nabilah A.; Gupta, Praveer; Labzin, Larisa I.; Schroder, Kate; Barbero, Sheila; Iyer, Abishek; Reid, Robert C.; Irvine, Katharine M.; Fairlie, David P.; Sweet, Matthew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Shakespear, Melanie R.; Hohenhaus, Daniel M.; Kelly, Greg M.; Kamal, Nabilah A.; Gupta, Praveer; Labzin, Larisa I.; Schroder, Kate; Barbero, Sheila; Iyer, Abishek; Reid, Robert C.; Irvine, Katharine M.; Fairlie, David P.; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Garceau, Valerie; Hume, David A.] Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Garceau, Valerie; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland	University of Queensland; University of Queensland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Sweet, MJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	m.sweet@imb.uq.edu.au	Reid, Robert/D-8041-2012; Labzin, Larisa/AAC-8618-2020; Iyer, Abishek/C-9767-2017; Sweet, Matthew J/F-2229-2011; Schroder, Kate/C-6132-2008; Irvine, Katharine M/A-5559-2011; Shakespear, Melanie/G-4867-2014; Fairlie, David P/F-8865-2014	Reid, Robert/0000-0002-0829-239X; Iyer, Abishek/0000-0001-9533-5265; Sweet, Matthew J/0000-0002-0406-8139; Schroder, Kate/0000-0001-9261-3805; Irvine, Katharine M/0000-0002-6716-1605; Shakespear, Melanie/0000-0002-9517-0699; Fairlie, David P/0000-0002-7856-8566; Labzin, Larisa/0000-0001-9098-4493; Hume, David/0000-0002-2615-1478	National Health and Medical Research Council of Australia [569735, APP1047921]; Cancer Council Queensland [511205]; Australian Research Council [FF0668733, FT100100657]; National Health and Medical Research Council [APP1027369, APP1003470]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969] Funding Source: researchfish; BBSRC [BBS/E/D/20251969] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by National Health and Medical Research Council of Australia Grants ID 569735 and APP1047921 and by Cancer Council Queensland Grant ID 511205.; Supported by Australian Research Council Federation Fellowship FF0668733 and National Health and Medical Research Council Senior Principal Research Fellowship APP1027369.; Supported by Australian Research Council Future Fellowship FT100100657 and honorary National Health and Medical Research Council of Australia Senior Research Fellowship APP1003470.	Aude-Garcia C, 2010, BIOCHEM J, V430, P237, DOI 10.1042/BJ20100131; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Barneda-Zahonero B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003503; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Bosisio D, 2008, J LEUKOCYTE BIOL, V84, P1540, DOI 10.1189/jlb.0708401; Brogdon JL, 2007, BLOOD, V109, P1123, DOI 10.1182/blood-2006-04-019711; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dhaun N, 2012, BRIT J PHARMACOL, V167, P720, DOI 10.1111/j.1476-5381.2012.02070.x; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hemmatazad H, 2009, ARTHRITIS RHEUM-US, V60, P1519, DOI 10.1002/art.24494; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066; Higashiyama R, 2010, MOD RHEUMATOL, V20, P11, DOI 10.1007/s10165-009-0224-7; Huang QQ, 2010, J LEUKOCYTE BIOL, V88, P253, DOI 10.1189/jlb.0310126; Iglarz M, 2010, CLIN SCI, V119, P453, DOI 10.1042/CS20100222; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim SH, 2007, ONCOL REP, V17, P647; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lagares D, 2010, ARTHRITIS RHEUM-US, V62, P878, DOI 10.1002/art.27307; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Needham LA, 2011, J PHARMACOL EXP THER, V339, P132, DOI 10.1124/jpet.111.183640; Nencioni A, 2007, CLIN CANCER RES, V13, P3933, DOI 10.1158/1078-0432.CCR-06-2903; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Song W, 2011, LEUKEMIA, V25, P161, DOI 10.1038/leu.2010.244; Stacey KJ, 2003, J IMMUNOL, V170, P3614, DOI 10.4049/jimmunol.170.7.3614; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tessier P, 2009, BIOORG MED CHEM LETT, V19, P5684, DOI 10.1016/j.bmcl.2009.08.010; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200	59	67	71	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25362	25374		10.1074/jbc.M113.496281	http://dx.doi.org/10.1074/jbc.M113.496281			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23853092	Green Published, hybrid			2022-12-25	WOS:000330619000034
J	Petri, A; Pfeil, BE; Oxelman, B				Petri, Anna; Pfeil, Bernard E.; Oxelman, Bengt			Introgressive Hybridization between Anciently Diverged Lineages of Silene (Caryophyllaceae)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GENE; CHLOROPLAST; EVOLUTION; HYBRID; ORIGIN; RETICULATE; SPECIATION; HISTORY; POA	Hybridization has played a major role during the evolution of angiosperms, mediating both gene flow between already distinct species and the formation of new species. Newly formed hybrids between distantly related taxa are often sterile. For this reason, interspecific crosses resulting in fertile hybrids have rarely been described to take place after more than a few million years after divergence. We describe here the traces of a reproductively successful hybrid between two ancestral species of Silene, diverged for about six million years prior to hybridization. No extant hybrids between the two parental lineages are currently known, but introgression of the RNA polymerase gene NRPA2 provides clear evidence of a temporary and fertile hybrid. Parsimony reconciliation between gene trees and the species tree, as well as consideration of clade ages, help exclude gene paralogy and lineage sorting as alternative hypotheses. This may represent one of the most extreme cases of divergence between species prior to introgressive hybridization discovered yet, notably at a homoploid level. Although species boundaries are generally believed to be stable after millions of years of divergence, we believe that this finding may indicate that gene flow between distantly related species is merely largely undetected at present.	[Petri, Anna; Pfeil, Bernard E.; Oxelman, Bengt] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Petri, A (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	anna.petri@bioenv.gu.se	Pfeil, Bernard E/C-1108-2008	Pfeil, Bernard E/0000-0001-8179-2270	Helge Ax:son Johnssons fund; Lundgrenska fund; Swedish Research Council [2006-3766, 2009-5202, 2009-5206]; Royal Swedish Academy of Sciences; Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund	Helge Ax:son Johnssons fund; Lundgrenska fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund	This work was supported by grants from Helge Ax:son Johnssons fund (http://www.haxsonj.se/) and the Lundgrenska fund (http://www.wmlundgren.se/) to AP, and from the Swedish Research Council (www.vr.se) to BO (2006-3766 and 2009-5202). BEP is supported by grants from the Swedish Research Council (2009-5206), the Royal Swedish Academy of Sciences (www.kva.se), Lars Hiertas Minne fund (http://www.larshiertasminne.se/), The Royal Physiographic Society in Lund (http://www.fysiografen.se/), Helge Ax:son Johnsons fund and the Lundgrenska fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Buggs RJA, 2011, TAXON, V60, P324, DOI 10.1002/tax.602003; Cha R S, 1992, PCR Methods Appl, V2, P14; CRANG RE, 1971, B TORREY BOT CLUB, V98, P214, DOI 10.2307/2483687; Doyle JJ, 2010, NEW PHYTOL, V186, P73, DOI 10.1111/j.1469-8137.2009.03118.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edmands S, 2002, TRENDS ECOL EVOL, V17, P520, DOI 10.1016/S0169-5347(02)02585-5; Erixon P, 2008, MOL PHYLOGENET EVOL, V48, P313, DOI 10.1016/j.ympev.2008.04.015; Frajman B, 2009, TAXON, V58, P811, DOI 10.1002/tax.583010; Ghatnekar L, 2006, P ROY SOC B-BIOL SCI, V273, P395, DOI 10.1098/rspb.2005.3355; HOLMGREN PK, 1990, INDEX HERBARIORUM 1, V120; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jenkins C, 2011, BIOL INVASIONS, V13, P1471, DOI 10.1007/s10530-010-9907-4; Joly S, 2009, MOL PHYLOGENET EVOL, V51, P365, DOI 10.1016/j.ympev.2009.02.015; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kronforst MR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-98; KRUCKEBERG AR, 1955, AM J BOT, V42, P373, DOI 10.2307/2438743; KRUCKEBERG ARTHUR. R., 1962, BRITTONIA, V14, P311, DOI 10.2307/2805248; Maureira-Butler IJ, 2008, SYST BIOL, V57, P466, DOI 10.1080/10635150802172168; Minder AM, 2007, MOL ECOL, V16, P2504, DOI 10.1111/j.1365-294X.2007.03292.x; Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459; Nylander J.A.A, 2004, MRMODELTEST 2 3 PROG; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oxelman B, 2000, NORD J BOT, V20, P743, DOI 10.1111/j.1756-1051.2000.tb00760.x; Oxelman B, 2011, ONWARDS SILENEAE TAX; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; Paun O, 2009, NEW PHYTOL, V182, P507, DOI 10.1111/j.1469-8137.2009.02767.x; Petri A, 2011, TAXON, V60, P953, DOI 10.1002/tax.604002; Popp M, 2005, SYST BOT, V30, P302, DOI 10.1600/0363644054223648; Popp M, 2004, SYST BIOL, V53, P914, DOI 10.1080/10635150490888840; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Popp M, 2007, AM J BOT, V94, P330, DOI 10.3732/ajb.94.3.330; Rambaut A, 2009, TRACER V1 5 0; Rambaut A, 2001, PHYLOGENETIC TREE; Rambaut A, 2002, SE AL SEQUENCE ALIGN; Rautenberg A, 2012, SYST BOT, V37, P226, DOI 10.1600/036364412X616792; Rautenberg A, 2010, MOL PHYLOGENET EVOL, V57, P978, DOI 10.1016/j.ympev.2010.08.003; Rautenberg A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-299; Suchard MA, 2003, J AM STAT ASSOC, V98, P427, DOI 10.1198/016214503000215; Swofford DL, 2002, PHYLOGENETIC ANAL US; Vallenback P, 2008, MOL PHYLOGENET EVOL, V46, P890, DOI 10.1016/j.ympev.2007.11.031; Vallenback P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013529	47	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67729	10.1371/journal.pone.0067729	http://dx.doi.org/10.1371/journal.pone.0067729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861793	Green Submitted, Green Published, gold			2022-12-25	WOS:000321692000012
J	Zhang, W; Li, R; Li, J; Wang, WQ; Tie, R; Tian, F; Liang, XY; Xing, WJ; He, Y; Yu, L; Xi, MM; Wang, SW; Zheng, QS; Zhang, HF				Zhang, Wei; Li, Rong; Li, Jia; Wang, Wenqing; Tie, Ru; Tian, Fei; Liang, Xiangyan; Xing, Wenjuan; He, Yong; Yu, Liang; Xi, Miaomiao; Wang, Siwang; Zheng, Qiangsun; Zhang, Haifeng			Alpha-Linolenic Acid Exerts an Endothelial Protective Effect against High Glucose Injury via PI3K/Akt Pathway	PLOS ONE			English	Article							INDUCED DIABETIC-RATS; POLYUNSATURATED FATTY-ACIDS; CARDIOVASCULAR RISK-FACTORS; ADHESION MOLECULES; MYOCARDIAL ISCHEMIA/REPERFUSION; INSULIN-RESISTANCE; INDUCED APOPTOSIS; CULTURED HUMAN; B PATHWAY; KAPPA-B	Mounting evidence has indicated that the cardiovascular protective effects of dietary alpha-linolenic acid (ALA), but whether ALA exerts an endothelial protective effect against high glucose injury and the underlying mechanisms remain largely unknown. Streptozocin-induced diabetic rats were randomized treated orally for 4 weeks with vehicle (0.01% alcohol) or ALA (500 mu g/kg per day by gavage). Human umbilical vein endothelial cells (HUVECs) were exposed to high glucose (28 mmol/L) stimulation for 48 hours. ALA significantly improved concentration-dependent vasorelaxation to ACh in diabetic aortic segments and inhibited endothelial inflammation as evidenced by decreased soluble P-selectin and intercellular adhesion molecule-1 (ICAM-1) in diabetic rats. Furthermore, both P-selectin and ICAM-1 expression were increased significantly in high glucose-induced HUVECs, resulting in enhanced neutrophils adhesion to HUVECs compared with normal glucose group. Treatment with ALA (50 mmol/L) increased Akt phosphorylation, attenuated P-selectin and ICAM-1 expressions and thus inhibited neutrophils adhesion in HUVECs exposed to high glucose, all of which was blocked by the PI3K inhibitors LY294002 and wortmannin. These data indicates that ALA inhibits endothelial inflammation and improved endothelial function in STZ-induced diabetic rats. The anti-adhesive effect of ALA against high glucose injury may partially be mediated by the PI3K/Akt pathway.	[Zhang, Wei; He, Yong; Yu, Liang; Zheng, Qiangsun] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Zhang, Wei; Tie, Ru; Tian, Fei; Liang, Xiangyan; Zhang, Haifeng] Fourth Mil Med Univ, Expt Teaching Ctr, Xian 710032, Peoples R China; [Li, Rong] Fourth Mil Med Univ, Xijing Hosp, Dept Geratol, Xian 710032, Peoples R China; [Li, Jia; Xing, Wenjuan] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [Wang, Wenqing] Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710032, Peoples R China; [Xi, Miaomiao] Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Peoples R China; [Wang, Siwang] Fourth Mil Med Univ, Pharmaceut Res Inst, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zheng, QS (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China.	tdxznk01@hotmail.com; hfzhang@fmmu.edu.cn		Zhang, Haifeng/0000-0003-1938-3796; Wang, Siwang/0000-0003-1888-4716	National Natural Science Foundation of China (NSFC) [81100083, 81270330, 81270401]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (NSFC numbers 81100083, 81270330 and 81270401) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2005, CIRCULATION, V112, P3232, DOI 10.1161/CIRCULATIONAHA.105.572008; Blann AD, 2000, J CLIN ENDOCR METAB, V85, P1745, DOI 10.1210/jc.85.5.1745; CALVER A, 1992, J CLIN INVEST, V90, P2548, DOI 10.1172/JCI116149; Chen HJ, 2003, J MOL CELL CARDIOL, V35, P769, DOI 10.1016/S0022-2828(03)00120-2; Djousse L, 2005, CIRCULATION, V111, P2921, DOI 10.1161/CIRCULATIONAHA.104.489534; Finnegan YE, 2003, AM J CLIN NUTR, V77, P783, DOI 10.1093/ajcn/77.4.783; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Grover-Paez F, 2009, DIABETES RES CLIN PR, V84, P1, DOI 10.1016/j.diabres.2008.12.013; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Hong HK, 2003, DIABETES RES CLIN PR, V62, P1, DOI 10.1016/S0168-8227(03)00142-6; Horani MH, 2006, NUTRITION, V22, P123, DOI 10.1016/j.nut.2005.05.012; JOHNSTONE MT, 1993, CIRCULATION, V88, P2510, DOI 10.1161/01.CIR.88.6.2510; Li J, 2009, J MOL CELL CARDIOL, V47, P512, DOI 10.1016/j.yjmcc.2009.07.010; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Matsumoto K, 2002, DIABETES RES CLIN PR, V55, P131, DOI 10.1016/S0168-8227(01)00296-0; McEwen B, 2010, DIABETES EDUCATOR, V36, P565, DOI 10.1177/0145721710372675; Omi H, 2002, J DIABETES COMPLICAT, V16, P201, DOI 10.1016/S1056-8727(01)00163-5; Ottonello L, 2009, BRIT J PHARMACOL, V157, P294, DOI 10.1111/j.1476-5381.2009.00162.x; Rodriguez-Manas L, 1998, BRIT J PHARMACOL, V123, P1495, DOI 10.1038/sj.bjp.0701749; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Song YQ, 2007, DIABETES, V56, P1898, DOI 10.2337/db07-0250; Toborek M, 2002, AM J CLIN NUTR, V75, P119, DOI 10.1093/ajcn/75.1.119; Vallejo S, 2000, J DIABETES COMPLICAT, V14, P224, DOI 10.1016/S1056-8727(00)00079-9; Xie NL, 2011, ARCH MED RES, V42, P171, DOI 10.1016/j.arcmed.2011.04.008; Xing WJ, 2013, HYPERTENSION, V61, P1028, DOI 10.1161/HYPERTENSIONAHA.111.00728; Zhang W, 2007, NUTRITION, V23, P762, DOI 10.1016/j.nut.2007.07.003; Zhang XH, 2010, BRIT J PHARMACOL, V159, P928, DOI 10.1111/j.1476-5381.2009.00594.x; Zhao GX, 2007, AM J CLIN NUTR, V85, P385, DOI 10.1093/ajcn/85.2.385; Zhao GX, 2004, J NUTR, V134, P2991, DOI 10.1093/jn/134.11.2991; Zhao GX, 2005, BIOCHEM BIOPH RES CO, V336, P909, DOI 10.1016/j.bbrc.2005.08.204	31	18	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68489	10.1371/journal.pone.0068489	http://dx.doi.org/10.1371/journal.pone.0068489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861910	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300064
J	Farar, V; Hrabovska, A; Krejci, E; Myslivecek, J				Farar, Vladimir; Hrabovska, Anna; Krejci, Eric; Myslivecek, Jaromir			Developmental Adaptation of Central Nervous System to Extremely High Acetylcholine Levels	PLOS ONE			English	Article							CHOLINE-ACETYLTRANSFERASE; POSTNATAL-DEVELOPMENT; BUTYRYLCHOLINESTERASE ACTIVITY; MUSCARINIC RECEPTORS; MEMBRANE ANCHOR; DEFICIENT MICE; MOUSE-BRAIN; RAT-BRAIN; IN-VIVO; PROTEIN	Acetylcholinesterase (AChE) is a key enzyme in termination of fast cholinergic transmission. In brain, acetylcholine (ACh) is produced by cholinergic neurons and released in extracellular space where it is cleaved by AChE anchored by protein PRiMA. Recently, we showed that the lack of AChE in brain of PRiMA knock-out (KO) mouse increased ACh levels 200-300 times. The PRiMA KO mice adapt nearly completely by the reduction of muscarinic receptor (MR) density. Here we investigated changes in MR density, AChE, butyrylcholinesterase (BChE) activity in brain in order to determine developmental period responsible for such adaptation. Brains were studied at embryonal day 18.5 and postnatal days (pd) 0, 9, 30, 120, and 425. We found that the AChE activity in PRiMA KO mice remained very low at all studied ages while in wild type (WT) mice it gradually increased till pd120. BChE activity in WT mice gradually decreased until pd9 and then increased by pd120, it continually decreased in KO mice till pd30 and remained unchanged thereafter. MR number increased in WT mice till pd120 and then became stable. Similarly, MR increased in PRiMA KO mice till pd30 and then remained stable, but the maximal level reached is approximately 50% of WT mice. Therefore, we provide the evidence that adaptive changes in MR happen up to pd30. This is new phenomenon that could contribute to the explanation of survival and nearly unchanged phenotype of PRiMA KO mice.	[Farar, Vladimir; Myslivecek, Jaromir] Charles Univ Prague, Inst Physiol, Fac Med 1, Prague, Czech Republic; [Farar, Vladimir; Krejci, Eric] Univ Paris 05, Ctr Etud Sensorimotricite, CNRS, UMR 8194, Paris, France; [Hrabovska, Anna] Comenius Univ, Fac Pharm, Dept Pharmacol & Toxicol, Bratislava, Slovakia	Charles University Prague; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Comenius University Bratislava	Myslivecek, J (corresponding author), Charles Univ Prague, Inst Physiol, Fac Med 1, Prague, Czech Republic.	jmys@lf1.cuni.cz	Myslivecek, Jaromir/A-1078-2008; Hrabovska, Anna/ABE-8931-2020; Farar, Vladimir/J-1581-2017	Myslivecek, Jaromir/0000-0002-4275-4607; Farar, Vladimir/0000-0003-0158-4645; Krejci, Eric/0000-0001-8564-0290	Grant Agency of Charles University [GAUK480613]	Grant Agency of Charles University	This work was supported by Grant GAUK480613 from Grant Agency of Charles University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Aosaki T, 2010, GERIATR GERONTOL INT, V10, pS148, DOI 10.1111/j.1447-0594.2010.00588.x; Aznavour N, 2005, J COMP NEUROL, V486, P61, DOI 10.1002/cne.20501; Bajgar J, 2008, CHEM-BIOL INTERACT, V175, P281, DOI 10.1016/j.cbi.2008.05.015; Bazalakova MH, 2006, HANDB EXP PHARM, V175, P525; Bernard W, 2006, TRENDS NEUROSCI, V29, P140, DOI 10.1016/j.tins.2006.01.006; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Bullock R, 2007, CURR ALZHEIMER RES, V4, P277; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; Dobbertin A, 2009, J NEUROSCI, V29, P4519, DOI 10.1523/JNEUROSCI.3863-08.2009; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Farar V, 2012, J NEUROCHEM, V122, P1065, DOI 10.1111/j.1471-4159.2012.07856.x; FIEDLER EP, 1987, J NEUROCHEM, V49, P983, DOI 10.1111/j.1471-4159.1987.tb00990.x; Geula C, 2007, EXP NEUROL, V204, P640, DOI 10.1016/j.expneurol.2006.12.015; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; Holler T, 1996, NEUROSCI LETT, V212, P107, DOI 10.1016/0304-3940(96)12808-1; Hut RA, 2011, BEHAV BRAIN RES, V221, P466, DOI 10.1016/j.bbr.2010.11.039; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; LAMMERDINGKOPPEL M, 1995, HISTOCHEM CELL BIOL, V103, P301, DOI 10.1007/BF01457415; Lassiter TL, 1998, DEV BRAIN RES, V105, P109, DOI 10.1016/S0165-3806(97)00177-6; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Marks MJ, 2010, J MOL NEUROSCI, V40, P96, DOI 10.1007/s12031-009-9264-x; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; Maxwell DM, 2006, ARCH TOXICOL, V80, P756, DOI 10.1007/s00204-006-0120-2; Mechawar N, 2001, NEUROSCIENCE, V108, P555, DOI 10.1016/S0306-4522(01)00389-X; Mesulam MM, 2002, NEUROSCIENCE, V110, P627, DOI 10.1016/S0306-4522(01)00613-3; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Moreno RD, 1998, INT J DEV NEUROSCI, V16, P123, DOI 10.1016/S0736-5748(98)00008-2; Mrvova K, 2012, CHEMICOBIOLOGICAL IN, V203, P348; Myslivecek J, 2007, N-S ARCH PHARMACOL, V376, P83, DOI 10.1007/s00210-007-0184-4; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; SAWYER TW, 1993, DEV BRAIN RES, V71, P147, DOI 10.1016/0165-3806(93)90115-Q; Svedberg MM, 2003, NEUROSCI LETT, V340, P148, DOI 10.1016/S0304-3940(03)00092-2; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Williams MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1779, DOI 10.1038/sj.npp.1301585; Xie HDQ, 2010, CHEM-BIOL INTERACT, V187, P78, DOI 10.1016/j.cbi.2010.02.018; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896; Yamada N, 2011, J APPL TOXICOLOGY; Zheng Q, 2000, TOXICOL SCI, V55, P124, DOI 10.1093/toxsci/55.1.124	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68265	10.1371/journal.pone.0068265	http://dx.doi.org/10.1371/journal.pone.0068265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861875	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700076
J	Intawicha, P; Wang, SH; Hsieh, YC; Lo, NW; Lee, KH; Huang, SY; Ju, JC				Intawicha, Payungsuk; Wang, Shih-Han; Hsieh, Ya-Chen; Lo, Neng-Wen; Lee, Kun-Hsiung; Huang, San-Yuan; Ju, Jyh-Cherng			Proteomic Profiling of Rabbit Embryonic Stem Cells Derived from Parthenotes and Fertilized Embryos	PLOS ONE			English	Article							EARLY-STAGE DIFFERENTIATION; LEUKEMIA INHIBITORY FACTOR; CYTOPLASMIC CHAPERONIN; IN-VITRO; MOUSE; PROTEINS; TUBULIN; IDENTIFICATION; PEROXIREDOXIN; EXPRESSION	Rabbit embryonic stem (rES) cells can be derived from various sources of embryos. However, understanding of the gene expression profile, which distincts embryonic stem (ES) cells from other cell types, is still extremely limited. In this study, we compared the protein profiles of three independent lines of rabbit cells, i.e., fibroblasts, fertilized embryo-derived stem (f-rES) cells, and parthenote-derived ES (p-rES) cells. Proteomic analyses were performed using two-dimensional gel electrophoresis (2-DE) and mass spectrometry. Collectively, the expression levels of 100 out of 284 protein spots differed significantly among these three cell types (p < 0.05). Of those differentially expressed spots, 91% were identified in the protein database and represented 63 distinct proteins. Proteins with known identities are mainly localized in the cytoplasmic compartments (48%), nucleus (14%), and cytoskeletal machineries (13%). These proteins were majorly involved in biological functions of energy and metabolic pathways (25%), cell growth and maintenance (25%), signal transduction (14%), and protein metabolisms (10%). When protein expression levels among cell types were compared, six proteins associated with a variety of cellular activities, including structural constituents of the cytoskeleton (tubulins), structural molecule (KRT8), catalytic molecules (alpha-enolase), receptor complex scaffold (14-3-3 protein sigma), microfilament motor proteins (Myosin-9), and heat shock protein (HSP60), were found highly expressed in p-rES cells. Two proteins related to HSP activity and structural constituent of cytoskeleton in f-rES cells, and one structural molecule activity protein in fibroblasts showed significantly higher expression levels (p < 0.05). Marker protein expressions in f-rES and p-rES cells were further confirmed by Western blotting and immunocytochemical staining. This study demonstrated unique proteomic profiles of the three rabbit cell types and revealed some novel proteins differentially expressed between f-rES and p-rES cells. These analyses provide insights into rES cell biology and would invite more in-depth studies toward rES cell applications.	[Intawicha, Payungsuk; Wang, Shih-Han; Hsieh, Ya-Chen; Huang, San-Yuan; Ju, Jyh-Cherng] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Lo, Neng-Wen] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan; [Lee, Kun-Hsiung; Huang, San-Yuan] Anim Technol Inst Taiwan, Div Biotechnol, Miaoli, Taiwan; [Huang, San-Yuan; Ju, Jyh-Cherng] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Nanosci & Nanotechnol, Taichung 40227, Taiwan	National Chung Hsing University; Tunghai University; National Chung Hsing University; National Chung Hsing University	Huang, SY (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.	syhuang@dragon.nchu.edu.tw; jcju@dragon.nchu.edu.tw	Wang, Shih-Han/HGA-7092-2022		National Science Council (NSC) [96-2313-B-005-013, 98-2628-B005-019-MY3, 101-2313-B-005 -013 -MY3]; Executive Yuan; Ministry of Education, Taiwan, Republic of China, under the ATU plan	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Executive Yuan; Ministry of Education, Taiwan, Republic of China, under the ATU plan	This study was supported in part by grants from National Science Council (NSC# 96-2313-B-005-013, NSC# 98-2628-B005-019-MY3, and NSC# 101-2313-B-005 -013 -MY3), Executive Yuan and the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama K, 2008, BBA-PROTEINS PROTEOM, V1784, P773, DOI 10.1016/j.bbapap.2008.02.001; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Catunda AP, 2008, CLONING STEM CELLS, V10, P523, DOI 10.1089/clo.2008.0023; Andre N, 2006, CANCER TREAT REV, V32, P65, DOI 10.1016/j.ctrv.2005.12.010; Arner A, 2003, J MUSCLE RES CELL M, V24, P165, DOI 10.1023/A:1026001513928; Arrigo AP, 1998, BIOL CHEM, V379, P19; Attard G, 2006, PATHOL BIOL, V54, P72, DOI 10.1016/j.patbio.2005.03.003; Baharvand H, 2008, J PROTEOME RES, V7, P412, DOI 10.1021/pr700560t; Bouwens L, 1998, J PATHOL, V184, P234; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chiang SK, 2008, REPROD DOMEST ANIM, V43, P181, DOI 10.1111/j.1439-0531.2007.00875.x; Di Quinzio MKW, 2007, AUST NZ J OBSTET GYN, V47, P9, DOI 10.1111/j.1479-828X.2006.00671.x; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; FUNDELE RH, 1990, DEVELOPMENT, V108, P203; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gong SP, 2008, STEM CELLS DEV, V17, P695, DOI 10.1089/scd.2007.0168; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; GRAVES KH, 1993, MOL REPROD DEV, V36, P424, DOI 10.1002/mrd.1080360404; Guo XX, 2001, ELECTROPHORESIS, V22, P3067, DOI 10.1002/1522-2683(200108)22:14<3067::AID-ELPS3067>3.0.CO;2-V; Gupta MK, 2009, PROTEOMICS, V9, P2846, DOI 10.1002/pmic.200800700; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; Honda A, 2008, REPROD BIOMED ONLINE, V17, P706, DOI 10.1016/S1472-6483(10)60320-3; Hsieh YC, 2011, CELL REPROGRAM, V13, P241, DOI 10.1089/cell.2010.0097; Huang SY, 2006, PROTEOMICS, V6, P5815, DOI 10.1002/pmic.200600054; Huang SY, 2005, PROTEOMICS, V5, P4205, DOI 10.1002/pmic.200401284; Intawicha P, 2009, CLONING STEM CELLS, V11, P27, DOI 10.1089/clo.2008.0040; Jadaliha M, 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0038532.ACCESSED; Jang JH, 2012, ANTIOXID REDOX SIGN, V16, P383, DOI 10.1089/ars.2011.4134; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Kim SH, 2001, J NEURAL TRANSM-SUPP, P223; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kubo E, 2009, LIFE SCI, V84, P857, DOI 10.1016/j.lfs.2009.03.019; Lee Yu-Il, 2011, Clin Exp Reprod Med, V38, P18, DOI 10.5653/cerm.2011.38.1.18; Leyens G, 2003, COMP BIOCHEM PHYS B, V136, P943, DOI 10.1016/S1096-4959(03)00290-2; Li JY, 2003, CELL RES, V13, P219, DOI 10.1038/sj.cr.7290167; Li Y, 2009, ELECTROPHORESIS, V30, P1431, DOI 10.1002/elps.200800836; Longshaw VM, 2009, EUR J CELL BIOL, V88, P153, DOI 10.1016/j.ejcb.2008.09.003; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Nasrabadi D, 2009, J PROTEOME RES, V8, P1527, DOI 10.1021/pr800880v; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; O'Flaherty C, 2011, BIOL REPROD, V84, P238, DOI 10.1095/biolreprod.110.085712; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Pasquier E, 2008, IUBMB LIFE, V60, P165, DOI 10.1002/iub.25; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prescott J, 2006, CANCER LETT, V231, P12, DOI 10.1016/j.canlet.2004.12.037; Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101; ROOBOL A, 1995, J CELL SCI, V108, P1477; SAS Institute Statistical Analysis System (SAS), 2002, US GUID STAT REL; Sato N, 2003, BIOCHEM BIOPH RES CO, V300, P847, DOI 10.1016/S0006-291X(02)02941-8; Schoonjans L, 1996, MOL REPROD DEV, V45, P439, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;439::AID-MRD5&gt;3.0.CO;2-S; Setati MM, 2010, IUBMB LIFE, V62, P61, DOI 10.1002/iub.283; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Stephanou A, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/238601; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Wang DJ, 2005, PROTEOMICS, V5, P4414, DOI 10.1002/pmic.200401304; Wang SE, 2010, ANAT REC, V293, P291, DOI 10.1002/ar.21031; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; Wen JY, 2007, J CELL BIOCHEM, V102, P149, DOI 10.1002/jcb.21285; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williamson AJK, 2008, MOL CELL PROTEOMICS, V7, P459, DOI 10.1074/mcp.M700370-MCP200; Xue F, 2012, CELL REPROGRAM, V14, P364, DOI 10.1089/cell.2012.0001; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yokota S, 1999, J BIOL CHEM, V274, P37070, DOI 10.1074/jbc.274.52.37070	70	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67772	10.1371/journal.pone.0067772	http://dx.doi.org/10.1371/journal.pone.0067772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861804	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700035
J	Pereira, CAP; Marra, AR; Camargo, LFA; Pignatari, ACC; Sukiennik, T; Behar, PRP; Medeiros, EAS; Ribeiro, J; Girao, E; Correa, L; Guerra, C; Carneiro, I; Brites, C; Reis, M; de Souza, MA; Tranchesi, R; Barata, CU; Edmond, MB				Pires Pereira, Carlos Alberto; Marra, Alexandre R.; Aranha Camargo, Luis Fernando; Campos Pignatari, Antonio Carlos; Sukiennik, Teresa; Petersen Behar, Paulo Renato; Servolo Medeiros, Eduardo Alexandrino; Ribeiro, Julival; Girao, Evelyne; Correa, Luci; Guerra, Carla; Carneiro, Irna; Brites, Carlos; Reis, Marise; de Souza, Marta Antunes; Tranchesi, Regina; Barata, Cristina U.; Edmond, Michael B.		Brazilian SCOPE Study Grp	Nosocomial Bloodstream Infections in Brazilian Pediatric Patients: Microbiology, Epidemiology, and Clinical Features	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PCR ASSAY; HOSPITALS; SURVEILLANCE; COLISTIN; UPDATE	Background: Nosocomial bloodstream infections (nBSIs) are an important cause of morbidity and mortality and are the most frequent type of nosocomial infection in pediatric patients. Methods: We identified the predominant pathogens and antimicrobial susceptibilities of nosocomial bloodstream isolates in pediatric patients (<= 16 years of age) in the Brazilian Prospective Surveillance for nBSIs at 16 hospitals from 12 June 2007 to 31 March 2010 (Br SCOPE project). Results: In our study a total of 2,563 cases of nBSI were reported by hospitals participating in the Br SCOPE project. Among these, 342 clinically significant episodes of BSI were identified in pediatric patients (<= 16 years of age). Ninety-six percent of BSIs were monomicrobial. Gram-negative organisms caused 49.0% of these BSIs, Gram-positive organisms caused 42.6%, and fungi caused 8.4%. The most common pathogens were Coagulase-negative staphylococci (CoNS) (21.3%), Klebsiella spp. (15.7%), Staphylococcus aureus (10.6%), and Acinetobacter spp. (9.2%). The crude mortality was 21.6% (74 of 342). Forty-five percent of nBSIs occurred in a pediatric or neonatal intensive-care unit (ICU). The most frequent underlying conditions were malignancy, in 95 patients (27.8%). Among the potential factors predisposing patients to BSI, central venous catheters were the most frequent (66.4%). Methicillin resistance was detected in 37 S. aureus isolates (27.1%). Of the Klebsiella spp. isolates, 43.2% were resistant to ceftriaxone. Of the Acinetobacter spp. and Pseudomonas aeruginosa isolates, 42.9% and 21.4%, respectively, were resistant to imipenem. Conclusions: In our multicenter study, we found a high mortality and a large proportion of gram-negative bacilli with elevated levels of resistance in pediatric patients.	[Pires Pereira, Carlos Alberto] Inst Oncol Pediat IOP GRAAC, Sao Paulo, Brazil; [Marra, Alexandre R.; Aranha Camargo, Luis Fernando; Correa, Luci] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Marra, Alexandre R.; Aranha Camargo, Luis Fernando; Campos Pignatari, Antonio Carlos; Servolo Medeiros, Eduardo Alexandrino] Univ Fed Sao Paulo UNIFESP, Sao Paulo, Brazil; [Campos Pignatari, Antonio Carlos; Tranchesi, Regina] Hosp 9 Julho, Sao Paulo, Brazil; [Sukiennik, Teresa] Santa Casa Porto Alegre, Porto Alegre, RS, Brazil; [Petersen Behar, Paulo Renato] Hosp Conceicao, Porto Alegre, RS, Brazil; [Ribeiro, Julival] Hosp Base, Brasilia, DF, Brazil; [Girao, Evelyne] Hosp Walter Cantidio, Fortaleza, Ceara, Brazil; [Guerra, Carla] Hosp Diadema, Sao Paulo, Brazil; [Brites, Carlos] Hosp Espanhol, Salvador, BA, Brazil; [Reis, Marise] Hosp Coracao, Natal, RN, Brazil; [Reis, Marise] Hosp UNIMED, Natal, RN, Brazil; [de Souza, Marta Antunes] Hosp Clin Goiania, Goiania, Go, Brazil; [Correa, Luci] Hosp Rim & Hipertensao, Sao Paulo, Brazil; [Barata, Cristina U.] Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil; [Edmond, Michael B.] Virginia Commonwealth Univ, Richmond, VA USA	Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP); Hospital do Coracao - HCor; Universidade Federal do Triangulo Mineiro; Virginia Commonwealth University	Marra, AR (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, Brazil.	alexandre.marra@einstein.br	Brites, Carlos/D-1353-2013; Faria, Carolina Pereira de Morais/HHT-0142-2022; Pignatari, Antonio CC/C-8427-2012; Medeiros, Eduardo Alexandrino/B-9825-2012	Brites, Carlos/0000-0002-4673-6991; Medeiros, Eduardo Alexandrino/0000-0002-6205-259X; Edmond, Michael/0000-0002-4144-8974; Camargo, Luis Fernando Aranha/0000-0002-3888-8661; Pignatari, Antonio/0000-0002-2146-8476	Pfizer, Inc.; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brasil [2006/57700-0]	Pfizer, Inc.(Pfizer); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brasil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was funded in part by an independent medical grant provided by Pfizer, Inc. We also thank the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brasil (grant 2006/57700-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariffin N, 2012, AM J INFECT CONTROL, V40, P572, DOI 10.1016/j.ajic.2012.02.032; Becerra MR, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-66; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Deshpande LM, 2006, MICROB DRUG RESIST, V12, P223, DOI 10.1089/mdr.2006.12.223; Elward AM, 2005, PEDIATRICS, V115, P868, DOI 10.1542/peds.2004-0256; Grisaru-Soen G, 2007, MED SCI MONITOR, V13, pCR251; Isaacs D, 2003, ARCH DIS CHILD-FETAL, V88, pF89, DOI 10.1136/fn.88.2.F89; Jean-Baptiste N, 2011, INFECT CONT HOSP EP, V32, P679, DOI 10.1086/660361; Joram N, 2012, EUR J CLIN MICROBIOL; Levin AS, 1999, CLIN INFECT DIS, V28, P1008, DOI 10.1086/514732; Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11; Mendes RE, 2007, J CLIN MICROBIOL, V45, P544, DOI 10.1128/JCM.01728-06; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Monteiro J, 2009, ANTIMICROB AGENTS CH, V53, P333, DOI 10.1128/AAC.00736-08; Paul M, 2010, J ANTIMICROB CHEMOTH, V65, P1019, DOI 10.1093/jac/dkq069; Slonim Anthony D., 2001, Pediatr Crit Care Med, V2, P170, DOI 10.1097/00130478-200104000-00012; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	21	34	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68144	10.1371/journal.pone.0068144	http://dx.doi.org/10.1371/journal.pone.0068144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861860	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700072
J	Aizenberg-Gershtein, Y; Izhaki, I; Halpern, M				Aizenberg-Gershtein, Yana; Izhaki, Ido; Halpern, Malka			Do Honeybees Shape the Bacterial Community Composition in Floral Nectar?	PLOS ONE			English	Article							FLOWER CONSTANCY; GUT BACTERIA; YEASTS; DIVERSITY; IDENTIFICATION; VARIABILITY; POPULATIONS; PROKARYOTES; ECOLOGY; PLANTS	Floral nectar is considered the most important reward animal-pollinated plants offer to attract pollinators. Here we explore whether honeybees, which act as pollinators, affect the composition of bacterial communities in the nectar. Nectar and honeybees were sampled from two plant species: Amygdalus communis and Citrus paradisi. To prevent the contact of nectar with pollinators, C. paradisi flowers were covered with net bags before blooming (covered flowers). Comparative analysis of bacterial communities in the nectar and on the honeybees was performed by the 454-pyrosequencing technique. No significant differences were found among bacterial communities in honeybees captured on the two different plant species. This resemblance may be due to the presence of dominant bacterial OTUs, closely related to the Arsenophonus genus. The bacterial communities of the nectar from the covered and uncovered C. paradisi flowers differed significantly; the bacterial communities on the honeybees differed significantly from those in the covered flowers' nectar, but not from those in the uncovered flowers' nectar. We conclude that the honeybees may introduce bacteria into the nectar and/or may be contaminated by bacteria introduced into the nectar by other sources such as other pollinators and nectar thieves.	[Aizenberg-Gershtein, Yana; Izhaki, Ido; Halpern, Malka] Univ Haifa, Dept Evolutionary & Environm Biol, Fac Nat Sci, IL-31999 Haifa, Israel; [Halpern, Malka] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Oranim, Tivon, Israel	University of Haifa; University of Haifa	Halpern, M (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, Fac Nat Sci, IL-31999 Haifa, Israel.	mhalpern@research.haifa.ac.il	Halpern, Malka/AAH-1498-2019; Izhaki, Ido/I-9712-2019	Halpern, Malka/0000-0002-3407-2198; Izhaki, Ido/0000-0002-4525-4683	Israel Science Foundation (ISF) [189/08, 1094/12]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by grants from the Israel Science Foundation (ISF, grants 189/08 and 1094/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Perez S, 2013, INT J SYST EVOL MICR, V63, P1532, DOI 10.1099/ijs.0.043489-0; Alvarez-Perez S, 2013, FEMS MICROBIOL ECOL, V83, P685, DOI 10.1111/1574-6941.12027; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Bailey MT, 2010, BRAIN BEHAV IMMUN, V24, P577, DOI 10.1016/j.bbi.2009.12.010; Baker H.G., 1983, P126; Brysch-Herzberg M, 2004, FEMS MICROBIOL ECOL, V50, P87, DOI 10.1016/j.femsec.2004.06.003; Canto A, 2011, FLORA, V206, P668, DOI 10.1016/j.flora.2011.02.003; Carter C, 2006, NATURWISSENSCHAFTEN, V93, P72, DOI 10.1007/s00114-005-0062-1; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Endo A, 2012, INT J SYST EVOL MICR, V62, P500, DOI 10.1099/ijs.0.031054-0; Felske A, 1997, MICROBIOL-UK, V143, P2983, DOI 10.1099/00221287-143-9-2983; FREE JB, 1963, J ANIM ECOL, V32, P119, DOI 10.2307/2521; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; GILLIAM M, 1983, APIDOLOGIE, V14, P299, DOI 10.1051/apido:19830403; GILLIAM M, 1990, APIDOLOGIE, V21, P99, DOI 10.1051/apido:19900202; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Gruter C, 2011, J EXP BIOL, V214, P1397, DOI 10.1242/jeb.050583; Halpern M, 2013, INT J SYST EVOL MICR, V63, P268, DOI 10.1099/ijs.0.033654-0; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P1827, DOI 10.1098/rspb.2009.2252; Herrera CM, 2009, ANN BOT-LONDON, V103, P1415, DOI 10.1093/aob/mcp026; Izhaki I, 2013, CURR MICROBIOL, V66, P227, DOI 10.1007/s00284-012-0261-x; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kim M, 2012, MICROB ECOL, V63, P674, DOI 10.1007/s00248-011-9953-1; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Lachance MA, 2001, FEMS YEAST RES, V1, P1; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Maurizio A, 1969, TRACHT PFLANZENBUCH; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; PHAFF HJ, 1978, INT J SYST BACTERIOL, V28, P326, DOI 10.1099/00207713-28-2-326; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Ruppel S, 2008, MICROB ECOL, V56, P364, DOI 10.1007/s00248-007-9354-7; SANDHU DK, 1985, MICROB ECOL, V11, P51, DOI 10.1007/BF02015108; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tadmor-Melamed H, 2004, FUNCT ECOL, V18, P844, DOI 10.1111/j.0269-8463.2004.00929.x; Vannette RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2601; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilkes TE, 2012, FRONT MICROBIOL SER, P225; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898	51	74	76	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67556	10.1371/journal.pone.0067556	http://dx.doi.org/10.1371/journal.pone.0067556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844027	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000079
J	Guo, Y; Duan, ZJ; Qian, Y				Guo, Ying; Duan, Zhaojun; Qian, Yuan			Changes in Human Parechovirus Profiles in Hospitalized Children with Acute Gastroenteritis after a Three-Year Interval in Lanzhou, China	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; CLINICAL STOOL SAMPLES; RT-MULTIPLEX PCR; HPEV GENOTYPES; INFECTIONS; PREVALENCE; EPIDEMIOLOGY; ENTEROVIRUS; INFANTS; ASSOCIATION	The changing profile of infection over time for Human Parechoviruses (HPeVs) is not well known and no detailed study has been reported to date in China. This investigation on HPeV infection in hospitalized children in Lanzhou, China revealed variations in epidemiological characteristics after a three-year interval. To assess the changes that had occurred, epidemiological and clinical characteristics of HPeVs were characterized and compared with previously reported data by our group. A comparable positivity rate (25.3%, 73/289) was revealed after the three-year interval with the majority of the infected children (95.9%, 70/73) being younger than two years of age. While a temporal change in the seasonal distribution was noted in the current study, HPeVs were more frequently detected during July to November compared to September to December in the previous study. Changes in HPeV genotypes patterns, a temporal change in the prevalence of HPeV1, a younger susceptible age to HPeV3 compared with HPeV1 and a tendency of older children to be infected with HPeV4 are in contrast to our previous report. HPeV2, a rarely reported genotype, was identified for the first time in China. In addition, an exclusive trinucleotide (GAT) insertion in the HPeV4 nucleotide sequence was identified. However, the profiles of co-infection with other enteric related viruses were similar to our previous findings. In summary, these data suggest temporal variation in the seasonal distribution of HPeV and changing patterns of HPeV genotypes over time in the study region.	[Guo, Ying; Qian, Yuan] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Guo, Ying; Qian, Yuan] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China; [Duan, Zhaojun] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Institute of Pediatrics (CIP); Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Duan, ZJ (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	zhaojund@126.com; yqianbjc@263.net						Abed Y, 2006, EMERG INFECT DIS, V12, P969, DOI 10.3201/eid1206.051675; Baumgarte S, 2008, J CLIN MICROBIOL, V46, P242, DOI 10.1128/JCM.01468-07; Bennett S, 2011, J CLIN MICROBIOL, V49, P2620, DOI 10.1128/JCM.02445-10; Benschop K, 2008, J CLIN MICROBIOL, V46, P3965, DOI 10.1128/JCM.01379-08; Benschop KSM, 2010, J GEN VIROL, V91, P145, DOI 10.1099/vir.0.014670-0; Benschop K, 2010, DIAGN MICR INFEC DIS, V68, P166, DOI 10.1016/j.diagmicrobio.2010.05.016; Benschop KSM, 2006, CLIN INFECT DIS, V42, P204, DOI 10.1086/498905; Boivin G, 2005, EMERG INFECT DIS, V11, P103, DOI 10.3201/eid1101.040606; Boros A, 2010, J CLIN VIROL, V47, P379, DOI 10.1016/j.jcv.2010.01.012; Calvert J, 2010, J GEN VIROL, V91, P1229, DOI 10.1099/vir.0.018747-0; Cashman O, 2010, VET MICROBIOL, V146, P238, DOI 10.1016/j.vetmic.2010.05.012; Chakravarti A, 2012, INDIAN J MED MICROBI, V30, P222, DOI 10.4103/0255-0857.96699; Chieochansin T, 2011, VIROLOGY, V421, P159, DOI 10.1016/j.virol.2011.09.021; Eis-Hubinger AM, 2013, J CLIN MICROBIOL, V51, P715, DOI 10.1128/JCM.02731-12; Ghazi F, 1998, J GEN VIROL, V79, P2641, DOI 10.1099/0022-1317-79-11-2641; Ghazi F, 2012, INT J INFECT DIS, V16, pE673, DOI 10.1016/j.ijid.2012.05.1020; Gupta S, 2010, EUR J PAEDIATR NEURO, V14, P531, DOI 10.1016/j.ejpn.2009.12.007; Han TH, 2011, ARCH VIROL, V156, P1471, DOI 10.1007/s00705-011-0995-y; Harvala H, 2008, J CLIN MICROBIOL, V46, P3446, DOI 10.1128/JCM.01207-08; Harvala H, 2009, J INFECT DIS, V199, P1753, DOI 10.1086/599094; Harvala H, 2011, J MED VIROL, V83, P889, DOI 10.1002/jmv.22023; Harvala H, 2010, CURR OPIN INFECT DIS, V23, P224, DOI 10.1097/QCO.0b013e32833890ca; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Ito M, 2010, J CLIN MICROBIOL, V48, P2683, DOI 10.1128/JCM.00086-10; Jokela P, 2005, J CLIN MICROBIOL, V43, P1239, DOI 10.1128/JCM.43.3.1239-1245.2005; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129, DOI 10.1086/514615; Katano H, 2011, J MED VIROL, V83, P322, DOI 10.1002/jmv.21962; Khamrin P, 2011, J VIROL METHODS, V173, P390, DOI 10.1016/j.jviromet.2011.02.012; King A.M.Q., 2000, VIRUS TAXONOMY, P657; Kolehmainen P, 2012, J CLIN VIROL, V54, P156, DOI 10.1016/j.jcv.2012.02.006; Kurugol Z, 2011, VACCINE, V29, P6259, DOI 10.1016/j.vaccine.2011.06.069; Landry ML, 2010, CLIN INFECT DIS, V50, P362, DOI 10.1086/649864; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legay V, 2002, J CLIN VIROL, V25, P193, DOI 10.1016/S1386-6532(02)00009-4; Lequin M, 2009, BMJ CASE REP, V2009, P2009; Levorson RE, 2009, PEDIATR INFECT DIS J, V28, P545, DOI 10.1097/INF.0b013e318194596a; Li LL, 2009, EMERG INFECT DIS, V15, P288, DOI 10.3201/eid1502.080341; Ljubin-Sternak S, 2011, J MED VIROL, V83, P137, DOI 10.1002/jmv.21848; Ngan TKP, 2011, J CLIN MICROBIOL, V49, P364, DOI 10.1128/JCM.02151-10; Ngan TKP, 2011, J MED VIROL, V83, P331, DOI 10.1002/jmv.21740; Noordhoek GT, 2008, J CLIN VIROL, V41, P75, DOI 10.1016/j.jcv.2007.09.011; Pajkrt D, 2009, PEDIATR INFECT DIS J, V28, P1008, DOI 10.1097/INF.0b013e3181a7ab5f; Pham NTK, 2010, J VIROL METHODS, V169, P193, DOI 10.1016/j.jviromet.2010.07.038; Pham NTK, 2010, J CLIN MICROBIOL, V48, P115, DOI 10.1128/JCM.01015-09; Phan TG, 2005, CLIN LAB, V51, P429; Piralla A, 2012, J MED VIROL, V84, P686, DOI 10.1002/jmv.23197; Renaud C, 2011, J CLIN VIROL, V51, P50, DOI 10.1016/j.jcv.2011.02.010; Sedmak G, 2010, CLIN INFECT DIS, V50, P357, DOI 10.1086/649863; Selvarangan R, 2011, PEDIATR INFECT DIS J, V30, P238, DOI 10.1097/INF.0b013e3181fbefc8; Shan TL, 2010, EMERG INFECT DIS, V16, P1168, DOI [10.3201/eid1607.091103, 10.3201/1607.091103]; Shan TL, 2009, J CLIN VIROL, V45, P371, DOI 10.1016/j.jcv.2009.05.033; Sharp J, 2013, PEDIATR INFECT DIS J, V32, P213, DOI 10.1097/INF.0b013e318276b328; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapia G, 2008, J MED VIROL, V80, P1835, DOI 10.1002/jmv.21283; Tapia G, 2011, PEDIATR DIABETES, V12, P58, DOI 10.1111/j.1399-5448.2010.00658.x; Tauriainen S, 2007, J MED VIROL, V79, P457, DOI 10.1002/jmv.20831; van der Sanden S, 2008, J CLIN MICROBIOL, V46, P2884, DOI 10.1128/JCM.00168-08; Verboon-Maciolek MA, 2008, ANN NEUROL, V64, P266, DOI 10.1002/ana.21445; Verboon-Maciolek MA, 2008, PEDIATR INFECT DIS J, V27, P241, DOI 10.1097/INF.0b013e31815c1b07; Wang YH, 2011, ARCH VIROL, V156, P2221, DOI 10.1007/s00705-011-1122-9; Watanabe K, 2007, EMERG INFECT DIS, V13, P889, DOI 10.3201/eid1306.060896; Williams CH, 2009, J GEN VIROL, V90, P1702, DOI 10.1099/vir.0.008813-0; Wolthers KC, 2008, CLIN INFECT DIS, V47, P358, DOI 10.1086/589752; Yamamoto M, 2009, JPN J INFECT DIS, V62, P244; Zhang DL, 2011, CLIN MICROBIOL INFEC, V17, P1563, DOI 10.1111/j.1469-0691.2010.03390.x; Zhong HQ, 2013, J MED VIROL, V85, P320, DOI 10.1002/jmv.23449; Zhong HQ, 2011, J MED VIROL, V83, P1428, DOI 10.1002/jmv.22114	67	18	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68321	10.1371/journal.pone.0068321	http://dx.doi.org/10.1371/journal.pone.0068321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844186	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000139
J	Pontes, B; Ayala, Y; Fonseca, ACC; Romao, LF; Amaral, RF; Salgado, LT; Lima, FR; Farina, M; Viana, NB; Moura-Neto, V; Nussenzveig, HM				Pontes, Bruno; Ayala, Yareni; Fonseca, Anna Carolina C.; Romao, Luciana F.; Amaral, Rackele F.; Salgado, Leonardo T.; Lima, Flavia R.; Farina, Marcos; Viana, Nathan B.; Moura-Neto, Vivaldo; Nussenzveig, H. Moyses			Membrane Elastic Properties and Cell Function	PLOS ONE			English	Article							TETHER FORMATION; DEVELOPING CNS; IN-VIVO; MICROGLIA; TENSION; BRAIN; PHAGOCYTOSIS; CYTOSKELETON; ACTIN; CURVATURE	Recent studies indicate that the cell membrane, interacting with its attached cytoskeleton, is an important regulator of cell function, exerting and responding to forces. We investigate this relationship by looking for connections between cell membrane elastic properties, especially surface tension and bending modulus, and cell function. Those properties are measured by pulling tethers from the cell membrane with optical tweezers. Their values are determined for all major cell types of the central nervous system, as well as for macrophage. Astrocytes and glioblastoma cells, which are considerably more dynamic than neurons, have substantially larger surface tensions. Resting microglia, which continually scan their environment through motility and protrusions, have the highest elastic constants, with values similar to those for resting macrophage. For both microglia and macrophage, we find a sharp softening of bending modulus between their resting and activated forms, which is very advantageous for their acquisition of phagocytic functions upon activation. We also determine the elastic constants of pure cell membrane, with no attached cytoskeleton. For all cell types, the presence of F-actin within tethers, contrary to conventional wisdom, is confirmed. Our findings suggest the existence of a close connection between membrane elastic constants and cell function.	[Pontes, Bruno; Ayala, Yareni; Fonseca, Anna Carolina C.; Amaral, Rackele F.; Lima, Flavia R.; Farina, Marcos; Viana, Nathan B.; Moura-Neto, Vivaldo; Nussenzveig, H. Moyses] Univ Fed Rio de Janeiro, LPO COPEA, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Ayala, Yareni; Viana, Nathan B.; Nussenzveig, H. Moyses] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil; [Romao, Luciana F.] Univ Fed Rio de Janeiro Macae, Rio De Janeiro, Brazil; [Salgado, Leonardo T.] Inst Pesquisas Jardim Bot Rio de Janeiro, Diretoria Pesquisas, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro	Nussenzveig, HM (corresponding author), Univ Fed Rio de Janeiro, LPO COPEA, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	hmoyses@globo.com	Viana, Nathan/AAH-5868-2021; Farina, Marcos/I-3744-2014; Pontes, Bruno/L-5121-2015; da Fonseca, Anna Carolina Carvalho/C-5825-2015; Romao, Luciana/I-4291-2015; Salgado, Leonardo T/F-1123-2013; da Fonseca, Anna Carolina Carvalho/AAQ-7440-2020; Moura-Neto, VIVALDO/V-9913-2019	Viana, Nathan/0000-0002-2528-0876; da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; Moura-Neto, VIVALDO/0000-0002-6266-043X; Souza Lima, Flavia Regina/0000-0003-0799-9235	Brazilian Agencies National Council for Scientific and Technological Development; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Brazilian Agencies National Council for Scientific and Technological Development; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funded by grants from Brazilian Agencies National Council for Scientific and Technological Development, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Bauer B, 2009, ANGEW CHEM, V121, P1684; Bauer B, 2006, LANGMUIR, V22, P9329, DOI 10.1021/la060828k; Belien ATJ, 1999, J CELL BIOL, V144, P373, DOI 10.1083/jcb.144.2.373; BO L, 1989, BIOPHYS J, V55, P509, DOI 10.1016/S0006-3495(89)82844-9; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Botelho RJ, 2011, CURR BIOL, V21, pR533, DOI 10.1016/j.cub.2011.05.053; Boulbitch A, 2000, PHYS REV E, V62, P3974, DOI 10.1103/PhysRevE.62.3974; Brenner MD, 2011, BIOPOLYMERS, V95, P332, DOI 10.1002/bip.21587; Brodal P, 2010, CENTRAL NERVOUS SYST; Campillo C, 2013, BIOPHYS J, V104, P1248, DOI 10.1016/j.bpj.2013.01.051; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; da Fonseca ACC, 2012, NEUROSCIENCE, V200, P130, DOI 10.1016/j.neuroscience.2011.10.025; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Derenyi I, 2007, LECT NOTES PHYS, V711, P141; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Faria J, 2006, DIFFERENTIATION, V74, P562, DOI 10.1111/j.1432-0436.2006.00090.x; Farrell B, 2013, INTEGR BIOL-UK, V5, P204, DOI 10.1039/c2ib20097j; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gomes FCA, 1999, GLIA, V26, P97; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jung S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00089; Keren K, 2011, P NATL ACAD SCI USA, V108, P14379, DOI 10.1073/pnas.1111671108; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Koster G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.068101; Koster G, 2005, THESIS LEIDEN U; Leporatti S, 2006, FEBS LETT, V580, P450, DOI 10.1016/j.febslet.2005.12.037; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001; Mallat M, 2005, CURR OPIN NEUROBIOL, V15, P101, DOI 10.1016/j.conb.2005.01.006; May RC, 2001, J CELL SCI, V114, P1061; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; NETO VM, 1983, EMBO J, V2, P1243, DOI 10.1002/j.1460-2075.1983.tb01576.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pontes B, 2011, BIOPHYS J, V101, P43, DOI 10.1016/j.bpj.2011.05.044; Powers TR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041901; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; SCOTT RE, 1976, SCIENCE, V194, P743, DOI 10.1126/science.982043; SCOTT RE, 1979, J CELL SCI, V35, P229; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shen HY, 2012, CELL, V150, P1300, DOI 10.1016/j.cell.2012.08.017; Streit WJ, 2001, NEUROTOXICOLOGY, V22, P619, DOI 10.1016/S0161-813X(01)00033-X; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wirtz D, 2013, BIOPHYS J, V104, P1217, DOI 10.1016/j.bpj.2013.02.003; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251	58	79	80	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67708	10.1371/journal.pone.0067708	http://dx.doi.org/10.1371/journal.pone.0067708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844071	gold, Green Submitted, Green Published			2022-12-25	WOS:000321733000097
J	Tzeng, HE; Lin, CL; Tsai, CH; Tang, CH; Hwang, WL; Cheng, YW; Sung, FC; Chung, CJ				Tzeng, Huey-En; Lin, Cheng-Li; Tsai, Chun-Hao; Tang, Chih-Hsin; Hwang, Wen-Li; Cheng, Ya-Wen; Sung, Fung-Chang; Chung, Chi-Jung			Time Trend of Multiple Myeloma and Associated Secondary Primary Malignancies in Asian Patients: A Taiwan Population-Based Study	PLOS ONE			English	Article							INCREASED RISK; MYELODYSPLASTIC SYNDROMES; BREAST-CANCER; UNITED-STATES; 2ND CANCER; LEUKEMIA; EPIDEMIOLOGY; CHEMOTHERAPY; NEOPLASMS; MELPHALAN	Studies involving second malignancies in patients with multiple myeloma are limited for the Asian population. Using data from population-based insurance claims, we assessed the risk of developing secondary malignancies after multiple myeloma, in particular hematologic malignancies. A retrospective cohort study was conducted in 3970 patients with newly diagnosed multiple myeloma from the registry of catastrophic illnesses between 1997 and 2009. A total of 15880 subjects without multiple myeloma were randomly selected as comparisons from the insured population, frequency-matched based on gender, age, and the date of diagnosis. The incidence of secondary malignancies was ascertained through cross-referencing with the National Cancer Registry System. The Cox proportional hazards model was used for analyses. The incidence of multiple myeloma in the insured population increased annually. The overall incidence of secondary malignancy was lower in the multiple myeloma cohort than in the comparison cohort (93.6 vs. 104.5 per 10,000 person-years, IRR = 0.90, 95% CI = 0.78-1.04). The incidence of hematologic malignancies was 11-fold greater for multiple myeloma patients (47.2 vs. 4.09 per 10,000 person-years) with an adjusted HR of 13.0 (95% CI = 7.79-21.6) compared with the comparison cohort. The relative risk of secondary malignancy was also strong for myeloid leukemia (21.2 vs. 1.36 per 10,000 person-years). Gender-and age-specific analysis for secondary hematologic malignancies showed that males and patients with multiple myeloma < 60 years of age had a higher risk of secondary malignancy than females and patients with multiple myeloma > 60 years of age. In conclusion, patients with multiple myeloma, especially younger patients, are at a high risk of hematologic malignancies.	[Tzeng, Huey-En; Tsai, Chun-Hao; Tang, Chih-Hsin] China Med Univ, Grad Inst Med, Taichung, Taiwan; [Tzeng, Huey-En; Hwang, Wen-Li] Taichung Vet Gen Hosp, Div Hematol Oncol, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ Hosp, Dept Orthopaed, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ & Hosp, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Cheng, Ya-Wen] Taipei Med Univ, Coll Med Sci & Technol, Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chung, Chi-Jung] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Med, Taichung, Taiwan.	chtang@mail.cmu.edu.tw; cjchung@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015; Chung, Chi-Jung/G-4755-2013; Tsai, Chun-Hao/H-3140-2013	Tang, Chih Hsin/0000-0002-7113-8352; Tsai, Chun-Hao/0000-0002-4428-3132	Executive Yuan National Science Council [NSC 100-2621-M-039-001]; Department of Health [DOH100-TD-B-111-004, DOH100-TD-C-111-005]; China Medical University Hospital [1MS1]	Executive Yuan National Science Council; Department of Health; China Medical University Hospital	This study was supported in part by the Executive Yuan National Science Council (Grant No. NSC 100-2621-M-039-001), the Department of Health (Grant Nos. DOH100-TD-B-111-004 and DOH100-TD-C-111-005), and the China Medical University Hospital (Grant No. 1MS1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SR, 1997, CANCER EPIDEM BIOMAR, V6, p[857, 49]; Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Barlogie B, 2008, BLOOD, V111, P94, DOI 10.1182/blood-2007-06-097444; Becker N, 2011, RECENT RESULTS CANC, V183, P25, DOI 10.1007/978-3-540-85772-3_2; BERGSAGEL DE, 1979, NEW ENGL J MED, V301, P743, DOI 10.1056/NEJM197910043011402; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Bouchardy C, 2008, GYNECOL ONCOL, V109, P210, DOI 10.1016/j.ygyno.2008.01.032; Chen HL, 2005, SCI TOTAL ENVIRON, V337, P31, DOI 10.1016/j.scitotenv.2004.06.021; CUZICK J, 1987, BRIT J CANCER, V55, P523, DOI 10.1038/bjc.1987.107; Dores GM, 2009, BRIT J HAEMATOL, V144, P86, DOI 10.1111/j.1365-2141.2008.07421.x; Fayers PM, 2011, BLOOD, V118, P1239, DOI 10.1182/blood-2011-03-341669; Fenk R, 2012, BRIT J HAEMATOL, V156, P683, DOI 10.1111/j.1365-2141.2011.08905.x; George ED, 1999, AM FAM PHYSICIAN, V59, P1885; Gold LS, 2009, CANCER EPIDEMIOL, V33, P276, DOI 10.1016/j.canep.2009.08.005; Govindarajan R, 1996, BRIT J HAEMATOL, V95, P349, DOI 10.1046/j.1365-2141.1996.d01-1891.x; Hasskarl J, 2011, LEUKEMIA LYMPHOMA, V52, P247, DOI 10.3109/10428194.2010.529207; Hirabayashi Y, 2008, JPN J CLIN ONCOL, V38, P720, DOI 10.1093/jjco/hyn113; Hsu JF, 2010, CHEMOSPHERE, V81, P469, DOI 10.1016/j.chemosphere.2010.07.044; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KYLE RA, 1970, NEW ENGL J MED, V283, P1121, DOI 10.1056/NEJM197011192832101; Landgren O, 2012, LEUKEMIA, V26, P844, DOI 10.1038/leu.2011.262; Landgren O, 2009, LEUKEMIA, V23, P1691, DOI 10.1038/leu.2009.134; Landgren O, 2011, NEW ENGL J MED, V365, P2241, DOI 10.1056/NEJMc1111010; LAW IP, 1977, ONCOLOGY-BASEL, V34, P20, DOI 10.1159/000225175; Lee KD, 2008, CANCER EPIDEM BIOMAR, V17, P2647, DOI 10.1158/1055-9965.EPI-08-0109; Mailankody S, 2011, BLOOD, V118, P4086, DOI 10.1182/blood-2011-05-355743; Moller H, 2007, BRIT J CANCER, V96, P1484, DOI 10.1038/sj.bjc.6603746; Moser EC, 2006, HAEMATOLOGICA, V91, P1481; Oivanen T, 2000, EUR J HAEMATOL, V65, P123; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; ROSNER F, 1977, JAMA-J AM MED ASSOC, V237, P120, DOI 10.1001/jama.1977.03270290020015; Rubino C, 2000, BREAST CANCER RES TR, V61, P183, DOI 10.1023/A:1006489918700; Schwartz GG, 1997, CANCER EPIDEM BIOMAR, V6, P49; Soong G, 2011, CHINA POST TAIPEI; 't Mannetje A, 2005, OCCUP ENVIRON MED, V62, P34, DOI 10.1136/oem.2004.015776; Tsung-Mei C, 2009, TAIWANS NATL HLTH IN; Turesson I, 2010, J CLIN ONCOL, V28, P830, DOI 10.1200/JCO.2009.25.4177	38	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68041	10.1371/journal.pone.0068041	http://dx.doi.org/10.1371/journal.pone.0068041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844152	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000132
J	Jutras, BL; Chenail, AM; Carroll, DW; Miller, MC; Zhu, HN; Bowman, A; Stevenson, B				Jutras, Brandon L.; Chenail, Alicia M.; Carroll, Dustin W.; Miller, M. Clarke; Zhu, Haining; Bowman, Amy; Stevenson, Brian			Bpur, the Lyme Disease Spirochete's PUR Domain Protein IDENTIFICATION AS A TRANSCRIPTIONAL MODULATOR AND CHARACTERIZATION OF NUCLEIC ACID INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; WHOLE-GENOME SEQUENCES; OUTER-SURFACE PROTEIN; BORRELIA-BURGDORFERI INFECTION; POSTNATAL BRAIN-DEVELOPMENT; INHIBITOR FACTOR-H; BINDING PROTEIN; GENE-EXPRESSION; CP32 PROPHAGES; ERP PROTEINS	The PUR domain is a nucleic acid-binding motif found in critical regulatory proteins of higher eukaryotes and in certain species of bacteria. During investigations into mechanisms by which the Lyme disease spirochete controls synthesis of its Erp surface proteins, it was discovered that the borrelial PUR domain protein, Bpur, binds with high affinity to double-stranded DNA adjacent to the erp transcriptional promoter. Bpur was found to enhance the effects of the erp repressor protein, BpaB. Bpur also bound single-stranded DNA and RNA, with relative affinities RNA > double-stranded DNA > single-stranded DNA. Rational site-directed mutagenesis of Bpur identified amino acid residues and domains critical for interactions with nucleic acids, and it revealed that the PUR domain has a distinct mechanism of interaction with each type of nucleic acid ligand. These data shed light on both gene regulation in the Lyme spirochete and functional mechanisms of the widely distributed PUR domain.	[Jutras, Brandon L.; Chenail, Alicia M.; Bowman, Amy; Stevenson, Brian] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Carroll, Dustin W.] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Miller, M. Clarke] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Zhu, Haining] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Louisville; University of Kentucky	Stevenson, B (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, MS Chandler Med Ctr 421, Lexington, KY 40536 USA.	brian.stevenson@uky.edu	Miller, M. Clarke/C-9483-2011; Zhu, Haining/A-6076-2008	Miller, M. Clarke/0000-0002-9877-6581; Zhu, Haining/0000-0001-5498-6694; Jutras, Brandon/0000-0002-7989-1031	National Institutes of Health [R01-AI044254, R21-AI106260]; National Research Fund for Tick-borne Diseases; University of Kentucky; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106260, R01AI044254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Fund for Tick-borne Diseases; University of Kentucky; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI044254 and R21-AI106260. This work was also supported by a grant from the National Research Fund for Tick-borne Diseases and a University of Kentucky grant-in-aid (to B. S.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams C. A., 2007, PROTEIN INTERACTIONS, P417; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Antonara S, 2007, MOL MICROBIOL, V66, P262, DOI 10.1111/j.1365-2958.2007.05924.x; Babb K, 2004, J BACTERIOL, V186, P2745, DOI 10.1128/JB.186.9.2745-2756.2004; Babb K, 2006, J BACTERIOL, V188, P4331, DOI 10.1128/JB.00005-06; Bono JL, 1998, MICROBIOL-UK, V144, P1033, DOI 10.1099/00221287-144-4-1033; Brissette CA, 2008, INT J MED MICROBIOL, V298, P257, DOI 10.1016/j.ijmm.2007.09.004; Brissette CA, 2009, MICROBIOL-SGM, V155, P863, DOI 10.1099/mic.0.024604-0; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Brisson D, 2013, APPL ENVIRON MICROB, V79, P4115, DOI 10.1128/AEM.00817-13; Burns LH, 2010, NUCLEIC ACIDS RES, V38, P5443, DOI 10.1093/nar/gkq284; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Casjens SR, 2011, J BACTERIOL, V193, P6995, DOI 10.1128/JB.05951-11; Casjens SR, 2011, J BACTERIOL, V193, P1489, DOI 10.1128/JB.01521-10; Chang CF, 1996, J VIROL, V70, P4150, DOI 10.1128/JVI.70.6.4150-4156.1996; Chang JC, 2011, PHYSIOL PLANTARUM, V143, P219, DOI 10.1111/j.1399-3054.2011.01501.x; CHEN NN, 1995, P NATL ACAD SCI USA, V92, P1087, DOI 10.1073/pnas.92.4.1087; Chenail AM, 2012, J BACTERIOL, V194, P4570, DOI 10.1128/JB.00661-12; Darbinian N, 2001, J NEUROIMMUNOL, V121, P3, DOI 10.1016/S0165-5728(01)00372-1; Darbinian N, 2008, J ALZHEIMERS DIS, V15, P71; de Oliveira FMB, 2004, MOL BIOCHEM PARASIT, V135, P21, DOI 10.1016/j.molbiopara.2003.12.009; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Fried MG, 1996, BIOCHEMISTRY-US, V35, P15295, DOI 10.1021/bi960971k; Gallia GL, 2001, J CELL BIOCHEM, V83, P355, DOI 10.1002/jcb.1247; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gilmore RD, 2001, MICROBES INFECT, V3, P799, DOI 10.1016/S1286-4579(01)01435-6; Graebsch A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013402; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200; HAAS S, 1993, MOL CELL BIOL, V13, P3103, DOI 10.1128/MCB.13.5.3103; HAAS S, 1995, J CELL BIOL, V130, P1171, DOI 10.1083/jcb.130.5.1171; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hokkanen S, 2012, HUM MOL GENET, V21, P473, DOI 10.1093/hmg/ddr476; Hovis KM, 2006, INFECT IMMUN, V74, P1967, DOI 10.1128/IAI.74.3.1967-1972.2006; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Inoue T, 2009, PROSTATE, V69, P861, DOI 10.1002/pros.20936; Jimenez-Castells C, 2012, ANAL CHEM, V84, P6515, DOI 10.1021/ac300766z; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Jutras Brandon L, 2012, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01f01s24; Jutras BL, 2013, J BACTERIOL, V195, P757, DOI 10.1128/JB.01956-12; Jutras BL, 2012, J BACTERIOL, V194, P3395, DOI 10.1128/JB.00252-12; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Kenedy MR, 2011, INFECT IMMUN, V79, P1451, DOI 10.1128/IAI.01274-10; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Kong TQ, 2007, J IMMUNOL, V179, P1934, DOI 10.4049/jimmunol.179.3.1934; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Mbow ML, 2002, HYBRIDOMA HYBRIDOM, V21, P179, DOI 10.1089/153685902760173890; Metts MS, 2003, INFECT IMMUN, V71, P3587, DOI 10.1128/IAI.71.6.3587-3596.2003; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Muralidharan V, 1997, J CELL BIOCHEM, V66, P524, DOI 10.1002/(SICI)1097-4644(19970915)66:4<524::AID-JCB11>3.0.CO;2-B; Muralidharan V, 2001, J CELL PHYSIOL, V186, P406, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1039>3.0.CO;2-P; O'Neill MJ, 2012, P NATL ACAD SCI USA, V109, P5639, DOI 10.1073/pnas.1121549109; OLMSTED MC, 1991, BIOPOLYMERS, V31, P1593, DOI 10.1002/bip.360311314; Penberthy WT, 2004, DEV BIOL, V275, P225, DOI 10.1016/j.ydbio.2004.08.007; Qiu WG, 2004, P NATL ACAD SCI USA, V101, P14150, DOI 10.1073/pnas.0402745101; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Riley SP, 2009, NUCLEIC ACIDS RES, V37, P1973, DOI 10.1093/nar/gkp027; Rosa P, 1999, METHOD MICROBIOL, V29, P209; Samuels D S, 1995, Methods Mol Biol, V47, P253; Schutzer SE, 2012, J BACTERIOL, V194, P545, DOI 10.1128/JB.06263-11; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Tretiakova A, 1998, J BIOL CHEM, V273, P22241, DOI 10.1074/jbc.273.35.22241; Wang HC, 2008, ANTICANCER RES, V28, P1441; Wang H, 2007, CANCER BIOL THER, V6, P596, DOI 10.4161/cbt.6.4.3889; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; Whetstine CR, 2009, APPL ENVIRON MICROB, V75, P6553, DOI 10.1128/AEM.02825-08; White MK, 2009, CELL CYCLE, V8, P414, DOI 10.4161/cc.8.3.7585; Witze ES, 2009, DEV BIOL, V327, P12, DOI 10.1016/j.ydbio.2008.11.015; Wortman MJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-81; Wortman MJ, 2005, BBA-MOL CELL RES, V1743, P64, DOI 10.1016/j.bbamcr.2004.08.010; Wywial E, 2009, GENE, V445, P26, DOI 10.1016/j.gene.2009.05.017; Yu L, 2012, ANAL BIOCHEM, V428, P137, DOI 10.1016/j.ab.2012.06.002; Zhao S, 2010, AM J PHYSIOL-ENDOC M, V298, pE524, DOI 10.1152/ajpendo.00597.2009; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	85	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26220	26234		10.1074/jbc.M113.491357	http://dx.doi.org/10.1074/jbc.M113.491357			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23846702	Green Published, hybrid			2022-12-25	WOS:000330623300052
J	Lee, YT; Kim, KS; Byrnes, C; de Vasconcellos, JF; Noh, SJ; Rabel, A; Meier, ER; Miller, JL				Lee, Y. Terry; Kim, Ki Soon; Byrnes, Colleen; de Vasconcellos, Jaira F.; Noh, Seung-Jae; Rabel, Antoinette; Meier, Emily R.; Miller, Jeffery L.			A Synthetic Model of Human Beta-Thalassemia Erythropoiesis Using CD34+Cells from Healthy Adult Donors	PLOS ONE			English	Article							INEFFECTIVE ERYTHROPOIESIS; ERYTHROID-CELLS; MOUSE MODEL; HEMOGLOBIN; EXPRESSION; MURINE; GLOBIN; APOPTOSIS; BLOOD	Based upon the lack of clinical samples available for research in many laboratories worldwide, a significant gap exists between basic and clinical studies of beta-thalassemia major. To bridge this gap, we developed an artificially engineered model for human beta thalassemia by knocking down beta-globin gene and protein expression in cultured CD34+ cells obtained from healthy adults. Lentiviral-mediated transduction of beta-globin shRNA (beta-KD) caused imbalanced globin chain production. Beta-globin mRNA was reduced by 90% compared to controls, while alpha-globin mRNA levels were maintained. HPLC analyses revealed a 96% reduction in HbA with only a minor increase in HbF. During the terminal phases of differentiation (culture days 14-21), beta-KD cells demonstrated increased levels of insoluble alpha-globin, as well as activated caspase-3. The majority of the beta-KD cells underwent apoptosis around the polychromatophilic stage of maturation. GDF15, a marker of ineffective erythropoiesis in humans with thalassemia, was significantly increased in the culture supernatants from the beta-KD cells. Knockdown of beta-globin expression in cultured primary human erythroblasts provides a robust ex vivo model for beta-thalassemia.	[Lee, Y. Terry; Kim, Ki Soon; Byrnes, Colleen; de Vasconcellos, Jaira F.; Noh, Seung-Jae; Rabel, Antoinette; Meier, Emily R.; Miller, Jeffery L.] NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Miller, JL (corresponding author), NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	jm7f@nih.gov		Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025094, ZIADK025101, ZIADK025098] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADVANI R, 1992, BLOOD, V79, P1058; Bhanu NV, 2005, BLOOD, V105, P387, DOI 10.1182/blood-2004-04-1599; Centis F, 2000, BLOOD, V96, P3624; Franceschi LD, 2006, HAEMATOLOGICA, V91, P1336; Franceschi LD, 2007, HAEMATOLOGICA, V92, P1319; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Ginzburg YZ, 2009, EXP HEMATOL, V37, P172, DOI 10.1016/j.exphem.2008.10.004; Khandros E, 2012, BLOOD, V119, P5265, DOI 10.1182/blood-2011-12-397729; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Kuypers FA, 1998, BLOOD, V91, P3044, DOI 10.1182/blood.V91.8.3044.3044_3044_3051; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; Mendel A, 2009, MSURJ, V4, P20; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sankaran VG, 2010, HEMATOL ONCOL CLIN N, V24, P1005, DOI 10.1016/j.hoc.2010.08.009; Schrier SL, 2002, CURR OPIN HEMATOL, V9, P123, DOI 10.1097/00062752-200203000-00007; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Tavazzi D, 1998, HEMOGLOBIN, V22, P483, DOI 10.3109/03630269809071545; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; WICKRAMASINGHE SN, 1975, BRIT J HAEMATOL, V30, P395, DOI 10.1111/j.1365-2141.1975.tb01853.x; Wojda U, 2002, BLOOD, V99, P3005, DOI 10.1182/blood.V99.8.3005.h8003005_3005_3013; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68307	10.1371/journal.pone.0068307	http://dx.doi.org/10.1371/journal.pone.0068307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861885	Green Submitted, Green Published, gold			2022-12-25	WOS:000321692000021
J	Wang, ZY; Wang, N; Han, SW; Wang, DM; Mo, SL; Yu, LZ; Huang, H; Tsui, K; Shen, JG; Chen, JP				Wang, Zhiyu; Wang, Neng; Han, Shouwei; Wang, Dongmei; Mo, Suilin; Yu, Linzhong; Huang, Hui; Tsui, Kamchuen; Shen, Jiangang; Chen, Jianping			Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; INDUCED ANGIOGENESIS; THERAPEUTIC TARGET; MESSENGER-RNA; LICORICE ROOT; TUMOR-GROWTH; KINASE; VEGF; MMP-2	Angiogenesis is crucial for cancer initiation, development and metastasis. Identifying natural botanicals targeting angiogenesis has been paid much attention for drug discovery in recent years, with the advantage of increased safety. Isoliquiritigenin (ISL) is a dietary chalcone-type flavonoid with various anti-cancer activities. However, little is known about the anti-angiogenic activity of isoliquiritigenin and its underlying mechanisms. Herein, we found that ISL significantly inhibited the VEGF-induced proliferation of human umbilical vein endothelial cells (HUVECs) at non-toxic concentration. A series of angiogenesis processes including tube formation, invasion and migration abilities of HUVECs were also interrupted by ISL in vitro. Furthermore, ISL suppressed sprout formation from VEGF-treated aortic rings in an ex-vivo model. Molecular mechanisms study demonstrated that ISL could significantly inhibit VEGF expression in breast cancer cells via promoting HIF-1 alpha (Hypoxia inducible factor-1 alpha) proteasome degradation and directly interacted with VEGFR-2 to block its kinase activity. In vivo studies further showed that ISL administration could inhibit breast cancer growth and neoangiogenesis accompanying with suppressed VEGF/VEGFR-2 signaling, elevated apoptosis ratio and little toxicity effects. Molecular docking simulation indicated that ISL could stably form hydrogen bonds and aromatic interactions within the ATP-binding region of VEGFR-2. Taken together, our study shed light on the potential application of ISL as a novel natural inhibitor for cancer angiogenesis via the VEGF/VEGFR-2 pathway. Future studies of ISL for chemoprevention or chemosensitization against breast cancer are thus warranted.	[Wang, Zhiyu; Wang, Neng; Shen, Jiangang; Chen, Jianping] Univ Hong Kong, Sch Chinese Med, Pokfulam, Hong Kong, Peoples R China; [Han, Shouwei] Univ Guangzhou Tradit Chinese Med, Clin Med Collage 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [Wang, Dongmei] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Mo, Suilin] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Linzhong] South Med Univ, Sch Chinese Med, Guangzhou, Guangdong, Peoples R China; [Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Tsui, Kamchuen] Hong Kong Associate Chinese Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Guangzhou University of Chinese Medicine; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China; Sun Yat Sen University	Chen, JP (corresponding author), Univ Hong Kong, Sch Chinese Med, Pokfulam, Hong Kong, Peoples R China.	jpjpchen@yahoo.com	wang, zhiyu/K-5255-2016	wang, zhiyu/0000-0002-5299-8410	Hong Kong Innovation and Technology Support Programme ITF [ITS/073/11FP]	Hong Kong Innovation and Technology Support Programme ITF	This work was supported by the Hong Kong Innovation and Technology Support Programme ITF funding (ITS/073/11FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo AG, 2007, CURR PHARM DESIGN, V13, P1787, DOI 10.2174/138161207780831284; Bagri A, 2010, TRENDS MOL MED, V16, P122, DOI 10.1016/j.molmed.2010.01.004; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Cuendet M, 2010, CANCER PREV RES, V3, P221, DOI 10.1158/1940-6207.CAPR-09-0049; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Faria A, 2006, J AGR FOOD CHEM, V54, P2392, DOI 10.1021/jf0526487; Fisher JF, 2010, METHODS MOL BIOL, V622, P471, DOI 10.1007/978-1-60327-299-5_27; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Ispanovic E, 2006, AM J PHYSIOL-CELL PH, V291, pC579, DOI 10.1152/ajpcell.00300.2005; Jhanji V, 2011, BRIT J OPHTHALMOL, V95, P1309, DOI 10.1136/bjophthalmol-2011-300110; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Kang SW, 2010, J NUTR BIOCHEM, V21, P55, DOI 10.1016/j.jnutbio.2008.10.004; Kargiotis O, 2008, ONCOGENE, V27, P4830, DOI 10.1038/onc.2008.122; Kiselyov A, 2007, EXPERT OPIN INV DRUG, V16, P83, DOI 10.1517/13543784.16.1.83; KOBAYASHI S, 1995, BIOL PHARM BULL, V18, P1382, DOI 10.1248/bpb.18.1382; Kumaran G, 2008, CLIN MED, V8, P455, DOI 10.7861/clinmedicine.8-4-455; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Lee YM, 2009, J MED FOOD, V12, P8, DOI 10.1089/jmf.2008.0039; Lee YJ, 2010, CANCER RES, V70, P8357, DOI 10.1158/0008-5472.CAN-10-1138; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li DF, 2009, FREE RADICAL BIO MED, V46, P731, DOI 10.1016/j.freeradbiomed.2008.11.011; Limer JL, 2004, BREAST CANCER RES, V6, P119, DOI 10.1186/bcr781; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; McTigue MA, 1999, STRUCT FOLD DES, V7, P319, DOI 10.1016/S0969-2126(99)80042-2; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Oguro Y, 2010, BIOORGAN MED CHEM, V18, P7260, DOI 10.1016/j.bmc.2010.08.017; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park I, 2009, CANCER LETT, V277, P174, DOI 10.1016/j.canlet.2008.12.005; Poveshchenko A. F., 2010, Uspekhi Fiziologicheskikh Nauk, V41, P68; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Randall LM, 2010, GYNECOL ONCOL, V117, P497, DOI 10.1016/j.ygyno.2010.02.021; Ruf W, 2010, THROMB RES, V125, pS36, DOI 10.1016/S0049-3848(10)70010-4; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Takahashi T, 2004, CANCER SCI, V95, P448, DOI 10.1111/j.1349-7006.2004.tb03230.x; Wang N, 2012, BREAST CANCER RES TR, V134, P943, DOI 10.1007/s10549-012-1977-9; Wang ZY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/873175; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; YAMAMOTO S, 1991, CARCINOGENESIS, V12, P317, DOI 10.1093/carcin/12.2.317; Ye L, 2009, INT J CANCER, V124, P1028, DOI 10.1002/ijc.24046; Yilmaz A, 2003, BIOCHEM BIOPH RES CO, V306, P730, DOI 10.1016/S0006-291X(03)01064-7; Zhang LQ, 2010, CELL RES, V20, P1319, DOI 10.1038/cr.2010.116; Zheng HC, 2006, ANTICANCER RES, V26, P3579	48	42	47	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68566	10.1371/journal.pone.0068566	http://dx.doi.org/10.1371/journal.pone.0068566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861918	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300069
J	Feyrer, F; Portz, D; Odum, D; Newman, KB; Sommer, T; Contreras, D; Baxter, R; Slater, SB; Sereno, D; Van Nieuwenhuyse, E				Feyrer, Frederick; Portz, Donald; Odum, Darren; Newman, Ken B.; Sommer, Ted; Contreras, Dave; Baxter, Randall; Slater, Steven B.; Sereno, Deanna; Van Nieuwenhuyse, Erwin			SmeltCam: Underwater Video Codend for Trawled Nets with an Application to the Distribution of the Imperiled Delta Smelt	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; WELL-MIXED ESTUARY; TIDAL TRANSPORT; OSMERUS-MORDAX; LONGITUDINAL DISTRIBUTION; SILHOUETTE PHOTOGRAPHY; REEF FISH; IN-SITU; LARVAL; ABUNDANCE	Studying rare and sensitive species is a challenge in conservation biology. The problem is exemplified by the case of the imperiled delta smelt Hypomesus transpacificus, a small delicate fish species endemic to the San Francisco Estuary, California. Persistent record-low levels of abundance and relatively high sensitivity to handling stress pose considerable challenges to studying delta smelt in the wild. To attempt to overcome these and other challenges we have developed the SmeltCam, an underwater video camera codend for trawled nets. The SmeltCam functions as an open-ended codend that automatically collects information on the number and species of fishes that pass freely through a trawled net without handling. We applied the SmeltCam to study the fine-scale distribution of juvenile delta smelt in the water column in the upper San Francisco Estuary. We learned that during flood tides delta smelt were relatively abundant throughout the water column and that during ebb tides delta smelt were significantly less abundant and occurred only in the lower half and sides of the water column. The results suggest that delta smelt manipulate their position in the water column to facilitate retention in favorable habitats. With the application of the SmeltCam we increased the survival of individual delta smelt by 72% compared to using a traditional codend, where all of the fish would have likely died due to handling stress. The SmeltCam improves upon similar previously developed silhouette photography or video recording devices and demonstrates how new technology can be developed to address important questions in conservation biology as well as lessen the negative effects associated with traditional sampling methods on imperiled species.	[Feyrer, Frederick; Van Nieuwenhuyse, Erwin] US Bur Reclamat, Bay Delta Off, Sacramento, CA USA; [Portz, Donald] US Bur Reclamat, Tech Serv Ctr, Denver, CO 80225 USA; [Odum, Darren] SureWorks LLC, Longmont, CO USA; [Newman, Ken B.] US Fish & Wildlife Serv, Lodi, CA USA; [Sommer, Ted] Calif Dept Water Resources, West Sacramento, CA USA; [Contreras, Dave; Baxter, Randall; Slater, Steven B.] Calif Dept Fish & Wildlife, Stockton, CA USA; [Sereno, Deanna] Costa Water Dist, Concord, CA USA	United States Department of the Interior; US Fish & Wildlife Service	Feyrer, F (corresponding author), US Bur Reclamat, Bay Delta Off, Sacramento, CA USA.	ffeyrer@usbr.gov	Newman, Ken/AAH-5654-2020	Newman, Kenneth/0000-0003-1734-5833	Bureau of Reclamation; California Department of Water Resources; California Department of Fish and Wildlife; State and Federal Contractors Water Agency (SFWCA)	Bureau of Reclamation; California Department of Water Resources; California Department of Fish and Wildlife; State and Federal Contractors Water Agency (SFWCA)	Funding for the research and development of the SmeltCam has been provided by the Bureau of Reclamation and the California Department of Water Resources. The California Department of Fish and Wildlife provided funding in the form of in-kind services. The State and Federal Contractors Water Agency (SFWCA) provided some additional funding to conduct the field study. SFWCA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2010, J EXP MAR BIOL ECOL, V391, P161, DOI 10.1016/j.jembe.2010.06.028; Bennett W. A, 2005, SAN FRANCISCO ESTUAR, V3; Bennett WA, 2002, LIMNOL OCEANOGR, V47, P1496, DOI 10.4319/lo.2002.47.5.1496; Bos AR, 1999, ARCH FISH MAR RES, V47, P47; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Castillo Gonzalo, 2012, San Francisco Estuary & Watershed Science, V10, P1; Culverhouse PF, 2006, MAR ECOL PROG SER, V312, P297, DOI 10.3354/meps312297; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Daum DW, 2005, N AM J FISH MANAGE, V25, P322, DOI 10.1577/M04-086.1; DAUVIN JC, 1990, MAR ECOL PROG SER, V60, P1, DOI 10.3354/meps060001; Dege M, 2004, AM FISH S S, V39, P49; DODSON JJ, 1989, ESTUARIES, V12, P66, DOI 10.2307/1351498; Draper AJ, 2004, J WATER RES PLAN MAN, V130, P480, DOI 10.1061/(ASCE)0733-9496(2004)130:6(480); Ellender BR, 2012, AQUAT CONSERV, V22, P58, DOI 10.1002/aqc.1236; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Feyrer F, 2011, ESTUAR COAST, V34, P120, DOI 10.1007/s12237-010-9343-9; Frezza TL, 2003, J FRESHWATER ECOL, V18, P269, DOI 10.1080/02705060.2003.9664493; Gibson RN, 2003, HYDROBIOLOGIA, V503, P153, DOI 10.1023/B:HYDR.0000008488.33614.62; Graham DL, 2003, MARINE ECOLOGY PROGR, V254, P129; Grimaldo LF, 2009, N AM J FISH MANAGE, V29, P1253, DOI 10.1577/M08-062.1; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; HUGHES DA, 1969, BIOL BULL, V136, P43, DOI 10.2307/1539667; Jackman S., 2012, PSCL CLASSES METHODS; Jordan F, 2008, ENVIRON BIOL FISH, V81, P313, DOI 10.1007/s10641-007-9202-0; Krumme U, 2004, FISH RES, V70, P1, DOI 10.1016/j.fishres.2004.07.004; LAPRISE R, 1989, J FISH BIOL, V35, P39; LAPRISE R, 1989, MAR ECOL PROG SER, V55, P101, DOI 10.3354/meps055101; LENZ J, 1995, ICES J MAR SCI, V52, P409, DOI 10.1016/1054-3139(95)80056-5; Mac Nally R, 2010, ECOL APPL, V20, P1417, DOI 10.1890/09-1724.1; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Morrison M, 2006, FISH RES, V82, P150, DOI 10.1016/j.fishres.2006.06.024; MOYLE PB, 1992, T AM FISH SOC, V121, P67, DOI 10.1577/1548-8659(1992)121<0067:LHASOD>2.3.CO;2; Newman K, 2008, SAN FRANCISCO ESTUAR; NORCROSS BL, 1984, T AM FISH SOC, V113, P153, DOI 10.1577/1548-8659(1984)113<153:OAETOF>2.0.CO;2; OLNEY JE, 1993, B MAR SCI, V52, P845; ORTNER PB, 1981, DEEP-SEA RES, V28, P1569, DOI 10.1016/0198-0149(81)90098-4; R Development Core Team, 2008, R LANG ENV STAT COMP; RIJNSDORP AD, 1985, T AM FISH SOC, V114, P461, DOI 10.1577/1548-8659(1985)114<461:STTONS>2.0.CO;2; Rockriver AK, 2004, AM FISH S S, V39, P97; Sommer T., 2011, SAN FRANC ESTUARY WA, V9, DOI 10.15447/sfews.2014v9iss2art2; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Stevens DE, 1983, T AM FISH SOC, V3, P425, DOI DOI 10.1577/1548-8659(1983)3<425:E0RF0A>2.0.00;2; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Swanson C, 1996, T AM FISH SOC, V125, P326, DOI 10.1577/1548-8659(1996)125&lt;0326:UOSAAP&gt;2.3.CO;2; Thompson WL, 2004, SAMPLING RARE ELUSIV; Thomson J, 2009, ECOLOGICAL APPL, V20, P1431; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	50	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67829	10.1371/journal.pone.0067829	http://dx.doi.org/10.1371/journal.pone.0067829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861814	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700042
J	Hyde, SJ; Rao, BS; Eckenroth, BE; Jackman, JE; Doublie, S				Hyde, Samantha J.; Rao, Bhalchandra S.; Eckenroth, Brian E.; Jackman, Jane E.; Doublie, Sylvie			Structural Studies of a Bacterial tRNA(HIS) Guanylyltransferase (Thg1)-Like Protein, with Nucleotide in the Activation and Nucleotidyl Transfer Sites	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE TRNA(HIS); TRANSFER-RNAS; CATALYZES; TERMINUS; THG1	All nucleotide polymerases and transferases catalyze nucleotide addition in a 5' to 3' direction. In contrast, tRNA(His) guanylyltransferase (Thg1) enzymes catalyze the unusual reverse addition (3' to 5') of nucleotides to polynucleotide substrates. In eukaryotes, Thg1 enzymes use the 3'-5' addition activity to add G(-1) to the 5'-end of tRNA(His), a modification required for efficient aminoacylation of the tRNA by the histidyl-tRNA synthetase. Thg1-like proteins (TLPs) are found in Archaea, Bacteria, and mitochondria and are biochemically distinct from their eukaryotic Thg1 counterparts TLPs catalyze 5'-end repair of truncated tRNAs and act on a broad range of tRNA substrates instead of exhibiting strict specificity for tRNA(His). Taken together, these data suggest that TLPs function in distinct biological pathways from the tRNA(His) maturation pathway, perhaps in tRNA quality control. Here we present the first crystal structure of a TLP, from the gram-positive soil bacterium Bacillus thuringiensis (BtTLP). The enzyme is a tetramer like human THG1, with which it shares substantial structural similarity. Catalysis of the 3'-5' reaction with 5'-monophosphorylated tRNA necessitates first an activation step, generating a 5'-adenylylated intermediate prior to a second nucleotidyl transfer step, in which a nucleotide is transferred to the tRNA 5'-end. Consistent with earlier characterization of human THG1, we observed distinct binding sites for the nucleotides involved in these two steps of activation and nucleotidyl transfer. A BtTLP complex with GTP reveals new interactions with the GTP nucleotide in the activation site that were not evident from the previously solved structure. Moreover, the BtTLP-ATP structure allows direct observation of ATP in the activation site for the first time. The BtTLP structural data, combined with kinetic analysis of selected variants, provide new insight into the role of key residues in the activation step.	[Hyde, Samantha J.; Eckenroth, Brian E.; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Rao, Bhalchandra S.; Jackman, Jane E.] Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol & Mol, Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA	University of Vermont; University System of Ohio; Ohio State University	Jackman, JE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol & Mol, Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA.	jackman.14@osu.edu; sdoublie@uvm.edu	jackman, jane/AAE-1854-2022	jackman, jane/0000-0001-9291-8852; Eckenroth, Brian/0000-0003-4818-311X; Doublie, Sylvie/0000-0002-6294-5304; , Samantha/0000-0002-0235-2654	National Institutes of Health [GM087543]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health Grant GM087543 (to J.E.J.). The beamline GM/CA CAT has been funded, in whole or in part, with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad MG, 2011, RNA, V17, P613, DOI 10.1261/rna.2517111; Abad MG, 2010, P NATL ACAD SCI USA, V107, P674, DOI 10.1073/pnas.0910961107; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOLEY L, 1982, P NATL ACAD SCI-BIOL, V79, P6475, DOI 10.1073/pnas.79.21.6475; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gu WF, 2005, MOL CELL BIOL, V25, P8191, DOI 10.1128/MCB.25.18.8191-8201.2005; Gu WF, 2003, GENE DEV, V17, P2889, DOI 10.1101/gad.1148603; Heinemann IU, 2010, FEBS LETT, V584, P3567, DOI 10.1016/j.febslet.2010.07.023; Hyde SJ, 2010, P NATL ACAD SCI USA, V107, P20305, DOI 10.1073/pnas.1010436107; Jackman JE, 2008, BIOCHEMISTRY-US, V47, P4817, DOI 10.1021/bi702517q; Jackman JE, 2006, P NATL ACAD SCI USA, V103, P8640, DOI 10.1073/pnas.0603068103; Jackman JE, 2012, RNA, V18, P886, DOI 10.1261/rna.032300.112; JAHN D, 1991, J BIOL CHEM, V266, P22832; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LONERGAN KM, 1993, SCIENCE, V259, P812, DOI 10.1126/science.8430334; LONERGAN KM, 1993, NUCLEIC ACIDS RES, V21, P4402, DOI 10.1093/nar/21.18.4402; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; ORELLANA O, 1986, MOL CELL BIOL, V6, P525, DOI 10.1128/MCB.6.2.525; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Preston MA, 2010, RNA, V16, P1068, DOI 10.1261/rna.2087510; Rao BS, 2011, NUCLEIC ACIDS RES, V39, P1833, DOI 10.1093/nar/gkq976; Sawaya Michael R, 2007, Methods Mol Biol, V364, P95; Smith BA, 2012, BIOCHEMISTRY-US, V51, P453, DOI 10.1021/bi201397f; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	32	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67465	10.1371/journal.pone.0067465	http://dx.doi.org/10.1371/journal.pone.0067465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844012	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000073
J	Nov, Y				Nov, Yuval			Fitness Loss and Library Size Determination in Saturation Mutagenesis	PLOS ONE			English	Article							DIRECTED EVOLUTION; TARGETED LIBRARIES; PROTEIN EVOLUTION; LANDSCAPES; DESIGN; CONSTRUCTION; IMPROVEMENT; ALGORITHMS; MATURATION; ADDITIVITY	Saturation mutagenesis is a widely used directed evolution technique, in which a large number of protein variants, each having random amino acids in certain predetermined positions, are screened in order to discover high-fitness variants among them. Several metrics for determining the library size (the number of variants screened) have been suggested in the literature, but none of them incorporates the actual fitness of the variants discovered in the experiment. We present the results of an extensive simulation study, which is based on probabilistic models for protein fitness landscape, and which investigates how the result of a saturation mutagenesis experiment - the fitness of the best variant discovered - varies as a function of the library size. In particular, we study the loss of fitness in the experiment: the difference between the fitness of the best variant discovered, and the fitness of the best variant in variant space. Our results are that the existing criteria for determining the library size are conservative, so smaller libraries are often satisfactory. Reducing the library size can save labor, time, and expenses in the laboratory.	Univ Haifa, Dept Stat, IL-31999 Haifa, Israel	University of Haifa	Nov, Y (corresponding author), Univ Haifa, Dept Stat, IL-31999 Haifa, Israel.	yuval@stat.haifa.ac.il						Aita T, 2000, J MATH BIOL, V41, P207, DOI 10.1007/s002850000046; Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; Arnold FH, 1996, CHEM ENG SCI, V51, P5091, DOI 10.1016/S0009-2509(96)00288-6; Barak Y, 2008, ISME J, V2, P171, DOI 10.1038/ismej.2007.100; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Boersma YL, 2008, CHEM BIOL, V15, P782, DOI 10.1016/j.chembiol.2008.06.009; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brouk M, 2010, APPL ENVIRON MICROB, V76, P6397, DOI 10.1128/AEM.00878-10; Carneiro M, 2010, P NATL ACAD SCI USA, V107, P1747, DOI 10.1073/pnas.0906192106; Champion E, 2010, CHEMCATCHEM, V2, P969, DOI 10.1002/cctc.201000111; DANDEKAR T, 1992, PROTEIN ENG, V5, P637, DOI 10.1093/protein/5.7.637; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Feingersch R, 2008, APPL ENVIRON MICROB, V74, P1555, DOI 10.1128/AEM.01849-07; Firth AE, 2008, NUCLEIC ACIDS RES, V36, pW281, DOI 10.1093/nar/gkn226; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Goldsmith M, 2013, METHOD ENZYMOL, V523, P257, DOI 10.1016/B978-0-12-394292-0.00012-6; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hughes MD, 2003, J MOL BIOL, V331, P973, DOI 10.1016/S0022-2836(03)00833-7; KAUFFMAN SA, 1989, J THEOR BIOL, V141, P211, DOI 10.1016/S0022-5193(89)80019-0; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; Maeda T, 2008, APPL MICROBIOL BIOT, V79, P77, DOI 10.1007/s00253-008-1416-3; Nov Y, 2005, J COMPUT BIOL, V12, P247, DOI 10.1089/cmb.2005.12.247; Nov Y, 2012, APPL ENVIRON MICROB, V78, P258, DOI 10.1128/AEM.06265-11; Patrick WM, 2005, BIOMOL ENG, V22, P105, DOI 10.1016/j.bioeng.2005.06.001; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Pavelka A, 2009, NUCLEIC ACIDS RES, V37, pW376, DOI 10.1093/nar/gkp410; Prasad S, 2011, CHEMPHYSCHEM, V12, P1550, DOI 10.1002/cphc.201100031; Reetz MT, 2008, CHEM COMMUN, P5499, DOI 10.1039/b813388c; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2013, ANGEW CHEM INT EDIT, V52, P2658, DOI 10.1002/anie.201207842; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Skinner MM, 1996, P NATL ACAD SCI USA, V93, P10753, DOI 10.1073/pnas.93.20.10753; SLEPIAN D, 1962, BELL SYST TECH J, V41, P463, DOI 10.1002/j.1538-7305.1962.tb02419.x; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Tang LX, 2012, BIOTECHNIQUES, V52, P149, DOI 10.2144/000113820; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Williams GJ, 2008, CHEM BIOL, V15, P393, DOI 10.1016/j.chembiol.2008.02.017; Wu HR, 1998, P NATL ACAD SCI USA, V95, P6037, DOI 10.1073/pnas.95.11.6037; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182	45	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68069	10.1371/journal.pone.0068069	http://dx.doi.org/10.1371/journal.pone.0068069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844158	Green Published, gold			2022-12-25	WOS:000321733000127
J	Shionome, T; Endo, S; Omagari, D; Asano, M; Toyoma, H; Ishigami, T; Komiyama, K				Shionome, Takashi; Endo, Shigeki; Omagari, Daisuke; Asano, Masatake; Toyoma, Hitoshi; Ishigami, Tomohiko; Komiyama, Kazuo			Nickel Ion Inhibits Nuclear Factor-Kappa B Activity in Human Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; HUMAN HEAD; SIGNALING PATHWAYS; GENE-EXPRESSION; TUMOR-GROWTH; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; METAL-IONS; RECEPTOR 4; IN-VIVO	Background: The spontaneous IL-8 secretion observed in OSCC is partially dependent on the disregulated activity of transcription factor NF-kappa B. Nickel compounds are well established human carcinogens, however, little is known about the influence of nickel on the spontaneous secretion of IL-8 in oral squamous cell carcinoma (OSCC) cells. The aim of the present study was to investigate whether Ni2+ ions can influence on IL-8 secretion by OSCC. Methods and Results: The IL-8 secretion was measured by ELISA. The expression of IL-8 mRNA was examined by real-time PCR. The NF-kappa B activity was measured by luciferase assay. The phosphorylation status and nuclear localization of NF-kappa B subunits were examined by Western blotting or Transfactor kit and immunofluorescence staining, respectively. The interaction of NF-kappa B p50 subunit and Ni2+ ions was examined by Ni2+-column pull down assay. The site-directed mutagenesis was used to generate a series of p50 mutants. Scratch motility assay was used to monitor the cell mobility. Our results demonstrated that, on the contrary to our expectations, Ni2+ ions inhibited the spontaneous secretion of IL-8. As IL-8 reduction was observed in a transcriptional level, we performed the luciferase assay and the data indicated that Ni2+ ions reduced the NF-kappa B activity. Measurement of p50 subunit in the nucleus and the immunofluorescence staining revealed that the inhibitory effect of Ni2+ ions was attributed to the prevention of p50 subunit accumulation to the nucleus. By Ni2+-column pull down assay, Ni2+ ions were shown to interact directly with His cluster in the N-terminus of p50 subunit. The inhibitory effect of Ni2+ ions was reverted in the transfectant expressing the His cluster-deleted p50 mutant. Moreover, Ni2+ ions inhibited the OSCC mobility in a dose dependent fashion. Conclusions: Taken together, inhibition of NF-kappa B activity by Ni2+ ion might be a novel therapeutic strategy for the treatment of oral cancer.	[Shionome, Takashi; Endo, Shigeki; Toyoma, Hitoshi; Ishigami, Tomohiko] Nihon Univ, Sch Dent, Dept Partial Denture Prosthodont, Tokyo 101, Japan; [Omagari, Daisuke; Asano, Masatake; Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan	Nihon University; Nihon University	Asano, M (corresponding author), Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan.	asano.masatake@nihon-u.ac.jp	Asano, Masatake/ABH-5102-2020		Nihon University Joint Research Grant; Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT) [S1001024, 23592778]; Health and Labour Sciences Research Grants and Research on international cooperation in medical science; Promotion and Mutual Aid Corporation for Private Schools of Japan	Nihon University Joint Research Grant; Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT); Health and Labour Sciences Research Grants and Research on international cooperation in medical science; Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This work was supported by Nihon University Joint Research Grant for 2010-2012 (to Dr. Okayama and Dr. Imamura); a grant of Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT), 2010-2014 (S1001024) and 2011-2013 (23592778); Health and Labour Sciences Research Grants and Research on international cooperation in medical science; The Promotion and Mutual Aid Corporation for Private Schools of Japan (2011); and Grant-in-aid for Scientific Research (C) (2011-2013). The funders had no role in study design, deta collection and analysis, decision to publish, or preparation of the manuscript.	Allen CT, 2007, HEAD NECK-J SCI SPEC, V29, P959, DOI 10.1002/hed.20615; Antonios D, 2010, J IMMUNOL, V185, P89, DOI 10.4049/jimmunol.0901992; Asano M, 1998, J IMMUNOL METHODS, V214, P131, DOI 10.1016/S0022-1759(98)00052-0; Asano M, 2004, DNA CELL BIOL, V23, P403, DOI 10.1089/1044549041474779; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bindhu OS, 2006, HEAD NECK-J SCI SPEC, V28, P916, DOI 10.1002/hed.20437; BRUNE D, 1986, BIOMATERIALS, V7, P163, DOI 10.1016/0142-9612(86)90097-9; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Cangul H, 2002, TOXICOL LETT, V127, P69, DOI 10.1016/S0378-4274(01)00485-4; Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008; Cruz MT, 2004, EXP DERMATOL, V13, P18, DOI 10.1111/j.0906-6705.2004.00105.x; Duffey DC, 1999, CANCER RES, V59, P3468; GOEBELER M, 1995, J IMMUNOL, V155, P2459; GUENICHE A, 1994, ARCH DERMATOL RES, V286, P466, DOI 10.1007/BF00371573; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Gursoy UK, 2007, EUR J ORTHODONT, V29, P555, DOI 10.1093/ejo/cjm074; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-343; Hirose K, 1996, ORAL MICROBIOL IMMUN, V11, P402, DOI 10.1111/j.1399-302X.1996.tb00202.x; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hosoki M, 2009, BIO-MED MATER ENG, V19, P53, DOI 10.3233/BME-2009-0563; Hsieh PC, 2010, J CLIN PERIODONTOL, V37, P705, DOI 10.1111/j.1600-051X.2010.01542.x; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lewis JB, 2005, J BIOMED MATER RES A, V74A, P474, DOI 10.1002/jbm.a.30383; Lewis JB, 2003, J BIOMED MATER RES A, V67A, P868, DOI 10.1002/jbm.a.10169; Lin L, 1996, MOL CELL BIOL, V16, P2248; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Mishra A, 2006, INT J CANCER, V119, P2840, DOI 10.1002/ijc.22262; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; NAVARRO C, 1993, MOL MICROBIOL, V9, P1181, DOI 10.1111/j.1365-2958.1993.tb01247.x; Omagari D, 2009, CLIN EXP IMMUNOL, V156, P294, DOI 10.1111/j.1365-2249.2009.03892.x; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; ROBERTS RS, 1989, TOXICOL IND HEALTH, V5, P975; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; SALNIKOW K, 1994, CANCER RES, V54, P6407; Sawhney M, 2007, INT J CANCER, V120, P2545, DOI 10.1002/ijc.22657; Scardina GA, 2009, MED ORAL PATOL ORAL, V14, pE558, DOI 10.4317/medoral.14.e558; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Schulz GE, 1993, CURR OPIN CELL BIOL, V5, P701, DOI 10.1016/0955-0674(93)90143-E; SHEN HM, 1994, ENVIRON HEALTH PERSP, V102, P275, DOI 10.1289/ehp.94102s1275; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H; Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5	50	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68257	10.1371/journal.pone.0068257	http://dx.doi.org/10.1371/journal.pone.0068257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844176	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000135
J	Hurtado, LA; Lee, EJ; Mateos, M				Hurtado, Luis A.; Lee, Eun Jung; Mateos, Mariana			Contrasting Phylogeography of Sandy vs. Rocky Supralittoral Isopods in the Megadiverse and Geologically Dynamic Gulf of California and Adjacent Areas	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; BAYESIAN PHYLOGENETIC INFERENCE; BAJA-CALIFORNIA; BEACH ISOPOD; POPULATION DIFFERENTIATION; CRUSTACEA ONISCIDEA; SOUTHERN-CALIFORNIA; CRYPTIC VICARIANCE; HISTORY; EVOLUTION	Phylogeographic studies of animals with low vagility and restricted to patchy habitats of the supralittoral zone, can uncover unknown diversity and shed light on processes that shaped evolution along a continent's edge. The Pacific coast between southern California and central Mexico, including the megadiverse Gulf of California, offers a remarkable setting to study biological diversification in the supralittoral. A complex geological history coupled with cyclical fluctuations in temperature and sea level provided ample opportunities for diversification of supralittoral organisms. Indeed, a previous phylogeographic study of Ligia, a supralittoral isopod that has limited dispersal abilities and is restricted to rocky patches, revealed high levels of morphologically cryptic diversity. Herein, we examined phylogeographic patterns of Tylos, another supralittoral isopod with limited dispersal potential, but whose habitat (i.e., sandy shores) appears to be more extensive and connected than that of Ligia. We conducted Maximum Likelihood and Bayesian phylogenetic analyses on mitochondrial and nuclear DNA sequences. These analyses revealed multiple highly divergent lineages with discrete regional distributions, despite the recognition of a single valid species for this region. A traditional species-diagnostic morphological trait distinguished several of these lineages. The phylogeographic patterns of Tylos inside the Gulf of California show a deep and complex history. In contrast, patterns along the Pacific region between southern California and the Baja Peninsula indicate a recent range expansion, probably postglacial and related to changes in sea surface temperature (SST). In general, the phylogeographic patterns of Tylos differed from those of Ligia. Differences in the extension and connectivity of the habitats occupied by Tylos and Ligia may account for the different degrees of population isolation experienced by these two isopods and their contrasting phylogeographic patterns. Identification of divergent lineages of Tylos in the study area is important for conservation, as some populations are threatened by human activities.	[Hurtado, Luis A.; Lee, Eun Jung; Mateos, Mariana] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hurtado, LA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lhurtado@tamu.edu	Hurtado, Luis A/B-5953-2008; Mateos, Mariana/B-5235-2008	Hurtado, Luis A/0000-0002-9773-4996; Mateos, Mariana/0000-0001-5738-0145	NSF [DEB 0743782]; TAMU-CONACyT; Division Of Environmental Biology [0743782] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); TAMU-CONACyT; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF grant DEB 0743782 to LAH and MM, and by TAMU-CONACyT grants to LAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWATER T, 1989, E PACIFIC OCEAN HAWA, P21, DOI DOI 10.1130/DNAG-GNA-N.21; Audouin V., 1826, DESCRIPTION EGYPTE H, P77; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; BROWN AC, 1994, ADV MAR BIOL, V30, P89, DOI 10.1016/S0065-2881(08)60062-0; Brown AC, 2001, ENCY OCEAN SCI, V5, P2496; Brusca RC, 1980, COMMON INTERTIDAL IN, P220; Brusca Richard C., 2010, P72; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; Camacho-Ibar VF, 2003, ORG GEOCHEM, V34, P425, DOI 10.1016/S0146-6380(02)00211-5; Carefoot Thomas H., 1995, Crustacean Issues, V9, P47; Carreno AL, 2002, NEW ISLAND BIOGEOGRA; Carvajal Maria de los Angeles, 2010, P219; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dorsey RJ, 1997, PLIOCENE CARBONATES, P83; Eberl R, J BIOGEOGR IN PRESS; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Escalona-Alcazar F.J., 2001, REV MEX CIENC GEOL, V18, P111; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fallaci M, 1996, MAR BIOL, V125, P751, DOI 10.1007/BF00349258; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Graham MH, 2003, TRENDS ECOL EVOL, V18, P33, DOI 10.1016/S0169-5347(02)00006-X; Grantham BA, 2003, ECOL APPL, V13, pS108; Grismer L., 1994, HERPETOLOGICAL NATUR, V2, P51; HAMNER WM, 1969, ECOLOGY, V50, P442, DOI 10.2307/1933895; HARPENDING HC, 1994, HUM BIOL, V66, P591; HAYES WB, 1970, ECOLOGY, V51, P721, DOI 10.2307/1934054; HAYES WB, 1977, PAC SCI, V31, P165; Held C, 2001, POLAR BIOL, V24, P497, DOI 10.1007/s003000100245; Helenes J, 2009, MAR MICROPALEONTOL, V72, P10, DOI 10.1016/j.marmicro.2009.02.003; Helenes J, 1999, J S AM EARTH SCI, V12, P589, DOI 10.1016/S0895-9811(99)00042-5; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; HOLANOV SH, 1980, J EXP MAR BIOL ECOL, V46, P81, DOI 10.1016/0022-0981(80)90093-3; Holt JW, 2000, GEOL SOC AM BULL, V112, P540, DOI 10.1130/0016-7606(2000)112<540:AACOGO>2.0.CO;2; Hubbard DM, ESTUAR COAS IN PRESS; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurtado LA, 2007, MAR BIOL, V151, P1863, DOI 10.1007/s00227-007-0620-5; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; Inman D.L, 1983, QUATERNARY COASTLINE, P1; Johnson ME, 2009, ATLAS COASTAL ECOSYS, P28; KARIG DE, 1972, EARTH PLANET SC LETT, V17, P169, DOI 10.1016/0012-821X(72)90272-5; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kawai Y, 2007, J OCEANOGR, V63, P721, DOI 10.1007/s10872-007-0063-0; KENSLEY B, 1974, Annals of the South African Museum, V65, P401; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LARSON RL, 1972, GEOL SOC AM BULL, V83, P3345, DOI 10.1130/0016-7606(1972)83[3345:BMAAPT]2.0.CO;2; Ledesma-Vasquez J, 2010, GULF CALIFORNIA BIOD, P7; Ledesma-Vasquez J, 2002, REV MEXICANA CIENCIA, V19, P145; Ledesma-Vazquez J., 2009, ATLAS COASTAL ECOSYS; Lee EJ, 2012, THESIS TEXAS A M U C; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Leyva C, 2006, NAT AREA J, V26, P117, DOI 10.3375/0885-8608(2006)26[117:CLFBTD]2.0.CO;2; Lindell J, 2005, MOL PHYLOGENET EVOL, V36, P682, DOI 10.1016/j.ympev.2005.04.031; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; Masselink G., 2003, INTRO COASTAL PROCES; McLachlan A, 2006, ECOLOGY SANDY SHORES, P91, DOI [10.1016/B978-012372569-1/50006-9, DOI 10.1016/B978-012372569-1/50006-9]; Meldahl Keith H., 1997, Geological Society of America Special Paper, V318, P39; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; Mortyn PG, 1996, PALEOCEANOGRAPHY, V11, P415, DOI 10.1029/96PA01236; MULAIK S. B., 1960, REV SOC MEX HIST NAT, V21, P79; Murphy Robert W., 2002, P181; Ochoa-Landin L., 2000, REV MEXICANA CIENCIA, V17, P83; Oskin M, 2003, GEOLOGY, V31, P23, DOI 10.1130/0091-7613(2003)031<0023:MISWPB>2.0.CO;2; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Palumbi Stephen R., 1996, P205; Peterson CH, 2005, BIOSCIENCE, V55, P887, DOI 10.1641/0006-3568(2005)055[0887:ATEIOB]2.0.CO;2; Podsiadlowski L, 2005, MAR BIOTECHNOL, V7, P618, DOI 10.1007/s10126-005-0017-8; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5 MCMC TRA; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; Riginos C, 2005, EVOLUTION, V59, P2678; Roehrdanz RL, 2002, MOL BIOL EVOL, V19, P841, DOI 10.1093/oxfordjournals.molbev.a004141; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schmalfuss Helmut, 2000, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V612, P1; Schmalfuss Helmut, 2003, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V654, P1; Schneider S, 1999, GENETICS, V152, P1079; SCHOENHERR AA, 1999, NATURAL HIST ISLANDS; SCHULTZ G A, 1970, Crustaceana (Leiden), V19, P297, DOI 10.1163/156854070X00383; SCHULTZ GA, 1984, J CRUSTACEAN BIOL, V4, P154, DOI 10.2307/1547904; Seapy R. R., 1980, CALIFORNIA ISLANDS, P307; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stock J. M., 2000, GEOLOGICAL SOC AM SP, V334, P143, DOI DOI 10.1130/0-8137-2334-5.143; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Taiti Stefano, 2004, V20, P211; Taiti Stefano, 1996, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V18, P459; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YM, 2012, J APPL METEOROL CLIM, V51, P986, DOI 10.1175/JAMC-D-11-0253.1; Van Name W. C., 1924, Zoologica New York, V5, P181; Van Name WG, 1936, B AM MUS NAT HIST, V71, P1; VANDEL ALBERT, 1960, FAUNE DE FRANCE, V64, P1; VANDENDOOL HM, 1985, MON WEATHER REV, V113, P878, DOI 10.1175/1520-0493(1985)113<0878:SALRAT>2.0.CO;2; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Wetzer R, 2001, CONTRIB ZOOL, V70, P23, DOI 10.1163/18759866-07001002; Wildish DJ, 2012, J NAT HIST, V46, P2329, DOI 10.1080/00222933.2012.708458; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zwickl D., 2006, GARLI GENETIC ALGORI	105	29	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67827	10.1371/journal.pone.0067827	http://dx.doi.org/10.1371/journal.pone.0067827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844103	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000105
J	Wang, F; Wang, PX; Wu, XL; Dang, SY; Chen, Y; Ni, YY; Gao, LH; Lu, SY; Kuang, Y; Huang, L; Fei, J; Wang, ZG; Pang, XF				Wang, Fang; Wang, Pei-xia; Wu, Xiao-lin; Dang, Su-ying; Chen, Yan; Ni, Ying-yin; Gao, Li-hong; Lu, Shun-yuan; Kuang, Ying; Huang, Lei; Fei, Jian; Wang, Zhu-gang; Pang, Xiao-fen			Deficiency of Adiponectin Protects against Ovariectomy-Induced Osteoporosis in Mice	PLOS ONE			English	Article							BONE-MINERAL DENSITY; MESENCHYMAL STEM-CELLS; MAPK SIGNALING PATHWAY; BODY-COMPOSITION; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; SERUM ADIPONECTIN; HUMAN OSTEOBLASTS; IN-VITRO; DIFFERENTIATION	Adipokine adiponectin (APN) has been recently reported to play a role in regulating bone mineral density (BMD). To explore the mechanism by which APN affects BMD, we investigated BMD and biomechanical strength properties of the femur and vertebra in sham-operated (Sham) and ovariectomized (OVX) APN knockout (KO) mice as compared to their operated wildtype (WT) littermates. The results show that APN deficiency has no effect on BMD but induces increased ALP activity and osteoclast cell number. While OVX indeed leads to significant bone loss in both femora and vertebras of WT mice with comparable osteogenic activity and a significant increase in osteoclast cell number when compared to that of sham control. However, no differences in BMD, ALP activity and osteoclast cell number were found between Sham and OVX mice deficient for APN. Further studies using bone marrow derived mesenchymal stem cells (MSCs) demonstrate an enhanced osteogenic differentiation and extracellular matrix calcification in APN KO mice. The possible mechanism for APN deletion induced acceleration of osteogenesis could involve increased proliferation of MSCs and higher expression of Runx2 and Osterix genes. These findings indicate that APN deficiency can protect against OVX-induced osteoporosis in mice, suggesting a potential role of APN in regulating the balance of bone formation and bone resorption, especially in the development of post-menopausal osteoporosis.	[Wang, Fang; Wu, Xiao-lin; Dang, Su-ying; Chen, Yan; Ni, Ying-yin; Huang, Lei; Wang, Zhu-gang] Shanghai Jiao Tong Univ, Dept Med Genet, E Inst Shanghai Univ, Sch Med SJTUSM, Shanghai 200030, Peoples R China; [Wang, Pei-xia; Gao, Li-hong; Pang, Xiao-fen] SJTUSM, Ruijin Hosp, Dept Geriatr, Shanghai, Peoples R China; [Lu, Shun-yuan; Kuang, Ying; Fei, Jian; Wang, Zhu-gang] Shanghai Res Ctr Model Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Pang, XF (corresponding author), SJTUSM, Ruijin Hosp, Dept Geriatr, Shanghai, Peoples R China.	xiaofenpang@yeah.net		Chen, Yan/0000-0001-5325-1151; Huang, Lei/0000-0002-4851-4807	National Natural Science Foundation of China [31000986, 30900156, 81071444]; Shanghai Science and Technology Commission [09JC1410300]; Health Bureau of Shanghai [2008053]; National Natural Science Foundation of Shanghai [10ZR1417400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Health Bureau of Shanghai; National Natural Science Foundation of Shanghai	This work is partially supported by the grants from the National Natural Science Foundation of China (31000986, 30900156, 81071444, URL: http://www.nsfc.gov. cn/Portal0/default152.htm), Shanghai Science and Technology Commission (09JC1410300, URL: http://www.stcsm.gov.cn/structure/index.htm), the Health Bureau of Shanghai (2008053, URL: http://wsj.sh.gov.cn/), and by grants from the National Natural Science Foundation of Shanghai (10ZR1417400, URL: http://www.stcsm.gov.cn/structure/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchetta J, 2009, NEPHROL DIAL TRANSPL, V24, P3120, DOI 10.1093/ndt/gfp262; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Buckwalter J A, 1987, Instr Course Lect, V36, P27; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Chao D, 2000, J AM GERIATR SOC, V48, P753, DOI 10.1111/j.1532-5415.2000.tb04749.x; Crepaldi G, 2007, J ENDOCRINOL INVEST, V30, P610, DOI 10.1007/BF03346357; Douchi T, 2000, OBSTET GYNECOL, V96, P13, DOI 10.1016/S0029-7844(00)00814-0; Ealey KN, 2008, EXP BIOL MED, V233, P1546, DOI 10.3181/0806-RM-192; Frost M, 2007, CALCIFIED TISSUE INT, V87, P36; Hankenson KD, 2000, J BONE MINER RES, V15, P851, DOI 10.1359/jbmr.2000.15.5.851; Ijuin M, 2002, MATURITAS, V43, P239, DOI 10.1016/S0378-5122(02)00273-6; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jurimae J, 2007, OSTEOPOROSIS INT, V18, P1253, DOI 10.1007/s00198-007-0365-5; Jun AY, 2012, FITOTERAPIA, V83, P1523, DOI 10.1016/j.fitote.2012.08.020; Jurimae J, 2005, HORM METAB RES, V37, P297, DOI 10.1055/s-861483; Jurimae J, 2007, AM J PHYSIOL-ENDOC M, V293, pE42, DOI 10.1152/ajpendo.00610.2006; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010; Lei Xianyang, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P559; Lenchik L, 2003, BONE, V33, P646, DOI 10.1016/S8756-3282(03)00237-0; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Magni P, 2010, CURR MOL MED, V10, P522; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; Park HA, 2007, J CLIN ENDOCR METAB, V92, P3809, DOI 10.1210/jc.2007-1040; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radak TL, 2004, NUTR REV, V62, P468, DOI 10.1111/j.1753-4887.2004.tb00019.x; Ren WH, 2006, PROG BIOCHEM BIOPHYS, V33, P846; Rendina E, 2012, J NUTR BIOCHEM, V23, P60, DOI 10.1016/j.jnutbio.2010.10.010; Richards JB, 2007, J CLIN ENDOCR METAB, V92, P1517, DOI 10.1210/jc.2006-2097; Riedt CS, 2005, J BONE MINER RES, V20, P455, DOI 10.1359/JBMR.041132; Ruscica M, 2012, VITAM HORM, V90, P321, DOI 10.1016/B978-0-12-398313-8.00012-9; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Shu RZ, 2009, LAB INVEST, V89, P1043, DOI 10.1038/labinvest.2009.63; Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639; Yamaguchi N, 2008, FEBS LETT, V582, P451, DOI 10.1016/j.febslet.2007.12.037; Yamaguchi N, 2007, FEMS IMMUNOL MED MIC, V49, P28, DOI 10.1111/j.1574-695X.2006.00164.x; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zhang H, 2010, J ENDOCRINOL INVEST, V33, P707, DOI [10.1007/BF03346674, 10.3275/6886]	46	10	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68497	10.1371/journal.pone.0068497	http://dx.doi.org/10.1371/journal.pone.0068497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844209	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000165
J	Zhan, WH; Shaboltas, AV; Skochilov, RV; Krasnoselskikh, TV; Abdala, N				Zhan, Weihai; Shaboltas, Alla V.; Skochilov, Roman V.; Krasnoselskikh, Tatiana V.; Abdala, Nadia			History of Childhood Abuse, Sensation Seeking, and Intimate Partner Violence under/Not under the Influence of a Substance: A Cross-Sectional Study in Russia	PLOS ONE			English	Article							ST-PETERSBURG; HISPANIC COUPLES; PHYSICAL ABUSE; ALCOHOL-USE; DRUG-USE; RISK; WOMEN; PERPETRATION; EXPERIENCES; BEHAVIORS	Objectives: To examine correlates of perpetration and victimization of intimate partner violence (IPV) under and not under the influence of a substance, we conducted a study among women in Russia. Methods: In 2011, a cross-sectional survey was conducted among patients receiving services at a clinic for sexually transmitted infections in St. Petersburg, Russia. Multinomial logistic regression was used for analysis. Results: Of 299 women, 104 (34.8%) and 113 (37.8%) reported a history of IPV perpetration and victimization, respectively. Nearly half (47.1%) of perpetrators and 61.1% of victims reported that the latest IPV event (perpetration and victimization, respectively) was experienced under the influence of a substance. Factors independently associated with IPV victimization under the influence of a substance were alcohol misuse and a higher number of lifetime sex partners, whereas only experience of childhood abuse (emotional and physical abuse) was independently associated with IPV victimization that did not occur under the influence of a substance. Childhood physical abuse, lower age of first sex, sensation seeking, and alcohol misuse were independently associated with IPV perpetration under the influence of a substance, while only childhood abuse (emotional and physical abuse) was independently associated with IPV perpetration that did not occur under the influence of a substance. Conclusions: IPV under and not under the influence of a substance had different correlates (e. g., alcohol misuse and sensation seeking). Despite the strong association between substance use and IPV, experience of childhood abuse is an important predictor of IPV perpetration and victimization in Russia, above and beyond substance use.	[Zhan, Weihai; Abdala, Nadia] Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA; [Shaboltas, Alla V.; Skochilov, Roman V.] St Petersburg State Univ, Dept Psychol, St Petersburg 199034, Russia; [Krasnoselskikh, Tatiana V.] St Petersburg Pavlov State Med Univ, Dept Dermatol & Venereal Dis, St Petersburg, Russia	Yale University; Saint Petersburg State University; Pavlov First Saint Petersburg State Medical University	Abdala, N (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.	nadia.abdala@yale.edu	Krasnoselskikh, Tatiana V/T-5370-2018; Shaboltas, Alla/AAP-7007-2020; Skochilov, Roman V/H-6541-2013; Shaboltas, Alla/AAP-7050-2020	Krasnoselskikh, Tatiana V/0000-0002-2278-5393; Skochilov, Roman V/0000-0001-6046-7655; Shaboltas, Alla/0000-0002-1966-6924	National Institute on Alcohol Abuse and Alcoholism [R01AA017389]; National Institute of Mental Health [T32MH020031]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294, T32MH020031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017389] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by grant number R01AA017389 (PI: N. Abdala) from the National Institute on Alcohol Abuse and Alcoholism (http://www.nih.gov/icd/). This study was supported by the award number T32MH020031 from the National Institute of Mental Health (http://www.nih.gov/icd/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-676; Babor TF, 2001, CH1211 WHO DEP MENT; Bell KM, 2008, CLIN PSYCHOL REV, V28, P1096, DOI 10.1016/j.cpr.2008.03.003; Berzenski S.R., 2010, J AGGRESS MALTREAT T, V19, P180, DOI [https://doi.org/10.1080/10926770903539474, DOI 10.1080/10926770903539474]; Caetano R, 2001, ALCOHOL RES HEALTH, V25, P58; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Castro R, 2003, AM J PUBLIC HEALTH, V93, P1110, DOI 10.2105/AJPH.93.7.1110; CHERMACK ST, 1995, J STUD ALCOHOL, V56, P449, DOI 10.15288/jsa.1995.56.449; Coid J, 2001, LANCET, V358, P450, DOI 10.1016/S0140-6736(01)05622-7; Coker AL, 2000, AM J PUBLIC HEALTH, V90, P553, DOI 10.2105/AJPH.90.4.553; Coleman S, 2012, AIDS CARE; Cunradi CB, 1999, ALCOHOL CLIN EXP RES, V23, P1492, DOI 10.1111/j.1530-0277.1999.tb04672.x; Derefinko K, 2011, AGGRESSIVE BEHAV, V37, P223, DOI 10.1002/ab.20387; Dixon L, 2011, CLIN PSYCHOL REV, V31, P1145, DOI 10.1016/j.cpr.2011.07.001; Donohew RL, 1999, J STUD ALCOHOL, V60, P622, DOI 10.15288/jsa.1999.60.622; Ehrensaft MK, 2003, J CONSULT CLIN PSYCH, V71, P741, DOI 10.1037/0022-006X.71.4.741; Fals-Stewart W, 2003, ADDICT BEHAV, V28, P1555, DOI 10.1016/j.addbeh.2003.08.035; Fang XM, 2007, AM J PREV MED, V33, P281, DOI 10.1016/j.amepre.2007.06.003; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Gil-Gonzalez D, 2008, J PUBLIC HEALTH-UK, V30, P14, DOI 10.1093/pubmed/fdm071; Herrenkohl Todd I, 2004, Violence Vict, V19, P123, DOI 10.1891/088667004780927954; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Kalichman SC, 2006, PSYCHOL ADDICT BEHAV, V20, P298, DOI 10.1037/0893-164X.20.3.298; LEONARD KE, 1993, J STUD ALCOHOL, P96, DOI 10.15288/jsas.1993.s11.96; Lokhmatkina NV, 2010, FAM PRACT, V27, P625, DOI 10.1093/fampra/cmq044; Lysova AV, 2008, J INTERPERS VIOLENCE, V23, P1579, DOI 10.1177/0886260508314320; Marcus RF, 2012, VIOLENCE VICTIMS, V27, P299, DOI 10.1891/0886-6708.27.3.299; Ross JM, 2011, BEHAV SCI LAW, V29, P711, DOI 10.1002/bsl.1004; Saewyc EM, 2009, J ADOLESCENT HEALTH, V45, P587, DOI 10.1016/j.jadohealth.2009.03.024; Schafer J, 2004, J INTERPERS VIOLENCE, V19, P127, DOI 10.1177/0886260503260244; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Swogger MT, 2012, CRIM JUSTICE BEHAV, V39, P910, DOI 10.1177/0093854812438160; Temple JR, 2008, ADDICT BEHAV, V33, P1244, DOI 10.1016/j.addbeh.2008.05.005; Tjaden P, 2000, EXTENT NATURE CONSEQ; Whitfield CL, 2003, J INTERPERS VIOLENCE, V18, P166, DOI 10.1177/0886260502238733; Zhan WH, 2012, J TRAUMA STRESS, V25, P86, DOI 10.1002/jts.21658; Zhan WH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-629	38	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68027	10.1371/journal.pone.0068027	http://dx.doi.org/10.1371/journal.pone.0068027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844148	Green Submitted, gold, Green Published			2022-12-25	WOS:000321341000130
J	Hartmann, W; Brenz, Y; Kingsley, MT; Ajonina-Ekoti, I; Brattig, NW; Liebau, E; Breloer, M				Hartmann, Wiebke; Brenz, Yannick; Kingsley, Manchang Tanyi; Ajonina-Ekoti, Irene; Brattig, Norbert W.; Liebau, Eva; Breloer, Minka			Nematode-Derived Proteins Suppress Proliferation and Cytokine Production of Antigen-Specific T Cells via Induction of Cell Death	PLOS ONE			English	Article							EXCRETORY-SECRETORY PRODUCTS; HUMAN ONCHOCERCIASIS; TETANUS VACCINATION; HUMORAL RESPONSES; FASCIOLA-HEPATICA; EOSINOPHIL APOPTOSIS; LYMPHATIC FILARIASIS; ALLERGIC RESPONSES; HELMINTH; INFECTION	In order to establish long-lasting infections in their mammalian host, filarial nematodes have developed sophisticated strategies to dampen their host's immune response. Proteins that are actively secreted by the parasites have been shown to induce the expansion of regulatory T cells and to directly interfere with effector T cell function. Here, we analyze the suppressive capacity of Onchocerca volvulus-derived excreted/secreted proteins. Addition of two recombinant O. volvulus proteins, abundant larval transcript-2 (OvALT-2) and novel larval transcript-1 (OvNLT-1) to cell cultures of T cell receptor transgenic CD4(+) and CD8(+) T cells suppressed antigen-specific stimulation in vitro. Ovalbumin-specific CD4(+) DO11.10 and OT-II T cells that had been stimulated with their cognate antigen in the presence of OvALT-2 or OvNLT-1 displayed reduced DNA synthesis quantified by H-3-thymidine incorporation and reduced cell division quantified by CFSE dilution. Furthermore, the IL-2 and IFN-gamma response of ovalbumin-specific CD8(+) OT-I T cells was suppressed by OvALT-2 and OvNLT-1. In contrast, another recombinant O. volvulus protein, microfilariae surface-associated antigen (Ov103), did not modulate T cell activation, thus serving as internal control for non-ESP-mediated artifacts. Suppressive capacity of the identified ESP was associated with induction of apoptosis in T cells demonstrated by increased exposure of phosphatidylserine on the plasma membrane. Of note, the digestion of recombinant proteins with proteinase K did not abolish the suppression of antigen-specific proliferation although the suppressive capacity of the identified excreted/secreted products was not mediated by low molecular weight contaminants in the undigested preparations. In summary, we identified two suppressive excreted/secreted products from O. volvulus, which interfere with the function of antigen-specific T cells in vitro.	[Hartmann, Wiebke; Brenz, Yannick; Kingsley, Manchang Tanyi; Brattig, Norbert W.; Breloer, Minka] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Kingsley, Manchang Tanyi] Wakwa Reg Ctr, Vet Res Lab, Inst Agr Res Dev, Ngaoundere, Cameroon; [Ajonina-Ekoti, Irene; Liebau, Eva] Univ Munster, Inst Anim Physiol, D-48149 Munster, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Munster	Breloer, M (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	breloer@bnitm.de	Breloer, Minka/F-3999-2018	Breloer, Minka/0000-0001-6199-4908	Deutsche Forschungsgemeinschaft [PAK 296 BR 1020/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft grant number PAK 296 BR 1020/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2001, INFECT IMMUN, V69, P262, DOI 10.1128/IAI.69.1.262-270.2001; Bennett SRM, 1998, J EXP MED, V188, P1977, DOI 10.1084/jem.188.11.1977; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTTNER DW, 1988, TROP MED PARASITOL, V39, P73; Chu BK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000708; CLOS J, 1994, PROTEIN EXPRES PURIF, V5, P133, DOI 10.1006/prep.1994.1020; Cooper PJ, 1999, INFECT IMMUN, V67, P5951, DOI 10.1128/IAI.67.11.5951-5957.1999; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Danilowicz-Luebert E, 2013, INT J PARASITOL, V43, P201, DOI 10.1016/j.ijpara.2012.10.014; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Guasconi L, 2012, VET IMMUNOL IMMUNOP, V148, P359, DOI 10.1016/j.vetimm.2012.06.022; Harnett W, 2008, PARASITE IMMUNOL, V30, P447, DOI 10.1111/j.1365-3024.2008.01045.x; Hartmann W, 2012, EXP PARASITOL, V132, P69, DOI 10.1016/j.exppara.2011.06.001; Hartmann W, 2011, J IMMUNOL, V187, P4088, DOI 10.4049/jimmunol.1004136; Helmby H, 2009, PARASITOL INT, V58, P121, DOI 10.1016/j.parint.2009.02.001; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hoerauf A, 2003, MICROBES INFECT, V5, P261, DOI 10.1016/S1286-4579(03)00026-1; Kolbaum J, 2011, EUR J IMMUNOL; Lizotte-Waniewski M, 2000, INFECT IMMUN, V68, P3491, DOI 10.1128/IAI.68.6.3491-3501.2000; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2001, PARASITE IMMUNOL, V23, P327, DOI 10.1046/j.1365-3024.2001.00397.x; McSorley HJ, 2012, EUR J IMMUNOL, V42, P2667, DOI 10.1002/eji.201142161; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Nono JK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001516; Nookala S, 2004, INFECT IMMUN, V72, P2598, DOI 10.1128/IAI.72.5.2598-2604.2004; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Sartono E, 1995, PARASITE IMMUNOL, V17, P587, DOI 10.1111/j.1365-3024.1995.tb01002.x; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Schonemeyer A, 2001, J IMMUNOL, V167, P3207, DOI 10.4049/jimmunol.167.6.3207; Serradell MC, 2007, VET IMMUNOL IMMUNOP, V117, P197, DOI 10.1016/j.vetimm.2007.03.007; Serradell MC, 2009, MOL BIOCHEM PARASIT, V163, P95, DOI 10.1016/j.molbiopara.2008.10.005; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subramanian S, 2004, PARASITOLOGY, V128, P467, DOI 10.1017/S0031182004004822; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Trujillo-Vargas CM, 2007, AM J RESP CRIT CARE, V175, P336, DOI 10.1164/rccm.200601-054OC	36	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e68380	10.1371/journal.pone.0068380	http://dx.doi.org/10.1371/journal.pone.0068380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23861729	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500160
J	Kato, Y; Yagi, H; Kaji, Y; Oshika, T; Goto, Y				Kato, Yusuke; Yagi, Hisashi; Kaji, Yuichi; Oshika, Tetsuro; Goto, Yuji			Benzalkonium Chloride Accelerates the Formation of the Amyloid Fibrils of Corneal Dystrophy-associated Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL TRANSITION; KERATO-EPITHELIN MUTATIONS; ACID-CONTAINING PROTEINS; HOT-SPOTS; IN-VITRO; AGGREGATION; PREDICTION; BETA(2)-MICROGLOBULIN; KERATOEPITHELIN; MECHANISM	Corneal dystrophies are genetic disorders resulting in progressive corneal clouding due to the deposition of amyloid fibrils derived from keratoepithelin, also called transforming growth factor beta-induced protein (TGFBI). The formation of amyloid fibrils is often accelerated by surfactants such as sodium dodecyl sulfate (SDS). Most eye drops contain benzalkonium chloride (BAC), a cationic surfactant, as a preservative substance. In the present study, we aimed to reveal the role of BAC in the amyloid fibrillation of keratoepithelin-derived peptides in vitro. We used three types of 22-residue synthetic peptides covering Leu110-Glu131 of the keratoepithelin sequence: an R-type peptide with wild-type R124, a C-type peptide with C124 associated with lattice corneal dystrophy type I, and a H-type peptide with H124 associated with granular corneal dystrophy type II. The time courses of spontaneous amyloid fibrillation and seed-dependent fibril elongation were monitored in the presence of various concentrations of BAC or SDS using thioflavin T fluorescence. BAC and SDS accelerated the fibrillation of all synthetic peptides in the absence and presence of seeds. Optimal acceleration occurred near the CMC, which suggests that the unstable and dynamic interactions of keratoepithelin peptides with amphipathic surfactants led to the formation of fibrils. These results suggest that eye drops containing BAC may deteriorate corneal dystrophies and that those without BAC are preferred especially for patients with corneal dystrophies.	[Kato, Yusuke; Yagi, Hisashi; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kaji, Yuichi; Oshika, Tetsuro] Univ Tsukuba, Inst Clin Med, Dept Ophthalmol, Tsukuba, Ibaraki 3058575, Japan	Osaka University; University of Tsukuba	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp			Ministry of Education, Science, Sports, and Grant for Scientific Research, Japan [22810014, 24370067, 24592618]; Takeda Science Foundation	Ministry of Education, Science, Sports, and Grant for Scientific Research, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the Ministry of Education, Science, Sports, and Grant for Scientific Research, 22810014 (2010-2011), 24370067 (2012-2015), and 24592618 (2012-2015), Japan and by the Takeda Science Foundation.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Adriaens E, 2001, PHARMACEUT RES, V18, P937, DOI 10.1023/A:1010928025753; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; El Kochairi I, 2006, MOL VIS, V12, P461; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hoshino M, 1997, FEBS LETT, V416, P72, DOI 10.1016/S0014-5793(97)01172-1; Kaji Y, 2012, BRIT J OPHTHALMOL, V96, P1127, DOI 10.1136/bjophthalmol-2012-301728; Kaji Y, 2010, CHEM BIODIVERS, V7, P1364, DOI 10.1002/cbdv.200900329; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Korvatska E, 1998, AM J HUM GENET, V62, P320, DOI 10.1086/301720; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Millucci L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021870; Mullen W, 1973, Surv Ophthalmol, V17, P469; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Ozawa D, 2011, J BIOL CHEM, V286, P10856, DOI 10.1074/jbc.M111.222901; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Schmitt-Bernard CF, 2002, EUR J BIOCHEM, V269, P5149, DOI 10.1046/j.1432-1033.2002.03205.x; Schmitt-Bernard CF, 2000, BIOCHEM BIOPH RES CO, V273, P649, DOI 10.1006/bbrc.2000.2955; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Stoppini M, 2004, PHARMACOL RES, V50, P419, DOI 10.1016/j.phrs.2003.12.025; Sureshbabu N, 2009, EUR BIOPHYS J BIOPHY, V38, P355, DOI 10.1007/s00249-008-0379-8; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019	44	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25109	25118		10.1074/jbc.M113.477695	http://dx.doi.org/10.1074/jbc.M113.477695			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861389	Green Published, hybrid			2022-12-25	WOS:000330619000011
J	Brandt, K; Maiwald, S; Herkenhoff-Hesselmann, B; Gnirss, K; Greie, JC; Dunn, SD; Deckers-Hebestreit, G				Brandt, Karsten; Maiwald, Sarah; Herkenhoff-Hesselmann, Brigitte; Gnirss, Kerstin; Greie, Joerg-Christian; Dunn, Stanley D.; Deckers-Hebestreit, Gabriele			Individual Interactions of the b Subunits within the Stator of the Escherichia coli ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; 2ND STALK; PERIPHERAL STALK; H+-ATPASE; DIMERIZATION DOMAIN; F1F0-ATP SYNTHASE; TERMINAL REGION; EPSILON-SUBUNIT; DELTA SUBUNITS; ALPHA-SUBUNIT	FOF1 ATP synthases are rotary nanomotors that couple proton translocation across biological membranes to the synthesis/hydrolysis of ATP. During catalysis, the peripheral stalk, composed of two b subunits and subunit delta in Escherichia coli, counteracts the torque generated by the rotation of the central stalk. Here we characterize individual interactions of the b subunits within the stator by use of monoclonal antibodies and nearest neighbor analyses via intersubunit disulfide bond formation. Antibody binding studies revealed that the C-terminal region of one of the two b subunits is principally involved in the binding of subunit delta, whereas the other one is accessible to antibody binding without impact on the function of FOF1. Individually substituted cysteine pairs suitable for disulfide cross-linking between the b subunits and the other stator subunits (b-alpha, b-beta, b-delta, and b-a) were screened and combined with each other to discriminate between the two b subunits (i.e. b(I) and b(II)). The results show the b dimer to be located at a non-catalytic alpha/beta cleft, with b(I) close to subunit alpha, whereas b(II) is proximal to subunit beta. Furthermore, b(I) can be linked to subunit delta as well as to subunit a. Among the subcomplexes formed were a-b(I)-alpha, b(II)-beta, alpha-b(I)-b(II)-beta, and a-b(I)-delta. Taken together, the data obtained define the different positions of the two b subunits at a non-catalytic interface and imply that each b subunit has a different role in generating stability within the stator. We suggest that b(I) is functionally related to the single b subunit present in mitochondrial ATP synthase.	[Brandt, Karsten; Maiwald, Sarah; Herkenhoff-Hesselmann, Brigitte; Gnirss, Kerstin; Greie, Joerg-Christian; Deckers-Hebestreit, Gabriele] Univ Osnabruck, Dept Microbiol, D-49069 Osnabruck, Germany; [Dunn, Stanley D.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	University Osnabruck; Western University (University of Western Ontario)	Deckers-Hebestreit, G (corresponding author), Univ Osnabruck, Dept Microbiol, Barbarastr 11, D-49076 Osnabruck, Germany.	deckers-hebestreit@biologie.uni-osnabrueck.de	Dunn, Stanley/D-3418-2013		Deutsche Forschungsgemeinschaft [DE482/1-1]; Canadian Institutes of Health Research [MT-10237]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Deutsche Forschungsgemeinschaft Grant DE482/1-1 (to G. D.-H.) and by Canadian Institutes of Health Research Grant MT-10237 (to S. D. D.).	Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; Birkenhager R, 1999, EUR J BIOCHEM, V264, P385, DOI 10.1046/j.1432-1327.1999.00652.x; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Claggett SB, 2007, J BACTERIOL, V189, P5463, DOI 10.1128/JB.00191-07; Claggett SB, 2009, J BIOL CHEM, V284, P16531, DOI 10.1074/jbc.M109.002980; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; DECKERSHEBESTREIT G, 1992, J BIOL CHEM, V267, P12364; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; DeLeon-Rangel J, 2013, FEBS LETT, V587, P892, DOI 10.1016/j.febslet.2013.02.012; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Dunn S. D., 2004, HDB ATPASES, P311; DUNN SD, 1980, J BIOL CHEM, V255, P6891; Dunn SD, 2001, BIOCHEMISTRY-US, V40, P187, DOI 10.1021/bi001821j; Fillingame RH, 2000, J EXP BIOL, V203, P9; FRIEDL P, 1979, EUR J BIOCHEM, V100, P175, DOI 10.1111/j.1432-1033.1979.tb02046.x; GABELLINI N, 1988, BIOCHIM BIOPHYS ACTA, V934, P227, DOI 10.1016/0005-2728(88)90186-7; Grabar TB, 2004, J BIOL CHEM, V279, P31205, DOI 10.1074/jbc.M404420200; Grabar TB, 2003, J BIOL CHEM, V278, P34751, DOI 10.1074/jbc.M303361200; HERRMANN RG, 1993, FEBS LETT, V326, P192, DOI 10.1016/0014-5793(93)81789-3; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Ishmukhametov RR, 2005, BBA-BIOENERGETICS, V1706, P110, DOI 10.1016/j.bbabio.2004.09.012; Jager H, 1998, EUR J BIOCHEM, V251, P122, DOI 10.1046/j.1432-1327.1998.2510122.x; Jones PC, 2000, J BIOL CHEM, V275, P31340, DOI 10.1074/jbc.M003687200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kish-Trier E, 2009, J BIOL CHEM, V284, P12031, DOI 10.1074/jbc.M808962200; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Krebstakies T, 2008, BIOCHEMISTRY-US, V47, P6907, DOI 10.1021/bi800173a; KUMAMOTO CA, 1986, J BIOL CHEM, V261, P37; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; McLachlin DT, 2000, BIOCHEMISTRY-US, V39, P3486, DOI 10.1021/bi992586b; McLachlin DT, 1998, J BIOL CHEM, V273, P15162, DOI 10.1074/jbc.273.24.15162; McLachlin DT, 1997, J BIOL CHEM, V272, P21233, DOI 10.1074/jbc.272.34.21233; McLachlin DT, 2000, J BIOL CHEM, V275, P17571, DOI 10.1074/jbc.M000375200; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; Motz C, 2004, J BIOL CHEM, V279, P49074, DOI 10.1074/jbc.M404543200; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Peng GH, 2006, FEBS LETT, V580, P5934, DOI 10.1016/j.febslet.2006.09.062; PORTER ACG, 1985, J BIOL CHEM, V260, P8182; Priya R, 2009, J BACTERIOL, V191, P7538, DOI 10.1128/JB.00540-09; Priya R, 2008, J BIOENERG BIOMEMBR, V40, P245, DOI 10.1007/s10863-008-9154-x; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Revington M, 1999, J BIOL CHEM, V274, P31094, DOI 10.1074/jbc.274.43.31094; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sorgen PL, 1999, J BIOL CHEM, V274, P36261, DOI 10.1074/jbc.274.51.36261; Sorgen PL, 1998, J BIOL CHEM, V273, P27873, DOI 10.1074/jbc.273.43.27873; Stalz WD, 2003, J BIOL CHEM, V278, P27068, DOI 10.1074/jbc.M302027200; STEFFENS K, 1987, J BIOL CHEM, V262, P5866; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; TAKEYAMA M, 1988, J BIOL CHEM, V263, P16106; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901; Weber J, 2004, J BIOL CHEM, V279, P25673, DOI 10.1074/jbc.M402738200; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; Wilkens S, 2000, J BIOENERG BIOMEMBR, V32, P333, DOI 10.1023/A:1005567717821; Wise JG, 2009, BIOPHYS J, V96, P2823, DOI 10.1016/j.bpj.2008.12.3938; Wood KS, 2007, J BIOL CHEM, V282, P31920, DOI 10.1074/jbc.M706259200; Zhang D, 2003, J BIOL CHEM, V278, P12319, DOI 10.1074/jbc.M212413200; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	71	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24465	24479		10.1074/jbc.M113.465633	http://dx.doi.org/10.1074/jbc.M113.465633			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846684	Green Published, hybrid			2022-12-25	WOS:000330612300016
J	Sun, CC; Qiao, HF; Zhou, Q; Wang, Y; Wu, YY; Zhou, Y; Li, Y				Sun, Changcheng; Qiao, Haifa; Zhou, Qin; Wang, Yan; Wu, Yuying; Zhou, Yi; Li, Yong			Modulation of GluK2a Subunit-containing Kainate Receptors by 14-3-3 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOSSY FIBER SYNAPSES; DIFFERENTIAL REGULATION; SYNAPTIC-TRANSMISSION; MOLECULAR-MECHANISMS; GLUTAMATE RECEPTORS; AUXILIARY SUBUNIT; ION CHANNELS; GLUR6; TRAFFICKING; PHOSPHORYLATION	Kainate receptors (KARs) are one of the ionotropic glutamate receptors that mediate excitatory postsynaptic currents (EPSCs) with characteristically slow kinetics. Although mechanisms for the slow kinetics of KAR-EPSCs are not totally understood, recent evidence has implicated a regulatory role of KAR-associated proteins. Here, we report that decay kinetics of GluK2a-containing receptors is modulated by closely associated 14-3-3 proteins. 14-3-3 binding requires PKC-dependent phosphorylation of serine residues localized in the carboxyl tail of the GluK2a subunit. In transfected cells, 14-3-3 binding to GluK2a slows desensitization kinetics of both homomeric GluK2a and heteromeric GluK2a/GluK5 receptors. Moreover, KAR-EPSCs at mossy fiber-CA3 synapses decay significantly faster in the 14-3-3 functional knock-out mice. Collectively, these results demonstrate that 14-3-3 proteins are an important regulator of GluK2a-containing KARs and may contribute to the slow decay kinetics of native KAR-EPSCs.	[Sun, Changcheng; Zhou, Qin; Wang, Yan; Li, Yong] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol,Inst Med Sci, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China; [Qiao, Haifa; Wu, Yuying; Zhou, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Shanghai Jiao Tong University; State University System of Florida; Florida State University	Li, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Inst Med Sci, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	liyong68@shsmu.edu.cn	Li, Yong/ABB-5588-2021		National Natural Science Foundation of China [81171230, 30970937]; National Basic Research Program of China Grant [2010CB912001]; Major Research Plan of the National Natural Science Foundation of China Grant [91132303]; Shanghai Pujiang Program Grant [11PJ1406100]; Shanghai Committee of Science and Technology Grant [11DZ2260200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China Grant(National Basic Research Program of China); Major Research Plan of the National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program Grant; Shanghai Committee of Science and Technology Grant	This work was supported by National Natural Science Foundation of China Grants 81171230 and 30970937 (to Y. L.), National Basic Research Program of China Grant 2010CB912001 (to Y. L.), Major Research Plan of the National Natural Science Foundation of China Grant 91132303 (to T. L. X. and Y. L.), the Shanghai Pujiang Program Grant 11PJ1406100 (to Y. L.), and Shanghai Committee of Science and Technology Grant 11DZ2260200.	Barberis A., 2012, FAST PERFUSION METHO, P173; Barberis A, 2008, J NEUROSCI, V28, P6402, DOI 10.1523/JNEUROSCI.1204-08.2008; Basiry SS, 1999, J NEUROSCI, V19, P644; Bowie D, 2003, J PHYSIOL-LONDON, V547, P373, DOI 10.1113/jphysiol.2002.033076; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Cho K, 2003, J PHYSIOL-LONDON, V548, P723, DOI 10.1113/jphysiol.2003.040188; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Cui CH, 1999, J NEUROSCI, V19, P8281; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P199, DOI 10.1113/jphysiol.2004.077412; Fisher JL, 2011, J NEUROSCI, V31, P17113, DOI 10.1523/JNEUROSCI.3685-11.2011; Fleck MW, 2003, J NEUROSCI, V23, P1219; Foote Molly, 2012, Int J Biochem Mol Biol, V3, P152; Frerking M, 2002, J NEUROSCI, V22, P7434; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Goldin M, 2007, J NEUROSCI, V27, P9560, DOI 10.1523/JNEUROSCI.1237-07.2007; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Kwon HB, 2008, NEURON, V60, P1082, DOI 10.1016/j.neuron.2008.10.045; Laezza F, 2007, MOL CELL NEUROSCI, V34, P539, DOI 10.1016/j.mcn.2006.12.003; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Mehta S, 2001, J BIOL CHEM, V276, P16092, DOI 10.1074/jbc.M100643200; Melyan Z, 2002, NEURON, V34, P107, DOI 10.1016/S0896-6273(02)00624-4; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NAGAMATSU S, 1992, J BIOL CHEM, V267, P467; Nasu-Nishimura Y, 2010, J BIOL CHEM, V285, P2847, DOI 10.1074/jbc.M109.081141; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Reiner A, 2012, CELL REP, V1, P234, DOI 10.1016/j.celrep.2012.01.003; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Ruiz A, 2005, J NEUROSCI, V25, P11710, DOI 10.1523/JNEUROSCI.4041-05.2005; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Straub C, 2011, NAT NEUROSCI, V14, P866, DOI 10.1038/nn.2837; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Vivithanaporn P, 2006, J BIOL CHEM, V281, P15475, DOI 10.1074/jbc.M512098200; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang EJ, 2007, J PHYSIOL-LONDON, V578, P259, DOI 10.1113/jphysiol.2006.118448; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	63	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24676	24690		10.1074/jbc.M113.462069	http://dx.doi.org/10.1074/jbc.M113.462069			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861400	Green Published, hybrid			2022-12-25	WOS:000330612300035
J	Matsubara, K; Fujino, M; Takeuchi, K; Iwata, S; Nakayama, T				Matsubara, Keita; Fujino, Motoko; Takeuchi, Kaoru; Iwata, Satoshi; Nakayama, Tetsuo			A New Method for the Detection of Neutralizing Antibodies against Mumps Virus	PLOS ONE			English	Article							COMPLEMENT-MEDIATED NEUTRALIZATION; VESICULAR STOMATITIS-VIRUS; REINFECTION; IMMUNITY; PROPOSAL; VSV	Neutralization test is the most reliable method of evaluating immunity against viral diseases but there is no standard procedure for mumps virus, with tests differing in the infectivity of the challenge virus, 50% plaque reduction or complete inhibition of cytopathic effects (CPE), and usage of complement. A reliable, easy, and simple neutralization test for mumps virus was developed in this study. A recombinant mumps virus expressing GFP was generated as a challenge virus. Complement was added to the neutralizing mixture at 1:200 when stocked serum samples were used. Neutralizing antibody titers were expressed as the reciprocal of the highest dilution that did not exceed two-fold of FU values (GFP expression) of the cell control wells. A total of 1,452 serum samples were assayed by inhibition of GFP expression in comparison with those examined by conventional 100% inhibition of CPE. 1,367 (94.1%) showed similar neutralizing antibody titers when examined by both methods. The GFP expression inhibition assay, using a recombinant mumps virus expressing GFP, is a simple and time-saving method.	[Matsubara, Keita] Hiroshima Prefectural Hosp, Dept Pediat, Minami Ku, Hiroshima, Japan; [Fujino, Motoko] Saiseikai Cent Hosp, Dept Pediat, Minato Ku, Tokyo, Japan; [Takeuchi, Kaoru] Univ Tsukuba, Fac Med, Div Biomed Sci, Dept Infect Biol, Tsukuba, Ibaraki, Japan; [Iwata, Satoshi] Keio Univ, Sch Med, Ctr Infect Dis & Infect Control, Shinjuku Ku, Tokyo, Japan; [Nakayama, Tetsuo] Kitasato Inst Life Sci, Lab Viral Infect, Minato Ku, Tokyo, Japan	Tokyo Saiseikai Central Hospital; University of Tsukuba; Keio University	Nakayama, T (corresponding author), Kitasato Inst Life Sci, Lab Viral Infect, Minato Ku, Tokyo, Japan.	tetsuo-n@lisci.kitasato-u.ac.jp	Iwata, Satoshi/L-9942-2013					[Anonymous], 2012, Wkly Epidemiol Rec, V87, P217; BEEBE DP, 1981, J IMMUNOL, V126, P1562; Carbone KM, 2007, FIELDS VIROLOGY, P1527; COOPER NR, 1984, J INVEST DERMATOL, V83, pS121, DOI 10.1111/1523-1747.ep12281847; Cusi MG, 2001, VIRUS RES, V74, P133, DOI 10.1016/S0168-1702(00)00254-9; Friedman HM, 2000, J IMMUNOL, V165, P4528, DOI 10.4049/jimmunol.165.8.4528; Fujino M, 2007, J VIROL METHODS, V142, P15, DOI 10.1016/j.jviromet.2007.01.001; Gershman K., 2006, Morbidity and Mortality Weekly Report, V55, P559; HISHIYAMA M, 1988, VACCINE, V6, P423, DOI 10.1016/0264-410X(88)90143-0; Hook LM, 2006, J VIROL, V80, P4038, DOI 10.1128/JVI.80.8.4038-4046.2006; Inou Y, 2004, J MED VIROL, V73, P97, DOI 10.1002/jmv.20065; Jin L, 2005, ARCH VIROL, V150, P1903, DOI 10.1007/s00705-005-0563-4; Johnson JB, 2008, VIROLOGY, V376, P112, DOI 10.1016/j.virol.2008.03.022; Lachmann PJ, 1997, IMMUNOL REV, V159, P69, DOI 10.1111/j.1600-065X.1997.tb01007.x; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Matsubara K, 2012, J INFECT CHEMOTHER, V18, P466, DOI 10.1007/s10156-011-0358-3; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; MILLS BJ, 1979, J IMMUNOL, V123, P2518; Nagai T, 2007, VACCINE, V25, P2742, DOI 10.1016/j.vaccine.2005.11.068; Ninomiya K, 2009, VACCINE, V27, P6160, DOI 10.1016/j.vaccine.2009.08.020; Nojd J, 2001, VACCINE, V19, P1727, DOI 10.1016/S0264-410X(00)00392-3; OKUNO Y, 1985, MICROBIOL IMMUNOL, V29, P327, DOI 10.1111/j.1348-0421.1985.tb00831.x; Orvell C, 2002, J GEN VIROL, V83, P2489, DOI 10.1099/0022-1317-83-10-2489; Pipkin PA, 1999, J VIROL METHODS, V79, P219, DOI 10.1016/S0166-0934(99)00019-1; SASAKI K, 1976, Kitasato Archives of Experimental Medicine, V49, P43; Usonis V, 2001, INFECTION, V29, P159, DOI 10.1007/s15010-001-1098-7; Yoshida N, 2008, J MED VIROL, V80, P517, DOI 10.1002/jmv.21106	27	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e65281	10.1371/journal.pone.0065281	http://dx.doi.org/10.1371/journal.pone.0065281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861738	gold, Green Published			2022-12-25	WOS:000321425300004
J	Gingell-Littlejohn, M; McGuinness, D; McGlynn, LM; Kingsmore, D; Stevenson, KS; Koppelstaetter, C; Clancy, MJ; Shiels, PG				Gingell-Littlejohn, Marc; McGuinness, Dagmara; McGlynn, Liane M.; Kingsmore, David; Stevenson, Karen S.; Koppelstaetter, Christian; Clancy, Marc J.; Shiels, Paul G.			Pre-Transplant CDKN2A Expression in Kidney Biopsies Predicts Renal Function and Is a Future Component of Donor Scoring Criteria	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; CELLULAR SENESCENCE; TRANSPLANTATION; P16(INK4A); TIME	CDKN2A is a proven and validated biomarker of ageing which acts as an off switch for cell proliferation. We have demonstrated previously that CDKN2A is the most robust and the strongest pre-transplant predictor of post-transplant serum creatinine when compared to "Gold Standard'' clinical factors, such as cold ischaemic time and donor chronological age. This report shows that CDKN2A is better than telomere length, the most celebrated biomarker of ageing, as a predictor of post-transplant renal function. It also shows that CDKN2A is as strong a determinant of post-transplant organ function when compared to extended criteria (ECD) kidneys. A multivariate analysis model was able to predict up to 27.1% of eGFR at one year post-transplant (p = 0.008). Significantly, CDKN2A was also able to strongly predict delayed graft function. A pre-transplant donor risk classification system based on CDKN2A and ECD criteria is shown to be feasible and commendable for implementation in the near future.	[Gingell-Littlejohn, Marc; McGuinness, Dagmara; McGlynn, Liane M.; Kingsmore, David; Stevenson, Karen S.; Clancy, Marc J.; Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Gingell-Littlejohn, Marc; Kingsmore, David; Stevenson, Karen S.; Clancy, Marc J.] Univ Glasgow, Western Infirm, Transplant Unit, Glasgow G11 6NT, Lanark, Scotland; [Koppelstaetter, Christian] Med Univ Innsbruck, Dept Internal Med, Div Nephrol, A-6020 Innsbruck, Austria	University of Glasgow; University of Glasgow; Medical University of Innsbruck	Shiels, PG (corresponding author), Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	paul.shiels@glasgow.ac.uk		Shiels, Paul/0000-0002-7577-9843; Stevenson, Karen/0000-0002-2170-511X; Clancy, Marc/0000-0002-1709-9743; Kingsmore, David/0000-0002-0401-2178; McGuinness, Dagmara/0000-0001-9057-3504	Darlinda's Charity for Renal Research	Darlinda's Charity for Renal Research	This work was supported by Darlinda's Charity for Renal Research (http://www.darlindascharity.co.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AM J KIDNEY DIS, V39, pS1; BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Halloran PF, 1999, J AM SOC NEPHROL, V10, P167; Koning OHJ, 1997, TRANSPLANTATION, V63, P1620, DOI 10.1097/00007890-199706150-00015; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lamb K, 2006, NEPHROL DIAL TRANSPL, V21, P259; Lamb Kelly J, 2009, SEB Exp Biol Ser, V62, P117; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayer G, 2006, NEPHROL DIAL TRANSPL, V21, P2, DOI 10.1093/ndt/gfi269; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Melk A, 2005, AM J TRANSPLANT, V5, P1375, DOI 10.1111/j.1600-6143.2005.00846.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Melk A, 2001, J AM SOC NEPHROL, V12, P385, DOI 10.1681/ASN.V122385; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; SANFILIPPO F, 1984, TRANSPLANTATION, V38, P643, DOI 10.1097/00007890-198412000-00019; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Shiels PG, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1415; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Shiels PG, 2010, J GERONTOL A-BIOL, V65, P789, DOI 10.1093/gerona/glq095; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Yarlagadda G, 2008, NEPHROL DIAL TRANSPL, V23, P2995, DOI 10.1093/ndt/gfn158	30	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68133	10.1371/journal.pone.0068133	http://dx.doi.org/10.1371/journal.pone.0068133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861858	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700070
J	Mohanty, SK; Donnelly, B; Bondoc, A; Jafri, M; Walther, A; Coots, A; McNeal, M; Witte, D; Tiao, GM				Mohanty, Sujit K.; Donnelly, Bryan; Bondoc, Alexander; Jafri, Mubeen; Walther, Ashley; Coots, Abigail; McNeal, Monica; Witte, David; Tiao, Gregory M.			Rotavirus Replication in the Cholangiocyte Mediates the Temporal Dependence of Murine Biliary Atresia	PLOS ONE			English	Article							REGULATORY T-CELLS; AUTOIMMUNE HEPATITIS; EPITHELIAL INJURY; OBSTRUCTION; MODEL; LYMPHOCYTES; ACTIVATION; INFECTION; NEWBORN	Biliary atresia (BA) is a neonatal disease that results in obliteration of the biliary tree. The murine model of BA, which mirrors the human disease, is based upon infection of newborn mice with rhesus rotavirus (RRV), leading to an obstructive cholangiopathy. The purpose of this study was to characterize the temporal relationship between viral infection and the induction of this model. BALB/c mice were infected with RRV on day of life (DOL) 0, 3, 5, and 7. Groups were characterized as early-infection (infection by DOL 3) or late-infection (infection after DOL 5). Early RRV infection induced symptoms in 95% of pups with a mortality rate of 80%. In contrast, late infection caused symptoms in only 50% of mice, and 100% of pups survived. The clinical findings correlated with histological analysis of extrahepatic biliary trees, cytokine expression, and viral titers. Primary murine cholangiocytes isolated, cultured, and infected with RRV yielded higher titers of infectious virus in those harvested from DOL 2 versus DOL 9 mice. Less interferon alpha and beta was produced in DOL 2 versus DOL 9 RRV infected primary cholangiocytes. Injection of BALB/c interferon alpha/beta receptor knockout (IFN-alpha beta R-/-) pups at DOL 7 showed increased symptoms (79%) and mortality (46%) when compared to late infected wild type mice. In conclusion, the degree of injury sustained by relatively immature cholangiocytes due to more robust RRV replication correlated with more severe clinical manifestations of cholangiopathy and higher mortality. Interferon alpha production by cholangiocytes appears to play a regulatory role. These findings confirm a temporal dependence of RRV infection in murine BA and begin to define a pathophysiologic role of the maturing cholangiocyte.	[Mohanty, Sujit K.; Donnelly, Bryan; Bondoc, Alexander; Jafri, Mubeen; Walther, Ashley; Coots, Abigail; Tiao, Gregory M.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat & Thorac Surg, Cincinnati, OH 45229 USA; [McNeal, Monica] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Witte, David] Cincinnati Childrens Hosp Med Ctr, Dept Pathol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Tiao, GM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat & Thorac Surg, Cincinnati, OH 45229 USA.	greg.tiao@cchmc.org		McNeal, Monica/0000-0002-3784-9062; Mohanty, Sujit/0000-0001-9559-4638	National Institutes of Health (NIH) [R01 DK-091566]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091566] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by National Institutes of Health (NIH) R01 DK-091566. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SR, 2007, J VIROL, V81, P1671, DOI 10.1128/JVI.02094-06; BANGARU B, 1980, LAB INVEST, V43, P456; Barnes BH, 2009, LIVER INT, V29, P1253, DOI 10.1111/j.1478-3231.2008.01921.x; Coots A, 2012, J SURG RES, V177, P275, DOI 10.1016/j.jss.2012.05.082; Czech-Schmidt G, 2001, J SURG RES, V101, P62, DOI 10.1006/jsre.2001.6234; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; Erickson N, 2008, HEPATOLOGY, V47, P1567, DOI 10.1002/hep.22229; Glaser S, 2006, WORLD J GASTROENTERO, V12, P3523, DOI 10.3748/wjg.v12.i22.3523; Graham KL, 2005, J GEN VIROL, V86, P3397, DOI 10.1099/vir.0.81102-0; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Hernandez HM, 2001, J PEDIATR GASTR NUTR, V32, P131, DOI 10.1097/00005176-200102000-00007; Jafri M, 2008, AM J PHYSL GASTROINT; Jafri M, 2008, AM J PHYSIOL-GASTR L, V295, pG16, DOI 10.1152/ajpgi.00442.2007; Jafri M, 2007, SURGERY, V142, P192, DOI 10.1016/j.surg.2007.03.008; Jafri M, 2009, J PEDIATR SURG, V44, P500, DOI 10.1016/j.jpedsurg.2008.07.007; Kerkar N, 1998, LANCET, V351, P409, DOI 10.1016/S0140-6736(97)06478-7; Lages CS, 2012, HEPATOLOGY, V56, P219, DOI 10.1002/hep.25662; Lopez S, 2006, CURR TOP MICROBIOL, V309, P39; Mack CL, 2007, SEMIN LIVER DIS, V27, P233, DOI 10.1055/s-2007-985068; Mack CL, 2004, PEDIATR RES, V56, P79, DOI 10.1203/01.PDR.0000130480.51066.FB; MCNEAL MM, 1994, VIROLOGY, V204, P642, DOI 10.1006/viro.1994.1579; Miethke AG, 2010, J HEPATOL, V52, P718, DOI 10.1016/j.jhep.2009.12.027; MORECKI R, 1984, HEPATOLOGY, V4, P1137, DOI 10.1002/hep.1840040608; Narayanaswamy B, 2007, HEPATOLOGY, V46, P180, DOI 10.1002/hep.21701; Petersen C, 1998, J HEPATOL, V28, P603, DOI 10.1016/S0168-8278(98)80283-3; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; RiepenhoffTalty M, 1996, J INFECT DIS, V174, P8, DOI 10.1093/infdis/174.1.8; Seo NS, 2008, P NATL ACAD SCI USA, V105, P8811, DOI 10.1073/pnas.0803934105; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Shivakumar P, 2007, GASTROENTEROLOGY, V133, P268, DOI 10.1053/j.gastro.2007.04.031; Shivakumar P, 2009, J CLIN INVEST, V119, P2281, DOI 10.1172/JCI38879; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790	32	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e69069	10.1371/journal.pone.0069069	http://dx.doi.org/10.1371/journal.pone.0069069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844248	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000032
J	Oh, Y; Jang, D; Sonn, JY; Choe, J				Oh, Yangkyun; Jang, Donghoon; Sonn, Jun Young; Choe, Joonho			Histamine-HisCl1 Receptor Axis Regulates Wake-Promoting Signals in Drosophila melanogaster	PLOS ONE			English	Article							GATED CHLORIDE CHANNEL; H-3 RECEPTOR; HYPOTHALAMIC REGULATION; PHOTORECEPTOR SYNAPSE; CIRCADIAN-RHYTHMS; SLEEP REGULATION; MUSHROOM BODIES; NERVOUS-SYSTEM; NEURAL CIRCUIT; KNOCKOUT MICE	Histamine and its two receptors, histamine-gated chloride channel subunit 1 (HisCl1) and ora transientless (Ort), are known to control photoreception and temperature sensing in Drosophila. However, histamine signaling in the context of neural circuitry for sleep-wake behaviors has not yet been examined in detail. Here, we obtained mutant flies with compromised or enhanced histamine signaling and tested their baseline sleep. Hypomorphic mutations in histidine decarboxylase (HDC), an enzyme catalyzing the conversion from histidine to histamine, caused an increase in sleep duration. Interestingly, hisCl1 mutants but not ort mutants showed long-sleep phenotypes similar to those in hdc mutants. Increased sleep duration in hisCl1 mutants was rescued by overexpressing hisCl1 in circadian pacemaker neurons expressing a neuropeptide pigment dispersing factor (PDF). Consistently, RNA interference (RNAi)-mediated depletion of hisCl1 in PDF neurons was sufficient to mimic hisCl1 mutant phenotypes, suggesting that PDF neurons are crucial for sleep regulation by the histamine-HisCl1 signaling. Finally, either hisCl1 mutation or genetic ablation of PDF neurons dampened wake-promoting effects of elevated histamine signaling via direct histamine administration. Taken together, these data clearly demonstrate that the histamine-HisCl1 receptor axis can activate and maintain the wake state in Drosophila and that wake-activating signals may travel via the PDF neurons.	[Oh, Yangkyun; Jang, Donghoon; Sonn, Jun Young; Choe, Joonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Choe, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	jchoe@kaist.ac.kr	Choe, Joonho/F-3066-2011	Sonn, Jun Young/0000-0002-5114-8983; Oh, Yangkyun/0000-0003-4070-7601	Brain Research Center of the 21st Century Frontier Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology (MEST), the Republic of Korea; National Research Foundation of Korea; MEST [20110015442]	Brain Research Center of the 21st Century Frontier Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST), the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Brain Research Center of the 21st Century Frontier Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (MEST), the Republic of Korea, and from the National Research Foundation of Korea grant funded by MEST (No. 20110015442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beersma D G, 1998, Sleep Med Rev, V2, P31, DOI 10.1016/S1087-0792(98)90052-1; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2003, BIOESSAYS, V25, P940, DOI 10.1002/bies.10333; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dai HM, 2007, NEUROSCI RES, V57, P306, DOI 10.1016/j.neures.2006.10.020; de Esch IJP, 2005, TRENDS PHARMACOL SCI, V26, P462, DOI 10.1016/j.tips.2005.07.002; de Lecea L, 2005, FEBS J, V272, P5675, DOI 10.1111/j.1742-4658.2005.04981.x; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Esbenshade TA, 2008, BRIT J PHARMACOL, V154, P1166, DOI 10.1038/bjp.2008.147; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hamasaka Y, 2006, J COMP NEUROL, V494, P314, DOI 10.1002/cne.20807; Hamblen MJ, 1998, GENETICS, V149, P165; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Iovchev M, 2002, J NEUROGENET, V16, P249, DOI 10.1080/01677060216293; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; LEURS R, 1994, J NEUROCHEM, V62, P519; Leurs R, 2005, NAT REV DRUG DISCOV, V4, P107, DOI 10.1038/nrd1631; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; MONTI JM, 1990, BRAIN RES BULL, V25, P229, DOI 10.1016/0361-9230(90)90065-8; Nassel DR, 1999, MICROSC RES TECHNIQ, V44, P121, DOI 10.1002/(SICI)1097-0029(19990115/01)44:2/3<121::AID-JEMT6>3.0.CO;2-F; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Parmentier R, 2002, J NEUROSCI, V22, P7695; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roeder T, 2003, EUR J PHARMACOL, V466, P85, DOI 10.1016/S0014-2999(03)01553-X; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Stuart AE, 2007, PROG NEUROBIOL, V82, P202, DOI 10.1016/j.pneurobio.2007.03.006; Szymusiak R, 2008, ANN NY ACAD SCI, V1129, P275, DOI 10.1196/annals.1417.027; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Yusein Shazie, 2008, Invertebrate Neuroscience, V8, P211, DOI 10.1007/s10158-008-0078-2; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	68	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68269	10.1371/journal.pone.0068269	http://dx.doi.org/10.1371/journal.pone.0068269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844178	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000136
J	Wang, J; Xu, L; Yun, X; Yang, K; Liao, DJ; Tian, LC; Jiang, HY; Lu, WJ				Wang, Jian; Xu, Lei; Yun, Xin; Yang, Kai; Liao, Dongjiang; Tian, Lichun; Jiang, Haiyang; Lu, Wenju			Proteomic Analysis Reveals that Proteasome Subunit Beta 6 Is Involved in Hypoxia-Induced Pulmonary Vascular Remodeling in Rats	PLOS ONE			English	Article							ARTERIAL SMOOTH-MUSCLE; RECEPTOR POTENTIAL EXPRESSION; CELL-GROWTH; PRESSURE-OVERLOAD; LUNG-CANCER; INHIBITION; THERAPY; SYSTEM; MG132; CA2+	Background: Chronic hypoxia (CH) is known to be one of the major causes of pulmonary hypertension (PH), which is characterized by sustained elevation of pulmonary vascular resistance resulting from vascular remodeling. In this study, we investigated whether the ubiquitin proteasome system (UPS) was involved in the mechanism of hypoxia-induced pulmonary vascular remodeling. We isolated the distal pulmonary artery (PA) from a previously defined chronic hypoxic pulmonary hypertension (CHPH) rat model, performed proteomic analyses in search of differentially expressed proteins belonging to the UPS, and subsequently identified their roles in arterial remodeling. Results: Twenty-two proteins were differently expressed between the CH and normoxic group. Among them, the expression of proteasome subunit beta (PSMB) 1 and PSMB6 increased after CH exposure. Given that PSMB1 is a well-known structural subunit and PSMB6 is a functional subunit, we sought to assess whether PSMB6 could be related to the multiple functional changes during the CHPH process. We confirmed the proteomic results by real-time PCR and Western blot. With the increase in quantity of the active subunit, proteasome activity in both cultured pulmonary artery smooth muscle cells (PASMCs) and isolated PA from the hypoxic group increased. An MTT assay revealed that the proteasome inhibitor MG132 was able to attenuate the hypoxia-induced proliferation of PASMC in a dose-dependent manner. Knockdown of PSMB6 using siRNA also prevented hypoxia-induced proliferation. Conclusion: The present study revealed the association between increased PSMB6 and CHPH. CH up-regulated proteasome activity and the proliferation of PASMCs, which may have been related to increased PSMB6 expression and the subsequently enhanced functional catalytic sites of the proteasome. These results suggested an essential role of the proteasome during CHPH development, a novel finding requiring further study.	[Wang, Jian; Xu, Lei; Yun, Xin; Yang, Kai; Liao, Dongjiang; Tian, Lichun; Lu, Wenju] Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wang, Jian; Xu, Lei; Yun, Xin; Yang, Kai; Jiang, Haiyang] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Lu, Wenju] Guangzhou Med Univ, Dept Lab Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Johns Hopkins University; Guangzhou Medical University	Wang, J (corresponding author), Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	jwang31@jhmi.edu; wlu92@yahoo.com	Yang, Kai/I-6524-2019; Yun, Xin/AHB-7710-2022	Yang, Kai/0000-0003-3044-2240; Yun, Xin/0000-0001-9624-1439	Hational Institutes of Health (NIH) research grants [R01HL093020]; National Natural Science Foundation of China [81070043, 81071917, 81173112, 81170052, 81220108001]; Chinese Central Government Key Research Projects of the 973 grants [2009CB522107]; Changjiang Scholars and Innovative Research Team in University grant [IRT0961]; Guangdong Department of Science and Technology of China [2009B050700041, 2010B03160030]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education research grant [cxzd1025]; Guangdong Natural Science Foundation team grant; Guangzhou Department of Education Yangcheng Scholarship [10A058S, 12A001S]; Guangzhou Elite Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093020] Funding Source: NIH RePORTER	Hational Institutes of Health (NIH) research grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Central Government Key Research Projects of the 973 grants(National Basic Research Program of China); Changjiang Scholars and Innovative Research Team in University grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong Department of Science and Technology of China; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education research grant; Guangdong Natural Science Foundation team grant; Guangzhou Department of Education Yangcheng Scholarship; Guangzhou Elite Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Hational Institutes of Health (NIH) research grants (R01HL093020), National Natural Science Foundation of China (81070043, 81071917, 81173112, 81170052, 81220108001), Chinese Central Government Key Research Projects of the 973 grants (2009CB522107), Changjiang Scholars and Innovative Research Team in University grant (IRT0961), Guangdong Department of Science and Technology of China (2009B050700041, 2010B03160030), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2008) China, Guangdong Department of Education research grant (cxzd1025), Guangdong Natural Science Foundation team grant (2010), Guangzhou Department of Education Yangcheng Scholarship (10A058S, 12A001S). Lei Xu was supported by the Guangzhou Elite Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beranova-Giorgianni S, 2003, TRAC-TREND ANAL CHEM, V22, P273, DOI 10.1016/S0165-9936(03)00508-9; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; Crnkovic S, 2011, RESP PHYSIOL NEUROBI, V179, P342, DOI 10.1016/j.resp.2011.09.016; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; de Wilt LHAM, 2012, BIOCHEM PHARMACOL, V83, P207, DOI 10.1016/j.bcp.2011.10.009; Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Eba S, 2013, AM J RESP CELL MOL B; Friehs I, 2008, AM J PHYSIOL-HEART C, V295, pH1373, DOI 10.1152/ajpheart.00886.2008; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Han YH, 2010, HUM EXP TOXICOL, V29, P607, DOI 10.1177/0960327109358733; Hedhli N, 2008, AM J PHYSIOL-HEART C, V295, pH1385, DOI 10.1152/ajpheart.00532.2008; Hedhli N, 2010, CARDIOVASC RES, V85, P321, DOI 10.1093/cvr/cvp226; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052576; Kim SY, 2012, AM J RESP CELL MOL, V47, P698, DOI 10.1165/rcmb.2011-0331OC; Koch A, 2011, CELL CYCLE, V10, P1200, DOI 10.4161/cc.10.8.15327; Li HH, 2011, AM J PATHOL, V178, P1043, DOI 10.1016/j.ajpath.2010.11.049; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V298, pC114, DOI 10.1152/ajpcell.00629.2008; Luo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056774; LUPAS A, 1993, ENZYME PROTEIN, V47, P252, DOI 10.1159/000468684; Ma Y, 2011, BIOCHEM PHARMACOL, V81, P1228, DOI 10.1016/j.bcp.2011.03.009; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Mato AR, 2012, ONCOLOGIST, V17, P694, DOI 10.1634/theoncologist.2011-0341; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Pan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013298; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powell SR, 2012, PROG MOL BIOL TRANSL, V109, P295, DOI 10.1016/B978-0-12-397863-9.00009-2; Saeki Y, 2012, METHODS MOL BIOL, V832, P315, DOI 10.1007/978-1-61779-474-2_22; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimoda LA, 2006, MICROCIRCULATION, V13, P657, DOI 10.1080/10739680600930305; Slingerland J, 1998, Results Probl Cell Differ, V22, P133; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195; Tashkin DP, 2009, RESP MED, V103, P963, DOI 10.1016/j.rmed.2009.02.013; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang C, 2008, J PHARMACOL SCI, V108, P71, DOI 10.1254/jphs.08069FP; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Wang J, 2013, AM J RESP CELL MOL, V48, P125, DOI 10.1165/rcmb.2012-0071OC; Weiss Curtis H, 2010, Proc Am Thorac Soc, V7, P77, DOI 10.1513/pats.200906-055JS; You BR, 2011, DRUG CHEM TOXICOL, V34, P45, DOI 10.3109/01480545.2010.494663; Zwickl P, 1999, PHILOS T R SOC B, V354, P1501, DOI 10.1098/rstb.1999.0494	44	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67942	10.1371/journal.pone.0067942	http://dx.doi.org/10.1371/journal.pone.0067942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844134	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000117
J	Frank, DU; Emechebe, U; Thomas, KR; Moon, AM				Frank, Deborah U.; Emechebe, Uchenna; Thomas, Kirk R.; Moon, Anne M.			Mouse Tbx3 Mutants Suggest Novel Molecular Mechanisms for Ulnar-Mammary Syndrome	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE RELATIONSHIP; EXPRESSION; MUTATIONS; GENE; LIMB; DEFECTS; FAMILY; DOMAIN	The transcription factor TBX3 plays critical roles in development and TBX3 mutations in humans cause Ulnar-mammary syndrome. Efforts to understand how altered TBX3 dosage and function disrupt the development of numerous structures have been hampered by embryonic lethality of mice bearing presumed null alleles. We generated a novel conditional null allele of Tbx3: after Cre-mediated recombination, no mRNA or protein is detectable. In contrast, a putative null allele in which exons 1-3 are deleted produces a truncated protein that is abnormally located in the cytoplasm. Heterozygotes and homozygotes for this allele have different phenotypes than their counterparts bearing a true null allele. Our observations with these alleles in mice, and the different types of TBX3 mutations observed in human ulnar-mammary syndrome, suggest that not all mutations observed in humans generate functionally null alleles. The possibility that mechanisms in addition to TBX3 haploinsufficiency may cause UMS or other malformations merits investigation in the human UMS population.	[Frank, Deborah U.; Moon, Anne M.] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; [Emechebe, Uchenna; Moon, Anne M.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Moon, Anne M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Moon, Anne M.] Univ Utah, Program Mol Med, Salt Lake City, UT USA; [Thomas, Kirk R.; Moon, Anne M.] Weis Ctr Res, Danville, PA USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Moon, AM (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA.	anne.moon@genetics.utah.edu	Frank, Deborah/K-7111-2019	Frank, Deborah/0000-0003-0901-5420; moon, anne/0000-0002-9090-1093	Primary Children's Medical Center Foundation Awards; March of Dimes Basil O'Connor Award; Pediatric Critical Care Scientist Development Program National Institutes of Health [K12HD047349]; National Institutes of Health [R01HD046767]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046767] Funding Source: NIH RePORTER	Primary Children's Medical Center Foundation Awards; March of Dimes Basil O'Connor Award(March of Dimes); Pediatric Critical Care Scientist Development Program National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by: Primary Children's Medical Center Foundation Awards (DUF, AMM); March of Dimes Basil O'Connor Award (DUF, AMM); Pediatric Critical Care Scientist Development Program National Institutes of Health [grant number K12HD047349] (DUF); and National Institutes of Health [grant number R01HD046767] (AMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Bimber B, 2007, DEV BIOL, V302, P230, DOI 10.1016/j.ydbio.2006.09.023; Carlson H, 2001, HUM MOL GENET, V10, P2403, DOI 10.1093/hmg/10.21.2403; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Fan C, 2009, J BIOL CHEM, V284, P25653, DOI 10.1074/jbc.M109.041368; Frank DU, 2012, P NATL ACAD SCI US; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lu JA, 2010, BBA-REV CANCER, V1806, P268, DOI 10.1016/j.bbcan.2010.07.001; MACMURRAY A, 1988, GENETICS, V120, P545; Meneghini V, 2006, EUR J MED GENET, V49, P151, DOI 10.1016/j.ejmg.2005.04.021; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Ribeiro I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000398; Sasaki G, 2002, AM J MED GENET, V110, P365, DOI 10.1002/ajmg.10447; Wollnik B, 2002, ANN GENET-PARIS, V45, P213, DOI 10.1016/S0003-3995(02)01144-9; Zhang Z, 2008, HUM MOL GENET, V17, P150, DOI 10.1093/hmg/ddm291	20	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67841	10.1371/journal.pone.0067841	http://dx.doi.org/10.1371/journal.pone.0067841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844108	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000108
J	Soma, S; Shimegi, S; Suematsu, N; Tamura, H; Sato, H				Soma, Shogo; Shimegi, Satoshi; Suematsu, Naofumi; Tamura, Hiroshi; Sato, Hiromichi			Modulation-Specific and Laminar-Dependent Effects of Acetylcholine on Visual Responses in the Rat Primary Visual Cortex	PLOS ONE			English	Article							NUCLEUS BASALIS-MAGNOCELLULARIS; CHOLINERGIC MODULATION; COMPLEX CELLS; BARREL CORTEX; INNERVATION; ORGANIZATION; MECHANISMS; EXCITATION; RECEPTORS; NICOTINE	Acetylcholine (ACh) is secreted from cholinergic neurons in the basal forebrain to regions throughout the cerebral cortex, including the primary visual cortex (V1), and influences neuronal activities across all six layers via a form of diffuse extrasynaptic modulation termed volume transmission. To understand this effect in V1, we performed extracellular multi-point recordings of neuronal responses to drifting sinusoidal grating stimuli from the cortical layers of V1 in anesthetized rats and examined the modulatory effects of topically administered ACh. ACh facilitated or suppressed the visual responses of individual cells with a laminar bias: response suppression prevailed in layers 2/3, whereas response facilitation prevailed in layer 5. ACh effects on the stimulus contrast-response function showed that ACh changes the response gain upward or downward in facilitated or suppressed cells, respectively. Next, ACh effects on the signal-to-noise (S/N) ratio and the grating-phase information were tested. The grating-phase information was calculated as the F1/F0 ratio, which represents the amount of temporal response modulation at the fundamental frequency (F1) of a drifting grating relative to the mean evoked response (F0). In facilitated cells, ACh improved the S/N ratio, while in suppressed cells it enhanced the F1/F0 ratio without any concurrent reduction in the S/N ratio. These effects were predominantly observed in regular-spiking cells, but not in fast-spiking cells. Electrophysiological and histological findings suggest that ACh promotes the signaling of grating-phase information to higher-order areas by a suppressive effect on supragranular layers and enhances feedback signals with a high S/N ratio to subcortical areas by a facilitatory effect on infragranular layers. Thus, ACh distinctly and finely controls visual information processing in a manner that is specific for the modulation and cell type and is also laminar dependent.	[Soma, Shogo; Shimegi, Satoshi; Suematsu, Naofumi; Tamura, Hiroshi; Sato, Hiromichi] Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan; [Shimegi, Satoshi; Sato, Hiromichi] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan	Osaka University; Osaka University	Shimegi, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan.	shimegi@vision.hss.osaka-u.ac.jp		Soma, Shogo/0000-0002-7381-9477; Suematsu, Naofumi/0000-0002-5431-1723	KAKENHI [21500369, 22500573, 17021026, 20500285, 23135521]; Japan Society for the Promotion of Science Research Fellowships	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science Research Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by KAKENHI, 21500369 to H. Sato, 22500573 to S. Shimegi, and 17021026, 20500285, 23135521 to H. Tamura. S. Soma was supported by the Japan Society for the Promotion of Science Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Arroyo S, 2012, J NEUROSCI, V32, P3859, DOI 10.1523/JNEUROSCI.0115-12.2012; Bardy C, 2006, J PHYSIOL-LONDON, V574, P731, DOI 10.1113/jphysiol.2006.110320; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; Bereshpolova Y, 2006, J NEUROSCI, V26, P2250, DOI 10.1523/JNEUROSCI.4402-05.2006; Bhattacharyya A, 2012, EUR J NEUROSCI, V35, P1270, DOI 10.1111/j.1460-9568.2012.08052.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CANDY JM, 1974, NEUROPHARMACOLOGY, V13, P423, DOI 10.1016/0028-3908(74)90130-0; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; CLARKE PBS, 1984, BRAIN RES, V323, P390, DOI 10.1016/0006-8993(84)90320-2; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Disney AA, 2006, J COMP NEUROL, V499, P49, DOI 10.1002/cne.21096; Disney AA, 2012, J NEUROPHYSIOL, V108, P1907, DOI 10.1152/jn.00188.2012; ECKENSTEIN FP, 1988, NEUROSCIENCE, V25, P457, DOI 10.1016/0306-4522(88)90251-5; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gulledge AT, 2007, J NEUROPHYSIOL, V97, P2215, DOI 10.1152/jn.00493.2006; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; JOHNSTON MV, 1981, EXP BRAIN RES, V43, P159; Jones BE, 2008, ANN NY ACAD SCI, V1129, P26, DOI 10.1196/annals.1417.026; KENANVAKNIN G, 1992, BRAIN RES, V574, P147, DOI 10.1016/0006-8993(92)90811-M; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; LEHMANN J, 1980, NEUROSCIENCE, V5, P1161, DOI 10.1016/0306-4522(80)90195-5; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; MALCOLM J. L., 1967, INT J NEUROPHARMACOL, V6, P509; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; MAYO W, 1993, BRAIN RES, V607, P324, DOI 10.1016/0006-8993(93)91524-V; MONTERO VM, 1968, J NEUROPHYSIOL, V31, P221, DOI 10.1152/jn.1968.31.2.221; MURPHY PC, 1991, NEUROSCIENCE, V40, P13, DOI 10.1016/0306-4522(91)90170-S; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; SAPER CB, 1984, J COMP NEUROL, V222, P313, DOI 10.1002/cne.902220302; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; Schiller PH, 2005, PROG BRAIN RES, V149, P157, DOI 10.1016/S0079-6123(05)49012-3; Sengpiel F, 1998, VISION RES, V38, P2067, DOI 10.1016/S0042-6989(97)00413-6; Shimegi S, 1999, J NEUROSCI, V19, P10164; Shimegi S, 2000, J NEUROSCI, V20, P6241, DOI 10.1523/JNEUROSCI.20-16-06241.2000; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Soma S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01138; Soma S, 2012, J NEUROPHYSIOL, V107, P283, DOI 10.1152/jn.00330.2011; St Peters M, 2011, J NEUROSCI, V31, P9760, DOI 10.1523/JNEUROSCI.1902-11.2011; STONE TW, 1972, J PHYSIOL-LONDON, V225, P485, DOI 10.1113/jphysiol.1972.sp009951; Tehovnik EJ, 2003, EUR J NEUROSCI, V17, P870, DOI 10.1046/j.1460-9568.2003.02489.x; UMBRIACO D, 1994, J COMP NEUROL, V348, P351, DOI 10.1002/cne.903480304; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	58	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68430	10.1371/journal.pone.0068430	http://dx.doi.org/10.1371/journal.pone.0068430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844199	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000161
J	Lawton, TJ; Bowen, KE; Sayavedra-Soto, LA; Arp, DJ; Rosenzweig, AC				Lawton, Thomas J.; Bowen, Kimberly E.; Sayavedra-Soto, Luis A.; Arp, Daniel J.; Rosenzweig, Amy C.			Characterization of a Nitrite Reductase Involved in Nitrifier Denitrification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMMONIA-OXIDIZING BACTERIA; NITROUS-OXIDE PRODUCTION; FAECALIS STRAIN S-6; NITROSOMONAS-EUROPAEA; ALCALIGENES-FAECALIS; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; TYPE-2 COPPER; MULTICOPPER OXIDASE; KINETIC-ANALYSIS	Nitrifier denitrification is the conversion of nitrite to nitrous oxide by ammonia-oxidizing organisms. This process, which is distinct from denitrification, is active under aerobic conditions in the model nitrifier Nitrosomonas europaea. The central enzyme of the nitrifier dentrification pathway is a copper nitrite reductase (CuNIR). To understand how a CuNIR, typically inactivated by oxygen, functions in this pathway, the enzyme isolated directly from N. europaea (NeNIR) was biochemically and structurally characterized. NeNIR reduces nitrite at a similar rate to other CuNIRs but appears to be oxygen tolerant. Crystal structures of oxidized and reduced NeNIR reveal a substrate channel to the active site that is much more restricted than channels in typical CuNIRs. In addition, there is a second fully hydrated channel leading to the active site that likely acts a water exit pathway. The structure is minimally affected by changes in pH. Taken together, these findings provide insight into the molecular basis for NeNIR oxygen tolerance.	[Lawton, Thomas J.; Bowen, Kimberly E.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Lawton, Thomas J.; Bowen, Kimberly E.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Sayavedra-Soto, Luis A.; Arp, Daniel J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Northwestern University; Northwestern University; Oregon State University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	amyr@northwestern.edu			Agriculture and Food Research Initiative Competitive Grant from the U. S. Department of Agriculture [2010-65115-20380]; Oregon Agricultural Experimental Station	Agriculture and Food Research Initiative Competitive Grant from the U. S. Department of Agriculture; Oregon Agricultural Experimental Station	This work was supported by Agriculture and Food Research Initiative Competitive Grant 2010-65115-20380 from the U. S. Department of Agriculture (to A. C. R.) and a grant from the Oregon Agricultural Experimental Station (to D. J. A).	Arp DJ, 2003, CRIT REV BIOCHEM MOL, V38, P471, DOI 10.1080/10409230390267446; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beaumont HJE, 2004, MOL MICROBIOL, V54, P148, DOI 10.1111/j.1365-2958.2004.04248.x; Beaumont HJE, 2005, J BACTERIOL, V187, P6849, DOI 10.1128/JB.187.19.6849-6851.2005; Beaumont HJE, 2002, J BACTERIOL, V184, P2557, DOI 10.1128/JB.184.9.2557-2560.2002; Bento I, 2006, J BIOL INORG CHEM, V11, P539, DOI 10.1007/s00775-006-0114-9; Boulanger MJ, 2002, J MOL BIOL, V315, P1111, DOI 10.1006/jmbi.2001.5251; Cantera JJL, 2007, ENVIRON MICROBIOL, V9, P765, DOI 10.1111/j.1462-2920.2006.01198.x; Casciotti KL, 2001, APPL ENVIRON MICROB, V67, P2213, DOI 10.1128/AEM.67.5.2213-2221.2001; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Chandran K, 2011, BIOCHEM SOC T, V39, P1832, DOI 10.1042/BST20110717; Cho CMH, 2006, APPL ENVIRON MICROB, V72, P4450, DOI 10.1128/AEM.02958-05; Cua LS, 2011, FEMS MICROBIOL LETT, V319, P169, DOI 10.1111/j.1574-6968.2011.02277.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DISPIRITO AA, 1985, BIOCHIM BIOPHYS ACTA, V806, P320, DOI 10.1016/0005-2728(85)90111-2; DISPIRITO AA, 1985, BIOCHIM BIOPHYS ACTA, V827, P320, DOI 10.1016/0167-4838(85)90217-1; Dodd FE, 1998, J MOL BIOL, V282, P369, DOI 10.1006/jmbi.1998.2007; Dundee L, 2001, SOIL BIOL BIOCHEM, V33, P1563, DOI 10.1016/S0038-0717(01)00059-1; Ellis MJ, 2003, J MOL BIOL, V328, P429, DOI 10.1016/S0022-2836(03)00308-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goldsmith RH, 2011, P NATL ACAD SCI USA, V108, P17269, DOI 10.1073/pnas.1113572108; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hooper AB, 1997, ANTON LEEUW INT J G, V71, P59, DOI 10.1023/A:1000133919203; HOOPER AB, 1968, BIOCHIM BIOPHYS ACTA, V162, P49, DOI 10.1016/0005-2728(68)90213-2; Hough MA, 2008, J MOL BIOL, V378, P353, DOI 10.1016/j.jmb.2008.01.097; Hough MA, 2008, BIOCHEMISTRY-US, V47, P13547, DOI 10.1021/bi801369y; Impagliazzo A, 2004, J AM CHEM SOC, V126, P5658, DOI 10.1021/ja049619h; Jacobson F, 2005, ACTA CRYSTALLOGR D, V61, P1190, DOI 10.1107/S0907444905017488; Jacobson F, 2007, J BIOL CHEM, V282, P6347, DOI 10.1074/jbc.M605746200; Jason J, 2007, ARCH MICROBIOL, V188, P349, DOI 10.1007/s00203-007-0255-4; KAKUTANI T, 1981, J BIOCHEM-TOKYO, V89, P463, DOI 10.1093/oxfordjournals.jbchem.a133221; KAKUTANI T, 1981, J BIOCHEM, V89, P453, DOI 10.1093/oxfordjournals.jbchem.a133220; Kataoka K, 2000, J BIOCHEM-TOKYO, V127, P345, DOI 10.1093/oxfordjournals.jbchem.a022613; Klotz MG, 2008, FEMS MICROBIOL LETT, V278, P146, DOI 10.1111/j.1574-6968.2007.00970.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lawton TJ, 2011, METHOD ENZYMOL, V496, P423, DOI 10.1016/B978-0-12-386489-5.00017-8; Lawton TJ, 2009, J BIOL CHEM, V284, P10174, DOI 10.1074/jbc.M900179200; Leferink NGH, 2012, FEBS J, V279, P2174, DOI 10.1111/j.1742-4658.2012.08601.x; Leferink NGH, 2011, BIOCHEMISTRY-US, V50, P4121, DOI 10.1021/bi200246f; Lieberman RL, 2001, BIOCHEMISTRY-US, V40, P5674, DOI 10.1021/bi0102611; MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER DJ, 1983, J GEN MICROBIOL, V129, P1645; Murphy LM, 2002, J MOL BIOL, V315, P859, DOI 10.1006/jmbi.2001.5253; Murphy MEP, 1997, J BIOL CHEM, V272, P28455, DOI 10.1074/jbc.272.45.28455; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nojiri M, 2009, NATURE, V462, P117, DOI 10.1038/nature08507; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POTH M, 1985, APPL ENVIRON MICROB, V49, P1134, DOI 10.1128/AEM.49.5.1134-1141.1985; RITCHIE GAF, 1974, BIOCHEM J, V138, P471, DOI 10.1042/bj1380471; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Schmidt I, 2004, MICROBIOL-SGM, V150, P4107, DOI 10.1099/mic.0.27382-0; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P214, DOI 10.1111/j.1462-2920.2005.00882.x; Stein LY, 1998, APPL ENVIRON MICROB, V64, P4098; VANDEKAMP M, 1990, EUR J BIOCHEM, V194, P109; Wijma HJ, 2006, J BIOL CHEM, V281, P16340, DOI 10.1074/jbc.M601610200; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	60	36	37	3	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25575	25583		10.1074/jbc.M113.484543	http://dx.doi.org/10.1074/jbc.M113.484543			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23857587	hybrid, Green Published			2022-12-25	WOS:000330619000052
J	Murakami, Y; Watari, K; Shibata, T; Uba, M; Ureshino, H; Kawahara, A; Abe, H; Izumi, H; Mukaida, N; Kuwano, M; Ono, M				Murakami, Yuichi; Watari, Kosuke; Shibata, Tomohiro; Uba, Manami; Ureshino, Hiroki; Kawahara, Akihiko; Abe, Hideyuki; Izumi, Hiroto; Mukaida, Naofumi; Kuwano, Michihiko; Ono, Mayumi			N-myc Downstream-regulated Gene 1 Promotes Tumor Inflammatory Angiogenesis through JNK Activation and Autocrine Loop of Interleukin-1 alpha by Human Gastric Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; METASTASIS SUPPRESSOR GENE; NECROSIS-FACTOR-ALPHA; KAPPA-B ACTIVATION; PANCREATIC-CANCER; PROSTATE-CANCER; MACROPHAGES; NDRG1; CAP43/NDRG1/DRG-1; OVEREXPRESSION	The expression of N-myc downstream-regulated gene 1 (NDRG1) was significantly correlated with tumor angiogenesis and malignant progression together with poor prognosis in gastric cancer. However, the underlying mechanism for the role of NDRG1 in the malignant progression of gastric cancer remains unknown. Here we examined whether and how NDRG1 could modulate tumor angiogenesis by human gastric cancer cells. We established NU/Cap12 and NU/Cap32 cells overexpressing NDRG1 in NUGC-3 cells, which show lower tumor angiogenesis in vivo. Compared with parental NU/Mock3, NU/Cap12, and NU/Cap32 cells: 1) induced higher tumor angiogenesis than NU/Mock3 cells accompanied by infiltration of tumor-associated macrophages in mouse dorsal air sac assay and Matrigel plug assay; 2) showed much higher expression of CXC chemokines, MMP-1, and the potent angiogenic factor VEGF-A; 3) increased the expression of the representative inflammatory cytokine, IL-1 alpha; 4) augmented JNK phosphorylation and nuclear expression of activator protein 1 (AP-1). Further analysis demonstrated that knockdown of AP-1 (Jun and/or Fos) resulted in down-regulation of the expression of VEGF-A, CXC chemokines, and MMP-1, and also suppressed expression of IL-1 alpha in NDRG1-overexpressing cell lines. Treatment with IL-1 receptor antagonist (IL-1ra) resulted in down-regulation of JNK and c-Jun phosphorylation, and the expression of VEGF-A, CXC chemokines, and MMP-1 in NU/Cap12 and NU/Cap32 cells. Finally, administration of IL-1ra suppressed both tumor angiogenesis and infiltration of macrophages by NU/Cap12 in vivo. Together, activation of JNK/AP-1 thus seems to promote tumor angiogenesis in relationship to NDRG1-induced inflammatory stimuli by gastric cancer cells.	[Murakami, Yuichi; Watari, Kosuke; Shibata, Tomohiro; Uba, Manami; Ureshino, Hiroki; Ono, Mayumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 8128582, Japan; [Kuwano, Michihiko] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut, Lab Mol Canc Biol, Fukuoka 8128582, Japan; [Murakami, Yuichi] St Marys Hosp, Kurume, Fukuoka 8308543, Japan; [Kawahara, Akihiko; Abe, Hideyuki] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka 8300011, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 8078555, Japan; [Mukaida, Naofumi] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 9200934, Japan	Kyushu University; Kyushu University; Kurume University; University of Occupational & Environmental Health - Japan; Kanazawa University	Ono, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 8128582, Japan.	mono@phar.kyushu-u.ac.jp	Mukaida, Naofumi/D-7623-2011	Mukaida, Naofumi/0000-0002-4193-1851; Watari, Kosuke/0000-0003-0260-2323	Japan Society for the Promotion of Science (JSPS) [23300350]; 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [23300350] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (B) 23300350 from the Japan Society for the Promotion of Science (JSPS) (to M. O.) and the 3rd Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare of Japan (to M. K.).	Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chua MS, 2007, MODERN PATHOL, V20, P76, DOI 10.1038/modpathol.3800711; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; FINKENZELLER G, 1995, BIOCHEM BIOPH RES CO, V208, P432, DOI 10.1006/bbrc.1995.1356; Fotovati A, 2006, CLIN CANCER RES, V12, P3010, DOI 10.1158/1078-0432.CCR-05-1962; Fukahori S, 2007, J PEDIATR SURG, V42, P1831, DOI 10.1016/j.jpedsurg.2007.07.008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guadagni S, 2000, WORLD J SURG, V24, P1550, DOI 10.1007/s002680010276; Guang RJ, 2000, CANCER RES, V60, P749; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Inagaki Y, 2009, DIGEST LIVER DIS, V41, P96, DOI 10.1016/j.dld.2008.04.003; ISHIKAWA Y, 1995, J BIOL CHEM, V270, P4158, DOI 10.1074/jbc.270.8.4158; Kawahara A, 2011, EXP THER MED, V2, P471, DOI 10.3892/etm.2011.222; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Koshiji M, 2007, WORLD J GASTROENTERO, V13, P2803, DOI 10.3748/wjg.v13.i20.2803; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; Sohda M, 2009, ANTICANCER RES, V29, P965; Song Y, 2010, HUM PATHOL, V41, P214, DOI 10.1016/j.humpath.2009.07.011; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Ureshino H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041312; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015	43	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25025	25037		10.1074/jbc.M113.472068	http://dx.doi.org/10.1074/jbc.M113.472068			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846687	Green Published, hybrid			2022-12-25	WOS:000330619000004
J	Semache, M; Zarrouki, B; Fontes, G; Fogarty, S; Kikani, C; Chawki, MB; Rutter, J; Poitout, V				Semache, Meriem; Zarrouki, Bader; Fontes, Ghislaine; Fogarty, Sarah; Kikani, Chintan; Chawki, Mohammad B.; Rutter, Jared; Poitout, Vincent			Per-Arnt-Sim Kinase Regulates Pancreatic Duodenal Homeobox-1 Protein Stability via Phosphorylation of Glycogen Synthase Kinase 3 beta in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-EXPRESSION; DNA-BINDING ACTIVITY; PAS KINASE; GLUCOSE; TRANSCRIPTION; DOMAIN; ACTIVATION; PDX-1; INHIBITION; MICE	In pancreatic beta-cells, glucose induces the binding of the transcription factor pancreatic duodenal homeobox-1 (PDX-1) to the insulin gene promoter to activate insulin gene transcription. At low glucose levels, glycogen synthase kinase 3 beta (GSK3 beta) is known to phosphorylate PDX-1 on C-terminal serine residues, which triggers PDX-1 proteasomal degradation. We previously showed that the serine/threonine Per-Arnt-Sim domain-containing kinase (PASK) regulates insulin gene transcription via PDX-1. However, the mechanisms underlying this regulation are unknown. In this study, we aimed to identify the role of PASK in the regulation of PDX-1 phosphorylation, protein expression, and stability in insulin-secreting cells and isolated rodent islets of Langerhans. We observed that glucose induces a decrease in overall PDX-1 serine phosphorylation and that overexpression of WT PASK mimics this effect. In vitro, PASK directly phosphorylates GSK3 beta on its inactivating phosphorylation site Ser(9). Overexpression of a kinase-dead (KD), dominant negative version of PASK blocks glucose-induced Ser(9) phosphorylation of GSK3 beta. Accordingly, GSK3 beta Ser(9) phosphorylation is reduced in islets from pask-null mice. Overexpression of WT PASK or KD GSK3 beta protects PDX-1 from degradation and results in increased PDX-1 protein abundance. Conversely, overexpression of KD PASK blocks glucose-induction of PDX-1 protein. We conclude that PASK phosphorylates and inactivates GSK3 beta, thereby preventing PDX-1 serine phosphorylation and alleviating GSK3 beta-mediated PDX-1 protein degradation in pancreatic beta-cells.	[Semache, Meriem; Zarrouki, Bader; Fontes, Ghislaine; Chawki, Mohammad B.; Poitout, Vincent] Univ Montreal, Montreal Diabet Res Ctr, CRCHUM, Quebec City, PQ H1W 4A4, Canada; [Semache, Meriem; Poitout, Vincent] Univ Montreal, Dept Biochem, Quebec City, PQ H1W 4A4, Canada; [Zarrouki, Bader; Poitout, Vincent] Univ Montreal, Dept Med, Quebec City, PQ H1W 4A4, Canada; [Fogarty, Sarah; Kikani, Chintan; Rutter, Jared] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Utah System of Higher Education; University of Utah	Poitout, V (corresponding author), CRCHUM Technopole Angus,2901 Rachel Est, Montreal, PQ H1W 4A4, Canada.	vincent.poitout@umontreal.ca		Poitout, Vincent/0000-0002-6555-5053; Chawki, Mohammad B./0000-0002-6220-3618; Kikani, Chintan/0000-0003-1140-0192	National Institutes of Health [R01 DK-58096, R01 DK-071962]; Fonds de Recherche en Sante du Quebec; Eli Lilly; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058096, R01DK071962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Eli Lilly(Eli Lilly); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK-58096 (to V. P.) and R01 DK-071962 (to J. R.).; Recipient of a doctoral studentship from the Fonds de Recherche en Sante du Quebec.; Supported by a postdoctoral fellowship from Eli Lilly.; Supported by a Mentor-based postdoctoral fellowship from the American Diabetes Association.	Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Amyot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036200; An R, 2006, BIOCHEM SOC T, V34, P791, DOI 10.1042/BST0340791; An R, 2010, BIOCHEM BIOPH RES CO, V399, P155, DOI 10.1016/j.bbrc.2010.07.035; Ben Shushan E, 1999, DNA CELL BIOL, V18, P471, DOI 10.1089/104454999315196; Borter E, 2007, DIABETES, V56, P113, DOI 10.2337/db06-0798; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Cardon CM, 2012, SEMIN CELL DEV BIOL, V23, P626, DOI 10.1016/j.semcdb.2011.12.007; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; da Silva Xavier G, 2004, P NATL ACAD SCI USA, V101, P8319, DOI 10.1073/pnas.0307737101; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Grose JH, 2010, SENSORS-BASEL, V10, P5668, DOI 10.3390/s100605668; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; Hao HX, 2008, IUBMB LIFE, V60, P204, DOI 10.1002/iub.32; Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kebede M, 2012, P NATL ACAD SCI USA, V109, P2376, DOI 10.1073/pnas.1114350109; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Kikani CK, 2010, J BIOL CHEM, V285, P41034, DOI 10.1074/jbc.M110.157594; Kishi A, 2003, AM J PHYSIOL-ENDOC M, V284, pE830, DOI 10.1152/ajpendo.00390.2002; Lebrun P, 2005, J BIOL CHEM, V280, P38203, DOI 10.1074/jbc.M504842200; Liu Z, 2008, DIABETOLOGIA, V51, P623, DOI 10.1007/s00125-007-0914-7; MACFARLANE WM, 1994, BIOCHEM J, V303, P625, DOI 10.1042/bj3030625; Macfarlane WM, 1997, J BIOL CHEM, V272, P20936, DOI 10.1074/jbc.272.33.20936; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; Meng R, 2010, CELL MOL LIFE SCI, V67, P2481, DOI 10.1007/s00018-010-0348-0; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Petersen HV, 1998, FEBS LETT, V431, P362, DOI 10.1016/S0014-5793(98)00776-5; Poitout V., 2004, INT TXB DIABETES MEL, P98; Rafiq I, 2000, J BIOL CHEM, V275, P15977, DOI 10.1074/jbc.275.21.15977; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; Rutter J, 2002, CELL, V111, P17, DOI 10.1016/S0092-8674(02)00974-1; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Semplici F, 2011, J BIOL CHEM, V286, P44005, DOI 10.1074/jbc.M111.254995; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Wilson WA, 2005, P NATL ACAD SCI USA, V102, P16596, DOI 10.1073/pnas.0508481102; Wu H, 1999, BIOCHEM J, V344, P813, DOI 10.1042/0264-6021:3440813; Xavier GD, 2011, DIABETOLOGIA, V54, P819, DOI 10.1007/s00125-010-2010-7	45	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24825	24833		10.1074/jbc.M113.495945	http://dx.doi.org/10.1074/jbc.M113.495945			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23853095	Green Published, hybrid			2022-12-25	WOS:000330612300047
J	Herbomel, G; Kloster-Landsberg, M; Folco, EG; Col, E; Usson, Y; Vourc'h, C; Delon, A; Souchier, C				Herbomel, Gaetan; Kloster-Landsberg, Meike; Folco, Eric G.; Col, Edwige; Usson, Yves; Vourc'h, Claire; Delon, Antoine; Souchier, Catherine			Dynamics of the Full Length and Mutated Heat Shock Factor 1 in Human Cells	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; NUCLEAR STRESS GRANULES; DNA-BINDING ACTIVITY; LIVING CELLS; LIVE CELLS; GENOME FUNCTION; IN-VIVO; TRANSCRIPTION; PROTEIN; GENE	Heat shock factor 1 is the key transcription factor of the heat shock response. Its function is to protect the cell against the deleterious effects of stress. Upon stress, HSF1 binds to and transcribes hsp genes and repeated satellite III (sat III) sequences present at the 9q12 locus. HSF1 binding to pericentric sat III sequences forms structures known as nuclear stress bodies (nSBs). nSBs represent a natural amplification of RNA pol II dependent transcription sites. Dynamics of HSF1 and of deletion mutants were studied in living cells using multi-confocal Fluorescence Correlation Spectroscopy (mFCS) and Fluorescence Recovery After Photobleaching (FRAP). In this paper, we show that HSF1 dynamics modifications upon heat shock result from both formation of high molecular weight complexes and increased HSF1 interactions with chromatin. These interactions involve both DNA binding with Heat Shock Element (HSE) and sat III sequences and a more transient sequence-independent binding likely corresponding to a search for more specific targets. We find that the trimerization domain is required for low affinity interactions with chromatin while the DNA binding domain is required for site-specific interactions of HSF1 with DNA.	[Herbomel, Gaetan; Folco, Eric G.; Col, Edwige; Vourc'h, Claire; Souchier, Catherine] Univ Grenoble 1, INSERM, IAB CRI U823, Team 10, La Tronche, France; [Kloster-Landsberg, Meike; Delon, Antoine] Univ Grenoble 1, CNRS, LIPhy UMR 5588, F-38402 St Martin Dheres, France; [Usson, Yves] Univ Grenoble 1, CNRS, TIMC IMAG UMR5525, La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Souchier, C (corresponding author), Univ Grenoble 1, INSERM, IAB CRI U823, Team 10, La Tronche, France.	Catherine.Souchier@ujf-grenoble.fr	Souchier, Catherine/M-2747-2013; Vourc'h, Claire/AAE-3119-2022; VOURC'H, Claire/AAG-8576-2021; USSON, Yves/B-2002-2014; Folco, Eric/M-2665-2013; VOURC'H, Claire/L-9319-2013	VOURC'H, Claire/0000-0002-7276-9359; USSON, Yves/0000-0003-0242-191X; VOURC'H, Claire/0000-0002-7276-9359	French "Agence Nationale de la Recherche'' [ANR-08-PCVI-0004-01]; "Region Rhone-Alpes", CIBLE; French Cancer Research Association "ARC''	French "Agence Nationale de la Recherche''(French National Research Agency (ANR)); "Region Rhone-Alpes", CIBLE(Region Auvergne-Rhone-Alpes); French Cancer Research Association "ARC''(Fondation ARC pour la Recherche sur le Cancer)	This project was funded by the French "Agence Nationale de la Recherche'' (http://www.agence-nationale-recherche.fr/) under contract ANR-08-PCVI-0004-01, by the "Region Rhone-Alpes'', CIBLE 2009 (http://www.rhonealpes.fr/), and by the French Cancer Research Association "ARC'' (http://www.arc-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alastalo TP, 2003, J CELL SCI, V116, P3557, DOI 10.1242/jcs.00671; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Biamonti G, 2011, COLD SPRING HARB PER, V2; Christians E, 1997, MOL CELL BIOL, V17, P778, DOI 10.1128/MCB.17.2.778; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; Delon A, 2006, BIOPHYS J, V90, P2548, DOI 10.1529/biophysj.105.069815; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Hensen S.M., 2013, CELL STRESS CHAPERON; Hinow P, 2006, BIOPHYS J, V91, P330, DOI 10.1529/biophysj.105.078303; Hu YZ, 2003, J BIOL CHEM, V278, P17299, DOI 10.1074/jbc.M300788200; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; Kang M, 2012, SIMPLIFIED EQUATION, P9999; Kim SA, 2005, FEBS LETT, V579, P6559, DOI 10.1016/j.febslet.2005.10.043; Kloster-Landsberg M, 2012, BIOPHYS J, V103, P1110, DOI 10.1016/j.bpj.2012.07.041; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Muller CB, 2008, J PHYS CHEM B, V112, P8236, DOI 10.1021/jp802280u; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Rafalska-Metcalf IU, 2007, J CELL SCI, V120, P2301, DOI 10.1242/jcs.008664; Ries J, 2012, BIOESSAYS, V34, P361, DOI 10.1002/bies.201100111; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Sheval EV, 2006, CELL BIOL INT, V30, P1028, DOI 10.1016/j.cellbi.2006.07.009; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xu YM, 2012, J PROTEOME RES, V11, P2625, DOI 10.1021/pr201151a; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	38	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67566	10.1371/journal.pone.0067566	http://dx.doi.org/10.1371/journal.pone.0067566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861773	Green Published, gold			2022-12-25	WOS:000321692000010
J	Ternhag, A; Cederstrom, A; Torner, A; Westling, K				Ternhag, Anders; Cederstrom, Agneta; Torner, Anna; Westling, Katarina			A Nationwide Cohort Study of Mortality Risk and Long-Term Prognosis in Infective Endocarditis in Sweden	PLOS ONE			English	Article							NATIVE VALVE ENDOCARDITIS; INTRAVENOUS-DRUG-USERS; STAPHYLOCOCCUS-AUREUS; POPULATION; SURGERY; TRENDS; IMPACT; BIAS	Objectives: Infective endocarditis (IE) remains a serious disease with substantial mortality. In this study we investigated the incidence of IE, as well as its associated short and long term mortality rates. Methods: The IE cases were identified in the Swedish national inpatient register using ICD-10 codes, and then linked to the population register in order to identify deaths in the cohort. Crude mortality rates among IE patients were obtained for different time intervals. These rates were directly standardized using sex-and age-matched mortality in the general population. Results: The cohort consisted of 7603 individuals and 7817 episodes of IE during 1997-2007. The 30 days all-cause crude mortality rate was 10.4% and the standardized mortality ratio (SMR) was 33.7 (95% confidence interval [CI]: 31.0-36.6). Excluding the first year of follow-up, the long term mortality (1-5 years) showed an increased SMR of 2.2 (95% CI: 2.0-2.3) compared to the general population. Significantly higher SMR was found for cases of IE younger than 65 years of age with a 1-5 year SMR of 6.3, and intravenous drug-users with a SMR of 19.1. Native valve IE cases, in which surgery was performed had lower crude mortality rates and Mantel-Haenzel odds ratios of less than one compared to those with medical therapy alone during 30-day and 5-years follow-up. Conclusions: The 30-days crude mortality rate for IE was 10.4% and long-term relative mortality risk remains increased even up to 5 years of follow-up, therefore a close monitoring of these patients would be of value.	[Ternhag, Anders; Cederstrom, Agneta; Westling, Katarina] Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden; [Torner, Anna] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ternhag, A (corresponding author), Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden.	anders.ternhag@karolinska.se		Ternhag, Anders/0000-0003-4968-8945; Westling, Katarina/0000-0002-8755-1037	Karolinska Institutet	Karolinska Institutet(Karolinska Institutet)	This work was supported in part by grants from Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; DELAHAYE F, 1995, EUR HEART J, V16, P48, DOI 10.1093/eurheartj/16.suppl_B.48; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Fedeli U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-48; Federspiel JJ, 2012, ARCH INTERN MED, V172, P363, DOI 10.1001/archinternmed.2011.1027; Fernandez-Hidalgo N, 2012, CLIN MICROBIOL INFEC, V18, pE522, DOI 10.1111/1469-0691.12033; Hill EE, 2008, AM J CARDIOL, V101, P1174, DOI 10.1016/j.amjcard.2007.12.015; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; Lalani T, 2010, CIRCULATION, V121, P1005, DOI 10.1161/CIRCULATIONAHA.109.864488; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Martinez-Selles M, 2008, MAYO CLIN PROC, V83, P1213, DOI 10.4065/83.11.1213; MATHEW J, 1995, ARCH INTERN MED, V155, P1641, DOI 10.1001/archinte.155.15.1641; Mokhles MM, 2011, ANN THORAC SURG, V91, P1407, DOI 10.1016/j.athoracsur.2011.02.007; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Thuny F, 2012, AM HEART J, V164, P94, DOI 10.1016/j.ahj.2012.04.003; Tleyjeh IM, 2010, J CLIN EPIDEMIOL, V63, P130, DOI 10.1016/j.jclinepi.2008.06.022; Tleyjeh Imad M, 2006, Curr Infect Dis Rep, V8, P265, DOI 10.1007/s11908-006-0070-0; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207; Yiu KH, 2007, INT J CARDIOL, V121, P119, DOI 10.1016/j.ijcard.2006.08.053	25	67	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67519	10.1371/journal.pone.0067519	http://dx.doi.org/10.1371/journal.pone.0067519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861768	Green Submitted, gold, Green Published			2022-12-25	WOS:000321692000009
J	Boyd, JC; Simpson, CA; Jung, ME; Gurd, BJ				Boyd, J. Colin; Simpson, Craig A.; Jung, Mary E.; Gurd, Brendon J.			Reducing the Intensity and Volume of Interval Training Diminishes Cardiovascular Adaptation but Not Mitochondrial Biogenesis in Overweight/Obese Men	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; EXERCISE INTENSITY; METABOLIC ADAPTATIONS; SPRINT INTERVAL; SIRT1 ACTIVITY; STROKE VOLUME; OXYGEN PULSE; IN-VITRO; PERFORMANCE; HUMANS	Objective: The purpose of this research was to determine if the adaptations to high intensity interval training (HIT) are mitigated when both intensity and training volume (i.e. exercise energy expenditure) are reduced. Methods: 19 overweight/obese, sedentary males (Age: 22.7 +/- 3.9 yrs, Body Mass Index: 31.4 +/- 2.6 kg/m(2), Waist Circumference: 106.5 +/- 6.6 cm) performed 9 sessions of interval training using a 1-min on, 1-min off protocol on a cycle ergometer over three weeks at either 70% (LO) or 100% (HI) peak work rate. Results: Cytochrome oxidase I protein content, cytochrome oxidase IV protein content, and citrate synthase maximal activity all demonstrated similar increases between groups with a significant effect of training for each. beta-hydroxyacyl-CoA dehydrogenase maximal activity tended to increase with training but did not reach statistical significance (p = 0.07). Peroxisome proliferator-activated receptor gamma coactivator-1 alpha and silent mating type information regulator 2 homolog 1 protein contents also increased significantly (p = 0.047), while AMP-activated protein kinase protein content decreased following the intervention (p = 0.019). VO(2)peak increased by 11.0 +/- 7.4% and 27.7 +/- 4.4% in the LO and HI groups respectively with significant effects of both training (p < 0.001) and interaction (p = 0.027). Exercise performance improved by 8.6 +/- 7.6% in the LO group and 14.1 +/- 4.3% in the HI group with a significant effect of training and a significant difference in the improvement between groups. There were no differences in perceived enjoyment or self-efficacy between groups despite significantly lower affect scores during training in the HI group. Conclusions: While improvements in aerobic capacity and exercise performance were different between groups, changes in oxidative capacity were similar despite reductions in both training intensity and volume.	[Boyd, J. Colin; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Simpson, Craig A.] Queens Univ, Dept Emergency Med, Kingston, ON, Canada; [Jung, Mary E.] Univ British Columbia Okanagan, Fac Hlth & Social Dev, Kelowna, BC, Canada	Queens University - Canada; Queens University - Canada; University of British Columbia; University of British Columbia Okanagan	Gurd, BJ (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	gurdb@queensu.ca			Canadian Foundation for Innovation [25476]; National Sciences and Engineering Research Council of Canada [402635-2011]	Canadian Foundation for Innovation(Canada Foundation for Innovation); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported with funding from the Canadian Foundation for Innovation (IOF#25476), and the National Sciences and Engineering Research Council of Canada (402635-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci S, 2010, NUTR METAB CARDIOVAS, V20, P608, DOI 10.1016/j.numecd.2009.04.015; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; BHAMBHANI Y, 1994, CAN J APPL PHYSIOL, V19, P49, DOI 10.1139/h94-003; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Coyle EF, 2005, J APPL PHYSIOL, V98, P1983, DOI 10.1152/japplphysiol.00215.2005; Dalleck L, 2010, INT J SPORTS MED, V31, P567, DOI 10.1055/s-0030-1254136; Daussin FN, 2007, EUR J APPL PHYSIOL, V101, P377, DOI 10.1007/s00421-007-0499-3; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Ekkekakis P, 2008, ANN BEHAV MED, V35, P136, DOI 10.1007/s12160-008-9025-z; Ekkekakis P, 2010, OBESITY, V18, P79, DOI 10.1038/oby.2009.204; Gaesser GA, 2011, J APPL PHYSIOL, V111, P1540, DOI 10.1152/japplphysiol.01237.2011; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Guiraud T, 2011, MED SCI SPORT EXER, V43, P211, DOI 10.1249/MSS.0b013e3181ebc5de; Gurd BJ, 2012, J APPL PHYSIOL, V112, P926, DOI 10.1152/japplphysiol.01262.2011; Gurd BJ, 2011, APPL PHYSIOL NUTR ME, V36, P589, DOI [10.1139/h11-070, 10.1139/H11-070]; Gurd BJ, 2011, AM J PHYSIOL-REG I, V301, pR67, DOI 10.1152/ajpregu.00417.2010; Gurd BJ, 2010, APPL PHYSIOL NUTR ME, V35, P350, DOI 10.1139/H10-030; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; MathieuCostello O, 1996, J APPL PHYSIOL, V80, P904, DOI 10.1152/jappl.1996.80.3.904; McKay BR, 2009, J APPL PHYSIOL, V107, P128, DOI 10.1152/japplphysiol.90828.2008; Metcalfe RS, 2012, EUR J APPL PHYSIOL, V112, P2767, DOI 10.1007/s00421-011-2254-z; Meyer P, 2012, J CARD FAIL, V18, P126, DOI 10.1016/j.cardfail.2011.10.010; Moran CN, 2011, METABOLISM, V60, P206, DOI 10.1016/j.metabol.2009.12.026; Munk PS, 2011, EUR J CARDIOV PREV R, V18, P850, DOI 10.1177/1741826710397600; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nordsborg NB, 2010, MED SCI SPORT EXER, V42, P1477, DOI 10.1249/MSS.0b013e3181d2d21c; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Richardson RS, 2000, MED SCI SPORT EXER, V32, P89; Stensvold D, 2012, METAB SYNDR RELAT D, V10, P267, DOI 10.1089/met.2011.0140; Tjonna AE, 2009, CLIN SCI, V116, P317, DOI 10.1042/CS20080249; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Whipp BJ, 1996, J APPL PHYSIOL, V81, P2674, DOI 10.1152/jappl.1996.81.6.2674; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002	43	69	71	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68091	10.1371/journal.pone.0068091	http://dx.doi.org/10.1371/journal.pone.0068091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861854	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300042
J	Challand, MR; Salvadori, E; Driesener, RC; Kay, CWM; Roach, PL; Spencer, J				Challand, Martin R.; Salvadori, Enrico; Driesener, Rebecca C.; Kay, Christopher W. M.; Roach, Peter L.; Spencer, James			Cysteine Methylation Controls Radical Generation in the Cfr Radical AdoMet rRNA Methyltransferase	PLOS ONE			English	Article							LYASE-ACTIVATING ENZYME; IRON-SULFUR CLUSTER; ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE; BIOTIN SYNTHASE; ESCHERICHIA-COLI; LYSINE 2,3-AMINOMUTASE; CRYSTAL-STRUCTURE; SAM ENZYMES; ENTEROCOCCUS-FAECALIS	The 'radical S-adenosyl-L-methionine (AdoMet)' enzyme Cfr methylates adenosine 2503 of the 23S rRNA in the peptidyltransferase centre (P-site) of the bacterial ribosome. This modification protects host bacteria, notably methicillin-resistant Staphylococcus aureus (MRSA), from numerous antibiotics, including agents (e.g. linezolid, retapamulin) that were developed to treat such organisms. Cfr contains a single [4Fe-4S] cluster that binds two separate molecules of AdoMet during the reaction cycle. These are used sequentially to first methylate a cysteine residue, Cys338; and subsequently generate an oxidative radical intermediate that facilitates methyl transfer to the unreactive C8 (and/or C2) carbon centres of adenosine 2503. How the Cfr active site, with its single [4Fe-4S] cluster, catalyses these two distinct activities that each utilise AdoMet as a substrate remains to be established. Here, we use absorbance and electron paramagnetic resonance (EPR) spectroscopy to investigate the interactions of AdoMet with the [4Fe-4S] clusters of wild-type Cfr and a Cys338 Ala mutant, which is unable to accept a methyl group. Cfr binds AdoMet with high (similar to 10 mu M) affinity notwithstanding the absence of the RNA cosubstrate. In wild-type Cfr, where Cys338 is methylated, AdoMet binding leads to rapid oxidation of the [4Fe-4S] cluster and production of 5'-deoxyadenosine (DOA). In contrast, while Cys338 Ala Cfr binds AdoMet with equivalent affinity, oxidation of the [4Fe-4S] cluster is not observed. Our results indicate that the presence of a methyl group on Cfr Cys338 is a key determinant of the activity of the enzyme towards AdoMet, thus enabling a single active site to support two distinct modes of AdoMet cleavage.	[Challand, Martin R.; Spencer, James] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Salvadori, Enrico; Kay, Christopher W. M.] UCL, Inst Struct & Mol Biol, London, England; [Salvadori, Enrico; Kay, Christopher W. M.] UCL, London Ctr Nanotechnol, London, England; [Driesener, Rebecca C.; Roach, Peter L.] Univ Southampton, Southampton, Hants, England; [Roach, Peter L.] Univ Southampton, Inst Life Sci, Southampton, Hants, England	University of Bristol; University of London; Birkbeck University London; University College London; University of London; University College London; University of Southampton; University of Southampton	Kay, CWM (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	c.kay@ucl.ac.uk; p.l.roach@soton.ac.uk; Jim.Spencer@bristol.ac.uk	Roach, Peter/AAW-7071-2021; Kay, Christopher William Michael/C-2467-2008; Challand, Martin/C-6395-2015	Kay, Christopher William Michael/0000-0002-5200-6004; Challand, Martin/0000-0002-9685-3504; Salvadori, Enrico/0000-0003-4394-9438	Leverhulme Trust [F/00 182/CO]; United Kingdom Biotechnology and Biological Sciences Research Council [BB/J017906/1]; BBSRC [BB/J017906/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017906/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Leverhulme Trust (www.leverhulme.ac.uk; award ref. F/00 182/CO to JS, PLR and RC) and the United Kingdom Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk; award ref. BB/J017906/1 to JS, PLR and MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atta M, 2010, CURR OPIN STRUC BIOL, V20, P684, DOI 10.1016/j.sbi.2010.09.009; Benjdia A, 2012, NUCLEIC ACIDS RES, V40, P9308, DOI 10.1093/nar/gks603; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Booth MPS, 2010, PROTEIN EXPRES PURIF, V74, P204, DOI 10.1016/j.pep.2010.07.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brickner SJ, 2008, J MED CHEM, V51, P1981, DOI 10.1021/jm800038g; BRUSCHI M, 1976, BIOCHIM BIOPHYS ACTA, V449, P275, DOI 10.1016/0005-2728(76)90139-0; Bui BTS, 2004, BIOCHEMISTRY-US, V43, P16432, DOI 10.1021/bi048040t; Challand MR, 2011, NAT PROD REP, V28, P1696, DOI 10.1039/c1np00036e; Challand MR, 2010, J BIOL CHEM, V285, P5240, DOI 10.1074/jbc.M109.056606; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Diaz L, 2012, ANTIMICROB AGENTS CH, V56, P3917, DOI 10.1128/AAC.00419-12; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; HAGEN KS, 1983, J AM CHEM SOC, V105, P3905, DOI 10.1021/ja00350a028; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hinckley GT, 2006, BIOCHEMISTRY-US, V45, P3219, DOI 10.1021/bi0519497; Hioe J, 2012, CHEM-EUR J, V18, P16463, DOI 10.1002/chem.201202869; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13496, DOI 10.1021/bi048693+; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Lieder KW, 1998, BIOCHEMISTRY-US, V37, P2578, DOI 10.1021/bi972417w; Lippard S. J., 1994, PRINCIPLES BIOINORGA, pXVII; Liu Y, 2012, ANTIMICROB AGENTS CH, V56, P1650, DOI 10.1128/AAC.06091-11; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; MOSS ML, 1990, J BIOL CHEM, V265, P18112; MULLER B, 1991, BIOCHEMISTRY-US, V30, P3709, DOI 10.1021/bi00229a017; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Ollagnier-de Choudens S, 2002, J BIOL CHEM, V277, P13449, DOI 10.1074/jbc.M111324200; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; Schluckebier G, 1997, J MOL BIOL, V265, P56, DOI 10.1006/jmbi.1996.0711; Selmer T, 2005, BIOL CHEM, V386, P981, DOI 10.1515/BC.2005.114; SHAPIRO SK, 1966, ANAL BIOCHEM, V15, P323, DOI 10.1016/0003-2697(66)90038-8; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STOLOWITZ ML, 1981, J AM CHEM SOC, V103, P6015, DOI 10.1021/ja00410a004; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Ugulava NB, 2003, BIOCHEMISTRY-US, V42, P2708, DOI 10.1021/bi0261084; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8343, DOI 10.1021/bi0104625; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; Wang SC, 2007, BIOCHEMISTRY-US, V46, P12889, DOI 10.1021/bi701745h; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Wang Y, 2012, J ANTIMICROB CHEMOTH, V67, P1094, DOI 10.1093/jac/dks020; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c; Zhang Q, 2011, J BIOL CHEM, V286, P21287, DOI 10.1074/jbc.M111.224832; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	65	9	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67979	10.1371/journal.pone.0067979	http://dx.doi.org/10.1371/journal.pone.0067979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861844	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300034
J	Nicholas, J; Charlton, J; Dregan, A; Gulliford, MC				Nicholas, Jennifer; Charlton, Judith; Dregan, Alex; Gulliford, Martin C.			Recent HbA1c Values and Mortality Risk in Type 2 Diabetes. Population-Based Case-Control Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; GLUCOSE CONTROL; VASCULAR COMPLICATIONS; CARDIOVASCULAR DEATH; SULFONYLUREA DRUGS; GLYCEMIC CONTROL; HEMOGLOBIN A1C; FOLLOW-UP; METAANALYSIS; MELLITUS	This study aimed to evaluate mortality within 365 days of HbA1c values of <6.5% or >9.0% in participants with clinical type 2 diabetes mellitus. A matched nested case-control study was implemented, within a cohort of participants with type 2 diabetes from 2000 to 2008. Conditional logistic regression was used to model the odds ratio for mortality adjusting for comorbidity and drug utilisation. There were 97,450 participants with type 2 diabetes; 16,585 cases that died during follow up were matched to 16,585 controls. The most recent HbA1c value was <6.5% (48 mmol/mol) for 22.2% of cases and 24.2% of controls, the HbA1c was >9.0% for 9.0% of cases and 7.7% of controls. In a complete case analysis, the adjusted odds ratio (AOR) for mortality associated with most recent HbA1c <6.5% was 1.31 (95% confidence interval (CI): 1.21,1.42). After multiple imputation of missing HbA1c values the AOR was 1.20 (CI: 1.12,1.28). The complete case analysis gave an AOR for HbA1c >9.0% of 1.51 (CI: 1.33, 1.70), in the multiple imputation analysis this was 1.29 (1.17,1.41). The risk associated with HbA1c <6.5% was age dependent. In the multiple imputation analysis the AOR was 1.53 (CI: 0.84 to 2.79) at age<55 years but 1.04 (CI: 0.92, 1.17) at age 85 years and over. In non-randomised data, values of HbA1c that are either <6.5% or >9.0% may be associated with increased mortality within one year in clinical type 2 diabetes. Relative risks may be higher at younger ages.	[Nicholas, Jennifer] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Charlton, Judith; Dregan, Alex; Gulliford, Martin C.] Kings Coll London, NIHR Biomed Res Ctr, Guys & St Thomas NHS Fdn Trust, London WC2R 2LS, England; [Charlton, Judith; Dregan, Alex; Gulliford, Martin C.] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Dregan, A (corresponding author), Kings Coll London, NIHR Biomed Res Ctr, Guys & St Thomas NHS Fdn Trust, London WC2R 2LS, England.	alexandru.dregan@kcl.ac.uk	Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075; Dregan, Alex/0000-0002-7620-4902	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; Medical Research Council; MHRA; National Institute for Health Research (NIHR) Biomedical Research Centre at King's College London	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MHRA; National Institute for Health Research (NIHR) Biomedical Research Centre at King's College London(National Institute for Health Research (NIHR))	This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Access to the GPRD database was funded through the Medical Research Council's license agreement with MHRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS3, DOI 10.2337/dc11-S003; BLAND JM, 1994, BRIT MED J, V309, P1128, DOI 10.1136/bmj.309.6962.1128; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Carson AP, 2010, CIRC-CARDIOVASC QUAL, V3, P661, DOI 10.1161/CIRCOUTCOMES.110.957936; Christman AL, 2011, J INVEST DERMATOL, V131, P2121, DOI 10.1038/jid.2011.176; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Forst T, 2013, DIABETES VASC DIS RE; Garratt KN, 1999, J AM COLL CARDIOL, V33, P119, DOI 10.1016/S0735-1097(98)00557-9; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2013, GLOB GUID TYOE 2 DIA; Iqbal N, 2008, ANN CLIN BIOCHEM, V45, P504, DOI 10.1258/acb.2008.008034; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Khaw KT, 2004, CANCER EPIDEM BIOMAR, V13, P915; Kowall B, 2011, EUR J EPIDEMIOL, V26, P637, DOI 10.1007/s10654-011-9609-y; Monami M, 2012, ADV THER, V29, P14, DOI 10.1007/s12325-011-0088-z; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Riveline JP, 2010, LANCET, V375, P1433, DOI 10.1016/S0140-6736(10)60612-5; Rubin DB, 2004, MULTIPLE IMPUTATION; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Sterne JA, 2009, BMJ-BRIT MED J, V338, pb2392; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zoungas S, 2012, DIABETOLOGIA, V55, P636, DOI 10.1007/s00125-011-2404-1; Zoungas S, 2012, NEW ENGL J MED, V363, P1410; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	37	46	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68008	10.1371/journal.pone.0068008	http://dx.doi.org/10.1371/journal.pone.0068008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861845	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000321425300035
J	Rumple, A; McMurray, M; Johns, J; Lauder, J; Makam, P; Radcliffe, M; Oguz, I				Rumple, Ashley; McMurray, Matthew; Johns, Josephine; Lauder, Jean; Makam, Pooja; Radcliffe, Marlana; Oguz, Ipek			3-Dimensional Diffusion Tensor Imaging (DTI) Atlas of the Rat Brain	PLOS ONE			English	Article							MAGNETIC-RESONANCE HISTOLOGY; DEVELOPING MOUSE-BRAIN; VARIABILITY; DATABASE; SPACE; ECHO	Anatomical atlases play an important role in the analysis of neuroimaging data in rodent neuroimaging studies. Having a high resolution, detailed atlas not only can expand understanding of rodent brain anatomy, but also enables automatic segmentation of new images, thus greatly increasing the efficiency of future analysis when applied to new data. These atlases can be used to analyze new scans of individual cases using a variety of automated segmentation methods. This project seeks to develop a set of detailed 3D anatomical atlases of the brain at postnatal day 5 (P5), 14 (P14), and adults (P72) in Sprague-Dawley rats. Our methods consisted of first creating a template image based on fixed scans of control rats, then manually segmenting various individual brain regions on the template. Using itk-SNAP software, subcortical and cortical regions, including both white matter and gray matter structures, were manually segmented in the axial, sagittal, and coronal planes. The P5, P14, and P72 atlases had 39, 45, and 29 regions segmented, respectively. These atlases have been made available to the broader research community.	[Rumple, Ashley; Johns, Josephine; Lauder, Jean; Makam, Pooja; Radcliffe, Marlana] Univ N Carolina, Chapel Hill, NC 27515 USA; [McMurray, Matthew] UIC, Chicago, IL USA; [Oguz, Ipek] UI, Iowa City, IA USA	University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago	Rumple, A (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	rumple@ad.unc.edu	McMurray, Matthew/AAO-5310-2021	McMurray, Matthew/0000-0002-1898-2933	UNC Neurodevelopment Disorders Research Center [HD 03110]; National Institutes of Health (NIH) STTR [R41 NS059095]; NIH [P01 DA022446, F31DA026251]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS059095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA022446, F31DA026251] Funding Source: NIH RePORTER	UNC Neurodevelopment Disorders Research Center; National Institutes of Health (NIH) STTR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the UNC Neurodevelopment Disorders Research Center HD 03110, the National Institutes of Health (NIH) STTR grant R41 NS059095, the NIH Program Project P01 DA022446, and F31DA026251. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, NEUROSCIENCE, V162, P1339, DOI 10.1016/j.neuroscience.2009.05.070; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Cai Yu, 2011, Front Psychiatry, V2, P54, DOI 10.3389/fpsyt.2011.00054; Calabrese E, 2013, NEUROIMAGE, V71, P196, DOI 10.1016/j.neuroimage.2013.01.017; Chuang N, 2011, NEUROIMAGE, V54, P80, DOI 10.1016/j.neuroimage.2010.07.043; Ehlers C., 2011, PROC SOC PHOTOOPT IN, V7962; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lee J, 2009, P SOC PHOTO-OPT INS, DOI [10.1117/12.812762, DOI 10.1117/12.812762]; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; MacKenzie-Graham A, 2006, NEUROIMAGE, V32, P1016, DOI 10.1016/j.neuroimage.2006.05.006; Mayer AD, 1998, DEV PSYCHOBIOL, V32, P131; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 1998, MAGNET RESON MED, V40, P511, DOI 10.1002/mrm.1910400403; Nie B, 2013, HUM BRAIN MAPP, V34, P1306, DOI 10.1002/hbm.21511; Oguz I, 2012, DEV NEUROSCI-BASEL, V34, P5, DOI 10.1159/000336825; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Veraart J, 2011, NEUROIMAGE, V58, P975, DOI 10.1016/j.neuroimage.2011.06.063; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang J, 2006, EMBS 06 28 ANN INT C, DOI [10.1109/IEMBS.2006.259388, DOI 10.1109/IEMBS.2006.259388]; Zhang JY, 2003, NEUROIMAGE, V20, P1639, DOI 10.1016/S1053-8119(03)00410-5	24	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67334	10.1371/journal.pone.0067334	http://dx.doi.org/10.1371/journal.pone.0067334			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861758	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300011
J	Ambrosini, E; Reddy, V; de Looper, A; Costantini, M; Lopez, B; Sinigaglia, C				Ambrosini, Ettore; Reddy, Vasudevi; de Looper, Annette; Costantini, Marcello; Lopez, Beatriz; Sinigaglia, C.			Looking Ahead: Anticipatory Gaze and Motor Ability in Infancy	PLOS ONE			English	Article							OTHERS ACTIONS; EYE TRACKING; GOAL OBJECT; PERCEPTION; HANDS; EXPERIENCE; SHIFTS; GRASP; REACH; AGE	The present study asks when infants are able to selectively anticipate the goals of observed actions, and how this ability relates to infants' own abilities to produce those specific actions. Using eye-tracking technology to measure on-line anticipation, 6-, 8- and 10-month-old infants and a control group of adults were tested while observing an adult reach with a whole hand grasp, a precision grasp or a closed fist towards one of two different sized objects. The same infants were also given a comparable action production task. All infants showed proactive gaze to the whole hand grasps, with increased degrees of proactivity in the older groups. Gaze proactivity to the precision grasps, however, was present from 8 months of age. Moreover, the infants' ability in performing precision grasping strongly predicted their ability in using the actor's hand shape cues to differentially anticipate the goal of the observed action, even when age was partialled out. The results are discussed in terms of the specificity of action anticipation, and the fine-grained relationship between action production and action perception.	[Ambrosini, Ettore; Costantini, Marcello] Univ G DAnnunzio, Dept Neurosci & Imaging, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy; [Ambrosini, Ettore; Costantini, Marcello] Fdn Univ G dAnnunzio, Inst Adv Biomed Technol ITAB, Chieti, Italy; [Reddy, Vasudevi; de Looper, Annette; Lopez, Beatriz] Univ Portsmouth, Dept Psychol, Ctr Situated Act & Commun, Portsmouth, Hants, England; [Sinigaglia, C.] Univ Milan, Dept Philosophy, Milan, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Portsmouth; University of Milan	Ambrosini, E (corresponding author), Univ G DAnnunzio, Dept Neurosci & Imaging, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy.	e.ambrosini@unich.it	Ambrosini, Ettore/K-5882-2016; Costantini, Marcello/F-7083-2011; SINIGAGLIA, CORRADO/AGY-7196-2022; Ambrosini, Ettore/AAH-5525-2019; sinigaglia, corrado/AAI-2220-2021	Ambrosini, Ettore/0000-0002-1439-5491; SINIGAGLIA, CORRADO/0000-0002-3365-7522; Ambrosini, Ettore/0000-0002-1439-5491; Lopez, Beatriz/0000-0001-5621-6044; Costantini, Marcello/0000-0002-0504-1296	Abruzzo region (Progetto Speciale Multiasse "Reti per l'alta formazione'')	Abruzzo region (Progetto Speciale Multiasse "Reti per l'alta formazione'')	The work was supported by funding to EA from the Abruzzo region (Progetto Speciale Multiasse "Reti per l'alta formazione'' - P.O. F.S.E. 2007-2013, Piano Operativo 2009-2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Ambrosini E, 2012, J EXP PSYCHOL HUMAN, V38, P263, DOI 10.1037/a0026570; Ambrosini E, 2011, J NEUROPHYSIOL, V106, P1437, DOI 10.1152/jn.00118.2011; Baldwin DA, 2001, CHILD DEV, V72, P708, DOI 10.1111/1467-8624.00310; Baldwin D, 2008, COGNITION, V106, P1382, DOI 10.1016/j.cognition.2007.07.005; Barrett TM, 2008, INFANT BEHAV DEV, V31, P1, DOI 10.1016/j.infbeh.2007.05.004; BRESSON F, 1977, NEUROPSYCHOLOGIA, V15, P311, DOI 10.1016/0028-3932(77)90040-9; Butterworth G, 1997, BRIT J DEV PSYCHOL, V15, P223, DOI 10.1111/j.2044-835X.1997.tb00736.x; Butterworth G, 1990, JOINT VISUAL ATTENTI; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P292, DOI 10.1111/j.1467-7687.2011.01127.x; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P35, DOI 10.1111/j.1467-7687.2011.01095.x; Corbetta D, 2002, J MOTOR BEHAV, V34, P83, DOI 10.1080/00222890209601933; Corbetta D, 2000, MOTOR CONSTRAINTS DE; Costantini M, 2012, ACTA PSYCHOL, V141, P199, DOI 10.1016/j.actpsy.2012.07.012; Costantini M, 2012, Q J EXP PSYCHOL, V65, P848, DOI 10.1080/17470218.2012.679945; Daum MM, 2011, EXP BRAIN RES, V208, P297, DOI 10.1007/s00221-010-2479-9; Daum MM, 2011, J EXP CHILD PSYCHOL, V108, P810, DOI 10.1016/j.jecp.2010.10.003; Daum MM, 2009, DEVELOPMENTAL SCI, V12, P854, DOI 10.1111/j.1467-7687.2009.00831.x; Eshuis R, 2009, PSYCHOL SCI, V20, P438, DOI 10.1111/j.1467-9280.2009.02317.x; Fagard J, 2000, DEVELOPMENTAL SCI, V3, P137, DOI 10.1111/1467-7687.00107; Falck-Ytter T, 2006, NAT NEUROSCI, V9, P878, DOI 10.1038/nn1729; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gibson E. J., 2000, ECOLOGICAL APPROACH; Gibson JJ, 1979, ECOLOGICAL APPROACH; Gredeback G, 2010, EXP BRAIN RES, V202, P493, DOI 10.1007/s00221-009-2138-1; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Gredeback G, 2009, DEV PSYCHOL, V45, P1190, DOI 10.1037/a0015667; Henrichs I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00391; HOFSTEN CV, 1979, J EXP CHILD PSYCHOL, V28, P158, DOI 10.1016/0022-0965(79)90109-7; Hunnius S, 2010, DEV PSYCHOL, V46, P446, DOI 10.1037/a0016543; Kanakogi Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1342; Kochukhova O, 2010, CHILD DEV, V81, P1729, DOI 10.1111/j.1467-8624.2010.01506.x; Loucks J, 2012, CHILD DEV, V83, P801, DOI 10.1111/j.1467-8624.2012.01735.x; Marshall PJ, 2011, DEV COGN NEUROS-NETH, V1, P110, DOI 10.1016/j.dcn.2010.09.001; Meltzoff AN, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P281; Melzer A, 2012, INFANT BEHAV DEV, V35, P570, DOI 10.1016/j.infbeh.2012.05.003; Paulus M, 2011, VISION RES, V51, P955, DOI 10.1016/j.visres.2010.12.012; REDDY V., 2008, INFANTS KNOW MINDS; Rosander K, 2011, NEUROPSYCHOLOGIA, V49, P2911, DOI 10.1016/j.neuropsychologia.2011.06.018; SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004; van Hof P, 2002, CHILD DEV, V73, P1353, DOI 10.1111/1467-8624.00476; VonHofsten C, 1996, VISION RES, V36, P81, DOI 10.1016/0042-6989(95)00054-4; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7	46	80	81	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67916	10.1371/journal.pone.0067916	http://dx.doi.org/10.1371/journal.pone.0067916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861832	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700060
J	Forget, KJ; Tremblay, G; Roucou, X				Forget, Karolyn J.; Tremblay, Guillaume; Roucou, Xavier			p53 Aggregates Penetrate Cells and Induce the Co-Aggregation of Intracellular p53	PLOS ONE			English	Article							MUTANT P53; TETRAMERIZATION DOMAIN; WILD-TYPE; AMYLOID FORMATION; DNA-BINDING; PRION; PROTEIN; PROPAGATION; STABILITY; INSIGHTS	Prion diseases are unique pathologies in which the infectious particles are prions, a protein aggregate. The prion protein has many particular features, such as spontaneous aggregation, conformation transmission to other native PrP proteins and transmission from an individual to another. Protein aggregation is now frequently associated to many human diseases, for example Alzheimer's disease, Parkinson's disease or type 2 diabetes. A few proteins associated to these conformational diseases are part of a new category of proteins, called prionoids: proteins that share some, but not all, of the characteristics associated with prions. The p53 protein, a transcription factor that plays a major role in cancer, has recently been suggested to be a possible prionoid. The protein has been shown to accumulate in multiple cancer cell types, and its aggregation has also been reproduced in vitro by many independent groups. These observations suggest a role for p53 aggregates in cancer development. This study aims to test the "prion-like" features of p53. Our results show in vitro aggregation of the full length and N-terminally truncated protein (p53C), and penetration of these aggregates into cells. According to our findings, the aggregates enter cells using macropinocytosis, a non-specific pathway of entry. Lastly, we also show that once internalized by the cell, p53C aggregates can co-aggregate with endogenous p53 protein. Together, these findings suggest prion-like characteristics for p53 protein, based on the fact that p53 can spontaneously aggregate, these aggregates can penetrate cells and co-aggregate with cellular p53.	[Forget, Karolyn J.; Tremblay, Guillaume; Roucou, Xavier] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada.	xavier.roucou@usherbrooke.ca			Canadian Institutes for Health Research [MOP -89881]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes for Health Research to Xavier Roucou (MOP -89881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guest WC, 2011, J TOXICOL ENV HEAL A, V74, P1433, DOI 10.1080/15287394.2011.618967; Higashimoto Y, 2006, BIOCHEMISTRY-US, V45, P1608, DOI 10.1021/bi051192j; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Iversen TG, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-33; Lee AS, 2003, J MOL BIOL, V327, P699, DOI 10.1016/S0022-2836(03)00175-X; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Moll UM, 1996, MOL CELL BIOL, V16, P1126; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rigacci S, 2008, BIOPHYS J, V94, P3635, DOI 10.1529/biophysj.107.122283; Roostaee A, 2009, J BIOL CHEM, V284, P30907, DOI 10.1074/jbc.M109.057950; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weinberg R.A., 2006, BIOL CANC, P864; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Xu X, 2012, J STRUCT BIOL, V177, P358, DOI 10.1016/j.jsb.2011.12.008; YOSHIMURA T, 1993, METHOD ENZYMOL, V221, P72, DOI 10.1016/0076-6879(93)21008-V	43	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e69242	10.1371/journal.pone.0069242	http://dx.doi.org/10.1371/journal.pone.0069242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844254	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000034
J	Zhang, JH; Jiang, YY; Lin, Y; Sun, YF; Zheng, SP; Han, SY				Zhang, Jun-Hui; Jiang, Yu-Yan; Lin, Ying; Sun, Yu-Fei; Zheng, Sui-Ping; Han, Shuang-Yan			Structure-Guided Modification of Rhizomucor miehei Lipase for Production of Structured Lipids	PLOS ONE			English	Article							MILK FAT SUBSTITUTES; SITE-DIRECTED MUTAGENESIS; ENZYMATIC INTERESTERIFICATION; IMMOBILIZED LIPASE; ORGANIC-SOLVENT; CANDIDA-RUGOSA; PALMITIC ACID; SN-2 POSITION; EVOLUTION; PROTEIN	To improve the performance of yeast surface-displayed Rhizomucor miehei lipase (RML) in the production of human milk fat substitute (HMFS), we mutated amino acids in the lipase substrate-binding pocket based on protein hydrophobicity, to improve esterification activity. Five mutants: Asn87Ile, Asn87Ile/Asp91Val, His108Leu/Lys109Ile, Asp256Ile/His257Leu, and His108Leu/Lys109Ile/Asp256Ile/His257Leu were obtained and their hydrolytic and esterification activities were assayed. Using Discovery Studio 3.1 to build models and calculate the binding energy between lipase and substrates, compared to wild-type, the mutant Asp256Ile/His257Leu was found to have significantly lower energy when oleic acid (3.97 KJ/mol decrease) and tripalmitin (7.55 KJ/mol decrease) were substrates. This result was in accordance with the esterification activity of Asp256Ile/His257Leu (2.37-fold of wild-type). The four mutants were also evaluated for the production of HMFS in organic solvent and in a solvent-free system. Asp256Ile/His257Leu had an oleic acid incorporation of 28.27% for catalyzing tripalmitin and oleic acid, and 53.18% for the reaction of palm oil with oleic acid. The efficiency of Asp256Ile/His257Leu was 1.82-fold and 1.65-fold that of the wild-type enzyme for the two reactions. The oleic acid incorporation of Asp256Ile/His257Leu was similar to commercial Lipozyme RM IM for palm oil acidolysis with oleic acid. Yeast surface-displayed RML mutant Asp256Ile/His257Leu is a potential, economically feasible catalyst for the production of structured lipids.	[Zhang, Jun-Hui; Jiang, Yu-Yan; Lin, Ying; Sun, Yu-Fei; Zheng, Sui-Ping; Han, Shuang-Yan] S China Univ Technol, Guangdong Key Lab Fermentat & Enzyme Engn, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Han, SY (corresponding author), S China Univ Technol, Guangdong Key Lab Fermentat & Enzyme Engn, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	syhan@scut.edu.cn	jiang, yu/HGU-0029-2022		National High-tech R&D Program of China [2012AA022205]; Guangdong Key Technology RD Program [2012B010300008]; Fundamental Research Funds for the Central Universities [2012ZZ0092]	National High-tech R&D Program of China; Guangdong Key Technology RD Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by National High-tech R&D Program of China (2012AA022205), Guangdong Key Technology R&D Program (No. 2012B010300008), the Fundamental Research Funds for the Central Universities (No. 2012ZZ0092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASRI M, 1995, J AM OIL CHEM SOC, V72, P407, DOI 10.1007/BF02636079; Chen ML, 2004, J AM OIL CHEM SOC, V81, P525, DOI 10.1007/s11746-006-0935-2; CHO SW, 1993, BIOTECHNOL BIOENG, V41, P204, DOI 10.1002/bit.260410206; DEREWENDA U, 1992, BIOCHEMISTRY-US, V31, P1532, DOI 10.1021/bi00120a034; Esteban L, 2011, BIOCHEM ENG J, V54, P62, DOI 10.1016/j.bej.2011.01.009; Gao B, 2011, J MOL CATAL B-ENZYM, V68, P286, DOI 10.1016/j.molcatb.2010.12.001; Garcia-Galan C, 2011, ADV SYNTH CATAL, V353, P2885, DOI 10.1002/adsc.201100534; Han ZL, 2009, APPL MICROBIOL BIOT, V85, P117, DOI 10.1007/s00253-009-2067-8; Hernandez K, 2011, ENZYME MICROB TECH, V48, P107, DOI 10.1016/j.enzmictec.2010.10.003; Huang DF, 2012, BIOCHEM ENG J, V63, P10, DOI 10.1016/j.bej.2010.08.009; HUGEJENSEN B, 1988, J AM OIL CHEM SOC, V65, P905, DOI 10.1007/BF02544508; Ibrahim NA, 2008, J AM OIL CHEM SOC, V85, P37, DOI 10.1007/s11746-007-1157-y; KOBORI H, 1992, PROTOPLASMA, V167, P193, DOI 10.1007/BF01403383; Kourist R, 2010, EUR J LIPID SCI TECH, V112, P64, DOI 10.1002/ejlt.200900143; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang XX, 2013, BIOTECHNOL LETT, V35, P367, DOI 10.1007/s10529-012-1085-2; LIE E, 1991, J CHEM TECHNOL BIOT, V50, P549; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; OTERO C, 1995, FEBS LETT, V360, P202, DOI 10.1016/0014-5793(95)00104-H; Palomo JM, 2002, J MOL CATAL B-ENZYM, V19, P279, DOI 10.1016/S1381-1177(02)00178-9; Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9; Reetz MT, 2010, J AM CHEM SOC, V132, P9144, DOI 10.1021/ja1030479; Reetz MT, 1999, TOP CURR CHEM, V200, P31; Reetz MT, 1997, ADV MATER, V9, P943, DOI 10.1002/adma.19970091203; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Rodrigues RC, 2010, J MOL CATAL B-ENZYM, V64, P1, DOI 10.1016/j.molcatb.2010.02.003; RUCKENSTEIN E, 1993, BIOTECHNOL BIOENG, V42, P821, DOI 10.1002/bit.260420706; Sahin N, 2006, J AGR FOOD CHEM, V54, P3717, DOI 10.1021/jf053103f; Santarossa G, 2005, FEBS LETT, V579, P2383, DOI 10.1016/j.febslet.2005.03.037; Sorensen ADM, 2010, J AM OIL CHEM SOC, V87, P185, DOI 10.1007/s11746-009-1479-z; Srivastava A, 2006, J AGR FOOD CHEM, V54, P5175, DOI 10.1021/jf060623h; Tecelao C, 2012, EUR J LIPID SCI TECH, V114, P266, DOI 10.1002/ejlt.201100226; Teichert SA, 2011, J AGR FOOD CHEM, V59, P5692, DOI 10.1021/jf200336t; Thomas A, 2005, J BIOL CHEM, V280, P40074, DOI 10.1074/jbc.M502123200; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Xu T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-257; YOKOZEKI K, 1982, EUR J APPL MICROBIOL, V14, P1, DOI 10.1007/BF00507995; Zou XQ, 2013, J AGR FOOD CHEM, V61, P167, DOI 10.1021/jf304094p	38	7	11	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67892	10.1371/journal.pone.0067892	http://dx.doi.org/10.1371/journal.pone.0067892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844120	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000112
J	Bivalacqua, TJ; Musicki, B; Hsu, LL; Berkowitz, DE; Champion, HC; Burnett, AL				Bivalacqua, Trinity J.; Musicki, Biljana; Hsu, Lewis L.; Berkowitz, Dan E.; Champion, Hunter C.; Burnett, Arthur L.			Sildenafil Citrate-Restored eNOS and PDE5 Regulation in Sickle Cell Mouse Penis Prevents Priapism Via Control of Oxidative/Nitrosative Stress	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL DYSFUNCTION; PULMONARY-HYPERTENSION; RECURRENT PRIAPISM; OXIDATIVE STRESS; ANIMAL-MODEL; MICE; ERECTION; REVERSES; THERAPY	Sildenafil citrate revolutionized the practice of sexual medicine upon its federal regulatory agency approval approximately 15 years ago as the prototypical phosphodiesterase type 5 inhibitor indicated for the treatment of male erectile dysfunction. We now provide scientific support for its alternative use in the management of priapism, a clinical disorder of prolonged and uncontrolled penile erection. Sildenafil administered continuously to sickle cell mice, which show a priapism phenotype, reverses oxidative/nitrosative stress effects in the penis, mainly via reversion of uncoupled endothelial nitric oxide synthase to the functional coupled state of the enzyme, which in turn corrects aberrant signaling and function of the nitric oxide/cyclic GMP/protein kinase G/phosphodiesterase type 5 cascade. Priapism tendencies in these mice are reverted partially toward normal neurostimulated erection frequencies and durations after sildenafil treatment in association with normalized cyclic GMP concentration, protein kinase G activity and phosphodiesterase type 5 activity in the penis. Thus, sildenafil exerts pleiotropic effects in the penis that extend to diverse erection disorders.	[Bivalacqua, Trinity J.; Musicki, Biljana; Burnett, Arthur L.] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Hsu, Lewis L.] NHLBI, Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Hsu, Lewis L.] Univ Illinois, Dept Pediat, Chicago, IL USA; [Berkowitz, Dan E.] Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Berkowitz, Dan E.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Champion, Hunter C.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Burnett, AL (corresponding author), Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA.	aburnet1@jhmi.edu	Hsu, Lewis L/H-8001-2019	Hsu, Lewis L/0000-0002-3156-2378	US Public Service Grants [HL090515, RO1DK067223]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067223, K08DK090370] Funding Source: NIH RePORTER	US Public Service Grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US Public Service Grants HL090515 and RO1DK067223 (to ALB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr-Roussel D, 2008, EUR UROL, V53, P1272, DOI 10.1016/j.eururo.2007.11.018; Bivalacqua TJ, 2007, EUR UROL, V51, P1732, DOI 10.1016/j.eururo.2006.10.061; Bivalacqua TJ, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.02.050; Bivalacqua TJ, 2009, J SEX MED, V6, P2494, DOI 10.1111/j.1743-6109.2009.01359.x; Bivalacqua TJ, 2009, J UROLOGY, V181, P899, DOI 10.1016/j.juro.2008.10.062; Broderick GA, 2012, J SEX MED, V9, P88, DOI 10.1111/j.1743-6109.2011.02317.x; Burnett AL, 2006, UROLOGY, V67, P1043, DOI 10.1016/j.urology.2005.11.045; Burnett AL, 2002, J ANDROL, V23, P92, DOI 10.1002/j.1939-4640.2002.tb02601.x; Burnett AL, 2006, J SEX MED, V3, P1077, DOI 10.1111/j.1743-6109.2006.00333.x; Burnett Arthur L, 2006, J Clin Hypertens (Greenwich), V8, P53; Champion HC, 2005, P NATL ACAD SCI USA, V102, P1661, DOI 10.1073/pnas.0407183102; Claudino MA, 2009, J SEX MED, V6, P2187, DOI 10.1111/j.1743-6109.2009.01337.x; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Hemnes AR, 2008, AM J PHYSIOL-LUNG C, V294, pL24, DOI 10.1152/ajplung.00245.2007; Hotston M, 2008, ASIAN J ANDROL, V10, P905, DOI 10.1111/j.1745-7262.2008.00380.x; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Kanika ND, 2010, INT J IMPOT RES, V22, P363, DOI 10.1038/ijir.2010.27; Kanika ND, 2009, AM J PHYSIOL-CELL PH, V297, pC916, DOI 10.1152/ajpcell.00656.2008; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Lin GT, 2003, J UROLOGY, V170, pS15, DOI 10.1097/01.ju.0000075500.11519.e8; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Munarriz R, 2003, UROLOGY, V62, P760, DOI 10.1016/S0090-4295(03)00484-9; Musicki B, 2005, MOL PHARMACOL, V68, P226, DOI 10.1124/mol.104.010678; Musicki B, 2012, J SEX MED, V9, P1980, DOI 10.1111/j.1743-6109.2012.02798.x; Musicki B, 2011, J SEX MED, V8, P419, DOI 10.1111/j.1743-6109.2010.02123.x; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Schafer A, 2008, BRIT J PHARMACOL, V153, P886, DOI 10.1038/sj.bjp.0707459; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Vicari E, 2010, J SEX MED, V7, P1247, DOI 10.1111/j.1743-6109.2009.01420.x; Vignozzi L, 2006, J SEX MED, V3, P419, DOI 10.1111/j.1743-6109.2006.00208.x; Wen J, 2010, J SEX MED, V7, P3011, DOI 10.1111/j.1743-6109.2009.01552.x; Wood KC, 2006, FREE RADICAL BIO MED, V40, P1443, DOI 10.1016/j.freeradbiomed.2005.12.015; Yamagishi S, 2011, PHARMACOL RES, V64, P187, DOI 10.1016/j.phrs.2011.05.009	33	41	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68028	10.1371/journal.pone.0068028	http://dx.doi.org/10.1371/journal.pone.0068028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844149	Green Published, gold, Green Accepted			2022-12-25	WOS:000321341000131
J	Falagas, ME; Korbila, IP; Kapaskelis, A; Manousou, K; Leontiou, L; Tansarli, GS				Falagas, Matthew E.; Korbila, Ioanna P.; Kapaskelis, Anastasios; Manousou, Kyriaki; Leontiou, Lili; Tansarli, Giannoula S.			Trends of Mortality due to Septicemia in Greece: An 8-Year Analysis	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; METALLO-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RISK-FACTORS; RESISTANCE; IMPACT; OUTBREAK; SEPSIS; CLONES	Background: Infectious diseases are among the major causes of death worldwide. We evaluated the trends of mortality due to septicemia in Greece and compared it with mortality due to other infections. Methods: Data on mortality stratified by cause of death during 2003-2010 was obtained from the Hellenic Statistical Authority. Deaths caused by infectious diseases were grouped by site of infection and analyzed using SPSS 17.0 software. Results: 45,451 deaths due to infections were recorded in Greece during the 8-year period of time, among which 12.2% were due to septicemia, 69.7% pneumonia, 1.5% pulmonary tuberculosis, 0.2% influenza, 0.5% other infections of the respiratory tract, 7.9% intra-abdominal infections (IAIs), 2.5% urinary tract infections (UTIs), 2.2% endocarditis or pericarditis or myocarditis, 1.6% hepatitis, 1% infections of the central nervous system, and 0.7% other infections. A percentage of 99.4% of deaths due to septicemia were caused by bacteria that were not reported on the death certificate (noted as indeterminate septicemia). More deaths due to indeterminate septicemia were observed during 2007-2010 compared to 2003-2006 (3,558 versus 1,966; p<0.05). Conclusion: Despite the limitations related to the quality of death certificates, this study shows that the mortality rate due to septicemia has almost doubled after 2007 in Greece. Proportionally, septicemia accounted for a greater increase in the mortality rate within the infectious causes of death for the same period of time. The emergence of resistance could partially explain this alarming phenomenon. Therefore, stricter infection control measures should be urgently applied in all Greek healthcare facilities.	[Falagas, Matthew E.; Korbila, Ioanna P.; Kapaskelis, Anastasios; Tansarli, Giannoula S.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.; Korbila, Ioanna P.; Kapaskelis, Anastasios] Mitera Hosp, Dept Internal Med Infect Dis, Hygeia Grp, Athens, Greece; [Manousou, Kyriaki; Leontiou, Lili] Natl Tech Univ Athens, Dept Appl Math & Phys, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; National Technical University of Athens; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr						[Anonymous], 2011, DEATHS PREL DAT 2011; Chaniotaki S, 2004, CLIN MICROBIOL INFEC, V10, P75, DOI 10.1111/j.1469-0691.2004.00807.x; Daikos GL, 2007, INT J ANTIMICROB AG, V29, P471, DOI 10.1016/j.ijantimicag.2006.11.006; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Daniels R, 2011, J ANTIMICROB CHEMOTH, V66, pII11, DOI 10.1093/jac/dkq515; Dremsizov T, 2006, CHEST, V129, P968, DOI 10.1378/chest.129.4.968; Falagas ME, 2007, J ANTIMICROB CHEMOTH, V60, P1124, DOI 10.1093/jac/dkm356; Fridkin SK, 2001, CRIT CARE MED, V29, pN64, DOI 10.1097/00003246-200104001-00002; Friedman B, 2011, SEPT US HOSP 2009; HCDCP, 2012, BACT MEAN EP DAT GRE; HCDCP, 2012, ED; HCDCP, 2011, 1 HCDCP; HCDCP, 2011, 10 HCDCP; Karapavlidou P, 2005, MICROB DRUG RESIST, V11, P351, DOI 10.1089/mdr.2005.11.351; Kopterides P, 2007, INT J ANTIMICROB AG, V30, P409, DOI 10.1016/j.ijantimicag.2007.06.026; Labelle A, 2012, CRIT CARE MED, V40, P2016, DOI 10.1097/CCM.0b013e318250aa72; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Maltezou HC, 2009, J INFECTION, V58, P213, DOI 10.1016/j.jinf.2009.01.010; Maraki S, 2012, ANTIMICROB AGENTS CH, V56, P3067, DOI 10.1128/AAC.06358-11; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Miyakis S, 2011, CLIN INFECT DIS, V53, P177, DOI 10.1093/cid/cir323; Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135; Park SH, 2012, ANN HEMATOL; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pournaras S, 2003, J ANTIMICROB CHEMOTH, V51, P1409, DOI 10.1093/jac/dkg239; Routsi C, 2010, INFECTION, V38, P173, DOI 10.1007/s15010-010-0008-1; Tsakris A, 2003, J ANTIMICROB CHEMOTH, V52, P1046, DOI 10.1093/jac/dkg470; Tsakris A, 2011, ANTIMICROB AGENTS CH, V55, P3164, DOI 10.1128/AAC.00102-11; Tzelepi E, 2003, INT J ANTIMICROB AG, V21, P285, DOI 10.1016/S0924-8579(02)00361-8	29	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67621	10.1371/journal.pone.0067621	http://dx.doi.org/10.1371/journal.pone.0067621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844042	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000063
J	Panupinthu, N; Yu, S; Zhang, D; Zhang, F; Gagea, M; Lu, Y; Grandis, JR; Dunn, SE; Lee, HY; Mills, GB				Panupinthu, N.; Yu, S.; Zhang, D.; Zhang, F.; Gagea, M.; Lu, Y.; Grandis, J. R.; Dunn, S. E.; Lee, H. Y.; Mills, G. B.			Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer	ONCOGENE			English	Article						autoregulation; crosstalk; feedback; G-protein-coupled receptor; receptor tyrosine kinase	GROWTH-FACTOR RECEPTOR; RIBOSOMAL S6 KINASE; LYSOPHOSPHATIDIC ACID PRODUCTION; ALLOSTERIC AKT INHIBITOR; BREAST-CANCER; NUCLEAR-LOCALIZATION; TUMOR-GROWTH; IN-VITRO; CELLS; YB-1	The Y-box binding protein-1 (YB-1) transcription factor is associated with unfavorable clinical outcomes. However, the mechanisms underlying this association remain to be fully elucidated. We demonstrate that YB-1 phosphorylation, indicative of YB-1 activation, is a powerful marker of outcomes for ovarian cancer patients. In ovarian cancer, YB-1 phosphorylation is induced by activation of the lysophosphatidic acid (LPA) receptor (LPAR) via SRC-dependent transactivation of the epidermal growth factor receptor (EGFR) that is coupled to MAPK/p90 ribosomal S6 kinase (p90RSK), but not phosphatidylinositol 3-kinase (PI3K)/AKT signaling. Activation of the LPAR/SRC/EGFR/MAPK/p90RSK/YB-1 axis leads to production of the EGFR ligand amphiregulin (AREG). AREG induces ongoing YB-1 phosphorylation as well as YB-1-dependent AREG expression, thus constituting an AREG/YB-1 self-reinforcing loop. Disruption of transactivation of the EGFR and the downstream self-reinforcing loop decreases invasiveness of ovarian cancer cells in vitro and limits ovarian cancer growth in xenograft models. These findings established the regulation and significance of YB-1 phosphorylation, therefore further exploration of this signaling axis as a therapeutic avenue in ovarian cancer is warranted.	[Panupinthu, N.; Yu, S.; Zhang, D.; Zhang, F.; Lu, Y.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Panupinthu, N.] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10400, Thailand; [Gagea, M.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Grandis, J. R.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Grandis, J. R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Dunn, S. E.] Univ British Columbia, Child & Family Res Inst, Dept Pediat, Vancouver, BC V5Z 1M9, Canada; [Dunn, S. E.] Univ British Columbia, Child & Family Res Inst, Dept Expt Med, Vancouver, BC V5Z 1M9, Canada; [Lee, H. Y.] Konyang Univ, Coll Med, Dept Pharmacol, Taejon, South Korea	University of Texas System; UTMD Anderson Cancer Center; Mahidol University; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; Konyang University; Konyang University Hospital	Panupinthu, N (corresponding author), Mahidol Univ, Fac Sci, Dept Physiol, 272 Rama VI Rd, Bangkok 10400, Thailand.	nattapon.pan@mahidol.ac.th			NIH [R01CA92160, P01CA099031, R01CA098372]; Breast Cancer Research Foundation; National Research Foundation of Korea [2011-0015761]; Canadian Institutes of Health Research; SPORE in head-and-neck cancer [P50CA197190]; American Cancer Society; CCSG [CA16672]; NATIONAL CANCER INSTITUTE [R01CA092160, P50CA083639, P50CA098258, P01CA099031, R01CA098372, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); SPORE in head-and-neck cancer; American Cancer Society(American Cancer Society); CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Drs Meng Gao and Zhiyong Ding at MD Anderson Cancer Center for authenticating the AKT1/AKT2 knockout cell lines.This work was supported by NIH grants R01CA92160 and P01CA099031 (to G.B.M.), and R01CA098372 (to J.R.G.), the Breast Cancer Research Foundation (to G.B.M.), the National Research Foundation of Korea 2011-0015761 (to H.Y.L.), Canadian Institutes of Health Research (to S.E.D.), the SPORE in head-and-neck cancer P50CA197190 (to J.R.G.), the American Cancer Society (to J.R.G.) and CCSG core grant CA16672 (to MD Anderson Cancer Center).	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Berquin IM, 2005, ONCOGENE, V24, P3177, DOI 10.1038/sj.onc.1208504; Berquin IM, 2001, ONCOGENE, V20, P4019, DOI 10.1038/sj.onc.1204537; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Busser B, 2010, MOL THER, V18, P528, DOI 10.1038/mt.2009.226; Cherrin C, 2010, CANCER BIOL THER, V9, P493, DOI 10.4161/cbt.9.7.11100; Chetrit A, 2008, J CLIN ONCOL, V26, P20, DOI 10.1200/JCO.2007.11.6905; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; Cook SJ, 1996, BIOCHEM J, V320, P237, DOI 10.1042/bj3200237; Eder AM, 2000, CLIN CANCER RES, V6, P2482; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Fang XJ, 2004, J BIOL CHEM, V279, P9653, DOI 10.1074/jbc.M306662200; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Jeong KJ, 2013, MOL ONCOL, V7, P121, DOI 10.1016/j.molonc.2012.10.001; Jing JP, 2012, MOL CANCER THER, V11, P720, DOI 10.1158/1535-7163.MCT-11-0505; Jones S, 2012, J PATHOL, V226, P413, DOI 10.1002/path.3967; Jurchott K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001231; Kamura T, 1999, CANCER, V85, P2450, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2450::AID-CNCR21>3.0.CO;2-U; Lasham A, 2012, JNCI-J NATL CANCER I, V104, P133, DOI 10.1093/jnci/djr512; Law JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012661; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lu Y, 2011, ONCOGENE, V30, P4567, DOI 10.1038/onc.2011.164; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; NORMANNO N, 1994, P NATL ACAD SCI USA, V91, P2790, DOI 10.1073/pnas.91.7.2790; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Okita M, 1997, INT J CANCER, V71, P31, DOI 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Rodland KD, 2008, J BIOL CHEM, V283, P31477, DOI 10.1074/jbc.M800456200; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siwak DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/568938; Smith JA, 2005, CANCER RES, V65, P1027; Snider AJ, 2010, AM J PHYSIOL-CELL PH, V298, pC163, DOI 10.1152/ajpcell.00001.2009; Stratford AL, 2012, STEM CELLS, V30, P1338, DOI 10.1002/stem.1128; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tabchy A, 2011, NAT STRUCT MOL BIOL, V18, P117, DOI 10.1038/nsmb0211-117; Talavera A, 2009, CANCER RES, V69, P5851, DOI 10.1158/0008-5472.CAN-08-4518; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Wakeling AE, 2002, CANCER RES, V62, P5749; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yahata H, 2002, J CANCER RES CLIN, V128, P621, DOI 10.1007/s00432-002-0386-6; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhang L, 2009, BIOINFORMATICS, V25, P650, DOI 10.1093/bioinformatics/btn663; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhang Q, 2007, MOL CANCER THER, V6, P1414, DOI 10.1158/1535-7163.MCT-06-0678	58	34	37	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2846	2856		10.1038/onc.2013.259	http://dx.doi.org/10.1038/onc.2013.259			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23851501	Green Accepted			2022-12-25	WOS:000337231800004
J	Wu, Q; Wang, H; Zhao, X; Shi, Y; Jin, M; Wan, B; Xu, H; Cheng, Y; Ge, H; Zhang, Y				Wu, Q.; Wang, H.; Zhao, X.; Shi, Y.; Jin, M.; Wan, B.; Xu, H.; Cheng, Y.; Ge, H.; Zhang, Y.			Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma	ONCOGENE			English	Article						GPR120; colorectal carcinoma; angiogenesis; migration	FREE FATTY-ACIDS; EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; INSULIN-SECRETION; BREAST-CANCER; GPR120; CELLS; INFLAMMATION; BEVACIZUMAB; EXPRESSION	G-protein-coupled receptor 120 (GPR120) functions as a receptor for unsaturated long-chain free fatty acids and has an important role in regulating lipid and glucose metabolism. However, a role for GPR120 in the development of tumors has not yet been clarified. Here, we show that GPR120 signaling promotes angiogenic switching and motility of human colorectal carcinoma (CRC) cells. We show that the expression of GPR120 is significantly induced in CRC tissues and cell lines, which is associated with tumor progression. Activation of GPR120 signaling in human CRC promotes angiogenesis in vitro and in vivo, largely by inducing the expression and secretion of proangiogenic mediators such as vascular endothelial growth factor (VEGF), interleukin-8 and cyclooxygenase-2-derived prostaglandin E-2. The PI3K/Akt-NF-kappa B pathway is activated by GPR120 signaling and is required for GPR120 signaling-induced angiogenic switching in CRC cells. And, GPR120 activation enhances the motility of CRC cells and induces epithelial-mesenchymal transition. Furthermore, in vivo study shows that activation of GPR120 promotes angiogenesis and tumor growth. Finally, we find that GPR120 expression is positively correlated with VEGF expression and inversely correlated with the epithelial marker E-cadherin in CRC tissues. Collectively, our results demonstrate that GPR120 functions as a tumor-promoting receptor in CRC and, therefore, shows promise as a new potential target for cancer therapeutics.	[Wu, Q.; Wang, H.; Zhao, X.; Shi, Y.; Jin, M.; Wan, B.; Xu, H.; Cheng, Y.; Ge, H.; Zhang, Y.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Wu, Q.; Wang, H.; Zhao, X.; Shi, Y.; Jin, M.; Wan, B.; Xu, H.; Cheng, Y.; Ge, H.; Zhang, Y.] Shanghai Jiao Tong Univ, Sch Med SJTUSM, Shanghai 200030, Peoples R China; [Wu, Q.; Wang, H.; Zhao, X.; Shi, Y.; Jin, M.; Wan, B.; Xu, H.; Cheng, Y.; Ge, H.; Zhang, Y.] SJTUSM, Shanghai Inst Immunol, Inst Med Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Zhang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China.	gehl@shsmu.edu.cn; yyzhang@sibs.ac.cn	Shi, Yufang/AAE-4431-2020	Shi, Yufang/0000-0001-8964-319X	Ministry of Science and Technology of China [2011CB966200, 2010CB945600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01040000]; Program of Chinese Academy of Sciences [KSCX1-YW-22]; National Natural Science Foundation of China [81071748, 30873045, 81130057]; China Postdoctoral Science Foundation [2012M510906]; Leading Academic Discipline Project of Shanghai Municipal Education Commission [J50207]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Leading Academic Discipline Project of Shanghai Municipal Education Commission(Shanghai Leading Academic Discipline Project)	We thank Dr G Brewer (University of Medicine and Dentistry of New Jersey) for his critical review of the manuscript. This work was supported by the Ministry of Science and Technology of China (2011CB966200, 2010CB945600), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01040000), the Program of Chinese Academy of Sciences (KSCX1-YW-22), the National Natural Science Foundation of China (81071748, 30873045, 81130057), the China Postdoctoral Science Foundation (2012M510906) and the Leading Academic Discipline Project of Shanghai Municipal Education Commission (J50207).	Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Habbel P, 2009, WORLD J GASTROENTERO, V15, P1079, DOI 10.3748/wjg.15.1079; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Hatanaka H, 2010, CANCER SCI, V101, P54, DOI 10.1111/j.1349-7006.2009.01348.x; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hossain Z, 2009, NUTR CANCER, V61, P123, DOI 10.1080/01635580802395725; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Im DS, 2012, PROG LIPID RES, V51, P232, DOI 10.1016/j.plipres.2012.02.003; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Koukourakis GV, 2011, CLIN TRANSL ONCOL, V13, P710, DOI 10.1007/s12094-011-0720-z; Oh DY, 2012, CELL METAB, V15, P564, DOI 10.1016/j.cmet.2012.04.009; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Polozova A, 2007, J MOL NEUROSCI, V33, P56, DOI 10.1007/s12031-007-0039-y; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Sakurai T, 2011, ONCOLOGY-BASEL, V81, P24, DOI 10.1159/000333256; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Strickler JH, 2012, ONCOLOGIST, V17, P513, DOI 10.1634/theoncologist.2012-0003; Strieter RM, 2005, NAT MED, V11, P925, DOI 10.1038/nm0905-925; Taborga M, 2007, MINI-REV MED CHEM, V7, P245, DOI 10.2174/138955707780059826; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Turk HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039682; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Wang YG, 2012, CANCER RES, V72, P5396, DOI 10.1158/0008-5472.CAN-12-0474; Wendt MK, 2013, ONCOGENE, V32, P2005, DOI 10.1038/onc.2012.230; Williams K, 2012, CANCER RES, V72, P5407, DOI 10.1158/0008-5472.CAN-12-1158; Wu YY, 2011, ONCOGENE, V30, P3682, DOI 10.1038/onc.2011.85; Xu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027399; Yeung Y, 2012, EXPERT REV ANTICANC, V12, P1263, DOI [10.1586/era.12.104, 10.1586/ERA.12.104]; Zhao F, 2011, BLOOD, V117, P1723, DOI 10.1182/blood-2010-04-281659; Zheng HX, 2013, ONCOGENE, V32, P1183, DOI 10.1038/onc.2012.126	41	102	105	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2013	32	49					5541	5550		10.1038/onc.2013.264	http://dx.doi.org/10.1038/onc.2013.264			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	269XF	23851494				2022-12-25	WOS:000328276400005
J	Leal, SS; Cardoso, I; Valentine, JS; Gomes, CM				Leal, Sonia S.; Cardoso, Isabel; Valentine, Joan S.; Gomes, Claudio M.			Calcium Ions Promote Superoxide Dismutase 1 (SOD1) Aggregation into Non-fibrillar Amyloid A LINK TO TOXIC EFFECTS OF CALCIUM OVERLOAD IN AMYOTROPHIC LATERAL SCLEROSIS (ALS)?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT COMPLEXES; TRANSGENIC MICE; METAL-IONS; CU,ZN-SUPEROXIDE DISMUTASE; SELECTIVE VULNERABILITY; MOTOR-NEURONS; AMPA RECEPTOR; WILD-TYPE; INTRACELLULAR CALCIUM; PROTEIN CONFORMATION	Imbalance in metal ion homeostasis is a hallmark in neurodegenerative conditions involving protein deposition, and amyotrophic lateral sclerosis (ALS) is no exception. In particular, Ca2+ dysregulation has been shown to correlate with superoxide dismutase-1 (SOD1) aggregation in a cellular model of ALS. Here we present evidence that SOD1 aggregation is enhanced and modulated by Ca2+. We show that at physiological pH, Ca2+ induces conformational changes that increase SOD1 beta-sheet content, as probed by far UV CD and attenuated total reflectance- FTIR, and enhances SOD1 hydrophobicity, as probed by ANS fluorescence emission. Moreover, dynamic light scattering analysis showed that Ca2+ boosts the onset of SOD1 aggregation. In agreement, Ca2+ decreases SOD1 critical concentration and nucleation time during aggregation kinetics, as evidenced by thioflavin T fluorescence emission. Attenuated total reflectance FTIR analysis showed that Ca2+ induced aggregates consisting preferentially of antiparallel beta-sheets, thus suggesting a modulation effect on the aggregation pathway. Transmission electron microscopy and analysis with conformational anti-fibril and anti-oligomer antibodies showed that oligomers and amyloidogenic aggregates constitute the prevalent morphology of Ca2+ -induced aggregates, thus indicating that Ca2+ diverts SOD1 aggregation from fibrils toward amorphous aggregates. Interestingly, the same heterogeneity of conformations is found in ALS-derived protein inclusions. We thus hypothesize that transient variations and dysregulation of cellular Ca2+ levels contribute to the formation of SOD1 aggregates in ALS patients. In this scenario, Ca2+ may be considered as a pathogenic effector in the formation of ALS proteinaceous inclusions.	[Leal, Sonia S.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780756 Oeiras, Portugal; [Cardoso, Isabel] Inst Biol Mol & Celular, Mol Neurobiol Unit, P-4150180 Oporto, Portugal; [Valentine, Joan S.] UCLA, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Universidade Nova de Lisboa; Universidade do Porto; University of California System; University of California Los Angeles	Gomes, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ 127, P-2780756 Oeiras, Portugal.	gomes@itqb.unl.pt	Valentine, Joan S/B-6665-2008; Gomes, Cláudio M./A-8152-2008; Leal, Sónia/F-1129-2015; Cardoso, Isabel/K-3903-2013	Valentine, Joan S/0000-0002-7174-925X; Gomes, Cláudio M./0000-0003-4662-6933; Leal, Sónia/0000-0001-8445-0065; Cardoso, Isabel/0000-0003-2472-7055	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) [PTDC/QUI-BIQ/117789/2010, PTDC/EBB-BIO/117793/2010, SFRH/BPD/47477/2008, PEst-OE/EQB/LA0004/2011]	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal)(Portuguese Foundation for Science and Technology)	This work was supported by the Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) through Research Grants PTDC/QUI-BIQ/117789/2010 and PTDC/EBB-BIO/117793/2010 (to C. M. G.), Postdoctoral Fellowship SFRH/BPD/47477/2008 (to S. S. L.), and Strategic Grant PEst-OE/EQB/LA0004/2011 (to the Instituto Tecnologia Quimica e Biologica Laboratorio Associado).	Ahl IM, 2004, PROTEIN EXPRES PURIF, V37, P311, DOI 10.1016/j.pep.2004.06.006; ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Assfalg M, 2003, J MOL BIOL, V330, P145, DOI 10.1016/S0022-2836(03)00533-3; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2005, J BIOL CHEM, V280, P35815, DOI 10.1074/jbc.M506637200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Beers DR, 2001, J NEUROCHEM, V79, P499, DOI 10.1046/j.1471-4159.2001.00582.x; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bilsland LG, 2008, J NEUROCHEM, V107, P1271, DOI 10.1111/j.1471-4159.2008.05699.x; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P627, DOI 10.1002/bip.1976.360150403; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; FERREDAMARE AR, 1994, STRUCTURE, V2, P357, DOI 10.1016/S0969-2126(00)00037-X; Forsberg K, 2011, ACTA NEUROPATHOL, V121, P623, DOI 10.1007/s00401-011-0805-3; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Franks KM, 2002, BIOESSAYS, V24, P1130, DOI 10.1002/bies.10193; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Guatteo E, 2007, NEUROBIOL DIS, V28, P90, DOI 10.1016/j.nbd.2007.07.002; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jaiswal MK, 2009, MOL PHARMACOL, V75, P478, DOI 10.1124/mol.108.050831; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kato S, 2001, NEUROPATHOLOGY, V21, P67, DOI 10.1046/j.1440-1789.2001.00359.x; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kim HJ, 2007, EXP MOL MED, V39, P574, DOI 10.1038/emm.2007.63; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kundu B, 2002, BIOCHEM BIOPH RES CO, V293, P572, DOI 10.1016/S0006-291X(02)00257-7; Kuner R, 2005, ANN NY ACAD SCI, V1053, P269, DOI 10.1196/annals.1344.024; Leal SS, 2012, COORDIN CHEM REV, V256, P2253, DOI 10.1016/j.ccr.2012.04.004; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li Y, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3592581; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Lowe R, 2004, PROTEIN SCI, V13, P3245, DOI 10.1110/ps.04879704; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Nath S, 2011, MOL CELL NEUROSCI, V46, P516, DOI 10.1016/j.mcn.2010.12.004; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nielsen MS, 2001, J BIOL CHEM, V276, P22680, DOI 10.1074/jbc.M101181200; Nobbmann Ulf, 2007, Biotechnol Genet Eng Rev, V24, P117; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Okuno A, 2006, BBA-PROTEINS PROTEOM, V1764, P1407, DOI 10.1016/j.bbapap.2006.06.006; Palecek J, 1999, J PHYSIOL-LONDON, V520, P485, DOI 10.1111/j.1469-7793.1999.00485.x; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Roy J, 1998, J NEUROSCI, V18, P9673; Rumfeldt JAO, 2009, J MOL BIOL, V385, P278, DOI 10.1016/j.jmb.2008.10.003; Sabado J, 2013, J NEUROPATH EXP NEUR, V72, P646, DOI 10.1097/NEN.0b013e318297fd10; Sabel CE, 2010, ANAL BIOCHEM, V397, P218, DOI 10.1016/j.ab.2009.10.037; Sasaki S, 2005, ACTA NEUROPATHOL, V109, P247, DOI 10.1007/s00401-004-0939-7; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shaw PJ, 2000, J NEUROL, V247, P17; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Siklos L, 1998, J NEUROPATH EXP NEUR, V57, P571, DOI 10.1097/00005072-199806000-00005; Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210; Stieber A, 2000, J NEUROL SCI, V177, P114, DOI 10.1016/S0022-510X(00)00351-8; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Talbot K, 2006, HUM MOL GENET, V15, pR182, DOI 10.1093/hmg/ddl202; Tamano H, 2011, METALLOMICS, V3, P656, DOI 10.1039/c1mt00008j; Tateno M, 2004, HUM MOL GENET, V13, P2183, DOI 10.1093/hmg/ddh246; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Tradewell ML, 2011, NEUROBIOL DIS, V42, P265, DOI 10.1016/j.nbd.2011.01.016; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07; van de Weert M, 2001, ANAL BIOCHEM, V297, P160, DOI 10.1006/abio.2001.5337; Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7; Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002; Vandenberghe W, 2000, J NEUROSCI, V20, P123, DOI 10.1523/JNEUROSCI.20-01-00123.2000; Vanselow BK, 2000, J PHYSIOL-LONDON, V525, P433, DOI 10.1111/j.1469-7793.2000.t01-1-00433.x; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Vetri V, 2005, BIOPHYS CHEM, V113, P83, DOI 10.1016/j.bpc.2004.07.042; von Lewinski F, 2008, NEUROSCI LETT, V445, P224, DOI 10.1016/j.neulet.2008.08.084; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Williams TL, 1997, ANN NEUROL, V42, P200, DOI 10.1002/ana.410420211; Winkler DD, 2009, BIOCHEMISTRY-US, V48, P3436, DOI 10.1021/bi8021735; Yates D, 2010, NAT REV NEUROL, V6, P57, DOI [10.1038/nrneurol.2010.154, 10.1038/nrneurol.2010.169, 10.1038/nrneurol.2010.58, 10.1038/nrneurol.2009.230, 10.1038/nrneurol.2010.20]	112	47	47	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25219	25228		10.1074/jbc.M113.470740	http://dx.doi.org/10.1074/jbc.M113.470740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861388	Green Published, hybrid			2022-12-25	WOS:000330619000021
J	Belzil, C; Neumayer, G; Vassilev, AP; Yap, KL; Konishi, H; Rivest, S; Sanada, K; Ikura, M; Nakatani, Y; Nguyen, MD				Belzil, Camille; Neumayer, Gernot; Vassilev, Alex P.; Yap, Kyoko L.; Konishi, Hiroaki; Rivest, Serge; Sanada, Kamon; Ikura, Mitsuhiko; Nakatani, Yoshihiro; Minh Dang Nguyen			A Ca2+-dependent Mechanism of Neuronal Survival Mediated by the Microtubule-associated Protein p600	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; METHYL-D-ASPARTATE; KINASE-II CLUSTERS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; CNS NEURONS; CALCIUM; CALMODULIN	In acute and chronic neurodegeneration, Ca2+ mishandling and disruption of the cytoskeleton compromise neuronal integrity, yet abnormalities in the signaling roles of cytoskeletal proteins remain largely unexplored. We now report that the microtubule-associated protein p600 (also known as UBR4) promotes neuronal survival. Following depletion of p600, glutamate-induced Ca2+ influx through NMDA receptors, but not AMPA receptors, initiates a degenerative process characterized by endoplasmic reticulum fragmentation and endoplasmic reticulum Ca2+ release via inositol 1,4,5-trisphosphate receptors. Downstream of NMDA receptors, p600 associates with the calmodulin-calmodulin-dependent protein kinase II alpha complex. A direct and atypical p600/calmodulin interaction is required for neuronal survival. Thus, p600 counteracts specific Ca2+-induced death pathways through regulation of Ca2+ homeostasis and signaling.	[Belzil, Camille; Neumayer, Gernot; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Belzil, Camille; Neumayer, Gernot; Minh Dang Nguyen] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Belzil, Camille; Neumayer, Gernot; Minh Dang Nguyen] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Belzil, Camille; Neumayer, Gernot; Minh Dang Nguyen] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Vassilev, Alex P.] NICHD, NIH, Bethesda, MD 20892 USA; [Yap, Kyoko L.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Konishi, Hiroaki] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara, Hiroshima 7270023, Japan; [Rivest, Serge] Univ Laval, Ctr Hosp Univ Laval, Ctr Rech, Quebec City, PQ G1V 0A6, Canada; [Sanada, Kamon] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Nakatani, Yoshihiro] Dana Farber Canc Inst, Boston, MA 02115 USA	University of Calgary; University of Calgary; University of Calgary; University of Calgary; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Laval University; University of Tokyo; Harvard University; Dana-Farber Cancer Institute	Nguyen, MD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, HMRB 151,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	mdnguyen@ucalgary.ca	SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957; Rivest, Serge/0000-0002-6082-770X; Ikura, Mitsuhiko/0000-0002-9524-1303	Canadian Institutes of Health Research (CIHR); Human Frontier Science Program Organization (HFSPO); Brenda Strafford Chair Foundation in Alzheimer's disease; Alberta Innovates Health Solutions (AIHS); Ted Fong/Hotchkiss Brain Institute; Austrian Academy of Sciences at the University of Calgary; Achievers in Medical Sciences award; CIHR; Canadian Cancer Society; AIHS; Grants-in-Aid for Scientific Research [24650161] Funding Source: KAKEN	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Brenda Strafford Chair Foundation in Alzheimer's disease; Alberta Innovates Health Solutions (AIHS); Ted Fong/Hotchkiss Brain Institute; Austrian Academy of Sciences at the University of Calgary; Achievers in Medical Sciences award; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); AIHS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR), the Human Frontier Science Program Organization (HFSPO), and the Brenda Strafford Chair Foundation in Alzheimer's disease (to M. D. N.).; Recipient of an Alberta Innovates Health Solutions (AIHS) studentship and a Ted Fong/Hotchkiss Brain Institute doctoral scholarship.; Recipient of a doctoral fellowship of the Austrian Academy of Sciences at the University of Calgary and an Achievers in Medical Sciences award.; Supported by CIHR and the Canadian Cancer Society and holder of a Canada Research Chair.; Recipient of a New Investigator Award from the CIHR and a Scholarship from AIHS.	ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Colbran R. J., 1992, NEUROCHEM INT, V2; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Dhavan R, 2002, J NEUROSCI, V22, P7879; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Kim S. T., 2013, AUTOPHAGY; KOCHHAR A, 1991, BRAIN RES, V542, P141, DOI 10.1016/0006-8993(91)91008-O; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mattson MP, 2001, BIOCHEM SOC SYMP, V67, P151, DOI 10.1042/bss0670151; Meng FJ, 2003, BRAIN RES, V967, P161, DOI 10.1016/S0006-8993(02)04267-1; Nakatani Y, 2005, P NATL ACAD SCI USA, V102, P15093, DOI 10.1073/pnas.0507458102; Nakaya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066269; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Ogburn KD, 2006, J BIOL CHEM, V281, P23274, DOI 10.1074/jbc.M600635200; OTT J, 1979, HUM GENET, V51, P79, DOI 10.1007/BF00278296; Qi YP, 1997, J NEUROSCI, V17, P1217; Rami A, 2009, NEUROPATH APPL NEURO, V35, P449, DOI 10.1111/j.1365-2990.2009.01034.x; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Smith MI, 2007, CELL DEATH DIFFER, V14, P1011, DOI 10.1038/sj.cdd.4402089; TAFT WC, 1988, BRAIN RES, V447, P159, DOI 10.1016/0006-8993(88)90978-X; Tao-Cheng JH, 2002, NEUROSCIENCE, V115, P435, DOI 10.1016/S0306-4522(02)00451-7; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2013, P NATL ACAD SCI USA, V110, P3800, DOI 10.1073/pnas.1217358110; Tenneti L, 2000, J NEUROCHEM, V74, P134, DOI 10.1046/j.1471-4159.2000.0740134.x; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; Van Riper DA, 2000, MOL CELL BIOCHEM, V213, P83, DOI 10.1023/A:1007116231678; Verkhratsky A, 2004, BIOL RES, V37, P693; Verkhratsky A, 2003, J CELL MOL MED, V7, P351, DOI 10.1111/j.1582-4934.2003.tb00238.x; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	53	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24452	24464		10.1074/jbc.M113.483107	http://dx.doi.org/10.1074/jbc.M113.483107			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861403	hybrid, Green Published			2022-12-25	WOS:000330612300015
J	van Saparoea, HBV; Glas, M; Vernooij, IGWH; Bitter, W; den Blaauwen, T; Luirink, J				van Saparoea, H. Bart van den Berg; Glas, Marjolein; Vernooij, Ingrid G. W. H.; Bitter, Wilbert; den Blaauwen, Tanneke; Luirink, Joen			Fine-mapping the Contact Sites of the Escherichia coli Cell Division Proteins FtsB and FtsL on the FtsQ Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPTAL LOCALIZATION; FUNCTIONAL DOMAINS; MEMBRANE-PROTEIN; MUTANT ALLELES; DIVISOME; RECRUIT; COMPLEX; PBP3; RING	Escherichia coli cell division is effected by a large assembly of proteins called the divisome, of which a subcomplex consisting of three bitopic inner membrane proteins, FtsQ, FtsB, and FtsL, is an essential part. These three proteins, hypothesized to link cytoplasmic to periplasmic events during cell division, contain large periplasmic domains that are of major importance for function and complex formation. The essential nature of this subcomplex, its low abundance, and its multiple interactions with key divisome components in the relatively accessible periplasm make it an attractive target for the development of protein-protein interaction inhibitors. Although the crystal structure of the periplasmic domain of FtsQ has been solved, the structure of the FtsQBL complex is unknown, with only very crude indications of the interactions in this complex. In this study, we used in vivo site-specific photo cross-linking to probe the surface of the FtsQ periplasmic domain for its interaction interfaces with FtsB and FtsL. An interaction hot spot for FtsB was identified around residue Ser-250 in the C-terminal region of FtsQ and a membrane-proximal interaction region for both proteins around residue Lys-59. Sequence alignment revealed a consensus motif overlapping with the C-terminal interaction hot spot, underlining the importance of this region in FtsQ. The identification of contact sites in the FtsQBL complex will guide future development of interaction inhibitors that block cell division.	[van Saparoea, H. Bart van den Berg; Glas, Marjolein; Vernooij, Ingrid G. W. H.; Bitter, Wilbert; Luirink, Joen] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, Dept Mol Cell Biol, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [den Blaauwen, Tanneke] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam	Luirink, J (corresponding author), Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.luirink@vu.nl	Bitter, W/CAJ-5778-2022; Luirink, Joen/AAB-8658-2021; Bitter, Wilbert/ABG-3726-2020; Bitter, Wilbert/AAA-6872-2019	Bitter, Wilbert/0000-0001-8347-6511; den Blaauwen, Tanneke/0000-0002-5403-5597; Luirink, J./0000-0001-8431-0804; van den Berg van Saparoea, Bart/0000-0003-3337-5506	European Commission [HEALTH-F3-2009-223431]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Contract HEALTH-F3-2009-223431 (DIVINOCELL).	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Addinall SG, 1997, MOL MICROBIOL, V25, P303, DOI 10.1046/j.1365-2958.1997.4641833.x; Alexeeva S, 2010, MOL MICROBIOL, V77, P384, DOI 10.1111/j.1365-2958.2010.07211.x; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, P NATL ACAD SCI USA, V99, P6316, DOI 10.1073/pnas.092128499; Buddelmeijer N, 1998, J BACTERIOL, V180, P6107; CARSON MJ, 1991, J BACTERIOL, V173, P2187, DOI 10.1128/JB.173.7.2187-2195.1991; Chen JC, 2002, J BACTERIOL, V184, P695, DOI 10.1128/JB.184.3.695-705.2002; Chen JC, 1999, J BACTERIOL, V181, P521, DOI 10.1128/JB.181.2.521-530.1999; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; Deseke E, 1998, EUR J ORG CHEM, V1998, P243, DOI 10.1002/(SICI)1099-0690(199802)1998:2<243::AID-EJOC243>3.0.CO;2-I; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Dubarry N, 2010, MOL MICROBIOL, V78, P1088, DOI 10.1111/j.1365-2958.2010.07412.x; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goehring NW, 2005, GENE DEV, V19, P127, DOI 10.1101/gad.1253805; Gonzalez MD, 2010, J BACTERIOL, V192, P2757, DOI 10.1128/JB.01609-09; Gonzalez MD, 2009, J BACTERIOL, V191, P2815, DOI 10.1128/JB.01597-08; Grenga L, 2010, NEW BIOTECHNOL, V27, P870, DOI 10.1016/j.nbt.2010.05.002; Grenga L, 2008, FEMS MICROBIOL LETT, V287, P163, DOI 10.1111/j.1574-6968.2008.01317.x; Guzman LM, 1997, J BACTERIOL, V179, P5094, DOI 10.1128/jb.179.16.5094-5103.1997; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 2009, J BACTERIOL, V191, P333, DOI 10.1128/JB.00331-08; LaPointe LM, 2013, BIOCHEMISTRY-US, V52, P2574, DOI 10.1021/bi400222r; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Robichon C, 2011, J BACTERIOL, V193, P4988, DOI 10.1128/JB.00324-11; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Villanelo F, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-28; Voges D, 2004, BIOCHEM BIOPH RES CO, V318, P601, DOI 10.1016/j.bbrc.2004.04.064; Weiss DS, 1997, MOL MICROBIOL, V25, P671, DOI 10.1046/j.1365-2958.1997.5041869.x; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	44	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24340	24350		10.1074/jbc.M113.485888	http://dx.doi.org/10.1074/jbc.M113.485888			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846696	Green Published, hybrid			2022-12-25	WOS:000330612300006
J	Brede, M				Brede, Markus			Costly Advertising and the Evolution of Cooperation	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; NETWORKS	In this paper, I investigate the co-evolution of fast and slow strategy spread and game strategies in populations of spatially distributed agents engaged in a one off evolutionary dilemma game. Agents are characterized by a pair of traits, a game strategy (cooperate or defect) and a binary 'advertising' strategy (advertise or don't advertise). Advertising, which comes at a cost a, allows investment into faster propagation of the agents' traits to adjacent individuals. Importantly, game strategy and advertising strategy are subject to the same evolutionary mechanism. Via analytical reasoning and numerical simulations I demonstrate that a range of advertising costs exists, such that the prevalence of cooperation is significantly enhanced through co-evolution. Linking costly replication to the success of cooperators exposes a novel co-evolutionary mechanism that might contribute towards a better understanding of the origins of cooperation-supporting heterogeneity in agent populations.	Univ Southampton, Dept Elect & Comp Sci, Southampton SO9 5NH, Hants, England	University of Southampton	Brede, M (corresponding author), Univ Southampton, Dept Elect & Comp Sci, Southampton SO9 5NH, Hants, England.	Brede.Markus@gmail.com						Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Beinhocker E., 2007, ORIGIN WEALTH; Brede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056016; Brede M, 2011, ARTIF LIFE, V17, P365, DOI 10.1162/artl_a_00044; Cao L, 2011, J THEOR BIOL, V272, P8, DOI 10.1016/j.jtbi.2010.12.008; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hebb Donald O., 1949, ORG BEHAV; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Penn AS, 2012, FEMS IMMUNOL MED MIC, V65, P226, DOI 10.1111/j.1574-695X.2012.00970.x; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Santos FC, 2011, J THEOR BIOL, V274, P30, DOI 10.1016/j.jtbi.2011.01.004; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2004, PHYS REV LETT, V89; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.037102; Szolnoki A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/093016; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; Szolnoki A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036110; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanimoto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.032101; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041130; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Weibull Jorgen W., EVOLUTIONARY GAME TH; Zhang HF, 2010, PHYSICA A, V389, P4734, DOI 10.1016/j.physa.2010.06.023; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118	42	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67056	10.1371/journal.pone.0067056	http://dx.doi.org/10.1371/journal.pone.0067056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861752	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000321692000006
J	Oluwagbemi, OO; Fornadel, CM; Adebiyi, EF; Norris, DE; Rasgon, JL				Oluwagbemi, Olugbenga O.; Fornadel, Christen M.; Adebiyi, Ezekiel F.; Norris, Douglas E.; Rasgon, Jason L.			ANOSPEX: A Stochastic, Spatially Explicit Model for Studying Anopheles Metapopulation Dynamics	PLOS ONE			English	Article							MOSQUITO-BORNE DISEASES; AEDES-AEGYPTI DIPTERA; LIFE TABLE MODEL; MALARIA TRANSMISSION; DESICCATION RESISTANCE; GAMBIAE POPULATION; WESTERN KENYA; LARVAE; CULICIDAE; TEMPERATURE	Anopheles mosquitoes transmit malaria, a major public health problem among many African countries. One of the most effective methods to control malaria is by controlling the Anopheles mosquito vectors that transmit the parasites. Mathematical models have both predictive and explorative utility to investigate the pros and cons of different malaria control strategies. We have developed a C++ based, stochastic spatially explicit model (ANOSPEX; Anopheles Spatially-Explicit) to simulate Anopheles metapopulation dynamics. The model is biologically rich, parameterized by field data, and driven by field-collected weather data from Macha, Zambia. To preliminarily validate ANOSPEX, simulation results were compared to field mosquito collection data from Macha; simulated and observed dynamics were similar. The ANOSPEX model will be useful in a predictive and exploratory manner to develop, evaluate and implement traditional and novel strategies to control malaria, and for understanding the environmental forces driving Anopheles population dynamics.	[Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Oluwagbemi, Olugbenga O.; Fornadel, Christen M.; Norris, Douglas E.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Oluwagbemi, Olugbenga O.; Fornadel, Christen M.; Norris, Douglas E.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA; [Oluwagbemi, Olugbenga O.; Adebiyi, Ezekiel F.] Covenant Univ, Dept Comp & Informat Sci, Coll Sci & Technol, Sch Nat & Appl Sci, Ota, Ogun State, Nigeria	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Covenant University	Rasgon, JL (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jlr54@psu.edu	Norris, Doug/GXV-3397-2022; Fornadel, Christen/AAF-3555-2020	Oluwagbemi, Olugbenga/0000-0001-9085-3370; Rasgon, Jason/0000-0002-4050-8429; Norris, Douglas/0000-0002-4631-2777; Fornadel, Christen/0000-0002-2498-8979	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID)(NIH/NIAID) [R21AI088311]; Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Fulbright Foundation Fellowship; Covenant University Staff Development Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088311, T32AI007417] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID)(NIH/NIAID); Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Fulbright Foundation Fellowship; Covenant University Staff Development Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID)(NIH/NIAID) grant R21AI088311 and a grant from the Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative to JLR. OOO was partially supported by a Fulbright Foundation Fellowship and the Covenant University Staff Development Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-225; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; ALY C, 1986, ENTOMOL EXP APPL, V42, P83, DOI 10.1007/BF00186162; Amalraj DD, 2005, MEM I OSWALDO CRUZ, V100, P893, DOI 10.1590/S0074-02762005000800012; [Anonymous], 1987, WILEY SERIES PROBABI; Arifin SMN, 2011, INT J AGENT TECHNOLO, V3, P1; Asidi AN, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-25; Axtell R., 1996, COMPUT MATH ORGAN TH, V2, P123, DOI DOI 10.1007/BF01299065; Baber I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010270; Bauschke H.H., 1993, SET-VALUED ANAL, V1, P185, DOI DOI 10.1007/BF01027691; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Becker N, 2008, PARASITOL RES, V103, pS19, DOI 10.1007/s00436-008-1210-2; BEHRISCH HW, 1969, BIOCHEM J, V115, P687, DOI 10.1042/bj1150687; Benedict MQ, 2010, J VECTOR ECOL, V35, P116, DOI 10.1111/j.1948-7134.2010.00037.x; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bond JG, 2004, P ROY SOC B-BIOL SCI, V271, P2161, DOI 10.1098/rspb.2004.2826; Cloern JE, 1995, LIMNOL OCEANOGR, V40, P1313, DOI 10.4319/lo.1995.40.7.1313; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; CUELLAR CB, 1969, B WORLD HEALTH ORGAN, V40, P205; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; Curtis CF, 2007, BRIDGING LAB FIELD R, P33; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; Dhiman R. C., 2008, Regional Health Forum, V12, P27; Diabate A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-5; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-62; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Fornadel CM, 2010, AM J TROP MED HYG, V83, P838, DOI 10.4269/ajtmh.2010.10-0088; FRANCHETTI C, 1986, J MATH ANAL APPL, V114, P305, DOI 10.1016/0022-247X(86)90085-5; GAHAN JB, 1964, B WORLD HEALTH ORGAN, V31, P445; GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; GILPIN ME, 1979, FORTS ZOOL, V25, P355; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; Gu JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021329; Gu WD, 2008, AM J TROP MED HYG, V78, P2, DOI 10.4269/ajtmh.2008.78.2; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Impoinvil DE, 2007, J AM MOSQUITO CONTR, V23, P124, DOI 10.2987/8756-971X(2007)23[124:CTATPE]2.0.CO;2; Irlich UM, 2009, AM NAT, V174, P819, DOI 10.1086/647904; JEPSON WF, 1947, B ENTOMOL RES, V38, P177, DOI 10.1017/S0007485300030273; Kaufman MG, 2006, J MED ENTOMOL, V43, P669, DOI 10.1603/0022-2585(2006)43[669:IOABTG]2.0.CO;2; KAVANAU JL, 1950, J GEN PHYSIOL, V34, P193, DOI 10.1085/jgp.34.2.193; Kessler S, 2008, J VECTOR ECOL, V33, P145, DOI 10.3376/1081-1710(2008)33[145:ROAGAS]2.0.CO;2; Kirby MJ, 2009, ACTA TROP, V109, P118, DOI 10.1016/j.actatropica.2008.09.025; Knols Bart G.J., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-19; Lee Y, 2009, J MED ENTOMOL, V46, P316, DOI 10.1603/033.046.0216; Louca V, 2009, J MED ENTOMOL, V46, P546, DOI 10.1603/033.046.0320; MACAN TT, 1961, BIOL REV, V36, P151, DOI 10.1111/j.1469-185X.1961.tb01582.x; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; McKenzie FE, 2000, PARASITOL TODAY, V16, P511, DOI 10.1016/S0169-4758(00)01789-0; Mogi M, 2007, J AM MOSQUITO CONTR, V23, P93, DOI 10.2987/8756-971X(2007)23[93:IAOIP]2.0.CO;2; Molineaux L, 1980, THE GARKI PROJECT; Mugittu K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-126; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; Olayemi IK, 2009, J VECTOR DIS, V46, P295; Omlin FX, 2007, AM J TROP MED HYG, V77, P264, DOI 10.4269/ajtmh.2007.77.264; Paaijmans KP, 2009, ACTA TROP, V109, P124, DOI 10.1016/j.actatropica.2008.07.010; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Purchase S, 2008, IMP C P UPPS; Ren XX, 2010, J VIROL, V84, P7726, DOI 10.1128/JVI.00631-10; Richards A. G., 1964, Physiological Zoology Chicago, V37, P199; Roper C, 2004, LANCET, V305, P1123; Ross R., 1911, PREVENTION MALARIA; Ross Ronald, 1928, STUDIES MALARIA; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; Schneider P, 2000, MED VET ENTOMOL, V14, P165, DOI 10.1046/j.1365-2915.2000.00204.x; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Scolari F, 2011, GENETICA, V139, P41, DOI 10.1007/s10709-010-9483-7; SEAWRIGHT JA, 1979, AM J TROP MED HYG, V28, P155, DOI 10.4269/ajtmh.1979.28.155; SERVICE MW, 1973, B ENTOMOL RES, V62, P359, DOI 10.1017/S0007485300003862; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Silver JB, 2008, MOSQUITO ECOLOGY FIE; Tuno N, 2005, J MED ENTOMOL, V42, P270, DOI 10.1603/0022-2585(2005)042[0270:SOAGSS]2.0.CO;2; von Neumman J., 1950, ANN MATH STUD, V22; WARD JV, 1982, ANNU REV ENTOMOL, V27, P97, DOI 10.1146/annurev.en.27.010182.000525; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Wilensky U, 2007, JASSS-J ARTIF SOC S, V10, P1; Wilke AB, 2009, ASIA PACIFIC J MOL B, V17, P65; Williams CR, 2008, J MED ENTOMOL, V45, P1173, DOI 10.1603/0022-2585(2008)45[1173:REOAAP]2.0.CO;2; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Yaro AS, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-19; Yurista PM, 1999, J PLANKTON RES, V21, P721, DOI 10.1093/plankt/21.4.721	96	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68040	10.1371/journal.pone.0068040	http://dx.doi.org/10.1371/journal.pone.0068040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861847	Green Published, Green Submitted, gold			2022-12-25	WOS:000321692000014
J	Lessler, J; Metcalf, CJE				Lessler, Justin; Metcalf, C. Jessica E.			Balancing Evidence and Uncertainty when Considering Rubella Vaccine Introduction	PLOS ONE			English	Article							IMMUNIZATION; EPIDEMIOLOGY; MEASLES; MUMPS	Background: Despite a safe and effective vaccine, rubella vaccination programs with inadequate coverage can raise the average age of rubella infection; thereby increasing rubella cases among pregnant women and the resulting congenital rubella syndrome (CRS) in their newborns. The vaccination coverage necessary to reduce CRS depends on the birthrate in a country and the reproductive number, R-0, a measure of how efficiently a disease transmits. While the birthrate within a country can be known with some accuracy, R-0 varies between settings and can be difficult to measure. Here we aim to provide guidance on the safe introduction of rubella vaccine into countries in the face of substantial uncertainty in R-0. Methods: We estimated the distribution of R-0 in African countries based on the age distribution of rubella infection using Bayesian hierarchical models. We developed an age specific model of rubella transmission to predict the level of R-0 that would result in an increase in CRS burden for specific birth rates and coverage levels. Combining these results, we summarize the safety of introducing rubella vaccine across demographic and coverage contexts. Findings: The median R-0 of rubella in the African region is 5.2, with 90% of countries expected to have an R-0 between 4.0 and 6.7. Overall, we predict that countries maintaining routine vaccination coverage of 80% or higher are can be confident in seeing a reduction in CRS over a 30 year time horizon. Conclusions: Under realistic assumptions about human contact, our results suggest that even in low birth rate settings high vaccine coverage must be maintained to avoid an increase in CRS. These results lend further support to the WHO recommendation that countries reach 80% coverage for measles vaccine before introducing rubella vaccination, and highlight the importance of maintaining high levels of vaccination coverage once the vaccine is introduced.	[Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Metcalf, C. Jessica E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford	Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	jlessler@jhsph.edu		Lessler, Justin/0000-0002-9741-8109	Bill and Melinda Gates Foundation (Vaccine Modeling Initiative) [705580-3]; National Institute of Allergy and Infectious Disease [K22AI092150]; Royal Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI092150] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation (Vaccine Modeling Initiative); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Royal Society(Royal Society of London); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of JL and CJEM was funded by a grant from the Bill and Melinda Gates Foundation (Vaccine Modeling Initiative, 705580-3). JL is the recipient of a Research Scholar Development Award from the National Institute of Allergy and Infectious Disease (K22AI092150). CJEM was supported by the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1986, J HYG-CAMBRIDGE, V96, P305, DOI 10.1017/S0022172400066079; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; BOULIANNE N, 1995, VACCINE, V13, P1611, DOI 10.1016/0264-410X(95)00098-L; Cormen TH, 2000, INTRO ALGORITHMS; Cutts FT, 2012, LANCET, V380, P217, DOI 10.1016/S0140-6736(12)61215-X; Cutts FT, 2000, EPIDEMIOL INFECT, V124, P467, DOI 10.1017/S0950268899003532; DeStefano F, 2011, EPIDEMIOL INFECT, V139, P1181, DOI 10.1017/S095026881000230X; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; GAVI Alliance, MEASL RUB VACC SUPP; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Goodson JL, 2011, J INFECT DIS, V204, pS215, DOI 10.1093/infdis/jir108; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Jimenez G, 2007, PEDIATR INFECT DIS J, V26, P382, DOI 10.1097/01.inf.0000260000.84792.9e; Lessler J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001110; Metcalf CJE, 2012, THEOR POPUL BIOL, V82, P275, DOI 10.1016/j.tpb.2011.12.001; Metcalf CJE, 2012, EPIDEMIOL INFECT, V140, P2290, DOI 10.1017/S0950268812000131; Metcalf CJE, 2011, J R SOC INTERFACE, V8, P369, DOI 10.1098/rsif.2010.0320; Metcalf CJE, 2012, J ROYAL SOC INTERFAC, V10; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Panagiotopoulos T, 1999, BRIT MED J, V319, P1462, DOI 10.1136/bmj.319.7223.1462; US Census Bureau, INT PROGR INF GAT; van der Heijden OG, 1998, EPIDEMIOL INFECT, V121, P653, DOI 10.1017/S0950268898001472; van der Veen Y, 2005, EUROSURVEILLANCE, V10, P2839; World Bank, BIRTH RAT CRUD; World Health Organization, WHO UNICEF EST MCV C; World Health Organization, 2012, IMM PROF CAP VERD	29	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67639	10.1371/journal.pone.0067639	http://dx.doi.org/10.1371/journal.pone.0067639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861777	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300020
J	Li, MJ; Yang, YH; Chen, XJ; Wang, FQ; Lin, WX; Yi, YJ; Zeng, L; Yang, SY; Zhang, ZY				Li, Ming Jie; Yang, Yan Hui; Chen, Xin Jian; Wang, Feng Qing; Lin, Wen Xiong; Yi, Yan Jie; Zeng, Lei; Yang, Shuo Ye; Zhang, Zhong Yi			Transcriptome/Degradome-Wide Identification of R. glutinosa miRNAs and Their Targets: The Role of miRNA Activity in the Replanting Disease	PLOS ONE			English	Article							AUXIN-RESPONSE-FACTOR; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; TRANSCRIPTION FACTORS; ROOT-FORMATION; SMALL RNA; MICRORNAS; PROTEIN; BIOGENESIS; PLANTS	Rehmannia glutinosa, a traditional Chinese medicine herb, is unable to grow normally in a soil where the same species has recently been cultivated. The biological basis of this so called "replanting disease" is unknown, but it may involve the action of microRNAs (miRNAs), which are known to be important regulators of plant growth and development. High throughput Solexa/Illumina sequencing was used to generate a transcript library of the R. glutinosa transcriptome and degradome in order to identify possible miRNAs and their targets implicated in the replanting disease. A total of 87,665 unigenes and 589 miRNA families (17 of which have not been identified in plants to date) was identified from the libraries made from a first year (FP) and a second year (SP) crop. A comparison between the FP and SP miRNAs showed that the abundance of eight of the novel and 295 of the known miRNA families differed between the FP and SP plants. Sequencing of the degradome sampled from FP and SP plants led to the identification of 165 transcript targets of 85 of the differentially abundant miRNA families. The interaction of some of these miRNAs with their target(s) is likely to form an important part of the molecular basis of the replanting disease of R. glutinosa.	[Li, Ming Jie; Yang, Yan Hui; Chen, Xin Jian; Wang, Feng Qing; Zhang, Zhong Yi] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Yang, Yan Hui; Yi, Yan Jie; Zeng, Lei; Yang, Shuo Ye] Henan Univ Technol, Coll Bioengn, Zhengzhou 450000, Peoples R China; [Lin, Wen Xiong; Zhang, Zhong Yi] Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Peoples R China	Henan Agricultural University; Henan University of Technology; Fujian Agriculture & Forestry University	Chen, XJ (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China.	xinjian1@yahoo.com; hauzzy@163.com			National Natural Science Foundation of China [30772729, 81072983, 31271674, 81274022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China ( Nos. 30772729, 81072983, 31271674 and 81274022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bruhn L, 2012, GENE DEV, V11, P640; Cao ZY, 2011, J EXP BOT, V62, P4675, DOI 10.1093/jxb/err190; Chagne D, 2012, PLANT PHYSIOL, DOI [http://dx.doi.org/10.1104/pp.112, DOI 10.1104/PP.112]; Du Jia-fang, 2009, Shengtaixue Zazhi, V28, P445; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Gazzani S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-62; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Grabov A, 2007, ANN BOT-LONDON, V99, P1035, DOI 10.1093/aob/mcm066; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Miyashima S, 2011, DEVELOPMENT, V138, P2303, DOI 10.1242/dev.060491; Nagatoshi Y, 2009, J BIOL CHEM, V284, P19301, DOI 10.1074/jbc.M109.001032; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pavlova S. V., 2003, Genetika, V39, P1301; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruan MB, 2009, GENOMICS, V94, P263, DOI 10.1016/j.ygeno.2009.07.002; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tang XR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003091; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-650; [温学森 Wen Xuesen], 2002, [中草药, Chinese Traditional and Herbal Drugs], V33, P946; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yang YH, 2013, ACTA PHYSIOL PLANT, V35, P645, DOI 10.1007/s11738-012-1105-9; Yang YH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-53; Yang YH, 2011, PLANT MOL BIOL REP, V29, P986, DOI 10.1007/s11105-011-0293-6; YU FP, 1994, ACTA PHYTOPATHOLOGIC, V24, P310; Zhan XQ, 2012, P NATL ACAD SCI USA, V109, P18198, DOI 10.1073/pnas.1216199109; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; ZHAO YJ, 1991, J CHIN MED MAT, V14, P3; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; 李先恩, 2006, [中国中药杂志, China Journal of Chinese Materia Medica], V31, P344	59	19	47	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68531	10.1371/journal.pone.0068531	http://dx.doi.org/10.1371/journal.pone.0068531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861915	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300067
J	Vogt, L; Ramasamy, U; Meyer, D; Pullens, G; Venema, K; Faas, MM; Schols, HA; de Vos, P				Vogt, Leonie; Ramasamy, Uttara; Meyer, Diederick; Pullens, Gerdie; Venema, Koen; Faas, Marijke M.; Schols, Henk A.; de Vos, Paul			Immune Modulation by Different Types of beta 2 -> 1-Fructans Is Toll-Like Receptor Dependent	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; NF-KAPPA-B; DENDRITIC CELLS; LACTOBACILLUS-RHAMNOSUS; INNATE IMMUNITY; DIETARY FIBER; PROBIOTICS; INULIN; FRUCTOOLIGOSACCHARIDES; ACTIVATION	Introduction: beta 2 -> 1-fructans are dietary fibers. Main objectives of this study were 1) to demonstrate direct signalling of beta 2 -> 1-fructans on immune cells, 2) to study whether this is mediated by the pattern recognition receptors Toll-like receptors (TLRs) and nucleotide-binding oligomerisation domain-containing proteins (NODs), and 3) to relate the observed effects to the chain length differences in beta 2 -> 1-fructans. Methods: Four different beta 2 -> 1-fructan formulations were characterised for their chain length profile. Human peripheral blood mononuclear cells (PBMCs) were stimulated in vitro with beta 2 -> 1-fructans, and production of IL-1Ra, IL-1 beta, IL-6, IL-10, IL-12p70, and TNF-alpha was analysed. Reporter cells for TLRs and NODs were incubated with beta 2 -> 1-fructans and analysed for NF-kappa B/AP-1 activation. Results: Cytokine production in human PBMCs was dose-and chain length-dependent. Strikingly, short chain enriched beta 2 -> 1-fructans induced a regulatory cytokine balance compared to long chain enriched beta 2 -> 1-fructans as measured by IL10/ IL-12 ratios. Activation of reporter cells showed that signalling was highly dependent on TLRs and their adapter, myeloid differentiation primary response protein 88 (MyD88). In human embryonic kidney reporter cells, TLR2 was prominently activated, while TLR4, 5, 7, 8, and NOD2 were mildly activated. Conclusions: beta 2 -> 1-fructans possess direct signalling capacity on human immune cells. By activating primarily TLR2, and to a lesser extent TLR4, 5, 7, 8, and NOD2, beta 2 -> 1-fructan stimulation results in NF-kappa B/AP-1 activation. Chain length of beta 2 -> 1fructans is important for the induced activation pattern and IL-10/IL-12 ratios.	[Vogt, Leonie; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Ramasamy, Uttara; Schols, Henk A.] Wageningen Univ, Food Chem Lab, NL-6700 AP Wageningen, Netherlands; [Meyer, Diederick] Sensus BV, Sci & Regulatory Affairs, Roosendaal, Netherlands; [Pullens, Gerdie] Cosun Food Technol Ctr, Prod Dev, Roosendaal, Netherlands; [Venema, Koen] TNO, Dept Biosci, NL-3700 AJ Zeist, Netherlands	University of Groningen; Wageningen University & Research; Netherlands Organization Applied Science Research	Vogt, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	L.M.Vogt@umcg.nl	de Vos, Paul/A-3170-2013	de vos, paul/0000-0001-9618-2408	European Union; The Northern Netherlands Provinces; KOERS NOORD	European Union(European Commission); The Northern Netherlands Provinces; KOERS NOORD	Within the framework of the Carbohydrate Competence Center, this research has been financially supported by the European Union, the European Regional Development Fund, and The Northern Netherlands Provinces (Samenwerkingsverband Noord-Nederland), KOERS NOORD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Benyacoub J, 2008, J NUTR, V138, P123, DOI 10.1093/jn/138.1.123; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Chen Z, 2008, CLIN IMMUNOL, V128, P400, DOI 10.1016/j.clim.2008.04.006; Chuang SC, 2012, AM J CLIN NUTR, V96, P164, DOI 10.3945/ajcn.111.028415; de Kivit S, 2011, EUR J PHARM; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hamer HM, 2010, CLIN NUTR, V29, P738, DOI 10.1016/j.clnu.2010.04.002; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hosono A, 2003, BIOSCI BIOTECH BIOCH, V67, P758, DOI 10.1271/bbb.67.758; Ito H, 2011, J AGR FOOD CHEM, V59, P5771, DOI 10.1021/jf200859z; Jacobs DR, 2007, AM J CLIN NUTR, V85, P1606, DOI 10.1093/ajcn/85.6.1606; Janardhana V, 2009, J NUTR, V139, P1404, DOI 10.3945/jn.109.105007; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Joosten LAB, 2008, P NATL ACAD SCI USA, V105, P9017, DOI 10.1073/pnas.0710445105; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly G, 2008, ALTERN MED REV, V13, P315; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Landberg R, 2012, AM J CLIN NUTR, V96, P3, DOI 10.3945/ajcn.112.040808; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lindsay JO, 2006, GUT, V55, P348, DOI 10.1136/gut.2005.074971; Lomax AR, 2009, CURR PHARM DESIGN, V15, P1428, DOI 10.2174/138161209788168155; Manhart N, 2003, NUTRITION, V19, P657, DOI 10.1016/S0899-9007(03)00059-5; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Meijerink M, 2012, FEMS IMMUNOL MED MIC, V65, P488, DOI 10.1111/j.1574-695X.2012.00981.x; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Nakamura Y, 2004, CLIN EXP IMMUNOL, V137, P52, DOI 10.1111/j.1365-2249.2004.02487.x; Niness KR, 1999, J NUTR, V129, p1402S, DOI 10.1093/jn/129.7.1402S; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Park JS, 2007, INT IMMUNOPHARMACOL, V7, P70, DOI 10.1016/j.intimp.2006.08.015; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Roller M, 2004, BRIT J NUTR, V92, P931, DOI 10.1079/BJN20041289; Roller M, 2004, J NUTR, V134, P153, DOI 10.1093/jn/134.1.153; Saavedra JM, 2002, BRIT J NUTR, V87, pS241, DOI 10.1079/BJN/2002543; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Seifert S, 2007, J NUTR, V137, p2563S, DOI 10.1093/jn/137.11.2563S; Shalhoub J, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-9; Siednienko Jakub, 2009, V517, P3, DOI 10.1007/978-1-59745-541-1_1; Starkie R, 2003, FASEB J, V17, P884, DOI 10.1096/fj.02-0670fje; Swanson KS, 2002, ARCH ANIM NUTR, V56, P309, DOI 10.1080/00039420214344; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; van Hoffen E, 2009, ALLERGY, V64, P484, DOI 10.1111/j.1398-9995.2008.01765.x; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Vinolo MAR, 2009, CLIN SCI, V117, P331, DOI 10.1042/CS20080642; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Vogt L, 2015, CRIT REV FOOD SCI, V55, P414, DOI 10.1080/10408398.2012.656772; Vos AP, 2007, CRIT REV IMMUNOL, V27, P97, DOI 10.1615/CritRevImmunol.v27.i2.10; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Zheng H, 2012, VET MICROBIOL, V156, P147, DOI 10.1016/j.vetmic.2011.10.014	63	130	133	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68367	10.1371/journal.pone.0068367	http://dx.doi.org/10.1371/journal.pone.0068367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861894	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300060
J	Sacolo, HN; Chung, MH; Chu, H; Liao, YM; Chen, CH; Ou, KL; Chang, LI; Chou, KR				Sacolo, Hlengiwe Nokuthula; Chung, Min-Huey; Chu, Hsin; Liao, Yuan-Mei; Chen, Chiung-Hua; Ou, Keng-Liang; Chang, Lu-I; Chou, Kuei-Ru			High Risk Sexual Behaviors for HIV among the In-School Youth in Swaziland: A Structural Equation Modeling Approach	PLOS ONE			English	Article							CONDOM USE; PLANNED BEHAVIOR; ADOLESCENTS; PREDICTORS; INTENTION; SAMPLE; DETERMINANTS; BELIEFS; ENGAGE	Background: Global efforts in response to the increased prevalence of the human immunodeficiency virus (HIV) are mainly aimed at reducing high risk sexual behaviors among young people. However, knowledge regarding intentions of young people to engage in protective sexual behaviors is still lacking in many countries around the world, especially in Sub-Saharan Africa where prevalence of human immunodeficiency virus is the highest. The objective of this study was to test the theory of planned behavior (TPB) for predicting factors associated with protective sexual behaviors, including sexual abstinence and condom use, among in-school youths aged between 15 and 19 years in Swaziland. Methods: This cross-sectional survey was conducted using a anonymous questionnaire. A two-stage stratified and cluster random sampling method was used. Approximately one hundred pupils from each of four schools agreed to participate in the study, providing a total sample size of 403 pupils of which 369 were ultimately included for data analysis. The response rate was 98%. Structural equation modeling was used to analyse hypothesized paths. Results: The TPB model used in this study was effective in predicting protective sexual behavior among Swazi in-school youths, as shown by model fit indices. All hypothesized constructs significantly predicted intentions for abstinence and condom use, except perceived abstinence controls. Subjective norms were the strongest predictors of intention for premarital sexual abstinence; however, perceived controls for condom use were the strongest predictors of intention for condom use. Conclusions: Our findings support application of the model in predicting determinants of condom use and abstinence intentions among Swazi in-school youths.	[Sacolo, Hlengiwe Nokuthula; Chung, Min-Huey; Liao, Yuan-Mei; Chang, Lu-I; Chou, Kuei-Ru] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan; [Chu, Hsin] Natl Def Med Ctr, Inst Aerosp & Undersea Med, Sch Med, Taipei, Taiwan; [Chu, Hsin] Natl Def Med Ctr, Dept Neurol, Triserv Gen Hosp, Taipei, Taiwan; [Chen, Chiung-Hua] Mei Ho Univ, Sch Nursing, Pingtung, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Graduat Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Devices & Prototyping Prod, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Implants & Microsurg Devices, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Dept Dent, Shuang Ho Hosp, Taipei, Taiwan	Taipei Medical University; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Chou, KR (corresponding author), Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan.	kueiru@tmu.edu.tw		chou, kueiru/0000-0002-4882-3503	Cheng Hsin General Hospital [CHGH 101-57]; Taipei Medical University Hospital [102TMU-TMUH-20]	Cheng Hsin General Hospital; Taipei Medical University Hospital	This manuscript was supported by Cheng Hsin General Hospital (project no. CHGH 101-57) and the Taipei Medical University Hospital (Project Number 102TMU-TMUH-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2010, RES THEOR NURS PRACT, V24, P187, DOI 10.1891/1541-6577.24.3.187; Bailey JA, 2008, J ADOLESCENT HEALTH, V42, P573, DOI 10.1016/j.jadohealth.2007.11.138; Basen-Engquist K, 1999, HEALTH EDUC RES, V14, P25, DOI 10.1093/her/14.1.25; Baumgartner SE, 2010, J YOUTH ADOLESCENCE, V39, P1226, DOI 10.1007/s10964-010-9512-y; Bleakley A, 2009, AM J HEALTH BEHAV, V33, P37; Brauner-Otto SR, 2010, SOC SCI RES, V39, P875, DOI 10.1016/j.ssresearch.2010.06.015; Busse P, 2010, COMMUN RES, V37, P239, DOI 10.1177/0093650209356393; Carmack CC, 2009, J PRIM PREV, V30, P659, DOI 10.1007/s10935-009-0199-3; Cha ES, 2007, INT J NURS STUD, V44, P1147, DOI 10.1016/j.ijnurstu.2006.04.015; Cha ES, 2008, ARCH SEX BEHAV, V37, P641, DOI 10.1007/s10508-007-9187-y; De La Rosa M, 2010, ARCH SEX BEHAV, V39, P1305, DOI 10.1007/s10508-009-9498-2; Doswell Willa M, 2011, J Pediatr Nurs, V26, pe45, DOI 10.1016/j.pedn.2011.03.007; Doswell WM, 2002, J THEORY CONSTRUCTIO, V7, P56; Fatusi AO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-136; Gardner M, 2012, J RES ADOLESCENCE, V22, P135, DOI 10.1111/j.1532-7795.2011.00752.x; Hanna K M, 1999, J Pediatr Nurs, V14, P59, DOI 10.1016/S0882-5963(99)80061-X; Henderson M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-53; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Hutchinson MK, 2012, J NURS SCHOLARSHIP, V44, P27, DOI 10.1111/j.1547-5069.2011.01431.x; Joint United Programme on HIV/AIDS, 2007, SWAZ HIV AIDS PROJ; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Lee YH, 2009, INT J NURS STUD, V46, P653, DOI 10.1016/j.ijnurstu.2008.11.007; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Makiwane M, 2012, AFRICAN J AIDS RES, V9, P17; Mathunjwa Tengetile R, 2006, J Natl Black Nurses Assoc, V17, P39; Molla M, 2007, AIDS CARE, V19, P425, DOI 10.1080/09540120600722692; Monahan KC, 2009, DEV PSYCHOL, V45, P1520, DOI 10.1037/a0017417; Myklestad I, 2007, HEALTH EDUC BEHAV, V34, P686, DOI 10.1177/1090198106289571; National Emergency Council on HIV and AIDS, 2009, SEAZ HIV PREV RESP M; Norris Anne E, 2003, J Pediatr Health Care, V17, P140, DOI 10.1016/S0891-5245(02)88312-2; Patrick ME, 2010, J RES ADOLESCENCE, V20, P456, DOI 10.1111/j.1532-7795.2010.00649.x; Philippa C, 1996, YOUTH STUDIES AUSTR, V3, P60; Potard C, 2012, EUR J CONTRACEP REPR, V17, P55, DOI 10.3109/13625187.2011.634455; Sayles JN, 2006, JAIDS-J ACQ IMM DEF, V43, P226, DOI 10.1097/01.qai.0000230527.17459.5c; Schumacher R.E., 2010, BEGINNERS GUIDE STRU; Selikow TA, 2009, SCAND J PUBLIC HEALT, V37, P107, DOI 10.1177/1403494809103903; Stevensons J, 1996, APPL MULTIVARIATE ST; Swazi Government Report, 2011, SCH LISTS; Swaziland Behavioral Surveillance Survey, 2002, SWAZ BEH SURV SURV; Swaziland National Network of People Living with HIV and AIDS, 2011, BEST PRACT CHALL GEN; Swaziland Second Behavioral Surveillance Survey, 2010, REP 2 BEH SURV SURV; Tobias BQ, 2001, INT J ADV COUNS, V23, P99, DOI DOI 10.1023/A:1010614313756; UNAIDS, 2009, SWAZ COUNTR REP MON; UNAIDS, 2012, SWAZ COUNTR REP MON; Uwah C., 2012, WORLD J AIDS, V2, P17, DOI https://doi.org/10.4236/wja.2012.21003; Van Rossem R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-632; Villarruel AM, 2004, NURS RES, V53, P172, DOI 10.1097/00006199-200405000-00004; Wand Handan, 2012, BMJ Open, V2, pe000285, DOI 10.1136/bmjopen-2011-000285; Warner TD, 2011, SOC SCI RES, V40, P1676, DOI 10.1016/j.ssresearch.2011.06.009; World AIDS Day Report, 2011, GET ZERO FASTER SMAR; Zwane I T, 2004, Int Nurs Rev, V51, P15, DOI 10.1111/j.1466-7657.2003.00214.x	51	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67289	10.1371/journal.pone.0067289	http://dx.doi.org/10.1371/journal.pone.0067289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861756	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700011
J	Carvalho, AL; Turner, DL; Fonseca, LL; Solopova, A; Catarino, T; Kuipers, OP; Voit, EO; Neves, AR; Santos, H				Carvalho, Ana Lucia; Turner, David L.; Fonseca, Luis L.; Solopova, Ana; Catarino, Teresa; Kuipers, Oscar P.; Voit, Eberhard O.; Neves, Ana Rute; Santos, Helena			Metabolic and Transcriptional Analysis of Acid Stress in Lactococcus lactis, with a Focus on the Kinetics of Lactic Acid Pools	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; STREPTOCOCCUS-LACTIS; ESCHERICHIA-COLI; IN-VIVO; PROTONMOTIVE FORCE; SUBSP LACTIS; LOW PH; CREMORIS; TRANSPORT; SYSTEM	The effect of pH on the glucose metabolism of non-growing cells of L. lactis MG1363 was studied by in vivo NMR in the range 4.8 to 6.5. Immediate pH effects on glucose transporters and/or enzyme activities were distinguished from transcriptional/translational effects by using cells grown at the optimal pH of 6.5 or pre-adjusted to low pH by growth at 5.1. In cells grown at pH 5.1, glucose metabolism proceeds at a rate 35% higher than in non-adjusted cells at the same pH. Besides the upregulation of stress-related genes (such as dnaK and groEL), cells adjusted to low pH overexpressed H+-ATPase subunits as well as glycolytic genes. At sub-optimal pHs, the total intracellular pool of lactic acid reached approximately 500 mM in cells grown at optimal pH and about 700 mM in cells grown at pH 5.1. These high levels, together with good pH homeostasis (internal pH always above 6), imply intracellular accumulation of the ionized form of lactic acid (lactate anion), and the concomitant export of the equivalent protons. The average number, n, of protons exported with each lactate anion was determined directly from the kinetics of accumulation of intra-and extracellular lactic acid as monitored online by C-13-NMR. In cells non-adjusted to low pH, n varies between 2 and 1 during glucose consumption, suggesting an inhibitory effect of intracellular lactate on proton export. We confirmed that extracellular lactate did not affect the lactate: proton stoichiometry. In adjusted cells, n was lower and varied less, indicating a different mix of lactic acid exporters less affected by the high level of intracellular lactate. A qualitative model for pH effects and acid stress adaptation is proposed on the basis of these results.	[Carvalho, Ana Lucia; Turner, David L.; Fonseca, Luis L.; Catarino, Teresa; Neves, Ana Rute; Santos, Helena] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Solopova, Ana; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands; [Fonseca, Luis L.; Voit, Eberhard O.] Georgia Inst Technol, Integrat BioSyst Inst, Atlanta, GA 30332 USA; [Fonseca, Luis L.; Voit, Eberhard O.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Fonseca, Luis L.; Voit, Eberhard O.] Emory Univ, Atlanta, GA 30322 USA; [Catarino, Teresa] Univ Nova Lisboa, Dept Quim, Fac Ciencias & Tecnol, P-2780156 Oeiras, Portugal	Universidade Nova de Lisboa; University of Groningen; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Universidade Nova de Lisboa	Santos, H (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	santos@itqb.unl.pt	Fonseca, Luis L/B-2265-2009; Santos, Helena/B-9141-2011; Catarino, Teresa/A-9267-2012; Turner, David L/B-9061-2011; Kuipers, Oscar/B-6752-2009	Fonseca, Luis L/0000-0002-7902-742X; Santos, Helena/0000-0002-8050-9485; Catarino, Teresa/0000-0003-3782-4014; Turner, David L/0000-0002-3754-6459; Kuipers, Oscar/0000-0001-5596-7735; Serafim de Carvalho Kok, Ana Lucia/0000-0002-3401-2240	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/30419/2006, SFRH//BPD/26902/2006]; Programa Operacional Ciencia e Inovacao (POCTI) [REDE/1517/RMN/2005]; U.S. National Science Foundation [MCB- 0946595]; FCT Project [PTDC/EBB-EBI/113727/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Ciencia e Inovacao (POCTI); U.S. National Science Foundation(National Science Foundation (NSF)); FCT Project(Portuguese Foundation for Science and Technology)	AL Carvalho and LL Fonseca were supported by fellowships (SFRH/BD/30419/2006 and SFRH//BPD/26902/2006) from Fundacao para a Ciencia e a Tecnologia (FCT). The NMR spectrometers are part of the National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010" and FCT. This work was funded in part by the U.S. National Science Foundation Project MCB- 0946595, Principal Investigator EO Voit, and by FCT Project PTDC/EBB- EBI/113727/2009 (to AR Neves). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amachi S, 1998, BIOSCI BIOTECH BIOCH, V62, P1574, DOI 10.1271/bbb.62.1574; Andersson U, 2001, J BIOL CHEM, V276, P42707, DOI 10.1074/jbc.M108279200; BAKKER EP, 1980, J BIOL CHEM, V255, P433; Bandell M, 1998, APPL ENVIRON MICROB, V64, P1594; BRINK BT, 1985, J BACTERIOL, V162, P383, DOI 10.1128/JB.162.1.383-390.1985; Budin-Verneuil A, 2005, PROTEOMICS, V5, P4794, DOI 10.1002/pmic.200401327; Casal M, 1999, J BACTERIOL, V181, P2620, DOI 10.1128/JB.181.8.2620-2623.1999; Castro R, 2009, MOL MICROBIOL, V71, P795, DOI 10.1111/j.1365-2958.2008.06564.x; Cho SL, 2008, INT J SYST EVOL MICR, V58, P1844, DOI 10.1099/ijs.0.65527-0; Cotter PD, 2003, APPL ENVIRON MICROB, V69, P702, DOI 10.1128/AEM.69.1.702-706.2003; CROW VL, 1977, J BACTERIOL, V131, P82, DOI 10.1128/JB.131.1.82-91.1977; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; FORDYCE AM, 1982, METHOD ENZYMOL, V90, P77, DOI 10.1016/S0076-6879(82)90109-4; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Frees D, 2003, INT J FOOD MICROBIOL, V87, P293, DOI 10.1016/S0168-1605(03)00104-1; Gaspar P, 2007, FEBS J, V274, P5924, DOI 10.1111/j.1742-4658.2007.06115.x; GASSON MJ, 1983, J BACTERIOL, V154, P1; GATJE G, 1991, APPL MICROBIOL BIOT, V34, P778, DOI 10.1007/BF00169349; Goel A, 2012, APPL ENVIRON MICROB, V78, P134, DOI 10.1128/AEM.05276-11; Hartke A, 1996, CURR MICROBIOL, V33, P194, DOI 10.1007/s002849900099; Hirshfield Irvin N., 2003, Science Progress, V86, P245, DOI 10.3184/003685003783238626; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kuipers OP, 2002, ANTON LEEUW INT J G, V82, P113, DOI 10.1023/A:1020691801251; Linares DM, 2010, J BACTERIOL, V192, P5806, DOI 10.1128/JB.00533-10; MARQUIS RE, 1987, APPL ENVIRON MICROB, V53, P198, DOI 10.1128/AEM.53.1.198-200.1987; Martinez AR, 2010, MOL ORAL MICROBIOL, V25, P331, DOI 10.1111/j.2041-1014.2010.00580.x; Mercade M, 2006, J APPL MICROBIOL, V100, P1364, DOI 10.1111/j.1365-2672.2006.02867.x; Mercade M, 2000, INT J FOOD MICROBIOL, V55, P161, DOI 10.1016/S0168-1605(00)00190-2; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2002, APPL ENVIRON MICROB, V68, P6332, DOI 10.1128/AEM.68.12.6332-6342.2002; OTTO R, 1980, P NATL ACAD SCI-BIOL, V77, P5502, DOI 10.1073/pnas.77.9.5502; Pool WA, 2006, METAB ENG, V8, P456, DOI 10.1016/j.ymben.2006.05.003; POOLMAN B, 1988, J BACTERIOL, V170, P700, DOI 10.1128/jb.170.2.700-707.1988; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; THOMPSON J, 1976, J BACTERIOL, V127, P719, DOI 10.1128/JB.127.2.719-730.1976; VADEBONCOEUR C, 1991, INFECT IMMUN, V59, P900, DOI 10.1128/IAI.59.3.900-906.1991; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; van Maris AJA, 2004, METAB ENG, V6, P245, DOI 10.1016/j.ymben.2004.05.001; Wei Y, 2000, J BIOL CHEM, V275, P30287, DOI 10.1074/jbc.M001112200; Xie Y, 2004, APPL ENVIRON MICROB, V70, P6738, DOI 10.1128/AEM.70.11.6738-6747.2004	42	29	30	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68470	10.1371/journal.pone.0068470	http://dx.doi.org/10.1371/journal.pone.0068470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844205	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000009
J	Ochoa, E; Iriondo, M; Bielsa, A; Ruiz-Irastorza, G; Estonba, A; Zubiaga, AM				Ochoa, Eguzkine; Iriondo, Mikel; Bielsa, Ana; Ruiz-Irastorza, Guillermo; Estonba, Andone; Zubiaga, Ana M.			Thrombotic Antiphospholipid Syndrome Shows Strong Haplotypic Association with SH2B3-ATXN2 Locus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; 3,000 SHARED CONTROLS; GENE-EXPRESSION; COPY NUMBER; MEDIATED THROMBOSIS; IMMUNE-RESPONSE; ISCHEMIC-STROKE; ADAPTER PROTEIN; COMMON DISEASES	Background: Thrombotic antiphospholipid syndrome is defined as a complex form of thrombophilia that is developed by a fraction of antiphospholipid antibody (aPLA) carriers. Little is known about the genetic risk factors involved in thrombosis development among aPLA carriers. Methods: To identify new loci conferring susceptibility to thrombotic antiphospholipid syndrome, a two-stage genotyping strategy was performed. In stage one, 19,000 CNV loci were genotyped in 14 thrombotic aPLA+ patients and 14 healthy controls by array-CGH. In stage two, significant CNV loci were fine-mapped in a larger cohort (85 thrombotic aPLA+, 100 non-thrombotic aPLA+ and 569 healthy controls). Results: Array-CGH and fine-mapping analysis led to the identification of 12q24.12 locus as a new susceptibility locus for thrombotic APS. Within this region, a TAC risk haplotype comprising one SNP in SH2B3 gene (rs3184504) and two SNPs in ATXN2 gene (rs10774625 and rs653178) exhibited the strongest association with thrombotic antiphospholipid syndrome (p-value = 5,9 x 10(-4) OR 95% CI 1.84 (1.32-2.55)). Conclusion: The presence of a TAC risk haplotype in ATXN2-SH2B3 locus may contribute to increased thrombotic risk in aPLA carriers.	[Ochoa, Eguzkine; Iriondo, Mikel; Estonba, Andone; Zubiaga, Ana M.] Univ Basque Country UPV EHU, Sch Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Bielsa, Ana; Ruiz-Irastorza, Guillermo] Univ Basque Country UPV EHU, Autoimmune Dis Res Unit, Serv Internal Med, Hosp Cruces, Leioa, Spain	University of Basque Country; Hospital Universitario Cruces; University of Basque Country	Zubiaga, AM (corresponding author), Univ Basque Country UPV EHU, Sch Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	ana.zubiaga@ehu.es	Iriondo, Mikel/AAA-7997-2019; Ochoa, Eguzkine/AAO-5639-2020; zubiaga, ana/S-3457-2019; Ruiz-Irastorza, Guillermo/P-7058-2014	Iriondo, Mikel/0000-0001-7835-0041; zubiaga, ana/0000-0002-2132-9708; Ruiz-Irastorza, Guillermo/0000-0001-7788-1043; Estonba, Andone/0000-0003-2851-5201; Ochoa, Eguzkine/0000-0002-1506-9065	Basque Government [Etortek IE09-256, Saiotek S-PE10UN82, Plan +Euskadi 09UE09+/57, Saiotek- PE08UN73, Saiotek- PE09UN64]; UPV/EHU [UFI 11/20]; Department of Education, Universities and Research of the Basque Government	Basque Government(Basque Government); UPV/EHU; Department of Education, Universities and Research of the Basque Government	This work was supported by the Basque Government (Etortek IE09-256, Saiotek S-PE10UN82 and Plan +Euskadi 09UE09+/57 to AMZ and Saiotek- PE08UN73 and Saiotek- PE09UN64 to AE) and by the UPV/EHU (UFI 11/20 to AMZ). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Alcina A, 2010, GENES IMMUN, V11, P439, DOI 10.1038/gene.2010.30; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bernales I, 2008, GENES IMMUN, V9, P38, DOI 10.1038/sj.gene.6364443; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de la Red G, 2009, THROMB HAEMOSTASIS, V101, P312, DOI 10.1160/TH08-06-0347; Devalliere J, 2011, BIOCHEM PHARMACOL, V82, P1391, DOI 10.1016/j.bcp.2011.06.023; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galli M, 2000, BRIT J HAEMATOL, V108, P865, DOI 10.1046/j.1365-2141.2000.01964.x; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hamid C, 2007, ANN RHEUM DIS, V66, P1000, DOI 10.1136/ard.2006.063909; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ikram MK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001184; Kenet G, 2000, STROKE, V31, P1283, DOI 10.1161/01.STR.31.6.1283; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Lavrikova EY, 2011, PEDIATR DIABETES, V12, P127, DOI 10.1111/j.1399-5448.2010.00656.x; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li YJ, 2000, J IMMUNOL, V164, P5199, DOI 10.4049/jimmunol.164.10.5199; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Lopez-Pedrera C, 2008, ARTHRITIS RHEUM-US, V58, P2835, DOI 10.1002/art.23756; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Pielberg G, 2003, GENOME RES, V13, P2171, DOI 10.1101/gr.1188203; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Potti A, 2006, BLOOD, V107, P1391, DOI 10.1182/blood-2005-07-2669; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ruiz-Irastorza G, 2011, LUPUS, V20, P206, DOI 10.1177/0961203310395803; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sivapalaratnam S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-64; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vega-Ostertag Mariano E, 2007, Curr Rheumatol Rep, V9, P190, DOI 10.1007/s11926-007-0031-0; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wild PS, 2011, CIRC-CARDIOVASC GENE, V4, P403, DOI 10.1161/CIRCGENETICS.110.958728; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004; Zhou H, 2004, BLOOD, V104, P2353, DOI 10.1182/blood-2004-01-0145	54	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67897	10.1371/journal.pone.0067897	http://dx.doi.org/10.1371/journal.pone.0067897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844121	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000113
J	Turke, M; Weisser, WW				Tuerke, Manfred; Weisser, Wolfgang W.			Species, Diaspore Volume and Body Mass Matter in Gastropod Seed Feeding Behavior	PLOS ONE			English	Article							ARIOLIMAX-COLUMBIANUS; BANANA SLUG; ANT; DISPERSAL; MYRMECOCHORY; MUTUALISM; FORESTS; SIZE; ELAIOSOMES; EARTHWORMS	Background: Seed dispersal of ant-dispersed plants (myrmecochores) is a well studied ecosystem function. Recently, slugs have been found to act as seed dispersers of myrmecochores. The aim of our study was to (1) further generalize the finding that gastropods feed on seeds of myrmecochores and hence may act as seed dispersers, (2) to test whether gastropod body mass and the volume of diaspores have an influence on the seed dispersal potential. Methodology and Principal Findings: We assessed the seed dispersal potential of four slug and snail species with a set of seven myrmecochorous plant species from seven different plant families common to Central European beech forests. Diaspores differed in shape and size. Gastropods differed in their readiness to feed on diaspores and in the proportion of seeds that were swallowed as a whole, and this readiness generally decreased with increasing diaspore size. Smaller Arionid slugs (58 mm body length; mean) mostly fed on the elaiosome but also swallowed small diaspores and therefore not only act as elaiosome consumers, a nutrient rich appendage on myrmecochorous diaspores, but may also disperse seeds. Large Arionid slugs (>100 mm body length) swallowed diaspores of all sizes. Diaspores swallowed by gastropods were defecated without damage. Within-species variability in body size also affect seed dispersal potential, as larger individuals of the red slug (Arion rufus) swallowed more diaspores of wood anemone (Anemone nemorosa) than smaller ones. Conclusions and Significance: Our results help to generalize the finding that gastropods consume and potentially disperse seeds of myrmecochores. The dispersal potential of gastropods is strongly influenced by diaspore size in relation to gastropod size.	[Tuerke, Manfred; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany	Friedrich Schiller University of Jena	Turke, M (corresponding author), Tech Univ Munich, Chair Terr Ecol, Res Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany.	manfred.tuerke@gmx.net	Weisser, Wolfgang W/B-9718-2014	Weisser, Wolfgang W/0000-0002-2757-8959; Turke, Manfred/0000-0002-8957-5454	German Research Foundation; Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [WE 3018/9-1]	German Research Foundation(German Research Foundation (DFG)); Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The work has been funded by the German Research Foundation (http://www.dfg.de) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (WE 3018/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, BIOL TERRESTRIAL MOL; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Bogon K, 1990, LANDSCHNECKEN BIOL B; Bojnansky V, 2007, ATLAS SEEDS FRUITS C; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; Boyd RS, 2001, AM J BOT, V88, P234, DOI 10.2307/2657014; Bronstein JL, 1997, OECOLOGIA, V112, P379, DOI 10.1007/s004420050323; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Calvino-Cancela M, 2012, PLANT ECOL, V213, P663, DOI 10.1007/s11258-012-0030-8; CANULLO R, 1985, Giornale Botanico Italiano, V119, P261; Eisenhauer N, 2010, SOIL BIOL BIOCHEM, V42, P1245, DOI 10.1016/j.soilbio.2010.04.012; Eisenhauer N, 2009, PEDOBIOLOGIA, V52, P151, DOI 10.1016/j.pedobi.2008.07.002; Fischer RC, 2008, OECOLOGIA, V155, P539, DOI 10.1007/s00442-007-0931-8; Fischer W, 1998, BODENKULTUR, V49, P281; Gervais JA, 1998, AM MIDL NAT, V140, P103, DOI 10.1674/0003-0031(1998)140[0103:TPFSDB]2.0.CO;2; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Gorb, 2003, SEED DISPERSAL ANTS; Honek A, 2009, AGR ECOSYST ENVIRON, V134, P126, DOI 10.1016/j.agee.2009.06.001; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; Kappes H, 2006, FOREST ECOL MANAG, V237, P450, DOI 10.1016/j.foreco.2006.09.067; Kappes H, 2009, LANDSCAPE ECOL, V24, P685, DOI 10.1007/s10980-009-9342-z; Kollmann J, 2001, AGR ECOSYST ENVIRON, V83, P285, DOI 10.1016/S0167-8809(00)00202-4; Lengyel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005480; Manzaneda AJ, 2012, ECOGRAPHY, V35, P322, DOI 10.1111/j.1600-0587.2011.06923.x; Manzaneda AJ, 2009, ECOLOGY, V90, P3009, DOI 10.1890/08-2274.1; Mark S, 1996, OECOLOGIA, V107, P95, DOI 10.1007/BF00582239; MESLER MR, 1983, AM J BOT, V70, P1460, DOI 10.2307/2443344; Muller J, 2005, EUR J FOREST RES, V124, P233, DOI 10.1007/s10342-005-0071-9; MULLER P., 1934, BER SCHWEIZ BOT GES, V43, P241; MULLER-SCHNEIDER P., 1967, VEGETATIO, V15, P27; Ness JH, 2004, ECOLOGY, V85, P1244, DOI 10.1890/03-0364; Pearson AK, 2006, VELIGER, V48, P143; PRIOR DJ, 1983, J EXP ZOOL, V225, P321, DOI 10.1002/jez.1402250215; Reifenrath K, 2012, J CHEM ECOL, V38, P1093, DOI 10.1007/s10886-012-0174-y; Sernander R., 1906, ENTWURF MONOGRAPHIE; Servigne P, 2008, INSECT SOC, V55, P220, DOI 10.1007/s00040-008-0991-8; Servigne P, 2008, THESIS U LIBRE BRUXE, P125; Shumway DL, 1994, APPL SOIL ECOL, V1, P11, DOI 10.1016/0929-1393(94)90019-1; Turke M, 2012, AM NAT, V179, P124, DOI 10.1086/663195; Turke M, 2010, OECOLOGIA, V163, P681, DOI 10.1007/s00442-010-1612-6; Ulbrich E, 1919, DTSCH MYRMEKOCHOREN, V117, P1; Weidema I, 2006, INVASIVE ALIEN ASPEC	42	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68788	10.1371/journal.pone.0068788	http://dx.doi.org/10.1371/journal.pone.0068788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844239	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000026
J	Chen, HL; Yi, MH; Sheng, Y; Cheng, HH; Zhou, RJ				Chen, Hengling; Yi, Minhan; Sheng, Yue; Cheng, Hanhua; Zhou, Rongjia			A Novel Testis-Enriched Gene Spata33 Is Expressed during Spermatogenesis	PLOS ONE			English	Article							COFILIN PHOSPHORYLATION; ACTIN REORGANIZATION; DEFICIENT MICE; Y-CHROMOSOME; PROTEIN; MOUSE; CELLS; MEIOSIS; INFERTILITY; DIFFERENTIATION	With an increasing incidence of male idiopathic infertility, identification of novel genes involved in spermatogenesis is an important aspect for the understanding of human testicular failure. In the present study, we have identified a novel gene Spata33, also called as 4732415M23Rik or C16orf55, which is conserved in mammalian species. Spata33 was predominantly expressed in the postpartum and adult mouse testes at mRNA and protein levels. Its expression was increased during the first wave of the spermatogenesis, indicating that Spata33 may be associated with the meiotic process. Further immunohistochemistry analysis revealed that Spata33 was mainly expressed in the spermatocytes, spermatogonia and round spermatids. Its expression was uniformly distributed in the nucleus and cytosol in these germ cells, which was further confirmed by Spata33-tagged with GFP staining in the GC-1 and TM4 cells. These results indicated that Spata33 was predominantly expressed in the mouse testis and associated with spermatogenesis. Identification and characterization of the novel testis-enriched gene Spata33 may provide a new route for understanding of spermatogenesis failure.	[Chen, Hengling; Yi, Minhan; Sheng, Yue; Cheng, Hanhua; Zhou, Rongjia] Wuhan Univ, Coll Life Sci, Dept Genet, Wuhan 430072, Peoples R China	Wuhan University	Cheng, HH (corresponding author), Wuhan Univ, Coll Life Sci, Dept Genet, Wuhan 430072, Peoples R China.	hhcheng@whu.edu.cn; rjzhou@whu.edu.cn	Zhou, Rongjia/G-4660-2013; Zhou, Rongjia/N-9739-2019	Zhou, Rongjia/0000-0002-9701-8009; Zhou, Rongjia/0000-0002-9701-8009	National Natural Science Foundation of China; National Key Basic Research project; National Key Technologies RD Program; Chinese 111 project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research project(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program); Chinese 111 project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China, the National Key Basic Research project, National Key Technologies R&D Program and the Chinese 111 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1999, REV REPROD, V4, P23, DOI 10.1530/revreprod/4.1.23; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Escalier D, 2001, HUM REPROD UPDATE, V7, P191, DOI 10.1093/humupd/7.2.191; Furuchi T, 1996, DEVELOPMENT, V122, P1703; GOETZ P, 1984, J CELL SCI, V65, P249; Hackstein JHP, 2000, TRENDS GENET, V16, P565, DOI 10.1016/S0168-9525(00)02140-5; He C, 2007, CARCINOGENESIS, V28, P2484, DOI 10.1093/carcin/bgm194; HILL CS, 1990, EMBO J, V9, P805, DOI 10.1002/j.1460-2075.1990.tb08177.x; HILL CS, 1991, EMBO J, V10, P1939, DOI 10.1002/j.1460-2075.1991.tb07720.x; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; Jangravi Z, 2013, J PROTEOME RES, V12, P6, DOI 10.1021/pr300864k; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kneitz B, 2000, GENE DEV, V14, P1085; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Nishimune Y, 2006, J ANDROL, V27, P326, DOI 10.2164/jandrol.05162; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Sha JH, 2002, MOL HUM REPROD, V8, P511, DOI 10.1093/molehr/8.6.511; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Vogt PH, 2005, REPROD BIOMED ONLINE, V10, P81, DOI 10.1016/S1472-6483(10)60807-3; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; White-Cooper H, 2010, PHILOS T R SOC B, V365, P1465, DOI 10.1098/rstb.2009.0323; Wilkins MR, 1999, METH MOL B, V112, P531; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Yu ZR, 2003, BIOL REPROD, V69, P37, DOI 10.1095/biolreprod.102.012609	37	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67882	10.1371/journal.pone.0067882	http://dx.doi.org/10.1371/journal.pone.0067882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844118	gold, Green Submitted, Green Published			2022-12-25	WOS:000321341000114
J	de Wit, E; Prescott, J; Baseler, L; Bushmaker, T; Thomas, T; Lackemeyer, MG; Martellaro, C; Milne-Price, S; Haddock, E; Haagmans, BL; Feldmann, H; Munster, VJ				de Wit, Emmie; Prescott, Joseph; Baseler, Laura; Bushmaker, Trenton; Thomas, Tina; Lackemeyer, Matthew G.; Martellaro, Cynthia; Milne-Price, Shauna; Haddock, Elaine; Haagmans, Bart L.; Feldmann, Heinz; Munster, Vincent J.			The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters	PLOS ONE			English	Article								In 2012 a novel coronavirus, MERS-CoV, associated with severe respiratory disease emerged in the Arabian Peninsula. To date, 55 human cases have been reported, including 31 fatal cases. Several of the cases were likely a result of human-to-human transmission. The emergence of this novel coronavirus prompts the need for a small animal model to study the pathogenesis of this virus and to test the efficacy of potential intervention strategies. In this study we explored the use of Syrian hamsters as a small animal disease model, using intratracheal inoculation and inoculation via aerosol. Clinical signs of disease, virus replication, histological lesions, cytokine upregulation nor seroconversion were observed in any of the inoculated animals, indicating that MERS-CoV does not replicate in Syrian hamsters.	[de Wit, Emmie; Prescott, Joseph; Baseler, Laura; Bushmaker, Trenton; Thomas, Tina; Martellaro, Cynthia; Milne-Price, Shauna; Haddock, Elaine; Feldmann, Heinz; Munster, Vincent J.] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Lackemeyer, Matthew G.] NIAID, Div Clin Res, Div Intramural Res, NIH, Frederick, MD USA; [Haagmans, Bart L.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Feldmann, Heinz] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Erasmus University Rotterdam; Erasmus MC; University of Manitoba	de Wit, E (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA.	emmie.dewit@nih.gov	Haagmans, Bart/E-9791-2015; de Wit, Emmie/A-1549-2019; Munster, Vincent/I-7607-2018	Haagmans, Bart/0000-0001-6221-2015; de Wit, Emmie/0000-0002-9763-7758; Munster, Vincent/0000-0002-2288-3196; Prescott, Joseph/0000-0001-5718-5155; Lackemeyer, Matthew/0000-0002-2174-9630	National Institute of Allergy and Infectious Diseases, National Institutes of Health; European Union [223498]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001179, ZIAAI001088] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. BLH was financed by the European Union FP7 project EMPERIE (contract number 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2008, INHAL TOXICOL, V20, P1179, DOI [10.1080/08958370802207318, 10.1080/08958370802207318 ]; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Corman V. M., 2012, EURO SURVEILL, V17; de Groot RJ, 2013, J VIROL, DOI 10.1128/JVI.01244-13; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hartings Justin M., 2004, Journal of Pharmacological and Toxicological Methods, V49, P39, DOI 10.1016/j.vascn.2003.07.001; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Roberts A, 2005, J VIROL, V79, P503, DOI 10.1128/JVI.79.1.503-511.2005; Roberts A, 2008, VIRUS RES, V133, P20, DOI 10.1016/j.virusres.2007.03.025; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; WHO, 2013, COR INF; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004	16	96	98	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69127	10.1371/journal.pone.0069127	http://dx.doi.org/10.1371/journal.pone.0069127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844250	Green Published, gold			2022-12-25	WOS:000321341000183
J	Merabishvili, M; Vervaet, C; Pirnay, JP; De Vos, D; Verbeken, G; Mast, J; Chanishvili, N; Vaneechoutte, M				Merabishvili, Maia; Vervaet, Chris; Pirnay, Jean-Paul; De Vos, Daniel; Verbeken, Gilbert; Mast, Jan; Chanishvili, Nino; Vaneechoutte, Mario			Stability of Staphylococcus aureus Phage ISP after Freeze-Drying (Lyophilization)	PLOS ONE			English	Article							BACTERIOPHAGE; VIABILITY; PRESERVATION; COMPLEX; OXYGEN	Staphylococcus aureus phage ISP was lyophilized, using an Amsco-Finn Aqua GT4 freeze dryer, in the presence of six different stabilizers at different concentrations. Stability of the lyophilized phage at 4 degrees C was monitored up to 37 months and compared to stability in Luria Bertani broth and physiological saline at 4 degrees C. Sucrose and trehalose were shown to be the best stabilizing additives, causing a decrease of only 1 log immediately after the lyophilization procedure and showing high stability during a 27 month storage period.	[Merabishvili, Maia; Pirnay, Jean-Paul; De Vos, Daniel; Verbeken, Gilbert] Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium; [Merabishvili, Maia; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, Dept Clin Chem Microbiol & Immunol, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Merabishvili, Maia; Chanishvili, Nino] Eliava Inst Bacteriophage Microbiol & Virol, R&D Dept, Tbilisi, Georgia; [Vervaet, Chris] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Technol, B-9000 Ghent, Belgium; [Mast, Jan] Vet & Agrochem Res Ctr, Electron Microscopy Unit, Brussels, Belgium	Queen Astrid Military Hospital; Ghent University; Ghent University	Merabishvili, M (corresponding author), Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium.	maia.merabishvili@mil.be	Vaneechoutte, Mario/A-6189-2009; Chanishvili, Nina/CAG-5114-2022; Merabishvili, Maia/GLU-4387-2022	Vaneechoutte, Mario/0000-0002-4586-203X; Chanishvili, Nina/0000-0002-7859-3032; Merabishvili, Maia/0000-0002-2566-0772; Mast, Jan/0000-0002-4879-3367; Pirnay, Jean-Paul/0000-0002-6863-5219	Royal Higher Institute for Defense [MED 12]	Royal Higher Institute for Defense	MM and JPP were financially supported by grant MED 12 of the Royal Higher Institute for Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017; Abedon Stephen T, 2011, Bacteriophage, V1, P66; Ackermann H.-W., 2004, WFCC NEWSLETTER, V38, P35; Alfadhel M, 2011, INT J PHARMACEUT, V416, P280, DOI 10.1016/j.ijpharm.2011.07.006; Anany H, 2011, APPL ENVIRON MICROB, V77, P6379, DOI 10.1128/AEM.05493-11; Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]; CARNE HR, 1974, J HYG-CAMBRIDGE, V72, P467, DOI 10.1017/S0022172400023706; CLARK WA, 1962, APPL MICROBIOL, V10, P466, DOI 10.1128/AEM.10.5.466-471.1962; COX CS, 1973, CAN J MICROBIOL, V19, P189, DOI 10.1139/m73-029; COX CS, 1974, J GEN MICROBIOL, V81, P207, DOI 10.1099/00221287-81-1-207; DAVIES JD, 1969, J HYG-CAMB, V67, P573, DOI 10.1017/S0022172400042030; Golshahi L, 2011, J APPL MICROBIOL, V110, P106, DOI 10.1111/j.1365-2672.2010.04863.x; GREAVES RIN, 1965, ANN NY ACAD SCI, V125, P548, DOI 10.1111/j.1749-6632.1965.tb45413.x; Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9; Jikia D, 2005, CLIN EXP DERMATOL, V30, P23, DOI 10.1111/j.1365-2230.2004.01600.x; Kvachadze L, 2011, MICROB BIOTECHNOL, V4, P643, DOI 10.1111/j.1751-7915.2011.00259.x; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; LION MB, 1961, J GEN MICROBIOL, V24, P191, DOI 10.1099/00221287-24-2-191; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Matinkhoo S, 2011, J PHARM SCI-US, V100, P5197, DOI 10.1002/jps.22715; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Puapermpoonsiri U, 2010, INT J PHARMACEUT, V389, P168, DOI 10.1016/j.ijpharm.2010.01.034; Puapermpoonsiri U, 2009, EUR J PHARM BIOPHARM, V72, P26, DOI 10.1016/j.ejpb.2008.12.001; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHAPIRA A, 1974, CRYOBIOLOGY, V11, P452, DOI 10.1016/0011-2240(74)90113-8; STEELE PRM, 1969, J HYG-CAMB, V67, P107, DOI 10.1017/S0022172400041486; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Weiss FA, 1957, SOCIETY AMERICAN BAC, P99; ZIERDT CH, 1959, AM J CLIN PATHOL, V31, P326; ZIERDT CH, 1988, APPL ENVIRON MICROB, V54, P2590, DOI 10.1128/AEM.54.10.2590-.1988	31	78	80	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68797	10.1371/journal.pone.0068797	http://dx.doi.org/10.1371/journal.pone.0068797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844241	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000181
J	Smolskaya, S; Zhang, ZJ; Alfonta, L				Smolskaya, Sviatlana; Zhang, Zhiwen Jonathan; Alfonta, Lital			Enhanced Yield of Recombinant Proteins with Site-Specifically Incorporated Unnatural Amino Acids Using a Cell-Free Expression System	PLOS ONE			English	Article							ELONGATION-FACTOR TU; TRANSFER-RNA SYNTHETASE; EXPANDED GENETIC-CODE; ESCHERICHIA-COLI; TRANSLATIONAL TERMINATION; RELEASE FACTOR-1; EFFICIENCY; SUPPRESSION; MUTAGENESIS; EVOLUTION	Using a commercial protein expression system, we sought the crucial elements and conditions for the expression of proteins with genetically encoded unnatural amino acids. By identifying the most important translational components, we were able to increase suppression efficiency to 55% and to increase mutant protein yields to levels higher than achieved with wild type expression (120%), reaching over 500 mu g/mL of translated protein (comprising 25 mu g in 50 mL of reaction mixture). To our knowledge, these results are the highest obtained for both in vivo and in vitro systems. We also demonstrated that efficiency of nonsense suppression depends greatly on the nucleotide following the stop codon. Insights gained in this thorough analysis could prove useful for augmenting in vivo expression levels as well.	[Smolskaya, Sviatlana; Alfonta, Lital] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Smolskaya, Sviatlana; Alfonta, Lital] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel; [Zhang, Zhiwen Jonathan] Santa Clara Univ, Sch Engn, Dept Bioengn, Santa Clara, CA 95053 USA	Ben Gurion University; Ben Gurion University; Santa Clara University	Zhang, ZJ (corresponding author), Santa Clara Univ, Sch Engn, Dept Bioengn, Santa Clara, CA 95053 USA.	zzhang@scu.edu; alfontal@bgu.ac.il	Alfonta, Lital/B-6101-2012; Alfonta, Lital/AAB-9689-2022	Alfonta, Lital/0000-0002-3805-8625; Alfonta, Lital/0000-0002-3805-8625; Smolskaya, Sviatlana/0000-0003-3734-8644	European Research Council under the European Union's Seventh Framework Programme [260647]; Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers	The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 260647 and from the Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers. LA holds the Elaine S. and Alvin W. Wene Career Development Chair in Biotechnology Engineering. SS acknowledges the Harbour Foundation for a Fay and Bert Harbour Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agafonov DE, 2005, FEBS LETT, V579, P2156, DOI 10.1016/j.febslet.2005.03.004; BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Eargle J, 2008, J MOL BIOL, V377, P1382, DOI 10.1016/j.jmb.2008.01.073; Goerke AR, 2009, BIOTECHNOL BIOENG, V102, P400, DOI 10.1002/bit.22070; Guo JT, 2009, ANGEW CHEM INT EDIT, V48, P9148, DOI 10.1002/anie.200904035; Hohsaka T, 2001, NUCLEIC ACIDS RES, V29, P3646, DOI 10.1093/nar/29.17.3646; Hohsaka T, 1996, J AM CHEM SOC, V118, P9778, DOI 10.1021/ja9614225; Jewett MC, 2004, BIOTECHNOL PROGR, V20, P102, DOI 10.1021/bp0341693; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu DR, 1999, P NATL ACAD SCI USA, V96, P4780, DOI 10.1073/pnas.96.9.4780; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Pape T, 2000, NAT STRUCT BIOL, V7, P104; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Poole ES, 1998, NUCLEIC ACIDS RES, V26, P954, DOI 10.1093/nar/26.4.954; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sando S, 2007, BIOORG MED CHEM LETT, V17, P1216, DOI 10.1016/j.bmcl.2006.12.013; Schrader JM, 2009, J MOL BIOL, V386, P1255, DOI 10.1016/j.jmb.2009.01.021; Short GF, 1999, BIOCHEMISTRY-US, V38, P8808, DOI 10.1021/bi990281r; Sisido M, 2001, APPL MICROBIOL BIOT, V57, P274; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xie JM, 2004, NAT BIOTECHNOL, V22, P1297, DOI 10.1038/nbt1013; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	32	11	11	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68363	10.1371/journal.pone.0068363	http://dx.doi.org/10.1371/journal.pone.0068363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844190	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000155
J	Wu, XL; Huang, RZ; Liu, ZH; Zhang, GP				Wu, Xuelong; Huang, Ruizhi; Liu, Zhihong; Zhang, Guoping			Functional Characterization of cis-Elements Conferring Vascular Vein Expression of At4g34880 Amidase Family Protein Gene in Arabidopsis	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; CELL-SPECIFIC EXPRESSION; BETA-GLUCURONIDASE; PHLOEM; PROMOTER; TRANSFORMATION; TRANSPORTER; SYMPORTER; NITROGEN; CARBON	The expression of At4g34880 gene encoding amidase in Arabidopsis was characterized in this study. A promoter region of 1.5 kb on the upstream of the start codon of the gene (referred as AmidP) was fused with uidA (GUS) reporter gene, and transformed into Arabidopsis plant for determining its spatial expression. The results indicated that AmidP drived GUS expression in vascular system, predominately in leaves. Truncation analysis of AmidP demonstrated that VASCULAR VEIN ELEMENT (VVE) motif with a region of 176 bp sequence (-1500 to -1324) was necessary and sufficient to direct the vascular vein specific GUS expression in the transgenic plant. Tandem copy of VVE increased vascular system expression, and 5'- and 3'-deletions of VVE motif in combination with a truncated -65 CaMV 35S minimal promoter showed that 11bp cis-acting element, naming DOF2 domain, played an essential role for the vascular vein specific expression. Meanwhile, it was also observed that the other cis-acting elements among the VVE region are also associated with specificity or strength of GUS activities in vascular system.	[Wu, Xuelong; Zhang, Guoping] Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xuelong; Huang, Ruizhi; Liu, Zhihong] Zhejiang Acad Agr Sci, Inst Virol & Biotechnol, Key Lab Plant Metab Engn Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences	Zhang, GP (corresponding author), Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	zhanggp@zju.edu.cn						ARNAUD A, 1976, FOLIA MICROBIOL, V21, P178, DOI 10.1007/BF02883153; Ayre BG, 2003, PLANT PHYSIOL, V133, P1229, DOI 10.1104/pp.103.027714; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BORK P, 1994, PROTEIN SCI, V3, P1344, DOI 10.1002/pro.5560030821; Buelow Lorenz, 2006, In Silico Biology, V6, P243; Casson S, 2005, PLANT J, V42, P111, DOI 10.1111/j.1365-313X.2005.02355.x; Ckurshumova W, 2011, PLANT SCI, V181, P96, DOI 10.1016/j.plantsci.2011.04.008; Clay NK, 2005, PLANT PHYSIOL, V138, P767, DOI 10.1104/pp.104.055756; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Donner TJ, 2010, PLANT SIGNAL BEHAV, V5, P70, DOI 10.4161/psb.5.1.10233; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; FRANKENBERGER WT, 1982, PLANT SOIL, V64, P153, DOI 10.1007/BF02184247; Freitas RL, 2007, PLANT MOL BIOL, V65, P603, DOI 10.1007/s11103-007-9225-0; Frommer WB, 1995, P NATL ACAD SCI USA, V92, P12036, DOI 10.1073/pnas.92.26.12036; Gardiner J, 2010, INT J DEV BIOL, V54, P1389, DOI 10.1387/ijdb.093006jg; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Hoffmann M, 2010, PLANT SIGNAL BEHAV, V5, P1642, DOI 10.4161/psb.5.12.13810; Ivashikina N, 2003, PLANT J, V36, P931, DOI 10.1046/j.1365-313X.2003.01931.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Lacombe E, 2000, PLANT J, V23, P663, DOI 10.1046/j.1365-313x.2000.00838.x; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; McGarry RC, 2008, PLANTA, V228, P839, DOI 10.1007/s00425-008-0786-1; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Patricelli MP, 2000, J BIOL CHEM, V275, P19177, DOI 10.1074/jbc.M001607200; Pollmann S, 2006, PLANTA, V224, P1241, DOI 10.1007/s00425-006-0304-2; Pommerrenig B, 2006, PLANT PHYSIOL, V142, P1427, DOI 10.1104/pp.106.089169; Sawa S, 2005, PLANT PHYSIOL, V138, P819, DOI 10.1104/pp.105.061689; Schneidereit A, 2008, PLANTA, V228, P651, DOI 10.1007/s00425-008-0767-4; Sharma Monica, 2009, Reviews in Environmental Science and Bio/Technology, V8, P343, DOI 10.1007/s11157-009-9175-x; Skirycz A, 2006, PLANT J, V47, P10, DOI 10.1111/j.1365-313X.2006.02767.x; Srivastava AC, 2008, PLANT PHYSIOL, V148, P200, DOI 10.1104/pp.108.124776; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Wright KM, 2003, PLANT PHYSIOL, V131, P1555, DOI 10.1104/pp.102.016022; Wu XueLong, 2011, Acta Agriculturae Zhejiangensis, V23, P645	35	4	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67562	10.1371/journal.pone.0067562	http://dx.doi.org/10.1371/journal.pone.0067562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844031	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000059
J	Yan, T; Chopp, M; Ning, RZ; Zacharek, A; Roberts, C; Chen, JL				Yan, Tao; Chopp, Michael; Ning, Ruizhuo; Zacharek, Alex; Roberts, Cynthia; Chen, Jieli			Intracranial Aneurysm Formation in Type-One Diabetes Rats	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; GLYCOSYLATION END-PRODUCTS; INDUCED CEREBRAL ANEURYSMS; ABDOMINAL AORTIC-ANEURYSM; RISK-FACTORS; MATRIX METALLOPROTEINASES; CLINICAL CONSEQUENCES; VASCULAR-DISEASE; MEDICAL THERAPY; RECEPTOR 4	Background & Objective: Diabetes mellitus (DM) plays an important role in the pathogenesis of vascular complications including arteriosclerosis and ischemic stroke. Whether DM impacts intracranial aneurysm (IA) formation has not been extensively investigated. In this study, we tested the underlying mechanism of type one DM (T1DM) induced IA formation in rats. Experimental Approaches: T1DM was induced by streptozotocin injection. Rats were euthanized at 0, 4 and 10 weeks after T1DM induction. To evaluate cerebral vascular perfusion, Fluorescein isothiocyanate - dye was injected at 5 min prior to euthanasia. Vascular perfusion was measured by laser scanning confocal microscopy. Trichrome, Elastica van Gieson, alpha-smooth muscle actin (a-SMA) and receptor of advanced glycation end-products (RAGE), toll-like receptor 4 (TLR4) and matrix metalloproteinase 9 (MMP9) immunostaining were performed. The IA formation was classified by 0-3 stages: 0: Normal; 1: Endothelial damage; 2: Moderate protrusion; and 3: Saccular aneurysm formation. Results: T1DM significantly increased IA formation identified by the classification of aneurysmal changes compared with non-DM rats (p < 0.05). However, T1DM induced IA formations were classified as stage 1 and stage 2, but not stage 3. Cerebral vascular perfusion was significantly decreased in T1DM rats compared to non-DM rats (p < 0.01). DM10W rats exhibited a significant decrease of cerebral vascular perfusion compared to DM4W rats (p < 0.05). T1DM rats also significantly increased the internal carotid artery (ICA) intimae and media thickness, and decreased the internal carotid artery diameter compared to non-DM rats. RAGE, MMP9 and TLR4 expression were significantly increased in T1DM rats compared to non-DM rats. The increased RAGE, TLR4 and MMP9 significantly correlated with IA formation (p < 0.05). Conclusion: T1DM increases IA formation. The increased RAGE, MMP9 and TLR4 expressions might contribute to IA formation in T1DM rats.	[Yan, Tao; Chen, Jieli] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Yan, Tao; Chopp, Michael; Ning, Ruizhuo; Zacharek, Alex; Roberts, Cynthia; Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Tianjin Medical University; Henry Ford Health System; Henry Ford Hospital; Oakland University	Chen, JL (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China.	jieli@neuro.hfh.edu	Yan, Tao/B-2930-2012	Yan, Tao/0000-0003-3138-4468	National Institute on Aging [RO1 AG031811]; National Institute of Neurological Disorders and Stroke [PO1 NS23393, 1R41NS064708]; American Heart Association [09GRNT2300151]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS064708, P01NS023393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031811, R01AG037506] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging RO1 AG031811 (JC) (http://www.nia.nih.gov/), National Institute of Neurological Disorders and Stroke PO1 NS23393 (MC) and 1R41NS064708 (JC) (http://www.ninds.nih.gov/), and American Heart Association grant 09GRNT2300151 (JC) (http://www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1984, ARCH NEUROL-CHICAGO, V41, P1033, DOI 10.1001/archneur.1984.04050210031009; Aoki T, 2008, STROKE, V39, P1276, DOI 10.1161/STROKEAHA.107.503086; Aoki T, 2011, LAB INVEST, V91, P619, DOI 10.1038/labinvest.2010.204; Aoki T, 2010, J NEUROSURG, V113, P851, DOI 10.3171/2009.9.JNS09329; ASARI S, 1993, CLIN NEUROL NEUROSUR, V95, P205, DOI 10.1016/0303-8467(93)90125-Z; Astrand H, 2007, EUR J VASC ENDOVASC, V33, P592, DOI 10.1016/j.ejvs.2006.11.011; Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; Dua MM, 2010, SURGERY, V148, P429, DOI 10.1016/j.surg.2010.05.014; EPSTEIN M, 1992, HYPERTENSION, V19, P403, DOI 10.1161/01.HYP.19.5.403; Fan X, 2013, STROKE, V44, P745, DOI 10.1161/STROKEAHA.111.000309; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Festa A, 1999, ARTERIOSCL THROM VAS, V19, P562, DOI 10.1161/01.ATV.19.3.562; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Fujita T, 2010, ANN SURG, V252, P203, DOI 10.1097/SLA.0b013e3181e495e6; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; GREENHALGH RM, 1980, J CARDIOVASC SURG, V21, P559; Grenier D, 2006, ORAL MICROBIOL IMMUN, V21, P190, DOI 10.1111/j.1399-302X.2006.00278.x; Guerreiro NE, 2004, SURG NEUROL, V62, P406, DOI 10.1016/j.surneu.2004.01.023; Haley AP, 2012, METAB BRAIN DIS; Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Inagawa T, 2010, WORLD NEUROSURG, V73, P155, DOI 10.1016/j.surneu.2009.03.007; Juvela S, 2001, STROKE, V32, P485, DOI 10.1161/01.STR.32.2.485; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; Kittaka M, 1996, STROKE, V27, P712, DOI 10.1161/01.STR.27.4.712; Kuzuya Masafumi, 2003, J Atheroscler Thromb, V10, P275; KWAK R, 1979, TOHOKU J EXP MED, V128, P267, DOI 10.1620/tjem.128.267; Lagares A, 1999, SURG NEUROL, V52, P623, DOI 10.1016/S0090-3019(99)00147-0; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lee AJ, 1997, EUR HEART J, V18, P671; Li HL, 2007, J CELL MOL MED, V11, P88, DOI 10.1111/j.1582-4934.2007.00011.x; Li WG, 2010, DIABETES, V59, P228, DOI 10.2337/db09-0902; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; McMillan WD, 1997, CIRCULATION, V96, P2228; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Naduk-Kik J, 2008, POSTEP HIG MED DOSW, V62, P442; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ning R, 2012, NEUROSCIENCE, V222, P326, DOI 10.1016/j.neuroscience.2012.07.018; Onda Hideaki, 2008, Brain and Nerve (Tokyo), V60, P1245; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Schmidt AM, 2000, TRENDS ENDOCRIN MET, V11, P368, DOI 10.1016/S1043-2760(00)00311-8; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Tada Y, 2011, STROKE, V42, P2286, DOI 10.1161/STROKEAHA.110.608034; Tada Y, 2010, J HYPERTENS, V28, P1883, DOI 10.1097/HJH;0b013e32833c2273; Takeshita H, 1999, J VIROL, V73, P5548, DOI 10.1128/JVI.73.7.5548-5555.1999; Tamura T, 2009, J HYPERTENS, V27, P1284, DOI 10.1097/HJH.0b013e328329d1a7; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; Thompson RW, 2002, CURR PROB SURG, V39, P98; WINN HR, 1983, J NEUROSURG, V59, P642, DOI 10.3171/jns.1983.59.4.0642; Yamagishi S, 2005, CURR DIABETES REV, V1, P93, DOI 10.2174/1573399052952631; Ye X, 2011, NEUROSCIENCE, V190, P339, DOI 10.1016/j.neuroscience.2011.06.004; Ye XC, 2011, EXP NEUROL, V232, P299, DOI 10.1016/j.expneurol.2011.09.022; Zhang F, 2009, ANN SURG, V250, P416, DOI [10.1097/SLA.0b013e3e181b41a18, 10.1097/SLA.0b013e3181b41a18]	63	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67949	10.1371/journal.pone.0067949	http://dx.doi.org/10.1371/journal.pone.0067949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844137	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000124
J	Lin, A; Yao, J; Zhuang, L; Wang, D; Han, J; Lam, EWF; Gan, B				Lin, A.; Yao, J.; Zhuang, L.; Wang, D.; Han, J.; Lam, E. W-F; Gan, B.		TCGA Res Network	The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress	ONCOGENE			English	Article						FoxO; mTORC1; energy stress; BNIP3	TSC1-TSC2 COMPLEX; TUMOR SUPPRESSORS; MAMMALIAN TARGET; GROWTH-CONTROL; AMPK; LKB1; AUTOPHAGY; KINASE; FOXOS; PHOSPHORYLATION	Normal cells possess adaptive mechanisms to couple energy availability with cell growth (cell size increase) and survival, and imbalances are associated with major diseases such as cancer. Inactivation of critical regulators involved in energy stress response, including adenosine monophosphate-activated protein kinase (AMPK), liver kinase B1 (LKB1), tuberous sclerosis complex 1 (TSC1) and tuberous sclerosis complex 2 (TSC2), leads to uncontrolled cell growth yet increased apoptosis under energy stress. These energy stress regulators are also important in tumor suppression and metabolism. Here, we show that forkhead box O (FoxO) transcription factor, a central regulator of tumor suppression and metabolism, plays a unique role in energy stress response. Fox Os inhibit the mammalian target of rapamycin complex 1 (mTORC1), a key regulator of cell growth, under energy stress, and inactivation of Fox Os alleviates energy stress-mediated mTORC1 repression. Surprisingly, unlike AMPK-, Lkb1- or Tsc1/2-deficient cells, FoxO-deficient cells exhibit decreased apoptosis under energy stress. FoxOs operate to inhibit mTORC1 signaling and cell survival independent of AMPK and TSC. Integrated transcriptomic and functional analyses identified BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3)-a negative regulator of both Rheb and Bcl2 prosurvival family members-as a key downstream target of FoxOs to inhibit mTORC1 function and promote apoptosis in response to energy stress. We show that p38 beta, but not AMPK, is likely to function upstream of FoxO-BNIP3 to mediate energy stress response. Finally, we reveal that low expression of FoxO or BNIP3 correlates with poor clinical outcomes in renal cancer patients. Together, our study uncovers a novel signaling circuit functioning to mediate cellular energy responses to control cell growth and survival. These findings also have important implications to human cancers.	[Lin, A.; Zhuang, L.; Wang, D.; Gan, B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Yao, J.] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Han, J.] Xiamen Univ, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Sch Life Sci, Xiamen, Peoples R China; [Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [TCGA Res Network] Univ Texas Hlth Sci Ctr Houston, Univ Texas MD Anderson Canc Ctr, TCGA Genome Data Anal Ctr, Houston, TX 77030 USA; [Gan, B.] Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Xiamen University; Imperial College London; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Gan, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bgan@mdanderson.org	Lam, Eric W-F/AAW-8566-2020; Gan, Boyi/HDM-4206-2022; Han, J/G-4671-2010	Lam, Eric W-F/0000-0003-1274-3576; 	MD Anderson Cancer Center, US Department of Defense [TS093049, PC100356]; LAM Foundation [LAM092P01-12]; Concern Foundation; Sidney Kimmel Foundation; TCGA grant from NCI/NIH [U24CA143883]; Cancer Research UK [12011] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U24CA143883, R01CA181196, P30CA016672] Funding Source: NIH RePORTER	MD Anderson Cancer Center, US Department of Defense(United States Department of Defense); LAM Foundation; Concern Foundation; Sidney Kimmel Foundation; TCGA grant from NCI/NIH; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Junjie Chen and Hui-Kuan Lin for critical reading of the paper. We also thank Dr Benoit Viollet for providing AMPK WT and KO MEFs and Dr Hsiao-Sheng Liu for providing BNIP3 expression plasmid. BG would also like to thank Ron DePinho for his encouragement and suggestions on this study. This study has been supported by grants from MD Anderson Cancer Center, US Department of Defense (TS093049 and PC100356), LAM Foundation (LAM092P01-12), Concern Foundation and Sidney Kimmel Foundation (to BG) and the TCGA grant U24CA143883 from NCI/NIH (to JY). BG is a Kimmel Scholar and a member of the MD Anderson Cancer Center (CA016672).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Davila D, 2012, CELL DEATH DIFFER, V19, P1677, DOI 10.1038/cdd.2012.49; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Ho KK, 2012, J BIOL CHEM, V287, P1545, DOI 10.1074/jbc.M111.284224; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Linehan WM, 2004, CANCER CELL, V6, P223, DOI 10.1016/j.ccr.2004.09.006; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168	46	59	61	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 12	2014	33	24					3183	3194		10.1038/onc.2013.273	http://dx.doi.org/10.1038/onc.2013.273			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK4QU	23851496	Green Accepted			2022-12-25	WOS:000338410000011
J	Guescini, M; Sisti, D; Rocchi, MBL; Panebianco, R; Tibollo, P; Stocchi, V				Guescini, Michele; Sisti, Davide; Rocchi, Marco B. L.; Panebianco, Renato; Tibollo, Pasquale; Stocchi, Vilberto			Accurate and Precise DNA Quantification in the Presence of Different Amplification Efficiencies Using an Improved Cy0 Method	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; QUANTITATIVE PCR; RELATIVE QUANTIFICATION; MESSENGER-RNA; INHIBITION; VALIDATION; ASSAYS; BIAS	Quantitative real-time PCR represents a highly sensitive and powerful technology for the quantification of DNA. Although real-time PCR is well accepted as the gold standard in nucleic acid quantification, there is a largely unexplored area of experimental conditions that limit the application of the Ct method. As an alternative, our research team has recently proposed the Cy0 method, which can compensate for small amplification variations among the samples being compared. However, when there is a marked decrease in amplification efficiency, the Cy0 is impaired, hence determining reaction efficiency is essential to achieve a reliable quantification. The proposed improvement in Cy0 is based on the use of the kinetic parameters calculated in the curve inflection point to compensate for efficiency variations. Three experimental models were used: inhibition of primer extension, non-optimal primer annealing and a very small biological sample. In all these models, the improved Cy0 method increased quantification accuracy up to about 500% without affecting precision. Furthermore, the stability of this procedure was enhanced integrating it with the SOD method. In short, the improved Cy0 method represents a simple yet powerful approach for reliable DNA quantification even in the presence of marked efficiency variations.	[Guescini, Michele; Sisti, Davide; Rocchi, Marco B. L.; Panebianco, Renato; Tibollo, Pasquale; Stocchi, Vilberto] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy	University of Urbino	Guescini, M (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Via I Maggetti, Urbino, Italy.	michele.guescini@uniurb.it	Rocchi, Marco BL/AAK-5926-2021; Guescini, Michele/L-1297-2019	Guescini, Michele/0000-0001-9372-7038; davide, sisti/0000-0002-7925-7495; Rocchi, marco/0000-0002-0056-5795				AKANE A, 1994, J FORENSIC SCI, V39, P362; Annibalini G, 2012, BMB REP, V45, P32, DOI 10.5483/BMBRep.2012.45.1.32; Bar T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng106; Bar T, 2012, NUCLEIC ACIDS RES, V40, P1395, DOI 10.1093/nar/gkr778; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chervoneva I, 2007, STAT MED, V26, P5596, DOI 10.1002/sim.3127; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Gingeras TR, 2005, CLIN CHEM, V51, P661, DOI 10.1373/clinchem.2004.045336; Goll R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-107; Guescini M, 2007, NUTR METAB CARDIOVAS, V17, P383, DOI 10.1016/j.numecd.2007.01.012; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Kainz P, 2000, BBA-GENE STRUCT EXPR, V1494, P23, DOI 10.1016/S0167-4781(00)00200-1; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nolan T, 2006, ANAL BIOCHEM, V351, P308, DOI 10.1016/j.ab.2006.01.051; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Shain EB, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn408; Sisti D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-186; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; Tichopad A, 2004, MOL CELL PROBE, V18, P45, DOI 10.1016/j.mcp.2003.09.001; Tichopad A, 2010, METHODS, V50, P308, DOI 10.1016/j.ymeth.2010.01.028; Tichopad A, 2009, CLIN CHEM, V55, P1816, DOI 10.1373/clinchem.2009.126201; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	37	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68481	10.1371/journal.pone.0068481	http://dx.doi.org/10.1371/journal.pone.0068481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861909	Green Published, gold, Green Submitted			2022-12-25	WOS:000321692000029
J	Ichikawa, T; Nakazato, K; Keller, PJ; Kajiura-Kobayashi, H; Stelzer, EHK; Mochizuki, A; Nonaka, S				Ichikawa, Takehiko; Nakazato, Kenichi; Keller, Philipp J.; Kajiura-Kobayashi, Hiroko; Stelzer, Ernst H. K.; Mochizuki, Atsushi; Nonaka, Shigenori			Live Imaging of Whole Mouse Embryos during Gastrulation: Migration Analyses of Epiblast and Mesodermal Cells	PLOS ONE			English	Article							INTERKINETIC NUCLEAR MIGRATION; LIGHT SHEET MICROSCOPY; NEURAL PROGENITORS; MOVEMENT; NEUROGENESIS; POLARITY; NEUROEPITHELIUM; ESTABLISHMENT; MECHANISMS; BLASTOCYST	During gastrulation in the mouse embryo, dynamic cell movements including epiblast invagination and mesodermal layer expansion lead to the establishment of the three-layered body plan. The precise details of these movements, however, are sometimes elusive, because of the limitations in live imaging. To overcome this problem, we developed techniques to enable observation of living mouse embryos with digital scanned light sheet microscope (DSLM). The achieved deep and high time-resolution images of GFP-expressing nuclei and following 3D tracking analysis revealed the following findings: (i) Interkinetic nuclear migration (INM) occurs in the epiblast at embryonic day (E) 6 and 6.5. (ii) INM-like migration occurs in the E5.5 embryo, when the epiblast is a monolayer and not yet pseudostratified. (iii) Primary driving force for INM at E6.5 is not pressure from neighboring nuclei. (iv) Mesodermal cells migrate not as a sheet but as individual cells without coordination.	[Ichikawa, Takehiko; Kajiura-Kobayashi, Hiroko; Nonaka, Shigenori] Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 444, Japan; [Nakazato, Kenichi; Mochizuki, Atsushi] RIKEN, Theoret Biol Lab, Adv Sci Inst, Wako, Saitama, Japan; [Keller, Philipp J.] Howard Hughes Med Inst, Ashburn, VA USA; [Stelzer, Ernst H. K.] Goethe Univ Frankfurt, Phys Biol FB IZN 15, Buchmann Inst Mol Life Sci BMLS, CEF MC, D-60054 Frankfurt, Germany; [Nonaka, Shigenori] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Hayama, Kanagawa, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); RIKEN; Howard Hughes Medical Institute; Goethe University Frankfurt; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Nonaka, S (corresponding author), Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 444, Japan.	snonaka@nibb.ac.jp	Stelzer, Ernst H K/A-7648-2011; Mochizuki, Atsushi/A-7917-2015; Nonaka, Shigenori/I-2132-2013	Stelzer, Ernst H K/0000-0003-1545-0736; Mochizuki, Atsushi/0000-0002-7714-1755; Nonaka, Shigenori/0000-0002-8093-0325; Ichikawa, Takehiko/0000-0002-2438-5502; Keller, Philipp/0000-0003-2896-4920	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18687902, 10J00353]; Japan Society for the Promotion of Science (JSPS); Human Frontier Science Program (HFSP); CREST	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program (HFSP)(Human Frontier Science Program); CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by Grant-in-Aid for Scientific Research 18687902 and 10J00353 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/); the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/index.html); the Human Frontier Science Program (HFSP, http://www.hfsp.org/), and CREST (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Arboleda-Estudillo Y, 2010, CURR BIOL, V20, P161, DOI 10.1016/j.cub.2009.11.036; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Davidson BP, 2000, CURR BIOL, V10, pR617, DOI 10.1016/S0960-9822(00)00675-8; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; FUJITA S, 1960, NATURE, V185, P702, DOI 10.1038/185702a0; Guerrier S, 2007, NEURON, V56, P1, DOI 10.1016/j.neuron.2007.09.019; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Latasa MJ, 2009, INT J DEV BIOL, V53, P895, DOI 10.1387/ijdb.082721ml; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2008, CURR OPIN NEUROBIOL, V18, P624, DOI 10.1016/j.conb.2009.03.008; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Khairy K, 2010, RECONSTRUCTING EMBRY; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Lewis SL, 2006, DEV DYNAM, V235, P2315, DOI 10.1002/dvdy.20846; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Minobe S, 2009, NEUROSCI RES, V63, P294, DOI 10.1016/j.neures.2009.01.006; Miyata T, 2008, DEV GROWTH DIFFER, V50, pS105, DOI 10.1111/j.1440-169x.2007.00980.x; NAKATSUJI N, 1986, J EMBRYOL EXP MORPH, V96, P99; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Nowotschin S, 2010, CURR OPIN GENET DEV, V20, P420, DOI 10.1016/j.gde.2010.05.008; Robb L, 2004, SEMIN CELL DEV BIOL, V15, P543, DOI 10.1016/j.semcdb.2004.04.005; Sauer FC, 1936, J MORPHOL, V37, P1; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Stern CD, 2004, GASTRULATION CELLS E, Vxvi; Tam PPL, 2001, BIOESSAYS, V23, P508, DOI 10.1002/bies.1070; Tamai H, 2007, GENES CELLS, V12, P983, DOI 10.1111/j.1365-2443.2007.01113.x; Tao H, 2009, P NATL ACAD SCI USA, V106, P14426, DOI 10.1073/pnas.0901332106; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Tomer R, 2011, CURR OPIN GENET DEV, V21, P558, DOI 10.1016/j.gde.2011.07.003; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016; Zernicka-Goetz M, 2002, DEVELOPMENT, V129, P815; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	41	47	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e64506	10.1371/journal.pone.0064506	http://dx.doi.org/10.1371/journal.pone.0064506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861733	Green Published, Green Submitted, gold			2022-12-25	WOS:000321692000001
J	Watari, K; Nakaya, M; Nishida, M; Kim, KM; Kurose, H				Watari, Kenji; Nakaya, Michio; Nishida, Motohiro; Kim, Kyeong-Man; Kurose, Hitoshi			beta-arrestin2 in Infiltrated Macrophages Inhibits Excessive Inflammation after Myocardial Infarction	PLOS ONE			English	Article							BETA-ARRESTIN; NITRIC-OXIDE; RECEPTOR; PATHWAYS; CELL; HYPERTROPHY; CHEMOTAXIS; APOPTOSIS; IMPROVES; ALPHA	Beta-arrestins (beta-arrestin1 and beta-arrestin2) are known as cytosolic proteins that mediate desensitization and internalization of activated G protein-coupled receptors. In addition to these functions, beta-arrestins have been found to work as adaptor proteins for intracellular signaling pathways. beta-arrestin1 and beta-arrestin2 are expressed in the heart and are reported to participate in normal cardiac function. However, the physiological and pathological roles of beta-arrestin1/2 in myocardial infarction (MI) have not been examined. Here, we demonstrate that beta-arrestin2 negatively regulates inflammatory responses of macrophages recruited to the infarct area. beta-arrestin2 knockout (KO) mice have higher mortality than wild-type (WT) mice after MI. In infarcted hearts, beta-arrestin2 was strongly expressed in infiltrated macrophages. The production of inflammatory cytokines was enhanced in beta-arrestin2 KO mice. In addition, p65 phosphorylation in the macrophages from the infarcted hearts of beta-arrestin2 KO mice was increased in comparison to that of WT mice. These results suggest that the infiltrated macrophages of beta-arrestin2 KO mice induce excessive inflammation at the infarct area. Furthermore, the inflammation in WT mice transplanted with bone marrow cells of beta-arrestin2 KO mice is enhanced by MI, which is similar to that in beta-arrestin2 KO mice. In contrast, the inflammation after MI in beta-arrestin2 KO mice transplanted with bone marrow cells of WT mice is comparable to that in WT mice transplanted with bone marrow cells of WT mice. In summary, our present study demonstrates that beta-arrestin2 of infiltrated macrophages negatively regulates inflammation in infarcted hearts, thereby enhancing inflammation when the beta-arrestin2 gene is knocked out. beta-arrestin2 plays a protective role in MI-induced inflammation.	[Watari, Kenji; Nakaya, Michio; Nishida, Motohiro; Kurose, Hitoshi] Kyushu Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Kim, Kyeong-Man] Chonnam Natl Univ, Pharmacol Lab, Coll Pharm, Kwangju, South Korea	Kyushu University; Chonnam National University	Kurose, H (corresponding author), Kyushu Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan.	kurose@phar.kyushu-u.ac.jp	Kim, Kyeong-Man/AAA-9847-2020	Nishida, Motohiro/0000-0002-2587-5458	Ministry of Education, Culture, Sports, Science, and Technology of Japan; SENSHIN Medical Research Foundation; JSPS; Grants-in-Aid for Scientific Research [22136008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. Nakaya, M. Nishida, and H. Kurose); from Grant-in-Aid for Scientific Research on Innovative Areas (M. Nakaya); from The SENSHIN Medical Research Foundation (M. Na.); from Bilateral Joint Research Project of JSPS (H. Kurose); and from Grant-in-Aid for JSPS Fellows (K. Watari). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Esposito G, 2011, BASIC RES CARDIOL, V106, P577, DOI 10.1007/s00395-011-0163-2; Fan HK, 2010, IMMUNOLOGY, V130, P344, DOI 10.1111/j.1365-2567.2009.03185.x; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Ibrahim IAAEH, 2012, J PHARMACOL SCI, V118, P408, DOI 10.1254/jphs.11R10CP; Ing DJ, 1999, CIRC RES, V84, P21; Jones SP, 1999, AM J PHYSIOL-HEART C, V276, pH1567, DOI 10.1152/ajpheart.1999.276.5.H1567; Kobara M, 2010, CARDIOVASC RES, V87, P424, DOI 10.1093/cvr/cvq078; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li HL, 2007, CIRCULATION, V115, P1885, DOI 10.1161/CIRCULATIONAHA.106.656835; Maekawa Y, 2009, CIRCULATION, V120, P1401, DOI 10.1161/CIRCULATIONAHA.109.865956; Mangmool S, 2010, J CELL BIOL, V189, P573, DOI 10.1083/jcb.200911047; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Noor N, 2011, J MOL CELL CARDIOL, V51, P534, DOI 10.1016/j.yjmcc.2010.11.005; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Singh MV, 2012, J MOL CELL CARDIOL, V52, P1135, DOI 10.1016/j.yjmcc.2012.01.021; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; WINSTON BW, 1995, P NATL ACAD SCI USA, V92, P1614, DOI 10.1073/pnas.92.5.1614; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Yang XH, 2012, APOPTOSIS, V17, P1019, DOI 10.1007/s10495-012-0741-2	34	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68351	10.1371/journal.pone.0068351	http://dx.doi.org/10.1371/journal.pone.0068351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861891	Green Submitted, gold, Green Published			2022-12-25	WOS:000321692000023
J	Hamby, KA; Kwok, RS; Zalom, FG; Chiu, JC				Hamby, Kelly A.; Kwok, Rosanna S.; Zalom, Frank G.; Chiu, Joanna C.			Integrating Circadian Activity and Gene Expression Profiles to Predict Chronotoxicity of Drosophila suzukii Response to Insecticides	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; DIPTERA DROSOPHILIDAE; DARK CYCLES; CLOCK GENE; LIGHT; RHYTHMS; ENTRAINMENT; TEMPERATURE; RESISTANCE; SUSCEPTIBILITY	Native to Southeast Asia, Drosophila suzukii (Matsumura) is a recent invader that infests intact ripe and ripening fruit, leading to significant crop losses in the U.S., Canada, and Europe. Since current D. suzukii management strategies rely heavily on insecticide usage and insecticide detoxification gene expression is under circadian regulation in the closely related Drosophila melanogaster, we set out to determine if integrative analysis of daily activity patterns and detoxification gene expression can predict chronotoxicity of D. suzukii to insecticides. Locomotor assays were performed under conditions that approximate a typical summer or winter day in Watsonville, California, where D. suzukii was first detected in North America. As expected, daily activity patterns of D. suzukii appeared quite different between 'summer' and 'winter' conditions due to differences in photoperiod and temperature. In the 'summer', D. suzukii assumed a more bimodal activity pattern, with maximum activity occurring at dawn and dusk. In the 'winter', activity was unimodal and restricted to the warmest part of the circadian cycle. Expression analysis of six detoxification genes and acute contact bioassays were performed at multiple circadian times, but only in conditions approximating Watsonville summer, the cropping season, when most insecticide applications occur. Five of the genes tested exhibited rhythmic expression, with the majority showing peak expression at dawn (ZT0, 6am). We observed significant differences in the chronotoxicity of D. suzukii towards malathion, with highest susceptibility at ZT0 (6am), corresponding to peak expression of cytochrome P450s that may be involved in bioactivation of malathion. High activity levels were not found to correlate with high insecticide susceptibility as initially hypothesized. Chronobiology and chronotoxicity of D. suzukii provide valuable insights for monitoring and control efforts, because insect activity as well as insecticide timing and efficacy are crucial considerations for pest management. However, field research is necessary for extrapolation to agricultural settings.	[Hamby, Kelly A.; Kwok, Rosanna S.; Zalom, Frank G.; Chiu, Joanna C.] Univ Calif Davis, Coll Agr & Environm Sci, Dept Entomol & Nematol, Davis, CA 95616 USA	University of California System; University of California Davis	Chiu, JC (corresponding author), Univ Calif Davis, Coll Agr & Environm Sci, Dept Entomol & Nematol, Davis, CA 95616 USA.	jcchiu@ucdavis.edu		Chiu, Joanna/0000-0001-7613-8127	CA Strawberry Commission [ST12-20]; NIH [R00 NS069542]; Clarence and Estelle Albaugh Endowment; NSF GRFP [2011129573]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061952] Funding Source: NIH RePORTER	CA Strawberry Commission; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clarence and Estelle Albaugh Endowment; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by CA Strawberry Commission grant ST12-20 to JCC and FGZ; NIH R00 NS069542 and Clarence and Estelle Albaugh Endowment to JCC. KAH is supported by NSF GRFP ID# 2011129573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, AM ENTOMOL; Arthurs SP, 2007, BIOL CONTROL, V41, P99, DOI 10.1016/j.biocontrol.2007.01.001; Barrozo RB, 2004, BIOL RHYTHM RES, V35, P79, DOI 10.1080/09291010412331313250; Beaver LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050454; Beaver LM, 2010, TOXICOL SCI, V115, P513, DOI 10.1093/toxsci/kfq083; BECK STANLEY D., 1963, BULL ENTOMOL SOC AMER, V9, P8; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Burrack HJ, 2013, PEST MANAG SCI, V69, P1173, DOI 10.1002/ps.3489; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; California Department of Pesticide Regulation, 2011, SUMM PEST US REP DAT; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chen WF, 2007, COLD SPRING HARB SYM, V72, P599, DOI 10.1101/sqb.2007.72.021; Chen WF, 2006, J BIOL RHYTHM, V21, P256, DOI 10.1177/0748730406289306; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Cini A, 2012, B INSECTOL, V65, P149; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; COLE CL, 1964, SCIENCE, V144, P1148, DOI 10.1126/science.144.3622.1148; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Costa LG., 2008, CASARETT DOULLS TOXI, P883; Crosby DG, 2008, ENVIRON TOXICOL CHEM, P95; Currie J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-49; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Eesa N. M., 1995, J ISLAMIC ACAD SCI, V8, P21; Feyereisen R, 2005, COMPREHENSEIVE MOL I, V4; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gerghiou GP, 1983, PEST RESISTANCE PEST; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Haviland DR, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM11034; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hooven LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006469; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; KANZAWA T., 1936, Journal of Plant Protection, V23, P66; Kanzawa T, 1936, J PLANT PROTECTION, V23, P127; Kanzawa T, 1939, ABSTR REV APPL ENT; Kanzawa T, 1936, J PLANT PROTECTION, V23, P183; Kanzawa T, 1936, REV APPL ENTOMOL, V24, P315; Kaushik R, 2007, PLOS BIOL, V5, P1257, DOI 10.1371/journal.pbio.0050146; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Lacey LA, 2008, ANNU REV ENTOMOL, V53, P121, DOI 10.1146/annurev.ento.53.103106.093419; Lavery DJ, 1999, MOL CELL BIOL, V19, P6488; Lee JC, 2012, J ECON ENTOMOL, V105, P1350, DOI 10.1603/EC12132; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Lorenzo MG, 1998, ACTA TROP, V70, P163, DOI 10.1016/S0001-706X(98)00025-4; Low KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049536; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Majercak J, 2004, MOL CELL BIOL, V24, P3359, DOI 10.1128/MCB.24.8.3359-3372.2004; McCart C, 2008, PEST MANAG SCI, V64, P639, DOI 10.1002/ps.1567; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Pedigo LP., 2009, ENTOMOLOGY PEST MANA; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; PICKEL C, 1994, J ECON ENTOMOL, V87, P1636, DOI 10.1093/jee/87.6.1636; Piechowicz Bartosz, 2012, Journal of Plant Protection Research, V52, P286, DOI 10.2478/v10045-012-0046-z; PITTENDRIGH CS, 1964, AM NAT, V98, P261, DOI 10.1086/282327; Rancourt B, 2000, J ECON ENTOMOL, V93, P1160, DOI 10.1603/0022-0493-93.4.1160; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Roberts T.R., 1998, METABOLIC PATHWAYS A, P360; Rodriguez J, 2013, P NATL ACAD SCI USA, V110, pE275, DOI 10.1073/pnas.1219969110; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; SHIPP E, 1976, ENTOMOL EXP APPL, V19, P163, DOI 10.1007/BF00345778; Smith S. C., 1994, Tropical Science, V34, P391; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; US Department of Agriculture, 2009, NONC FRUITS NUTS 200; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Vincent C, 2000, ENTOMOL EXP APPL, V97, P347, DOI 10.1023/A:1004141002662; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; WARE GW, 1980, J ECON ENTOMOL, V73, P15, DOI 10.1093/jee/73.1.15; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zalom FG, 2006, ENCY PEST MANAGEMENT, V1, P1; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004	96	61	61	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68472	10.1371/journal.pone.0068472	http://dx.doi.org/10.1371/journal.pone.0068472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861907	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300063
J	Hernandez-Rodriguez, CS; Hernandez-Martinez, P; Van Rie, J; Escriche, B; Ferre, J				Sara Hernandez-Rodriguez, Carmen; Hernandez-Martinez, Patricia; Van Rie, Jeroen; Escriche, Baltasar; Ferre, Juan			Shared Midgut Binding Sites for Cry1A. 105, Cry1Aa, Cry1Ab, Cry1Ac and Cry1Fa Proteins from Bacillus thuringiensis in Two Important Corn Pests, Ostrinia nubilalis and Spodoptera frugiperda	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; INSECT RESISTANCE MANAGEMENT; DOMAIN-III; DELTA-ENDOTOXINS; CROSS-RESISTANCE; PLUTELLA-XYLOSTELLA; CRYSTAL PROTEINS; LEPIDOPTERA CRAMBIDAE; SUSCEPTIBLE STRAINS; HUBNER LEPIDOPTERA	First generation of insect-protected transgenic corn (Bt-corn) was based on the expression of Cry1Ab or Cry1Fa proteins. Currently, the trend is the combination of two or more genes expressing proteins that bind to different targets. In addition to broadening the spectrum of action, this strategy helps to delay the evolution of resistance in exposed insect populations. One of such examples is the combination of Cry1A. 105 with Cry1Fa and Cry2Ab to control O. nubilalis and S. frugiperda. Cry1A. 105 is a chimeric protein with domains I and II and the C-terminal half of the protein from Cry1Ac, and domain III almost identical to Cry1Fa. The aim of the present study was to determine whether the chimeric Cry1A. 105 has shared binding sites either with Cry1A proteins, with Cry1Fa, or with both, in O. nubilalis and in S. frugiperda. Brush-border membrane vesicles (BBMV) from last instar larval midguts were used in competition binding assays with I-125-labeled Cry1A. 105, Cry1Ab, and Cry1Fa, and unlabeled Cry1A. 105, Cry1Aa, Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab and Cry2Ae. The results showed that Cry1A. 105, Cry1Ab, Cry1Ac and Cry1Fa competed with high affinity for the same binding sites in both insect species. However, Cry2Ab and Cry2Ae did not compete for the binding sites of Cry1 proteins. Therefore, according to our results, the development of cross-resistance among Cry1Ab/Ac, Cry1A. 105, and Cry1Fa proteins is possible in these two insect species if the alteration of shared binding sites occurs. Conversely, cross-resistance between these proteins and Cry2A proteins is very unlikely in such case.	[Sara Hernandez-Rodriguez, Carmen; Hernandez-Martinez, Patricia; Escriche, Baltasar; Ferre, Juan] Univ Valencia, Dept Genet, E-46100 Burjassot, Spain; [Van Rie, Jeroen] Bayer CropSci NV, Ghent, Belgium	University of Valencia; Bayer AG; Bayer CropScience	Ferre, J (corresponding author), Univ Valencia, Dept Genet, E-46100 Burjassot, Spain.	Juan.Ferre@uv.es	Ferré, Juan/L-9426-2014; Patricia, Hernandez-Martinez/Q-3082-2019; Hernandez Rodriguez, C Sara Hernández-Rodríguez/J-6739-2012; Escriche, Baltasar/N-5136-2014	Ferré, Juan/0000-0001-5535-0612; Patricia, Hernandez-Martinez/0000-0002-3263-5786; Hernandez Rodriguez, C Sara Hernández-Rodríguez/0000-0002-1234-1190; Escriche, Baltasar/0000-0003-4889-793X	Bayer CropScience	Bayer CropScience(Bayer AG)	Funding for this study was provided by Bayer CropScience. JVR is employed by Bayer CropScience and JF provides consultancy services to this company. Bayer Cropscience provided plasmids for this study. Bayer may hold patents covering some of the material described herein or their uses. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ballester V, 1999, APPL ENVIRON MICROB, V65, P1413; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; BOSCH D, 1994, BIO-TECHNOL, V12, P915, DOI 10.1038/nbt0994-915; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 1997, J BACTERIOL, V179, P2793, DOI 10.1128/jb.179.9.2793-2801.1997; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Coates BS, 2011, GENETICA, V139, P961, DOI 10.1007/s10709-011-9590-0; Crespo ALB, 2011, J INVERTEBR PATHOL, V107, P185, DOI 10.1016/j.jip.2011.04.007; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; de Maagd RA, 1999, MOL MICROBIOL, V31, P463, DOI 10.1046/j.1365-2958.1999.01188.x; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; DENOLF P, 1993, APPL ENVIRON MICROB, V59, P1828, DOI 10.1128/AEM.59.6.1828-1837.1993; Environmental Protection Agency, 2010, BACILLUS THURINGIENS; Environmental Protection Agency, 2009, MON 89034 X TC1507 X; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; Ferre Juan, 2008, V5, P41; Finney D.J., 1971, PROBIT ANAL; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Gonzalez-Cabrera J., 2006, APPL ENVIRON MICROB, V59, P1828; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Granero F, 1996, BIOCHEM BIOPH RES CO, V224, P779, DOI 10.1006/bbrc.1996.1099; Hernandez CS, 2005, APPL ENVIRON MICROB, V71, P5627, DOI 10.1128/AEM.71.9.5627-5629.2005; Hernandez-Martinez P, 2012, APPL ENVIRON MICROB, V78, P6759, DOI 10.1128/AEM.01689-12; Hernandez-Rodriguez CS, 2012, APPL ENVIRON MICROB, V78, P4048, DOI 10.1128/AEM.07591-11; Herrero S, 2004, BIOCHEM J, V384, P507, DOI 10.1042/BJ20041094; Herrero S, 2002, APPL ENVIRON MICROB, V68, P4090, DOI 10.1128/AEM.68.8.4090-4094.2002; Hua G, 2001, APPL ENVIRON MICROB, V67, P872, DOI 10.1128/AEM.67.2.872-879.2001; Jakka SRK, 2011, P 2011 INT C INV PAT; Jurat-Fuentes JL, 2002, APPL ENVIRON MICROB, V68, P5711, DOI 10.1128/AEM.68.11.5711-5717.2002; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; LEE MK, 1995, APPL ENVIRON MICROB, V61, P3836, DOI 10.1128/AEM.61.11.3836-3842.1995; LEE MK, 1995, BIOCHEM BIOPH RES CO, V216, P306, DOI 10.1006/bbrc.1995.2625; Li HR, 2004, BIOCHEM BIOPH RES CO, V323, P52, DOI 10.1016/j.bbrc.2004.08.054; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Oppert B, 2010, J STORED PROD RES, V46, P143, DOI 10.1016/j.jspr.2010.01.003; Pereira EJG, 2008, ENTOMOL EXP APPL, V126, P115, DOI 10.1111/j.1570-7458.2007.00642.x; Pereira EJG, 2010, J INVERTEBR PATHOL, V103, P1, DOI 10.1016/j.jip.2009.08.014; Rang C, 2004, CURR MICROBIOL, V49, P22, DOI 10.1007/s00284-003-4258-3; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Hernandez-Rodriguez CS, 2008, APPL ENVIRON MICROB, V74, P7654, DOI 10.1128/AEM.01373-08; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Siqueira HAA, 2004, J ECON ENTOMOL, V97, P1049, DOI 10.1603/0022-0493(2004)097[1049:COCONL]2.0.CO;2; Siqueira HAA, 2006, APPL ENVIRON MICROB, V72, P5318, DOI 10.1128/AEM.00219-06; Storer Nicholas P, 2012, GM Crops Food, V3, P154, DOI 10.4161/gmcr.20945; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P1640, DOI 10.1073/pnas.94.5.1640; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P12780, DOI 10.1073/pnas.94.24.12780; TABASHNIK BE, 1994, APPL ENVIRON MICROB, V60, P4627, DOI 10.1128/AEM.60.12.4627-4629.1994; Thompson M A, 1995, Genet Eng (N Y), V17, P99; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wu XY, 2009, J INVERTEBR PATHOL, V100, P29, DOI 10.1016/j.jip.2008.10.003; Wyniger R, 1974, INSEKTENZUCHT METHOD; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	64	96	102	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68164	10.1371/journal.pone.0068164	http://dx.doi.org/10.1371/journal.pone.0068164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861865	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300046
J	Anandakrishnan, R; Baker, C; Izadi, S; Onufriev, AV				Anandakrishnan, Ramu; Baker, Charles; Izadi, Saeed; Onufriev, Alexey V.			Point Charges Optimally Placed to Represent the Multipole Expansion of Charge Distributions	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; DERIVING ATOMIC CHARGES; GAUSSIAN-BASIS SETS; ELECTROSTATIC POTENTIALS; WATER; ALGORITHM; DENSITY; BORON; AMBER	We propose an approach for approximating electrostatic charge distributions with a small number of point charges to optimally represent the original charge distribution. By construction, the proposed optimal point charge approximation (OPCA) retains many of the useful properties of point multipole expansion, including the same far-field asymptotic behavior of the approximate potential. A general framework for numerically computing OPCA, for any given number of approximating charges, is described. We then derive a 2-charge practical point charge approximation, PPCA, which approximates the 2-charge OPCA via closed form analytical expressions, and test the PPCA on a set of charge distributions relevant to biomolecular modeling. We measure the accuracy of the new approximations as the RMS error in the electrostatic potential relative to that produced by the original charge distribution, at a distance (2) over tilde x the extent of the charge distribution-the mid-field. The error for the 2-charge PPCA is found to be on average 23% smaller than that of optimally placed point dipole approximation, and comparable to that of the point quadrupole approximation. The standard deviation in RMS error for the 2-charge PPCA is 53% lower than that of the optimal point dipole approximation, and comparable to that of the point quadrupole approximation. We also calculate the 3-charge OPCA for representing the gas phase quantum mechanical charge distribution of a water molecule. The electrostatic potential calculated by the 3-charge OPCA for water, in the mid-field (2.8 angstrom from the oxygen atom), is on average 33.3% more accurate than the potential due to the point multipole expansion up to the octupole order. Compared to a 3 point charge approximation in which the charges are placed on the atom centers, the 3-charge OPCA is seven times more accurate, by RMS error. The maximum error at the oxygen-Na distance (2.23 angstrom) is half that of the point multipole expansion up to the octupole order.	[Anandakrishnan, Ramu; Onufriev, Alexey V.] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA; [Baker, Charles] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Izadi, Saeed] Virginia Tech, Dept Engn Sci & Mech, Blacksburg, VA USA; [Onufriev, Alexey V.] Virginia Tech, Dept Phys, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Harvard University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Onufriev, AV (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	alexey@cs.vt.edu	Anandakrishnan, Ramu/AAB-9040-2020	Anandakrishnan, Ramu/0000-0003-0422-3984; Onufriev, Alexey/0000-0002-4930-6612	National Institute of Health [GM076121]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076121] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health (grant number GM076121 to AO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandakrishnan R, 2011, J CHEM THEORY COMPUT, V7, P544, DOI 10.1021/ct100390b; Anandakrishnan R, 2010, J COMPUT CHEM, V31, P691, DOI 10.1002/jcc.21357; Ball P., 1999, LIFES MATRIX BIOGRAP; Basdevant N, 2007, J PHYS CHEM B, V111, P9390, DOI 10.1021/jp0727190; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bishop TC, 1997, J COMPUT CHEM, V18, P1785, DOI 10.1002/(SICI)1096-987X(19971115)18:14<1785::AID-JCC7>3.0.CO;2-G; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Cai W, 2007, J COMPUT PHYS, V223, P846, DOI 10.1016/j.jcp.2006.10.019; CARRIER J, 1988, SIAM J SCI STAT COMP, V9, P669, DOI 10.1137/0909044; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Cheng H, 1999, J COMPUT PHYS, V155, P468, DOI 10.1006/jcph.1999.6355; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; CLOUGH SA, 1973, J CHEM PHYS, V59, P2254, DOI 10.1063/1.1680328; COLONNA F, 1992, J COMPUT CHEM, V13, P1234, DOI 10.1002/jcc.540131007; Cruz FA, 2009, INT J NUMER METH ENG, V79, P1577, DOI 10.1002/nme.2611; Dill KA, 2005, ANNU REV BIOPH BIOM, V34, P173, DOI 10.1146/annurev.biophys.34.040204.144517; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Franks F., 2000, WATER MATRIX LIFE; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Gordon JC, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2956499; Gramada A, 2011, COMPUT PHYS COMMUN, V182, P1455, DOI 10.1016/j.cpc.2011.03.014; Gramada A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066601; GREENGARD L, 1987, J COMPUT PHYS, V73, P325, DOI 10.1016/0021-9991(87)90140-9; Greengard L., 1997, Acta Numerica, V6, P229, DOI 10.1017/S0962492900002725; Guillot B, 2002, J MOL LIQ, V101, P219, DOI 10.1016/S0167-7322(02)00094-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ichiye T, 2006, J CHEM PHYS, V124; Izvekov S, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2038787; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kale S, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3688228; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KELL GS, 1975, J CHEM ENG DATA, V20, P97, DOI 10.1021/je60064a005; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Koumoutsakos P, 1995, 96N25344 NASA AM RES; Lambert CG, 1996, J COMPUT PHYS, V126, P274, DOI 10.1006/jcph.1996.0137; LEE FS, 1992, J CHEM PHYS, V97, P3100, DOI 10.1063/1.462997; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Mukhopadhyay A, 2012, J PHYS CHEM B, V116, P9776, DOI 10.1021/jp305226j; Niu SQ, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3569563; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Platt DE, 1996, J COMPUT CHEM, V17, P358, DOI 10.1002/(SICI)1096-987X(199602)17:3<358::AID-JCC10>3.0.CO;2-G; Pollock EL, 1995, COMMENTS PPPM FMM EW; Salsbury FR, 2010, CURR OPIN PHARMACOL, V10, P738, DOI 10.1016/j.coph.2010.09.016; Schlick T., 2010, MOL MODELING SIMULAT, V2nd ed.; SCHMIDT KE, 1991, J STAT PHYS, V63, P1223, DOI 10.1007/BF01030008; Sigfridsson E, 1998, J COMPUT CHEM, V19, P377, DOI 10.1002/(SICI)1096-987X(199803)19:4<377::AID-JCC1>3.0.CO;2-P; STONE AJ, 1985, MOL PHYS, V56, P1047, DOI 10.1080/00268978500102891; STONE AJ, 1981, CHEM PHYS LETT, V83, P233, DOI 10.1016/0009-2614(81)85452-8; Swart M, 2001, J COMPUT CHEM, V22, P79, DOI 10.1002/1096-987X(20010115)22:1<79::AID-JCC8>3.0.CO;2-B; TAIT MJ, 1971, NATURE, V230, P91, DOI 10.1038/230091a0; Te JA, 2010, CHEM PHYS LETT, V499, P219, DOI 10.1016/j.cplett.2010.09.043; Tu YQ, 2000, CHEM PHYS LETT, V329, P283, DOI 10.1016/S0009-2614(00)01026-5; Walsh TR, 2009, J COMPUT CHEM, V30, P893, DOI 10.1002/jcc.21111; WOON DE, 1995, J CHEM PHYS, V103, P4572, DOI 10.1063/1.470645; Wu YJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2136877; Ying LX, 2006, J COMPUT PHYS, V213, P451, DOI 10.1016/j.jcp.2005.09.010	58	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67715	10.1371/journal.pone.0067715	http://dx.doi.org/10.1371/journal.pone.0067715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861790	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700028
J	Figarska, SM; Vonk, JM; van Diemen, CC; Postma, DS; Boezen, HM				Figarska, Sylwia M.; Vonk, Judith M.; van Diemen, Cleo C.; Postma, Dirkje S.; Boezen, H. Marike			ADAM33 Gene Polymorphisms and Mortality. A Prospective Cohort Study	PLOS ONE			English	Article							LUNG-FUNCTION; ASTHMA; SUSCEPTIBILITY; ASSOCIATION; DISEASE; DISINTEGRIN; POPULATION; AIRWAYS	The ADAM33 gene is associated with the pathophysiology of Chronic Obstructive Pulmonary Disease (COPD) and atherosclerosis. In this study we investigated all-cause, COPD and cardiovascular mortality, in relation to single nucleotide polymorphisms (SNPs) in ADAM33 (Q_1, S_1, S_2, T_1 and T_2) that were genotyped in 1,390 subjects from the Vlagtwedde/Vlaardingen cohort. Participants were examined at entry in 1989/1990 and followed up till evaluation of the vital status on December 31st, 2008. Using Cox proportional hazards regression we estimated the risk of the SNPs in relation to mortality, adjusting for gender, age, FEV1, height, place of residence and packyears of smoking. Additionally, we performed stratified analyses according to gender and smoking habits. After 18 years, 284 (20.4%) subjects had died (107 due to cardiovascular disease and 20 due to COPD). Individuals homozygous for the minor allele of SNP T_2 had an increased risk of all-cause and cardiovascular mortality compared to wild types: hazard ratio 3.6 (95% confidence interval 2.0 to 6.7) and 3.4 (1.2 to 9.5) respectively. Individuals homozygous for the minor allele of S_1, S_2, T_2 or Q_1 had a significantly increased risk of COPD mortality. In stratified analyses the risk of all-cause mortality associated with SNP T_2 did not change: females 3.5 (1.5 to 8.3), males 3.1 (1.2 to 7.6), never smokers 3.8 (0.9 to 16.3), ever smokers 3.6 (1.8 to 7.2). This study shows for the first time that ADAM33 is a pleiotropic gene that is associated with all-cause, COPD and cardiovascular mortality, independent of potential confounders.	[Figarska, Sylwia M.; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Diemen, Cleo C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Figarska, Sylwia M.; Vonk, Judith M.; Postma, Dirkje S.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	h.m.boezen@umcg.nl	Vonk, Judith/K-8477-2019; Vonk, Judith M/ABA-3009-2020	Vonk, Judith/0000-0001-7531-4547; Vonk, Judith M/0000-0001-7531-4547; Figarska, Sylwia/0000-0003-3601-1548; van Diemen, Cleo/0000-0001-9283-2207	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, The Netherlands; Netherlands Asthma Foundation [3.2.02.51]; Stichting Astma Bestrijding [2005/020]	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, The Netherlands; Netherlands Asthma Foundation; Stichting Astma Bestrijding	This work was supported by the Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, The Netherlands. The Vlagtwedde\Vlaardingen study was supported by unrestricted grants of the Netherlands Asthma Foundation (grant number 3.2.02.51) and Stichting Astma Bestrijding (grant number 2005/020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Blagosklonny MV, 2010, AGING-US, V2, P177, DOI 10.18632/aging.100139; Blakey JD, 2009, THORAX, V64, P381, DOI 10.1136/thx.2008.102053; Butcher SK, 2004, AGING CELL, V3, P151, DOI 10.1111/j.1474-9728.2004.00103.x; Chen C, 2006, MOL CELL BIOL, V26, P6950, DOI 10.1128/MCB.00646-06; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Gosman MME, 2007, THORAX, V62, P242, DOI 10.1136/thx.2006.060988; Haitchi HM, 2005, AM J RESP CRIT CARE, V171, P958, DOI 10.1164/rccm.200409-1251OC; Holgate ST, 2010, DRUG NEWS PERSPECT, V23, P381, DOI 10.1358/dnp.2010.23.6.1437242; Holloway JW, 2010, ATHEROSCLEROSIS, V211, P224, DOI 10.1016/j.atherosclerosis.2010.02.023; Korytina G F, 2012, Mol Biol (Mosk), V46, P487; Lao JI, 2005, ANN NY ACAD SCI, V1057, P50, DOI 10.1196/annals.1356.003; Lee YH, 2012, INFLAMM RES, V61, P1355, DOI 10.1007/s00011-012-0536-5; Naumova E, 2004, EXP GERONTOL, V39, P637, DOI 10.1016/j.exger.2003.08.014; Puxeddu I, 2008, J ALLERGY CLIN IMMUN, V121, P1400, DOI 10.1016/j.jaci.2008.03.003; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sadeghnejad A, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-21; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Simpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Swindell WR, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-55; Tripathi P, 2012, ANN HUM BIOL, V39, P479, DOI 10.3109/03014460.2012.716451; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67768	10.1371/journal.pone.0067768	http://dx.doi.org/10.1371/journal.pone.0067768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861802	Green Submitted, gold, Green Published			2022-12-25	WOS:000323350700033
J	Palavesam, A; Esnault, C; O'Brochta, DA				Palavesam, Azhahianambi; Esnault, Caroline; O'Brochta, David A.			Post-Integration Silencing of piggyBac Transposable Elements in Aedes aegypti	PLOS ONE			English	Article							INSERTIONAL MUTAGENESIS; TRIBOLIUM-CASTANEUM; ANOPHELES-GAMBIAE; DNA TRANSPOSONS; GENE-TRANSFER; VECTOR; EXPRESSION; TRANSFORMATION; EVOLUTION; GENOME	The piggyBac transposon, originating in the genome of the Lepidoptera Trichoplusia ni, has a broad host range, making it useful for the development of a number of transposon-based functional genomic technologies including gene vectors, enhancer-, gene- and protein-traps. While capable of being used as a vector for the creation of transgenic insects and insect cell lines, piggyBac has very limited mobility once integrated into the genome of the yellow fever mosquito, Aedes aegypti. A transgenic Aedes aegypti cell line (AagPB8) was created containing three integrated piggyBac elements and the remobilization potential of the elements was tested. The integrated piggyBac elements in AagPB8 were transpositionally silent in the presence of functional transposase, which was shown to be capable of catalyzing the movement of plasmid-borne piggyBac elements in the same cells. The structural integrity of one of the integrated elements along with the quality of element-flanking DNA, which is known to influence transposition rates, were tested in D. melanogaster. The element was found to be structurally intact, capable of transposition and excision in the soma and germ-line of Drosophila melanogaster, and in a DNA sequence context highly conducive to element movement in Drosophila melanogaster. These data show that transpositional silencing of integrated piggyBac elements in the genome of Aedes aegypti appears to be a function of higher scale genome organization or perhaps epigenetic factors, and not due to structural defects or suboptimal integration sites.	[Palavesam, Azhahianambi; Esnault, Caroline; O'Brochta, David A.] Univ Maryland, Dept Entomol, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [O'Brochta, David A.] Inst Biosci & Biotechnol Res, Rockville, MD USA	University System of Maryland; University of Maryland College Park	O'Brochta, DA (corresponding author), Univ Maryland, Dept Entomol, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.	dobrocht@umd.edu	Palavesam, Azhahianambi/H-3307-2019; Esnault, Caroline/C-7221-2015; Palavesam, Azhahianambi/K-7606-2015	Palavesam, Azhahianambi/0000-0002-7108-6767; Palavesam, Azhahianambi/0000-0002-7108-6767	National Institute of Allergy and Infectious diseases [R01AI070812]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070812] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institute of Allergy and Infectious diseases, grant number R01AI070812. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2011, BMC GENOMICS, P12; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bonin CP, 2004, GENETICS, V167, P1801, DOI 10.1534/genetics.104.027557; Bonizzoni M, 2007, INSECT MOL BIOL, V16, P645, DOI 10.1111/j.1365-2583.2007.00756.x; Castaneda J, 2011, MUTAT RES-FUND MOL M, V714, P95, DOI 10.1016/j.mrfmmm.2011.05.002; Castillo DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-258; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; Esnault C, 2011, GENETICS, V187, P319, DOI 10.1534/genetics.110.122168; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fraser MJ, 2012, ANNU REV ENTOMOL, V57, P267, DOI 10.1146/annurev.ento.54.110807.090545; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Guimond N, 2003, MOL GENET GENOMICS, V268, P779, DOI 10.1007/s00438-002-0800-4; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Hikosaka A, 2007, MOL BIOL EVOL, V24, P2648, DOI 10.1093/molbev/msm191; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Kang Y, 2009, CELL BIOL INT, V33, P509, DOI 10.1016/j.cellbi.2009.01.017; LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; Lorenzen MD, 2007, INSECT MOL BIOL, V16, P265, DOI 10.1111/j.1365-2583.2007.00727.x; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Pagan HJT, 2010, GENOME BIOL EVOL, V2, P293, DOI 10.1093/gbe/evq021; Peleg J, 1968, AM J TROPICAL MED HY, V17, P219; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Sethuraman N, 2007, INSECT BIOCHEM MOLEC, V37, P941, DOI 10.1016/j.ibmb.2007.05.004; Sun ZC, 2008, INSECT MOL BIOL, V17, P9, DOI 10.1111/j.1365-2583.2008.00780.x; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wilson R, 2003, INSECT BIOCHEM MOLEC, V33, P853, DOI 10.1016/S0965-1748(03)00044-4; Wu M, 2008, INSECT SCI, V15, P521, DOI 10.1111/j.1744-7917.2008.00241.x; Zhao YG, 1998, INSECT BIOCHEM MOLEC, V28, P213, DOI 10.1016/S0965-1748(98)00020-4; Zimowska GJ, 2006, INSECT BIOCHEM MOLEC, V36, P421, DOI 10.1016/j.ibmb.2006.03.001	39	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68454	10.1371/journal.pone.0068454	http://dx.doi.org/10.1371/journal.pone.0068454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861905	Green Submitted, gold, Green Published			2022-12-25	WOS:000323350700086
J	Su, MY; Kuo, CI; Chang, CF; Chang, CI				Su, Ming-Yuan; Kuo, Chiao-I; Chang, Chi-Fon; Chang, Chung-I			Three-Dimensional Structure of Human NLRP10/PYNOD Pyrin Domain Reveals a Homotypic Interaction Site Distinct from Its Mouse Homologue	PLOS ONE			English	Article							NOD-LIKE RECEPTORS; NMR STRUCTURE; PROTEIN; DYNAMICS; ASC; INFLAMMASOME; FOLD; LCA	NLRPs (Nucleotide-binding domain, leucine-rich repeat and pyrin domain containing proteins) are a family of patternrecognition receptors (PRRs) that sense intracellular microbial components and endogenous stress signals. NLRP10 (also known as PYNOD) is a unique NLRP member characterized by a lack of the putative ligand-binding leucine-rich repeat domain. Recently, human NLRP10 has been shown to inhibit the self-association of ASC into aggregates and ASC-mediated procaspase-1 processing. However, such activities are not found in mouse NLRP10. Here we report the solution structure and dynamics of human NLRP10 pyrin domain (PYD), whose helix H3 and loop H2-H3 adopt a conformation distinct from those of mouse NLRP10. Docking studies show that human and mouse NLRP10 PYDs may interact differently with ASC PYD. These results provide a possible structural explanation for the contrasting effect of NLRP10 on ASC aggregation in human cells versus mouse models. Finally, we also provide evidence that in human NLRP10 the PYD domain may not interact with the NOD domain to regulate its intrinsic nucleotide hydrolysis activity.	[Su, Ming-Yuan; Kuo, Chiao-I; Chang, Chung-I] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Su, Ming-Yuan; Chang, Chung-I] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan; [Chang, Chi-Fon] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chang, CF (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	chifon@gate.sinica.edu.tw; chungi@gate.sinica.edu.tw		Chang, Chi-Fon/0000-0002-2961-0748; Chang, Chung-I/0000-0003-0989-1228; Su, Ming-Yuan/0000-0003-1581-0914	National Science Council of Taiwan [NSC99-2320-B-001-MY2, NSC 101-2811-M-001-164]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by the National Science Council of Taiwan (http://web1.nsc.gov.tw) under grant nos. NSC99-2320-B-001-MY2 and NSC 101-2811-M-001-164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Chang CI, 2007, CELL MOL LIFE SCI, V64, P1395, DOI 10.1007/s00018-007-6567-3; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; Eibl C, 2012, BIOCHEMISTRY-US, V51, P7330, DOI 10.1021/bi3007059; Eisenbarth SC, 2012, NATURE, V484, P510, DOI 10.1038/nature11012; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Pinheiro AS, 2011, J MOL BIOL, V413, P790, DOI 10.1016/j.jmb.2011.09.024; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Saito K, SOLUTION STRUC UNPUB; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Su MY, 2012, BIOMOLECULAR NMR ASS; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081	34	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67843	10.1371/journal.pone.0067843	http://dx.doi.org/10.1371/journal.pone.0067843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861819	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700047
J	Gysels, M; Evans, N; Menaca, A; Higginson, IJ; Harding, R; Pool, R				Gysels, Marjolein; Evans, Natalie; Menaca, Arantza; Higginson, Irene J.; Harding, Richard; Pool, Robert		Project PRISMA	Diversity in Defining End of Life Care: An Obstacle or the Way Forward?	PLOS ONE			English	Article							PALLIATIVE-CARE; DEFINITIONS; PERSPECTIVE; ADVANCE	Aim: The terms used to describe care at the end of life (EoL), and its definitions, have evolved over time and reflect the changes in meaning the concept has undergone as the field develops. We explore the remit of EoL care as defined by experts in EoL care, from across Europe and beyond, to understand its current usage and meanings. Method: A qualitative survey attached to a call for expertise on cultural issues in EoL care was sent to experts in the field identified through the literature, European EoL care associations, and conferences targeted at EoL care professionals. Respondents were asked to identify further contacts for snowball recruitment. The responses were analysed using content and discourse analysis. Results: Responses were received from 167 individuals (33% response rate), mainly from academics (39%) and clinical practitioners working in an academic context (23%) from 19 countries in Europe and beyond. 29% of respondents said explicitly that there was no agreed definition of EoL care in practice and only 14% offered a standard definition (WHO, or local institution). 2% said that the concept of EoL care was not used in their country, and 5% said that there was opposition to the concept for religious or cultural reasons. Two approaches were identified to arrive at an understanding of EoL care: exclusively by drawing boundaries through setting time frames, and inclusively by approaching its scope in an integrative way. This led to reflections about terminology and whether defining EoL care is desirable. Conclusion: The global expansion of EoL care contributes to the variety of interpretations of what it means. This complicates the endeavour of defining the field. However, when diversity is taken seriously it can open up new perspectives to underpin the ethical framework of EoL care.	[Gysels, Marjolein; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Gysels, Marjolein; Higginson, Irene J.; Harding, Richard] Kings Coll London, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Gysels, Marjolein; Menaca, Arantza; Pool, Robert] Univ Barcelona, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Evans, Natalie] Vrije Univ Amsterdam, Dept Publ & Occupat Hlth, Emgo Inst Hlth & Care Res, Expertise Ctr Palliat Care,Med Ctr, Amsterdam, Netherlands	University of Amsterdam; University of London; King's College London; ISGlobal; CRESIB; University of Barcelona; Vrije Universiteit Amsterdam	Gysels, M (corresponding author), Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands.	mhgysels@gmail.com	Evans, Natalie/M-1631-2013; Daveson, Barbara A/G-3122-2012; Murtagh, Fliss/C-3216-2009; Higginson, Irene Julie/C-7309-2012	Evans, Natalie/0000-0001-7124-9282; Deliens, Luc/0000-0002-8158-2422; Haugen, Dagny Faksvag/0000-0002-8592-4995; Koffman, Jonathan/0000-0001-8513-5681; Harding, Richard/0000-0001-9653-8689; Murtagh, Fliss/0000-0003-1289-3726; Higginson, Irene Julie/0000-0002-3687-1313; Daveson, Barbara/0000-0001-8039-8749	European Commission FP7 [Health-F2-2008-201655]	European Commission FP7(European CommissionEuropean Commission Joint Research Centre)	Funding provided by European Commission FP7(contract number: Health-F2-2008-201655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew EVW, 2013, PALLIATIVE MED, V27, P131, DOI 10.1177/0269216311429619; Bernheim JL, 2008, BRIT MED J, V336, P864, DOI 10.1136/bmj.39497.397257.AD; Boldt AM, 2006, J PALLIAT MED, V9, P1128, DOI 10.1089/jpm.2006.9.1128; Borry P, 2005, BIOETHICS, V19, P49, DOI 10.1111/j.1467-8519.2005.00424.x; Chapple A, 2006, INT J NURS STUD, V43, P1011, DOI 10.1016/j.ijnurstu.2005.11.007; Cherny NI, 2009, CANCER-AM CANCER SOC, V115, P1808, DOI 10.1002/cncr.24212; Clark D, 2000, PALLIATIVE MED, V14, P479, DOI 10.1191/026921600701536408; CLARK D, 1999, REFLECTIONS PALLIATI; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Department of Health, 2008, END LIF CAR STRAT AD; Evans N, 2012, J PALLIAT MED, V15, P812, DOI 10.1089/jpm.2011.0526; Evans N, 2012, PATIENT EDUC COUNS, V87, P277, DOI 10.1016/j.pec.2011.10.004; Evans N, 2012, J PAIN SYMPTOM MANAG, V43, P261, DOI 10.1016/j.jpainsymman.2011.04.012; Evans N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-141; Fadul N, 2009, CANCER-AM CANCER SOC, V115, P2013, DOI 10.1002/cncr.24206; Gott M, 2012, PALLIATIVE MED, V26, P232, DOI 10.1177/0269216311408993; Griffiths J., 1998, EUTHANASIA LAW NETHE; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; HAMILTON J, 1995, CAN MED ASSOC J, V153, P334; Harding R, 2010, EUR J CANCER, V46, P1493, DOI 10.1016/j.ejca.2010.01.035; Hermsen MA, 2001, PALLIATIVE MED, V15, P425, DOI 10.1191/026921601680419483; Hui D, 2012, J PAIN SYMPTOM MANAG, V43, P582, DOI 10.1016/j.jpainsymman.2011.04.016; Kleinman A, 2009, LANCET, V373, P292, DOI 10.1016/S0140-6736(09)60087-8; Larkin PJ, 2008, NURS ETHICS, V15, P234, DOI 10.1177/0969733007086021; Lorenz K, 2004, END OF LIFE CARE OUT; Lynn J, 2003, LIVING WELL END LIFE; Menaca A, 2011, CRITICAL REV ONCOLOG, DOI [10.1177/0269216311429619, DOI 10.1177/0269216311429619]; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Pastrana T, 2008, PALLIATIVE MED, V22, P222, DOI 10.1177/0269216308089803; Putnam RD, 1998, HOUS POLICY DEBATE, V9, pV; Saunders, 1964, NEED I CARE PATIENT, P1; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; St John of God Health Care, 2019, OUR VIS; The A-M, 2010, VERLOSSERS NAAST GOD; Walshe C, 2011, DIET AND NUTRITION IN PALLIATIVE CARE, P17; World Health Organisation, WHO DEF PALL CAR	37	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68002	10.1371/journal.pone.0068002	http://dx.doi.org/10.1371/journal.pone.0068002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844145	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000124
J	King, AJ; Arnone, MR; Bleam, MR; Moss, KG; Yang, JS; Fedorowicz, KE; Smitheman, KN; Erhardt, JA; Hughes-Earle, A; Kane-Carson, LS; Sinnamon, RH; Qi, HW; Rheault, TR; Uehling, DE; Laquerre, SG				King, Alastair J.; Arnone, Marc R.; Bleam, Maureen R.; Moss, Katherine G.; Yang, Jingsong; Fedorowicz, Kelly E.; Smitheman, Kimberly N.; Erhardt, Joseph A.; Hughes-Earle, Angela; Kane-Carson, Laurie S.; Sinnamon, Robert H.; Qi, Hongwei; Rheault, Tara R.; Uehling, David E.; Laquerre, Sylvie G.			Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; B-RAF; SELECTIVE INHIBITOR; KINASE; MELANOMA; RESISTANCE; MUTATIONS; PATHWAY; SORAFENIB; DISCOVERY	Mitogen-Activated Protein Kinase (MAPK) pathway activation has been implicated in many types of human cancer. BRAF mutations that constitutively activate MAPK signalling and bypass the need for upstream stimuli occur with high prevalence in melanoma, colorectal carcinoma, ovarian cancer, papillary thyroid carcinoma, and cholangiocarcinoma. In this report we characterize the novel, potent, and selective BRAF inhibitor, dabrafenib (GSK2118436). Cellular inhibition of BRAF(V600E) kinase activity by dabrafenib resulted in decreased MEK and ERK phosphorylation and inhibition of cell proliferation through an initial G(1) cell cycle arrest, followed by cell death. In a BRAF(V600E)-containing xenograft model of human melanoma, orally administered dabrafenib inhibited ERK activation, downregulated Ki67, and upregulated p27, leading to tumor growth inhibition. However, as reported for other BRAF inhibitors, dabrafenib also induced MAPK pathway activation in wild-type BRAF cells through CRAF (RAF1) signalling, potentially explaining the squamous cell carcinomas and keratoacanthomas arising in patients treated with BRAF inhibitors. In addressing this issue, we showed that concomitant administration of BRAF and MEK inhibitors abrogated paradoxical BRAF inhibitor-induced MAPK signalling in cells, reduced the occurrence of skin lesions in rats, and enhanced the inhibition of human tumor xenograft growth in mouse models. Taken together, our findings offer preclinical proof of concept for dabrafenib as a specific and highly efficacious BRAF inhibitor and provide evidence for its potential clinical benefits when used in combination with a MEK inhibitor.	[King, Alastair J.; Arnone, Marc R.; Bleam, Maureen R.; Moss, Katherine G.; Smitheman, Kimberly N.; Laquerre, Sylvie G.] GlaxoSmithKline Dept Oncol Biol, Collegeville, PA USA; [Yang, Jingsong; Fedorowicz, Kelly E.] GlaxoSmithKline Dept Enzymol & Mechanist Pharmaco, Collegeville, PA USA; [Erhardt, Joseph A.] GlaxoSmithKline Portfolio Management, Collegeville, PA USA; [Hughes-Earle, Angela] GlaxoSmithKline Dept Safety Assessment, King Of Prussia, PA USA; [Kane-Carson, Laurie S.] GlaxoSmithKline, GlaxoSmithKline Dept Screening & Compound Profili, Durham, NC USA; [Sinnamon, Robert H.; Qi, Hongwei] GlaxoSmithKline Dept Biol Reagents & Assay Dev, King Of Prussia, PA USA; [Rheault, Tara R.; Uehling, David E.] GlaxoSmithKline, GlaxoSmithKline Dept Med Chem, Durham, NC USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Laquerre, SG (corresponding author), GlaxoSmithKline Dept Oncol Biol, Collegeville, PA USA.	sylvie.g.laquerre@gsk.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnault JP, 2009, J CLIN ONCOL, V27, pE59, DOI 10.1200/JCO.2009.23.4823; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Carnahan J, 2010, MOL CANCER THER, V9, P2399, DOI 10.1158/1535-7163.MCT-10-0181; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cichowski K, 2010, NATURE, V464, P358, DOI 10.1038/464358a; Corcoran RB, 2011, ONCOTARGET, V2, P336; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dubauskas Z, 2009, CLIN GENITOURIN CANC, V7, P20, DOI 10.3816/CGC.2009.n.003; Eggermont AMM, 2011, EUR J CANCER, V47, P2150, DOI 10.1016/j.ejca.2011.06.052; FLAHERTY K, 2009, J CLIN ONCOL S, V27, pNIL18; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Hong DS, 2008, ARCH DERMATOL, V144, P779, DOI 10.1001/archderm.144.6.779; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kefford R., 2010, J CLIN ONCOL S, V28; Kefford R, 2010, PIGM CELL MELANOMA R, V23, P874; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kong HH, 2008, ARCH DERMATOL, V144, P820, DOI 10.1001/archderm.144.6.820; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ralph JM, 2011, 242 ACS NAT M; Rheault TR, 2013, ACS MED CHEM LETT, V4, P358, DOI 10.1021/ml4000063; Rominger CM, 2007, ARCH BIOCHEM BIOPHYS, V464, P130, DOI 10.1016/j.abb.2007.04.004; Sharfman WH, 2011, J CLIN ONCOL S, V29; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	46	116	129	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67583	10.1371/journal.pone.0067583	http://dx.doi.org/10.1371/journal.pone.0067583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844038	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000084
J	Lai, HS; Lin, WH; Lai, SL; Lin, HY; Hsu, WM; Chou, CH; Lee, PH				Lai, Hong-Shiee; Lin, Wen-Hsi; Lai, Shuo-Lun; Lin, Hao-Yu; Hsu, Wen-Ming; Chou, Chia-Hung; Lee, Po-Huang			Interleukin-6 Mediates Angiotensinogen Gene Expression during Liver Regeneration	PLOS ONE			English	Article							PARTIAL-HEPATECTOMY; ANGIOGENESIS; APOPTOSIS; PROLIFERATION; HEPATOCYTES; ACTIVATION; SYSTEM; CELLS	Background: Angiotensinogen is the precursor of angiotensin II, which is associated with ischemia-reperfusion injury. Angiotensin II reduces liver regeneration after hepatectomy and causes dysfunction and failure of reduced-size liver transplants. However, the regulation of angiotensinogen during liver regeneration is still unclear. Aims: To investigate the regulation of angiotensinogen during liver regeneration for preventing angiotensin II-related ischemia-reperfusion injury during liver regeneration. Methods: A mouse in vitro partial hepatectomy animal model was used to evaluate the expression of interleukin-6 (IL-6) and angiotensinogen during liver regeneration. Serum IL-6 and angiotensinogen were detected by enzyme immunoassay (EIA). Angiotensinogen mRNA was detected by RT-PCR. Tissue levels of angiotensinogen protein were detected by Western blot analysis. Primary cultures of mouse hepatocytes were used to investigate IL-6-induced angiotensinogen. Chemical inhibitors were used to perturb signal transduction pathways. Synthetic double-stranded oligodeoxynucleotides (ODNs) were used as 'decoy' cis-elements to investigate transcription. Ki 67 staining and quantification were used to verify liver regeneration. Results: In the in vivo model, the levels of serum IL-6 and angiotensinogen correlated. In the in vitro model, IL-6 transcriptionally regulated angiotensinogen expression. Additionally, IL-6 mediated angiotensinogen expression through the Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) and JAK/p38 signaling. Decoy ODN analyses revealed that STAT3 and nuclear factor-kB (NF-kB) also played critical roles in the transcriptional regulation of angiotensinogen by IL-6. IL-6-mediated signaling, JAK2, STAT3 and p38 inhibitors reduced angiotensinogen expression in the partially hepatectomized mice. Conclusion: During liver regeneration, IL-6-enhanced angiotensinogen expression is dependent on the JAK/STAT3 and JAK/p38/NF-kB signaling pathways. Interruption of the molecular mechanisms of angiotensinogen regulation may be applied as the basis of therapeutic strategies for preventing angiotensin II-related ischemia-reperfusion injury during liver regeneration.	[Lai, Hong-Shiee] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lai, HS (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	hslai@ntu.edu.tw		Lai, Shuo-Lun/0000-0002-2480-4252; LIN, HAO-YU/0000-0001-5611-7003; HSU, WEN-MING/0000-0002-5145-9538; Lai, Hong-Shiee/0000-0002-7958-2183; LEE, PO-HUANG/0000-0001-5831-035X	Taiwan National Science Council [NSC 96-2314-B-002-079-MY3, NSC 100-2314-B-002-019-MY3]; National Taiwan University Hospital [NTUH 97-S883, NTUH 100-S1491]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by Taiwan National Science Council grants NSC 96-2314-B-002-079-MY3 and NSC 100-2314-B-002-019-MY3, and National Taiwan University Hospital grants NTUH 97-S883 and NTUH 100-S1491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; Brand M, 2007, J MOL MED-JMM, V85, P451, DOI 10.1007/s00109-006-0141-6; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Drixler TA, 2003, BRIT J SURG, V90, P1384, DOI 10.1002/bjs.4275; Drixler TA, 2002, ANN SURG, V236, P703, DOI 10.1097/00000658-200212000-00002; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; FUKAMIZU A, 1990, J BIOL CHEM, V265, P7576; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Gewiese-Rabsch J, 2010, BBA-MOL BASIS DIS, V1802, P1054, DOI 10.1016/j.bbadis.2010.07.023; Gilgenkrantz H, 2011, CLIN RES HEPATOL GAS, V35, P623, DOI 10.1016/j.clinre.2011.04.002; Greene AK, 2003, ANN SURG, V237, P530, DOI 10.1097/00000658-200304000-00015; Guo LP, 2004, HEPATOLOGY, V40, P583, DOI 10.1002/hep.20369; Higgins GM, 1931, ARCH PATHOL, V12, P186; Kawasaki T, 2010, J HEPATOL, V53, P648, DOI 10.1016/j.jhep.2010.04.021; KUMA S, 1990, IMMUNOBIOLOGY, V180, P235, DOI 10.1016/S0171-2985(11)80331-1; Lai HS, 2009, AM SURGEON, V75, P49; Lai HS, 2005, SURG TODAY, V35, P396, DOI 10.1007/s00595-004-2962-7; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lee DL, 2006, AM J PHYSIOL-HEART C, V290, pH935, DOI 10.1152/ajpheart.00708.2005; Liu F, 2008, J AM SOC NEPHROL, V19, P269, DOI 10.1681/ASN.2007010074; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; Miura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037974; Padrissa-Altes S, 2009, LIVER TRANSPLANT, V15, P313, DOI 10.1002/lt.21693; Peng JF, 2002, REGUL PEPTIDES, V110, P25, DOI 10.1016/S0167-0115(02)00156-8; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Shanmukhappa K, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-40; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Sookoian S, 2005, AM J GASTROENTEROL, V100, P636, DOI 10.1111/j.1572-0241.2005.41168.x; Sun ZJ, 2003, HYPERTENSION, V41, P322, DOI 10.1161/01.HYP.0000050964.96018.FA; Togo S, 2004, J HEPATOL, V40, P464, DOI 10.1016/j.jhep.2003.11.005; Wang RQ, 2000, J CELL PHYSIOL, V185, P253; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu CS, 2009, SCAND J GASTROENTERO, V44, P462, DOI 10.1080/00365520802495560	36	24	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67868	10.1371/journal.pone.0067868	http://dx.doi.org/10.1371/journal.pone.0067868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844114	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000109
J	Van Kaer, L; Rabacal, WAS; Algood, HMS; Parekh, VV; Olivares-Villagomez, D				Van Kaer, Luc; Rabacal, Whitney A. S.; Algood, Holly M. Scott; Parekh, Vrajesh V.; Olivares-Villagomez, Danyvid			In Vitro Induction of Regulatory CD4(+)CD8 alpha(+) T Cells by TGF-beta, IL-7 and IFN-gamma	PLOS ONE			English	Article							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; INFLAMMATORY-BOWEL-DISEASE; THYMUS LEUKEMIA ANTIGEN; EPITHELIAL-CELLS; LAMINA PROPRIA; MOUSE MODEL; CD8; MICE; EXPRESSION; PROLIFERATION	In vitro CD4(+) T cell differentiation systems have made important contributions to understanding the mechanisms underlying the differentiation of naive CD4(+) T cells into effector cells with distinct biological functions. Mature CD4(+) T cells expressing CD8 alpha alpha homodimers are primarily found in the intestinal mucosa of men and mice, and to a lesser extent in other tissues such as peripheral blood. Although CD4(+)CD8 alpha(+) T cells are easily identified, very little is known about their development and immunological functions. It has been reported, however, that CD4(+)CD8 alpha(+) T cells possess regulatory properties. In this report, we present a novel in vitro differentiation system where CD4(+) T cells are stimulated to become CD4(+)CD8 alpha(+) T cells in the presence of TGF-beta, IL-7 and IFN-gamma, resulting in cells with very similar features as CD4(+)CD8 alpha(+) intraepithelial lymphocytes. This novel in vitro differentiation culture should provide a powerful and tractable tool for dissecting the differentiation and biological functions of CD4(+)CD8 alpha(+) T cells.	[Van Kaer, Luc; Rabacal, Whitney A. S.; Algood, Holly M. Scott; Parekh, Vrajesh V.; Olivares-Villagomez, Danyvid] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Algood, Holly M. Scott] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Algood, Holly M. Scott] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Van Kaer, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	luc.van.kaer@vanderbilt.edu; danyvid.olivares-villagomez@vanderbilt.edu	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309	Digestive Disease Research Center (DDRC) at Vanderbilt University School of Medicine; National Institutes of Health (NIH) [P30DK058404, AI072471, AI070305, HL089667, DK081536]; Office of Medical Research, Department of Veterans Affairs; National Multiple Sclerosis Society of America; NATIONAL CANCER INSTITUTE [P01CA116087] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK081536] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000915] Funding Source: NIH RePORTER	Digestive Disease Research Center (DDRC) at Vanderbilt University School of Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); National Multiple Sclerosis Society of America(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by a pilot grant from the Digestive Disease Research Center (DDRC) at Vanderbilt University School of Medicine, funded by National Institutes of Health (NIH) grant P30DK058404 (DOV), NIH grants AI072471, AI070305, HL089667, DK081536 (LVK), Merit Review Grants from the Office of Medical Research, Department of Veterans Affairs (HMSA), and a postdoctoral fellowship from the National Multiple Sclerosis Society of America (VVP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 1998, EUR J GASTROEN HEPAT, V10, P325, DOI 10.1097/00042737-199804000-00009; Aranda R, 1997, J IMMUNOL, V158, P3464; Bernardo SR, 2013, NATURE IMMUNOLOGY, V14, P271; Carton J, 2004, EUR J GASTROEN HEPAT, V16, P961, DOI 10.1097/00042737-200410000-00003; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; DEMARIA A, 1987, EUR J IMMUNOL, V17, P1815, DOI 10.1002/eji.1830171221; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Desfrancois J, 2009, INT J CANCER, V125, P374, DOI 10.1002/ijc.24366; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FUJIHASHI K, 1993, J IMMUNOL, V151, P6681; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Hassan H, 2011, P NATL ACAD SCI USA, V108, P18330, DOI 10.1073/pnas.1105835108; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Montufar-Solis D, 2007, IMMUNOL REV, V215, P189, DOI 10.1111/j.1600-065X.2006.00471.x; MORRISSEY PJ, 1995, J IMMUNOL, V154, P2678; MOSLEY RL, 1990, INT IMMUNOL, V2, P361, DOI 10.1093/intimm/2.4.361; Olivares-Villagomez D, 2011, J IMMUNOL, V187, P4051, DOI 10.4049/jimmunol.1101052; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; Ostanin DV, 2010, INT IMMUNOL, V22, P927, DOI 10.1093/intimm/dxq447; OTTENHOFF THM, 1986, NATURE, V322, P462, DOI 10.1038/322462a0; PALIARD X, 1988, NATURE, V335, P642, DOI 10.1038/335642a0; SENJU M, 1991, GUT, V32, P918, DOI 10.1136/gut.32.8.918; Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Urry Z, 2012, EUR J IMMUNOL, V42, P2697, DOI 10.1002/eji.201242370; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Yang H, 2008, AM J PHYSIOL-GASTR L, V294, pG1421, DOI 10.1152/ajpgi.00060.2008; Yang H, 2007, AM J PHYSIOL-GASTR L, V292, pG84, DOI 10.1152/ajpgi.00192.2006; Yu SH, 2008, P NATL ACAD SCI USA, V105, P20834, DOI 10.1073/pnas.0808700106; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	38	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67821	10.1371/journal.pone.0067821	http://dx.doi.org/10.1371/journal.pone.0067821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844100	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000104
J	Derecka, K; Blythe, MJ; Malla, S; Genereux, DP; Guffanti, A; Pavan, P; Moles, A; Snart, C; Ryder, T; Ortori, CA; Barrett, DA; Schuster, E; Stoger, R				Derecka, Kamila; Blythe, Martin J.; Malla, Sunir; Genereux, Diane P.; Guffanti, Alessandro; Pavan, Paolo; Moles, Anna; Snart, Charles; Ryder, Thomas; Ortori, Catharine A.; Barrett, David A.; Schuster, Eugene; Stoeger, Reinhard			Transient Exposure to Low Levels of Insecticide Affects Metabolic Networks of Honeybee Larvae	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; NUTRITIONAL CONTROL; DROSOPHILA; HSP90; GROWTH; MYC; DETOXIFICATION; ENZYMES; INSULIN	The survival of a species depends on its capacity to adjust to changing environmental conditions, and new stressors. Such new, anthropogenic stressors include the neonicotinoid class of crop-protecting agents, which have been implicated in the population declines of pollinating insects, including honeybees (Apis mellifera). The low-dose effects of these compounds on larval development and physiological responses have remained largely unknown. Over a period of 15 days, we provided syrup tainted with low levels (2 mu g/L-1) of the neonicotinoid insecticide imidacloprid to beehives located in the field. We measured transcript levels by RNA sequencing and established lipid profiles using liquid chromatography coupled with mass spectrometry from worker-bee larvae of imidacloprid-exposed (IE) and unexposed, control (C) hives. Within a catalogue of 300 differentially expressed transcripts in larvae from IE hives, we detect significant enrichment of genes functioning in lipid-carbohydrate-mitochondrial metabolic networks. Myc-involved transcriptional response to exposure of this neonicotinoid is indicated by overrepresentation of E-box elements in the promoter regions of genes with altered expression. RNA levels for a cluster of genes encoding detoxifying P450 enzymes are elevated, with coordinated downregulation of genes in glycolytic and sugar-metabolising pathways. Expression of the environmentally responsive Hsp90 gene is also reduced, suggesting diminished buffering and stability of the developmental program. The multifaceted, physiological response described here may be of importance to our general understanding of pollinator health. Muscles, for instance, work at high glycolytic rates and flight performance could be impacted should low levels of this evolutionarily novel stressor likewise induce downregulation of energy metabolising genes in adult pollinators.	[Derecka, Kamila; Snart, Charles; Stoeger, Reinhard] Univ Nottingham, Sch Biosci, Nottingham, Leics, England; [Blythe, Martin J.; Malla, Sunir] Univ Nottingham, Ctr Genet & Genom, Deep Seq, Nottingham NG7 2RD, England; [Genereux, Diane P.] Westfield State Univ, Dept Biol, Westfield, MA USA; [Guffanti, Alessandro; Pavan, Paolo; Moles, Anna] Genomnia Srl, Milan, Italy; [Ryder, Thomas] Pk Apiaries, Nottingham, England; [Ortori, Catharine A.; Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England; [Schuster, Eugene] UCL, Dept Genet Evolut & Environm, Inst Hlth Ageing, London, England	University of Nottingham; University of Nottingham; Massachusetts System of Public Higher Education; Westfield State University; University of Nottingham; University of London; University College London	Stoger, R (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Nottingham, Leics, England.	reinhard.stoger@nottingham.ac.uk	Serrano, Jose/A-2854-2009; Barrett, David A/C-9922-2011	Serrano, Jose/0000-0002-1565-5216; Barrett, David A/0000-0001-6900-9474; Genereux, Diane/0000-0001-5770-0989; Moles, Anna/0000-0002-5805-5763; Stoger, Reinhard/0000-0002-2301-0805; Snart, Charles/0000-0003-3164-3271; Schuster, Eugene/0000-0001-5076-2810	Co-operative Group, UK	Co-operative Group, UK	This project was supported by The Co-operative Group, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo S. A., 2012, HORM BEHAV; Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonferroni C., 1936, PUBBL R 1 SUPER SCI, V8, P3; Bujold M, 2010, MOL CELL BIOL, V30, P793, DOI 10.1128/MCB.01327-09; Chen B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-25; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Eanes WF, 2006, P NATL ACAD SCI USA, V103, P19413, DOI 10.1073/pnas.0607095104; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frei C, 2005, EMBO J, V24, P623, DOI 10.1038/sj.emboj.7600523; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Henry M, 2012, SCIENCE, V337, DOI 10.1126/science.1224930; Hilgers V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000396; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kunieda T, 2006, INSECT MOL BIOL, V15, P563, DOI 10.1111/j.1365-2583.2006.00677.x; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-7; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Matsuda K, 2009, MOL PHARMACOL, V76, P1, DOI 10.1124/mol.109.055186; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Shah S, 2012, PEST MANAG SCI, V68, P38, DOI 10.1002/ps.2218; Shomron N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000397; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Staples JF, 1997, J EXP BIOL, V200, P1247; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Team RDC, R LANG ENV STAT COMP; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Vansant G, 2006, INT J TOXICOL, V25, P85, DOI 10.1080/10915810600605690; Varghese J, 2010, GENE DEV, V24, P2748, DOI 10.1101/gad.1995910; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002779; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitehorn PR, 2012, SCIENCE; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	72	85	88	5	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68191	10.1371/journal.pone.0068191	http://dx.doi.org/10.1371/journal.pone.0068191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844170	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000143
J	Kantor, ED; Lampe, JW; Kratz, M; White, E				Kantor, Elizabeth D.; Lampe, Johanna W.; Kratz, Mario; White, Emily			Lifestyle Factors and Inflammation: Associations by Body Mass Index	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CANCER-RISK; PHYSICAL-ACTIVITY; FATTY-ACIDS; ALCOHOL INTAKE; DIETARY FIBER; MARKERS; OBESITY; INTERLEUKIN-6; SEX	Chronic inflammation, which is associated with obesity, may play a role in the etiology of several diseases. Thus, reducing inflammation may offer a disease-prevention strategy, particularly among the obese. Several modifiable factors have been associated with inflammation, including: dietary fiber intake, saturated fat intake, physical activity, smoking, alcohol, and use of certain supplements and medications (glucosamine, chondroitin, fish oil, vitamin E, statins and aspirin). To study whether these associations differ by body mass index (BMI), we used data on 9,895 adults included in the 1999-2004 cycles of the National Health and Nutrition Examination Survey (NHANES). Survey-weighted linear regression was used to evaluate the associations between modifiable factors and serum high-sensitivity C-reactive protein (hsCRP) concentrations across the following groups: underweight/normal weight (BMI<25 kg/m(2)), overweight (25-<30 kg/m(2)) and obese (30+ kg/m(2)). While several factors were significantly associated with decreased hsCRP among the normal weight or overweight groups (increased fiber intake, lower saturated fat intake, physical activity, not smoking, and use of chondroitin, fish oil and statins), only increasing dietary fiber intake and moderate alcohol consumption were associated with reduced hsCRP among the obese. Effect modification by BMI was statistically significant for the saturated fat-hsCRP and smoking-hsCRP associations. These results suggest that posited anti-inflammatory drugs and behaviors may be less strongly associated with inflammation among the obese than among lower weight persons.	[Kantor, Elizabeth D.; Lampe, Johanna W.; Kratz, Mario; White, Emily] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Kantor, Elizabeth D.; Lampe, Johanna W.; Kratz, Mario; White, Emily] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Kantor, ED (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	ekantor@fhcrc.org		Kantor, Elizabeth/0000-0002-9124-5323	National Cancer Institute (NCI) [K05CA154337]; Office of Dietary Supplements from NCI [R01CA142545, R25CA094880]; NATIONAL CANCER INSTITUTE [K05CA154337, R25CA094880, R01CA142545] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Dietary Supplements from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant K05CA154337 from the National Cancer Institute (NCI) and Office of Dietary Supplements and grants R01CA142545 and R25CA094880 from NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani UA, 2004, J NUTR, V134, P1181, DOI 10.1093/jn/134.5.1181; [Anonymous], 2013, FOOD LAB GUID GUID I; Arikawa AY, 2011, MED SCI SPORT EXER, V43, P1002, DOI 10.1249/MSS.0b013e3182059eda; Arya S, 2006, NUTRITION, V22, P865, DOI 10.1016/j.nut.2006.05.002; Cai QY, 2006, J CLIN ONCOL, V24, P5010, DOI 10.1200/JCO.2006.06.4931; Campbell PT, 2009, MED SCI SPORT EXER, V41, P1533, DOI 10.1249/MSS.0b013e31819c7feb; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chan DC, 2002, CLIN CHEM, V48, P877; Chaturvedi AK, 2013, AM J EPIDEMIOL, V177, P14, DOI 10.1093/aje/kws357; Devaraj S, 2007, AM J CLIN NUTR, V86, P1392; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Gao XR, 2009, J PHARM PHARMACOL, V61, P1505, DOI 10.1211/jpp/61.11.0010; Goris AHC, 2001, BRIT J NUTR, V85, P629, DOI 10.1079/BJN2001322; Grammer TB, 2011, ATHEROSCLEROSIS, V215, P487, DOI 10.1016/j.atherosclerosis.2011.01.005; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; HEITMANN BL, 1995, BRIT MED J, V311, P986; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Hullar MAJ, NESTLE NUTR WORKSHOP, V73, P67; Kantor ED, 2012, AM J EPIDEMIOL, V176, P1002, DOI 10.1093/aje/kws186; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Klein-Platat C, 2005, AM J CLIN NUTR, V82, P1178, DOI 10.1093/ajcn/82.6.1178; Lam YY, 2011, OBESITY, V19, P2113, DOI 10.1038/oby.2011.68; Lovu M, 2008, OSTEOARTHR CARTILAGE, V16, pS14, DOI 10.1016/j.joca.2008.06.008; Makhoul Z, 2011, EUR J CLIN NUTR, V65, P808, DOI 10.1038/ejcn.2011.39; Mariadason JM, 1999, GUT, V44, P394, DOI 10.1136/gut.44.3.394; McCarty MF, 1999, MED HYPOTHESES, V52, P465, DOI 10.1054/mehy.1997.0684; Micallef MA, 2009, EUR J CLIN NUTR, V63, P1154, DOI 10.1038/ejcn.2009.20; Milani RV, 2004, J AM COLL CARDIOL, V43, P1056, DOI 10.1016/j.jacc.2003.10.041; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; MOSHAGE HJ, 1988, BIOCHEM BIOPH RES CO, V155, P112, DOI 10.1016/S0006-291X(88)81056-8; Nakamura H, 2002, J RHEUMATISM JOINT S, V21, P175; National Center for Health Statistics, 2006, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2005, NHANES 2003 2004 PUB; Neilson HK, 2008, AM J CLIN NUTR, V87, P279, DOI 10.1093/ajcn/87.2.279; Nicholls SJ, 2006, AM J CARDIOL, V97, P1553, DOI 10.1016/j.amjcard.2005.12.042; Oliveira A, 2009, EUR J CLIN NUTR, V63, P1345, DOI 10.1038/ejcn.2009.61; Oliveira A, 2010, ALCOHOL ALCOHOLISM, V45, P119, DOI 10.1093/alcalc/agp092; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Plenge JK, 2002, CIRCULATION, V106, P1447, DOI 10.1161/01.CIR.0000029743.68247.31; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Touvier M, 2013, AM J EPIDEMIOL, V177, P3, DOI 10.1093/aje/kws359; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Volpato S, 2004, CIRCULATION, V109, P607, DOI 10.1161/01.CIR.0000109503.13955.00; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Wener MH, 2000, J RHEUMATOL, V27, P2351; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zelvyte I, 2002, PHARMACOL RES, V45, P147, DOI 10.1006/phrs.2001.0922	55	47	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67833	10.1371/journal.pone.0067833	http://dx.doi.org/10.1371/journal.pone.0067833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844105	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000106
J	Shadrach, KG; Rayborn, ME; Hollyfield, JG; Bonilha, VL				Shadrach, Karen G.; Rayborn, Mary E.; Hollyfield, Joe G.; Bonilha, Vera L.			DJ-1-Dependent Regulation of Oxidative Stress in the Retinal Pigment Epithelium (RPE)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DAMAGE; PARKINSONISM PROTEIN DJ-1; MACULAR DEGENERATION AMD; EARLY-ONSET PARKINSONISM; AGE-RELATED MACULOPATHY; CYSTEINE-SULFINIC ACID; CELL-DEATH; ALPHA-SYNUCLEIN; ANTIOXIDATIVE STRESS; CEREBROSPINAL-FLUID	Background: DJ-1 is found in many tissues, including the brain, where it has been extensively studied due to its association with Parkinson's disease. DJ-1 functions as a redox-sensitive molecular chaperone and transcription regulator that robustly protects cells from oxidative stress. Methodology: Retinal pigment epithelial (RPE) cultures were treated with H2O2 for various times followed by biochemical and immunohistological analysis. Cells were transfected with adenoviruses carrying the full-length human DJ-1 cDNA and a mutant construct, which has the cysteine residues at amino acid 46, 53 and 106 mutated to serine (C to S) prior to stress experiments. DJ-1 localization, levels of expression and reactive oxygen species (ROS) generation were also analyzed in cells expressing exogenous DJ-1 under baseline and oxidative stress conditions. The presence of DJ-1 and oxidized DJ-1 was evaluated in human RPE total lysates. The distribution of DJ-1 was assessed in AMD and non-AMD cryosectionss and in isolated human Bruch's membrane (BM)/choroid from AMD eyes. Principal Findings: DJ-1 in RPE cells under baseline conditions, displays a diffuse cytoplasmic and nuclear staining. After oxidative challenge, more DJ-1 was associated with mitochondria. Increasing concentrations of H2O2 resulted in a dose-dependent increase in DJ-1. Overexpression of DJ-1 but not the C to S mutant prior to exposure to oxidative stress led to significant decrease in the generation of ROS. DJ-1 and oxDJ-1 intensity of immunoreactivity was significantly higher in the RPE lysates from AMD eyes. More DJ-1 was localized to RPE cells from AMD donors with geographic atrophy and DJ-1 was also present in isolated human BM/choroid from AMD eyes. Conclusions/Significance: DJ-1 regulates RPE responses to oxidative stress. Most importantly, increased DJ-1 expression prior to oxidative stress leads to decreased generation of ROS, which will be relevant for future studies of AMD since oxidative stress is a known factor affecting this disease.	[Shadrach, Karen G.; Rayborn, Mary E.; Hollyfield, Joe G.; Bonilha, Vera L.] Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation	Bonilha, VL (corresponding author), Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA.	bonilhav@ccf.org	Bonilha, Vera/AAS-8566-2020	Bonilha, Vera/0000-0002-6166-5124	NIH [EY014240]; The Foundation Fighting Blindness and Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY014240, R56EY014240] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Foundation Fighting Blindness and Research to Prevent Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH grants EY014240, Research Center Grants from The Foundation Fighting Blindness and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MA, 2012, J CANCER, V3, P390, DOI 10.7150/jca.4280; Akazawa YO, 2010, NEUROSCI LETT, V483, P201, DOI 10.1016/j.neulet.2010.08.007; Anderson DH, 2001, AM J OPHTHALMOL, V131, P767, DOI 10.1016/S0002-9394(00)00961-2; Bando H, 2007, EXP EYE RES, V84, P135, DOI 10.1016/j.exer.2006.09.008; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bitar MS, 2012, INVEST OPHTH VIS SCI, V53, P5806, DOI 10.1167/iovs.12-10119; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Blasiak J, 2013, INT J MOL SCI, V14, P2996, DOI 10.3390/ijms14022996; BOK D, 1993, J CELL SCI, P189; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bonilha VL, 2013, EXP EYE RES, V111, P71, DOI 10.1016/j.exer.2013.03.017; Bonilha VL, 1999, J CELL BIOL, V147, P1533, DOI 10.1083/jcb.147.7.1533; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cao GF, 2011, BIOCHEM BIOPH RES CO, V414, P499, DOI 10.1016/j.bbrc.2011.09.094; Chan CM, 2008, MOL VIS, V14, P2528; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Chen Y, 2012, J CANCER RES CLIN, V138, P1463, DOI 10.1007/s00432-012-1205-3; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Chong EWT, 2007, BMJ-BRIT MED J, V335, P755, DOI 10.1136/bmj.39350.500428.47; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Drobek-Slowik Monika, 2007, Postepy Hig Med Dosw (Online), V61, P28; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Gao X, 2011, DRUG TODAY, V47, P215, DOI 10.1358/dot.2011.47.3.1519657; George S, 2010, J MOL NEUROSCI, V42, P243, DOI 10.1007/s12031-010-9378-1; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Gonzalez-Polo RA, 2009, J NEUROCHEM, V109, P889, DOI 10.1111/j.1471-4159.2009.06020.x; Gu XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038673; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Huang XS, 2013, CELL BIOCH FUNCT; Hulleman JD, 2007, BIOCHEMISTRY-US, V46, P5776, DOI 10.1021/bi7001778; Inberg A, 2010, J BIOL CHEM, V285, P25686, DOI 10.1074/jbc.M110.109751; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Jeong HJ, 2012, EXP MOL MED, V44, P586, DOI 10.3858/emm.2012.44.10.067; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kenney MC, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-4; Kenney MC, 2010, INVEST OPHTH VIS SCI, V51, P4289, DOI 10.1167/iovs.09-4778; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim SJ, 2012, BIOCHEM BIOPH RES CO, V422, P8, DOI 10.1016/j.bbrc.2012.04.063; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kitamura Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-48; Knobbe CB, 2011, J PROTEOME RES, V10, P4388, DOI 10.1021/pr200225c; Larsen NJ, 2011, NEUROSCIENCE, V196, P251, DOI 10.1016/j.neuroscience.2011.08.016; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Lin JS, 2012, BIOCHEMISTRY-US, V51, P3799, DOI 10.1021/bi3003296; Lisitskaya K. V., 2011, Biomeditsinskaya Khimiya, V57, P392; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; MICELI MV, 1994, EXP CELL RES, V214, P242, DOI 10.1006/excr.1994.1254; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030874; Mullett SJ, 2011, J NEUROCHEM, V117, P375, DOI 10.1111/j.1471-4159.2011.07175.x; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Oda M, 2012, CANCER SCI, V103, P1172, DOI 10.1111/j.1349-7006.2012.02267.x; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Ooe H, 2006, NEUROSCI LETT, V404, P166, DOI 10.1016/j.neulet.2006.05.031; Ottolini D, 2013, HUM MOL GENET; Pardo M, 2006, INT J CANCER, V119, P1014, DOI 10.1002/ijc.21942; Parisi V, 2008, OPHTHALMOLOGY, V115, P324, DOI 10.1016/j.ophtha.2007.05.029; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Robert G, 2012, CELL DEATH DIFFER, V19, P1769, DOI 10.1038/cdd.2012.55; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Salvesen L, 2012, PARKINSONISM RELAT D, V18, P899, DOI 10.1016/j.parkreldis.2012.03.013; SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Schutt F, 2007, KLIN MONATSBL AUGENH, V224, P580, DOI 10.1055/s-2007-963339; Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shi M, 2012, NEUROBIOL AGING, V33; Shimwell NJ, 2012, BRIT J CANCER, V107, P1595, DOI 10.1038/bjc.2012.405; Shinbo YM, 2005, INT J ONCOL, V26, P641; Stenirri S, 2012, CLIN CHEM LAB MED, V50, P1021, DOI 10.1515/cclm-2011-0854; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yamashita S, 2010, J NEUROCHEM, V113, P860, DOI 10.1111/j.1471-4159.2010.06658.x; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Yoshida K, 2003, MOL REPROD DEV, V66, P391, DOI 10.1002/mrd.10360; Zeng HZ, 2011, INT J MOL SCI, V12, P3489, DOI 10.3390/ijms12063489; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	111	36	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67983	10.1371/journal.pone.0067983	http://dx.doi.org/10.1371/journal.pone.0067983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844142	Green Published, gold			2022-12-25	WOS:000321341000126
J	Shaffer, TL; Balder, R; Buskirk, SW; Hogan, RJ; Lafontaine, ER				Shaffer, Teresa L.; Balder, Rachel; Buskirk, Sean W.; Hogan, Robert J.; Lafontaine, Eric R.			Use of the Chinchilla Model to Evaluate the Vaccinogenic Potential of the Moraxella catarrhalis Filamentous Hemagglutinin-like Proteins MhaB1 and MhaB2	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; NONTYPABLE HAEMOPHILUS-INFLUENZAE; PNEUMOCOCCAL CONJUGATE VACCINE; OBSTRUCTIVE PULMONARY-DISEASE; BRO BETA-LACTAMASE; ACUTE MAXILLARY SINUSITIS; HUMAN EPITHELIAL-CELLS; HUMAN IMMUNE-RESPONSE; ACUTE OTITIS-MEDIA; BRANHAMELLA-CATARRHALIS	Moraxella catarrhalis causes significant health problems, including 15-20% of otitis media cases in children and,10% of respiratory infections in adults with chronic obstructive pulmonary disease. The lack of an efficacious vaccine, the rapid emergence of antibiotic resistance in clinical isolates, and high carriage rates reported in children are cause for concern. In addition, the effectiveness of conjugate vaccines at reducing the incidence of otitis media caused by Streptococcus pneumoniae and nontypeable Haemophilus influenzae suggest that M. catarrhalis infections may become even more prevalent. Hence, M. catarrhalis is an important and emerging cause of infectious disease for which the development of a vaccine is highly desirable. Studying the pathogenesis of M. catarrhalis and the testing of vaccine candidates have both been hindered by the lack of an animal model that mimics human colonization and infection. To address this, we intranasally infected chinchilla with M. catarrhalis to investigate colonization and examine the efficacy of a protein-based vaccine. The data reveal that infected chinchillas produce antibodies against antigens known to be major targets of the immune response in humans, thus establishing immune parallels between chinchillas and humans during M. catarrhalis infection. Our data also demonstrate that a mutant lacking expression of the adherence proteins MhaB1 and MhaB2 is impaired in its ability to colonize the chinchilla nasopharynx, and that immunization with a polypeptide shared by MhaB1 and MhaB2 elicits antibodies interfering with colonization. These findings underscore the importance of adherence proteins in colonization and emphasize the relevance of the chinchilla model to study M. catarrhalis-host interactions.	[Shaffer, Teresa L.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Balder, Rachel; Buskirk, Sean W.; Hogan, Robert J.; Lafontaine, Eric R.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Hogan, Robert J.] Univ Georgia, Dept Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lafontaine, ER (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	elafon10@uga.edu	Buskirk, Sean/AAM-1228-2021	Buskirk, Sean/0000-0003-1213-8130	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI051477]; University of Georgia's College of Veterinary Medicine and Office of the Vice President for Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI051477, R01AI051477] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Georgia's College of Veterinary Medicine and Office of the Vice President for Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) (AI051477) and start-up funds from the University of Georgia's College of Veterinary Medicine and Office of the Vice President for Research to ERL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; Ahmed A, 2008, PEDIATR INFECT DIS J, V27, P459, DOI 10.1097/INF.0b013e3181646d82; Akimana C, 2007, FEMS MICROBIOL LETT, V271, P12, DOI 10.1111/j.1574-6968.2007.00693.x; Arguedas A, 2010, INT J PEDIATR OTORHI, V74, P1419, DOI 10.1016/j.ijporl.2010.09.022; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Bakaletz LO, 2009, EXPERT REV VACCINES, V8, P1063, DOI 10.1586/ERV.09.63; Bakaletz Lauren O., 1995, Trends in Microbiology, V3, P110, DOI 10.1016/S0966-842X(00)88892-7; BAKALETZ LO, 1993, J INFECT DIS, V168, P865, DOI 10.1093/infdis/168.4.865; Bakaletz LO, 1999, INFECT IMMUN, V67, P2746, DOI 10.1128/IAI.67.6.2746-2762.1999; BAKALETZ LO, 1995, INFECT IMMUN, V63, P4188, DOI 10.1128/IAI.63.10.4188-4190.1995; Balder R, 2007, INFECT IMMUN, V75, P2765, DOI 10.1128/IAI.00079-07; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; Becker PD, 2007, INFECT IMMUN, V75, P1778, DOI 10.1128/IAI.01081-06; BERMAN S, 1995, PEDIATRICS, V96, P126; Berner R, 1996, EUR J CLIN MICROBIOL, V15, P506, DOI 10.1007/BF01691320; Bingen E, 2005, PEDIATR INFECT DIS J, V24, P731, DOI 10.1097/01.inf.0000172939.13159.3b; Bookwalter JE, 2008, INFECT IMMUN, V76, P48, DOI 10.1128/IAI.00980-07; Bootsma HJ, 1999, J BACTERIOL, V181, P5090, DOI 10.1128/JB.181.16.5090-5093.1999; Bootsma HJ, 2000, MOL MICROBIOL, V36, P93, DOI 10.1046/j.1365-2958.2000.01828.x; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Brockson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040088; Brook I, 2005, OTOLARYNG CLIN N AM, V38, P1171, DOI 10.1016/j.otc.2005.08.007; Brook I, 2005, ANN OTO RHINOL LARYN, V114, P573, DOI 10.1177/000348940511400714; Brook I, 2005, J LARYNGOL OTOL, V119, P251, DOI 10.1258/0022215054020304; Brook I, 2007, INT J PEDIATR OTORHI, V71, P575, DOI 10.1016/j.ijporl.2006.10.025; Brook I, 2006, J MED MICROBIOL, V55, P943, DOI 10.1099/jmm.0.46346-0; Brooks MJ, 2008, INFECT IMMUN, V76, P5322, DOI 10.1128/IAI.00572-08; Bullard B, 2005, INFECT IMMUN, V73, P5127, DOI 10.1128/IAI.73.8.5127-5136.2005; Buznach N, 2005, PEDIATR INFECT DIS J, V24, P823, DOI 10.1097/01.inf.0000178066.24569.98; CATLIN BW, 1990, CLIN MICROBIOL REV, V3, P293, DOI 10.1128/CMR.3.4.293-320.1990; Chen DX, 1999, INFECT IMMUN, V67, P1310, DOI 10.1128/IAI.67.3.1310-1316.1999; Christensen J J, 1999, APMIS Suppl, V88, P1; Cope LD, 1999, J BACTERIOL, V181, P4026, DOI 10.1128/JB.181.13.4026-4034.1999; Cripps AW, 2005, VACCINE, V23, P2304, DOI 10.1016/j.vaccine.2005.01.023; DELBECCARO MA, 1992, J PEDIATR-US, V120, P81, DOI 10.1016/S0022-3476(05)80605-5; Enright MC, 1997, J MED MICROBIOL, V46, P360, DOI 10.1099/00222615-46-5-360; Esel D, 2007, CLIN MICROBIOL INFEC, V13, P1023, DOI 10.1111/j.1469-0691.2007.01776.x; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623; FADEN H, 1994, J INFECT DIS, V169, P1312, DOI 10.1093/infdis/169.6.1312; Faden H, 2001, EUR J PEDIATR, V160, P407, DOI 10.1007/s004310100754; Forsgren A, 2008, CLIN INFECT DIS, V46, P726, DOI 10.1086/527396; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Giebink GS, 1999, MICROB DRUG RESIST, V5, P57, DOI 10.1089/mdr.1999.5.57; Giebink GS, 2005, ANN OTO RHINOL LARYN, V114, P86, DOI 10.1177/00034894051140S110; Giebink GS, 1997, ANN NY ACAD SCI, V830, P330, DOI 10.1111/j.1749-6632.1997.tb51906.x; Harris RH, 2004, J BIOL CHEM, V279, P20250, DOI 10.1074/jbc.M400499200; Hauck CR, 2002, MED MICROBIOL IMMUN, V191, P55, DOI 10.1007/s00430-002-0119-0; HELMINEN ME, 1993, INFECT IMMUN, V61, P2003, DOI 10.1128/IAI.61.5.2003-2010.1993; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Holm MM, 2004, INFECT IMMUN, V72, P1906, DOI 10.1128/IAI.72.4.1906-1913.2004; Holm MM, 2003, INFECT IMMUN, V71, P4977, DOI 10.1128/IAI.71.9.4977-4984.2003; Hoopman TC, 2012, INFECT IMMUN, V80, P982, DOI 10.1128/IAI.05918-11; Hunter MH, 2001, AM FAM PHYSICIAN, V64, P603; Hurd S, 2000, CHEST, V117, P1; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jacobs MR, 2004, CLIN LAB MED, V24, P503, DOI 10.1016/j.cll.2004.03.008; Johnson DM, 2003, DIAGN MICR INFEC DIS, V47, P373, DOI 10.1016/S0732-8893(03)00089-0; Kadry AA, 2003, INT J ANTIMICROB AG, V22, P532, DOI 10.1016/S0924-8579(03)00158-4; Karalus R, 2000, MICROBES INFECT, V2, P547, DOI 10.1016/S1286-4579(00)00314-2; Kennedy BJ, 2000, INFECT IMMUN, V68, P2756, DOI 10.1128/IAI.68.5.2756-2765.2000; Kerschner JE, 2010, INT J PEDIATR OTORHI, V74, P980, DOI 10.1016/j.ijporl.2010.05.009; Kerschner JE, 2010, ANN OTO RHINOL LARYN, V119, P270, DOI 10.1177/000348941011900411; Kerschner JE, 2009, ARCH OTOLARYNGOL, V135, P33, DOI 10.1001/archoto.2008.513; Klein J O, 1992, Adv Pediatr, V39, P127; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Klugman KP, 1996, J ANTIMICROB CHEMOTH, V38, P133, DOI 10.1093/jac/38.suppl_A.133; Kyd JM, 1998, J MED MICROBIOL, V47, P159, DOI 10.1099/00222615-47-2-159; Lafontaine ER, 2000, J BACTERIOL, V182, P1364, DOI 10.1128/JB.182.5.1364-1373.2000; LaFontaine ER, 2009, CLIN VACCINE IMMUNOL, V16, P653, DOI 10.1128/CVI.00460-08; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Lipski SL, 2007, INFECT IMMUN, V75, P314, DOI 10.1128/IAI.01330-06; Liu DF, 2007, INFECT IMMUN, V75, P2818, DOI 10.1128/IAI.00074-07; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; MACIVER I, 1993, J INFECT DIS, V168, P469, DOI 10.1093/infdis/168.2.469; Manninen R, 1997, J ANTIMICROB CHEMOTH, V40, P387, DOI 10.1093/jac/40.3.387; Mathers K, 1999, PEDIATR INFECT DIS J, V18, P982, DOI 10.1097/00006454-199911000-00010; McGillivary G, 2007, MOL IMMUNOL, V44, P2446, DOI 10.1016/j.molimm.2006.10.008; McGillivary G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013224; McGillivary G, 2009, CELL MICROBIOL, V11, P1399, DOI 10.1111/j.1462-5822.2009.01339.x; Meier PS, 2006, FEMS MICROBIOL LETT, V262, P72, DOI 10.1111/j.1574-6968.2006.00365.x; Meier PS, 2003, PEDIATR INFECT DIS J, V22, P256, DOI 10.1097/00006454-200303000-00011; Meier PS, 2003, INFECT IMMUN, V71, P6793, DOI 10.1128/IAI.71.12.6793-6798.2003; Miyamoto N, 1997, MICROB PATHOGENESIS, V23, P119, DOI 10.1006/mpat.1997.0140; MURPHY TF, 1989, MICROB PATHOGENESIS, V6, P159, DOI 10.1016/0882-4010(89)90066-1; Murphy TF, 2005, INFECT IMMUN, V73, P8161, DOI 10.1128/IAI.73.12.8161-8166.2005; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2005, INFECT IMMUN, V73, P3471, DOI 10.1128/IAI.73.6.3471-3478.2005; Murphy TF, 1999, INFECT IMMUN, V67, P4578, DOI 10.1128/IAI.67.9.4578-4585.1999; Murphy TF, 2003, INFECT IMMUN, V71, P1288, DOI 10.1128/IAI.71.3.1288-1294.2003; Murphy TF, 1996, MICROBIOL REV, V60, P267, DOI 10.1128/MMBR.60.2.267-279.1996; Murphy TF, 1998, J INFECT DIS, V178, P1667, DOI 10.1086/314501; Murphy TF, 2005, EXPERT REV VACCINES, V4, P843, DOI 10.1586/14760584.4.6.843; Neumayer U, 1999, J HEART VALVE DIS, V8, P114; Niemann HH, 2004, MICROBES INFECT, V6, P101, DOI 10.1016/j.micinf.2003.11.001; Nigrovic LE, 2008, ACAD EMERG MED, V15, P522, DOI 10.1111/j.1553-2712.2008.00117.x; NIH-NHLBI website, MORB MORT 2009 CHART; Novotny LA, 2000, INFECT IMMUN, V68, P2119, DOI 10.1128/IAI.68.4.2119-2128.2000; PATRICK CC, 1987, INFECT IMMUN, V55, P2902, DOI 10.1128/IAI.55.12.2902-2911.1987; Pearson MM, 2002, INFECT IMMUN, V70, P4523, DOI 10.1128/IAI.70.8.4523-4533.2002; Peng DX, 2005, INFECT IMMUN, V73, P4222, DOI 10.1128/IAI.73.7.4222-4230.2005; Pichichero Michael E, 2002, Expert Opin Pharmacother, V3, P1073; Plamondon P, 2007, INFECT IMMUN, V75, P2929, DOI 10.1128/IAI.00396-07; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Revai K, 2006, PEDIATRICS, V117, P1823, DOI 10.1542/peds.2005-1983; Richter SS, 2000, ANTIMICROB AGENTS CH, V44, P444, DOI 10.1128/AAC.44.2.444-446.2000; RUUSKANEN O, 1994, PEDIATR INFECT DIS J, V13, pS23, DOI 10.1097/00006454-199401001-00006; Sambrook J, 2001, MOL CLONING LAB MANU; Schmitz FJ, 2002, J CLIN MICROBIOL, V40, P1546, DOI 10.1128/JCM.40.4.1546-1548.2002; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Song JM, 2010, VIROLOGY, V405, P165, DOI 10.1016/j.virol.2010.05.034; St Geme J W 3rd, 1997, Adv Pediatr, V44, P43; Stefanou J, 2000, SCAND J INFECT DIS, V32, P217, DOI 10.1080/003655400750045394; STOOL SE, 1989, PEDIATR INFECT DIS J, V8, pS11; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Sullivan SD, 2000, CHEST, V117, P5; SUZUKI K, 1994, INFECT IMMUN, V62, P1710, DOI 10.1128/IAI.62.5.1710-1718.1994; Thorsson B, 1998, SCAND J INFECT DIS, V30, P105, DOI 10.1080/003655498750003447; Timpe JM, 2003, INFECT IMMUN, V71, P4341, DOI 10.1128/IAI.71.8.4341-4350.2003; TURNER HR, 1985, SOUTHERN MED J, V78, P1021, DOI 10.1097/00007611-198508000-00041; UNHANAND M, 1992, J INFECT DIS, V165, P644, DOI 10.1093/infdis/165.4.644; Utsunomiya T, 1984, Nihon Naika Gakkai Zasshi, V73, P1506; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; World Health Organization, 2004, CHRON SUPP OT MED CS; World Health Organization website, 2008, FACT SHEET TOP 10 CA; World Health Organization website, WORLD HLTH STAT 2008	132	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67881	10.1371/journal.pone.0067881	http://dx.doi.org/10.1371/journal.pone.0067881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844117	Green Submitted, gold, Green Published			2022-12-25	WOS:000321341000113
J	Neumann, S; Schmid, SL				Neumann, Sylvia; Schmid, Sandra L.			Dual Role of BAR Domain-containing Proteins in Regulating Vesicle Release Catalyzed by the GTPase, Dynamin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; DEPENDENT CONFORMATIONAL-CHANGES; EXCESS MEMBRANE RESERVOIR; SH3 DOMAIN; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; AMPHIPATHIC HELICES; SUPPORTED BILAYERS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS	Dynamin-2 (Dyn2) is ubiquitously expressed and catalyzes membrane fission during clathrin-mediated endocytosis in nonneuronal cells. We have previously shown that Dyn2 inefficiently generates membrane curvature and only mediates fission of highly curved membranes. This led to the hypothesis that other endocytic accessory proteins (EAPs) generate curvature needed to sculpt a sufficiently narrow neck to trigger Dyn2 assembly and fission. Candidates for this activity are EAPs that bind to the dynamin proline/arginine-rich domain (PRD) through their SH3 (src homology-3) domains and also encode curvature-generating BAR (Bin/Amphiphysin/Rvs) domains. We show that at low concentrations, amphiphysin and endophilin, but not SNX9 or the curvature-generating epsin N-terminal homology (ENTH) domain, are able to generate tubules from planar membrane templates and to synergize with Dyn2 Delta PRD to catalyze vesicle release. Unexpectedly, SH3-PRD interactions were inhibitory and reciprocally regulate scaffold assembly. Of the three proteins studied, only full-length amphiphysin functions synergistically with full-length Dyn2 to catalyze vesicle release. The differential activity of these proteins correlates with the relative potency of their positive, curvature-generating activity, and the negative regulatory effects mediated by SH3 domain interactions. Our findings reveal opportunities for the spatio-temporal coordination of membrane curvature generation, dynamin assembly, and fission during clathrin-mediated endocytosis.	[Neumann, Sylvia; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), UT Southwestern Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	sandra.schmid@utsouthwestern.edu		Schmid, Sandra/0000-0002-1690-7024	National Institutes of Health [R01GM42455, MH61345]; AHA Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061345, R37MH061345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM42455 and MH61345 (to S. L. S.) and an AHA Fellowship (to S. N.).	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Dores MR, 2010, TRAFFIC, V11, P151, DOI 10.1111/j.1600-0854.2009.01003.x; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Goh SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051628; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Henry AG, 2012, DEV CELL, V23, P519, DOI 10.1016/j.devcel.2012.08.003; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; Lai CL, 2012, J MOL BIOL, V423, P800, DOI 10.1016/j.jmb.2012.08.010; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu J, 2010, CURR OPIN CELL BIOL, V22, P36, DOI 10.1016/j.ceb.2009.11.009; Liu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055691; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Neumann S, 2013, NAT PROTOC, V8, P213, DOI 10.1038/nprot.2012.152; Overstreet E, 2003, CURR BIOL, V13, P854, DOI 10.1016/S0960-9822(03)00326-9; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pucadyil TJ, 2010, BIOPHYS J, V99, P517, DOI 10.1016/j.bpj.2010.04.036; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Rao YJ, 2012, EUR J CELL BIOL, V91, P226, DOI 10.1016/j.ejcb.2011.02.004; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Vazquez FX, 2013, BIOPHYS J, V104, P396, DOI 10.1016/j.bpj.2012.12.009; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	63	46	48	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25119	25128		10.1074/jbc.M113.490474	http://dx.doi.org/10.1074/jbc.M113.490474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861397	Green Published, hybrid			2022-12-25	WOS:000330619000012
J	Proenca, CC; Stoehr, N; Bernhard, M; Seger, S; Genoud, C; Roscic, A; Paganetti, P; Liu, SM; Murphy, LO; Kuhn, R; Bouwmeester, T; Galimberti, I				Proenca, Catia C.; Stoehr, Natacha; Bernhard, Mario; Seger, Shanon; Genoud, Christel; Roscic, Ana; Paganetti, Paolo; Liu, Shanming; Murphy, Leon O.; Kuhn, Rainer; Bouwmeester, Tewis; Galimberti, Ivan			Atg4b-Dependent Autophagic Flux Alleviates Huntington's Disease Progression	PLOS ONE			English	Article							HIPPOCAMPAL SLICE CULTURES; AGGREGATE-PRONE PROTEINS; NEURODEGENERATIVE DISEASES; MUTANT HUNTINGTIN; MTOR INHIBITORS; MOUSE MODELS; CLEARANCE; POLYGLUTAMINE; DISORDERS; INDUCTION	The accumulation of aggregated mutant huntingtin (mHtt) inclusion bodies is involved in Huntigton's disease (HD) progression. Medium sized-spiny neurons (MSNs) in the corpus striatum are highly vulnerable to mHtt aggregate accumulation and degeneration, but the mechanisms and pathways involved remain elusive. Here we have developed a new model to study MSNs degeneration in the context of HD. We produced organotypic cortico-striatal slice cultures (CStS) from HD transgenic mice mimicking specific features of HD progression. We then show that induction of autophagy using catalytic inhibitors of mTOR prevents MSNs degeneration in HD CStS. Furthermore, disrupting autophagic flux by overexpressing Atg4b in neurons and slice cultures, accelerated mHtt aggregation and neuronal death, suggesting that Atg4b-dependent autophagic flux influences HD progression. Under these circumstances induction of autophagy using catalytic inhibitors of mTOR was inefficient and did not affect mHtt aggregate accumulation and toxicity, indicating that mTOR inhibition alleviates HD progression by inducing Atg4b-dependent autophagic flux. These results establish modulators of Atg4b-dependent autophagic flux as new potential targets in the treatment of HD.	[Proenca, Catia C.; Stoehr, Natacha; Bernhard, Mario; Liu, Shanming; Murphy, Leon O.; Bouwmeester, Tewis; Galimberti, Ivan] Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland; [Seger, Shanon; Roscic, Ana; Paganetti, Paolo; Kuhn, Rainer] Novartis Pharma AG Basel, Basel, Switzerland; [Genoud, Christel] Friedrich Miescher Inst Basel, Basel, Switzerland	Novartis; Novartis; Friedrich Miescher Institute for Biomedical Research	Galimberti, I (corresponding author), Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland.	ivan.galimberti@novartis.com	Paganetti, Paolo/AAF-8039-2020	genoud, christel/0000-0002-0933-9911; Paganetti, Paolo/0000-0003-1896-6324	Novartis	Novartis(Novartis)	All the work was funded by Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; de Almeida LP, 2002, J NEUROSCI, V22, P3473; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2009, AUTOPHAGY, V5, P88, DOI 10.4161/auto.5.1.7183; Galimberti I, 2006, NEURON, V50, P749, DOI 10.1016/j.neuron.2006.04.026; Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016; Ginovart N, 1997, BRAIN, V120, P503, DOI 10.1093/brain/120.3.503; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Gogolla N, 2006, NAT PROTOC, V1, P2452, DOI 10.1038/nprot.2006.180; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Horne EA, 2013, EUR J NEUROSCI, V37, P429, DOI 10.1111/ejn.12045; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakamura K, 2007, DRUG TODAY, V43, P97, DOI 10.1358/dot.2007.43.2.1050788; Nyfeler B, 2012, METHODS MOL BIOL, V821, P239, DOI 10.1007/978-1-61779-430-8_14; Nyfeler B, 2011, MOL CELL BIOL, V31, P2867, DOI 10.1128/MCB.05430-11; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar Brinda, 2006, Molecular Aspects of Medicine, V27, P520, DOI 10.1016/j.mam.2006.08.008; Regulier Etienne, 2004, V277, P199; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	45	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68357	10.1371/journal.pone.0068357	http://dx.doi.org/10.1371/journal.pone.0068357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861892	Green Submitted, gold, Green Published			2022-12-25	WOS:000321692000024
J	Monette, A; Valiente-Echeverria, F; Rivero, M; Cohen, EA; Lopez-Lastra, M; Mouland, AJ				Monette, Anne; Valiente-Echeverria, Fernando; Rivero, Matias; Cohen, Eric A.; Lopez-Lastra, Marcelo; Mouland, Andrew J.			Dual Mechanisms of Translation Initiation of the Full-Length HIV-1 mRNA Contribute to Gag Synthesis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CAP-INDEPENDENT TRANSLATION; RIBOSOME ENTRY SITE; HOST PROTEIN-SYNTHESIS; EUKARYOTIC TRANSLATION; POLY(A)-BINDING PROTEIN; GENOMIC RNA; 5-UNTRANSLATED REGION; MEDIATED TRANSLATION; EFFICIENT CLEAVAGE	The precursor group-specific antigen (wpr55(Gag)) is central to HIV-1 assembly. Its expression alone is sufficient to assemble into virus-like particles. It also selects the genomic RNA for encapsidation and is involved in several important virus-host interactions for viral assembly and restriction, making its synthesis essential for aspects of viral replication. Here, we show that the initiation of translation of the HIV-1 genomic RNA is mediated through both a cap-dependent and an internal ribosome entry site (IRES)-mediated mechanisms. In support of this notion, pr55(Gag) synthesis was maintained at 70% when cap-dependent translation initiation was blocked by the expression of elF4G- and PABP targeting viral proteases in two in vitro systems and in HIV-1-expressing cells directly infected with poliovirus. While our data reveal that IRES-dependent translation of the viral genomic RNA ensures pr55(Gag) expression, the synthesis of other HIV-1 proteins, including that of pr160(Gag/Pol), Vpr and Tat is suppressed early during progressive poliovirus infection. The data presented herein implies that the unspliced HIV-1 genomic RNA utilizes both cap-dependent and IRES-dependent translation initiation to supply pr55(Gag) for virus assembly and production.	[Monette, Anne; Valiente-Echeverria, Fernando; Mouland, Andrew J.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, HIV Trafficking Lab 1, Montreal, PQ H3T 1E2, Canada; [Monette, Anne; Valiente-Echeverria, Fernando; Mouland, Andrew J.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Rivero, Matias; Lopez-Lastra, Marcelo] Pontificia Univ Catolica Chile, Escuela Med, Ctr Invest Med, Inst Milenio Inmunol & Inmunoterapia,Lab Virol Mo, Santiago, Chile; [Cohen, Eric A.] Inst Rech Clin Montreal, Lab Human Retrovirol, Montreal, PQ, Canada; [Mouland, Andrew J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; Pontificia Universidad Catolica de Chile; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University	Lopez-Lastra, M (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Ctr Invest Med, Inst Milenio Inmunol & Inmunoterapia,Lab Virol Mo, Alameda 340, Santiago, Chile.	malopez@med.puc.cl; andrew.mouland@mcgill.ca	Lopez-Lastra, Marcelo/HHM-9832-2022; Valiente-Echeverria, Fernando/I-6881-2018	Valiente-Echeverria, Fernando/0000-0001-9156-2516; Lopez-Lastra, Marcelo/0000-0002-7936-8478	Canadian Institutes of Health Research (CIHR) Doctoral Award; Becas Chile-Conicyt; Canada Research Chair in Human Retrovirology; McGill Fraser; Monat and MacPherson career award; Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (FONDECYT) [1090318, 1130270]; Programa ICM through Proyecto Instituto Milenio [P09/016-F]; CIHR [HET-85519, MOP-56974]	Canadian Institutes of Health Research (CIHR) Doctoral Award(Canadian Institutes of Health Research (CIHR)); Becas Chile-Conicyt; Canada Research Chair in Human Retrovirology; McGill Fraser; Monat and MacPherson career award; Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa ICM through Proyecto Instituto Milenio; CIHR(Canadian Institutes of Health Research (CIHR))	AM is a recipient of a Canadian Institutes of Health Research (CIHR) Doctoral Award; FVE is supported by a Postdoctoral Fellowship award from Becas Chile-Conicyt; EAC is a Canada Research Chair in Human Retrovirology and AJM is the recipient of a McGill Fraser, Monat and MacPherson career award. This work is supported by grant Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (FONDECYT) Nos 1090318 and 1130270 to MLL, the Programa ICM through Proyecto Instituto Milenio P09/016-F IMII to MLL, and grants from the CIHR to EAC (#HET-85519) and to AJM (#MOP-56974). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Berkhout B, 2011, NUCLEIC ACIDS RES, V39, P5232, DOI 10.1093/nar/gkr113; Bonderoff JM, 2008, J VIROL, V82, P9389, DOI 10.1128/JVI.00006-08; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Charnay N, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-74; COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P601; de Breyne S, 2013, VIRUS RES; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Foeger N, 2005, FEBS J, V272, P2602, DOI 10.1111/j.1742-4658.2005.04689.x; FUERST TR, 1989, J MOL BIOL, V206, P333, DOI 10.1016/0022-2836(89)90483-X; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gottlinger HG, 2001, AIDS, V15, pS13; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 1995, CURR TOP MICROBIOL, V203, P1; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kemler I, 2010, J VIROL, V84, P6352, DOI 10.1128/JVI.00363-10; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; Lehmann M, 2009, J BIOL CHEM, V284, P14572, DOI 10.1074/jbc.M808531200; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Lopez-Lastra M, 2010, REV MED VIROL, V20, P177, DOI 10.1002/rmv.649; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; MEDINA M, 1993, VIROLOGY, V194, P355, DOI 10.1006/viro.1993.1267; Miele G, 1996, J VIROL, V70, P944, DOI 10.1128/JVI.70.2.944-951.1996; Molle D, 2009, J BIOL CHEM, V284, P19727, DOI 10.1074/jbc.M109.019844; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Mouland AJ, 2002, VIROLOGY, V292, P321, DOI 10.1006/viro.2001.1261; MOULAND AJ, 1992, MOL ENDOCRINOL, V6, P1781, DOI 10.1210/me.6.11.1781; Ohlmann T, 2002, J MOL BIOL, V318, P9, DOI 10.1016/S0022-2836(02)00070-0; OHLMANN T, 1995, NUCLEIC ACIDS RES, V23, P334; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Plank TD, 2013, NUCL ACIDS IN PRESS; Poole E, 2005, TRAFFIC, V6, P741, DOI 10.1111/j.1600-0854.2005.00312.x; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; Smith RWP, 2010, BIOCHEM J, V426, P1, DOI 10.1042/BJ20091571; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Strong R, 2004, J GEN VIROL, V85, P2953, DOI 10.1099/vir.0.80254-0; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Valiente-Echeverria F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056962; Vallejos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035031; Vallejos M, 2011, NUCLEIC ACIDS RES, V39, P6186, DOI 10.1093/nar/gkr189; Vallejos M, 2010, NUCLEIC ACIDS RES, V38, P618, DOI 10.1093/nar/gkp890; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998	70	37	37	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68108	10.1371/journal.pone.0068108	http://dx.doi.org/10.1371/journal.pone.0068108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861855	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300043
J	Carnevali, L; Trombini, M; Porta, A; Montano, N; de Boer, SF; Sgoifo, A				Carnevali, Luca; Trombini, Mimosa; Porta, Alberto; Montano, Nicola; de Boer, Sietse F.; Sgoifo, Andrea			Vagal Withdrawal and Susceptibility to Cardiac Arrhythmias in Rats with High Trait Aggressiveness	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SOCIAL STRESS; INDIVIDUAL-DIFFERENCES; FREQUENCY-DOMAIN; BEHAVIOR PATTERN; A BEHAVIOR; PERSONALITY; MORTALITY; HOSTILITY; RESPONSES	Personality characteristics, e. g. aggressiveness, have long been associated with an increased risk of cardiac disease. However, the underlying mechanisms remain unclear. In this study we used a rodent model for characterizing cardiac autonomic modulation in rats that differ widely in their level of aggressive behavior. To reach this goal, high-aggressive (HA, n = 10) and non-aggressive (NA, n = 10) rats were selected from a population (n = 121) of adult male Wild-type Groningen rats on the basis of their latency time to attack (ALT, s) a male intruder in a resident-intruder test lasting 600 s. In order to obtain information on their cardiac autonomic modulation, ECG recordings were subsequently obtained via radiotelemetry at rest, during stressful stimuli and under autonomic pharmacological manipulations, and analyzed by means of time- and frequency-domain indexes of heart rate variability. During resting conditions, HA rats (ALT<90 s) displayed reduced heart rate variability, mostly in terms of lower vagal modulation compared to NA rats (ALT>600 s). Exposure to stressful stimuli (i.e. restraint and psychosocial stress) provoked similar tachycardic responses between the two groups. However, under stress conditions HA rats displayed a reduced vagal antagonism and an increased incidence of tachyarrhythmias compared to NA rats. In addition, beta-adrenergic pharmacological stimulation induced a much larger incidence of ventricular tachyarrhythmias in HA rats compared to NA counterparts. These findings are consistent with the view that high levels of aggressive behavior in rats are associated to signs of cardiac autonomic impairment and increased arrhythmogenic susceptibility that may predict vulnerability to cardiac morbidity and mortality.	[Carnevali, Luca; Trombini, Mimosa; Sgoifo, Andrea] Univ Parma, Dept Neurosci, Stress Physiol Lab, I-43100 Parma, Italy; [Porta, Alberto] Univ Milan, Ist Ortoped Galeazzi, Dept Biomed Sci Hlth, Milan, Italy; [Montano, Nicola] Univ Milan, Luigi Sacco Hosp, Dept Biomed & Clin Sci, Milan, Italy; [Montano, Nicola] St Annes Univ Hosp, ICRC Dept Cardiovasc Dis, Brno, Czech Republic; [de Boer, Sietse F.] Univ Groningen, Dept Behav Physiol, Ctr Behav & Neurosci, Groningen, Netherlands	University of Parma; IRCCS Istituto Ortopedico Galeazzi; University of Milan; University of Milan; Luigi Sacco Hospital; St Anne's University Hospital Brno (FNUSA-ICRC); University of Groningen	Sgoifo, A (corresponding author), Univ Parma, Dept Neurosci, Stress Physiol Lab, I-43100 Parma, Italy.	andrea.sgoifo@unipr.it	Sgoifo, Andrea/AAC-6278-2022; Porta, Alberto/K-4390-2016; Carnevali, Luca/P-9508-2019; Carnevali, Luca/E-5322-2017	Sgoifo, Andrea/0000-0002-9428-6198; Porta, Alberto/0000-0002-6720-9824; Carnevali, Luca/0000-0001-9053-7976; Carnevali, Luca/0000-0001-9053-7976; Montano, Nicola/0000-0001-9206-0075	University of Parma (FIL)	University of Parma (FIL)	This study was supported by a grant from the University of Parma (FIL 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN EL, 1971, P SOC EXP BIOL MED, V136, P268; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Betensky JD, 2010, ANN BEHAV MED, V39, P184, DOI 10.1007/s12160-010-9176-6; BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164; Camm AJ, 1996, CIRCULATION, V93, P1043; Carnevali L, 2013, PSYCHOSOM MED, V75, P42, DOI 10.1097/PSY.0b013e318276cb0d; CASE RB, 1985, NEW ENGL J MED, V312, P737, DOI 10.1056/NEJM198503213121201; de Boer SF, 2003, BEHAV GENET, V33, P485, DOI 10.1023/A:1025766415159; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; FRIEDMAN M, 1959, JAMA-J AM MED ASSOC, V169, P1286, DOI 10.1001/jama.1959.03000290012005; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; HALLER J, 1995, PSYCHONEUROENDOCRINO, V20, P65, DOI 10.1016/0306-4530(94)E0042-8; Huikuri HV, 1999, ARTERIOSCL THROM VAS, V19, P1979, DOI 10.1161/01.ATV.19.8.1979; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; KOOLHAAS JM, 1980, PROG NEUROBIOL, V15, P247, DOI 10.1016/0301-0082(80)90024-6; Kop WJ, 1999, PSYCHOSOM MED, V61, P476, DOI 10.1097/00006842-199907000-00012; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; La Rovere MT, 1998, LANCET, V351, P478; Liao DP, 1997, AM J EPIDEMIOL, V145, P696, DOI 10.1093/aje/145.8.696; LORE R, 1977, SCI AM, V236, P106, DOI 10.1038/scientificamerican0577-106; Magagnin V, 2011, PHYSIOL MEAS, V32, P1775, DOI 10.1088/0967-3334/32/11/S05; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Safa-Tisseront V, 1998, J HYPERTENS, V16, P1989, DOI 10.1097/00004872-199816121-00020; Sgoifo A, 2005, NEUROSCI BIOBEHAV R, V29, P59, DOI 10.1016/j.neubiorev.2004.07.001; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; Sgoifo A, 1999, NEUROSCI BIOBEHAV R, V23, P915, DOI 10.1016/S0149-7634(99)00025-1; Sgoifo A, 1998, AGGRESSIVE BEHAV, V24, P287, DOI 10.1002/(SICI)1098-2337(1998)24:4<287::AID-AB4>3.0.CO;2-G; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1403, DOI 10.1016/S0031-9384(96)00229-6; SHEKELLE RB, 1985, AM J EPIDEMIOL, V122, P559, DOI 10.1093/oxfordjournals.aje.a114135; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Smith TW, 2004, J PERS, V72, P1217, DOI 10.1111/j.1467-6494.2004.00296.x; SMITH TW, 1992, HEALTH PSYCHOL, V11, P139, DOI 10.1037/0278-6133.11.3.139; Souza HCD, 2009, AUTON NEUROSCI-BASIC, V150, P38, DOI 10.1016/j.autneu.2009.04.007; STEIN PK, 1994, AM HEART J, V127, P1376, DOI 10.1016/0002-8703(94)90059-0; Trombini M, 2012, STRESS, V15, P457, DOI 10.3109/10253890.2011.639414; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Verrier RL, 2004, CURR OPIN CARDIOL, V19, P2, DOI 10.1097/00001573-200401000-00003; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447	43	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68316	10.1371/journal.pone.0068316	http://dx.doi.org/10.1371/journal.pone.0068316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861886	gold, Green Published			2022-12-25	WOS:000323350700079
J	Kochupurakkal, BS; Iglehart, JD				Kochupurakkal, Bose S.; Iglehart, J. Dirk			Nourseothricin N-Acetyl Transferase: A Positive Selection Marker for Mammalian Cells	PLOS ONE			English	Article							TRANSFORMATION	Development of Nourseothricin N-acetyl transferase (NAT) as a selection marker for mammalian cells is described. Mammalian cells are acutely susceptible to Nourseothricin, similar to the widely used drug Puromycin, and NAT allows for quick and robust selection of transfected/transduced cells in the presence of Nourseothricin. NAT is compatible with other selection markers puromycin, hygromycin, neomycin, blasticidin, and is a valuable addition to the repertoire of mammalian selection markers.	[Kochupurakkal, Bose S.; Iglehart, J. Dirk] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Iglehart, J. Dirk] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Iglehart, JD (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	JIGLEHART@partners.org			Teri Brodeur Fellowship; Hale Fellowship; Women's Cancer Program at Dana-Farber Cancer Institute; National Cancer Institute Specialized Program in Research Excellence in Breast Cancer at Dana-Farber/Harvard Cancer Center [CA89393]; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER	Teri Brodeur Fellowship; Hale Fellowship; Women's Cancer Program at Dana-Farber Cancer Institute; National Cancer Institute Specialized Program in Research Excellence in Breast Cancer at Dana-Farber/Harvard Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	KSB is a recipient of the Teri Brodeur Fellowship and the Hale Fellowship. The work was supported by the Women's Cancer Program at Dana-Farber Cancer Institute and National Cancer Institute Specialized Program in Research Excellence in Breast Cancer at Dana-Farber/Harvard Cancer Center (CA89393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; KRUGEL H, 1993, GENE, V127, P127, DOI 10.1016/0378-1119(93)90627-F; Mortensen RM, 2009, CURR PROTOC MOL BIOL, V9; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van Peer AF, 2009, APPL ENVIRON MICROB, V75, P1243, DOI 10.1128/AEM.02162-08; Van TT, 2006, J PARASITOL, V92, P668, DOI 10.1645/GE-706R.1; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	10	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68509	10.1371/journal.pone.0068509	http://dx.doi.org/10.1371/journal.pone.0068509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861913	Green Published, gold			2022-12-25	WOS:000323350700090
J	Nielsen, SB; Macchi, F; Raccosta, S; Langkilde, AE; Giehm, L; Kyrsting, A; Svane, ASP; Manno, M; Christiansen, G; Nielsen, NC; Oddershede, L; Vestergaard, B; Otzen, DE				Nielsen, Soren Bang; Macchi, Francesca; Raccosta, Samuele; Langkilde, Annette Eva; Giehm, Lise; Kyrsting, Anders; Svane, Anna Sigrid Pii; Manno, Mauro; Christiansen, Gunna; Nielsen, Niels Christian; Oddershede, Lene; Vestergaard, Bente; Otzen, Daniel Erik			Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures	PLOS ONE			English	Article							SMALL-ANGLE-SCATTERING; POINT MUTATIONS A30P; FIBER DIFFRACTION; DISEASE; FIBRILLIZATION; NEUROTOXICITY; PATHOGENESIS; POLYMORPHISM; AGGREGATION; FILAMENTS	Parkinson's Disease (PD) is a neurodegenerative movement disorder affecting millions of people worldwide. One of the key players in the development of the disease is the protein alpha-synuclein (aSN), which aggregates in the brain of PD patients. The aSN mutant A30P has been reported to cause early-onset familial PD and shows different aggregation behavior compared to wt aSN. Here we use a multidisciplinary approach to compare the aggregation process of wt and A30P aSN. In agreement with previous studies, we observe an initial lag phase followed by a continuous structural development of fibrils until reaching an apparent monomer-aggregate equilibrium state and a plateau in Thioflavin T (ThT) fluorescence intensity. However, at later timepoints A30P shows greater propensity than alpha SN wt to form dense bundled fibril networks. Combining small angle x-ray scattering, x-ray fibre diffraction and linear dichroism, we demonstrate that while the microscopic structure of the individual fibril essentially remains constant throughout the experiment, the formation of dense A30P fibril networks occur through a continuous assembly pathway while the formation of less dense wt fibril networks with fewer contact points follows a continuous path during the elongation phase and a second rearrangement phase after reaching the ThT fluorescence plateau. Our work thus highlights that structural rearrangements proceed beyond the plateau in ThT-based monitoring of the fibrillation process, and the density and morphology of the resulting fibril networks is highly dependent on the aSN form studied.	[Nielsen, Soren Bang; Macchi, Francesca; Giehm, Lise; Svane, Anna Sigrid Pii; Nielsen, Niels Christian; Otzen, Daniel Erik] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Nielsen, Soren Bang; Macchi, Francesca; Giehm, Lise; Otzen, Daniel Erik] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Raccosta, Samuele; Langkilde, Annette Eva; Vestergaard, Bente] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Raccosta, Samuele; Manno, Mauro] Natl Res Council Italy, Inst Biophys, Palermo, Italy; [Kyrsting, Anders; Oddershede, Lene] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Svane, Anna Sigrid Pii; Nielsen, Niels Christian] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Christiansen, Gunna] Univ Aarhus, Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Copenhagen; Niels Bohr Institute; Aarhus University; Aarhus University	Vestergaard, B (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	bv@farma.ku.dk; dao@inano.au.dk	Nielsen, Søren B/D-5936-2011; Raccosta, Samuele/P-3682-2018; Manno, Mauro/F-1385-2010	Raccosta, Samuele/0000-0001-7775-5928; Manno, Mauro/0000-0001-9843-0428; Langkilde, Annette Eva/0000-0003-2467-4205; Nielsen, Niels Chr./0000-0003-2978-4366; Kyrsting, Anders/0000-0003-2845-1287; Vestergaard, Bente/0000-0001-8011-6414; Otzen, Daniel/0000-0002-2918-8989; Christiansen, Gunna/0000-0003-0540-1367	Lundbeck Foundation (BioNET 2); Danish Councils for Independent Research in Natural Sciences (FNU) [11-113326]; Medical Sciences (FSS); innovation consortium CureND and Aalborg University; Novo Nordisk A/S; Research Training Council; Aarhus University; Danish National Research Foundation (inSPIN) [DNRF59]	Lundbeck Foundation (BioNET 2); Danish Councils for Independent Research in Natural Sciences (FNU); Medical Sciences (FSS)(Danish Medical Research Council); innovation consortium CureND and Aalborg University; Novo Nordisk A/S(Novo Nordisk); Research Training Council; Aarhus University; Danish National Research Foundation (inSPIN)(Danmarks Grundforskningsfond)	S.B.N. was supported by the Lundbeck Foundation (BioNET 2) and by grant 11-113326 from the Danish Councils for Independent Research in Natural Sciences (FNU) and Medical Sciences (FSS). L.G. was supported by a predoctoral grant from the innovation consortium CureND and Aalborg University. F.M. was supported by a predoctoral grant from Novo Nordisk A/S, the Research Training Council and Aarhus University. S.R. was supported by the Doctoral School in Physics at the University of Palermo. A.E.L. was also supported by the Lundbeck Foundation. B.V. was supported by the Danish Council for Independent Research Medical Sciences (Sapere Aude). D.E.O., A.P.S.S., and N.C.N. are supported by the Danish National Research Foundation (inSPIN) grant number DNRF59. The authors are grateful to DANSCATT for economical support during data collection (A.E.L., B.V., L.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi R, 2007, J BIOL CHEM, V282, P8978, DOI 10.1074/jbc.M611738200; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; BROWNSTEIN KR, 1977, J MAGN RESON, V26, P17, DOI 10.1016/0022-2364(77)90230-X; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Clark GNI, 2010, P NATL ACAD SCI USA, V107, P14003, DOI 10.1073/pnas.1006599107; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Dafforn TR, 2004, BIOPHYS J, V86, P404, DOI 10.1016/S0006-3495(04)74116-8; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Halliday G, 2012, EXPERT REV NEUROTHER, V12, P673, DOI [10.1586/ern.12.47, 10.1586/ERN.12.47]; Harada R, 2009, BBA-MOL BASIS DIS, V1792, P998, DOI 10.1016/j.bbadis.2009.06.010; Hazy E, 2011, BIOPHYS J, V101, P2260, DOI 10.1016/j.bpj.2011.08.052; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Kamiyoshihara T, 2007, BIOCHEM BIOPH RES CO, V355, P398, DOI 10.1016/j.bbrc.2007.01.162; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuffel A, 2012, J PHYS CHEM B, V116, P12113, DOI 10.1021/jp305172t; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Makin OS, 2007, J APPL CRYSTALLOGR, V40, P966, DOI 10.1107/S0021889807034681; Marshall KE, 2010, BIOPHYS J, V98, P330, DOI 10.1016/j.bpj.2009.10.020; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rodger A., 2006, ENCY ANAL CHEM; Segers-Nolten I, 2007, P ANN INT IEEE EMBS, P6609; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	43	47	47	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67713	10.1371/journal.pone.0067713	http://dx.doi.org/10.1371/journal.pone.0067713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861789	gold, Green Published			2022-12-25	WOS:000323350700027
J	Carvalho, SM; Andisi, VF; Gradstedt, H; Neef, J; Kuipers, OP; Neves, AR; Bijlsma, JJE				Carvalho, Sandra M.; Andisi, Vahid Farshchi; Gradstedt, Henrik; Neef, Jolanda; Kuipers, Oscar P.; Neves, Ana R.; Bijlsma, Jetta J. E.			Pyruvate Oxidase Influences the Sugar Utilization Pattern and Capsule Production in Streptococcus pneumoniae	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; IN-VIVO; LACTOBACILLUS-PLANTARUM; LACTOCOCCUS-LACTIS; CELLULAR PHOSPHOGLUCOMUTASE; POLYSACCHARIDE BIOSYNTHESIS; PHENOTYPIC VARIANTS; RESPIRATORY-TRACT; EPITHELIAL-CELLS; GENOME SEQUENCE	Pyruvate oxidase is a key function in the metabolism and lifestyle of many lactic acid bacteria and its activity depends on the presence of environmental oxygen. In Streptococcus pneumoniae the protein has been suggested to play a major role in metabolism and has been implicated in virulence, oxidative stress survival and death in stationary phase. Under semi-aerobic conditions, transcriptomic and metabolite profiling analysis of a spxB mutant grown on glucose showed minor changes compared to the wild type, apart from the significant induction of two operons involved in carbohydrate uptake and processing. This induction leads to a change in the sugar utilization capabilities of the bacterium, as indicated by the analysis of the growth profiles of the D39 parent and spxB mutant on alternative carbohydrates. Metabolic analysis and growth experiments showed that inactivation of SpxB has no effect on the glucose fermentation pattern, except under aerobic conditions. More importantly, we show that mutation of spxB results in the production of increased amounts of capsule, the major virulence factor of S. pneumoniae. Part of this increase can be attributed to induction of capsule operon (cps) transcription. Therefore, we propose that S. pneumoniae utilizes pyruvate oxidase as an indirect sensor of the oxygenation of the environment, resulting in the adaption of its nutritional capability and the amount of capsule to survive in the host.	[Carvalho, Sandra M.; Neves, Ana R.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Andisi, Vahid Farshchi; Gradstedt, Henrik; Neef, Jolanda] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Universidade Nova de Lisboa; University of Groningen; University of Groningen	Bijlsma, JJE (corresponding author), Univ Groningen, Dept Med Microbiol, Univ Med Ctr Groningen, Groningen, Netherlands.	j.j.e.bijlsma@umcg.nl	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735; Carvalho, Sandra/0000-0002-3144-411X; Neef, Jolanda/0000-0002-4898-4948	Fundacao para a Ciencia e a Tecnologia (FCT) Ph.D. grant [SFRH/BD/35947/2007]; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); FEDER [PTDC/BIA-MIC/099963/2008, PEst-OE/EQB/LA0004/2011]; Programa Operacional Ciencia e Inovacao (POCTI); FCT; Rosalind Franklin Fellow of the UMCG; NWO [40-00506-98-9021, 175-010-2009-023]	Fundacao para a Ciencia e a Tecnologia (FCT) Ph.D. grant; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); Programa Operacional Ciencia e Inovacao (POCTI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Rosalind Franklin Fellow of the UMCG; NWO(Netherlands Organization for Scientific Research (NWO))	S. M. Carvalho was supported by Fundacao para a Ciencia e a Tecnologia (FCT) Ph.D. grant (SFRH/BD/35947/2007). The Portuguese team work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) and FEDER, project PTDC/BIA-MIC/099963/2008 and through grant PEst-OE/EQB/LA0004/2011. The NMR spectrometers are part of The National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010" and FCT. JJE Bijlsma and H. Gradstedt were funded by a Rosalind Franklin Fellow of the UMCG. Part of this work has been performed at the UMCG Microscopy and Imaging center (UMIC), which is sponsored by NWO-grants 40-00506-98-9021, and 175-010-2009-023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Belanger AE, 2004, J BACTERIOL, V186, P8164, DOI 10.1128/JB.186.24.8164-8171.2004; Benisty R, 2010, BBA-MOL CELL BIOL L, V1801, P1098, DOI 10.1016/j.bbalip.2010.06.004; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Braun JS, 2002, J CLIN INVEST, V109, P19; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058492; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; DUANE PG, 1993, INFECT IMMUN, V61, P4392, DOI 10.1128/IAI.61.10.4392-4397.1993; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Gualdi L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-200; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hardy GG, 2000, J BACTERIOL, V182, P1854, DOI 10.1128/JB.182.7.1854-1863.2000; Hardy GG, 2001, INFECT IMMUN, V69, P2309, DOI 10.1128/IAI.69.4.2309-2317.2001; Hirst RA, 2000, INFECT IMMUN, V68, P1557, DOI 10.1128/IAI.68.3.1557-1562.2000; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Karlyshev AV, 2000, BIOTECHNIQUES, V28, P1078, DOI 10.2144/00286bm05; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Li-Korotky HS, 2009, INT J PEDIATR OTORHI, V73, P1417, DOI 10.1016/j.ijporl.2009.07.007; Lorquet F, 2004, J BACTERIOL, V186, P3749, DOI 10.1128/JB.186.12.3749-3759.2004; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Meiattini F, 1988, METHOD ENZYMAT AN, P566; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Neef J, 2011, INFECT IMMUN, V79, P2314, DOI 10.1128/IAI.00677-10; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Obaro S, 2002, J MED MICROBIOL, V51, P98, DOI 10.1099/0022-1317-51-2-98; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Orihuela CJ, 2003, SCAND J INFECT DIS, V35, P647, DOI 10.1080/00365540310015854; Overweg K, 2000, INFECT IMMUN, V68, P4604, DOI 10.1128/IAI.68.8.4604-4610.2000; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Pericone CD, 2002, J BACTERIOL, V184, P4392, DOI 10.1128/JB.184.16.4392-4399.2002; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Pesakhov S, 2007, BBA-BIOMEMBRANES, V1768, P590, DOI 10.1016/j.bbamem.2006.12.016; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; Price CE, 2011, FEMS MICROBIOL REV; Ramos A, 2001, APPL ENVIRON MICROB, V67, P33, DOI 10.1128/AEM.67.1.33-41.2001; Ramos-Montanez S, 2008, MOL MICROBIOL, V67, P729, DOI 10.1111/j.1365-2958.2007.06082.x; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Sanders JW, 1998, MOL GEN GENET, V257, P681, DOI 10.1007/s004380050697; SEDEWITZ B, 1984, J BACTERIOL, V160, P462, DOI 10.1128/JB.160.1.462-465.1984; Seki M, 2004, J BACTERIOL, V186, P2046, DOI 10.1128/JB.186.7.2046-2051.2004; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Taniai H, 2008, J BACTERIOL, V190, P3572, DOI 10.1128/JB.01882-07; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Weiser JN, 2001, INFECT IMMUN, V69, P5430, DOI 10.1128/IAI.69.9.5430-5439.2001; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944; Yum DY, 1999, APPL ENVIRON MICROB, V65, P3341; Zheng LY, 2011, APPL ENVIRON MICROB, V77, P4318, DOI 10.1128/AEM.00309-11; Zheng LY, 2011, J BACTERIOL, V193, P516, DOI 10.1128/JB.01131-10	70	31	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68277	10.1371/journal.pone.0068277	http://dx.doi.org/10.1371/journal.pone.0068277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844180	gold, Green Submitted, Green Published			2022-12-25	WOS:000321733000137
J	Deng, N; Sanchez, CG; Lasky, JA; Zhu, DX				Deng, Nan; Sanchez, Cecilia G.; Lasky, Joseph A.; Zhu, Dongxiao			Detecting Splicing Variants in Idiopathic Pulmonary Fibrosis from Non-Differentially Expressed Genes	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; RNA-SEQ EXPERIMENTS; MESSENGER-RNA; PEROXISOME PROLIFERATION; CHROMATIN ORGANIZATION; DNA METHYLATION; TENASCIN-C; EXON ARRAY; LUNG; PROTEIN	Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease of unknown cause that lacks a proven therapy for altering its high mortality rate. Microarrays have been employed to investigate the pathogenesis of IPF, but are presented mostly at the gene-expression level due to technologic limitations. In as much as, alternative RNA splicing isoforms are increasingly identified as potential regulators of human diseases, including IPF, we propose a new approach with the capacity to detect splicing variants using RNA-seq data. We conducted a joint analysis of differential expression and differential splicing on annotated human genes and isoforms, and identified 122 non-differentially expressed genes with a high degree of "switch'' between major and minor isoforms. Three cases with variant mechanisms for alternative splicing were validated using qRT-PCR, among the group of genes in which expression was not significantly changed at the gene level. We also identified 35 novel transcripts that were unique to the fibrotic lungs using exon-exon junction evidence, and selected a representative for qRT-PCR validation. The results of our study are likely to provide new insight into the pathogenesis of pulmonary fibrosis and may eventuate in new treatment targets.	[Deng, Nan; Zhu, Dongxiao] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Sanchez, Cecilia G.; Lasky, Joseph A.] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA	Wayne State University; Tulane University	Lasky, JA (corresponding author), Tulane Univ, Sch Med, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.	jlasky@tulane.edu; dzhu@wayne.edu	Zhu, Dongxiao/G-4049-2010		Tulane health sciences center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103629] Funding Source: NIH RePORTER	Tulane health sciences center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported a pilot grant from Tulane health sciences center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadou C, 2011, DNA CELL BIOL, V30, P267, DOI 10.1089/dna.2010.1094; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Cao WH, 1997, RNA, V3, P1456; Chen W, 2010, NUCLEIC ACIDS RES, V38, P2788, DOI 10.1093/nar/gkq007; Cho JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-8; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Choi JK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r70; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Deng N, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr042; El-Karef A, 2007, J HEPATOL, V46, P664, DOI 10.1016/j.jhep.2006.10.011; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Karnati S, 2008, HISTOCHEM CELL BIOL, V130, P719, DOI 10.1007/s00418-008-0462-3; Karnati S, 2009, HISTOCHEM CELL BIOL, V131, P447, DOI 10.1007/s00418-009-0566-4; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kliment CR, 2010, FREE RADICAL BIO MED, V49, P707, DOI 10.1016/j.freeradbiomed.2010.04.036; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Laajala E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r77; Lasky JA, 2000, ENVIRON HEALTH PERSP, V108, P751, DOI 10.2307/3454412; Li XL, 2005, CELL CYCLE, V4, P1706, DOI 10.4161/cc.4.12.2210; Liu NS, 2009, EMBO J, V28, P3485, DOI 10.1038/emboj.2009.282; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Neverov AD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-266; Nicolas P, 2009, BIOINFORMATICS, V25, P2341, DOI 10.1093/bioinformatics/btp395; Plate M, 2010, MOL CELLS, V29, P355, DOI 10.1007/s10059-010-0038-7; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Ramani AK, 2011, GENOME RES, V21, P342, DOI 10.1101/gr.114645.110; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roser-Page S, 2011, AM J MED SCI; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shen SH, 2010, BIOINFORMATICS, V26, P268, DOI 10.1093/bioinformatics/btp643; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tanaka H, 2006, LIVER INT, V26, P311, DOI 10.1111/j.1478-3231.2005.01229.x; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Titorenko VI, 2011, TRAFFIC, V12, P252, DOI 10.1111/j.1600-0854.2010.01144.x; Torres-Gonzalez E, 2012, AM J RESP CELL MOL, V46, P748, DOI 10.1165/rcmb.2011-0224OC; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White ES, 2010, EXP CELL RES, V316, P2644, DOI 10.1016/j.yexcr.2010.06.028; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; ZHAO Y, 1995, AM J PHYSIOL-LUNG C, V268, pL173, DOI 10.1152/ajplung.1995.268.2.L173	72	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68352	10.1371/journal.pone.0068352	http://dx.doi.org/10.1371/journal.pone.0068352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844188	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000154
J	Palmer, AL; Dolan, BP				Palmer, Amy L.; Dolan, Brian P.			MHC Class I Antigen Presentation of DRiP-Derived Peptides from a Model Antigen Is Not Dependent on the AAA ATPase p97	PLOS ONE			English	Article							DEFECTIVE RIBOSOMAL PRODUCTS; CROSS-PRESENTATION; ENDOPLASMIC-RETICULUM; DENDRITIC CELLS; PROTEIN-SYNTHESIS; VIRAL PROTEIN; MAJOR SOURCE; DEGRADATION; VCP/P97; PHAGOCYTOSIS	CD8(+) T cells are responsible for killing cells of the body that have become infected or oncogenically transformed. In order to do so, effector CD8(+) T cells must recognize their cognate antigenic peptide bound to a MHC class I molecule that has been directly presented by the target cell. Due to the rapid nature of antigen presentation, it is believed that antigenic peptides are derived from a subset of newly synthesized proteins which are degraded almost immediately following synthesis and termed Defective Ribosomal Products or DRiPs. We have recently reported on a bioassay which can distinguish antigen presentation of DRiP substrates from other forms of rapidly degraded proteins and found that poly-ubiquitin chain disassembly may be necessary for efficient DRiP presentation. The AAA ATPase p97 protein is necessary for efficient crosspresentation of antigens on MHC class I molecules and plays an important role in extracting mis-folded proteins from the endoplasmic reticulum. Here, we find that genetic ablation or chemical inhibition of p97 does not diminish DRiP antigen presentation to any great extent nor does it alter the levels of MHC class I molecules on the cell surface, despite our observations that p97 inhibition increased the levels of poly-ubiquitinated proteins in the cell. These data demonstrate that inhibiting poly-ubiquitin chain disassembly alone is insufficient to abolish DRiP presentation.	[Palmer, Amy L.; Dolan, Brian P.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA	Oregon State University	Dolan, BP (corresponding author), Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA.	Brian.Dolan@oregonstate.edu			NIH [1K22AI089861 - 01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI089861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH grant 1K22AI089861 - 01A1 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Cardinaud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008692; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096; Dolan BP, 2010, J IMMUNOL, V185, P6728, DOI 10.4049/jimmunol.1002543; Dolan BP, 2010, J IMMUNOL, V184, P1419, DOI 10.4049/jimmunol.0901907; ESQUIVEL F, 1992, J EXP MED, V175, P163, DOI 10.1084/jem.175.1.163; Giodini A, 2009, P NATL ACAD SCI USA, V106, P3324, DOI 10.1073/pnas.0813305106; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; KORMAN AJ, 1980, J EXP MED, V152, pS65; Larsson M, 2001, EUR J IMMUNOL, V31, P3432, DOI 10.1002/1521-4141(200112)31:12<3432::AID-IMMU3432>3.0.CO;2-R; Lev A, 2010, P NATL ACAD SCI USA, V107, P6964, DOI 10.1073/pnas.0910997107; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Lu XJ, 2012, P NATL ACAD SCI USA, V109, P15407, DOI 10.1073/pnas.1208696109; Mackay LK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000699; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Soetandyo N, 2010, J CELL SCI, V123, P1031, DOI 10.1242/jcs.059758; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Zehner M, 2011, P NATL ACAD SCI USA, V108, P9933, DOI 10.1073/pnas.1102397108	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67796	10.1371/journal.pone.0067796	http://dx.doi.org/10.1371/journal.pone.0067796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844095	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000098
J	Williams, JAE; Greenwood, J; Moss, SE				Williams, Jennifer A. E.; Greenwood, John; Moss, Stephen E.			Retinal Changes Precede Visual Dysfunction in the Complement Factor H Knockout Mouse	PLOS ONE			English	Article							MACULAR DEGENERATION; REGULATORY PROTEINS; PIGMENT EPITHELIUM; AGED MICE; GENE; POLYMORPHISM; DEFICIENCY; ACTIVATION; EXPRESSION; MEMBRANE	We previously reported that aged mice lacking complement factor H (CFH) exhibit visual defects and structural changes in the retina. However, it is not known whether this phenotype is age-related or is the consequence of disturbed development. To address this question we investigated the effect of Cfh gene deletion on the retinal phenotype of young and mid-age mice. Cfh(-/-) mouse eyes exhibited thickening of the retina and reduced nuclear density, but relatively normal scotopic and photopic electroretinograms. At 12 months there was evidence of subtle astroglial activation in the Cfh(-/-) eyes, and significant elevation of the complement regulator, decay-accelerating factor (DAF) in Muller cells. In the retinal pigment epithelium (RPE) of young control and Cfh(-/-) animals mitochondria and melanosomes were oriented basally and apically respectively, whereas the apical positioning of melanosomes was significantly perturbed in the mid-age Cfh(-/-) RPE. We conclude that deletion of Cfh in the mouse leads to defects in the retina that precede any marked loss of visual function, but which become progressively more marked as the animals age. These observations are consistent with a lifelong role for CFH in retinal homeostasis.	[Williams, Jennifer A. E.; Greenwood, John; Moss, Stephen E.] UCL Inst Ophthalmol, Dept Cell Biol, London, England	University of London; University College London	Moss, SE (corresponding author), UCL Inst Ophthalmol, Dept Cell Biol, London, England.	s.moss@ucl.ac.uk		Greenwood, John/0000-0003-4496-2984	Medical Research Council; Wellcome Trust [090669]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	The work was funded by the Medical Research Council and the Wellcome Trust (grant reference 090669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Chang B, 2008, HUM MOL GENET, V17, P3929, DOI 10.1093/hmg/ddn295; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Faber C, 2012, INVEST OPHTH VIS SCI, V53, P6324, DOI 10.1167/iovs.12-10385; Fett AL, 2012, HISTOL HISTOPATHOL, V27, P357, DOI 10.14670/HH-27.357; Gouras P, 2010, GRAEF ARCH CLIN EXP, V248, P973, DOI 10.1007/s00417-010-1325-x; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Kim YH, 2009, GRAEF ARCH CLIN EXP, V247, P651, DOI 10.1007/s00417-009-1049-y; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Lyzogubov VV, 2010, AM J PATHOL, V177, P1870, DOI 10.2353/ajpath.2010.091168; Mandal NA, 2006, INVEST OPHTH VIS SCI, V47, P4091, DOI 10.1167/iovs.05-1655; MISHIMA H, 1981, EXP EYE RES, V33, P75, DOI 10.1016/S0014-4835(81)80083-8; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw PX, 2012, P NATL ACAD SCI USA, V109, P13757, DOI 10.1073/pnas.1121309109; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195; Ufret-Vincenty RL, 2010, INVEST OPHTH VIS SCI, V51, P5878, DOI 10.1167/iovs.09-4457; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; WING GL, 1978, INVEST OPHTH VIS SCI, V17, P601	27	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68616	10.1371/journal.pone.0068616	http://dx.doi.org/10.1371/journal.pone.0068616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844226	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000175
J	Zhang, XL; Jiang, L; Wang, GQ; Yu, L; Zhang, Q; Xin, Q; Wu, W; Gong, ZZ; Chen, ZZ				Zhang, Xingliang; Jiang, Lun; Wang, Guoqiang; Yu, Lin; Zhang, Qi; Xin, Qi; Wu, Wei; Gong, Zhizhong; Chen, Zhongzhou			Structural Insights into the Abscisic Acid Stereospecificity by the ABA Receptors PYR/PYL/RCAR	PLOS ONE			English	Article							MOLECULAR-BASIS; INHIBITION; MECHANISM; ANALOGS; COMPLEX; REVEAL	The phytohormone abscisic acid ((+)-ABA) plays a key role in many processes. The biological and biochemical activities of unnatural (-)-ABA have been extensively investigated since 1960s. However, the recognition mechanism by which only a few members among PYR/PYL/RCAR (PYLs) family can bind (-)-ABA remains largely unknown. Here we systematically characterized the affinity of PYLs binding to the (-)-ABA and reported the crystal structures of apo-PYL5, PYL3-(-)-ABA and PYL9-(+)-ABA. PYL5 showed the strongest binding affinity with (-)-ABA among all the PYLs. PYL9 is a stringently exclusive (+)-ABA receptor with interchangeable disulfide bonds shared by a subclass of PYLs. PYL3 is a dual receptor to both ABA enantiomers. The binding orientation and pocket of (-)-ABA in PYLs are obviously different from those of (+)-ABA. Steric hindrance and hydrophobic interaction are the two key factors in determining the stereospecificity of PYLs binding to (-)-ABA, which is further confirmed by gain-of-function and loss-of-function mutagenesis. Our results provide novel insights of the bioactivity of ABA enantiomers onto PYLs, and shed light on designing the selective ABA receptors agonists.	[Zhang, Xingliang; Jiang, Lun; Wang, Guoqiang; Yu, Lin; Zhang, Qi; Wu, Wei; Chen, Zhongzhou] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhang, Xingliang] Guangdong Med Coll, Clin Med Res Ctr, Affiliated Hosp, Guangzhou, Guangdong, Peoples R China; [Xin, Qi; Gong, Zhizhong] China Agr Univ, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University; Guangdong Medical University; China Agricultural University	Chen, ZZ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	chenzhongzhou@cau.edu.cn	Gong, Zhizhong/AAS-4796-2021; chen, zhong/E-3900-2015	chen, zhong/0000-0003-1319-9664; Zhang, Qi/0000-0003-1121-8817	Chinese Universities Scientific Fund [2013QJ027]; National Basic Research Program of China (973 Program) [2011CB965304, 2009CB825501]; National Natural Science Foundation of China [31222032, 90919043, 31070664, J1103520]; Fok Ying Tung Education Foundation [121025]	Chinese Universities Scientific Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by Chinese Universities Scientific Fund (2013QJ027), National Basic Research Program of China (973 Program, 2011CB965304 and 2009CB825501), National Natural Science Foundation of China (31222032, 90919043 and 31070664), Chinese Universities Scientific Fund and Fok Ying Tung Education Foundation (121025). YL was supported by National Natural Science Foundation of China (J1103520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BALSEVICH JJ, 1994, PLANT PHYSIOL, V106, P135, DOI 10.1104/pp.106.1.135; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dupeux F, 2011, EMBO J, V30, P4171, DOI 10.1038/emboj.2011.294; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Hao Q, 2011, MOL CELL, V42, P662, DOI 10.1016/j.molcel.2011.05.011; Huang DQ, 2007, PLANT J, V50, P414, DOI 10.1111/j.1365-313X.2007.03056.x; Lin BL, 2005, J EXP BOT, V56, P2935, DOI 10.1093/jxb/eri290; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; MILBORROW BV, 1974, ANNU REV PLANT PHYS, V25, P259, DOI 10.1146/annurev.pp.25.060174.001355; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nambara E, 2002, GENETICS, V161, P1247; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Sun DM, 2012, BIOCHEM BIOPH RES CO, V418, P122, DOI 10.1016/j.bbrc.2011.12.145; Szostkiewicz I, 2010, PLANT J, V61, P25, DOI 10.1111/j.1365-313X.2009.04025.x; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALKERSIMMONS MK, 1992, PLANT PHYSIOL, V99, P501, DOI 10.1104/pp.99.2.501; WALKERSIMMONS MK, 1994, PLANT PHYSIOL, V106, P1279, DOI 10.1104/pp.106.4.1279; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhang XL, 2012, STRUCTURE, V20, P780, DOI 10.1016/j.str.2012.02.019	31	33	44	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67477	10.1371/journal.pone.0067477	http://dx.doi.org/10.1371/journal.pone.0067477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844015	gold, Green Submitted, Green Published			2022-12-25	WOS:000321341000048
J	Luo, SC; Lou, YC; Rajasekaran, M; Chang, YW; Hsiao, CD; Chen, CP				Luo, Shih-Chi; Lou, Yuan-Chao; Rajasekaran, Mahalingam; Chang, Yi-Wei; Hsiao, Chwan-Deng; Chen, Chinpan			Structural Basis of a Physical Blockage Mechanism for the Interaction of Response Regulator PmrA with Connector Protein PmrD from Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; POLYMYXIN-RESISTANT; 2-COMPONENT SYSTEM; RECEIVER DOMAIN; ACTIVATION; PHOSPHORYLATION; CHEY; STABILITY; PATHWAYS	In bacteria, the two-component system is the most prevalent for sensing and transducing environmental signals into the cell. The PmrA-PmrB two-component system, responsible for sensing external stimuli of high Fe3+ and mild acidic conditions, can control the genes involved in lipopolysaccharide modification and polymyxin resistance in pathogens. In Klebsiella pneumoniae, the small basic connector protein PmrD protects phospho- PmrA and prolongs the expression of PmrA-activated genes. We previously determined the phospho-PmrA recognition mode of PmrD. However, how PmrA interacts with PmrD and prevents its dephosphorylation remains unknown. To address this question, we solved the x-ray crystal structure of the N-terminal receiver domain of BeF3--activated PmrA ( PmrA(N)) at 1.70 angstrom. With this structure, we applied the data-driven docking method based on NMR chemical shift perturbation to generate the complex model of PmrD-PmrA(N), which was further validated by site-directed spin labeling experiments. In the complex model, PmrD may act as a blockade to prevent phosphatase from contacting with the phosphorylation site on PmrA.	[Luo, Shih-Chi; Lou, Yuan-Chao; Rajasekaran, Mahalingam; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Chang, Yi-Wei; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Chen, Chinpan] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Chung Hsing University	Chen, CP (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	bmchinp@ibms.sinica.edu.tw	Mahalingam, Rajasekaran/E-2065-2013; Luo, Shih-Chi/C-1042-2011; Hsiao, Chwan-Deng/AAZ-8869-2021; Chen, Chinpan/O-4202-2018; Chang, Yi-Wei/ABH-1418-2020	Luo, Shih-Chi/0000-0001-7723-3230; Hsiao, Chwan-Deng/0000-0002-7012-1532; Chang, Yi-Wei/0000-0003-2391-473X; Mahalingam, Rajasekaran/0000-0003-2228-5628	Academia Sinica; National Science Council in Taiwan [NSC 97-2311-B-001-013-MY3]; Ministry of Education (Taiwan) under the ATU plan	Academia Sinica(Academia Sinica - Taiwan); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education (Taiwan) under the ATU plan(Ministry of Education, Taiwan)	This work was supported by grants from Academia Sinica and the National Science Council (NSC 97-2311-B-001-013-MY3) in Taiwan and in part by the Ministry of Education (Taiwan) under the ATU plan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Asensio A, 2000, CLIN INFECT DIS, V30, P55, DOI 10.1086/313590; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Birck C, 2003, J BACTERIOL, V185, P254, DOI 10.1128/JB.185.1.254-261.2003; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Cho HS, 2001, CURR OPIN STRUC BIOL, V11, P679, DOI 10.1016/S0959-440X(01)00271-8; CHOTHIA C, 1976, P NATL ACAD SCI USA, V73, P3793, DOI 10.1073/pnas.73.11.3793; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; Gerken H, 2009, MOL MICROBIOL, V72, P1408, DOI 10.1111/j.1365-2958.2009.06728.x; Goddard T. D., 2008, SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Helander IM, 1996, EUR J BIOCHEM, V237, P272, DOI 10.1111/j.1432-1033.1996.0272n.x; Hoch J.A., 1995, 2 COMPONENT SIGNAL T, DOI [10.1128/9781555818319, DOI 10.1128/9781555818319]; Itou J, 2009, BIOSCI BIOTECH BIOCH, V73, P870, DOI 10.1271/bbb.80795; JANIN J, 1976, J MOL BIOL, V100, P197, DOI 10.1016/S0022-2836(76)80148-9; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; Luo SC, 2010, J STRUCT BIOL, V172, P319, DOI 10.1016/j.jsb.2010.06.007; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; O'Connell MR, 2009, PROTEOMICS, V9, P5224, DOI 10.1002/pmic.200900303; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parashar V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000589; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Perraud AL, 1999, TRENDS MICROBIOL, V7, P115, DOI 10.1016/S0966-842X(99)01458-4; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Sambrook J., 1989, MOL CLONING LABORATO, V3, pA3; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; Stock AM, 2006, J BACTERIOL, V188, P7328, DOI 10.1128/JB.01268-06; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; Varughese KI, 2006, J BACTERIOL, V188, P4970, DOI 10.1128/JB.00160-06; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wolanin PM, 2003, BIOCHEMISTRY-US, V42, P14075, DOI 10.1021/bi034883t; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0; Yamada S, 2009, STRUCTURE, V17, P1333, DOI 10.1016/j.str.2009.07.016; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	61	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25551	25561		10.1074/jbc.M113.481978	http://dx.doi.org/10.1074/jbc.M113.481978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861396	Green Published, hybrid			2022-12-25	WOS:000330619000050
J	Gao, Y; Liu, Y; Zhou, L; Guo, ZH; Rong, MD; Liu, XN; Lai, CH; Ding, XL				Gao, Yan; Liu, Ying; Zhou, Lei; Guo, Zehong; Rong, Mingdeng; Liu, Xiangning; Lai, Chunhua; Ding, Xianglong			The Effects of Different Wavelength UV Photofunctionalization on Micro-Arc Oxidized Titanium	PLOS ONE			English	Article							APATITE-FORMING ABILITY; SURFACE MODIFICATION; PROTEIN ADSORPTION; CELL RESPONSE; BONE RESPONSE; TIO2; INTEGRATION; IMPLANTS; OSSEOINTEGRATION; DEGRADATION	Many challenges exist in improving early osseointegration, one of the most critical factors in the long-term clinical success of dental implants. Recently, ultraviolet (UV) light-mediated photofunctionalization of titanium as a new potential surface treatment has aroused great interest. This study examines the bioactivity of titanium surfaces treated with UV light of different wavelengths and the underlying associated mechanism. Micro-arc oxidation (MAO) titanium samples were pretreated with UVA light (peak wavelength of 360 nm) or UVC light (peak wavelength of 250 nm) for up to 24 h. UVC treatment promoted the attachment, spread, proliferation and differentiation of MG-63 osteoblast-like cells on the titanium surface, as well as the capacity for apatite formation in simulated body fluid (SBF). These biological influences were not observed after UVA treatment, apart from a weaker effect on apatite formation. The enhanced bioactivity was substantially correlated with the amount of Ti-OH groups, which play an important role in improving the hydrophilicity, along with the removal of hydrocarbons on the titanium surface. Our results showed that both UVA and UVC irradiation altered the chemical properties of the titanium surface without sacrificing its excellent physical characteristics, suggesting that this technology has extensive potential applications and merits further investigation.	[Gao, Yan; Liu, Ying; Zhou, Lei; Lai, Chunhua; Ding, Xianglong] Southern Med Univ, Guangdong Prov Stomatol Hosp, Ctr Oral Implantol, Guangzhou, Guangdong, Peoples R China; [Liu, Ying] Southern Med Univ, Dept Stomatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Liu, Ying] Southern Med Univ, Coll Stomatol, Guangzhou, Guangdong, Peoples R China; [Guo, Zehong; Rong, Mingdeng] Southern Med Univ, Guangdong Prov Stomatol Hosp, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China; [Liu, Xiangning] Jinan Univ, Guangzhou Overseas Chinese Hosp, Dept Prosthodont, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Jinan University	Zhou, L (corresponding author), Southern Med Univ, Guangdong Prov Stomatol Hosp, Ctr Oral Implantol, Guangzhou, Guangdong, Peoples R China.	zho668@263.net	rong, mingdeng/GRJ-8507-2022		National Natural Science Foundation of China [81170998]; Medical Science Research Foundation of Guangdong Province [C2012034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science Research Foundation of Guangdong Province	The study was supported by the National Natural Science Foundation of China (http://nsfc.pubmed.cn/)(No. 81170998) and Medical Science Research Foundation of Guangdong Province (http://www.gdwst.gov.cn/) (C2012034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita H, 2009, ACTA BIOMATER, V5, P3247, DOI 10.1016/j.actbio.2009.04.022; Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Alborzi A, 1996, J CRAN GENET DEV BIO, V16, P94; Att W, 2009, BIOMATERIALS, V30, P4268, DOI 10.1016/j.biomaterials.2009.04.048; Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016; Chen XB, 2008, BIOTECHNOL BIOENG, V101, P378, DOI 10.1002/bit.21900; Colombo JS, 2012, J DENT, V40, P338, DOI 10.1016/j.jdent.2012.01.010; Cooper LF, 1998, J PROSTHET DENT, V80, P439, DOI 10.1016/S0022-3913(98)70009-5; Davies JE, 1998, INT J PROSTHODONT, V11, P391; Davies John E, 2003, J Dent Educ, V67, P932; Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049; De Maeztu MA, 2008, INT J ORAL MAX SURG, V37, P441, DOI 10.1016/j.ijom.2008.01.010; Di Veroli GY, 2013, AM J PHYSIOL-HEART C, V304, pH104, DOI 10.1152/ajpheart.00511.2012; Doi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049051; Guo ZH, 2010, INT J ORAL MAX IMPL, V25, P130; Han Y, 2008, ACTA BIOMATER, V4, P1518, DOI 10.1016/j.actbio.2008.03.005; Hori N, 2010, INT J ORAL MAX IMPL, V25, P49; Iwasa F, 2011, INT J NANOMED, V6, P1327, DOI 10.2147/IJN.S22099; Jager M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/69036; Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.011; Kandori K, 2009, J PHYS CHEM B, V113, P11016, DOI 10.1021/jp904481z; Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1; Lee YJ, 2012, J PERIODONTAL IMPLAN, V42, P81, DOI 10.5051/jpis.2012.42.3.81; Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048; Lim YW, 2009, CLIN ORTHOP RELAT R, V467, P2251, DOI 10.1007/s11999-009-0879-6; Linderback P, 2010, BIOMATERIALS, V31, P4795, DOI 10.1016/j.biomaterials.2010.02.060; Mata A, 2003, IEEE T NANOBIOSCI, V2, P287, DOI 10.1109/TNB.2003.820268; Miyauchi T, 2010, BIOMATERIALS, V31, P3827, DOI 10.1016/j.biomaterials.2010.01.133; Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200; Ohno H, 1998, Dent Mater J, V17, P285; Price NJ, 1999, J ELECTRON SPECTROSC, V98, P257, DOI 10.1016/S0368-2048(98)00291-6; Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X; Raghavendra S, 2005, INT J ORAL MAX IMPL, V20, P425; Rupp F, 2011, INT J ORAL MAX IMPL, V26, P1256; Sawase T, 2007, CLIN ORAL IMPLAN RES, V18, P680, DOI 10.1111/j.1600-0501.2007.01404.x; Son HS, 2009, J HAZARD MATER, V166, P954, DOI 10.1016/j.jhazmat.2008.11.107; Sul Young-Taeg, 2002, Clin Implant Dent Relat Res, V4, P78, DOI 10.1111/j.1708-8208.2002.tb00156.x; Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8; Tsukimura N, 2011, BIOMATERIALS, V32, P4358, DOI 10.1016/j.biomaterials.2011.03.001; Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414; Ueno T, 2011, BIOMATERIALS, V32, P7297, DOI 10.1016/j.biomaterials.2011.06.033; Viornery C, 2002, LANGMUIR, V18, P2582, DOI 10.1021/la010908i; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Wong CC, 2003, CHEMOSPHERE, V50, P981, DOI 10.1016/S0045-6535(02)00640-9; Yada M, 2010, COLLOID SURFACE B, V80, P116, DOI 10.1016/j.colsurfb.2010.05.032; Yan SF, 2011, COLLOID SURFACE B, V86, P218, DOI 10.1016/j.colsurfb.2011.04.004; Yang ZP, 2008, ACTA BIOMATER, V4, P560, DOI 10.1016/j.actbio.2007.10.003; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320; Zhao XY, 2011, COLLOID SURFACE B, V86, P260, DOI 10.1016/j.colsurfb.2011.03.044	49	32	33	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68086	10.1371/journal.pone.0068086	http://dx.doi.org/10.1371/journal.pone.0068086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861853	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300041
J	Majek, O; Gondos, A; Jansen, L; Emrich, K; Holleczek, B; Katalinic, A; Nennecke, A; Eberle, A; Brenner, H				Majek, Ondrej; Gondos, Adam; Jansen, Lina; Emrich, Katharina; Holleczek, Bernd; Katalinic, Alexander; Nennecke, Alice; Eberle, Andrea; Brenner, Hermann		GEKID Canc Survival Working Grp	Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; LONG-TERM SURVIVAL; UP-TO-DATE; GENDER INFLUENCES TREATMENT; EUROCARE HIGH-RESOLUTION; PERIOD ANALYSIS; RELATIVE SURVIVAL; POSTMENOPAUSAL WOMEN; EARLY 21ST-CENTURY; COLON-CANCER	Risk of colorectal cancer (CRC) is considerably higher in men compared to women; however, there is inconclusive evidence of sex differences in CRC prognosis. We aimed to assess and explain sex differences in 5-year relative survival using standard and model-based period analysis among 164,996 patients diagnosed with CRC from 1997 to 2006 and reported to 11 German cancer registries covering a population of 33 million inhabitants. Age-adjusted 5-year relative survival was higher in women (64.5% vs. 61.9%, P < 0.0001). A substantial survival advantage of women was confirmed in multivariate analysis after adjusting for CRC stage and subsite in subjects under 65 years of age (relative excess risk, RER 0.86, 95% CI 0.82-0.90), but not in older subjects (RER 1.01, 95% CI 0.98-1.04); this pattern was similar in the 1st and in the 2nd to 5th year after diagnosis. The survival advantage of women varied by CRC stage and age and was most pronounced for localized disease (RERs 0.59-0.88 in various age subgroups) and in patients under 45 years of age (RERs 0.59, 0.72 and 0.76 in patients with localized, regional or advanced disease, respectively). On the contrary, sex differences in survival did not vary by location of CRC. In conclusion, our large population-based study confirmed a survival advantage of female compared to male CRC patients, most notably in young and middle aged patients and patients with localized disease. The effect of sex hormones, either endogenous or through hormonal replacement therapy, might be the most plausible explanation for the observed patterns.	[Majek, Ondrej; Gondos, Adam; Jansen, Lina] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Majek, Ondrej] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic; [Emrich, Katharina] Johannes Gutenberg Univ Mainz, Canc Registry Rhineland Palatinate, Inst Med Biostat Epidemiol & Informat, Univ Med Ctr, D-55122 Mainz, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Katalinic, Alexander] Med Univ Lubeck, Inst Canc Epidemiol, Canc Registry Schleswig Holstein, D-23538 Lubeck, Germany; [Nennecke, Alice] Minist Hlth & Consumer Protect, Hamburg Canc Registry, Hamburg, Germany; [Eberle, Andrea] Leibniz Inst Prevent Res & Epidemiol BIPS, Canc Registry Bremen, Bremen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Institute of Biostatistics & Analyses; Masaryk University Brno; Johannes Gutenberg University of Mainz; University of Lubeck; Leibniz Institute for Prevention Research & Epidemiology (BIPS)	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.	h.brenner@dkfz.de	Katalinic, Alexander/D-2512-2010; Jansen, Lina/D-7255-2016; Brenner, Hermann/ABE-6383-2020; Majek, Ondrej/E-4521-2011; Brenner, Hermann/B-4627-2017	Katalinic, Alexander/0000-0003-0490-1554; Jansen, Lina/0000-0001-8004-4940; Brenner, Hermann/0000-0002-6129-1572; Majek, Ondrej/0000-0002-0034-3084; Brenner, Hermann/0000-0002-6129-1572	German Cancer Aid (Deutsche Krebshilfe) [108257]; Masaryk University [MUNI/A/0828/2011]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Masaryk University	This work was supported by the German Cancer Aid (Deutsche Krebshilfe, www.krebshilfe.de, grant number 108257) and Masaryk University (www.muni.cz, grant number MUNI/A/0828/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrino F, 2002, ENCR RECOMMENDATION; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Brenner H, 2002, INT J EPIDEMIOL, V31, P456, DOI 10.1093/ije/31.2.456; Brenner H, 2002, J CLIN ONCOL, V20, P826, DOI 10.1200/JCO.20.3.826; Brenner H, 2002, EUR J CANCER, V38, P690, DOI 10.1016/S0959-8049(02)00003-5; Brenner H, 2006, AM J EPIDEMIOL, V164, P689, DOI 10.1093/aje/kwj243; Chan JA, 2006, J CLIN ONCOL, V24, P5680, DOI 10.1200/JCO.2006.08.0580; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Cosper PF, 2011, CANCER RES, V71, P1710, DOI 10.1158/0008-5472.CAN-10-3145; Dent OF, 2009, ANN SURG, V249, P402, DOI 10.1097/SLA.0b013e31819a0469; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez E, 2001, BRIT J CANCER, V84, P722, DOI 10.1054/bjoc.2000.1622; Finlayson E, 2009, DIS COLON RECTUM, V52, P1991, DOI 10.1097/01.dcr.0000364983.74288.29; Franceschi S, 2000, BRIT J CANCER, V82, P1860, DOI 10.1054/bjoc.1999.1084; Fritz AG., 2000, INT CLASSIFICATION D, Vvii, P240; Gatta G, 2000, GUT, V47, P533, DOI 10.1136/gut.47.4.533; Gatta G, 2010, ACTA ONCOL, V49, P776, DOI 10.3109/02841861003782009; Gonzalez EC, 2001, DIS COLON RECTUM, V44, P251, DOI 10.1007/BF02234301; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; Heier M, 2009, MATURITAS, V62, P9, DOI 10.1016/j.maturitas.2008.10.002; Heitmann C, 2005, MENOPAUSE, V12, P405, DOI 10.1097/01.GME.0000153890.77135.00; Hendifar A, 2009, CLIN CANCER RES, V15, P6391, DOI 10.1158/1078-0432.CCR-09-0877; HENSON DE, 1995, CANCER-AM CANCER SOC, V76, P1687, DOI 10.1002/1097-0142(19951115)76:10<1687::AID-CNCR2820761002>3.0.CO;2-I; Hiripi E, 2012, ANN ONCOL, V23, P472, DOI 10.1093/annonc/mdr131; Koo JH, 2008, AM J GASTROENTEROL, V103, P1488, DOI 10.1111/j.1572-0241.2007.01779.x; Koo JH, 2010, J GASTROEN HEPATOL, V25, P33, DOI 10.1111/j.1440-1746.2009.05992.x; Majek O, 2012, BRIT J CANCER, V106, P1875, DOI 10.1038/bjc.2012.189; Mandelson MT, 2003, CANCER CAUSE CONTROL, V14, P979, DOI 10.1023/B:CACO.0000007970.04094.76; McArdle CS, 2003, BRIT J SURG, V90, P711, DOI 10.1002/bjs.4098; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Micheli A, 2009, EUR J CANCER, V45, P1017, DOI 10.1016/j.ejca.2008.11.008; Paulson EC, 2009, DIS COLON RECTUM, V52, P1982, DOI 10.1007/DCR.0b013e3181beb42a; Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022; Slattery ML, 1999, CANCER CAUSE CONTROL, V10, P467, DOI 10.1023/A:1008974215622; Stock C, 2010, ENDOSCOPY, V42, P546, DOI 10.1055/s-0029-1244127; Swaminathan R, 2011, IARC Sci Publ, P7; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Wichmann MW, 2001, BRIT J SURG, V88, P1092, DOI 10.1046/j.0007-1323.2001.01819.x; Wong N D, 2001, Prev Cardiol, V4, P109, DOI 10.1111/j.1520-037X.2001.00570.x	42	99	104	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68077	10.1371/journal.pone.0068077	http://dx.doi.org/10.1371/journal.pone.0068077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861851	Green Published, gold			2022-12-25	WOS:000321425300040
J	Pulli, B; Ali, M; Forghani, R; Schob, S; Hsieh, KLC; Wojtkiewicz, G; Linnoila, JJ; Chen, JW				Pulli, Benjamin; Ali, Muhammad; Forghani, Reza; Schob, Stefan; Hsieh, Kevin L. C.; Wojtkiewicz, Gregory; Linnoila, Jenny J.; Chen, John W.			Measuring Myeloperoxidase Activity in Biological Samples	PLOS ONE			English	Article							IN-VIVO; INHIBITION; ASSAY; MICE; POLYMORPHISM; LEUKOCYTE; BIOMARKER; OXIDANTS; DAMAGE	Background: Enzymatic activity measurements of the highly oxidative enzyme myeloperoxidase (MPO), which is implicated in many diseases, are widely used in the literature, but often suffer from nonspecificity and lack of uniformity. Thus, validation and standardization are needed to establish a robust method that is highly specific, sensitive, and reproducible for assaying MPO activity in biological samples. Principal findings: We found conflicting results between in vivo molecular MR imaging of MPO, which measures extracellular activity, and commonly used in vitro MPO activity assays. Thus, we established and validated a protocol to obtain extra- and intracellular MPO from murine organs. To validate the MPO activity assays, three different classes of MPO activity assays were used in spike and recovery experiments. However, these assay methods yielded inconsistent results, likely because of interfering substances and other peroxidases present in tissue extracts. To circumvent this, we first captured MPO with an antibody. The MPO activity of the resultant samples was assessed by ADHP and validated against samples from MPO-knockout mice in murine disease models of multiple sclerosis, steatohepatitis, and myocardial infarction. We found the measurements performed using this protocol to be highly specific and reproducible, and when performed using ADHP, to be highly sensitive over a broad range. In addition, we found that intracellular MPO activity correlated well with tissue neutrophil content, and can be used as a marker to assess neutrophil infiltration in the tissue. Conclusion: We validated a highly specific and sensitive assay protocol that should be used as the standard method for all MPO activity assays in biological samples. We also established a method to obtain extra- and intracellular MPO from murine organs. Extracellular MPO activity gives an estimate of the oxidative stress in inflammatory diseases, while intracellular MPO activity correlates well with tissue neutrophil content. A detailed step-by-step protocol is provided.	[Pulli, Benjamin; Ali, Muhammad; Schob, Stefan; Hsieh, Kevin L. C.; Wojtkiewicz, Gregory; Linnoila, Jenny J.; Chen, John W.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Pulli, Benjamin; Ali, Muhammad; Schob, Stefan; Hsieh, Kevin L. C.; Wojtkiewicz, Gregory; Linnoila, Jenny J.; Chen, John W.] Harvard Univ, Sch Med, Boston, MA USA; [Pulli, Benjamin; Chen, John W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Forghani, Reza] McGill Univ, Jewish Gen Hosp, Dept Radiol, Montreal, PQ H3T 1E2, Canada; [Forghani, Reza] McGill Univ, Montreal, PQ, Canada; [Hsieh, Kevin L. C.] Far Eastern Mem Hosp, Dept Med Imaging, Taipei, Taiwan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; McGill University; McGill University; Far Eastern Memorial Hospital	Chen, JW (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	jwchen@mgh.harvard.edu	Wojtkiewicz, Gregory/L-3660-2018	Wojtkiewicz, Gregory/0000-0002-3148-8411; schob, stefan/0000-0003-2846-5443; Ali, Muhammad/0000-0001-8964-4416; Forghani, Reza/0000-0002-8572-1864; Pulli, Benjamin/0000-0002-1795-9897	NIH [R01-NS070835, R01-NS072167]; Ernst Schering Foundation in Berlin, Germany; National Natural Science Foundation, Beijing, China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070835, R01NS072167] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernst Schering Foundation in Berlin, Germany; National Natural Science Foundation, Beijing, China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the NIH (R01-NS070835 and R01-NS072167 to JWC). Additional funds have come from a fellowship from the Ernst Schering Foundation in Berlin, Germany, and a grant from the National Natural Science Foundation, Beijing, China, awarded to BP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADLEY PP, 1982, BLOOD, V60, P618; Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Chapman AL, 2013, J BIOL CHEM; Chen JW, 2008, BRAIN, V131, P1123, DOI 10.1093/brain/awn004; Chen JW, 2006, RADIOLOGY, V240, P473, DOI 10.1148/radiol.2402050994; Chevrier I, 2006, ATHEROSCLEROSIS, V188, P150, DOI 10.1016/j.atherosclerosis.2005.10.012; Feyler A, 2002, CANCER EPIDEM BIOMAR, V11, P1550; Forghani R, 2012, RADIOLOGY, V263, P451, DOI 10.1148/radiol.12111593; Franck T, 2009, TALANTA, V80, P723, DOI 10.1016/j.talanta.2009.07.052; Gray E, 2008, NEUROSCI LETT, V444, P195, DOI 10.1016/j.neulet.2008.08.035; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Haqqani AS, 1999, ANAL BIOCHEM, V273, P126, DOI 10.1006/abio.1999.4206; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; HOFSTEIN R, 1983, J NEUROCHEM, V40, P1448, DOI 10.1111/j.1471-4159.1983.tb13589.x; Holzer M, 2012, ANTIOXID REDOX SIGN, V17, P1043, DOI 10.1089/ars.2011.4403; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kapralov A, 2009, J BIOL CHEM, V284, P30395, DOI 10.1074/jbc.M109.045567; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Lefkowitz Doris L., 2010, Current Immunology Reviews, V6, P123; Meng Y, 2005, ANAL BIOCHEM, V345, P227, DOI 10.1016/j.ab.2005.07.026; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Miller S. D., 2010, CURR PROTOC IMMUNOL; Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510; O'Driscoll S, 2008, BRIT J HAEMATOL, V140, P206, DOI 10.1111/j.1365-2141.2007.06894.x; ORMROD DJ, 1987, J PHARMACOL METHOD, V18, P137, DOI 10.1016/0160-5402(87)90006-4; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Segelmark M, 1997, CLIN EXP IMMUNOL, V108, P167, DOI 10.1046/j.1365-2249.1997.d01-992.x; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Talib J, 2012, FREE RADICAL BIO MED, V53, P20, DOI 10.1016/j.freeradbiomed.2012.04.018; Whiteman M, 2008, BIOCHEM BIOPH RES CO, V371, P50, DOI 10.1016/j.bbrc.2008.03.153; Wingfield P. T., 2001, CURR PROTOC PROTEIN; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Xia Y, 1997, ANAL BIOCHEM, V245, P93, DOI 10.1006/abio.1996.9940; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	47	209	210	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67976	10.1371/journal.pone.0067976	http://dx.doi.org/10.1371/journal.pone.0067976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861842	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300033
J	Baptista, C; Barreto, HC; Sao-Jose, C				Baptista, Catarina; Barreto, Hugo Condessa; Sao-Jose, Carlos			High Levels of DegU-P Activate an Esat-6-Like Secretion System in Bacillus subtilis	PLOS ONE			English	Article							RESPONSE REGULATOR DEGU; PROTEIN SECRETION; VII SECRETION; CRYSTAL-STRUCTURE; GEL-FILTRATION; VIRULENCE; EXPRESSION; ESX-1; GENE; PATHOGENESIS	The recently discovered Type VII/Esat-6 secretion systems seem to be widespread among bacteria of the phyla Actinobacteria and Firmicutes. In some species they play an important role in pathogenic interactions with eukaryotic hosts. Several studies have predicted that the locus yukEDCByueBC of the non-pathogenic, Gram-positive bacterium Bacillus subtilis would encode an Esat-6-like secretion system (Ess). We provide here for the first time evidences for the functioning of this secretion pathway in an undomesticated B. subtilis strain. We show that YukE, a small protein with the typical features of the secretion substrates from the WXG100 superfamily is actively secreted to culture media. YukE secretion depends on intact yukDCByueBC genes, whose products share sequence or structural homology with known components of the S. aureus Ess. Biochemical characterization of YukE indicates that it exists as a dimer both in vitro and in vivo. We also show that the B. subtilis Ess essentially operates in late stationary growth phase in absolute dependence of phosphorylated DegU, the response regulator of the two-component system DegS-DegU. We present possible reasons that eventually have precluded the study of this secretion system in the B. subtilis laboratory strain 168.	[Baptista, Catarina; Barreto, Hugo Condessa; Sao-Jose, Carlos] Univ Lisbon, CPM URIA, Fac Farm, P-1699 Lisbon, Portugal	Universidade de Lisboa	Sao-Jose, C (corresponding author), Univ Lisbon, CPM URIA, Fac Farm, P-1699 Lisbon, Portugal.	csaojose@ff.ul.pt	Baptista, Catarina/U-8910-2017; Baptista, Catarina/O-9660-2019; iMed.ULisboa, M2B/B-5277-2014; Barreto, Hugo C./AAQ-1945-2020; Sao-Jose, Carlos Jorge/J-6703-2012	Baptista, Catarina/0000-0002-1263-7880; Baptista, Catarina/0000-0002-1263-7880; iMed.ULisboa, M2B/0000-0002-1245-3715; Barreto, Hugo C./0000-0002-6980-1047; Sao-Jose, Carlos Jorge/0000-0002-4890-9446	Fundacao para a Ciencia e a Tecnologia (FCT, MCTES, Portugal) [SFRH/BPD/63392/2009]	Fundacao para a Ciencia e a Tecnologia (FCT, MCTES, Portugal)(Portuguese Foundation for Science and Technology)	C. Baptista's work has been supported through post-doc fellowship SFRH/BPD/63392/2009 from Fundacao para a Ciencia e a Tecnologia (FCT, MCTES, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson M, 2011, J BACTERIOL, V193, P1583, DOI 10.1128/JB.01096-10; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; CABRE F, 1989, J CHROMATOGR, V472, P347, DOI 10.1016/S0021-9673(00)94133-5; Caldwell RB, 2004, APPL ENVIRON MICROB, V70, P610, DOI 10.1128/AEM.70.1.610-612.2004; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Chen YH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-219; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; DAHL MK, 1992, J BIOL CHEM, V267, P14509; De Hoon M J L, 2004, Pac Symp Biocomput, P276; Desvaux M, 2006, FEMS MICROBIOL REV, V30, P774, DOI 10.1111/j.1574-6976.2006.00035.x; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Dubois JYF, 2009, ANTIMICROB AGENTS CH, V53, P651, DOI 10.1128/AAC.01189-08; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Fyans JK, 2013, MOL PLANT PATHOL, V14, P119, DOI 10.1111/j.1364-3703.2012.00835.x; Garufi G, 2008, J BACTERIOL, V190, P7004, DOI 10.1128/JB.00458-08; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Hsueh YH, 2011, MOL MICROBIOL, V81, P1092, DOI 10.1111/j.1365-2958.2011.07755.x; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jakutyte L, 2011, J BACTERIOL, V193, P4893, DOI 10.1128/JB.05104-11; Kabisch J, 2013, J BIOTECHNOL, V163, P97, DOI 10.1016/j.jbiotec.2012.06.034; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Margot P, 1996, MICROBIOL-UK, V142, P3437, DOI 10.1099/13500872-142-12-3437; McLoon AL, 2011, J BACTERIOL, V193, P2027, DOI 10.1128/JB.01542-10; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Ogura M, 2012, J BIOCHEM, V151, P643, DOI 10.1093/jb/mvs036; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Otto A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1137; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Patrick JE, 2009, J BACTERIOL, V191, P7129, DOI 10.1128/JB.00905-09; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Sambrook J., 2001, MOL CLONING LAB MANU; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sao-Jose C, 2004, J BACTERIOL, V186, P8337, DOI 10.1128/JB.186.24.8337-8346.2004; Sao-Jose C, 2000, J BACTERIOL, V182, P5823, DOI 10.1128/JB.182.20.5823-5831.2000; Shukla A, 2010, ACTA CRYSTALLOGR F, V66, P1421, DOI 10.1107/S1744309110036286; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Sundaramoorthy R, 2008, J MOL BIOL, V383, P603, DOI 10.1016/j.jmb.2008.08.047; Sutcliffe IC, 2011, ANTON LEEUW INT J G, V99, P127, DOI 10.1007/s10482-010-9507-4; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; van den Ent F, 2005, FEBS LETT, V579, P3837, DOI 10.1016/j.febslet.2005.06.002; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Way SS, 2005, INFECT IMMUN, V73, P6151, DOI 10.1128/IAI.73.9.6151-6153.2005; Wirth SE, 2012, MOL MICROBIOL, V83, P654, DOI 10.1111/j.1365-2958.2011.07958.x; YASBIN RE, 1975, J BACTERIOL, V121, P296, DOI 10.1128/JB.121.1.296-304.1975; Yu XW, 2012, CELL SIGNAL, V24, P1841, DOI 10.1016/j.cellsig.2012.05.014; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08; Zoltner M, 2013, BIOCHEM J, V449, P469, DOI 10.1042/BJ20121209	69	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67840	10.1371/journal.pone.0067840	http://dx.doi.org/10.1371/journal.pone.0067840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861817	gold, Green Submitted, Green Published			2022-12-25	WOS:000323350700045
J	Boyer, DM; Seiffert, ER; Gladman, JT; Bloch, JI				Boyer, Doug M.; Seiffert, Erik R.; Gladman, Justin T.; Bloch, Jonathan I.			Evolution and Allometry of Calcaneal Elongation in Living and Extinct Primates	PLOS ONE			English	Article							EARLIEST LATE EOCENE; MIDDLE EOCENE; POSITIONAL BEHAVIOR; FOOT MORPHOLOGY; PHYLOGENETIC-RELATIONSHIPS; FUNCTIONAL-MORPHOLOGY; LOCOMOTOR BEHAVIOR; SKELETAL REMAINS; OMOMYIDAE; ORIGINS	Specialized acrobatic leaping has been recognized as a key adaptive trait tied to the origin and subsequent radiation of euprimates based on its observed frequency in extant primates and inferred frequency in extinct early euprimates. Hypothesized skeletal correlates include elongated tarsal elements, which would be expected to aid leaping by allowing for increased rates and durations of propulsive acceleration at takeoff. Alternatively, authors of a recent study argued that pronounced distal calcaneal elongation of euprimates (compared to other mammalian taxa) was related primarily to specialized pedal grasping. Testing for correlations between calcaneal elongation and leaping versus grasping is complicated by body size differences and associated allometric affects. We re-assess allometric constraints on, and the functional significance of, calcaneal elongation using phylogenetic comparative methods, and present an evolutionary hypothesis for the evolution of calcaneal elongation in primates using a Bayesian approach to ancestral state reconstruction (ASR). Results show that among all primates, logged ratios of distal calcaneal length to total calcaneal length are inversely correlated with logged body mass proxies derived from the area of the calcaneal facet for the cuboid. Results from phylogenetic ANOVA on residuals from this allometric line suggest that deviations are explained by degree of leaping specialization in prosimians, but not anthropoids. Results from ASR suggest that non-allometric increases in calcaneal elongation began in the primate stem lineage and continued independently in haplorhines and strepsirrhines. Anthropoid and lorisid lineages show stasis and decreasing elongation, respectively. Initial increases in calcaneal elongation in primate evolution may be related to either development of hallucal-grasping or a combination of grasping and more specialized leaping behaviors. As has been previously suggested, subsequent increases in calcaneal elongation are likely adaptations for more effective acrobatic leaping, highlighting the importance of this behavior in early euprimate evolution.	[Boyer, Doug M.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Boyer, Doug M.; Gladman, Justin T.] CUNY, Grad Ctr, Dept Anthropol, New York, NY USA; [Boyer, Doug M.; Gladman, Justin T.] New York Consortium Evolutionary Primatol, New York, NY USA; [Seiffert, Erik R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Bloch, Jonathan I.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Duke University; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of Florida	Boyer, DM (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.	doug.boyer@duke.edu		Boyer, Douglas/0000-0002-8697-2999; Bloch, Jonathan/0000-0003-1484-6931	National Science Foundation (NSF) [BCS 1317525, BCS 1231288, EAR-0640076, EAR-0719941]; American Association of Physical Anthropologists Professional Development Grant; NSF DDIG [SBE 1028505]; NYCEP IGERT [NSF DGE-0991660]; CUNY Graduate Center Provost's Digital Innovations Grant; CUNY Graduate Center Doctoral Student Research Grant; Yale Institute for Biospheric Studies (YIBS); Division Of Behavioral and Cognitive Sci [1317525, 1231288, 1028505] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); American Association of Physical Anthropologists Professional Development Grant; NSF DDIG(National Science Foundation (NSF)); NYCEP IGERT; CUNY Graduate Center Provost's Digital Innovations Grant; CUNY Graduate Center Doctoral Student Research Grant; Yale Institute for Biospheric Studies (YIBS); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Major funding for this project was provided by National Science Foundation (NSF) grants to D. Boyer and E. Seiffert including BCS 1317525 (formerly BCS 1125507) and BCS 1231288, an American Association of Physical Anthropologists Professional Development Grant in 2009 to D. Boyer, and an NSF DDIG to S. Chester and E.J. Sargis SBE 1028505. A NSF grant to J.I. Bloch, J. Krigbaum and R. Secord (EAR-0640076) and one to J. I. Bloch (EAR-0719941) also provided support. J. Gladman and D. Boyer were also supported by a NYCEP IGERT (NSF DGE-0991660). J. Gladman was additionally supported by a CUNY Graduate Center Provost's Digital Innovations Grant and the CUNY Graduate Center Doctoral Student Research Grant. A portion of this manuscript was written while J. I. Bloch was supported by an Edward P. Bass Distinguished Visiting Environmental Scholarship from the Yale Institute for Biospheric Studies (YIBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anemone RL, 2000, J HUM EVOL, V38, P607, DOI 10.1006/jhev.1999.0371; BEARD KC, 1993, MAMMAL PHYLOGENY : PLACENTALS, P129; BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Berge C., 1986, P146; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Bloch JI, 2002, SCIENCE, V298, P1606, DOI 10.1126/science.1078249; Bloch Jonathan I., 2007, P535, DOI 10.1007/978-0-387-33507-0_16; Bloch JI, 2007, P NATL ACAD SCI USA, V104, P1159, DOI 10.1073/pnas.0610579104; BOCK WJ, 1965, EVOLUTION, V19, P269, DOI 10.2307/2406439; Boyer DM, 2009, NEW CRANIAL POSTCRAN; Boyer DM, 2010, AM J PHYS ANTHROPOL, V143, P383, DOI 10.1002/ajpa.21328; Campbell CJ, 2011, PRIMATES PERSPECTIVE; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; Cartmill M., 1972, FUNCTIONAL EVOLUTION, P97, DOI DOI 10.4324/9781315132129; Cartmill M, 2012, EVOL ANTHROPOL, V21, P208, DOI 10.1002/evan.21324; Cartmill Matt, 1992, Evolutionary Anthropology, V1, P105, DOI 10.1002/evan.1360010308; Charles-Dominic P., 1974, P131; Charles-Dominique P, 1977, LOCOMOTION DEFENSIVE, P53; Charles-Dominique P., 1977, ECOLOGY BEHAV NOCTUR; Chester SGB, 2010, J MAMM EVOL, V17, P227, DOI 10.1007/s10914-010-9141-y; COVERT HH, 1993, J HUM EVOL, V25, P351, DOI 10.1006/jhev.1993.1054; COVERT HH, 1988, J HUM EVOL, V17, P57, DOI 10.1016/0047-2484(88)90049-8; CROMPTON RH, 1993, P ROY SOC B-BIOL SCI, V254, P41, DOI 10.1098/rspb.1993.0124; Crompton RH, 1995, CREATURES OF THE DARK, P11; Crompton RH, 2007, DEV PRIMATOL-PROG PR, P127, DOI 10.1007/978-0-387-34810-0_6; CROVELLA S, 1994, PRIMATES, V35, P519, DOI 10.1007/BF02381961; Dagosto M, 1999, ANN CARNEGIE MUS, V68, P175; DAGOSTO M, 1983, FOLIA PRIMATOL, V41, P49, DOI 10.1159/000156119; Dagosto Marian, 2007, P489, DOI 10.1007/978-0-387-33507-0_15; Delson Eric, 2000, Anthropological Papers of the American Museum of Natural History, V83, P1; DEMES B, 1989, FOLIA PRIMATOL, V53, P125, DOI 10.1159/000156412; Demes B, 1996, J HUM EVOL, V31, P367, DOI 10.1006/jhev.1996.0066; Demes B, 2005, AM J PHYS ANTHROPOL, V128, P348, DOI 10.1002/ajpa.20043; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Fleagle J.G., 1985, P1; FLEAGLE JG, 1992, J HUM EVOL, V22, P285, DOI 10.1016/0047-2484(92)90060-M; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Franzen JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005723; Gebo DL, 2004, YEARB PHYS ANTHROPOL, V47, P40, DOI 10.1002/ajpa.20154; Gebo DL, 2012, J HUM EVOL, V63, P205, DOI 10.1016/j.jhevol.2012.03.010; GEBO DL, 1988, J HUM EVOL, V17, P135, DOI 10.1016/0047-2484(88)90052-8; GEBO DL, 1987, AM J PRIMATOL, V13, P271, DOI 10.1002/ajp.1350130305; GEBO DL, 1988, FOLIA PRIMATOL, V50, P3, DOI 10.1159/000156332; GEBO DL, 1995, AM J PHYS ANTHROPOL, V97, P49, DOI 10.1002/ajpa.1330970105; GEBO DL, 1991, AM J PHYS ANTHROPOL, V86, P51, DOI 10.1002/ajpa.1330860105; GINGERICH PD, 1981, J HUM EVOL, V10, P345, DOI 10.1016/S0047-2484(81)80057-7; Gingerich Philip D., 2012, Palaeobiodiversity Palaeoenvironments, V92, P649, DOI 10.1007/s12549-012-0093-5; Gladman JT, AM J PHYS A IN PRESS; Godfrey L., 1986, Primate Conservation, P92; GODFREY LR, 1988, J HUM EVOL, V17, P93, DOI 10.1016/0047-2484(88)90051-6; Groves CP, 2001, PRIMATE TAXONOMY; Gunnell GF, 2002, J HUM EVOL, V43, P353, DOI 10.1006/jhev.2002.0582; HALL-CRAGGS E. C. B., 1965, J ZOOL PROC ZOOL SOC LONDON, V147, P20; HALLCRAGGS EC, 1965, J ANAT, V99, P119; Hamrick MW, 1996, AM J PHYS ANTHROPOL, V99, P319, DOI 10.1002/(SICI)1096-8644(199602)99:2<319::AID-AJPA8>3.0.CO;2-T; Hartwig WC, 2002, PRIMATE FOSSIL RECOR; HOFFSTETTER R, 1977, B MEM SOC ANTHRO PAR, V4, P327, DOI 10.3406/bmsap.1977.1886; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Jungers WL, 1997, P NATL ACAD SCI USA, V94, P11998, DOI 10.1073/pnas.94.22.11998; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; KAY RF, 1990, NATURE, V345, P342, DOI 10.1038/345342a0; Kay Richard F., 2004, P91; Le Gros Clark W. E., 1959, ANTECEDENTS MAN; Lemelin P, 1999, J ZOOL, V247, P165, DOI 10.1017/S0952836999002046; Lemelin Pierre, 2007, P329, DOI 10.1007/978-0-387-33507-0_10; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; Maiolino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048171; Martins EP, 1999, SYST BIOL, V48, P642, DOI 10.1080/106351599260210; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MASTERS JC, 1994, PRIMATES, V35, P177, DOI 10.1007/BF02382053; Masters JC, 2002, AM J PHYS ANTHROPOL, V117, P79, DOI 10.1002/ajpa.10001; Masters JC, 2007, AM J PRIMATOL, V69, P6, DOI 10.1002/ajp.20322; Menegaz RA, 2009, J HUM EVOL, V57, P672, DOI 10.1016/j.jhevol.2009.04.010; Morton DJ, 1924, AM J PHYS ANTHROPOL, V7, P1, DOI 10.1002/ajpa.1330070114; Moya-Sola Salvador, 2012, Swiss Journal of Palaeontology, V131, P147, DOI 10.1007/s13358-011-0032-5; NAPIER JR, 1967, FOLIA PRIMATOL, V6, P204, DOI 10.1159/000155079; NASH LT, 1989, INT J PRIMATOL, V10, P57, DOI 10.1007/BF02735704; Ni XJ, 2013, NATURE, V498, P60, DOI 10.1038/nature12200; Ni XJ, 2004, NATURE, V427, P65, DOI 10.1038/nature02126; Nunn C. L., 2011, COMP APPROACH EVOLUT; Orlando L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-121; Orme C.D.L., 2011, CAPER COMP ANAL PHYL; Oxnard C.E., 1990, ANIMAL LIFESTYLES AN; OXNARD CE, 1981, AM J PHYS ANTHROPOL, V54, P421, DOI 10.1002/ajpa.1330540316; Pagel M, 2011, BAYES TRAITS; Pages E., 1980, P97; Patel BA, 2012, J HUM EVOL, V63, P99, DOI 10.1016/j.jhevol.2012.05.002; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Polly PD, 2001, AM NAT, V157, P596, DOI 10.1086/320622; Rambaut A, 2009, TRACER V1 5; Ravosa MJ, 2004, J HUM EVOL, V46, P357, DOI 10.1016/j.jhevol.2003.12.002; Roberts TE, 2011, MOL PHYLOGENET EVOL, V60, P358, DOI 10.1016/j.ympev.2011.04.021; Roig Imma, 2009, Paleolusitana, V1, P419; ROSE KD, 1985, AM J PHYS ANTHROPOL, V66, P73, DOI 10.1002/ajpa.1330660107; Rose KD, 2011, AM J PHYS ANTHROPOL, V146, P281, DOI 10.1002/ajpa.21579; Rose KD, 2009, J HUM EVOL, V56, P366, DOI 10.1016/j.jhevol.2009.01.008; Rose Kenneth D., 1994, Evolutionary Anthropology, V3, P159, DOI 10.1002/evan.1360030505; SAVAGE DE, 1978, FOLIA PRIMATOL, V30, P1, DOI 10.1159/000155853; Schmitt D, 1996, FOLIA PRIMATOL, V67, P137, DOI 10.1159/000157215; Secord R, 2012, SCIENCE, V335, P959, DOI 10.1126/science.1213859; Seiffert ER, 2005, P NATL ACAD SCI USA, V102, P11396, DOI 10.1073/pnas.0505310102; Seiffert Erik R., 2004, P157; Seiffert ER, 2010, P NATL ACAD SCI USA, V107, P9712, DOI 10.1073/pnas.1001393107; Seiffert ER, 2009, NATURE, V461, P1118, DOI 10.1038/nature08429; Seligsohn D., 1974, P543; Silcox MT, 2009, J HUM EVOL, V56, P315, DOI 10.1016/j.jhevol.2008.10.007; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Smith T, 2006, P NATL ACAD SCI USA, V103, P11223, DOI 10.1073/pnas.0511296103; Soligo C, 2006, J HUM EVOL, V50, P414, DOI 10.1016/j.jhevol.2005.11.001; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; SZALAY F S, 1976, Bulletin of the American Museum of Natural History, V156, P157; Szalay F.S., 1979, EVOLUTIONARY HIST PR; Szalay Frederick S., 2007, P457, DOI 10.1007/978-0-387-33507-0_14; SZALAY FS, 1980, FOLIA PRIMATOL, V34, P1, DOI 10.1159/000155946; TATTERSALL I, 1974, ANTHROPOL PAP AM MUS, V52, P137; Tattersall I, 1982, SUBFOSSIL LEMURS PRI, P206; Tornow Matthew A., 2008, Bulletin of the Peabody Museum of Natural History, V49, P43, DOI 10.3374/0079-032X(2008)49[43:SAOTEP]2.0.CO;2; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913	121	50	51	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67792	10.1371/journal.pone.0067792	http://dx.doi.org/10.1371/journal.pone.0067792			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844094	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000103
J	Dhainaut, A; Hoff, M; Syversen, U; Haugeberg, G				Dhainaut, Alvilde; Hoff, Mari; Syversen, Unni; Haugeberg, Glenn			Cortical Hand Bone Porosity and Its Association with Distal Radius Fracture in Middle Aged and Elderly Women	PLOS ONE			English	Article							X-RAY RADIOGRAMMETRY; MINERAL DENSITY; INTRACORTICAL POROSITY; POSTMENOPAUSAL WOMEN; HR-PQCT; OSTEOPOROSIS; MICROSTRUCTURE; EPIDEMIOLOGY; WRIST; TIBIA	Objective: Reduced bone mineral density (BMD), assessed by Dual Energy X-ray absorptiometry (DXA), is a well-known risk factor for fragility fracture. A large proportion of patients with fracture have only slightly reduced BMD. Assessment of other bone structure features than BMD may improve identification of individuals at increased fracture risk. Digital X-ray radiogrammetry (DXR), which is a feasible tool for measurement of metacarpal cortical bone density, also gives an estimate of cortical bone porosity. Our primary aim was to explore the association between cortical porosity in the hand assessed by DXR and distal radius fracture. Methods: This case-control study included 123 women > 50 years with distal radius fracture, and 170 controls. DXR was used to measure metacarpal BMD (DXR-BMD), cortical porosity (DXR-porosity), thickness (DXR-CT) and bone width (DXR-W) of the hand. Femoral neck BMD was measured by DXA. Results: The fracture group had a statistically significant lower DXR-BMD (0.492 vs. 0.524 g/cm(2) p < 0.001), higher cortical DXR-porosity (0.01256 vs. 0.01093, p < 0.001), less DXR-CT (0.148 vs. 0.161cm, p < 0.001) and lower femoral neck DXA-BMD (0.789 vs. 0.844 g/cm(2), p = 0.001) than the controls. In logistic regression analysis adjusted for age, a significant association with distal radius fracture (OR, 95% CI) was found for body mass index (0.930, 0.880-0.983), DXA-BMD (0.996, 0.995-0.999), DXR-BMD (0.990, 0.985-0.998), DXR-porosity (1.468, 1.278-1.687) and DXR-CT (0.997, 0.996-0.999). In an adjusted model, DXR-porosity remained the only variable associated with distal radius fracture (1.415, 1.194-1.677). Conclusion: DXR derived porosity is associated with fracture at distal radius and might be a sensitive marker for skeletal fragility.	[Dhainaut, Alvilde; Hoff, Mari; Haugeberg, Glenn] Norwegian Univ Sci & Technol, Dept Neurosci, Div Rheumatol, N-7034 Trondheim, Norway; [Hoff, Mari] St Olavs Hosp, Dept Rheumatol, Trondheim, Norway; [Syversen, Unni] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Syversen, Unni] St Olavs Hosp, Dept Endocrinol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Dhainaut, A (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, Div Rheumatol, N-7034 Trondheim, Norway.	alvilde.dhainaut@ntnu.no	Hoff, Mari/AAZ-7302-2021	Hoff, Mari/0000-0002-9992-8663	Competence Development Fund of Southern Norway; Hospital of Southern Norway; Samarbeidsorganet; SECTRA	Competence Development Fund of Southern Norway; Hospital of Southern Norway; Samarbeidsorganet; SECTRA	This work has been supported and funded by the Competence Development Fund of Southern Norway and the Hospital of Southern Norway. PhD Fellow AD has been funded by Samarbeidsorganet (the liaison body operating between the NTNU University and the Central Regional Health Authority). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MH, AD and GH have presented lectures and open seminars for medical professionals in Scandinavia, where SECTRA has been a part sponsor. All authors state that they have no further conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 1994, ASS FRACT RISK ITS A; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Bonnick SL, 2010, CURR CLIN PRACT, P1, DOI 10.1007/978-1-60327-499-9; Bouxsein Mary L, 2006, Curr Osteoporos Rep, V4, P49, DOI 10.1007/s11914-006-0002-9; Bouxsein ML, 2002, OSTEOPOROSIS INT, V13, P358, DOI 10.1007/s001980200040; Burghardt AJ, 2010, J BONE MINER RES, V25, P983, DOI 10.1359/jbmr.091104; Dhainaut A, 2010, J CLIN DENSITOM, V13, P418, DOI 10.1016/j.jocd.2010.07.005; Diamantopoulos AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043367; Granke M, 2011, BONE, V49, P1020, DOI 10.1016/j.bone.2011.08.002; Hoff M, 2009, J CLIN DENSITOM, V12, P17, DOI 10.1016/j.jocd.2008.10.005; Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001; Hyldstrup L, 2001, CALCIFIED TISSUE INT, V68, P135, DOI 10.1007/s002230001204; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kazakia GJ, 2011, J BIOMECH, V44, P257, DOI 10.1016/j.jbiomech.2010.10.010; Lofthus CM, 2008, OSTEOPOROSIS INT, V19, P781, DOI 10.1007/s00198-007-0499-5; Macdonald HM, 2011, J BONE MINER RES, V26, P50, DOI 10.1002/jbmr.171; Nicks KM, 2012, J BONE MINER RES, V27, P637, DOI 10.1002/jbmr.1468; Nishiyama KK, 2010, J BONE MINER RES, V25, P882, DOI 10.1359/jbmr.091020; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1247, DOI 10.1007/s00198-009-1065-0; Oyen J, 2009, OSTEOPOROSINT; Oyen J, 2011, J BONE JOINT SURG AM, V93A, P348, DOI 10.2106/JBJS.J.00303; Patsch JM, 2012, JBONE MINERRES, V10; Rohde G, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-90; Rosholm A, 2001, OSTEOPOROSIS INT, V12, P961, DOI 10.1007/s001980170026; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Sornay-Rendu E, 2009, OSTEOPOROSIS INT, V20, P1291, DOI 10.1007/s00198-009-1008-9; Ural A, 2007, J BIOMECH ENG-T ASME, V129, P625, DOI 10.1115/1.2768377; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Walker MD, 2011, J BONE MINER RES, V26, P1392, DOI 10.1002/jbmr.352; Wang XF, 2012, OSTEOPOROSIS INT, V23, P411, DOI 10.1007/s00198-011-1739-2; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	31	11	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68405	10.1371/journal.pone.0068405	http://dx.doi.org/10.1371/journal.pone.0068405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844197	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000003
J	Lazarevic, V; Gaia, N; Girard, M; Francois, P; Schrenzel, J				Lazarevic, Vladimir; Gaia, Nadia; Girard, Myriam; Francois, Patrice; Schrenzel, Jacques			Comparison of DNA Extraction Methods in Analysis of Salivary Bacterial Communities	PLOS ONE			English	Article							MICROBIOME; PERIODONTITIS; ALIGNMENTS; SEQUENCES; TAXONOMY; HEALTH; FLORA	Culture-independent high-throughput sequencing-based methods are widely used to study bacterial communities. Although these approaches are superior to traditional culture-based methods, they introduce bias at the experimental and bioinformatics levels. We assessed the diversity of the human salivary microbiome by pyrosequencing of the 16S rDNA V1-3 amplicons using metagenomic DNA extracted by two different protocols: a simple proteinase K digestion without a subsequent DNA clean-up step, and a bead-beating mechanical lysis protocol followed by column DNA purification. A high degree of congruence was found between the two extraction methods, most notably in regard to the microbial community composition. The results showed that for a given bioinformatics pipeline, all the taxa with an average proportion >0.12% in samples processed using one extraction method were also detected in samples extracted using the other method. The same taxa tended to be abundant and frequent for both extraction methods. The relative abundance of sequence reads assigned to the phyla Actinobacteria, Spirochaetes, TM7, Synergistetes, and Tenericutes was significantly higher in the mechanically-treated samples than in the enzymatically-treated samples, whereas the phylum Firmicutes showed the opposite pattern. No significant differences in diversity indices were found between the extraction methods, although the mechanical lysis method revealed higher operational taxonomic unit richness. Differences between the extraction procedures outweighed the variations due to the bioinformatics analysis pipelines used.	[Lazarevic, Vladimir; Gaia, Nadia; Girard, Myriam; Francois, Patrice; Schrenzel, Jacques] Univ Hosp Geneva, Div Infect Dis, Genom Res Lab, Geneva, Switzerland	University of Geneva	Lazarevic, V (corresponding author), Univ Hosp Geneva, Div Infect Dis, Genom Res Lab, Geneva, Switzerland.	vladimir.lazarevic@genomic.ch	Schrenzel, Jacques/AAC-5685-2021; francois, patrice/AAL-5583-2020; Schrenzel, Jacques/P-8525-2017	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X; Lazarevic, Vladimir/0000-0002-6839-2536	HUG institutional funds	HUG institutional funds	This work was supported by HUG institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lazarevic V, 2011, J INTEGR OMICS, V1, P25, DOI DOI 10.5584/JI0MICS.V1I1.43; Lazarevic Vladimir, 2012, J Clin Bioinforma, V2, P4, DOI 10.1186/2043-9113-2-4; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moore E, 2004, MOL MICROBIAL ECOLOG, V2nd, P3; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RICHARDSON ROBERT L., 1958, JOUR DENTAL RES, V37, P697, DOI 10.1177/00220345580370041701; ROSS PW, 1971, J CLIN PATHOL, V24, P717, DOI 10.1136/jcp.24.8.717; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sergeant MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038094; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang L, 2009, MOL DIAGN THER, V13, P245, DOI 10.2165/11317160-000000000-00000	39	60	61	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67699	10.1371/journal.pone.0067699	http://dx.doi.org/10.1371/journal.pone.0067699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844068	Green Submitted, gold, Green Published			2022-12-25	WOS:000321733000095
J	Sandera, M; Albrecht, T; Stopka, P				Sandera, Martin; Albrecht, Tomas; Stopka, Pavel			Variation in Apical Hook Length Reflects the Intensity of Sperm Competition in Murine Rodents	PLOS ONE			English	Article							POSTCOPULATORY SEXUAL SELECTION; FEMALE PROMISCUITY; ACROSOME REACTION; GENUS APODEMUS; CYTOCHROME-B; TESTES SIZE; EVOLUTION; COOPERATION; SPERMATOZOON; MORPHOMETRY	Background: Post-copulatory sexual selection has been shown to shape morphology of male gametes. Both directional and stabilizing selection on sperm phenotype have been documented in vertebrates in response to sexual promiscuity. Methodology: Here we investigated the degree of variance in apical hook length and tail length in six taxa of murine rodents. Conclusions: Tail sperm length and apical hook length were positively associated with relative testis mass, our proxy for levels of sperm competition, thus indicating directional post-copulatory selection on sperm phenotypes. Moreover, our study shows that increased levels of sperm competition lead to the reduction of variance in the hook length, indicating stabilizing selection. Hence, the higher risk of sperm competition affects increasing hook length together with decreasing variance in the hook length. Species-specific post-copulatory sexual selection likely optimizes sperm morphology.	[Sandera, Martin; Albrecht, Tomas; Stopka, Pavel] Charles Univ Prague, Biocev Grp, Dept Zool, Fac Sci, Prague, Czech Republic; [Albrecht, Tomas] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Stopka, P (corresponding author), Charles Univ Prague, Biocev Grp, Dept Zool, Fac Sci, Prague, Czech Republic.	pstopka@natur.cuni.cz	Albrecht, Tomas/A-1130-2011; Stopka, Pavel/A-6193-2008	Stopka, Pavel/0000-0002-1104-1655; Albrecht, Tomas/0000-0002-9213-0034	Academy of Sciences of the Czech Republic [IAA601110908]; BIOCEV	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); BIOCEV	This work was supported by the Academy of Sciences of the Czech Republic grant no. IAA601110908 (http://www.isvav.cz/projectDetail.do? rowId = IAA601110908). Institutional funding from BIOCEV covers the salary of the corresponding author (http://www.biocev.eu/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2434; [Anonymous], 2010, R LANG ENV STAT COMP; Baskevich MI, 2004, ZOOL ZH, V83, P725; Birkhead TR, 2010, J ZOOL, V281, P78, DOI 10.1111/j.1469-7998.2010.00701.x; Birkhead TR, 2005, NATURE, V434, P383, DOI 10.1038/nature03374; Breed WG, 2007, J ZOOL, V272, P299, DOI 10.1111/j.1469-7998.2006.00269.x; Breed WG, 2005, J MORPHOL, V265, P271, DOI 10.1002/jmor.10357; Breed WG, 2004, J MORPHOL, V261, P52, DOI 10.1002/jmor.10228; Breed WG, 2000, J MAMMAL, V81, P758, DOI 10.1644/1545-1542(2000)081&lt;0758:BMTMAS&gt;2.3.CO;2; Bryja J, 2005, ACTA THERIOL, V50, P189, DOI 10.1007/BF03194482; Bryja J, 2008, BEHAV ECOL SOCIOBIOL, V63, P251, DOI 10.1007/s00265-008-0656-7; Calhim S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000413; Clift LE, 2009, J REPROD IMMUNOL, V81, P62, DOI 10.1016/j.jri.2009.02.006; Clift LE, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-29; Dean MD, 2006, MOL ECOL, V15, P4141, DOI 10.1111/j.1365-294X.2006.03068.x; delBarco-Trillo J, 2004, NATURE, V431, P446, DOI 10.1038/nature02845; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Fisher HS, 2010, NATURE, V463, P801, DOI 10.1038/nature08736; Fitzpatrick JL, 2011, EVOLUTION, V65, P3006, DOI 10.1111/j.1558-5646.2011.01343.x; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gage MJG, 2003, P ROY SOC B-BIOL SCI, V270, P625, DOI 10.1098/rspb.2002.2258; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Immler S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000170; Immler S, 2007, P ROY SOC B-BIOL SCI, V274, P561, DOI 10.1098/rspb.2006.3752; Johnson PM, 2007, REPRODUCTION, V134, P739, DOI 10.1530/REP-07-0363; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; KRZANOWSKA H, 1981, J REPROD FERTIL, V62, P385, DOI 10.1530/jrf.0.0620385; Laskemoen T, 2013, BEHAV ECOL SOCIOBIOL, V67, P301, DOI 10.1007/s00265-012-1450-0; Lifjeld JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013456; Lupold S, 2011, REPRODUCTION, V141, P595, DOI 10.1530/REP-10-0501; Martin Y, 2000, MOL PHYLOGENET EVOL, V16, P37, DOI 10.1006/mpev.1999.0760; Michaux JR, 2002, MOL PHYLOGENET EVOL, V23, P123, DOI 10.1016/S1055-7903(02)00007-6; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parker GA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0335; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; ROLDAN ERS, 1992, BIOL REV, V67, P551, DOI 10.1111/j.1469-185X.1992.tb01193.x; Sandera M, 2011, BIOLOGIA, V66, P916, DOI 10.2478/s11756-011-0095-1; Sebek Z., 1962, Symposium Theriologicum (Proc Int Symp Meth Mamm Invest Brno 1960) Praha, P318; Sokal R. R, 1981, BIOMETRY; Suzuki H, 2008, BIOCHEM GENET, V46, P329, DOI 10.1007/s10528-008-9149-7	44	18	18	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68427	10.1371/journal.pone.0068427	http://dx.doi.org/10.1371/journal.pone.0068427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844198	Green Published, gold			2022-12-25	WOS:000321733000004
J	Sandlund, OT; Gjelland, KO; Bohn, T; Knudsen, R; Amundsen, PA				Sandlund, Odd Terje; Gjelland, Karl Oystein; Bohn, Thomas; Knudsen, Rune; Amundsen, Per-Arne			Contrasting Population and Life History Responses of a Young Morph-Pair of European Whitefish to the Invasion of a Specialised Coregonid Competitor, Vendace	PLOS ONE			English	Article							CHARR SALVELINUS-ALPINUS; HABITAT USE; GROWTH; FISH; LAVARETUS; NORWAY; ALBULA; DIVERSIFICATION; ZOOPLANKTON; COEXISTENCE	Invasions of non-native species represent a global problem of great scientific interest. Here we study in detail the response in population and life history characteristics of closely related native species, with divergent habitat preferences, that are impacted by an invading species over a sufficient time period to allow a new stable state to become established. A time series of 20 years starting at the first occurrence of the invader (vendace Coregonus albula (L.)) allows exploration of the long term population and life history response of two ecologically, morphologically, and genetically different native sympatric morphs (DR- and SR-) of congeneric whitefish C. lavaretus (L.). The whitefish morphs are taxonomically equally related to the invading vendace, but only the planktivorous DR-whitefish share its pelagic niche. We would expect that the ecological differences between the whitefish morphs may be used as a predictor of competitive effects. Vendace exhibited an initial boom-and-bust development, and has continued to fluctuate in density. The responses of the pelagic DR- whitefish were: i) an immediate habitat shift, ii) a subsequent population decline caused by increased annual mortality, and iii) a new stable state at a lower density and apparently relaxed competition. The ecologically more distant benthivorous SR-whitefish also showed significant, but a much more limited response during this process, indicating damped indirect interactions through the food-web. This long-term case-study found that in two native eco-species equally related to the invader, only one of the eco-species was highly affected. Direct competition for resources is obviously important for species interactions, whereas the taxonomic relatedness per se seems to offer little predictive power for invasion effects.	[Sandlund, Odd Terje; Gjelland, Karl Oystein] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Gjelland, Karl Oystein; Knudsen, Rune; Amundsen, Per-Arne] Univ Tromso, Dept Arctic & Marine Biol, Fac Biosci Fisheries & Econ, Tromso, Norway; [Bohn, Thomas] GenOk Ctr Biosafety, Tromso, Norway; [Bohn, Thomas] Univ Tromso, Inst Pharm, Fac Hlth Sci, Tromso, Norway	Norwegian Institute Nature Research; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Sandlund, OT (corresponding author), Norwegian Inst Nat Res, Tungasletta 2, N-7004 Trondheim, Norway.	odd.t.sandlund@nina.no	Gjelland, Karl/I-7023-2012	Gjelland, Karl/0000-0003-4036-4207; Bohn, Thomas/0000-0002-3851-9313; Amundsen, Per-Arne/0000-0002-2203-8216	Norwegian Research Council [NFR 183984/S30, 186320/V40]; Directorate for Nature Management; Governor of Finnmark County	Norwegian Research Council(Research Council of NorwayEuropean Commission); Directorate for Nature Management; Governor of Finnmark County	Financial support was given by the Norwegian Research Council (NFR 183984/S30 and 186320/V40), the Directorate for Nature Management, and the Governor of Finnmark County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; AMUNDSEN P-A, 1988, Finnish Fisheries Research, V9, P425; Amundsen PA, 2004, ANN ZOOL FENN, V41, P291; Amundsen PA, 2002, ERGEB LIMNOL, V57, P577; Amundsen PA, 1997, SCI TOTAL ENVIRON, V201, P211, DOI 10.1016/S0048-9697(97)84058-2; Amundsen PA, 1999, BIOL CONSERV, V88, P405, DOI 10.1016/S0006-3207(98)00110-4; Amundsen PA, 2011, ENVIRON MONIT ASSESS, V182, P301, DOI 10.1007/s10661-011-1877-1; Amundsen PA, 2009, FRESHWATER BIOL, V54, P24, DOI 10.1111/j.1365-2427.2008.02088.x; Baxter CV, 2007, OECOLOGIA, V153, P461, DOI 10.1007/s00442-007-0743-x; Berg MP, 2010, EVOL ECOL, V24, P617, DOI 10.1007/s10682-009-9347-8; Beyers DW, 1998, J N AM BENTHOL SOC, V17, P367, DOI 10.2307/1468339; Bohn T, 2004, ANN ZOOL FENN, V41, P125; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Bohn T, 2002, ERGEB LIMNOL, V57, P183; Bohn T, 2001, ECOLOGY, V82, P2150, DOI 10.1890/0012-9658(2001)082[2150:TCEOAI]2.0.CO;2; Bohn T, 2008, BIOL INVASIONS, V10, P359, DOI 10.1007/s10530-007-9135-8; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Darwin C., 1859, ORIGIN SPECIES MEANS; Dauvalter V, 2011, J ENVIRON SCI HEAL A, V46, P1020, DOI 10.1080/10934529.2011.584503; Davis M. A., 2009, INVASION BIOL; Dostal P, 2011, AM NAT, V177, P655, DOI 10.1086/659060; Falk-Petersen J, 2006, BIOL INVASIONS, V8, P1409, DOI 10.1007/s10530-005-0710-6; GALLUCCI VF, 1979, T AM FISH SOC, V108, P14, DOI 10.1577/1548-8659(1979)108<14:RFATAS>2.0.CO;2; Gjelland KO, 2007, J FISH BIOL, V71, P196, DOI 10.1111/j.1095-8649.2007.01678.x; Holmes E.E., 2012, ANAL MULTIVARIATE TI; Holmes EE, 2012, R J, V4, P11; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Kahilainen KK, 2011, EVOL ECOL, V25, P573, DOI 10.1007/s10682-010-9411-4; Karjalainen J, 2000, J FISH BIOL, V56, P837, DOI 10.1111/j.1095-8649.2000.tb00876.x; Kristoffersen K, 1984, 5 FYLK FINNM; Liso S, 2011, J FISH BIOL, V78, P332, DOI 10.1111/j.1095-8649.2010.02831.x; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; Mayer-Pinto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047871; Mooij WM, 1999, T AM FISH SOC, V128, P483, DOI 10.1577/1548-8659(1999)128<0483:AACOFG>2.0.CO;2; Moyle Peter B., 1999, Population and Community Biology Series, V24, P177; Museth J, 2007, ADV LIMNOL, V60, P343; MUTENIA A, 1994, REHABILITATION OF FRESHWATER FISHERIES, P280; Mutenia Ahti, 1992, Polskie Archiwum Hydrobiologii, V39, P797; NAESJE TF, 1986, ENVIRON BIOL FISH, V15, P309; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pinheiro J., 2019, NLME LINEAR NONLINEA; RICKER W E, 1975, P382; Roy ED, 2010, ECOL SOC, V15; Salonen E, 2007, ADV LIMNOL, V60, P331; Sandlund OT, 2013, ADV LIMNOL, V64, P345, DOI 10.1127/1612-166X/2013/0064-0013; Sandlund OT, 2010, HYDROBIOLOGIA, V650, P27, DOI 10.1007/s10750-009-0075-4; SANDLUND OT, 1991, J FISH BIOL, V38, P873, DOI 10.1111/j.1095-8649.1991.tb03627.x; Sarvala J, 1995, ERGEB LIMNOL, V46, P187; Simberloff D, 2004, BIOL INVASIONS, V6, P161, DOI 10.1023/B:BINV.0000022133.49752.46; Siwertsson A, 2012, ADV LIMNOL, V63, P229; Siwertsson A, 2010, EVOL ECOL RES, V12, P929; Smith E. P., 2013, ENCY ENV, V1, P141, DOI DOI 10.1002/9780470057339.VAB001.PUB2; SMITH EP, 1993, CAN J FISH AQUAT SCI, V50, P627, DOI 10.1139/f93-072; STEWARTOATEN A, 1992, ECOLOGY, V73, P1396, DOI 10.2307/1940685; SVARDSON G, 1976, Institute of Freshwater Research Drottningholm Report, P144; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; WELKER MT, 1994, T AM FISH SOC, V123, P703, DOI 10.1577/1548-8659(1994)123<0703:GASOLF>2.3.CO;2; Williamson M., 1996, BIOL INVASIONS; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; Wootton R.J., 1998, ECOLOGY TELEOST FISH	63	10	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68156	10.1371/journal.pone.0068156	http://dx.doi.org/10.1371/journal.pone.0068156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844164	Green Published, gold			2022-12-25	WOS:000321733000131
J	Wang, Y; Wu, HJ; Liu, QJ; Wang, CH; Fu, L; Wang, H; Zhu, WJ; Fu, WJ; Lv, YJ; Wang, SK; Hu, LK				Wang, Yang; Wu, Haijian; Liu, Qiji; Wang, Cuihong; Fu, Lei; Wang, Han; Zhu, Wenjie; Fu, Weijiang; Lv, Yajuan; Wang, Shikun; Hu, Likuan			Association of CHRNA5-A3-B4 Variation with Esophageal Squamous Cell Carcinoma Risk and Smoking Behaviors in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER RISK; SUSCEPTIBILITY LOCUS; NICOTINIC RECEPTOR; TOBACCO; ACETYLCHOLINE; NITROSAMINES; POLYMORPHISM; VARIANTS; AREAS	Background: CHRNA5-A3-B4, the gene cluster encoding nicotinic acetylcholine receptor subunits, is associated with lung cancer risk and smoking behaviors in people of European descent. Because cigarette smoking is also a major risk factor for esophageal squamous cell carcinoma (ESCC), we investigated the associations between variants in CHRNA5-A3-B4 and ESCC risk, as well as smoking behaviors, in a Chinese population. Methods: A case-control study of 866 ESCC patients and 952 healthy controls was performed to study the association of polymorphisms (rs667282 and rs3743073) in CHRNA5-A3-B4 with cancer risk using logistic regression models. The relationships between CHRNA5-A3-B4 polymorphisms and smoking behaviors that can be quantified by cigarettes smoked per day (CPD) and pack-years of smoking were separately estimated with Kruskal-Wallis tests among all 840 smokers. Results: CHRNA5-A3-B4 rs667282 TT/TG genotypes were associated with significantly increased risk of ESCC [ adjusted odds ratio (OR) = 1.32, 95% confidence interval (CI) = 1.03 - 1.69, P = 0.029]. The increased ESCC risk was even higher among younger subjects (<= 60 years) (OR = 1.44, 95% CI = 1.04 - 1.98, P = 0.024). These effects were not found in another polymorphism rs3743073. No evident association between the two polymorphisms and smoking behaviors was observed. Conclusions: These results support the hypothesis that CHRNA5-A3-B4 is a susceptibility gene cluster for ESCC. The relationship between CHRNA5-A3-B4 and smoking behaviors in a Chinese population needs further investigation.	[Wang, Yang; Wu, Haijian; Wang, Cuihong; Zhu, Wenjie; Fu, Weijiang; Wang, Shikun; Hu, Likuan] Shandong Univ, Qilu Hosp, Radiat Dept, Ctr Oncol, Jinan, Shandong, Peoples R China; [Wu, Haijian; Wang, Shikun] Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Wu, Haijian; Wang, Shikun] Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China; [Liu, Qiji] Shandong Univ, Dept Med Genet, Sch Med, Jinan, Shandong, Peoples R China; [Fu, Lei] Shandong Tumor Hosp & Inst, Radiat Dept, Jinan, Shandong, Peoples R China; [Wang, Han] Shandong Univ, Hosp 2, Ctr Oncol, Jinan, Shandong, Peoples R China; [Lv, Yajuan] Shandong Univ, Jinan Cent Hosp, Dept Oncol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Hu, LK (corresponding author), Shandong Univ, Qilu Hosp, Radiat Dept, Ctr Oncol, Jinan, Shandong, Peoples R China.	hulikuan.sdu@hotmail.com			National Natural Science Foundation of China [30300310, 30671956]; Natural Science Foundation of Shandong Province [ZR2012HM083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work is supported by grants from National Natural Science Foundation of China (No. 30300310 and No. 30671956) and Natural Science Foundation of Shandong Province (No. ZR2012HM083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Arredondo J, 2006, CANCER BIOL THER, V5, P511, DOI 10.4161/cbt.5.5.2601; Benowitz NL, 2008, AM J MED, V121, pS3, DOI 10.1016/j.amjmed.2008.01.015; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Darazy M, 2011, GENET TEST MOL BIOMA, V15, P423, DOI 10.1089/gtmb.2010.0206; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Demeester Steven R, 2009, Gastrointest Cancer Res, V3, pS2; Grando SA, 2008, J PHARMACOL SCI, V106, P174, DOI 10.1254/jphs.FM0070087; HALVORSEN RA, 1986, RADIOLOGY, V161, P147, DOI 10.1148/radiology.161.1.3763857; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; HECHT SS, 1986, CANCER RES, V46, P4162; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Hu YC, 2011, MODERN PATHOL, V24, P899, DOI 10.1038/modpathol.2011.47; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janes AC, 2012, DRUG ALCOHOL DEPEN, V120, P7, DOI 10.1016/j.drugalcdep.2011.06.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin G, 2012, J THORAC ONCOL, V7, P808, DOI 10.1097/JTO.0b013e31824c7d7c; Li MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012183; Li QQ, 2010, DIS ESOPHAGUS, V23, P253, DOI 10.1111/j.1442-2050.2009.01003.x; MOSS AA, 1981, AM J ROENTGENOL, V136, P1051, DOI 10.2214/ajr.136.6.1051; Nishino K, 2008, J OBSTET GYNAECOL RE, V34, P994, DOI 10.1111/j.1447-0756.2008.00798.x; Niu XM, 2010, J THORAC ONCOL, V5, P658, DOI 10.1097/JTO.0b013e3181d5e447; Russo P, 2012, LIFE SCI, V91, P1087, DOI 10.1016/j.lfs.2012.05.003; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Thunnissen FB, 2009, J THORAC ONCOL, V4, P943, DOI 10.1097/JTO.0b013e3181ad83fc; Wang DL, 2012, CANCER EPIDEMIOL, V36, P276, DOI 10.1016/j.canep.2011.10.008; Wang JB, 2008, JPN J CLIN ONCOL, V38, P87, DOI 10.1093/jjco/hym169; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Wu IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055834; Yang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046071; Yuan JM, 2011, CARCINOGENESIS, V32, P1366, DOI 10.1093/carcin/bgr125	39	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67664	10.1371/journal.pone.0067664	http://dx.doi.org/10.1371/journal.pone.0067664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844051	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000069
J	Shan, L; Li, X; Liu, L; Ding, X; Wang, Q; Zheng, Y; Duan, Y; Xuan, C; Wang, Y; Yang, F; Shang, Y; Shi, L				Shan, L.; Li, X.; Liu, L.; Ding, X.; Wang, Q.; Zheng, Y.; Duan, Y.; Xuan, C.; Wang, Y.; Yang, F.; Shang, Y.; Shi, L.			GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation	ONCOGENE			English	Article						breast cancer; cell proliferation; gene transcription	DNA-DAMAGE RESPONSE; LUMINAL CELL FATE; BREAST-CANCER; ESTROGEN-RECEPTOR; GENE-EXPRESSION; CYCLIN D1; MAMMARY-GLAND; DIFFERENTIATION; BINDING; METASTASIS	The transcription factor GATA3 is a key regulator of mammary gland development and a definitive marker of luminal breast cancer. However, the molecular mechanisms underlying the role of GATA3 in breast carcinogenesis is still not fully understood. We report here that GATA3 promotes cell proliferation and tumorigenesis by facilitating the G(1)/S transition through its transcription regulation of the CCND1 gene in breast cancer cells. We found that GATA3 is physically associated with poly-ADP ribose polymerase-1 (PARP1), an enzyme modifying nuclear proteins by poly(ADP-ribosyl)ation. We showed that PARP1 acts as a transcription coactivator for GATA3 in breast cancer cells and demonstrated that GATA3 cooperates with PARP1 in transactivation of the CCND1 gene. We demonstrated that PARP1 competes with linker histone H1 to maintain a transcriptional competent chromatin environment for CCND1 gene. Our results unveiled a molecular basis for the coordinated regulation between GATA3 and PARP1 in transcription activation, providing a mechanism for GATA3 in breast carcinogenesis.	[Shan, L.; Li, X.; Liu, L.; Wang, Q.; Zheng, Y.; Duan, Y.; Xuan, C.; Wang, Y.; Shang, Y.; Shi, L.] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China; [Ding, X.; Yang, F.] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China	Tianjin Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Shi, L (corresponding author), Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	shilei@tmu.edu.cn	duan, yang/GZA-6440-2022		National Natural Science Foundation of China [81130048, 81272284, 91219102]; Ministry of Science and Technology of China [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants (81130048 to YS, 81272284 and 91219102 to Lei Shi) from the National Natural Science Foundation of China and grants (973 Program: 2011CB504204 to YS) from the Ministry of Science and Technology of China.	Aguilar-Quesada R, 2007, CURR MED CHEM, V14, P1179, DOI 10.2174/092986707780597998; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Blokzijl A, 2002, CURR BIOL, V12, P35, DOI 10.1016/S0960-9822(01)00623-6; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ciocca V, 2009, HUM PATHOL, V40, P489, DOI 10.1016/j.humpath.2008.09.010; Cipak L, 2010, NEOPLASMA, V57, P401, DOI 10.4149/neo_2010_05_401; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; FANTL V, 1993, CANCER SURV, V18, P77; GILLETT C, 1994, CANCER RES, V54, P1812; Haffner MC, 2011, CLIN CANCER RES, V17, P3858, DOI 10.1158/1078-0432.CCR-10-2044; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hoch RV, 1999, INT J CANCER, V84, P122; Hoene V, 2009, BRIT J CANCER, V101, P1481, DOI 10.1038/sj.bjc.6605276; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Hwang SS, 2010, IMMUNOLOGY, V131, P50, DOI 10.1111/j.1365-2567.2010.03271.x; Imagawa S, 1997, BLOOD, V89, P1430, DOI 10.1182/blood.V89.4.1430; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kurokawa R, 2009, RNA BIOL, V6, P233, DOI 10.4161/rna.6.3.8329; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Parikh P, 2005, J AM COLL SURGEONS, V200, P705, DOI 10.1016/j.jamcollsurg.2004.12.025; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; Tulin A, 2011, NAT BIOTECHNOL, V29, P1078, DOI 10.1038/nbt.2058; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wilson BJ, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-49; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yoon NK, 2010, HUM PATHOL, V41, P1794, DOI 10.1016/j.humpath.2010.06.010; Zhang C, 2007, STEM CELLS DEV, V16, P605, DOI 10.1089/scd.2006.0077; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	58	30	30	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 12	2014	33	24					3205	3216		10.1038/onc.2013.270	http://dx.doi.org/10.1038/onc.2013.270			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK4QU	23851505				2022-12-25	WOS:000338410000013
J	Ory, V; Tassi, E; Cavalli, LR; Sharif, GM; Saenz, F; Baker, T; Schmidt, MO; Mueller, SC; Furth, PA; Wellstein, A; Riegel, AT				Ory, V.; Tassi, E.; Cavalli, L. R.; Sharif, G. M.; Saenz, F.; Baker, T.; Schmidt, M. O.; Mueller, S. C.; Furth, P. A.; Wellstein, A.; Riegel, A. T.			The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ	ONCOGENE			English	Article						AIB1; DCIS; tumor-initiating cells; coactivator; xenografts	MAMMARY TUMORIGENESIS; MOLECULAR MARKERS; EPITHELIAL ACINI; SRC FAMILY; STEM-CELLS; RECEPTOR; AIB1; GENE; MICE; PROGRESSION	The key molecular events required for the formation of ductal carcinoma in situ (DCIS) and its progression to invasive breast carcinoma have not been defined. Here, we show that the nuclear receptor coactivator amplified in breast cancer 1 (AIB1) is expressed at low levels in normal breast but is highly expressed in DCIS lesions. This is of significance since reduction of AIB1 in human MCFDCIS cells restored a more normal three-dimensional mammary acinar structure. Reduction of AIB1 in MCFDCIS cells, both before DCIS development or in existing MCFDCIS lesions in vivo, inhibited tumor growth and led to smaller, necrotic lesions. AIB1 reduction in MCFDCIS cells was correlated with significant reduction in the CD24-/CD44+ breast cancer-initiating cell (BCIC) population, and a decrease in myoepithelial progenitor cells in the DCIS lesions in vitro and in vivo. The loss of AIB1 in MCFDCIS cells was also accompanied by a loss of expression of NOTCH 2, 3 and 4, JAG2, HES1, GATA3, human epidermal growth factor receptor 2 (HER2) and HER3 in vivo. These signaling molecules have been associated with differentiation of breast epithelial progenitor cells. These data indicate that AIB1 has a central role in the initiation and maintenance of DCIS and that reduction of AIB1 causes loss of BCIC, loss of components of the NOTCH, HER2 and HER3 signaling pathways and fewer DCIS myoepithelial progenitor cells in vivo. We propose that increased expression of AIB1, through the maintenance of BCIC, facilitates formation of DCIS, a necessary step before development of invasive disease.	[Ory, V.; Tassi, E.; Cavalli, L. R.; Sharif, G. M.; Saenz, F.; Baker, T.; Schmidt, M. O.; Mueller, S. C.; Furth, P. A.; Wellstein, A.; Riegel, A. T.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Riegel, AT (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, E307 Res Bldg,3970 Reservoir Rd NW, Washington, DC 20057 USA.	ariege01@georgetown.edu	Schmidt, Marcel/AAV-8054-2021; Cavalli, Luciane R/J-6100-2012; Saenz, Francisco/ABE-7477-2020	Schmidt, Marcel/0000-0002-3991-2766; Saenz, Francisco/0000-0003-4738-4710; Wellstein, Anton/0000-0002-0570-4950; Cavalli, Luciane Regina/0000-0001-5619-9037	Department of Defense Breast Cancer Research Program [BC098103]; NIH/NCI [CA113477]; National Cancer Institute [P30CA051008]; NATIONAL CANCER INSTITUTE [R01CA113477, R01CA112176, T32CA009686, P30CA051008] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Department of Defense Breast Cancer Research Program BC098103 (VO) and by NIH/NCI Grants CA113477 (ATR). This project was also supported by Award Number P30CA051008 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Defense.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Otaiby M, 2012, AM J PATHOL, V180, P1474, DOI 10.1016/j.ajpath.2011.12.032; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Balko JM, 2012, P NATL ACAD SCI USA, V109, P221, DOI 10.1073/pnas.1115802109; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Cavalli LR, 2008, CANCER GENET CYTOGEN, V186, P120, DOI 10.1016/j.cancergencyto.2008.06.011; Cavalli LR, 2008, CANCER GENET CYTOGEN, V187, P19, DOI 10.1016/j.cancergencyto.2008.07.004; Chien CD, 2011, J BIOL CHEM, V286, P26813, DOI 10.1074/jbc.M110.216200; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Cody HS, 2007, ANN SURG ONCOL, V14, P2179, DOI 10.1245/s10434-006-9300-9; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Espina V, 2011, NAT REV CANCER, V11, P618, DOI 10.1038/nrc2950-c2; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Kuang SQ, 2005, CANCER RES, V65, P7993, DOI 10.1158/0008-5472.CAN-05-1179; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lauritsen KJ, 2002, ONCOGENE, V21, P7147, DOI 10.1038/sj.onc.1205943; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Miller FR, 2000, J MAMMARY GLAND BIOL, V5, P379, DOI 10.1023/A:1009577811584; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakles RE, 2011, MOL ENDOCRINOL, V25, P549, DOI 10.1210/me.2010-0114; Nofech-Mozes S, 2005, ADV ANAT PATHOL, V12, P256, DOI 10.1097/01.pap.0000184177.65919.5e; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; Porter D, 2003, MOL CANCER RES, V1, P362; Pradeep CR, 2012, ONCOGENE, V31, P907, DOI 10.1038/onc.2011.279; Qutob MS, 2002, MOL CELL BIOL, V22, P6611, DOI 10.1128/MCB.22.18.6611-6626.2002; RADFORD DM, 1995, CANCER RES, V55, P5180; Rosenfield SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047876; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; STRATTON MR, 1995, J PATHOL, V175, P195, DOI 10.1002/path.1711750207; Sung YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007445; Torres-Arzayus MI, 2010, CANCER RES, V70, P4102, DOI 10.1158/0008-5472.CAN-09-4080; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367	44	11	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 5	2014	33	23					3033	3042		10.1038/onc.2013.263	http://dx.doi.org/10.1038/onc.2013.263			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EL	23851504	Green Accepted			2022-12-25	WOS:000337232200010
J	Doppler, HR; Bastea, LI; Lewis-Tuffin, LJ; Anastasiadis, PZ; Storz, P				Doeppler, Heike R.; Bastea, Ligia I.; Lewis-Tuffin, Laura J.; Anastasiadis, Panos Z.; Storz, Peter			Protein Kinase D1-mediated Phosphorylations Regulate Vasodilator-stimulated Phosphoprotein (VASP) Localization and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENA/VASP PROTEINS; ACTIN CYTOSKELETON; FOCAL ADHESION; BARBED END; C-MU; ACTIVATION; MOTILITY; RHOA; DYNAMICS	Enabled/Vasodilator-stimulated phosphoprotein (Ena/VASP) protein family members link actin dynamics and cellular signaling pathways. VASP localizes to regions of dynamic actin reorganization such as the focal adhesion contacts, the leading edge or filopodia, where it contributes to F-actin filament elongation. Here we identify VASP as a novel substrate for protein kinase D1 (PKD1). We show that PKD1 directly phosphorylates VASP at two serine residues, Ser-157 and Ser-322. These phosphorylations occur in response to RhoA activation and mediate VASP re-localization from focal contacts to the leading edge region. The net result of this PKD1-mediated phosphorylation switch in VASP is increased filopodia formation and length at the leading edge. However, such signaling when persistent induced membrane ruffling and decreased cell motility.	[Doeppler, Heike R.; Bastea, Ligia I.; Lewis-Tuffin, Laura J.; Anastasiadis, Panos Z.; Storz, Peter] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Mayo Clin, Griffin Room 306,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			National Institutes of Health [NS069753, GM086435, CA140182]; Florida Department of Health [10BG11]; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA140182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS069753 (to P. Z. A.), GM086435, and CA140182 (to P. S.). This work was also supported by Bankhead-Coley Grant (10BG11) from the Florida Department of Health (to P. S.).	Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Ball LJ, 2000, EMBO J, V19, P4903, DOI 10.1093/emboj/19.18.4903; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; BUTT E, 1994, J BIOL CHEM, V269, P14509; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hardy L. R., 2012, CURRENT PROTOCOLS NE, P17; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; Jaggi M, 2005, CANCER RES, V65, P483; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Machesky LM, 2000, CELL, V101, P685, DOI 10.1016/S0092-8674(00)80879-X; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pusapati GV, 2012, J BIOL CHEM, V287, P9473, DOI 10.1074/jbc.M112.339564; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427	47	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24382	24393		10.1074/jbc.M113.474676	http://dx.doi.org/10.1074/jbc.M113.474676			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23846685	Green Published, hybrid			2022-12-25	WOS:000330612300010
J	Pokidysheva, E; Zientek, KD; Ishikawa, Y; Mizuno, K; Vranka, JA; Montgomery, NT; Keene, DR; Kawaguchi, T; Okuyama, K; Bachinger, HP				Pokidysheva, Elena; Zientek, Keith D.; Ishikawa, Yoshihiro; Mizuno, Kazunori; Vranka, Janice A.; Montgomery, Nathan T.; Keene, Douglas R.; Kawaguchi, Tatsuya; Okuyama, Kenji; Baechinger, Hans Peter			Posttranslational Modifications in Type I Collagen from Different Tissues Extracted from Wild Type and Prolyl 3-Hydroxylase 1 Null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC CHARACTERIZATION; CROSS-LINKING; 3-HYDROXYPROLINE; MUTATIONS; PROTEINS; DEFICIENCY; ENZYMES; CRTAP	Type I collagen extracted from tendon, skin, and bone of wild type and prolyl 3-hydroxylase 1 (P3H1) null mice shows distinct patterns of 3-hydroxylation and glycosylation of hydroxylysine residues. The A1 site (Pro-986) in the alpha 1-chain of type I collagen is almost completely 3-hydroxylated in every tissue of the wild type mice. In contrast, no 3-hydroxylation of this proline residue was found in P3H1 null mice. Partial 3-hydroxylation of the A3 site (Pro-707) was present in tendon and bone, but absent in skin in both alpha-chains of the wild type animals. Type I collagen extracted from bone of P3H1 null mice shows a large reduction in 3-hydroxylation of the A3 site in both alpha-chains, whereas type I collagen extracted from tendon of P3H1 null mice shows little difference as compared with wild type. These results demonstrate that the A1 site in type I collagen is exclusively 3-hydroxylated by P3H1, and presumably, this enzyme is required for the 3-hydroxylation of the A3 site of both alpha-chains in bone but not in tendon. The increase in glycosylation of hydroxylysine in P3H1 null mice in bone was found to be due to an increased occupancy of normally glycosylated sites. Despite the severe disorganization of collagen fibrils in adult tissues, the D-period of the fibrils is unchanged. Tendon fibrils of newborn P3H1 null mice are well organized with only a slight increase in diameter. The absence of 3-hydroxyproline and/or the increased glycosylation of hydroxylysine in type I collagen disturbs the lateral growth of the fibrils.	[Pokidysheva, Elena; Zientek, Keith D.; Ishikawa, Yoshihiro; Mizuno, Kazunori; Vranka, Janice A.; Montgomery, Nathan T.; Keene, Douglas R.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Pokidysheva, Elena; Ishikawa, Yoshihiro; Montgomery, Nathan T.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Kawaguchi, Tatsuya; Okuyama, Kenji] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Osaka 5600043, Japan	Oregon Health & Science University; Osaka University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospital for Children	Shriners Hospital for Children	This work was supported by grants from Shriners Hospital for Children (to H. P. B. and D. R. K.).	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dreisewerd K, 2004, ANAL CHEM, V76, P3482, DOI 10.1021/ac049928q; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fernandes RJ, 2011, J BIOL CHEM, V286, P30662, DOI 10.1074/jbc.M111.267906; Henkel W, 2007, J PROTEOME RES, V6, P4269, DOI 10.1021/pr070318r; Hosemann R., 1962, DIRECT ANAL DIFFRACT; Hudson DM, 2012, BIOCHEMISTRY-US, V51, P2417, DOI 10.1021/bi2019139; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; OGLE JD, 1962, J BIOL CHEM, V237, P3667; PIHLAJANIEMI T, 1991, J HEPATOL, V13, pS2, DOI 10.1016/0168-8278(91)90002-S; RISTELI J, 1978, ANAL BIOCHEM, V84, P423, DOI 10.1016/0003-2697(78)90060-X; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SPIRO RG, 1969, J BIOL CHEM, V244, P602; Taga Y, 2013, J PROTEOME RES, V12, P2225, DOI 10.1021/pr400079d; Taga Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010397; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729	32	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24742	24752		10.1074/jbc.M113.464156	http://dx.doi.org/10.1074/jbc.M113.464156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23861401	Green Published, hybrid			2022-12-25	WOS:000330612300040
J	Rosenzweig, JM; Glenn, JD; Calabresi, PA; Whartenby, KA				Rosenzweig, Jason M.; Glenn, Justin D.; Calabresi, Peter A.; Whartenby, Katharine A.			KLF4 Modulates Expression of IL-6 in Dendritic Cells via Both Promoter Activation and Epigenetic Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR; IL-6-DEFICIENT MICE; GENE; DIFFERENTIATION; INTERLEUKIN-6; INDUCTION; KRUPPEL-LIKE-FACTOR-4; LIPOPOLYSACCHARIDE; IDENTIFICATION	The initiation and maintenance of the immune response require a coordinated regulation of signal transduction pathways. Identifying the mechanisms by which these pathways are controlled and modulated is a significant goal of immunology. In the present report, we show a novel role for the zinc finger transcription factor Kruppel-like factor 4 (KLF4) in the modulation of the inflammatory immune response via its regulation of IL-6. We analyzed the role of KLF4 in the production of IL-6 by dendritic cells. Our data indicate that KLF4 can act in a dual function manner. It acts as a transcription factor in that it can bind to and activate the IL-6 promoter at specific binding sites. KLF4 also has a role in the chromatin remodeling of the IL-6 promoter in that cells deficient in KLF4 exhibited a relative hypoacetylation. These results indicate a molecular role for KLF4 in modulating the intensity of the inflammatory response and help to explain its pleiotropic role in different settings.	[Rosenzweig, Jason M.; Glenn, Justin D.; Calabresi, Peter A.; Whartenby, Katharine A.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Neurol, Baltimore, MD 21287 USA; [Whartenby, Katharine A.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Whartenby, KA (corresponding author), Dept Neurol, 601 N Wolfe St, Baltimore, MD 21287 USA.	whartenby@jhmi.edu	Calabresi, Peter A./AAF-2288-2019	Glenn, Justin/0000-0002-3567-6233; Calabresi, Peter/0000-0002-7776-6472	National Multiple Sclerosis Society [R01 NS41435]; Silverman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041435] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Silverman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the National Multiple Sclerosis Society, R01 NS41435, and the Silverman Foundation.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Kharas MG, 2007, BLOOD, V109, P747, DOI 10.1182/blood-2006-03-011106; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Musselman C.A., NATURE STRUCT MOL BI, V19, P1218; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Patel N. V., CANC EPIDEMIOL BIOMA, V19, P2631; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yusuf I, 2008, INT IMMUNOL, V20, P671, DOI 10.1093/intimm/dxn024; ZHANG YH, 1994, P NATL ACAD SCI USA, V91, P2225, DOI 10.1073/pnas.91.6.2225	33	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23868	23874		10.1074/jbc.M113.479576	http://dx.doi.org/10.1074/jbc.M113.479576			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23846700	Green Published, hybrid			2022-12-25	WOS:000330611400026
J	Vest, KE; Leary, SC; Winge, DR; Cobine, PA				Vest, Katherine E.; Leary, Scot C.; Winge, Dennis R.; Cobine, Paul A.			Copper Import into the Mitochondrial Matrix in Saccharomyces cerevisiae Is Mediated by Pic2, a Mitochondrial Carrier Family Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; FLUORESCENT SENSOR; IRON; TRANSPORT; SCO1; TRAFFICKING; MITOFERRIN; MECHANISM; COMPLEX; OXYGEN	Saccharomyces cerevisiae must import copper into the mitochondrial matrix for eventual assembly of cytochrome c oxidase. This copper is bound to an anionic fluorescent molecule known as the copper ligand (CuL). Here, we identify for the first time a mitochondrial carrier family protein capable of importing copper into the matrix. In vitro transport of the CuL into the mitochondrial matrix was saturable and temperature-dependent. Strains with a deletion of PIC2 grew poorly on copper-deficient non-fermentable medium supplemented with silver and under respiratory conditions when challenged with a matrix-targeted copper competitor. Mitochondria from pic2 Delta cells had lower total mitochondrial copper and exhibited a decreased capacity for copper uptake. Heterologous expression of Pic2 in Lactococcus lactis significantly enhanced CuL transport into these cells. Therefore, we propose a novel role for Pic2 in copper import into mitochondria.	[Vest, Katherine E.; Cobine, Paul A.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Leary, Scot C.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Winge, Dennis R.] Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; [Winge, Dennis R.] Univ Utah, Dept Med, Salt Lake City, UT 84132 USA	Auburn University System; Auburn University; University of Saskatchewan; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Cobine, PA (corresponding author), Auburn Univ, Dept Biol Sci, 101 Rouse Life Sci, Auburn, AL 36849 USA.	paul.cobine@auburn.edu	Cobine, Paul A/G-3107-2011; Cobine, Paul/AAH-6619-2020	Cobine, Paul A/0000-0001-6012-0985; Cobine, Paul/0000-0001-6012-0985; Vest, Katherine/0000-0002-3391-8649	National Institutes of Health [GM083292]; National Science Foundation [BIO-MCB-1158497]; Saskatchewan Health Research Foundation; Direct For Biological Sciences [1158497] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Saskatchewan Health Research Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health GM083292 (to D. R. W.). This work was also supported by National Science Foundation Grant BIO-MCB-1158497 (to P. A. C.) and by Saskatchewan Health Research Foundation Establishment and Natural Sciences and Engineering Research Discovery grants (to S. C. L.).	Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Jin YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000053; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Kunji ERS, 2005, CURR OPIN BIOTECH, V16, P546, DOI 10.1016/j.copbio.2005.08.006; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Morales JG, 2010, BIOCHEMISTRY-US, V49, P5436, DOI 10.1021/bi100558z; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Takabatake R, 2001, J BIOCHEM, V129, P827, DOI 10.1093/oxfordjournals.jbchem.a002926; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Wang YM, 2011, EXP HEMATOL, V39, P784, DOI 10.1016/j.exphem.2011.05.003; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036; Zatulovskiy EA, 2012, J INORG BIOCHEM, V116, P88, DOI 10.1016/j.jinorgbio.2012.07.003; Zischka H, 2011, J CLIN INVEST, V121, P1508, DOI 10.1172/JCI45401; Zotova L, 2010, J BIOL CHEM, V285, P14399, DOI 10.1074/jbc.M109.059956	37	69	69	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23884	23892		10.1074/jbc.M113.470674	http://dx.doi.org/10.1074/jbc.M113.470674			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23846699	Green Published, hybrid			2022-12-25	WOS:000330611400028
J	Dmytrenko, L; Cicanic, M; Anderova, M; Vorisek, I; Ottersen, OP; Sykova, E; Vargova, L				Dmytrenko, Lesia; Cicanic, Michal; Anderova, Miroslava; Vorisek, Ivan; Ottersen, Ole Petter; Sykova, Eva; Vargova, Lydia			The Impact of Alpha-Syntrophin Deletion on the Changes in Tissue Structure and Extracellular Diffusion Associated with Cell Swelling under Physiological and Pathological Conditions	PLOS ONE			English	Article							AQUAPORIN-4 WATER CHANNELS; RAT SPINAL-CORD; CEREBRAL-ISCHEMIA; POTASSIUM CHANNEL; VOLUME CHANGES; GLIAL-CELLS; BRAIN; MICE; K+; SPACE	Aquaporin-4 (AQP4) is the primary cellular water channel in the brain and is abundantly expressed by astrocytes along the blood-brain barrier and brain-cerebrospinal fluid interfaces. Water transport via AQP4 contributes to the activity-dependent volume changes of the extracellular space (ECS), which affect extracellular solute concentrations and neuronal excitability. AQP4 is anchored by alpha-syntrophin (alpha-syn), the deletion of which leads to reduced AQP4 levels in perivascular and subpial membranes. We used the real-time iontophoretic method and/or diffusion-weighted magnetic resonance imaging to clarify the impact of alpha-syn deletion on astrocyte morphology and changes in extracellular diffusion associated with cell swelling in vitro and in vivo. In mice lacking alpha-syn, we found higher resting values of the apparent diffusion coefficient of water (ADC(W)) and the extracellular volume fraction (alpha). No significant differences in tortuosity (lambda) or non-specific uptake (k'), were found between alpha-syn-negative (alpha-syn -/-) and alpha-syn-positive (alpha-syn +/+) mice. The deletion of alpha-syn resulted in a significantly smaller relative decrease in alpha observed during elevated K+ (10 mM) and severe hypotonic stress (-100 mOsmol/l), but not during mild hypotonic stress (-50 mOsmol/l). After the induction of terminal ischemia/anoxia, the final values of ADC(W) as well as of the ECS volume fraction alpha indicate milder cell swelling in alpha-syn -/- in comparison with alpha-syn +/+ mice. Shortly after terminal ischemia/anoxia induction, the onset of a steep rise in the extracellular potassium concentration and an increase in lambda was faster in alpha-syn -/- mice, but the final values did not differ between alpha-syn -/- and alpha-syn +/+ mice. This study reveals that water transport through AQP4 channels enhances and accelerates astrocyte swelling. The substantially altered ECS diffusion parameters will likely affect the movement of neuroactive substances and/or trophic factors, which in turn may modulate the extent of tissue damage and/or drug distribution.	[Dmytrenko, Lesia; Cicanic, Michal; Anderova, Miroslava; Vorisek, Ivan; Sykova, Eva; Vargova, Lydia] Inst Expt Med AS CR, Vvi, Prague, Czech Republic; [Cicanic, Michal; Anderova, Miroslava; Vorisek, Ivan; Sykova, Eva; Vargova, Lydia] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Ottersen, Ole Petter] Univ Oslo, Ctr Mol Biol & Neurosci, Oslo, Norway; [Ottersen, Ole Petter] Univ Oslo, Dept Anat, Oslo, Norway	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; University of Oslo; University of Oslo	Vargova, L (corresponding author), Inst Expt Med AS CR, Vvi, Prague, Czech Republic.	lydie.vargova@lfmotol.cuni.cz	Anderova, Miroslava/H-2249-2014; Sykova, Eva/H-2659-2014; Vargova, Lydia/H-2568-2014	Anderova, Miroslava/0000-0002-9030-4571; 	Grant Agency of the Czech Republic [309/09/1597, P303/11/2378, P304/12/G069]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This study was supported by the grants 309/09/1597, P303/11/2378 and P304/12/G069 from the Grant Agency of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Haj-Yasein NN, 2011, GLIA, V59, P1635, DOI 10.1002/glia.21205; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; Magistretti PJ, 2000, PROG BRAIN RES, V125, P229; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Neprasova H, 2007, PFLUG ARCH EUR J PHY, V453, P839, DOI 10.1007/s00424-006-0151-9; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; Papadopoulos MC, 2004, FASEB J, V18, P425, DOI 10.1096/fj.04-2834fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Strohschein S, 2011, GLIA, V59, P973, DOI 10.1002/glia.21169; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1136, DOI 10.1152/ajpcell.00478.2001; SVOBODA J, 1991, BRAIN RES, V560, P216, DOI 10.1016/0006-8993(91)91235-S; Sykova E, 1997, NEUROSCIENTIST, V3, P28, DOI 10.1177/107385849700300113; Sykova E, 1999, GLIA, V25, P56, DOI 10.1002/(SICI)1098-1136(19990101)25:1<56::AID-GLIA6>3.0.CO;2-4; SYKOVA E, 1992, MONITORING NEURONAL, P261; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Vorisek I, 2009, ACTA PHYSIOL, V195, P101, DOI 10.1111/j.1748-1716.2008.01924.x; Vorisek I, 1997, J CEREBR BLOOD F MET, V17, P191; Xiao F, 2009, NEUROSCIENCE, V161, P39, DOI 10.1016/j.neuroscience.2009.03.017; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; Zador Z, 2008, FASEB J, V22, P870, DOI 10.1096/fj.07-9468com; Zeynalov E, 2008, CRIT CARE MED, V36, P2634, DOI 10.1097/CCM.0b013e3181847853; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007	46	17	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68044	10.1371/journal.pone.0068044	http://dx.doi.org/10.1371/journal.pone.0068044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861848	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300037
J	Song, EL; Ma, X; Li, HZ; Zhang, P; Ni, D; Chen, WH; Gao, Y; Fan, Y; Pang, HG; Shi, TP; Ding, Q; Wang, BJ; Zhang, Y; Zhang, X				Song, Erlin; Ma, Xin; Li, Hongzhao; Zhang, Peng; Ni, Dong; Chen, Weihao; Gao, Yu; Fan, Yang; Pang, Haigang; Shi, Taoping; Ding, Qiang; Wang, Baojun; Zhang, Yu; Zhang, Xu			Attenuation of Kruppel-Like Factor 4 Facilitates Carcinogenesis by Inducing G1/S Phase Arrest in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GASTRIC-CANCER DEVELOPMENT; TUMOR-SUPPRESSOR GENE; PROGNOSTIC-FACTORS; CYCLE PROGRESSION; EXPRESSION; KLF4; P21; KRUPPEL-LIKE-FACTOR-4; GROWTH; DIFFERENTIATION	Kruppel-like factor 4 (KLF4) is a transcription factor with diverse functions in various cancer types; however, the function of KLF4 in clear cell renal cell carcinoma (ccRCC) carcinogenesis remains unknown. In this study, we initially examined KLF4 expression by using a cohort of surgically removed ccRCC specimens and cell lines. Results indicated that the transcription and translation of KLF4 were lower in ccRCC tissues than in patient-matched normal tissues. Furthermore, the KLF4 expression was significantly downregulated in the five ccRCC cell lines at protein and mRNA levels compared with that in normal renal proximal tubular epithelial cell lines (HKC). KLF4 downregulation was significantly correlated with tumor stage and tumor diameter. Promoter hypermethylation may contribute to its low expression. In addition, in vitro studies indicated that the KLF4 overexpression significantly inhibited proliferation in human ccRCC cell lines 786-O and ACHN. Moreover, the KLF4 overexpression arrested the cell cycle progress at the G1/S phase transition by upregulating p21(WAF1/CIP1) expression and downregulating cyclin D1 expression, KLF4 knockdown in HKC cells did the opposite. In vivo studies confirmed the anti-proliferative effect of KLF4. Our results suggested that KLF4 had an important function in suppressing the growth of ccRCC.	[Song, Erlin; Ma, Xin; Li, Hongzhao; Zhang, Peng; Ni, Dong; Chen, Weihao; Gao, Yu; Fan, Yang; Pang, Haigang; Shi, Taoping; Ding, Qiang; Wang, Baojun; Zhang, Yu; Zhang, Xu] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Med Sch Chinese PLA, Beijing, Peoples R China; [Song, Erlin] Chinese PLA 211 Hosp, Dept Urol, Harbin, Peoples R China	Chinese People's Liberation Army General Hospital	Zhang, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Med Sch Chinese PLA, Beijing, Peoples R China.	xzhang@foxmail.com	zhang, xu/GYE-3558-2022		National Natural Science Foundation of China [81100483]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Natural Science Foundation of China (No. 81100483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035022; Allory Y, 2011, PATHOBIOLOGY, V78, P90, DOI 10.1159/000315543; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Barroca H, 2009, PATHOL RES PRACT, V205, P466, DOI 10.1016/j.prp.2009.01.005; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen YJ, 2008, CANCER BIOL THER, V7, P777, DOI 10.4161/cbt.7.5.5768; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Delahunt B, 2007, PATHOLOGY, V39, P459, DOI 10.1080/00313020701570061; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 2000, CANCER RES, V60, P6488; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Gossage L, 2010, NAT REV CLIN ONCOL, V7, P277, DOI 10.1038/nrclinonc.2010.42; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; JIANG HP, 1994, ONCOGENE, V9, P3397; Kanai M, 2006, CLIN CANCER RES, V12, P6395, DOI 10.1158/1078-0432.CCR-06-1034; Le Magnen C, 2013, EUR J CANCER, V49, P955, DOI 10.1016/j.ejca.2012.09.023; Leng ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056082; Li J, 2012, CARCINOGENESIS, V33, P1239, DOI 10.1093/carcin/bgs143; Li Q, 2012, GASTROENTEROLOGY, V143, P799, DOI 10.1053/j.gastro.2012.05.043; Lian X, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.02.024; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; Liu S, 2011, UROL ONCOL; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Miura K, 1996, CANCER RES, V56, P1629; Lopez CM, 2012, CLIN GENITOURIN CANC, V10, P262, DOI 10.1016/j.clgc.2012.06.005; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Park SH, 2008, CANCER BIOL THER, V7, P2015, DOI 10.4161/cbt.7.12.7069; Patel NV, 2010, CANCER EPIDEM BIOMAR, V19, P2631, DOI 10.1158/1055-9965.EPI-10-0677; Roth MJ, 2001, CANCER RES, V61, P4098; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Tai SK, 2011, CANCER SCI, V102, P895, DOI 10.1111/j.1349-7006.2011.01859.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Wang JY, 2012, J NEURO-ONCOL, V106, P473, DOI 10.1007/s11060-011-0692-4; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2010, GASTROENTEROLOGY, V139, P2135, DOI 10.1053/j.gastro.2010.08.022; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wei S, 2012, CARCINOGENESIS, V33, P538, DOI 10.1093/carcin/bgr319; Weiss RH, 2007, J UROLOGY, V177, P63, DOI 10.1016/j.juro.2006.08.073; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yuen JSP, 2009, MOL CANCER THER, V8, P1448, DOI 10.1158/1535-7163.MCT-09-0101; Zbar B, 2003, ANNU REV MED, V54, P217, DOI 10.1146/annurev.med.54.101601.152514; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	59	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67758	10.1371/journal.pone.0067758	http://dx.doi.org/10.1371/journal.pone.0067758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861801	gold, Green Submitted, Green Published			2022-12-25	WOS:000321425300028
J	Braun, K; Larcombe, L; Orr, P; Nickerson, P; Wolfe, J; Sharma, M				Braun, Kali; Larcombe, Linda; Orr, Pamela; Nickerson, Peter; Wolfe, Joyce; Sharma, Meenu			Killer Immunoglobulin-Like Receptor (KIR) Centromeric-AA Haplotype Is Associated with Ethnicity and Tuberculosis Disease in a Canadian First Nations Cohort	PLOS ONE			English	Article							VARIANT KIR1D; GENE; POPULATIONS; KIR2DS4; POLYMORPHISMS; INFECTION; STRAIN	Killer immunoglobulin-like receptors (KIR) on natural killer (NK) cells interact with other immune cells to monitor the immune system and combat infectious diseases, such as tuberculosis (TB). The balance of activating and inhibiting KIR interactions helps determine the NK cell response. In order to examine the enrichment or depletion of KIRs as well as to explore the association between TB status and inhibitory/stimulatory KIR haplotypes, we performed KIR genotyping on samples from 93 Canadian First Nations (Dene, Cree, and Ojibwa) individuals from Manitoba with active, latent, or no TB infection, and 75 uninfected Caucasian controls. There were significant differences in KIR genes between Caucasians and First Nations samples and also between the First Nations ethnocultural groups (Dene, Cree, and Ojibwa). When analyzing ethnicity and tuberculosis status in the study population, it appears that the KIR profile and centromeric haplotype are more predictive than the presence or absence of individual genes. Specifically, the decreased presence of haplotype B centromeric genes and increased presence of centromeric-AA haplotypes in First Nations may contribute to an inhibitory immune profile, explaining the high rates of TB in this population.	[Braun, Kali; Sharma, Meenu] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Larcombe, Linda; Orr, Pamela; Nickerson, Peter] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Wolfe, Joyce; Sharma, Meenu] Publ Hlth Agcy Canada, Natl Reference Ctr Mycobacteriol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; Public Health Agency of Canada	Sharma, M (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	meenu.sharma@phac-aspc.gc.ca	Sharma, Meenu/AAE-2536-2022; Sharma, Meenu/GWM-5030-2022	Sharma, Meenu/0000-0002-6020-9995; Nickerson, Peter/0000-0002-7393-7799; Larcombe, Linda/0000-0002-7828-1290	University of Manitoba	University of Manitoba	No specific funding was sought for this project. Kali Braun is Dr. Sharma's graduate student and was funded by a graduate student stipend from the University of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR 2011; Arvanitakis Z, 1998, NEUROLOGY, V50, P1827, DOI 10.1212/WNL.50.6.1827; Carrington M, 2003, THE KIR GENE CLUSTER; Clifford H.T., 1975, INTRO NUMERICAL CLAS; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Giebel S, 2008, LEUKEMIA, V22, P2129, DOI 10.1038/leu.2008.108; Gutierrez-Rodriguez ME, 2006, HUM IMMUNOL, V67, P85, DOI 10.1016/j.humimm.2005.11.007; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; La D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029200; Larcombe L, 2005, GENES IMMUN, V6, P140, DOI 10.1038/sj.gene.6364157; Larcombe L, 2011, INT J CIRCUMPOL HEAL, V70, P141, DOI 10.3402/ijch.v70i2.17806; Larcombe LA, 2008, J INFECT DIS, V198, P1175, DOI 10.1086/592049; Mahfouz R, 2011, INT J TUBERC LUNG D, V15, P1688, DOI 10.5588/ijtld.11.0138; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Mendez A, 2006, TISSUE ANTIGENS, V68, P386, DOI 10.1111/j.1399-0039.2006.00685.x; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Morris GAJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016656; Petrelli D, 2004, TUBERCULOSIS, V84, P317, DOI 10.1016/j.tube.2004.01.001; Public Health Agency of Canada, 2007, CANADIAN TUBERCULOSI; Reid JK, 2007, CHEST, V131, P1806, DOI 10.1378/chest.06-1133; Rempel JD, 2011, EUR J HUM GENET, V19, P1276, DOI 10.1038/ejhg.2011.114; Shahsavar F, 2012, IRAN J IMMUNOL, V9, P39, DOI IJIv9i1A3; Sharma MK, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-3; Trajman A, 2013, PULM MED, V2013, DOI 10.1155/2013/601737; Vernon A, 2013, SEMIN RESP CRIT CARE, V34, P67, DOI 10.1055/s-0032-1333544; Versalovic J, MANUAL CLIN MICROBIO; Wilson S., 2008, RES IS CEREMONY INDI; Zhang Y, 2010, LEUKEMIA RES, V34, P55, DOI 10.1016/j.leukres.2009.04.022; Zhuang YL, 2012, INT J IMMUNOGENET, V39, P114, DOI 10.1111/j.1744-313X.2011.01063.x	33	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67842	10.1371/journal.pone.0067842	http://dx.doi.org/10.1371/journal.pone.0067842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861818	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700046
J	Brown, T; Bourne, D; Rodriguez-Lanetty, M				Brown, Tanya; Bourne, David; Rodriguez-Lanetty, Mauricio			Transcriptional Activation of c3 and hsp70 as Part of the Immune Response of Acropora millepora to Bacterial Challenges	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; CORAL POCILLOPORA-DAMICORNIS; ANEMONE ANEMONIA-VIRIDIS; SEA-ANEMONE; ARTEMIA-FRANCISCANA; MONTASTRAEA-FAVEOLATA; SCLERACTINIAN CORALS; INNATE IMMUNITY; CLIMATE-CHANGE; COMPLEMENT	The impact of disease outbreaks on coral physiology represents an increasing concern for the fitness and resilience of reef ecosystems. Predicting the tolerance of corals to disease relies on an understanding of the coral immune response to pathogenic interactions. This study explored the transcriptional response of two putative immune genes (c3 and c-type lectin) and one stress response gene (hsp70) in the reef building coral, Acropora millepora challenged for 48 hours with bacterial strains, Vibrio coralliilyticus and Alteromonas sp. at concentrations of 10(6) cells ml(-1). Coral fragments challenged with V. coralliilyticus appeared healthy while fragments challenged with Alteromonas sp. showed signs of tissue lesions after 48 hr. Coral-associated bacterial community profiles assessed using denaturing gradient gel electrophoresis changed after challenge by both bacterial strains with the Alteromonas sp. treatment demonstrating the greatest community shift. Transcriptional profiles of c3 and hsp70 increased at 24 hours and correlated with disease signs in the Alteromonas sp. treatment. The expression of hsp70 also showed a significant increase in V. coralliilyticus inoculated corals at 24 h suggesting that even in the absence of disease signs, the microbial inoculum activated a stress response in the coral. C-type lectin did not show a response to any of the bacterial treatments. Increase in gene expression of c3 and hsp70 in corals showing signs of disease indicates their potential involvement in immune and stress response to microbial challenges.	[Brown, Tanya; Rodriguez-Lanetty, Mauricio] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Bourne, David] Australia Inst Marine Sci, Townsville, Qld, Australia	State University System of Florida; Florida International University	Rodriguez-Lanetty, M (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	rodmauri@fiu.edu	Bourne, David G/B-5073-2008	Bourne, David G/0000-0002-1492-8710; Brown, Tanya/0000-0003-0103-7510	NSF-OCE grant [0851123]	NSF-OCE grant	This research was funded by NSF-OCE grant (0851123) awarded to MRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; Altincicek B, 2006, DEV COMP IMMUNOL, V30, P1108, DOI 10.1016/j.dci.2006.03.002; Antonius A, 1982, P 4 INT COR REEF S M, V2, P7; Baruah K, 2011, FISH SHELLFISH IMMUN, V31, P134, DOI 10.1016/j.fsi.2011.04.008; Baruah K, 2010, FISH SHELLFISH IMMUN, V29, P733, DOI 10.1016/j.fsi.2010.07.011; Baugh LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018086; Bellantuono AJ, 2012, P ROY SOC B-BIOL SCI, V279, P1100, DOI 10.1098/rspb.2011.1780; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; BIGGER CH, 1982, J IMMUNOL, V129, P1570; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Choresh O, 2001, MAR BIOTECHNOL, V3, P501, DOI 10.1007/s10126-001-0007-4; Choresh O, 2007, J THERM BIOL, V32, P367, DOI 10.1016/j.jtherbio.2007.04.006; Core RD, 2011, R LANG ENV STAT COMP; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Dunn SR, 2009, ISJ-INVERT SURVIV J, V6, P7; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; Feder ME, 1999, AM ZOOL, V39, P857; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; GARLAND CD, 1983, AUST J MAR FRESH RES, V34, P483; Gates RD, 1999, AM ZOOL, V39, P30; Geffen Y, 2005, MAR BIOL, V146, P931, DOI 10.1007/s00227-004-1505-5; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Hashimoto K, 2004, CORAL REEFS, V23, P485, DOI 10.1007/s00338-004-0410-1; Hayes Raymond L., 1995, Molecular Marine Biology and Biotechnology, V4, P36; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Ibrahaim Abdelnasser S.S., 2008, Research Journal of Microbiology, V3, P614; Kim K, 2009, DIS AQUAT ORGAN, V87, P1, DOI 10.3354/dao02177; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Klein J, 1997, SCAND J IMMUNOL, V46, P558, DOI 10.1046/j.1365-3083.1997.d01-164.x; Koh EGL, 1997, J CHEM ECOL, V23, P379, DOI 10.1023/B:JOEC.0000006366.58633.f4; Kooperman N, 2007, FEMS MICROBIOL LETT, V276, P106, DOI 10.1111/j.1574-6968.2007.00921.x; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P149, DOI 10.3354/meps117149; Littman RA, 2009, MAR ECOL PROG SER, V389, P45, DOI 10.3354/meps08180; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mullen KM, 2004, CORAL RESISTANCE DIS; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Norland S, 2004, GEL 2K 1 2; Oksanen SF, 2011, VEGAN COMMUNITY ECOL, V1; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; PAUL JH, 1986, MAR ECOL PROG SER, V33, P29, DOI 10.3354/meps033029; Prohaszka Z, 2002, CELL STRESS CHAPERON, V7, P17, DOI 10.1379/1466-1268(2002)007<0017:HSPIAP>2.0.CO;2; Prohaszka Z, 2004, TISSUE ANTIGENS, V64, P334; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Rinkevich B, 2011, VISIONS PERSPECTIVES; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodriguez-Lanetty M, 2008, J BIOCHEM BIOPH METH, V70, P985, DOI 10.1016/j.jbbm.2007.08.005; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; SHARP VA, 1994, J EXP MAR BIOL ECOL, V179, P179, DOI 10.1016/0022-0981(94)90113-9; Sharp VA, 1997, J THERM BIOL, V22, P11, DOI 10.1016/S0306-4565(96)00029-0; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Sung YY, 2008, CELL STRESS CHAPERON, V13, P59, DOI 10.1007/s12192-008-0011-y; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; Tom M, 1999, BIOCHEM BIOPH RES CO, V262, P103, DOI 10.1006/bbrc.1999.1165; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Wang KJ, 2008, DEV COMP IMMUNOL, V32, P1326, DOI 10.1016/j.dci.2008.04.007; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Wood-Charlson EM, 2009, DEV COMP IMMUNOL, V33, P881, DOI 10.1016/j.dci.2009.01.008; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	84	36	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67246	10.1371/journal.pone.0067246	http://dx.doi.org/10.1371/journal.pone.0067246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861754	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000323350700010
J	Alonso, A; Marsal, S; Tortosa, R; Canela-Xandri, O; Julia, A				Alonso, Arnald; Marsal, Sara; Tortosa, Rauel; Canela-Xandri, Oriol; Julia, Antonio			GStream: Improving SNP and CNV Coverage on Genome-Wide Association Studies	PLOS ONE			English	Article							COPY NUMBER VARIATION; 3,000 SHARED CONTROLS; HIDDEN-MARKOV MODEL; RHEUMATOID-ARTHRITIS; MACULAR DEGENERATION; STRUCTURAL VARIATION; JAPANESE POPULATION; COMMON VARIANTS; GENOTYPING DATA; DISEASE	We present GStream, a method that combines genome-wide SNP and CNV genotyping in the Illumina microarray platform with unprecedented accuracy. This new method outperforms previous well-established SNP genotyping software. More importantly, the CNV calling algorithm of GStream dramatically improves the results obtained by previous state-of-the-art methods and yields an accuracy that is close to that obtained by purely CNV-oriented technologies like Comparative Genomic Hybridization (CGH). We demonstrate the superior performance of GStream using microarray data generated from HapMap samples. Using the reference CNV calls generated by the 1000 Genomes Project (1KGP) and well-known studies on whole genome CNV characterization based either on CGH or genotyping microarray technologies, we show that GStream can increase the number of reliably detected variants up to 25% compared to previously developed methods. Furthermore, the increased genome coverage provided by GStream allows the discovery of CNVs in close linkage disequilibrium with SNPs, previously associated with disease risk in published Genome-Wide Association Studies (GWAS). These results could provide important insights into the biological mechanism underlying the detected disease risk association. With GStream, large-scale GWAS will not only benefit from the combined genotyping of SNPs and CNVs at an unprecedented accuracy, but will also take advantage of the computational efficiency of the method.	[Alonso, Arnald; Marsal, Sara; Tortosa, Rauel; Canela-Xandri, Oriol; Julia, Antonio] Vall dHebron Hosp Res Inst, Rheumatol Res Grp, Barcelona, Spain; [Alonso, Arnald] Univ Politecn Cataluna, Dept ESAII, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Universitat Politecnica de Catalunya	Julia, A (corresponding author), Vall dHebron Hosp Res Inst, Rheumatol Res Grp, Barcelona, Spain.	toni.julia@vhir.org		Julia Cano, Antonio/0000-0001-6064-3620; marsal, sara/0000-0001-5515-3854	Spanish Ministry of Economy and Competitiveness Strategic Project grants [PSE-010000-2006-6, IPT-010000-2010-36]	Spanish Ministry of Economy and Competitiveness Strategic Project grants	This work was supported by the Spanish Ministry of Economy and Competitiveness Strategic Project grants [PSE-010000-2006-6, IPT-010000-2010-36]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji OR, 2010, CLIN ENDOCRINOL, V72, P422, DOI 10.1111/j.1365-2265.2009.03638.x; Alonso A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-264; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Bergmann C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032318; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fujita PA, 2011, NUCL ACIDS RES; Gamazon ER, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001292; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Halper-Stromberg E, 2011, BIOINFORMATICS, V27, P1052, DOI 10.1093/bioinformatics/btr106; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Illumina, 2010, GEN WID DNA AN BEADC; Illumina, 2005, ILL GENCALL DAT AN S; Jiang YA, 2011, GENET EPIDEMIOL, V35, P125, DOI 10.1002/gepi.20558; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Li GX, 2012, BIOINFORMATICS, V28, P358, DOI 10.1093/bioinformatics/btr673; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Pankratz N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020988; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Ragoussis J, 2009, ANNU REV GENOM HUM G, V10, P117, DOI 10.1146/annurev-genom-082908-150116; Ritchie ME, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-68; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tang ChengCai, 2012, Journal of Resources and Ecology, V3, P8; Teng YN, 2002, J CLIN ENDOCR METAB, V87, P5258, DOI 10.1210/jc.2002-020016; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; Thio CL, 2005, J VIROL, V79, P9192, DOI 10.1128/JVI.79.14.9192-9196.2005; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang LL, 2002, AM J HUM GENET, V71, P165, DOI 10.1086/341234; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079	72	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68822	10.1371/journal.pone.0068822	http://dx.doi.org/10.1371/journal.pone.0068822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844243	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000028
J	Chatterjee, B; Lee, CY; Lin, C; Chen, EHL; Huang, CL; Yang, CC; Chen, RPY				Chatterjee, Biswanath; Lee, Chung-Yu; Lin, Chen; Chen, Eric H. -L.; Huang, Chao-Li; Yang, Chien-Chih; Chen, Rita P-Y.			Amyloid Core Formed of Full-Length Recombinant Mouse Prion Protein Involves Sequence 127-143 but Not Sequence 107-126	PLOS ONE			English	Article							IN-VITRO; SCRAPIE PRION; CONFORMATIONAL TRANSITIONS; MOLECULAR-STRUCTURE; SECONDARY STRUCTURE; SYNTHETIC PEPTIDES; ALPHA-HELICES; FIBRILS; CONVERSION; RESIDUES	The principal event underlying the development of prion disease is the conversion of soluble cellular prion protein (PrPC) into its disease-causing isoform, PrPSc. This conversion is associated with a marked change in secondary structure from predominantly alpha-helical to a high beta-sheet content, ultimately leading to the formation of aggregates consisting of ordered fibrillar assemblies referred to as amyloid. In vitro, recombinant prion proteins and short prion peptides from various species have been shown to form amyloid under various conditions and it has been proposed that, theoretically, any protein and peptide could form amyloid under appropriate conditions. To identify the peptide segment involved in the amyloid core formed from recombinant full-length mouse prion protein mPrP(23-230), we carried out seed-induced amyloid formation from recombinant prion protein in the presence of seeds generated from the short prion peptides mPrP(107-143), mPrP(107-126), and mPrP(127-143). Our results showed that the amyloid fibrils formed from mPrP(107-143) and mPrP(127-143), but not those formed from mPrP(107-126), were able to seed the amyloidogenesis of mPrP(23-230), showing that the segment residing in sequence 127-143 was used to form the amyloid core in the fibrillization of mPrP(23-230).	[Chatterjee, Biswanath; Lee, Chung-Yu; Lin, Chen; Chen, Eric H. -L.; Chen, Rita P-Y.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lee, Chung-Yu; Chen, Rita P-Y.] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Huang, Chao-Li; Yang, Chien-Chih] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Chen, RPY (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	pyc@gate.sinica.edu.tw	Chen, Rita P/M-8397-2013; Chattopadhyay, Biswanath Chatterjee/AAF-9104-2021	Chen, Rita P/0000-0003-3987-033X; YANG, CHIEN-CHIH/0000-0002-6238-2871; Chen, Eric H.-L./0000-0003-1641-5086	Academia Sinica; National Science Council, Taiwan, R. O. C. [NSC 97-2321-B-001-032, NSC 98-2311-B-001-019, NSC 99-2321-B-001-038, NSC 100-2321-B-001-026]; National Science Council	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica and the National Science Council, Taiwan, R. O. C. (grant nos. NSC 97-2321-B-001-032, NSC 98-2311-B-001-019, NSC 99-2321-B-001-038, and NSC 100-2321-B-001-026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ilia Baskakov for kindly providing the plasmid containing the mouse PrP gene. The ESI-TOF mass identification of proteins was performed by the Core Facilities at the Institute of Biological Chemistry, Academia Sinica, supported by the National Science Council and the Academia Sinica. We thank Mr. Tai-Lang Lin and the Core Facility of the Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan for assistance in transmission electron microscopy.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Dupiereux I, 2005, BIOCHEM BIOPH RES CO, V331, P894, DOI 10.1016/j.bbrc.2005.04.012; Ettaiche M, 2000, J BIOL CHEM, V275, P36487, DOI 10.1074/jbc.C000579200; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Hsu RL, 2009, J AGR FOOD CHEM, V57, P503, DOI 10.1021/jf803072r; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kourie JI, 2000, J NEUROSCI RES, V62, P120, DOI 10.1002/1097-4547(20001001)62:1<120::AID-JNR13>3.0.CO;2-2; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Lee LYL, 2007, J AM CHEM SOC, V129, P1644, DOI 10.1021/ja0667413; Lee SW, 2008, J MOL BIOL, V378, P1142, DOI 10.1016/j.jmb.2008.03.035; Liao TY, 2011, FEBS J, V278, P4351, DOI 10.1111/j.1742-4658.2011.08353.x; Lin MX, 1997, J BIOL CHEM, V272, P44; Lin NS, 2010, CHEM-EUR J, V16, P5492, DOI 10.1002/chem.200903290; Makarava Natallia, 2008, V459, P131, DOI 10.1007/978-1-59745-234-2_10; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Serpell LC, 2000, BIOCHEMISTRY-US, V39, P13269, DOI 10.1021/bi000637v; Serpell LC, 1997, CELL MOL LIFE SCI, V53, P871, DOI 10.1007/s000180050107; Singh J, 2012, J MOL BIOL, V423, P217, DOI 10.1016/j.jmb.2012.06.040; Supattapone S, 2001, MOL CELL BIOL, V21, P2608, DOI 10.1128/MCB.21.7.2608-2616.2001; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Thellung S, 2000, INT J DEV NEUROSCI, V18, P481, DOI 10.1016/S0736-5748(00)00005-8; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Yamaguchi KI, 2008, BIOCHEMISTRY-US, V47, P13242, DOI 10.1021/bi801562w; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	50	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67967	10.1371/journal.pone.0067967	http://dx.doi.org/10.1371/journal.pone.0067967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844138	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000120
J	Fan, HQ; Tang, W; Wang, ZX; Wang, SJ; Qin, YH; Fu, Q; Gao, Y; Sun, M; Zhang, M; Zhou, HW; Yang, T				Fan, Hong-Qi; Tang, Wei; Wang, Zhi-Xiao; Wang, Su-Juan; Qin, Yue-Hua; Fu, Qi; Gao, Yuan; Sun, Min; Zhang, Mei; Zhou, Hong-Wen; Yang, Tao			Association of Serum Uric Acid with 2-Hour Postload Glucose in Chinese with Impaired Fasting Plasma Glucose and/or HbA1c	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; 20-YEAR FOLLOW-UP; CARDIOVASCULAR-DISEASE; RISK-FACTOR; DIABETES-MELLITUS; ENDOTHELIAL DYSFUNCTION; CELL-PROLIFERATION; METABOLIC SYNDROME; MORTALITY; MEN	Objective: To examine whether serum uric acid (SUA) is associated with 2-hour postload glucose (2-h PG) in Chinese with impaired fasting plasma glucose (IFG) and/or HbA1c (IA1C). Research Design and Methods: Anthropometric and biochemical examinations, such as SUA concentration, were performed in 3763 individuals from all the villages in Baqiao County, China. A 75-g oral glucose tolerance test (OGTT) was conducted in 1197 Chinese with prediabetes as having IFG (110 <= fasting plasma glucose [FPG] < 126 mg/dl and HbA1c < 6.5%), IA1C (5.7% <= HbA1c < 6.5% and FPG < 126 mg/dl), or both. Results: The present study included 1197 participants with IFG and/or IA1C (mean age 56.5 +/- 10.3 years; 50.6% men). In multivariate linear regression, after adjustment for gender, age, smoking and drinking, body mass index (BMI), systolic and diastolic blood pressure (SBP, DBP), lipid profiles, logarithmic transformed C-reactive protein (log-CRP), estimated glomerular filtration rate (e-GFR), FPG and HbA1c, with a 1-mg/dl increment of SUA, 2-h PG increased by 5.04 +/- 0.72 (P < 0.001), 3.06 +/- 1.08 (P = 0.001), 5.40 +/- 1.26 (P < 0.001), and 2.34 +/- 2.16 mg/dl (P = 0.056) in all participants, in participants with normal glucose tolerance (NGT), with impaired glucose tolerance (IGT), and with 2-h newly diagnosed diabetes (2-h NDM, with 2-h PG >= 200 mg/dl), respectively. In both men and women, 2-h PG increased progressively and significantly from the lower to the upper SUA tertiles (P < 0.001). Moreover, in multivariate logistic regression, 1-standard deviation (SD; 1.53 mg/dl) increment of SUA was significantly associated with a 36% higher risk for 2-h NDM (Odds ratio [CI 95%]: 1.36 [1.09-1.99]; P = 0.03). Conclusion: SUA is significantly associated with 2-h PG in Chinese with IFG and/or IA1C.	[Fan, Hong-Qi; Wang, Zhi-Xiao; Wang, Su-Juan; Qin, Yue-Hua; Fu, Qi; Gao, Yuan; Sun, Min; Zhang, Mei; Zhou, Hong-Wen; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Tang, Wei] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Endocrinol, Jiangyin, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn			National Natural Science Foundation of China [81100578]; National Key Technologies R&D Program of China [2007BAI07A10]; Jiangsu Province Science and Technology Support Program [BE2009613]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program); Jiangsu Province Science and Technology Support Program	This study was supported by grants from the National Natural Science Foundation of China (81100578), the National Key Technologies R&D Program of China, during the 11th Five-Year Plan Period (2007BAI07A10) and the Jiangsu Province Science and Technology Support Program (BE2009613).	Abdul-Ghani MA, 2008, DIABETES CARE, V31, P1650, DOI 10.2337/dc08-0225; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; [Anonymous], 1995, DIABETES, V44, P968; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Barrett-Connor E, 1998, DIABETES CARE, V21, P1236, DOI 10.2337/diacare.21.8.1236; Borch-Johnsen K, 1999, LANCET, V354, P617; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Gao W, 2008, DIABETES RES CLIN PR, V79, P151, DOI 10.1016/j.diabres.2007.07.018; Groeneveld Y, 1999, DIABETIC MED, V16, P2, DOI 10.1046/j.1464-5491.1999.00003.x; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Haffner SM, 2000, NEW ENGL J MED, V342, P1040, DOI 10.1056/NEJM200004063421408; HERMAN JB, 1976, DIABETOLOGIA, V12, P47, DOI 10.1007/BF01221964; Hodge AM, 2001, INT J OBESITY, V25, P126, DOI 10.1038/sj.ijo.0801522; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jansson SPO, 2010, DIABETES CARE, V33, P551, DOI 10.2337/dc09-0680; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mercuro G, 2004, AM J CARDIOL, V94, P932, DOI 10.1016/j.amjcard.2004.06.032; Nan HR, 2007, DIABETES RES CLIN PR, V76, P68, DOI 10.1016/j.diabres.2006.07.022; Perticone F, 2012, DIABETES CARE, V35, P153, DOI 10.2337/dc11-1727; PETRIE JC, 1986, BRIT MED J, V293, P611, DOI 10.1136/bmj.293.6547.611; Pour OR, 2011, CLIN CHEM, V57, P215, DOI 10.1373/clinchem.2010.149096; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; TUOMILEHTO J, 1988, AM J EPIDEMIOL, V127, P321, DOI 10.1093/oxfordjournals.aje.a114807; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS64, DOI 10.1681/ASN.2005121345	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67759	10.1371/journal.pone.0067759	http://dx.doi.org/10.1371/journal.pone.0067759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844086	Green Submitted, gold, Green Published			2022-12-25	WOS:000321733000100
J	Kung, LH; Gong, KR; Adedoyin, M; Ng, J; Bhargava, A; Ohara, PT; Jasmin, L				Kung, Ling-Hsuan; Gong, Kerui; Adedoyin, Mary; Ng, Johnson; Bhargava, Aditi; Ohara, Peter T.; Jasmin, Luc			Evidence for Glutamate as a Neuroglial Transmitter within Sensory Ganglia	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; SATELLITE GLIAL-CELLS; CHRONIC CONSTRICTION INJURY; PERIPHERAL NERVOUS-SYSTEM; MOUSE TRIGEMINAL GANGLIA; PRIMARY AFFERENT NEURONS; EXCITATORY AMINO-ACIDS; RAT DRG NEURONS; SPINAL-CORD; SUBSTANCE-P	This study examines key elements of glutamatergic transmission within sensory ganglia of the rat. We show that the soma of primary sensory neurons release glutamate when depolarized. Using acute dissociated mixed neuronal/glia cultures of dorsal root ganglia (DRG) or trigeminal ganglia and a colorimetric assay, we show that when glutamate uptake by satellite glial cells (SGCs) is inhibited, KCl stimulation leads to simultaneous increase of glutamate in the culture medium. With calcium imaging we see that the soma of primary sensory neurons and SGCs respond to AMPA, NMDA, kainate and mGluR agonists, and selective antagonists block this response. Using whole cell patch-clamp technique, inward currents were recorded from small diameter (<30 mu m) DRG neurons from intact DRGs (ex-vivo whole ganglion preparation) in response to local application of the above glutamate receptor agonists. Following a chronic constriction injury (CCI) of either the inferior orbital nerve or the sciatic nerve, glutamate expression increases in the trigeminal ganglia and DRG respectively. This increase occurs in neurons of all diameters and is present in the somata of neurons with injured axons as well as in somata of neighboring uninjured neurons. These data provides additional evidence that glutamate can be released within the sensory ganglion, and that the somata of primary sensory neurons as well as SGCs express functional glutamate receptors at their surface. These findings, together with our previous gene knockdown data, suggest that glutamatergic transmission within the ganglion could impact nociceptive threshold.	[Kung, Ling-Hsuan; Gong, Kerui; Adedoyin, Mary; Ohara, Peter T.; Jasmin, Luc] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Ng, Johnson] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Bhargava, Aditi] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Chinese University of Hong Kong; University of California System; University of California San Francisco	Ohara, PT (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	peter.ohara@ucsf.edu			NIH [NS061241, NS051336]; Painless Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051336, R21NS079897, R01NS061241] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Painless Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH NS061241, NS051336 and the Painless Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; Akagi Y, 2003, J BIOCHEM, V134, P353, DOI 10.1093/jb/mvg152; Anderson CM, 2001, J NEUROCHEM, V79, P1207; AZERAD J, 1992, CR ACAD SCI III-VIE, V314, P469; Barreto-Chang Odmara L, 2009, J Vis Exp, DOI 10.3791/1067; BASBAUM AI, 1991, PAIN, V47, P359, DOI 10.1016/0304-3959(91)90229-Q; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BATTAGLIA G, 1988, J COMP NEUROL, V277, P302, DOI 10.1002/cne.902770210; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Benarroch EE, 2010, NEUROLOGY, V74, P259, DOI 10.1212/WNL.0b013e3181cc89e3; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Berger UV, 2000, J COMP NEUROL, V421, P385, DOI 10.1002/(SICI)1096-9861(20000605)421:3<385::AID-CNE7>3.0.CO;2-S; Bernabucci M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-77; Berta T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-18; Broman J, 2000, HAND CHEM N, V18, P1; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; CANGRO CB, 1985, BRAIN RES, V336, P158, DOI 10.1016/0006-8993(85)90428-7; Carlton SM, 2007, J COMP NEUROL, V501, P780, DOI 10.1002/cne.21285; Carlton SM, 2011, J NEUROSCI, V31, P12727, DOI 10.1523/JNEUROSCI.6558-10.2011; Carozzi V, 2008, CNS NEUROL DISORD-DR, V7, P348, DOI 10.2174/187152708786441876; Carozzi VA, 2008, J ANAT, V213, P539, DOI 10.1111/j.1469-7580.2008.00984.x; Castillo C, 2011, NEUROSCIENCE, V177, P308, DOI 10.1016/j.neuroscience.2010.12.040; Ceruti S, 2011, J NEUROSCI, V31, P3638, DOI 10.1523/JNEUROSCI.6440-10.2011; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Crawford JH, 1997, J NEUROPHYSIOL, V77, P2573, DOI 10.1152/jn.1997.77.5.2573; Crawford JH, 2000, NEUROPHARMACOLOGY, V39, P621, DOI 10.1016/S0028-3908(99)00167-7; de Groot J, 2000, NEUROREPORT, V11, P497, DOI 10.1097/00001756-200002280-00014; DEBIASI S, 1988, P NATL ACAD SCI USA, V85, P7820; DEVOR M, 1985, SOMATOSENS MOT RES, V3, P139, DOI 10.3109/07367228509144581; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Gu YP, 2010, NEURON GLIA BIOL, V6, P53, DOI 10.1017/S1740925X10000116; Guo H, 2001, J PHYSIOL-LONDON, V537, P115, DOI 10.1111/j.1469-7793.2001.0115k.x; Hai T, 1999, GENE EXPRESSION, V7, P321; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Inquimbert P, 2012, PAIN, V153, P2422, DOI 10.1016/j.pain.2012.08.011; Ivanusic JJ, 2009, J COMP NEUROL, V517, P276, DOI 10.1002/cne.22160; Jasmin L, 2010, NEURON GLIA BIOL, V6, P63, DOI 10.1017/S1740925X10000098; JEFTINIJA S, 1991, NEUROSCI LETT, V125, P191, DOI 10.1016/0304-3940(91)90025-O; Jung H, 2008, J NEUROCHEM, V104, P254, DOI 10.1111/j.1471-4159.2007.04969.x; KAIKAI MA, 1991, HISTOCHEM J, V23, P171, DOI 10.1007/BF01046588; KANEKO T, 1988, BRAIN RES, V457, P160, DOI 10.1016/0006-8993(88)90069-8; Keast JR, 2000, J COMP NEUROL, V424, P577; Kernisant M, 2008, J NEUROSCI METH, V172, P43, DOI 10.1016/j.jneumeth.2008.04.013; Kuo LT, 2011, J MOL NEUROSCI, V43, P503, DOI 10.1007/s12031-010-9473-3; Li JY, 2012, NEUROSCI LETT, V531, P52, DOI 10.1016/j.neulet.2012.10.014; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; LOVINGER DM, 1988, NEUROSCI LETT, V94, P314, DOI 10.1016/0304-3940(88)90037-7; Marsala M, 1995, J NEUROSCI METH, V62, P43, DOI 10.1016/0165-0270(95)00053-4; MCMAHON HT, 1991, J NEUROCHEM, V56, P86, DOI 10.1111/j.1471-4159.1991.tb02566.x; McRoberts JA, 2011, NEUROSCIENCE, V172, P474, DOI 10.1016/j.neuroscience.2010.10.045; Miller KE, 2002, BRAIN RES, V945, P202, DOI 10.1016/S0006-8993(02)02802-0; Miller KE, 2011, PHARMACOL THERAPEUT, V130, P283, DOI 10.1016/j.pharmthera.2011.01.005; Moller KA, 1998, J NEUROSCI METH, V84, P41, DOI 10.1016/S0165-0270(98)00083-1; Napier IA, 2012, J NEUROPHYSIOL, V107, P649, DOI 10.1152/jn.00763.2011; Neugebauer V, 2007, Handb Exp Pharmacol, P217; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; Niederberger E, 2006, BIOCHEM BIOPH RES CO, V346, P393, DOI 10.1016/j.bbrc.2006.05.163; Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Purkiss J, 2000, BIOCHEM PHARMACOL, V59, P1403, DOI 10.1016/S0006-2952(00)00260-4; Purkiss John R., 1998, Biochemical Society Transactions, V26, pS108; SATO K, 1993, NEUROREPORT, V4, P1263, DOI 10.1097/00001756-199309000-00013; Schaeffer V, 2010, PROG NEUROBIOL, V92, P33, DOI 10.1016/j.pneurobio.2010.04.009; Shoji Y, 2010, HISTOCHEM CELL BIOL, V134, P13, DOI 10.1007/s00418-010-0711-0; SKILLING SR, 1990, J NEUROSCI, V10, P1309; Suadicani SO, 2010, NEURON GLIA BIOL, V6, P43, DOI 10.1017/S1740925X09990408; SWETT JE, 1991, EXP NEUROL, V114, P82, DOI 10.1016/0014-4886(91)90087-S; TACHIBANA M, 1994, J COMP NEUROL, V344, P431, DOI 10.1002/cne.903440307; Takeda M, 2012, BRAIN BEHAV IMMUNITY; THIO LL, 1991, J NEUROSCI, V11, P3430; Van Steenwinckel J, 2009, NEUROSCIENCE, V161, P838, DOI 10.1016/j.neuroscience.2009.03.087; Vikelis Michail, 2007, CNS & Neurological Disorders-Drug Targets, V6, P251; VOS BP, 1994, J NEUROSCI, V14, P2708; WANAKA A, 1987, EXP BRAIN RES, V65, P691; Weng HR, 2006, NEUROSCIENCE, V138, P1351, DOI 10.1016/j.neuroscience.2005.11.061; WESTLUND KN, 1992, BRAIN RES REV, V17, P15, DOI 10.1016/0165-0173(92)90003-5; WHEELER DD, 1966, J CELL PHYSIOL, V67, P141, DOI 10.1002/jcp.1040670116; Willcockson H, 2008, CELL TISSUE RES, V334, P17, DOI 10.1007/s00441-008-0662-0; Xiao Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-12; Xin WJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-15; Yang CQ, 2012, DIGEST DIS SCI, V57, P865, DOI 10.1007/s10620-011-1970-x; YU YB, 1987, EUR J PHARMACOL, V141, P371, DOI 10.1016/0014-2999(87)90554-1; Zhang Q, 2004, J BIOL CHEM, V279, P12724, DOI 10.1074/jbc.M312845200; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104	87	74	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68312	10.1371/journal.pone.0068312	http://dx.doi.org/10.1371/journal.pone.0068312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844184	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000152
J	Sun, ZF; Smyth, K; Garcia, K; Mattson, E; Li, L; Xiao, ZG				Sun, Zhifeng; Smyth, Kendra; Garcia, Karla; Mattson, Elliot; Li, Lei; Xiao, Zhengguo			Nicotine Inhibits Memory CTL Programming	PLOS ONE			English	Article							CD8 T-CELLS; OBSTRUCTIVE PULMONARY-DISEASE; IFN-GAMMA PRODUCTION; ACETYLCHOLINE-RECEPTORS; CLONAL EXPANSION; EFFECTOR FUNCTION; CUTTING EDGE; I IFN; ANTIINFLAMMATORY PATHWAY; SIGNALING MECHANISMS	Nicotine is the main tobacco component responsible for tobacco addiction and is used extensively in smoking and smoking cessation therapies. However, little is known about its effects on the immune system. We confirmed that multiple nicotinic receptors are expressed on mouse and human cytotoxic T lymphocytes (CTLs) and demonstrated that nicotinic receptors on mouse CTLs are regulated during activation. Acute nicotine presence during activation increases primary CTL expansion in vitro, but impairs in vivo expansion after transfer and subsequent memory CTL differentiation, which reduces protection against subsequent pathogen challenges. Furthermore, nicotine abolishes the regulatory effect of rapamycin on memory CTL programming, which can be attributed to the fact that rapamycin enhances expression of nicotinic receptors. Interestingly, naive CTLs from chronic nicotine-treated mice have normal memory programming, which is impaired by nicotine during activation in vitro. In conclusion, simultaneous exposure to nicotine and antigen during CTL activation negatively affects memory development.	[Sun, Zhifeng; Smyth, Kendra; Garcia, Karla; Mattson, Elliot; Li, Lei; Xiao, Zhengguo] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Xiao, ZG (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	xiao0028@umd.edu		Xiao, Zhengguo/0000-0002-3359-6491	National Institutes of Health [R21AI095715A]; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health Grants R21AI095715A (to XZ) and Startup from the University of Maryland (to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Al-Wadei HAN, 2009, CARCINOGENESIS, V30, P506, DOI 10.1093/carcin/bgp010; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Benowitz NL, 2011, CLIN PHARMACOL THER, V90, P491, DOI 10.1038/clpt.2011.191; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Djordjevic Mirjana V, 2009, Handb Exp Pharmacol, P61, DOI 10.1007/978-3-540-69248-5_3; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Gentry CL, 2002, CNS NEUROL DISORD-DR, V1, P359, DOI 10.2174/1568007023339184; Glantz SA, 2011, BMJ, V343; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ilhan SO, 2008, EUR J PHARMACOL, V587, P267, DOI 10.1016/j.ejphar.2008.03.029; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kavoussi B, 2007, INTEGR CANCER THER, V6, P251, DOI 10.1177/1534735407305892; Kawashima K, 2003, LIFE SCI, V72, P2101, DOI 10.1016/S0024-3205(03)00068-7; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lawson GM, 1998, J CLIN PHARMACOL, V38, P502, DOI 10.1002/j.1552-4604.1998.tb05787.x; Levite M, 2000, ANN NY ACAD SCI, V917, P307; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li QS, 2006, J IMMUNOL, V177, P7618, DOI 10.4049/jimmunol.177.11.7618; Li XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025177; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Peng HS, 2004, LIFE SCI, V76, P263, DOI 10.1016/j.lfs.2004.05.031; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rodu B, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-19; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; Schmidt CS, 1999, J IMMUNOL, V163, P2561; Scott DA, 2006, WORLD J GASTROENTERO, V12, P7451, DOI 10.3748/wjg.v12.i46.7451; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sopori ML, 1998, J NEUROIMMUNOL, V83, P148, DOI 10.1016/S0165-5728(97)00231-2; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tammimaki A, 2011, BIOCHEM PHARMACOL, V82, P808, DOI 10.1016/j.bcp.2011.06.014; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tournier JM, 2011, CURR OPIN ONCOL, V23, P83, DOI 10.1097/CCO.0b013e3283412ea1; Traves SL, 2004, J LEUKOCYTE BIOL, V76, P441, DOI 10.1189/jlb.1003495; Tuesta LM, 2011, BIOCHEM PHARMACOL, V82, P984, DOI 10.1016/j.bcp.2011.06.026; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; Wang DW, 2010, J PHARMACOL EXP THER, V335, P553, DOI 10.1124/jpet.110.169961; Way SS, 2007, J IMMUNOL, V178, P4498, DOI 10.4049/jimmunol.178.7.4498; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376; Xiao ZG, 2007, INT IMMUNOL, V19, P733, DOI 10.1093/intimm/dxm039; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484	83	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68183	10.1371/journal.pone.0068183	http://dx.doi.org/10.1371/journal.pone.0068183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844169	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000142
J	Valencia, M; Artieda, J; Bolam, JP; Mena-Segovia, J				Valencia, Miguel; Artieda, Julio; Bolam, J. Paul; Mena-Segovia, Juan			Dynamic Interaction of Spindles and Gamma Activity during Cortical Slow Oscillations and Its Modulation by Subcortical Afferents	PLOS ONE			English	Article							WAVE SLEEP; CORTICOTHALAMIC FEEDBACK; PEDUNCULOPONTINE NEURONS; NEOCORTICAL NEURONS; CELLULAR MECHANISMS; IN-VITRO; STATES; CORTEX; MEMORY; COHERENCE	Slow oscillations are a hallmark of slow wave sleep. They provide a temporal framework for a variety of phasic events to occur and interact during sleep, including the expression of high-frequency oscillations and the discharge of neurons across the entire brain. Evidence shows that the emergence of distinct high-frequency oscillations during slow oscillations facilitates the communication among brain regions whose activity was correlated during the preceding waking period. While the frequencies of oscillations involved in such interactions have been identified, their dynamics and the correlations between them require further investigation. Here we analyzed the structure and dynamics of these signals in anesthetized rats. We show that spindles and gamma oscillations coexist but have distinct temporal dynamics across the slow oscillation cycle. Furthermore, we observed that spindles and gamma are functionally coupled to the slow oscillations and between each other. Following the activation of ascending pathways from the brainstem by means of a carbachol injection in the pedunculopontine nucleus, we were able to modify the gain in the gamma oscillations that are independent of the spindles while the spindle amplitude was reduced. Furthermore, carbachol produced a decoupling of the gamma oscillations that are dependent on the spindles but with no effect on their amplitude. None of the changes in the high-frequency oscillations affected the onset or shape of the slow oscillations, suggesting that slow oscillations occur independently of the phasic events that coexist with them. Our results provide novel insights into the regulation, dynamics and homeostasis of cortical slow oscillations.	[Valencia, Miguel; Artieda, Julio] Univ Navarra, Neurophysiol Lab, Neurosci Area, Ctr Invest Med Aplicada, E-31080 Pamplona, Spain; [Bolam, J. Paul; Mena-Segovia, Juan] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3QT, England	University of Navarra; University of Oxford	Mena-Segovia, J (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, S Parks Rd, Oxford OX1 3QT, England.	juan.mena-segovia@pharm.ox.ac.uk	Valencia, Miguel/C-3055-2009; Artieda, Julio/L-4704-2014	Valencia, Miguel/0000-0001-5617-5270; Artieda, Julio/0000-0003-0987-0873; Bolam, J Paul/0000-0002-5008-8405; Mena-Segovia, Juan/0000-0002-9991-8254	Medical Research Council United Kingdom; UTE Proyecto Centro de Investigacion Medica Aplicada; Gobierno de Navarra, Education Department, Jeronimo de Ayanz Programme; Spanish Ministry of Science and Innovation, Juan de la Cierva Programme [JCI-2010-07876]; MRC [MC_U138164490] Funding Source: UKRI; Medical Research Council [MC_U138164490] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UTE Proyecto Centro de Investigacion Medica Aplicada; Gobierno de Navarra, Education Department, Jeronimo de Ayanz Programme; Spanish Ministry of Science and Innovation, Juan de la Cierva Programme(Ministry of Science and Innovation, Spain (MICINN)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council United Kingdom and the UTE Proyecto Centro de Investigacion Medica Aplicada. MV and JM-S acknowledge financial support from the Gobierno de Navarra, Education Department, Jeronimo de Ayanz Programme. MV acknowledges financial support from the Spanish Ministry of Science and Innovation, Juan de la Cierva Programme Ref. JCI-2010-07876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub A, 2012, NEUROIMAGE, V59, P1491, DOI 10.1016/j.neuroimage.2011.08.023; Bonjean M, 2011, J NEUROSCI, V31, P9124, DOI 10.1523/JNEUROSCI.0077-11.2011; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Compte A, 2008, J NEUROSCI, V28, P13828, DOI 10.1523/JNEUROSCI.2684-08.2008; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Cox R, 2012, LEARN MEMORY, V19, P264, DOI 10.1101/lm.026252.112; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Eschenko O, 2012, CEREB CORTEX, V22, P426, DOI 10.1093/cercor/bhr121; Fuentealba P, 2004, P NATL ACAD SCI USA, V101, P9816, DOI 10.1073/pnas.0402761101; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; Magill PJ, 2000, J NEUROSCI, V20, P820, DOI 10.1523/JNEUROSCI.20-02-00820.2000; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mena-Segovia J, 2008, J PHYSIOL-LONDON, V586, P2947, DOI 10.1113/jphysiol.2008.153874; Mena-Segovia J, 2011, PROG BRAIN RES, V193, P85, DOI 10.1016/B978-0-444-53839-0.00006-5; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, P119; Poil SS, 2008, HUM BRAIN MAPP, V29, P770, DOI 10.1002/hbm.20590; Ros H, 2010, NEUROSCIENCE, V170, P78, DOI 10.1016/j.neuroscience.2010.06.068; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schweimer JV, 2011, NEUROSCIENCE, V196, P115, DOI 10.1016/j.neuroscience.2011.08.072; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 1996, P NATL ACAD SCI USA, V93, P2533, DOI 10.1073/pnas.93.6.2533; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; van Albada SJ, 2007, J NEUROSCI METH, V161, P205, DOI 10.1016/j.jneumeth.2006.11.004; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011	36	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67540	10.1371/journal.pone.0067540	http://dx.doi.org/10.1371/journal.pone.0067540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844020	Green Published, gold			2022-12-25	WOS:000321341000050
J	Wang, JG; Kuai, XC; Ren, BQ; Gong, GF; Zhou, XM				Wang, Jian-Gang; Kuai, Xing-Cheng; Ren, Bi-Qiao; Gong, Guang-Fu; Zhou, Xin-Min			Reduced Leaflet Stress in the Stentless Quadrileaflet Mitral Valve: A Finite Element Model	PLOS ONE			English	Article							FOLLOW-UP; PORCINE; HEART; CALCIFICATION; BOVINE; REPLACEMENT; BIOPROSTHESIS; DEGENERATION; EXPERIENCE; FATIGUE	Background: Failure of bioprosthetics is usually caused by calcification of the leaflets as a consequence of high tensile stresses. The stentless valve resembles native mitral valve anatomy, has a flexible leaflet attachment and a suspension at the papillary muscles, and preserves annuloventricular continuity. In this study, the effects of the stentless valve design on leaflet stress were investigated with a finite element model. Methods: Finite element models of the stentless quadrileaflet mitral valve were created in the close and open configurations. The geometry of the stented trileaflet mitral valve was also analyzed for comparative purposes. Under the designated pressures, the regional stresses were evaluated, and the distributions of stresses were assessed. Results: Regardless of whether the valve is in the open or close configuration, the maximum first principal stress was significantly lower in the stentless valve than in the stented valve. For the stentless valves, limited stress concentration was discretely distributed in the papillary flaps under both close and open conditions. In contrast, in the stented valve, increased stress concentration was evident at the central belly under the open condition and at the commissural attachment under close condition. In either configuration, the maximum second principal stress was markedly lower in the stentless valve than in the stented valve. Conclusions: The stentless valve was associated with a significant reduction in leaflet stress and a more homogeneous stress distribution compared to the stented valve. These findings are consistent with recent reports of the clinical effectiveness of the stentless quadrileaflet mitral valve.	[Wang, Jian-Gang] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Kuai, Xing-Cheng; Ren, Bi-Qiao] Hunan Univ, Dept Engn Mech, Changsha 410082, Hunan, Peoples R China; [Gong, Guang-Fu; Zhou, Xin-Min] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China	Capital Medical University; Hunan University; Central South University	Wang, JG (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	wangjiangang7545@126.com	wang, jian/GVS-0711-2022					Aldous IG, 2009, AM J PHYSIOL-HEART C, V296, pH1898, DOI 10.1152/ajpheart.01173.2008; Askeland D.R., 2006, SCI ENG MAT, V5th, P198; Aybek T, 2000, J HEART VALVE DIS, V9, P667; Bathe KJ, 1999, COMPUT STRUCT, V72, P1, DOI 10.1016/S0045-7949(99)00042-5; Bourguignon T, 2011, J HEART VALVE DIS, V20, P673; Cacciola G, 2000, J BIOMECH, V33, P521, DOI 10.1016/S0021-9290(99)00222-5; Conti CA, 2010, J THORAC CARDIOV SUR, V140, P890, DOI 10.1016/j.jtcvs.2010.01.016; Hofmann B, 2001, ANN THORAC SURG, V71, pS323, DOI 10.1016/S0003-4975(01)02544-9; Jamieson WRE, 2011, J THORAC CARDIOV SUR, V141, P1449, DOI 10.1016/j.jtcvs.2010.05.055; Jorge-Herrero E, 2010, ARTIF ORGANS, V34, pE168, DOI 10.1111/j.1525-1594.2009.00978.x; Lehmann S, 2004, J HEART VALVE DIS, V13, P410; Middlemost S J, 1999, Semin Thorac Cardiovasc Surg, V11, P183; Middlemost SJ, 2003, J HEART VALVE DIS, V12, P758; Middlemost SJ, 1999, J HEART VALVE DIS, V8, P180; MILANO A, 1984, AM J CARDIOL, V53, P1066, DOI 10.1016/0002-9149(84)90638-6; Mirnajafi A, 2010, J BIOMED MATER RES A, V94A, P205, DOI 10.1002/jbm.a.32659; Raghavan D, 2010, J BIOMED MATER RES B, V92B, P168, DOI 10.1002/jbm.b.31503; Simionescu DT, 2003, J HEART VALVE DIS, V12, P226; Sinha P, 2012, J THORAC CARDIOV SUR, V143, P224, DOI 10.1016/j.jtcvs.2011.09.043; Srivatsa SS, 1997, J CLIN INVEST, V99, P996, DOI 10.1172/JCI119265; Stevanella M, 2010, MED ENG PHYS, V32, P1213, DOI 10.1016/j.medengphy.2010.08.013; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Vrandecic M, 1997, EUR J CARDIO-THORAC, V12, P56, DOI 10.1016/S1010-7940(97)01221-9; Walther T, 1999, THORAC CARDIOV SURG, V47, P357, DOI 10.1055/s-2007-1013174; Whitlock RP, 2012, CHEST, V141, pE576S, DOI 10.1378/chest.11-2305; Xu C, 2012, ANN THORAC SURG, V93, P1141, DOI 10.1016/j.athoracsur.2012.01.069; Zuppiroli A, 1998, AM J CARDIOL, V82, P823, DOI 10.1016/S0002-9149(98)00454-8	27	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67683	10.1371/journal.pone.0067683	http://dx.doi.org/10.1371/journal.pone.0067683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844060	gold, Green Submitted, Green Published			2022-12-25	WOS:000321341000074
J	Wu, J; Cai, GQ; Tu, JY; Li, LX; Liu, S; Luo, XP; Zhou, LP; Fan, CC; Zhou, YM				Wu, Jian; Cai, Guangqin; Tu, Jiangying; Li, Lixia; Liu, Sheng; Luo, Xinping; Zhou, Lipeng; Fan, Chuchuan; Zhou, Yongming			Identification of QTLs for Resistance to Sclerotinia Stem Rot and BnaC.IGMT5.a as a Candidate Gene of the Major Resistant QTL SRC6 in Brassica napus	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; WHITE MOLD; OILSEED RAPE; LINKAGE MAP; ARABIDOPSIS; CANOLA; EXPRESSION; AVOIDANCE; CULTIVARS; GENOMES	Stem rot caused by Sclerotinia sclerotiorum in many important dicotyledonous crops, including oilseed rape (Brassica napus), is one of the most devastating fungal diseases and imposes huge yield loss each year worldwide. Currently, breeding for Sclerotinia resistance in B. napus, as in other crops, can only rely on germplasms with quantitative resistance genes. Thus, the identification of quantitative trait locus (QTL) for S. sclerotiorum resistance/tolerance in this crop holds immediate promise for the genetic improvement of the disease resistance. In this study, ten QTLs for stem resistance (SR) at the mature plant stage and three QTLs for leaf resistance (LR) at the seedling stage in multiple environments were mapped on nine linkage groups (LGs) of a whole genome map for B. napus constructed with SSR markers. Two major QTLs, LRA9 on LG A9 and SRC6 on LG C6, were repeatedly detected across all environments and explained 8.54-15.86% and 29.01%-32.61% of the phenotypic variations, respectively. Genotypes containing resistant SRC6 or LRA9 allele showed a significant reduction in disease lesion after pathogen infection. Comparative mapping with Arabidopsis and data mining from previous gene profiling experiments identified that the Arabidopsis homologous gene of IGMT5 (At1g76790) was related to the SRC6 locus. Four copies of the IGMT5 gene in B. napus were isolated through homologous cloning, among which, only BnaC.IGMT5.a showed a polymorphism between parental lines and can be associated with the SRC6. Furthermore, two parental lines exhibited a differential expression pattern of the BnaC.IGMT5.a gene in responding to pathogen inoculation. Thus, our data suggested that BnaC.IGMT5.a was very likely a candidate gene of this major resistance QTL.	[Wu, Jian; Cai, Guangqin; Tu, Jiangying; Li, Lixia; Liu, Sheng; Luo, Xinping; Zhou, Lipeng; Fan, Chuchuan; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University	Zhou, YM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	ymzhou@mail.hzau.edu.cn		Wu, Jian/0000-0002-5350-8938; Fan, Chuchuan/0000-0001-8443-7194	Ministry of Science and Technology of China [2006CB101604, 2011AA10A104, 2012AA101107]; Ministry of Agriculture of China [nycytx-00503]; Huazhong Agricultural University [STSIF 2012YB14]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Huazhong Agricultural University	The work was supported by the funding from Ministry of Science and Technology of China (Grant nos. 2006CB101604, 2011AA10A104, and 2012AA101107), Ministry of Agriculture of China (nycytx-00503), and Huazhong Agricultural University (STSIF 2012YB14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arahana VS, 2001, CROP SCI, V41, P180, DOI 10.2135/cropsci2001.411180x; Bert PF, 2002, THEOR APPL GENET, V105, P985, DOI 10.1007/s00122-002-1004-3; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bradley CA, 2006, PLANT DIS, V90, P215, DOI 10.1094/PD-90-0215; Cai GQ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-105; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; CHURCHILL GA, 1994, GENETICS, V138, P963; Ender M, 2005, CROP SCI, V45, P2482, DOI 10.2135/cropsci2005.0064; Eynck C, 2012, MOL PLANT PATHOL, V13, P887, DOI 10.1111/j.1364-3703.2012.00798.x; Fan CC, 2010, THEOR APPL GENET, V121, P1289, DOI 10.1007/s00122-010-1388-4; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Hegedus DD, 2005, FEMS MICROBIOL LETT, V251, P177, DOI 10.1016/j.femsle.2005.07.040; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Huang YongJu, 2000, Chinese Journal of Oil Crop Sciences, V22, P1; Kolkman JM, 2003, CROP SCI, V43, P539, DOI 10.2135/cropsci2003.0539; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li D, 2001, ACTA BOT BOREALI-OCC, V21, P451; Li Y., 1999, P 10 INT RAP C CANB; LIU C, 1991, Scientia Agricultura Sinica, V24, P43; Liu ShengYi, 2003, Chinese Journal of Oil Crop Sciences, V25, P54; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; McCartney H., 1999, P 10 INT RAP C CANB; Mei J, 2011, EUPHYTICA, V177, P393, DOI 10.1007/s10681-010-0274-0; Mei JQ, 2013, THEOR APPL GENET, V126, P549, DOI 10.1007/s00122-012-2000-x; Mestries E, 1998, MOL BREEDING, V4, P215, DOI 10.1023/A:1009694626992; Miklas PN, 2001, CROP SCI, V41, P309, DOI 10.2135/cropsci2001.412309x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Oilcrop Research Institute Chinese Academy of Sciences, 1975, SCLER DIS OILS CROPS; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; PHILLIPS D V, 1990, Phytopathology, V80, P1039; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; PURDY LH, 1979, PHYTOPATHOLOGY, V69, P875, DOI 10.1094/Phyto-69-875; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rogers LA, 2005, J EXP BOT, V56, P1651, DOI 10.1093/jxb/eri162; Ronicke S, 2005, PHYTOPATHOLOGY, V95, P834, DOI 10.1094/PHYTO-95-0834; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; TURKINGTON TK, 1993, PHYTOPATHOLOGY, V83, P682, DOI 10.1094/Phyto-83-682; Wang HanZhong, 2004, Scientia Agricultura Sinica, V37, P23; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yang B, 2007, PLANT SCI, V173, P156, DOI 10.1016/j.plantsci.2007.04.012; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yin XR, 2010, EUPHYTICA, V173, P25, DOI 10.1007/s10681-009-0095-1; Yu B, 2010, PLANT BREEDING, V129, P39, DOI 10.1111/j.1439-0523.2009.01662.x; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Yue B, 2008, PHYTOPATHOLOGY, V98, P926, DOI 10.1094/PHYTO-98-8-0926; ZENG ZB, 1994, GENETICS, V136, P1457; Zhao JW, 2007, PLANTA, V227, P13, DOI 10.1007/s00425-007-0586-z; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]; Zhao JW, 2003, THEOR APPL GENET, V106, P759, DOI 10.1007/s00122-002-1171-2; Zhao JW, 2006, THEOR APPL GENET, V112, P509, DOI 10.1007/s00122-005-0154-5	57	66	76	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67740	10.1371/journal.pone.0067740	http://dx.doi.org/10.1371/journal.pone.0067740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844081	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000089
J	Xie, L; Zhu, D; Kang, YH; Liang, T; He, Y; Gaisano, HY				Xie, Li; Zhu, Dan; Kang, Youhou; Liang, Tao; He, Yu; Gaisano, Herbert Y.			Exocyst Sec5 Regulates Exocytosis of Newcomer Insulin Granules Underlying Biphasic Insulin Secretion	PLOS ONE			English	Article							CALCIUM-CHANNELS; RALA GTPASE; BETA-CELLS; SUBUNIT; COMPLEX; GLUCOSE; FUSION; STIMULATION; SYNCOLLIN; MUNC13-1	The exocyst complex subunit Sec5 is a downstream effector of RalA-GTPase which promotes RalA-exocyst interactions and exocyst assembly, serving to tether secretory granules to docking sites on the plasma membrane. We recently reported that RalA regulates biphasic insulin secretion in pancreatic islet beta cells in part by tethering insulin secretory granules to Ca2+ channels to assist excitosome assembly. Here, we assessed beta cell exocytosis by patch clamp membrane capacitance measurement and total internal reflection fluorescence microscopy to investigate the role of Sec5 in regulating insulin secretion. Sec5 is present in human and rodent islet beta cells, localized to insulin granules. Sec5 protein depletion in rat INS-1 cells inhibited depolarization-induced release of primed insulin granules from both readily-releasable pool and mobilization from the reserve pool. This reduction in insulin exocytosis was attributed mainly to reduction in recruitment and exocytosis of newcomer insulin granules that undergo minimal docking time at the plasma membrane, but which encompassed a larger portion of biphasic glucose stimulated insulin secretion. Sec5 protein knockdown had little effect on predocked granules, unless vigorously stimulated by KCl depolarization. Taken together, newcomer insulin granules in beta cells are more sensitive than predocked granules to Sec5 regulation.	[Xie, Li; Zhu, Dan; Kang, Youhou; Liang, Tao; He, Yu; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto	Gaisano, HY (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes for Health Research [MOP 86544]; Canadian Diabetes Association	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported by a grant from the Canadian Institutes for Health Research (MOP 86544) to Herbert Gaisano, and a postdoctoral fellowship from the Canadian Diabetes Association to Li Xie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Beronja S, 2005, J CELL BIOL, V169, P635, DOI 10.1083/jcb.200410081; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Fernandez NA, 2011, AM J PHYSIOL-CELL PH, V300, pC1513, DOI 10.1152/ajpcell.00433.2010; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Gaisano HY, 2012, DIABETOLOGIA, V55, P877, DOI 10.1007/s00125-012-2483-7; Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hays LB, 2005, J ENDOCRINOL, V185, P57, DOI 10.1677/joe.1.05934; Hazelett CC, 2011, MOL BIOL CELL, V22, P4787, DOI 10.1091/mbc.E11-07-0657; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; Kowluru A, 1996, J CLIN INVEST, V98, P540, DOI 10.1172/JCI118822; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lam P, 2013, DIABETES; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Ljubicic S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007770; Lopez JA, 2008, J BIOL CHEM, V283, P17939, DOI 10.1074/jbc.M800321200; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Proks P, 1996, J PHYSIOL-LONDON, V496, P255, DOI 10.1113/jphysiol.1996.sp021682; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tse FW, 2000, J PHYSIOL-LONDON, V526, P99, DOI 10.1111/j.1469-7793.2000.00099.x; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Whyte JRC, 2002, J CELL SCI, V115, P2627; Xie L, 2012, DIABETOLOGIA, V55, P2693, DOI 10.1007/s00125-012-2640-z; Xie L, 2013, TRAFFIC, V14, P428, DOI 10.1111/tra.12047; Zhu D, 2013, DIABETOLOGIA, V56, P359, DOI 10.1007/s00125-012-2757-0; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	44	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67561	10.1371/journal.pone.0067561	http://dx.doi.org/10.1371/journal.pone.0067561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844030	Green Submitted, gold, Green Published			2022-12-25	WOS:000321341000058
J	Xiu, FM; Stanojcic, M; Jeschke, MG				Xiu, Fangming; Stanojcic, Mile; Jeschke, Marc G.			Norepinephrine Inhibits Macrophage Migration by Decreasing CCR2 Expression	PLOS ONE			English	Article							THERMAL-INJURY; BONE-MARROW; HEMATOPOIETIC STEM; COLD STRESS; BURN INJURY; SEPSIS; PHAGOCYTOSIS; MONOCYTES; CELLS; INFILTRATION	Increased incidences of infectious and septic complications during post-burn courses represent the main contributor to burn injury mortality. Sustained increases in catecholamine levels, especially norepinephrine (NE), contribute to immune disturbances in severely burned patients. The precise mechanisms underlying NE-mediated immunoregulation are not fully understood. Here we hypothesize that persistently elevated NE levels are associated with immunodysfunctions. We examined the effects of NE on the phenotype and functions of bone marrow-derived macrophages (BMMs). Whole mouse bone marrow cells were treated in vitro with 40 ng/mL of M-CSF and with 1 x 10(-6) M or 1 x 10(-8) M of NE or without NE for 7 days; cells were collected and stained with antibodies for CD11b, F4/80, MHC II and the inflammatory CC chemokine receptor 2 (CCR2). We found 1 x 10(-6) M of NE inhibited MHC II and CCR2 expression on CD11b(+)/F4/80(+) BMM cells. It also inhibited BMM proliferation by inhibiting CSF-1R expression. On the contrary, 1 x 10(-8) M of NE slightly increased both MHC II and CCR2 expression on CD11b(+)/F4/80(+) BMM cells but inhibited CD11b(+)/F4/80(+) BMM proliferation. MCP-1 based migration assay showed that the migration of 1 x 10(-6) M of NE-treated BMM toward MCP-1 was significantly decreased compared to BMM without NE treatment. Both 1 x 10(-8) M and 1 x 10(-6) M of NE enhanced TNF-alpha production and phagocytosis of FITC-Dextran. Intracellular staining of transcriptional factor MafB showed that 1 x 10(-6) M of NE treatment enhanced its expression, whereas 1 x 10(-8) M of NE decreased expression. Stimulation with LPS in the last 24-hours of BMM culture further decreased CCR2 and MHC II expression of these BMM, suggesting the synergistic effect of LPS and NE on macrophage. Our results demonstrate that NE regulates macrophage differentiation, proliferation and function, and may play a critical role in the dysfunctional immune response post-burn.	[Xiu, Fangming; Stanojcic, Mile; Jeschke, Marc G.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst,Dept Immunol, Ross Tilley Burn Ctr,Div Plast Surg,Dept Surg, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Jeschke, MG (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst,Dept Immunol, Ross Tilley Burn Ctr,Div Plast Surg,Dept Surg, Toronto, ON, Canada.	marc.jeschke@sunnybrook.ca			Canadian Institutes of Health Research [123336]; CFI Leader's Opportunity Fund [25407]; NIH [RO1 GM087285-01]; Physicians' Services Incorporated Foundation - Health Research Grant Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087285] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CFI Leader's Opportunity Fund(Canada Foundation for Innovation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Physicians' Services Incorporated Foundation - Health Research Grant Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grant funding sources: Canadian Institutes of Health Research # 123336; CFI Leader's Opportunity Fund: Project # 25407. NIH RO1 GM087285-01; and Physicians' Services Incorporated Foundation - Health Research Grant Program. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baccan GC, 2010, NEUROIMMUNOMODULAT, V17, P379, DOI 10.1159/000292058; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Cohen MJ, 2004, ANN SURG, V240, P132, DOI 10.1097/01.sla.0000130724.84914.d6; Deng JP, 2004, AM J PHYSIOL-CELL PH, V287, pC730, DOI 10.1152/ajpcell.00562.2003; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Enomoto N, 2004, J GASTROENTEROL, V39, P1175, DOI 10.1007/s00535-004-1468-9; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gosain A, 2007, SURGERY, V142, P170, DOI 10.1016/j.surg.2007.04.015; Gosain A, 2009, J SURG RES, V152, P311, DOI 10.1016/j.jss.2008.05.001; Howell K, 2012, J LEUKOCYTE BIOL, V91, P69, DOI 10.1189/jlb.0711338; HU XX, 1991, J NEUROIMMUNOL, V31, P35, DOI 10.1016/0165-5728(91)90084-K; Jeschke MG, 2007, CRIT CARE, V11, DOI 10.1186/cc6102; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Kapoor A, 2011, AM J RESP CRIT CARE, V183, P150, DOI 10.1164/rccm.201009-1403ED; Kelly JL, 1997, ANN SURG, V225, P530, DOI 10.1097/00000658-199705000-00010; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Koo DJ, 2000, INT J MOL MED, V5, P457; Kraft R, 2012, LANCET, V379, P1013, DOI 10.1016/S0140-6736(11)61345-7; Kulp GA, 2010, SHOCK, V33, P369, DOI 10.1097/SHK.0b013e3181b92340; MAEJIMA K, 1984, INFECT IMMUN, V43, P6, DOI 10.1128/IAI.43.1.6-10.1984; Muthu K, 2008, J BURN CARE RES, V29, P12, DOI 10.1097/BCR.0b013e31815fa499; Muthu K, 2010, J LEUKOCYTE BIOL, V88, P715, DOI 10.1189/jlb.0410186; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Santangelo S, 2001, ANN SURG, V233, P97, DOI 10.1097/00000658-200101000-00015; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Schwacha MG, 2003, BURNS, V29, P1, DOI 10.1016/S0305-4179(02)00187-0; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Sesti-Costa R, 2010, NEUROIMMUNOMODULAT, V17, P79, DOI 10.1159/000258690; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Szelenyi J, 2000, J NEUROIMMUNOL, V103, P34, DOI 10.1016/S0165-5728(99)00234-9; Tang YM, 2001, ANN SURG, V233, P266, DOI 10.1097/00000658-200102000-00017; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Weischenfeldt J, 2008, CSH PROTOC, V2008; Williams John G., 1994, Journal of Burn Care and Rehabilitation, V15, P493, DOI 10.1097/00004630-199411000-00006; Yi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030404; Zhou YH, 1999, J LEUKOCYTE BIOL, V65, P265, DOI 10.1002/jlb.65.2.265	40	29	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69167	10.1371/journal.pone.0069167	http://dx.doi.org/10.1371/journal.pone.0069167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844252	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000185
J	Bauer, JW; Brandl, C; Haubenreisser, O; Wimmer, B; Weber, M; Karl, T; Klausegger, A; Breitenbach, M; Hintner, H; von der Haar, T; Tuite, MF; Breitenbach-Koller, L				Bauer, Johann W.; Brandl, Clemens; Haubenreisser, Olaf; Wimmer, Bjoern; Weber, Manuela; Karl, Thomas; Klausegger, Alfred; Breitenbach, Michael; Hintner, Helmut; von der Haar, Tobias; Tuite, Mick F.; Breitenbach-Koller, Lore			Specialized Yeast Ribosomes: A Customized Tool for Selective mRNA Translation	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; 80S RIBOSOME; EXPRESSION; PROTEINS; GENES; PHOSPHORYLATION; IDENTIFICATION; DUPLICATION; SPECIFICITY	Evidence is now accumulating that sub-populations of ribosomes-so-called specialized ribosomes-can favour the translation of subsets of mRNAs. Here we use a large collection of diploid yeast strains, each deficient in one or other copy of the set of ribosomal protein (RP) genes, to generate eukaryotic cells carrying distinct populations of altered 'specialized' ribosomes. We show by comparative protein synthesis assays that different heterologous mRNA reporters based on luciferase are preferentially translated by distinct populations of specialized ribosomes. These mRNAs include reporters carrying premature termination codons (PTC) thus allowing us to identify specialized ribosomes that alter the efficiency of translation termination leading to enhanced synthesis of the wild-type protein. This finding suggests that these strains can be used to identify novel therapeutic targets in the ribosome. To explore this further we examined the translation of the mRNA encoding the extracellular matrix protein laminin beta 3 (LAMB3) since a LAMB3-PTC mutant is implicated in the blistering skin disease Epidermolysis bullosa (EB). This screen identified specialized ribosomes with reduced levels of RP L35B as showing enhanced synthesis of full-length LAMB3 in cells expressing the LAMB3-PTC mutant. Importantly, the RPL35B sub-population of specialized ribosomes leave both translation of a reporter luciferase carrying a different PTC and bulk mRNA translation largely unaltered.	[Bauer, Johann W.; Brandl, Clemens; Haubenreisser, Olaf; Wimmer, Bjoern; Weber, Manuela; Karl, Thomas; Breitenbach, Michael; Hintner, Helmut; Breitenbach-Koller, Lore] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Bauer, Johann W.; Klausegger, Alfred; Hintner, Helmut] Gen Hosp Salzburg PMU, Dept Dermatol, Salzburg, Austria; [von der Haar, Tobias; Tuite, Mick F.] Univ Kent, Kent Fungal Grp, Sch Biosci, Canterbury, Kent, England	Salzburg University; University of Kent	Tuite, MF (corresponding author), Univ Kent, Kent Fungal Grp, Sch Biosci, Canterbury, Kent, England.	M.F.Tuite@kent.ac.uk; Hannelore.koller@sbg.ac.at	Tuite, Mick/ABC-7909-2020; Klausegger, Alfred/R-2078-2019; Klausegger, Alfred/G-8001-2018	Tuite, Mick/0000-0002-5214-540X; Klausegger, Alfred/0000-0001-6160-9934; von der Haar, Tobias/0000-0002-6031-9254; Breitenbach-Koller, Hannelore/0000-0002-8387-6408; Hintner, Helmut/0000-0001-9199-0991	Epidermolysis bullosa Society DEBRA [Austria P_147200_09]	Epidermolysis bullosa Society DEBRA	This work was funded by a grant from the Epidermolysis bullosa Society DEBRA (Austria P_147200_09) to JWB and LBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOVICH N, 1984, MOL CELL BIOL, V4, P1871, DOI 10.1128/MCB.4.9.1871; Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; Angov E, 2011, METHODS MOL BIOL, V705, P1, DOI 10.1007/978-1-61737-967-3_1; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Barrett LW, 2012, CELL MOL LIFE SCI; Bhushan S, 2010, MOL CELL, V40, P138, DOI 10.1016/j.molcel.2010.09.009; Chen Q, 2011, MOL BIOL CELL, V22, P2646, DOI 10.1091/mbc.E11-03-0239; Connolly K, 2009, TRENDS BIOCHEM SCI, V34, P256, DOI 10.1016/j.tibs.2009.01.011; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; Filipovska A, 2013, FEBS LETT, V587, P1189, DOI 10.1016/j.febslet.2013.02.032; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gilbert WV, 2011, TRENDS BIOCHEM SCI, V36, P127, DOI 10.1016/j.tibs.2010.12.002; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kelly DE, 2001, COMPAR FUNCT GENOM, V2, P236, DOI 10.1002/cfg.95; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Laimer M, 2010, DERMATOL CLIN, V28, P55, DOI 10.1016/j.det.2009.10.006; Lee K, 1996, RNA, V2, P1270; Malik Vinod, 2010, Ther Adv Neurol Disord, V3, P379, DOI 10.1177/1756285610388693; Maya D, 2008, BIOTECHNOL LETT, V30, P979, DOI 10.1007/s10529-008-9647-z; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Nilsson J, 2007, J MOL BIOL, V369, P429, DOI 10.1016/j.jmb.2007.03.035; Nudelman I, 2010, BIOORGAN MED CHEM, V18, P3735, DOI 10.1016/j.bmc.2010.03.060; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Oender K, 2003, YEAST, V20, P281, DOI 10.1002/yea.963; Peltz SW, 2009, RNA BIOL, V6, P329, DOI 10.4161/rna.6.3.8953; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Simoff I, 2009, CURR GENET, V55, P111, DOI 10.1007/s00294-009-0228-z; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Steffen KK, 2012, GENETICS, V191, P107, DOI 10.1534/genetics.111.136549; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Takacs JE, 2011, RNA, V17, P439, DOI 10.1261/rna.2475211; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Thyer R, 2013, J AM CHEM SOC, V135, P2, DOI 10.1021/ja3069177; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Wilson DN, 2012, COLD SPRING HARB PER, V4; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; WOOD TK, 1991, BIOTECHNOL BIOENG, V38, P891, DOI 10.1002/bit.260380811; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; You T, 2010, YEAST, V27, P785, DOI 10.1002/yea.1770; Young BD, 2012, BIOCHEMISTRY-US, V51, P5091, DOI 10.1021/bi300186g	53	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67609	10.1371/journal.pone.0067609	http://dx.doi.org/10.1371/journal.pone.0067609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861776	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000321692000011
J	Aube, M; Roby, J; Kocifaj, M				Aube, Martin; Roby, Johanne; Kocifaj, Miroslav			Evaluating Potential Spectral Impacts of Various Artificial Lights on Melatonin Suppression, Photosynthesis, and Star Visibility	PLOS ONE			English	Article							CO-DISTRIBUTES; NIGHT LAN; AT-NIGHT; BREAST; CANCER; POLLUTION; HUMANS; PHOTORECEPTOR; PERFORMANCE; MODEL	Artificial light at night can be harmful to the environment, and interferes with fauna and flora, star visibility, and human health. To estimate the relative impact of a lighting device, its radiant power, angular photometry and detailed spectral power distribution have to be considered. In this paper we focus on the spectral power distribution. While specific spectral characteristics can be considered harmful during the night, they can be considered advantageous during the day. As an example, while blue-rich Metal Halide lamps can be problematic for human health, star visibility and vegetation photosynthesis during the night, they can be highly appropriate during the day for plant growth and light therapy. In this paper we propose three new indices to characterize lamp spectra. These indices have been designed to allow a quick estimation of the potential impact of a lamp spectrum on melatonin suppression, photosynthesis, and star visibility. We used these new indices to compare various lighting technologies objectively. We also considered the transformation of such indices according to the propagation of light into the atmosphere as a function of distance to the observer. Among other results, we found that low pressure sodium, phosphor-converted amber light emitting diodes (LED) and LED 2700 K lamps filtered with the new Ledtech's Equilib filter showed a lower or equivalent potential impact on melatonin suppression and star visibility in comparison to high pressure sodium lamps. Low pressure sodium, LED 5000 K-filtered and LED 2700 K-filtered lamps had a lower impact on photosynthesis than did high pressure sodium lamps. Finally, we propose these indices as new standards for the lighting industry to be used in characterizing their lighting technologies. We hope that their use will favor the design of new environmentally and health-friendly lighting technologies.	[Aube, Martin] Cegep Sherbrooke, Dept Phys, Sherbrooke, PQ, Canada; [Roby, Johanne] Cegep Sherbrooke, Dept Chim, Sherbrooke, PQ, Canada; [Kocifaj, Miroslav] Slovak Acad Sci, Astron Inst, Bratislava, Slovakia	Slovak Academy of Sciences; Astronomical Institute, SAS	Aube, M (corresponding author), Cegep Sherbrooke, Dept Phys, Sherbrooke, PQ, Canada.	martin.aube@cegepsherbrooke.qc.ca	Kocifaj, Miroslav/AFT-6322-2022	Kocifaj, Miroslav/0000-0001-9277-4692	Fond de recherche du Quebec - Nature et Technologie (FRQNT); Cegep de Sherbrooke - CERTEE; Slovak National Grant Agency VEGA [2/0002/12]; Programme de soutien aux chercheurs et aux chercheuses du collegial from ministere de l'Enseignement superieur, de la Recherche, de la Science et de la Technologie, Quebec	Fond de recherche du Quebec - Nature et Technologie (FRQNT); Cegep de Sherbrooke - CERTEE; Slovak National Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Programme de soutien aux chercheurs et aux chercheuses du collegial from ministere de l'Enseignement superieur, de la Recherche, de la Science et de la Technologie, Quebec	This work was supported by Fond de recherche du Quebec - Nature et Technologie (FRQNT) Programme pour le degagement d'enseignement des chercheurs de college Regroupements strategiques (http://www.fqrnt.gouv.qc.ca/) and Cegep de Sherbrooke - CERTEE (http://cegepsherbrooke.qc.ca). This work was partially supported by the Slovak National Grant Agency VEGA (grant No. 2/0002/12). This work was also partially supported by the Programme de soutien aux chercheurs et aux chercheuses du collegial from ministere de l'Enseignement superieur, de la Recherche, de la Science et de la Technologie, Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedrosian TA, 2011, PSYCHONEUROENDOCRINO, V36, P1062, DOI 10.1016/j.psyneuen.2011.01.004; Bisketzis N., 2004, WSEAS Transactions on Circuits and Systems, V3, P1380; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; Braak CJ, 2001, J QUANT SPECTROSC RA, V69, P585, DOI 10.1016/S0022-4073(00)00103-5; Brainard GC, 2001, J NEUROSCI, V21, P6405; Briggs W. R., 2006, ECOLOGICAL CONSEQUEN, P389; Bruce-White C., 2011, REV IMPACT ARTIFICIA; Buchanan Bryant W., 2006, P192; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Calo F, 2011, TORTUES MARINES POLL; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; CIE, 1932, 1931 COMM INT ECL P 1931 COMM INT ECL P, P19; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; CLARK JB, 1975, PLANT PHYSIOL, V55, P401, DOI 10.1104/pp.55.2.401; Commission International de l'Eclairage (CIE), 1995, 133 CIE; [DIN] Deutsches Institut fur Normung, 2000, 503110DIN; Falchi F, 2011, J ENVIRON MANAGE, V92, P2714, DOI 10.1016/j.jenvman.2011.06.029; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Fritsches KA, 2012, MAR FRESHW BEHAV PHY, V45, P79, DOI 10.1080/10236244.2012.690576; Gall D, 2004, P 2004 CIE S LIGHT H, P129; Gauthreaux Sidney A. Jr., 2006, P67; Geisler-Moroder D, 2010, 5 EUR C COLOUR GRAPH, P346; Green RN, 1997, CLOUDS EARTHS RADIAN; Gushchin G. P, 1988, METHODS INSTRUMENTAT; Haim A., 2010, SLEEP SCI, V3, P32; Hansen J, 2001, JNCI-J NATL CANCER I, V93, P1513, DOI 10.1093/jnci/93.20.1513; Horvath H, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001472; Judd D. B., 1951, P 12 SESS CIE STOCKH, V1, P11; Kloog I, 2009, CHRONOBIOL INT, V26, P108, DOI 10.1080/07420520802694020; Kloog I, 2008, CHRONOBIOL INT, V25, P65, DOI 10.1080/07420520801921572; Kloog I, 2010, CANCER CAUSE CONTROL, V21, P2059, DOI 10.1007/s10552-010-9624-4; Kocifaj M, 2007, APPL OPTICS, V46, P3013, DOI 10.1364/AO.46.003013; Kokhanovsky A., 2004, LIGHT SCATTERING MED; Kuijper Dries P. J., 2008, Lutra, V51, P37; Lamphar HAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056563; LECKNER B, 1978, SOL ENERGY, V20, P143, DOI 10.1016/0038-092X(78)90187-1; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; MCCAMY CS, 1992, COLOR RES APPL, V17, P142, DOI 10.1002/col.5080170211; Mishchenko M. I., 2002, SCATTERING ABSORPTIO; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Nightingale Barbara, 2006, P257; Perry Gad, 2006, P169; Pesava P, 2001, J AEROSOL SCI, V32, P1249, DOI 10.1016/S0021-8502(01)00053-2; Rea M. S., 2004, Lighting Research & Technology, V36, P85, DOI 10.1191/13657828041i114oa; Rea MS, 2009, OUTDOOR LIGHTING VIS, V6; Rich C., 2006, ECOLOGICAL CONSEQUEN; ROSENTHAL NE, 1989, SEASONAL AFFECTIVE D; Salmon Michael, 2003, Biologist (London), V50, P163; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Stevens RG, 2011, CHRONOBIOL INT, V28, P653, DOI 10.3109/07420528.2011.606945; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Thomas GE., 2002, RAD TRANSFER ATMOSPH; Toublanc D, 1996, APPL OPTICS, V35, P3270, DOI 10.1364/AO.35.003270; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Vos J., 1978, COLOR RES APPL, V3, P125, DOI DOI 10.1002/COL.5080030309; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; Zeitzer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022078	61	107	109	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67798	10.1371/journal.pone.0067798	http://dx.doi.org/10.1371/journal.pone.0067798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861808	Green Published, gold			2022-12-25	WOS:000321425300030
J	Song, HD; Zhu, FQ				Song, Hyun Deok; Zhu, Fangqiang			Conformational Dynamics of a Ligand-Free Adenylate Kinase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; FREE-ENERGY; STRUCTURAL-CHARACTERIZATION; TRANSITIONS; DEFICIENCY; CATALYSIS; COMMUNICATION; MOTIONS; ROLES	Adenylate kinase (AdK) is a phosphoryl-transfer enzyme with important physiological functions. Based on a ligand-free open structure and a ligand-bound closed structure solved by crystallography, here we use molecular dynamics simulations to examine the stability and dynamics of AdK conformations in the absence of ligands. We first perform multiple simulations starting from the open or the closed structure, and observe their free evolutions during a simulation time of 100 or 200 nanoseconds. In all seven simulations starting from the open structure, AdK remained stable near the initial conformation. The eight simulations initiated from the closed structure, in contrast, exhibited large variation in the subsequent evolutions, with most (seven) undergoing large-scale spontaneous conformational changes and approaching or reaching the open state. To characterize the thermodynamics of the transition, we propose and apply a new sampling method that employs a series of restrained simulations to calculate a one-dimensional free energy along a curved pathway in the high-dimensional conformational space. Our calculated free energy profile features a single minimum at the open conformation, and indicates that the closed state, with a high (similar to 13 kcal/mol) free energy, is not metastable, consistent with the observed behaviors of the unrestrained simulations. Collectively, our simulations suggest that it is energetically unfavorable for the ligand-free AdK to access the closed conformation, and imply that ligand binding may precede the closure of the enzyme.	[Song, Hyun Deok; Zhu, Fangqiang] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Zhu, FQ (corresponding author), Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA.	fzhu0@iupui.edu			Enhance Interdisciplinary Research and Education, Institute of Mathematical Modeling and Computational Science, School of Science, IUPUI	Enhance Interdisciplinary Research and Education, Institute of Mathematical Modeling and Computational Science, School of Science, IUPUI	Grants to Enhance Interdisciplinary Research and Education, Institute of Mathematical Modeling and Computational Science, School of Science, IUPUI. Release Time for Research, IUPUI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brokaw JB, 2010, BIOPHYS J, V99, P3420, DOI 10.1016/j.bpj.2010.09.040; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Cukier RI, 2009, J PHYS CHEM B, V113, P1662, DOI 10.1021/jp8053795; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khavrutskii IV, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2363379; Kubitzki MB, 2008, STRUCTURE, V16, P1175, DOI 10.1016/j.str.2008.04.013; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; Lin Y, 2000, BIOCHEMISTRY-US, V39, P3636, DOI 10.1021/bi991921t; Lin Y, 2000, BIOCHEMISTRY-US, V39, P3647, DOI 10.1021/bi992460e; Lu Q, 1996, P NATL ACAD SCI USA, V93, P5720, DOI 10.1073/pnas.93.12.5720; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Matsunaga Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002555; MATSUURA S, 1989, J BIOL CHEM, V264, P10148; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Ovchinnikov V, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3544209; Peng C, 2010, BIOPHYS J, V98, P2356, DOI 10.1016/j.bpj.2010.01.044; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potoyan DA, 2012, J PHYS CHEM B, V116, P1709, DOI 10.1021/jp209980b; Ramanathan A, 2012, PROTEINS, V80, P2536, DOI 10.1002/prot.24135; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shapiro YE, 2006, J PHYS CHEM B, V110, P11519, DOI 10.1021/jp060282a; Snow C, 2007, PROTEINS, V67, P325, DOI 10.1002/prot.21280; Vanden-Eijnden E, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3130083; Weinan E, 2005, J PHYS CHEM B, V109, P6688, DOI 10.1021/jp0455430; Whitford PC, 2008, J BIOL CHEM, V283, P2042, DOI 10.1074/jbc.M707632200; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zhu FQ, 2012, J COMPUT CHEM, V33, P453, DOI 10.1002/jcc.21989; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	45	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68023	10.1371/journal.pone.0068023	http://dx.doi.org/10.1371/journal.pone.0068023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861846	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300036
J	Belatik, A; Hotchandani, S; Carpentier, R				Belatik, Ahmed; Hotchandani, Surat; Carpentier, Robert			Inhibition of the Water Oxidizing Complex of Photosystem II and the Reoxidation of the Quinone Acceptor Q(A)(-) by Pb2+	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE RISE; OXYGEN-EVOLVING COMPLEX; MOLECULAR-MECHANISM; THERMO-LUMINESCENCE; ELECTRON-ACCEPTOR; THERMOLUMINESCENCE; BICARBONATE; KINETICS; REDUCTION; SYSTEM	The action of the environmental toxic Pb2+ on photosynthetic electron transport was studied in thylakoid membranes isolated from spinach leaves. Fluorescence and thermoluminescence techniques were performed in order to determine the mode of Pb2+ action in photosystem II (PSII). The invariance of fluorescence characteristics of chlorophyll a (Chl a) and magnesium tetraphenylporphyrin (MgTPP), a molecule structurally analogous to Chl a, in the presence of Pb2+ confirms that Pb cation does not interact directly with chlorophyll molecules in PSII. The results show that Pb interacts with the water oxidation complex thus perturbing charge recombination between the quinone acceptors of PSII and the S-2 state of the Mn4Ca cluster. Electron transfer between the quinone acceptors Q(A) and Q(B) is also greatly retarded in the presence of Pb2+. This is proposed to be owing to a transmembrane modification of the acceptor side of the photosystem.	[Belatik, Ahmed; Hotchandani, Surat; Carpentier, Robert] Univ Quebec Trois Rivieres, Grp Rech Biol Vegetale, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres	Carpentier, R (corresponding author), Univ Quebec Trois Rivieres, Grp Rech Biol Vegetale, Trois Rivieres, PQ, Canada.	Robert.Carpentier@uqtr.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by a grant from Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1998, PHOTOSYNTH RES, V56, P1, DOI 10.1023/A:1005946808488; Babani F, 1996, J PLANT PHYSIOL, V148, P555, DOI 10.1016/S0176-1617(96)80075-7; BABICH H, 1980, CRC CR REV MICROBIOL, V8, P99, DOI 10.3109/10408418009081123; Baker AJM, 1990, EVOLUTIONARY ASPECTS, P155; Barazzouk S, 2005, J PHYS CHEM B, V109, P716, DOI 10.1021/jp046474s; Beauchemkin R, 2007, BBA-BIOENERGETICS, V1767, P905, DOI 10.1016/j.bbabio.2007.04.001; Belatik A, 2013, J PHOTOCH B IN PRESS; Belatik A, 2012, PHOTOCHEM PHOTOBIOL, V88, P67, DOI 10.1111/j.1751-1097.2011.01016.x; Boisvert S, 2007, BIOMETALS, V20, P879, DOI 10.1007/s10534-007-9081-z; Boisvert S, 2006, FEBS J, V273, P4770, DOI 10.1111/j.1742-4658.2006.05475.x; Boucher N, 1999, PHOTOSYNTH RES, V59, P167, DOI 10.1023/A:1006194621553; Bukhov NG, 2004, BBA-BIOENERGETICS, V1657, P121, DOI 10.1016/j.bbabio.2004.04.008; Callender E., 2004, TREATISE GEOCHEMISTR, V9, P67, DOI DOI 10.1016/B0-08-043751-6/09161-1; Chugh LK, 1999, PLANT PHYSIOL BIOCH, V37, P297, DOI 10.1016/S0981-9428(99)80028-X; DEMETER S, 1984, BIOCHIM BIOPHYS ACTA, V764, P24, DOI 10.1016/0005-2728(84)90136-1; Ducruet JM, 2005, PHOTOSYNTH RES, V84, P161, DOI 10.1007/s11120-004-6433-1; Ducruet JM, 2003, J EXP BOT, V54, P2419, DOI 10.1093/jxb/erg268; EATONRYE JJ, 1988, BIOCHIM BIOPHYS ACTA, V935, P248, DOI 10.1016/0005-2728(88)90221-6; Farineau J, 1983, OXYGEN EVOLVING SYST, P317; Gauthier A, 2006, BBA-BIOENERGETICS, V1757, P1547, DOI 10.1016/j.bbabio.2006.09.005; Gauthier A, 2010, PHOTOCHEM PHOTOBIOL, V86, P1064, DOI 10.1111/j.1751-1097.2010.00765.x; Giardi MT, 1997, PHYSIOL PLANTARUM, V101, P635, DOI 10.1111/j.1399-3054.1997.tb01048.x; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HOMANN PH, 1993, PHOTOSYNTH RES, V35, P29, DOI 10.1007/BF02185409; Joly D, 2005, PHOTOSYNTH RES, V84, P107, DOI 10.1007/s11120-004-7763-8; Joly D, 2007, J PHOTOCH PHOTOBIO B, V88, P43, DOI 10.1016/j.jphotobiol.2007.04.014; JURSINIC P, 1976, BIOCHIM BIOPHYS ACTA, V440, P322, DOI 10.1016/0005-2728(76)90066-9; KRIEGER A, 1993, BIOCHIM BIOPHYS ACTA, V1144, P411, DOI 10.1016/0005-2728(93)90128-3; Kruger GHJ, 1997, PHYSIOL PLANTARUM, V101, P265, DOI 10.1034/j.1399-3054.1997.1010203.x; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Ling QF, 2009, BIOL TRACE ELEM RES, V129, P251, DOI 10.1007/s12011-008-8283-8; Mamedov F, 2000, BIOCHEMISTRY-US, V39, P10478, DOI 10.1021/bi992877k; Mamedov F, 2002, PHOTOSYNTH RES, V74, P61, DOI 10.1023/A:1020835822266; MOHANTY N, 1989, PHYSIOL PLANTARUM, V76, P386, DOI 10.1111/j.1399-3054.1989.tb06208.x; Morlot M, 1996, ASPECTS ANAL PLOMB E; ONO TA, 1995, BBA-BIOENERGETICS, V1229, P239, DOI 10.1016/0005-2728(95)00010-G; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Pospisil P, 2002, BBA-BIOENERGETICS, V1554, P94, DOI 10.1016/S0005-2728(02)00216-5; Pospisil P, 1999, PHOTOSYNTH RES, V62, P55, DOI 10.1023/A:1006369009170; Prasad M. N. V., 1999, HEAVY METAL STRESS P; Putrenko II, 1999, BIOCHEMISTRY-US, V38, P10632, DOI 10.1021/bi990518j; Rajagopal S, 2003, BBA-BIOENERGETICS, V1606, P147, DOI 10.1016/S0005-2728(03)00111-7; RASHID A, 1990, FEBS LETT, V271, P181, DOI 10.1016/0014-5793(90)80401-4; RASHID A, 1994, FEBS LETT, V350, P296, DOI 10.1016/0014-5793(94)00789-6; Raskin I., 2000, PHYTOREMEDIATION TOX; REBEIZ CA, 1973, ANNU REV PLANT PHYS, V24, P129, DOI 10.1146/annurev.pp.24.060173.001021; Renger G, 2011, J PHOTOCH PHOTOBIO B, V104, P35, DOI 10.1016/j.jphotobiol.2011.01.023; ROBINSON HH, 1984, Z NATURFORSCH C, V39, P382; RUTHERFORD AW, 1982, BIOCHIM BIOPHYS ACTA, V682, P457, DOI 10.1016/0005-2728(82)90061-5; Sane PV, 2004, METH MOL B, V274, P229; SCHMIDT W, 1990, PHOTOSYNTH RES, V25, P241, DOI 10.1007/BF00033165; Shaffer M, 2001, WASTE LANDS THREAT T; Sigfridsson KGV, 2004, BBA-BIOENERGETICS, V1659, P19, DOI 10.1016/j.bbabio.2004.07.003; Sterckeman T, 2000, ENVIRON POLLUT, V107, P377, DOI 10.1016/S0269-7491(99)00165-7; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Strasser RJ, 1992, RES PHOTOSYNTHESIS, P23; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; VANRENSEN JJS, 1988, FEBS LETT, V226, P347, DOI 10.1016/0014-5793(88)81452-2; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; VASS I, 1987, BIOCHIM BIOPHYS ACTA, V892, P224, DOI 10.1016/0005-2728(87)90178-2; Wani PA, 2007, CURR MICROBIOL, V54, P237, DOI 10.1007/s00284-006-0451-5; WU JT, 1984, BOT BULL ACAD SINICA, V25, P125; Xiao W, 2008, BIOL TRACE ELEM RES, V126, P269, DOI 10.1007/s12011-008-8196-6; Yruela I, 1996, BIOCHEMISTRY-US, V35, P9469, DOI 10.1021/bi951667e	64	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68142	10.1371/journal.pone.0068142	http://dx.doi.org/10.1371/journal.pone.0068142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861859	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700071
J	Loupakis, F; Cremolini, C; Yang, DY; Salvatore, L; Zhang, W; Wakatsuki, T; Bohanes, P; Schirripa, M; Benhaim, L; Lonardi, S; Antoniotti, C; Aprile, G; Graziano, F; Ruzzo, A; Lucchesi, S; Ronzoni, M; De Vita, F; Tonini, G; Falcone, A; Lenz, HJ				Loupakis, Fotios; Cremolini, Chiara; Yang, Dongyun; Salvatore, Lisa; Zhang, Wu; Wakatsuki, Takeru; Bohanes, Pierre; Schirripa, Marta; Benhaim, Leonor; Lonardi, Sara; Antoniotti, Carlotta; Aprile, Giuseppe; Graziano, Francesco; Ruzzo, Annamaria; Lucchesi, Sara; Ronzoni, Monica; De Vita, Ferdinando; Tonini, Giuseppe; Falcone, Alfredo; Lenz, Heinz-Josef			Prospective Validation of Candidate SNPs of VEGF/VEGFR Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab	PLOS ONE			English	Article							CLINICAL-TRIAL DESIGNS; CHINESE POPULATION; GENETIC-VARIATIONS; PHASE-3 TRIAL; POLYMORPHISMS; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; BIOMARKERS; RESISTANCE	Purpose: The potential impact of different SNPs of VEGF/VEGFR pathway on the clinical outcome of mCRC patients receiving bev-containing regimens has been investigated in retrospective experiences with contrasting results. We previously reported the association of VEGFA rs833061 C/T variants with PFS in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab. The primary objective of this work was to prospectively validate that retrospective finding. A confirmatory analysis of other SNPs of VEGF/VEGFR pathway genes was included. Experimental design: To detect a HR for PFS of 1.7 for VEGFA rs833061 T/T compared to C-variants in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab, setting two-sided alpha = 0.05 and beta = 0.20, 199 events were required. VEGFA rs699946 A/G, rs699947 A/C, VEGFR1 rs9582036 A/C and rs7993418 A/G, VEGFR2 rs11133360 C/T, rs12505758 C/T and rs2305948 C/T and EPAS1 rs4145836 A/G were also tested. Germ-line DNA was extracted from peripheral blood. SNPs were analyzed by PCR and sequencing. Results: Four-hundred-twenty-four pts were included. At the univariate analysis, no differences according to VEGFA rs833061 C/T variants were observed in PFS (p = 0.38) or OS (p = 0.95). Among analyzed SNPs, only VEGFR2 rs12505758 C-variants, compared to T/T, were associated to shorter PFS (HR: 1.36 [1.05-1.75], p = 0.015, dominant genetic model) and OS, with a trend toward significance (HR: 1.34 [0.95-1.88], p = 0.088). In the multivariate model, this association retained significance (HR: 1.405 [1.082-1.825], p = 0.012) in PFS, that was lost by applying multiple testing correction (p = 0.14). Conclusion: This prospective experience failed to validate the hypothesized predictive impact of VEGFA rs833061 variants. Retrospective findings on different candidate SNPs were not confirmed. Only VEGFR2 rs12505758 variants, whose prognostic and not predictive impact was previously reported, correlated with PFS. Given the complexity of angiogenesis, it is rather unlike that a single germ-line SNP might be a good predictor of benefit from bevacizumab.	[Loupakis, Fotios; Yang, Dongyun; Zhang, Wu; Wakatsuki, Takeru; Bohanes, Pierre; Benhaim, Leonor; Lenz, Heinz-Josef] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Loupakis, Fotios; Cremolini, Chiara; Salvatore, Lisa; Schirripa, Marta; Antoniotti, Carlotta; Falcone, Alfredo] Azienda Osped Univ Pisana, Ist Toscano Tumori, Pisa, Italy; [Lonardi, Sara] Oncol Inst Veneto, Unit Med Oncol 1, Padua, Italy; [Aprile, Giuseppe] Azienda Osped Univ Udine, Udine, Italy; [Graziano, Francesco] Azienda Osped Osped San Salvatore, Med Oncol Unit, Pesaro, Italy; [Ruzzo, Annamaria] Univ Urbino, Sect Biochem & Mol Biol G Fornaini, Dept Biomol Sci, I-61029 Urbino, Italy; [Lucchesi, Sara] Ist Toscano Tumori, Med Oncol Unit, Azienda Pontedera USL5, Pisa, Italy; [Ronzoni, Monica] Ist Sci San Raffaele, Unit Oncol, Milan, Italy; [De Vita, Ferdinando] Univ Naples 2, Med Oncol Unit, Naples, Italy; [Tonini, Giuseppe] Univ Campus Biomed, Med Oncol Unit, Rome, Italy	University of Southern California; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Pisa; Azienda Ospedaliero Universitaria Pisana; IRCCS Istituto Oncologico Veneto (IOV); University of Udine; University Hospital of Udine; University of Urbino; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita della Campania Vanvitelli; University Campus Bio-Medico - Rome Italy	Loupakis, F (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	fotiosloupakis@gmail.com	Salvatore, Lisa/L-7746-2019; Ruzzo, Annamaria/Q-2155-2016; Lonardi, Sara/F-4228-2014; Loupakis, Fotios/I-7243-2012; Falcone, Alfredo/G-5217-2013; Yang, Dongyun/M-2579-2019; Cremolini, Chiara/AAC-1889-2019; Schirripa, Marta/F-3688-2017	Ruzzo, Annamaria/0000-0003-2815-1890; Lonardi, Sara/0000-0002-7593-8138; Loupakis, Fotios/0000-0001-9651-0395; Yang, Dongyun/0000-0003-0736-4977; Schirripa, Marta/0000-0001-8316-4411; Tonini, Giuseppe/0000-0003-4442-8677; Ronzoni, Monica/0000-0002-2845-275X; CREMOLINI, CHIARA/0000-0002-0520-4841; Falcone, Alfredo/0000-0001-5840-2529; Salvatore, Lisa/0000-0003-3864-0719				Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Bocci G, 2011, PHARMACOGENOMICS, V12, P1077, DOI [10.2217/pgs.11.75, 10.2217/PGS.11.75]; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; Buyse M, 2010, NAT REV CLIN ONCOL, V7, P309, DOI 10.1038/nrclinonc.2010.43; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Gerger A, 2011, CLIN CANCER RES, V17, P5783, DOI 10.1158/1078-0432.CCR-11-1115; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Grothey A, 2008, J CLIN ONCOL, V26, P183, DOI 10.1200/JCO.2007.13.8099; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Lambrechts D, 2011, EUR J CANCER, V47, pS173, DOI 10.1016/S0959-8049(11)70907-8; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Loupakis F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-247; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mandrekar SJ, 2009, J CLIN ONCOL, V27, P4027, DOI 10.1200/JCO.2009.22.3701; Pander J, 2011, ANN ONCOL, V22, P1147, DOI 10.1093/annonc/mdq572; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Schultheis AM, 2008, CLIN CANCER RES, V14, P7554, DOI 10.1158/1078-0432.CCR-08-0351; Tejpar S, 2012, ONCOLOGIST, V17, P1039, DOI 10.1634/theoncologist.2012-0068; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	24	53	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e66774	10.1371/journal.pone.0066774	http://dx.doi.org/10.1371/journal.pone.0066774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861747	gold, Green Submitted, Green Published			2022-12-25	WOS:000323350700007
J	Choi, IK; Li, Y; Oh, E; Kim, J; Yun, CO				Choi, Il-Kyu; Li, Yan; Oh, Eonju; Kim, Jaesung; Yun, Chae-Ok			Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-gamma- and TNF-alpha-Co-Producing T Cell-Mediated Antitumor Immunity	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INTERFERON-GAMMA; GM-CSF; MYCOBACTERIUM-TUBERCULOSIS; INTERLEUKIN (IL)-12; CANCER-THERAPY; GENE-TRANSFER; IL-12; TUMOR; CYTOKINES	Cytokine immunogene therapy is a promising strategy for cancer treatment. Interleukin (IL)-12 boosts potent antitumor immunity by inducing T helper 1 cell differentiation and stimulating cytotoxic T lymphocyte and natural killer cell cytotoxicity. IL-23 has been proposed to have similar but not overlapping functions with IL-12 in inducing Th1 cell differentiation and antitumor immunity. However, the therapeutic effects of intratumoral co-expression of IL-12 and IL-23 in a cancer model have yet to be investigated. Therefore, we investigated for the first time an effective cancer immunogene therapy of syngeneic tumors via intratumoral inoculation of oncolytic adenovirus co-expressing IL-23 and p35, RdB/IL23/p35. Intratumoral administration of RdB/IL23/p35 elicited strong antitumor effects and increased survival in a murine B16-F10 syngeneic tumor model. The levels of IL-12, IL-23, interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha) were elevated in RdB/IL23/p35-treated tumors. Moreover, the proportion of regulatory T cells was markedly decreased in mice treated with RdB/IL23/p35. Consistent with these data, mice injected with RdB/IL23/p35 showed massive infiltration of CD4(+) and CD8(+) T cells into the tumor as well as enhanced induction of tumor-specific immunity. Importantly, therapeutic mechanism of antitumor immunity mediated by RdB/IL23/p35 is associated with the generation and recruitment of IFN-gamma- and TNF-alpha-co-producing T cells in tumor microenvironment. These results provide a new insight into therapeutic mechanisms of IL-12 plus IL-23 and provide a potential clinical cancer immunotherapeutic agent for improved antitumor immunity.	[Choi, Il-Kyu; Oh, Eonju; Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea; [Li, Yan] Yonsei Univ, Grad Program Nanomed Sci, Seoul 120749, South Korea; [Kim, Jaesung] Univ Utah, Ctr Controlled Chem Delivery, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84108 USA	Hanyang University; Yonsei University; Utah System of Higher Education; University of Utah	Yun, CO (corresponding author), Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea.	chaeok@hanyang.ac.kr	Yun, Chae-Ok/P-3698-2015	Yun, Chae-Ok/0000-0002-9466-4531	Ministry of Knowledge Economy [10030051]; Korea Science and Engineering Foundation [R15-2004-024-02001-0, 2009K001644, 2010-0029220]; Korea Food and Drug Administration [KFDA-13172-306]; KOSEF through National Core Research Center for Nanomedical Technology, Seoul, Korea	Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); KOSEF through National Core Research Center for Nanomedical Technology, Seoul, Korea	This work was supported by grants from the Ministry of Knowledge Economy (10030051, Dr. CO Yun), the Korea Science and Engineering Foundation (R15-2004-024-02001-0, 2009K001644, 2010-0029220, Dr. CO Yun), and the Korea Food and Drug Administration (KFDA-13172-306 to Dr. CO Yun). Yan Li is a graduate student sponsored by KOSEF through National Core Research Center for Nanomedical Technology, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 1997, J IMMUNOL, V159, P2125; ASTEAMEZAGA M, 1994, CELL IMMUNOL, V156, P480, DOI 10.1006/cimm.1994.1192; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; BLOOM BR, 1994, IMMUNOBIOLOGY, V191, P526, DOI 10.1016/S0171-2985(11)80459-6; Cao XF, 2009, CANCER RES, V69, P8700, DOI 10.1158/0008-5472.CAN-09-1145; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Choi IK, 2011, GENE THER, V18, P898, DOI 10.1038/gt.2011.37; Choi KJ, 2006, GENE THER, V13, P1010, DOI 10.1038/sj.gt.3302759; Choi KJ, 2012, GENE THER, V19, P711, DOI 10.1038/gt.2011.125; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gadducci A, 2004, BIOMED PHARMACOTHER, V58, P24, DOI 10.1016/j.biopha.2003.11.003; Haicheur N, 2000, CLIN EXP IMMUNOL, V119, P28, DOI 10.1046/j.1365-2249.2000.01112.x; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Helms T, 2000, J IMMUNOL, V164, P3723, DOI 10.4049/jimmunol.164.7.3723; Huang JH, 2010, MOL THER, V18, P264, DOI 10.1038/mt.2009.205; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Kaiga T, 2007, J IMMUNOL, V178, P7571, DOI 10.4049/jimmunol.178.12.7571; Kim J, 2007, HUM GENE THER, V18, P773, DOI 10.1089/hum.2006.167; Lee YS, 2006, CLIN CANCER RES, V12, P5859, DOI 10.1158/1078-0432.CCR-06-0935; Li QX, 2008, INT J CANCER, V123, P493, DOI 10.1002/ijc.23692; LING P, 1995, J IMMUNOL, V154, P116; Ma XJ, 2001, MICROBES INFECT, V3, P121, DOI 10.1016/S1286-4579(00)01359-9; Malmberg KJ, 2004, CANCER IMMUNOL IMMUN, V53, P879, DOI 10.1007/s00262-004-0577-x; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Mizuguchi H, 2003, HUM GENE THER, V14, P1265, DOI 10.1089/104303403767740803; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pei DS, 2010, EXPERT OPIN BIOL TH, V10, P917, DOI 10.1517/14712598.2010.481668; Podhajcer OL, 2007, CYTOKINE GROWTH F R, V18, P183, DOI 10.1016/j.cytogfr.2007.01.014; Portielje JEA, 2003, CLIN CANCER RES, V9, P76; Prevost-Blondel A, 2000, J IMMUNOL, V164, P3645, DOI 10.4049/jimmunol.164.7.3645; Ramakrishna E, 2009, CANCER RES, V69, P1448, DOI 10.1158/0008-5472.CAN-08-1160; RANGES GE, 1987, J EXP MED, V166, P991, DOI 10.1084/jem.166.4.991; Reay J, 2009, CANCER GENE THER, V16, P776, DOI 10.1038/cgt.2009.27; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Stoop JN, 2007, HEPATOLOGY, V46, P699, DOI 10.1002/hep.21761; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zhang SN, 2011, MOL THER, V19, P1558, DOI 10.1038/mt.2011.29; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	53	37	41	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67512	10.1371/journal.pone.0067512	http://dx.doi.org/10.1371/journal.pone.0067512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844018	Green Published, Green Submitted, gold			2022-12-25	WOS:000321733000077
J	Kezic, JM; McMenamin, PG				Kezic, Jelena M.; McMenamin, Paul G.			The Effects of CX(3)CR1 Deficiency and Irradiation on the Homing of Monocyte-Derived Cell Populations in the Mouse Eye	PLOS ONE			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; RETINAL MICROGLIA; RESIDENT-MICROGLIA; DENDRITIC CELLS; CHEMOKINE; CX3CR1; MIGRATION; RADIATION; TURNOVER; RECRUITMENT	This study examined whether CX(3)CR1 deficiency altered monocytic cell replenishment dynamics in ocular tissues in the context of radiation chimeras. Long-term effects of irradiation and effects of sublethal irradiation on ocular macrophages were also assessed. Bone marrow from BALB/c Cx(3)cr1(+/gfp) or Cx(3)cr1(gfp/gfp) mice was used to reconstitute full body irradiated WT mice and donor cell densities in the uveal tract were compared at 4 and 8 weeks post-transplantation. BALB/c and C57BL/6J chimeric mice were examined at 6 months of age to determine strain-related differences in microglial replenishment and radiation sensitivity. A separate cohort of mice were sublethally irradiated (5.5 Gy) and retinal tissue assessed 8 and 12 weeks later. CX(3)CR1 deficiency altered the early replenishment of monocytes in the posterior iris but not in the iris stroma, choroid or retina. In six month old chimeric mice, there were significantly higher GFP(+) cell densities in the uveal tract when compared to non-irradiated 8-12 week old Cx(3)cr1(+/gfp) mice. Additionally, MHC Class II expression was upregulated on hyalocytes and GFP(+) cells in the peripheral retina and the repopulation of microglia appeared to be more rapid in C57BL/6J mice compared to BALB/c mice. Transient expression of MHC Class II was observed on retinal vasculature in sublethally irradiated mice. These data indicate CX(3)CR1-deficiency only slightly alters monocyte-derived cell replenishment in the murine uveal tract. Lethal irradiation leads to long-term increase in monocytic cell density in the uveal tract and retinal microglial activation, possibly as a sequelae to local irradiation induced injury. Microglial replenishment in this model appears to be strain dependent.	[Kezic, Jelena M.; McMenamin, Paul G.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Kezic, Jelena M.] Univ Melbourne, Ctr Eye Res Australia, Dept Ophthalmol, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia	Monash University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Kezic, JM (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.	Jelena.Kezic@monash.edu		McMenamin, Paul/0000-0002-7141-1283				Agarwal RK, 2004, METH MOLEC MED, V102, P395; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Albini TA, 2005, BRIT J OPHTHALMOL, V89, P901, DOI 10.1136/bjo.2004.060293; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Blomster LV, 2011, MOL CELL NEUROSCI, V48, P236, DOI 10.1016/j.mcn.2011.08.004; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Chinnery HR, 2008, IMMUNOLOGY, V125, P541, DOI 10.1111/j.1365-2567.2008.02868.x; Chinnery HR, 2007, INVEST OPHTH VIS SCI, V48, P1568, DOI 10.1167/iovs.06-0746; Chinnery HR, 2012, NEUROBIOL AGING, V33, P1769, DOI 10.1016/j.neurobiolaging.2011.03.010; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Dagkalis A, 2009, IMMUNOLOGY, V128, P25, DOI 10.1111/j.1365-2567.2009.03046.x; Echigo T, 2004, J ALLERGY CLIN IMMUN, V113, P940, DOI 10.1016/S0091-6749(04)01061-9; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Haston CK, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00094; Haston CK, 1997, CANCER RES, V57, P5286; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kezic J, 2008, J LEUKOCYTE BIOL, V84, P721, DOI 10.1189/jlb.0308166; Kezic J, 2008, INVEST OPHTH VIS SCI, V49, P1599, DOI 10.1167/iovs.07-0953; Kezic J, 2010, INVEST OPHTH VIS SCI, V51, P5121, DOI 10.1167/iovs.10-5325; Kipnis J, 2004, EUR J NEUROSCI, V19, P1191, DOI 10.1111/j.1460-9568.2004.03207.x; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Liang KJ, 2009, REGULATION DYNAMIC B, P4444; Lindsay KJ, 2007, BRIT J RADIOL, V80, pS2, DOI 10.1259/bjr/60507340; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Lyszkiewicz M, 2011, EUR J IMMUNOL, V41, P1256, DOI 10.1002/eji.201040977; McMenamin PG, 2000, INVEST OPHTH VIS SCI, V41, P3043; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Muther PS, 2010, INVEST OPHTH VIS SCI, V51, P4831, DOI 10.1167/iovs.09-4923; Nanki T, 2004, J IMMUNOL, V173, P7010, DOI 10.4049/jimmunol.173.11.7010; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Papadopoulos EJ, 1999, EUR J IMMUNOL, V29, P2551, DOI 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; Ruitenberg MJ, 2008, J NEUROIMMUNOL, V205, P80, DOI 10.1016/j.jneuroim.2008.09.010; Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551; Su SB, 2007, INVEST OPHTH VIS SCI, V48, P4616, DOI 10.1167/iovs.07-0233; Sun B, 1997, J IMMUNOL, V159, P1004; Sunnemark D, 2003, BRAIN PATHOL, V13, P617; Suzuki F, 2005, J IMMUNOL, V175, P6987, DOI 10.4049/jimmunol.175.10.6987; Tanaka R, 2003, NEUROSCIENCE, V117, P531, DOI 10.1016/S0306-4522(02)00954-5; Vagaja NN, 2012, INVEST OPHTH VIS SCI, V53, P1445, DOI 10.1167/iovs.11-8601; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Xu HP, 2007, INVEST OPHTH VIS SCI, V48, P1701, DOI 10.1167/iovs.06-0697; Zhao L, 2009, EXP EYE RES, V88, P1004, DOI 10.1016/j.exer.2008.12.013; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	55	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68570	10.1371/journal.pone.0068570	http://dx.doi.org/10.1371/journal.pone.0068570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844223	gold, Green Published			2022-12-25	WOS:000321733000016
J	Dong, BC; Wang, JZ; Liu, RH; Zhang, MX; Yu, FH				Dong, Bi-Cheng; Wang, Jiu-Zhong; Liu, Rui-Hua; Zhang, Ming-Xiang; Yu, Fei-Hai			Effects of Heterogeneous Competitor Distribution and Ramet Aggregation on the Growth and Size Structure of a Clonal Plant	PLOS ONE			English	Article							SOIL NUTRIENT HETEROGENEITY; ENVIRONMENTAL HETEROGENEITY; TEMPORAL HETEROGENEITY; FORAGING BEHAVIOR; SPATIAL-PATTERNS; MODULAR CONCEPT; PLASTICITY; POPULATIONS; RESPONSES; LIGHT	Spatially heterogeneous distribution of interspecific competitors and intraspecific aggregation of offspring ramets may affect the growth and size structure of clonal plant populations, but these have been rarely studied. We conducted a greenhouse experiment in which we grew a population of eight offspring ramets (plants) of the stoloniferous clonal plant Hydrocotyle vulgaris aggregately or segregately in two homogeneous treatments with or without a competing grass Festuca elata and a heterogeneous treatment with a patchy distribution of the grass. In patchy grass treatments, H. vulgaris produced markedly more biomass, ramets and stolons in open patches (without grasses) than in grass patches, but displayed lower size variations as measured by coefficient of variation of biomass, ramets and stolons among the eight plants. In open areas, H. vulgaris produced statistically the same amounts of biomass and even more stolons and showed higher size variations in patchy grass treatments than in open (no grass) treatments. In grass areas, H. vulgaris grew much worse and displayed higher size variations in patchy grass treatments than in full grass treatments. Ramet aggregation decreased the growth of H. vulgaris in open treatments and in both open and grass patches in patchy grass treatments, but had little effect in full grass treatments. Ramet aggregation had little effect on size variations. Therefore, heterogeneous distribution of competitors can affect the growth and size structure of clonal plant populations, and ramet aggregation may decrease population growth when they grow in open environments or heterogeneous environments with a patchy distribution of interspecific competitors.	[Dong, Bi-Cheng; Liu, Rui-Hua; Zhang, Ming-Xiang; Yu, Fei-Hai] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Wang, Jiu-Zhong] Beijing Forestry Univ, Sch Forestry, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Yu, FH (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	feihaiyu@bjfu.edu.cn	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745; Dong, Bi-Cheng/0000-0002-9658-9969	Beijing Forestry University [BLYJ201104]; Fundamental Research Funds for the Central Universities [TD-JC-2013-1]; Program for New Century Excellent Talents in University [NECT-10-0234]	Beijing Forestry University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by the Specific Programs in Graduate Science and Technology Innovation of Beijing Forestry University (BLYJ201104), the Fundamental Research Funds for the Central Universities (TD-JC-2013-1) and the Program for New Century Excellent Talents in University (NECT-10-0234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1996, VEGETATIO, V122, P83, DOI 10.1007/BF00052818; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Begon M., 2009, ECOLOGY INDIVIDUALS; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; Bolker BM, 2003, AM NAT, V162, P135, DOI 10.1086/376575; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Cahill JF, 2011, ANNU REV ECOL EVOL S, V42, P289, DOI 10.1146/annurev-ecolsys-102710-145006; Caldwell M.M., 1994, EXPLOITATION ENV HET; Casper BB, 1998, AM J BOT, V85, P1680, DOI 10.2307/2446501; Casper BB, 1996, AM J BOT, V83, P333, DOI 10.2307/2446168; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; Chu Y, 2006, J INTEGR PLANT BIOL, V48, P400, DOI 10.1111/j.1744-7909.2006.00237.x; Day KJ, 2003, J ECOL, V91, P541, DOI 10.1046/j.1365-2745.2003.00799.x; Day KJ, 2003, J ECOL, V91, P305, DOI 10.1046/j.1365-2745.2003.00763.x; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; DEKROON H, 2003, ROOT ECOLOGY; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; DONG M, 1995, OECOLOGIA, V101, P282, DOI 10.1007/BF00328813; EVANS JP, 1995, ECOLOGY, V76, P1147, DOI 10.2307/1940922; Facelli E, 2002, OECOLOGIA, V133, P54, DOI 10.1007/s00442-002-1022-5; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; GIBSON DJ, 1988, J ECOL, V76, P233, DOI 10.2307/2260466; Gough L, 2001, EVOL ECOL, V15, P547, DOI 10.1023/A:1016061604630; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; Hagiwara Y, 2012, ECOL RES, V27, P1079, DOI 10.1007/s11284-012-0989-6; Hagiwara Y, 2010, ANN BOT-LONDON, V106, P173, DOI 10.1093/aob/mcq096; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Huber-Sannwald E, 1998, ECOLOGY, V79, P2267, DOI 10.1890/0012-9658(1998)079[2267:EONPAR]2.0.CO;2; Huber-Sannwald E, 2001, PROG BOT, V62, P451; Hutchings MJ, 2008, EVOL ECOL, V22, P313, DOI 10.1007/s10682-007-9178-4; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Hutchings MJ, 2003, ECOLOGY, V84, P2322, DOI 10.1890/02-0290; Leeflang L, 1998, OECOLOGIA, V117, P235, DOI 10.1007/s004420050653; Lenssen JPM, 2005, ECOLOGY, V86, P1358, DOI 10.1890/04-0939; Li PX, 2008, J ARID ENVIRON, V72, P953, DOI 10.1016/j.jaridenv.2007.11.004; Liu HD, 2009, FLORA, V204, P298, DOI 10.1016/j.flora.2008.03.003; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; MCCONNAUGHAY KDM, 1991, ECOLOGY, V72, P94, DOI 10.2307/1938905; Miao LiHua, 2011, Journal of Zhejiang University (Agriculture and Life Sciences), V37, P425; Monzeglio U, 2005, OECOLOGIA, V145, P619, DOI 10.1007/s00442-005-0168-3; NOVOPLANSKY A, 1990, OECOLOGIA, V82, P490, DOI 10.1007/BF00319791; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Price EAC, 1996, OIKOS, V75, P279, DOI 10.2307/3546251; QUINN GP, 2002, EXPT DESIGN DATA ANA, P443; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; ROSS MA, 1972, J ECOL, V60, P77, DOI 10.2307/2258041; Stark JM, 1994, EXPLOITATION ENV HET, P255; Stoll P, 2001, ECOLOGY, V82, P319, DOI 10.1890/0012-9658(2001)082[0319:IAACII]2.0.CO;2; STUEFER JF, 1994, OECOLOGIA, V100, P302, DOI 10.1007/BF00316958; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Von Ende CN., 2001, DESIGN ANAL ECOLOGIC, P134; von Felten S, 2008, J PLANT ECOL, V1, P33, DOI 10.1093/jpe/rtm006; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039105; WEINER J, 1985, ECOLOGY, V66, P743, DOI 10.2307/1940535; WEINER J, 1986, OIKOS, V47, P211, DOI 10.2307/3566048; Winkler E, 2001, EVOL ECOL, V15, P281, DOI 10.1023/A:1016080714200; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314; Zobel M, 2010, OIKOS, V119, P802, DOI 10.1111/j.1600-0706.2010.18296.x	62	3	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68557	10.1371/journal.pone.0068557	http://dx.doi.org/10.1371/journal.pone.0068557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844221	gold, Green Published			2022-12-25	WOS:000321341000173
J	Grasmeijer, F; Hagedoorn, P; Frijlink, HW; de Boer, HA				Grasmeijer, Floris; Hagedoorn, Paul; Frijlink, Henderik W.; de Boer, H. Anne			Mixing Time Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation	PLOS ONE			English	Article							POWDER INHALER FORMULATIONS; DRUG PARTICLE DETACHMENT; CLASSIFIER TECHNOLOGY ACT; AIR CLASSIFIER; APPARENT SOLUBILITY; CARRIER CRYSTALS; SURFACE; MODE	This paper deals with the effects of mixing time on the homogeneity and dispersion performance of adhesive mixtures for inhalation. Interactions between these effects and the carrier size fraction, the type of drug and the inhalation flow rate were studied. Furthermore, it was examined whether or not changes in the dispersion performance as a result of prolonged mixing can be explained with a balance of three processes that occur during mixing, knowing drug redistribution over the lactose carrier; (de-) agglomeration of the drug (and fine lactose) particles; and compression of the drug particles onto the carrier surface. For this purpose, mixtures containing salmeterol xinafoate or fluticasone propionate were mixed for different periods of time with a fine or coarse crystalline lactose carrier in a Turbula mixer. Drug detachment experiments were performed using a classifier based inhaler at different flow rates. Scanning electron microscopy and laser diffraction techniques were used to measure drug distribution and agglomeration, whereas changes in the apparent solubility were measured as a means to monitor the degree of mechanical stress imparted on the drug particles. No clear trend between mixing time and content uniformity was observed. Quantitative and qualitative interactions between the effect of mixing time on drug detachment and the type of drug, the carrier size fraction and the flow rate were measured, which could be explained with the three processes mentioned. Generally, prolonged mixing caused drug detachment to decrease, with the strongest decline occurring in the first 120 minutes of mixing. For the most cohesive drug (salmeterol) and the coarse carrier, agglomerate formation seemed to dominate the overall effect of mixing time at a low inhalation flow rate, causing drug detachment to increase with prolonged mixing. The optimal mixing time will thus depend on the formulation purpose and the choice for other, interacting variables.	[Grasmeijer, Floris; Hagedoorn, Paul; Frijlink, Henderik W.; de Boer, H. Anne] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands	University of Groningen	Grasmeijer, F (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	F.Grasmeijer@rug.nl	Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198	Department of Pharmaceutical Technology and Biopharmacy of the University of Groningen	Department of Pharmaceutical Technology and Biopharmacy of the University of Groningen	The work was funded by the Department of Pharmaceutical Technology and Biopharmacy of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begat P, 2004, PHARM RES-DORDR, V21, P1826, DOI 10.1023/B:PHAM.0000045236.60029.cb; Bridson RH, 2007, INT J PHARM, V339, P84, DOI 10.1016/j.ijpharm.2007.02.022; Cordts E, 2012, DRUGS DELIV LUNGS, V23, P146; de Boer AH, 2004, PHARM RES-DORDR, V21, P2167, DOI 10.1007/s11095-004-5171-6; de Boer AH, 2003, INT J PHARMACEUT, V260, P187, DOI 10.1016/S0378-5173(03)00250-3; de Boer AH, 2003, INT J PHARM, V260, P201, DOI 10.1016/S0378-5173(03)00264-3; de Boer AH, 2005, INT J PHARMACEUT, V294, P173, DOI 10.1016/j.ijpharm.2005.01.035; DEVILLIERS MM, 1993, POWDER TECHNOL, V75, P159, DOI 10.1016/0032-5910(93)80077-N; Dickhoff BHJ, 2002, EUR J PHARM BIOPHARM, V54, P245, DOI 10.1016/S0939-6411(02)00082-6; Dickhoff BHJ, 2003, EUR J PHARM BIOPHARM, V56, P291, DOI 10.1016/S0939-6411(03)00109-7; ELAMIN AA, 1994, INT J PHARMACEUT, V111, P159, DOI 10.1016/0378-5173(94)00132-4; HERSEY JA, 1975, POWDER TECHNOL, V11, P41, DOI 10.1016/0032-5910(75)80021-0; HUTTENRAUCH R, 1985, PHARM RES-DORDR, P302, DOI 10.1023/A:1016397719020; Jones MD, 2008, PHARM RES-DORDR, V25, P337, DOI 10.1007/s11095-007-9467-1; Kale K, 2009, EUR J PHARM BIOPHARM, V72, P156, DOI 10.1016/j.ejpb.2008.12.015; KULVANICH P, 1987, J PHARM PHARMACOL, V39, P732, DOI 10.1111/j.2042-7158.1987.tb06978.x; Lacey PMC, 1997, CHEM ENG RES DES, V75, pS49, DOI 10.1016/S0263-8762(97)80004-4; LAM KK, 1991, POWDER TECHNOL, V65, P167, DOI 10.1016/0032-5910(91)80179-M; Le VNP, 2012, EUR J PHARM BIOPHARM, V80, P596, DOI 10.1016/j.ejpb.2011.12.004; Mosharraf M, 2003, DRUG DEV IND PHARM, V29, P603, DOI 10.1081/DDC-120021310; Mosharraf M, 1999, EUR J PHARM SCI, V9, P145, DOI 10.1016/S0928-0987(99)00043-3; Podczeck F, 1996, INT J PHARM, V145, P65, DOI 10.1016/S0378-5173(96)04718-7; Price R, 2010, C LACT CARR INH PROD; Shur J, 2008, PHARM RES-DORDR, V25, P1931, DOI 10.1007/s11095-008-9538-y; STANIFORTH JN, 1987, J PHARM PHARMACOL, V39, P329, DOI 10.1111/j.2042-7158.1987.tb03393.x; Staniforth JN., 1981, INT J PHARM TECH PRO, V2, P7; TRAVERS DN, 1975, POWDER TECHNOL, V12, P189, DOI 10.1016/0032-5910(75)80011-8	27	20	20	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69263	10.1371/journal.pone.0069263	http://dx.doi.org/10.1371/journal.pone.0069263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844256	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000188
J	Islam, MR; Khatun, R; Uddin, MKM; Khan, MSR; Rahman, MT; Ahmed, T; Banu, S				Islam, Mohammad R.; Khatun, Razia; Uddin, Mohammad Khaja Mafij; Khan, Md. Siddiqur Rahman; Rahman, Md. Toufiq; Ahmed, Tahmeed; Banu, Sayera			Yield of Two Consecutive Sputum Specimens for the Effective Diagnosis of Pulmonary Tuberculosis	PLOS ONE			English	Article							DECOMPRESSION-SICKNESS; AIR SATURATION; OXYGEN; ASCENT; ATA	Background: From long instances, it is debatable whether three sputum specimens are required for the diagnosis of pulmonary tuberculosis (TB) or TB can be diagnosed effectively using two consecutive sputum specimens. This study was set out to evaluate the significance of examining multiple sputum specimens in diagnosis of TB. Methods: We retrospectively reviewed the acid-fast bacillus (AFB) smear and culture results of three consecutive days' sputum specimens from 413 confirmed TB patients which were detected as part of a larger active case finding study in Dhaka Central Jail, the largest correctional facility in Bangladesh. Results: AFB was detected from 81% (n = 334) patients, of which 89% (n = 297) were diagnosed from the first and additional 9% (n = 30) were from the second sputum specimen. M. tuberculosis growth was observed for 406 patients and 85% (n = 343) were obtained from the first sputum and additional 10% (n = 42) were from the second one. The third specimen didn't show significant additional diagnostic value for the detection of AFB by microscopy or growth of the M. tuberculosis. Conclusions: We concluded from our study results that examining two consecutive sputum specimens is sufficient enough for the effective diagnosis of TB. It can also decrease the laboratory workload and hence improve the quality of work in settings with high TB burden like Bangladesh.	[Khatun, Razia; Uddin, Mohammad Khaja Mafij; Khan, Md. Siddiqur Rahman; Rahman, Md. Toufiq; Ahmed, Tahmeed; Banu, Sayera] Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, Dhaka 1000, Bangladesh; [Islam, Mohammad R.] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka 1000, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); University of Dhaka	Banu, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, GPO Box 128, Dhaka 1000, Bangladesh.	sbanu@icddrb.org	Khan, Mohammad Siddiqur/J-3025-2018	Khan, Mohammad Siddiqur/0000-0003-2479-6405; Banu, Sayera/0000-0002-5121-1962	Government of Bangladesh through IHP-HNPRP; icddr,b;  [GR-00410]	Government of Bangladesh through IHP-HNPRP; icddr,b; 	This work was supported by grants from the Government of Bangladesh through IHP-HNPRP and icddr,b. The grant number is GR-00410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PD, 1984, UNDERSEA BIOMED RES, V11, P387; BERGHAGE T E, 1976, Undersea Biomedical Research, V3, P387; Blatteau JE, 2012, 1206 IRBA; Blatteau JE, 2012, EUR J APPL PHYSIOL, V112, P2257, DOI 10.1007/s00421-011-2195-6; Bregeon F, 2002, RESP PHYSIOL NEUROBI, V132, P191, DOI 10.1016/S1569-9048(02)00069-1; Bregeon F, 2010, J PHYSIOL-LONDON, V588, P1309, DOI 10.1113/jphysiol.2010.187658; Clark JM, 1999, J APPL PHYSIOL, V86, P243, DOI 10.1152/jappl.1999.86.1.243; Clark JM, 2003, BENNETT ELLIOTTS PHY, V5th, P358; Clarke Jr, 1999, LUNG BIOL HEALTH DIS, V132, P1; Degryse J, 2012, RESPIRATION, V83, P543, DOI 10.1159/000334907; Dromsky DM, 2000, J APPL PHYSIOL, V89, P791, DOI 10.1152/jappl.2000.89.2.791; ECKENHOFF RG, 1986, UNDERSEA BIOMED RES, V13, P305; ECKENHOFF RG, 1985, UNDERSEA BIOMED RES, V12, P41; ECKENHOFF RG, 1987, AVIAT SPACE ENVIR MD, V58, P658; Eftedal O, 2007, THESIS NORWEGIAN U S; GARDETTE B, 1979, UNDERSEA BIOMED RES, V6, P99; Hamilton R.W., 2003, BENNETT ELLIOTTS PHY, P455; Harvey C, 1989, SP891 NAV SUBM MED R; Hugon J, 2010, THESIS U MEDITERRANE; Jammes Y, 2006, PHYSL MED PLONGEE, P86; Lambersten CJ, 1973, AEROSPACE MED, V44, P703; Latson G, 2000, 1100 NEDU TR NAV SEA; Miller JW, 1979, NOAA DIVING MANUAL D, P1; Nishi R. Y., 2003, BENNETT ELLIOTTS PHY, P501; Risberg J, 2008, 1100 NEDU TR NAV SEA; Sawatzky KD, 1991, THESIS YORK U TORONT; Thalmann ED, 1989, UHMS PUBLICATION, V74(VAL)1-1-88, P33; THORSEN E, 1994, EUR RESPIR J, V7, P4, DOI 10.1183/09031936.94.07010004	28	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67678	10.1371/journal.pone.0067678	http://dx.doi.org/10.1371/journal.pone.0067678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844057	gold, Green Submitted, Green Published			2022-12-25	WOS:000321341000073
J	Lavigne, JP; Cuzon, G; Combescure, C; Bourg, G; Sotto, A; Nordmann, P				Lavigne, Jean-Philippe; Cuzon, Gaelle; Combescure, Christophe; Bourg, Gisele; Sotto, Albert; Nordmann, Patrice			Virulence of Klebsiella pneumoniae Isolates Harboring bla(KPC-2) Carbapenemase Gene in a Caenorhabditis elegans Model	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; KPC; PLASMID; EPIDEMIOLOGY; EFFLUX; SPP.	Klebsiella pneumoniae carbapenemase (KPC) is a carbapenemase increasingly reported worldwide in Enterobacteriaceae. The aim of this study was to analyze the virulence of several KPC-2-producing K. pneumoniae isolates. The studied strains were (i) five KPC-2 clinical strains from different geographical origins, belonging to different ST-types and possessing plasmids of different incompatibility groups; (ii) seven transformants obtained after electroporation of either these natural KPC plasmids or a recombinant plasmid harboring only the bla(KPC-2) gene into reference strains K. pneumoniae ATCC10031/CIP53153; and (iii) five clinical strains cured of plasmids. The virulence of K. pneumoniae isolates was evaluated in the Caenorhabditis elegans model. The clinical KPC producers and transformants were significantly less virulent (LT50: 5.5 days) than K. pneumoniae reference strain (LT50: 4.3 days) (p<0.01). However, the worldwide spread KPC-2 positive K. pneumoniae ST258 strains and reference strains containing plasmids extracted from K. pneumoniae ST258 strains had a higher virulence than KPC-2 strains belonging to other ST types (LT50: 5 days vs. 6 days, p<0.01). The increased virulence observed in cured strains confirmed this trend. The bla(KPC-2) gene itself was not associated to increased virulence.	[Lavigne, Jean-Philippe; Bourg, Gisele; Sotto, Albert] Univ Montpellier I, INSERM, U1047, UFR Med, Nimes, France; [Lavigne, Jean-Philippe] CHU Caremeau, Bacteriol Lab, Nimes, France; [Cuzon, Gaelle; Nordmann, Patrice] Univ Paris 11, AP HP Bicetre, INSERM, Serv Bacteriol Virol Hyg,U914, Le Kremlin Bicetre, France; [Combescure, Christophe] Univ Geneva, Div Clin Epidemiol, Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Geneva	Lavigne, JP (corresponding author), Univ Montpellier I, INSERM, U1047, UFR Med, Nimes, France.	jean.philippe.lavigne@chu-nimes.fr	Sotto, Albert/AFJ-9023-2022; Lavigne, Jean-Philippe/E-1756-2014	Lavigne, Jean-Philippe/0000-0002-9484-0304; Sotto, Albert/0000-0002-6463-9386	INSERM, France, Universite de Montpellier 1, La Ville de Nimes; La Region Languedoc Roussillon (Grant "Chercheur d'Avenir"); INSERM; NIH National Center for Research Resources (NCRR)	INSERM, France, Universite de Montpellier 1, La Ville de Nimes; La Region Languedoc Roussillon (Grant "Chercheur d'Avenir")(Region Occitanie); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	INSERM U1047 is supported by INSERM, France, Universite de Montpellier 1, La Ville de Nimes and La Region Languedoc Roussillon (Grant "Chercheur d'Avenir"). INSERM U914 is supported by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fer-15 was provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Bialek S, 2010, ANTIMICROB AGENTS CH, V54, P4373, DOI 10.1128/AAC.01607-09; Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; Chmelnitsky I, 2009, J ANTIMICROB CHEMOTH, V64, P718, DOI 10.1093/jac/dkp272; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; DiMartino P, 1997, J CLIN MICROBIOL, V35, P1499, DOI 10.1128/JCM.35.6.1499-1503.1997; El Fertas-Aissani R, 2012, PATHOL BIOL; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V63, P427, DOI 10.1093/jac/dkn547; Frasson I, 2012, J CLIN MICROBIOL, V50, P3768, DOI 10.1128/JCM.01892-12; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gasink LB, 2009, INFECT CONT HOSP EP, V30, P1180, DOI 10.1086/648451; Kassis-Chikhani N, 2013, ANTIMICROB AGENTS CH, V57, P618, DOI 10.1128/AAC.01712-12; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Lavigne JP, 2006, CLIN MICROBIOL INFEC, V12, P1199, DOI 10.1111/j.1469-0691.2006.01536.x; Marchaim D, 2008, ANTIMICROB AGENTS CH, V52, P1413, DOI 10.1128/AAC.01103-07; Monteiro J, 2009, ANTIMICROB AGENTS CH, V53, P333, DOI 10.1128/AAC.00736-08; Naas T, 2005, ANTIMICROB AGENTS CH, V49, P4423, DOI 10.1128/AAC.49.10.4423-4424.2005; Naas T, 2008, ANTIMICROB AGENTS CH, V52, P1257, DOI 10.1128/AAC.01451-07; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Sahly H, 2008, ANTIMICROB AGENTS CH, V52, P3029, DOI 10.1128/AAC.00010-08; Siu LK, 2012, MICROB DRUG RESIST, V18, P380, DOI 10.1089/mdr.2011.0241; Villegas MV, 2007, ANTIMICROB AGENTS CH, V51, P1553, DOI 10.1128/AAC.01405-06; Villegas MV, 2006, ANTIMICROB AGENTS CH, V50, P2880, DOI 10.1128/AAC.00186-06	26	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67847	10.1371/journal.pone.0067847	http://dx.doi.org/10.1371/journal.pone.0067847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844109	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000109
J	Lonskaya, I; Partridge, J; Lalchandani, RR; Chung, A; Lee, T; Vicini, S; Hoe, HS; Lim, ST; Conant, K				Lonskaya, Irina; Partridge, John; Lalchandani, Rupa R.; Chung, Andrew; Lee, Taehee; Vicini, Stefano; Hoe, Hyang-Sook; Lim, Seung T.; Conant, Katherine			Soluble ICAM-5, a Product of Activity Dependent Proteolysis, Increases mEPSC Frequency and Dendritic Expression of GluA1	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTOR TRAFFICKING; AMYLOID PRECURSOR PROTEIN; CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; SYNAPTIC PLASTICITY; MATRIX METALLOPROTEINASES; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; SPINE ENLARGEMENT	Matrix metalloproteinases (MMPs) are zinc dependent endopeptidases that can be released from neurons in an activity dependent manner to play a role in varied forms of learning and memory. MMP inhibitors impair hippocampal long term potentiation (LTP), spatial memory, and behavioral correlates of drug addiction. Since MMPs are thought to influence LTP through a beta(1) integrin dependent mechanism, it has been suggested that these enzymes cleave specific substrates to generate integrin binding ligands. In previously published work, we have shown that neuronal activity stimulates rapid MMP dependent shedding of intercellular adhesion molecule-5 (ICAM-5), a synaptic adhesion molecule expressed on dendrites of the telencephalon. We have also shown that the ICAM-5 ectodomain can interact with beta(1) integrins to stimulate integrin dependent phosphorylation of cofilin, an event that occurs with dendritic spine maturation and LTP. In the current study, we investigate the potential for the ICAM-5 ectodomain to stimulate changes in alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor (AMPAR) dependent glutamatergic transmission. Single cell recordings show that the ICAM-5 ectodomain stimulates an increase in the frequency, but not the amplitude, of AMPA mini excitatory post synaptic currents (mEPSCs). With biotinylation and precipitation assays, we also show that the ICAM-5 ectodomain stimulates an increase in membrane levels of GluA1, but not GluA2, AMPAR subunits. In addition, we observe an ICAM-5 associated increase in GluA1 phosphorylation at serine 845. Concomitantly, ICAM-5 affects an increase in GluA1 surface staining along dendrites without affecting an increase in dendritic spine number. Together these data are consistent with the possibility that soluble ICAM-5 increases glutamatergic transmission and that post-synaptic changes, including increased phosphorylation and dendritic insertion of GluA1, could contribute. We suggest that future studies are warranted to determine whether ICAM-5 is one of a select group of synaptic CAMs whose shedding contributes to MMP dependent effects on learning and memory.	[Lonskaya, Irina; Chung, Andrew; Lee, Taehee; Hoe, Hyang-Sook; Lim, Seung T.; Conant, Katherine] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Partridge, John; Vicini, Stefano] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Partridge, John; Lalchandani, Rupa R.; Vicini, Stefano; Hoe, Hyang-Sook; Lim, Seung T.; Conant, Katherine] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University	Conant, K (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	kec84@georgetown.edu		Vicini, Stefano/0000-0001-8671-5194; Tuan, Rupa Lalchandani/0000-0002-2525-4993	National Multiple Sclerosis Society; National Institutes of Mental Health [MH096822]; von Matsch Professorship in Neurological diseases; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH096822] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); von Matsch Professorship in Neurological diseases; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the National Multiple Sclerosis Society, the National Institutes of Mental Health (MH096822), and the von Matsch Professorship in Neurological diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson T, 2008, J NEUROPHYSIOL, V100, P2605, DOI 10.1152/jn.90476.2008; Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Alenghat FJ, 2009, J CELL BIOCHEM, V106, P529, DOI 10.1002/jcb.22001; Bajor M, 2013, NEUROCHEM RES, V38, P1113, DOI 10.1007/s11064-012-0919-6; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bernard-Trifilo JA, 2005, J NEUROCHEM, V93, P834, DOI 10.1111/j.1471-4159.2005.03062.x; Bilousova TV, 2006, J NEUROCHEM, V97, P44, DOI 10.1111/j.1471-4159.2006.03701.x; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Brown TE, 2008, SYNAPSE, V62, P886, DOI 10.1002/syn.20562; Brown Travis E, 2007, Learn Mem, V14, P214, DOI 10.1101/lm.476207; Chan CS, 2006, J NEUROSCI, V26, P223, DOI 10.1523/JNEUROSCI.4110-05.2006; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Conant K, 2012, CURR HIV RES, V10, P384, DOI 10.2174/157016212802138733; Conant K, 2011, J NEUROCHEM, V118, P521, DOI 10.1111/j.1471-4159.2010.07153.x; Dumanis SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017203; Dziembowska M, 2012, J NEUROSCI, V32, P14538, DOI 10.1523/JNEUROSCI.6028-11.2012; Emond MR, 2010, J PHYSIOL-LONDON, V588, P1929, DOI 10.1113/jphysiol.2010.187229; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Goel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018264; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Howell MD, 2012, NEUROSCIENCE, V217, P6, DOI 10.1016/j.neuroscience.2012.05.034; Huang Z, 2006, J NEUROSCI, V26, P11208, DOI 10.1523/JNEUROSCI.3526-06.2006; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kerrisk ME, 2013, J NEUROSCI, V33, P6742, DOI 10.1523/JNEUROSCI.0528-13.2013; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Larsen PH, 2006, J NEUROSCI, V26, P2207, DOI 10.1523/JNEUROSCI.1880-05.2006; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee KJ, 2010, NEUROSCIENCE, V169, P344, DOI 10.1016/j.neuroscience.2010.04.078; Lee KFH, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/704103; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Meighan PC, 2007, J NEUROCHEM, V102, P2085, DOI 10.1111/j.1471-4159.2007.04682.x; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Milward EA, 2007, J NEUROIMMUNOL, V187, P9, DOI 10.1016/j.jneuroim.2007.04.010; Mortillo S, 2012, J COMP NEUROL, V520, P2041, DOI 10.1002/cne.23027; MURASE K, 1989, NEUROSCI LETT, V103, P56, DOI 10.1016/0304-3940(89)90485-0; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Ning L, 2013, J CELL SCI, V126, P77, DOI 10.1242/jcs.106674; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Partridge JG, 2009, J NEUROPHYSIOL, V102, P3038, DOI 10.1152/jn.00272.2009; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Pozo K, 2012, P NATL ACAD SCI USA, V109, P1323, DOI 10.1073/pnas.1113736109; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Szepesi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063314; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Van Hove I, 2012, J NEUROCHEM, V123, P203, DOI 10.1111/j.1471-4159.2012.07900.x; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Warren MS, 2012, J NEUROSCI, V32, P2824, DOI 10.1523/JNEUROSCI.3942-11.2012; Wiera G, 2013, HIPPOCAMPUS, V23, P529, DOI 10.1002/hipo.22112; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213	74	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69136	10.1371/journal.pone.0069136	http://dx.doi.org/10.1371/journal.pone.0069136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844251	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000184
J	Ma, X; Wehland, M; Aleshcheva, G; Hauslage, J; Wasser, K; Hemmersbach, R; Infanger, M; Bauer, J; Grimm, D				Ma, Xiao; Wehland, Markus; Aleshcheva, Ganna; Hauslage, Jens; Wasser, Kai; Hemmersbach, Ruth; Infanger, Manfred; Bauer, Johann; Grimm, Daniela			Interleukin-6 Expression under Gravitational Stress Due to Vibration and Hypergravity in Follicular Thyroid Cancer Cells	PLOS ONE			English	Article							RANDOM POSITIONING MACHINE; PROTEIN-KINASE-C; GENE-EXPRESSION; ENDOTHELIAL-CELLS; GROWTH-FACTOR; SIMULATED MICROGRAVITY; SIGNALING PATHWAYS; PARABOLIC FLIGHT; IL-6 EXPRESSION; CARCINOMA CELLS	It is known that exposing cell lines in vitro to parabolic flights changes their gene expression and protein production patterns. Parabolic flights and spaceflight in general are accompanied by transient hypergravity and vibration, which may impact the cells and therefore, have to be considered too. To estimate the possible impact of transient hypergravity and vibration, we investigated the effects of these forces separately using dedicated ground-based facilities. We placed follicular thyroid ML-1 and CGTH W-1 cancer cells in a specific centrifuge (MuSIC Multi Sample Incubator Centrifuge; SAHC Short Arm Human Centrifuge) simulating the hypergravity phases that occur during one (P1) and 31 parabolas (P31) of parabolic flights, respectively. On the Vibraplex device, the same cell lines were treated with vibration waves corresponding to those that occur during a whole parabolic flight lasting for two hours. After the various treatments, cells were harvested and analyzed by quantitative real-time PCR, focusing on the genes involved in forming (ACTB, MYO9, TUBB, VIM, TLN1, and ITGB1) and modulating (EZR, RDX, and MSN) the cytoskeleton, as well as those encoding growth factors (EGF, CTGF, IL6, and IL8) or protein kinases (PRKAA1 and PRKCA). The analysis revealed alterations in several genes in both cell lines; however, fewer genes were affected in ML-1 than CGTH W-1 cells. Interestingly, IL6 was the only gene whose expression was changed in both cell lines by each treatment, while PKCA transcription remained unaffected in all experiments. We conclude that a PKCa-independent mechanism of IL6 gene activation is very sensitive to physical forces in thyroid cells cultured in vitro as monolayers.	[Ma, Xiao; Grimm, Daniela] Aarhus Univ, Inst Biomed, Aarhus, Denmark; [Wehland, Markus; Aleshcheva, Ganna; Infanger, Manfred; Grimm, Daniela] Otto Von Guericke Univ, Clin Plast Aesthet & Hand Surg, Magdeburg, Germany; [Hauslage, Jens; Wasser, Kai; Hemmersbach, Ruth] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Bauer, Johann] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Aarhus University; Otto von Guericke University; Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society	Grimm, D (corresponding author), Aarhus Univ, Inst Biomed, Aarhus, Denmark.	daniela.grimm@farm.au.dk		Grimm, Daniela/0000-0002-4991-3105; Wehland, Markus/0000-0002-8160-859X; Hauslage, Jens/0000-0003-2184-7000	German Space Agency DLR [50WB1124]; European Space Agency [CORA-GBF-2010-203, 4000102119]; Aarhus University, Denmark	German Space Agency DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); European Space Agency(European Space AgencyEuropean Commission); Aarhus University, Denmark	This study was supported by the German Space Agency DLR (BMWi grant 50WB1124), as well as by the European Space Agency (ESA grant CORA-GBF-2010-203 with contract number 4000102119) and Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust G, 1996, EXP CLIN ENDOCR DIAB, V104, P64, DOI 10.1055/s-0029-1211705; Bin Kwon Y, 2007, J DERMATOL SCI, V46, P91, DOI 10.1016/j.jdermsci.2007.01.007; Bordin L, 2003, BIOCHEMISTRY-US, V42, P4485, DOI 10.1021/bi026842n; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Chung KF, 2006, CURR DRUG TARGETS, V7, P675, DOI 10.2174/138945006777435263; Copland IB, 2007, J CELL PHYSIOL, V210, P133, DOI 10.1002/jcp.20840; Crenshaw HC, 1996, EXP CELL RES, V227, P285, DOI 10.1006/excr.1996.0278; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Goretzki P E, 1990, Recent Results Cancer Res, V118, P48; Grimm D, 1997, THYROID, V7, P859, DOI 10.1089/thy.1997.7.859; GRIMM D, 1995, THYROID, V5, P155, DOI 10.1089/thy.1995.5.155; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Grosse J, 2012, FASEB J, V26, P5124, DOI 10.1096/fj.12-215749; Grosse J, 2012, FASEB J, V26, P639, DOI 10.1096/fj.11-194886; GRUBECKLOEBENSTEIN B, 1989, CLIN EXP IMMUNOL, V77, P324; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Infanger M, 2007, CARDIOVASC PATHOL, V16, P291, DOI 10.1016/j.carpath.2007.04.001; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; Lin JD, 1996, J SURG ONCOL, V63, P112, DOI 10.1002/(SICI)1096-9098(199610)63:2<112::AID-JSO8>3.3.CO;2-4; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064402; Ma X, 2012, ELECTROPHORESIS, V33, P1349, DOI 10.1002/elps.201100598; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; Park CC, 2009, EXPERT REV PROTEOMIC, V6, P243, DOI 10.1586/EPR.09.46; Pietsch J, 2013, INT J MOL SCI, V14, P1164, DOI 10.3390/ijms14011164; Pietsch J, 2012, PROTEOMICS, V12, P2539, DOI 10.1002/pmic.201200070; Pietsch J, 2011, PROTEOMICS, V11, P2095, DOI 10.1002/pmic.201000817; Pietsch J, 2011, MICROGRAVITY SCI TEC, V23, P381, DOI 10.1007/s12217-011-9258-5; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Riecke K, 2002, ARCH TOXICOL, V76, P360, DOI 10.1007/s00204-002-0338-6; Rothermund L, 2002, AM J HYPERTENS, V15, P644, DOI 10.1016/S0895-7061(02)02956-4; Schmidt W, 2004, MICROGRAVITY SCI TEC, V15, P42, DOI 10.1007/BF02870951; Schonberger J, 2000, J MOL MED, V78, P102, DOI 10.1007/s001090000085; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sugihara E, 2013, INT J CANCER, V132, P1249, DOI 10.1002/ijc.27961; Szabo-Fresnais N, 2008, MOL CELL ENDOCRINOL, V284, P28, DOI 10.1016/j.mce.2007.12.017; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; Wehland M, 2013, CELL PHYSIOL BIOCHEM, V31, P432, DOI 10.1159/000343380; Wise GE, 2003, J DENT RES, V82, P298, DOI 10.1177/154405910308200411; Zampetaki A, 2005, AM J PHYSIOL-HEART C, V288, pH2946, DOI 10.1152/ajpheart.00919.2004	47	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68140	10.1371/journal.pone.0068140	http://dx.doi.org/10.1371/journal.pone.0068140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844163	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000139
J	Schabussova, I; Ul-Haq, O; Hoflehner, E; Akgun, J; Wagner, A; Loupal, G; Joachim, A; Ruttkowski, B; Maizels, RM; Wiedermann, U				Schabussova, Irma; Ul-Haq, Onisa; Hoflehner, Elisabeth; Akguen, Johnnie; Wagner, Angelika; Loupal, Gerhard; Joachim, Anja; Ruttkowski, Baerbel; Maizels, Rick M.; Wiedermann, Ursula			Oesophagostomum dentatum Extract Modulates T Cell-Dependent Immune Responses to Bystander Antigens and Prevents the Development of Allergy in Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLACEBO-CONTROLLED TRIAL; TRICHURIS-SUIS THERAPY; SKIN-TEST REACTIVITY; HELMINTH INFECTION; HUMORAL RESPONSES; HUMAN ONCHOCERCIASIS; AIRWAY INFLAMMATION; TETANUS VACCINATION; HOOKWORM INFECTION	One third of the human population is currently infected by one or more species of parasitic helminths. Certain helminths establish long-term chronic infections resulting in a modulation of the host's immune system with attenuated responsiveness to "bystander" antigens such as allergens or vaccines. In this study we investigated whether parasite-derived products suppress the development of allergic inflammation in a mouse model. We show that extract derived from adult male Oesophagostomum dentatum (eMOD) induced Th2 and regulatory responses in BALB/c mice. Stimulation of bone marrow-derived dendritic cells induced production of regulatory cytokines IL-10 and TGF-beta. In a mouse model of birch pollen allergy, co-administration of eMOD with sensitizing allergen Bet v 1 markedly reduced the production of allergen-specific antibodies in serum as well as IgE-dependent basophil degranulation. Furthermore, eMOD prevented the development of airway inflammation, as demonstrated by attenuation of bronchoalveolar lavages eosinophil influx, peribronchial inflammatory infiltrate, and mucus secretion in lungs and IL-4 and IL-5 levels in lung cell cultures. Reduced secretion of Th2-related cytokines by birch pollen-re-stimulated splenocytes and mesenteric lymph node cells was observed in eMOD-treated/sensitized and challenged mice in comparison to sensitized and challenged controls. The suppressive effects of eMOD were heat-stable. Immunization with model antigens in the presence of eMOD reduced production of antibodies to thymus-dependent but not to thymus-independent antigen, suggesting that suppression of the immune responses by eMOD was mediated by interference with antigen presenting cell or T helper cell function but did not directly suppress B cell function. In conclusion, we have shown that eMOD possesses immunomodulatory properties and that heat-stable factors in eMOD are responsible for the dramatic suppression of allergic responses in a mouse model of type I allergy. The identification and characterization of parasite-derived immune-modulating molecules might have potential for designing novel prophylactic/therapeutic strategies for immune-mediated diseases.	[Schabussova, Irma; Ul-Haq, Onisa; Hoflehner, Elisabeth; Akguen, Johnnie; Wagner, Angelika; Wiedermann, Ursula] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Loupal, Gerhard] Univ Vet Med, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria; [Joachim, Anja; Ruttkowski, Baerbel] Univ Vet Med, Inst Parasitol, Vienna, Austria; [Maizels, Rick M.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Edinburgh	Schabussova, I (corresponding author), Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	irma.schabussova@meduniwien.ac.at		Wagner, Angelika/0000-0002-5447-9534; Joachim, Anja/0000-0003-3082-6885; Wiedermann, Ursula/0000-0002-1302-3223; Schabussova, Irma/0000-0002-2109-2640	Austrian Science Fund [F46]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was financially supported by SFB grant "Towards prevention and therapy of allergy", F46 from Austrian Science Fund. The Austrian Science Fund had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara-Neves NM, 2012, J ALLERGY CLIN IMMUN, V129, P359, DOI 10.1016/j.jaci.2011.09.015; Bager P, 2012, J ALLERGY CLIN IMMUN, V125, pe121; Baumgart M, 2006, J IMMUNOL, V176, P5374, DOI 10.4049/jimmunol.176.9.5374; Boitelle A, 2005, INT J PARASITOL, V35, P765, DOI 10.1016/j.ijpara.2005.02.013; Bourke CD, 2012, CLIN EXP ALLERGY, V42, P1582, DOI 10.1111/j.1365-2222.2012.04063.x; Cardoso LS, 2010, CLIN EXP IMMUNOL, V160, P266, DOI 10.1111/j.1365-2249.2009.04084.x; Cooper PJ, 1999, INFECT IMMUN, V67, P5951, DOI 10.1128/IAI.67.11.5951-5957.1999; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Doetze A, 2000, INT IMMUNOL, V12, P623, DOI 10.1093/intimm/12.5.623; Donnelly S, 2006, CHEM IMMUNOL ALLERGY, V90, P45, DOI 10.1159/000088880; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x; Esen M, 2012, VACCINE; Feary J, 2009, CLIN EXP ALLERGY, V39, P1060, DOI 10.1111/j.1365-2222.2009.03187.x; Feary JR, 2010, CLIN EXP ALLERGY, V40, P299, DOI 10.1111/j.1365-2222.2009.03433.x; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; Flohr C, 2010, CLIN EXP ALLERGY, V40, P131, DOI 10.1111/j.1365-2222.2009.03346.x; Flohr C, 2009, CLIN EXP ALLERGY, V39, P20, DOI 10.1111/j.1365-2222.2008.03134.x; Flohr C, 2006, J ALLERGY CLIN IMMUN, V118, P1305, DOI 10.1016/j.jaci.2006.08.035; Gasser RB, 2007, BIOTECHNOL ADV, V25, P281, DOI 10.1016/j.biotechadv.2007.01.008; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hartgers FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000227; Hartmann W, 2012, EXP PARASITOL; Hartmann W, 2011, J IMMUNOL, V187, P4088, DOI 10.4049/jimmunol.1004136; Hufnagl K, 2003, CLIN EXP IMMUNOL, V133, P170, DOI 10.1046/j.1365-2249.2003.02210.x; Ilic N, 2011, PARASITE IMMUNOL, V33, P572, DOI 10.1111/j.1365-3024.2011.01322.x; Joachim A, 2001, PARASITOL INT, V50, P41, DOI 10.1016/S1383-5769(00)00070-2; Joachim A, 1999, PARASITOLOGY, V119, P491, DOI 10.1017/S0031182099004965; Johnston MJG, 2010, INFECT IMMUN, V78, P1364, DOI 10.1128/IAI.01349-08; KILIAN HD, 1989, TROP MED PARASITOL, V40, P445; Kuijk LM, 2012, MOL IMMUNOL, V51, P210, DOI 10.1016/j.molimm.2012.03.020; Lack G, 1996, J IMMUNOL, V157, P1432; Lee KH, 2008, VET PARASITOL, V156, P216, DOI 10.1016/j.vetpar.2008.06.016; LYNCH NR, 1993, J ALLERGY CLIN IMMUN, V92, P404, DOI 10.1016/0091-6749(93)90119-Z; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; McSorley HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024092; McSorley HJ, 2012, EUR J IMMUNOL; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Noland GS, 2010, VACCINE, V28, P2917, DOI 10.1016/j.vaccine.2010.02.055; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Randolph DA, 1999, J IMMUNOL, V162, P2375; Rodrigues LC, 2008, CLIN EXP ALLERGY, V38, P1769, DOI 10.1111/j.1365-2222.2008.03027.x; ROUGEMONT A, 1977, LANCET, V1, P309; Schabussova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040271; Schabussova I, 2011, VACCINE, V29, P1981, DOI 10.1016/j.vaccine.2010.12.101; Schabussova I, 2008, CURR OPIN ALLERGY CL, V8, P557, DOI 10.1097/ACI.0b013e328317b88b; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Slotved HC, 1996, VET PARASITOL, V63, P237, DOI 10.1016/0304-4017(95)00916-7; Smits HH, 2010, CURR ALLERGY ASTHM R, V10, P3, DOI 10.1007/s11882-009-0085-3; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Taylor MD, 2009, EUR J IMMUNOL, V39, P192, DOI 10.1002/eji.200838727; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; van Riet E, 2007, J INFECT DIS, V196, P1671, DOI 10.1086/522010; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128; Zheng XP, 2008, J NEUROIMMUNOL, V194, P107, DOI 10.1016/j.jneuroim.2007.12.001	64	21	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67544	10.1371/journal.pone.0067544	http://dx.doi.org/10.1371/journal.pone.0067544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844022	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000052
J	Wang, ZJ; Dong, YC; Desneux, N; Niu, CY				Wang, Zhijian; Dong, Yongcheng; Desneux, Nicolas; Niu, Changying			RNAi Silencing of the HaHMG-CoA Reductase Gene Inhibits Oviposition in the Helicoverpa armigera Cotton Bollworm	PLOS ONE			English	Article							COENZYME-A REDUCTASE; JUVENILE-HORMONE BIOSYNTHESIS; BOMBYX-MORI; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; PHEROMONE BIOSYNTHESIS; MEVALONATE PATHWAY; MOLECULAR-CLONING; GERMAN-COCKROACH; IPS-PINI; EXPRESSION	RNA interference (RNAi) has considerable promise for developing novel pest control techniques, especially because of the threat of the development of resistance against current strategies. For this purpose, the key is to select pest control genes with the greatest potential for developing effective pest control treatments. The present study demonstrated that the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase; HMGR) gene is a potential target for insect control using RNAi. HMGR is a key enzyme in the mevalonate pathway in insects. A complete cDNA encoding full length HMGR (encoding an 837-aa protein) was cloned from Helicoverpa armigera (Lepidoptera: Noctuidae). The HaHMGR (H. armigera HMGR) knockdown using systemic RNAi in vivo inhibited the fecundity of the females, effectively inhibited ovipostion, and significantly reduced vitellogenin (Vg) mRNA levels. Moreover, the oviposition rate of the female moths was reduced by 98% by silencing HaHMGR compared to the control groups. One-pair experiments showed that both the proportions of valid mating and fecundity were zero. Furthermore, the HaHMGR-silenced females failed to lay eggs (approximate 99% decrease in oviposition) in the semi-field cage performance. The present study demonstrated the potential implications for developing novel pest management strategies using HaHMGR RNAi in the control of H. armigera and other insect pests.	[Wang, Zhijian; Dong, Yongcheng; Niu, Changying] Huazhong Agr Univ, Hubei Key Lab Insect Resource Applicat & Sustaina, Plant Sci & Technol Coll, Wuhan, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France	Huazhong Agricultural University; INRAE	Niu, CY (corresponding author), Huazhong Agr Univ, Hubei Key Lab Insect Resource Applicat & Sustaina, Plant Sci & Technol Coll, Wuhan, Peoples R China.	niuchangying88@163.com	Dong, YongCheng/ABG-7107-2021; Desneux, Nicolas/J-6262-2013		National Natural Science Foundation of China [IBN-31071690]; Fundamental Research Funds for the Central Universities [2011PY055]; International Atomic Energy Agency [16015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); International Atomic Energy Agency(International Atomic Energy Agency)	This study was financially supported by the National Natural Science Foundation of China (grant IBN-31071690), the Fundamental Research Funds for the Central Universities (2011PY055), and International Atomic Energy Agency (via Research Contract No. 16015 to CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; BJOSTAD LB, 1984, INSECT BIOCHEM, V14, P275, DOI 10.1016/0020-1790(84)90060-X; Bochar DA, 1999, MOL GENET METAB, V66, P122, DOI 10.1006/mgme.1998.2786; Burse A, 2008, INSECT BIOCHEM MOLEC, V38, P76, DOI 10.1016/j.ibmb.2007.09.006; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; Duportets L, 2000, INSECT MOL BIOL, V9, P385, DOI 10.1046/j.1365-2583.2000.00200.x; Eigenheer AL, 2003, GENE, V316, P127, DOI 10.1016/S0378-1119(03)00749-2; FEYEREISEN R, 1987, MOL CELL ENDOCRINOL, V53, P227, DOI 10.1016/0303-7207(87)90178-X; FEYEREISEN R, 1987, J BIOL CHEM, V262, P2676; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FONAGY A, 1992, J PESTIC SCI, V17, P47; GERTLER FB, 1988, MOL CELL BIOL, V8, P2713, DOI 10.1128/MCB.8.7.2713; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Keeling CI, 2004, NATURWISSENSCHAFTEN, V91, P324, DOI 10.1007/s00114-004-0523-y; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MARTINEZGONZALEZ J, 1993, EUR J BIOCHEM, V213, P233, DOI 10.1111/j.1432-1033.1993.tb17753.x; MONGER DJ, 1982, J BIOL CHEM, V257, P1921; NIJHOUT HF, 1994, INSECT HORMONES, P267; OLENDER EH, 1992, J BIOL CHEM, V267, P4223; OZAWA R, 1995, REGUL PEPTIDES, V57, P319, DOI 10.1016/0167-0115(95)00045-D; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Shahraki GH, 2011, NEOTROP ENTOMOL, V40, P607, DOI 10.1590/S1519-566X2011000500013; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Sheng ZT, 2008, ARCH INSECT BIOCHEM, V69, P143, DOI 10.1002/arch.20268; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tittiger C, 1999, CELL MOL LIFE SCI, V55, P121, DOI 10.1007/s000180050275; Tittiger C, 2003, MOL CELL ENDOCRINOL, V199, P11, DOI 10.1016/S0303-7207(02)00358-1; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Zapata R, 2003, PEST MANAG SCI, V59, P1111, DOI 10.1002/ps.736; Zapata R, 2002, ARCH INSECT BIOCHEM, V49, P177, DOI 10.1002/arch.10018; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	37	40	47	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67732	10.1371/journal.pone.0067732	http://dx.doi.org/10.1371/journal.pone.0067732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844078	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000087
J	Tagliabue, M; McIntyre, J				Tagliabue, Michele; McIntyre, Joseph			When Kinesthesia Becomes Visual: A Theoretical Justification for Executing Motor Tasks in Visual Space	PLOS ONE			English	Article							MULTISENSORY SPATIAL REPRESENTATIONS; POSTERIOR CORPUS-CALLOSUM; EYE-HAND COORDINATION; REFERENCE FRAMES; PROPRIOCEPTIVE LOCALIZATION; INTERHEMISPHERIC-TRANSFER; POSITION-INFORMATION; INTERMANUAL TRANSFER; SENSORIMOTOR CONTROL; SENSORY INTEGRATION	Several experimental studies in the literature have shown that even when performing purely kinesthetic tasks, such as reaching for a kinesthetically felt target with a hidden hand, the brain reconstructs a visual representation of the movement. In our previous studies, however, we did not observe any role of a visual representation of the movement in a purely kinesthetic task. This apparent contradiction could be related to a fundamental difference between the studied tasks. In our study subjects used the same hand to both feel the target and to perform the movement, whereas in most other studies, pointing to a kinesthetic target consisted of pointing with one hand to the finger of the other, or to some other body part. We hypothesize, therefore, that it is the necessity of performing inter-limb transformations that induces a visual representation of purely kinesthetic tasks. To test this hypothesis we asked subjects to perform the same purely kinesthetic task in two conditions: INTRA and INTER. In the former they used the right hand to both perceive the target and to reproduce its orientation. In the latter, subjects perceived the target with the left hand and responded with the right. To quantify the use of a visual representation of the movement we measured deviations induced by an imperceptible conflict that was generated between visual and kinesthetic reference frames. Our hypothesis was confirmed by the observed deviations of responses due to the conflict in the INTER, but not in the INTRA, condition. To reconcile these observations with recent theories of sensori-motor integration based on maximum likelihood estimation, we propose here a new model formulation that explicitly considers the effects of covariance between sensory signals that are directly available and internal representations that are 'reconstructed' from those inputs through sensori-motor transformations.	[Tagliabue, Michele; McIntyre, Joseph] Univ Paris 05, Inst Neurosci & Cognit, Sorbonne Paris Cite, Ctr Etud Sensorimotricite,CNRS,UMR 8194, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Tagliabue, M (corresponding author), Univ Paris 05, Inst Neurosci & Cognit, Sorbonne Paris Cite, Ctr Etud Sensorimotricite,CNRS,UMR 8194, Paris, France.	michele.tagliabue@parisdescartes.fr	McIntyre, Joseph/K-6395-2015	McIntyre, Joseph/0000-0003-4974-4257	French space agency (Centre national d'etudes spatiales)	French space agency (Centre national d'etudes spatiales)(Centre National D'etudes Spatiales)	This work was supported by the French space agency (Centre national d'etudes spatiales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Baud-Bovy G, 1998, J NEUROSCI, V18, P1528; Baud-Bovy G, 2004, EXP BRAIN RES, V157, P197, DOI 10.1007/s00221-004-1833-1; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Burns JK, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00221; Charron JF, 1996, NEUROPSYCHOLOGIA, V34, P873, DOI 10.1016/0028-3932(96)00002-4; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003; Fabri M, 2001, J COGNITIVE NEUROSCI, V13, P1071, DOI 10.1162/089892901753294365; Fiehler K, 2010, EXP BRAIN RES, V203, P485, DOI 10.1007/s00221-010-2251-1; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Ghahramani Z, 1997, ADV PSYCHOL, V119, P117; Goble DJ, 2008, J NEUROPHYSIOL, V99, P3063, DOI 10.1152/jn.90259.2008; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Jones SAH, 2012, NEUROPSYCHOLOGIA, V50, P1462, DOI 10.1016/j.neuropsychologia.2012.02.031; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Luyat M, 2005, NEUROSCI LETT, V385, P215, DOI 10.1016/j.neulet.2005.05.044; McGuire LMM, 2009, NAT NEUROSCI, V12, P1056, DOI 10.1038/nn.2357; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; McIntyre J, 2008, J NEUROSCI, V28, P1246, DOI 10.1523/JNEUROSCI.2066-07.2008; MonWilliams M, 1997, P ROY SOC B-BIOL SCI, V264, P1007, DOI 10.1098/rspb.1997.0139; Nefs HT, 2005, EXP BRAIN RES, V163, P123, DOI 10.1007/s00221-005-2227-8; O'Reilly JX, 2012, EUR J NEUROSCI, V35, P1169, DOI 10.1111/j.1460-9568.2012.08010.x; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Rao AK, 2001, EXP BRAIN RES, V138, P438, DOI 10.1007/s002210100717; Sabes PN, 2011, PROG BRAIN RES, V191, P195, DOI 10.1016/B978-0-444-53752-2.00004-7; Sarlegna FR, 2007, EXP BRAIN RES, V176, P267, DOI 10.1007/s00221-006-0613-5; Schlicht EJ, 2007, J NEUROPHYSIOL, V97, P4203, DOI 10.1152/jn.00160.2007; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Soechting J F, 1990, J Cogn Neurosci, V2, P32, DOI 10.1162/jocn.1990.2.1.32; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Sternad D, 2007, EXP BRAIN RES, V176, P559, DOI 10.1007/s00221-006-0640-2; Tagliabue M, 2012, NEUROSCI LETT, V513, P78, DOI 10.1016/j.neulet.2012.02.011; Tagliabue M, 2011, J NEUROSCI, V31, P1397, DOI 10.1523/JNEUROSCI.0623-10.2011; TILLERY SIH, 1991, J NEUROSCI, V11, P770; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van der Horst BJ, 2008, EXP BRAIN RES, V187, P491, DOI 10.1007/s00221-008-1390-0; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302	48	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68438	10.1371/journal.pone.0068438	http://dx.doi.org/10.1371/journal.pone.0068438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861903	Green Submitted, gold, Green Published			2022-12-25	WOS:000321425300062
J	Xia, J; Zhang, CR; Zhang, S; Li, FF; Feng, MG; Wang, XW; Liu, SS				Xia, Jun; Zhang, Chang-Rong; Zhang, Shan; Li, Fang-Fang; Feng, Ming-Guang; Wang, Xiao-Wei; Liu, Shu-Sheng			Analysis of Whitefly Transcriptional Responses to Beauveria bassiana Infection Reveals New Insights into Insect-Fungus Interactions	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; DNA-REPAIR PROTEINS; BEMISIA-TABACI; ENTOMOPATHOGENIC FUNGUS; ABC TRANSPORTER; IMMUNE-RESPONSE; METARHIZIUM-ANISOPLIAE; ACYRTHOSIPHON-PISUM; QUANTITATIVE PCR; ISOCITRATE LYASE	Background: The fungal pathogen, Beauveria bassiana, is an efficient biocontrol agent against a variety of agricultural pests. A thorough understanding of the basic principles of insect-fungus interactions may enable the genetic modification of Beauveria bassiana to enhance its virulence. However, the molecular mechanism of insect response to Beauveria bassiana infection is poorly understood, let alone the identification of fungal virulent factors involved in pathogenesis. Methodology/Principal Findings: Here, next generation sequencing technology was applied to examine the expression of whitefly (Bemisia tabaci) genes in response to the infection of Beauveria bassiana. Results showed that, compared to control, 654 and 1,681 genes were differentially expressed at 48 hours and 72 hours post-infected whiteflies, respectively. Functional and enrichment analyses indicated that the DNA damage stimulus response and drug metabolism were important anti-fungi strategies of the whitefly. Mitogen-activated protein kinase (MAPK) pathway was also likely involved in the whitefly defense responses. Furthermore, the notable suppression of general metabolism and ion transport genes observed in 72 hours post-infected B. tabaci might be manipulated by fungal secreted effectors. By mapping the sequencing tags to B. bassiana genome, we also identified a number of differentially expressed fungal genes between the early and late infection stages. These genes are generally associated with fungal cell wall synthesis and energy metabolism. The expression of fungal cell wall protein genes might play an important role in fungal pathogenesis and the dramatically up-regulated enzymes of carbon metabolism indicate the increasing usage of energy during the fungal infection. Conclusions/Significance: To our knowledge, this is the first report on the molecular mechanism of fungus-whitefly interactions. Our results provide a road map for future investigations on insect-pathogen interactions and genetically modifying the fungus to enhance its efficiency in whitefly control.	[Xia, Jun; Zhang, Chang-Rong; Zhang, Shan; Li, Fang-Fang; Wang, Xiao-Wei; Liu, Shu-Sheng] Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou, Zhejiang, Peoples R China; [Feng, Ming-Guang] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University	Wang, XW (corresponding author), Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou, Zhejiang, Peoples R China.	xwwang@zju.edu.cn; shshliu@zju.edu.cn			Fundamental Research Funds for the Central Universities [2013FZA6013]; National Natural Science Foundation of China [31021003]; National Basic Research Program of China [2009CB119203]; Qianjiang Talent Plan [2011R10012]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Qianjiang Talent Plan	This work was supported by the Fundamental Research Funds for the Central Universities (no. 2013FZA6013), the National Natural Science Foundation of China (31021003), the National Basic Research Program of China (2009CB119203) and the Qianjiang Talent Plan (2011R10012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Alleyne M, 1997, J INSECT PHYSIOL, V43, P143, DOI 10.1016/S0022-1910(96)00090-X; Altincicek B, 2008, INSECT MOL BIOL, V17, P711, DOI 10.1111/j.1365-2583.2008.00835.x; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Boyce JD, 2009, INFECT IMMUN, V77, P1532, DOI 10.1128/IAI.01144-08; Brown J.K., 2007, APSNET FEATUR, V1, P25, DOI [10.1094/APSnetFeature-2007-0107, DOI 10.1094/APSNETFEATURE-2007-0107, DOI 10.1094/APSNETFEATURE-2007-010]; Brown JK, 2002, ADV BOT RES, V36, P65, DOI 10.1016/S0065-2296(02)36059-2; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Chengxiang H, 2011, GENE, V484, P35, DOI 10.1016/j.gene.2011.05.023; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; Collette JR, 2011, CURR OPIN MICROBIOL, V14, P668, DOI 10.1016/j.mib.2011.09.007; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; Daniel C, 2010, J APPL ENTOMOL, V134, P675, DOI 10.1111/j.1439-0418.2009.01486.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Padilla-Guerrero IE, 2011, MICROBIOL-SGM, V157, P199, DOI 10.1099/mic.0.042697-0; Fan YH, 2007, APPL ENVIRON MICROB, V73, P295, DOI 10.1128/AEM.01974-06; Fang WG, 2010, FUNGAL GENET BIOL, V47, P602, DOI 10.1016/j.fgb.2010.03.011; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Faria M, 2001, CROP PROT, V20, P767, DOI 10.1016/S0261-2194(01)00110-7; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gwynn DM, 2005, P ROY SOC B-BIOL SCI, V272, P1803, DOI 10.1098/rspb.2005.3089; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Horowitz AR, 2011, WHITEFLY, BEMISIA TABACI (HOMOPTERA: ALEYRODIDAE) INTERACTION WITH GEMINIVIRUS-INFECTED HOST PLANTS: BEMISIA TABACI, HOST PLANTS AND GEMINIVIRUSES, P293, DOI 10.1007/978-94-007-1524-0_11; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Leshkowitz D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-79; Li JM, 2011, INSECT SCI, V18, P11, DOI 10.1111/j.1744-7917.2010.01386.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu P, 2005, J BACTERIOL, V187, P6039, DOI 10.1128/JB.187.17.6039-6045.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DD, 2008, APPL MICROBIOL BIOT, V81, P515, DOI 10.1007/s00253-008-1695-8; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Nauen R., 2005, Pflanzenschutz-Nachrichten Bayer, V58, P485; Nauen R., 2008, Bayer CropScience Journal, V61, P245; Nelson N, 1999, EMBO J, V18, P4361, DOI 10.1093/emboj/18.16.4361; PENDLAND JC, 1993, J BACTERIOL, V175, P5962, DOI 10.1128/JB.175.18.5962-5969.1993; Perraud AL, 2004, MOL IMMUNOL, V41, P657, DOI 10.1016/j.molimm.2004.04.013; Piper PW, 1997, CELL STRESS CHAPERON, V2, P12, DOI 10.1379/1466-1268(1997)002<0012:HTIPMH>2.3.CO;2; Qin Y, 2010, APPL ENVIRON MICROB, V76, P4611, DOI 10.1128/AEM.00302-10; Saito T, 2005, APPL ENTOMOL ZOOL, V40, P169, DOI 10.1303/aez.2005.169; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Scanga CA, 2004, INFECT IMMUN, V72, P2400, DOI 10.1128/IAI.72.4.2400-2404.2004; Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Serebrov VV, 2006, BIOL BULL+, V33, P581, DOI 10.1134/S1062359006060082; Shi WB, 2009, EXP APPL ACAROL, V48, P229, DOI 10.1007/s10493-009-9238-2; Song JQ, 2011, CELL HOST MICROBE, V9, P115, DOI 10.1016/j.chom.2011.01.011; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Sun D, 2011, B ENTOMOL RES, V1, P1; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tanabe M, 2006, INFECT IMMUN, V74, P3687, DOI 10.1128/IAI.01837-05; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Toledo AV, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3501; Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108; Torrado-Leon E, 2006, MYCOPATHOLOGIA, V162, P411, DOI 10.1007/s11046-006-0077-y; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vassiliou V, 2011, INSECT SCI, V18, P30, DOI 10.1111/j.1744-7917.2010.01387.x; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wall DM, 2005, INFECT IMMUN, V73, P6736, DOI 10.1128/IAI.73.10.6736-6741.2005; Wang CS, 2005, EUKARYOT CELL, V4, P937, DOI 10.1128/EC.4.5.937-947.2005; Wang P, 2010, INSECT SCI, V17, P508, DOI 10.1111/j.1744-7917.2010.01353.x; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wraight SP, 2000, BIOL CONTROL, V17, P203, DOI 10.1006/bcon.1999.0799; Wu M, 2011, INFECT IMMUN, V79, P75, DOI 10.1128/IAI.00815-10; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Yin Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000269; Zibaee A, 2009, BIOCONTROL SCI TECHN, V19, P485, DOI 10.1080/09583150902847127	87	25	29	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68185	10.1371/journal.pone.0068185	http://dx.doi.org/10.1371/journal.pone.0068185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861870	Green Submitted, gold, Green Published			2022-12-25	WOS:000321425300050
J	Herrera, VL; Pasion, KA; Tan, GA; Moran, AM; Ruiz-Opazo, N				Herrera, Victoria L.; Pasion, Khristine A.; Tan, Glaiza A.; Moran, Ann Marie; Ruiz-Opazo, Nelson			Sex-Specific Effects on Spatial Learning and Memory, and Sex-Independent Effects on Blood Pressure of a < 3.3 Mbp Rat Chromosome 2 QTL Region in Dahl Salt-Sensitive Rats	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; COGNITIVE PERFORMANCE; HYPERTENSION; DEMENTIA; NAVIGATION; IMPAIRMENT; RISK; GENE; MICE	Epidemiological studies have consistently found that hypertension is associated with poor cognitive performance. We hypothesize that a putative causal mechanism underlying this association is due to genetic loci affecting both blood pressure and cognition. Consistent with this notion, we reported several blood pressure (BP) quantitative trait loci (QTLs) that co-localized with navigational performance (Nav)-QTLs influencing spatial learning and memory in Dahl rats. The present study investigates a chromosome 2 region harboring BP-f4 and Nav-8 QTLs. We developed two congenic strains, S.R2A and S.R2B introgressing Dahl R-chromosome 2 segments into Dahl S chromosome 2 region spanning BP-f4 and Nav-8 QTLs. Radiotelemetric blood pressure analysis identified only S.R2A congenic rats with lower systolic blood pressure (females: -26.0 mmHg, P = 0.003; males: -30.9 mmHg, P < 1x10(-5)), diastolic blood pressure (females: -21.2 mmHg, P = 0.01; males: -25.7 mmHg, P < 1x10(-5)), and mean arterial pressure (females: -23.9 mmHg, P = 0.004; males: -28.0 mmHg, P < 1x10(-5)) compared with corresponding Dahl S controls, confirming the presence of BP-f4 QTL on rat chromosome 2. The S.R2B congenic segment did not affect blood pressure. Testing of S.R2A, S.R2B, and Dahl S male rats in the Morris water maze (MWM) task revealed significantly decreased spatial navigation performance in S.R2A male congenic rats when compared with Dahl S male controls (P < 0.05). The S.R2B congenic segment did not affect performance of the MWM task in males. The S.R2A female rats did not differ in spatial navigation when compared with Dahl S female controls, indicating that the Nav-8 effect on spatial navigation is male-specific. Our results suggest the existence of a single QTL on chromosome 2 176.6-179.9 Mbp region which affects blood pressure in both males and females and cognition solely in males.	[Herrera, Victoria L.; Pasion, Khristine A.; Tan, Glaiza A.; Moran, Ann Marie; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA	Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA.	nruizo@bu.edu		Ruiz-Opazo, Nelson/0000-0001-8234-1332; Herrera, Victoria/0000-0001-8991-2134	NIH [RO1 HL086532]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086532] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant RO1 HL086532 to N.R-O. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deng AY, 2001, MAMM GENOME, V12, P612, DOI 10.1007/s00335-001-2054-6; Elias MF, 2007, HYPERTENSION, V49, P439, DOI 10.1161/01.HYP.0000256361.68158.24; Fisher PJ, 1999, HUM MOL GENET, V8, P915, DOI 10.1093/hmg/8.5.915; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Freitag MH, 2006, STROKE, V37, P33, DOI 10.1161/01.STR.0000196941.58869.2d; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Guo ZC, 1999, ARCH NEUROL-CHICAGO, V56, P991, DOI 10.1001/archneur.56.8.991; Hebert LE, 2004, NEUROLOGY, V62, P2021, DOI 10.1212/01.WNL.0000129258.93137.4B; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 2008, PHYSIOL GENOMICS, V35, P316, DOI 10.1152/physiolgenomics.00044.2008; Herrera VLM, 2005, PHYSIOL GENOMICS, V23, P257, DOI 10.1152/physiolgenomics.00144.2005; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; Kaneko Y, 2005, PHYSIOL GENOMICS, V20, P157, DOI 10.1152/physiolgenomics.00108.2004; Kilander L, 1998, HYPERTENSION, V31, P780, DOI 10.1161/01.HYP.31.3.780; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Knecht S, 2008, HYPERTENSION, V51, P663, DOI 10.1161/HYPERTENSIONAHA.107.105577; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Ruiz-Opazo N, 2004, MOL MED, V10, P36, DOI 10.2119/2003-00044.Herrera; Ruiz-Opazo N, 2004, PHYSIOL GENOMICS, V16, P329, DOI 10.1152/physiolgenomics.00162.2003; Ruiz-Opazo N, 2004, HYPERTENSION, V43, P797, DOI 10.1161/01.HYP.0000120153.04064.8d; Ruiz-Opazo N, 2006, PHYSIOL GENOMICS, V26, P145, DOI 10.1152/physiolgenomics.00019.2006; Seshadri S, 2001, ARCH INTERN MED, V161, P2343, DOI 10.1001/archinte.161.19.2343; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67673	10.1371/journal.pone.0067673	http://dx.doi.org/10.1371/journal.pone.0067673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861781	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700020
J	Montrucchio, DP; Cordova, MM; Santos, ARS				Montrucchio, Deise Prehs; Cordova, Marina Machado; Soares Santos, Adair Roberto			Plant Derived Aporphinic Alkaloid S-(+)-Dicentrine Induces Antinociceptive Effect in Both Acute and Chronic Inflammatory Pain Models: Evidence for a Role of TRPA1 Channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; SUBSTANTIA-GELATINOSA NEURONS; ION-CHANNEL; ALPHA-1-ADRENOCEPTOR ANTAGONIST; MOLECULAR-MECHANISMS; COLD; DICENTRINE; CONTRIBUTES; INHIBITION; HYPERALGESIA	S-(+)-Dicentrine is an aporphinic alkaloid found in several plant species, mainly from Lauraceae family, which showed significant antinociceptive activity in an acute model of visceral pain in mice. In this work, we extended the knowledge on the antinociceptive properties of S-(+)-dicentrine and showed that this alkaloid also attenuates mechanical and cold hypersensitivity associated with cutaneous inflammation induced by Complete Freund's Adjuvant in mice. Given orally, S-(+)-dicentrine (100 mg/kg) reversed CFA-induced mechanical hypersensitivity, evaluated as the paw withdrawal threshold to von Frey hairs, and this effect lasted up to 2 hours. S-(+)-Dicentrine also reversed CFA-induced cold hypersensitivity, assessed as the responses to a drop of acetone in the injured paw, but did not reverse the heat hypersensitivity, evaluated as the latency time to paw withdrawal in the hot plate (50 degrees C). Moreover, S-(+)-dicentrine (100 mg/kg, p.o.) was effective in inhibit nociceptive responses to intraplantar injections of cinnamaldehyde, a TRPA1 activator, but not the responses induced by capsaicin, a TRPV1 activator. When administered either by oral or intraplantar routes, S-(+)- dicentrine reduced the licking time (spontaneous nociception) and increased the latency time to paw withdrawal in the cold plate (cold hypersensitivity), both induced by the intraplantar injection of cinnamaldehyde. Taken together, our data adds information about antinociceptive properties of S-(+)-dicentrine in inflammatory conditions, reducing spontaneous nociception and attenuating mechanical and cold hypersensitivity, probably via a TRPA1-dependent mechanism. It also indicates that S-(+)-dicentrine might be potentially interesting in the development of new clinically relevant drugs for the management of persistent pain, especially under inflammatory conditions.	[Montrucchio, Deise Prehs] Univ Fed Parana, Dept Farm, Setor Ciencias Saude, BR-80060000 Curitiba, PR, Brazil; [Montrucchio, Deise Prehs; Soares Santos, Adair Roberto] Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97119900 Santa Maria, RS, Brazil; [Montrucchio, Deise Prehs; Cordova, Marina Machado; Soares Santos, Adair Roberto] Univ Fed Santa Catarina, Lab Neurobiol Dor & Inflamacao, Dept Ciencias Fisiol, Florianopolis, SC, Brazil	Universidade Federal do Parana; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Catarina (UFSC)	Santos, ARS (corresponding author), Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97119900 Santa Maria, RS, Brazil.	adair.santos@ufsc.br	Santos, Adair/C-5565-2013	Santos, Adair/0000-0002-6435-4698	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC), Brazil	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES) and Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade EL, 2012, PHARMACOL THERAPEUT, V133, P189, DOI 10.1016/j.pharmthera.2011.10.008; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen KS, 1997, J NAT PROD, V60, P645, DOI 10.1021/np9700735; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Cordova MM, 2011, NEUROSCI LETT, V495, P173, DOI 10.1016/j.neulet.2011.02.007; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Ferreira J, 2001, NEUROPHARMACOLOGY, V41, P1006, DOI 10.1016/S0028-3908(01)00142-3; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Huang RL, 1998, PLANTA MED, V64, P212, DOI 10.1055/s-2006-957411; Jiang LH, 2011, CURR DRUG TARGETS, V12, P724; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Klafke JZ, 2012, NEUROSCIENCE, V222, P136, DOI 10.1016/j.neuroscience.2012.07.022; Knowlton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025894; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; KONDO Y, 1990, J PHARMACOBIO-DYNAM, V13, P426, DOI 10.1248/bpb1978.13.426; Konkimalla VB, 2010, BIOCHEM PHARMACOL, V79, P1092, DOI 10.1016/j.bcp.2009.11.025; Kosugi M, 2007, J NEUROSCI, V27, P4443, DOI 10.1523/JNEUROSCI.0557-07.2007; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Luszczki JJ, 2007, PROG NEURO-PSYCHOPH, V31, P529, DOI 10.1016/j.pnpbp.2006.11.020; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Montrucchio DP, 2012, PLANTA MED, V78, P1543, DOI 10.1055/s-0032-1315026; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Palmer JA, 2008, NEUROSCIENCE, V154, P1554, DOI 10.1016/j.neuroscience.2008.04.047; Pertovaara A, 2011, EUR J PHARMACOL, V666, P1, DOI 10.1016/j.ejphar.2011.05.027; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Premkumar LS, 2013, LIFE SCI, V92, P415, DOI 10.1016/j.lfs.2012.08.010; Reeh P W, 2001, Curr Opin Pharmacol, V1, P45, DOI 10.1016/S1471-4892(01)00014-5; Santos ARS, 1999, J PHARMACOL EXP THER, V289, P417; Stevigny C., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P173, DOI 10.2174/1568011053174864; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 2009, BRAIN RES REV, V60, P2, DOI 10.1016/j.brainresrev.2008.12.018; TENG CM, 1991, BRIT J PHARMACOL, V104, P651, DOI 10.1111/j.1476-5381.1991.tb12484.x; Tsai TH, 2008, J NAT PROD, V71, P289, DOI 10.1021/np070564h; Uta D, 2010, EUR J NEUROSCI, V31, P1960, DOI 10.1111/j.1460-9568.2010.07255.x; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Weng YQ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-75; YU SM, 1993, BRIT J PHARMACOL, V108, P1055, DOI 10.1111/j.1476-5381.1993.tb13505.x; YU SM, 1992, BRIT J PHARMACOL, V106, P797, DOI 10.1111/j.1476-5381.1992.tb14415.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	55	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67730	10.1371/journal.pone.0067730	http://dx.doi.org/10.1371/journal.pone.0067730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861794	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700029
J	Santiquet, N; Robert, C; Richard, FJ				Santiquet, Nicolas; Robert, Claude; Richard, Francois J.			The Dynamics of Connexin Expression, Degradation and Localisation Are Regulated by Gonadotropins during the Early Stages of In Vitro Maturation of Swine Oocytes	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; CUMULUS CELLS; INTERCELLULAR COMMUNICATION; GENE-EXPRESSION; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; FOLLICULAR DEVELOPMENT; PROTEASOME INHIBITORS; MEIOTIC RESUMPTION; PORCINE OOCYTES	Gap junctional communication (GJC) plays a primordial role in oocyte maturation and meiotic resumption in mammals by directing the transfer of numerous molecules between cumulus cells and the oocyte. Gap junctions are made of connexins (Cx), proteins that regulate GJC in numerous ways. Understanding the dynamic regulation of connexin arrangements during in vitro maturation (IVM) could provide a powerful tool for controlling meiotic resumption and consequently in vitro development of fully competent oocytes. However, physiological events happening during the early hours of IVM may still be elucidated. The present study reports the dynamic regulation of connexin expression, degradation and localization during this stage. Cx43, Cx45 and Cx60 were identified as the main connexins expressed in swine COC. Cx43 and Cx45 transcripts were judged too static to be a regulator of GJC, while Cx43 protein expression was highly responsive to gonadotropins, suggesting that it might be the principal regulator of GJC. In addition, the degradation of Cx43 expressed after 4.5 h of IVM in response to equine chorionic gonadotropin appeared to involve the proteasomal complex. Cx43 localisation appeared to be associated with GJC. Taken together, these results show for the first time that gonadotropins regulate Cx43 protein expression, degradation and localisation in porcine COC during the first several hours of IVM. Regulation of Cx43 may in turn, via GJC, participate in the development of fully competent oocytes.	[Santiquet, Nicolas; Robert, Claude; Richard, Francois J.] Univ Laval, Dept Anim Sci, Ctr Rech Biol Reprod, FSAA, Quebec City, PQ, Canada	Laval University	Richard, FJ (corresponding author), Univ Laval, Dept Anim Sci, Ctr Rech Biol Reprod, FSAA, Quebec City, PQ, Canada.	Francois.Richard@fsaa.ulaval.ca		Robert, Claude/0000-0001-9690-8088; Richard, Francois J./0000-0003-0226-2971	NSERC operating grant	NSERC operating grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC operating grant to Francois J. Richard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert CL, 2001, INTERCELLULAR COMMUN; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Blomstrand F, 1999, NEUROSCIENCE, V92, P255, DOI 10.1016/S0306-4522(98)00738-6; BORNSLAEGER EA, 1985, BIOL REPROD, V33, P698, DOI 10.1095/biolreprod33.3.698; BRISSETTE JL, 1994, P NATL ACAD SCI USA, V91, P6453, DOI 10.1073/pnas.91.14.6453; Cheng Y, 2005, J REPROD DEVELOP, V51, P627, DOI 10.1262/jrd.17035; Conti M, 2012, MOL CELL ENDOCRINOL, V356, P65, DOI 10.1016/j.mce.2011.11.002; Cottrell GT, 2005, BBA-BIOMEMBRANES, V1711, P126, DOI 10.1016/j.bbamem.2004.11.013; Darrow BJ, 1996, CIRC RES, V79, P174, DOI 10.1161/01.RES.79.2.174; DARROW BJ, 1995, CIRC RES, V76, P381, DOI 10.1161/01.RES.76.3.381; Defamie N, 2001, CARCINOGENESIS, V22, P1537, DOI 10.1093/carcin/22.9.1537; deFeijter AW, 1996, MOL CARCINOGEN, V16, P203, DOI 10.1002/(SICI)1098-2744(199608)16:4<203::AID-MC4>3.3.CO;2-F; DEKEL N, 1981, DEV BIOL, V86, P356, DOI 10.1016/0012-1606(81)90193-7; Dermietzel R, 1998, VIRCHOWS ARCH, V432, P177, DOI 10.1007/s004280050153; Dhein S, 2010, N-S ARCH PHARMACOL, V381, P221, DOI 10.1007/s00210-009-0473-1; Elenes S, 2001, BIOPHYS J, V81, P1406, DOI 10.1016/S0006-3495(01)75796-7; Eugenin EA, 2012, J NEUROIMMUNE PHARM, V7, P499, DOI 10.1007/s11481-012-9352-5; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Gershon E, 2008, MOL CELL ENDOCRINOL, V282, P18, DOI 10.1016/j.mce.2007.11.001; Granot I, 1997, MOL REPROD DEV, V47, P231, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;231::AID-MRD1&gt;3.0.CO;2-M; Granot I, 2002, BIOL REPROD, V66, P568, DOI 10.1095/biolreprod66.3.568; GRANOT I, 1994, J BIOL CHEM, V269, P30502; GrazulBilska AT, 1997, BIOL REPROD, V57, P947, DOI 10.1095/biolreprod57.5.947; Grikscheit K, 2008, CELL COMMUN ADHES, V15, P185, DOI 10.1080/15419060802013943; GUAN XJ, 1995, TOXICOL APPL PHARM, V130, P79, DOI 10.1006/taap.1995.1011; Hesketh GG, 2009, J CARDIOVASC PHARM, V54, P263, DOI 10.1097/FJC.0b013e3181ba0811; Itahana K, 1998, ENDOCRINOLOGY, V139, P320, DOI 10.1210/en.139.1.320; Itahana K, 1996, ENDOCRINOLOGY, V137, P5036, DOI 10.1210/en.137.11.5036; Johnson ML, 1999, ENDOCRINE, V10, P43, DOI 10.1385/ENDO:10:1:43; Juneja SC, 1999, BIOL REPROD, V60, P1263, DOI 10.1095/biolreprod60.5.1263; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Kidder GM, 2002, REPRODUCTION, V123, P613, DOI 10.1530/rep.0.1230613; King TJ, 2004, CANCER RES, V64, P7191, DOI 10.1158/0008-5472.CAN-04-0624; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; KOVAL M, 1995, J CELL BIOL, V130, P987, DOI 10.1083/jcb.130.4.987; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 1999, CANCER RES, V59, P4104; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; LARSEN WJ, 1987, DEV BIOL, V122, P61, DOI 10.1016/0012-1606(87)90332-0; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lenhart JA, 1998, BIOL REPROD, V58, P583, DOI 10.1095/biolreprod58.2.583; Luciano AM, 2011, BIOL REPROD; Manthey D, 1999, J BIOL CHEM, V274, P14716, DOI 10.1074/jbc.274.21.14716; MAYERHOFER A, 1995, MOL REPROD DEV, V41, P331, DOI 10.1002/mrd.1080410308; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; Melton CM, 2001, COMP BIOCHEM PHYS B, V130, P43, DOI 10.1016/S1096-4959(01)00403-1; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Nelles E, 1996, P NATL ACAD SCI USA, V93, P9565, DOI 10.1073/pnas.93.18.9565; Nicholson BJ, 2000, BRAZ J MED BIOL RES, V33, P369, DOI 10.1590/S0100-879X2000000400002; Nitta M, 2010, J ANIM SCI, V88, P3269, DOI 10.2527/jas.2009-2781; Norris RP, 2008, DEVELOPMENT, V135, P3229, DOI 10.1242/dev.025494; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Okazaki T, 2003, MOL CELL ENDOCRINOL, V209, P43, DOI 10.1016/j.mce.2003.08.002; Okuma A, 1996, J REPROD FERTILITY, V107; Ortiz-Lazareno PC, 2008, IMMUNOLOGY, V124, P534, DOI 10.1111/j.1365-2567.2008.02806.x; PETTERS RM, 1993, J REPROD FERTIL, P61; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Rackauskas M, 2007, BIOPHYS J, V92, P1952, DOI 10.1529/biophysj.106.099358; Rackauskas M, 2010, MEDICINA-LITHUANIA, V46, P1, DOI 10.3390/medicina46010001; RACOWSKY C, 1989, EUR J CELL BIOL, V49, P244; RACOWSKY C, 1984, J REPROD FERTIL, V72, P107, DOI 10.1530/jrf.0.0720107; ROGERS M, 1990, MOL CARCINOGEN, V3, P335, DOI 10.1002/mc.2940030605; SALMON ED, 1984, J CELL BIOL, V99, P2165, DOI 10.1083/jcb.99.6.2165; Santiquet NW, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099754; Sasseville M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-47; Sasseville M, 2009, MOL ENDOCRINOL, V23, P700, DOI 10.1210/me.2008-0320; SCHILLER PC, 1992, MOL ENDOCRINOL, V6, P1433, DOI 10.1210/me.6.9.1433; Sela-Abramovich S, 2006, ENDOCRINOLOGY, V147, P2280, DOI 10.1210/en.2005-1011; SHERIZLY I, 1988, HUM REPROD, V3, P761, DOI 10.1093/oxfordjournals.humrep.a136780; Shimada M, 2003, BIOL REPROD, V68, P1142, DOI 10.1095/biolreprod.102.010082; Shimada M, 2001, BIOL REPROD, V64, P1255, DOI 10.1095/biolreprod64.4.1255; Shimizu S, 2012, BIOCH BIOPHYSICAL RE; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520; Shu YM, 2008, HUM REPROD, V23, P504, DOI 10.1093/humrep/dem344; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Sommersberg B, 2000, BIOL REPROD, V63, P1661, DOI 10.1095/biolreprod63.6.1661; Sun QY, 2001, MOL REPROD DEV, V59, P192, DOI 10.1002/mrd.1022; Thomas RE, 2004, BIOL REPROD, V70, P548, DOI 10.1095/biolreprod.103.021204; Vaccari S, 2009, BIOL REPROD, V81, P595, DOI 10.1095/biolreprod.109.077768; VALDIMARSSON G, 1993, MOL REPROD DEV, V36, P7, DOI 10.1002/mrd.1080360103; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; Veitch GI, 2004, J CELL SCI, V117, P2699, DOI 10.1242/jcs.01124; Wang Q, 2010, J PHARMACOL EXP THER, V333, P903, DOI 10.1124/jpet.109.165274; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; WIESEN JF, 1993, ENDOCRINOLOGY, V133, P741, DOI 10.1210/en.133.2.741; Wright CS, 2001, REPRODUCTION, V121, P77, DOI 10.1530/rep.0.1210077; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693	93	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68456	10.1371/journal.pone.0068456	http://dx.doi.org/10.1371/journal.pone.0068456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861906	gold, Green Submitted, Green Published			2022-12-25	WOS:000323350700087
J	Wada, N; Hashinaga, T; Otabe, S; Yuan, XH; Kurita, Y; Kakino, S; Ohoki, T; Nakayama, H; Fukutani, T; Tajiri, Y; Yamada, K				Wada, Nobuhiko; Hashinaga, Toshihiko; Otabe, Shuichi; Yuan, Xiaohong; Kurita, Yayoi; Kakino, Satomi; Ohoki, Tsuyoshi; Nakayama, Hitomi; Fukutani, Tomoka; Tajiri, Yuji; Yamada, Kentaro			Selective Modulation of Wnt Ligands and Their Receptors in Adipose Tissue by Chronic Hyperadiponectinemia	PLOS ONE			English	Article							NF-KAPPA-B; BETA-CATENIN; SIGNALING PATHWAY; FRIZZLED HOMOLOGS; CELL-ADHESION; PPAR-GAMMA; ADIPONECTIN; ACTIVATION; DIFFERENTIATION; ADIPOGENESIS	Background: Adiponectin-transgenic mice had many small adipocytes in both subcutaneous and visceral adipose tissues, and showed higher sensitivity to insulin, longer life span, and reduced chronic inflammation. We hypothesized that adiponectin regulates Wnt signaling in adipocytes and thereby modulates adipocyte proliferation and chronic inflammation in adipose tissue. Materials and Methods: We examined the expression of all Wnt ligands and their receptors and the activity of Wnt signaling pathways in visceral adipose tissue from wild-type mice and two lines of adiponectin-transgenic mice. The effects of adiponectin were also investigated in cultured 3T3-L1 cells. Results: The Wnt5b, Wnt6, Frizzled 6 (Fzd6), and Fzd9 genes were up-regulated in both lines of transgenic mice, whereas Wnt1, Wnt2, Wnt5a, Wnt9b, Wnt10b, Wnt11, Fzd1, Fzd2, Fzd4, Fzd7, and the Fzd coreceptor low-density-lipoprotein receptor-related protein 6 (Lrp6) were reduced. There was no difference in total beta-catenin levels in whole-cell extracts, non-phospho-beta-catenin levels in nuclear extracts, or mRNA levels of beta-catenin target genes, indicating that hyperadiponectinemia did not affect canonical Wnt signaling. In contrast, phosphorylated calcium/calmodulin-dependent kinase II (p-CaMKII) and phosphorylated Jun N-terminal kinase (p-JNK) were markedly reduced in adipose tissue from the transgenic mice. The adipose tissue of the transgenic mice consisted of many small cells and had increased expression of adiponectin, whereas cyclooxygenase-2 expression was reduced. Wnt5b expression was elevated in preadipocytes of the transgenic mice and decreased in diet-induced obese mice, suggesting a role in adipocyte differentiation. Some Wnt genes, Fzd genes, and p-CaMKII protein were down-regulated in 3T3-L1 cells cultured with a high concentration of adiponectin. Conclusion: Chronic hyperadiponectinemia selectively modulated the expression of Wnt ligands, Fzd receptors and LRP coreceptors accompanied by the inhibition of the Wnt/Ca2+ and JNK signaling pathways, which may be involved in the altered adipocyte cellularity, endogenous adiponectin production, and anti-inflammatory action induced by hyperadiponectinemia.	[Wada, Nobuhiko; Hashinaga, Toshihiko; Otabe, Shuichi; Yuan, Xiaohong; Kurita, Yayoi; Kakino, Satomi; Ohoki, Tsuyoshi; Nakayama, Hitomi; Fukutani, Tomoka; Tajiri, Yuji; Yamada, Kentaro] Kurume Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Kurume, Fukuoka 830, Japan	Kurume University	Yamada, K (corresponding author), Kurume Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Kurume, Fukuoka 830, Japan.	yamada@med.kurume-u.ac.jp			Japan Society for the Promotion of Science [21591154]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research (C) 21591154 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Bilkovski R, 2010, J BIOL CHEM, V285, P6170, DOI 10.1074/jbc.M109.054338; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Endo H, 2009, GUT, V58, P1637, DOI 10.1136/gut.2009.183624; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jung MY, 2012, J IMMUNOL, V188, P2592, DOI 10.4049/jimmunol.1102588; Katoh M, 2005, INT J ONCOL, V26, P1129; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Koyanagi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005765; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miyazaki T, 2005, BIOCHEM BIOPH RES CO, V333, P79, DOI 10.1016/j.bbrc.2005.05.076; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Swain Rajeeb Kumar, 2005, Cell Commun Signal, V3, P12, DOI 10.1186/1478-811X-3-12; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; van Tienen FHJ, 2009, BIOCHEM BIOPH RES CO, V387, P207, DOI 10.1016/j.bbrc.2009.07.004; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339	44	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67712	10.1371/journal.pone.0067712	http://dx.doi.org/10.1371/journal.pone.0067712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861788	Green Submitted, Green Published, gold			2022-12-25	WOS:000323350700026
J	Campanholle, G; Mittelsteadt, K; Nakagawa, S; Kobayashi, A; Lin, SL; Gharib, SA; Heinecke, JW; Hamerman, JA; Altemeier, WA; Duffield, JS				Campanholle, Gabriela; Mittelsteadt, Kristen; Nakagawa, Shunsaku; Kobayashi, Akio; Lin, Shuei-Liong; Gharib, Sina A.; Heinecke, Jay W.; Hamerman, Jessica A.; Altemeier, William A.; Duffield, Jeremy S.			TLR-2/TLR-4 TREM-1 Signaling Pathway Is Dispensable in Inflammatory Myeloid Cells during Sterile Kidney Injury	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ACTIVATING RECEPTOR; CUTTING EDGE; LIVER-INJURY; MACROPHAGES; RESPONSES; ROLES; NEUTROPHILS; MODULATION; PERICYTES	Inflammatory macrophages are abundant in kidney disease, stimulating repair, or driving chronic inflammation and fibrosis. Damage associated molecules (DAMPs), released from injured cells engage pattern recognition receptors (PRRs) on macrophages, contributing to activation. Understanding mechanisms of macrophage activation during kidney injury may lead to strategies to alleviate chronic disease. We identified Triggering-Receptor-in-Myeloid-cells (TREM)-1, a regulator of TLR signaling, as highly upregulated in kidney inflammatory macrophages and tested the roles of these receptors in macrophage activation and kidney disease. Kidney DAMPs activated macrophages in vitro, independently of TREM-1, but partially dependent on TLR-2/-4, MyD88. In two models of progressive interstitial kidney disease, TREM-1 blockade had no impact on disease or macrophage activation in vivo, but TLR-2/-4, or MyD88 deficiency was anti-inflammatory and anti-fibrotic. When MyD88 was mutated only in the myeloid lineage, however, there was no bearing on macrophage activation or disease progression. Instead, TLR-2/-4 or MyD88 deficiency reduced activation of mesenchyme lineage cells resulting in reduced inflammation and fibrosis, indicating that these pathways play dominant roles in activation of myofibroblasts but not macrophages. To conclude, TREM-1, TLR2/4 and MyD88 signaling pathways are redundant in myeloid cell activation in kidney injury, but the latter appear to regulate activation of mesenchymal cells.	[Campanholle, Gabriela; Nakagawa, Shunsaku; Duffield, Jeremy S.] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Campanholle, Gabriela; Mittelsteadt, Kristen; Nakagawa, Shunsaku; Gharib, Sina A.; Altemeier, William A.; Duffield, Jeremy S.] Univ Washington, Ctr Lung Biol, Dept Med & Pathol, Seattle, WA 98195 USA; [Campanholle, Gabriela; Mittelsteadt, Kristen; Nakagawa, Shunsaku; Heinecke, Jay W.; Altemeier, William A.; Duffield, Jeremy S.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Heinecke, Jay W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Kobayashi, Akio] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kobayashi, Akio] Harvard Univ, Sch Med, Boston, MA USA; [Lin, Shuei-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hamerman, Jessica A.] Virginia Mason, Benaroya Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Taiwan University; National Taiwan University Hospital; Benaroya Research Institute; Virginia Mason Medical Center	Duffield, JS (corresponding author), Univ Washington, Div Nephrol, Seattle, WA 98195 USA.	jeremysd@u.washington.edu	Lin, Shuei-Liong/AGR-2002-2022	Lin, Shuei-Liong/0000-0002-1041-5571; Nakagawa, Shunsaku/0000-0002-1285-122X; Altemeier, William/0000-0001-8860-405X; GHARIB, SINA A./0000-0002-2480-4367	National Institutes of Health (NIH) Genzyme GRIP Award, University of Washington [DK84077, DK87389, DK93493, DK94768]; NIH [HL086883, AI 073441]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073441, R01AI081948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094933, R01DK084077, R01DK093493, RC1DK087389, P30DK017047, R24DK094768] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Genzyme GRIP Award, University of Washington; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Duffield Lab is funded by National Institutes of Health (NIH) Grants (DK84077, DK87389, DK93493, DK94768) Genzyme GRIP Award, University of Washington. This work was also supported by NIH Grants HL086883 (to W.A.A.) and AI 073441 (to J.A.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2010, J AM SOC NEPHROL, V21, P1270, DOI 10.1681/ASN.2010030233; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Castano AP, 2009, SCI TRANSLATIONAL ME, V1; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chun CD, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-57; Chung DH, 2002, EUR J IMMUNOL, V32, P59, DOI 10.1002/1521-4141(200201)32:1<59::AID-IMMU59>3.0.CO;2-U; Derive Marc, 2010, Self Nonself, V1, P225, DOI 10.4161/self.1.3.12891; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; El Mezayen R, 2007, IMMUNOL LETT, V111, P36, DOI 10.1016/j.imlet.2007.04.011; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gibot S, 2008, CRIT CARE MED, V36, P504, DOI 10.1097/01.CCM.0B013E318161FAF3; Gibot S, 2007, EUR J IMMUNOL, V37, P456, DOI 10.1002/eji.200636387; Gibot S, 2006, J INFECT DIS, V194, P975, DOI 10.1086/506950; Goncalves GM, 2011, SCAND J IMMUNOL, V73, P428, DOI 10.1111/j.1365-3083.2011.02523.x; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Harlow E., 1999, USING ANTIBODIES LAB; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kamei K, 2009, J HEPATOBILIARY PANC, V17, P305; Klesney-Tait J, 2013, J CLIN INVEST, V123, P138, DOI 10.1172/JCI64181; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; Murakami Y, 2009, ARTHRITIS RHEUM-US, V60, P1615, DOI 10.1002/art.24554; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Netea MG, 2006, J LEUKOCYTE BIOL, V80, P1454, DOI 10.1189/jlb.1205758; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Schrimpf C, 2012, J AM SOC NEPHROL, V23, P868, DOI 10.1681/ASN.2011080851; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Wu MH, 2011, INFECT IMMUN, V79, P2709, DOI 10.1128/IAI.00144-11; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yasuda T, 2008, CRIT CARE MED, V36, P2048, DOI 10.1097/CCM.0b013e31817b8824; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	53	44	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68640	10.1371/journal.pone.0068640	http://dx.doi.org/10.1371/journal.pone.0068640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844229	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000020
J	Dishowitz, MI; Mutyaba, PL; Takacs, JD; Barr, AM; Engiles, JB; Ahn, J; Hankenson, KD				Dishowitz, Michael I.; Mutyaba, Patricia L.; Takacs, Joel D.; Barr, Andrew M.; Engiles, Julie B.; Ahn, Jaimo; Hankenson, Kurt D.			Systemic Inhibition of Canonical Notch Signaling Results in Sustained Callus Inflammation and Alters Multiple Phases of Fracture Healing	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; FUTURE-DIRECTIONS; BONE REGENERATION; TRANSGENIC MICE; CELLS; ARTHRITIS; ACTIVATION; REPAIR; THROMBOSPONDIN-2; PROLIFERATION	The Notch signaling pathway is an important regulator of embryological bone development, and many aspects of development are recapitulated during bone repair. We have previously reported that Notch signaling components are upregulated during bone fracture healing. However, the significance of the Notch pathway in bone regeneration has not been described. Therefore, the objective of this study was to determine the importance of Notch signaling in regulating bone fracture healing by using a temporally controlled inducible transgenic mouse model (Mx1-Cre; dnMAML(f/-)) to impair RBPjk-mediated canonical Notch signaling. The Mx1 promoter was synthetically activated resulting in temporally regulated systemic dnMAML expression just prior to creation of bilateral tibial fractures. This allowed for mice to undergo unaltered embryological and post-natal skeletal development. Results showed that systemic Notch inhibition prolonged expression of inflammatory cytokines and neutrophil cell inflammation, and reduced the proportion of cartilage formation within the callus at 10 days-post-fracture (dpf) Notch inhibition did not affect early bone formation at 10dpf, but significantly altered bone maturation and remodeling at 20dpf. Increased bone volume fraction in dnMAML fractures, which was due to a moderate decrease in callus size with no change in bone mass, coincided with increased trabecular thickness but decreased connectivity density, indicating that patterning of bone was altered. Notch inhibition decreased total osteogenic cell density, which was comprised of more osteocytes rather than osteoblasts. dnMAML also decreased osteoclast density, suggesting that osteoclast activity may also be important for altered fracture healing. It is likely that systemic Notch inhibition had both direct effects within cell types as well as indirect effects initiated by temporally upstream events in the fracture healing cascade. Surprisingly, Notch inhibition did not alter cell proliferation. In conclusion, our results demonstrate that the Notch signaling pathway is required for the proper temporal progression of events required for successful bone fracture healing.	[Dishowitz, Michael I.; Barr, Andrew M.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Mutyaba, Patricia L.; Takacs, Joel D.; Hankenson, Kurt D.] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Philadelphia, PA 19104 USA; [Engiles, Julie B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Ahn, Jaimo; Hankenson, Kurt D.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Hankenson, KD (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Philadelphia, PA 19104 USA.	kdhank@vet.upenn.edu	Hankenson, Kurt/AFS-9417-2022; Engiles, Julie/K-1916-2015; Hankenson, Kurt/ABI-1547-2020	Hankenson, Kurt/0000-0001-6361-143X; Engiles, Julie/0000-0001-9057-2093; 	Congressionally Directed Medical Research Program [W81XWH-10-1-0825]; Osteosynthesis and Trauma Care Foundation; Penn Center for Musculoskeletal Disorders (National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P30 AR050950]; Ruth L. Kirschstein National Research Service Award (NIH/National Institute of Dental and Craniofacial Research) [F31DE020231]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE020231] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010919] Funding Source: NIH RePORTER	Congressionally Directed Medical Research Program(United States Department of Defense); Osteosynthesis and Trauma Care Foundation; Penn Center for Musculoskeletal Disorders (National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases); Ruth L. Kirschstein National Research Service Award (NIH/National Institute of Dental and Craniofacial Research); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Congressionally Directed Medical Research Program (W81XWH-10-1-0825), the Osteosynthesis and Trauma Care Foundation, and the Penn Center for Musculoskeletal Disorders (National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases P30 AR050950). MID was supported by a Ruth L. Kirschstein National Research Service Award (NIH/National Institute of Dental and Craniofacial Research F31DE020231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblowi J, 2009, AM J PATHOL, V175, P1574, DOI 10.2353/ajpath.2009.090148; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Buie HR, 2008, J BONE MINER RES, V23, P2048, DOI 10.1359/JBMR.080808; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Caparbo VF, 2009, CLIN RHEUMATOL, V28, P71, DOI 10.1007/s10067-008-0985-y; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Carragee EJ, 2011, SPINE J, V11, P695, DOI 10.1016/j.spinee.2011.08.418; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Dishowitz MI, 2012, J ORTHOP RES, V30, P296, DOI 10.1002/jor.21518; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2005, J BONE MINER RES, V20, P1715, DOI 10.1359/JBMR.050702; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Hankenson KD, 2000, J BONE MINER RES, V15, P851, DOI 10.1359/jbmr.2000.15.5.851; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kohn A, 2012, DEVELOPMENT, V139, P1198, DOI 10.1242/dev.070649; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.teb.2011.0182, 10.1089/ten.TEB.2011.0182]; Niki Y, 2001, J CLIN INVEST, V107, P1127, DOI 10.1172/JCI11530; Oldershaw RA, 2008, STEM CELLS, V26, P666, DOI 10.1634/stemcells.2007-0806; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; Shitaye H, 2010, POSTNATAL EXPRESSION; Tao JN, 2010, J BONE MINER RES, V25, P2175, DOI 10.1002/jbmr.115; Taylor DK, 2009, J BONE MINER RES, V24, P1043, DOI [10.1359/jbmr.090101, 10.1359/JBMR.090101]; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140	46	42	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68726	10.1371/journal.pone.0068726	http://dx.doi.org/10.1371/journal.pone.0068726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844237	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000025
J	El-Halfawy, OM; Valvano, MA				El-Halfawy, Omar M.; Valvano, Miguel A.			Chemical Communication of Antibiotic Resistance by a Highly Resistant Subpopulation of Bacterial Cells	PLOS ONE			English	Article							POLYMYXIN-B RESISTANCE; ESCHERICHIA-COLI-CELLS; BURKHOLDERIA-CENOCEPACIA; PSEUDOMONAS-AERUGINOSA; OXIDATIVE STRESS; POLYAMINES; GENE; LIPOPOLYSACCHARIDE; PEPTIDE; AMINOARABINOSE	The overall antibiotic resistance of a bacterial population results from the combination of a wide range of susceptibilities displayed by subsets of bacterial cells. Bacterial heteroresistance to antibiotics has been documented for several opportunistic Gram-negative bacteria, but the mechanism of heteroresistance is unclear. We use Burkholderia cenocepacia as a model opportunistic bacterium to investigate the implications of heterogeneity in the response to the antimicrobial peptide polymyxin B (PmB) and also other bactericidal antibiotics. Here, we report that B. cenocepacia is heteroresistant to PmB. Population analysis profiling also identified B. cenocepacia subpopulations arising from a seemingly homogenous culture that are resistant to higher levels of polymyxin B than the rest of the cells in the culture, and can protect the more sensitive cells from killing, as well as sensitive bacteria from other species, such as Pseudomonas aeruginosa and Escherichia coli. Communication of resistance depended on upregulation of putrescine synthesis and YceI, a widely conserved low-molecular weight secreted protein. Deletion of genes for the synthesis of putrescine and YceI abrogate protection, while pharmacologic inhibition of putrescine synthesis reduced resistance to polymyxin B. Polyamines and YceI were also required for heteroresistance of B. cenocepacia to various bactericidal antibiotics. We propose that putrescine and YceI resemble "danger" infochemicals whose increased production by a bacterial subpopulation, becoming more resistant to bactericidal antibiotics, communicates higher level of resistance to more sensitive members of the population of the same or different species.	[El-Halfawy, Omar M.; Valvano, Miguel A.] Univ Western Ontario, Ctr Human Immunol, London, ON, Canada; [El-Halfawy, Omar M.; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [El-Halfawy, Omar M.] Univ Alexandria, Fac Pharm, Dept Pharmaceut Microbiol, Alexandria, Egypt; [Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland	Western University (University of Western Ontario); Western University (University of Western Ontario); Egyptian Knowledge Bank (EKB); Alexandria University; Queens University Belfast	Valvano, MA (corresponding author), Univ Western Ontario, Ctr Human Immunol, London, ON, Canada.	m.valvano@qub.ac.uk	Valvano, Miguel A/G-8759-2012; El-Halfawy, Omar/AAE-2491-2020	Valvano, Miguel A/0000-0001-8229-3641; El-Halfawy, Omar/0000-0003-2829-5851	Cystic Fibrosis Canada and a Marie Curie Career Integration Grant [618095]; Ontario Graduate Scholarship	Cystic Fibrosis Canada and a Marie Curie Career Integration Grant; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was supported by a grant from Cystic Fibrosis Canada and a Marie Curie Career Integration Grant, project 618095. O.M.E. was supported by an Ontario Graduate Scholarship. M.A.V. held a Canada Research Chair in Infectious Diseases and Microbial Pathogenesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JM, 2009, J ANTIMICROB CHEMOTH, V64, P454, DOI 10.1093/jac/dkp244; Bernier SP, 2011, MOL MICROBIOL, V81, P705, DOI 10.1111/j.1365-2958.2011.07724.x; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; FAY GD, 1972, APPL MICROBIOL, V23, P710, DOI 10.1128/AEM.23.4.710-713.1972; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Gao JL, 2004, MOL MICROBIOL, V53, P1757, DOI 10.1111/j.1365-2958.2004.04240.x; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Hamad MA, 2012, MOL MICROBIOL, V85, P962, DOI 10.1111/j.1365-2958.2012.08154.x; HIRSCH JG, 1952, J EXP MED, V95, P191, DOI 10.1084/jem.95.2.191; Johnson L, 2012, J BACTERIOL, V194, P813, DOI 10.1128/JB.05230-11; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; KREUZER K, 1975, GENETICS, V81, P457; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1615, DOI 10.1128/AAC.50.5.1615-1622.2006; Kwon DH, 2007, ANTIMICROB AGENTS CH, V51, P2070, DOI 10.1128/AAC.01472-06; Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Loutet SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-472; Loutet SA, 2011, ENV MICROBIOL REP, V3, P278, DOI 10.1111/j.1758-2229.2010.00222.x; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Loutet SA, 2009, MICROBIOL-SGM, V155, P2029, DOI 10.1099/mic.0.027607-0; Marolda Cristina L., 2006, V347, P237; Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosales-Reyes R, 2012, MICROBIOL-SGM, V158, P2315, DOI 10.1099/mic.0.060988-0; Ross BM, 2009, RAPID COMMUN MASS SP, V23, P3973, DOI 10.1002/rcm.4340; Schmerk CL, 2011, J BACTERIOL, V193, P6712, DOI 10.1128/JB.05979-11; Sisinni L, 2010, FEBS J, V277, P1896, DOI 10.1111/j.1742-4658.2010.07612.x; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; Tkachenko AG, 2006, BIOCHEMISTRY-MOSCOW+, V71, P185, DOI 10.1134/S0006297906020118; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; Wright RM, 2001, J CLIN PATHOL, V54, P803, DOI 10.1136/jcp.54.10.803; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhang MH, 2000, CRIT CARE MED, V28, pN60, DOI 10.1097/00003246-200004001-00007	40	55	60	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68874	10.1371/journal.pone.0068874	http://dx.doi.org/10.1371/journal.pone.0068874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844246	Green Submitted, gold, Green Published			2022-12-25	WOS:000321733000030
J	Kellner, S; Kollar, LB; Ochel, A; Ghate, M; Helm, M				Kellner, Stefanie; Kollar, Laura Bettina; Ochel, Antonia; Ghate, Manjunath; Helm, Mark			Structure-Function Relationship of Substituted Bromomethylcoumarins in Nucleoside Specificity of RNA Alkylation	PLOS ONE			English	Article							COVALENT ATTACHMENT; RIBOSOMAL-RNA; DNA; PSEUDOURIDINE; CHEMISTRY; DERIVATIZATION; FLUOROPHORES; NUCLEOTIDES; YEAST; TOOL	Selective alkylation of RNA nucleotides is an important field of RNA biochemistry, e. g. in applications of fluorescent labeling or in structural probing experiments, yet detailed structure-function studies of labeling agents are rare. Here, bromomethylcoumarins as reactive compounds for fluorescent labeling of RNA are developed as an attractive scaffold on which electronic properties can be modulated by varying the substituents. Six different 4-bromomethylcoumarins of various substitution patterns were tested for nucleotide specificity of RNA alkylation using tRNA from Escherichia coli as substrate. Using semi-quantitative LC-MS/MS analysis, reactions at mildly acidic and slightly alkaline pH were compared. For all tested compounds, coumarin conjugates with 4-thiouridine, pseudouridine, guanosine, and uridine were identified, with the latter largely dominating. This data set shows that selectivity of ribonucleotide alkylation depends on the substitution pattern of the reactive dye, and even more strongly on the modulation of the reaction conditions. The latter should be therefore carefully optimized when striving to achieve selectivity. Interestingly, the highest selectivity for labeling of a modified nucleoside, namely of 4-thiouridine, was achieved with a compound whose selectivity was somewhat less dependent on reaction conditions than the other compounds. In summary, bromomethylcoumarin derivatives are a highly interesting class of compounds, since their selectivity for 4-thiouridine can be efficiently tuned by variation of substitution pattern and reaction conditions.	[Kellner, Stefanie; Kollar, Laura Bettina; Ochel, Antonia; Helm, Mark] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany; [Ghate, Manjunath] Nirma Univ, Inst Pharm, Ahmadabad, Gujarat, India	Johannes Gutenberg University of Mainz; Nirma University	Helm, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany.	mhelm@uni-mainz.de	Helm, Mark/AAD-5433-2022; Ghate, Manjunath/E-7576-2015	/0000-0003-3224-7502; Ghate, Manjunath/0000-0001-7564-903X; Helm, Mark/0000-0002-0154-0928	DFG [HE3397/4, INST 247/622-1]	DFG(German Research Foundation (DFG))	This work was in part supported by the DFG (HE3397/4 and INST 247/622-1) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Behm-Ansmant I, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/408053; BURGER A, 1947, J ORG CHEM, V12, P342, DOI 10.1021/jo01166a021; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Durairaj A, 2008, RAPID COMMUN MASS SP, V22, P3727, DOI 10.1002/rcm.3789; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; El-Sagheer AH, 2010, P NATL ACAD SCI USA, V107, P15329, DOI 10.1073/pnas.1006447107; Emmerechts G, 2005, J CHROMATOGR B, V825, P233, DOI 10.1016/j.jchromb.2005.06.041; Fauster K, 2012, ACS CHEM BIOL, V7, P581, DOI 10.1021/cb200510k; Ghate M, 2003, EUR J MED CHEM, V38, P297, DOI 10.1016/S0223-5234(03)00016-3; Giege R, 1999, COMPREHENSIVE NATURA, P63; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Jahn K, 2011, BIOCONJUGATE CHEM, V22, P95, DOI 10.1021/bc100422k; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; JUZUMIENE DI, 1995, J BIOL CHEM, V270, P12794, DOI 10.1074/jbc.270.21.12794; KASAI H, 1979, NUCLEIC ACIDS RES, V7, P231, DOI 10.1093/nar/7.1.231; Kellner S, 2011, NUCLEIC ACIDS RES, V39, P7348, DOI 10.1093/nar/gkr449; Keri RS, 2010, EUR J MED CHEM, V45, P2597, DOI 10.1016/j.ejmech.2010.02.048; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kimoto M, 2010, J AM CHEM SOC, V132, P4988, DOI 10.1021/ja100806c; Lee TH, 2007, BIOPHYS J, V92, P3275, DOI 10.1529/biophysj.106.094623; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Meyer KC, 2012, DIFFUSE LUNG DISEASE: A PRACTICAL APPROACH, SECOND EDITION, P3, DOI 10.1007/978-1-4419-9771-5_1; Motorin Y, 2011, NUCLEIC ACIDS RES, V39, P1943, DOI 10.1093/nar/gkq825; Ouellet J, 2011, BIOPHYS J, V101, P1148, DOI 10.1016/j.bpj.2011.07.007; PEATTIE DA, 1980, P NATL ACAD SCI-BIOL, V77, P4679, DOI 10.1073/pnas.77.8.4679; PLUMBRIDGE JA, 1980, NUCLEIC ACIDS RES, V8, P827; PREJEAN JD, 1984, DRUG METAB REV, V15, P619, DOI 10.3109/03602538409029975; Proudnikov D, 1996, NUCLEIC ACIDS RES, V24, P4535, DOI 10.1093/nar/24.22.4535; Qin PZF, 1999, METHODS, V18, P60, DOI 10.1006/meth.1999.0757; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SINGER B, 1976, NATURE, V264, P333, DOI 10.1038/264333a0; Singer B, 2010, PYRIMIDINES NUCLEOSI, P269; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; SPRINZL M, 1974, EUR J BIOCHEM, V49, P595, DOI 10.1111/j.1432-1033.1974.tb03863.x; Threlfall RN, 2012, ORG BIOMOL CHEM, V10, P746, DOI 10.1039/c1ob06614e; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wintermeyer W, 1979, Methods Enzymol, V59, P110; Xie Y, 2010, J AM CHEM SOC, V132, P11896, DOI 10.1021/ja105244t; YANG CH, 1974, BIOCHEMISTRY-US, V13, P3615, DOI 10.1021/bi00714a033; YANG CH, 1973, J BIOCHEM-TOKYO, V73, P1243, DOI 10.1093/oxfordjournals.jbchem.a130197; YOSHIDA M, 1968, BIOCHIM BIOPHYS ACTA, V157, P455, DOI 10.1016/0005-2787(68)90145-7	46	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67945	10.1371/journal.pone.0067945	http://dx.doi.org/10.1371/journal.pone.0067945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844135	Green Submitted, gold, Green Published			2022-12-25	WOS:000321733000118
J	Kypriotou, M; Boechat, C; Huber, M; Hohl, D				Kypriotou, Magdalini; Boechat, Cloe; Huber, Marcel; Hohl, Daniel			Spontaneous Atopic Dermatitis-Like Symptoms in a/a ma ft/ma ft/J Flaky Tail Mice Appear Early after Birth	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; OF-FUNCTION MUTATIONS; NF-KAPPA-B; ICHTHYOSIS VULGARIS; BARRIER FUNCTION; CORNIFIED ENVELOPE; STRATUM-CORNEUM; ALLERGIC INFLAMMATION; FILAGGRIN DEFICIENCY; TOPICAL APPLICATION	Loss-of-function mutations in human profilaggrin gene have been identified as the cause of ichthyosis vulgaris (IV), and as a major predisposition factor for atopic dermatitis (AD). Similarly, flaky tail (a/a ma ft/ma ft/J) mice were described as a model for IV, and shown to be predisposed to eczema. The aim of this study was to correlate the flaky tail mouse phenotype with human IV and AD, in order to dissect early molecular events leading to atopic dermatitis in mice and men, suffering from filaggrin deficiency. Thus, 5-days old flaky tail pups were analyzed histologically, expression of cytokines was measured in skin and signaling pathways were investigated by protein analysis. Human biopsies of IV and AD patients were analyzed histologically and by real time PCR assays. Our data show acanthosis and hyperproliferation in flaky tail epidermis, associated with increased IL1 beta and thymic stromal lymphopoietin (TSLP) expression, and Th2-polarization. Consequently, NFkB and Stat pathways were activated, and IL6 mRNA levels were increased. Further, quantitative analysis of late epidermal differentiation markers revealed increased Small proline-rich protein 2A (Sprr2a) synthesis. Th2-polarization and Sprr2a increase may result from high TSLP expression, as shown after analysis of 5-days old K14-TSLP tg mouse skin biopsies. Our findings in the flaky tail mouse correlate with data obtained from patient biopsies of AD, but not IV. We propose that proinflammatory cytokines are responsible for acanthosis in flaky tail epidermis, and together with the Th2-derived cytokines lead to morphological changes. Accordingly, the a/a ma ft/ma ft/J mouse model can be used as an appropriate model to study early AD onset associated with profilaggrin deficiency.	[Kypriotou, Magdalini; Boechat, Cloe; Huber, Marcel; Hohl, Daniel] CHU Vaudois, Beaumont Hosp, Serv Dermatol & Venereol, Lab Cutaneous Biol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hohl, D (corresponding author), CHU Vaudois, Beaumont Hosp, Serv Dermatol & Venereol, Lab Cutaneous Biol, Lausanne, Switzerland.	Daniel.Hohl@chuv.ch	Huber, Marcel/M-8822-2016; Hohl, Daniel M/N-7554-2016	Huber, Marcel/0000-0003-3821-2378; 	National Swiss Foundation [31003A-120343]; Gottfried und Julia Bangerter-Rhyner-Stiftung	National Swiss Foundation(Swiss National Science Foundation (SNSF)); Gottfried und Julia Bangerter-Rhyner-Stiftung	The project was funded by the National Swiss Foundation Project #31003A-120343 and by the Gottfried und Julia Bangerter-Rhyner-Stiftung (http://www.bangerter-stiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelova-Fischer I, 2010, J INVEST DERMATOL, V130, P2505, DOI 10.1038/jid.2010.143; Baron SE, 2012, CLIN EXP DERMATOL, V37, P7, DOI 10.1111/j.1365-2230.2012.04336.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chappaz S, 2007, BLOOD, V110, P3862, DOI 10.1182/blood-2007-02-074245; Dale BA, 1997, J INVEST DERMATOL, V108, P179, DOI 10.1111/1523-1747.ep12334205; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Fernandez MI, 2011, BLOOD, V118, P3862, DOI 10.1182/blood-2010-12-323089; FROST P, 1966, ARCH DERMATOL, V94, P113, DOI 10.1001/archderm.94.2.113; GRECO MA, 1995, J INVEST DERMATOL, V104, P204, DOI 10.1111/1523-1747.ep12612759; Holzmann S, 2004, J INVEST DERMATOL, V122, P1165, DOI 10.1111/j.0022-202X.2004.22520.x; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jutel M, 2011, CURR ALLERGY ASTHM R, V11, P139, DOI 10.1007/s11882-011-0178-7; Kamekura R, 2010, HISTOCHEM CELL BIOL, V133, P339, DOI 10.1007/s00418-009-0674-1; Kawasaki H, 2010, INT IMMUNOLOGY, V22, piii63; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Keratinocytes Nickoloff BJ, 1994, J AM ACAD DERMATOL, V30, P535; Kezic S, 2012, J ALLERGY CLIN IMMUN, V129, P1031, DOI 10.1016/j.jaci.2011.12.989; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Moniaga CS, 2013, AM J PATHOL, V182, P841, DOI 10.1016/j.ajpath.2012.11.039; Moniaga CS, 2010, AM J PATHOL, V176, P2385, DOI 10.2353/ajpath.2010.090957; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Nakamura H, 2002, GENE THER, V9, P1221, DOI 10.1038/sj.gt.3301724; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nozaki I, 2005, LAB INVEST, V85, P109, DOI 10.1038/labinvest.3700213; O'Regan GM, 2008, J ALLERGY CLIN IMMUN, V122, P689, DOI 10.1016/j.jaci.2008.08.002; Obarzanek-Fojt M, 2011, EUR J CELL BIOL, V90, P279, DOI 10.1016/j.ejcb.2010.11.001; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Okano J, 2012, J CELL SCI, V125, P1827, DOI 10.1242/jcs.101550; Okulicz JF, 2003, INT J DERMATOL, V42, P95, DOI 10.1046/j.1365-4362.2003.01308.x; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Rice RH, 1999, ANAT RECORD, V254, P231; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2007, J INVEST DERMATOL, V127, P1282, DOI 10.1038/sj.jid.5700876; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Scharschmidt TC, 2009, J ALLERGY CLIN IMMUN, V124, P496, DOI 10.1016/j.jaci.2009.06.046; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stern LE, 2001, J PEDIATR SURG, V36, P190, DOI 10.1053/jpsu.2001.20050; Tanaka A, 2007, J INVEST DERMATOL, V127, P855, DOI 10.1038/sj.jid.5700603; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; TOSHITANI A, 1993, J INVEST DERMATOL, V100, P299, DOI 10.1111/1523-1747.ep12469875; Vercelli D, 2009, NAT GENET, V41, P512, DOI 10.1038/ng0509-512; Vermeij WP, 2011, J INVEST DERMATOL, V131, P1435, DOI 10.1038/jid.2010.433; Vermeij WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011957; Yano S, 2008, J CELL PHYSIOL, V214, P1, DOI 10.1002/jcp.21300; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zimmermann N, 2005, AM J RESP CELL MOL, V32, P428, DOI 10.1165/rcmb.2004-0269OC	66	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67869	10.1371/journal.pone.0067869	http://dx.doi.org/10.1371/journal.pone.0067869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844115	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000110
J	Wang, CL; Zhao, Y; Su, YY; Li, RM; Lin, YF; Zhou, XD; Ye, L				Wang, Chenglin; Zhao, Yuan; Su, Yingying; Li, Ruimin; Lin, Yunfeng; Zhou, Xuedong; Ye, Ling			C-Jun N-Terminal Kinase (JNK) Mediates Wnt5a-Induced Cell Motility Dependent or Independent of RhoA Pathway in Human Dental Papilla Cells	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; TYROSINE PHOSPHORYLATION; FOCAL ADHESIONS; TISSUE INTERACTIONS; ACTIN ORGANIZATION; APICAL PAPILLA; EXPRESSION; PAXILLIN; POLARITY	Wnt5a plays an essential role in tissue development by regulating cell migration, though the molecular mechanisms are still not fully understood. Our study investigated the pathways involved in Wnt5a-dependent cell motility during the formation of dentin and pulp. Over-expression of Wnt5a promoted cell adhesion and formation of focal adhesion complexes (FACs) in human dental papilla cells (hDPCs), while inhibiting cell migration. Instead of activating the canonical Wnt signal pathway in hDPCs, Wnt5a stimulation induced activation of the JNK signal in a RhoA-dependent or independent manner. Inhibiting JNK abrogated Wnt5a-induced FACs formation but not cytoskeletal rearrangement. Both dominant negative RhoA (RhoA T19N) and constitutively active RhoA mutants (RhoA Q63L) blocked the Wnt5a-dependent changes in hDPCs adhesion, migration and cytoskeletal rearrangement here too, with the exception of the formation of FACs. Taken together, our study suggested that RhoA and JNK signaling have roles in mediating Wnt5a-dependent adhesion and migration in hDPCs, and the Wnt5a/JNK pathway acts both dependently and independently of the RhoA pathway.	[Wang, Chenglin; Zhao, Yuan; Su, Yingying; Li, Ruimin; Lin, Yunfeng; Zhou, Xuedong; Ye, Ling] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China; [Wang, Chenglin; Zhao, Yuan; Su, Yingying; Li, Ruimin; Lin, Yunfeng; Zhou, Xuedong; Ye, Ling] Sichuan Univ, West China Sch Stomatol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Ye, L (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China.	yeling@scu.edu.cn	wang, meng/GWZ-9558-2022; ye, ling/AFP-0048-2022; Lin, Yunfeng/H-3393-2011; ZHOU, XUE/F-6129-2013	ye, ling/0000-0002-8417-7676; Lin, Yunfeng/0000-0003-1224-6561; Zhou, Xuedong/0000-0002-9319-7302; Wang, Chenglin/0000-0002-6117-6996	NSFC [81070801, 81200759]; New Century Excellent Talents Fund [NCET-10-0577]; Innovative Research Team of Education Department of Sichuan Province [13TD0038]; Sichuan Province Science and Technology Support Program [2012SZ0034]; Scientific Research Foundation of Sichuan University Young Teachers [2012SCU11900-4]	NSFC(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Fund(Program for New Century Excellent Talents in University (NCET)); Innovative Research Team of Education Department of Sichuan Province; Sichuan Province Science and Technology Support Program; Scientific Research Foundation of Sichuan University Young Teachers	This work was supported by NSFC Grant 81070801 and 81200759, New Century Excellent Talents Fund NCET-10-0577, Innovative Research Team of Education Department of Sichuan Province 13TD0038, Sichuan Province Science and Technology Support Program 2012SZ0034 and Scientific Research Foundation of Sichuan University Young Teachers 2012SCU11900-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Allen WE, 1997, J CELL SCI, V110, P707; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Biz MT, 2010, CELL TISSUE RES, V340, P459, DOI 10.1007/s00441-010-0961-0; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chai Y, 2003, MICROSC RES TECHNIQ, V60, P469, DOI 10.1002/jemt.10287; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Endo Y, 2005, J BIOL CHEM, V280, P777, DOI 10.1074/jbc.M406391200; Even-Ram S, 2009, EXTRACELLULAR MATRIX; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Huang GTJ, 2008, J ENDODONT, V34, P645, DOI 10.1016/j.joen.2008.03.001; Ikeda E, 2006, BIOCHEM BIOPH RES CO, V342, P1257, DOI 10.1016/j.bbrc.2006.02.101; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Lin MK, 2011, DEV DYNAM, V240, P432, DOI 10.1002/dvdy.22550; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Nakamura K, 2000, J BIOL CHEM, V275, P27155; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Obara N, 2006, CELL TISSUE RES, V325, P197, DOI 10.1007/s00441-005-0136-6; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Peng L, 2010, INT ENDOD J, V43, P404, DOI 10.1111/j.1365-2591.2010.01693.x; Peng L, 2010, ARCH ORAL BIOL, V55, P108, DOI 10.1016/j.archoralbio.2009.12.002; Peng L, 2009, BIOCHEM BIOPH RES CO, V390, P1072, DOI 10.1016/j.bbrc.2009.10.136; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; THESLEFF I, 1981, DIFFERENTIATION, V18, P75, DOI 10.1111/j.1432-0436.1981.tb01107.x; Thesleff I, 1996, ANAT REC, V245, P151; Thesleff I, 1995, CONNECT TISSUE RES, V32, P9, DOI 10.3109/03008209509013700; THOMAS HF, 1989, ARCH ORAL BIOL, V34, P27, DOI 10.1016/0003-9969(89)90043-5; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653; Wang CL, 2010, J ENDODONT, V36, P238, DOI 10.1016/j.joen.2009.09.007; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	78	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e69440	10.1371/journal.pone.0069440	http://dx.doi.org/10.1371/journal.pone.0069440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844260	gold, Green Published, Green Submitted			2022-12-25	WOS:000321733000035
J	Tura, A; Sbrignadello, S; Mambelli, E; Ravazzani, P; Santoro, A; Pacini, G				Tura, Andrea; Sbrignadello, Stefano; Mambelli, Emanuele; Ravazzani, Paolo; Santoro, Antonio; Pacini, Giovanni			Sodium Concentration Measurement during Hemodialysis through Ion-Exchange Resin and Conductivity Measure Approach: In Vitro Experiments	PLOS ONE			English	Article							SELECTIVE ELECTRODES; POTASSIUM; PLASMA; DIALYSIS	Sodium measurement during hemodialysis treatment is important to preserve the patient from clinical events related to hypo- or hyper-natremia Usually, sodium measurement is performed through laboratory equipment which is typically expensive, and requires manual intervention. We propose a new method, based on conductivity measurement after treatment of dialysate solution through ion-exchange resin. To test this method, we performed in vitro experiments. We prepared 40 ml sodium chloride (NaCl) samples at 280, 140, 70, 35, 17.5, 8.75, 4.375 mEq/l, and some "mixed samples", i.e., with added potassium chloride (KCl) at different concentrations (4.375-17.5 mEq/l), to simulate the confounding factors in a conductivity-based sodium measurement. We measured the conductivity of all samples. Afterwards, each sample was treated for 1 min with 1 g of Dowex G-26 resin, and conductivity was measured again. On average, the difference in the conductivity between mixed samples and corresponding pure NaCl samples (at the same NaCl concentration) was 20.9%. After treatment with the exchange resin, it was 14.7%, i.e., 42% lower. Similar experiments were performed with calcium chloride and magnesium chloride as confounding factors, with similar results. We also performed some experiments on actual dialysate solution during hemodialysis sessions in 15 patients, and found that the correlation between conductivity measures and sodium concentration improved after resin treatment (R=0.839 before treatment, R=0.924 after treatment, P<0.0001). We conclude that ion-exchange resin treatment coupled with conductivity measures may improve the measurement of sodium compared to conductivity measures alone, and may become a possible simple approach for continuous and automatic sodium measurement during hemodialysis.	[Tura, Andrea; Sbrignadello, Stefano; Ravazzani, Paolo; Pacini, Giovanni] CNR, Inst Biomed Engn, Padua, Italy; [Mambelli, Emanuele; Santoro, Antonio] St Orsola Marcello Malpighi Hosp, Nephrol Dialysis & Hypertens Unit, Bologna, Italy	Consiglio Nazionale delle Ricerche (CNR); IRCCS Azienda Ospedaliero-Universitaria di Bologna	Tura, A (corresponding author), CNR, Inst Biomed Engn, Padua, Italy.	tura@isib.cnr.it	Ravazzani, Paolo/B-9139-2015	Ravazzani, Paolo/0000-0003-0282-3329; Sbrignadello, Stefano/0000-0002-3795-2887				Awan SA, 2005, IEEE T INSTRUM MEAS, V54, P516, DOI 10.1109/TIM.2005.843582; Burnett RW, 2000, CLIN CHEM LAB MED, V38, P1065, DOI 10.1515/CCLM.2000.159; Caduff A, 2011, DIABETOLOGIA, V54, P2678, DOI 10.1007/s00125-011-2210-9; Charra Bernard, 2007, Hemodial Int, V11, P21, DOI 10.1111/j.1542-4758.2007.00148.x; Goureau Y, 1990, ASAIO Trans, V36, pM444; Gourzi M., 2003, Journal of Medical Engineering & Technology, V27, P276, DOI 10.1080/0309190031000098845; Gourzi M., 2005, Journal of Medical Engineering & Technology, V29, P22, DOI 10.1080/03091900410001720247; Guyton AC, 1999, J AM SOC NEPHROL, V10, P2248; Hecking M, 2011, AM J NEPHROL, V33, P39, DOI 10.1159/000322572; Kim Gheun-Ho, 2009, Electrolyte Blood Press, V7, P31, DOI 10.5049/EBP.2009.7.2.31; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; LADENSON JH, 1977, J LAB CLIN MED, V90, P654; Locatelli F, 1995, INT J ARTIF ORGANS, V18, P716, DOI 10.1177/039139889501801106; MAAS AHJ, 1985, CLIN CHEM, V31, P482; Musso CG, 2009, INT UROL NEPHROL, V41, P357, DOI 10.1007/s11255-009-9548-7; PETITCLERC T, 1992, BLOOD PURIFICAT, V10, P309, DOI 10.1159/000170062; PETITCLERC T, 1993, INT J ARTIF ORGANS, V16, P585, DOI 10.1177/039139889301600804; PETITCLERC T, 1995, NEPHROL DIAL TRANSPL, V10, P212; Santos SFF, 2008, CLIN J AM SOC NEPHRO, V3, P522, DOI 10.2215/CJN.03360807; Sbrignadello S, 2013, J SPECTROSC, V2013, DOI 10.1155/2013/571372; Titze J, 2002, AM J PHYSIOL-RENAL, V283, pF134, DOI 10.1152/ajprenal.00323.2001; Tura A, 2007, BIOPHYS CHEM, V129, P235, DOI 10.1016/j.bpc.2007.06.001; Tura A, 2010, SENSORS-BASEL, V10, P5346, DOI 10.3390/s100605346; WORTH HGJ, 1985, ANN CLIN BIOCHEM, V22, P343, DOI 10.1177/000456328502200402	24	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69227	10.1371/journal.pone.0069227	http://dx.doi.org/10.1371/journal.pone.0069227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844253	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000186
J	Wu, P; Han, SH; Chen, T; Qin, GX; Li, L; Guo, XJ				Wu, Ping; Han, Shaohua; Chen, Tao; Qin, Guangxing; Li, Long; Guo, Xijie			Involvement of MicroRNAs in Infection of Silkworm with Bombyx mori Cytoplasmic Polyhedrosis Virus (BmCPV)	PLOS ONE			English	Article							WING DEVELOPMENT; EXPRESSION; IDENTIFICATION; MOSQUITO; BIOGENESIS; REOVIRIDAE; SUPPRESSES; APOPTOSIS; PATTERNS; DEFENSE	Bombyx mori cytoplasmic polyhedrosis virus (BmCPV) is one of the most important pathogens of silkworm. MicroRNAs (miRNAs) have been demonstrated to play key roles in regulating host-pathogen interaction. However, there are limited reports on the miRNAs expression profiles during insect pathogen challenges. In this study, four small RNA libraries from BmCPV-infected midgut of silkworm at 72 h post-inoculation and 96 h post-inoculation and their corresponding control midguts were constructed and deep sequenced. A total of 316 known miRNAs (including miRNA*) and 90 novel miRNAs were identified. Fifty-eight miRNAs displayed significant differential expression between the infected and normal midgut (P value <= 0.01 and fold change > = 2.0 or < = 0.5), among which ten differentially expressed miRNA were validated by qRT-PCR method. Further bioinformatics analysis of predicted target genes of differentially expressed miRNAs showed that the miRNA targets were involved in stimulus and immune system process in silkworm.	[Wu, Ping; Han, Shaohua; Chen, Tao; Qin, Guangxing; Li, Long; Guo, Xijie] Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Wu, Ping; Chen, Tao; Li, Long; Guo, Xijie] Minist Agr, Qual Inspect Ctr Sericulture Prod, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Ministry of Agriculture & Rural Affairs	Guo, XJ (corresponding author), Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China.	guoxijie@126.com	Guo, Xijie/GPX-9247-2022		National Basic Research Program of China [2012CB114600]; Natural Science Foundation of Jiangsu [BK2010353]; Technology and Science Support Project of Zhengjiang [NY2011028]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Technology and Science Support Project of Zhengjiang	This project was financially supported by the National Basic Research Program of China (Grant No. 2012CB114600), the Natural Science Foundation of Jiangsu (No. BK2010353), and Technology and Science Support Project of Zhengjiang (No. NY2011028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asgari S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00048; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bejarano F, 2010, DEV BIOL, V338, P63, DOI 10.1016/j.ydbio.2009.11.025; Biryukova I, 2009, DEV BIOL, V327, P487, DOI 10.1016/j.ydbio.2008.12.036; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Cao J, 2008, INSECT BIOCHEM MOLEC, V38, P1066, DOI 10.1016/j.ibmb.2008.09.008; Chawla G, 2011, INT REV CEL MOL BIO, V286, P1, DOI 10.1016/B978-0-12-385859-7.00001-X; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng TC, 2008, DEV COMP IMMUNOL, V32, P464, DOI 10.1016/j.dci.2007.03.010; Clarke TE, 2002, J GEN VIROL, V83, P1565, DOI 10.1099/0022-1317-83-7-1565; Deng ZL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-115; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Eun SH, 2013, DEVELOPMENT, V140, P23, DOI 10.1242/dev.086397; FUJIIKAWATA I, 1970, J MOL BIOL, V51, P247, DOI 10.1016/0022-2836(70)90140-3; Graham RI, 2006, J INVERTEBR PATHOL, V91, P79, DOI 10.1016/j.jip.2005.11.003; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hussain M, 2008, J VIROL, V82, P9164, DOI 10.1128/JVI.01109-08; Hussain M, 2010, J VIROL, V84, P612, DOI 10.1128/JVI.01794-09; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kumarswamy R, 2010, CELL BIOL INT, V34, P851, DOI 10.1042/CBI20100035; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-85; Liu SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-455; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; MAGNOLER A, 1974, J INVERTEBR PATHOL, V23, P263, DOI 10.1016/0022-2011(74)90089-5; Manavella P, 2012, PLANT PHYSL; Martin EC, 2014, MOL CARCINOGEN, V53, P38, DOI 10.1002/mc.21946; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Nairz K, 2006, DEV BIOL, V291, P314, DOI 10.1016/j.ydbio.2005.11.047; Narayanan K, 2004, CURR SCI INDIA, V86, P800; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; RUBINSTEIN R, 1976, VIROLOGY, V69, P323, DOI 10.1016/0042-6822(76)90219-1; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shapiro A, 2005, J VIROL, V79, P9430, DOI 10.1128/JVI.79.15.9430-9438.2005; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Singh J, 2010, VIROLOGY, V407, P120, DOI 10.1016/j.virol.2010.07.033; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Tanaka H, 2009, INSECT MOL BIOL, V18, P71, DOI 10.1111/j.1365-2583.2009.00851.x; Tsang WP, 2009, CARCINOGENESIS, V30, P953, DOI 10.1093/carcin/bgp094; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Varghese J, 2010, GENE DEV, V24, P2748, DOI 10.1101/gad.1995910; Wang XG, 2012, POULTRY SCI, V91, P139, DOI 10.3382/ps.2011-01656; Wu P, 2011, MOL BIOL REP, V38, P333, DOI 10.1007/s11033-010-0112-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yao HP, 2006, J ZHEJIANG U SC A S2, V7, P350, DOI DOI 10.1631/JZUS.2006.AS0350; Yun EY, 2009, DEV COMP IMMUNOL, V33, P1064, DOI 10.1016/j.dci.2009.05.008; Zhang XF, 2012, INSECT BIOCHEM MOLEC, V42, P381, DOI 10.1016/j.ibmb.2012.01.006; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156; Zhu HF, 2010, CHAOS, V20, DOI 10.1063/1.3368727	65	48	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68209	10.1371/journal.pone.0068209	http://dx.doi.org/10.1371/journal.pone.0068209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844171	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000144
J	Zeng, F; Qin, W; Yang, Y; Zhang, DH; Liu, JX; Zhou, GY; Sun, JB; Lu, SF; Tang, Y; Chen, Y; Lan, L; Yu, SG; Li, Y; Gao, X; Gong, QY; Tian, J; Liang, FR				Zeng, Fang; Qin, Wei; Yang, Yue; Zhang, Danhua; Liu, Jixin; Zhou, Guangyu; Sun, Jinbo; Lu, Shengfeng; Tang, Yong; Chen, Yuan; Lan, Lei; Yu, Shuguang; Li, Ying; Gao, Xin; Gong, Qiyong; Tian, Jie; Liang, Fanrong			Regional Brain Structural Abnormality in Meal-Related Functional Dyspepsia Patients: A Voxel-Based Morphometry Study	PLOS ONE			English	Article							MATTER ABNORMALITIES; GASTRIC DISTENSION; ANXIETY; REGISTRATION; DEPRESSION; ROBUST	Background and Aims: Brain dysfunction in functional dyspepsia (FD) has been identified by multiple neuroimaging studies. This study aims to investigate the regional gray matter density (GMD) changes in meal-related FD patients and their correlations with clinical variables, and to explore the possible influence of the emotional state on FD patients's brain structures. Methods: Fifty meal-related FD patients and forty healthy subjects (HS) were included and underwent a structural magnetic resonance imaging scan. Voxel-based morphometry analysis was employed to identify the cerebral structure alterations in meal-related FD patients. Regional GMD changes' correlations with the symptoms and their durations, respectively, have been analyzed. Results: Compared to the HS, the meal-related FD patients showed a decreased GMD in the bilateral precentral gyrus, medial prefrontal cortex (MPFC), anterior cingulate cortex (ACC) and midcingulate cortex (MCC), left orbitofrontal cortex (OFC) and right insula (p<0.05, FWE Corrected, Cluster size>50). After controlling for anxiety and depression, the meal-related FD patients showed a decreased GMD in the bilateral middle frontal gyrus, left MCC, right precentral gyrus and insula (p<0.05, FWE Corrected, Cluster size>50). Before controlling psychological factors, the GMD decreases in the ACC were negatively associated with the symptom scores of the Nepean Dyspepsia Index (NDI) (r = -0.354, p = 0.048, Bonferroni correction) and the duration of FD (r = -0.398, p = 0.02, Bonferroni correction) respectively. Conclusions: The regional GMD of meal-related FD patients, especially in the regions of the homeostatic afferent processing network significantly differed from that of the HS, and the psychological factors might be one of the essential factors significantly affecting the regional brain structure of meal-related FD patients.	[Zeng, Fang; Zhang, Danhua; Tang, Yong; Chen, Yuan; Lan, Lei; Yu, Shuguang; Li, Ying; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China; [Qin, Wei; Liu, Jixin; Zhou, Guangyu; Sun, Jinbo; Tian, Jie] Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Yang, Yue] Sichuan Acad Med Sci, Psychosomat Med Dept, Chengdu, Sichuan, Peoples R China; [Yang, Yue] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Lu, Shengfeng] Nanjing Univ Tradit Chinese Med, Key Lab Acupuncture & Med Res Minister Educ, Nanjing, Jiangsu, Peoples R China; [Gao, Xin] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Gong, Qiyong] Sichuan Univ, West China Hosp, Ctr Med Imaging, Dept Radiol,Huaxi MR Res Ctr, Chengdu 610064, Sichuan, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Chengdu University of Traditional Chinese Medicine; Xidian University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Nanjing University of Chinese Medicine; University of Pennsylvania; Sichuan University; Chinese Academy of Sciences; Institute of Automation, CAS	Gao, X (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jerric@pcbi.upenn.edu; 0001170@cdutcm.edu.cn	JinBo, Sun/GLT-2082-2022; Tian, Jie/H-1190-2011; tian, jie/M-6336-2013; 秦, 伟/J-9770-2016; Gong, Qiyong/W-3052-2019	Tian, Jie/0000-0003-0498-0432; 秦, 伟/0000-0003-4583-0406; Gong, Qiyong/0000-0002-5912-4871; Yu, Shuguang/0000-0002-1413-8989; Liang, Fanrong/0000-0003-2210-2027; Zhou, Guangyu/0000-0003-0897-6465	Youth Foundation of National Natural Science Foundation of China [81001504]; State Key Program for Basic Research of China [2012CB518501]; Youth Foundation of Sichuan Province [2012JQ0052]	Youth Foundation of National Natural Science Foundation of China; State Key Program for Basic Research of China(State Key Development Program for Basic Research of China); Youth Foundation of Sichuan Province	This study was supported by the "Youth Foundation of National Natural Science Foundation of China (NO. 81001504)'', the "State Key Program for Basic Research of China (NO. 2012CB518501)'' and the "Youth Foundation of Sichuan Province (NO. 2012JQ0052)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2007, TR07JA1 FMRIB; Andersson JLR, TR07JA2 FMRIB; Aro P, 2009, GASTROENTEROLOGY, V137, P94, DOI 10.1053/j.gastro.2009.03.039; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Brook RA, 2012, DIGEST DIS SCI, V57, P109, DOI 10.1007/s10620-011-1822-8; Brun Rita, 2010, Therap Adv Gastroenterol, V3, P145, DOI 10.1177/1756283X10362639; Chen JYW, 2011, BRAIN RES, V1392, P121, DOI 10.1016/j.brainres.2011.03.069; Chou LT, 2001, J CLIN GASTROENTEROL, V33, P127, DOI 10.1097/00004836-200108000-00007; Chunfang W, 1986, CHIN J NERV MENL DIS, V12, P267; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P235, DOI 10.5056/jnm.2011.17.3.235; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; HAUG TT, 1994, J PSYCHOSOM RES, V38, P281, DOI 10.1016/0022-3999(94)90033-7; HAUG TT, 1995, SCAND J GASTROENTERO, V30, P97, DOI 10.3109/00365529509093244; Hsu YC, 2009, AM J GASTROENTEROL, V104, P2534, DOI 10.1038/ajg.2009.328; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Lorena SLS, 2004, J CLIN GASTROENTEROL, V38, P230, DOI 10.1097/00004836-200403000-00007; Mayer EA, 2009, NEUROGASTROENT MOTIL, V21, P579, DOI 10.1111/j.1365-2982.2009.01304.x; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Mayer EA, 2011, ANNU REV MED, V62, P381, DOI 10.1146/annurev-med-012309-103958; Ringel Y, 2006, DIGEST DIS, V24, P278, DOI 10.1159/000092881; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Talley NJ, 2010, EXPERT REV GASTROENT, V4, P5, DOI 10.1586/EGH.09.73; Talley NJ, 1999, AM J GASTROENTEROL, V94, P2390; Tian XP, 2009, WORLD J GASTROENTERO, V15, P3173, DOI 10.3748/wjg.15.3173; Van Oudenhove L, 2010, GASTROENTEROLOGY, V139, P36, DOI 10.1053/j.gastro.2010.04.015; Van Oudenhove L, 2010, AM J GASTROENTEROL, V105, P913, DOI 10.1038/ajg.2010.39; Vandenberghe J, 2007, GASTROENTEROLOGY, V132, P1684, DOI 10.1053/j.gastro.2007.03.037; Veldhuijzen DS, 2013, PAIN, V154, P548, DOI 10.1016/j.pain.2012.12.019; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wu WY, 1990, SHANGHAI ARCH PSYC S, V2, P44; Zeng F, 2011, GASTROENTEROLOGY, V141, P499, DOI 10.1053/j.gastro.2011.05.003; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou GY, 2013, AM J GASTROENTEROL, V108, P260, DOI 10.1038/ajg.2012.405; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	41	23	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68383	10.1371/journal.pone.0068383	http://dx.doi.org/10.1371/journal.pone.0068383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844192	gold, Green Published, Green Submitted			2022-12-25	WOS:000321341000156
J	Zhang, JB; Yue, TL; Yuan, YH				Zhang, Jiangbo; Yue, Tianli; Yuan, Yahong			Alicyclobacillus Contamination in the Production Line of Kiwi Products in China	PLOS ONE			English	Article							FRUIT PROCESSING ENVIRONMENT; OFF-FLAVOR COMPOUNDS; BACILLUS-ACIDOTERRESTRIS; ORANGE JUICE; SP NOV.; IDENTIFICATION; ACIDOCALDARIUS; RESISTANCE; BACTERIA; SOIL	Alicyclobacillus are spoilage microbes of many juice products, but contamination of kiwi products by Alicyclobacillus is seldom reported. This study aims to investigate the whole production line of kiwi products in China to assess the potential risk of their contamination. A total of 401 samples from 18 commercial products, 1 processing plant and 16 raw material orchards were tested, and 76 samples were positive, from which 76 strains of microbes were isolated and identified as 4 species of Alicyclobacillus, including Alicyclobacillus acidoterrestris, Alicyclobacillus contaminans, Alicyclobacillus herbarius and Alicyclobacillus cycloheptanicus, and another 9 strains as 3 species of Bacillus by sequencing of their 16S rDNA. Through phylogenetic tree construction and RAPD-PCR amplification, it was found that there exist genotypic diversities to some extent among these isolates. Four test strains (each from one species of the 4 Alicyclobacillus species isolated in this study) could spoil pH adjusted kiwi fruit juice and some commercial kiwi fruit products with producing guaiacol (11-34 ppb).	[Zhang, Jiangbo; Yue, Tianli; Yuan, Yahong] Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China	Northwest A&F University - China	Yue, TL (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China.	yuetl@nwsuaf.edu.cn	yue, tianli/AEY-3384-2022	yue, tianli/0000-0002-4768-5831	China State "12th-Five-Year Plan" Scientific and Technological Schemes Support [2012BAK17B06]; National Natural Science Foundation of China [31071550, 31171721]	China State "12th-Five-Year Plan" Scientific and Technological Schemes Support; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the China State "12th-Five-Year Plan" Scientific and Technological Schemes Support (2012BAK17B06) (http://www.most.gov.cn/), and the National Natural Science Foundation of China (31071550, 31171721)(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart J., 2000, FRUIT PROCESS, V10, P251; BLOCHER JC, 1983, FOOD TECHNOL-CHICAGO, V37, P87; Borlinghaus A., 1997, Fruit Processing, V7, P262; CERNY G, 1984, Z LEBENSM UNTERS FOR, V179, P224, DOI 10.1007/BF01041898; Chang SS, 2004, CRIT REV MICROBIOL, V30, P55, DOI 10.1080/10408410490435089; Chen SQ, 2006, FOOD MICROBIOL, V23, P439, DOI 10.1016/j.fm.2005.07.005; Danyluk MD, 2011, FOOD MICROBIOL, V28, P472, DOI 10.1016/j.fm.2010.10.008; De Clerck E, 2004, RES MICROBIOL, V155, P483, DOI 10.1016/j.resmic.2004.02.007; DEINHARD G, 1987, SYST APPL MICROBIOL, V10, P47, DOI 10.1016/S0723-2020(87)80009-7; Durak MZ, 2010, INT J FOOD MICROBIOL, V142, P286, DOI 10.1016/j.ijfoodmicro.2010.07.003; Eiroa MNU, 1999, J FOOD PROTECT, V62, P883, DOI 10.4315/0362-028X-62.8.883; Eisele TA, 2005, J FOOD SCI, V70, pS267, DOI 10.1111/j.1365-2621.2005.tb07201.x; Gocmen D, 2005, LETT APPL MICROBIOL, V40, P172, DOI 10.1111/j.1472-765X.2004.01636.x; Goto K, 2008, LETT APPL MICROBIOL, V46, P289, DOI 10.1111/j.1472-765X.2007.02307.x; Goto K, 2002, EXTREMOPHILES, V6, P333, DOI 10.1007/s00792-001-0262-3; Goto K., 2006, MICROBIOL CULT COLLE, V22, P1; Gouws PA, 2005, INT J FOOD SCI TECH, V40, P789, DOI 10.1111/j.1365-2621.2005.01006.x; Groenewald WH, 2009, FOOD MICROBIOL, V26, P71, DOI 10.1016/j.fm.2008.07.008; Howard I, 2006, ACB WORKSH OCT 2005; Huang H, 2001, NEW ZEAL J CROP HORT, V29, P1, DOI 10.1080/01140671.2001.9514154; IFU (International Federation of Fruit Juice Producers), 2007, 12 IFU, P1; Jensen N, 2003, LETT APPL MICROBIOL, V36, P9, DOI 10.1046/j.1472-765X.2003.01251.x; Jiang CY, 2008, INT J SYST EVOL MICR, V58, P2898, DOI 10.1099/ijs.0.2008/000562-0; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Oteiza JM, 2011, INT J FOOD MICROBIOL, V151, P229, DOI 10.1016/j.ijfoodmicro.2011.09.004; Pettipher GL, 1997, LETT APPL MICROBIOL, V24, P185, DOI 10.1046/j.1472-765X.1997.00373.x; Pinhatti M. E. M. C., 1997, FRUIT PROCESS, V7, P350; Previdi M. P., 1999, Industria Conserve, V74, P231; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDOVAL AJ, 1992, J FOOD SCI, V57, P1369, DOI 10.1111/j.1365-2621.1992.tb06860.x; Siegmund B, 2006, J AGR FOOD CHEM, V54, P5984, DOI 10.1021/jf060602n; Smit Y, 2011, FOOD MICROBIOL, V28, P331, DOI 10.1016/j.fm.2010.11.008; SPLITTSTOESSER DF, 1994, J FOOD PROTECT, V57, P1080, DOI 10.4315/0362-028X-57.12.1080; Steyn CE, 2011, INT J FOOD MICROBIOL, V147, P1, DOI 10.1016/j.ijfoodmicro.2011.03.004; Ten LN, 2006, J MICROBIOL BIOTECHN, V16, P1554; UCHINO F, 1967, AGR BIOL CHEM TOKYO, V31, P817, DOI 10.1080/00021369.1967.10858890; Walker M, 2008, INT J FOOD SCI TECH, V43, P250, DOI 10.1111/j.1365-2621.2006.01427.x; Walls I, 2000, FOOD AUST, V52, P286; Walls I, 1998, DAIRY FOOD ENV SANIT, V18, P99; WISOTZKEY JD, 1992, INT J SYST BACTERIOL, V42, P263, DOI 10.1099/00207713-42-2-263; Wisse C.A., 1998, DIARY FOOD ENV SANIT, V18, P504; Zierler B, 2004, ANAL CHIM ACTA, V520, P3, DOI 10.1016/j.aca.2004.03.084	42	38	44	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67704	10.1371/journal.pone.0067704	http://dx.doi.org/10.1371/journal.pone.0067704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844069	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000080
J	Kao, SH; Wang, WL; Chen, CY; Chang, YL; Wu, YY; Wang, YT; Wang, SP; Nesvizhskii, AI; Chen, YJ; Hong, TM; Yang, PC				Kao, S-H; Wang, W-L; Chen, C-Y; Chang, Y-L; Wu, Y-Y; Wang, Y-T; Wang, S-P; Nesvizhskii, A. I.; Chen, Y-J; Hong, T-M; Yang, P-C			GSK3 beta controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug	ONCOGENE			English	Article						GSK3 beta; Slug; CHIP; post-translational modification	UBIQUITIN LIGASE CHIP; GLYCOGEN-SYNTHASE KINASE-3; E-CADHERIN; TRANSCRIPTION FACTORS; CANCER; PROTEIN; PHOSPHORYLATION; CHAPERONE; INHIBITION; EXPRESSION	Glycogen synthase kinase 3 beta (GSK3 beta) is highly inactivated in epithelial cancers and is known to inhibit tumor migration and invasion. The zinc-finger-containing transcriptional repressor, Slug, represses E-cadherin transcription and enhances epithelial mesenchymal transition (EMT). In this study, we find that the GSK3 beta-pSer9 level is associated with the expression of Slug in non-small cell lung cancer. GSK3 beta-mediated phosphorylation of Slug facilitates Slug protein turnover. Proteomic analysis reveals that the carboxyl terminus of Hsc70-interacting protein (CHIP) interacts with wild-type Slug (wtSlug). Knockdown of CHIP stabilizes the wtSlug protein and reduces Slug ubiquitylation and degradation. In contrast, nonphosphorylatable Slug-4SA is not degraded by CHIP. The accumulation of nondegradable Slug may further lead to the repression of E-cadherin expression and promote cancer cell migration, invasion and metastasis. Our findings provide evidence of a de novo GSK3 beta-CHIP-Slug pathway that may be involved in the progression of metastasis in lung cancer.	[Kao, S-H; Yang, P-C] Natl Taiwan Univ, Inst Mol Med, Taipei 100, Taiwan; [Wang, W-L; Chen, C-Y; Wu, Y-Y; Wang, S-P; Yang, P-C] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, C-Y] Chang Gung Univ Sci & Technol, Dept Nutr & Hlth Sci, Taoyuan, Taiwan; [Chang, Y-L] Natl Taiwan Univ, Dept Pathol, Taipei 100, Taiwan; [Chang, Y-L] Natl Taiwan Univ, Grad Inst Pathol, Taipei 100, Taiwan; [Wu, Y-Y; Hong, T-M] Natl Cheng Kung Univ, Grad Inst Clin Med, Taipei, Taiwan; [Wang, Y-T; Chen, Y-J] Acad Sinica, Chem Biol & Mol Biophys Program, Taiwan Int Grad Program, Taipei 115, Taiwan; [Wang, Y-T; Chen, Y-J] Acad Sinica, Inst Chem, Taipei, Taiwan; [Wang, Y-T] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei 100, Taiwan; [Wang, S-P] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA; [Nesvizhskii, A. I.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Nesvizhskii, A. I.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Yang, P-C] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Yang, P-C] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 100, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Chang Gung University of Science & Technology; National Taiwan University; National Taiwan University; National Cheng Kung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Rockefeller University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Hong, TM (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Med, 138 Sheng Li Rd, Tainan 704, Taiwan.	tmhong@mail.ncku.edu.tw; pcyang@ntu.edu.tw	Wang, Shu-Ping/S-4379-2018; Nesvizhskii, Alexey/A-5410-2012; Chen, Yu-Ju/E-9481-2015	Wang, Shu-Ping/0000-0002-5895-1269; Nesvizhskii, Alexey/0000-0002-2806-7819; Chen, Yu-Ju/0000-0002-3178-6697; CHANG, YIH-LEONG/0000-0001-5309-0554; YANG, PAN-CHYR/0000-0001-6330-6048	National Science Council, Taiwan [NSC99-2628-B-006-031-MY3 NSC101-2325-B-006-018, NSC100-2321-8-002-071, NSC101-2321-B002-068]; National Taiwan University, Taiwan [10R71601-2]; National Institute of Health, USA [R01-GM-094231]; Human Frontier Science Program long-term fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094231] Funding Source: NIH RePORTER	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University); National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program long-term fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank MC Hung (Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, USA) for providing the plasmids for GSK3 beta, and Wen-Lung Wang, Yi-Ying Wu, Chi-Yuan Chen for technical assistance. This work was supported by grants from the National Science Council, Taiwan (NSC99-2628-B-006-031-MY3 NSC101-2325-B-006-018, NSC100-2321-8-002-071 and NSC101-2321-B002-068), National Taiwan University, Taiwan (10R71601-2), and National Institute of Health, USA (R01-GM-094231, to AIN). SP Wang is supported by a Human Frontier Science Program long-term fellowship. shRNA constructs were obtained from the National RNAi Core Facility at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, Taipei, Taiwan.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Al-Mulla F, 2011, CANCER RES, V71, P1334, DOI 10.1158/0008-5472.CAN-10-3102; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Cheng JC, PLOS ONE, V7; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DEGROOT RP, 1993, ONCOGENE, V8, P841; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; G-Amlak M, 2002, BIOCHEM BIOPH RES CO, V297, P760, DOI 10.1016/S0006-291X(02)02278-7; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hajra KM, 2002, CANCER RES, V62, P1613; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; John JK, 2012, J INVEST DERMATOL, V132, P2818, DOI 10.1038/jid.2012.237; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karrasch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026340; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kim JY, 2012, FEBS J, V279, P2929, DOI 10.1111/j.1742-4658.2012.08674.x; Lee HY, 2005, CLIN CANCER RES, V11, P6065, DOI 10.1158/1078-0432.CCR-05-0009; Leis H, 2002, MOL CARCINOGEN, V35, P180, DOI 10.1002/mc.10087; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Patel R, 2013, J CLIN INVEST, V123, P1157, DOI 10.1172/JCI63672; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang SY, 2013, GUT, V62, P496, DOI 10.1136/gutjnl-2011-301522; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yang L, 2007, CANCER RES, V67, P5587, DOI 10.1158/0008-5472.CAN-06-2287; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zheng HC, 2007, ANTICANCER RES, V27, P3561; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	68	92	94	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 12	2014	33	24					3172	3182		10.1038/onc.2013.279	http://dx.doi.org/10.1038/onc.2013.279			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK4QU	23851495	Green Accepted			2022-12-25	WOS:000338410000010
J	Liu, LL; Xie, N; Sun, S; Plymate, S; Mostaghel, E; Dong, X				Liu, L. L.; Xie, N.; Sun, S.; Plymate, S.; Mostaghel, E.; Dong, X.			Mechanisms of the androgen receptor splicing in prostate cancer cells	ONCOGENE			English	Article						prostate cancer; androgen deprivation therapy; RNA splice variant; alternative splicing	GENE-EXPRESSION; TRANSCRIPTION; PROGRESSION; VARIANTS; RESISTANCE; RECRUITMENT; THERAPIES; RESOURCE; PSF	Prostate tumors develop resistance to androgen deprivation therapy (ADT) by multiple mechanisms, one of which is to express constitutively active androgen receptor (AR) splice variants lacking the ligand-binding domain. AR splice variant 7 (AR-V7, also termed AR3) is the most abundantly expressed variant that drives prostate tumor progression under ADT conditions. However, the molecular mechanism by which AR-V7 is generated remains unclear. In this manuscript, we demonstrated that RNA splicing of AR-V7 in response to ADT was closely associated with AR gene transcription initiation and elongation rates. Enhanced AR gene transcription by ADT provides a prerequisite condition that further increases the interactions between AR pre-mRNA and splicing factors. Under ADT conditions, recruitment of several RNA splicing factors to the 3' splicing site for AR-V7 was increased. We identified two RNA splicing enhancers and their binding proteins (U2AF65 and ASF/SF2) that had critical roles in splicing AR pre-mRNA into AR-V7. These data indicate that ADT-induced AR gene transcription rate and splicing factor recruitment to AR pre-mRNA contribute to the enhanced AR-V7 levels in prostate cancer cells.	[Liu, L. L.; Xie, N.; Dong, X.] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Sun, S.; Plymate, S.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98104 USA; [Sun, S.; Plymate, S.] VAPSHCS GRECC, Seattle, WA 98104 USA; [Mostaghel, E.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Dong, X.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of British Columbia; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; Fred Hutchinson Cancer Center; University of Toronto	Plymate, S (corresponding author), Univ Washington, Sch Med, Dept Med, Box 359625,325 9th Ave, Seattle, WA 98104 USA.	splymate@u.washington.edu; xdong@prostatecentre.com	Dong, Xuesen/AGF-9228-2022		Pacific Northwest Prostate Cancer SPORE, National Cancer Institute [P50CA097186]; Prostate Cancer Canada [RS2013-58]; Canadian Institute of Health Research [MOP-97934]; Department of Defence plus Veterans Administration Grants; Prostate Cancer Foundation; NIH [P01 CA163227]; NATIONAL CANCER INSTITUTE [P01CA163227, P50CA097186] Funding Source: NIH RePORTER	Pacific Northwest Prostate Cancer SPORE, National Cancer Institute; Prostate Cancer Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Defence plus Veterans Administration Grants; Prostate Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Pacific Northwest Prostate Cancer SPORE, National Cancer Institute (P50CA097186; XD and SRP); Prostate Cancer Canada (RS2013-58; to XD) and Canadian Institute of Health Research (MOP-97934; XD); Department of Defence plus Veterans Administration Grants (SRP), NIH P01 CA163227 (SRP) and Prostate Cancer Foundation (SRP).	Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Chew SL, 1999, P NATL ACAD SCI USA, V96, P10655, DOI 10.1073/pnas.96.19.10655; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Heemers HV, 2010, PROSTATE, V70, P959, DOI 10.1002/pros.21130; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Olshavsky NA, 2010, CANCER RES, V70, P3975, DOI 10.1158/0008-5472.CAN-09-3468; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Rokhlin OW, 2006, MOL CANCER RES, V4, P113, DOI 10.1158/1541-7786.MCR-05-0085; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Xie N, 2012, MOL ENDOCRINOL, V26, P1370, DOI 10.1210/me.2012-1088; Yang X, 2011, J BIOL CHEM, V286, P36152, DOI 10.1074/jbc.M111.265124; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970	48	214	223	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 12	2014	33	24					3140	3150		10.1038/onc.2013.284	http://dx.doi.org/10.1038/onc.2013.284			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK4QU	23851510	Green Accepted			2022-12-25	WOS:000338410000007
J	Darr, J; Klochendler, A; Isaac, S; Eden, A				Darr, J.; Klochendler, A.; Isaac, S.; Eden, A.			Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis	ONCOGENE			English	Article						SMARCB1/Snf5; Swi/Snf; malignant rhabdoid tumors	TUMOR-SUPPRESSOR GENE; CHROMATIN REMODELING COMPLEX; FACTOR BINDING-PROTEINS; CELL-CYCLE ARREST; GROWTH-FACTOR; SWI/SNF COMPLEX; RHABDOID TUMORS; BREAST-CANCER; INSULIN; APOPTOSIS	SMARCB1 (Snf5/Ini1/Baf47) is a potent tumor suppressor, the loss of which serves as the diagnostic feature in malignant rhabdoid tumors (MRT) and atypical teratoid/rhabdoid tumors (AT/RT), two highly aggressive forms of pediatric neoplasms. SMARCB1 is a core subunit of Swi/Snf chromatin remodeling complexes, and loss of SMARCB1 or other subunits of these complexes has been observed in a variety of tumor types. Here, we restore Smarcb1 expression in cells derived from Smarcb1-deficient tumors, which developed in Smarcb1 heterozygous p53(-/-) mice. We find that while re-introduction of Smarcb1 does not induce growth arrest, it restores sensitivity to programmed cell death and completely abolishes the ability of the tumor cells to grow as xenografts. We describe persistent activation of AKT signaling in Smarcb1-deficient cells, which stems from PI3K (phosphatidylinositol 3'-kinase)-mediated signaling and which contributes to the survival and proliferation of the tumor cells. We further demonstrate that inhibition of AKT is effective in preventing proliferation of Smarcb1-deficient cells in vitro and inhibits the development of xenografted tumors in vivo. Profiling Smarcb1-dependent gene expression, we find genes that require Smarcb1 and Swi/Snf for their expression to be enriched for extracellular matrix and cell adhesion functions. We find that Smarcb1 is required for transcriptional activation of Igfbp7, a member of the insulin-like growth factor-binding proteins family and a tumor suppressor in itself, and show that re-introduction of Igfbp7 alone can hinder tumor development. Our results define a novel mechanism for Smarcb1-mediated tumorigenesis and highlight potential therapeutic targets.	[Darr, J.; Klochendler, A.; Isaac, S.; Eden, A.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Eden, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Dev Biol, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	eden@vms.huji.ac.il		Jonatan, Darr/0000-0002-2992-4448	Israel Cancer Research Fund (ICRF) [2011-3094-PG]; Association for International Cancer Research [AICR 03-109]	Israel Cancer Research Fund (ICRF); Association for International Cancer Research	We thank Dr Ittai Ben-Porath, Professor Eli Keshet and Professor Alex Levitzki for reagents and helpful discussions. This work was funded by the Israel Cancer Research Fund (ICRF, 2011-3094-PG) and by the Association for International Cancer Research (AICR 03-109).	Ae K, 2002, ONCOGENE, V21, P3112, DOI 10.1038/sj.onc.1205414; Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Ahmed S, 2003, BIOCHEM BIOPH RES CO, V310, P612, DOI 10.1016/j.bbrc.2003.09.058; Arcaro A, 2007, BIOCHEM J, V406, P57, DOI 10.1042/BJ20070309; Barzily-Rokni M, 2011, NUCLEIC ACIDS RES, V39, P1326, DOI 10.1093/nar/gkq994; Beattie J, 2009, BIOCHEM BIOPH RES CO, V381, P572, DOI 10.1016/j.bbrc.2009.02.088; Benatar T, 2012, BREAST CANCER RES TR, V133, P563, DOI 10.1007/s10549-011-1816-4; Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burger AM, 2005, EUR J CANCER, V41, P1515, DOI 10.1016/j.ejca.2005.04.023; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Charboneau A, 2006, J CELL PHYSIOL, V209, P422, DOI 10.1002/jcp.20737; Chen D, 2011, CLIN CANCER RES, V17, P6693, DOI 10.1158/1078-0432.CCR-10-2774; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; CollettSolberg PF, 1996, ENDOCRIN METAB CLIN, V25, P591, DOI 10.1016/S0889-8529(05)70342-X; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; FIGUEROA JA, 1993, J CELL PHYSIOL, V157, P229, DOI 10.1002/jcp.1041570204; Foster K, 2009, CANCER CHEMOTH PHARM, V63, P783, DOI 10.1007/s00280-008-0796-5; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hollmann TJ, 2011, AM J SURG PATHOL, V35, pE47, DOI 10.1097/PAS.0b013e31822b325b; Hooper AT, 2009, CIRC RES, V105, P201, DOI 10.1161/CIRCRESAHA.109.196790; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jozwiak J, 2010, FOLIA NEUROPATHOL, V48, P185; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Medjkane S, 2004, CANCER RES, V64, P3406, DOI 10.1158/0008-5472.CAN-03-3004; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MUCHARDT C, 1995, NUCLEIC ACIDS RES, V23, P1127, DOI 10.1093/nar/23.7.1127; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Nocentini S, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-11; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; Pen A, 2011, CANCER BIOL THER, V12, P634, DOI 10.4161/cbt.12.7.17171; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Reincke BS, 2003, J CELL PHYSIOL, V194, P303, DOI 10.1002/jcp.10201; Reisman DN, 2003, CANCER RES, V63, P560; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sato Y, 2007, CANCER SCI, V98, P1055, DOI 10.1111/j.1349-7006.2007.00502.x; Smith MJ, 2012, HUM MOL GENET, V21, P5239, DOI 10.1093/hmg/dds370; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamura K, 2009, EUR J PHARMACOL, V610, P61, DOI 10.1016/j.ejphar.2009.01.045; Tsikitis M, 2005, P NATL ACAD SCI USA, V102, P12129, DOI 10.1073/pnas.0505300102; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 2002, ONCOGENE, V21, P6403, DOI 10.1038/sj.onc.1205841; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vizioli MG, 2010, ONCOGENE, V29, P3835, DOI 10.1038/onc.2010.136; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	63	24	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 5	2014	33	23					3024	3032		10.1038/onc.2013.261	http://dx.doi.org/10.1038/onc.2013.261			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EL	23851500				2022-12-25	WOS:000337232200009
J	Salomon, C; Ryan, J; Sobrevia, L; Kobayashi, M; Ashman, K; Mitchell, M; Rice, GE				Salomon, Carlos; Ryan, Jennifer; Sobrevia, Luis; Kobayashi, Miharu; Ashman, Keith; Mitchell, Murray; Rice, Gregory E.			Exosomal Signaling during Hypoxia Mediates Microvascular Endothelial Cell Migration and Vasculogenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BLOOD; INHIBITION; PROTEOMICS; MECHANISM; BIOMARKER; PROTEINS	Vasculogenesis and angiogenesis are critical processes in fetal circulation and placental vasculature development. Placental mesenchymal stem cells (pMSC) are known to release paracrine factors (some of which are contained within exosomes) that promote angiogenesis and cell migration. The aims of this study were: to determine the effects of oxygen tension on the release of exosomes from pMSC; and to establish the effects of pMSC-derived exosomes on the migration and angiogenic tube formation of placental microvascular endothelial cells (hPMEC). pMSC were isolated from placental villi (8-12 weeks of gestation, n = 6) and cultured under an atmosphere of 1%, 3% or 8% O-2. Cell-conditioned media were collected and exosomes (exo-pMSC) isolated by differential and buoyant density centrifugation. The dose effect (5-20 mu g exosomal protein/ml) of pMSC-derived exosomes on hPMEC migration and tube formation were established using a real-time, live-cell imaging system (Incucyte (TM)). The exosome pellet was resuspended in PBS and protein content was established by mass spectrometry (MS). Protein function and canonical pathways were identified using the PANTHER program and Ingenuity Pathway Analysis, respectively. Exo-pMSC were identified, by electron microscopy, as spherical vesicles, with a typical cup-shape and diameters around of 100 nm and positive for exosome markers: CD63, CD9 and CD81. Under hypoxic conditions (1% and 3% O-2) exo-pMSC released increased by 3.3 and 6.7 folds, respectively, when compared to the controls (8% O-2; p<0.01). Exo-pMSC increased hPMEC migration by 1.6 fold compared to the control (p<0.05) and increased hPMEC tube formation by 7.2 fold (p<0.05). MS analysis identified 390 different proteins involved in cytoskeleton organization, development, immunomodulatory, and cell-to-cell communication. The data obtained support the hypothesis that pMSC- derived exosomes may contribute to placental vascular adaptation to low oxygen tension under both physiological and pathological conditions.	[Salomon, Carlos; Ryan, Jennifer; Sobrevia, Luis; Kobayashi, Miharu; Ashman, Keith; Mitchell, Murray; Rice, Gregory E.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia; [Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, Cellular & Mol Physiol Lab,Div Obstet & Gynaecol, Santiago, Chile	University of Queensland; Pontificia Universidad Catolica de Chile	Salomon, C (corresponding author), Univ Queensland, Clin Res Ctr, Herston, Qld, Australia.	c.salomongallo@uq.edu.au	RICE, GREGORY E/F-2412-2010; Mitchell, Murray/A-8639-2010; Salomon, Carlos F/L-2167-2013; Sobrevia, Luis/H-9608-2016; Ashman, Keith/G-2328-2011	RICE, GREGORY E/0000-0001-7177-0246; Mitchell, Murray/0000-0002-6167-7176; Salomon, Carlos F/0000-0003-4474-0046; Sobrevia, Luis/0000-0001-5802-2243	CONICYT (Pasantia Doctoral en el Extranjero BECAS Chile) [ACT-73 PIA]; FONDECYT [1110977]; CONICYT; Faculty of Medicine/PUC	CONICYT (Pasantia Doctoral en el Extranjero BECAS Chile); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Faculty of Medicine/PUC	This research was supported by CONICYT (ACT-73 PIA, Pasantia Doctoral en el Extranjero BECAS Chile) and FONDECYT (1110977). CS holds CONICYT-PhD fellowships and Faculty of Medicine/PUC-PhD fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree MH, 2012, STEM CELL REV; Afroze SH, 2011, MOL CELL BIOCHEM, V354, P291, DOI 10.1007/s11010-011-0829-y; Alderton GK, 2012, NAT REV CANCER, V12, P447, DOI 10.1038/nrc3304; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bullerdiek J, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-27; Burlacu A, 2012, STEM CELLS DEV; Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022; Corrado C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042310; Dai S, 2008, MOL THER, V16, P782, DOI 10.1038/mt.2008.1; De Luca A, 2012, J CELL BIOCHEM, V113, P3363, DOI 10.1002/jcb.24212; English A.C, 2012, PLOS ONE, V7, pe47768; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gross JC, 2012, NATURE CELL BIOL, V14, P1036; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hofmann NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044468; Im E, 2007, J BIOL CHEM, V282, P29122, DOI 10.1074/jbc.M702637200; Jauniaux Eric, 2003, Reprod Biomed Online, V7, P250; Jung JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044572; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kshirsagar SK, 2012, PLACENTA; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lee C, 2012, CIRCULATION; Li Guo, 2011, Adv Exp Med Biol, V720, P51, DOI 10.1007/978-1-4614-0254-1_5; Li YY, 2011, ELECTROPHORESIS, V32, P1976, DOI 10.1002/elps.201000598; Liang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046158; Liu Y, 2008, EXP CELL RES, V314, P774, DOI 10.1016/j.yexcr.2007.10.008; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Pisitkun T, 2012, PROTEOM CLIN APPL, V6, P268, DOI 10.1002/prca.201100108; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Salomon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040578; Steigman Shaun A, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e02s1; Thebaud B, 2012, CIRCULATION, V126, P2553, DOI 10.1161/CIRCULATIONAHA.112.146738; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thon JN, 2012, BLOOD, V120, P1975, DOI 10.1182/blood-2012-04-420968; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; Vrijsen KR, 2010, J CELL MOL MED, V14, P1064, DOI 10.1111/j.1582-4934.2010.01081.x; Welt FG, 2012, CIRC HEART FAIL; Welton JL, 2010, MOL CELL PROTEOMICS, V9, P1324, DOI 10.1074/mcp.M000063-MCP201; Xu RX, 2009, CLIN EXP PHARMACOL P, V36, P176, DOI 10.1111/j.1440-1681.2008.05041.x; Zhang HG, 2012, BIOTECH HISTOCHEM, V87, P161, DOI 10.3109/10520291003659042; Zhang HC, 2012, STEM CELLS DEV; Zhang YA, 2010, ELECTROPHORESIS, V31, P3797, DOI 10.1002/elps.201000401; Zhang ZY, 2012, BIOMATERIALS, V33, P2656, DOI 10.1016/j.biomaterials.2011.12.025; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	55	228	242	9	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68451	10.1371/journal.pone.0068451	http://dx.doi.org/10.1371/journal.pone.0068451			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861904	gold, Green Published, Green Submitted			2022-12-25	WOS:000321692000028
J	Boote, C; Dooley, EP; Gardner, SJ; Kamma-Lorger, CS; Hayes, S; Nielsen, K; Hjortdal, J; Sorensen, T; Terrill, NJ; Meek, KM				Boote, Craig; Dooley, Erin P.; Gardner, Steven J.; Kamma-Lorger, Christina S.; Hayes, Sally; Nielsen, Kim; Hjortdal, Jesper; Sorensen, Thomas; Terrill, Nicholas J.; Meek, Keith M.			Quantification of Collagen Ultrastructure after Penetrating Keratoplasty - Implications for Corneal Biomechanics	PLOS ONE			English	Article							RAY-SCATTERING TECHNIQUES; WOUND DEHISCENCE; ORIENTATION; ORGANIZATION; FIBRILS; TISSUE; STROMA; EYES	Purpose: To quantify long-term changes in stromal collagen ultrastructure following penetrating keratoplasty (PK), and evaluate their possible implications for corneal biomechanics. Methods: A pair of 16 mm post-mortem corneo-scleral buttons was obtained from a patient receiving bilateral penetrating keratoplasty 12 (left)/28 (right) years previously. Small-angle x-ray scattering quantified collagen fibril spacing, diameter and spatial order at 0.5 mm or 0.25 mm intervals along linear scans across the graft margin. Corresponding control data was collected from two corneo-scleral buttons with no history of refractive surgery. Wide-angle x-ray scattering quantified collagen fibril orientation at 0.25 mm (horizontal) x0.25 mm (vertical) intervals across both PK specimens. Quantification of orientation changes in the graft margin were verified by equivalent analysis of data from a 13 year post-operative right PK specimen obtained from a second patient in a previous study, and comparison made with new and published data from normal corneas. Results: Marked changes to normal fibril alignment, in favour of tangentially oriented collagen, were observed around the entire graft margin in all PK specimens. The total number of meridional fibrils in the wound margin was observed to decrease by up to 40%, with the number of tangentially oriented fibrils increasing by up to 46%. As a result, in some locations the number of fibrils aligned parallel to the wound outnumbered those spanning it by up to five times. Localised increases in fibril spacing and diameter, with an accompanying reduction in matrix order, were also evident. Conclusions: Abnormal collagen fibril size and spatial order within the PK graft margin are indicative of incomplete stromal wound remodelling and the long term persistence of fibrotic scar tissue. Lasting changes in collagen fibril orientation in and around PK wounds may alter corneal biomechanics and compromise the integrity of the graft-host interface in the long term.	[Boote, Craig; Dooley, Erin P.; Gardner, Steven J.; Kamma-Lorger, Christina S.; Hayes, Sally; Meek, Keith M.] Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Grp, Cardiff CF10 3AX, S Glam, Wales; [Nielsen, Kim; Hjortdal, Jesper] Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus, Denmark; [Sorensen, Thomas; Terrill, Nicholas J.] Diamond Light Source, Didcot, Oxon, England	Cardiff University; Aarhus University; Diamond Light Source	Meek, KM (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Grp, Cardiff CF10 3AX, S Glam, Wales.	meekkm@cf.ac.uk	Terrill, Nick J/D-2639-2017; Sørensen, Thomas Lykke-Møller/AAA-7052-2020	Terrill, Nick J/0000-0002-8783-1282; Boote, Craig/0000-0003-0348-6547; Hayes, Sally/0000-0001-8550-0108; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499	Medical Research Council [G0600755, MR/K000837/1]; MRC [MR/K000837/1, G0600755] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council (Grants G0600755 and MR/K000837/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abahussin M, 2009, INVEST OPHTH VIS SCI, V50, P5159, DOI 10.1167/iovs.09-3669; Aghamohammadzadeh H, 2004, STRUCTURE, V12, P249, DOI 10.1016/j.str.2004.01.002; Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Boote C, 2012, INVEST OPHTH VIS SCI, V53, P2786, DOI 10.1167/iovs.11-9305; Boote C, 2011, BIOPHYS J, V101, P33, DOI 10.1016/j.bpj.2011.05.029; BORCHERDING MS, 1975, EXP EYE RES, V21, P59, DOI 10.1016/0014-4835(75)90057-3; Boyce BL, 2008, BIOMATERIALS, V29, P3896, DOI 10.1016/j.biomaterials.2008.06.011; CALKINS JL, 1981, INVEST OPHTH VIS SCI, V21, P322; CINTRON C, 1973, EXP EYE RES, V17, P251, DOI 10.1016/0014-4835(73)90176-0; Connon CJ, 2003, WOUND REPAIR REGEN, V11, P71, DOI 10.1046/j.1524-475X.2003.11111.x; Dawson DG, 2005, AM J OPHTHALMOL, V139, P168, DOI 10.1016/j.ajo.2004.08.078; Daxer A, 1997, INVEST OPHTH VIS SCI, V38, P121; FARLEY MK, 1987, AM J OPHTHALMOL, V104, P44, DOI 10.1016/0002-9394(87)90291-1; Farrell R., 2000, PRINCIPLES PRACTICE, P629; Hayes S, 2010, EYE, V24, P728, DOI 10.1038/eye.2009.159; Kamma-Lorger CS, 2009, EXP EYE RES, V88, P953, DOI 10.1016/j.exer.2008.12.005; Kamma-Lorger CS, 2009, MOL VIS, V15, P378; LANG GK, 1986, AM J OPHTHALMOL, V101, P28, DOI 10.1016/0002-9394(86)90461-7; Meek Keith M, 2009, Biophys Rev, V1, P83, DOI 10.1007/s12551-009-0011-x; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; Meek KM, 2003, MATRIX BIOL, V22, P467, DOI 10.1016/S0945-053X(03)00081-7; Meek KM, 2001, PROG RETIN EYE RES, V20, P95, DOI 10.1016/S1350-9462(00)00016-1; Meek KM, 1999, J REFRACT SURG, V15, P695; MELLES GR, 1990, ARCH OPHTHALMOL-CHIC, V108, P1460, DOI 10.1001/archopht.1990.01070120108039; MORRISON JC, 1982, ARCH OPHTHALMOL-CHIC, V100, P1835; MORRISON JC, 1982, OPHTHALMOLOGY, V89, P715; MORRISON JC, 1983, ARCH OPHTHALMOL-CHIC, V101, P1927; Nguyen TD, 2011, BIOMECH MODEL MECHAN, V10, P323, DOI 10.1007/s10237-010-0237-3; Pettinelli DJ, 2005, ARCH OPHTHALMOL-CHIC, V123, P853, DOI 10.1001/archopht.123.6.853; Pramanik S, 2006, OPHTHALMOLOGY, V113, P1633, DOI 10.1016/j.ophtha.2006.02.058; RAWE IM, 1994, BIOPHYS J, V67, P1743, DOI 10.1016/S0006-3495(94)80648-4; SEN DK, 1969, ACTA OPHTHALMOL, V47, P1041; SMELSER GK, 1965, EXP EYE RES, V4, P349, DOI 10.1016/S0014-4835(65)80051-3; Steele C, 2009, OPTOMETRY TODAY, V24, P28; Vrana E, 2008, J BIOMED MATER RES A, V84A, P454, DOI 10.1002/jbm.a.31442	37	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68166	10.1371/journal.pone.0068166	http://dx.doi.org/10.1371/journal.pone.0068166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861866	gold, Green Accepted, Green Published			2022-12-25	WOS:000321425300047
J	Jiang, X; Dong, M; Cheng, JQ; Huang, SC; He, YT; Ma, KF; Tang, BS; Guo, Y				Jiang, Xin; Dong, Ming; Cheng, Jinquan; Huang, Sichun; He, Yitao; Ma, Kefu; Tang, Bingshan; Guo, Yi			Decreased Leukocyte Telomere Length (LTL) Is Associated with Stroke but Unlikely to Be Causative	PLOS ONE			English	Article							PREMATURE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; CIGARETTE-SMOKING; RISK; STRESS; CELLS; WOMEN; LIFE; ATHEROSCLEROSIS; MEN	Aims: Interindividual variability in telomere length is highly heritable. Leukocyte telomere length (LTL) shortening has been shown to be associated with the process of atherosclerosis. But whether the inheritance of LTL is related to stroke is still unclear. The aim of this study was to test if telomere shortening was associated with stroke and whether this association was mainly due to inheritance or acquired cardiovascular risk factors. Methods: Our study was focused on stroke in patients and their siblings. 450 subjects were recruited into this study: 150 patients with ischemic stroke as case group, 150 siblings of patients free of stroke (sibling group) and 150 healthy people as normal control. LTL was measured by real-time Polymerase Chain Reactions. The association between LTL and the cardiovascular risk factors was also determined. Results: A significant decrease of LTL was found in case group when comparing with sibling (0.92 +/- 0.77 vs 1.68 +/- 1.24, p < 0.001) and normal groups (0.92 +/- 0.77 vs 1.95 +/- 1.07, p < 0.001), but no significant difference was found between sibling group and healthy control (p = 0.330). Shorter telomere length was independently associated with hypertension (p = 0.029, OR = 2.189, 95% CI: 1.084-4.421), recent social pressure (p = 0.001, OR = 3.121, 95% CI: 1.597-6.101), age (p = 0.004, OR = 1.055, 95% CI: 1.017-1.093), HDL (p = 0.022, OR = 0.227, 95% CI: 0.064-0.810) and diabetes (p = 0.018, OR = 3.174, 95% CI: 1.221-8.252). Additionally, shortened length of telomere (p = 0.017, OR = 3.996, 95% CI: 1.283-12.774) was an independent risk biomarker for stroke among case and sibling groups. Conclusion: The present study has demonstrated that decreased LTL might be associated with ischemic stroke but unlikely to be causative.	[Jiang, Xin] Jinan Univ, Clin Med Coll 2, Dept Geriatr, Shenzhen, Guangdong, Peoples R China; [Dong, Ming] Shenzhen Univ, Coll Med, Shenzhen, Guangdong, Peoples R China; [Cheng, Jinquan] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Huang, Sichun; He, Yitao; Ma, Kefu; Tang, Bingshan; Guo, Yi] Jinan Univ, Clin Med Coll 2, Dept Neurol, Shenzhen, Guangdong, Peoples R China	Jinan University; Shenzhen University; Shenzhen Center for Disease Control & Prevention (SZCDC); Jinan University	Guo, Y (corresponding author), Jinan Univ, Clin Med Coll 2, Dept Neurol, Shenzhen, Guangdong, Peoples R China.	10473101@qq.com			Medical Scientific Research Foundation of Guangdong Province, China [A2009589]	Medical Scientific Research Foundation of Guangdong Province, China	This paper was supported by Medical Scientific Research Foundation of Guangdong Province, China (No: A2009589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; [Anonymous], 1998, J CLIN EPIDEMIOL, V41, P105; Aviv A, 2012, MUTAT RES-FUND MOL M, V730, P68, DOI 10.1016/j.mrfmmm.2011.05.001; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Chen W, 2009, ATHEROSCLEROSIS, V205, P620, DOI 10.1016/j.atherosclerosis.2009.01.021; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; De Felice B, 2012, GENE, V500, P101, DOI 10.1016/j.gene.2012.03.040; Dei Cas A, 2011, NUTR METAB CARDIOVAS, V21, P512, DOI 10.1016/j.numecd.2009.11.011; Ding H, 2012, STROKE, V43, P658, DOI 10.1161/STROKEAHA.111.637207; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Fyhrquist F, 2011, J Hum Hypertens, V25, P711, DOI 10.1038/jhh.2011.57; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Graakjaer J, 2006, ANN NY ACAD SCI, V1067, P311, DOI 10.1196/annals.1354.042; Graakjaer J, 2006, HUM GENET, V119, P344, DOI 10.1007/s00439-006-0137-x; Kontush A, 2005, ATHEROSCLEROSIS, V182, P277, DOI 10.1016/j.atherosclerosis.2005.03.001; Kurz DJ, 2006, ARTERIOSCL THROM VAS, V26, pE114, DOI 10.1161/01.ATV.0000222961.24912.69; Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mukherjee M, 2009, HEART, V95, P669, DOI 10.1136/hrt.2008.150250; Nofer Jerzy-Roch, 2005, Expert Rev Cardiovasc Ther, V3, P1071, DOI 10.1586/14779072.3.6.1071; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Salpea KD, 2008, J MOL MED, V86, P815, DOI 10.1007/s00109-008-0347-x; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Satoh M, 2009, CLIN SCI, V116, P827, DOI 10.1042/CS20080404; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Warlow CP, 1998, LANCET, V352, pSIII1	33	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68254	10.1371/journal.pone.0068254	http://dx.doi.org/10.1371/journal.pone.0068254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861874	gold, Green Published, Green Submitted			2022-12-25	WOS:000321425300052
J	Katsel, P; Tan, WL; Fam, P; Purohit, DP; Haroutunian, V				Katsel, Pavel; Tan, Weilun; Fam, Peter; Purohit, Dushyant P.; Haroutunian, Vahram			Cycle Checkpoint Abnormalities during Dementia: A Plausible Association with the Loss of Protection against Oxidative Stress in Alzheimer's Disease	PLOS ONE			English	Article							MULTIPLE BRAIN-REGIONS; NEURONAL CELL-DEATH; GENE-EXPRESSION; ATAXIA-TELANGIECTASIA; TAU PHOSPHORYLATION; ELDERLY-PATIENTS; DNA-REPLICATION; RATING-SCALE; G2/M PHASE; SCHIZOPHRENIA	Background: Increasing evidence suggests an association between neuronal cell cycle (CCL) events and the processes that underlie neurodegeneration in Alzheimer's disease (AD). Elevated levels of oxidative stress markers and mitochondrial dysfunction are also among early events in AD. Recent studies have reported the role of CCL checkpoint proteins and tumor suppressors, such as ATM and p53 in the control of glycolysis and oxidative metabolism in cancer, but their involvement in AD remains uncertain. Methods and Findings: In this postmortem study, we measured gene expression levels of eight CCL checkpoint proteins in the superior temporal cortex (STC) of persons with varying severities of AD dementia and compare them to those of cognitively normal controls. To assess whether the CCL changes associated with cognitive impairment in AD are specific to dementia, gene expression of the same proteins was also measured in STC of persons with schizophrenia (SZ), which is also characterized by mitochondrial dysfunction. The expression of CCL-checkpoint and DNA damage response genes: MDM4, ATM and ATR was strongly upregulated and associated with progression of dementia (cognitive dementia rating, CDR), appearing as early as questionable or mild dementia (CDRs 0.5-1). In addition to gene expression changes, the downstream target of ATM-p53 signaling - TIGAR, a p53-inducible protein, the activation of which can regulate energy metabolism and protect against oxidative stress was progressively decreased as severity of dementia evolved, but it was unaffected in subjects with SZ. In contrast to AD, different CCL checkpoint proteins, which include p53, CHEK1 and BRCA1 were significantly downregulated in SZ. Conclusions: These results support the activation of an ATM signaling and DNA damage response network during the progression of AD dementia, while the progressive decrease in the levels of TIGAR suggests loss of protection initiated by ATM-p53 signaling against intensifying oxidative stress in AD.	[Katsel, Pavel; Tan, Weilun; Haroutunian, Vahram] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Fam, Peter; Haroutunian, Vahram] James J Peters VA Med Ctr, Dept Psychiat, Bronx, NY USA; [Haroutunian, Vahram] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Purohit, Dushyant P.] Mt Sinai Sch Med, Dept Pathol, New York, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Katsel, P (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY USA.	pavel.katsel@mssm.edu			National Institutes of Health [P01-AG02219, P50-AG05138, MH066392, MH064673]; Veteran Administration MIRECC, Leir Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066392, R01MH064673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002219, P50AG005138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Administration MIRECC, Leir Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (P01-AG02219, P50-AG05138, MH066392 and by MH064673 to VH), Veteran Administration MIRECC, Leir Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Arendt T, 2012, MOL NEUROBIOL, V46, P125, DOI 10.1007/s12035-012-8262-0; Bajic VP, 2011, CELL MOL BIOL LETT, V16, P359, DOI 10.2478/s11658-011-0011-2; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; Benes FM, 2003, ARCH GEN PSYCHIAT, V60, P359, DOI 10.1001/archpsyc.60.4.359; Benes FM, 2009, P NATL ACAD SCI USA, V106, P11731, DOI 10.1073/pnas.0903066106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bonda DJ, 2009, AGING-US, V1, P382, DOI 10.18632/aging.100044; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Budhraja V, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-1; Chen JM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-60; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; Conejero-Goldberg C, 2008, J MOL NEUROSCI, V35, P143, DOI 10.1007/s12031-008-9044-z; Copani A, 1999, FASEB J, V13, P2225, DOI 10.1096/fasebj.13.15.2225; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Di Domenico F, 2009, NEUROCHEM RES, V34, P727, DOI 10.1007/s11064-009-9924-9; Dooneief G, 1996, NEUROLOGY, V46, P1746, DOI 10.1212/WNL.46.6.1746; Ekins S, 2006, DRUG METAB DISPOS, V34, P495, DOI 10.1124/dmd.105.008458; Evans Teresa A, 2007, Int J Med Sci, V4, P140; Fillenbaum GG, 1996, AGING-CLIN EXP RES, V8, P379, DOI 10.1007/BF03339599; Girard PM, 2002, ONCOGENE, V21, P4191, DOI 10.1038/sj.onc.1205596; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Haroutunian V, 2009, NEUROBIOL AGING, V30, P561, DOI 10.1016/j.neurobiolaging.2007.07.021; Haroutunian V, 2008, ARCH NEUROL-CHICAGO, V65, P1211, DOI 10.1001/archneur.65.9.1211; Haroutunian V, 2006, AM J PSYCHIAT, V163, P1834, DOI 10.1176/appi.ajp.163.10.1834; Harris PLR, 2000, NEUROBIOL AGING, V21, P837, DOI 10.1016/S0197-4580(00)00218-9; Herrup Karl, 2012, Front Biosci (Elite Ed), V4, P2101; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Kallhoff-Munoz V, 2008, J NEUROSCI, V28, P11421, DOI 10.1523/JNEUROSCI.2873-08.2008; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Katsel P, 2005, SCHIZOPHR RES, V77, P241, DOI 10.1016/j.schres.2005.03.020; Katsel P, 2009, PLOS ONE, V4, P7642; Katsel P, 2008, NEUROPSYCHOPHARMACOL, V33, P2993, DOI 10.1038/npp.2008.19; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Kerns D, 2010, SCHIZOPHR RES, V120, P150, DOI 10.1016/j.schres.2010.04.012; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lu PJ, 1999, NATURE, V399, P784; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Madan E, 2012, BRIT J CANCER, V107, P516, DOI 10.1038/bjc.2012.260; Mariani TJ, 2002, FASEB J, V16, P321, DOI 10.1096/fj.02-0351fje; Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X; McShea A, 1997, AM J PATHOL, V150, P1933; McShea A, 2007, BBA-MOL BASIS DIS, V1772, P467, DOI 10.1016/j.bbadis.2006.09.010; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MIRRA SS, 1987, GUIDE CERAD PROTOCOL; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Ogawa O, 2003, ACTA NEUROPATHOL, V105, P524, DOI 10.1007/s00401-003-0684-3; Ogawa O, 2003, AGING CELL, V2, P105, DOI 10.1046/j.1474-9728.2003.00042.x; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Previll LA, 2007, NEUROCHEM RES, V32, P639, DOI 10.1007/s11064-006-9146-3; Purohit DP, 1998, ARCH GEN PSYCHIAT, V55, P205, DOI 10.1001/archpsyc.55.3.205; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; SMITH TW, 1995, J NEUROPATH EXP NEUR, V54, P297, DOI 10.1097/00005072-199505000-00002; Sourlingas TG, 2003, PSYCHIAT RES, V118, P55, DOI 10.1016/S0165-1781(03)00041-6; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Thakur A, 2008, INT J CLIN EXP PATHO, V1, P134; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Uberti D, 2008, NEURODEGENER DIS, V5, P209, DOI 10.1159/000113704; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Yang Y, 2003, J NEUROSCI, V23, P2557; Yurov YB, 2001, BRAIN DEV-JPN, V23, pS186, DOI 10.1016/S0387-7604(01)00363-1; Yurov YB, 2008, SCHIZOPHR RES, V98, P139, DOI 10.1016/j.schres.2007.07.035; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhu X, 2008, NEUROPATH APPL NEURO, V34, P457, DOI 10.1111/j.1365-2990.2007.00908.x; Zhu XW, 2004, J NEUROSCI RES, V75, P698, DOI 10.1002/jnr.20028; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462	85	44	44	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68361	10.1371/journal.pone.0068361	http://dx.doi.org/10.1371/journal.pone.0068361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861893	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300059
J	Lemay, DG; Ballard, OA; Hughes, MA; Morrow, AL; Horseman, ND; Nommsen-Rivers, LA				Lemay, Danielle G.; Ballard, Olivia A.; Hughes, Maria A.; Morrow, Ardythe L.; Horseman, Nelson D.; Nommsen-Rivers, Laurie A.			RNA Sequencing of the Human Milk Fat Layer Transcriptome Reveals Distinct Gene Expression Profiles at Three Stages of Lactation	PLOS ONE			English	Article							GROWTH-FACTOR-I; MAMMARY-GLAND; DELAYED-ONSET; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; RISK-FACTORS; IDENTIFICATION; FREQUENCY; INFLAMMATION; NETWORKS	Aware of the important benefits of human milk, most U.S. women initiate breastfeeding but difficulties with milk supply lead some to quit earlier than intended. Yet, the contribution of maternal physiology to lactation difficulties remains poorly understood. Human milk fat globules, by enveloping cell contents during their secretion into milk, are a rich source of mammary cell RNA. Here, we pair this non-invasive mRNA source with RNA-sequencing to probe the milk fat layer transcriptome during three stages of lactation: colostral, transitional, and mature milk production. The resulting transcriptomes paint an exquisite portrait of human lactation. The resulting transcriptional profiles cluster not by postpartum day, but by milk Na:K ratio, indicating that women sampled during similar postpartum time frames could be at markedly different stages of gene expression. Each stage of lactation is characterized by a dynamic range (10(5)-fold) in transcript abundances not previously observed with microarray technology. We discovered that transcripts for isoferritins and cathepsins are strikingly abundant during colostrum production, highlighting the potential importance of these proteins for neonatal health. Two transcripts, encoding beta-casein (CSN2) and alpha-lactalbumin (LALBA), make up 45% of the total pool of mRNA in mature lactation. Genes significantly expressed across all stages of lactation are associated with making, modifying, transporting, and packaging milk proteins. Stage-specific transcripts are associated with immune defense during the colostral stage, up-regulation of the machinery needed for milk protein synthesis during the transitional stage, and the production of lipids during mature lactation. We observed strong modulation of key genes involved in lactose synthesis and insulin signaling. In particular, protein tyrosine phosphatase, receptor type, F (PTPRF) may serve as a biomarker linking insulin resistance with insufficient milk supply. This study provides the methodology and reference data set to enable future targeted research on the physiological contributors of sub-optimal lactation in humans.	[Lemay, Danielle G.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Ballard, Olivia A.; Hughes, Maria A.; Morrow, Ardythe L.; Nommsen-Rivers, Laurie A.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Ballard, Olivia A.; Morrow, Ardythe L.; Horseman, Nelson D.; Nommsen-Rivers, Laurie A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	University of California System; University of California Davis; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Nommsen-Rivers, LA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	laurie.nommsen-rivers@cchmc.org		Lemay, Danielle/0000-0003-3318-0485	Cincinnati Children's Hospital Perinatal Institute; National Center for Research Resources (NCRR) [P51RR000169-49S1]; National Center for Advancing Translational Sciences [NIH 8 UL1 TR000077-04]; National Institutes of Health (NIH) [HD13021]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Perinatal Institute; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the Cincinnati Children's Hospital Perinatal Institute (http://www.cincinnatichildrens.org/service/p/perinatal/default/); Cincinnati Diabetes and Obesity Center (http://diabetes.uc.edu/Research/Overview.aspx); National Center for Research Resources (NCRR) (P51RR000169-49S1); the National Center for Advancing Translational Sciences (NIH 8 UL1 TR000077-04); and National Institutes of Health (NIH) HD13021. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; AROSIO P, 1986, CLIN CHIM ACTA, V161, P201, DOI 10.1016/0009-8981(86)90213-5; Barboza M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015248; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Berlato C, 2009, ENDOCRINOLOGY, V150, P2924, DOI 10.1210/en.2008-0668; Bernier-Dodier P, 2010, J DAIRY SCI, V93, P555, DOI 10.3168/jds.2009-2320; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Chagnon MJ, 2004, BIOCHEM CELL BIOL, V82, P664, DOI 10.1139/O04-120; Chapman DJ, 1999, J AM DIET ASSOC, V99, P450, DOI 10.1016/S0002-8223(99)00109-1; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Dallas DC, 2013, J PROTEOME RES, V12, P2295, DOI 10.1021/pr400212z; Declercq E, 2009, AM J PUBLIC HEALTH, V99, P929, DOI 10.2105/AJPH.2008.135236; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Filteau SM, 1999, IMMUNOLOGY, V97, P595, DOI 10.1046/j.1365-2567.1999.00834.x; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Garcia-San Frutos M, 2012, MECH AGEING DEV, V133, P489, DOI 10.1016/j.mad.2012.06.001; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491; Geraghty SR, 2010, J HUM LACT, V26, P49, DOI 10.1177/0890334409347467; Gunderson EP, 2010, DIABETES, V59, P495, DOI 10.2337/db09-1197; Hauck FR, 2011, PEDIATRICS, V128, P103, DOI 10.1542/peds.2010-3000; Hill P D, 1994, J Hum Lact, V10, P79, DOI 10.1177/089033449401000212; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Institute of Medicine Committee on Obesity Prevention Policies for Young Children, 2011, EARLY CHILDH OB PREV; Ip S, 2007, BREASTFEEDING MATERN; Jackson JG, 2004, J NUTR BIOCHEM, V15, P517, DOI 10.1016/j.jnutbio.2003.10.009; Jensen RG., 1995, HDB MILK COMPOSITION, P919; Koren S, 2007, BEST PRACT RES CL EN, V21, P621, DOI 10.1016/j.beem.2007.08.004; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; Li RW, 2008, PEDIATRICS, V122, pS69, DOI 10.1542/peds.2008-1315i; Littlejohn MD, 2010, PHYSIOL GENOMICS, V41, P21, DOI 10.1152/physiolgenomics.00108.2009; Macheda ML, 2003, CELL TISSUE RES, V311, P91, DOI 10.1007/s00441-002-0661-5; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; Manso MA, 2007, J CHROMATOGR A, V1146, P110, DOI 10.1016/j.chroma.2007.01.100; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Menzies KK, 2009, FUNCT INTEGR GENOMIC, V9, P197, DOI 10.1007/s10142-008-0103-x; NEVILLE MC, 1991, AM J CLIN NUTR, V54, P81, DOI 10.1093/ajcn/54.1.81; Nommsen-Rivers LA, 2011, BREASTFEED MED; Nommsen-Rivers LA, 2010, AM J CLIN NUTR, V92, P574, DOI 10.3945/ajcn.2010.29192; PATTON S, 1986, LIPIDS, V21, P170, DOI 10.1007/BF02534441; PATTON S, 1988, BIOCHIM BIOPHYS ACTA, V965, P146, DOI 10.1016/0304-4165(88)90050-5; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Roncada P, 2013, J PROTEOMICS; Sanchez-Juanes F, 2009, BIOL CHEM, V390, P31, DOI 10.1515/BC.2009.003; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Shields SL, 2011, J DAIRY RES, V78, P301, DOI 10.1017/S0022029911000410; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; U.S. Department of Health and Human Services, 2011, SURG GEN CALL ACTION; Wall EH, 2010, J DAIRY SCI, V93, P4062, DOI 10.3168/jds.2010-3162; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	55	121	126	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67531	10.1371/journal.pone.0067531	http://dx.doi.org/10.1371/journal.pone.0067531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861770	Green Submitted, Green Published, gold			2022-12-25	WOS:000321425300016
J	Lalmohamed, A; MacGregor, AJ; de Vries, F; Leufkens, HGM; van Staa, TP				Lalmohamed, Arief; MacGregor, Alexander J.; de Vries, Frank; Leufkens, Hubertus G. M.; van Staa, Tjeerd P.			Patterns of Risk of Cancer in Patients with Metal-on-Metal Hip Replacements versus Other Bearing Surface Types: A Record Linkage Study between a Prospective Joint Registry and General Practice Electronic Health Records in England	PLOS ONE			English	Article							KNEE REPLACEMENT; NATIONWIDE-COHORT; ARTHROPLASTY; IMPLANTS; OSTEOARTHRITIS; FRACTURE; SURGERY	Background: There are concerns that metal-on-metal hip implants may cause cancer. The objective of this study was to evaluate patterns and timing of risk of cancer in patients with metal-on-metal total hip replacements (THR). Methods: In a linkage study between the English National Joint Registry (NJR) and the Clinical Practice Research Datalink (CPRD), we selected all THR surgeries (NJR) between 2003 and 2010 (n = 11,540). THR patients were stratified by type of bearing surface. Patients were followed up for cancer and Poisson regression was used to derive adjusted relative rates (RR). Results: The risk of cancer was similar in patients with hip resurfacing (RR 0.69; 95% Confidence Interval [CI] 0.39-1.22) or other types of bearing surfaces (RR 0.96; 95% CI 0.64-1.43) compared to individuals with stemmed metal-on-metal THR. The pattern of cancer risk over time did not support a detrimental effect of metal hip implants. There was substantial confounding: patients with metal-on-metal THRs used fewer drugs and had less comorbidity. Conclusions: Metal-on-metal THRs were not associated with an increased risk of cancer. There were substantial baseline differences between the different hip implants, indicating possibility of confounding in the comparisons between different types of THR implants.	[Lalmohamed, Arief; de Vries, Frank; Leufkens, Hubertus G. M.; van Staa, Tjeerd P.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Lalmohamed, Arief] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands; [MacGregor, Alexander J.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [de Vries, Frank; van Staa, Tjeerd P.] Southampton Gen Hosp, Med Res Council MRC Lifecourse Epidemiol Unit, Southampton SO9 4XY, Hants, England; [de Vries, Frank] Maastricht Univ Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands; [de Vries, Frank] CAPHRI, Maastricht, Netherlands; [van Staa, Tjeerd P.] Med & Healthcare Prod Regulatory Agcy, London, England	Utrecht University; Utrecht University; Utrecht University Medical Center; University of East Anglia; University of Southampton; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; The Medicines & Healthcare Products Regulatory Agency	van Staa, TP (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	tjeerd.vanstaa@mhra.gsi.gov.uk	de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319; van Staa, Tjeerd/0000-0001-9363-742X; MacGregor, Alex/0000-0003-2163-2325	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands) [017.007.010]	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands)(Netherlands Organization for Scientific Research (NWO)Netherlands Government)	Support was provided by the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands; grant 017.007.010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT JOINT REG ENGL W; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P2357, DOI 10.1007/s11999-010-1262-3; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Datamonitor Healthcare, 2007, REP HIP KNEE REPL MA; Gillespie W, 2000, J BONE JOINT SURG BR, V82B, P475, DOI 10.1302/0301-620X.82B4.10452; HARRIS WH, 1990, NEW ENGL J MED, V323, P725, DOI 10.1056/NEJM199009133231106; Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI [10.1080/10408440701845534, 10.1080/10408440701845534 ]; Lalmohamed A, 2012, ARCH INTERN MED, V172, P1229, DOI 10.1001/archinternmed.2012.2713; Lalmohamed A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5085; Lalmohamed A, 2012, CALCIFIED TISSUE INT, V90, P144, DOI 10.1007/s00223-011-9558-1; Lewold S, 1996, INT J CANCER, V68, P30, DOI 10.1002/(SICI)1097-0215(19960927)68:1<30::AID-IJC6>3.0.CO;2-Y; LUMB GD, 1994, SCI TOTAL ENVIRON, V148, P185, DOI 10.1016/0048-9697(94)90395-6; Makela KT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4646; MATHIESEN EB, 1995, J BONE JOINT SURG BR, V77B, P345, DOI 10.1302/0301-620X.77B3.7744912; NYREN O, 1995, JNCI-J NATL CANCER I, V87, P28, DOI 10.1093/jnci/87.1.28; Olsen JH, 1999, INT J CANCER, V81, P719, DOI 10.1002/(SICI)1097-0215(19990531)81:5<719::AID-IJC8>3.0.CO;2-D; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; Paavolainen P, 1999, J ARTHROPLASTY, V14, P272, DOI 10.1016/S0883-5403(99)90051-7; Paavolainen P, 1999, ACTA ORTHOP SCAND, V70, P609, DOI 10.3109/17453679908997851; Parry MC, 2010, BIOMATERIALS, V31, P4477, DOI 10.1016/j.biomaterials.2010.02.038; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Ravi T, 2001, J BONE JOINT SURG AM, V83, P774; Signorello LB, 2001, J NATL CANCER I, V93, P1405, DOI 10.1093/jnci/93.18.1405; Smith AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2383; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; VISURI T, 1991, ORTHOPEDICS, V14, P137; Visuri T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-78	27	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e65891	10.1371/journal.pone.0065891	http://dx.doi.org/10.1371/journal.pone.0065891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861740	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000323350700004
J	Ortmann, M; Knief, A; Deuster, D; Brinkheetker, S; Zwitserlood, P; Zehnhoff-Dinnesen, AA; Dobel, C				Ortmann, Magdalene; Knief, Arne; Deuster, Dirk; Brinkheetker, Stephanie; Zwitserlood, Pienie; Zehnhoff-Dinnesen, Antoinette Am; Dobel, Christian			Neural Correlates of Speech Processing in Prelingually Deafened Children and Adolescents with Cochlear Implants	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; INTERMODAL SELECTIVE ATTENTION; EVENT-RELATED POTENTIALS; HUMAN AUDITORY-CORTEX; WORKING-MEMORY; PHONOLOGICAL AWARENESS; PHONEME REPRESENTATIONS; LANGUAGE-DEVELOPMENT; EVOKED-POTENTIALS; PERCEPTION	Prelingually deafened children with cochlear implants stand a good chance of developing satisfactory speech performance. Nevertheless, their eventual language performance is highly variable and not fully explainable by the duration of deafness and hearing experience. In this study, two groups of cochlear implant users (CI groups) with very good basic hearing abilities but non-overlapping speech performance (very good or very bad speech performance) were matched according to hearing age and age at implantation. We assessed whether these CI groups differed with regard to their phoneme discrimination ability and auditory sensory memory capacity, as suggested by earlier studies. These functions were measured behaviorally and with the Mismatch Negativity (MMN). Phoneme discrimination ability was comparable in the CI group of good performers and matched healthy controls, which were both better than the bad performers. Source analyses revealed larger MMN activity (155-225 ms) in good than in bad performers, which was generated in the frontal cortex and positively correlated with measures of working memory. For the bad performers, this was followed by an increased activation of left temporal regions from 225 to 250 ms with a focus on the auditory cortex. These results indicate that the two CI groups developed different auditory speech processing strategies and stress the role of phonological functions of auditory sensory memory and the prefrontal cortex in positively developing speech perception and production.	[Ortmann, Magdalene; Dobel, Christian] Univ Munster, Inst Biomagnetismus & Biosignalanal, Munster, Germany; [Ortmann, Magdalene] Univ Cologne, Jean Uhrmacher Inst Clin ENT Res, D-50931 Cologne, Germany; [Knief, Arne; Deuster, Dirk; Brinkheetker, Stephanie; Zehnhoff-Dinnesen, Antoinette Am] Univ Hosp Muenster, Dept Phoniatr & Pedaudiol, Munster, Germany; [Zwitserlood, Pienie] Univ Munster, Dept Psychol, Munster, Germany	University of Munster; University of Cologne; University of Munster; University of Munster	Ortmann, M (corresponding author), Univ Munster, Inst Biomagnetismus & Biosignalanal, Munster, Germany.	ortmannm@uni-muenster.de	Deuster, Dirk/L-4635-2014; Wiltbank, Milo C/B-1506-2010	Deuster, Dirk/0000-0002-3476-3300; Wiltbank, Milo C/0000-0001-8188-0991	Deutsche Forschungsgemeinschaft [DFG] [DO 711/7-1]; Konrad-Adenauer-Stiftung; FAZIT-Stiftung	Deutsche Forschungsgemeinschaft [DFG](German Research Foundation (DFG)); Konrad-Adenauer-Stiftung; FAZIT-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft [DFG DO 711/7-1 to C.D., A.Z.D. and P.Z., http://www.dfg.de), the Konrad-Adenauer-Stiftung (PhD grant to M.O., www.kas.de) and the FAZIT-Stiftung (PhD grant to M.O., www.fazit-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1992, ELECTROEN CLIN NEURO, V82, P356, DOI 10.1016/0013-4694(92)90005-3; Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; Anderson Ilona, 2008, Cochlear Implants Int, V9, P119, DOI 10.1179/cim.2008.9.3.119; Angermaier MJW, 1977, PSYCHOLINGUISTISCHER; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; BATES M, 1995, P NATL ACAD SCI USA, V92, P9977, DOI 10.1073/pnas.92.22.9977; Bollinger J, 2010, J NEUROSCI, V30, P14399, DOI 10.1523/JNEUROSCI.1547-10.2010; Bortz J, 2010, STAT SOZIALWISSENSCH, P655; Ceponiene R, 1999, DEV PSYCHOL, V35, P709, DOI 10.1037/0012-1649.35.3.709; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Colletti L, 2011, INT J PEDIATR OTORHI, V75, P504, DOI 10.1016/j.ijporl.2011.01.005; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; Debener S, 2008, PSYCHOPHYSIOLOGY, V45, P20, DOI 10.1111/j.1469-8986.2007.00610.x; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; Dillon CM, 2006, VOLTA REV, V106, P121; Dillon CM, 2004, INT CONGR SER, V1273, P304, DOI 10.1016/j.ics.2004.07.042; Dobel C, 2009, J COGNITIVE NEUROSCI, P1; Dobel C, 2009, PHILOS T R SOC B, V364, P3697, DOI 10.1098/rstb.2009.0158; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Ecalle J, 2009, DYSLEXIA, V15, P218, DOI [10.1002/dys.373, 10.1002/DYS.373]; Eggermont JJ, 2002, AUDIOL NEURO-OTOL, V7, P71, DOI 10.1159/000057656; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; EIMAS PD, 1985, SCI AM, V252, P46, DOI 10.1038/scientificamerican0185-46; Eulitz C, 2004, J COGNITIVE NEUROSCI, V16, P577, DOI 10.1162/089892904323057308; Fakhri M, 2012, BEHAV NEUROL, V25, P351, DOI 10.1155/2012/824049; Fiori A, 2010, HNO, V58, P934, DOI 10.1007/s00106-010-2088-8; Francis AL, 2007, J SPEECH LANG HEAR R, V50, P1445, DOI 10.1044/1092-4388(2007/100); Friesen LM, 2010, HEARING RES, V259, P95, DOI 10.1016/j.heares.2009.10.012; Gazzaley A, 2011, NEUROPSYCHOLOGIA, V49, P1410, DOI 10.1016/j.neuropsychologia.2010.12.022; Geers AE, 2003, EAR HEARING, V24, p59S, DOI 10.1097/01.AUD.0000051690.43989.5D; Gillon GT, 2007, PHONOLOGICAL AWARENE, P270; Giraud AL, 2001, AUDIOL NEURO-OTOL, V6, P381, DOI 10.1159/000046847; Gomot M, 2000, NEUROREPORT, V11, P3109, DOI 10.1097/00001756-200009280-00014; Halgren E, 2011, HUM BRAIN MAPP, V32, P1260, DOI 10.1002/hbm.21106; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Harris Margaret, 2004, J Deaf Stud Deaf Educ, V9, P253, DOI 10.1093/deafed/enh016; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jemel B, 2002, BRAIN TOPOGR, V15, P13, DOI 10.1023/A:1019944805499; Keller F, 1969, FREIBURGER SPRACHVER; Kelly AS, 2005, CLIN NEUROPHYSIOL, V116, P1235, DOI 10.1016/j.clinph.2005.02.011; KRAUS N, 1993, HEARING RES, V65, P118, DOI 10.1016/0378-5955(93)90206-G; KRAUS N, 1992, EAR HEARING, V13, P158, DOI 10.1097/00003446-199206000-00004; Kronenberger WG, 2011, J SPEECH LANG HEAR R, V54, P1182, DOI 10.1044/1092-4388(2010/10-0119); KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; KURTZBERG D, 1995, EAR HEARING, V16, P105, DOI 10.1097/00003446-199502000-00008; Lai YX, 2011, BRAIN RES, V1367, P170, DOI 10.1016/j.brainres.2010.10.036; Locke JL, 1997, BRAIN LANG, V58, P265, DOI 10.1006/brln.1997.1791; Lonka E, 2004, AUDIOL NEURO-OTOL, V9, P160, DOI 10.1159/000077265; Luck SJ, 2005, INTRO EVENT RELATED, P376; Lyxell B, 2008, INT J AUDIOL, V47, pS47, DOI 10.1080/14992020802307370; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Maillart C, 2006, INT J LANG COMM DIS, V41, P253, DOI 10.1080/13682820500221667; McCarthy JJ, 1968, ILLINOIS TEST PSYCHO; Menning H, 2002, LEARN MEMORY, V9, P253, DOI 10.1101/lm.49402; Miller BL, 2006, HUMAN FRONTAL LOBES, P666; Miyamoto RT, 1999, ACTA OTO-LARYNGOL, V119, P219; Murty VP, 2011, NEUROIMAGE, V57, P1264, DOI 10.1016/j.neuroimage.2011.05.006; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Opitz B, 1999, PSYCHOPHYSIOLOGY, V36, P142, DOI 10.1017/S0048577299980848; PAAVILAINEN P, 1991, ELECTROEN CLIN NEURO, V78, P466, DOI 10.1016/0013-4694(91)90064-B; Pantev C, 1998, AUDIOL NEURO-OTOL, V3, P183, DOI 10.1159/000013789; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Picton TW, 1999, AUDIOL NEURO-OTOL, V4, P64, DOI 10.1159/000013823; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; Ponton CW, 2001, HEARING RES, V154, P32, DOI 10.1016/S0378-5955(01)00214-3; Ponton CW, 2000, AUDIOL NEURO-OTOL, V5, P167, DOI 10.1159/000013878; Pulvermuller F, 2005, J COGNITIVE NEUROSCI, V17, P884, DOI 10.1162/0898929054021111; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Rinne T, 2005, NEUROIMAGE, V26, P66, DOI 10.1016/j.neuroimage.2005.01.017; Roman S, 2005, HEARING RES, V201, P10, DOI 10.1016/j.heares.2004.08.021; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Rvachew S, 2003, AM J SPEECH-LANG PAT, V12, P463, DOI 10.1044/1058-0360(2003/092); Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Sandmann P, 2009, BRAIN, V132, P1967, DOI 10.1093/brain/awp034; Sarant JZ, 2001, EAR HEARING, V22, P18, DOI 10.1097/00003446-200102000-00003; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schneiders JA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00173; Shalgi S, 2007, NEUROPSYCHOLOGIA, V45, P1878, DOI 10.1016/j.neuropsychologia.2006.11.023; Shestakova A, 2002, NEUROREPORT, V13, P1813, DOI 10.1097/00001756-200210070-00025; Shtyrov Y, 2004, EUR J NEUROSCI, V19, P1083, DOI 10.1111/j.0953-816X.2004.03126.x; STAHL SA, 1994, J EDUC PSYCHOL, V86, P221, DOI 10.1037/0022-0663.86.2.221; STREETER LA, 1976, NATURE, V259, P39, DOI 10.1038/259041a0; Surakka V, 1998, COGNITIVE BRAIN RES, V7, P159, DOI 10.1016/S0926-6410(98)00021-4; Sussman E, 2001, COGNITIVE BRAIN RES, V12, P431, DOI 10.1016/S0926-6410(01)00067-2; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Swan D, 1997, J EXP CHILD PSYCHOL, V66, P18, DOI 10.1006/jecp.1997.2375; Tavabi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004452; Todd J, 2010, NEUROPSYCHOLOGIA, V48, P3009, DOI 10.1016/j.neuropsychologia.2010.06.009; Todd J, 2010, BRAIN RES, V1310, P113, DOI 10.1016/j.brainres.2009.11.019; Tsao FM, 2004, CHILD DEV, V75, P1067, DOI 10.1111/j.1467-8624.2004.00726.x; Wass M, 2008, SCAND J PSYCHOL, V49, P559, DOI 10.1111/j.1467-9450.2008.00680.x; Watson DR, 2007, AUDIOL NEURO-OTOL, V12, P65, DOI 10.1159/000097793; Wechsler D., 1997, TECHNICAL MANUAL, Vthird; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161	108	20	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67696	10.1371/journal.pone.0067696	http://dx.doi.org/10.1371/journal.pone.0067696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861784	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700023
J	Gorrindo, P; Lane, CJ; Lee, EB; McLaughlin, B; Levitt, P				Gorrindo, Phillip; Lane, Christianne Joy; Lee, Evon Batey; McLaughlin, BethAnn; Levitt, Pat			Enrichment of Elevated Plasma F-2t-Isoprostane Levels in Individuals with Autism Who Are Stratified by Presence of Gastrointestinal Dysfunction	PLOS ONE			English	Article							SPECTRUM DISORDERS; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; GUT MICROBIOTA; OXIDANT STRESS; CHILDREN; SYMPTOMS; F-2-ISOPROSTANES; POPULATION; PREVALENCE	Etiology is unknown in the majority of individuals with autism spectrum disorder (ASD). One strategy to investigate pathogenesis is to stratify this heterogeneous disorder based on a prominent phenotypic feature that enriches for homogeneity within population strata. Co-occurring gastrointestinal dysfunction (GID) characterizes a subset of children with ASD. Our current objective was to investigate a potential pathophysiological measure to test the hypothesis that children with both ASD and GID have a more severe metabolic dysfunction than children with ASD-only, given that the highly metabolically active brain and gastrointestinal system may additively contribute measurable impairment. Plasma levels of F-2t-Isoprostanes (F-2-IsoPs), a gold standard biomarker of oxidative stress, were measured in 87 children in four groups: ASD-GID, ASD-only, GID-only and Unaffected. F-2-IsoP levels were elevated in all 3 clinical groups compared to the Unaffected group, with the ASD-GID group significantly elevated above the ASD-only group (mean, SD in pg/mg: ASD-GID 53.6, 24.4; ASD-only 36.5, 13.3; p = 0.007). Adjusting for age, sex, and triglyceride levels, F-2-IsoP levels remained significantly different between study groups, with a moderate effect size of eta(2)(p) = 0.187 (p = 0.001). Elevation in peripheral oxidative stress is consistent with, and may contribute to, the more severe functional impairments in the ASD-GID group. With unique medical, metabolic, and behavioral features in children with ASD-GID, the present findings serve as a compelling rationale for both individualized approaches to clinical care and integrated studies of biomarker enrichment in ASD subgroups that may better address the complex etiology of ASD.	[Gorrindo, Phillip] Vanderbilt Univ, Med Scientist Training Program, Nashville, TN 37235 USA; [Lane, Christianne Joy] Univ So Calif, Keck Sch Med, Dept Biostat, Los Angeles, CA 90033 USA; [Lee, Evon Batey; McLaughlin, BethAnn] Vanderbilt Univ, Kennedy Ctr Res Human Dev, Nashville, TN 37235 USA; [Lee, Evon Batey] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Lee, Evon Batey] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Lee, Evon Batey] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37235 USA; [McLaughlin, BethAnn] Vanderbilt Univ, Dept Neurol, Nashville, TN 37235 USA; [McLaughlin, BethAnn] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [McLaughlin, BethAnn] Vanderbilt Univ, JB Marshall Neurovasc Lab, Nashville, TN 37235 USA; [Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Levitt, Pat] Childrens Hosp Los Angeles, Inst Dev Mind, Los Angeles, CA 90027 USA	Vanderbilt University; University of Southern California; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Southern California; Children's Hospital Los Angeles	Gorrindo, P (corresponding author), Vanderbilt Univ, Med Scientist Training Program, 221 Kirkland Hall, Nashville, TN 37235 USA.	phillip.gorrindo@Vanderbilt.Edu	McLaughlin, BethAnn/D-9580-2012	McLaughlin, BethAnn/0000-0003-0228-6500; Gorrindo, Phillip/0000-0002-0296-8790	National Institutes of Health awards National Institute of Child Health and Human Development [R21HD065289]; National Institute of General Medical Sciences [T32GM07347]; National Center for Research Resources [TL1RR024978]; National Center for Advancing Translational Sciences [UL1TR000445]; Marino Autism Research Institute; Pediatric Clinical Research Center at Vanderbilt University; Scott Family Foundation; Vanderbilt Autism Treatment Network Site; Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065289] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	National Institutes of Health awards National Institute of Child Health and Human Development; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Marino Autism Research Institute; Pediatric Clinical Research Center at Vanderbilt University; Scott Family Foundation; Vanderbilt Autism Treatment Network Site; Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health awards National Institute of Child Health and Human Development R21HD065289 (PL), National Institute of General Medical Sciences T32GM07347 for the Vanderbilt Medical Scientist Training Program (PG), National Center for Research Resources TL1RR024978 (PG), and National Center for Advancing Translational Sciences UL1TR000445 for the Vanderbilt Institute for Clinical and Translational Research. Additional support was provided by the Marino Autism Research Institute, the Pediatric Clinical Research Center at Vanderbilt University, The Scott Family Foundation, and the Vanderbilt Autism Treatment Network Site, a program funded by Autism Speaks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 2012, PEDIATR CARDIOL, V33, P562, DOI 10.1007/s00246-012-0166-2; Anney RJL, 2011, EUROPEAN J HUMAN GEN; Baber KF, 2008, J PEDIATR GASTR NUTR, V47, P299, DOI 10.1097/MPG.0b013e31816c4372; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb4034, 10.1186/gb-2012-13-7-247]; Black C, 2002, BRIT MED J, V325, P419, DOI 10.1136/bmj.325.7361.419; Bowers K, 2011, J NEURODEV DISORD, V3, P132, DOI 10.1007/s11689-011-9077-4; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D; Campbell DB, 2009, PEDIATRICS, V123, P1018, DOI 10.1542/peds.2008-0819; Constantino J.N., 2012, MOL PSYCHIAT; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Cracowski JL, 2002, AM J GASTROENTEROL, V97, P99; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Gorrindo P, 2012, AUTISM RES, V5, P101, DOI 10.1002/aur.237; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Ibrahim SH, 2009, PEDIATRICS, V124, P680, DOI 10.1542/peds.2008-2933; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P711, DOI 10.1016/j.freeradbiomed.2004.10.024; Kelly PJ, 2008, STROKE, V39, P100, DOI 10.1161/STROKEAHA.107.488189; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Levy SE, 2007, BIOL PSYCHIAT, V61, P492, DOI 10.1016/j.biopsych.2006.07.013; Lu AT, 2010, MOL PSYCHIAT; Melnyk S, 2011, J AUTISM DEV DISORDE; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Molloy CA, 2003, AUTISM, V7, P165, DOI 10.1177/1362361303007002004; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Proudfoot JM, 2009, J LIPID RES, V50, P716, DOI 10.1194/jlr.M800607-JLR200; Rice K, 2012, J AM ACAD CHILD PSY, V51, P238, DOI 10.1016/j.jaac.2011.12.017; Rudie JD, 2012, NEURON IN PRESS; Scott-Van Zeeland AA, 2009, SCI TRANSL MED, V2, P1; State M., 2011, NAT NEUROSCI, V14, P1; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; Walker L. S., 2000, MANUAL QUESTIONNAIRE; Wang LW, 2011, J DEV BEHAV PEDIATR, V32, P351, DOI 10.1097/DBP.0b013e31821bd06a; Yao YM, 2006, ARCH NEUROL-CHICAGO, V63, P1161, DOI 10.1001/archneur.63.8.1161; Zeiger SLH, 2009, FREE RADICAL BIO MED, V47, P1422, DOI 10.1016/j.freeradbiomed.2009.08.011	46	23	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68444	10.1371/journal.pone.0068444	http://dx.doi.org/10.1371/journal.pone.0068444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844202	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000007
J	Gross, J; Wajid, S; Price, DC; Zelzion, E; Li, JY; Chan, CX; Bhattacharya, D				Gross, Jeferson; Wajid, Sana; Price, Dana C.; Zelzion, Ehud; Li, Junyi; Chan, Cheong Xin; Bhattacharya, Debashish			Evidence for Widespread Exonic Small RNAs in the Glaucophyte Alga Cyanophora paradoxa	PLOS ONE			English	Article							FUNGUS MUCOR-CIRCINELLOIDES; TRANS-ACTING SIRNAS; TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; MESSENGER-RNAS; IDENTIFICATION; MICRORNAS; GENOME; INTERFERENCE; BIOGENESIS	RNAi (RNA interference) relies on the production of small RNAs (sRNAs) from double-stranded RNA and comprises a major pathway in eukaryotes to restrict the propagation of selfish genetic elements. Amplification of the initial RNAi signal by generation of multiple secondary sRNAs from a targeted mRNA is catalyzed by RNA-dependent RNA polymerases (RdRPs). This phenomenon is known as transitivity and is particularly important in plants to limit the spread of viruses. Here we describe, using a genome-wide approach, the distribution of sRNAs in the glaucophyte alga Cyanophora paradoxa. C. paradoxa is a member of the supergroup Plantae (also known as Archaeplastida) that includes red algae, green algae, and plants. The ancient (>1 billion years ago) split of glaucophytes within Plantae suggests that C. paradoxa may be a useful model to learn about the early evolution of RNAi in the supergroup that ultimately gave rise to plants. Using next-generation sequencing and bioinformatic analyses we find that sRNAs in C. paradoxa are preferentially associated with mRNAs, including a large number of transcripts that encode proteins arising from different functional categories. This pattern of exonic sRNAs appears to be a general trend that affects a large fraction of mRNAs in the cell. In several cases we observe that sRNAs have a bias for a specific strand of the mRNA, including many instances of antisense predominance. The genome of C. paradoxa encodes four sequences that are homologous to RdRPs in Arabidopsis thaliana. We discuss the possibility that exonic sRNAs in the glaucophyte may be secondarily derived from mRNAs by the action of RdRPs. If this hypothesis is confirmed, then transitivity may have had an ancient origin in Plantae.	[Gross, Jeferson; Wajid, Sana; Price, Dana C.; Zelzion, Ehud; Li, Junyi; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Gross, Jeferson; Wajid, Sana; Price, Dana C.; Zelzion, Ehud; Li, Junyi; Bhattacharya, Debashish] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Chan, Cheong Xin] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Chan, Cheong Xin] ARC Ctr Excellence Bioinformat, Brisbane, Qld, Australia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Queensland	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	bhattacharya@aesop.rutgers.edu	Chan, Cheong Xin/A-7005-2008	Chan, Cheong Xin/0000-0002-3729-8176	National Science Foundation [MGSP 0625440, MCB 0946528]; Rutgers University, New Brunswick	National Science Foundation(National Science Foundation (NSF)); Rutgers University, New Brunswick	This research was made possible by grants from the National Science Foundation (MGSP 0625440, MCB 0946528) awarded to DB. Partial support was provided to DB by Rutgers University, New Brunswick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2010, SEMIN CELL DEV BIOL, V21, P798, DOI 10.1016/j.semcdb.2010.03.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arif MA, 2013, INT J MOL SCI, V14, P1516, DOI 10.3390/ijms14011516; Calo S, 2012, MOL MICROBIOL, V83, P379, DOI 10.1111/j.1365-2958.2011.07939.x; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gierga G, 2012, ISME J, V6, P1544, DOI 10.1038/ismej.2011.215; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Huang AY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-337; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kawasaki H, 2005, CURR OPIN MOL THER, V7, P125; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; Norden-Krichmar TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022870; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Reyes-Prieto A, 2007, MOL BIOL EVOL, V24, P2358, DOI 10.1093/molbev/msm186; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Talmor-Neiman M, 2006, PLANT J, V48, P511, DOI 10.1111/j.1365-313X.2006.02895.x; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128	36	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67669	10.1371/journal.pone.0067669	http://dx.doi.org/10.1371/journal.pone.0067669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844054	gold, Green Submitted, Green Published			2022-12-25	WOS:000321733000090
J	Weaver, EA; Nehete, PN; Nehete, BP; Yang, GJ; Buchl, SJ; Hanley, PW; Palmer, D; Montefiori, DC; Ferrari, G; Ng, P; Sastry, KJ; Barry, MA				Weaver, Eric A.; Nehete, Pramod N.; Nehete, Bharti P.; Yang, Guojun; Buchl, Stephanie J.; Hanley, Patrick W.; Palmer, Donna; Montefiori, David C.; Ferrari, Guido; Ng, Philip; Sastry, K. Jagannadha; Barry, Michael A.			Comparison of Systemic and Mucosal Immunization with Helper-Dependent Adenoviruses for Vaccination against Mucosal Challenge with SHIV	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS SHIVSF162P3; IMMUNE-RESPONSES; RHESUS MACAQUES; SIMIAN AIDS; T-CELLS; ANTI-AD5 IMMUNITY; VECTOR; HIV-1; IMMUNOGENICITY; PROTECTION	Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has been hypothesized that vaccines delivered at mucosal surfaces may mediate better protection against HIV-1 than vaccines that are delivered systemically. To test this, rhesus macaques were vaccinated by intramuscular (i.m.) or intravaginal (ivag.) routes with helper-dependent adenoviral (HD-Ad) vectors expressing HIV-1 envelope. Macaques were first immunized intranasally with species C Ad serotype 5 (Ad5) prior to serotype-switching with species C HD-Ad6, Ad1, Ad5, and Ad2 vectors expressing env followed by rectal challenge with CCR5-tropic SHIV-SF162P3. Vaccination by the systemic route generated stronger systemic CD8 T cell responses in PBMC, but weaker mucosal responses. Conversely, mucosal immunization generated stronger CD4 T cell central memory (Tcm) responses in the colon. Intramuscular immunization generated higher levels of env-binding antibodies, but neither produced neutralizing or cytotoxic antibodies. After mucosal SHIV challenge, both groups controlled SHIV better than control animals. However, more animals in the ivag. group had lower viral set points than in in the i.m. group. These data suggest mucosal vaccination may have improve protection against sexually-transmitted HIV. These data also demonstrate that helper-dependent Ad vaccines can mediate robust vaccine responses in the face of prior immunity to Ad5 and during four rounds of adenovirus vaccination.	[Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Dept Internal Med, Div Infect Dis, Translat Immunovirol Program,Dept Immunol, Rochester, MN 55905 USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Nehete, Pramod N.; Nehete, Bharti P.; Buchl, Stephanie J.; Hanley, Patrick W.; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Houston, TX 77030 USA; [Yang, Guojun; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Palmer, Donna; Ng, Philip] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Montefiori, David C.; Ferrari, Guido] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Duke University	Barry, MA (corresponding author), Mayo Clin, Dept Internal Med, Div Infect Dis, Translat Immunovirol Program,Dept Immunol, Rochester, MN 55905 USA.	mab@mayo.edu	Ferrari, Guido/A-6088-2015; Ferrari, Guido/Z-2137-2019	Ferrari, Guido/0000-0001-7747-3349; Sastry, Jagannadha/0000-0002-6987-4422; Nehete, Pramod/0000-0002-2815-2677; Hanley, Patrick/0000-0003-2300-1818	NIH/NIAID [HHSN27201100016C];  [AI096967];  [AI06795];  [AI065304];  [AI42694];  [AI46969];  [HL083047];  [DK067324]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042694, R01AI096967, R01AI097241, R01AI046969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067324] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants AI096967, AI06795, and AI065304 to M.A.B., grants AI42694 and AI46969 to J.S., and grants HL083047 and DK067324 to P.N. This work was also supported by NIH/NIAID contract HHSN27201100016C to D.C.M and contract HHSN27201100016C to G.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfe P, 2004, VIROLOGY, V318, P267, DOI 10.1016/j.virol.2003.09.022; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Chen HH, 1997, P NATL ACAD SCI USA, V94, P1645, DOI 10.1073/pnas.94.5.1645; Cohen J, 2011, SCIENCE, P333; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; He H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019607; Hsu M, 2003, J MED PRIMATOL, V32, P211, DOI 10.1034/j.1600-0684.2003.00027.x; Hsu M, 2003, J VIROL, V77, P989, DOI 10.1128/JVI.77.2.989-998.2003; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Lehner T, 2002, AIDS, V16, pS125, DOI 10.1097/00002030-200216004-00017; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; McCoy K, 2007, J VIROL, V81, P6594, DOI 10.1128/JVI.02497-06; Mercier GT, 2007, VACCINE, V25, P8687, DOI 10.1016/j.vaccine.2007.10.030; Mitchell MF, 1996, AM J OBSTET GYNECOL, V174, P1094, DOI 10.1016/S0002-9378(96)70650-6; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Morral N, 1998, HUM GENE THER, V9, P2709, DOI 10.1089/hum.1998.9.18-2709; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Nehete PN, 2003, J MED PRIMATOL, V32, P67, DOI 10.1034/j.1600-0684.2003.00011.x; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Parks RJ, 1999, GENE THER, V6, P1565, DOI 10.1038/sj.gt.3300995; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Pinto AR, 2003, J IMMUNOL, V171, P6774, DOI 10.4049/jimmunol.171.12.6774; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Reyes RA, 2004, J VIROL, V78, P2121, DOI 10.1128/JVI.78.4.2121-2130.2004; Santra S, 2009, VACCINE, V27, P5837, DOI 10.1016/j.vaccine.2009.07.050; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Someya K, 2007, VIROLOGY; Weaver EA, 2009, VIRUSES-BASEL, V1, P920, DOI 10.3390/v1030920; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059	36	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67574	10.1371/journal.pone.0067574	http://dx.doi.org/10.1371/journal.pone.0067574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844034	Green Published, gold			2022-12-25	WOS:000321733000082
J	da Silva, RV; Malvezi, AD; Augusto, LD; Kian, D; Tatakihara, VLH; Yamauchi, LM; Yamada-Ogatta, SF; Rizzo, LV; Schenkman, S; Pinge, P				da Silva, Rosiane V.; Malvezi, Aparecida D.; Augusto, Leonardo da Silva; Kian, Danielle; Tatakihara, Vera Lucia H.; Yamauchi, Lucy M.; Yamada-Ogatta, Sueli F.; Rizzo, Luiz V.; Schenkman, Sergio; Pinge-Filho, Phileno			Oral Exposure to Phytomonas serpens Attenuates Thrombocytopenia and Leukopenia during Acute Infection with Trypanosoma cruzi	PLOS ONE			English	Article							TRANS-SIALIDASE; CHAGAS-DISEASE; PROTECTIVE IMMUNITY; OXIDATIVE STRESS; TOMATO PARASITE; ANTIGENS; ANEMIA; SERA; NEURAMINIDASE; DIAGNOSIS	Mice infected with Trypanosoma cruzi, the agent of Chagas disease, rapidly develop anemia and thrombocytopenia. These effects are partially promoted by the parasite trans-sialidase (TS), which is shed in the blood and depletes sialic acid from the platelets, inducing accelerated platelet clearance and causing thrombocytopenia during the acute phase of disease. Here, we demonstrate that oral immunization of C57BL/6 mice with Phytomonas serpens, a phytoflagellate parasite that shares common antigens with T. cruzi but has no TS activity, reduces parasite burden and prevents thrombocytopenia and leukopenia. Immunization also reduces platelet loss after intraperitoneal injection of TS. In addition, passive transfer of immune sera raised in mice against P. serpens prevented platelet clearance. Thus, oral exposure to P. serpens attenuates the progression of thrombocytopenia induced by TS from T. cruzi. These findings are not only important for the understanding of the pathogenesis of T. cruzi infection but also for developing novel approaches of intervention in Chagas disease.	[da Silva, Rosiane V.; Malvezi, Aparecida D.; Tatakihara, Vera Lucia H.; Pinge-Filho, Phileno] Univ Estadual Londrina, Dept Ciencias Patol, Lab Imunopatol Expt, Londrina, Parana, Brazil; [Kian, Danielle; Yamauchi, Lucy M.; Yamada-Ogatta, Sueli F.] Univ Estadual Londrina, Dept Microbiol, Londrina, Parana, Brazil; [Rizzo, Luiz V.] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [Augusto, Leonardo da Silva; Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP)	Pinge, P (corresponding author), Univ Estadual Londrina, Dept Ciencias Patol, Lab Imunopatol Expt, Londrina, Parana, Brazil.	pingefilho@uel.br	Pinge-Filho, Phileno/G-2844-2012; Yamada-Ogatta, Sueli Fumie/C-7020-2019; Rizzo, Luiz Vicente/B-4458-2009; Schenkman, Sergio/A-9227-2013	Yamada-Ogatta, Sueli Fumie/0000-0003-1183-146X; Schenkman, Sergio/0000-0001-9353-8480; da Silva Augusto, Leonardo/0000-0003-0430-8216	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq); Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico (CNPq), and Fundacao Araucaria. Rosiane V. da Silva was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bregano JW, 2003, FEMS IMMUNOL MED MIC, V39, P257, DOI 10.1016/S0928-8244(03)00256-6; BRIONES MRS, 1995, J MOL EVOL, V41, P120, DOI 10.1007/BF00170663; Buscaglia CA, 1999, BLOOD, V93, P2025, DOI 10.1182/blood.V93.6.2025.406k19_2025_2032; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; CAMARGO EP, 1990, PARASITOL TODAY, V6, P22, DOI 10.1016/0169-4758(90)90388-K; de Souza TDCB, 2011, PROTEIN J, V30, P212, DOI 10.1007/s10930-011-9322-4; Cardoso J.E., 1980, Memorias do Instituto Oswaldo Cruz, V75, P97, DOI 10.1590/S0074-02761980000200009; Claster S, 2002, J INFECT DIS, V185, pS105, DOI 10.1086/340202; CSETE M, 1985, CURR TOP MICROBIOL, V117, P153; DA SILVA L. H. P., 1953, Folia Clinica et Biologica, V20, P191; Dacie J.V., 1995, PRACTICAL HAEMATOLOG; dC-Rubin SSC, 2012, CELL MICROBIOL, V14, P1522, DOI 10.1111/j.1462-5822.2012.01831.x; DETITTO EH, 1988, CLIN IMMUNOL IMMUNOP, V46, P157, DOI 10.1016/0090-1229(88)90016-5; DOLLET M, 1984, ANNU REV PHYTOPATHOL, V22, P115, DOI 10.1146/annurev.py.22.090184.000555; Estevam M, 2012, FEMS IMMUNOL MED MIC, V64, P334, DOI 10.1111/j.1574-695X.2011.00917.x; Giorgi ME, 2010, GLYCOCONJUGATE J, V27, P549, DOI 10.1007/s10719-010-9300-7; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; GAZZINELLI RT, 1991, J PROTOZOOL, V38, P320, DOI 10.1111/j.1550-7408.1991.tb01366.x; Goncalves CCM, 2002, AM J TROP MED HYG, V66, P91, DOI 10.4269/ajtmh.2002.66.91; Graca-de Souza VK, 2010, BIOL RES, V43, P233, DOI [/S0716-97602010000200011, 10.4067/S0716-97602010000200011]; IKEDE B O, 1977, Acta Tropica, V34, P53; JANKEVICIUS JV, 1989, J PROTOZOOL, V36, P265, DOI 10.1111/j.1550-7408.1989.tb05361.x; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; LEGUIZAMON MS, 1994, J INFECT DIS, V170, P1570, DOI 10.1093/infdis/170.6.1570; LOPES JD, 1981, AM J TROP MED HYG, V30, P1183, DOI 10.4269/ajtmh.1981.30.1183; Malvezi AD, 2004, FEMS IMMUNOL MED MIC, V41, P69, DOI 10.1016/j.femsim.2004.01.005; Marcondes MCG, 2000, MICROBES INFECT, V2, P347, DOI 10.1016/S1286-4579(00)00333-6; Marques AF, 2010, GLYCOBIOLOGY, V20, P1528; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; MEDINAACOSTA E, 1994, EUR J BIOCHEM, V225, P333, DOI 10.1111/j.1432-1033.1994.00333.x; Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248; Paul REL, 2003, MOL CELLS, V15, P139; PEREIRACHIOCCOLA VL, 1994, INFECT IMMUN, V62, P2973, DOI 10.1128/IAI.62.7.2973-2978.1994; Pinge-Filho P, 2005, IMMUNOL LETT, V96, P283, DOI 10.1016/j.imlet.2004.09.010; Py M, 2011, CURR NEUROL NEUROSCI, V11, P536, DOI 10.1007/s11910-011-0225-8; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; REPKA D, 1985, Revista Brasileira de Biologia, V45, P309; Santiago HC, 2005, J IMMUNOL, V175, P8165, DOI 10.4049/jimmunol.175.12.8165; Schauer R, 2011, CHEMBIOCHEM, V12, P2246, DOI 10.1002/cbic.201100421; SCHENKMAN S, 1994, J BIOL CHEM, V269, P7970; SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; SOUZA MDC, 1974, J PROTOZOOL, V21, P579, DOI 10.1111/j.1550-7408.1974.tb03705.x; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Tatakihara VLH, 2008, FEMS IMMUNOL MED MIC, V52, P47, DOI 10.1111/j.1574-695X.2007.00340.x; Toso A, 2011, REV MED CHILE, V139, P258, DOI /S0034-98872011000200017; Tribulatti MV, 2005, INFECT IMMUN, V73, P201, DOI 10.1128/IAI.73.1.201-207.2005; VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68299	10.1371/journal.pone.0068299	http://dx.doi.org/10.1371/journal.pone.0068299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844182	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000151
J	Gil-Farina, I; Di Scala, M; Vanrell, L; Olague, C; Vales, A; High, KA; Prieto, J; Mingozzi, F; Gonzalez-Aseguinolaza, G				Gil-Farina, Irene; Di Scala, Marianna; Vanrell, Lucia; Olaguee, Cristina; Vales, Africa; High, Katherine A.; Prieto, Jesus; Mingozzi, Federico; Gonzalez-Aseguinolaza, Gloria			IL12-Mediated Liver Inflammation Reduces the Formation of AAV Transcriptionally Active Forms but Has No Effect over Preexisting AAV Transgene Expression	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; GENE-TRANSFER; T-CELLS; VECTORS; HEPATOCYTES; HEMOPHILIA; ACTIVATION; ADENOVIRUS; ELIMINATE; PATHWAY	Recombinant adenoassociated viral vectors (rAAV) have proven to be excellent candidates for gene therapy clinical applications. Recent results showed that cellular immunity to AAV represents a major challenge facing the clinical use of systemic administration of these vectors. Interestingly, no preclinical animal model has previously fully reproduced the clinical findings. The aim of the present work was to enhance the T cell immune response against AAV capsid in mice by the administration of a rAAV expressing the immunostimulatory cytokine IL-12. Our results indicate that although IL-12 expression enhanced the AAV capsid-specific immune response it failed to eliminate transduced hepatocytes and long-term expression was achieved. We found that AAV-mediated transgene expression is altered by IL-12-induced liver inflammation. However, IL-12 expression has no effect over preexisting AAV-mediated transgene expression. IL-12 down-regulates AAV mediated transgene expression via induction of IFN-gamma production by NK and T cells, but without altering the transduction efficiency measured by viral genomes. Our results indicate that liver inflammation affects the formation of transcriptionally active AAV vector genomes through an unknown mechanism that can be avoided by the use of DNA-demethylating or anti-inflammatory agents.	[Gil-Farina, Irene; Di Scala, Marianna; Vanrell, Lucia; Olaguee, Cristina; Vales, Africa; Prieto, Jesus; Gonzalez-Aseguinolaza, Gloria] Ctr Appl Med Res, Div Hepatol & Gene Therapy, Pamplona, Spain; [High, Katherine A.; Mingozzi, Federico] Childrens Hosp Philadelphia, Howard Hughes Med Inst, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Prieto, Jesus] Univ Navarra, Univ Navarra Clin, Liver Unit, E-31080 Pamplona, Spain; [Prieto, Jesus] Univ Navarra, Univ Navarra Clin, Ctr Invest Biomed Red Area Temat Enfermedades Hep, E-31080 Pamplona, Spain	University of Navarra; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra	Gonzalez-Aseguinolaza, G (corresponding author), Ctr Appl Med Res, Div Hepatol & Gene Therapy, Pamplona, Spain.	ggasegui@unav.es	High, Katherine A./AAB-9322-2020; Gonzalez-Aseguinolaza, Gloria/H-9928-2015	Gonzalez-Aseguinolaza, Gloria/0000-0002-1600-4562; Prieto, Jesus/0000-0002-1091-9593; Di Scala, Marianna/0000-0002-4460-6472; Gil-Farina, Irene/0000-0002-9839-1411; High, Katherine/0000-0002-0805-6223; Vanrell, Lucia/0000-0002-3255-4820	FPI; Fondo de Investigaciones Sanitarias; European Union VII Framework program (FP7-health) [AIPGENE-2010-261506]; UTE project CIMA; Fundacion Barrie de la Maza y Condesa de Fenosa; Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas Instituto de Salud Carlos III; Ministerio Educacion y Ciencia/Ministerio de Ciencia e Innovacion [SAF 2006-03623, SAF2009-08524]; Fundacion Mutua Madrilena	FPI(Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); European Union VII Framework program (FP7-health); UTE project CIMA; Fundacion Barrie de la Maza y Condesa de Fenosa; Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas Instituto de Salud Carlos III; Ministerio Educacion y Ciencia/Ministerio de Ciencia e Innovacion; Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	IGF and LV are in receipt of FPI grants, MDS is in receipt of a fellowship from Fondo de Investigaciones Sanitarias. This work was supported by grants from European Union VII Framework program (FP7-health: AIPGENE-2010-261506), UTE project CIMA, Fundacion Barrie de la Maza y Condesa de Fenosa, Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas Instituto de Salud Carlos III, SAF 2006-03623 and SAF2009-08524 (Ministerio Educacion y Ciencia/Ministerio de Ciencia e Innovacion) and Fundacion Mutua Madrilena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Breous E, 2011, GASTROENTEROLOGY, V141, P348, DOI 10.1053/j.gastro.2011.04.002; Jayandharan GR, 2011, P NATL ACAD SCI USA, V108, P3743, DOI 10.1073/pnas.1012753108; Kramer MG, 2003, MOL THER, V7, P375, DOI 10.1016/S1525-0016(02)00060-6; Li CW, 2007, J VIROL, V81, P7540, DOI 10.1128/JVI.00529-07; Li H, 2007, MOL THER, V15, P792, DOI 10.1038/sj.mt.6300090; Li H, 2011, MOL THER, V19, P2021, DOI 10.1038/mt.2011.81; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Martino AT, 2013, BLOOD, V121, P2224, DOI 10.1182/blood-2012-10-460733; Martino AT, 2011, BLOOD, V117, P6459, DOI 10.1182/blood-2010-10-314518; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Reboredo M, 2008, GENE THER, V15, P277, DOI 10.1038/sj.gt.3303073; Rogers GL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00194; Sabatino DE, 2005, MOL THER, V12, P1023, DOI 10.1016/j.ymthe.2005.09.009; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Suzuki M, 2013, MOL THER, V21, P796, DOI 10.1038/mt.2012.277; Vanrell L, 2011, MOL THER, V19, P1245, DOI 10.1038/mt.2011.37; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang LL, 2007, HUM GENE THER, V18, P185, DOI 10.1089/hum.2007.001; Washburn ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010585; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	24	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67748	10.1371/journal.pone.0067748	http://dx.doi.org/10.1371/journal.pone.0067748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844082	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000090
J	Karper, JC; Ewing, MM; de Vries, MR; de Jager, SCA; Peters, EAB; de Boer, HC; van Zonneveld, AJ; Kuiper, J; Huizinga, EG; Brondijk, THC; Jukema, JW; Quax, PHA				Karper, Jacco C.; Ewing, Mark M.; de Vries, Margreet R.; de Jager, Saskia C. A.; Peters, Erna A. B.; de Boer, Hetty C.; van Zonneveld, Anton-Jan; Kuiper, Johan; Huizinga, Eric G.; Brondijk, T. Harma C.; Jukema, J. Wouter; Quax, Paul H. A.			TLR Accessory Molecule RP105 (CD180) Is Involved in Post-Interventional Vascular Remodeling and Soluble RP105 Modulates Neointima Formation	PLOS ONE			English	Article							RECEPTOR HOMOLOG RP105; TOLL-LIKE RECEPTOR-4; TRANSGENIC MICE; IN-VIVO; TOLL-LIKE-RECEPTOR-4; EXPRESSION; RESTENOSIS; MUSCLE; ATHEROSCLEROSIS; PROLIFERATION	Background: RP105 (CD180) is TLR4 homologue lacking the intracellular TLR4 signalling domain and acts a TLR accessory molecule and physiological inhibitor of TLR4-signaling. The role of RP105 in vascular remodeling, in particular post-interventional remodeling is unknown. Methods and Results: TLR4 and RP105 are expressed on vascular smooth muscle cells (VSMC) as well as in the media of murine femoral artery segments as detected by qPCR and immunohistochemistry. Furthermore, the response to the TLR4 ligand LPS was stronger in VSMC from RP105(-/-) mice resulting in a higher proliferation rate. In RP105(-/-) mice femoral artery cuff placement resulted in an increase in neointima formation as compared to WT mice (4982 +/- 974 mu m(2) vs. 1947 +/- 278 mu m(2), p = 0.0014). Local LPS application augmented neointima formation in both groups, but in RP105(-/-) mice this effect was more pronounced (10316 +/- 1243 mu m(2) vs. 4208 +/- 555 mu m(2), p = 0.0002), suggesting a functional role for RP105. For additional functional studies, the extracellular domain of murine RP105 was expressed with or without its adaptor protein MD1 and purified. SEC-MALSanalysis showed a functional 2: 2 homodimer formation of the RP105-MD1 complex. This protein complex was able to block the TLR4 response in whole blood ex-vivo. In vivo gene transfer of plasmid vectors encoding the extracellular part of RP105 and its adaptor protein MD1 were performed to initiate a stable endogenous soluble protein production. Expression of soluble RP105-MD1 resulted in a significant reduction in neointima formation in hypercholesterolemic mice (2500 +/- 573 vs. 6581 +/- 1894 mu m(2), p < 0.05), whereas expression of the single factors RP105 or MD1 had no effect. Conclusion: RP105 is a potent inhibitor of post-interventional neointima formation.	[Karper, Jacco C.; Ewing, Mark M.; de Vries, Margreet R.; Peters, Erna A. B.; Quax, Paul H. A.] LUMC, Dept Surg, Leiden, Netherlands; [Karper, Jacco C.; Ewing, Mark M.; de Vries, Margreet R.; Peters, Erna A. B.; de Boer, Hetty C.; van Zonneveld, Anton-Jan; Quax, Paul H. A.] LUMC, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Ewing, Mark M.; de Vries, Margreet R.; Jukema, J. Wouter] LUMC, Dept Cardiol, Leiden, Netherlands; [de Jager, Saskia C. A.; Kuiper, Johan] Leiden Univ, Dept Biopharmaceut, NL-2300 RA Leiden, Netherlands; [de Boer, Hetty C.; van Zonneveld, Anton-Jan] LUMC, Dept Nephrol, Leiden, Netherlands; [Huizinga, Eric G.; Brondijk, T. Harma C.] Univ Utrecht, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Utrecht University	Quax, PHA (corresponding author), LUMC, Dept Surg, Leiden, Netherlands.	p.h.a.quax@lumc.nl	Quax, Paul/ABD-5294-2020; de Vries, Margreet/Z-5653-2019; van Zonneveld, Anton Jan/D-8060-2018; Jukema, J. Wouter/ABD-6503-2021; de+Jager, Saskia/AAE-1132-2022; Quax, Paul/W-8520-2019; de+Jager, Saskia/ABC-4264-2020; Brondijk, Harma/AAD-6485-2019	Quax, Paul/0000-0002-6853-5760; van Zonneveld, Anton Jan/0000-0002-1676-7738; Jukema, J. Wouter/0000-0002-3246-8359; Brondijk, Harma/0000-0002-0234-673X; de Jager, Saskia/0000-0002-5233-0066	Dutch Top Institute Pharma project [D1-101]; Foundation "De Drie Lichten'' in the Netherlands	Dutch Top Institute Pharma project; Foundation "De Drie Lichten'' in the Netherlands	This study was (partly) performed within the framework of the Dutch Top Institute Pharma project D1-101. This project has been supported by the Foundation "De Drie Lichten'' in the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Divanovic S, 2005, J ENDOTOXIN RES, V11, P363, DOI 10.1179/096805105X67300; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Divanovic S, 2007, J LEUKOCYTE BIOL, V82, P265, DOI 10.1189/jlb.0107021; Eefting D, 2007, ATHEROSCLEROSIS, V193, P335, DOI 10.1016/j.atherosclerosis.2006.09.032; Eefting D, 2010, CARDIOVASC RES, V88, P367, DOI 10.1093/cvr/cvq203; Freudenberg J, 2010, HUM MOL GENET, V19, P3863, DOI 10.1093/hmg/ddq304; Hadley JS, 2007, SHOCK, V27, P466, DOI 10.1097/01.shk.0000245033.69977.c5; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Jukema JW, 2012, NAT REV CARDIOL, V9, P79, DOI 10.1038/nrcardio.2011.148; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Karper JC, 2011, ARTERIOSCL THROM VAS, V31, P1033, DOI 10.1161/ATVBAHA.111.223271; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lardenoye JHP, 2000, CIRC RES, V87, P248, DOI 10.1161/01.RES.87.3.248; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Miyake K, 1998, J IMMUNOL, V161, P1348; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; Monraats PS, 2005, CIRCULATION, V112, P2417, DOI 10.1161/CIRCULATIONAHA.105.536268; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Shimamoto A, 2006, CIRCULATION, V114, pI270, DOI 10.1161/CIRCULATIONAHA.105.000901; Shimizu T, 2011, J MOL BIOL, VS0022-2836, P01026; Tada Y, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2529; Tanne A, 2009, J EXP MED, V206, P2205, DOI 10.1084/jem.20090188; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Yoon SI, 2011, NAT STRUCT MOL BIOL, V18, P1028, DOI 10.1038/nsmb.2106; Zhang YP, 2009, EUR CYTOKINE NETW, V20, P148, DOI 10.1684/ecn.2009.0156	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67923	10.1371/journal.pone.0067923	http://dx.doi.org/10.1371/journal.pone.0067923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844130	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000120
J	Li, XY; Pu, JX; Jiang, SY; Su, J; Kong, LM; Mao, BY; Sun, HD; Li, Y				Li, Xingyao; Pu, Jianxin; Jiang, Shiyou; Su, Jia; Kong, Lingmei; Mao, Bingyu; Sun, Handong; Li, Yan			Henryin, an ent-kaurane Diterpenoid, Inhibits Wnt Signaling through Interference with beta-Catenin/TCF4 Interaction in Colorectal Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; COLON-CANCER; RESPONSE ELEMENT; ACTIVATION; EXPRESSION; PATHWAY; COMPLEX; GROWTH; APC; ANTAGONISTS	Aberrant Wnt/beta-catenin signaling has been strongly associated with the tumorigenesis of human colorectal cancer. Inhibitors of this pathway may then offer therapeutic strategies as well as chemoprevention for this malignant disease. Henryin is an ent-kaurane diterpenoid isolated from Isodon rubescens var. lushanensis, a plant long been used in folk medicine to prevent inflammation and gastrointestinal disease. In the present study, we report that henryin selectively inhibits the proliferation of human colorectal cancer cells with a GI(50) value in the nano-molar range. Microarray analysis and reporter assays showed that henryin worked as a novel antagonist of Wnt signaling pathway. Henryin reduced the expression of Cyclin D1 and C-myc, and induced G1/S phase arrest in HCT116 cells. Concurrently, henryin did not affect the cytosol-nuclear distribution of soluble beta-catenin, but impaired the association of beta-catenin/TCF4 transcriptional complex likely through directly blocking the binding of beta-catenin to TCF4. We also then analyzed the structure-activity relationship among the ent-kaurane type diterpenoids. Our data suggests that henryin, as a novel inhibitor of Wnt signaling, could be a potential candidate for further preclinical evaluation for colon cancer treatment, and as such warrants further exploration.	[Li, Xingyao; Pu, Jianxin; Su, Jia; Kong, Lingmei; Sun, Handong; Li, Yan] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming, Peoples R China; [Jiang, Shiyou; Mao, Bingyu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Li, Xingyao; Jiang, Shiyou; Su, Jia; Kong, Lingmei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, HD (corresponding author), Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming, Peoples R China.	hdsun@mail.kib.ac.cn; liyanb@mail.kib.ac.cn	Mao, Bingyu/L-9955-2014	Jiang, Shi-You/0000-0001-9406-4934; Mao, Bingyu/0000-0002-7993-3158	100 Talents Program of the Chinese Academy of Sciences; West Light Foundation of the Chinese Academy of Sciences; Major State Basic Research Development Program of China [2009CB522300]; Natural Science Foundation of China [81173076, 81172939]; Recruited Top Talent of Sciences and Technology of Yunnan Province, China [2009C1120]	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Major State Basic Research Development Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Recruited Top Talent of Sciences and Technology of Yunnan Province, China	This work was supported by both the 100 Talents Program (YL) and the West Light Foundation (JP) of the Chinese Academy of Sciences, the Major State Basic Research Development Program of China (No. 2009CB522300), the Natural Science Foundation of China (No. 81173076, 81172939), and the Recruited Top Talent of Sciences and Technology of Yunnan Province (2009C1120), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen HJ, 2012, BIOCHEM PHARMACOL, V84, P1143, DOI 10.1016/j.bcp.2012.08.011; Choi H, 2010, BIOCHEM BIOPH RES CO, V391, P915, DOI 10.1016/j.bbrc.2009.11.164; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Kang Y.-J., 2012, MOL PHARM; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Leung CH, 2006, MOL PHARMACOL, V70, P1946, DOI 10.1124/mol.106.028480; LI J, 1984, Acta Botanica Yunnanica, V6, P453; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Oshima H, 2012, J GASTROENTEROL, V47, P97, DOI 10.1007/s00535-011-0523-6; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Su Y, 2009, CARCINOGENESIS, V30, P331, DOI 10.1093/carcin/bgn279; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; Tarapore RS, 2012, CARCINOGENESIS, V33, P483, DOI 10.1093/carcin/bgr305; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282; Wang W, 2011, CELL RES, V21, P730, DOI 10.1038/cr.2011.30; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zhang HB, 2010, CHEM PHARM BULL, V58, P56, DOI 10.1248/cpb.58.56; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104; Zhang T, 2001, CANCER RES, V61, P8664	37	37	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68525	10.1371/journal.pone.0068525	http://dx.doi.org/10.1371/journal.pone.0068525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844215	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000169
J	Matsushita, H; Hijioka, M; Hisatsune, A; Isohama, Y; Iwamoto, S; Terasawa, H; Katsuki, H				Matsushita, Hideaki; Hijioka, Masanori; Hisatsune, Akinori; Isohama, Yoichiro; Iwamoto, Shigeto; Terasawa, Hiroaki; Katsuki, Hiroshi			MRI-Based Analysis of Intracerebral Hemorrhage in Mice Reveals Relationship between Hematoma Expansion and the Severity of Symptoms	PLOS ONE			English	Article							PREDICTOR; RECOVERY; MODELS; RATS	Intracerebral hemorrhage (ICH) is featured by poor prognosis such as high mortality rate and severe neurological dysfunction. In humans, several valuables including hematoma volume and ventricular expansion of hemorrhage are known to correlate with the extent of mortality and neurological dysfunction. However, relationship between hematoma conditions and the severity of symptoms in animal ICH models has not been clarified. Here we addressed this issue by using 7-tesla magnetic resonance imaging (MRI) on collagenase-induced ICH model in mice. We found that the mortality rate and the performance in behavioral tests did not correlate well with the volume of hematoma. In contrast, when hemorrhage invaded the internal capsule, mice exhibited high mortality and showed poor sensorimotor performance. High mortality rate and poor performance in behavioral tests were also observed when hemorrhage invaded the lateral ventricle, although worsened symptoms associated with ventricular hemorrhage were apparent only during early phase of the disease. These results clearly indicate that invasion of the internal capsule or the lateral ventricle by hematoma is a critical determinant of poor prognosis in experimental ICH model in mice as well as in human ICH patients. MRI assessment may be a powerful tool to refine investigations of pathogenic mechanisms and evaluations of drug effects in animal models of ICH.	[Matsushita, Hideaki; Hijioka, Masanori; Hisatsune, Akinori; Isohama, Yoichiro; Katsuki, Hiroshi] Kumamoto Univ, Dept Chemicopharmacol Sci, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Hisatsune, Akinori] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Japan; [Iwamoto, Shigeto; Terasawa, Hiroaki] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Struct Bioimaging, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Katsuki, H (corresponding author), Kumamoto Univ, Dept Chemicopharmacol Sci, Grad Sch Pharmaceut Sci, Kumamoto, Japan.	hkatsuki@gpo.kumamoto-u.ac.jp	HIJIOKA, Masanori/N-6665-2017; HIJIOKA, Masanori/AAL-3018-2020	HIJIOKA, Masanori/0000-0001-6912-3496; HIJIOKA, Masanori/0000-0001-6912-3496; Katsuki, Hiroshi/0000-0001-7595-3154	Smoking Research Foundation; Mitsubishi Pharma Research Foundation; MEXT KAKENHI [23117714]; JSPS KAKENHI [24659118]	Smoking Research Foundation; Mitsubishi Pharma Research Foundation; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Smoking Research Foundation, Mitsubishi Pharma Research Foundation, MEXT KAKENHI Grant Number 23117714, and JSPS KAKENHI Grant Number 24659118. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the funders (Mitsubishi Pharma Research Foundation) is based on commercial source, but this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors have no relation with this foundation concerning employment, consultancy, patents, products in development or marketed products etc.	Arboix A, 2002, ACTA NEUROL SCAND, V105, P282, DOI 10.1034/j.1600-0404.2002.1o170.x; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hijioka M, 2012, NEUROSCIENCE, V222, P10, DOI 10.1016/j.neuroscience.2012.07.024; Katsuki H, 2010, J PHARMACOL SCI, V114, P366, DOI 10.1254/jphs.10R05CR; Liliang PC, 2001, STROKE, V32, P1195, DOI 10.1161/01.STR.32.5.1195; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, J CEREBR BLOOD F MET, V26, P1031, DOI 10.1038/sj.jcbfm.9600255; MacLellan CL, 2010, STROKE, V41, pS95, DOI 10.1161/STROKEAHA.110.594457; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; Matsushita H, 2012, EUR J PHARMACOL, V683, P125, DOI 10.1016/j.ejphar.2012.03.023; Matsushita H, 2011, J CEREBR BLOOD F MET, V31, P222, DOI 10.1038/jcbfm.2010.80; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; MORI E, 1985, STROKE, V16, P454, DOI 10.1161/01.STR.16.3.454; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Shaya M, 2005, SURG NEUROL, V63, P343, DOI 10.1016/j.surneu.2004.06.019; TAPIA JF, 1983, STROKE, V14, P505, DOI 10.1161/01.STR.14.4.505; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0	19	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67691	10.1371/journal.pone.0067691	http://dx.doi.org/10.1371/journal.pone.0067691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844065	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000079
J	Otsuka, T; Kitami, O; Kondo, K; Ota, H; Oshima, S; Tsuchiya, A; Shirai, T; Fujii, K; Nakamure, M; Shoji, Y; Nakamura, H; Masuda, Y; Komiyama, K; Yoshida, K; Ishikawa, Y; Iwaya, A; Takahashi, S; Okazaki, M; Hotomi, M; Yamanaka, N				Otsuka, Taketo; Kitami, Osamu; Kondo, Kouji; Ota, Hisayuki; Oshima, Shinsuke; Tsuchiya, Akio; Shirai, Takatoshi; Fujii, Koyata; Nakamure, Michihide; Shoji, Yasuhiro; Nakamura, Hisano; Masuda, Yasuko; Komiyama, Kenichi; Yoshida, Kazunaga; Ishikawa, Yukio; Iwaya, Atsushi; Takahashi, Sugata; Okazaki, Minoru; Hotomi, Muneki; Yamanaka, Noboru			Incidence Survey of Acute Otitis Media in Children in Sado Island, Japan-Sado Otitis Media Study (SADOMS)	PLOS ONE			English	Article							LIFE	Background: Acute otitis media (AOM) is one of the most common forms of bacterial infection and cause for clinic visits in children. The incidence of AOM was 0.9-1.2 episodes per person-year during the first 2 years of life in previous reports conducted before 2000. The aim of this study was to 1) evaluate the latest AOM incidence in pediatric outpatients and 2) identify the bacterial pathogens from these patients and ascertain their serotypes and resistance. Methods: The study was conducted in a closed population, involving all pediatricians and otolaryngologists in Sado Island allowing accurate determination of AOM incidence. In each month, one week was assigned as "surveillance week", and all outpatients with acute illness aged 0-18 years examined during the surveillance weeks were enrolled. AOM was diagnosed on the basis of otoscopic findings and clinical symptoms were recorded. Specimens were collected from the nasopharynx or middle ear cavity of AOM patients and examined for bacteria. Antimicrobial susceptibilities, serotypes, and molecular typing for resistance were determined among Streptococcus pneumoniae and Haemophilus influenzae. Results: In total, 8,283 clinic visits were conducted, and 354 episodes (4.3%, 95% CI: 3.9-4.7%) among 312 children were diagnosed as AOM. The incidence of AOM was highest in children of 1 year of age (0.54 episodes/child/year, 95% CI: 0.44-0.64). Serotype coverage of 7- and 13-valent pneumococcal conjugate vaccines in this study were 38.0% (95% CI: 29.3-47.3) and 62.8% (95% CI: 53.6-71.4), respectively. Of 122 H. influenzae isolates available for typing, 120 were nontypeable and 2 were type b. A high proportion of S. pneumoniae isolates (46%) showed resistance to penicillin. Approximately half of H. influenzae isolates had genetic markers for beta-lactamase-negative ampicillin-resistance. Conclusions: Approximately 4-5% of pediatric outpatients, even without AOM-related symptoms, had AOM in our study. Pediatricians as well as otolaryngologists should check the tympanic membrane findings of all pediatric outpatients.	[Otsuka, Taketo; Fujii, Koyata; Nakamure, Michihide; Shoji, Yasuhiro; Nakamura, Hisano; Okazaki, Minoru] Sado Gen Hosp, Dept Pediat, Sado, Niigata, Japan; [Kitami, Osamu] Shiseido Otolaryngol Clin, Sado, Niigata, Japan; [Kondo, Kouji] Kondo Clin, Sado, Niigata, Japan; [Ota, Hisayuki; Oshima, Shinsuke; Tsuchiya, Akio] Sado Gen Hosp, Dept Otolaryngol, Sado, Niigata, Japan; [Shirai, Takatoshi; Iwaya, Atsushi] Ryotsu Hosp, Dept Pediat, Sado, Niigata, Japan; [Masuda, Yasuko; Komiyama, Kenichi; Yoshida, Kazunaga; Ishikawa, Yukio] Sado Gen Hosp, Dept Clin Lab, Sado, Niigata, Japan; [Takahashi, Sugata] Niigata Univ, Dept Otolaryngol, Niigata, Japan; [Hotomi, Muneki; Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan	Niigata University; Wakayama Medical University	Otsuka, T (corresponding author), Sado Gen Hosp, Dept Pediat, Sado, Niigata, Japan.	ootsukataketo@hotmail.com						[Anonymous], 2008, M100S18 CLIN LAB STA; Auinger P, 2003, PEDIATRICS, V112, P514, DOI 10.1542/peds.112.3.514; CARLSON LH, 1999, EVIDENCE BASED OTITI, P105; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623; Hotomi M, 2007, ANTIMICROB AGENTS CH, V51, P3969, DOI 10.1128/AAC.00422-07; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P594, DOI 10.1016/j.anl.2010.02.005; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Nagai K, 2001, J ANTIMICROB CHEMOTH, V48, P915, DOI 10.1093/jac/48.6.915; Roy E, 2007, J HEALTH POPUL NUTR, V25, P414; Shaikh N, 2012, ACAD PEDIATR, V12, P214, DOI 10.1016/j.acap.2012.01.007; Subcommittee of Clinical Practice Guideline for Diagnosis and Management of Acute Otitis Media in Children (Japan Otological Society Japan Society for Pediatric Otorhinolaryngology Japan Society for Infectious Diseases in Otolaryngology), 2012, Auris Nasus Larynx, V39, P1, DOI 10.1016/j.anl.2011.09.008; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Syrjanen RK, 2005, PEDIATR INFECT DIS J, V24, P801, DOI 10.1097/01.inf.0000178072.83531.4f; TaitKamradt A, 1997, ANTIMICROB AGENTS CH, V41, P2251, DOI 10.1128/AAC.41.10.2251; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Wada A, 2013, PEDIAT INFE IN PRESS	17	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68711	10.1371/journal.pone.0068711	http://dx.doi.org/10.1371/journal.pone.0068711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844235	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000178
J	Singh, A; Yamamoto, M; Kam, SHY; Ruan, J; Gauvreau, GM; O'Byrne, PM; FitzGerald, JM; Schellenberg, R; Boulet, LP; Wojewodka, G; Kanagaratham, C; De Sanctis, JB; Radzioch, D; Tebbutt, SJ				Singh, Amrit; Yamamoto, Masatsugu; Kam, Sarah H. Y.; Ruan, Jian; Gauvreau, Gail M.; O'Byrne, Paul M.; FitzGerald, J. Mark; Schellenberg, Robert; Boulet, Louis-Philippe; Wojewodka, Gabriella; Kanagaratham, Cynthia; De Sanctis, Juan B.; Radzioch, Danuta; Tebbutt, Scott J.			Gene-Metabolite Expression in Blood Can Discriminate Allergen-Induced Isolated Early from Dual Asthmatic Responses	PLOS ONE			English	Article							INHALATION CHALLENGE; AIRWAY INFLAMMATION; CELLS; RESOLUTION; IMMEDIATE	Some asthmatic individuals undergoing allergen inhalation challenge develop an isolated early response whereas others develop a dual response (early plus late response). In the present study we have used transcriptomics (microarrays) and metabolomics (mass spectrometry) of peripheral blood to identify molecular patterns that can discriminate allergen-induced isolated early from dual asthmatic responses. Peripheral blood was obtained prior to (pre-) and 2 hours post allergen inhalation challenge from 33 study participants. In an initial cohort of 14 participants, complete blood counts indicated significant differences in neutrophil and lymphocyte counts at pre-challenge between early and dual responders. At post-challenge, significant genes (ALOX15, FADS2 and LPCAT2) and metabolites (lysolipids) were enriched in lipid metabolism pathways. Enzymes encoding for these genes are involved in membrane biogenesis and metabolism of fatty acids into pro-inflammatory and anti-inflammatory mediators. Correlation analysis indicated a strong negative correlation between ALOX15, FADS2, and IL5RA expression with 2-arachidonoylglycerophosphocholine levels in dual responders. However, measuring arachidonic acid and docosahexaenoic acid levels in a validation cohort of 19 participants indicated that the free form of DHA (nmoles/mu g of protein) was significantly (p = 0.03) different between early and dual responders after allergen challenge. Collectively these results may suggest an imbalance in lipid metabolism which dictates pro- (anti-)inflammatory and pro-resolving mechanisms. Future studies with larger sample sizes may reveal novel mechanisms and therapeutic targets of the late phase asthmatic response.	[Singh, Amrit; Yamamoto, Masatsugu; Kam, Sarah H. Y.; Ruan, Jian; Schellenberg, Robert; Tebbutt, Scott J.] Univ British Columbia, St Pauls Hosp, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Singh, Amrit; Yamamoto, Masatsugu; Kam, Sarah H. Y.; Ruan, Jian; FitzGerald, J. Mark; Tebbutt, Scott J.] Inst Heart Lung Hlth, Vancouver, BC, Canada; [Singh, Amrit; Tebbutt, Scott J.] NCE CECR PROOF Ctr Excellence, Vancouver, BC, Canada; [Gauvreau, Gail M.; O'Byrne, Paul M.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Yamamoto, Masatsugu; FitzGerald, J. Mark; Schellenberg, Robert; Tebbutt, Scott J.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada; [FitzGerald, J. Mark] Vancouver Gen Hosp, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Boulet, Louis-Philippe] Univ Laval, Ctr Pneumol Hop, Ste Foy, PQ G1K 7P4, Canada; [Wojewodka, Gabriella; Kanagaratham, Cynthia; De Sanctis, Juan B.; Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [De Sanctis, Juan B.] Cent Univ Venezuela, Inst Immunol, Caracas, Venezuela	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; McMaster University; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Laval University; McGill University; University of Central Venezuela	Tebbutt, SJ (corresponding author), Univ British Columbia, St Pauls Hosp, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada.	Scott.Tebbutt@hli.ubc.ca	Yamamoto, Masatsugu/AAH-7093-2020; De Sanctis, Juan B./H-5050-2019	Yamamoto, Masatsugu/0000-0003-0596-555X; De Sanctis, Juan B./0000-0002-5480-4608; Tebbutt, Scott/0000-0002-7908-1581; Radzioch, Danuta/0000-0002-1601-2757; O'Byrne, Paul/0000-0003-0979-281X	AllerGen NCE Inc. (Allergy, Genes and Environment Network)	AllerGen NCE Inc. (Allergy, Genes and Environment Network)	This study was funded by AllerGen NCE Inc. (Allergy, Genes and Environment Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamko DJ, 2012, CHEST, V141, P1295, DOI 10.1378/chest.11-2028; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; BARNES PJ, 1992, THORAX, V47, P979, DOI 10.1136/thx.47.11.979; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; COCKCROFT DW, 1983, CHEST, V84, P505, DOI 10.1378/chest.84.4.505; EBINA M, 1990, AM REV RESPIR DIS, V141, P1327, DOI 10.1164/ajrccm/141.5_Pt_1.1327; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gauvreau Gail M., 2007, V14, P21, DOI 10.1159/000107052; Gauvreau GM, 2011, AM J RESP CRIT CARE, V183, P1007, DOI 10.1164/rccm.201008-1210OC; Gauvreau GM, 2000, AM J RESP CRIT CARE, V161, P1473, DOI 10.1164/ajrccm.161.5.9908090; Gonzalez I, 2009, J BIOL SYST, V17, P173, DOI 10.1142/S0218339009002831; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Hakonarson H, 2001, AM J RESP CELL MOL, V25, P761, DOI 10.1165/ajrcmb.25.6.4628; Hamann J, 2007, EUR J IMMUNOL, V37, P2797, DOI 10.1002/eji.200737553; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hansel Nadia N, 2007, Proc Am Thorac Soc, V4, P32, DOI 10.1513/pats.200606-132JG; Hatzivlassiou M, 2010, ALLERGY, V65, P355, DOI 10.1111/j.1398-9995.2009.02184.x; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; Huber PJ, 1981, ROBUST STAT; Jarjour NN, 1997, AM J RESP CRIT CARE, V155, P1515, DOI 10.1164/ajrccm.155.5.9154851; Kam SHY, 2012, J ASTHMA, V49, P219, DOI 10.3109/02770903.2011.654300; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Levy BD, 2012, CLIN CHEST MED, V33, P559, DOI 10.1016/j.ccm.2012.06.006; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; Luskin AT, 2005, J ALLERGY CLIN IMMUN, V115, pS539, DOI 10.1016/j.jaci.2005.01.027; Matsumoto K, 2002, J ALLERGY CLIN IMMUN, V109, P281, DOI 10.1067/mai.2002.121144; Murray J J, 1985, Trans Assoc Am Physicians, V98, P275; NAYLOR BERNARD, 1962, THORAX, V17, P69, DOI 10.1136/thx.17.1.69; Perogamvros I, 2012, NAT REV ENDOCRINOL, V8, P717, DOI 10.1038/nrendo.2012.134; Rzehak P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013261; SCHLENK H, 1960, ANAL CHEM, V32, P1412, DOI 10.1021/ac60167a011; Seeds MC, 2009, AM J RESP CELL MOL, V41, P358, DOI 10.1165/rcmb.2008-0192OC; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Singh A, 2012, PROTEOMICS CLIN APPL; Symth GK, 2004, STAT APPL GENETICS M; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Team RDC, 2009, R LANG ENV STAT COMP; Tesfaigzi Y, 2008, CURR MOL MED, V8, P408, DOI 10.2174/156652408785160961; Tulic MK, 2001, RESP RES, V2, P333, DOI 10.1186/rr83; Verstraelen S, 2008, TOXICOL IN VITRO, V22, P1419, DOI 10.1016/j.tiv.2008.05.008; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; WENZEL SE, 1989, AM REV RESPIR DIS, V139, P450, DOI 10.1164/ajrccm/139.2.450; Wood JJ, 1998, AM J RESP CRIT CARE, V157, P99, DOI 10.1164/ajrccm.157.1.9704125; Yamamoto M., 2012, BMC GENOMICS, V13; Yao PL, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-89	54	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67907	10.1371/journal.pone.0067907	http://dx.doi.org/10.1371/journal.pone.0067907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844124	Green Published, gold			2022-12-25	WOS:000321341000117
J	Steinmann, C; Blaedel, KL; Christensen, AS; Jensen, JH				Steinmann, Casper; Blaedel, Kristoffer L.; Christensen, Anders S.; Jensen, Jan H.			Interface of the Polarizable Continuum Model of Solvation with Semi-Empirical Methods in the GAMESS Program	PLOS ONE			English	Article							ELECTROSTATIC INTERACTION; ENERGY GRADIENTS; OPTIMIZATION; MOLECULES; CONVERGENCE; GEOMETRY; PDB2PQR; SOLUTE; SCF	An interface between semi-empirical methods and the polarized continuum model (PCM) of solvation successfully implemented into GAMESS following the approach by Chudinov et al (Chem. Phys. 1992, 160, 41). The interface includes energy gradients and is parallelized. For large molecules such as ubiquitin a reasonable speedup (up to a factor of six) is observed for up to 16 cores. The SCF convergence is greatly improved by PCM for proteins compared to the gas phase.	[Steinmann, Casper] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [Blaedel, Kristoffer L.; Christensen, Anders S.; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen	Jensen, JH (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	jhjensen@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; Svendsen, Casper/T-6775-2018	Jensen, Jan Halborg/0000-0002-1465-1010; Svendsen, Casper/0000-0002-5638-1346				Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Caricato M, 2004, J PHYS CHEM A, V108, P6248, DOI 10.1021/jp048888r; Chaban G, 1997, THEOR CHEM ACC, V97, P88, DOI 10.1007/s002140050241; CHUDINOV GE, 1992, CHEM PHYS, V160, P41, DOI 10.1016/0301-0104(92)87090-V; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; DEWAR MJS, 1977, J AM CHEM SOC, V99, P4899, DOI 10.1021/ja00457a004; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DEWAR MJS, 1977, THEOR CHIM ACTA, V46, P89, DOI 10.1007/BF00548085; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; FISCHER TH, 1992, J PHYS CHEM-US, V96, P9768, DOI 10.1021/j100203a036; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Li H, 2003, THEOR CHEM ACC, V109, P71, DOI 10.1007/s00214-002-0427-x; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li H, 2004, J COMPUT CHEM, V25, P1449, DOI 10.1002/jcc.20072; LUQUE FJ, 1993, J PHYS CHEM-US, V97, P4386, DOI 10.1021/j100119a022; Mennucci B, 2012, WIRES COMPUT MOL SCI, V2, P386, DOI 10.1002/wcms.1086; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; NEGRE M, 1992, CHEM PHYS LETT, V196, P27, DOI 10.1016/0009-2614(92)85924-Y; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; PASCUALAHUIR JL, 1987, J COMPUT CHEM, V8, P778, DOI 10.1002/jcc.540080605; PULAY P, 1982, J COMPUT CHEM, V3, P556, DOI 10.1002/jcc.540030413; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Su PF, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3077917; Thellamurege NM, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4773280; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009	29	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67725	10.1371/journal.pone.0067725	http://dx.doi.org/10.1371/journal.pone.0067725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844075	Green Published, gold, Green Submitted			2022-12-25	WOS:000321341000084
J	Kalakonda, S; Nallar, SC; Lindner, DJ; Sun, P; Lorenz, RR; Lamarre, E; Reddy, SP; Kalvakolanu, DV				Kalakonda, S.; Nallar, S. C.; Lindner, D. J.; Sun, P.; Lorenz, R. R.; Lamarre, E.; Reddy, S. P.; Kalvakolanu, D. V.			GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis	ONCOGENE			English	Article						tyrosine kinases; tumor suppression; cytoskeleton; metastasis; cytokines	SQUAMOUS-CELL CARCINOMA; REGULATORY GENE-PRODUCT; C-SRC; RETINOIC ACID; BONE METASTASIS; FAMILY KINASES; TUMOR-CELLS; COMPLEX-I; CANCER; CORTACTIN	The non-receptor tyrosine kinase Src is a major player in multiple physiological responses including growth, survival and differentiation. Overexpression and/or oncogenic mutation in the Src gene have been documented in human tumors. The v-Src protein is an oncogenic mutant of Src, which promotes cell survival, migration, invasion and division. GRIM-19 is an antioncogene isolated using a genome-wide knockdown screen. Genes associated with Retinoid-IFN-induced Mortality (GRIM)-19 binds to transcription factor STAT3 and ablates its pro-oncogenic effects while v-Src activates STAT3 to promote its oncogenic effects. However, we found that GRIM-19 inhibits the pro-oncogenic effects of v-Src independently of STAT3. Here, we report the identification of functionally inactivating GRIM-19 mutations in a set of head and neck cancer patients. While wild-type GRIM-19 strongly ablated v-Src-induced cell migration, cytoskeletal remodeling and tumor metastasis, the tumor-derived mutants ((LP)-P-71, (LP)-P-91 and A(95)T) did not. These mutants were also incapable of inhibiting the drug resistance of v-Src-transformed cells. v-Src downregulated the expression of Pag1, a lipid raft-associated inhibitor of Src, which was restored by wild-type GRIM-19. The tumor-derived mutant GRIM-19 proteins failed to upregulate Pag1. These studies show a novel mechanism that deregulates Src activity in cancer cells.	[Kalakonda, S.; Nallar, S. C.; Sun, P.; Kalvakolanu, D. V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Program Oncol,Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Lindner, D. J.] Taussig Canc Ctr, Cleveland, OH USA; [Lorenz, R. R.; Lamarre, E.] Cleveland Clin Fdn, Head & Neck Inst, Cleveland, OH 44195 USA; [Reddy, S. P.] Univ Illinois, Coll Med, Dept Pediat, Chicago, IL USA	University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Program Oncol,Greenebaum Canc Ctr, 660 West Redwood St,Howard Hall Room 324, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu	Lindner, Daniel/ABB-5440-2020		National Institutes of Health [CA105005]; University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE [R01CA105005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Michael Kahn (University of California at Los Angeles, CA) for lentiviral luciferase (pCCL-c-MNDU3c-Luc) vector. This study is supported by the National Institutes of Health grant CA105005 and an intramural award from the Cigarette restitution funds of the University of Maryland Greenebaum Cancer Center to DVK.	Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Byers LA, 2009, CLIN CANCER RES, V15, P6852, DOI 10.1158/1078-0432.CCR-09-0767; Chen JYF, 2008, NEOPLASIA, V10, P1393, DOI 10.1593/neo.08854; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Gong Long-Bo, 2007, Ai Zheng, V26, P683; Hofman ER, 1998, MOL CELL BIOL, V18, P6493, DOI 10.1128/MCB.18.11.6493; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang LQ, 2006, ONCOGENE, V25, P5495, DOI 10.1038/sj.onc.1209554; Kalakonda S, 2007, AM J PATHOL, V171, P1352, DOI 10.2353/ajpath.2007.070241; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koppikar P, 2008, CLIN CANCER RES, V14, P4284, DOI 10.1158/1078-0432.CCR-07-5226; Li XH, 2008, INT J ONCOL, V33, P69; Li YS, 2001, CANCER RES, V61, P6906; Lindner DJ, 1997, CLIN CANCER RES, V3, P931; Liu Yan-bo, 2011, Zhonghua Nan Ke Xue, V17, P21; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; MATSOUKA PT, 1989, MOL ENDOCRINOL, V3, P1845, DOI 10.1210/mend-3-11-1845; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Sun P, 2009, ONCOGENE, V28, P1339, DOI 10.1038/onc.2008.480; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; Suzuki K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195362; Theocharis S, 2012, J CANCER RES CLIN, V138, P1369, DOI 10.1007/s00432-012-1215-1; Valle Casuso JC, 2012, PLOS ONE, V7; van Oijen MGCT, 1998, J ORAL PATHOL MED, V27, P147; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; WHITE MK, 1991, MOL CELL BIOL, V11, P4448, DOI 10.1128/MCB.11.9.4448; Yamada S, 2010, PATHOL ONCOL RES, V16, P523, DOI 10.1007/s12253-009-9245-y; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhang YM, 2011, CANCER SCI, V102, P1991, DOI 10.1111/j.1349-7006.2011.02059.x; Zhou Ai-Min, 2009, Ai Zheng, V28, P431; Zhou Y, 2009, J INTERF CYTOK RES, V29, P695, DOI 10.1089/jir.2009.0003	47	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 12	2014	33	24					3195	3204		10.1038/onc.2013.271	http://dx.doi.org/10.1038/onc.2013.271			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK4QU	23851499	Green Accepted			2022-12-25	WOS:000338410000012
J	Zhang, N; Wang, X; Huo, Q; Sun, M; Cai, C; Liu, Z; Hu, G; Yang, Q				Zhang, N.; Wang, X.; Huo, Q.; Sun, M.; Cai, C.; Liu, Z.; Hu, G.; Yang, Q.			MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin	ONCOGENE			English	Article						miR-30a; metadherin; breast cancer; metastasis	ASTROCYTE-ELEVATED GENE-1; CANCER PROGRESSION; EXPRESSION; CELLS; HETEROZYGOSITY; IDENTIFICATION; APOPTOSIS; INVASION; REGIONS; HEAD	Accumulating data have shown the involvement of microRNAs in cancerous processes as either oncogenes or tumor suppressor genes. Here, we established miR-30a as a tumor suppressor gene in breast cancer development and metastasis. Ectopic expression of miR-30a in breast cancer cell lines resulted in the suppression of cell growth and metastasis in vitro. Consistently, the xenograft mouse model also unveiled the suppressive effects of miR-30a on tumor growth and distal pulmonary metastasis. With dual luciferase reporter assay, we revealed that miR-30a could bind to the 3'-untranslated region of metadherin (MTDH) gene, thus exerting inhibitory effect on MTDH. Furthermore, we demonstrated that silence of MTDH could recapitulate the effects of miR-30a overexpression, while overexpression of MTDH could partially abrogate miR-30a-mediated suppression. Of significance, expression level of miR-30a was found to be significantly lower in primary breast cancer tissues than in the paired normal tissues. Further evaluation verified that miR-30a was negatively correlated with the extent of lymph node and lung metastasis in patients with breast cancer. Taken together, our findings indicated miR-30a inhibits breast cancer proliferation and metastasis by directly targeting MTDH, and miR-30a can serve as a prognostic marker for breast cancer. Manipulation of miR-30a may provide a promising therapeutic strategy for breast cancer treatment.	[Zhang, N.; Wang, X.; Huo, Q.; Sun, M.; Cai, C.; Yang, Q.] Shandong Univ, Dept Breast Surg, Qilu Hosp, Jinan 250012, Peoples R China; [Liu, Z.] Shandong Univ, Sch Med, Inst Cell Biol, Jinan 250012, Peoples R China; [Hu, G.] Chinese Acad Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Hu, G.] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Yang, Q.] Shandong Univ, Key Lab Expt Teratol, Minist Educ, Sch Med, Jinan 250012, Peoples R China; [Yang, Q.] Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250012, Peoples R China	Shandong University; Shandong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shandong University; Shandong University	Yang, Q (corresponding author), Shandong Univ, Dept Breast Surg, Qilu Hosp, Wenhua Xi Rd 107, Jinan 250012, Peoples R China.	qifengy@gmail.com	yang, qiang/GYJ-0971-2022; Zhang, Ning/GNP-1966-2022; Zhang, Ning/GOJ-8058-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513; Hu, Guohong/0000-0002-2980-5166	National Natural Science Foundation of China [30772133, 81072150, 81172529, 81272903]; Shandong Science and Technology Development Plan [2012GZC22115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Science and Technology Development Plan	We thank Shi Yan, Cunzhong Yuan and Ning Yang for collecting the clinical samples. This work was supported by National Natural Science Foundation of China (no. 30772133; no. 81072150; no. 81172529; no. 81272903) and Shandong Science and Technology Development Plan (no. 2012GZC22115):	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chappell SA, 1997, BRIT J CANCER, V75, P1324, DOI 10.1038/bjc.1997.224; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Hui ABY, 2011, CLIN CANCER RES, V17, P7539, DOI 10.1158/1078-0432.CCR-11-2102; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kong XL, 2012, CANCER BIOL THER, V13, P43, DOI 10.4161/cbt.13.1.18868; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Lagana A, 2009, DATABASE, V2009; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li C, 2011, J SURG ONCOL, V103, P184, DOI 10.1002/jso.21788; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Nohata N, 2011, J HUM GENET, V56, P595, DOI 10.1038/jhg.2011.66; Noviello C, 1996, CLIN CANCER RES, V2, P1601; Ouzounova M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-139; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang L, 2012, ONCOGENE, V31, P2499, DOI 10.1038/onc.2011.444; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Xia ZB, 2010, CLIN NEUROL NEUROSUR, V112, P413, DOI 10.1016/j.clineuro.2010.02.007; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zhang N, 2013, J BIOL CHEM, V288, P9396, DOI 10.1074/jbc.M112.395913; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	52	133	140	0	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 12	2014	33	24					3119	3128		10.1038/onc.2013.286	http://dx.doi.org/10.1038/onc.2013.286			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK4QU	23851509				2022-12-25	WOS:000338410000005
J	Fonseca-Maldonado, R; Vieira, DS; Alponti, JS; Bonneil, E; Thibault, P; Ward, RJ				Fonseca-Maldonado, Raquel; Vieira, Davi Serradella; Alponti, Juliana Sanchez; Bonneil, Eric; Thibault, Pierre; Ward, Richard John			Engineering the Pattern of Protein Glycosylation Modulates the Thermostability of a GH11 Xylanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; ENDOPLASMIC-RETICULUM; PICHIA-PASTORIS; QUALITY-CONTROL; GLYCANS; SIMULATION; EXPRESSION; STABILITY; EFFICIENT; DYNAMICS	Protein glycosylation is a common post-translational modification, the effect of which on protein conformational and stability is incompletely understood. Here we have investigated the effects of glycosylation on the thermostability of Bacillus subtilis xylanase A(XynA) expressed in Pichia pastoris. Intact mass analysis of the heterologous wild-type XynA revealed two, three, or four Hex(8-16)GlcNAc(2) modifications involving asparagine residues at positions 20, 25, 141, and 181. Molecular dynamics (MD) simulations of the XynA modified with various combinations of branched Hex(9)GlcNAc(2) at these positions indicated a significant contribution from protein-glycan interactions to the overall energy of the glycoproteins. The effect of glycan content and glycosylation position on protein stability was evaluated by combinatorial mutagenesis of all six potential N-glycosylation sites. The majority of glycosylated enzymes expressed in P. pastoris presented increased thermostability in comparison with their unglycosylated counterparts expressed in Escherichia coli. Steric effects of multiple glycosylation events were apparent, and glycosylation position rather than the number of glycosylation events determined increases in thermostability. The MD simulations also indicated that clustered glycan chains tended to favor less stabilizing glycan-glycan interactions, whereas more dispersed glycosylation patterns favored stabilizing protein-glycan interactions.	[Fonseca-Maldonado, Raquel] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049900 Sao Paulo, Brazil; [Vieira, Davi Serradella; Alponti, Juliana Sanchez; Ward, Richard John] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14049901 Sao Paulo, Brazil; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Ward, Richard John] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol, BR-13083970 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universite de Montreal	Ward, RJ (corresponding author), Univ Sao Paulo, FFCLRP, Dept Quim, Ave Bandeirantes 3900, Ribeirao Preto, SP, Brazil.	rjward@ffclrp.usp.br	Maldonado, Raquel/C-2706-2013; Ward, Richard John/C-2460-2012; Vieira, Davi S/E-7424-2015; Fapesp, Biota/F-8655-2017	Ward, Richard John/0000-0003-1136-5737; Vieira, Davi S/0000-0001-8353-6262; Fapesp, Biota/0000-0002-9887-8449	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/18850-2, 2009/50838-5, 2008/57908-6, 2010/52322-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [574002/2008-1, 140124/2009-8, 307795/2009-8]; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES); Canadian Center of Excellence in Commercialization and Research (CECR); Canadian Foundation for Innovation; Fonds de Recherche du Quebec en Sante (FRQS)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Canadian Center of Excellence in Commercialization and Research (CECR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche du Quebec en Sante (FRQS)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2010/18850-2, 2009/50838-5, 2008/57908-6, and 2010/52322-3; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 574002/2008-1, 140124/2009-8, and 307795/2009-8; and Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES). The Institute for Research in Immunology and Cancer is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canadian Foundation for Innovation, and the Fonds de Recherche du Quebec en Sante (FRQS).	[Anonymous], [No title captured], DOI DOI 10.1016/B978-0-12-059820-5.50015-X; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cheng SM, 2010, CHEMPHYSCHEM, V11, P2367, DOI 10.1002/cphc.201000205; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Georis J, 2000, PROTEIN SCI, V9, P466; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hecht ML, 2009, CURR OPIN CHEM BIOL, V13, P354, DOI 10.1016/j.cbpa.2009.05.127; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Kawasaki N, 2009, BIOL PHARM BULL, V32, P796, DOI 10.1248/bpb.32.796; KUKURUZINSKA MA, 1987, ANNU REV BIOCHEM, V56, P915, DOI 10.1146/annurev.biochem.56.1.915; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu DN, 2012, J PHYS CHEM B, V116, P390, DOI 10.1021/jp203926r; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miyamo S., 2002, J COMPUT CHEM, V13, P952; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Mulloy B, 2010, BIOCHEM SOC T, V38, P1329, DOI 10.1042/BST0381329; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Ruller R, 2006, BIOTECHNOL APPL BIOC, V43, P9, DOI 10.1042/BA20050016; Ruller R, 2008, PROTEINS, V70, P1280, DOI 10.1002/prot.21617; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shental-Bechor D, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3650700; Sinha S, 2007, BIOPHYS J, V92, P208, DOI 10.1529/biophysj.106.092668; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Straumann N, 2006, BIOCHEM J, V393, P459, DOI 10.1042/BJ20050857; Taylor M. E., 2011, INTRO GLYCOBIOLOGY; Torrez M, 2003, BIOPHYS J, V85, P2845, DOI 10.1016/S0006-3495(03)74707-9; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Vieira DS, 2009, MOL PHYS, V107, P59, DOI 10.1080/00268970902717959; von der Lieth C., 2010, BIOINFORMATICS GLYCO; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WOODS RJ, 1994, NAT STRUCT BIOL, V1, P499, DOI 10.1038/nsb0894-499; Woods RJ, 1998, GLYCOCONJUGATE J, V15, P209, DOI 10.1023/A:1006984709892; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yuried E., 2012, STRUCTURAL GLYCOBIOL	50	51	66	3	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25522	25534		10.1074/jbc.M113.485953	http://dx.doi.org/10.1074/jbc.M113.485953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846692	Green Published, hybrid			2022-12-25	WOS:000330619000047
J	Furger, E; Frei, DC; Schibli, R; Fischer, E; Prota, AE				Furger, Evelyne; Frei, Dominik C.; Schibli, Roger; Fischer, Eliane; Prota, Andrea E.			Structural Basis for Universal Corrinoid Recognition by the Cobalamin Transport Protein Haptocorrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-B-12 TRANSPORT; PLASMA TRANSPORT; INTRINSIC-FACTOR; BINDING; ANALOGS; TRANSCOBALAMIN; MECHANISMS; COMPLEX; MODEL	Cobalamin (Cbl; vitamin B-12) is an essential micronutrient synthesized only by bacteria. Mammals have developed a sophisticated uptake system to capture the vitamin from the diet. Cbl transport is mediated by three transport proteins: transcobalamin, intrinsic factor, and haptocorrin (HC). All three proteins have a similar overall structure but a different selectivity for corrinoids. Here, we present the crystal structures of human HC in complex with cyanocobalamin and cobinamide at 2.35 and 3.0 angstrom resolution, respectively. The structures reveal that many of the interactions with the corrin ring are conserved among the human Cbl transporters. However, the non-conserved residues Asn-120, Arg-357, and Asn-373 form distinct interactions allowing for stabilization of corrinoids other than Cbl. A central binding motif forms interactions with the e-and f-side chains of the corrin ring and is conserved in corrinoid-binding proteins of other species. In addition, the alpha- and beta-domains of HC form several unique interdomain contacts and have a higher shape complementarity than those of intrinsic factor and transcobalamin. The stabilization of ligands by all of these interactions is reflected in higher melting temperatures of the protein-ligand complexes. Our structural analysis offers fundamental insights into the unique binding behavior of HC and completes the picture of Cbl interaction with its three transport proteins.	[Furger, Evelyne; Schibli, Roger; Fischer, Eliane] Paul Scherrer Inst, Ctr Radiopharmaceut Sci, CH-5232 Villigen, Switzerland; [Frei, Dominik C.; Prota, Andrea E.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Schibli, Roger] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	Paul Scherrer Institute; Paul Scherrer Institute; ETH Zurich	Fischer, E (corresponding author), Paul Scherrer Inst, Ctr Radiopharmaceut Sci, OIPA 10A, CH-5232 Villigen, Switzerland.	eliane.fischer@psi.ch; andrea.prota@psi.ch	Prota, Andrea Enrico/R-9526-2019; Fischer, Eliane/M-2590-2013	Prota, Andrea Enrico/0000-0003-0875-5339; Fischer, Eliane/0000-0002-3399-3737; Schibli, Roger/0000-0002-1537-3833	Swiss National Science Foundation [31003A-112455]; Novartis Foundation for Medical-Biological Research Grant [10C74]; Research Committee (FoKo) of the Paul Scherrer Institut	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for Medical-Biological Research Grant; Research Committee (FoKo) of the Paul Scherrer Institut	This work was supported by Swiss National Science Foundation Grant 31003A-112455, Novartis Foundation for Medical-Biological Research Grant 10C74 (to A. E. P.), and the Research Committee (FoKo) of the Paul Scherrer Institut (to E. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen R H, 1975, Prog Hematol, V9, P57; Alpers D. H., 1999, Chemistry and biochemistry of B12., P411; Andersen CBF, 2010, NATURE, V464, P445, DOI 10.1038/nature08874; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BURGER RL, 1975, J BIOL CHEM, V250, P7707; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2006, FEBS J, V273, P4742, DOI 10.1111/j.1742-4658.2006.05478.x; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; Furger E, 2012, THESIS ETH ZURICH; Furger E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037421; Greibe E, 2012, J BIOL CHEM, V287, P33917, DOI 10.1074/jbc.M112.398016; Greibe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035660; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; KOLHOUSE JF, 1977, J CLIN INVEST, V60, P1381, DOI 10.1172/JCI108899; Mathews FS, 2007, P NATL ACAD SCI USA, V104, P17311, DOI 10.1073/pnas.0703228104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moestrup SK, 2006, CURR OPIN HEMATOL, V13, P119, DOI 10.1097/01.moh.0000219654.65538.5b; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO E, 1998, VITAMIN B12 B12 PROT, P461, DOI DOI 10.1002/9783527612192.CH30; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Randaccio L, 2010, MOLECULES, V15, P3228, DOI 10.3390/molecules15053228; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolters M, 2004, PREV MED, V39, P1256, DOI 10.1016/j.ypmed.2004.04.047; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394; YANG SY, 1982, BLOOD, V59, P747	37	28	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25466	25476		10.1074/jbc.M113.483271	http://dx.doi.org/10.1074/jbc.M113.483271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23846701	hybrid, Green Published			2022-12-25	WOS:000330619000042
J	Hsu, KS; Kao, HY				Hsu, Kuo-Sheng; Kao, Hung-Ying			beta-Transducin Repeat-containing Protein 1 (beta-TrCP1)-mediated Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) Protein Degradation Promotes Tumor Necrosis Factor alpha (TNF alpha)-induced Inflammatory Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; TRANSCRIPTIONAL REPRESSION; ADIPOSE-TISSUE; KINASE ALPHA; TNF-ALPHA; TRCP; COREPRESSOR; PHOSPHORYLATION; ACTIVATION; PATHWAY	Cytokine modulation of the endothelium is considered an important contributor to the inflammation response. TNF alpha is an early response gene during the initiation of inflammation. However, the detailed mechanism by which TNF alpha induces proinflammatory gene expression is not completely understood. In this report, we demonstrate that silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) represses the expression of a subset of TNF alpha target genes in human umbilical vein endothelial cells. Upon TNF alpha stimulation, we observed an increase in the E3 ubiquitin ligase beta-TrCP1 and a decrease in SMRT protein levels. We show that beta-TrCP1 interacts with SMRT in a phosphorylation-independent manner and cooperates with the E2 ubiquitin-conjugating enzyme E2D2 to promote ubiquitination-dependent SMRT degradation. Knockdown of beta-TrCP1 increases SMRT protein accumulation, increases SMRT association with its targeted promoters, and decreases SMRT target gene expression. Taken together, our results support a model in which TNF alpha-induced beta-TrCP1 accumulation promotes SMRT degradation and the subsequent induction of proinflammatory gene expression.	[Hsu, Kuo-Sheng; Kao, Hung-Ying] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu		Hsu, Kuo-Sheng/0000-0002-5700-6943	National Institutes of Health [R01 DK078965, HL093269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078965 and HL093269 (to H. Y. K.).	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Ann EJ, 2012, J BIOL CHEM, V287, P36814, DOI 10.1074/jbc.M112.356048; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Cheng XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-453; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Fernandez-Real JM, 2012, DIABETOLOGIA, V55, P273, DOI 10.1007/s00125-011-2387-y; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Jang MK, 2001, J BIOL CHEM, V276, P20005, DOI 10.1074/jbc.M010211200; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Mehra VC, 2005, J LEUKOCYTE BIOL, V78, P805, DOI 10.1189/jlb.0405182; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Speigelman VS, 2001, J BIOL CHEM, V276, P27152, DOI 10.1074/jbc.M100031200; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spiegelman VS, 2002, J BIOL CHEM, V277, P36624, DOI 10.1074/jbc.M204524200; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Stanya KJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-7; Su YT, 2013, MOL CELL BIOL, V33, P1546, DOI 10.1128/MCB.01146-12; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6	48	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25375	25386		10.1074/jbc.M113.473124	http://dx.doi.org/10.1074/jbc.M113.473124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23861398	Green Published, hybrid			2022-12-25	WOS:000330619000035
J	Yamanaka, T; Raffaelli, D; White, PCL				Yamanaka, Tsuyuko; Raffaelli, David; White, Piran C. L.			Non-Linear Interactions Determine the Impact of Sea-Level Rise on Estuarine Benthic Biodiversity and Ecosystem Processes	PLOS ONE			English	Article							INTERTIDAL HABITAT; HUMBER ESTUARY; MACROFAUNA; ZOOPLANKTON; DIVERSITY; RESPONSES; BEACHES; ECOLOGY; BIOMASS; FUTURE	Sea-level rise induced by climate change may have significant impacts on the ecosystem functions and ecosystem services provided by intertidal sediment ecosystems. Accelerated sea-level rise is expected to lead to steeper beach slopes, coarser particle sizes and increased wave exposure, with consequent impacts on intertidal ecosystems. We examined the relationships between abundance, biomass, and community metabolism of benthic fauna with beach slope, particle size and exposure, using samples across a range of conditions from three different locations in the UK, to determine the significance of sediment particle size beach slope and wave exposure in affecting benthic fauna and ecosystem function in different ecological contexts. Our results show that abundance, biomass and oxygen consumption of intertidal macrofauna and meiofauna are affected significantly by interactions among sediment particle size, beach slope and wave exposure. For macrofauna on less sloping beaches, the effect of these physical constraints is mediated by the local context, although for meiofauna and for macrofauna on intermediate and steeper beaches, the effects of physical constraints dominate. Steeper beach slopes, coarser particle sizes and increased wave exposure generally result in decreases in abundance, biomass and oxygen consumption, but these relationships are complex and non-linear. Sea-level rise is likely to lead to changes in ecosystem structure with generally negative impacts on ecosystem functions and ecosystem services. However, the impacts of sea-level rise will also be affected by local ecological context, especially for less sloping beaches.	[Yamanaka, Tsuyuko; Raffaelli, David; White, Piran C. L.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Yamanaka, Tsuyuko] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England	University of York - UK; University of Liverpool	White, PCL (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	piran.white@york.ac.uk	White, Piran Crawfurd Limond/AAH-6851-2021	White, Piran Crawfurd Limond/0000-0002-7496-5775	University of York	University of York(European Commission)	The work was supported by the University of York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BANSE K, 1982, MAR ECOL PROG SER, V9, P281, DOI 10.3354/meps009281; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; Bulling MT, 2006, MAR ECOL PROG SER, V311, P295, DOI 10.3354/meps311295; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Bulling MT, 2010, PHILOS T RO IN PRESS; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; Feller R.J., 1988, P181; Fujii T, 2007, ESTUAR COAST SHELF S, V75, P101, DOI 10.1016/j.ecss.2007.02.027; Fujii T, 2008, MAR ECOL PROG SER, V371, P23, DOI 10.3354/meps07652; Galbraith H, 2002, WATERBIRDS, V25, P173, DOI 10.1675/1524-4695(2002)025[0173:GCCASL]2.0.CO;2; GERLACH SA, 1985, MAR ECOL PROG SER, V26, P161, DOI 10.3354/meps026161; GOSSCUSTARD JD, 1990, DEV HYDROB, V57, P189; Hall S.J., 1994, P333; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; IPCC Working Group I, 2007, CLIMATE CHANGE 2007; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kurihara H, 2004, J OCEANOGR, V60, P743, DOI 10.1007/s10872-004-5766-x; LEACH JH, 1970, LIMNOL OCEANOGR, V15, P514, DOI 10.4319/lo.1970.15.4.0514; Lercari D, 2006, ESTUAR COAST SHELF S, V68, P27, DOI 10.1016/j.ecss.2005.12.017; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/NGEO1441, 10.1038/ngeo1441]; MCLACHLAN A, 1990, J COASTAL RES, V6, P57; MCLACHLAN A, 1981, S AFR J ZOOL, V16, P219; McLachlan A, 1996, MAR ECOL PROG SER, V131, P205, DOI 10.3354/meps131205; McLachlan A, 2006, ECOLOGY SANDY SHORES; McLachlan A., 1993, J COASTAL RES, V15, P27, DOI DOI 10.2307/25735721; McLusky D.S., 2004, ESTUARINE ECOSYSTEM; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; PETHICK J, 1993, GEOGR J, V159, P162, DOI 10.2307/3451406; Pinheiro J, 2006, NLME 3 1 90 R PACKAG; Pinheiro J, 2001, MIXED EFFECTS MODELS; Raffaelli D, 1996, INTERTIDAL ECOLOGY; Raffaelli DG, 2006, MAR ECOL PROG SER, V311, P285, DOI 10.3354/meps311285; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Rodriguez GJ, 2002, ESTUARINE COASTAL SH, V58, P63; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Solan M, 2006, MAR ECOL PROG SER, V311, P175, DOI 10.3354/meps311175; THOMAS MLH, 1986, OPHELIA, V25, P1; White PCL, 2010, ISSUES ENV IN PRESS; Yamanaka T, 2012, J ANIM ECOL, V81, P463, DOI 10.1111/j.1365-2656.2011.01921.x; Yamanaka T, 2010, ESTUAR COAST SHELF S, V88, P267, DOI 10.1016/j.ecss.2010.03.023; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	46	10	10	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68160	10.1371/journal.pone.0068160	http://dx.doi.org/10.1371/journal.pone.0068160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861863	Green Published, Green Submitted, gold			2022-12-25	WOS:000321692000017
J	Gentle, NL; Paximadis, M; Puren, A; Tiemessen, CT				Gentle, Nikki L.; Paximadis, Maria; Puren, Adrian; Tiemessen, Caroline T.			Genetic Variability in Markers of HLA-C Expression in Two Diverse South African Populations	PLOS ONE			English	Article							HIV-1 INFECTION; CLASS-I; ASSOCIATION; DETERMINANTS; ALLELES; LINKAGE	An insertion-deletion (indel) polymorphism within the 39 untranslated region (UTR) of HLA-C has been shown to be involved in the regulation of HLA-C expression. Individuals who carry a deletion at this position exhibit increased HLA-C expression, which associates with lower viral set point in HIV-1 infected individuals. This 263 indel (rs67384697) is reported to be in strong linkage disequilibrium (LD) with a single nucleotide polymorphism (SNP) 35 kilobases upstream of HLA-C (-35T/C; rs9264942) in Caucasian individuals, making this SNP a potential marker for both HLA-C expression and HIV-1 disease progression. We therefore examined genetic variation within the HLA-C 3' UTR of 265 Black and Caucasian South Africans by direct sequencing and identified haplotypes encompassing the 263 indel and another indel at position 230 in both populations. Concomitant evaluation of variability at the -35 SNP revealed this polymorphism to be an inappropriate marker for the 263 indel in these populations. These findings provide important insights into genetic variability within the regulatory regions of HLA-C that have potential implications for our understanding of the regulation of HLA-C expression and its impact on HIV-1 disease progression.	[Gentle, Nikki L.; Paximadis, Maria; Puren, Adrian; Tiemessen, Caroline T.] Natl Inst Communicable Dis, Ctr HIV & STIs, Natl Hlth Lab Serv, Johannesburg, Gauteng, South Africa; [Gentle, Nikki L.; Paximadis, Maria; Puren, Adrian; Tiemessen, Caroline T.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, Gauteng, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Paximadis, M (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STIs, Natl Hlth Lab Serv, Johannesburg, Gauteng, South Africa.	paxim@nicd.ac.za	Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018	Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Tiemessen, Caroline/0000-0002-0991-1690; Gentle, Nikki/0000-0001-7988-4491	National Research Foundation; University of the Witwatersrand's Medical Faculty Research Endowment Fund	National Research Foundation; University of the Witwatersrand's Medical Faculty Research Endowment Fund	This work was funded in part by the National Research Foundation and University of the Witwatersrand's Medical Faculty Research Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Excoffier Laurent, 2003, Human Genomics, V1, P7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; LEWONTIN RC, 1964, GENETICS, V49, P49; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; O'hUigin C, 2011, AM J HUM GENET, V89, P424, DOI 10.1016/j.ajhg.2011.07.024; Paximadis M, 2012, HUM IMMUNOL, V73, P80, DOI 10.1016/j.humimm.2011.10.013; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Shrestha S, 2009, AIDS, V23, P673, DOI 10.1097/QAD.0b013e328325d414; SLATKIN M, 1994, GENETICS, V137, P331; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Xu Y, 2011, TISSUE ANTIGENS, V78, P102, DOI 10.1111/j.1399-0039.2011.01710.x	24	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67780	10.1371/journal.pone.0067780	http://dx.doi.org/10.1371/journal.pone.0067780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861805	Green Published, Green Submitted, gold			2022-12-25	WOS:000321425300029
J	Ma, MPC; Robinson, PJ; Chircop, M				Ma, Maggie P. C.; Robinson, Phillip J.; Chircop, Megan			Sorting Nexin 9 Recruits Clathrin Heavy Chain to the Mitotic Spindle for Chromosome Alignment and Segregation	PLOS ONE			English	Article							HUMAN CANCER-CELLS; MEDIATED ENDOCYTOSIS; AURORA-A; CYTOKINESIS FAILURE; TYROSINE PHOSPHORYLATION; SOMATIC-CELLS; DYNAMIN-I; PROTEIN; MITOSIS; ORGANIZATION	Sorting nexin 9 (SNX9) and clathrin heavy chain (CHC) each have roles in mitosis during metaphase. Since the two proteins directly interact for their other cellular function in endocytosis we investigated whether they also interact for metaphase and operate on the same pathway. We report that SNX9 and CHC functionally interact during metaphase in a specific molecular pathway that contributes to stabilization of mitotic spindle kinetochore (K)-fibres for chromosome alignment and segregation. This function is independent of their endocytic role. SNX9 residues in the clathrin-binding low complexity domain are required for CHC association and for targeting both CHC and transforming acidic coiled-coil protein 3 (TACC3) to the mitotic spindle. Mutation of these sites to serine increases the metaphase plate width, indicating inefficient chromosome congression. Therefore SNX9 and CHC function in the same molecular pathway for chromosome alignment and segregation, which is dependent on their direct association.	[Ma, Maggie P. C.; Robinson, Phillip J.; Chircop, Megan] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney	Chircop, M (corresponding author), Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia.	mchircop@cmri.org.au	Robinson, Phillip J/G-4008-2011	Robinson, Phillip J/0000-0002-7878-0313	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by research grants to MC and PJR from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Barr AR, 2008, MOL CELL BIOL, V28, P7199, DOI 10.1128/MCB.01040-08; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Boersema PJ, 2010, MOL CELL PROTEOMICS, V9, P84, DOI 10.1074/mcp.M900291-MCP200; Booth DG, 2011, EMBO J, V30, P906, DOI 10.1038/emboj.2011.15; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Cheeseman Liam P, 2011, Commun Integr Biol, V4, P409, DOI 10.4161/cib.4.4.15250; Chircop M, 2010, BIOCHIM BIOPHYS ACTA, V1813, P1689; Chircop M, 2010, CELL MOL LIFE SCI, V67, P3725, DOI 10.1007/s00018-010-0401-z; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Dislich B, 2011, BIOCHEM J, V433, P75, DOI 10.1042/BJ20100709; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fabbro M, 2004, J BIOL CHEM, V279, P31251, DOI 10.1074/jbc.M405372200; Fielding AB, 2012, P NATL ACAD SCI USA, V109, P6572, DOI 10.1073/pnas.1117401109; Fu WX, 2010, J CELL SCI, V123, P3645, DOI 10.1242/jcs.075911; Gerald NJ, 2001, CELL MOTIL CYTOSKEL, V48, P213, DOI 10.1002/1097-0169(200103)48:3<213::AID-CM1010>3.0.CO;2-V; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hirst J, 2008, TRAFFIC, V9, P1354, DOI 10.1111/j.1600-0854.2008.00764.x; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Joshi S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-78; Joshi S, 2010, MOL CANCER THER, V9, P1995, DOI 10.1158/1535-7163.MCT-10-0161; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lin CH, 2010, J CELL BIOL, V189, P1097, DOI 10.1083/jcb.200911120; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Ma MPC, 2012, J CELL SCI, V125, P4372, DOI 10.1242/jcs.105981; Mayer BJ, 2001, J CELL SCI, V114, P1253; Morita M, 2010, J BIOCHEM, V148, P533, DOI 10.1093/jb/mvq116; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Odell LR, 2010, J MED CHEM, V53, P5267, DOI 10.1021/jm100442u; Park J, 2010, J CELL SCI, V123, P1742, DOI 10.1242/jcs.064170; Rieder CL, 2005, CHROMOSOMA, V114, P310, DOI 10.1007/s00412-005-0028-2; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Smith CM, 2012, TRAFFIC, V13, P1628, DOI 10.1111/tra.12001; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Tanenbaum ME, 2010, CHROMOSOMA, V119, P415, DOI 10.1007/s00412-010-0267-8; Tsai CF, 2008, J PROTEOME RES, V7, P4058, DOI 10.1021/pr800364d; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Yamauchi T, 2008, EMBO J, V27, P1852, DOI 10.1038/emboj.2008.118; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Zhang J, 2009, J BIOL CHEM, V284, P21659, DOI 10.1074/jbc.M109.007278	56	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68387	10.1371/journal.pone.0068387	http://dx.doi.org/10.1371/journal.pone.0068387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861900	gold, Green Published, Green Submitted			2022-12-25	WOS:000321425300061
J	Regnstrom, K; Yan, JL; Nguyen, L; Callaway, K; Yang, YL; Diep, L; Xing, WM; Adhikari, A; Beroza, P; Hom, RK; Riley, B; Rudolph, D; Jobling, MF; Baker, J; Johnston, J; Konradi, A; Bova, MP; Artis, RD				Regnstroem, Karin; Yan, Jiangli; Lan Nguyen; Callaway, Kari; Yang, Yanli; Diep, Linnea; Xing, Weimei; Adhikari, Anirban; Beroza, Paul; Hom, Roy K.; Riley, Brigit; Rudolph, Don; Jobling, Michael F.; Baker, Jeanne; Johnston, Jennifer; Konradi, Andrei; Bova, Michael P.; Artis, Rick D.			Label Free Fragment Screening Using Surface Plasmon Resonance as a Tool for Fragment Finding - Analyzing Parkin, a Difficult CNS Target	PLOS ONE			English	Article							DOMAIN; SPR	Surface Plasmon Resonance (SPR) is rarely used as a primary High-throughput Screening (HTS) tool in fragment-based approaches. With SPR instruments becoming increasingly high-throughput it is now possible to use SPR as a primary tool for fragment finding. SPR becomes, therefore, a valuable tool in the screening of difficult targets such as the ubiquitin E3 ligase Parkin. As a prerequisite for the screen, a large number of SPR tests were performed to characterize and validate the active form of Parkin. A set of compounds was designed and used to define optimal SPR assay conditions for this fragment screen. Using these conditions, more than 5000 pre-selected fragments from our in-house library were screened for binding to Parkin. Additionally, all fragments were simultaneously screened for binding to two off target proteins to exclude promiscuous binding compounds. A low hit rate was observed that is in line with hit rates usually obtained by other HTS screening assays. All hits were further tested in dose responses on the target protein by SPR for confirmation before channeling the hits into Nuclear Magnetic Resonance (NMR) and other hit-confirmation assays.	[Regnstroem, Karin; Yan, Jiangli; Lan Nguyen; Callaway, Kari; Yang, Yanli; Diep, Linnea; Xing, Weimei; Adhikari, Anirban; Beroza, Paul; Hom, Roy K.; Riley, Brigit; Rudolph, Don; Jobling, Michael F.; Baker, Jeanne; Johnston, Jennifer; Konradi, Andrei; Bova, Michael P.; Artis, Rick D.] Elan Pharmaceut, San Francisco, CA USA		Regnstrom, K (corresponding author), Elan Pharmaceut, San Francisco, CA USA.	Karin.Regnstrom@gmail.com	yang, yang/HGT-7999-2022; Yang, Ya-Li/GYU-4320-2022; Lang, Ming/HIK-0758-2022	Johnston, Jennifer/0000-0002-4867-9230	Elan Pharmaceuticals	Elan Pharmaceuticals	Funding for all experiments was provided by Elan Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following authors are paid employees of Elan Pharmaceuticals, who funded this study: Karin Regnstrom, Jiangli Yan, Lan Nguyen, Kari Callaway, Yanli Yang, Linnea Diep, Anirban Adhikari, Paul Beroza, Roy Hom, Don Rudolph, Michael Jobling, Brigit Riley, Jeanne Baker, Jennifer Johnston, Andrei Konradi, Michael Bova, and Rick Artis. There are no patents, other products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Andersson K, 2006, EXPERT OPIN DRUG DIS, V1, P439, DOI 10.1517/17460441.1.5.439; Auger KR, 2005, METHOD ENZYMOL, V399, P701, DOI 10.1016/S0076-6879(05)99046-0; Burchell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034748; Chaugule VK, 2011, EMBO J, P1; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Danielson UH, 2009, CURR TOP MED CHEM, V9, P1725, DOI 10.2174/156802609790102392; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Giannetti AM, 2011, METHOD ENZYMOL, V493, P169, DOI 10.1016/B978-0-12-381274-2.00008-X; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang JN, 2005, METHOD ENZYMOL, V399, P740, DOI 10.1016/S0076-6879(05)99049-6; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P15404, DOI 10.1073/pnas.202608799; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P667, DOI 10.1073/pnas.012317299; Kobayashi M, 2010, J BIOMOL SCREEN, V15, P978, DOI 10.1177/1087057110375614; Marblestone JG, 2010, J BIOMOL SCREEN, V15, P1220, DOI 10.1177/1087057110380456; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Myszka D., 2011, DRUG DISCOVERY W WIN, V12, P51; Navratilova I, 2010, ACS MED CHEM LETT, V1, P44, DOI 10.1021/ml900002k; Oprea TI, 2001, J CHEM INF COMP SCI, V41, P1308, DOI 10.1021/ci010366a; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Perspicace S, 2009, J BIOMOL SCREEN, V14, P337, DOI 10.1177/1087057109332595; Rankin Carolyn A, 2011, Open Biochem J, V5, P9, DOI 10.2174/1874091X01105010009; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Schlehe JS, 2008, J BIOL CHEM, V283, P13771, DOI 10.1074/jbc.M707494200; Tomoo K, 2008, BBA-PROTEINS PROTEOM, V1784, P1059, DOI 10.1016/j.bbapap.2008.04.009; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	32	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e66879	10.1371/journal.pone.0066879	http://dx.doi.org/10.1371/journal.pone.0066879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861750	Green Published, gold, Green Submitted			2022-12-25	WOS:000321425300009
J	Das, S; Banerjee, B; Hossain, M; Thangamuniyandi, M; Dasgupta, S; Chongdar, N; Kumar, GS; Basu, G				Das, Supratik; Banerjee, Baisakhi; Hossain, Maidul; Thangamuniyandi, Muruganandan; Dasgupta, Saumya; Chongdar, Nipa; Kumar, Gopinatha Suresh; Basu, Gautam			Characterization of DNA Binding Property of the HIV-1 Host Factor and Tumor Suppressor Protein Integrase Interactor 1 (INI1/hSNF5)	PLOS ONE			English	Article							RHABDOID TUMORS; COMPLEX; YEAST; REPRESSION; TRANSCRIPTION; SWI2/SNF2; REGION; SNF5	Integrase Interactor 1 (INI1/hSNF5) is a component of the hSWI/SNF chromatin remodeling complex. The INI1 gene is either deleted or mutated in rhabdoid cancers like ATRT (Atypical terratoid and rhabdoid tumor). INI1 is also a host factor for HIV-1 replication. INI1 binds DNA non-specifically. However, the mechanism of DNA binding and its biological role are unknown. From agarose gel retardation assay (AGRA), Ni-NTA pull-down and atomic force microscopy (AFM) studies we show that amino acids 105-183 of INI1 comprise the minimal DNA binding domain (DBD). The INI1 DBD is absent in plants and in yeast SNF5. It is present in Caenorhabditis elegans SNF5, Drosophila melanogaster homologue SNR1 and is a highly conserved domain in vertebrates. The DNA binding property of this domain in SNR1, that is only 58% identical to INI1/hSNF5, is conserved. Analytical ultracentrifugation studies of INI1 DBD and INI1 DBD: DNA complexes at different concentrations show that the DBD exists as a monomer at low protein concentration and two molecules of monomer binds one molecule of DNA. At high protein concentration, it exists as a dimer and binds two DNA molecules. Furthermore, isothermal calorimetry (ITC) experiments demonstrate that the DBD monomer binds DNA with a stoichiometry (N) of similar to 0.5 and K-d = 0.94 mu M whereas the DBD dimer binds two DNA molecules sequentially with K'(d1) = 222 mu M and K'(d2) = 1.16 mu M. Monomeric DBD binding to DNA is enthalpy driven (Delta H = -29.9 KJ/mole). Dimeric DBD binding to DNA is sequential with the first binding event driven by positive entropy (Delta H'(1) = 115.7 KJ/mole, T Delta S'(1) = 136.8 KJ/mole) and the second binding event driven by negative enthalpy (Delta H'(2) = -106.3 KJ/mole, T Delta S'(2) = -75.7 KJ/mole). Our model for INI1 DBD binding to DNA provides new insights into the mechanism of DNA binding by INI1.	[Das, Supratik] Univ Calcutta, Dept Biochem, Kolkata, India; [Banerjee, Baisakhi] Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, India; [Hossain, Maidul; Kumar, Gopinatha Suresh] CSIR Indian Inst Chem Biol, Biophys Chem Lab, Kolkata, India; [Thangamuniyandi, Muruganandan] CSIR Indian Inst Chem Biol, Kolkata, India; [Dasgupta, Saumya; Chongdar, Nipa] Bose Inst, Dept Biophys, Kolkata, India	University of Calcutta; University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Bose Institute	Das, S (corresponding author), West Bengal State Univ, Dept Biochem, Kolkata, India.	radas_03@yahoo.com	KUMAR, P. SURESH/AAT-8951-2020; Kumar, Gopinatha Suresh/W-1461-2019; Kumar, Dr Suresh/HHZ-2615-2022; DASGUPTA, SAUMYA/ABF-3864-2020; Hossain, Maidul/AAW-7669-2021	KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553; DASGUPTA, SAUMYA/0000-0003-2995-6324; Hossain, Maidul/0000-0003-1408-2273; Chongdar, Nipa/0000-0002-3894-2285	Council for Scientific and Industrial Research, Government of India [13(8350-A)/Pool/2009]	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by a contingency grant of the Scientist's Pool Scheme fellowship from the Council for Scientific and Industrial Research, Government of India to SD [Sanction No. 13(8350-A)/Pool/2009]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boese A, 2009, J GEN VIROL, V90, P2503, DOI 10.1099/vir.0.013656-0; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Caramel J, 2008, CANCER RES, V68, P6154, DOI 10.1158/0008-5472.CAN-08-0115; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Das S, 2009, J BIOL CHEM, V284, P19903, DOI 10.1074/jbc.M808141200; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kar SR, 2001, BIOCHEMISTRY-US, V40, P13378, DOI 10.1021/bi011289f; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Lesbats P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001280; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Morozov A, 2007, CLIN CANCER RES, V13, P4721, DOI 10.1158/1078-0432.CCR-07-0054; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; Ray A, 2009, MOL CELL BIOL, V29, P6206, DOI 10.1128/MCB.00503-09; Roberts CWM, 2009, CANCER BIOL THER, V8, P412, DOI 10.4161/cbt.8.5.8019; Singh M, 2006, BIOL CHEM, V387, P1469, DOI 10.1515/BC.2006.184; Tsikitis M, 2005, P NATL ACAD SCI USA, V102, P12129, DOI 10.1073/pnas.0505300102; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wilsker D, 2004, NUCLEIC ACIDS RES, V32, P1345, DOI 10.1093/nar/gkh277; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	22	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e66581	10.1371/journal.pone.0066581	http://dx.doi.org/10.1371/journal.pone.0066581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861745	Green Submitted, gold, Green Published			2022-12-25	WOS:000323350700006
J	Gaboriaud, C; Gupta, RK; Martin, L; Lacroix, M; Serre, L; Teillet, F; Arlaud, GJ; Rossi, V; Thielens, NM				Gaboriaud, Christine; Gupta, Rajesh Kumar; Martin, Lydie; Lacroix, Monique; Serre, Laurence; Teillet, Florence; Arlaud, Gerard J.; Rossi, Veronique; Thielens, Nicole M.			The Serine Protease Domain of MASP-3: Enzymatic Properties and Crystal Structure in Complex with Ecotin	PLOS ONE			English	Article							MANNAN-BINDING-LECTIN; CATALYTIC DOMAIN; PATHWAY ACTIVATION; SUBSTRATE SPECIFICITIES; FACTOR-I; REVEALS; C1S; MBL; RECOGNITION; INHIBITOR	Mannan-binding lectin (MBL), ficolins and collectin-11 are known to associate with three homologous modular proteases, the MBL-Associated Serine Proteases (MASPs). The crystal structures of the catalytic domains of MASP-1 and MASP-2 have been solved, but the structure of the corresponding domain of MASP-3 remains unknown. A link between mutations in the MASP1/3 gene and the rare autosomal recessive 3MC (Mingarelli, Malpuech, Michels and Carnevale,) syndrome, characterized by various developmental disorders, was discovered recently, revealing an unexpected important role of MASP-3 in early developmental processes. To gain a first insight into the enzymatic and structural properties of MASP-3, a recombinant form of its serine protease (SP) domain was produced and characterized. The amidolytic activity of this domain on fluorescent peptidyl-aminomethylcoumarin substrates was shown to be considerably lower than that of other members of the C1r/C1s/MASP family. The E. coli protease inhibitor ecotin bound to the SP domains of MASP-3 and MASP-2, whereas no significant interaction was detected with MASP-1, C1r and C1s. A tetrameric complex comprising an ecotin dimer and two MASP-3 SP domains was isolated and its crystal structure was solved and refined to 3.2 angstrom. Analysis of the ecotin/MASP-3 interfaces allows a better understanding of the differential reactivity of the C1r/C1s/MASP protease family members towards ecotin, and comparison of the MASP-3 SP domain structure with those of other trypsin-like proteases yields novel hypotheses accounting for its zymogen-like properties in vitro.	[Gaboriaud, Christine; Gupta, Rajesh Kumar; Martin, Lydie; Lacroix, Monique; Serre, Laurence; Teillet, Florence; Arlaud, Gerard J.; Rossi, Veronique; Thielens, Nicole M.] IBS, Direct Sci Vivant, Commissariat Energie Atom & Energies Alternat, Grenoble, France; [Gaboriaud, Christine; Gupta, Rajesh Kumar; Martin, Lydie; Lacroix, Monique; Teillet, Florence; Arlaud, Gerard J.; Rossi, Veronique; Thielens, Nicole M.] IBS, CNRS, Grenoble, France; [Gaboriaud, Christine; Gupta, Rajesh Kumar; Martin, Lydie; Lacroix, Monique; Serre, Laurence; Teillet, Florence; Arlaud, Gerard J.; Rossi, Veronique; Thielens, Nicole M.] Univ Grenoble Alpes, IBS, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Gaboriaud, C (corresponding author), IBS, Direct Sci Vivant, Commissariat Energie Atom & Energies Alternat, Grenoble, France.	christine.gaboriaud@ibs.fr	Thielens, Nicole M/F-2512-2013; Rossi, Véronique/AAF-3412-2021	Thielens, Nicole M/0000-0002-7354-0302; Rossi, Véronique/0000-0002-6700-3578; SERRE, laurence/0000-0002-6794-1492; gaboriaud, christine/0000-0001-5308-0516; Gupta, Rajesh Kumar/0000-0001-8820-0661	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Universite Joseph Fourier (Grenoble, France); French National Research Agency [ANR-09-PIRI-0021]; Embassy of France in India	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier (Grenoble, France); French National Research Agency(French National Research Agency (ANR)); Embassy of France in India	This work was supported by the Commissariat a l'Energie Atomique, the Centre National de la Recherche Scientifique, the Universite Joseph Fourier (Grenoble, France) and partly by a grant from the French National Research Agency (ANR-09-PIRI-0021). RKG was supported by a post-doctoral scholarship of the Embassy of France in India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLAUD GJ, 1979, BIOCHIM BIOPHYS ACTA, V576, P151, DOI 10.1016/0005-2795(79)90494-X; ARLAUD GJ, 1979, MOL IMMUNOL, V16, P445, DOI 10.1016/0161-5890(79)90069-5; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Bricogne G., 2009, BUSTER; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Cortesio CL, 2006, ARCH BIOCHEM BIOPHYS, V449, P164, DOI 10.1016/j.abb.2006.02.006; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Eggers CT, 2001, J MOL BIOL, V308, P975, DOI 10.1006/jmbi.2001.4754; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Gillmor SA, 2000, J MOL BIOL, V299, P993, DOI 10.1006/jmbi.2000.3812; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; Iwaki D, 2006, J IMMUNOL, V177, P8626, DOI 10.4049/jimmunol.177.12.8626; Jin L, 2005, J BIOL CHEM, V280, P4704, DOI 10.1074/jbc.M411309200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Kidmose RT, 2012, P NATL ACAD SCI USA, V109, P15425, DOI 10.1073/pnas.1208031109; Lacroix M, 2001, J BIOL CHEM, V276, P36233, DOI 10.1074/jbc.M105688200; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCGRATH ME, 1994, EMBO J, V13, P1502, DOI 10.1002/j.1460-2075.1994.tb06411.x; Megyeri M, 2013, J BIOL CHEM, V288, P8922, DOI 10.1074/jbc.M112.446500; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Perona JJ, 1997, BIOCHEMISTRY-US, V36, P5381, DOI 10.1021/bi9617522; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sekine H, 2013, ADV EXP MED BIOL, V735, P41, DOI 10.1007/978-1-4614-4118-2_3; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Sorensen R, 2005, SPRINGER SEMIN IMMUN, V27, P299, DOI 10.1007/s00281-005-0006-z; Stover CM, 1999, J IMMUNOL, V162, P3481; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Tsiftsoglou SA, 2004, J IMMUNOL, V173, P367, DOI 10.4049/jimmunol.173.1.367; Wang SX, 2003, BIOCHEMISTRY-US, V42, P7959, DOI 10.1021/bi027320a; Wang SX, 2001, BIOCHEMISTRY-US, V40, P10038, DOI 10.1021/bi010712h; Waugh SM, 2000, NAT STRUCT BIOL, V7, P762, DOI 10.1038/78992; Yang SQ, 1998, J MOL BIOL, V279, P945, DOI 10.1006/jmbi.1998.1748; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	65	13	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67962	10.1371/journal.pone.0067962	http://dx.doi.org/10.1371/journal.pone.0067962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861840	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700066
J	Li, B; Dong, SH; Wu, JJ; Zhang, JY; Chen, G; Dong, QJ; Zhu, XH; Wang, XL				Li, Biao; Dong, Shihua; Wu, Jiajun; Zhang, Jianye; Chen, Gang; Dong, Quanjiang; Zhu, Xinhong; Wang, Xiaolong			Preparation of 5 '-O-(1-Thiotriphosphate)-Modified Oligonucleotides Using Polymerase-Endonuclease Amplification Reaction (PEAR)	PLOS ONE			English	Article							ANTISENSE OLIGONUCLEOTIDES; IN-VIVO; INHIBITION; ADJUVANT; DELIVERY; DUPLEXES; MIRNA	Antisense oligonucleotides (ASODNs) have been widely used as an important tool for regulating gene expression, and developed into therapeutics. Natural ODNs are susceptible to nuclease degradation, nucleic acid analogues, however, have less side effects, stronger stability and more potent activities. Large-scale de novo synthesis of a certain oligonucleotide has been very difficult and costly. In a previous preliminary study, we developed the polymerase-endonuclease amplification reaction (PEAR) for amplification and large-scale preparation of natural antisense ODNs. Here we extended the method in preparation of a widely used modified oligonucleotide with 5'-O-(1-Thiotriphosphate) modifications. Using electrospray ionization liquid chromatography mass spectrometry (ESI/LC/MS) detection, the purity of the PEAR product was measured as high as 100.0%. Using PEAR a large amount of a specific oligonucleotide can be produced starting from a small amount of synthetic seeds. It is suggested that PEAR can be a useful tool for large-scale production of modified oligonucleotides.	[Li, Biao; Dong, Shihua; Wu, Jiajun; Zhang, Jianye; Chen, Gang; Wang, Xiaolong] Ocean Univ China, Dept Biotechnol, Qingdao, Shandong, Peoples R China; [Dong, Quanjiang; Zhu, Xinhong] Qingdao Municipal Hosp, Qingdao, Shandong, Peoples R China	Ocean University of China; Qingdao Municipal Hospital	Wang, XL (corresponding author), Ocean Univ China, Dept Biotechnol, Qingdao, Shandong, Peoples R China.	Xiaolong@ouc.edu.cn	dong, quanjiang/AAD-3581-2019; Chen, gang/AAZ-5181-2021; Wu, JiaJun/GQH-7885-2022		National Science Foundation of China [81072567, 30600463]; Shandong Provincial Science Foundation [ZR2010HM056]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Science Foundation	This research was supported by the National Science Foundation of China through grants 81072567 and 30600463, and partially by Shandong Provincial Science Foundation grant ZR2010HM056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Astriab-Fisher A, 2004, BIOCHEM PHARMACOL, V68, P403, DOI 10.1016/j.bcp.2004.03.040; Butler M, 2005, NEUROSCIENCE, V131, P705, DOI 10.1016/j.neuroscience.2004.11.038; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; Davis S, 2006, NUCLEIC ACIDS RES, V34, P2294, DOI 10.1093/nar/gkl183; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Friedberg JW, 2009, BRIT J HAEMATOL, V146, P282, DOI 10.1111/j.1365-2141.2009.07773.x; Hail Mark E., 2004, American Biotechnology Laboratory, V22, P12; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lohmann JS, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-49; Lu YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1053; McGowan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049006; Menova P, 2012, CHEM COMMUN, V48, P6921, DOI 10.1039/c2cc32930a; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Nakagawa O, 2010, J AM CHEM SOC, V132, P8848, DOI 10.1021/ja102635c; Persico AM, 1998, NEUROSCIENCE, V82, P1115; Roush W, 1997, SCIENCE, V276, P1192, DOI 10.1126/science.276.5316.1192; Senti G, 2009, CLIN EXP ALLERGY, V39, P562, DOI 10.1111/j.1365-2222.2008.03191.x; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, CHEMBIOCHEM, V8, P490, DOI 10.1002/cbic.200600501; Veedu RN, 2009, ORG BIOMOL CHEM, V7, P1404, DOI 10.1039/b819946a; Wang XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008430; Weiler J, 2006, GENE THER, V13, P496, DOI 10.1038/sj.gt.3302654	26	2	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67558	10.1371/journal.pone.0067558	http://dx.doi.org/10.1371/journal.pone.0067558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861771	Green Published, gold, Green Submitted			2022-12-25	WOS:000323350700017
J	Rosa, RD; Vergnes, A; de Lorgeril, J; Goncalves, P; Perazzolo, LM; Saune, L; Romestand, B; Fievet, J; Gueguen, Y; Bachere, E; Destoumieux-Garzon, D				Rosa, Rafael Diego; Vergnes, Agnes; de Lorgeril, Julien; Goncalves, Priscila; Perazzolo, Luciane Maria; Saune, Laure; Romestand, Bernard; Fievet, Julie; Gueguen, Yannick; Bachere, Evelyne; Destoumieux-Garzon, Delphine			Functional Divergence in Shrimp Anti-Lipopolysaccharide Factors (ALFs): From Recognition of Cell Wall Components to Antimicrobial Activity	PLOS ONE			English	Article							BLACK TIGER SHRIMP; ANTI-LPS FACTOR; PENAEUS-MONODON; LITOPENAEUS-VANNAMEI; MOLECULAR-CLONING; GENE-EXPRESSION; NMR STRUCTURE; PEPTIDES; HEMOCYTES; MECHANISM	Antilipopolysaccharide factors (ALFs) have been described as highly cationic polypeptides with a broad spectrum of potent antimicrobial activities. In addition, ALFs have been shown to recognize LPS, a major component of the Gram-negative bacteria cell wall, through conserved amino acid residues exposed in the four-stranded beta-sheet of their three dimensional structure. In penaeid shrimp, ALFs form a diverse family of antimicrobial peptides composed by three main variants, classified as ALF Groups A to C. Here, we identified a novel group of ALFs in shrimp (Group D ALFs), which corresponds to anionic polypeptides in which many residues of the LPS binding site are lacking. Both Group B (cationic) and Group D (anionic) shrimp ALFs were produced in a heterologous expression system. Group D ALFs were found to have impaired LPS-binding activities and only limited antimicrobial activity compared to Group B ALFs. Interestingly, all four ALF groups were shown to be simultaneously expressed in an individual shrimp and to follow different patterns of gene expression in response to a microbial infection. Group B was by far the more expressed of the ALF genes. From our results, nucleotide sequence variations in shrimp ALFs result in functional divergence, with significant differences in LPS-binding and antimicrobial activities. To our knowledge, this is the first functional characterization of the sequence diversity found in the ALF family.	[Rosa, Rafael Diego; Vergnes, Agnes; de Lorgeril, Julien; Saune, Laure; Romestand, Bernard; Fievet, Julie; Gueguen, Yannick; Bachere, Evelyne; Destoumieux-Garzon, Delphine] Univ Montpellier 2, Univ Montpellier 1, Inst Francais Rech Exploitat Mer, Inst Rech Dev,CNRS,UMR5119, F-34095 Montpellier, France; [Goncalves, Priscila; Perazzolo, Luciane Maria] Univ Fed Santa Catarina, Dept Cell Biol Embryol & Genet, Lab Immunol Appl Aquaculture, Florianopolis, SC, Brazil; Ifremer, UMR5119, ECOSYM, F-34095 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidade Federal de Santa Catarina (UFSC); Ifremer	Destoumieux-Garzon, D (corresponding author), Univ Montpellier 2, Univ Montpellier 1, Inst Francais Rech Exploitat Mer, Inst Rech Dev,CNRS,UMR5119, F-34095 Montpellier, France.	ddestoum@ifremer.fr	Rosa, Rafael Diego/L-6944-2019; VERGNES, Agnès/O-3659-2014; Bachere, Evelyne/O-6117-2014; de Lorgeril, Julien/O-7488-2014; Gueguen, Yannick/O-3248-2014; Destoumieux-Garzón, Delphine/O-3328-2014	Rosa, Rafael Diego/0000-0002-4076-3163; de Lorgeril, Julien/0000-0002-6400-5455; Gueguen, Yannick/0000-0002-8749-9582; Destoumieux-Garzón, Delphine/0000-0002-8793-9138; Goncalves, Priscila/0000-0001-7299-3169; Saune, Laure/0000-0003-3490-5396; Perazzolo, Luciane Maria/0000-0002-5539-4911	IFREMER; CNRS; CNPq-Brazil; CAPES Brazil	IFREMER; CNRS(Centre National de la Recherche Scientifique (CNRS)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study received financial support from IFREMER and CNRS. RDR was supported by a doctoral fellowship from CNPq-Brazil and PG by a master fellowship provided by CAPES Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2007, BIOCHEM J, V406, P297, DOI 10.1042/BJ20070279; Bhunia A, 2011, J BIOL CHEM, V286, P24394, DOI 10.1074/jbc.M110.189662; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Carriel-Gomes MC, 2007, MEM I OSWALDO CRUZ, V102, P469, DOI 10.1590/S0074-02762007005000028; de la Vega E, 2008, MOL IMMUNOL, V45, P1916, DOI 10.1016/j.molimm.2007.10.039; de Lorgeril J, 2008, MOL IMMUNOL, V45, P3438, DOI 10.1016/j.molimm.2008.04.002; Goncalves P, 2012, MOL IMMUNOL, V51, P363, DOI 10.1016/j.molimm.2012.03.032; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2006, DEV COMP IMMUNOL, V30, P283, DOI 10.1016/j.dci.2005.04.003; Hetru C, 1997, Methods Mol Biol, V78, P35; HOESS A, 1993, EMBO J, V12, P3351, DOI 10.1002/j.1460-2075.1993.tb06008.x; Jimenez-Vega F, 2007, J SHELLFISH RES, V26, P1169, DOI 10.2983/0730-8000(2007)26[1169:IOLVAA]2.0.CO;2; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Liu FS, 2005, MAR BIOTECHNOL, V7, P600, DOI 10.1007/s10126-005-5006-4; Liu Y, 2012, FISH SHELLFISH IMMUN, V32, P724, DOI 10.1016/j.fsi.2012.01.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Mekata T, 2010, LETT APPL MICROBIOL, V50, P112, DOI 10.1111/j.1472-765X.2009.02763.x; Mora P, 2008, J PEPT SCI, V14, P963, DOI 10.1002/psc.1033; MORITA T, 1985, J BIOCHEM, V97, P1611, DOI 10.1093/oxfordjournals.jbchem.a135218; Nagoshi H, 2006, MOL IMMUNOL, V43, P2061, DOI 10.1016/j.molimm.2005.12.009; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Ponprateep S, 2012, FISH SHELLFISH IMMUN, V32, P26, DOI 10.1016/j.fsi.2011.10.010; Rosa RD, 2010, ISJ-INVERT SURVIV J, V7, P262; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Rosa RD, 2008, FISH SHELLFISH IMMUN, V25, P693, DOI 10.1016/j.fsi.2008.08.001; Schmitt P, 2012, DEV COMP IMMUNOLOGY; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Somboonwiwat K, 2006, J BIOCHEM MOL BIOL, V39, P26; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Somboonwiwat K, 2008, DEV COMP IMMUNOL, V32, P1170, DOI 10.1016/j.dci.2008.03.008; Supungul P, 2004, DIS AQUAT ORGAN, V61, P123, DOI 10.3354/dao061123; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA S, 1982, BIOCHEM BIOPH RES CO, V105, P717, DOI 10.1016/0006-291X(82)91493-0; Tassanakajon A, 2010, MAR BIOTECHNOL, V12, P487, DOI [10.1007/s10126-010-9288-9, 10.1007/s10126-011-9381-8]; Tharntada S, 2008, FISH SHELLFISH IMMUN, V24, P46, DOI 10.1016/j.fsi.2007.07.010; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Thomas P, 2012, MOL BIOL REP, V39, P6943, DOI 10.1007/s11033-012-1521-3; Wang KJ, 2007, MOL IMMUNOL, V44, P1961, DOI 10.1016/j.molimm.2006.09.036; Yang Y, 2009, BIOPOLYMERS, V91, P207, DOI 10.1002/bip.21119; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yedery RD, 2009, FISH SHELLFISH IMMUN, V27, P275, DOI 10.1016/j.fsi.2009.05.009	46	61	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67937	10.1371/journal.pone.0067937	http://dx.doi.org/10.1371/journal.pone.0067937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861837	Green Published, gold			2022-12-25	WOS:000323350700064
J	Henriques, A; Rodriguez-Caballero, A; Nieto, WG; Langerak, AW; Criado, I; Lecrevisse, Q; Gonzalez, M; Pais, ML; Paiva, A; Almeida, J; Orfao, A				Henriques, Ana; Rodriguez-Caballero, Arancha; Nieto, Wendy G.; Langerak, Anton W.; Criado, Ignacio; Lecrevisse, Quentin; Gonzalez, Marcos; Pais, Maria L.; Paiva, Artur; Almeida, Julia; Orfao, Alberto			Combined Patterns of IGHV Repertoire and Cytogenetic/Molecular Alterations in Monoclonal B Lymphocytosis versus Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							CHRONIC LYMPHOPROLIFERATIVE DISORDERS; CELL LYMPHOCYTOSIS; NATURAL-HISTORY; CLL; GENE; STANDARDIZATION; CLASSIFICATION; IMMUNOGLOBULIN; PROGNOSIS; NOTCH1	Background: Chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis (MBL) with (MBLhi) or without (MBLlo) absolute B-lymphocytosis precedes most CLL cases, the specific determinants for malignant progression remaining unknown. Methodology/Principal Findings: For this purpose, simultaneous iFISH and molecular analysis of well-established cytogenetic alterations of chromosomes 11, 12, 13, 14 and 17 together with the pattern of rearrangement of the IGHV genes were performed in CLL-like cells from MBL and CLL cases. Our results based on 78 CLL-like MBL and 117 CLL clones from 166 subjects living in the same geographical area, show the existence of three major groups of clones with distinct but partially overlapping patterns of IGHV gene usage, IGHV mutational status and cytogenetic alterations. These included a group enriched in MBLlo clones expressing specific IGHV subgroups (e.g. VH3-23) with no or isolated good-prognosis cytogenetic alterations, a second group which mainly consisted of clinical MBLhi and advanced stage CLL with a skewed but different CLL-associated IGHV gene repertoire (e.g. VH1-69), frequently associated with complex karyotypes and poor-prognosis cytogenetic alterations, and a third group of clones with intermediate features, with prevalence of mutated IGHV genes, and higher numbers of del(13q)(+) clonal B-cells. Conclusions/Significance: These findings suggest that the specific IGHV repertoire and IGHV mutational status of CLL-like B-cell clones may modulate the type of cytogenetic alterations acquired, their rate of acquisition and/or potentially also their clinical consequences. Further long-term follow-up studies investigating the IGHV gene repertoire of MBLlo clones in distinct geographic areas and microenvironments are required to confirm our findings and shed light on the potential role of some antigen-binding BCR specificities contributing to clonal evolution.	[Henriques, Ana; Rodriguez-Caballero, Arancha; Nieto, Wendy G.; Criado, Ignacio; Lecrevisse, Quentin; Almeida, Julia; Orfao, Alberto] Univ Salamanca, Dept Med & Cytometry Serv, Canc Res Ctr IBMCC, USAL CSIC, E-37008 Salamanca, Spain; [Henriques, Ana; Rodriguez-Caballero, Arancha; Nieto, Wendy G.; Criado, Ignacio; Lecrevisse, Quentin; Almeida, Julia; Orfao, Alberto] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain; [Henriques, Ana; Pais, Maria L.; Paiva, Artur] Portuguese Inst Blood & Transplantat IP, Blood & Transplantat Ctr Coimbra, Coimbra, Portugal; [Langerak, Anton W.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands; [Gonzalez, Marcos] Univ Salamanca, Serv Hematol, Univ Hosp Salamanca, IBMCC,IBSAL, E-37008 Salamanca, Spain; [Gonzalez, Marcos] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Universidade de Coimbra; Erasmus University Rotterdam; Erasmus MC; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Orfao, A (corresponding author), Univ Salamanca, Dept Med & Cytometry Serv, Canc Res Ctr IBMCC, USAL CSIC, E-37008 Salamanca, Spain.	orfao@usal.es	Orfao, Alberto/B-5801-2017; Henriques, Ana/B-7587-2019; Paiva, Artur/AFM-0035-2022; Paiva, Artur/AAH-2330-2022; Criado, Ignacio/ABF-7031-2020	Henriques, Ana/0000-0002-5096-791X; Paiva, Artur/0000-0002-6562-5859; Paiva, Artur/0000-0002-6562-5859; Criado, Ignacio/0000-0003-4120-343X	Fundacao para a Ciencia e Tecnologia of Portugal [SFRH/BD/31609/2006]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer [AECC-2008]; Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER [RD06/0020/0035]; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain [FIS PI06/0824-FEDER, PS09/02430-FEDER, FIS PI12/00905]; Gerencia Regional de Salud de Castilla y Leon and Ayuda al Grupo de Excelencia de Castilla y Leon, Consejeria de Educacion [GR37, GRS206/A/08]; Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain [SAN/1778/2009]; Fundacion Memoria D. Samuel Solorzano, Universidad de Salamanca, Salamanca, Spain [FS/1-2010]	Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; Gerencia Regional de Salud de Castilla y Leon and Ayuda al Grupo de Excelencia de Castilla y Leon, Consejeria de Educacion; Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain(Junta de Castilla y Leon); Fundacion Memoria D. Samuel Solorzano, Universidad de Salamanca, Salamanca, Spain	AH was supported by a grant from the Fundacao para a Ciencia e Tecnologia of Portugal (SFRH/BD/31609/2006), ARC was supported by a grant from Fundacion Cientifica de la Asociacion Espanola contra el Cancer (AECC-2008). This work was financially supported by the following grants: Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER (RD06/0020/0035); FIS PI06/0824-FEDER, PS09/02430-FEDER and FIS PI12/00905, from the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; GRS206/A/08 from the Gerencia Regional de Salud de Castilla y Leon and Ayuda al Grupo GR37 de Excelencia de Castilla y Leon, Consejeria de Educacion; SAN/1778/2009, Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain and FS/1-2010 Fundacion Memoria D. Samuel Solorzano, Universidad de Salamanca, Salamanca, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathangelidis A, 2012, BLOOD, V119, P4467, DOI 10.1182/blood-2011-11-393694; Almeida J, 2011, LEUKEMIA, V25, P718, DOI 10.1038/leu.2010.305; Arcaini L, 2009, BLOOD CELL MOL DIS, V42, P286, DOI 10.1016/j.bcmd.2009.01.004; Buhler A, 2010, CLIN CANCER RES, V16, P373, DOI 10.1158/1078-0432.CCR-09-2948; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Casabonne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052808; Chu CC, 2008, BLOOD, V112, P5122, DOI 10.1182/blood-2008-06-162024; Costa ES, 2010, LEUKEMIA, V24, P1927, DOI 10.1038/leu.2010.160; Dagklis A, 2009, BLOOD, V114, P26, DOI 10.1182/blood-2008-09-176933; Del Giudice I, 2012, HAEMATOL-HEMATOL J, V97, P437, DOI 10.3324/haematol.2011.060129; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Gonzalez D, 2003, LEUKEMIA, V17, P1398, DOI 10.1038/sj.leu.2402964; Kalina T, 2012, LEUKEMIA, V26, P1986, DOI 10.1038/leu.2012.122; Kern W, 2012, BR J HAEMAT IN PRESS, DOI [10.1111/j.1365-2141.2011.09010.x, DOI 10.1111/J.1365-2141.2011.09010.X.IN]; Kostareli E, 2008, SRP ARK CELOK LEK, V136, P319, DOI 10.2298/SARH0806319K; Lanasa MC, 2011, LEUKEMIA, V25, P1459, DOI 10.1038/leu.2011.117; Lanasa MC, 2010, LEUKEMIA, V24, P133, DOI 10.1038/leu.2009.192; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Lenze D, 2006, BLOOD, V107, P1141, DOI 10.1182/blood-2005-04-1722; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; MARTIN T, 1992, J EXP MED, V175, P983, DOI 10.1084/jem.175.4.983; Nieto WG, 2010, CYTOM PART B-CLIN CY, V78B, pS24, DOI 10.1002/cyto.b.20543; Nieto WG, 2009, BLOOD, V114, P33, DOI 10.1182/blood-2009-01-197368; Quijano S, 2008, CYTOM PART B-CLIN CY, V74B, P139, DOI 10.1002/cyto.b.20390; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Rawstron AC, 2007, BRIT J HAEMATOL, V139, P724, DOI 10.1111/j.1365-2141.2007.06863.x; Rawstron Andy C, 2009, Hematology Am Soc Hematol Educ Program, P430, DOI 10.1182/asheducation-2009.1.430; Rossi D, 2012, BLOOD, V119, P521, DOI 10.1182/blood-2011-09-379966; Sanchez ML, 2002, LEUKEMIA, V16, P1460, DOI 10.1038/sj.leu.2402584; Scarfo L, 2012, LEUKEMIA, V26, P1703, DOI 10.1038/leu.2012.20; Scarfo L, 2010, SEMIN CANCER BIOL, V20, P384, DOI 10.1016/j.semcancer.2010.08.005; Schwaenen C, 2004, P NATL ACAD SCI USA, V101, P1039, DOI 10.1073/pnas.0304717101; Shanafelt TD, 2010, LEUKEMIA, V24, P512, DOI 10.1038/leu.2009.287; Shanafelt TD, 2008, LEUKEMIA RES, V32, P1458, DOI 10.1016/j.leukres.2007.11.030; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3959, DOI 10.1200/JCO.2008.21.2704; Swerdlow E., 2008, WHO CLASSIFICATION T; Tobin G, 2004, BLOOD, V104, P2879, DOI 10.1182/blood-2004-01-0132; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vardi A, 2013, BLOOD; Zenz T, 2011, BLOOD REV, V25, P131, DOI 10.1016/j.blre.2011.02.002	40	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67751	10.1371/journal.pone.0067751	http://dx.doi.org/10.1371/journal.pone.0067751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844084	Green Published, gold, Green Submitted			2022-12-25	WOS:000321733000099
J	Malapi-Wight, M; Smith, J; Campbell, J; Bluhm, BH; Shim, WB				Malapi-Wight, Martha; Smith, Jonathon; Campbell, Jacquelyn; Bluhm, Burton H.; Shim, Won-Bo			Sda1, a Cys(2)-His(2) Zinc Finger Transcription Factor, Is Involved in Polyol Metabolism and Fumonisin B-1 Production in Fusarium verticillioides	PLOS ONE			English	Article							D-ARABITOL DEHYDROGENASE; L-XYLULOSE REDUCTASE; ASPERGILLUS-NIGER; SORBITOL DEHYDROGENASE; TRICHODERMA-REESEI; HYPOCREA-JECORINA; FILAMENTOUS FUNGI; L-ARABINOSE; MANNITOL DEHYDROGENASE; GIBBERELLA-FUJIKUROI	The ubiquitous ascomycete Fusarium verticillioides causes ear rot and stalk rot of maize, both of which reduce grain quality and yield. Additionally, F. verticillioides produces the mycotoxin fumonisin B-1 (FB1) during infection of maize kernels, and thus potentially compromises human and animal health. The current knowledge is fragmentary regarding the regulation of FB1 biosynthesis, particularly when considering interplay with environmental factors such as nutrient availability. In this study, SDA1 of F. verticillioides, predicted to encode a Cys-2 His-2 zinc finger transcription factor, was shown to play a key role in catabolizing select carbon sources. Growth of the SDA1 knock-out mutant (Delta sda1) was completely inhibited when sorbitol was the sole carbon source and was severely impaired when exclusively provided mannitol or glycerol. Deletion of SDA1 unexpectedly increased FB1 biosynthesis, but reduced arabitol and mannitol biosynthesis, as compared to the wild-type progenitor. Trichoderma reesei ACE1, a regulator of cellulase and xylanase expression, complemented the F. verticillioides Delta sda1 mutant, which indicates that Ace1 and Sda1 are functional orthologs. Taken together, the data indicate that Sda1 is a transcriptional regulator of carbon metabolism and toxin production in F. verticillioides.	[Malapi-Wight, Martha; Shim, Won-Bo] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Smith, Jonathon; Bluhm, Burton H.] Univ Arkansas, Dept Plant Pathol, Fayetteville, AR 72701 USA; [Campbell, Jacquelyn; Shim, Won-Bo] Texas A&M Univ, Dept Plant Pathol & Microbiol, Bioenvironm Sci Program, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University of Arkansas System; University of Arkansas Fayetteville; Texas A&M University System; Texas A&M University College Station	Shim, WB (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	wbshim@neo.tamu.edu		Malapi, Martha/0000-0003-2249-6257	National Research Initiative of the United States Department of Agriculture (USDA) Cooperative state Research, Education, and Service [2007-35319-18334]	National Research Initiative of the United States Department of Agriculture (USDA) Cooperative state Research, Education, and Service	This study was supported in part by the National Research Initiative of the United States Department of Agriculture (USDA) Cooperative state Research, Education, and Service (Grant 2007-35319-18334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Barrera LO, 2006, CURR OPIN CELL BIOL, V18, P291, DOI 10.1016/j.ceb.2006.04.002; Bluhm BH, 2005, MOL PLANT MICROBE IN, V18, P1333, DOI 10.1094/MPMI-18-1333; BRAHMACHARI SK, 1995, ELECTROPHORESIS, V16, P1705, DOI 10.1002/elps.11501601283; Brodhagen M, 2006, MOL PLANT PATHOL, V7, P285, DOI [10.1111/j.1364-3703.2006.00338.x, 10.1111/J.1364-3703.2006.00338.X]; Brown DW, 2007, EUKARYOT CELL, V6, P1210, DOI 10.1128/EC.00400-06; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; CHANLIAUD E, 1995, J CEREAL SCI, V21, P195, DOI 10.1016/0733-5210(95)90035-7; Clark AJ, 2003, PLANTA, V216, P614, DOI 10.1007/s00425-002-0833-2; David H, 2003, EUR J BIOCHEM, V270, P4243, DOI 10.1046/j.1432-1033.2003.03798.x; Desjardins AE, 2000, MICROBIOL-UK, V146, P2059, DOI 10.1099/00221287-146-8-2059; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; El-Kabbani O, 2004, CURR MED CHEM, V11, P465, DOI 10.2174/0929867043455927; Fairhead C, 1996, YEAST, V12, P1439; Fillinger S, 2001, MOL MICROBIOL, V39, P145, DOI 10.1046/j.1365-2958.2001.02223.x; Flaherty JE, 2004, APPL ENVIRON MICROB, V70, P2653, DOI 10.1128/AEM.70.5.2653-2659.2004; Flaherty JE, 2003, APPL ENVIRON MICROB, V69, P5222, DOI 10.1128/AEM.69.9.5222-5227.2003; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; Fu J, 2006, FUNGAL GENET BIOL, V43, P200, DOI 10.1016/j.fgb.2005.09.007; GELDERBLOM WCA, 1988, APPL ENVIRON MICROB, V54, P1806, DOI 10.1128/AEM.54.7.1806-1811.1988; Han S, 2001, MOL GENET GENOMICS, V266, P260, DOI 10.1007/s004380100552; Horer S, 2001, J BIOL CHEM, V276, P27555, DOI 10.1074/jbc.M102850200; Huisman MMH, 2000, CARBOHYD POLYM, V43, P269, DOI 10.1016/S0144-8617(00)00154-5; HULT K, 1978, EUR J BIOCHEM, V88, P607, DOI 10.1111/j.1432-1033.1978.tb12487.x; Hwang YYC, 2003, FASEB J, V17, P2331, DOI 10.1096/fj.03-0128fje; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; JENNINGS DH, 1984, ADV MICROB PHYSIOL, V25, P149; Kim H, 2008, FUNGAL GENET BIOL, V45, P947, DOI 10.1016/j.fgb.2008.03.007; Kim H, 2011, MICROBIOL-SGM, V157, P2658, DOI 10.1099/mic.0.052506-0; Koivistoinen OM, 2012, FEBS LETT, V586, P378, DOI 10.1016/j.febslet.2012.01.004; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; LARKINS RG, 1992, DIABETOLOGIA, V35, P499, DOI 10.1007/BF00400475; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; Link T, 2005, BIOCHEM J, V389, P289, DOI 10.1042/BJ20050301; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Marasas WFO, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.2307/3435014; Metz B, 2009, FEBS LETT, V583, P1309, DOI 10.1016/j.febslet.2009.03.027; Minorsky PV, 2002, PLANT PHYSIOL, V129, P929, DOI 10.1104/pp.900040; Missmer SA, 2006, ENVIRON HEALTH PERSP, V114, P237, DOI 10.1289/ehp.8221; Mojzita D, 2010, FEBS LETT, V584, P3540, DOI 10.1016/j.febslet.2010.06.037; Munkvold GP, 1997, PLANT DIS, V81, P556, DOI 10.1094/PDIS.1997.81.6.556; Myung K, 2009, J AGR FOOD CHEM, V57, P5089, DOI 10.1021/jf900783u; NYUNOYA H, 1984, CAN J MICROBIOL, V30, P45, DOI 10.1139/m84-008; Oates PJ, 2002, INT REV NEUROBIOL, V50, P325; Park DL, 2002, ADV EXP MED BIOL, V504, P277; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Portnoy T, 2011, EUKARYOT CELL, V10, P262, DOI 10.1128/EC.00208-10; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Proctor RH, 1999, FUNGAL GENET BIOL, V27, P100, DOI 10.1006/fgbi.1999.1141; Rauscher R, 2006, EUKARYOT CELL, V5, P447, DOI 10.1128/EC.5.3.447-456.2006; Richard P, 2002, BIOCHEMISTRY-US, V41, P6432, DOI 10.1021/bi025529i; RODRIGUES F, 2006, SUGAR METABOLISM YEA; Ruijter GJG, 2003, EUKARYOT CELL, V2, P690, DOI 10.1128/EC.2.4.690-698.2003; Rutten L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-166; Sagaram US, 2007, MICROBIOL-SGM, V153, P2850, DOI 10.1099/mic.0.2007/007708-0; Sagaram US, 2007, MOL PLANT PATHOL, V8, P375, DOI 10.1111/J.1364-3703.2007.00398.X; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Shelest E, 2008, FEMS MICROBIOL LETT, V286, P145, DOI 10.1111/j.1574-6968.2008.01293.x; Shim WB, 2001, APPL ENVIRON MICROB, V67, P1607, DOI 10.1128/AEM.67.4.1607-1612.2001; Shim WB, 1999, FEMS MICROBIOL LETT, V177, P109, DOI 10.1111/j.1574-6968.1999.tb13720.x; Smith JE, 2012, METABOLOMICS, V8, P376, DOI 10.1007/s11306-011-0322-3; Solomon PS, 2007, TRENDS MICROBIOL, V15, P257, DOI 10.1016/j.tim.2007.04.002; Solomon PS, 2005, MOL PLANT MICROBE IN, V18, P110, DOI 10.1094/MPMI-18-0110; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Trail F, 2002, PHYTOCHEMISTRY, V61, P791, DOI 10.1016/S0031-9422(02)00430-2; Velez H, 2007, FUNGAL GENET BIOL, V44, P258, DOI 10.1016/j.fgb.2006.09.008; Visentin I, 2012, EUKARYOT CELL, V11, P252, DOI 10.1128/EC.05159-11; WANG E, 1991, J BIOL CHEM, V266, P14486; Warfield CY, 1999, APPL ENVIRON MICROB, V65, P2853; White D.G., 1999, COMPENDIUM CORN DIS, P44; WITTEVEEN CFB, 1989, J GEN MICROBIOL, V135, P2163; WONG B, 1995, J BACTERIOL, V177, P2971, DOI 10.1128/jb.177.11.2971-2976.1995	76	10	13	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67656	10.1371/journal.pone.0067656	http://dx.doi.org/10.1371/journal.pone.0067656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844049	Green Submitted, Green Published, gold			2022-12-25	WOS:000321733000088
J	Ge, YJ; Waldemer, RJ; Nalluri, R; Nuzzi, PD; Chen, J				Ge, Yejing; Waldemer, Rachel J.; Nalluri, Ramakrishna; Nuzzi, Paul D.; Chen, Jie			RNAi Screen Reveals Potentially Novel Roles of Cytokines in Myoblast Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; MAMMALIAN TARGET; P38 MAPK; CHEMOKINE; FUSION; INTERLEUKIN-6; RECRUITMENT; INHIBITION; ACTIVATION	Cytokines are cell-secreted signaling molecules that modulate various cellular functions, with the best-characterized roles in immune responses. The expression of numerous cytokines in skeletal muscle tissues and muscle cells has been reported, but their function in skeletal myogenesis, the formation of skeletal muscle, has been largely underexplored. To systematically examine the potential roles of cytokines in skeletal myogenesis, we undertook an RNAi screen of 134 mouse cytokine genes for their involvement in the differentiation of C2C12 myoblasts. Our results have uncovered 29 cytokines as strong candidates for novel myogenic regulators, potentially conferring positive and negative regulation at distinct stages of myogenesis. These candidates represent a diverse collection of cytokine families, including interleukins, TNF-related factors, and chemokines. Our findings suggest the fundamental importance of cytokines in the cell-autonomous regulation of myoblast differentiation, and may facilitate future identification of novel therapeutic targets for improving muscle regeneration and growth in health and diseases.	[Ge, Yejing; Waldemer, Rachel J.; Nalluri, Ramakrishna; Nuzzi, Paul D.; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA.	jiechen@illinois.edu		Waldemer-Streyer, Rachel/0000-0002-7199-9443; Chen, Jie/0000-0002-7887-3747	National Institutes of Health [AR048914, GM089771]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health to JC (AR048914 & GM089771). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2008, J BIOL CHEM, V283, P23224, DOI 10.1074/jbc.M801379200; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Bae GU, 2008, J BIOL CHEM, V283, P8301, DOI 10.1074/jbc.M706730200; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Chong SW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-54; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hara M, 2011, J EXP MED, V208, P715, DOI 10.1084/jem.20101059; Henningsen J, 2011, MOL BIOSYST, V7, P311, DOI 10.1039/c0mb00209g; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Jansen Katie M., 2008, V475, P115, DOI 10.1007/978-1-59745-250-2_7; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Krop IE, 2001, P NATL ACAD SCI USA, V98, P9796, DOI 10.1073/pnas.171138398; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Melchonna R, 2010, MUSCLE NERVE, V41, P828, DOI 10.1002/mus.21611; Miyake T, 2009, J BIOL CHEM, V284, P19679, DOI 10.1074/jbc.M109.017319; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009; Okazaki S, 1996, CELL PROLIFERAT, V29, P173; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shigematsu H, 2005, INT J CANCER, V113, P600, DOI 10.1002/ijc.20622; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Tato Cristina M, 2008, Cell, V132, DOI 10.1016/j.cell.2008.01.001; Tato CM, 2008, CELL, V132, P1062; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Xiao F, 2011, CELL RES, V21, P350, DOI 10.1038/cr.2010.144; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	42	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68068	10.1371/journal.pone.0068068	http://dx.doi.org/10.1371/journal.pone.0068068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844157	gold, Green Submitted, Green Published			2022-12-25	WOS:000321341000137
J	Serrat, R; Lopez-Domenech, G; Mirra, S; Quevedo, M; Garcia-Fernandez, J; Ulloa, F; Burgaya, F; Soriano, E				Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Garcia-Fernandez, Jordi; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo			The Non-Canonical Wnt/PKC Pathway Regulates Mitochondrial Dynamics through Degradation of the Arm-Like Domain-Containing Protein Alex3	PLOS ONE			English	Article							BETA-CATENIN; KINASE-C; EPITHELIAL-CELLS; PROGENITOR CELLS; COLON-CANCER; STEM-CELLS; PKC-DELTA; WNT5A; DIFFERENTIATION; PROLIFERATION	The regulation of mitochondrial dynamics is vital in complex cell types, such as neurons, that transport and localize mitochondria in high energy-demanding cell domains. The Armcx3 gene encodes a mitochondrial-targeted protein (Alex3) that contains several arm-like domains. In a previous study we showed that Alex3 protein regulates mitochondrial aggregation and trafficking. Here we studied the contribution of Wnt proteins to the mitochondrial aggregation and dynamics regulated by Alex3. Overexpression of Alex3 in HEK293 cells caused a marked aggregation of mitochondria, which was attenuated by treatment with several Wnts. We also found that this decrease was caused by Alex3 degradation induced by Wnts. While the Wnt canonical pathway did not alter the pattern of mitochondrial aggregation induced by Alex3, we observed that the Wnt/PKC non-canonical pathway regulated both mitochondrial aggregation and Alex3 protein levels, thereby rendering a mitochondrial phenotype and distribution similar to control patterns. Our data suggest that the Wnt pathway regulates mitochondrial distribution and dynamics through Alex3 protein degradation.	[Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo] Inst Res Biomed Barcelona, Dev Neurobiol & Regenerat Lab, Barcelona, Spain; [Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Garcia-Fernandez, Jordi] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Garcia-Fernandez, Jordi] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Soriano, Eduardo] Fdn CIEN, Madrid, Spain	University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBERNED; University of Barcelona; University of Barcelona	Soriano, E (corresponding author), Univ Barcelona, Dept Cell Biol, Barcelona, Spain.	esoriano@ub.edu	Soriano, Eduardo/AAB-3216-2019; mirra, serena/AAG-4925-2021; López Doménech, Guillermo López Doménech/X-6075-2018; Reñé, Román Serrat/A-2500-2017; Garcia-Fernandez, Jordi/B-3839-2013; Ulloa, Fausto/AAB-2787-2019	Soriano, Eduardo/0000-0002-3204-9285; López Doménech, Guillermo López Doménech/0000-0002-3114-2082; Reñé, Román Serrat/0000-0001-5530-2135; Garcia-Fernandez, Jordi/0000-0001-5677-5970; 	Ministerio de Economia y Competitividad [MINECO], Spain [BFU2008-3980]; MINECO [BFU2010-21507]; Instituto de Salud Carlos III [PI12-02108]	Ministerio de Economia y Competitividad [MINECO], Spain(Spanish Government); MINECO(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants BFU2008-3980 (Ministerio de Economia y Competitividad [MINECO], Spain) to ES, BFU2010-21507 (MINECO) to FU and PI12-02108 (Instituto de Salud Carlos III) to FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2010, BONE, V47, P140, DOI 10.1016/j.bone.2010.04.593; Luna-Ulloa LB, 2011, IUBMB LIFE, V63, P915, DOI 10.1002/iub.559; Brocardo M, 2008, J BIOL CHEM, V283, P5950, DOI 10.1074/jbc.M708775200; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Deng L, 2009, CELL PROLIFERAT, V42, P721, DOI 10.1111/j.1365-2184.2009.00639.x; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Garcia-Frigola C, 2004, MOL BRAIN RES, V122, P133, DOI 10.1016/j.molbrainres.2003.12.014; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Han XJ, 2011, ACTA MED OKAYAMA, V65, P1; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kowalczyk JE, 2009, NEUROCHEM INT, V55, P157, DOI 10.1016/j.neuint.2009.01.009; Koyanagi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005765; Kurochkin IV, 2001, BIOCHEM BIOPH RES CO, V280, P340, DOI 10.1006/bbrc.2000.4125; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liang HL, 2007, J EXP MED, V204, P3077, DOI 10.1084/jem.20062692; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013; Lopez-Domenech G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1829; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Medrano EE, 2007, PIGM CELL RES, V20, P258, DOI 10.1111/j.1600-0749.2007.00383.x; Mezhybovska M, 2009, BRIT J CANCER, V101, P1596, DOI 10.1038/sj.bjc.6605342; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mou ZM, 2009, J BIOL CHEM, V284, P13629, DOI 10.1074/jbc.M901177200; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Samarzija I, 2009, BIOCHEM BIOPH RES CO, V386, P449, DOI 10.1016/j.bbrc.2009.06.033; Santos A, 2010, CYTOTHERAPY, V12, P924, DOI 10.3109/14653241003774011; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Smalley MJ, 1999, CANCER METAST REV, V18, P215, DOI 10.1023/A:1006369223282; Spinsanti P, 2008, J NEUROCHEM, V104, P1588, DOI 10.1111/j.1471-4159.2007.05111.x; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Winter EE, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-54; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu JM, 2006, MOL CELL BIOCHEM, V288, P17, DOI 10.1007/s11010-005-9113-3; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	56	22	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67773	10.1371/journal.pone.0067773	http://dx.doi.org/10.1371/journal.pone.0067773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844091	Green Published, Green Submitted, gold			2022-12-25	WOS:000321341000095
J	Chen, SF; Lin, YS; Jao, SW; Chang, YC; Liu, CL; Lin, YJ; Nieh, S				Chen, Su-Feng; Lin, Yaoh-Shiang; Jao, Shu-Wen; Chang, Yun-Ching; Liu, Chia-Lin; Lin, Yu-Ju; Nieh, Shin			Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSTIC IMPACT; DRUG-RESISTANCE; BREAST-CANCER; TUMOR-GROWTH; E-CADHERIN; EXPRESSION; CD133; SURVIVAL; OPINION	Background: Metastasis occurs in a series of discrete steps involving invasion, angiogenesis, lymphovascular space permeation, and establishment of secondary tumors. Malignant pleural effusion (MPE), a type of tumor metastasis, is usually a poor prognostic sign for patients with pulmonary adenocarcinoma, although its underlying mechanism has received less attention than other types of metastases have. The objective of the current study was to confirm whether cancer stem cells (CSCs) in MPE contribute to the "metastatic cascade'' through the epithelial - mesenchymal transition (EMT), anoikis, and adaptation in the microenvironment. Methods: Pulmonary tissue and corresponding cell blocks of MPE samples from 20 patients with primary adenocarcinoma were analyzed by immunohistochemical staining with CSC-representative markers (CD133, Nanog, and OCT-4) and EMT-associated markers (E-cadherin and vimentin). Correlations between these variables and clinico-pathological parameters were analyzed. Primary cultures from eight cases of MPE were investigated to characterize the CSC properties, including marker expression, sphere formation, and differentiation. Results: Expressions of CSC-representative markers for 20 cases of MPE cell blocks were quite diverse and variable ranging from 15% to 90%. Stronger expression of CSC-representative markers and alteration of EMT-associated markers were found at the invasive fronts and in MPEs compared with the expression in primary pulmonary tumor tissues. The expression of OCT-4 in MPEs significantly related to distant metastasis and stage, as well as inversely correlated with patient survival. Primary cultures confirmed the CSC properties in MPE. Five of eight cases of MPE yielded adequate cell clusters, which also showed variable expressions of CSC markers in addition to sphere formation and the ability for differentiation and metastasis. Conclusion: This pilot study offers a better understanding of the metastatic cascade. Establishing a model of MPE will provide further insight into the role of CSCs in metastasis and may explain the high therapeutic failure rates for patients with MPE.	[Chen, Su-Feng] China Med Univ, Dept Dent Hyg, Taichung, Taiwan; [Lin, Yaoh-Shiang] Kaohsiung Vet Gen Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Jao, Shu-Wen] Natl Def Med Ctr, Div Colon & Rectal Surg, Taipei, Taiwan; [Jao, Shu-Wen; Chang, Yun-Ching; Liu, Chia-Lin; Lin, Yu-Ju; Nieh, Shin] Triserv Gen Hosp, Taipei, Taiwan; [Chang, Yun-Ching; Liu, Chia-Lin] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Yu-Ju; Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan	China Medical University Taiwan; Kaohsiung Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Nieh, S (corresponding author), Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan.	niehshin1014@yahoo.com.tw	Yang, Xiaohan/AAM-2449-2020; Yang, Xiaohan/A-6975-2011	Yang, Xiaohan/0000-0001-5207-4210; Yang, Xiaohan/0000-0001-5207-4210	National Science Council, Republic of China [NSC100-2320-B-016-009]; Tri-Service General Hospital [TSGH-C101-076]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	This study was partly supported by the National Science Council, Republic of China, Grant Nos. NSC100-2320-B-016-009 and by the Tri-Service General Hospital, Grant No. TSGH-C101-076. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic T, 2012, DIAGN CYTOPATHOL, V40, P311, DOI 10.1002/dc.21563; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Bertrand K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/534139; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen KL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-72; Chen SF, 2007, HISTOPATHOLOGY, V51, P173, DOI 10.1111/j.1365-2559.2007.02755.x; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031864; Cheng DS, 2000, CHEST, V118, P1747, DOI 10.1378/chest.118.6.1747; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Elloul S, 2010, CLIN EXP METASTAS, V27, P161, DOI 10.1007/s10585-010-9315-2; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Guo HS, 2012, ONCOL REP, V27, P880, DOI 10.3892/or.2011.1559; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hackbarth JS, 2010, CLIN BIOCHEM, V43, P1051, DOI 10.1016/j.clinbiochem.2010.05.016; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Hsu IL, 2009, LUNG CANCER, V65, P371, DOI 10.1016/j.lungcan.2008.12.007; Ishigami S, 2010, ANTICANCER RES, V30, P2453; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Mancini R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021320; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; NAGASAWA T, 1983, ACTA CYTOL, V27, P119; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rapp UR, 2008, CELL CYCLE, V7, P45, DOI 10.4161/cc.7.1.5203; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sikora JJ, 2004, CANCER DETECT PREV, V28, P325, DOI 10.1016/j.cdp.2004.04.003; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Thelmo MC, 2010, FETAL PEDIATR PATHOL, V29, P45, DOI 10.3109/15513810903266625; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Wei L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3042; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	53	79	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e54659	10.1371/journal.pone.0054659	http://dx.doi.org/10.1371/journal.pone.0054659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23861841	Green Published, gold, Green Submitted			2022-12-25	WOS:000319167000001
J	Xu, CB; Li, XM; Zhang, LH				Xu, Chengbin; Li, Xuemei; Zhang, Lihong			The Effect of Calcium Chloride on Growth, Photosynthesis, and Antioxidant Responses of Zoysia japonica under Drought Conditions	PLOS ONE			English	Article							WHEAT TRITICUM-AESTIVUM; PROLINE METABOLISM; OXIDATIVE STRESS; WATER-DEFICIT; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; TOLERANCE; ACID; L.; INVOLVEMENT	Few attempts have been made to study the alleviating effects of signal molecules on zoysiagrass (Zoysia japonica) under drought stress. Calcium chloride has been shown to ameliorate the adverse effects of drought stress on many plants. It is necessary to investigate how to enhance drought tolerance of zoysiagrass using calcium chloride. The study elucidated the effects of calcium chloride on zoysiagrass under drought conditions by investigating the following parameters: biomass, chlorophyll (Chl) content, net photosynthetic rate (Pn), chlorophyll fluorescence, antioxidant enzymes, proline content, and malondialdehyde (MDA) content. Experimental conditions consisted of an aqueous CaCl2 solution at 5, 10, and 20 mM sprayed on zoysiagrass leaves for 3 d, following by an inducement of drought conditions by withholding water for 16 d. Under drought conditions, all CaCl2 pretreatments were found to increase the above-ground fresh biomass, as well as below-ground fresh and dry biomass. The resulting Chl (a, b, a +b) contents of the 5 and 10 mM CaCl2 pretreatment groups were higher than those of the control. In the later stages of drought conditions, the chlorophyll fluorescence parameter Fv/Fm was higher in leaves treated with 10 mM CaCl2 than in the leaves of the other two treatment groups. Zoysiagrass pretreated with 10 mM CaCl2 possessed both the maximum observed Pn and antioxidant enzyme activities. Meanwhile, lower MDA and proline contents were recorded in the plants pretreated with 5 and 10 mM CaCl2 under drought conditions. As a whole, the drought tolerance of zoysiagrass was improved to some extent by the application of a moderate calcium concentration.	[Xu, Chengbin; Zhang, Lihong] Liaoning Univ, Sch Environm Sci, Shenyang 110036, Peoples R China; [Li, Xuemei] Shenyang Normal Univ, Coll Chem & Life Sci, Shenyang, Peoples R China	Liaoning University; Shenyang Normal University	Zhang, LH (corresponding author), Liaoning Univ, Sch Environm Sci, Shenyang 110036, Peoples R China.	lihongzhang132@163.com		Roe, Oluf Dimitri/0000-0002-4870-5822	National Nature Science Foundation of China [31070285, 31270369]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Nature Science Foundation of China (31070285, 31270369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SB, 2007, ENVIRON EXP BOT, V59, P21, DOI 10.1016/j.envexpbot.2005.09.009; Ahmed M, 2011, AGR WATER MANAGE, V98, P1808, DOI 10.1016/j.agwat.2011.07.003; Antosiewicz DM, 2004, ENVIRON POLLUT, V129, P237, DOI 10.1016/j.envpol.2003.10.025; Arshi A, 2006, ACTA PHYSIOL PLANT, V28, P137, DOI 10.1007/s11738-006-0040-z; Guimaraes FVA, 2011, PLANT GROWTH REGUL, V65, P55, DOI 10.1007/s10725-011-9574-1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Ben Amor N, 2010, ACTA PHYSIOL PLANT, V32, P453, DOI 10.1007/s11738-009-0420-2; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Cousson A, 2009, BIOL PLANTARUM, V53, P53, DOI 10.1007/s10535-009-0008-0; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Diaz-Espejo A, 2007, PLANT CELL ENVIRON, V30, P922, DOI 10.1111/j.1365-3040.2007.001686.x; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Du HM, 2008, ACTA HORTIC, P207; Fu JM, 2001, ENVIRON EXP BOT, V45, P105, DOI 10.1016/S0098-8472(00)00084-8; Hojati M, 2011, J PLANT PHYSIOL, V168, P782, DOI 10.1016/j.jplph.2010.11.009; Huang B, 1999, PLANT SOIL, V208, P179, DOI 10.1023/A:1004472314631; Ishibashi Y, 2011, J PLANT PHYSIOL, V168, P1562, DOI 10.1016/j.jplph.2011.02.003; Israr M, 2011, J HAZARD MATER, V186, P1520, DOI 10.1016/j.jhazmat.2010.12.021; Issam N, 2012, PLANT GROWTH REGUL, V68, P37, DOI 10.1007/s10725-012-9691-5; Jaleel CA, 2007, COLLOID SURFACE B, V60, P110, DOI 10.1016/j.colsurfb.2007.06.006; Ku HM, 2012, BIOL PLANTARUM, V56, P337, DOI 10.1007/s10535-012-0095-1; Levitt J, 1980, CHILLING FREEZING HI; Liang X, 2009, J HYDROL, V376, P243, DOI 10.1016/j.jhydrol.2009.07.035; Ma QQ, 2006, J PLANT PHYSIOL, V163, P165, DOI 10.1016/j.jplph.2005.04.023; Ma R, 2005, J ARID ENVIRON, V63, P177, DOI 10.1016/j.jaridenv.2005.01.021; Mafakheri A, 2010, AUST J CROP SCI, V4, P580; Maggio A, 2002, PLANT J, V31, P699, DOI 10.1046/j.1365-313X.2002.01389.x; Mao Pei Sheng, 2009, Grassland Science, V55, P1, DOI 10.1111/j.1744-697X.2009.00129.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Monclus R, 2006, NEW PHYTOL, V169, P765, DOI 10.1111/j.1469-8137.2005.01630.x; Nayyar H, 2002, BIOL PLANTARUM, V45, P65, DOI 10.1023/A:1015132019686; Shan CJ, 2010, PLANT SCI, V178, P130, DOI 10.1016/j.plantsci.2009.11.002; Shao HB, 2008, CR BIOL, V331, P587, DOI 10.1016/j.crvi.2008.03.012; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Shoresh M, 2011, FREE RADICAL BIO MED, V51, P1221, DOI 10.1016/j.freeradbiomed.2011.03.036; Siddiqui MH, 2011, PROTOPLASMA, V248, P503, DOI 10.1007/s00709-010-0197-6; Soares-Cordeiro AS, 2009, PHOTOSYNTHETICA, V47, P304, DOI 10.1007/s11099-009-0047-y; Tan W, 2011, J PLANT PHYSIOL, V168, P2063, DOI 10.1016/j.jplph.2011.06.009; Tattini M, 2009, ENVIRON EXP BOT, V65, P72, DOI 10.1016/j.envexpbot.2008.01.005; Upadhyaya H, 2011, PLANT CELL REP, V30, P495, DOI 10.1007/s00299-010-0958-x; Wang KH, 2012, J PLANT PHYSIOL, V169, P492, DOI 10.1016/j.jplph.2011.12.007; Wang Y, 2009, BIOL PLANTARUM, V53, P179, DOI 10.1007/s10535-009-0030-2; Wang Y, 2009, PROG NAT SCI-MATER, V19, P435, DOI 10.1016/j.pnsc.2008.07.016; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xu X, 2008, TREE PHYSIOL, V28, P1751, DOI 10.1093/treephys/28.11.1751; Zehra A, 2012, S AFR J BOT, V78, P122, DOI 10.1016/j.sajb.2011.05.016; Zhao HJ, 2007, PLANT GROWTH REGUL, V51, P255, DOI 10.1007/s10725-007-9167-1; Zhou B, 2009, BIOL PLANTARUM, V53, P63, DOI 10.1007/s10535-009-0009-z	49	104	116	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68214	10.1371/journal.pone.0068214	http://dx.doi.org/10.1371/journal.pone.0068214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23936312	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000145
J	Ali, K; Warusevitane, A; Lally, F; Sim, J; Sills, S; Pountain, S; Nevatte, T; Allen, M; Roffe, C				Ali, Khalid; Warusevitane, Anushka; Lally, Frank; Sim, Julius; Sills, Sheila; Pountain, Sarah; Nevatte, Tracy; Allen, Martin; Roffe, Christine			The Stroke Oxygen Pilot Study: A Randomized Controlled Trial of the Effects of Routine Oxygen Supplementation Early after Acute Stroke-Effect on Key Outcomes at Six Months	PLOS ONE			English	Article							VALIDATION; SCALE	Introduction: Post-stroke hypoxia is common, and may adversely affect outcome. We have recently shown that oxygen supplementation may improve early neurological recovery. Here, we report the six-month outcomes of this pilot study. Methods: Patients with a clinical diagnosis of acute stroke were randomized within 24 h of admission to oxygen supplementation at 2 or 3 L/min for 72 h or to control treatment (room air). Outcomes (see below) were assessed by postal questionnaire at 6 months. Analysis was by intention-to-treat, and statistical significance was set at p <= 0.05. Results: Out of 301 patients randomized two refused/withdrew consent and 289 (148 in the oxygen and 141 in the control group) were included in the analysis: males 44%, 51%; mean (SD) age 73 (12), 71 (12); median (IQR) National Institutes of Health Stroke Scale score 6 (3, 10), 5 (3, 10) for the two groups respectively. At six months 22 (15%) patients in the oxygen group and 20 (14%) in the control group had died; mean survival in both groups was 162 days (p = 0.99). Median (IQR) scores for the primary outcome, the modified Rankin Scale, were 3 (1, 5) and 3 (1, 4) for the oxygen and control groups respectively. The covariate-adjusted odds ratio was 1.04 (95% CI 0.67, 1.60), indicating that the odds of a lower (i.e. better) score were non-significantly higher in the oxygen group (p = 0.86). The mean differences in the ability to perform basic (Barthel Index) and extended activities of daily living (NEADL), and quality of life (EuroQol) were also non-significant. Conclusions: None of the key outcomes differed at 6 months between the groups. Although not statistically significant and generally of small magnitude, the effects were predominantly in favour of the oxygen group; a larger trial, powered to show differences in longer-term functional outcomes, is now on-going.	[Ali, Khalid] Acad Dept Geriatr, Brighton, E Sussex, England; [Ali, Khalid] Sussex Med Sch, Brighton, E Sussex, England; [Warusevitane, Anushka; Lally, Frank; Sills, Sheila; Pountain, Sarah; Nevatte, Tracy; Roffe, Christine] North Staffordshire Combined Healthcare Trust, Stoke Stroke Res Grp, Stoke On Trent, Staffs, England; [Lally, Frank; Roffe, Christine] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England; [Sim, Julius] Keele Univ, Hlth Serv Res Unit, Keele, Staffs, England; [Allen, Martin] Univ Hosp North Staffordshire, Dept Resp Med, Stoke On Trent, Staffs, England	University of Brighton; Keele University; Keele University	Roffe, C (corresponding author), North Staffordshire Combined Healthcare Trust, Stoke Stroke Res Grp, Stoke On Trent, Staffs, England.	christine.roffe@northstaffs.nhs.uk	Roffe, Christine/AAT-5611-2020; Paul, Soumitra/E-5821-2015; Gayen, Dipak/N-8906-2017	Roffe, Christine/0000-0002-5259-6649; Ali, Nusrat/0000-0001-7356-6759; Paul, Soumitra/0000-0001-7560-5512; Datta, Swapan/0000-0003-2961-8915; Gayen, Dipak/0000-0002-4563-0992; SARKAR, SAILENDRA NATH/0000-0002-4059-8612	North Staffordshire Medical Institute; British Geriatrics Society	North Staffordshire Medical Institute; British Geriatrics Society	The authors would like to thank the North Staffordshire Medical Institute for funding the purchase of the pulse oximeters and the British Geriatrics Society for supporting Dr. KM Ali with a Specialist Registrar Research Start Up Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2006, STROKE, V37, P865, DOI 10.1161/01.STR.0000204053.36966.80; Ali Khalid, 2007, J Stroke Cerebrovasc Dis, V16, P239, DOI 10.1016/j.jstrokecerebrovasdis.2007.07.004; Appelros P, 2004, CEREBROVASC DIS, V17, P21, DOI 10.1159/000073894; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bravata DM, 2010, ARCH INTERN MED, V170, P804, DOI 10.1001/archinternmed.2010.92; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cabello JB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007160.pub2; Collin C, 1988, Int Disabil Stud, V10, P61; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Dennis M, 2012, STROKE, V43, P851, DOI 10.1161/STROKEAHA.111.639708; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Ellul J, 1998, AGE AGEING, V27, P115, DOI 10.1093/ageing/27.2.115; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; Lewis S, 2008, J NEUROL NEUROSUR PS, V79, P397, DOI 10.1136/jnnp.2007.126045; Nouri F., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Nuutinen J, 2006, ACTA NEUROL SCAND, V113, P100, DOI 10.1111/j.1600-0404.2005.00550.x; Robinson TG, 2005, J HYPERTENS, V23, P455; Roffe C, 2003, STROKE, V34, P2641, DOI 10.1161/01.STR.0000095188.65567.4F; Roffe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019113; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rowat AM, 2006, CEREBROVASC DIS, V21, P166, DOI 10.1159/000090528; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Silva Y, 2005, CEREBROVASC DIS, V19, P23, DOI 10.1159/000081908; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Sulter G, 2000, J NEUROL SCI, V179, P65, DOI 10.1016/S0022-510X(00)00378-6; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wright CC, 2003, J CLIN EPIDEMIOL, V56, P833, DOI 10.1016/S0895-4356(03)00155-0; Young FB, 2005, STROKE, V36, P2187, DOI 10.1161/01.STR.0000181089.41324.70	35	77	81	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e59274	10.1371/journal.pone.0059274	http://dx.doi.org/10.1371/journal.pone.0059274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23844166	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300001
J	Xu, C; Wang, CS; Sun, XY; Zhang, R; Gleason, ML; Eiji, T; Sun, GY				Xu, Chao; Wang, Chunsheng; Sun, Xinyao; Zhang, Rong; Gleason, Mark L.; Eiji, Tanaka; Sun, Guangyu			Multiple Group I Introns in the Small-Subunit rDNA of Botryosphaeria dothidea: Implication for Intraspecific Genetic Diversity	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; SCYTALIDIUM-DIMIDIATUM; TERTIARY INTERACTIONS; POPULATION-STRUCTURE; SECONDARY; PISTACHIO; REPRESENTATION; PATHOGENICITY; HYALINUM; BINDING	Botryosphaeria dothidea is a widespread and economically important pathogen on various fruit trees, and it often causes die-back and canker on limbs and fruit rot. In characterizing intraspecies genetic variation within this fungus, group I introns, rich in rDNA of fungi, may provide a productive region for exploration. In this research, we analysed complete small subunit (SSU) ribosomal DNA (rDNA) sequences of 37 B. dothidea strains, and found four insertions, designated Bdo.S943, Bdo.S1199-A, Bdo.S1199-B and Bdo.S1506, at three positions. Sequence analysis and structure prediction revealed that both Bdo.S943 and Bdo.S1506 belonged to subgroup IC1 of group I introns, whereas Bdo.S1199-A and Bdo.S1199-B corresponded to group IE introns. Moreover, Bdo.S1199-A was found to host an open reading frame (ORF) for encoding the homing endonuclease (HE), whereas Bdo.S1199-B, an evolutionary descendant of Bdo.S1199-A, included a degenerate HE. The above four introns were novel, and were the first group I introns observed and characterized in this species. Differential distribution of these introns revealed that all strains could be separated into four genotypes. Genotype III (no intron) and genotype IV (Bdo.S1199-B) were each found in only one strain, whereas genotype I (Bdo.S1199-A) and genotype II (Bdo.S943 and Bdo.S1506) occurred in 95% of the strains. There is a correlation between B. dothidea genotypes and hosts or geographic locations. Thus, these newly discovered group I introns can help to advance understanding of genetic differentiation within B. dothidea.	[Xu, Chao; Wang, Chunsheng; Sun, Xinyao; Zhang, Rong; Sun, Guangyu] Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Gleason, Mark L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Eiji, Tanaka] Ishikawa Prefectural Univ, Nonoichi, Ishikawa, Japan	Northwest A&F University - China; Iowa State University; Ishikawa Prefecture University	Sun, GY (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	sgy@nwsuaf.edu.cn	Zhang, Xinyu/S-4946-2016	Zhang, Xinyu/0000-0001-8154-9334; CAI, LEI/0000-0002-8131-7274; chao, xu/0000-0002-6398-4129; Tanaka, Eiji/0000-0003-4752-8825	National Natural Science Foundation of China [31170015, 31171797]; 111 Project from Education Ministry of China [B07049]; Top Talent Project of Northwest AF University; earmarked fund for Modern Agro-industry Technology Research System [nycytx-08-04-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from Education Ministry of China(Ministry of Education, China - 111 Project); Top Talent Project of Northwest AF University; earmarked fund for Modern Agro-industry Technology Research System	This work was supported by National Natural Science Foundation of China (31170015, 31171797), the 111 Project from Education Ministry of China (B07049), Top Talent Project of Northwest A&F University and the earmarked fund for Modern Agro-industry Technology Research System (nycytx-08-04-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr ME, 1972, PRELIMINARY STUDIES, P525; Belfort M, 1995, J BIOL CHEM, V270, P30237, DOI 10.1074/jbc.270.51.30237; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Cech TR, 2002, BIOCHEM SOC T, V30, P1162, DOI 10.1042/BST0301162; Choi IY, 2011, PLANT DIS, V95, P227, DOI 10.1094/PDIS-05-10-0371; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Hall TA., NUCL ACIDS S SER OXF, V41, P95; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, MOL BIOL EVOL, V21, P129, DOI 10.1093/molbev/msh005; Haugen P, 2002, EUR J BIOCHEM, V269, P1641, DOI 10.1046/j.1432-1327.2002.02802.x; Jurica MS, 1999, CELL MOL LIFE SCI, V55, P1304, DOI 10.1007/s000180050372; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Li ZJ, 2005, NUCLEIC ACIDS RES, V33, P2118, DOI 10.1093/nar/gki517; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma ZH, 2004, PHYTOPATHOLOGY, V94, P326, DOI 10.1094/PHYTO.2004.94.4.326; Ma ZH, 2002, PHYTOPATHOLOGY, V92, P519, DOI 10.1094/PHYTO.2002.92.5.519; Ma ZH, 2001, PHYTOPATHOLOGY, V91, P665, DOI 10.1094/PHYTO.2001.91.7.665; Machouart M, 2004, FEMS MICROBIOL LETT, V238, P455, DOI 10.1016/j.femsle.2004.08.011; Machouart M, 2011, FUNGAL BIOL-UK, V115, P1038, DOI 10.1016/j.funbio.2011.05.002; Machouart-Dubach M, 2002, FEMS MICROBIOL LETT, V208, P187, DOI 10.1111/j.1574-6968.2002.tb11080.x; MICHAILIDES TJ, 1991, PHYTOPATHOLOGY, V81, P566, DOI 10.1094/Phyto-81-566; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Muller KM, 2001, MOL BIOL EVOL, V18, P1654, DOI 10.1093/oxfordjournals.molbev.a003954; Nikoh N, 2001, MOL BIOL EVOL, V18, P1631, DOI 10.1093/oxfordjournals.molbev.a003952; Slippers B, 2004, MYCOLOGIA, V96, P83, DOI 10.2307/3761991; Suh SO, 1999, J MOL EVOL, V48, P493, DOI 10.1007/PL00006493; Takizawa K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-94; Tang W, 2012, PLANT DIS, V96, P486, DOI 10.1094/PDIS-08-11-0635; Taylor A, 2005, AUSTRALAS PLANT PATH, V34, P187, DOI 10.1071/AP05018; WEAVER DJ, 1974, PHYTOPATHOLOGY, V64, P1429, DOI 10.1094/Phyto-64-1429; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zhang Y, 2000, RNA, V6, P937, DOI 10.1017/S1355838200991726; Zhang Y, 2009, FEBS LETT, V583; Zhou Z, 2011, SCI AGR SINICA, V6, P009; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	28	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67808	10.1371/journal.pone.0067808	http://dx.doi.org/10.1371/journal.pone.0067808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	24098811	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000101
J	Blatteau, JE; Brubakk, AO; Gempp, E; Castagna, O; Risso, JJ; Vallee, N				Blatteau, Jean-Eric; Brubakk, Alf O.; Gempp, Emmanuel; Castagna, Olivier; Risso, Jean-Jacques; Vallee, Nicolas			Sidenafil Pre-Treatment Promotes Decompression Sickness in Rats	PLOS ONE			English	Article							BUBBLE FORMATION; NITRIC-OXIDE; SILDENAFIL; DIVE; PEROXYNITRITE; ACTIVATION; DAMAGE; PDE5	Vascular bubble formation after decompression contributes to endothelial injuries which form the basis for the development of decompression sickness (DCS). Nitric oxide (NO) is a powerful vasodilator that contributes to vessel homeostasis. It has been shown that NO-releasing agent may reduce bubble formation and prevent serious decompression sickness. The use of sildenafil, a well-known, phosphodiesterase-5 blocker, which act by potentiating the vasodilatory effect on smooth muscle relaxation, has never been studied in DCS. The purpose of the present study was to evaluate the clinical effects of sildenafil pre-treatment on DCS in a rat model. 67 rats were subjected to a simulated dive at 90 msw for 45 min before staged decompression. The experimental group received 10 mg/kg of sildenafil one hour before exposure (n = 35) while controls were not treated (n = 32). Clinical assessment took place over a period of 30 min after surfacing. At the end, blood samples were collected for blood cells counts and the level of circulating bubbles in the right cavities was quantified. There were significantly more manifestations of DCS in the sildenafil group than in the controls (34.3% vs 6.25%, respectively, p = 0.012). Platelet count was more reduced in treated rats than in controls (-21.7% vs -7%, respectively, p = 0.029), whereas bubble grades did not differ between groups. We concluded that pre-treatment with sildenafil promotes the onset and severity of neurological DCS. When considering the use of phosphodiesterase-5 blockers in the context of diving, careful discussion with physician should be recommended.	[Blatteau, Jean-Eric; Castagna, Olivier; Risso, Jean-Jacques; Vallee, Nicolas] Inst Rech Biomed Armees, Dept Environm Operat Environm Extremes, Equipe Residante Rech Subaquat Operat, Toulon, France; [Brubakk, Alf O.] Norwegian Univ Sci & Technol, Med Technol Ctr, Fac Med, Dept Physiol & Biomed Engn, N-7034 Trondheim, Norway; [Castagna, Olivier] Univ Toulon & Var, Lab Motricite Humaine Educ Sport & Sante, Equipe Accueil 6309, Toulon, France; [Gempp, Emmanuel] HIA St Anne, Serv Med Hyperbare & Expertise Plonge, Toulon, France	Norwegian University of Science & Technology (NTNU); Universite de Toulon; Hospital Instruction Of Armees Sainte-Anne	Blatteau, JE (corresponding author), Inst Rech Biomed Armees, Dept Environm Operat Environm Extremes, Equipe Residante Rech Subaquat Operat, Toulon, France.	je.blatteau@infonie.fr						AHN HS, 1991, ELECTRON LETT, V27, P191, DOI 10.1049/el:19910123; Barnett CF, 2006, VASC HEALTH RISK MAN, V2, P411, DOI 10.2147/vhrm.2006.2.4.411; BERGHAGE TE, 1979, UNDERSEA BIOMED RES, V6, P1; Bert P, 1878, BAROMETRIC PRESSURE; Blatteau JE, 2006, AVIAT SPACE ENVIR MD, V77, P1068; Blatteau JE, 2011, NEUROCRIT CARE, V15, P120, DOI 10.1007/s12028-010-9370-1; Blatteau JE, 2008, AVIAT SPACE ENVIR MD, V79, P1100, DOI 10.3357/ASEM.2377.2008; Byoun HS, 2010, J KOREAN NEUROSURG S, V47, P210, DOI 10.3340/jkns.2010.47.3.210; Demchenko IT, 2009, J APPL PHYSIOL, V106, P1234, DOI 10.1152/japplphysiol.91407.2008; Dujic Z, 2006, MED SCI SPORT EXER, V38, P1432, DOI 10.1249/01.mss.0000228936.78916.23; Francis T. J. R., 2003, BENNETT ELLIOTTS PHY, P530; Gempp E, 2010, RES SPORTS MED, V18, P205, DOI 10.1080/15438627.2010.490189; GIRY PBL, 1977, UNDERSEA BIOMED RES, V4, P147; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Gopal VK, 2001, EUR J BIOCHEM, V268, P3304, DOI 10.1046/j.1432-1327.2001.02233.x; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hurlimann D, 2002, EUR HEART J SUPPL, V4, pA1, DOI 10.1016/S1520-765X(02)90067-2; Kotera J, 2000, J HISTOCHEM CYTOCHEM, V48, P685, DOI 10.1177/002215540004800512; LABORIT. H., 1961, AGRESSOLOGIE, V2, P229; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Lin CS, 2006, CURR PHARM DESIGN, V12, P3439, DOI 10.2174/138161206778343064; Mollerlokken A, 2006, J APPL PHYSIOL, V101, P1541, DOI 10.1152/japplphysiol.01191.2005; Montcalm-Smith EA, 2008, AVIAT SPACE ENVIR MD, V79, P7, DOI 10.3357/ASEM.2071.2008; Nishi R. Y., 2003, BENNETT ELLIOTTS PHY, P501; Nossum V, 1999, UNDERSEA HYPERBAR M, V26, P1; Nyquist PA, 2004, AVIAT SPACE ENVIR MD, V 75, P211; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Padma-Nathan H, 1998, INT J CLIN PRACT, V52, P375; Phillips BG, 2000, CIRCULATION, V102, P3068; PHILP R B, 1974, Undersea Biomedical Research, V1, P117; Pontier JM, 2008, AVIAT SPACE ENVIR MD, V79, P1096, DOI 10.3357/ASEM.2352.2008; Sawatzky KD, 1991, THESIS YORK U TORONT; Takizawa Shunya, 2003, J Stroke Cerebrovasc Dis, V12, P196, DOI 10.1016/S1052-3057(03)00074-0; THORSEN T, 1987, UNDERSEA BIOMED RES, V14, P45; Wisloff U, 2004, J PHYSIOL-LONDON, V555, P825, DOI 10.1113/jphysiol.2003.055467; Wisloff U, 2003, J PHYSIOL-LONDON, V546, P577, DOI 10.1113/jphysiol.2002.030338; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73	37	20	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60639	10.1371/journal.pone.0060639	http://dx.doi.org/10.1371/journal.pone.0060639			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580342	Green Published, Green Submitted, gold			2022-12-25	WOS:000317898000044
J	Chen, SY; Huang, X; Yan, XQ; Liang, Y; Wang, YZ; Li, XF; Peng, XJ; Ma, XY; Zhang, LX; Cai, YY; Ma, T; Cheng, LQ; Qi, DM; Zheng, HJ; Yang, XH; Li, XX; Liu, GS				Chen, Shuangyan; Huang, Xin; Yan, Xueqing; Liang, Ye; Wang, Yuezhu; Li, Xiaofeng; Peng, Xianjun; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Ma, Tian; Cheng, Liqin; Qi, Dongmei; Zheng, Huajun; Yang, Xiaohan; Li, Xiaoxia; Liu, Gongshe			Transcriptome Analysis in Sheepgrass (Leymus chinensis): A Dominant Perennial Grass of the Eurasian Steppe	PLOS ONE			English	Article							FREEZING TOLERANCE; SSR-MARKERS; ARABIDOPSIS-THALIANA; COLD-ACCLIMATION; MICROSATELLITE MARKERS; PHYLOGENETIC ANALYSIS; GENOME ANNOTATION; GENE DISCOVERY; SALT TOLERANCE; TRITICEAE	Background: Sheepgrass [Leymus chinensis (Trin.) Tzvel.] is an important perennial forage grass across the Eurasian Steppe and is known for its adaptability to various environmental conditions. However, insufficient data resources in public databases for sheepgrass limited our understanding of the mechanism of environmental adaptations, gene discovery and molecular marker development. Results: The transcriptome of sheepgrass was sequenced using Roche 454 pyrosequencing technology. We assembled 952,328 high-quality reads into 87,214 unigenes, including 32,416 contigs and 54,798 singletons. There were 15,450 contigs over 500 bp in length. BLAST searches of our database against Swiss-Prot and NCBI non-redundant protein sequences (nr) databases resulted in the annotation of 54,584 (62.6%) of the unigenes. Gene Ontology (GO) analysis assigned 89,129 GO term annotations for 17,463 unigenes. We identified 11,675 core Poaceae-specific and 12,811 putative sheepgrass-specific unigenes by BLAST searches against all plant genome and transcriptome databases. A total of 2,979 specific freezing-responsive unigenes were found from this RNAseq dataset. We identified 3,818 EST-SSRs in 3,597 unigenes, and some SSRs contained unigenes that were also candidates for freezing-response genes. Characterizations of nucleotide repeats and dominant motifs of SSRs in sheepgrass were also performed. Similarity and phylogenetic analysis indicated that sheepgrass is closely related to barley and wheat. Conclusions: This research has greatly enriched sheepgrass transcriptome resources. The identified stress-related genes will help us to decipher the genetic basis of the environmental and ecological adaptations of this species and will be used to improve wheat and barley crops through hybridization or genetic transformation. The EST-SSRs reported here will be a valuable resource for future gene-phenotype studies and for the molecular breeding of sheepgrass and other Poaceae species.	[Chen, Shuangyan; Huang, Xin; Yan, Xueqing; Liang, Ye; Li, Xiaofeng; Peng, Xianjun; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Ma, Tian; Cheng, Liqin; Qi, Dongmei; Li, Xiaoxia; Liu, Gongshe] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Huang, Xin; Yan, Xueqing; Liang, Ye; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Li, Xiaoxia] Chinese Acad Sci, Grad Schoo1, Beijing, Peoples R China; [Wang, Yuezhu; Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Yang, Xiaohan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; United States Department of Energy (DOE); Oak Ridge National Laboratory	Chen, SY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	sychen@ibcas.ac.cn; lixx258258@163.com; liugs@ibcas.ac.cn	Yang, Xiaohan/AAM-2449-2020; Yang, Xiaohan/A-6975-2011	Yang, Xiaohan/0000-0001-5207-4210; Yang, Xiaohan/0000-0001-5207-4210	National High Technology Research and Development Program of China ("863") [2011AA100209]; National Natural Science Foundation of China [30970291, 31170316]; Key Project of the Chinese Academy of Sciences [KSCX2-EW-J-1]; Project of Ningxia Agricultural Comprehensive Development Office [NNTK-11-04, NTKJ-2012-03]	National High Technology Research and Development Program of China ("863")(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); Project of Ningxia Agricultural Comprehensive Development Office	This work was supported by the National High Technology Research and Development Program of China ("863", 2011AA100209), the National Natural Science Foundation of China (30970291; 31170316), the Key Project of the Chinese Academy of Sciences (KSCX2-EW-J-1), and the Project of Ningxia Agricultural Comprehensive Development Office (NNTK-11-04; NTKJ-2012-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Bai WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012125; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Bushman BS, 2008, GENOME, V51, P779, DOI 10.1139/G08-062; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chen PD, 2005, THEOR APPL GENET, V111, P941, DOI 10.1007/s00122-005-0026-z; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; da Maia LC, 2009, GENET MOL BIOL, V32, P822, DOI 10.1590/S1415-47572009005000091; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Deschamps S, 2010, PLANT GENOME-US, V3, P53, DOI 10.3835/plantgenome2009.09.0026; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Fan X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-247; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; He RF, 2012, AM J BOT, V99, P232, DOI 10.3732/ajb.1100429; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; [马红媛 Hongyuan Ma], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P181; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Jin H, 2006, PLANT SCI, V170, P1081, DOI 10.1016/j.plantsci.2006.01.002; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu X, 2001, ACTA BOT SIN, V43, P948; Liu ZP, 2008, MOL PHYLOGENET EVOL, V46, P278, DOI 10.1016/j.ympev.2007.10.009; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Ma PD, 2012, APPL BIOCHEM BIOTECH, V166, P479, DOI 10.1007/s12010-011-9443-4; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Niu SL, 2008, J EXP BOT, V59, P1431, DOI 10.1093/jxb/ern051; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Peng XJ, 2011, PLANT CELL REP, V30, P1493, DOI 10.1007/s00299-011-1058-2; Qi LL, 2008, THEOR APPL GENET, V117, P1155, DOI 10.1007/s00122-008-0853-9; Reyes JC, 2006, CURR OPIN PLANT BIOL, V9, P21, DOI 10.1016/j.pbi.2005.11.010; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sha LN, 2008, BIOCHEM GENET, V46, P605, DOI 10.1007/s10528-008-9175-5; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Subbarao GV, 2007, PLANT SOIL, V299, P55, DOI 10.1007/s11104-007-9360-z; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang LJ, 2009, BIOTECHNOL LETT, V31, P313, DOI 10.1007/s10529-008-9864-5; Wang RZ, 2008, J PLANT GROWTH REGUL, V27, P39, DOI 10.1007/s00344-007-9029-0; WANG RRC, 1994, GENOME, V37, P231, DOI 10.1139/g94-032; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Wang YH, 2007, CLIMATIC CHANGE, V82, P437, DOI 10.1007/s10584-006-9145-z; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Xu ZZ, 2009, J EXP BOT, V60, P3737, DOI 10.1093/jxb/erp216; Young ET, 2000, GENETICS, V154, P1053; ZHANG HB, 1991, AM J BOT, V78, P871, DOI 10.2307/2445166; Zhang L, 2010, J ENVIRON QUAL, V39, P251, DOI 10.2134/jeq2009.0109; Zhang WD, 2004, GRASS FORAGE SCI, V59, P180, DOI 10.1111/j.1365-2494.2004.00419.x; Zhou Q, 2008, J GENET GENOMICS, V35, P639, DOI 10.1016/S1673-8527(08)60085-5; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	88	79	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67974	10.1371/journal.pone.0067974	http://dx.doi.org/10.1371/journal.pone.0067974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861841	gold, Green Published, Green Submitted			2022-12-25	WOS:000323350700067
J	Chan, CM; Chang, HH; Wang, VC; Huang, CL; Hung, CF				Chan, Chi-Ming; Chang, Hsun-Hsien; Wang, Vin-Chi; Huang, Chuen-Lin; Hung, Chi-Feng			Inhibitory Effects of Resveratrol on PDGF-BB-Induced Retinal Pigment Epithelial Cell Migration via PDGFR beta, PI3K/Akt and MAPK pathways	PLOS ONE			English	Article							EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY; EXTRACELLULAR-MATRIX PROTEINS; VASCULAR SMOOTH-MUSCLE; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; IN-VIVO; (-)-EPIGALLOCATECHIN GALLATE; DIABETIC-RETINOPATHY; ADJUNCTIVE TREATMENT; ARPE19 CELLS	Purpose: In diseases such as proliferative vitreoretinopathy (PVR), proliferative diabetic retinopathy, and age-related macular degeneration, retinal pigment epithelial (RPE) cells proliferate and migrate. Moreover, platelet-derived growth factor (PDGF) has been shown to enhance proliferation and migration of RPE cells in PVR. Even resveratrol can suppress the migration and adhesion of many cell types, its effects on RPE cell migration and adhesion remain unknown. In this study, we investigated the inhibitory effects of resveratrol on RPE cell migration induced by PDGF-BB, an isoform of PDGF, and adhesion to fibronectin, a major ECM component of PVR tissue. Methods: The migration of RPE cells was assessed by an electric cell-substrate impedance sensing migration assay and a Transwell migration assay. A cell viability assay was used to determine the viability of resveratrol treated-cells. The cell adhesion to fibronectin was examined by an adhesion assay. The interactions of resveratrol with PDGF-BB were analyzed by a dot binding assay. The PDGF-BB-induced signaling pathways were determined by western blotting and scratch wound healing assay. Results: Resveratrol inhibited PDGF-BB-induced RPE cell migration in a dose-dependent manner, but showed no effects on ARPE19 cell adhesion to fibronectin. The cell viability assay showed no cytotoxicity of resveratrol on RPE cells and the dot binding assay revealed no direct interactions of resveratrol with PDGF-BB. Inhibitory effects of resveratrol on PDGF-BB-induced platelet-derived growth factor receptor beta (PDGFR beta) and tyrosine phosphorylation and the underlying pathways of PI3K/Akt, ERK and p38 activation were found; however, resveratrol and PDGF-BB showed no effects on PDGFR alpha and JNK activation. Scratch wound healing assay demonstrated resveratrol and the specific inhibitors of PDGFR, PI3K, MEK or p38 suppressed PDGF-BB-induced cell migration. Conclusions: These results indicate that resveratrol is an effective inhibitor of PDGF-BB-induced RPE cell migration via PDGFRb, PI3K/Akt and MAPK pathways, but has no effects on the RPE cell adhesion to fibronectin.	[Chan, Chi-Ming] Cardinal Tien Hosp, Dept Ophthalmol, New Taipei City, Taiwan; [Chan, Chi-Ming; Wang, Vin-Chi; Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Chang, Hsun-Hsien; Hung, Chi-Feng] Harvard Univ, Childrens Hosp Informat Program, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol,Med Sch, Boston, MA USA; [Wang, Vin-Chi] Cardinal Tien Hosp, Neurol Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Cardinal Tien Hosp, Med Res Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Natl Def Med Ctr, Dept Physiol & Biophys, Grad Inst Physiol, Taipei, Taiwan	Cardinal Tien Hospital; Fu Jen Catholic University; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Cardinal Tien Hospital; Cardinal Tien Hospital; National Defense Medical Center	Hung, CF (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan.	054317@gmail.com	Hung, Chi-Feng/AAL-4977-2021; Chan, Chi-Ming/GWZ-3612-2022	Hung, Chi-Feng/0000-0003-3478-5451; Troughton, Richard/0000-0001-7484-4036	National Science Council, Taipei, Taiwan [NSC97-2320-B-030-001-MY3]; Cardinal Tien Hospital, Taipei, Taiwan [FU10008]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Cardinal Tien Hospital, Taipei, Taiwan	This work was supported by the research grants from the National Science Council (NSC97-2320-B-030-001-MY3) and from Cardinal Tien Hospital (FU10008), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akiyama H, 2006, J CELL PHYSIOL, V207, P407, DOI 10.1002/jcp.20583; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; CAMPOCHIARO PA, 1994, J CELL SCI, V107, P2459; Cao LM, 2010, INVEST OPHTH VIS SCI, V51, P6658, DOI 10.1167/iovs.10-5524; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Chan CM, 2010, MOL VIS, V16, P586; Chan CM, 2009, BIOCHEM BIOPH RES CO, V388, P172, DOI 10.1016/j.bbrc.2009.07.155; Chan CM, 2008, MOL VIS, V14, P2528; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Charteris DG, 2002, EYE, V16, P369, DOI 10.1038/sj.eye.6700194; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Cicha I, 2011, J ATHEROSCLER THROMB, V18, P1031, DOI 10.5551/jat.8136; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; de Silva DJ, 2008, BRIT J OPHTHALMOL, V92, P954, DOI 10.1136/bjo.2007.131540; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; HAMILTON CW, 1982, AM J OPHTHALMOL, V94, P473, DOI 10.1016/0002-9394(82)90241-0; Haugland HK, 1997, ANTICANCER RES, V17, P1035; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hinton DR, 1998, EXP CELL RES, V239, P11, DOI 10.1006/excr.1997.3873; HISCOTT P, 1994, BRIT J OPHTHALMOL, V78, P219, DOI 10.1136/bjo.78.3.219; Ho J, 2011, OPHTHALMOLOGY, V118, P687, DOI 10.1016/j.ophtha.2010.08.010; Hughes AD, 1996, GEN PHARMACOL-VASC S, V27, P1079, DOI 10.1016/S0306-3623(96)00060-2; Ikuno Y, 2000, INVEST OPHTH VIS SCI, V41, P3107; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P2406; Kim Dong Shoo, 2007, Nutr Res Pract, V1, P285, DOI 10.4162/nrp.2007.1.4.285; Kiselev KV, 2011, APPL MICROBIOL BIOT, V90, P417, DOI 10.1007/s00253-011-3184-8; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; Lee MF, 2011, J AGR FOOD CHEM, V59, P11853, DOI 10.1021/jf202426k; Lei HT, 2011, INVEST OPHTH VIS SCI, V52, P5016, DOI 10.1167/iovs.11-7442; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Lubbers J, 2011, CELL BIOL TOXICOL, V27, P95, DOI 10.1007/s10565-010-9173-3; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; Ong ET, 2011, TOXICOL APPL PHARM, V256, P198, DOI 10.1016/j.taap.2011.08.013; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Penumathsa SV, 2009, CAN J PHYSIOL PHARM, V87, P275, DOI 10.1139/Y09-013; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Powell RJ, 1996, J VASC SURG, V24, P51, DOI 10.1016/S0741-5214(96)70144-1; Praidou A, 2009, CURR EYE RES, V34, P152, DOI 10.1080/02713680802585920; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3649; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; Saishin Y, 2003, INVEST OPHTH VIS SCI, V44, P3656, DOI 10.1167/iovs.02-1143; SCHEIFFARTH OF, 1988, GRAEF ARCH CLIN EXP, V226, P357, DOI 10.1007/BF02172967; Seo MS, 2000, AM J PATHOL, V157, P995, DOI 10.1016/S0002-9440(10)64612-3; SmithThomas L, 1996, CURR EYE RES, V15, P739, DOI 10.3109/02713689609003457; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Tang FY, 2008, MOL NUTR FOOD RES, V52, P683, DOI 10.1002/mnfr.200700325; Venkatesan B, 2009, AM J PHYSIOL-HEART C, V297, pH874, DOI 10.1152/ajpheart.00311.2009; VINORES SA, 1995, EXP EYE RES, V60, P607, DOI 10.1016/S0014-4835(05)80003-X; WAGNER M, 1995, CURR EYE RES, V14, P373, DOI 10.3109/02713689508999935; WALTMAN SR, 1978, DIABETES, V27, P85, DOI 10.2337/diabetes.27.2.85; Wang KT, 2011, J AGR FOOD CHEM, V59, P3649, DOI 10.1021/jf104718g; Xianfeng-Huang, 2011, ANTI-CANCER AGENT ME, V11, P479; Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431; Zheng YP, 2003, JPN J OPHTHALMOL, V47, P158, DOI 10.1016/S0021-5155(02)00698-6	64	70	78	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56819	10.1371/journal.pone.0056819	http://dx.doi.org/10.1371/journal.pone.0056819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457620	Green Published, Green Submitted, gold			2022-12-25	WOS:000315602700096
J	Lee, HY; Seo, JS; Cho, JH; Jung, H; Kim, JK; Lee, JS; Rhee, S; Choi, YD				Lee, Han Yong; Seo, Ju-Seok; Cho, Jang Hee; Jung, Harin; Kim, Ju-Kon; Lee, Jong Seob; Rhee, Sangkee; Choi, Yang Do			Oryza sativa COI Homologues Restore Jasmonate Signal Transduction in Arabidopsis coi1-1 Mutants	PLOS ONE			English	Article							METHYL JASMONATE; TRANSCRIPTION FACTOR; ACID BIOSYNTHESIS; MALE-STERILITY; GENE ENCODES; PROTEINS; DEFENSE	CORONATINE INSENSITIVE 1 (COI1) encodes an E3 ubiquitin ligase complex component that interacts with JAZ proteins and targets them for degradation in response to JA signaling. The Arabidopsis genome has a single copy of COI1, but the Oryza sativa genome has three closely related COI homologs. To examine the functions of the three OsCOIs, we used yeast two-hybrid assays to examine their interactions with JAZ proteins and found that OsCOIs interacted with OsJAZs and with JAZs, in a coronatine dependent manner. We also tested whether OsCOI1a and OsCOI1b could complement Arabidopsis coi1-1 mutants and found that overexpression of either gene in the coi1-1 mutant resulted in restoration of JA signal transduction and production of seeds, indicating successful complementation. Although OsCOI2 interacted with a few OsJAZs, we were not able to successfully complement the coi1-1 mutant with OsCOI2. Molecular modeling revealed that the three OsCOIs adopt 3D structures similar to COI1. Structural differences resulting from amino acid variations, especially among amino acid residues involved in the interaction with coronatine and JAZ proteins, were tested by mutation analysis. When His-391 in OsCOI2 was substituted with Tyr-391, OsCOI2 interacted with a wider range of JAZ proteins, including OsJAZ1, 2, 5 similar to 9 and 11, and complemented coi1-1 mutants at a higher frequency than the other OsCOIs and COI1. These results indicate that the three OsCOIs are orthologues of COI1 and play key roles in JA signaling.	[Lee, Han Yong; Seo, Ju-Seok; Cho, Jang Hee; Rhee, Sangkee; Choi, Yang Do] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Jung, Harin; Kim, Ju-Kon] Myongji Univ, Sch Biotechnol & Environm Engn, Yongin, South Korea; [Lee, Jong Seob] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Seoul National University (SNU); Myongji University; Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	srheesnu@snu.ac.kr; choiyngd@snu.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea through the National Center for GM Crops [PJ008053, PJ007971]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea through the National Center for GM Crops	This work was supported by a grant from the Next-Generation BioGreen 21 Program (project nos. PJ008053 to YDC and PJ007971 to JKK), Rural Development Administration, Republic of Korea through the National Center for GM Crops. A graduate research assistantship to HYL, JSS and HJ from the Brain Korea 21 project of the MOEST is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2010, JASMONATES ARABIDOPS, P1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Carpenter CD, 1998, METH MOL B, V82, P85; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shin B, 2002, PLANT J, V30, P23, DOI 10.1046/j.1365-313X.2002.01264.x; Steiner-Lange S, 2003, PLANT J, V34, P519, DOI 10.1046/j.1365-313X.2003.01745.x; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Ye M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036214	28	70	92	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52802	10.1371/journal.pone.0052802	http://dx.doi.org/10.1371/journal.pone.0052802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320078	Green Submitted, gold, Green Published			2022-12-25	WOS:000313429800020
J	Zhang, Y; Zhang, WN; Lu, K; Ji, RR; Wang, FL; Liu, T				Zhang, Yu; Zhang, Wei-Nan; Lu, Ke; Ji, Rongrong; Wang, Fanglin; Liu, Ting			Phrasal Paraphrase Based Question Reformulation for Archived Question Retrieval	PLOS ONE			English	Article								Lexical gap in cQA search, resulted by the variability of languages, has been recognized as an important and widespread phenomenon. To address the problem, this paper presents a question reformulation scheme to enhance the question retrieval model by fully exploring the intelligence of paraphrase in phrase-level. It compensates for the existing paraphrasing research in a suitable granularity, which either falls into fine-grained lexical-level or coarse-grained sentence-level. Given a question in natural language, our scheme first detects the involved key-phrases by jointly integrating the corpus-dependent knowledge and question-aware cues. Next, it automatically extracts the paraphrases for each identified key-phrase utilizing multiple online translation engines, and then selects the most relevant reformulations from a large group of question rewrites, which is formed by full permutation and combination of the generated paraphrases. Extensive evaluations on a real world data set demonstrate that our model is able to characterize the complex questions and achieves promising performance as compared to the state-of-the-art methods.	[Zhang, Yu; Zhang, Wei-Nan; Liu, Ting] Harbin Inst Technol, Res Ctr Social Comp & Informat Retrieval, Harbin, Heilongjiang, Peoples R China; [Lu, Ke] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ji, Rongrong] Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China; [Wang, Fanglin] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	Harbin Institute of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xiamen University; National University of Singapore	Ji, RR (corresponding author), Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China.	rrji@ee.columbia.edu; hardegg@gmail.com		zhang, longxian/0000-0002-5706-131X; ling, hong/0000-0002-1886-1242; Liu, Jun/0000-0002-0522-6733				[Anonymous], 2006, P LREC; [Anonymous], 2012, P 2012 JOINT C EMP M; Bannard Colin, 2005, P 43 ANN M ASS COMP, P597, DOI [10.3115/1219840.1219914, DOI 10.3115/1219840.1219914]; Barzilay R, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P16; Bendersky M, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P605; Bendersky M, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P941, DOI 10.1145/2348283.2348408; Bendersky Michael, 2010, P 3 ACM INT C WEB SE, P31, DOI [10.1145/1718487.1718492, DOI 10.1145/1718487.1718492]; Bendersky Michael, 2008, P 31 ANN INT ACM SIG, P491, DOI DOI 10.1145/1390334.1390419; Buscaldi D, 2005, CROSS LANG EV FOR CL; CALLAN JP, 1995, INFORM PROCESS MANAG, V31, P327, DOI 10.1016/0306-4573(94)00050-D; Callison-Burch Chris, 2008, P C EMP METH NAT LAN, P196; Chakrabarti D., 2011, P 5 INT AAAI C WEBL, V11, P66; Dinh D, 2011, LECT NOTES COMPUT SC, V6611, P375, DOI 10.1007/978-3-642-20161-5_38; Duclaye F, 2003, P EACL WORKSH NAT LA, P35; Gao Y., 2017, ACM MULTIMEDIA, P1517; Gao Yue, 2010, P INT C MULT, P123; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Grineva Maria, 2009, P 18 INT C WORLD WID, P661, DOI DOI 10.1145/1526709.1526798; Harabagiu S, 2001, P TEXT RETR C QUEST; Harman D., 1988, 11th International Conference on Research and Development in Information Retrieval, P321; Hovy E., 2001, P 10 TEXT RETRIEVAL; Jianfeng Gao, 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P170; Jinxi Xu, 1996, SIGIR Forum, P4; Kai Wang, 2010, P 23 INT C COMP LING, P1155; Lam-Adesina A. M., 2001, SIGIR Forum, P1; Mihalcea R., 2004, P 2004 C EMP METH NA, P404, DOI DOI 10.3115/1219044.1219064; Ponte J. M., 1998, P 21 ANN INT ACM SIG, P275, DOI DOI 10.1145/290941.291008; Riezler S, 2007, P 45 ANN M ASS COMP, V45, P464; Robertson S, 2002, INFORM RETRIEVAL, V5, P239, DOI 10.1023/A:1015702129514; Robertson S. E., 1995, Text REtrieval Conference (TREC-3) (NIST SP 500-225), P109; Robertson SE, 1999, TREC 99, V8; Sang J., 2012, P 20 ACM INT C MULT, P19; Sang JT, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037687; Song F, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P279, DOI 10.1145/312624.312698; Srikanth M., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P425; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang K, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P187, DOI 10.1145/1571941.1571975; Xu J, 2011, P 20 INT C COMP WORL, P153, DOI [10.1145/1963192.1963270, DOI 10.1145/1963192.1963270]; Xue X., 2008, P 31 ANN INT ACM SIG, P475, DOI 10.1145/1390334.1390416; Yang H, 2005, PDCAT 2005: SIXTH INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED COMPUTING, APPLICATIONS AND TECHNOLOGIES, PROCEEDINGS, P40; Yonggang Qiu, 1993, SIGIR Forum, P160; Zhang ST, 2012, LECT NOTES COMPUT SC, V7573, P660, DOI 10.1007/978-3-642-33709-3_47; Zhang ST, 2012, IEEE T SYST MAN CY B, V42, P838, DOI 10.1109/TSMCB.2011.2179533; Zhao S, 2008, P ACL 08, P1021; Zhao SQ, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1795; Zhao Shiqi, 2010, P COL 2010, P1326; Zhao Shiqi, 2009, P JOINT C 47 ANN M A, V2, P834	48	100	109	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e64601	10.1371/journal.pone.0064601	http://dx.doi.org/10.1371/journal.pone.0064601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23977002	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500006
J	Li, X; Yao, XP; Wang, YB; Hu, FL; Wang, F; Jiang, LY; Liu, YP; Wang, D; Sun, GZ; Zhao, YS				Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Wang, Da; Sun, Guizhi; Zhao, Yashuang			MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features	PLOS ONE			English	Article							REVISED BETHESDA GUIDELINES; MICROSATELLITE INSTABILITY; HMLH1 PROMOTER; LYNCH-SYNDROME; COLON-CANCER; INSTITUTE WORKSHOP; GENE METHYLATION; BRAF MUTATION; HEREDITARY; HYPERMETHYLATION	Purpose: To describe the frequency of MLH1 promoter methylation in colorectal cancer (CRC); to explore the associations between MLH1 promoter methylation and clinicopathological and molecular factors using a systematic review and meta-analysis. Methods: A literature search of the PubMed and Embase databases was conducted to identify relevant articles published up to September 7, 2012 that described the frequency of MLH1 promoter methylation or its associations with clinicopathological and molecular factors in CRC. The pooled frequency, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated. Results: The pooled frequency of MLH1 promoter methylation in unselected CRC was 20.3% (95% CI: 16.8-24.1%). They were 18.7% (95% CI: 14.7-23.6%) and 16.4% (95% CI: 11.9-22.0%) in sporadic and Lynch syndrome (LS) CRC, respectively. Significant associations were observed between MLH1 promoter methylation and gender (pooled OR = 1.641, 95% CI: 1.215-2.215; P = 0.001), tumor location (pooled OR = 3.804, 95% CI: 2.715-5.329; P<0.001), tumor differentiation (pooled OR = 2.131, 95% CI: 1.464-3.102; P<0.001), MSI (OR: 27.096, 95% CI: 13.717-53.526; P<0.001). Significant associations were also observed between MLH1 promoter methylation and MLH1 protein expression, BRAF mutation (OR = 14.919 (95% CI: 6.427-34.631; P<0.001) and 9.419 (95% CI: 2.613-33.953; P = 0.001), respectively). Conclusion: The frequency of MLH1 promoter methylation in unselected CRC was 20.3%. They were 18.7% in sporadic CRC and 16.4% in LS CRC, respectively. MLH1 promoter methylation may be significantly associated with gender, tumor location, tumor differentiation, MSI, MLH1 protein expression, and BRAF mutation.	[Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Zhao, Yashuang] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Da] Harbin Med Univ, Dept Sci & Technol Adm, Harbin, Heilongjiang Pr, Peoples R China; [Sun, Guizhi] Harbin Med Univ, Canc Hosp, Dept Surg, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhao, YS (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.	zhao_yashuang@263.net	Wang, Fan/I-6099-2019; Zhao, Yashuang/I-6145-2019; li, xia/HHZ-7468-2022; Li, Xiaobing/B-1267-2019; Liu, YuPeng/P-3181-2018	Wang, Fan/0000-0002-9869-9504; Liu, Guowen/0000-0002-2672-6104; Li, Xiaobing/0000-0001-9105-6365; Liu, YuPeng/0000-0002-8652-1987	National Natural Science Foundation of China for Priority Areas [NSFC 30972538]; Education Bureau of Heilongjiang Province [11531100]; Graduate Foundation; Scientific Research of Heilongjiang Province [YJSCX2009-224HLJ]; Harbin Medical University [HCXB2009009]	National Natural Science Foundation of China for Priority Areas; Education Bureau of Heilongjiang Province; Graduate Foundation; Scientific Research of Heilongjiang Province; Harbin Medical University	This study was supported by grants from National Natural Science Foundation of China for Priority Areas (NSFC 30972538), Education Bureau of Heilongjiang Province (11531100), and the Graduate Foundation, supported by the Scientific Research of Heilongjiang Province (YJSCX2009-224HLJ) and Harbin Medical University (HCXB2009009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Anacleto C, 2005, NEOPLASIA, V7, P331, DOI 10.1593/neo.04502; Arnold CN, 2004, CANCER BIOL THER, V3, P73, DOI 10.4161/cbt.3.1.590; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belshaw NJ, 2004, CANCER EPIDEM BIOMAR, V13, P1495; Bettstetter M, 2007, CLIN CANCER RES, V13, P3221, DOI 10.1158/1078-0432.CCR-06-3064; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boland CR, 1998, CANCER RES, V58, P5248; Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058; Cunningham JM, 1998, CANCER RES, V58, P3455; de Vogel S, 2009, ANN ONCOL, V20, P1216, DOI 10.1093/annonc/mdn782; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Deng GR, 1999, CANCER RES, V59, P2029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dykes SL, 2003, CANCER-AM CANCER SOC, V98, P48, DOI 10.1002/cncr.11445; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fox EJ, 2006, J MOL DIAGN, V8, P68, DOI 10.2353/jmoldx.2006.050084; Garagnani P, 2012, CURR PHARM DES; Gay LJ, 2011, NUTR CANCER, V63, P1000, DOI 10.1080/01635581.2011.596987; Gazzoli I, 2002, CANCER RES, V62, P3925; GLOBOCAN, 2008, CANC FACT SHEET; Grady WM, 2001, CANCER RES, V61, P900; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Q, 2012, DIAGN MOL PATHOL, V21, P24, DOI 10.1097/PDM.0b013e318230effd; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Jass JR, 2002, EUR J CANCER, V38, P858, DOI 10.1016/S0959-8049(02)00041-2; Julie C, 2008, AM J GASTROENTEROL, V103, P2825, DOI 10.1111/j.1572-0241.2008.02084.x; Kane MF, 1997, CANCER RES, V57, P808; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029; Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708; Lee KH, 2011, LANGENBECK ARCH SURG, V396, P1017, DOI 10.1007/s00423-011-0812-9; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Mathers JC, ADV GENET, V71, P3; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Menigatti M, 2001, GENE CHROMOSOME CANC, V31, P357, DOI 10.1002/gcc.1154; Mirchev M, 2007, J IMAB ANN P SCI PAP, P95; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nakagawa H, 2001, CANCER RES, V61, P6991; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Park IJ, 2007, J KOREAN MED SCI, V22, pS91, DOI 10.3346/jkms.2007.22.S.S91; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Potocnik U, 2001, CANCER GENET CYTOGEN, V126, P85, DOI 10.1016/S0165-4608(00)00399-X; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Raedle J, 2001, ANN INTERN MED, V135, P566, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00007; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Shannon BA, 2001, CANCER LETT, V167, P91, DOI 10.1016/S0304-3835(01)00431-1; Shi XZ, 2006, BIOMED CHROMATOGR, V20, P815, DOI 10.1002/bmc.606; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Strazzullo M, 2003, CANCER-AM CANCER SOC, V98, P1540, DOI 10.1002/cncr.11651; Tannergard P, 1997, HUM GENET, V101, P51, DOI 10.1007/s004390050585; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Velayos FS, 2005, J GASTROINTEST SURG, V9, P329, DOI 10.1016/j.gassur.2004.05.007; Vilkin A, 2009, CANCER-AM CANCER SOC, V115, P760, DOI 10.1002/cncr.24019; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Ward R, 2001, GUT, V48, P821, DOI 10.1136/gut.48.6.821; Ward RL, 2005, J PATHOL, V207, P377, DOI 10.1002/path.1851; Yamamoto H, 2002, GENE CHROMOSOME CANC, V33, P322, DOI 10.1002/gcc.10010; Yiu R, 2005, DIS COLON RECTUM, V48, P2061, DOI 10.1007/s10350-005-0171-0; Zhou HH, 2008, WORLD J GASTROENTERO, V14, P7329, DOI 10.3748/wjg.14.7329	78	84	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59064	10.1371/journal.pone.0059064	http://dx.doi.org/10.1371/journal.pone.0059064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23861826	gold, Green Published, Green Submitted			2022-12-25	WOS:000317263900009
